Citrus Sinensis ID: 017334

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370---
Protein Sequence
MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHPEAITANTEVCSS
Secondary Structure (PSIPRED)
cccccccccccccccccEEEEccEEEEEcccccccccccccccEEEEEEEEcccccEEEEEccccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHccHHcccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccEEEEEEEccEEEEEccEEEEEEEEEccccEEEEEEEcccccEEEEEEEccEccccEccHHHHHHHHHHcccccccEccEEEEEccccHHHcccEEEEHHHHHHcHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHcccHHHHcEcccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccHHHHHHcccHHHHHHHHHccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHcccccccccccccccccHHHHHHHHHHHHHHHcccHHHHcHccccc
Coil and Loop (DISEMBL)
matpveppngirspgkhyYSMWQTLFEIdtkyvpikpigrgayGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALkdvmmpshrrnfkdVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYlhsanilhrdlkpgnllvnancdlkicdfglartsngknqfmTEYVVTrwyrapelllccdnygtsidVWSVGCIFAEllgrkpifpgtecLNQLKLIINILGsrreedlefidnpkarkyikslpytpgtpfsrlypdahPLAIDLLQKMlvfdptkrisvtealqhpymsplydpssnppaqvpidldmdeESGEEMIREMMLKEMLHyhpeaitantevcss
Flexible Loop (DISEMBL)
matpveppngirspgkHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVialkdvmmpshRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFglartsngknqFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILgsrreedlefidnpkarkyikslpytpGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHPeaitantevcss
Low Complexity Region (SEG)
MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHPEAITANTEVCSS
Disordered region (IsUnstruct)
***************KHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH*********************************************************
Disordered Region (DISOPRED)
*******************SMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPY****PFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLH***************
Disordered Region (DISEMBL)
MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHPEAITANTEVCSS
Disordered Region (DISPRO)
***********RSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHPEAI*********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHPEAITANTEVCSS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	373	2.2.26 [Sep-21-2011]
Q40517	372	Mitogen-activated protein	N/A	no	0.991	0.994	0.908	0.0
Q40884	384	Mitogen-activated protein	N/A	no	0.981	0.953	0.901	0.0
Q39021	370	Mitogen-activated protein	yes	no	0.991	1.0	0.862	0.0
Q5Z859	369	Mitogen-activated protein	yes	no	0.981	0.991	0.863	0.0
Q6Z437	370	Mitogen-activated protein	no	no	0.981	0.989	0.860	0.0
Q39022	376	Mitogen-activated protein	no	no	0.997	0.989	0.858	0.0
Q39027	368	Mitogen-activated protein	no	no	0.986	1.0	0.828	0.0
O23236	361	Mitogen-activated protein	no	no	0.965	0.997	0.785	1e-173
Q40531	371	Mitogen-activated protein	N/A	no	0.935	0.940	0.594	1e-123
Q84UI5	398	Mitogen-activated protein	no	no	0.916	0.859	0.578	1e-120

>sp|Q40517|NTF3_TOBAC Mitogen-activated protein kinase homolog NTF3 OS=Nicotiana tabacum GN=NTF3 PE=1 SV=1

 Score =  715 bits (1846), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/370 (90%), Positives = 358/370 (96%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNGIR+PGKHYYSMWQ+LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MATPVEPPNGIRTPGKHYYSMWQSLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKINNAFENR+DALRTLRELKLLRHL+HENVIALKDVMMP HRR+FKDVYLVYELMDTDL
Sbjct: 61  KKINNAFENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ L+NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQTLSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTS+GK+QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP+FPGTECL
Sbjct: 181 RTSSGKDQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPVFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+REED+EFIDNPKARKYIKSLPY+PGTPFSRLYP AHPLAIDLLQ+ML
Sbjct: 241 NQLKLIINILGSQREEDIEFIDNPKARKYIKSLPYSPGTPFSRLYPHAHPLAIDLLQRML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISV EALQHPYMSPLYDP+++PPAQVPI+LD+DE+ GEE IREMM  E+L YH
Sbjct: 301 VFDPSKRISVIEALQHPYMSPLYDPNTDPPAQVPINLDIDEDLGEETIREMMWSEILEYH 360

Query: 361 PEAITANTEV 370
           PEA TA  EV
Sbjct: 361 PEAATAAMEV 370

Nicotiana tabacum (taxid: 4097)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q40884|MAPK_PETHY Mitogen-activated protein kinase homolog 1 OS=Petunia hybrida GN=MEK1 PE=2 SV=1

 Score =  705 bits (1819), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/366 (90%), Positives = 356/366 (97%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNGIR+PGKHYYSMWQ+LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MATPVEPPNGIRTPGKHYYSMWQSLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKINNAFENR+DALRTLRELKLLRHL+HENVIALKDVMMP  RR+FKDVYLVYELMDTDL
Sbjct: 61  KKINNAFENRIDALRTLRELKLLRHLRHENVIALKDVMMPIQRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ L+NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQTLSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTS+GK+QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA++LGRKP+FPGTECL
Sbjct: 181 RTSSGKDQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFADVLGRKPVFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+REED+EFIDNPKARKYIKSLPY+PGTPFSRLYP+AHPLAIDLLQ+ML
Sbjct: 241 NQLKLIINILGSQREEDIEFIDNPKARKYIKSLPYSPGTPFSRLYPNAHPLAIDLLQRML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISV EALQHPYMSPLYDP+++PPAQVPI+LD+DE+  EE IREMM +E+LHYH
Sbjct: 301 VFDPSKRISVMEALQHPYMSPLYDPNTDPPAQVPINLDIDEDLVEETIREMMWEEILHYH 360

Query: 361 PEAITA 366
           PEA  A
Sbjct: 361 PEAAVA 366

Petunia hybrida (taxid: 4102)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39021|MPK1_ARATH Mitogen-activated protein kinase 1 OS=Arabidopsis thaliana GN=MPK1 PE=1 SV=2

 Score =  681 bits (1757), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/370 (86%), Positives = 348/370 (94%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MAT V+PPNGIR+ GKHY+SMWQTLFEIDTKY+PIKPIGRGAYG+VCSSVN +TNEKVAI
Sbjct: 1   MATLVDPPNGIRNEGKHYFSMWQTLFEIDTKYMPIKPIGRGAYGVVCSSVNSDTNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+N +ENR+DALRTLRELKLLRHL+HENVIALKDVMMP H+ +FKDVYLVYELMDTDL
Sbjct: 61  KKIHNVYENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHKMSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ L+NDHCQYFLFQLLRGLKY+HSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           R SN K QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF GTECL
Sbjct: 181 RASNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFQGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLI+NILGS+REEDLEFIDNPKA++YI+SLPY+PG   SRLYP AH LAIDLLQKML
Sbjct: 241 NQLKLIVNILGSQREEDLEFIDNPKAKRYIRSLPYSPGMSLSRLYPGAHVLAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISV+EALQHPYM+PLYDP++NPPAQVPIDLD+DE+  EEMIREMM  EMLHYH
Sbjct: 301 VFDPSKRISVSEALQHPYMAPLYDPNANPPAQVPIDLDVDEDLREEMIREMMWNEMLHYH 360

Query: 361 PEAITANTEV 370
           P+A T NTE+
Sbjct: 361 PQASTLNTEL 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q5Z859|MPK4_ORYSJ Mitogen-activated protein kinase 4 OS=Oryza sativa subsp. japonica GN=MPK4 PE=2 SV=1

 Score =  679 bits (1751), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/366 (86%), Positives = 341/366 (93%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MA  V+PPNG+ + GKHYY+MWQTLFEIDTKYVPIKPIGRGAYGIVCSS+NR TNEKVAI
Sbjct: 1   MAMMVDPPNGMGNQGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGIVCSSINRATNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKINN F+NRVDALRTLRELKLLRHL+HENVIALKD+MMP HRR+FKDVYLVYELMDTDL
Sbjct: 61  KKINNVFDNRVDALRTLRELKLLRHLRHENVIALKDIMMPVHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ L+NDHCQYFLFQLLRGLKYLHSA ILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQPLSNDHCQYFLFQLLRGLKYLHSAGILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RT+N K QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL
Sbjct: 181 RTNNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLI+N+LG+  E D+EFIDNPKARKYIK+LPYTPG P + +YP AHPLAIDLLQKML
Sbjct: 241 NQLKLIVNVLGTMSEADIEFIDNPKARKYIKTLPYTPGIPLTSMYPQAHPLAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISVTEAL+HPYMSPLYDPS+NPPAQVPIDLD+DE  G +MIREMM +EMLHYH
Sbjct: 301 VFDPSKRISVTEALEHPYMSPLYDPSANPPAQVPIDLDIDENLGVDMIREMMWQEMLHYH 360

Query: 361 PEAITA 366
           PE +  
Sbjct: 361 PEVVAG 366

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q6Z437|MPK3_ORYSJ Mitogen-activated protein kinase 3 OS=Oryza sativa subsp. japonica GN=MPK3 PE=2 SV=1

 Score =  675 bits (1741), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 315/366 (86%), Positives = 340/366 (92%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MA  V+PPNG+ + GK+YYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSS+NRETNEKVAI
Sbjct: 1   MAIMVDPPNGMGNQGKYYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSINRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+N F+NRVDALRTLRELKLLRHL+HENVIALKD+MMP HRR+FKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFDNRVDALRTLRELKLLRHLRHENVIALKDIMMPVHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKS Q L+NDHCQYFLFQLLRGLKYLHSA ILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSPQGLSNDHCQYFLFQLLRGLKYLHSAEILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RT++ K QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL
Sbjct: 181 RTNSSKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLI+N+LG+  E DLEFIDNPKAR+YIKSLPYTPG P + +YP AHPLAIDLLQKML
Sbjct: 241 NQLKLIVNVLGTMSESDLEFIDNPKARRYIKSLPYTPGVPLASMYPHAHPLAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           +FDPTKRISVTEAL+HPYMSPLYDPS+NPPAQVPIDLD+DE    +MIREMM  EMLHYH
Sbjct: 301 IFDPTKRISVTEALEHPYMSPLYDPSANPPAQVPIDLDIDENISADMIREMMWHEMLHYH 360

Query: 361 PEAITA 366
           PE + A
Sbjct: 361 PEVVAA 366

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39022|MPK2_ARATH Mitogen-activated protein kinase 2 OS=Arabidopsis thaliana GN=MPK2 PE=1 SV=2

 Score =  674 bits (1738), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/374 (85%), Positives = 351/374 (93%), Gaps = 2/374 (0%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPV+PPNGIR+ GKHY+SMWQTLFEIDTKYVPIKPIGRGAYG+VCSSVNRE+NE+VAI
Sbjct: 1   MATPVDPPNGIRNQGKHYFSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSVNRESNERVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+N FENR+DALRTLRELKLLRHL+HENV+ALKDVMM +H+R+FKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRIDALRTLRELKLLRHLRHENVVALKDVMMANHKRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ L+NDHCQYFLFQLLRGLKY+HSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTSN K QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP+FPGTECL
Sbjct: 181 RTSNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPVFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQ+KLIINILGS+REEDLEFIDNPKA++YI+SLPY+PG  FSRLYP A+ LAIDLLQKML
Sbjct: 241 NQIKLIINILGSQREEDLEFIDNPKAKRYIESLPYSPGISFSRLYPGANVLAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPI--DLDMDEESGEEMIREMMLKEMLH 358
           V DP+KRISVTEALQHPYM+PLYDPS+NPPAQVPI  D+D DE+ G EMIRE+M KEM+H
Sbjct: 301 VLDPSKRISVTEALQHPYMAPLYDPSANPPAQVPIDLDVDEDEDLGAEMIRELMWKEMIH 360

Query: 359 YHPEAITANTEVCS 372
           YHPEA T N    S
Sbjct: 361 YHPEAATINNNEVS 374

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39027|MPK7_ARATH Mitogen-activated protein kinase 7 OS=Arabidopsis thaliana GN=MPK7 PE=2 SV=2

 Score =  651 bits (1680), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 305/368 (82%), Positives = 338/368 (91%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MA  VEPPNGI+  GKHYYSMWQTLFEIDTKYVPIKPIGRGAYG+VCSS+NRETNE+VAI
Sbjct: 1   MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+N FENRVDALRTLRELKLLRH++HENVIALKDVM+P++R +FKDVYLVYELMDTDL
Sbjct: 61  KKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ+L++DHC+YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTS G  QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKPIFPGTECL
Sbjct: 181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIIN++GS++E D+ FIDNPKAR++IKSLPY+ GT  S LYP A+PLAIDLLQ+ML
Sbjct: 241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDPTKRISVT+AL HPYM+ L+DP SNPPA VPI LD+DE   E +IREMM  EML+YH
Sbjct: 301 VFDPTKRISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENMEEPVIREMMWNEMLYYH 360

Query: 361 PEAITANT 368
           PEA  +N 
Sbjct: 361 PEAEISNA 368

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|O23236|MPK14_ARATH Mitogen-activated protein kinase 14 OS=Arabidopsis thaliana GN=MPK14 PE=2 SV=1

 Score =  606 bits (1562), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 286/364 (78%), Positives = 328/364 (90%), Gaps = 4/364 (1%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MA  V+PPNGIR  GKHYY+MWQTLFEIDTKYVPIKPIGRGAYG+VCSS+N ETNE+VAI
Sbjct: 1   MAMLVDPPNGIRQEGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINSETNERVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+N FENR+DALRTLRELKLLRH++HENVI+LKDVM+P+HR +F+DVYLVYELMD+DL
Sbjct: 61  KKIHNVFENRIDALRTLRELKLLRHVRHENVISLKDVMLPTHRYSFRDVYLVYELMDSDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           +QIIKSSQ+L++DHC+YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 NQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RT     QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKPIFPGTECL
Sbjct: 181 RTY---EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 237

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIIN++GS+++ DL+FIDN KAR++IKSLP++ GT FS +YP A+PLAIDLLQ+ML
Sbjct: 238 NQLKLIINVVGSQQDWDLQFIDNQKARRFIKSLPFSKGTHFSHIYPHANPLAIDLLQRML 297

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPI-DLDMDEESGEEMIREMMLKEMLHY 359
           VFDPTKRISV++AL HPYM  L +P  NP   VP+  L++DE    +MIREMM +EMLHY
Sbjct: 298 VFDPTKRISVSDALLHPYMEGLLEPECNPSENVPVSSLEIDENMEGDMIREMMWEEMLHY 357

Query: 360 HPEA 363
            P A
Sbjct: 358 LPRA 361

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  443 bits (1139), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 210/353 (59%), Positives = 270/353 (76%), Gaps = 4/353 (1%)

Query: 15  GKHY-YSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD 72
           GK+  Y++    FE+ +KY+P I+P+GRGAYG+VC + N ET E+VAIKKI NAFENR+D
Sbjct: 19  GKYVEYNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSETKEEVAIKKIGNAFENRID 78

Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
           A RTLRE+KLL H+ HEN+I +KD++ P  R  F DVY+VYELMDTDLHQII+SSQALT+
Sbjct: 79  AKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYELMDTDLHQIIRSSQALTD 138

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
           DHCQYFL+QLLRGLKY+HSAN+LHRDLKP NLL+NANCDLKICDFGLART++  + FMTE
Sbjct: 139 DHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEAD-FMTE 197

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
           YVVTRWYRAPELLL C  Y  +ID+WSVGCI  EL+ R+P+FPG +   QL LII +LGS
Sbjct: 198 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFPGRDYAQQLGLIIALLGS 257

Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
             + DL F+ +  ARKY+K LP  P  PFS+ +PD  PLA+DL ++MLVFDP KRI+V +
Sbjct: 258 PEDSDLGFLRSDNARKYVKHLPRVPRHPFSQKFPDVSPLALDLAERMLVFDPAKRITVED 317

Query: 313 ALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHPEAI 364
           AL HP++  L++ +  P    P + D ++ S  E+ I+E++  E L + P  +
Sbjct: 318 ALNHPFLISLHEINEEPVCDSPFNFDFEQASLSEDDIKELIWNEALKFDPNTM 370

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  432 bits (1112), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 200/346 (57%), Positives = 270/346 (78%), Gaps = 4/346 (1%)

Query: 19  YSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL 77
           Y+++  +FE+  KY P I PIG+GAYGIVCS++N ET E+VAIKKI NAF+N++DA RTL
Sbjct: 53  YNIFGNVFEVTAKYKPPILPIGKGAYGIVCSALNSETGEQVAIKKIANAFDNKIDAKRTL 112

Query: 78  RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQY 137
           RE+KLLRH+ HEN++A++D++ P  R +F DVY+ YELMDTDLHQII+S+QAL+ +HCQY
Sbjct: 113 REIKLLRHMDHENIVAIRDIIPPPQRNSFNDVYIAYELMDTDLHQIIRSNQALSEEHCQY 172

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           FL+Q+LRGLKY+HSAN+LHRDLKP NLL+NANCDLKICDFGLART++ +  FMTEYVVTR
Sbjct: 173 FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-ETDFMTEYVVTR 231

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
           WYRAPELLL    Y  +IDVWSVGCIF EL+ RKP+FPG + ++QL+L++ ++G+  E D
Sbjct: 232 WYRAPELLLNSSEYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPNEAD 291

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
           L+F+ N  AR+YI+ LP      F   +P  HPLAIDL++KML FDP +RI+V  AL HP
Sbjct: 292 LDFV-NENARRYIRQLPRHARQSFPEKFPHVHPLAIDLVEKMLTFDPRQRITVEGALAHP 350

Query: 318 YMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHPE 362
           Y++ L+D S  P    P   D ++ +  EE +++++ +E L ++P+
Sbjct: 351 YLASLHDISDEPVCSSPFSFDFEQHALSEEQMKDLIYQEGLAFNPD 396

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	373
449469951	386	PREDICTED: mitogen-activated protein kin	0.991	0.958	0.916	0.0
350539781	372	mitogen-activated protein kinase 9 [Sola	0.989	0.991	0.913	0.0
359492156	371	PREDICTED: mitogen-activated protein kin	0.991	0.997	0.908	0.0
2499614	372	RecName: Full=Mitogen-activated protein	0.991	0.994	0.908	0.0
255538738	372	big map kinase/bmk, putative [Ricinus co	0.997	1.0	0.908	0.0
224066145	372	predicted protein [Populus trichocarpa]	0.991	0.994	0.916	0.0
74231016	372	mitogen-activated protein kinase [Gossyp	0.994	0.997	0.911	0.0
224082906	377	predicted protein [Populus trichocarpa]	0.997	0.986	0.908	0.0
2499612	384	RecName: Full=Mitogen-activated protein	0.981	0.953	0.901	0.0
359806531	371	uncharacterized protein LOC100798863 [Gl	0.994	1.0	0.892	0.0

>gi|449469951|ref|XP_004152682.1| PREDICTED: mitogen-activated protein kinase homolog NTF3-like [Cucumis sativus] gi|449521433|ref|XP_004167734.1| PREDICTED: mitogen-activated protein kinase homolog NTF3-like [Cucumis sativus]

 Score =  718 bits (1853), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/370 (91%), Positives = 357/370 (96%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNG+RS GKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MATPVEPPNGVRSQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           K+I+NAFENR+DALRTLRELKLLRHL+HENVI LKDVMMP HRR+FKDVYLVYELMDTDL
Sbjct: 61  KRIHNAFENRIDALRTLRELKLLRHLRHENVICLKDVMMPIHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct: 121 HQIIKSSQTLTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTSNGKNQFMTEYVVTRWYRAPELLLCC+NYGTSIDVWSVGCIFAELLGRKPIFPGTECL
Sbjct: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCENYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIIN+LGS+REEDLEFIDNPKAR+YIKSLPY+PG P SRLYP AHPLAIDLLQKML
Sbjct: 241 NQLKLIINLLGSQREEDLEFIDNPKARRYIKSLPYSPGAPLSRLYPSAHPLAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISVTEALQHPYMSPLYDP+SNPPAQVPIDL++DEE GEEMIREMM KEMLHYH
Sbjct: 301 VFDPSKRISVTEALQHPYMSPLYDPNSNPPAQVPIDLEIDEELGEEMIREMMWKEMLHYH 360

Query: 361 PEAITANTEV 370
           PE +  + E+
Sbjct: 361 PEDLEEHAEM 370

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350539781|ref|NP_001233761.1| mitogen-activated protein kinase 9 [Solanum lycopersicum] gi|300433305|gb|ADK13095.1| mitogen-activated protein kinase 9 [Solanum lycopersicum]

 Score =  717 bits (1851), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/369 (91%), Positives = 358/369 (97%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNGIRSPGKHYYSMWQ+LFEIDTKYVPIKPIGRGAYGIVCSSVNRE+NEKVAI
Sbjct: 1   MATPVEPPNGIRSPGKHYYSMWQSLFEIDTKYVPIKPIGRGAYGIVCSSVNRESNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKINNAFENRVDALRTLRELKLLRHL+HENVIALKDVMMP HRR+FKDVYLVYELMDTDL
Sbjct: 61  KKINNAFENRVDALRTLRELKLLRHLRHENVIALKDVMMPIHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQI+KSSQ LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIVKSSQTLTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTS+GK+QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP+FPGTECL
Sbjct: 181 RTSSGKDQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPVFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+REEDLEFIDNPKARKYIKSLPY+PGTPFSRLYP AHPLAIDLLQ+ML
Sbjct: 241 NQLKLIINILGSQREEDLEFIDNPKARKYIKSLPYSPGTPFSRLYPQAHPLAIDLLQRML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISV EALQHPYMSPLYDP+++PPAQVPI+LD+DE+ GEE IR+MM  E+LHYH
Sbjct: 301 VFDPSKRISVMEALQHPYMSPLYDPNTDPPAQVPINLDIDEDLGEETIRDMMWTEILHYH 360

Query: 361 PEAITANTE 369
           PEA TA  E
Sbjct: 361 PEAATAAME 369

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359492156|ref|XP_002281075.2| PREDICTED: mitogen-activated protein kinase homolog NTF3-like [Vitis vinifera] gi|147781744|emb|CAN70091.1| hypothetical protein VITISV_030027 [Vitis vinifera]

 Score =  716 bits (1848), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/370 (90%), Positives = 356/370 (96%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNG R  GKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVN+ETNEKVAI
Sbjct: 1   MATPVEPPNGTRCEGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNKETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+NAF+NRVDALRTLRE+KLLRHL+HENVIALKDVMMP HRR+FKDVYLVYELMDTDL
Sbjct: 61  KKIHNAFDNRVDALRTLREIKLLRHLRHENVIALKDVMMPIHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTS GK QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL
Sbjct: 181 RTSTGKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+RE D+EFIDNPKARKYIKSLP++PGTPFSRLYP+AHP+AIDLLQKML
Sbjct: 241 NQLKLIINILGSQREADIEFIDNPKARKYIKSLPFSPGTPFSRLYPNAHPMAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           +FDP+KRI VTEALQHP+MS LYDPS NPPAQVPIDLD+DE+ GEEMIREMM KEMLHYH
Sbjct: 301 IFDPSKRIGVTEALQHPFMSSLYDPSKNPPAQVPIDLDIDEDLGEEMIREMMWKEMLHYH 360

Query: 361 PEAITANTEV 370
           PEA+T+N E 
Sbjct: 361 PEAVTSNGEA 370

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|2499614|sp|Q40517.1|NTF3_TOBAC RecName: Full=Mitogen-activated protein kinase homolog NTF3; AltName: Full=P43 gi|406751|emb|CAA49592.1| NTF3 [Nicotiana tabacum]

 Score =  715 bits (1846), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/370 (90%), Positives = 358/370 (96%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNGIR+PGKHYYSMWQ+LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MATPVEPPNGIRTPGKHYYSMWQSLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKINNAFENR+DALRTLRELKLLRHL+HENVIALKDVMMP HRR+FKDVYLVYELMDTDL
Sbjct: 61  KKINNAFENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ L+NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQTLSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTS+GK+QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP+FPGTECL
Sbjct: 181 RTSSGKDQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPVFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+REED+EFIDNPKARKYIKSLPY+PGTPFSRLYP AHPLAIDLLQ+ML
Sbjct: 241 NQLKLIINILGSQREEDIEFIDNPKARKYIKSLPYSPGTPFSRLYPHAHPLAIDLLQRML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISV EALQHPYMSPLYDP+++PPAQVPI+LD+DE+ GEE IREMM  E+L YH
Sbjct: 301 VFDPSKRISVIEALQHPYMSPLYDPNTDPPAQVPINLDIDEDLGEETIREMMWSEILEYH 360

Query: 361 PEAITANTEV 370
           PEA TA  EV
Sbjct: 361 PEAATAAMEV 370

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255538738|ref|XP_002510434.1| big map kinase/bmk, putative [Ricinus communis] gi|223551135|gb|EEF52621.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  714 bits (1843), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/372 (90%), Positives = 358/372 (96%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNG+   GKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MATPVEPPNGVSIHGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+NAFENRVDALRTLRELKLLRHL+H+NVI L+DVMMP HRR+FKDVYLVYELMDTDL
Sbjct: 61  KKIHNAFENRVDALRTLRELKLLRHLRHDNVIQLRDVMMPIHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQAL+NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQALSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTSNGK QFMTEYVVTRWYRAPELLLCCD YGTSIDVWSVGCIFAELLGRKPIFPGTECL
Sbjct: 181 RTSNGKGQFMTEYVVTRWYRAPELLLCCDYYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+REEDLEFIDNPKA+KYIKSLPY+PGTPFSRLYP+AHPLAIDLL KML
Sbjct: 241 NQLKLIINILGSQREEDLEFIDNPKAKKYIKSLPYSPGTPFSRLYPNAHPLAIDLLLKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRI+VTEALQHPYMSPL+DPSSNPPAQVPIDLD+DE+ GEEMIREMM KE+LHYH
Sbjct: 301 VFDPSKRITVTEALQHPYMSPLFDPSSNPPAQVPIDLDIDEDLGEEMIREMMWKEILHYH 360

Query: 361 PEAITANTEVCS 372
           PEA TA   +C+
Sbjct: 361 PEAATATGLICA 372

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224066145|ref|XP_002302017.1| predicted protein [Populus trichocarpa] gi|222843743|gb|EEE81290.1| predicted protein [Populus trichocarpa]

 Score =  713 bits (1841), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/370 (91%), Positives = 355/370 (95%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNG+R+ GKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRET EKVAI
Sbjct: 1   MATPVEPPNGVRNQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETTEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+NAFENRVDALRTLRELKLLRHL HENVI LKDVMMP  RR+FKDVYLVYELMDTDL
Sbjct: 61  KKIHNAFENRVDALRTLRELKLLRHLLHENVIGLKDVMMPIQRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQALTN+HCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANC+LKICDFGLA
Sbjct: 121 HQIIKSSQALTNEHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCELKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL
Sbjct: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLII+ILGS+REEDLEFIDNPKA+KYIKSLPY+PGTP SRLYP+AHPLAIDLLQKML
Sbjct: 241 NQLKLIISILGSQREEDLEFIDNPKAKKYIKSLPYSPGTPLSRLYPNAHPLAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRI+VT AL+HPYMS LYDPSSNPPAQVPIDLD+DEE GEEMIREMM KEMLHYH
Sbjct: 301 VFDPSKRITVTGALEHPYMSLLYDPSSNPPAQVPIDLDIDEELGEEMIREMMWKEMLHYH 360

Query: 361 PEAITANTEV 370
           PEA   N EV
Sbjct: 361 PEAAAVNGEV 370

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|74231016|gb|ABA00652.1| mitogen-activated protein kinase [Gossypium hirsutum] gi|297748115|gb|ADI52624.1| mitogen-activated protein kinase [Gossypium hirsutum]

 Score =  712 bits (1838), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/371 (91%), Positives = 354/371 (95%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPV+PPNGI   GKHYYSMWQT FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MATPVKPPNGIHYQGKHYYSMWQTTFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKINNAFENRVDALRTLRELKLLRHL+HENVIA KDVMMP+HRR+FKDVYLVYELMDTDL
Sbjct: 61  KKINNAFENRVDALRTLRELKLLRHLRHENVIASKDVMMPTHRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQVLTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTSN K QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL
Sbjct: 181 RTSNAKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS++EEDLEFIDNPKARKYIKSLPY+ G+PFS LYP+AHPLAIDLLQKML
Sbjct: 241 NQLKLIINILGSQKEEDLEFIDNPKARKYIKSLPYSLGSPFSHLYPNAHPLAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISVTEALQHPYM+PLYDP+SNP AQVP+DLD+DE+ GEEMIRE M KEMLHYH
Sbjct: 301 VFDPSKRISVTEALQHPYMAPLYDPNSNPSAQVPLDLDIDEDLGEEMIREKMWKEMLHYH 360

Query: 361 PEAITANTEVC 371
           PEA TAN  VC
Sbjct: 361 PEAATANGGVC 371

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082906|ref|XP_002306886.1| predicted protein [Populus trichocarpa] gi|222856335|gb|EEE93882.1| predicted protein [Populus trichocarpa]

 Score =  712 bits (1838), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/372 (90%), Positives = 355/372 (95%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MA PVEPPNG+R  GKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MAAPVEPPNGVRIQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI+NAFENRVDALRTLRELKLLRHL+HENVIALKDVMMP+ RR+F DVYLVYELMDTDL
Sbjct: 61  KKIHNAFENRVDALRTLRELKLLRHLRHENVIALKDVMMPTQRRSFNDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQAL+NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQALSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTSNG NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL
Sbjct: 181 RTSNGNNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+ EEDLEFIDN KA+KYIKSLPY+PGTPFS LYP+AHPLAIDLLQKML
Sbjct: 241 NQLKLIINILGSQSEEDLEFIDNMKAKKYIKSLPYSPGTPFSHLYPNAHPLAIDLLQKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           +FDP+KRI+VT AL+HPYMSPLYDPS NPPAQVPIDLD+DEE GEEMIREMM KEML YH
Sbjct: 301 IFDPSKRITVTGALEHPYMSPLYDPSCNPPAQVPIDLDIDEELGEEMIREMMWKEMLLYH 360

Query: 361 PEAITANTEVCS 372
           PEA  AN EVC+
Sbjct: 361 PEAAAANGEVCA 372

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|2499612|sp|Q40884.1|MAPK_PETHY RecName: Full=Mitogen-activated protein kinase homolog 1; AltName: Full=PMEK1 gi|603871|emb|CAA58466.1| MAP/ERK kinase 1 [Petunia x hybrida]

 Score =  705 bits (1819), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 330/366 (90%), Positives = 356/366 (97%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNGIR+PGKHYYSMWQ+LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MATPVEPPNGIRTPGKHYYSMWQSLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKINNAFENR+DALRTLRELKLLRHL+HENVIALKDVMMP  RR+FKDVYLVYELMDTDL
Sbjct: 61  KKINNAFENRIDALRTLRELKLLRHLRHENVIALKDVMMPIQRRSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQ L+NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQTLSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RTS+GK+QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA++LGRKP+FPGTECL
Sbjct: 181 RTSSGKDQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFADVLGRKPVFPGTECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+REED+EFIDNPKARKYIKSLPY+PGTPFSRLYP+AHPLAIDLLQ+ML
Sbjct: 241 NQLKLIINILGSQREEDIEFIDNPKARKYIKSLPYSPGTPFSRLYPNAHPLAIDLLQRML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDP+KRISV EALQHPYMSPLYDP+++PPAQVPI+LD+DE+  EE IREMM +E+LHYH
Sbjct: 301 VFDPSKRISVMEALQHPYMSPLYDPNTDPPAQVPINLDIDEDLVEETIREMMWEEILHYH 360

Query: 361 PEAITA 366
           PEA  A
Sbjct: 361 PEAAVA 366

Source: Petunia x hybrida

Species: Petunia x hybrida

Genus: Petunia

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359806531|ref|NP_001241004.1| uncharacterized protein LOC100798863 [Glycine max] gi|255637091|gb|ACU18877.1| unknown [Glycine max]

 Score =  704 bits (1817), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/371 (89%), Positives = 353/371 (95%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MATPVEPPNGIR+ GKHYYSMWQTLFE D+KYVPIKPIGRGAYGIVCSSVNRETNEKVAI
Sbjct: 1   MATPVEPPNGIRTEGKHYYSMWQTLFEFDSKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           KKI NAFENRVDALRTLRELKLLRHL HENVIALKD+MMP HR +FKDVYLVYELMDTDL
Sbjct: 61  KKIQNAFENRVDALRTLRELKLLRHLHHENVIALKDIMMPVHRNSFKDVYLVYELMDTDL 120

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           HQIIKSSQAL+NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL+NANCDLKICDFGLA
Sbjct: 121 HQIIKSSQALSNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLINANCDLKICDFGLA 180

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           RT+  KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG+ECL
Sbjct: 181 RTNCSKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGSECL 240

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
           NQLKLIINILGS+REED+EFIDNPKA+KYIKSLPY+PG+PFSRLYP+AHPLAIDLL KML
Sbjct: 241 NQLKLIINILGSQREEDIEFIDNPKAKKYIKSLPYSPGSPFSRLYPNAHPLAIDLLAKML 300

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
           VFDPTKRISVTEALQHPYM+PLYDP+ +PPA +PIDLD+DE+ GEEMIREMM KEMLHYH
Sbjct: 301 VFDPTKRISVTEALQHPYMAPLYDPNCDPPAVIPIDLDIDEDLGEEMIREMMWKEMLHYH 360

Query: 361 PEAITANTEVC 371
           PE+   N  +C
Sbjct: 361 PESAMENAGLC 371

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	373
TAIR|locus:2202892	376	MPK2 "mitogen-activated protei	0.997	0.989	0.860	1.1e-179
TAIR|locus:2012808	370	MPK1 "mitogen-activated protei	0.991	1.0	0.862	4.5e-178
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.983	0.997	0.831	5e-170
TAIR|locus:2115445	361	MPK14 "mitogen-activated prote	0.965	0.997	0.785	4.8e-158
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.916	0.865	0.583	5.8e-114
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.943	0.936	0.565	1.6e-111
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.911	0.936	0.586	2.6e-111
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.916	0.924	0.588	6.8e-111
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.927	0.920	0.577	4.8e-110
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.941	0.951	0.553	1.4e-105

TAIR|locus:2202892 MPK2 "mitogen-activated protein kinase homolog 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1744 (619.0 bits), Expect = 1.1e-179, P = 1.1e-179
 Identities = 322/374 (86%), Positives = 352/374 (94%)

Query:     1 MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
             MATPV+PPNGIR+ GKHY+SMWQTLFEIDTKYVPIKPIGRGAYG+VCSSVNRE+NE+VAI
Sbjct:     1 MATPVDPPNGIRNQGKHYFSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSVNRESNERVAI 60

Query:    61 KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
             KKI+N FENR+DALRTLRELKLLRHL+HENV+ALKDVMM +H+R+FKDVYLVYELMDTDL
Sbjct:    61 KKIHNVFENRIDALRTLRELKLLRHLRHENVVALKDVMMANHKRSFKDVYLVYELMDTDL 120

Query:   121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
             HQIIKSSQ L+NDHCQYFLFQLLRGLKY+HSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct:   121 HQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query:   181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
             RTSN K QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP+FPGTECL
Sbjct:   181 RTSNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPVFPGTECL 240

Query:   241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
             NQ+KLIINILGS+REEDLEFIDNPKA++YI+SLPY+PG  FSRLYP A+ LAIDLLQKML
Sbjct:   241 NQIKLIINILGSQREEDLEFIDNPKAKRYIESLPYSPGISFSRLYPGANVLAIDLLQKML 300

Query:   301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES--GEEMIREMMLKEMLH 358
             V DP+KRISVTEALQHPYM+PLYDPS+NPPAQVPIDLD+DE+   G EMIRE+M KEM+H
Sbjct:   301 VLDPSKRISVTEALQHPYMAPLYDPSANPPAQVPIDLDVDEDEDLGAEMIRELMWKEMIH 360

Query:   359 YHPEAITANTEVCS 372
             YHPEA T N    S
Sbjct:   361 YHPEAATINNNEVS 374

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

TAIR|locus:2012808 MPK1 "mitogen-activated protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1729 (613.7 bits), Expect = 4.5e-178, P = 4.5e-178
 Identities = 319/370 (86%), Positives = 348/370 (94%)

Query:     1 MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
             MAT V+PPNGIR+ GKHY+SMWQTLFEIDTKY+PIKPIGRGAYG+VCSSVN +TNEKVAI
Sbjct:     1 MATLVDPPNGIRNEGKHYFSMWQTLFEIDTKYMPIKPIGRGAYGVVCSSVNSDTNEKVAI 60

Query:    61 KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
             KKI+N +ENR+DALRTLRELKLLRHL+HENVIALKDVMMP H+ +FKDVYLVYELMDTDL
Sbjct:    61 KKIHNVYENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHKMSFKDVYLVYELMDTDL 120

Query:   121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
             HQIIKSSQ L+NDHCQYFLFQLLRGLKY+HSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct:   121 HQIIKSSQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query:   181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
             R SN K QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF GTECL
Sbjct:   181 RASNTKGQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFQGTECL 240

Query:   241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
             NQLKLI+NILGS+REEDLEFIDNPKA++YI+SLPY+PG   SRLYP AH LAIDLLQKML
Sbjct:   241 NQLKLIVNILGSQREEDLEFIDNPKAKRYIRSLPYSPGMSLSRLYPGAHVLAIDLLQKML 300

Query:   301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
             VFDP+KRISV+EALQHPYM+PLYDP++NPPAQVPIDLD+DE+  EEMIREMM  EMLHYH
Sbjct:   301 VFDPSKRISVSEALQHPYMAPLYDPNANPPAQVPIDLDVDEDLREEMIREMMWNEMLHYH 360

Query:   361 PEAITANTEV 370
             P+A T NTE+
Sbjct:   361 PQASTLNTEL 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006635 "fatty acid beta-oxidation" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0008219 "cell death" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009737 "response to abscisic acid stimulus" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009755 "hormone-mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0016558 "protein import into peroxisome matrix" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0009734 "auxin mediated signaling pathway" evidence=TAS

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1653 (586.9 bits), Expect = 5.0e-170, P = 5.0e-170
 Identities = 305/367 (83%), Positives = 338/367 (92%)

Query:     1 MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
             MA  VEPPNGI+  GKHYYSMWQTLFEIDTKYVPIKPIGRGAYG+VCSS+NRETNE+VAI
Sbjct:     1 MAMLVEPPNGIKQQGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINRETNERVAI 60

Query:    61 KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
             KKI+N FENRVDALRTLRELKLLRH++HENVIALKDVM+P++R +FKDVYLVYELMDTDL
Sbjct:    61 KKIHNVFENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDL 120

Query:   121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
             HQIIKSSQ+L++DHC+YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct:   121 HQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query:   181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
             RTS G  QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKPIFPGTECL
Sbjct:   181 RTSQGNEQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 240

Query:   241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
             NQLKLIIN++GS++E D+ FIDNPKAR++IKSLPY+ GT  S LYP A+PLAIDLLQ+ML
Sbjct:   241 NQLKLIINVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRML 300

Query:   301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYH 360
             VFDPTKRISVT+AL HPYM+ L+DP SNPPA VPI LD+DE   E +IREMM  EML+YH
Sbjct:   301 VFDPTKRISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDENMEEPVIREMMWNEMLYYH 360

Query:   361 PEAITAN 367
             PEA  +N
Sbjct:   361 PEAEISN 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2115445 MPK14 "mitogen-activated protein kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 1540 (547.2 bits), Expect = 4.8e-158, P = 4.8e-158
 Identities = 286/364 (78%), Positives = 328/364 (90%)

Query:     1 MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
             MA  V+PPNGIR  GKHYY+MWQTLFEIDTKYVPIKPIGRGAYG+VCSS+N ETNE+VAI
Sbjct:     1 MAMLVDPPNGIRQEGKHYYTMWQTLFEIDTKYVPIKPIGRGAYGVVCSSINSETNERVAI 60

Query:    61 KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
             KKI+N FENR+DALRTLRELKLLRH++HENVI+LKDVM+P+HR +F+DVYLVYELMD+DL
Sbjct:    61 KKIHNVFENRIDALRTLRELKLLRHVRHENVISLKDVMLPTHRYSFRDVYLVYELMDSDL 120

Query:   121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
             +QIIKSSQ+L++DHC+YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA
Sbjct:   121 NQIIKSSQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180

Query:   181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
             RT     QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE+LGRKPIFPGTECL
Sbjct:   181 RTYE---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECL 237

Query:   241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML 300
             NQLKLIIN++GS+++ DL+FIDN KAR++IKSLP++ GT FS +YP A+PLAIDLLQ+ML
Sbjct:   238 NQLKLIINVVGSQQDWDLQFIDNQKARRFIKSLPFSKGTHFSHIYPHANPLAIDLLQRML 297

Query:   301 VFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPID-LDMDEESGEEMIREMMLKEMLHY 359
             VFDPTKRISV++AL HPYM  L +P  NP   VP+  L++DE    +MIREMM +EMLHY
Sbjct:   298 VFDPTKRISVSDALLHPYMEGLLEPECNPSENVPVSSLEIDENMEGDMIREMMWEEMLHY 357

Query:   360 HPEA 363
              P A
Sbjct:   358 LPRA 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1124 (400.7 bits), Expect = 5.8e-114, P = 5.8e-114
 Identities = 202/346 (58%), Positives = 274/346 (79%)

Query:    19 YSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL 77
             Y+++  +FE+  KY P I PIG+GAYGIVCS++N ETNE VAIKKI NAF+N++DA RTL
Sbjct:    49 YNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSAMNSETNESVAIKKIANAFDNKIDAKRTL 108

Query:    78 RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQY 137
             RE+KLLRH+ HEN++A++D++ P  R  F DVY+ YELMDTDLHQII+S+QAL+ +HCQY
Sbjct:   109 REIKLLRHMDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQY 168

Query:   138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
             FL+Q+LRGLKY+HSAN+LHRDLKP NLL+NANCDLKICDFGLAR ++ ++ FMTEYVVTR
Sbjct:   169 FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ESDFMTEYVVTR 227

Query:   198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
             WYRAPELLL   +Y  +IDVWSVGCIF EL+ RKP+FPG + ++QL+L++ ++G+  EE+
Sbjct:   228 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEE 287

Query:   258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
             LEF+ N  A++YI+ LP  P    +  +P  HPLAIDL++KML FDP +RI+V +AL HP
Sbjct:   288 LEFL-NENAKRYIRQLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHP 346

Query:   318 YMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHPE 362
             Y++ L+D S  P   +P + D +  +  EE ++E++ +E L ++PE
Sbjct:   347 YLNSLHDISDEPECTIPFNFDFENHALSEEQMKELIYREALAFNPE 392

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1101 (392.6 bits), Expect = 1.6e-111, P = 1.6e-111
 Identities = 202/357 (56%), Positives = 275/357 (77%)

Query:    10 GIRSPGKHY--YSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNA 66
             G+ + G  Y  Y+++  LFE+  KYVP ++PIGRGAYGIVC++ N ET E+VAIKKI NA
Sbjct:    18 GVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAATNSETGEEVAIKKIGNA 77

Query:    67 FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS 126
             F+N +DA RTLRE+KLL+H+ HENVIA+KD++ P  R NF DVY+VYELMDTDLHQII+S
Sbjct:    78 FDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRS 137

Query:   127 SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK 186
             +Q LT+DHC++FL+QLLRGLKY+HSAN+LHRDLKP NLL+NANCDLK+ DFGLART + +
Sbjct:   138 NQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKS-E 196

Query:   187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI 246
               FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI  E + R+P+FPG + ++QL+LI
Sbjct:   197 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLI 256

Query:   247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK 306
               ++GS  +  L F+ +  AR+Y++ LP  P   F+  +P+    A+DLL+KMLVFDP++
Sbjct:   257 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSR 316

Query:   307 RISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHPE 362
             RI+V EAL HPY++PL+D +  P    P + D ++ +  EE I+E++ +E + ++P+
Sbjct:   317 RITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
 Identities = 201/343 (58%), Positives = 266/343 (77%)

Query:    19 YSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL 77
             Y++   +FE+ +KY+P I+PIGRGAYGIVC + N ETNE+VAIKKI NAF+NRVDA RTL
Sbjct:    19 YNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKIANAFDNRVDAKRTL 78

Query:    78 RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQY 137
             RE+KLL H+ H+NVI +KD++    +  F+DVY+VYELMDTDLHQII+S+Q LT+DHCQY
Sbjct:    79 REIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQY 138

Query:   138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
             FL+Q+LRGLKY+HSAN+LHRDLKP NL++N NCDLKICDFGLARTSN + + MTEYVVTR
Sbjct:   139 FLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSN-ETEIMTEYVVTR 197

Query:   198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
             WYRAPELLL    Y  +ID+WSVGCIF E+L R+ +FPG + + QLKLI  +LGS  + D
Sbjct:   198 WYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSD 257

Query:   258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
             L+F+ +  ARKY+K LP+     F   +P+  P+A+DL +KMLVFDP+KRI+V EAL+ P
Sbjct:   258 LDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQP 317

Query:   318 YMSPLYDPSSNPPAQVPIDLDMDEESGEEM-IREMMLKEMLHY 359
             Y++ L++ +  P    P   D +E + +E  I+E++ +E LH+
Sbjct:   318 YLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1095 (390.5 bits), Expect = 6.8e-111, P = 6.8e-111
 Identities = 203/345 (58%), Positives = 268/345 (77%)

Query:    19 YSMWQTLFEIDTKY-VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL 77
             Y ++ +LFEI +KY  PI PIGRGAYGIVCS ++ ETNE VA+KKI NAF+N +DA RTL
Sbjct:    24 YDIFGSLFEITSKYRPPIIPIGRGAYGIVCSVLDTETNELVAMKKIANAFDNHMDAKRTL 83

Query:    78 RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQY 137
             RE+KLLRHL HEN+IA++DV+ P  RR F DVY+  ELMDTDLHQII+S+Q+L+ +HCQY
Sbjct:    84 REIKLLRHLDHENIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQY 143

Query:   138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
             FL+QLLRGLKY+HSANI+HRDLKP NLL+NANCDLKICDFGLAR ++ +N FMTEYVVTR
Sbjct:   144 FLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKICDFGLARPTS-ENDFMTEYVVTR 202

Query:   198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
             WYRAPELLL   +Y  +IDVWSVGCIF EL+ RKP+FPG + ++Q++L+  +LG+  E D
Sbjct:   203 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESD 262

Query:   258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
             L F  N  A++YI+ LP  P  P ++L+   +P+AIDL+ +ML FDP +RI+V +AL H 
Sbjct:   263 LGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQ 322

Query:   318 YMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHP 361
             Y++ L+DP+  P  Q P   + +++   EE I+EM+ +E +  +P
Sbjct:   323 YLAKLHDPNDEPICQKPFSFEFEQQPLDEEQIKEMIYQEAIALNP 367

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1087 (387.7 bits), Expect = 4.8e-110, P = 4.8e-110
 Identities = 202/350 (57%), Positives = 273/350 (78%)

Query:    15 GKHY-YSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD 72
             G+++ Y+++  LFE+  KYVP I+PIGRGAYG VC++V+ ET+E++AIKKI  AF+N+VD
Sbjct:    24 GRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSETHEEIAIKKIGKAFDNKVD 83

Query:    73 ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
             A RTLRE+KLLRHL+HENV+ +KD++ P  + +F DVY+V+ELMDTDLHQII+S+Q+L +
Sbjct:    84 AKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLND 143

Query:   133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
             DHCQYFL+Q+LRGLKY+HSAN+LHRDLKP NLL+N+NCDLKI DFGLART++ + ++MTE
Sbjct:   144 DHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTS-ETEYMTE 202

Query:   193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
             YVVTRWYRAPELLL    Y ++IDVWSVGCIFAE++ R+P+FPG + ++QLKLI  ++GS
Sbjct:   203 YVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELIGS 262

Query:   253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                  LEF+ +  ARKY+K LP  P   FS  +P  +  AIDLL+KMLVFDP KRI+V E
Sbjct:   263 PDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPVKRITVEE 322

Query:   313 ALQHPYMSPLYDPSSNPPAQVPIDLDMDEESG-EEMIREMMLKEMLHYHP 361
             AL +PY+S L+D +  P          ++ S  EE I+E++  E + ++P
Sbjct:   323 ALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIKELVWLESVKFNP 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
 Identities = 197/356 (55%), Positives = 265/356 (74%)

Query:    10 GIRSPGKHY--YSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNA 66
             G+   G  Y  Y+++  LFE+  KYVP ++PIGRGA GIVC++ N ET E+VAIKKI NA
Sbjct:    15 GVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKIGNA 74

Query:    67 FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS 126
             F N +DA RTLRE+KLL+H+ H+NVIA+ D++ P    NF DV++VYELMDTDLH II+S
Sbjct:    75 FGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIRS 134

Query:   127 SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK 186
             +Q LT+DH ++FL+QLLRGLKY+HSAN+LHRDLKP NLL+NANCDLKI DFGLART + +
Sbjct:   135 NQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKS-E 193

Query:   187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI 246
               FMTEYVVTRWYRAPELLL C  Y  +ID+WSVGCI  E++ R+P+FPG + + QL+LI
Sbjct:   194 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLI 253

Query:   247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK 306
               ++GS  +  L F+ +  AR+Y++ LP  P   F+  +P+    A+DLLQKMLVFDP +
Sbjct:   254 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNR 313

Query:   307 RISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHP 361
             RI+V EAL HPY++PL++ +  P    P   D ++ S  EE I+E++ +E + ++P
Sbjct:   314 RITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.5949	0.9356	0.9407	N/A	no
Q40884	MAPK_PETHY	2, ., 7, ., 1, 1, ., 2, 4	0.9016	0.9812	0.9531	N/A	no
Q6Z437	MPK3_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8606	0.9812	0.9891	no	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.5686	0.9436	0.9487	N/A	no
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.5751	0.9168	0.8680	N/A	no
O23236	MPK14_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.7857	0.9651	0.9972	no	no
P40417	ERKA_DROME	2, ., 7, ., 1, 1, ., 2, 4	0.5014	0.8927	0.7816	yes	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.5478	0.9168	0.9268	N/A	no
P42525	ERK1_DICDI	2, ., 7, ., 1, 1, ., 2, 4	0.5375	0.9222	0.6502	yes	no
Q5Z859	MPK4_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8633	0.9812	0.9918	yes	no
P28482	MK01_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.5043	0.8981	0.9305	yes	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.5498	0.9624	0.9134	N/A	no
Q40517	NTF3_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.9081	0.9919	0.9946	N/A	no
P16892	FUS3_YEAST	2, ., 7, ., 1, 1, ., 2, 4	0.5163	0.7855	0.8300	yes	no
P26696	MK01_XENLA	2, ., 7, ., 1, 1, ., 2, 4	0.5058	0.8954	0.9252	N/A	no
Q39027	MPK7_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8288	0.9865	1.0	no	no
Q39022	MPK2_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8582	0.9973	0.9893	no	no
Q39021	MPK1_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8621	0.9919	1.0	yes	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.4957	0.9061	0.9086	yes	no
P63085	MK01_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.5043	0.8981	0.9357	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.5606	0.9624	0.9276	N/A	no
P63086	MK01_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.5043	0.8981	0.9357	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.993
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	373
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	0.0
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-166
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-155
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-151
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-146
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-137
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-131
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-125
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-122
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-115
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-114
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-113
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-113
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-110
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-108
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-105
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-105
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-96
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-95
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-94
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-93
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-92
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-89
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-87
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-87
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-87
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-86
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-82
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-81
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-80
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-77
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-77
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-77
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-76
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-75
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-74
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-73
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-72
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-72
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-71
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-71
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-69
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-68
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-68
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-66
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-66
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-61
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-59
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-59
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-57
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-57
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-56
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-56
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-54
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-52
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-47
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-46
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-46
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-45
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-43
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-40
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-39
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-37
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-37
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-36
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-34
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-33
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-33
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-33
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-30
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-29
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-28
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-27
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-27
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-27
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-27
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-26
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-26
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-26
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-25
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-25
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-24
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-24
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-24
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-23
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-22
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-21
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-21
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-20
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-20
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-18
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-18
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-18
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-16
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-14
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-13
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-13
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-11
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-10
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-07
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	6e-04
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.001
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.002
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.002
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.002
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.003
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	0.003

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  699 bits (1806), Expect = 0.0
 Identities = 247/337 (73%), Positives = 287/337 (85%), Gaps = 1/337 (0%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           FE+DTKYVPIKPIGRGAYGIVCS+ N ETNEKVAIKKI NAF+NR+DA RTLRE+KLLRH
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
           L HENVIA+KD+M P HR  F DVY+VYELMDTDLHQII+SSQ L++DHCQYFL+QLLRG
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG 120

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           LKY+HSAN+LHRDLKP NLL+NANCDLKICDFGLART++ K  FMTEYVVTRWYRAPELL
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           L C  Y T+IDVWSVGCIFAELLGRKP+FPG + ++QLKLI  +LGS  EEDL FI N K
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           AR+YI+SLPYTP   F+RL+P A+PLAIDLL+KMLVFDP+KRI+V EAL HPY++ L+DP
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300

Query: 326 SSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHP 361
           S  P  Q P   D +E++  EE I+E++  EML YHP
Sbjct: 301 SDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  559 bits (1444), Expect = 0.0
 Identities = 198/330 (60%), Positives = 255/330 (77%), Gaps = 5/330 (1%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +KPIG GAYG+VCS+V++ T  KVAIKKI+N F++ +DA R LRE+KLLRHL+HEN
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +I L D++ P    +F DVY+V ELM+TDLH++IKS Q LT+DH QYFL+Q+LRGLKYLH
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNG---KNQFMTEYVVTRWYRAPELLLC 207
           SAN++HRDLKP N+LVN+NCDLKICDFGLAR  +    +  F+TEYVVTRWYRAPELLL 
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
              Y  +ID+WSVGCIFAELL RKP+FPG + ++QL LI+ +LG+  EEDL+FI + KAR
Sbjct: 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSS 327
            Y+KSLP  P  P S+L+P A P AIDLL+KMLVFDP KRI+  EAL HPY++ L+DP  
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300

Query: 328 NPPAQVPIDLDMDEESG--EEMIREMMLKE 355
            P A+ P D D  ++    EE ++E++ +E
Sbjct: 301 EPVAKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  468 bits (1207), Expect = e-166
 Identities = 173/319 (54%), Positives = 234/319 (73%), Gaps = 5/319 (1%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F++  +Y  +  IG GAYG+VCS+ ++ T  KVAIKKI+  FE++    RTLRE+K+LR 
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRR 59

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            +HEN+I + D++ P    +F DVY+V ELM+TDL+++IK+ Q L+NDH QYFL+Q+LRG
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRG 118

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKN-QFMTEYVVTRWYRAP 202
           LKY+HSAN+LHRDLKP NLL+N NCDLKICDFGLAR       +  F+TEYV TRWYRAP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  +ID+WSVGCI AE+L  +P+FPG + L+QL LI+ +LG+  +EDL  I 
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
           + +AR YIKSLP+ P  P+++L+P+A P A+DLL KML F+P KRI+V EAL HPY+   
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298

Query: 323 YDPSSNPPAQVPIDLDMDE 341
           +DPS  P A+ P   D + 
Sbjct: 299 HDPSDEPVAEEPFPFDFEL 317

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  440 bits (1134), Expect = e-155
 Identities = 178/335 (53%), Positives = 247/335 (73%), Gaps = 6/335 (1%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F++ ++Y PI+ IG GAYG+VCS+++  + +KVAIKKI +AF+    A RTLRELK+LRH
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH 60

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            +H+N+IA++D++ P    +FKDVY+V +LM++DLH II S Q LT +H +YFL+QLLRG
Sbjct: 61  FKHDNIIAIRDILRPP-GADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGKNQFMTEYVVTRWYRA 201
           LKY+HSAN++HRDLKP NLLVN +C+L+I DFG+AR    +      FMTEYV TRWYRA
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PELLL    Y T+ID+WSVGCIFAE+LGR+ +FPG   ++QLKLI+++LGS  EE L  I
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            + + RKYI++LP     P+S+++P A P A+DLL +ML FDP +RI+V +ALQHP+++ 
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299

Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKE 355
            +DP   P    P D D +  E   E ++E ++KE
Sbjct: 300 YHDPDDEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  428 bits (1103), Expect = e-151
 Identities = 165/346 (47%), Positives = 238/346 (68%), Gaps = 5/346 (1%)

Query: 17  HYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT 76
           +   + +T++E+  +Y  + P+G GAYG VCS+ + +T  KVAIKK++  F++ + A RT
Sbjct: 2   YRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT 61

Query: 77  LRELKLLRHLQHENVIALKDVMMP-SHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHC 135
            REL+LL+H+ HENVI L DV  P S   +F+DVYLV  LM  DL+ I+K  Q L++DH 
Sbjct: 62  YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHI 120

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV 195
           Q+ ++Q+LRGLKY+HSA I+HRDLKP N+ VN +C+LKI DFGLAR ++ +   MT YV 
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVA 177

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           TRWYRAPE++L   +Y  ++D+WSVGCI AELL  K +FPG++ ++QLK I+N++G+  E
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
           E L+ I +  AR YI+SLP  P   F  ++  A+PLAIDLL+KMLV DP KRI+  EAL 
Sbjct: 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297

Query: 316 HPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHP 361
           HPY++  +DP   P A          +   +  +E++ KE++++ P
Sbjct: 298 HPYLAEYHDPEDEPVAPPYDQSFESRDLTVDEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  416 bits (1070), Expect = e-146
 Identities = 186/328 (56%), Positives = 242/328 (73%), Gaps = 8/328 (2%)

Query: 35  IKPIGRGAYGIVCSSVNRETN--EKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENV 91
           IK +G+GAYGIVCS+ N ET+  E VAIKKI N F  ++ A R LRELKLLRH + H+N+
Sbjct: 5   IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
             L D+ +     NF ++YL  ELM+ DLHQII+S Q LT+ H Q F++Q+L GLKY+HS
Sbjct: 65  TCLYDMDIVFPG-NFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS 123

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSN---GKNQ-FMTEYVVTRWYRAPELLLC 207
           AN+LHRDLKPGNLLVNA+C+LKICDFGLAR  +   G+N  FMTEYV TRWYRAPE++L 
Sbjct: 124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
             +Y  +IDVWSVGCI AELLGRKP+F G + ++QL  I+ +LG+  EE L  I +PKA+
Sbjct: 184 FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQ 243

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSS 327
            YI+SLP  P  PF  ++P+A+PLA+DLL+K+L FDPTKRISV EAL+HPY++  +DP  
Sbjct: 244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDD 303

Query: 328 NPPAQVPIDLDMDEESGEEMIREMMLKE 355
            P  Q P D   + E   E +R+M+++E
Sbjct: 304 EPVCQKPFDFSFESEDSMEELRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  394 bits (1014), Expect = e-137
 Identities = 165/331 (49%), Positives = 230/331 (69%), Gaps = 7/331 (2%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG+G+YG+VCS+++  T EKVAIKKIN+ FE+  DA R LRE+KLLR L+H +++ +K +
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
           M+P  RR FKD+Y+V+ELM++DLHQ+IK++  LT +H Q+FL+QLLR LKY+H+AN+ HR
Sbjct: 68  MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHR 127

Query: 158 DLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELLLCC-DNYGT 213
           DLKP N+L NA+C LKICDFGLAR +        F T+YV TRWYRAPEL       Y  
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 187

Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL 273
           +ID+WS+GCIFAE+L  KP+FPG   ++QL LI ++LG+   E +  + N KAR+Y+ S+
Sbjct: 188 AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSM 247

Query: 274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQV 333
                 PFS+ +P+A PLA+ LL+++L FDP  R +  EAL  PY   L      P AQ 
Sbjct: 248 RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQP 307

Query: 334 PIDLDMDEES---GEEMIREMMLKEMLHYHP 361
              L+ + E     +E +RE++ +E+L YHP
Sbjct: 308 ITKLEFEFERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  379 bits (976), Expect = e-131
 Identities = 150/322 (46%), Positives = 215/322 (66%), Gaps = 10/322 (3%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
            I  KY  ++ +G+GAYGIV  +++R T E VA+KKI +AF N  DA RT RE+  L+ L
Sbjct: 4   HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL 63

Query: 87  -QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
             H N++ L +V+      N KD+YLV+E M+TDLH +I+++  L + H +Y ++QLL+ 
Sbjct: 64  GDHPNIVKLLNVIKAE---NDKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKA 119

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYR 200
           LKY+HS N++HRDLKP N+L+N++C +K+ DFGLAR+      N +N  +T+YV TRWYR
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE+LL    Y   +D+WSVGCI  E+L  KP+FPGT  LNQL+ II ++G    ED+E 
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           I +P A   + SLP  P  P   L P A   A+DLL+K+LVF+P KR++  EAL+HPY++
Sbjct: 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299

Query: 321 PLYDPSSNPPAQVPIDLDMDEE 342
             ++PS  P    PI + +D+ 
Sbjct: 300 QFHNPSDEPVLPYPITIPLDDN 321

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  362 bits (931), Expect = e-125
 Identities = 161/333 (48%), Positives = 226/333 (67%), Gaps = 9/333 (2%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           T+FEI  +YV ++P+G GA+G+VCS+ ++ T + VAIKKI   F   V A RT RELKLL
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLL 143
           +HL+HEN+I+L D+ +       +D+Y V EL+ TDLH+++ S + L     QYFL+Q+L
Sbjct: 64  KHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQIL 118

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           RGLKY+HSA ++HRDLKP N+L+N NCDLKICDFGLAR  + +   MT YV TR+YRAPE
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTGYVSTRYYRAPE 175

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           ++L    Y   +D+WS GCIFAE+L  KP+FPG + +NQ  +I ++LG+  ++ +  I +
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY 323
               ++++SLP     PFS  + +A P AIDLL+KMLVFDP KRIS  EAL HPY++P +
Sbjct: 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295

Query: 324 DPSSNPPAQVPIDLDM-DEESGEEMIREMMLKE 355
           DP+  P A+   D    D +   +  + MM  E
Sbjct: 296 DPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  353 bits (908), Expect = e-122
 Identities = 141/289 (48%), Positives = 181/289 (62%), Gaps = 9/289 (3%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +  IG G YG+V  + ++ T E VAIKKI   FE+       LRE+KLL+ L H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLH 150
           I L DV      R+  D+YLV+E MDTDL+++IK  Q  L     + +L+QLL+GL + H
Sbjct: 61  IKLLDVF-----RHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ILHRDLKP NLL+N    LK+ DFGLAR+     +  T YVVTRWYRAPELLL    
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDNPKARKY 269
           Y T +D+WSVGCIFAELL R+P+FPG   ++QL  I   LG+   E   +F     AR Y
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT--SLARNY 233

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
             S P   G P  +L+P+A P A+DLL +ML +DP KRI+  +AL HPY
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  339 bits (870), Expect = e-115
 Identities = 161/340 (47%), Positives = 234/340 (68%), Gaps = 5/340 (1%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VCS+ +    +KVA+KK++  F++ + A RT REL+L
Sbjct: 8   KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRL 67

Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+    NF +VYLV  LM  DL+ I+K  Q L+++H Q+ ++Q
Sbjct: 68  LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQ 126

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           LLRGLKY+HSA I+HRDLKP N+ VN +C+L+I DFGLAR ++ +   MT YV TRWYRA
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRA 183

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  K +FPG + ++QLK I+ ++G+   E L+ I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  ARKYI+SLP+ P     +++  A+PLAIDLL+KMLV D  KRIS +EAL HPY S 
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303

Query: 322 LYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHP 361
            +DP   P A+   +   ++E   E  +E+  +E+  + P
Sbjct: 304 YHDPEDEPEAEPYDESPENKERTIEEWKELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  336 bits (862), Expect = e-114
 Identities = 158/342 (46%), Positives = 222/342 (64%), Gaps = 10/342 (2%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  +K +G GAYG VCS++++ T EKVAIKK++  F++ + A R  REL L
Sbjct: 8   KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67

Query: 83  LRHLQHENVIALKDVMMP-SHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H+QHENVI L DV         F+D YLV   M TDL +I+     L+ D  QY ++Q
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQ 125

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +L GLKY+HSA I+HRDLKPGNL VN +C+LKI DFGLAR ++ +   MT YVVTRWYRA
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRA 182

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  K +F G + L+QL  I+ + G    E ++ +
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
           ++  A+ YIKSLP  P   FS L+P A P A+DLL+KML  D  KR++ TEAL+HPY   
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Query: 322 LYDPSSNPPAQVPIDLDMDEE--SGEEMIREMMLKEMLHYHP 361
             D       Q P D  ++ E  S +E  ++ + KE+  + P
Sbjct: 303 FRDADEETEQQ-PYDDSLENEKLSVDEW-KKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  334 bits (858), Expect = e-113
 Identities = 143/291 (49%), Positives = 199/291 (68%), Gaps = 8/291 (2%)

Query: 34  PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA 93
           P +PIG GA+G+V S  +    ++VA+KK+ N F+N V   R  RELK+L   +H+NV++
Sbjct: 4   PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63

Query: 94  LKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
             D++ P H   F+++Y+V ELM +DLH+II S Q L++DH + FL+Q+LRGLKYLHSA 
Sbjct: 64  ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSN-GKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ILHRD+KPGNLLVN+NC LKICDFGLAR     +++ MT+ VVT++YRAPE+L+   +Y 
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183

Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
           +++D+WSVGCIFAELLGR+ +F     + QL LI ++LG+   E +       AR +I  
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM-RSACEGARAHILR 242

Query: 273 LPYTPGTPFSRLY----PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            P+ P +    LY       H  A+ LL +MLVFDP KRIS  +AL HPY+
Sbjct: 243 GPHKPPS-LPVLYTLSSQATHE-AVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  332 bits (853), Expect = e-113
 Identities = 161/343 (46%), Positives = 233/343 (67%), Gaps = 11/343 (3%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69

Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 128

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 185

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305

Query: 322 LYDPSSNPPAQVPIDLDMDEESGEEMIRE---MMLKEMLHYHP 361
            +DP   P A  P D     ES + +I E   +   E++ + P
Sbjct: 306 YHDPDDEPVAD-PYDQSF--ESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  326 bits (836), Expect = e-110
 Identities = 156/342 (45%), Positives = 225/342 (65%), Gaps = 9/342 (2%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  +K +G GAYG VCS+++R T  KVAIKK+   F++ + A R  REL+L
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 83  LRHLQHENVIALKDVMMPSHRRN-FKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P    + F D YLV   M TDL +++K  + L+ D  Q+ ++Q
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-LSEDRIQFLVYQ 126

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +L+GLKY+H+A I+HRDLKPGNL VN +C+LKI DFGLAR ++ +   MT YVVTRWYRA
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRA 183

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AE+L  KP+F G + L+QL  I+ + G+  +E ++ +
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  A+ Y+K LP      F  L P+A+PLA+++L+KMLV D   RI+  EAL HPY   
Sbjct: 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Query: 322 LYDPSSNPPAQVPIDLDMDE--ESGEEMIREMMLKEMLHYHP 361
            +DP     A  P D   DE  +S EE  R +   E+L + P
Sbjct: 304 FHDPEDETEAP-PYDDSFDEVDQSLEEWKR-LTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  317 bits (816), Expect = e-108
 Identities = 123/294 (41%), Positives = 172/294 (58%), Gaps = 20/294 (6%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR------TLRELKLLRH 85
           Y  ++ +G G YG+V  + +++T E VA+KKI      R+D          LRE+ LL+ 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI------RLDNEEEGIPSTALREISLLKE 54

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLR 144
           L+H N++ L DV+        + +YLV+E  D DL + +      L+ +  +  ++QLLR
Sbjct: 55  LKHPNIVKLLDVI-----HTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           GL Y HS  ILHRDLKP N+L+N +  LK+ DFGLAR      +  T  VVT WYRAPE+
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
           LL   +Y T++D+WSVGCIFAE++  KP+FPG   ++QL  I  ILG+  EE    +   
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT-- 227

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           K   Y  + P  P     ++ P   P  IDLL KML ++P KRIS  EAL+HPY
Sbjct: 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  313 bits (805), Expect = e-105
 Identities = 149/335 (44%), Positives = 205/335 (61%), Gaps = 24/335 (7%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +  T + VAIKK++  F+N   A R  REL L+
Sbjct: 10  STFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLM 69

Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 70  KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MDLDHERMSYLLYQM 127

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 186

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   II  LG+      EF+ 
Sbjct: 187 EVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT---PSDEFMS 242

Query: 263 --NPKARKYIKSLPYTPGTPFSRLYPDA-------HP------LAIDLLQKMLVFDPTKR 307
              P  R Y+++ P   G  F  L+PD                 A DLL KMLV DP KR
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302

Query: 308 ISVTEALQHPYMSPLYDPSS-NPPAQVPIDLDMDE 341
           ISV +ALQHPY++  YDPS    P   P D  +DE
Sbjct: 303 ISVDDALQHPYINVWYDPSEVEAPPPAPYDHSIDE 337

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  311 bits (798), Expect = e-105
 Identities = 141/314 (44%), Positives = 189/314 (60%), Gaps = 26/314 (8%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDAL-RT-LRELKLLRHLQ 87
           +Y   K +G G Y +V  + ++ET   VAIKKI     +   D +  T LRE+KLL+ L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGL 146
           H N+I L DV    H+ N   + LV+E M+TDL ++IK  S  LT    + ++   LRGL
Sbjct: 61  HPNIIGLLDVF--GHKSN---INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +YLHS  ILHRDLKP NLL+ ++  LK+ DFGLAR+    N+ MT  VVTRWYRAPELL 
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLF 175

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
              +YG  +D+WSVGCIFAELL R P  PG   ++QL  I   LG+  EE     + P  
Sbjct: 176 GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE-----NWPGV 230

Query: 267 RKYIKSLPY------TPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                SLP        P TP  +++P A   A+DLLQ++L  +P KRI+  +AL+HPY S
Sbjct: 231 ----TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Query: 321 PLYDPSSNPPAQVP 334
              DP+  PP+Q+P
Sbjct: 287 N--DPAPTPPSQLP 298

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  288 bits (740), Expect = 2e-96
 Identities = 121/297 (40%), Positives = 167/297 (56%), Gaps = 21/297 (7%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD--ALRTLRELKLLRHLQHE 89
           Y  I  IG G YG V  + N++T E VA+KKI    EN  +   +  +RE+KLL+ L+H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKY 148
           N++ LK+++  S  +    +Y+V+E MD DL  ++ S +   T    + ++ QLL GL+Y
Sbjct: 59  NIVRLKEIVT-SKGKG--SIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN-QFMTEYVVTRWYRAPELLLC 207
           LHS  ILHRD+K  N+L+N +  LK+ DFGLAR    +N    T  V+T WYR PELLL 
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
              YG  +D+WSVGCI AEL   KPIF G+  L QL+ I  + GS  +E+   +      
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235

Query: 268 KYIKSLPYTPGTPFSRL------YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           + +K           RL        D    A+DLL K+L  DP KRIS  +ALQH Y
Sbjct: 236 ENLKPKKPYK----RRLREFFKHLIDPS--ALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  283 bits (727), Expect = 4e-95
 Identities = 102/289 (35%), Positives = 156/289 (53%), Gaps = 36/289 (12%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +G G++G V  + +++T + VAIK I      + D  R LRE+K+L+ L+H N+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L DV       +   +YLV E  +  DL  ++K    L+ D  +++L Q+L  L+YLH
Sbjct: 60  VRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  I+HRDLKP N+L++ +  +K+ DFGLAR  +   + +T +V T  Y APE+LL    
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFVGTPEYMAPEVLL-GKG 172

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG ++D+WS+G I  ELL  KP FPG    +QL  +                       I
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPG---DDQLLELFKK--------------------I 209

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                    P   + P+    A DL++K+LV DP KR++  EALQHP+ 
Sbjct: 210 GKPKPPFPPPEWDISPE----AKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  282 bits (723), Expect = 5e-94
 Identities = 118/291 (40%), Positives = 169/291 (58%), Gaps = 10/291 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +  IG GA+GIV  + +RET E VA+KK+           + LRE+K L+  QH  
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIK-SSQALTNDHCQYFLFQLLRGLKYL 149
           V+ L DV       +     LV E M +DL ++++   + L     + ++  LL+G+ Y+
Sbjct: 61  VVKLLDVF-----PHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLAR-TSNGKNQFMTEYVVTRWYRAPELLLCC 208
           H+  I+HRDLKP NLL++A+  LKI DFGLAR  S  + +  +  V TRWYRAPELL   
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED-LEFIDNPKAR 267
             Y   +D+W+VGCIFAELL   P+FPG   + QL ++   LG+  EE        P   
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           K   + P +   P   ++PDA P A+DLL+ +LV+DP+KR+S  EAL+HPY
Sbjct: 236 KI--TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  280 bits (719), Expect = 2e-93
 Identities = 117/292 (40%), Positives = 178/292 (60%), Gaps = 13/292 (4%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HEN 90
           Y  IK +G G +G V  + N+ET E VAIKK+   F +  + +  LRE+K LR L  H N
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS--SQALTNDHCQYFLFQLLRGLKY 148
           ++ LK+V      R   ++Y V+E M+ +L+Q++K    +  +    +  ++Q+L+GL +
Sbjct: 60  IVKLKEV-----FRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           +H     HRDLKP NLLV+    +KI DFGLAR    +  + T+YV TRWYRAPE+LL  
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYVSTRWYRAPEILLRS 173

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK-AR 267
            +Y + +D+W++GCI AEL   +P+FPG+  ++QL  I ++LG+  ++D  + +  K A 
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD--WPEGYKLAS 231

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           K     P    T   +L P+A P AIDL++ ML +DP KR + ++ALQHPY 
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  276 bits (708), Expect = 4e-92
 Identities = 102/289 (35%), Positives = 147/289 (50%), Gaps = 30/289 (10%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +G G++G V  + ++ T + VA+K +    E         RE+++LR L H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L D        +   +YLV E  +  DL   +     L+ D  +    Q+LRGL+YLH
Sbjct: 61  VRLIDAFE-----DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  I+HRDLKP N+L++ N  +KI DFGLA+     +  +T +V T WY APE+LL  + 
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +DVWS+G I  ELL  KP F G   L+QL+LI  ILG   E D     +       
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG------ 229

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                                A DL++K L  DP+KR +  E LQHP+ 
Sbjct: 230 ------------------SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  272 bits (698), Expect = 2e-89
 Identities = 125/334 (37%), Positives = 196/334 (58%), Gaps = 23/334 (6%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F++ ++Y+ ++P+G G+ G+V S+V+ + +++VA+KKI     +       LRE+K++R 
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRR 58

Query: 86  LQHENVIALKDVMMPSHRRN---------FKDVYLVYELMDTDLHQIIKSSQALTNDHCQ 136
           L H+N++ + +V+ PS                VY+V E M+TDL  +++    L+ +H +
Sbjct: 59  LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEEHAR 117

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSN---GKNQFMTE 192
            F++QLLRGLKY+HSAN+LHRDLKP N+ +N  +  LKI DFGLAR  +       +++E
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
            +VT+WYR+P LLL  +NY  +ID+W+ GCIFAE+L  KP+F G   L Q++LI+  +  
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
            REED   + N             P  P   L P  +P A+D L+++L F+P  R++  E
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGE-PRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 313 ALQHPYMSPLYDPSSNPPAQVP------IDLDMD 340
           AL HPYMS    P   P +  P      +D  + 
Sbjct: 297 ALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILL 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  266 bits (681), Expect = 1e-87
 Identities = 119/292 (40%), Positives = 169/292 (57%), Gaps = 10/292 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  +  +G GAYG+V    N+ T E VAIKK   + ++       LRE+K+LR L+HEN
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYL 149
           ++ LK+      R     +YLV+E ++  L +++++S   L  D  + +++QLL+ + Y 
Sbjct: 62  IVNLKEAFRRKGR-----LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKNQFMTEYVVTRWYRAPELLLCC 208
           HS NI+HRD+KP N+LV+ +  LK+CDFG AR         +T+YV TRWYRAPELL+  
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE-FIDNPKAR 267
            NYG  +DVW++GCI AELL  +P+FPG   ++QL LI   LG       E F  NP+  
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236

Query: 268 KYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFDPTKRISVTEALQHPY 318
                 P  P     R YP      A+D L+  L  DP +R++  E LQHPY
Sbjct: 237 GVAFPEPSQP-ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  267 bits (684), Expect = 2e-87
 Identities = 154/352 (43%), Positives = 217/352 (61%), Gaps = 26/352 (7%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VA+KK++  F+N+  A R  REL LL
Sbjct: 15  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLL 74

Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I     L ++   Y L+Q+
Sbjct: 75  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQM 132

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+   N  MT YVVTR+YRAP
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC-TNFMMTPYVVTRYYRAP 191

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  EL+    IF GT+ ++Q   +I  LG+      EF++
Sbjct: 192 EVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT---PSAEFMN 247

Query: 263 --NPKARKYIKSLPYTPGTPFSRLYPD-AHP-----------LAIDLLQKMLVFDPTKRI 308
              P  R Y+++ P  PG  F  L+PD   P            A DLL KMLV DP KRI
Sbjct: 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307

Query: 309 SVTEALQHPYMSPLYDPSS--NPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
           SV EAL+HPY++  YDP+    PP Q+  D  ++E E   E  +E++ KE++
Sbjct: 308 SVDEALRHPYITVWYDPAEAEAPPPQIY-DAQLEEREHAIEEWKELIYKEVM 358

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  267 bits (683), Expect = 4e-87
 Identities = 151/350 (43%), Positives = 219/350 (62%), Gaps = 22/350 (6%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77

Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 135

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL- 252

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312

Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  266 bits (680), Expect = 1e-86
 Identities = 152/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70

Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 71  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 128

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 187

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 188 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 245

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            EALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 306 DEALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 355

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  251 bits (643), Expect = 6e-82
 Identities = 119/295 (40%), Positives = 161/295 (54%), Gaps = 17/295 (5%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA--LRTLRELKLLRHLQ-- 87
           Y  +  IG GAYG V  + +  T   VA+KK+        +   L TLRE+ LL+ L+  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLREIALLKQLESF 58

Query: 88  -HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIK--SSQALTNDHCQYFLFQLLR 144
            H N++ L DV           + LV+E +D DL   +       L  +  +  + QLLR
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           G+ +LHS  I+HRDLKP N+LV ++  +KI DFGLAR        +T  VVT WYRAPE+
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVVTLWYRAPEV 177

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
           LL   +Y T +D+WSVGCIFAEL  R+P+F GT   +QL  I +++G   EE+      P
Sbjct: 178 LLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW-----P 231

Query: 265 K-ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           +       S P      F    P+     +DLL+KML F+P KRIS  EALQHPY
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  249 bits (637), Expect = 5e-81
 Identities = 118/287 (41%), Positives = 170/287 (59%), Gaps = 13/287 (4%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD--ALRTLRELKLLRHLQHENVIALK 95
           I  G YG+V  + +++T E VA+KK+    E   +   + +LRE+ +L  LQH N++ +K
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 96  DVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +V++ S   N   +Y+V E ++ DL  ++++  Q       +  + QLL G+ +LH   I
Sbjct: 71  EVVVGS---NLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           LHRDLK  NLL+N    LKICDFGLAR      +  T+ VVT WYRAPELLL    Y T+
Sbjct: 128 LHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTA 187

Query: 215 IDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDNPKARKYIKSL 273
           ID+WSVGCIFAELL +KP+FPG   ++QL  I  +LG+  E+    F + P A+K  K+ 
Sbjct: 188 IDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK--KTF 245

Query: 274 PYTPGTPFSRLYPDAHP--LAIDLLQKMLVFDPTKRISVTEALQHPY 318
              P     + +P         DLL ++L +DP KRIS  +AL+HPY
Sbjct: 246 TKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  247 bits (634), Expect = 1e-80
 Identities = 119/292 (40%), Positives = 168/292 (57%), Gaps = 15/292 (5%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ IG G YG+V  + ++ T E VA+KKI    E+       +RE+ LL+ L H N+
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYL 149
           + L DV+   ++     +YLV+E +D DL + + SS    L     + +L+QLL+G+ Y 
Sbjct: 61  VRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           HS  +LHRDLKP NLL++    LK+ DFGLAR      +  T  VVT WYRAPE+LL   
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK- 268
            Y T +D+WS+GCIFAE++ R+P+FPG   ++QL  I   LG+  E+       P     
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW-----PGVTSL 230

Query: 269 --YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
             Y  + P       S++ P+     +DLL KMLV+DP KRIS   ALQHPY
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  241 bits (616), Expect = 1e-77
 Identities = 111/305 (36%), Positives = 162/305 (53%), Gaps = 22/305 (7%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +  +G G +G V  +   +T   VA+KKI    E     +  LRE+K+L+ L+H NV
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 92  IALKDVMM---PSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLK 147
           + L D+ +      +R    VY+V   MD DL  ++++ S  LT    + ++ QLL G+ 
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG-KNQFM----------TEYVVT 196
           YLH  +ILHRD+K  N+L++    LKI DFGLAR  +G                T  VVT
Sbjct: 130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
           RWYR PELLL    Y T++D+W +GC+FAE+  R+PI  G   ++QL LI  + G+  EE
Sbjct: 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEE 249

Query: 257 DL-EFIDNPKARKYIKSLPYTPG--TPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
               +   P          Y       F +L P+     +DLL K+L  DP KR++ ++A
Sbjct: 250 TWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE----GLDLLSKLLSLDPYKRLTASDA 305

Query: 314 LQHPY 318
           L+HPY
Sbjct: 306 LEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  238 bits (608), Expect = 8e-77
 Identities = 120/290 (41%), Positives = 166/290 (57%), Gaps = 9/290 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ IG G YG V  + NRET+E VA+K++    ++       LRE+ LL+ L+H+N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH-CQYFLFQLLRGLKYL 149
           ++ L DV+    +     + LV+E  D DL +   S     +    + F+FQLL+GL + 
Sbjct: 61  IVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           HS N+LHRDLKP NLL+N N +LK+ DFGLAR      +  +  VVT WYR P++L    
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 210 NYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
            Y TSID+WS GCIFAEL    +P+FPG +  +QLK I  +LG+  EE    +   K   
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS--KLPD 233

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           Y     Y   T    + P  +    DLLQ +LV +P +RIS  EALQHPY
Sbjct: 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  238 bits (608), Expect = 9e-77
 Identities = 119/291 (40%), Positives = 169/291 (58%), Gaps = 13/291 (4%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  ++ +G G Y  V    NR T E VA+K+I+   E    +   +RE+ L++ L+HEN+
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPS-TAIREISLMKELKHENI 60

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS---SQALTNDHCQYFLFQLLRGLKY 148
           + L DV+   H  N   + LV+E MD DL + + +     AL  +  + F +QLL+G+ +
Sbjct: 61  VRLHDVI---HTEN--KLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN-GKNQFMTEYVVTRWYRAPELLLC 207
            H   +LHRDLKP NLL+N   +LK+ DFGLAR      N F  E VVT WYRAP++LL 
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVLLG 174

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
              Y TSID+WSVGCI AE++  +P+FPGT   +QL  I  I+G+  E     I      
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LP 232

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           +Y  + P  P     +L+P A PL IDLL ++L  +P  RIS  +ALQHP+
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  237 bits (607), Expect = 3e-76
 Identities = 120/291 (41%), Positives = 166/291 (57%), Gaps = 13/291 (4%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL--RTLRELKLLRHLQHENVIALK 95
           IG G YGIV  + +  + E VA+KK+    +N  D +   +LRE+ LL +L+H N++ LK
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 96  DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANI 154
           +V++  H  +   ++LV E  + DL  ++ +     +    +  + QLLRGL+YLH   I
Sbjct: 73  EVVVGKHLDS---IFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           +HRDLK  NLL+     LKI DFGLART     + MT  VVT WYRAPELLL C  Y T+
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA 189

Query: 215 IDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE-FIDNPKARKYIKSL 273
           ID+W+VGCI AELL  KP+ PG   + QL LII +LG+  E     F D P   K+  +L
Sbjct: 190 IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF--TL 247

Query: 274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM--SPL 322
           P  P       +P      + LL  +L++DP KR +  EAL+  Y    PL
Sbjct: 248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  236 bits (604), Expect = 2e-75
 Identities = 127/342 (37%), Positives = 181/342 (52%), Gaps = 43/342 (12%)

Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALR-------- 75
           F I  +Y+     +G G YG V  + +  T + VAIKK+      N V   R        
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 76  ---TLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
              TLRELK++  ++HEN++ L DV +     +F  + LV ++M +DL +++     LT 
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTE 118

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART---------- 182
              +  L Q+L GL  LH    +HRDL P N+ +N+    KI DFGLAR           
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 183 ----SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE 238
               +  + + MT  VVT WYRAPELL+  + Y  ++D+WSVGCIFAELL  KP+FPG  
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238

Query: 239 CLNQLKLIINILGSRREEDLEFIDN-PKARKYIKSLPYTPGTP--FSRLYPDAHPLAIDL 295
            ++QL  I  +LG+  E      DN P+A+K      +TP  P     ++P+A   AIDL
Sbjct: 239 EIDQLGRIFELLGTPNE------DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDL 292

Query: 296 LQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDL 337
           LQ +L  +P +RIS  EAL+H Y     DP    P+Q+P + 
Sbjct: 293 LQSLLKLNPLERISAKEALKHEYFKS--DPLPCDPSQLPFNF 332

Length = 335

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  232 bits (592), Expect = 3e-74
 Identities = 120/297 (40%), Positives = 175/297 (58%), Gaps = 10/297 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  ++ IG G YG+V  + +R TNE +A+KKI    E+       +RE+ LL+ +QH N
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH--CQYFLFQLLRGLKY 148
           ++ L+DV+    R     +YLV+E +D DL + + SS     +    + +L+Q+LRG+ Y
Sbjct: 63  IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 149 LHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
            HS  +LHRDLKP NLL++   + LK+ DFGLAR      +  T  VVT WYRAPE+LL 
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
             +Y T +D+WSVGCIFAE++ +KP+FPG   +++L  I  ILG+  EE    + +    
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LP 235

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD 324
            Y  + P  P    + + P   P  +DLL KML  DP+KRI+   AL+H Y   L D
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292

Length = 294

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  228 bits (582), Expect = 6e-73
 Identities = 114/286 (39%), Positives = 161/286 (56%), Gaps = 9/286 (3%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64

Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSA 152
            DV+          +YLV+E +  DL + + +S    +     + +LFQLL+GL + HS 
Sbjct: 65  LDVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y 
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179

Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
           T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+  E     + +     Y  S
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP--DYKPS 237

Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            P      FS++ P       DLL +ML +DP KRIS   AL HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  227 bits (580), Expect = 2e-72
 Identities = 107/289 (37%), Positives = 168/289 (58%), Gaps = 10/289 (3%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HEN 90
           Y  +  IG G +  V  + +R+T +  AIK +   F++ ++ +  LRE++ LR L  H N
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPN 59

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYL 149
           ++ L +V+     R    + LV+ELMD +L+++IK   + L     + +++QLL+ L ++
Sbjct: 60  ILRLIEVL---FDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   I HRD+KP N+L+  +  LK+ DFG  R    K  + TEY+ TRWYRAPE LL   
Sbjct: 117 HRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPY-TEYISTRWYRAPECLLTDG 174

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            YG  +D+W+VGC+F E+L   P+FPGT  L+Q+  I ++LG+   E L+          
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF-RKSRHMN 233

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
               P   GT   +L P+A    +DLL+K+L +DP +RI+  +AL+HPY
Sbjct: 234 YNF-PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  226 bits (577), Expect = 4e-72
 Identities = 109/299 (36%), Positives = 168/299 (56%), Gaps = 24/299 (8%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  +  IG G+YG+V    NRET + VAIKK   + ++ V     LRE+++L+ L+H N
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L +V     RR  K ++LV+E  D T L+++ K+ + +     +  ++Q L+ + + 
Sbjct: 62  LVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H  N +HRD+KP N+L+     +K+CDFG AR   G     T+YV TRWYRAPELL+   
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            YG  +DVW++GC+FAELL  +P++PG   ++QL LI   LG     DL     P+ ++ 
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG-----DLI----PRHQQI 227

Query: 270 IKSLPYTPG---------TPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +  +  G          P    +P+    A+  L+  L  DPT+R+S  E L+HPY 
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  224 bits (573), Expect = 1e-71
 Identities = 110/291 (37%), Positives = 163/291 (56%), Gaps = 10/291 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y  I+ IG G YG+V    N++T + VA+KKI    E        +RE+ LL+ LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQI---IKSSQALTNDHCQYFLFQLLRGLK 147
           ++ L+DV+M   R     +YL++E +  DL +    +   Q +  +  + +L+Q+L+G+ 
Sbjct: 61  IVCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           + HS  +LHRDLKP NLL++    +K+ DFGLAR      +  T  VVT WYRAPE+LL 
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
              Y T +D+WS+G IFAE+  +KP+F G   ++QL  I  ILG+  E+    +      
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT--SLP 233

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            Y  + P            +     +DLL+KML++DP KRIS  +AL HPY
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  223 bits (570), Expect = 5e-71
 Identities = 110/292 (37%), Positives = 172/292 (58%), Gaps = 12/292 (4%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  +  +G G+YG+V    ++ET + VAIKK   + ++++     +RE+++L+ L+HEN
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L +V      R  K +YLV+E +D T L  + K    L     + +LFQ+LRG+++ 
Sbjct: 62  LVNLIEVF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           HS NI+HRD+KP N+LV+ +  +K+CDFG ART     +  T+YV TRWYRAPELL+   
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILG--SRREEDLEFIDNPKAR 267
            YG ++D+W+VGC+  E+L  +P+FPG   ++QL  II  LG    R +++ F  NP   
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-FQKNPLFA 235

Query: 268 KYIKSLPYTPGT-PFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
                LP      P  + +P    L +DL ++ L  DP  R S ++ L H +
Sbjct: 236 --GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  220 bits (562), Expect = 2e-69
 Identities = 120/315 (38%), Positives = 163/315 (51%), Gaps = 41/315 (13%)

Query: 38  IGRGAYGIVCSSV--NRETNEKVAIKKINNAFENRVD-ALRTLRELKLLRHLQHENVIAL 94
           IGRG YG V  +   N +  ++ AIKK     E     +    RE+ LLR L+HENV++L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYF-----LFQLLRGLKYL 149
            +V +       K VYL+++  + DL QIIK  +               L+Q+L G+ YL
Sbjct: 68  VEVFL---EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 150 HSANILHRDLKPGNLLVNANCD----LKICDFGLARTSNGKNQFMTE---YVVTRWYRAP 202
           HS  +LHRDLKP N+LV         +KI D GLAR  N   + + +    VVT WYRAP
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC---------LNQLKLIINILGSR 253
           ELLL   +Y  +ID+W++GCIFAELL  +PIF G E           +QL+ I  +LG+ 
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTP 244

Query: 254 REEDLEFIDN----PKARKYIKSLPYTPGTPFSRLYP------DAHPLAIDLLQKMLVFD 303
            E+D   I          K  K+  Y    P + L               DLL+K+L +D
Sbjct: 245 TEKDWPDIKKMPEYDTLMKDFKTKTY----PSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300

Query: 304 PTKRISVTEALQHPY 318
           PTKRI+  EAL+HPY
Sbjct: 301 PTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  216 bits (552), Expect = 5e-68
 Identities = 113/314 (35%), Positives = 159/314 (50%), Gaps = 35/314 (11%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL--RTLRELKLLR 84
           +  +KY  +  IG+G +G V  + +++T + VA+KK+    EN  +      LRE+K+L+
Sbjct: 9   DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQ 66

Query: 85  HLQHENVIALKDV--MMPSHRRNFK-DVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLF 140
            L+HENV+ L ++     +    +K   YLV+E  + DL  ++ +     T    +  + 
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART----SNGKNQFMTEYVVT 196
            LL GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR      N K    T  VVT
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
            WYR PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + GS   E
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246

Query: 257 ------DLEFIDN---PKARKYIKSLPYTPGTPFSRLYP---DAHPLAIDLLQKMLVFDP 304
                  LE       P+ +K              RL P   D H  A+DL+ K+LV DP
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKE---------RLKPYVKDPH--ALDLIDKLLVLDP 295

Query: 305 TKRISVTEALQHPY 318
            KRI    AL H +
Sbjct: 296 AKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  215 bits (550), Expect = 6e-68
 Identities = 115/292 (39%), Positives = 166/292 (56%), Gaps = 13/292 (4%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +  +G G+Y  V    ++ T + VA+K+I    E        +RE  LL+ L+H N+
Sbjct: 7   YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANI 65

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH-CQYFLFQLLRGLKYLH 150
           + L D++   H +  K + LV+E +DTDL Q +       + H  + FLFQLLRGL Y H
Sbjct: 66  VTLHDII---HTK--KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              +LHRDLKP NLL++   +LK+ DFGLAR  +  ++  +  VVT WYR P++LL    
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPG-TECLNQLKLIINILGSRREEDLEFI-DNPKARK 268
           Y TS+D+W VGCIF E+   +P+FPG T+  +QL  I  +LG+  EE    +  NP+ + 
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240

Query: 269 YIKSLPYTPGTPFSRLYP--DAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           Y  S P+ P  P     P  D  P   +L  K L ++P KRIS  EA++HPY
Sbjct: 241 Y--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  212 bits (541), Expect = 1e-66
 Identities = 116/305 (38%), Positives = 165/305 (54%), Gaps = 24/305 (7%)

Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
            K+  I  IG G YG V  + +++T E VA+KK+    E     +  +RE+K+LR L H 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 90  NVIALKDVMMPSH-----RRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLL 143
           N++ LK+++         +++    YLV+E MD DL  +++S     + DH + F+ QLL
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN-GKNQFMTEYVVTRWYRAP 202
            GL Y H  N LHRD+K  N+L+N    +K+ DFGLAR  N  +++  T  V+T WYR P
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           ELLL  + YG +IDVWS GCI  EL  +KPIF   + L QL+LI  + GS          
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS---------P 237

Query: 263 NPKARKYIKSLPY----TPGTPFSR-LYPDAH---PLAIDLLQKMLVFDPTKRISVTEAL 314
            P     +  LPY     P   + R L  +       A+DLL  ML  DP+KR +  EAL
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297

Query: 315 QHPYM 319
             P++
Sbjct: 298 NSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  211 bits (540), Expect = 2e-66
 Identities = 110/295 (37%), Positives = 157/295 (53%), Gaps = 10/295 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y  ++ IG G YG V  + ++ T + VA+KK     +        LRE+ LL+ L    
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 91  -VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQII-----KSSQALTNDHCQYFLFQLLR 144
            ++ L DV     +     +YLV+E +D+DL + +        + L     + F++QLL+
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           G+ + H   ++HRDLKP NLLV+     LKI D GL R  +   +  T  +VT WYRAPE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           +LL   +Y T +D+WSVGCIFAE+  ++P+FPG   L QL  I  +LG+  E+    +  
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            +        P       SR  PD  P  +DLLQKML +DP KRIS   AL HPY
Sbjct: 242 LRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  198 bits (504), Expect = 3e-61
 Identities = 109/283 (38%), Positives = 167/283 (59%), Gaps = 9/283 (3%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G GAYG+V    ++ET E VAIKK  ++ EN      TLRELK+LR L+ EN++ LK+ 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE- 67

Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILH 156
              + RR  K +YLV+E ++ ++ ++++     +  +  + +++QL++ + + H  +I+H
Sbjct: 68  ---AFRRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123

Query: 157 RDLKPGNLLVNANCDLKICDFGLART-SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           RD+KP NLL++ N  LK+CDFG AR  S G N   TEYV TRWYR+PELLL    YG ++
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAV 182

Query: 216 DVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE-FIDNPKARKYIKSLP 274
           D+WSVGCI  EL   +P+FPG   ++QL  I  +LG    E ++ F  NP+         
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242

Query: 275 YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
             P +   R       + +DL++ +L  +PT R    + L HP
Sbjct: 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  192 bits (490), Expect = 5e-59
 Identities = 112/293 (38%), Positives = 157/293 (53%), Gaps = 10/293 (3%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y+ +  +G G Y  V    ++ T+  VA+K+I    E        +RE+ LL+ L+H N+
Sbjct: 8   YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPC-TAIREVSLLKDLKHANI 66

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH-CQYFLFQLLRGLKYLH 150
           + L D++        K + LV+E +D DL Q +       N H  + FLFQLLRGL Y H
Sbjct: 67  VTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              +LHRDLKP NLL+N   +LK+ DFGLAR  +   +  +  VVT WYR P++LL   +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI-DNPKARKY 269
           Y T ID+W VGCIF E+   +P+FPG+    QL  I  ILG+  EE    I  N + + Y
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
             + P           P       +LL K+L F+  KRIS  EA++HPY   L
Sbjct: 242 --NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  192 bits (488), Expect = 8e-59
 Identities = 112/294 (38%), Positives = 155/294 (52%), Gaps = 11/294 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR---HLQ 87
           +Y P+  IG GAYG V  + +  +   VA+K +          L T+RE+ LL+      
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYFLFQLLRG 145
           H N++ L DV   S       V LV+E +D DL   +       L  +  +  + Q LRG
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L +LH+  I+HRDLKP N+LV +   +K+ DFGLAR  + +   +T  VVT WYRAPE+L
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVL 179

Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           L    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I +++G   E+D    D   
Sbjct: 180 L-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTL 237

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            R      P  P  P   + P+       LL +ML F+P KRIS   ALQHP+ 
Sbjct: 238 PRGAFS--PRGP-RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  189 bits (480), Expect = 2e-57
 Identities = 108/292 (36%), Positives = 157/292 (53%), Gaps = 8/292 (2%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y+ ++ +G G Y  V    ++ T   VA+K+I    E        +RE+ LL+ L+H N+
Sbjct: 8   YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC-TAIREVSLLKDLKHANI 66

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH-CQYFLFQLLRGLKYLH 150
           + L D++        K + LV+E +D DL Q +     + + H  + FL+Q+LRGL Y H
Sbjct: 67  VTLHDIVHTD-----KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              +LHRDLKP NLL+N   +LK+ DFGLAR  +   +  +  VVT WYR P++LL    
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           Y T ID+W VGCIF E+   +P+FPG+   ++L LI  +LG+  EE    I +    K  
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
               Y P  P     P      I+LL K L ++  KRIS  EA++H Y   L
Sbjct: 242 NFPKYKP-QPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  187 bits (476), Expect = 5e-57
 Identities = 109/289 (37%), Positives = 156/289 (53%), Gaps = 10/289 (3%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           YV +  +G G Y  V    ++ T   VA+K+I    E        +RE+ LL++L+H N+
Sbjct: 7   YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC-TAIREVSLLKNLKHANI 65

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH-CQYFLFQLLRGLKYLH 150
           + L D++        + + LV+E +D+DL Q + +   L + H  + F+FQLLRGL Y H
Sbjct: 66  VTLHDIIHTE-----RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              ILHRDLKP NLL+N   +LK+ DFGLAR  +   +  +  VVT WYR P++LL    
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI-DNPKARKY 269
           Y T ID+W VGCI  E+   +P+FPG+    +L LI  +LG+  EE    I  N + R Y
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
               P     P     P      IDLL  +L+++   RIS   AL+H Y
Sbjct: 241 --LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  187 bits (475), Expect = 8e-57
 Identities = 111/298 (37%), Positives = 164/298 (55%), Gaps = 13/298 (4%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F   T Y+ ++ +G G+Y  V   ++R   + VA+K I+   E  V     +RE  LL+ 
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKG 59

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQ-IIKSSQALTNDHCQYFLFQLLR 144
           L+H N++ L D++       F     V+E M TDL Q +I+    L   + + F+FQLLR
Sbjct: 60  LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           GL Y+H  +ILHRDLKP NLL++   +LK+ DFGLAR  +  +Q  +  VVT WYR P++
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT-ECLNQLKLIINILGSRREE---DLEF 260
           LL   +Y +++D+W  GCIF E+L  +P FPG  +   QL+ I  +LG   E+    +  
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           + N K   ++   P      + RL     P A DL  +ML+  P  RIS  +AL HPY
Sbjct: 235 LPNYKPEWFLPCKPQQLRVVWKRL--SRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  182 bits (464), Expect = 4e-56
 Identities = 67/193 (34%), Positives = 103/193 (53%), Gaps = 9/193 (4%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G +G V  + +++T +KVAIK I     +       LRE+++L+ L H N++ L  V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGV 59

Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANIL 155
                  +   +YLV E  +   L  ++K     L+ D     L Q+L GL+YLHS  I+
Sbjct: 60  FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114

Query: 156 HRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           HRDLKP N+L++++   +K+ DFGL++        +   V T  Y APE+LL    Y   
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 215 IDVWSVGCIFAEL 227
            D+WS+G I  EL
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  184 bits (468), Expect = 9e-56
 Identities = 114/295 (38%), Positives = 165/295 (55%), Gaps = 14/295 (4%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHLQ-- 87
           +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +LRHL+  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 88  -HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLR 144
            H NV+ L DV   S       + LV+E +D DL   +       +  +  +  +FQLLR
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           GL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR  + +   +T  VVT WYRAPE+
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEV 180

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDN 263
           LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I++++G   EED    +  
Sbjct: 181 LL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           P+      +       P  +   D   L  DLL K L F+P KRIS   AL HPY
Sbjct: 240 PRQ-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  179 bits (457), Expect = 2e-54
 Identities = 82/295 (27%), Positives = 137/295 (46%), Gaps = 41/295 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH 88
           ++   + +GRG++G V  +++++T E +A+K +      E  ++AL   RE+++L  LQH
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE--REIRILSSLQH 58

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY-ELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGL 146
            N++        S R   K+   ++ E +    L  ++K    L     + +  Q+L GL
Sbjct: 59  PNIVRYYG----SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGL 114

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV--TRWYRAPEL 204
            YLHS  I+HRD+K  N+LV+++  +K+ DFG A+             V  T ++ APE+
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
           +   + YG + D+WS+GC   E+   KP +   E  N +  +  I  S            
Sbjct: 175 IR-GEEYGRAADIWSLGCTVIEMATGKPPWS--ELGNPMAALYKIGSS------------ 219

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                    P  P              A D L+K L  DP KR +  E LQHP++
Sbjct: 220 ------GEPPEIP--------EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  179 bits (456), Expect = 2e-52
 Identities = 116/325 (35%), Positives = 179/325 (55%), Gaps = 24/325 (7%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           IG G++G+V  ++  +T+EKVAIKK+  +  ++NR        EL ++++L H N+I LK
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR--------ELLIMKNLNHINIIFLK 125

Query: 96  DVM-MPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLFQLLRGLKY 148
           D       ++N K+++L  V E +   +H+ +K    ++ AL     + + +QL R L Y
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 149 LHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           +HS  I HRDLKP NLL++ N   LK+CDFG A+      Q    Y+ +R+YRAPEL+L 
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA-GQRSVSYICSRFYRAPELMLG 244

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
             NY T ID+WS+GCI AE++   PIF G   ++QL  II +LG+  E+ L+   NP   
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK-EMNPNYA 303

Query: 268 KYIKSLPYTPGTPFSRLYPDAHP-LAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS 326
                 P        +++P   P  AI+ + + L ++P KR++  EAL  P+   L DP 
Sbjct: 304 DI--KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPC 361

Query: 327 SNPPAQVPIDLDMDEESGEEMIREM 351
              P  +    D+      E I+EM
Sbjct: 362 IKLPKYIDKLPDLFNFCDAE-IKEM 385

Length = 440

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  164 bits (415), Expect = 4e-47
 Identities = 85/325 (26%), Positives = 140/325 (43%), Gaps = 41/325 (12%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHE 89
            Y  ++ +G G++G V  + +    + VA+K +    E++   + R LRE+++L  L H 
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 90  -NVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ---ALTNDHCQYFLFQLLR 144
            N++ L D            +YLV E +D   L  ++K       L+     + L Q+L 
Sbjct: 58  PNIVKLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 145 GLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLAR------TSNGKNQFMTEYVVTR 197
            L+YLHS  I+HRD+KP N+L++ +   +K+ DFGLA+      +++      +  V T 
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 198 WYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
            Y APE+LL        +S D+WS+G    ELL   P F G +  +     + I+     
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----- 227

Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
                             P                 A DLL+K+L  DP  R+S +  L 
Sbjct: 228 -------------LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Query: 316 HPYMSPLYDPSSNPPAQVPIDLDMD 340
           H  ++ L    S+    +  D    
Sbjct: 275 HDLLAHLKLKESDLSDLLKPDDSAP 299

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  157 bits (400), Expect = 5e-46
 Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 53/300 (17%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  IK IG+G++G V     +   +   +K+I+ +  +  +    L E+K+L+ L H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQ-----YFLFQ 141
           +I   +        +F++   +  +M+     DL Q IK  Q              +  Q
Sbjct: 61  IIKYYE--------SFEEKGKLCIVMEYADGGDLSQKIKK-QKKEGKPFPEEQILDWFVQ 111

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           L   LKYLHS  ILHRD+KP N+ + +N  +K+ DFG+++  +         V T +Y +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171

Query: 202 PELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           PEL   C N  Y    D+WS+GC+  EL   K  F G    N L+L + IL         
Sbjct: 172 PEL---CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE---NLLELALKIL--------- 216

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                  +     +P    +              +L+  +L  DP +R S+ + LQ P++
Sbjct: 217 -------KGQYPPIPSQYSSELR-----------NLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  159 bits (402), Expect = 6e-46
 Identities = 105/296 (35%), Positives = 160/296 (54%), Gaps = 13/296 (4%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +G G+Y  V    ++   + VA+K I    E        +RE  LL+ L+H N+
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ-EEEGTPFTAIREASLLKGLKHANI 65

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQII-KSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L D++   H +  + + LV+E + TDL Q + K    L  ++ + FLFQLLRGL Y+H
Sbjct: 66  VLLHDII---HTK--ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              ILHRDLKP NLL++   +LK+ DFGLAR  +  +   +  VVT WYR P++LL    
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECL-NQLKLIINILGSRREED---LEFIDNPKA 266
           Y T +D+W VGCIF E++     FPG + + +QL+ I  +LG+  E+    +  + + K 
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
            ++    P      +++L    H  A DL  K+L   P  R+S   AL H Y S L
Sbjct: 241 ERFTLYSPKNLRQAWNKLSYVNH--AEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  157 bits (397), Expect = 5e-45
 Identities = 113/318 (35%), Positives = 166/318 (52%), Gaps = 45/318 (14%)

Query: 38  IGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           +GRG YG V  +  ++  ++   A+K+I    E    ++   RE+ LLR L+H NVIAL+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64

Query: 96  DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA---------LTNDHCQYFLFQLLRGL 146
            V +    R    V+L+++  + DL  IIK  +A         L     +  L+Q+L G+
Sbjct: 65  KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 147 KYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSNGKNQFMTEY---VVTRWY 199
            YLH+  +LHRDLKP N+LV         +KI D G AR  N   + + +    VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE---------CLNQLKLIINIL 250
           RAPELLL   +Y  +ID+W++GCIFAELL  +PIF   +           +QL  I +++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 251 GSRREEDLEFI----DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAID-----LLQKMLV 301
           G   ++D E I    + P  +K  +   Y   +     Y + H +  D     LLQK+L 
Sbjct: 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIK--YMEKHKVKPDSKVFLLLQKLLT 299

Query: 302 FDPTKRISVTEALQHPYM 319
            DPTKRI+  +ALQ PY 
Sbjct: 300 MDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  154 bits (391), Expect = 4e-44
 Identities = 112/316 (35%), Positives = 164/316 (51%), Gaps = 41/316 (12%)

Query: 38  IGRGAYGIVCSSVNRE--TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           +GRG YG V  +  ++   +   A+K+I    E    ++   RE+ LLR L+H NVI+L+
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64

Query: 96  DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA---------LTNDHCQYFLFQLLRGL 146
            V +    R    V+L+++  + DL  IIK  +A         L     +  L+Q+L G+
Sbjct: 65  KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 147 KYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSNGKNQFMTEY---VVTRWY 199
            YLH+  +LHRDLKP N+LV         +KI D G AR  N   + + +    VVT WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE---------CLNQLKLIINIL 250
           RAPELLL   +Y  +ID+W++GCIFAELL  +PIF   +           +QL  I N++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 251 GSRREEDLEFIDN-PKARKYIKSLPYTPGTPFSRL-YPDAHPL-----AIDLLQKMLVFD 303
           G   ++D E I   P+    +K       T  S + Y + H +     A  LLQK+L  D
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301

Query: 304 PTKRISVTEALQHPYM 319
           P KRI+  +A+Q PY 
Sbjct: 302 PIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  151 bits (384), Expect = 1e-43
 Identities = 77/290 (26%), Positives = 138/290 (47%), Gaps = 39/290 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            +  ++ IG+G +G V  + ++ T ++VAIK I    E++    + + E+++L+  +H N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPN 58

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKY 148
           ++        S+ +   ++++V E      L  ++KS+ Q LT     Y   +LL+GL+Y
Sbjct: 59  IVKYYG----SYLKK-DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LHS  I+HRD+K  N+L+ ++ ++K+ DFGL+       +     V T ++ APE++   
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTMVGTPYWMAPEVIN-G 171

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y    D+WS+G    EL   KP +                      +L  +   KA  
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYS---------------------ELPPM---KALF 207

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            I +    PG      + D      D L+K L  +P KR +  + L+HP+
Sbjct: 208 KIATNG-PPGLRNPEKWSD--EFK-DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  150 bits (380), Expect = 5e-43
 Identities = 85/291 (29%), Positives = 136/291 (46%), Gaps = 43/291 (14%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G+G+ G+V    ++ T +  A+KKI+    +     + LRELK LR  +   V+  
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVK- 63

Query: 95  KDVMMPSHRRNFKD--VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                  +   +K+  + +V E MD   L  ++K    +      Y   Q+L+GL YLH+
Sbjct: 64  ------CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 152 -ANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKNQFMTEYVVTRWYRAPELLLCCD 209
             +I+HRD+KP NLL+N+  ++KI DFG+++   N  +Q  T +V T  Y +PE +   +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT-FVGTVTYMSPERIQ-GE 175

Query: 210 NYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +Y  + D+WS+G    E  LG+ P F      +  +L+  I                   
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFP-FLPPGQPSFFELMQAICDG---------------- 218

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                P  P   FS       P   D +   L  DP KR S  E LQHP++
Sbjct: 219 ---PPPSLPAEEFS-------PEFRDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  143 bits (364), Expect = 2e-40
 Identities = 86/302 (28%), Positives = 141/302 (46%), Gaps = 55/302 (18%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH 88
              Y  ++ IG GA G V  + +R T ++VAIKK+    +N+      + E+ +++  +H
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKH 74

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLR 144
            N++   D    S+     ++++V E MD    TD+  I ++   +      Y   ++L+
Sbjct: 75  PNIVDYYD----SYLVG-DELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQ 127

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPE 203
           GL+YLHS N++HRD+K  N+L++ +  +K+ DFG A     K +     VV T ++ APE
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYWMAPE 186

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           ++    +YG  +D+WS+G +  E+  G  P                             +
Sbjct: 187 VIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLR--------------------------E 219

Query: 263 NP-KARKYIKSLPYTPGTPFSRLYPDAH---PLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            P +A   I     T G P   L  +     P   D L K LV DP KR S  E LQHP+
Sbjct: 220 PPLRALFLIT----TKGIP--PL-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272

Query: 319 MS 320
           + 
Sbjct: 273 LK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 9e-39
 Identities = 82/286 (28%), Positives = 135/286 (47%), Gaps = 43/286 (15%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIALKD 96
           IGRGA+G+V   +N ET + VAIK+I+   + + +AL+++  E+ LL++L+H N++    
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 97  VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
                       +Y++ E  +   L QIIK            +++Q+L+GL YLH   ++
Sbjct: 67  -----SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121

Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           HRD+K  N+L   +  +K+ DFG+A   N  ++     V T ++ APE++       T+ 
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE-MSGASTAS 180

Query: 216 DVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY-IKSL 273
           D+WS+GC   ELL G  P +                      DL    NP A  + I   
Sbjct: 181 DIWSLGCTVIELLTGNPPYY----------------------DL----NPMAALFRIVQD 214

Query: 274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            + P      L     P   D L +    DP  R +  + L+HP++
Sbjct: 215 DHPP------LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  135 bits (342), Expect = 2e-37
 Identities = 88/298 (29%), Positives = 141/298 (47%), Gaps = 52/298 (17%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA---FENRVDALRTLRELKLLRHLQHENVIAL 94
           I +GAYG V  +  + T +  AIK I  A    +N+VD + T R++  L   Q   V   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYV--- 55

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
             V +    +  K++YLV E +   DL  ++++  +L  D  + ++ +++  L+YLHS  
Sbjct: 56  --VKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLART-SNGKNQFM-------TEYVVTRWYRAPELL 205
           I+HRDLKP N+L+++N  LK+ DFGL++     +   +          V T  Y APE++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           L    +  ++D WS+GCI  E L   P F G       ++  NIL       +E+ +   
Sbjct: 174 L-GQGHSKTVDWWSLGCILYEFLVGIPPFHGE---TPEEIFQNILNG----KIEWPE--- 222

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SVTEALQHPYMS 320
                                +    AIDL+ K+LV DP KR+   S+ E   HP+  
Sbjct: 223 -------------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  133 bits (336), Expect = 9e-37
 Identities = 78/285 (27%), Positives = 137/285 (48%), Gaps = 39/285 (13%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV--DALRTL-RELKLLRHLQHENVIAL 94
           +G G++G V   +N +  +  A+K+++ A + +   +A++ L +E+ LL  LQH N+   
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI--- 64

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
             V      R   ++Y+  EL+    L +++K   +      + +  Q+L GL+YLH  N
Sbjct: 65  --VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
            +HRD+K  N+LV+ N  +K+ DFG+A+    +  F   +  + ++ APE++     YG 
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGYGL 181

Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL 273
           + D+WS+GC   E+   KP  P ++    +  +  I  S                  K L
Sbjct: 182 AADIWSLGCTVLEMATGKP--PWSQL-EGVAAVFKIGRS------------------KEL 220

Query: 274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           P  P      L  +A     D + K L  DP+ R +  E L+HP+
Sbjct: 221 PPIPDH----LSDEAK----DFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 1e-36
 Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 52/292 (17%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVIAL 94
           +G+G++G V     ++T +  A+K +          V+   TL E  +L  + H  ++ L
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE--HTLTERNILSRINHPFIVKL 58

Query: 95  KDVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
                      F+    +YLV E     +L   +      + +  +++  +++  L+YLH
Sbjct: 59  H--------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  I++RDLKP N+L++A+  +K+ DFGLA+  + +      +  T  Y APE+LL    
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG- 169

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG ++D WS+G +  E+L  KP F      ++ ++   IL    ++ L F   P+     
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAE---DRKEIYEKIL----KDPLRF---PE----- 214

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SVTEALQHPYM 319
                      S       P A DL+  +L  DPTKR+      E   HP+ 
Sbjct: 215 ---------FLS-------PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  126 bits (320), Expect = 3e-34
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 32/215 (14%)

Query: 35  IKPIGRGAYGIVCSSVNRETN----EKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHE 89
            K +G GA+G V     +        +VA+K +  +A E +++    LRE +++R L H 
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF--LREARIMRKLDHP 61

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQ-ALTNDHCQYFLFQLLRGLK 147
           NV+ L  V           +Y+V E M+  DL   ++ ++  L+      F  Q+ RG++
Sbjct: 62  NVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYR 200
           YL S N +HRDL   N LV  N  +KI DFGL+R  +  +    +Y          RW  
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYD---DDYYRKRGGKLPIRWM- 170

Query: 201 APE-LLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           APE L      + +  DVWS G +  E+  LG +P
Sbjct: 171 APESLKEGK--FTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  126 bits (319), Expect = 4e-34
 Identities = 83/303 (27%), Positives = 137/303 (45%), Gaps = 52/303 (17%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y  ++ IG+G++G V     +   + +  K+I+       +  + + E+ +LR L+H N
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYF--------LFQ 141
           ++   D +     R+ + +Y+V E  +  DL Q+I+  +       +Y         L Q
Sbjct: 61  IVRYYDRI---IDRSNQTLYIVMEYCEGGDLAQLIQKCKKER----KYIEEEFIWRILTQ 113

Query: 142 LLRGLKYLH-----SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT 196
           LL  L   H        +LHRDLKP N+ ++AN ++K+ DFGLA+     + F   YV T
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
            +Y +PE L    +Y    D+WS+GC+  EL    P F      NQL+L   I   +   
Sbjct: 174 PYYMSPEQLN-HMSYDEKSDIWSLGCLIYELCALSPPFTAR---NQLQLASKIKEGK--- 226

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                         + +PY       R   + +    ++++ ML  DP KR S  E LQ 
Sbjct: 227 -------------FRRIPY-------RYSSELN----EVIKSMLNVDPDKRPSTEELLQL 262

Query: 317 PYM 319
           P +
Sbjct: 263 PLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (314), Expect = 2e-33
 Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 31/215 (14%)

Query: 35  IKPIGRGAYGIVCS----SVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHE 89
            K +G GA+G V              +VA+K +  +A E +++    LRE +++R L H 
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF--LREARIMRKLDHP 61

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQ--ALTNDHCQYFLFQLLRGL 146
           N++ L  V           + +V E M   DL   ++ ++   L+      F  Q+ RG+
Sbjct: 62  NIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYR 200
           +YL S N +HRDL   N LV  N  +KI DFGL+R           Y V       RW  
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD----DYYKVKGGKLPIRWM- 171

Query: 201 APE-LLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           APE L      + +  DVWS G +  E+  LG +P
Sbjct: 172 APESLKEGK--FTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  125 bits (316), Expect = 2e-33
 Identities = 88/318 (27%), Positives = 140/318 (44%), Gaps = 72/318 (22%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQH 88
           +   K IG G++  V  +  +ETN++ AIK ++      E +V  ++  +E+ L R   H
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLNGH 61

Query: 89  ENVIALKDVMMPSHRRNFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +I L           F+D   +Y V E   + +L Q I+   +L     +++  ++L 
Sbjct: 62  PGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------------------TSN 184
            L+YLHS  I+HRDLKP N+L++ +  +KI DFG A+                       
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK 244
              +    +V T  Y +PELL      G S D+W++GCI  ++L  KP F G+   N+  
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGS---NEYL 229

Query: 245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDP 304
               IL    + +  F   P                     P+  P A DL++K+LV DP
Sbjct: 230 TFQKIL----KLEYSF---P---------------------PNFPPDAKDLIEKLLVLDP 261

Query: 305 TKRISV----TEALQHPY 318
             R+ V     E   HP+
Sbjct: 262 QDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  122 bits (309), Expect = 9e-33
 Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 49/291 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT-LRELKLLRHLQHENVIALKD 96
           IG+GA+G VC    R+T +  A+K +N        ++R  L E ++L+ L H  ++ L  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL-- 65

Query: 97  VMMPSHRRNFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   +F+D   +YLV +L+   DL   +      + +  ++++ +++  L+YLHS 
Sbjct: 66  ------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I+HRD+KP N+L++    + I DF +A      +   T    T  Y APE +LC   Y 
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVT-PDTLTTSTSGTPGYMAPE-VLCRQGYS 177

Query: 213 TSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            ++D WS+G    E L G++P + G    +   +   I   +   D              
Sbjct: 178 VAVDWWSLGVTAYECLRGKRP-YRG----HSRTIRDQIRAKQETAD-------------- 218

Query: 272 SLPYTPGTPFSRLYPDAHPL-AIDLLQKMLVFDPTKRISVT--EALQHPYM 319
                       LYP      AID + K+L  DP KR+     +   HPY 
Sbjct: 219 -----------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  116 bits (293), Expect = 2e-30
 Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 41/289 (14%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G +G V ++VN +T E +A+K+I     +         E+K+L  L+H N++    V
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
            +  HR   + VY+  E      L ++++  + L     + +  QLL GL YLHS  I+H
Sbjct: 68  EV--HR---EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 157 RDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEYVVTRWYRAPELLL--CCDN 210
           RD+KP N+ ++ N  +K+ DFG    L   +    + +     T  Y APE++       
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           +G + D+WS+GC+  E+  G++P                            +DN     +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRP-------------------------WSELDNEFQIMF 217

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
                + P  P S       P   D L + L  DP KR + +E LQHP+
Sbjct: 218 HVGAGHKPPIPDSL---QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  112 bits (283), Expect = 5e-29
 Identities = 78/305 (25%), Positives = 136/305 (44%), Gaps = 58/305 (19%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKK--INNAFENRVDALRTLREL 80
           + +F+I  K      +G G+YG V  ++++ET + VAIK   +    +        ++E+
Sbjct: 2   EEVFDILEK------LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE------IIKEI 49

Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQ 136
            +L+      ++        S+ +N  D+++V E       +D+ +I   +  LT +   
Sbjct: 50  SILKQCDSPYIVKYYG----SYFKN-TDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIA 102

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT 196
             L+Q L+GL+YLHS   +HRD+K GN+L+N     K+ DFG++             + T
Sbjct: 103 AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGT 162

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
            ++ APE++     Y    D+WS+G    E+   KP +     +  + +I N        
Sbjct: 163 PFWMAPEVIQ-EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------- 213

Query: 257 DLEFIDNPKARKYIKSLPYTPGTP--FSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
                  P         P T   P  +S       P   D ++K LV DP +R S  + L
Sbjct: 214 ------KP---------PPTLSDPEKWS-------PEFNDFVKKCLVKDPEERPSAIQLL 251

Query: 315 QHPYM 319
           QHP++
Sbjct: 252 QHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  111 bits (280), Expect = 1e-28
 Identities = 83/297 (27%), Positives = 130/297 (43%), Gaps = 55/297 (18%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQH 88
           Y+PI+ +G+GA+G        E +  V  K++N      + R DAL    E+ +L  LQH
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQH 58

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTD---LHQIIKSSQALTNDHCQ--YFLFQLL 143
            N+IA  +  M        D  L+ E+   +   L+  I   +    +     ++LFQ++
Sbjct: 59  PNIIAYYNHFM-------DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAP 202
             + Y+H A ILHRD+K  N+ +     +K+ DFG+++    +   M E VV T +Y +P
Sbjct: 112 SAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAETVVGTPYYMSP 170

Query: 203 ELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           EL   C    Y    D+W++GC+  ELL  K  F  T   N L L++ I+       +  
Sbjct: 171 EL---CQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVKIVQGNYTPVVS- 223

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                         Y+              L   LLQ+    DP KR +  E L  P
Sbjct: 224 -------------VYSSEL---------ISLVHSLLQQ----DPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  110 bits (277), Expect = 4e-28
 Identities = 69/231 (29%), Positives = 100/231 (43%), Gaps = 37/231 (16%)

Query: 35  IKPIGRGAYGIVCS----SVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
            K +G GA+G V           T  KVA+K +   A E   +    L E  +++ L H 
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF--LEEASIMKKLSHP 61

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS-QALTNDHCQYFLFQLLRGLK 147
           N++ L  V           +Y+V E M   DL   ++   + LT         Q+ +G++
Sbjct: 62  NIVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYR 200
           YL S N +HRDL   N LV  N  +KI DFGL+R     +     Y          +W  
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD----YYRKRGGGKLPIKWM- 171

Query: 201 APELLLCCDNYGTSI--DVWSVGCIFAEL--LGRKPIFPG---TECLNQLK 244
           APE L    +   +   DVWS G +  E+  LG +P +PG    E L  L+
Sbjct: 172 APESL---KDGKFTSKSDVWSFGVLLWEIFTLGEQP-YPGMSNEEVLELLE 218

Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 5e-28
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 14/209 (6%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIA 93
           ++ IG G YG V  + +++T + VAIK ++   +   +      E  +LR    H N+  
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNIAT 67

Query: 94  LKDVMM-PSHRRNFKDVYLVYELMD----TDLHQ-IIKSSQALTNDHCQYFLFQLLRGLK 147
                +  +   N   ++LV EL      TDL + + K  + L  +   Y L + LRGL 
Sbjct: 68  FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLH   ++HRD+K  N+L+  N ++K+ DFG++   +        ++ T ++ APE++ C
Sbjct: 128 YLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIAC 187

Query: 208 CDN----YGTSIDVWSVGCIFAELLGRKP 232
            +     Y    DVWS+G    EL   KP
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (275), Expect = 6e-28
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 49/288 (17%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG+G++G+V   V +      A+K+I+ +  NR +    + E ++L  L    +I     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII----- 62

Query: 98  MMPSHRRNFKDVYLVYELMD----TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHS 151
               +  +F D   +  +M+     DLH+++K    + L  D    F  Q+L GL +LHS
Sbjct: 63  ---RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN- 210
             ILHRD+K  NL ++A  ++KI D G+A+  +    F    V T +Y +PE  LC D  
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE--LCEDKP 177

Query: 211 YGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           Y    DVW++G +  E   G+ P     +  NQ  LI+ I+             P ++ Y
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGVFP--------PVSQMY 225

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
            + L                     L+ + L  D  +R    + L++P
Sbjct: 226 SQQL-------------------AQLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (273), Expect = 1e-27
 Identities = 85/298 (28%), Positives = 127/298 (42%), Gaps = 54/298 (18%)

Query: 33  VPIKPIGRGAYGIVCSSVNRETNEKVAIKKI----NNAFENRVDALRTLRELKLLRHLQH 88
             +  +G G  G+V   ++R T + +A+K I    N A + ++     LREL +L     
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKCNS 58

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFL-FQLLRGL 146
             ++            N  D+ +  E MD   L +I+K  Q    +     +   +L+GL
Sbjct: 59  PYIVGFYGAFY-----NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGL 113

Query: 147 KYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
            YLH    I+HRD+KP N+LVN+   +K+CDFG++      N     +V T  Y APE +
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTFVGTSSYMAPERI 171

Query: 206 LCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTEC----LNQLKLIINILGSRREEDLEF 260
              D Y    D+WS+G    EL  GR P  P  +        L+ I+N       E    
Sbjct: 172 QGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-------EP--- 220

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              P         P  P   FS       P   D +   L+ DP +R S  E L+HP+
Sbjct: 221 ---P---------PRLPSGKFS-------PDFQDFVNLCLIKDPRERPSYKELLEHPF 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 2e-27
 Identities = 81/296 (27%), Positives = 136/296 (45%), Gaps = 54/296 (18%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKI-----NNAFENRVDALRTLRELKLLRHLQHEN 90
           K +G+GA+G V    + +T  ++A+K++     +   +  V+AL    E++LL++LQHE 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC--EIQLLKNLQHER 65

Query: 91  VI----ALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRG 145
           ++     L+D            + +  E M    +   +K+  ALT    + +  Q+L G
Sbjct: 66  IVQYYGCLRD---DET------LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRAP 202
           ++YLHS  I+HRD+K  N+L ++  ++K+ DFG ++   T       M     T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++   + YG   DVWSVGC   E+L  KP  P  E    +  I  I             
Sbjct: 177 EVIS-GEGYGRKADVWSVGCTVVEMLTEKP--PWAE-FEAMAAIFKI------------- 219

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              A +     P  P  P         P A + L++  V +  KR S  E L+H +
Sbjct: 220 ---ATQ-----PTNPQLP-----SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  108 bits (271), Expect = 2e-27
 Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 53/293 (18%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKV-AIKKINNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G+YG V   V R ++ +  A+K+++    ++ +    + E+++L  + H N+I+
Sbjct: 5   LKKLGKGSYGSV-YKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIIS 63

Query: 94  LKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQA----LTNDHCQYFLFQLLRGLKY 148
            K+  +  ++     + +V E     DL + I   +     +          QLLRGL+ 
Sbjct: 64  YKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LH   ILHRDLK  N+L+ AN  +KI D G+++    K       + T  Y APE+    
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQIGTPHYMAPEVWK-G 175

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y    D+WS+GC+  E+    P F                  R  +DL        R 
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEA----------------RSMQDL--------RY 211

Query: 269 YIKSLPYTPGTP-FSRLYPDAHPLAIDLLQ---KMLVFDPTKRISVTEALQHP 317
            ++   Y P  P +S+          DL      ML   P  R +  + L  P
Sbjct: 212 KVQRGKYPPIPPIYSQ----------DLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 2e-27
 Identities = 88/302 (29%), Positives = 133/302 (44%), Gaps = 63/302 (20%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +KPI +GA+G V  +  R T +  AIK               L++  ++   Q  NV A 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIK--------------VLKKSDMIAKNQVTNVKAE 46

Query: 95  KDVMMPSHRRNF----------KD-VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
           + +MM      +          KD +YLV E ++  D   +IK+   L  D  + ++ ++
Sbjct: 47  RAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV 106

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + G++ LH   I+HRD+KP NLL++    LK+ DFGL+R      +F    V T  Y AP
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF----VGTPDYLAP 162

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           E +L   +   S D WS+GC+  E L G  P    T       +  NIL  R       I
Sbjct: 163 ETILGVGDDKMS-DWWSLGCVIFEFLFGYPPFHAETP----DAVFDNILSRR-------I 210

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEALQHPY 318
           + P+  K   S                 P A+DL+ ++L  DP KR+      E   HP+
Sbjct: 211 NWPEEVKEFCS-----------------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253

Query: 319 MS 320
             
Sbjct: 254 FK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  108 bits (271), Expect = 2e-27
 Identities = 82/294 (27%), Positives = 126/294 (42%), Gaps = 50/294 (17%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---NAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           +G GA+     + + +T   +A+K++    N    + + +  LR E++L+  L H ++I 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 94  LKDVMMPSHRRNFKDVYLVYELM-----DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           +          +F    L  E M        L +     +A+  ++ +    QLLRGL Y
Sbjct: 68  MLGATC--EDSHFN---LFVEWMAGGSVSHLLSKYGAFKEAVIINYTE----QLLRGLSY 118

Query: 149 LHSANILHRDLKPGNLLVNANC-DLKICDFG----LARTSNGKNQFMTEYVVTRWYRAPE 203
           LH   I+HRD+K  NLL+++    L+I DFG    LA    G  +F  + + T  + APE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           +L   + YG S DVWSVGC+  E+   KP +   +  N L LI                 
Sbjct: 179 VLR-GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK--------------- 222

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                 I S    P  P   L P       D+  + L   P  R    E L+HP
Sbjct: 223 ------IASATTAPSIP-EHLSPGLR----DVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  108 bits (271), Expect = 3e-27
 Identities = 85/311 (27%), Positives = 136/311 (43%), Gaps = 76/311 (24%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKI----------NNAFENRVDALRTLRELKLLRHLQ 87
           IG+G YG V  ++N  T E +A+K++          ++  ++ V ALR+  E++ L+ L 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRS--EIETLKDLD 66

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLH------------QIIKSSQALTNDHC 135
           H N++                 YL +E  +  L               +++         
Sbjct: 67  HLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS-----NGKNQFM 190
           ++F  Q+L GL YLHS  ILHRDLK  NLLV+A+   KI DFG+++ S     N +N  M
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 191 TEYVVTRWYRAPELL-LCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIIN 248
              V   ++ APE++      Y   +D+WS+GC+  E+  GR+P                
Sbjct: 171 QGSV---FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--------------- 212

Query: 249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI 308
                   D E I    A   + +    P  P   +  +  P+A+D L      +P  R 
Sbjct: 213 -------SDEEAI---AAMFKLGNKRSAPPIP-PDVSMNLSPVALDFLNACFTINPDNRP 261

Query: 309 SVTEALQHPYM 319
           +  E LQHP++
Sbjct: 262 TARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  106 bits (267), Expect = 1e-26
 Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 22/244 (9%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA--FENRVDALRTLRELKLLRHLQHENVIALK 95
           +G G +G V     +  N   A+K +      E          E ++L    H  ++ L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQE-HIFSEKEILEECNHPFIVKL- 58

Query: 96  DVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                   R FKD   +Y LM+     +L  I++          ++++  ++   +YLH+
Sbjct: 59  -------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLKP NLL+++N  +K+ DFG A+      +  T +  T  Y APE++L    Y
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIIL-NKGY 169

Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN--PKARKY 269
             S+D WS+G +  ELL  +P F   +  + +++  +IL  +    LEF +     A+  
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDD-EDPMEIYNDIL--KGNGKLEFPNYIDKAAKDL 226

Query: 270 IKSL 273
           IK L
Sbjct: 227 IKQL 230

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 5e-26
 Identities = 82/289 (28%), Positives = 136/289 (47%), Gaps = 41/289 (14%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G GA+G V  + ++ET    A K I    E  ++      E+ +L   +H N++ L + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV--EIDILSECKHPNIVGLYEA 70

Query: 98  MMPSHRRNFKDVYLVYELMDTD-LHQII-KSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
                      ++++ E  D   L  I+ +  + LT    +Y   Q+L  L +LHS  ++
Sbjct: 71  YF-----YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125

Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC---CDN-Y 211
           HRDLK GN+L+  + D+K+ DFG++  +    Q    ++ T ++ APE++ C    DN Y
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPY 185

Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
               D+WS+G    EL   +P  P  E LN +++++ IL                    K
Sbjct: 186 DYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLKIL--------------------K 222

Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           S P T   P S+     +    D L+  LV DP  R +  E L+HP++S
Sbjct: 223 SEPPTLDQP-SKWSSSFN----DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  104 bits (261), Expect = 7e-26
 Identities = 83/289 (28%), Positives = 130/289 (44%), Gaps = 45/289 (15%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL---RTLRELKLLRHLQHENVI 92
           K IG+G + +V  ++       VA+KK+   FE  +DA      L+E+ LL+ L H NVI
Sbjct: 8   KKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFE-MMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQ---YFLFQLLRGL 146
                 + ++  N     +V EL D  DL ++IK    Q           YF+ QL   L
Sbjct: 66  KYLASFIENNELN-----IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV-QLCSAL 119

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +++HS  I+HRD+KP N+ + A   +K+ D GL R  + K       V T +Y +PE + 
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             + Y    D+WS+GC+  E+   +  F G + +N   L   I      E  ++      
Sbjct: 180 -ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKI------EKCDY------ 225

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
                  P  P   +S        L  DL+ + +  DP KR  ++  LQ
Sbjct: 226 -------PPLPADHYSE------ELR-DLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 9e-26
 Identities = 76/302 (25%), Positives = 135/302 (44%), Gaps = 64/302 (21%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQHE 89
            +  ++ IG+G++G V  ++++ TN+ VAIK I+   E   D +  + +E++ L   +  
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSP 59

Query: 90  NVI-----ALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLF 140
            +       LK   +          +++ E        DL +  K    L   +  + L 
Sbjct: 60  YITKYYGSFLKGSKL----------WIIMEYCGGGSCLDLLKPGK----LDETYIAFILR 105

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEYVVT 196
           ++L GL+YLH    +HRD+K  N+L++   D+K+ DFG    L  T + +N F    V T
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF----VGT 161

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
            ++ APE ++    Y    D+WS+G    EL   +P  P ++ L+ ++++  I       
Sbjct: 162 PFWMAPE-VIKQSGYDEKADIWSLGITAIELAKGEP--PLSD-LHPMRVLFLI------- 210

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                  PK      + P   G  FS+ +        D +   L  DP +R S  E L+H
Sbjct: 211 -------PK-----NNPPSLEGNKFSKPFK-------DFVSLCLNKDPKERPSAKELLKH 251

Query: 317 PY 318
            +
Sbjct: 252 KF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 9e-26
 Identities = 69/236 (29%), Positives = 103/236 (43%), Gaps = 42/236 (17%)

Query: 36  KPIGRGAYGIVCS---SVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENV 91
           K +G GA+G V             +VA+K +  +A E        L+E ++++ L H NV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF--LKEARVMKKLGHPNV 58

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQ---------YFLFQ 141
           + L  V           +YLV E M+  DL   ++ S+ +     +          F  Q
Sbjct: 59  VRLLGVCTEEEP-----LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT----- 196
           + +G++YL S   +HRDL   N LV  +  +KI DFGL+R     +     Y        
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD----YYRKKTGGKL 169

Query: 197 --RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG---TECLNQLK 244
             RW  APE L   D  + +  DVWS G +  E+  LG  P +PG    E L  L+
Sbjct: 170 PIRWM-APESLK--DGIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLR 221

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  103 bits (258), Expect = 4e-25
 Identities = 71/207 (34%), Positives = 109/207 (52%), Gaps = 17/207 (8%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           +V +  IG G++G V  + N  TNE VA+KK++ + +   +  +  ++E+K L+ L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            I  K   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 83  TIEYKGCYLKEH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLA 135

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L+     +K+ DFG A  S+  N F    V T ++ APE++L 
Sbjct: 136 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF----VGTPYWMAPEVILA 191

Query: 208 CD--NYGTSIDVWSVGCIFAELLGRKP 232
            D   Y   +DVWS+G    EL  RKP
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  102 bits (257), Expect = 4e-25
 Identities = 77/299 (25%), Positives = 140/299 (46%), Gaps = 48/299 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC + ++ T  +VA+KK++   + R + L    E+ ++R  QH N++     
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL--FNEVVIMRDYQHPNIVE---- 80

Query: 98  MMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
           M  S+     ++++V E ++    TD    I +   +  +        +L+ L +LH+  
Sbjct: 81  MYSSYLVG-DELWVVMEFLEGGALTD----IVTHTRMNEEQIATVCLAVLKALSFLHAQG 135

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGL-ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++HRD+K  ++L+ ++  +K+ DFG  A+ S    +     V T ++ APE ++    YG
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPE-VISRLPYG 193

Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP-KARKYIK 271
           T +D+WS+G +  E++  +P +                         F + P +A K I+
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPY-------------------------FNEPPLQAMKRIR 228

Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
                   P  +      P     L +MLV DP +R +  E L HP+++    PSS  P
Sbjct: 229 DNL----PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  101 bits (253), Expect = 1e-24
 Identities = 72/293 (24%), Positives = 135/293 (46%), Gaps = 36/293 (12%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  + + + VA+KK++   + R + L    E+ ++R  QHENV+ + + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 85

Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   +  +        +L+ L  LH+  ++HR
Sbjct: 86  YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140

Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG     + +       V T ++ APEL+     YG  +D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDI 199

Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP 277
           WS+G +  E++  +P +     L  +K+I + L             PK +   K  P   
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPKLKNLHKVSPSLK 247

Query: 278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           G                 L ++LV DP +R +  E L+HP+++    PS   P
Sbjct: 248 G----------------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 2e-24
 Identities = 71/269 (26%), Positives = 121/269 (44%), Gaps = 27/269 (10%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRV-DALRTLRELKLLRHLQHENVIALK 95
           IGRGAYG V    +  T   VA+K IN +  ++ V D  R +  L  LR  Q  N+    
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 96  DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
              +   R     ++++ E  +    + +  +  +   +    + ++L  LKY+H   ++
Sbjct: 69  GSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI 123

Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           HRD+K  N+LV    ++K+CDFG+A   N  +   + +V T ++ APE++     Y T  
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 216 DVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL------EFI-----DNP 264
           D+WS+G    E+    P +   +    + LI      R E++       EF+     + P
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEP 243

Query: 265 KAR---------KYIKSLPYTPGTPFSRL 284
           K R         K+IK+   TP +    L
Sbjct: 244 KERLSAEELLKSKWIKAHSKTPVSILKEL 272

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  100 bits (251), Expect = 2e-24
 Identities = 81/297 (27%), Positives = 135/297 (45%), Gaps = 52/297 (17%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKK-----INNAFENR----VDALRTLRELKLLRHLQH 88
           IG G++G V   +N  + E +A+K+     ++ + ++R    +DAL   RE+ LL+ LQH
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQH 65

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           EN++      + +   N    Y+    +   L+      + L  +    F+ Q+L+GL Y
Sbjct: 66  ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLNY 121

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLAR------TSNGKNQFMTEYVVTRWYRAP 202
           LH+  I+HRD+K  N+LV+    +KI DFG+++       S   N        + ++ AP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++    +Y    D+WS+GC+  E+L  K  FP      QL+ I  I             
Sbjct: 182 EVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFKIGE----------- 226

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                    + P  P         +    AID L+K    D  KR +  E L+HP++
Sbjct: 227 --------NASPEIPS--------NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 85/355 (23%), Positives = 139/355 (39%), Gaps = 91/355 (25%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  IK IGRGA+G V    +++T +  A+K +  +               +++  Q  +V
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS--------------DMIKRNQIAHV 48

Query: 92  IALKDVMMPSHRR-------NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLF 140
            A +D++  +          +F+D   +YLV E M   DL  ++        +  ++++ 
Sbjct: 49  RAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA 108

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-----------RTSNGKNQF 189
           +L+  L  +H    +HRD+KP N+L++A+  +K+ DFGL              ++  N  
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 190 MTEYVVTRW------------------YRAPELLLCCDNYGTSIDVWSVGCIFAELL-GR 230
             + V+ R                   Y APE+L     YG   D WS+G I  E+L G 
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGF 227

Query: 231 KPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHP 290
            P +  T      K+I        +E L F                   P         P
Sbjct: 228 PPFYSDTLQETYNKII------NWKESLRF-------------------PPDPPVS---P 259

Query: 291 LAIDLLQKMLVFDPTKRI-SVTEALQHPYMS--PLYDPSSNPPAQVPI---DLDM 339
            AIDL+ + L+ DP  R+ S  E   HP+       +     P  VP     LD 
Sbjct: 260 EAIDLICR-LLCDPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDT 313

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 99.6 bits (248), Expect = 4e-24
 Identities = 82/295 (27%), Positives = 133/295 (45%), Gaps = 44/295 (14%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  IK IG G++G +  +  +  +E   IK+I+       +   + +E+ LL  ++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQAL--TNDHCQYFLFQLLRGLK 147
           ++        + R     +++V E  D  DL + I   + +  + D    +  Q+  GLK
Sbjct: 61  IVTFFASFQENGR-----LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 148 YLHSANILHRDLKPGNLLVNANCDL-KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           ++H   ILHRD+K  N+ ++ N  + K+ DFG+AR  N   +     V T +Y +PE+  
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-- 173

Query: 207 CCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
            C N  Y    D+WS+GC+  EL   K  F G   L+QL L I                 
Sbjct: 174 -CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI----------------- 214

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             + Y    P +P   FSR   D   L   L +      P  R S+T  L+ P++
Sbjct: 215 -CQGYFA--PISPN--FSR---DLRSLISQLFK----VSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 57/304 (18%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHEN 90
           Y  I+ IG GA  +V +++    NEKVAIK+I+    +  VD LR  +E++ +    H N
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR--KEVQAMSQCNHPN 60

Query: 91  VIALKDVMMPSHRRNF---KDVYLVYELMDT-DLHQIIKSSQA---LTNDHCQYFLFQLL 143
           V+         +  +F    +++LV   +    L  I+KSS     L        L ++L
Sbjct: 61  VV--------KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVV--TRWY 199
           +GL+YLHS   +HRD+K GN+L+  +  +KI DFG++ +    G            T  +
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKP---IFPGTECLNQLKLIINILGSRRE 255
            APE++     Y    D+WS G    EL  G  P     P       +K+++  L +   
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-------MKVLMLTLQN--- 222

Query: 256 EDLEFIDNPKARKYIKSLPY-TPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
                 D P       SL        +S+ +         ++   L  DP+KR +  E L
Sbjct: 223 ------DPP-------SLETGADYKKYSKSFR-------KMISLCLQKDPSKRPTAEELL 262

Query: 315 QHPY 318
           +H +
Sbjct: 263 KHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  100 bits (250), Expect = 4e-24
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 17/207 (8%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           +  ++ IG G++G V  + +  TNE VAIKK++ + +   +  +  ++E++ L+ L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            I  K   +  H       +LV E      +D+ ++ K  + L            L+GL 
Sbjct: 77  TIEYKGCYLREH-----TAWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLA 129

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS   +HRD+K GN+L+     +K+ DFG A   +  N F    V T ++ APE++L 
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF----VGTPYWMAPEVILA 185

Query: 208 CD--NYGTSIDVWSVGCIFAELLGRKP 232
            D   Y   +DVWS+G    EL  RKP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =   99 bits (250), Expect = 5e-24
 Identities = 75/290 (25%), Positives = 134/290 (46%), Gaps = 72/290 (24%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR----TLRELKLLRHLQHEN 90
           IK +G G++G V    ++ + +  A+K ++ A   ++  L+     L E ++L+ ++H  
Sbjct: 6   IKTLGTGSFGRVMLVRHKGSGKYYALKILSKA---KIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGL 146
           ++ L          +F+D   +Y +M+     +L   ++ S        +++  Q++  L
Sbjct: 63  LVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR-W------- 198
           +YLHS +I++RDLKP NLL++++  +KI DFG A+            V  R +       
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK-----------RVKGRTYTLCGTPE 163

Query: 199 YRAPELLLCCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
           Y APE++L    YG ++D W++G  I+  L G  P F      N +++   IL  +    
Sbjct: 164 YLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFD----DNPIQIYEKILEGK---- 214

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
           + F   P                FS       P A DL++ +L  D TKR
Sbjct: 215 VRF---PS--------------FFS-------PDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 97.2 bits (242), Expect = 3e-23
 Identities = 69/264 (26%), Positives = 128/264 (48%), Gaps = 35/264 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KYV +K IG G++G      ++E  ++  IK+IN +  +  +   + +E+ +L +++H N
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQ--ALTNDHCQYFLFQLLR 144
           ++         ++ +F++   +Y +MD     DL++ I + +      D    +  Q+  
Sbjct: 61  IV--------QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL 112

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
            LK++H   ILHRD+K  N+ +  +  +K+ DFG+AR  N   +     + T +Y +PE+
Sbjct: 113 ALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172

Query: 205 LLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL-------GSRRE 255
              C+N  Y    D+W++GC+  E+   K  F   E  N   L++ I+        S   
Sbjct: 173 ---CENRPYNNKSDIWALGCVLYEMCTLKHAF---EAGNMKNLVLKIIRGSYPPVSSHYS 226

Query: 256 EDLE------FIDNPKARKYIKSL 273
            DL       F  NP+ R  + S+
Sbjct: 227 YDLRNLVSQLFKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 4e-23
 Identities = 78/306 (25%), Positives = 133/306 (43%), Gaps = 55/306 (17%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           Q  +E+      I+ IG G YG V  + +  T E VAIK I     +  + ++  +E+ +
Sbjct: 2   QEDYEL------IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ--QEISM 53

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYF 138
           L+  +H N++A       S+ R  K +++V E        D++Q+ +    L+     Y 
Sbjct: 54  LKECRHPNIVAY----FGSYLRRDK-LWIVMEYCGGGSLQDIYQVTRG--PLSELQIAYV 106

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA----RTSNGKNQFMTEYV 194
             + L+GL YLH    +HRD+K  N+L+  + D+K+ DFG++     T   +  F    +
Sbjct: 107 CRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF----I 162

Query: 195 VTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
            T ++ APE+        Y    D+W++G    EL   +P       +  L LI     S
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-----S 217

Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
           +       + +                   +  P  H    D ++K L  DP KR + T+
Sbjct: 218 KSNFPPPKLKDK-----------------EKWSPVFH----DFIKKCLTKDPKKRPTATK 256

Query: 313 ALQHPY 318
            LQHP+
Sbjct: 257 LLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 96.5 bits (240), Expect = 5e-23
 Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 67/304 (22%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  I+ +GRGA+GIV     +   + V IK+I      + + L    E ++L+ L H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALT-----NDHCQ--------- 136
           +I   +        NF        L D  L  +++ +   T        C          
Sbjct: 61  IIEYYE--------NF--------LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVV 195
           +F  Q+L  L ++H+  ILHRDLK  N+L++ +   +KI DFG+++  + K++  T  V 
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVG 163

Query: 196 TRWYRAPELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
           T  Y +PEL   C+   Y    D+W++GC+  EL   K  F   E  N   L++ I+   
Sbjct: 164 TPCYISPEL---CEGKPYNQKSDIWALGCVLYELASLKRAF---EAANLPALVLKIMSGT 217

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                     P + +Y   L                     L+  ML  DP+KR  +++ 
Sbjct: 218 F--------APISDRYSPDLRQ-------------------LILSMLNLDPSKRPQLSQI 250

Query: 314 LQHP 317
           +  P
Sbjct: 251 MAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.5 bits (242), Expect = 6e-23
 Identities = 68/207 (32%), Positives = 109/207 (52%), Gaps = 17/207 (8%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           +  ++ IG G++G V  + +  TNE VAIKK++ + +   +  +  ++E+K L+ ++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            I  K   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 87  SIEYKGCYLREH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLA 139

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L+     +K+ DFG A  ++  N F    V T ++ APE++L 
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF----VGTPYWMAPEVILA 195

Query: 208 CD--NYGTSIDVWSVGCIFAELLGRKP 232
            D   Y   +DVWS+G    EL  RKP
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 72/293 (24%), Positives = 137/293 (46%), Gaps = 36/293 (12%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  + T ++VA+KK++   + R + L    E+ ++R   HENV+ + + 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHENVVDMYNS 87

Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   +  +        +LR L YLH+  ++HR
Sbjct: 88  YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142

Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+ ++  +K+ DFG     + +       V T ++ APE++     YGT +D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDI 201

Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP 277
           WS+G +  E++  +P +     L  ++ I + L  R +      D+ K    ++      
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK------DSHKVSSVLRG----- 250

Query: 278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
                             L  MLV +P++R +  E LQHP++     PS   P
Sbjct: 251 -----------------FLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 94.3 bits (234), Expect = 5e-22
 Identities = 69/283 (24%), Positives = 131/283 (46%), Gaps = 38/283 (13%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  + +  +VA+K ++   + R + L    E+ ++R  QH+NV+ +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHQNVVEMYKS 86

Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +       ++++++ E +       I S   L  +        +L+ L YLHS  ++HR
Sbjct: 87  YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141

Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG     +         V T ++ APE ++    YGT +D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE-VISRTPYGTEVDI 200

Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP-KARKYIKSLPYT 276
           WS+G +  E++  +P +                         F D+P +A K ++  P  
Sbjct: 201 WSLGIMVIEMVDGEPPY-------------------------FSDSPVQAMKRLRDSP-- 233

Query: 277 PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
              P  +      P+  D L++ML  +P +R +  E L HP++
Sbjct: 234 --PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 93.5 bits (232), Expect = 9e-22
 Identities = 82/305 (26%), Positives = 139/305 (45%), Gaps = 51/305 (16%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           I  +G GA+G V  + N+ET    A K I+   E  ++    + E+ +L    H N++ L
Sbjct: 10  IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKL 67

Query: 95  KDVMMPSHRRNFKDVYLVYEL-----MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
            D     +     +++++ E      +D  + ++    + LT    +    Q L  L YL
Sbjct: 68  LDAFYYEN-----NLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYL 119

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   I+HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 210 N----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           +    Y    DVWS+G    E+   +P  P  E LN +++++ I                
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP--PHHE-LNPMRVLLKI---------------- 220

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
                KS P T   P SR   +      D L+K L  +   R + T+ LQHP+++     
Sbjct: 221 ----AKSEPPTLAQP-SRWSSEFK----DFLKKCLEKNVDARWTTTQLLQHPFVT----V 267

Query: 326 SSNPP 330
           +SN P
Sbjct: 268 NSNKP 272

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 75/299 (25%), Positives = 126/299 (42%), Gaps = 41/299 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           K V +  +G GA G V     + T    A+K I     N     + LREL++ +  +   
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPY 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL----FQLLRG 145
           ++      +     +   + +  E  +   L  I K  +       +  L      +L+G
Sbjct: 61  IVKYYGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK--NQFMTEYVVTRWYRAPE 203
           L YLHS  I+HRD+KP N+L+     +K+CDFG++    G+  N     +  T +Y APE
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAPE 173

Query: 204 LLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP-GTECLNQLKLIINILGSRREEDLEFI 261
            +     Y  + DVWS+G    E+   R P  P G   L  ++L+  I+      + E  
Sbjct: 174 RIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---NMPNPELK 229

Query: 262 DNPKA-RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           D P    K+ +                      D +++ L  DPT+R +  + L+HP++
Sbjct: 230 DEPGNGIKWSEEFK-------------------DFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 71/242 (29%), Positives = 103/242 (42%), Gaps = 33/242 (13%)

Query: 35  IKPIGRGAYGIV---CSSVNRE-TNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQHE 89
           IK +G G +G V         + T E+VA+K +N++ E +        RE+++LR L HE
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEILRTLDHE 66

Query: 90  NVIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRG 145
           N++  K V      R+ + +  YL    +   L +          +  +  LF  Q+ +G
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-----HRDQINLKRLLLFSSQICKG 121

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-------TRW 198
           + YL S   +HRDL   N+LV +   +KI DFGLA+       +   Y V         W
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY---YYVKEPGESPIFW 178

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRREE 256
           Y APE L        S DVWS G    EL   G     P  E    L++I    G     
Sbjct: 179 Y-APECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEF---LRMIGIAQGQMIVT 233

Query: 257 DL 258
            L
Sbjct: 234 RL 235

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 91.6 bits (227), Expect = 3e-21
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 38/291 (13%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +G+G+YG V    +R   ++  IKK+N    +R +     +E +LL  L+H N+
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLFQLLRGLKY 148
           +A ++    S       +Y+V    +  DL+  +K    + L  +    +  Q+   L+Y
Sbjct: 62  VAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LH  +ILHRDLK  N+ +     +K+ D G+AR    +    +  + T +Y +PE L   
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSN 176

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y    DVW++GC   E+   K  F   + +N   L+  I+  +               
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKD-MNS--LVYRIIEGK--------------- 218

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
               LP  P         D  P   +L+  ML   P KR SV   L+ PY+
Sbjct: 219 ----LPPMP--------KDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 17/207 (8%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           +  ++ IG G++G V  + +   +E VAIKK++ + +   +  +  ++E++ L+ L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            I  +   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 77  TIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L++    +K+ DFG A      N F    V T ++ APE++L 
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILA 185

Query: 208 CD--NYGTSIDVWSVGCIFAELLGRKP 232
            D   Y   +DVWS+G    EL  RKP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA-LKD 96
           +G+G YGIV ++ +  T  ++AIK+I       V  L    E+ L  +L+H N++  L  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIVQYLGS 73

Query: 97  VMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF---QLLRGLKYLHSAN 153
                  + F +     ++    L  +++S      D+ Q  +F   Q+L GLKYLH   
Sbjct: 74  DSENGFFKIFME-----QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 154 ILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN-- 210
           I+HRD+K  N+LVN     +KI DFG ++   G N     +  T  Y APE++   D   
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI---DKGP 185

Query: 211 --YGTSIDVWSVGCIFAELLGRKPIF 234
             YG   D+WS+GC   E+   KP F
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 78/261 (29%), Positives = 115/261 (44%), Gaps = 31/261 (11%)

Query: 76  TLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQII-KSSQALTNDH 134
           TL E  LL+++ H +VI +KD ++           +V     +DL+  + K S+ L  D 
Sbjct: 104 TLIEAMLLQNVNHPSVIRMKDTLVSG-----AITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158

Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYV 194
                 Q+L GL+YLH+  I+HRD+K  N+ +N    + I D G A+       F+    
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LA 217

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIF---------PGTECLNQLK 244
            T    APE +L  D Y +  D+WS G +  E+L     IF             C + L 
Sbjct: 218 GTVETNAPE-VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276

Query: 245 LIINILGSRREEDLEFIDNPKAR---KYIK-----SLPYTPGTPFSRLYPDAHPLAIDLL 296
            II+ L    E   EF  +P +R    +I+       PYT    F R+  +       L+
Sbjct: 277 KIISTLKVHPE---EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRV--NLPIDGEFLV 331

Query: 297 QKMLVFDPTKRISVTEALQHP 317
            KML FD   R S  E L +P
Sbjct: 332 HKMLTFDAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 37/290 (12%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           I  +G GA+G V  + N+ET    A K I    E  ++    + E+++L    H  ++ L
Sbjct: 17  IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--MVEIEILATCNHPYIVKL 74

Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                   +      +     +D  + ++    + LT    Q    Q+L  L+YLHS  I
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMKI 131

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC----CDN 210
           +HRDLK GN+L+  + D+K+ DFG++  +    Q    ++ T ++ APE+++C       
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           Y    D+WS+G    E+   +P  P  E LN +++++ I                     
Sbjct: 192 YDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVLLKI--------------------A 228

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           KS P T   P S+   +      D L+  L   P  R S  + L+HP++S
Sbjct: 229 KSEPPTLSQP-SKWSMEFR----DFLKTALDKHPETRPSAAQLLEHPFVS 273

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 73/299 (24%), Positives = 131/299 (43%), Gaps = 52/299 (17%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH 88
             KY   + IG+GA G V ++++  T ++VAIK++N   + + + +  + E+ ++R  +H
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKH 75

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYE--------LMDTDLHQIIKSSQALTNDHCQYFLF 140
            N++            N+ D YLV +        L    L  ++  +  +          
Sbjct: 76  PNIV------------NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCR 122

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           + L+ L++LHS  ++HRD+K  N+L+  +  +K+ DFG       +    +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE++     YG  +D+WS+G +  E++  +P +     L  L LI              
Sbjct: 183 APEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------- 228

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                          T GTP  +       +  D L + L  D  KR S  E LQHP++
Sbjct: 229 ---------------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 90.8 bits (225), Expect = 3e-20
 Identities = 86/322 (26%), Positives = 134/322 (41%), Gaps = 50/322 (15%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  ++    GA G   + ++ +T E V IK              T  E  +LR + H ++
Sbjct: 94  FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG--------GTATEAHILRAINHPSI 145

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ--LLRGLKYL 149
           I LK     +     K   L+     TDL+  + + + +    C     +  +LR ++YL
Sbjct: 146 IQLKGTFTYN-----KFTCLILPRYKTDLYCYLAAKRNIAI--CDILAIERSVLRAIQYL 198

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWY--------RA 201
           H   I+HRD+K  N+ +N   D+ + DFG A        F  +    ++Y         A
Sbjct: 199 HENRIIHRDIKAENIFINHPGDVCLGDFGAA-------CFPVDINANKYYGWAGTIATNA 251

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP------GTECLNQLKLIINILGSRR 254
           PE LL  D YG ++D+WS G +  E+      +F         +   Q+KLII   G+  
Sbjct: 252 PE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310

Query: 255 EEDLEFIDNPKA---RKYIKSLPYTPGTPFSR-LYPDAHPLAID---LLQKMLVFDPTKR 307
               EF  + +A     YI     +   P SR L+ + + L ID   L+ KML FD   R
Sbjct: 311 N---EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR 367

Query: 308 ISVTEALQHPYMSPLYDPSSNP 329
            S    L       + DP  NP
Sbjct: 368 PSAEALLDFAAFQDIPDPYPNP 389

Length = 391

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.5 bits (219), Expect = 4e-20
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQHENVIA 93
           K IGRG +  V  +      + VA+KK+   FE      R   ++E+ LL+ L H NVI 
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66

Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQII---KSSQALTNDHC--QYFLFQLLRGLK 147
             D  +  +  N     +V EL D  DL Q+I   K  + L  +    +YF+ QL   ++
Sbjct: 67  YLDSFIEDNELN-----IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-QLCSAVE 120

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           ++HS  ++HRD+KP N+ + A   +K+ D GL R  + K       V T +Y +PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 179

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
            + Y    D+WS+GC+  E+   +  F G
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 87.7 bits (217), Expect = 6e-20
 Identities = 79/296 (26%), Positives = 133/296 (44%), Gaps = 43/296 (14%)

Query: 31  KYVPIKPIGRGAYGIVC----SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +Y+  + +G+G++G V          E   KV +K+I     N  + ++  +E +LL  L
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVGELNPNETVQANQEAQLLSKL 59

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLR 144
            H  ++      +   R  F  +    E  D D  L ++  + + L+ +    +  QLL 
Sbjct: 60  DHPAIVKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           G+ Y+H   ILHRDLK  N+ +  N  LKI DFG++R   G     T +  T +Y +PE 
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE- 175

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
            L    Y +  D+WS+GCI  E+      F G    N L +++ I           ++ P
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRI-----------VEGP 221

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAID-LLQKMLVFDPTKRISVTEALQHPYM 319
                      TP        P+ +   ++ ++Q ML  DP+ R S  E L++P++
Sbjct: 222 -----------TPS------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 87.3 bits (216), Expect = 8e-20
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH 88
           +Y  ++ +G G++G      +  +++K A+K+I    +     D   + +E  LL  ++H
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVED---SRKEAVLLAKMKH 57

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRG 145
            N++A K+            +Y+V E  D  DL Q IK  +      D    +  Q+  G
Sbjct: 58  PNIVAFKESFEADGH-----LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           ++++H   +LHRD+K  N+ +  N  +K+ DFG AR       +   YV T +Y  PE+ 
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW 172

Query: 206 LCCDN--YGTSIDVWSVGCIFAEL 227
              +N  Y    D+WS+GCI  EL
Sbjct: 173 ---ENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 33/288 (11%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLL-RHLQHEN--VIA 93
           IG+G +G V     ++T    A+K ++      + +   T+ E  +L R L  E+  ++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 94  LK-DVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
           LK      S      D+YLV + M   +L   ++     + D  ++++ +L+  L++LH 
Sbjct: 61  LKFSFQTDS------DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK 114

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            +I++RDLKP N+L++A   + +CDFGL++ +   N+    +  T  Y APE+LL    Y
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174

Query: 212 GTSIDVWSVGCIFAEL-LGRKPIF-PGTE------CLNQLKLIINILGSRREEDLEFID- 262
              +D WS+G +  E+  G  P +   T+         +++   N+L     E  +F+  
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSD---EGRQFVKG 231

Query: 263 ----NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK 306
               NP+ R     L         + +P    +  DLL K  +  P K
Sbjct: 232 LLNRNPQHR-----LGAHRDAVELKEHPFFADIDWDLLSKKQITPPFK 274

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 15/206 (7%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-----RVDALRTLRELKLLRHLQHEN 90
           K +G+GA+G V    + +T  ++A+K++    E+      V+AL    E++LL++L HE 
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC--EIQLLKNLLHER 65

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++     +     R      +  E M    +   +KS  ALT +  + +  Q+L G+ YL
Sbjct: 66  IVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRAPELLL 206
           HS  I+HRD+K  N+L ++  ++K+ DFG ++   T       M     T ++ +PE ++
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VI 181

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKP 232
             + YG   D+WSVGC   E+L  KP
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 77/309 (24%), Positives = 136/309 (44%), Gaps = 60/309 (19%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F+I T+      +G+G YG V  +  ++T E VA+K++             L +L  +RH
Sbjct: 3   FQILTQ------VGQGGYGQVFLAKKKDTGEIVALKRMKK---------SLLFKLNEVRH 47

Query: 86  LQHENVIALKDVMMPSHRR-------NFKDVYLVYELMD----TDLHQIIKSSQALTNDH 134
           +  E     +D++  +           F+D   +Y  M+     D   ++ +   L+ DH
Sbjct: 48  VLTE-----RDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH 102

Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYV 194
            ++++ ++   +  LH    +HRDLKP N L++A+  +K+ DFGL   S G   +    V
Sbjct: 103 ARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGL---SKGIVTYANSVV 159

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR 254
            +  Y APE+L     Y  ++D WS+GC+  E L   P F G+      +   N+   + 
Sbjct: 160 GSPDYMAPEVLR-GKGYDFTVDYWSLGCMLYEFLCGFPPFSGS---TPNETWENLKYWK- 214

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
               E +  P        +   P    S         A DL+ K++  DP++R    E +
Sbjct: 215 ----ETLQRP--------VYDDPRFNLSD-------EAWDLITKLIN-DPSRRFGSLEDI 254

Query: 315 Q-HPYMSPL 322
           + HP+   +
Sbjct: 255 KNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 80/305 (26%), Positives = 134/305 (43%), Gaps = 40/305 (13%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLRHLQHEN 90
           +  +G G  G+V   ++R +   +A K    +I  A  N++     +RELK+L       
Sbjct: 6   LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI-----IRELKVLHECNSPY 60

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++               ++ +  E MD   L Q++K +  +  +        +LRGL YL
Sbjct: 61  IVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYL 115

Query: 150 ---HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK--NQFMTEYVVTRWYRAPEL 204
              H   I+HRD+KP N+LVN+  ++K+CDFG++    G+  +     +V TR Y +PE 
Sbjct: 116 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 169

Query: 205 LLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIIN-------ILGSRREE 256
           L    +Y    D+WS+G    E+  GR PI P      +L+ +            S R  
Sbjct: 170 LQ-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPV 226

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH--PLAIDLLQKMLVFDPTKRISVTEAL 314
                D+P+     + L Y    P  +L P         D + K L  +P +R  + E  
Sbjct: 227 SGHPPDSPRPMAIFELLDYIVNEPPPKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELT 285

Query: 315 QHPYM 319
           +HP++
Sbjct: 286 KHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.3 bits (213), Expect = 4e-19
 Identities = 69/289 (23%), Positives = 132/289 (45%), Gaps = 36/289 (12%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAIK+IN   + + + +  + E+ +++ L++ N
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNPN 77

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 78  IVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           +  ++HRD+K  N+L+  +  +K+ DFG       +    +  V T ++ APE++     
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKA 191

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----------------------- 228

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                T GTP  +      P+  D L + L  D  KR S  E LQHP++
Sbjct: 229 -----TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 85.5 bits (211), Expect = 5e-19
 Identities = 59/205 (28%), Positives = 107/205 (52%), Gaps = 13/205 (6%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-----RVDALRTLRELKLLRHLQHEN 90
           K +G+GA+G V    + +T  ++A K++    E+      V AL    E++LL++LQHE 
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHER 65

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++     +     +    +++ Y +    +   +K+  ALT    + +  Q+L G+ YLH
Sbjct: 66  IVQYYGCLRDRAEKTLT-IFMEY-MPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRAPELLLC 207
           S  I+HRD+K  N+L ++  ++K+ DFG ++   T       +     T ++ +PE ++ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VIS 182

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKP 232
            + YG   DVWS+GC   E+L  KP
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 82/308 (26%), Positives = 128/308 (41%), Gaps = 64/308 (20%)

Query: 33  VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHLQHENV 91
             I+ +GRGAYG+V    +  T   +A+K+I  A  N  +  R L +L + +R +     
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIR-ATVNSQEQKRLLMDLDISMRSVDCPYT 62

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLH----QIIKSSQALTNDHCQYFLFQLLRGLK 147
           +     +    R    DV++  E+MDT L     ++      +  D        +++ L+
Sbjct: 63  VTFYGALF---REG--DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 148 YLHSA-NILHRDLKPGNLLVNANCDLKICDFG--------LARTSN-GKNQFMTEYVVTR 197
           YLHS  +++HRD+KP N+L+N N  +K+CDFG        +A+T + G   +M       
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYM------- 170

Query: 198 WYRAPELL---LCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSR 253
              APE +   L    Y    DVWS+G    EL  GR P         QLK ++      
Sbjct: 171 ---APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE----- 222

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                            +  P  P   FS       P   D + K L  +  +R +  E 
Sbjct: 223 -----------------EPSPQLPAEKFS-------PEFQDFVNKCLKKNYKERPNYPEL 258

Query: 314 LQHPYMSP 321
           LQHP+   
Sbjct: 259 LQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 57/205 (27%), Positives = 109/205 (53%), Gaps = 13/205 (6%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKI-----NNAFENRVDALRTLRELKLLRHLQHEN 90
           K +GRGA+G V    + +T  ++A+K++     +      V+AL    E++LL++L+H+ 
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC--EIQLLKNLRHDR 65

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++     +     +    +++ Y +    +   +K+  ALT +  + +  Q+L+G+ YLH
Sbjct: 66  IVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRAPELLLC 207
           S  I+HRD+K  N+L ++  ++K+ DFG ++   T       +     T ++ +PE ++ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE-VIS 182

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKP 232
            + YG   DVWSV C   E+L  KP
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 35/214 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G +G V   + +    +VAIK + +    +    +   E++ L+ L+H+++I+L  V
Sbjct: 14  LGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLKQQDFQK--EVQALKRLRHKHLISLFAV 70

Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANI 154
                    + VY++ ELM+   L   ++S   Q L          Q+  G+ YL   N 
Sbjct: 71  CSVG-----EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--------TSNGKNQFMTEYVVTRWYRAPELLL 206
           +HRDL   N+LV  +   K+ DFGLAR        +S+ K       +  +W  APE   
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK-------IPYKW-TAPEAA- 176

Query: 207 CCDNYGT---SIDVWSVGCIFAELLGRKPI-FPG 236
              ++GT     DVWS G +  E+     + +PG
Sbjct: 177 ---SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 87/320 (27%), Positives = 145/320 (45%), Gaps = 78/320 (24%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK I  GAYG V    ++ET ++ A+KKIN             ++  +LR+ Q + V   
Sbjct: 6   IKLISNGAYGAVYLVRHKETRQRFAMKKIN-------------KQNLILRN-QIQQVFVE 51

Query: 95  KDVM----------MPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
           +D++          M       + + +V E ++  D   ++K+  AL  D  + +  + +
Sbjct: 52  RDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------TSN--------GKNQF 189
             L+YLH+  I+HRDLKP NLL+ +   +K+ DFGL++      T+N           +F
Sbjct: 112 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171

Query: 190 MTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAE-LLGRKPIFPGT--ECLNQLKL 245
           + + V  T  Y APE++L    YG  +D W++G I  E L+G  P F  T  E   Q   
Sbjct: 172 LDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ--- 227

Query: 246 IINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPT 305
           +I+       +D+E+ +  +A      LP                 A DL+ ++L  +P 
Sbjct: 228 VIS-------DDIEWPEGDEA------LP---------------ADAQDLISRLLRQNPL 259

Query: 306 KRI---SVTEALQHPYMSPL 322
           +R+      E  QH +   L
Sbjct: 260 ERLGTGGAFEVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 83.2 bits (205), Expect = 5e-18
 Identities = 69/300 (23%), Positives = 132/300 (44%), Gaps = 36/300 (12%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + + + +  + E+ ++R  ++ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPN 78

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG       +    +  V T ++ APE++     
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKA 192

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------------- 229

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
                T GTP  +       +  D L + L  D  KR S  E LQH ++      SS  P
Sbjct: 230 -----TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 84/332 (25%), Positives = 144/332 (43%), Gaps = 58/332 (17%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIAL 94
           K +G+G +G V     + T +  A+K +       + +   TL E ++L++ +H  + AL
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
           K       R  F     V E  +  +L   +   +  + D  +++  +++  L YLHS +
Sbjct: 61  KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           +++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG 
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGR 174

Query: 214 SIDVWSVGCIFAELL-GRKPIFPGT-ECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
           ++D W +G +  E++ GR P +    E L +L L+         E++ F   P       
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EEIRF---P------- 215

Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSP----- 321
                       L P+A  L   LL+K    DP +R+        E ++H + +      
Sbjct: 216 ----------RTLSPEAKSLLAGLLKK----DPKQRLGGGPEDAKEIMEHRFFASINWQD 261

Query: 322 LYDPSSNPP--AQVPIDLD---MDEESGEEMI 348
           +      PP   QV  + D    DEE   + I
Sbjct: 262 VVQKKLEPPFKPQVTSETDTRYFDEEFTAQSI 293

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 83/325 (25%), Positives = 133/325 (40%), Gaps = 52/325 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKD 96
           IG+G++G V     R+T    A+K I  A   +R +   TL E  +L  +    ++ LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 97  VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
                 +     +YLV   ++  +L   ++          +++  +LL  L+ LH  N++
Sbjct: 61  SFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115

Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           +RDLKP N+L++    + +CDFGL + +   +     +  T  Y APELLL    Y  ++
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-GHGYTKAV 174

Query: 216 DVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPY 275
           D W++G +  E+L   P F         + I+       +E L F D             
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-------QEPLRFPDGFDRD-------- 219

Query: 276 TPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ---HPYMSPL---------Y 323
                           A DLL  +L  DPT+R+    A +   HP+ S L          
Sbjct: 220 ----------------AKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGI 263

Query: 324 DPSSNPPAQVPIDL-DMDEESGEEM 347
            P   P     ID  + DEE   E 
Sbjct: 264 QPPFKPAVSSAIDTSNFDEEFTREK 288

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 30/211 (14%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR--TLRELKLLRHLQHENVI 92
           +  IG GA G V   ++R T    A+K I   + N  D +R    RE+++LR + H NV+
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVV 135

Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHC--QYFL----FQLLRGL 146
              D+       N  ++ ++ E MD           +L   H   + FL     Q+L G+
Sbjct: 136 KCHDM----FDHN-GEIQVLLEFMD---------GGSLEGTHIADEQFLADVARQILSGI 181

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            YLH  +I+HRD+KP NLL+N+  ++KI DFG++R            V T  Y +PE + 
Sbjct: 182 AYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241

Query: 207 CCDNYGT----SIDVWSVGCIFAEL-LGRKP 232
              N+G     + D+WS+G    E  LGR P
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 82.5 bits (203), Expect = 8e-18
 Identities = 67/289 (23%), Positives = 129/289 (44%), Gaps = 36/289 (12%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAIK++N   + + + +  + E+ ++R  ++ N
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNPN 77

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L +LH
Sbjct: 78  IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG       +    +  V T ++ APE++     
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKA 191

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA----------------------- 228

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                T GTP  +       +  D L + L  D  +R S  E LQHP++
Sbjct: 229 -----TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 82.2 bits (203), Expect = 9e-18
 Identities = 43/92 (46%), Positives = 55/92 (59%), Gaps = 4/92 (4%)

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +++GL YL S  ILHRD+KP N+LVN    +K+CDFG++      N     YV T  Y A
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYVGTNAYMA 161

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEL-LGRKP 232
           PE +   + YG   DVWS+G  F EL LGR P
Sbjct: 162 PERIS-GEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.2 bits (203), Expect = 9e-18
 Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 35/289 (12%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           I  +G G  G V    +  T   +A K ++   ++ V   + LREL+++   +   +++ 
Sbjct: 10  ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK-QILRELQIMHECRSPYIVSF 68

Query: 95  KDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
               +     N  ++ +  E MD   L +I K    +  +        ++ GL YL++ +
Sbjct: 69  YGAFL-----NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 154 -ILHRDLKPGNLLVNANCDLKICDFGLARTSNGK--NQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRD+KP N+LVN+   +K+CDFG++    G+  N     +V T  Y +PE +     
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQ-GGK 178

Query: 211 YGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           Y    DVWS+G    EL LG+ P        +     + IL     + L+ I        
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-----DLLQQIVQEPP--- 230

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
               P  P + F            D +   L+ DPT+R +  +    P 
Sbjct: 231 ----PRLPSSDFP-------EDLRDFVDACLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 79/328 (24%), Positives = 139/328 (42%), Gaps = 53/328 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +GRG +G V     + T +  A+K +  +          L +  +    +  +++++ + 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKS--------VLLAQETVSFFEEERDILSISNS 60

Query: 98  -MMPSHRRNFKD---VYLVYELM-DTDLHQII-KSSQALTNDHCQYFLFQLLRGLKYLHS 151
             +P  +  F+D   +YLV E     DL  ++ +       D  Q++L +L+  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFG-LARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              +HRD+KP N+L++    +K+ DFG  AR +  K       V T  Y APE+L   + 
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 211 -----YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
                YG   D WS+G I  E++ GR P   GT      K   NI+  +R   L+F ++P
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT----SAKTYNNIMNFQRF--LKFPEDP 234

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS--PL 322
           K                           +DL+Q +L     +R+       HP+ S    
Sbjct: 235 KVSSD----------------------FLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271

Query: 323 YDPSSNPPAQVP-IDLDMDEESGEEMIR 349
            +  ++ P  VP +  D D  + +E  +
Sbjct: 272 NNIRNSLPPFVPTLKSDDDTSNFDEPEK 299

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 16/209 (7%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA---LRTLRELKLLRHLQHENVI 92
           K IGRG +  V  +        VA+KK+     + +DA      ++E+ LL+ L H NVI
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQ--IFDLMDAKARADCIKEIDLLKQLNHPNVI 65

Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII----KSSQALTNDHCQYFLFQLLRGLK 147
                 +  +  N     +V EL D  DL ++I    K  + +       +  QL   L+
Sbjct: 66  KYYASFIEDNELN-----IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           ++HS  ++HRD+KP N+ + A   +K+ D GL R  + K       V T +Y +PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH- 179

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
            + Y    D+WS+GC+  E+   +  F G
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 76/288 (26%), Positives = 129/288 (44%), Gaps = 33/288 (11%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 4   DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLH 58

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K +  +           ++
Sbjct: 59  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 113

Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y +P
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 171

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           E L    +Y    D+WS+G    E+ +GR PI P      +L+L   + G   E D    
Sbjct: 172 ERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELEL---MFGCPVEGDPAES 225

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFDPTKRI 308
           +           P  PG P S   PD+  P+AI  L   +V +P  ++
Sbjct: 226 ETSPR-------PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL 266

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 38  IGRGAYGIV-CSSVNRETNEKVAIKKINNAFENRVDALRTLRELK----LLRHLQHENVI 92
           +G+GAYG V C   N    + +A+K++     N + A +   +L+    LL+ L+H N++
Sbjct: 8   LGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 +     N   +++ + +    +  I+     L       +  Q+L G+ YLH+ 
Sbjct: 66  QYLGTCL---DDNTISIFMEF-VPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR------TSNGKNQFMTEYVVTRWYRAPELLL 206
            ++HRD+K  N+++  N  +K+ DFG AR           +  +     T ++ APE++ 
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKP 232
               YG   D+WS+GC   E+   KP
Sbjct: 182 -ESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 49/299 (16%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHL-QHENV 91
           I+ IG+G YG V    N++     A+K ++  +  +  ++A     E  +L+ L  H NV
Sbjct: 27  IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA-----EYNILQSLPNHPNV 81

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMD----TDLHQ-IIKSSQALTNDHCQYFLFQLLRGL 146
           +    +   + +     ++LV EL +    T+L + ++   Q L      Y L+  L GL
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           ++LH+  I+HRD+K  N+L+     +K+ DFG++             V T ++ APE++ 
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201

Query: 207 CCDNYGTS----IDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           C   Y  S     DVWS+G    EL  G  P+F     ++ +K +  I            
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD----MHPVKTLFKI------------ 245

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAID-LLQKMLVFDPTKRISVTEALQHPYM 319
                       P  P  P + L+P+    + +  + + L+ D   R SVT  L+HP++
Sbjct: 246 ------------PRNP--PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.1 bits (197), Expect = 8e-17
 Identities = 78/289 (26%), Positives = 130/289 (44%), Gaps = 33/289 (11%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 4   DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLH 58

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K ++ +  +        +L
Sbjct: 59  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 113

Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           RGL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y +P
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 171

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           E L    +Y    D+WS+G    EL +GR PI P        K +  I G         +
Sbjct: 172 ERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPP-----PDAKELEAIFGR------PVV 219

Query: 262 DNPKARKY-IKSLPYTPGTPFSRLYPDAHP-LAIDLLQKMLVFDPTKRI 308
           D  +   + I   P  PG P S    D+ P +AI  L   +V +P  ++
Sbjct: 220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL 268

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 82/342 (23%), Positives = 132/342 (38%), Gaps = 105/342 (30%)

Query: 34  PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA 93
            IK IGRGA+G V     ++T    A+KK              LR+ ++L   Q  +V A
Sbjct: 5   SIKVIGRGAFGEVRLVQKKDTGHIYAMKK--------------LRKSEMLEKEQVAHVRA 50

Query: 94  LKDVMMPSHRR-------NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQL 142
            +D++  +          +F+D   +YL+ E L   D+  ++      T +  ++++ + 
Sbjct: 51  ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAET 110

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL----------------------- 179
           +  +  +H    +HRD+KP NLL++A   +K+ DFGL                       
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 180 ------------ARTSNGK-NQFMTEY--VVTRWYRAPELLLCCDNYGTSIDVWSVGCIF 224
                        +    K N+    Y  V T  Y APE+ L    Y    D WS+G I 
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIM 229

Query: 225 AELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA--RKYI---KSLPYTPGT 279
            E+L   P F                           DNP+   RK I   ++L +    
Sbjct: 230 YEMLVGYPPF-------------------------CSDNPQETYRKIINWKETLQFPDEV 264

Query: 280 PFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SVTEALQHPY 318
           P S       P A DL+++ L  +  +R+    V E   HP+
Sbjct: 265 PLS-------PEAKDLIKR-LCCEAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G +G V    +R +    A+K +          +  +  LK  +H+ +E  + L
Sbjct: 6   IKTVGTGTFGRVHLVRDRISEHYYALKVMA---------IPEVIRLKQEQHVHNEKRV-L 55

Query: 95  KDVMMPSHRRNF---KDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           K+V  P   R F    D   +Y LM+     +L   +++S   +N    ++  +++  L+
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE 115

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS  I++RDLKP N+L++    +K+ DFG A+    +   +     T  Y APE++  
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG---TPEYLAPEVIQ- 171

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              +  ++D W++G +  E+L   P F
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 61/248 (24%), Positives = 109/248 (43%), Gaps = 33/248 (13%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKIN--------------NAFENRVDALRT 76
           Y  ++ +G GA+G V     +   +  +A+K+IN               +  + V  +  
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS----SQALT 131
           ++E      L+H N++      + + R     +Y+V +L++   L +   S     Q  T
Sbjct: 62  IKE-----QLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFT 111

Query: 132 NDHCQYFLFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
            +       Q++  L+YLH    I+HRDL P N+++  +  + I DFGLA+        +
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKL 170

Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL 250
           T  V T  Y  PE++   + YG   DVW+ GCI  ++   +P F  T  L+    I+  +
Sbjct: 171 TSVVGTILYSCPEIVK-NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229

Query: 251 GSRREEDL 258
                E +
Sbjct: 230 YEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 1e-16
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 39/215 (18%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G G +G+V     R     VAIK I     +  D    + E K++  L H N++ L
Sbjct: 9   LKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDD---FIEEAKVMMKLSHPNLVQL 64

Query: 95  KDVMMPSHRRNFKDVYLVYELMD-----TDLHQ---IIKSSQALTNDHCQYFLFQLLRGL 146
             V         + +++V E M        L +    + +   L  D C      +   +
Sbjct: 65  YGVCT-----KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCS----DVCEAM 113

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWY 199
           +YL S   +HRDL   N LV  +  +K+ DFGLAR       TS+   +F       +W 
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-----PVKW- 167

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
             PE+      + +  DVWS G +  E+   G+ P
Sbjct: 168 APPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 83/325 (25%), Positives = 144/325 (44%), Gaps = 53/325 (16%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHENVIAL 94
           K +G+G +G V     + + +  A+K +        D +  TL E ++L++ +H  + +L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
           K       R  F     V E ++  +L   +   +  + D  +++  +++  L YLHS  
Sbjct: 61  KYSFQTKDRLCF-----VMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG 
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGR 174

Query: 214 SIDVWSVGCIFAELL-GRKPIF-PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
           ++D W +G +  E++ GR P +    E L +L L+         ED++F           
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EDIKF----------- 214

Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMS-----P 321
             P T       L  DA      LL  +L+ DP KR+        E ++H + +      
Sbjct: 215 --PRT-------LSADAK----SLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD 261

Query: 322 LYDPSSNPPAQVPIDLDMDEESGEE 346
           +YD    PP +  +  + D    +E
Sbjct: 262 VYDKKLVPPFKPQVTSETDTRYFDE 286

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 73/234 (31%), Positives = 106/234 (45%), Gaps = 55/234 (23%)

Query: 28  IDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLRELK 81
           ID  YV I K IG G +G VC    +   +K   VAIK  K  ++ + R+D    L E  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEAS 57

Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYF--- 138
           ++    H N+I L+ V+  S     + V ++ E M+        S      ++   F   
Sbjct: 58  IMGQFDHPNIIRLEGVVTKS-----RPVMIITEYMENG------SLDKFLRENDGKFTVG 106

Query: 139 -LFQLLRGL----KYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TS 183
            L  +LRG+    KYL   N +HRDL   N+LVN+N   K+ DFGL+R          T 
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166

Query: 184 NGKNQFMTEYVVTRWYRAPELLLCCDNYG---TSIDVWSVGCIFAELL--GRKP 232
            GK       +  RW  APE +     Y    ++ DVWS G +  E++  G +P
Sbjct: 167 GGK-------IPIRW-TAPEAI----AYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 3e-16
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 45/291 (15%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           +G+G +G VC+   R T +  A KK+     + R      L E ++L  +    V++L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-- 65

Query: 97  VMMPSHRRNFKDVY-LVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
               ++    KD   LV  LM   D   H     +     +   ++  ++  GL+ LH  
Sbjct: 66  ----AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++    ++I D GLA     + + +   V T  Y APE++   + Y 
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVK-NERYT 179

Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
            S D W +GC+  E++  K  F                  R+E+    +   +  + +K 
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQ----------------RKEK----VKREEVERRVKE 219

Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPY 318
                   FS     A  +   LL K    DP  R+        E   HP+
Sbjct: 220 DQEEYSEKFS---EAARSICRQLLTK----DPGFRLGCRGEGAEEVKAHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 4e-16
 Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 33/211 (15%)

Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQHE 89
           I+ +G+G +G V  C    +   T E VA+KK+ ++     + LR   RE+++L+ LQH+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHD 65

Query: 90  NVIALKDVMMPSHRRNFKDV--YLVY-ELMDTDLHQIIKSSQALTNDHCQYFLF--QLLR 144
           N++  K V   + RRN + V  YL Y  L D     + K  + L  DH +  L+  Q+ +
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD----YLQKHRERL--DHRKLLLYASQICK 119

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR------- 197
           G++YL S   +HRDL   N+LV +   +KI DFGL +      ++   Y V         
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY---YKVREPGESPIF 176

Query: 198 WYRAPELLLCCDN-YGTSIDVWSVGCIFAEL 227
           WY APE L   ++ +  + DVWS G +  EL
Sbjct: 177 WY-APESL--TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 6e-16
 Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG+G +G V     R   +KVA+K + +       A   L E  ++  L+H N++ L  V
Sbjct: 14  IGKGEFGDVMLGDYR--GQKVAVKCLKDD-STAAQAF--LAEASVMTTLRHPNLVQLLGV 68

Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKS-SQALTNDHCQY-FLFQLLRGLKYLHSANI 154
           ++         +Y+V E M    L   ++S  +A+     Q  F   +  G++YL   N 
Sbjct: 69  VLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           +HRDL   N+LV+ +   K+ DFGLA+ ++ + Q   +  V +W  APE L     + T 
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEAS-QGQDSGKLPV-KW-TAPEALR-EKKFSTK 179

Query: 215 IDVWSVGCIFAEL--LGRKP 232
            DVWS G +  E+   GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.0 bits (190), Expect = 7e-16
 Identities = 82/314 (26%), Positives = 127/314 (40%), Gaps = 75/314 (23%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKI---NNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IG G  G V     ++T   +A+K++    N  EN+    R L +L              
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK----RILMDL-------------- 64

Query: 95  KDVMMPSHR------------RNFKDVYLVYELMDTDLHQIIKSSQALTND----HCQYF 138
            DV++ SH              +  DV++  ELM T L +++K  Q    +         
Sbjct: 65  -DVVLKSHDCPYIVKCYGYFITDS-DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVA 122

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-RTSNGKNQFMTEYVVTR 197
           + + L  LK  H   ++HRD+KP N+L++A+ ++K+CDFG++ R  + K +  T      
Sbjct: 123 IVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCA 178

Query: 198 WYRAPELL---LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR 254
            Y APE +        Y    DVWS+G    EL      FP   C  + +++  IL    
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELA--TGQFPYKNCKTEFEVLTKILQ--- 233

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
                  + P       SLP   G  FS       P     +   L  D  KR    E L
Sbjct: 234 -------EEP------PSLPPNEG--FS-------PDFCSFVDLCLTKDHRKRPKYRELL 271

Query: 315 QHPYMSPLYDPSSN 328
           QHP++   Y+ +  
Sbjct: 272 QHPFIR-RYETAEV 284

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 22/212 (10%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA- 93
           ++ +G G YG V    + +T +  AIK + +  E+  + ++   E+ +L+   H   IA 
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKL--EINMLKKYSHHRNIAT 77

Query: 94  -LKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                +  S   +   ++LV E       TDL +  K + AL  D   Y   ++LRGL +
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-ALKEDWIAYICREILRGLAH 136

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEYVVTRWYRAPEL 204
           LH+  ++HRD+K  N+L+  N ++K+ DFG    L RT   +N F+     T ++ APE+
Sbjct: 137 LHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG----TPYWMAPEV 192

Query: 205 LLCCDN----YGTSIDVWSVGCIFAELLGRKP 232
           + C +N    Y    D+WS+G    E+    P
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQ-HENV 91
           I+ IG+G YG V   +N++   K A+K ++  +  +  ++A     E  +L+ L  H NV
Sbjct: 23  IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA-----EYNILKALSDHPNV 77

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMD----TDLHQ-IIKSSQALTNDHCQYFLFQLLRGL 146
           +    +      +N   ++LV EL +    TDL +  +K  + +      Y L + L GL
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           ++LH    +HRD+K  N+L+     +K+ DFG++             V T ++ APE++ 
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197

Query: 207 CCD----NYGTSIDVWSVGCIFAEL 227
           C       Y    DVWS+G    EL
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 31/219 (14%)

Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +        +   KVA+K +   A  +  +AL  + ELK++ HL  H
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL--MSELKIMSHLGNH 98

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYE------LMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           EN++ L              + ++ E      L++  L +  K    LT +    F +Q+
Sbjct: 99  ENIVNLLGACTIG-----GPILVITEYCCYGDLLNF-LRR--KRESFLTLEDLLSFSYQV 150

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YVVTRWY 199
            +G+ +L S N +HRDL   N+L+     +KICDFGLAR     + ++ +    +  +W 
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
            APE +  C  Y    DVWS G +  E+  LG  P +PG
Sbjct: 211 -APESIFNC-VYTFESDVWSYGILLWEIFSLGSNP-YPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 11/203 (5%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHENVIAL 94
           K +G+G +G V     + T    A+K +        D +  T+ E ++L++ +H  + AL
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
           K       R  F     V E  +  +L   +   +  T +  +++  +++  L+YLHS +
Sbjct: 61  KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN-YG 212
           +++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   DN YG
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE--DNDYG 173

Query: 213 TSIDVWSVGCIFAELL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFY 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 81/325 (24%), Positives = 140/325 (43%), Gaps = 72/325 (22%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G++G V  + ++ T E  AIK               L++ ++L+  Q ++V   K +
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIK--------------CLKKREILKMKQVQHVAQEKSI 71

Query: 98  MMP-SH------RRNFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGL 146
           +M  SH        +F+D   VY + E ++  +L   ++ +    ND  +++  +L+   
Sbjct: 72  LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAF 131

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +YLHS +I++RDLKP NLL++    +K+ DFG A+    +   +     T  Y APE++ 
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCG---TPEYLAPEVIQ 188

Query: 207 CCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
               +G ++D W++G +  E + G  P F  T      ++   IL  R    L+F +   
Sbjct: 189 -SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIYEKILAGR----LKFPNWFD 239

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMS 320
            R                        A DL++ +L  D TKR+      V +   HPY  
Sbjct: 240 GR------------------------ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275

Query: 321 -----PLYDPSSNPPAQVPIDLDMD 340
                 LY      P  V +    D
Sbjct: 276 GANWDKLYARYYPAPIPVRVKSPGD 300

Length = 329

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 43/220 (19%)

Query: 36  KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAF--ENRVDALRTLRELKLLRHLQHEN 90
           K IG G +G V   + +    K   VAIK +   +  + R D    L E  ++    H N
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEASIMGQFSHHN 67

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRG---- 145
           +I L+ V+       FK   ++ E M+   L + ++       +   Y L  +LRG    
Sbjct: 68  IIRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAG 119

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-----------TSNGKNQFMTEYV 194
           +KYL   N +HRDL   N+LVN+N + K+ DFGL+R           TS GK       +
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK-------I 172

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
             RW  APE  +    + ++ DVWS G +  E++  G +P
Sbjct: 173 PIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 24/208 (11%)

Query: 35  IKPIGRGAYGIV--CSSVNR--ETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           I+ +G G +G V  C        T E+VA+K +   +  N +  L+  +E+++LR+L HE
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHE 66

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQY-FLFQLLRGLK 147
           N++  K +         K   L+ E + +  L + +  ++   N   Q  +  Q+ +G+ 
Sbjct: 67  NIVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR-------WYR 200
           YL S   +HRDL   N+LV +   +KI DFGL +      ++   Y V         WY 
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY---YTVKDDLDSPVFWY- 179

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELL 228
           APE L+    Y  S DVWS G    ELL
Sbjct: 180 APECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.4 bits (182), Expect = 5e-15
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ +G G YG V    + +T +  AIK ++   +   +  + +  LK   H  H N+   
Sbjct: 11  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATY 68

Query: 95  KDVMMPSHRRNFKD-VYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLH 150
               +  +     D ++LV E      +  +IK+++   L  +   Y   ++LRGL +LH
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEYVVTRWYRAPELLL 206
              ++HRD+K  N+L+  N ++K+ DFG    L RT   +N F+     T ++ APE++ 
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG----TPYWMAPEVIA 184

Query: 207 CCDN----YGTSIDVWSVGCIFAELLGRKP 232
           C +N    Y    D+WS+G    E+    P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 89/333 (26%), Positives = 147/333 (44%), Gaps = 59/333 (17%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIAL 94
           K +G+G +G V     + T    A+K +       + +   TL E ++L++ +H  + AL
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA- 152
           K       R  F     V E  +  +L   +   +  + D  +++  +++  L YLHS  
Sbjct: 61  KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           N+++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YG 174

Query: 213 TSIDVWSVGCIFAELL-GRKPIF-PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            ++D W +G +  E++ GR P +    E L +L L+         E++ F          
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EEIRF---------- 215

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL--- 322
              P T       L P+A  L   LL+K    DP +R+        E +QH + + +   
Sbjct: 216 ---PRT-------LSPEAKSLLSGLLKK----DPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261

Query: 323 --YDPSSNPP--AQVPIDLD---MDEESGEEMI 348
             Y+    PP   QV  + D    DEE   +MI
Sbjct: 262 DVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMI 294

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 61/218 (27%), Positives = 86/218 (39%), Gaps = 41/218 (18%)

Query: 36  KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           K +G G +G V   V    + K   VA+K +             LRE  ++  L H  ++
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-HIAAGKKEFLREASVMAQLDHPCIV 59

Query: 93  ALKDV-----MMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGL 146
            L  V     +M           LV EL     L + +K  + +     +    Q+  G+
Sbjct: 60  RLIGVCKGEPLM-----------LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWY 199
            YL S + +HRDL   N+L+      KI DFG++R     +     Y  T       +WY
Sbjct: 109 AYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS---DYYRATTAGRWPLKWY 165

Query: 200 RAPELLLCCDNYGT---SIDVWSVGCIFAEL--LGRKP 232
            APE    C NYG      DVWS G    E    G KP
Sbjct: 166 -APE----CINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 73.3 bits (180), Expect = 8e-15
 Identities = 63/241 (26%), Positives = 110/241 (45%), Gaps = 27/241 (11%)

Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIA 93
           IG+G +G V      +++ +    A+K +N   +   V+    L+E  +++   H NV++
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQF--LKEGIIMKDFSHPNVLS 60

Query: 94  LKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSA 152
           L  + +PS       V L Y +   DL   I+S +   T      F  Q+ +G++YL S 
Sbjct: 61  LLGICLPSE--GSPLVVLPY-MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL-------- 204
             +HRDL   N +++ +  +K+ DFGLAR     + +  EY     +   +L        
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR-----DIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
            L    + T  DVWS G +  EL+ R  P +P    ++   + + +L  RR    E+  +
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYLLQGRRLLQPEYCPD 229

Query: 264 P 264
           P
Sbjct: 230 P 230

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 73.6 bits (181), Expect = 8e-15
 Identities = 67/238 (28%), Positives = 104/238 (43%), Gaps = 55/238 (23%)

Query: 36  KPIGRGAYGIVCSS-----VNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHL-QH 88
           KP+G GA+G V  +      N      VA+K + ++A E  +  L  + E+++++ + +H
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL--VSEMEMMKMIGKH 75

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYEL-----------------MDTDLHQIIKSSQALT 131
           +N+I L  V           +Y+V E                              + LT
Sbjct: 76  KNIINLLGVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 132 NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---------- 181
                 F +Q+ RG+++L S   +HRDL   N+LV  +  +KI DFGLAR          
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 182 TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 191 TTNGR-------LPVKWM-APEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.7 bits (181), Expect = 9e-15
 Identities = 77/304 (25%), Positives = 121/304 (39%), Gaps = 69/304 (22%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT-LRELKLLRHLQHENVIALKD 96
           +G+G YG V   ++R T   +A+K+I    +         + EL +L       ++    
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE--SKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 97  VMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                       VY+  E MD      L+    +++ +  D  +   + +++GLK+L   
Sbjct: 67  AFFIE-----GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 153 -NILHRDLKPGNLLVNANCDLKICDFG--------LARTSNGKNQFMTEYVVTRWYRAPE 203
            NI+HRD+KP N+LVN N  +K+CDFG        LA+T+ G   +M          APE
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYM----------APE 171

Query: 204 LLLCCD-----NYGTSIDVWSVGCIFAEL-LGRKPIFPGT--ECLNQLKLIINILGSRRE 255
            +          Y    DVWS+G    E+ LGR P  P T      QL  I++       
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD------- 224

Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
                                 G P   L       A D + K L   P +R +  + L+
Sbjct: 225 ----------------------GDP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261

Query: 316 HPYM 319
           HP++
Sbjct: 262 HPWL 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 17/245 (6%)

Query: 35  IKPIGRGAYG---IVCSSVNRETNEKVAIKKINNA--FENRVDALRTLRELKLLRHLQHE 89
           +K +G+G YG    V      +T +  A+K +  A    N+ D   T  E  +L  ++H 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            ++ L        +     +YL+ E L   +L   ++       D   ++L ++   L++
Sbjct: 61  FIVDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEH 115

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LH   I++RDLKP N+L++A   +K+ DFGL + S  +      +  T  Y APE+L+  
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS 175

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             +G ++D WS+G +  ++L   P F      N+ K I  IL  + + +L     P+AR 
Sbjct: 176 -GHGKAVDWWSLGALMYDMLTGAPPFTAE---NRKKTIDKIL--KGKLNLPPYLTPEARD 229

Query: 269 YIKSL 273
            +K L
Sbjct: 230 LLKKL 234

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 82/324 (25%), Positives = 133/324 (41%), Gaps = 40/324 (12%)

Query: 27  EIDTKYVPIKPIGRGAYG--IVCSSVNRETNEKVAIKKINNAFENRVDALRTL------- 77
           E    +  I  +  GA+G   +C+ +   T E  A + +N+  + +    R +       
Sbjct: 145 EFLAHFRVIDDLPAGAFGKIFICA-LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG 203

Query: 78  --------RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA 129
                    E+  L  L HEN++ +++++     R+  + Y++ +  D DL+  +     
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAF 258

Query: 130 LTND-----HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-S 183
              D       +  + QLL  ++Y+H   ++HRD+K  N+ +N +  + + DFG A    
Sbjct: 259 DWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318

Query: 184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK--PIFPGTECLN 241
             +  F   +V T    +PE +L  D Y    D+WS G I  ++L     PI  G     
Sbjct: 319 KEREAFDYGWVGTVATNSPE-ILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG--K 375

Query: 242 QLKLIINILGSRREEDLEFIDNP-KARKYIKSLPYT-PGTPFSRLYPDAHPLAIDL---L 296
             K ++ I+ S    D EF D P K   YI S      G     L  +   L  D    L
Sbjct: 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLG-LPADFEYPL 434

Query: 297 QKMLVFDPTKRISVTEALQHPYMS 320
            KML FD   R    E L  P  S
Sbjct: 435 VKMLTFDWHLRPGAAELLALPLFS 458

Length = 501

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 49/297 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           +G+G +G VC+   + T +  A KK++    + R      L E K+L  +    +++L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-- 58

Query: 97  VMMPSHRRNFKD-VYLVYELMDT-DLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSA 152
               ++    KD + LV  LM+  DL   I +            ++  Q++ GL++LH  
Sbjct: 59  ----AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++ + +++I D GLA    G  + +     T  Y APE+L   + Y 
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGRAGTPGYMAPEVLQ-GEVYD 172

Query: 213 TSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            S+D +++GC   E++ GR P         Q K              E ++  + ++   
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP-------FRQRK--------------EKVEKEELKRRTL 211

Query: 272 SLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL 322
            +           YPD   P A DL + +L  DP KR+     S  E  +HP    L
Sbjct: 212 EMAVE--------YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 10/204 (4%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  I+ +G G YG V  + N  T E  A+K I    E   D     +E+ +++  +H N+
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +A     +   +     +++  E      L  I   +  L+     Y   + L+GL YLH
Sbjct: 69  VAYFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S   +HRD+K  N+L+  N D+K+ DFG+A            ++ T ++ APE+     N
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 211 --YGTSIDVWSVGCIFAELLGRKP 232
             Y    D+W+VG    EL   +P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 36/217 (16%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G G +G V        + KVAIK +    +  +     L E  L++ LQH  ++ L
Sbjct: 11  VKKLGAGQFGEVWMGYYN-GHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRL 66

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHS 151
             V+        + +Y++ E M+   L   +K+ +   LT +       Q+  G+ ++  
Sbjct: 67  YAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-------TRWYRAPEL 204
            N +HRDL+  N+LV+     KI DFGLAR          EY          +W  APE 
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIED-----NEYTAREGAKFPIKW-TAPEA 174

Query: 205 LLCCDNYGT-SI--DVWSVGCIFAELL--GRKPIFPG 236
           +    NYGT +I  DVWS G +  E++  GR P +PG
Sbjct: 175 I----NYGTFTIKSDVWSFGILLTEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 76/321 (23%), Positives = 129/321 (40%), Gaps = 66/321 (20%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V +   R T +  A KK+N                +L +   +E  +  K +
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKK--------------RLKKRKGYEGAMVEKRI 46

Query: 98  MMPSHRR-------NFK---DVYLVYELMDT-DL----HQIIKSSQALTNDHCQYFLFQL 142
           +   H R        F+   D+ LV  +M+  DL    + + + +         ++  Q+
Sbjct: 47  LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI 106

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + GL++LH   I++RDLKP N+L++ + +++I D GLA            Y  T  + AP
Sbjct: 107 ISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           ELL   + Y  S+D +++G    E++  +  F                   R E +E   
Sbjct: 167 ELLQ-GEEYDFSVDYFALGVTLYEMIAARGPF-----------------RARGEKVE--- 205

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHP 317
           N + ++ I +   T    FS   P +      LL K    DP KR+     +      HP
Sbjct: 206 NKELKQRILNDSVTYPDKFS---PASKSFCEALLAK----DPEKRLGFRDGNCDGLRTHP 258

Query: 318 YMSPLY----DPSSNPPAQVP 334
               L     +    PP  VP
Sbjct: 259 LFRDLNWRQLEAGMLPPPFVP 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 68/216 (31%), Positives = 97/216 (44%), Gaps = 37/216 (17%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQHENVIALK 95
           IG+G +G V   V +  N +VA+K            L+   L+E ++L+   H N++ L 
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTCR---STLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 96  DVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
            V +       + +Y+V EL+     L  + K    LT             G++YL S N
Sbjct: 59  GVCVQK-----QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLAR--------TSNGKNQFMTEYVVTRWYRAPELL 205
            +HRDL   N LV  N  LKI DFG++R         S+G  Q     +  +W  APE L
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ-----IPIKW-TAPEAL 167

Query: 206 LCCDNYG---TSIDVWSVGCIFAEL--LGRKPIFPG 236
               NYG   +  DVWS G +  E   LG  P +PG
Sbjct: 168 ----NYGRYTSESDVWSYGILLWETFSLGDTP-YPG 198

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 67/222 (30%), Positives = 105/222 (47%), Gaps = 40/222 (18%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G +G V       T +KVA+K I    +  V A   L E  ++  L H+N++ L  V
Sbjct: 14  IGEGEFGAVLQG--EYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKS-SQALTNDHCQYFLFQLLR-------GLKY 148
           ++         +Y+V ELM   +L   +++  +AL +      + QLL+       G++Y
Sbjct: 68  IL------HNGLYIVMELMSKGNLVNFLRTRGRALVS------VIQLLQFSLDVAEGMEY 115

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           L S  ++HRDL   N+LV+ +   K+ DFGLAR   G        +  +W  APE L   
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKW-TAPEALK-H 171

Query: 209 DNYGTSIDVWSVGCIFAELL--GRKPIFPG------TECLNQ 242
             + +  DVWS G +  E+   GR P +P        EC+ +
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP-YPKMSLKEVKECVEK 212

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 67/223 (30%), Positives = 102/223 (45%), Gaps = 30/223 (13%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
            + +G G +G V       T  KVA+K +       +     L+E ++++ L+H+ ++ L
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTT-KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQL 66

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHS 151
             V         + +Y+V E M    L   +KS   + L          Q+  G+ YL S
Sbjct: 67  YAVC-----SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCC 208
            N +HRDL   N+LV  N   KI DFGLAR    ++   T     ++   + APE     
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAA--- 176

Query: 209 DNYGT-SI--DVWSVGCIFAELL--GRKPIFPG---TECLNQL 243
            NYG  +I  DVWS G +  E++  GR P +PG    E L Q+
Sbjct: 177 -NYGRFTIKSDVWSFGILLTEIVTYGRVP-YPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 67/312 (21%), Positives = 125/312 (40%), Gaps = 68/312 (21%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ +G GAYG V             ++K+      ++ A++ L++  +++  +       
Sbjct: 5   LRVLGTGAYGKV-----------FLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT 53

Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIK------------SSQALTNDHCQYFLFQ 141
           +  ++ + RR    V L Y    DT LH I+               +  T    + ++ +
Sbjct: 54  ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAE 113

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-------YV 194
           ++  L +LH   I++RD+K  N+L+++   + + DFGL++      +F+ E       + 
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK------EFLAEEEERAYSFC 167

Query: 195 VTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
            T  Y APE++      +  ++D WS+G +  ELL     F      N    I       
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI------- 220

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SV 310
                       +R+ +KS P  P              A D +QK+L  DP KR+     
Sbjct: 221 ------------SRRILKSKPPFP--------KTMSAEARDFIQKLLEKDPKKRLGANGA 260

Query: 311 TEALQHPYMSPL 322
            E   HP+   +
Sbjct: 261 DEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 71.4 bits (176), Expect = 3e-14
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 42/210 (20%)

Query: 117 DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKIC 175
           D DL  ++K    L+    +  + QL+  L  LH  NI+H D+K  N+L +   D + +C
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFP 235
           D+GL +         + Y  T  Y +PE +    NY  S D W+VG +  ELL  K  F 
Sbjct: 153 DYGLCKIIGTP----SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFK 207

Query: 236 GT--ECLNQLKLIINILGSRREEDLEFI--DNPKARKYIKSLPYTPGTPFSRLYPDAHPL 291
               E L+     +  L  R+++ L FI   +  A                         
Sbjct: 208 EDEDEELD-----LESLLKRQQKKLPFIKNVSKNAN------------------------ 238

Query: 292 AIDLLQKMLVFDPTKR-ISVTEALQHPYMS 320
             D +Q ML ++   R  +  E ++HP++ 
Sbjct: 239 --DFVQSMLKYNINYRLTNYNEIIKHPFLK 266

Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 79/291 (27%), Positives = 124/291 (42%), Gaps = 47/291 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           +G+G +G VC+   R T +  A KK+     + R      L E ++L  +    V++L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-- 65

Query: 97  VMMPSHRRNFKDVY-LVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
               ++    KD   LV  LM   D   H               ++  ++  GL+ LH  
Sbjct: 66  ----AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++ +  ++I D GLA     + Q +   V T  Y APE++   + Y 
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVK-NERYT 179

Query: 213 TSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            S D W++GC+  E++ G+ P         Q K  I     +REE           + +K
Sbjct: 180 FSPDWWALGCLLYEMIAGQSP-------FQQRKKKI-----KREE---------VERLVK 218

Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHP 317
            +       FS   PDA  L   LL K    DP +R+        E  +HP
Sbjct: 219 EVQEEYSEKFS---PDARSLCKMLLCK----DPKERLGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 22/214 (10%)

Query: 35  IKPIGRGAYG-IVCSSVNRETNEKVAIKKINNA---FENRVDALRTLRELKLLRHLQHEN 90
           I+ +G G++G ++ ++   E    VAIK+   +    + +VD      E K+L ++ H  
Sbjct: 35  IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD--HVFSERKILNYINHPF 92

Query: 91  VIALKDVMMPSHRRNFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGL 146
            + L          +FKD   +YLV E ++  +    ++ ++   ND   ++  Q++   
Sbjct: 93  CVNLYG--------SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +YL S NI++RDLKP NLL++ +  +K+ DFG A+  + +   +     T  Y APE+LL
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCG---TPEYIAPEILL 201

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
               +G + D W++G    E+L   P F   E L
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 55/240 (22%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRGA+G V   +++ +   +A+K+I +  + + +  R L +L               DV
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-EQKRLLMDL---------------DV 55

Query: 98  MMPSHR---------RNFK--DVYLVYELMDTDLHQIIKSSQALTNDHCQ-----YFLFQ 141
           +M S             F+  D ++  ELMD  L +  K    +                
Sbjct: 56  VMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115

Query: 142 LLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGL--------ARTSNGKNQFMTE 192
            ++ L YL     I+HRD+KP N+L++ N ++K+CDFG+        A+T +        
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-------- 167

Query: 193 YVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAEL-LGRKPIFPG-TECLNQLKLIIN 248
               R Y APE +     D Y    DVWS+G    E+  G+ P +P      +QL  ++ 
Sbjct: 168 -AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP-YPKWNSVFDQLTQVVK 225

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.4 bits (172), Expect = 7e-14
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 38/217 (17%)

Query: 36  KPIGRGAYGIV-CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           K +G G +G V  ++ N+ T  KVA+K +       V+A   L E  +++ LQH+ ++ L
Sbjct: 12  KKLGAGQFGEVWMATYNKHT--KVAVKTMKPG-SMSVEAF--LAEANVMKTLQHDKLVKL 66

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLF--QLLRGLKYLHS 151
             V+        + +Y++ E M    L   +KS +       +   F  Q+  G+ ++  
Sbjct: 67  HAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-------TRWYRAPEL 204
            N +HRDL+  N+LV+A+   KI DFGLAR          EY          +W  APE 
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIED-----NEYTAREGAKFPIKW-TAPEA 174

Query: 205 LLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
           +    N+G+     DVWS G +  E++  GR P +PG
Sbjct: 175 I----NFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 14/201 (6%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           +G+G +G VC+   R T +  A K++     + R      L E ++L  +  + V+ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-- 65

Query: 97  VMMPSHRRNFKDVY-LVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
               ++    KD   LV  +M   D   H     +     +   ++  ++L GL+ LH  
Sbjct: 66  ----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           N ++RDLKP N+L++    ++I D GLA     + + +   V T  Y APE +L    Y 
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVGYMAPE-VLNNQRYT 179

Query: 213 TSIDVWSVGCIFAELL-GRKP 232
            S D W +GC+  E++ G+ P
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 70.3 bits (172), Expect = 8e-14
 Identities = 71/232 (30%), Positives = 105/232 (45%), Gaps = 50/232 (21%)

Query: 28  IDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAF--ENRVDALRTLRELK 81
           ID   + I K IG G +G VCS   +   ++   VAIK +   +  + R D    L E  
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD---FLSEAS 57

Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLF 140
           ++    H N+I L+ V+  S     K V +V E M+   L   ++          Q+ + 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDG------QFTVI 106

Query: 141 QL---LRG----LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-----------T 182
           QL   LRG    +KYL     +HRDL   N+LVN+N   K+ DFGL+R           T
Sbjct: 107 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT 166

Query: 183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
             GK       +  RW  APE  +    + ++ DVWS G +  E++  G +P
Sbjct: 167 RGGK-------IPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 35/206 (16%)

Query: 119 DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG 178
           DL   I+SS        +++  +++ GL++LH   I++RDLK  N+L++ +  +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGT 237
           + + +       + +  T  Y APE+L     Y  S+D WS G +  E+L G+ P F G 
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQSP-FHGE 199

Query: 238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQ 297
           +   + +L  +IL           D P   ++I                +A     D L 
Sbjct: 200 D---EDELFDSIL----------NDRPHFPRWISK--------------EAK----DCLS 228

Query: 298 KMLVFDPTKRISVTEAL-QHPYMSPL 322
           K+   DPTKR+ V   + QHP+   +
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPFFRGI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 16/201 (7%)

Query: 35  IKPIGRGAYG---IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +K +G+G++G   +V      +  +  A+K +  A     D +RT  E  +L  + H  +
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L        +     +YL+ + L   DL   +      T +  +++L +L   L +LH
Sbjct: 61  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  I++RDLKP N+L++    +K+ DFGL++ S    +    +  T  Y APE++    N
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV----N 171

Query: 211 ---YGTSIDVWSVGCIFAELL 228
              +  S D WS G +  E+L
Sbjct: 172 RRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 27/209 (12%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G G +G+V     R    KVAIK IN    +  D    + E K++  L H  ++ L
Sbjct: 9   MKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLVQL 64

Query: 95  KDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
             V         K +Y+V E M+    L+ + +    L+ D        +  G++YL   
Sbjct: 65  YGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELL 205
           + +HRDL   N LV++   +K+ DFG+ R       TS+   +F       +W   PE+ 
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-----PVKW-SPPEVF 173

Query: 206 LCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                Y +  DVWS G +  E+   G+ P
Sbjct: 174 N-FSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 82/332 (24%), Positives = 139/332 (41%), Gaps = 62/332 (18%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           K IG+G++G V  + ++   +  A+K +           + + + K  +H+  E  + LK
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQK---------KAILKKKEEKHIMSERNVLLK 51

Query: 96  DVMMP---SHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           +V  P       +F+    +Y ++D     +L   ++  +       +++  ++   L Y
Sbjct: 52  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGY 111

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LHS NI++RDLKP N+L+++   + + DFGL + +   N   + +  T  Y APE+L   
Sbjct: 112 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH-K 170

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y  ++D W +G +  E+L   P F      N  ++  NIL                  
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILN----------------- 210

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV----TEALQHPYMSPL-- 322
             K L         +L P+    A  LL+ +L  D TKR+       E   H + SP+  
Sbjct: 211 --KPL---------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259

Query: 323 -------YDPSSNPPAQVPIDLD-MDEESGEE 346
                    P  NP    P DL   D E  EE
Sbjct: 260 DDLINKKITPPFNPNVSGPNDLRHFDPEFTEE 291

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 81/334 (24%), Positives = 141/334 (42%), Gaps = 62/334 (18%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           K IG+G++G V  + ++   +  A+K +         A+   +E K   H+  E  + LK
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKK------AILKKKEQK---HIMAERNVLLK 51

Query: 96  DVMMP---SHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           +V  P       +F+    +Y ++D     +L   ++  ++      +++  ++   L Y
Sbjct: 52  NVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LHS NI++RDLKP N+L+++   + + DFGL +     ++  + +  T  Y APE+L   
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y  ++D W +G +  E+L   P F      +  ++  NIL                  
Sbjct: 172 P-YDRTVDWWCLGAVLYEMLYGLPPF---YSRDTAEMYDNILN----------------- 210

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ----HPYMSPL-- 322
             K L         RL P+    A  LL+ +L  D TKR+   +       H + S +  
Sbjct: 211 --KPL---------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259

Query: 323 -------YDPSSNPPAQVPIDL-DMDEESGEEMI 348
                    P  NP    P+DL   D E  EE +
Sbjct: 260 DDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPV 293

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.9 bits (171), Expect = 1e-13
 Identities = 69/229 (30%), Positives = 106/229 (46%), Gaps = 42/229 (18%)

Query: 28  IDTKYVPIKP-IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLL 83
           ID   V I+  IG G +G VC    +   ++   VAIK + + +  +      L E  ++
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIM 59

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-----DTDLHQIIKSSQALTNDHCQYF 138
               H N+I L+ V+  S     + V ++ E M     D+ L Q         ND  Q+ 
Sbjct: 60  GQFDHPNIIHLEGVVTKS-----RPVMIITEFMENGALDSFLRQ---------NDG-QFT 104

Query: 139 LFQL---LRG----LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQF 189
           + QL   LRG    +KYL   N +HRDL   N+LVN+N   K+ DFGL+R    +  +  
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164

Query: 190 MTEY----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
            T      +  RW  APE  +    + ++ DVWS G +  E++  G +P
Sbjct: 165 YTSSLGGKIPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 66/291 (22%), Positives = 125/291 (42%), Gaps = 45/291 (15%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHENVIAL 94
           K +G+G++G V  +  + T+E  A+K +      + D +  T+ E ++L          L
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLA--LAGKHPFL 58

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
               + S  +    ++ V E ++  DL   I+ S        +++  +++ GL++LH   
Sbjct: 59  --TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  N+L+++   +KI DFG+ +         + +  T  Y APE+L     YG 
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILS-YQPYGP 175

Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDNPKARKYIKS 272
           ++D W++G +  E+L  +  F G +                E++L + I   + R Y + 
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDD----------------EDELFQSILEDEVR-YPRW 218

Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA-----LQHPY 318
           L                  A  +L+  L  +P KR+            HP+
Sbjct: 219 L---------------SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 10/201 (4%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           I+ IG G YG V  + N  T E  AIK I    E   D     +E+ +++  +H N++A 
Sbjct: 14  IQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNIVA- 70

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
                 S+ R  K +++  E      L  I   +  L+     Y   + L+GL YLHS  
Sbjct: 71  ---YFGSYLRRDK-LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC--CDNY 211
            +HRD+K  N+L+  N  +K+ DFG++            ++ T ++ APE+        Y
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 212 GTSIDVWSVGCIFAELLGRKP 232
               D+W+VG    EL   +P
Sbjct: 187 NQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 60/219 (27%), Positives = 110/219 (50%), Gaps = 34/219 (15%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K IGRGA+G            +VA+ K+ NA  ++V A++ L + ++L+  +       
Sbjct: 6   LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 51

Query: 95  KDVMMPSHRR-------NFKDVYLVYELMD----TDLHQII-KSSQALTNDHCQYFLFQL 142
           +DV++    +        F+D   +Y +MD     DL  ++ K    L  D  +++L ++
Sbjct: 52  RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG--LARTSNGKNQFMTEYVVTRWYR 200
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG  L    +G  Q  +  V T  Y 
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYI 170

Query: 201 APELLLCCDN----YGTSIDVWSVG-CIFAELLGRKPIF 234
           +PE+L   ++    YG   D WS+G C++  L G  P +
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 47/278 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRT-LRELKLLRHLQHENVIA 93
           +GRG +G V  +  ++T E  AIK +        + V++L    R  +     +H  ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 94  LKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           L              V  V E     DL   I +    +     ++   ++ GL+YLH  
Sbjct: 67  LFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHEN 120

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLK  NLL++    +KI DFGL +   G     + +  T  + APE+L    +Y 
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYT 179

Query: 213 TSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            ++D W +G  I+  L+G  P FPG +                EE  + I N + R    
Sbjct: 180 RAVDWWGLGVLIYEMLVGESP-FPGDD---------------EEEVFDSIVNDEVR---- 219

Query: 272 SLPYTPGTPFSRLYPDAHPL-AIDLLQKMLVFDPTKRI 308
                        YP      AI +++++L  +P +R+
Sbjct: 220 -------------YPRFLSREAISIMRRLLRRNPERRL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 77/334 (23%), Positives = 141/334 (42%), Gaps = 62/334 (18%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           K IG+G++G V  +  +   +  A+K +           + +   K  +H+  E  + LK
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQK---------KIVLNRKEQKHIMAERNVLLK 51

Query: 96  DVMMP---SHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           +V  P       +F+    +Y ++D     +L   ++  ++      +++  ++   L Y
Sbjct: 52  NVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGY 111

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LHS NI++RDLKP N+L+++   + + DFGL +    ++   T +  T  Y APE++   
Sbjct: 112 LHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIR-K 170

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y  ++D W +G +  E+L   P F    C +  ++  NIL                  
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPF---YCRDVAEMYDNILH----------------- 210

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV----TEALQHPYMSPL-- 322
             K L   PG   +         A  +L+++L  D  +R+       E  +HP+   L  
Sbjct: 211 --KPLVLRPGASLT---------AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259

Query: 323 YD-------PSSNPPAQVPIDL-DMDEESGEEMI 348
            D       P  NP  + P D+ + D    EE +
Sbjct: 260 TDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETV 293

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 40/217 (18%)

Query: 107 KDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL 165
           ++++ V E ++  DL   I+S          ++  +++ GL++LHS  I++RDLK  N+L
Sbjct: 69  ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128

Query: 166 VNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
           ++ +  +KI DFG+ + +   +     +  T  Y APE+LL    Y TS+D WS G +  
Sbjct: 129 LDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL-GQKYNTSVDWWSFGVLLY 187

Query: 226 ELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFI--DNPKARKYIKSLPYTPGTPFS 282
           E+L G+ P                  G   EE  + I  DNP   +++            
Sbjct: 188 EMLIGQSPFH----------------GHDEEELFQSIRMDNPCYPRWLTR---------- 221

Query: 283 RLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL-QHPY 318
                    A D+L K+ V +P +R+ V   + QHP+
Sbjct: 222 --------EAKDILVKLFVREPERRLGVKGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 27/206 (13%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G +G+V      E   KVAIK I     +  D    + E +++  L H  ++ L  V
Sbjct: 12  IGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEED---FIEEAQVMMKLSHPKLVQLYGV 67

Query: 98  MMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANIL 155
                      + LV+E M+   L   +++ +   + +        +  G+ YL S+N++
Sbjct: 68  CTER-----SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI 122

Query: 156 HRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLCC 208
           HRDL   N LV  N  +K+ DFG+ R       TS+   +F       +W  +PE +   
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-----PVKW-SSPE-VFSF 175

Query: 209 DNYGTSIDVWSVGCIFAELL--GRKP 232
             Y +  DVWS G +  E+   G+ P
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 64/217 (29%), Positives = 91/217 (41%), Gaps = 36/217 (16%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEK----VAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           IK +G GA+G V   V     EK    VAIK +     +       L E  ++  + H +
Sbjct: 12  IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPH 70

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-------TDLHQIIKSSQALTNDHCQYFLFQLL 143
           V+ L  + + S       V L+ +LM           H+    SQ L N     +  Q+ 
Sbjct: 71  VVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLN-----WCVQIA 119

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------R 197
           +G+ YL    ++HRDL   N+LV     +KI DFGLA+  +       EY         +
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE---KEYHAEGGKVPIK 176

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
           W  A E +L    Y    DVWS G    EL+  G KP
Sbjct: 177 WM-ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 51/234 (21%)

Query: 35  IKPIGRGAYGIV-----CSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQH 88
            + +G GA+G V              E VA+K +     N  DA +   RE +LL + QH
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQH 67

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS--------------SQALTND 133
           EN++    V             +V+E M+  DL++ ++S                 LT  
Sbjct: 68  ENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 134 HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY 193
                  Q+  G+ YL S + +HRDL   N LV  +  +KI DFG++R     + + T+Y
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDY 177

Query: 194 --------VVTRWYRAPELLLCCDNYG---TSIDVWSVGCIFAELL--GRKPIF 234
                   +  RW   PE ++    Y    T  DVWS G +  E+   G++P +
Sbjct: 178 YRVGGHTMLPIRWM-PPESIM----YRKFTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 41/215 (19%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRG +G V S   R  N  VA+K         + A + L+E ++L+   H N++ L  V
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLIGV 61

Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR-------GLKYLH 150
                      +Y+V EL+             L  +  +  + +L++       G++YL 
Sbjct: 62  CTQKQ-----PIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEYLE 111

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR--------TSNGKNQFMTEYVVTRWYRAP 202
           S + +HRDL   N LV     LKI DFG++R        ++ G  Q     +  +W  AP
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ-----IPVKW-TAP 165

Query: 203 ELLLCCDNYG---TSIDVWSVGCIFAEL--LGRKP 232
           E L    NYG   +  DVWS G +  E   LG  P
Sbjct: 166 EAL----NYGRYSSESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 20/212 (9%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK IGRGA+G V + V  +  E++   KI N +E        L+  +     +  NV+  
Sbjct: 6   IKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWE-------MLKRAETACFREERNVLVN 57

Query: 95  KDVM-MPSHRRNFKDVYLVYELMD----TDLHQII-KSSQALTNDHCQYFLFQLLRGLKY 148
            D   + +    F+D   +Y +MD     DL  ++ K    L  D  ++++ +++  +  
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLC 207
           +H  + +HRD+KP N+L++ N  +++ DFG     N      +   V T  Y +PE+L  
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177

Query: 208 CDN----YGTSIDVWSVG-CIFAELLGRKPIF 234
            ++    YG   D WS+G C++  L G  P +
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 87/359 (24%), Positives = 145/359 (40%), Gaps = 43/359 (11%)

Query: 8   PNGIRSPGKHYYSMWQTLFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNA 66
           PN  R  G H+Y +     ++ T+   I   +G G +G V  + +R+  E  A+K + N 
Sbjct: 107 PNQSREEG-HFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV 165

Query: 67  FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD----VYLVYELMDTDLHQ 122
            +   DA   ++ ++ +R     +   L  +     +R F++    + +V       L  
Sbjct: 166 PKYTRDAKIEIQFMEKVRQADPADRFPLMKI-----QRYFQNETGHMCIVMPKYGPCLLD 220

Query: 123 IIKSSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNAN------------ 169
            I      ++ H    +FQ    L Y H+  +++H DLKP N+L+  +            
Sbjct: 221 WIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280

Query: 170 ----CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
               C ++ICD G       +    T  V TR YR+PE++L    +  S D+WS+GCI  
Sbjct: 281 PPDPCRVRICDLG---GCCDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIY 336

Query: 226 ELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL----PYTPGTPF 281
           EL   K ++   + L  L L+   LG    E        +AR    S     P T     
Sbjct: 337 ELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHL 396

Query: 282 SRLYPD-------AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQV 333
           +R+             L  DL+  +L +D  KR++  +   HPY+   Y      P   
Sbjct: 397 ARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYP 455

Length = 467

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHENVI 92
           IK IGRGA+G V    ++ + +  A+K ++  FE   R D+     E  ++ H   E ++
Sbjct: 48  IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSEWIV 106

Query: 93  ALKDVMMPSHRRNFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            L           F+D   +Y+V E M   DL  ++ S+  +     +++  +++  L  
Sbjct: 107 QLHYA--------FQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDA 157

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLC 207
           +HS   +HRD+KP N+L++ +  LK+ DFG     +       +  V T  Y +PE+L  
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 208 --CDN-YGTSIDVWSVGCIFAELL-GRKPIF 234
              D  YG   D WSVG    E+L G  P +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 14/201 (6%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           +G+G +G VC+   + T +  A KK++    + +      L E ++L     E V +   
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL-----EKVNSPFI 55

Query: 97  VMMPSHRRNFKDVYLVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
           V +     +   + LV  LM   D   H      + L  +   ++  Q+  G+ +LHS +
Sbjct: 56  VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLA-RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           I++RD+KP N+L++   + ++ D GLA    +GK   +T+   T  Y APE+L   + Y 
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILK-EEPYS 172

Query: 213 TSIDVWSVGC-IFAELLGRKP 232
             +D +++GC I+  + GR P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 75/364 (20%), Positives = 140/364 (38%), Gaps = 108/364 (29%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G GAYG V             ++K+      ++ A++ L++  L++  +       
Sbjct: 5   LKVLGTGAYGKV-----------FLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRT 53

Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIK------------SSQALTNDHCQYFLFQ 141
           +  ++   R++   V L Y    +  LH I+                  + D  +++  +
Sbjct: 54  ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-------YV 194
           ++  L++LH   I++RD+K  N+L+++   + + DFGL++      +F++E       + 
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFC 167

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSR 253
            T  Y APE++     +G ++D WS+G +  ELL G  P                 L   
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF---------------TLEGE 212

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI----- 308
           R    E      +R+ +K  P  P            P A DLL K+L  DP KR+     
Sbjct: 213 RNTQSEV-----SRRILKCDPPFP--------SFIGPEAQDLLHKLLRKDPKKRLGAGPQ 259

Query: 309 SVTEALQHPY-------------------------------------MSPLYDPSSNPPA 331
             +E  +HP+                                     + P+Y P+  PP+
Sbjct: 260 GASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPS 319

Query: 332 QVPI 335
              +
Sbjct: 320 GARV 323

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 75/323 (23%), Positives = 135/323 (41%), Gaps = 74/323 (22%)

Query: 34  PIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHENVI 92
            IK +G+G  G V     + T +  A+K ++      R    R L E ++L  L H  + 
Sbjct: 5   KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64

Query: 93  ALKDVMMPSHRRNFKDVYLVYEL-MDTDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYL 149
            L              + LV +     +L ++++    + L+ +  +++  ++L  L+YL
Sbjct: 65  TLYASFQTETY-----LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT------------------ 191
           H   I++RDLKP N+L++ +  + + DF L++ S+ +   ++                  
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 192 -----------EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTEC 239
                       +V T  Y APE ++  D +G+++D W++G +  E+L G  P       
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTTPFK----- 233

Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
                      GS R+E    I         K + +    P S         A DL++K+
Sbjct: 234 -----------GSNRDETFSNILK-------KEVTFPGSPPVSS-------SARDLIRKL 268

Query: 300 LVFDPTKRI----SVTEALQHPY 318
           LV DP+KR+       E  QHP+
Sbjct: 269 LVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 12/200 (6%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENR---VDALRTLRELKLLRHLQHENVIAL 94
           IGRG+Y  V     ++T    A+K +     N    +D ++T + +   +   H  ++ L
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGL 61

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
                   R     ++ V E ++  DL   ++  + L  +H +++  ++   L YLH   
Sbjct: 62  HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   ++YG 
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-GEDYGF 175

Query: 214 SIDVWSVGCIFAELL-GRKP 232
           S+D W++G +  E++ GR P
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 62/217 (28%), Positives = 91/217 (41%), Gaps = 40/217 (18%)

Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIK--KINNAFENRVDALRTLRELKLLRHLQH 88
           I+ +G G +G V        N  T E VA+K  K     +N        +E+ +L+ L H
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSG---WKKEINILKTLYH 65

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLF--QLLR 144
           EN++  K        +  K + L+ E   + +    + K    L     Q  LF  Q+  
Sbjct: 66  ENIVKYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA----QLLLFAQQICE 118

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-----------TSNGKNQFMTEY 193
           G+ YLHS + +HRDL   N+L++ +  +KI DFGLA+             +G +      
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF--- 175

Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR 230
               WY A E L        S DVWS G    ELL  
Sbjct: 176 ----WY-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 34/243 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  IK IG G +G V    ++ T E    K I+       +  + + E+ ++R L+H+N
Sbjct: 14  EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKN 73

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLF----QLLRG 145
           ++   D  +  ++ N K +Y++ E  D  DL + I+    +     ++ +     QLL  
Sbjct: 74  IVRYIDRFL--NKANQK-LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 146 LKYLHS-------ANILHRDLKPGNLLV-----------------NANCDLKICDFGLAR 181
           L Y H+         +LHRDLKP N+ +                 N     KI DFGL++
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 182 TSNGKNQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
              G        V T +Y +PELLL    +Y    D+W++GCI  EL   K  F      
Sbjct: 191 NI-GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249

Query: 241 NQL 243
           +QL
Sbjct: 250 SQL 252

Length = 1021

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 49/211 (23%), Positives = 106/211 (50%), Gaps = 27/211 (12%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           K IG+G++G V           +A +K + +F     A++ L++  +L+  +  +++A +
Sbjct: 1   KVIGKGSFGKVL----------LAKRKSDGSFY----AVKVLQKKTILKKKEQNHIMAER 46

Query: 96  DVMMPSHRRNF-----------KDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
           +V++ + +  F           + +Y V + ++  +L   ++  +       +++  ++ 
Sbjct: 47  NVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVA 106

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
             + YLHS NI++RDLKP N+L+++   + + DFGL +      +  + +  T  Y APE
Sbjct: 107 SAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPE 166

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
           +L   + Y  ++D W +G +  E+L   P F
Sbjct: 167 VLR-KEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 67/309 (21%), Positives = 136/309 (44%), Gaps = 60/309 (19%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G GAYG V             ++K++     ++ A++ L++  +++  +       
Sbjct: 5   LKVLGTGAYGKV-----------FLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT 53

Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIK------------SSQALTNDHCQYFLFQ 141
           +  ++   R++   V L Y    DT LH I+               +       Q +  +
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKNQFMTEYVVTRWYR 200
           ++  L++LH   I++RD+K  N+L+++N  + + DFGL++     + +    +  T  Y 
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDL 258
           AP+++   D  +  ++D WS+G +  ELL G  P     E  +Q ++             
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI------------- 220

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEA 313
                  +R+ +KS P     P+ +   +   LA D++Q++L+ DP KR+        E 
Sbjct: 221 -------SRRILKSEP-----PYPQ---EMSALAKDIIQRLLMKDPKKRLGCGPSDADEI 265

Query: 314 LQHPYMSPL 322
            +HP+   +
Sbjct: 266 KKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 31/233 (13%)

Query: 34  PIKPIGRGAYGIVCSSVNRETNEK-----VAIKKINNAFENRVDALRTLRELKLLRHLQH 88
            I  +GRG +G V  +  +   E+     V +K +    +  +      REL + R L H
Sbjct: 9   EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL-QSEFRRELDMFRKLSH 67

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIK---------SSQALTNDHCQYF 138
           +NV+ L  +      R  +  Y++ E  D  DL Q ++             L+       
Sbjct: 68  KNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN--QFMTEYVVT 196
             Q+  G+ +L +A  +HRDL   N LV++  ++K+    L++        +     +  
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG---TECLNQLK 244
           RW  APE +   D++ T  DVWS G +  E+   G  P F G    E LN+L+
Sbjct: 183 RWL-APEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELP-FYGLSDEEVLNRLQ 232

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 51/200 (25%), Positives = 97/200 (48%), Gaps = 12/200 (6%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG+Y  V     ++T    A+K I       +  +D ++T + +       H  ++ L
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLVGL 61

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
                   R     ++ V E +   DL   ++  + L  +H +++  ++   L +LH   
Sbjct: 62  HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  N+L++A   +K+ D+G+ +         + +  T  Y APE+L   ++YG 
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR-GEDYGF 175

Query: 214 SIDVWSVGCIFAELL-GRKP 232
           S+D W++G +  E++ GR P
Sbjct: 176 SVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 26/222 (11%)

Query: 26  FEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +EID   +  ++ +G G +G V   +   T   VA+K +       +D    L E ++++
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMK 56

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQY-----FL 139
            L+H  +I L  V         + +Y+V ELM      +++  Q       +        
Sbjct: 57  KLRHPKLIQLYAVCTLE-----EPIYIVTELMKYG--SLLEYLQGGAGRALKLPQLIDMA 109

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW- 198
            Q+  G+ YL + N +HRDL   N+LV  N   K+ DFGLAR    K          ++ 
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKFP 167

Query: 199 --YRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPG 236
             + APE  L  + +    DVWS G +  E++  GR P +PG
Sbjct: 168 IKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 49/220 (22%)

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT 196
           ++  +++ GL++LHS  I++RDLK  N++++ +  +KI DFG+ + +   +   + +  T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRRE 255
             Y APE+L     Y  S+D WS G +  E+L G+ P                  G   +
Sbjct: 160 PDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFH----------------GDDED 202

Query: 256 EDLEFI--DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
           E  E I  D P   ++I        T  S+          D+L+K+   DPT+R+ V   
Sbjct: 203 ELFESIRVDTPHYPRWI--------TKESK----------DILEKLFERDPTRRLGVVGN 244

Query: 314 LQ-HPYMSPL---------YDPSSNPPAQVPIDL-DMDEE 342
           ++ HP+   +          DP   P  + P D  + D E
Sbjct: 245 IRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDRE 284

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 81/310 (26%), Positives = 123/310 (39%), Gaps = 43/310 (13%)

Query: 28  IDTKYVPIKPIGRGAYG--IVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLR 84
           +  +Y  +  +  G+ G   VC+    E  +KV +K +           +T  RE+ +L+
Sbjct: 90  VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILK 141

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
            + H  +I L         R    V +V      DL   +  S  L  +       +LL 
Sbjct: 142 TISHRAIINLIHAY-----RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLE 196

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY--VVTRWYRAP 202
            L YLH   I+HRD+K  N+ ++   +  + DFG A   +        Y    T    +P
Sbjct: 197 ALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSP 256

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE---CLNQLKLIINILGSRREEDLE 259
           E LL  D Y    D+WS G +  E+  +     G +     +QL+ II  +   +   LE
Sbjct: 257 E-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM---QVHPLE 312

Query: 260 FIDNPKAR------KYIKSL--PYT-PGTPFSRLYPDAHPLAID---LLQKMLVFDPTKR 307
           F  N          +Y   L  PYT P  P  R Y     + +D   L+ KML FD   R
Sbjct: 313 FPQNGSTNLCKHFKQYAIVLRPPYTIP--PVIRKY----GMHMDVEYLIAKMLTFDQEFR 366

Query: 308 ISVTEALQHP 317
            S  + L  P
Sbjct: 367 PSAQDILSLP 376

Length = 392

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 9/216 (4%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHEN 90
           +  ++ IG+G++G V   ++  T E VAIK I+   E   D +  ++ E+ +L       
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +       +   +     ++++ E +       +     L   +    L ++L+GL YLH
Sbjct: 64  ITRYYGSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S   +HRD+K  N+L++   D+K+ DFG+A            +V T ++ APE++     
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK-QSA 177

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI 246
           Y    D+WS+G    EL   +P       +  L LI
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 38/126 (30%), Positives = 73/126 (57%), Gaps = 3/126 (2%)

Query: 109 VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN 167
           ++LV E ++  DL   ++  + L  +H +++  ++   L +LH   I++RDLK  N+L++
Sbjct: 71  LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130

Query: 168 ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL 227
           A+  +K+ D+G+ +   G     + +  T  Y APE+L   + YG S+D W++G +  E+
Sbjct: 131 ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEM 189

Query: 228 L-GRKP 232
           + GR P
Sbjct: 190 MAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 67/270 (24%), Positives = 111/270 (41%), Gaps = 70/270 (25%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +V IK IG GA+G VC            ++K++    N + A++TLR+  +L   Q  +V
Sbjct: 3   FVKIKTIGIGAFGEVC-----------LVRKVDT---NALYAMKTLRKADVLMRNQAAHV 48

Query: 92  IALKDVMMPSHRR-------NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLF 140
            A +D++  +          +F+D   +Y +MD     D+  ++        D  ++++ 
Sbjct: 49  KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA 108

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA--------RTSNGKNQFMTE 192
           +L   ++ +H    +HRD+KP N+L++ +  +K+ DFGL              K     +
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168

Query: 193 -----------------------------------YVVTRWYRAPELLLCCDNYGTSIDV 217
                                               V T  Y APE+LL    Y    D 
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDW 227

Query: 218 WSVGCIFAELL-GRKPIFPGTECLNQLKLI 246
           WSVG I  E+L G+ P    T    QLK+I
Sbjct: 228 WSVGVILYEMLVGQPPFLADTPAETQLKVI 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 16/220 (7%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLR-HLQHENV 91
           K +G+G++G V  +  + T+E  AIK +       ++ VD   T+ E ++L    +H  +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDC--TMTEKRILALAAKHPFL 58

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
            AL        R     ++ V E ++  DL   I+ S+       +++  ++   L +LH
Sbjct: 59  TALHCCFQTKDR-----LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              +++RDLK  N+L++A    K+ DFG+ +         T +  T  Y APE+L   + 
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE- 172

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL 250
           YG S+D W++G +  E++  +P F   E  N+  L  +IL
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPF---EADNEDDLFESIL 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 32/215 (14%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANI 154
              +    F   Y++ E M   +L   ++    Q +      Y   Q+   ++YL   N 
Sbjct: 71  C--TREPPF---YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT---------RWYRAPELL 205
           +HRDL   N LV  N  +K+ DFGL+R        MT    T         +W  APE  
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSR-------LMTGDTYTAHAGAKFPIKW-TAPE-S 176

Query: 206 LCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
           L  + +    DVW+ G +  E+   G  P +PG +
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGID 210

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 12/219 (5%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHEN 90
           +  ++ IG+G++G V   ++  T + VAIK I+   E   D +  ++ E+ +L       
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           V         S+ ++ K ++++ E +       +     L        L ++L+GL YLH
Sbjct: 64  VTK----YYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S   +HRD+K  N+L++ + ++K+ DFG+A            +V T ++ APE++     
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK-QSA 177

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
           Y +  D+WS+G    EL   +P  P +E L+ +K++  I
Sbjct: 178 YDSKADIWSLGITAIELAKGEP--PHSE-LHPMKVLFLI 213

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 32/213 (15%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V     ++    VA+K         +  ++ L E ++L+   H N++ L  V
Sbjct: 3   LGKGNFGEVFKGTLKDKT-PVAVKTCKEDLPQELK-IKFLSEARILKQYDHPNIVKLIGV 60

Query: 98  MMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
              + R   + +Y+V EL+     L  + K    L       F      G+ YL S N +
Sbjct: 61  C--TQR---QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115

Query: 156 HRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLCC 208
           HRDL   N LV  N  LKI DFG++R       +S+G  Q     +  +W  APE L   
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-----IPIKW-TAPEAL--- 166

Query: 209 DNYG---TSIDVWSVGCIFAEL--LGRKPIFPG 236
            NYG   +  DVWS G +  E   LG  P +PG
Sbjct: 167 -NYGRYSSESDVWSYGILLWETFSLGVCP-YPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  L+H N++ L
Sbjct: 11  LQTIGKGEFGDVMLGDYRGN--KVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL +
Sbjct: 65  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + ++      T  +  +W  APE L     +
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALR-EKKF 176

Query: 212 GTSIDVWSVGCIFAEL--LGRKP 232
            T  DVWS G +  E+   GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.9 bits (160), Expect = 4e-12
 Identities = 63/240 (26%), Positives = 113/240 (47%), Gaps = 38/240 (15%)

Query: 36  KPIGRGAYGIV----CSSVNRETNE-KVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           + +G GA+G V    C ++  E ++  VA+K + +A +N        RE +LL +LQHE+
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELLTNLQHEH 68

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS-------------SQALTNDHCQ 136
           ++    V +         + +V+E M   DL++ +++                LT     
Sbjct: 69  IVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT---EY 193
           +   Q+  G+ YL S + +HRDL   N LV  N  +KI DFG++R     + +       
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183

Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGT-----ECLNQLKLI 246
           +  RW   PE ++    + T  DVWS+G +  E+   G++P +  +     EC+ Q +++
Sbjct: 184 LPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 19/210 (9%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIK--KINNAFENRVDALRTLRELKLLRHLQHENVI 92
           +  +G+G++G V  +  + T+E  AIK  K +   ++  D   T+ E         + V+
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD-DVECTMVE---------KRVL 54

Query: 93  ALKD-----VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGL 146
           AL         + S  +    +Y V E ++  DL   I+        H  ++  ++  GL
Sbjct: 55  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGL 114

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            +LHS  I++RDLK  N++++A   +KI DFG+ + +    +    +  T  Y APE++ 
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
               YG S+D W+ G +  E+L  +P F G
Sbjct: 175 -YQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 14/201 (6%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           +G+G +G VC+   R T +  A KK+     + R      L E ++L  +    V++L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-- 65

Query: 97  VMMPSHRRNFKDVY-LVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
               ++    KD   LV  +M   D   H     +         ++  +L  GL+ L   
Sbjct: 66  ----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++    ++I D GLA     + + +   V T  Y APE++   + Y 
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRVGTVGYMAPEVIN-NEKYT 179

Query: 213 TSIDVWSVGCIFAELL-GRKP 232
            S D W +GC+  E++ G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 65.1 bits (158), Expect = 6e-12
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 22/220 (10%)

Query: 36  KPIGRGAYGIVCSSV--NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA 93
           K +G G +G V        ++  KVA+K +  A   R +    L E   ++   H NV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 94  LKDV-MMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLL-------- 143
           L  V +       +    ++   M   DLH  +  S+    D  QY   Q+L        
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR--LGDCPQYLPTQMLVKFMTDIA 122

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGK--NQFMTEYVVTRWYR 200
            G++YL S + +HRDL   N ++N N ++ + DFGL++   NG    Q     +  +W  
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAELLGR-KPIFPGTE 238
              L    D  Y T  DVWS G    E+  R +  +PG E
Sbjct: 183 IESL---ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 23/217 (10%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 14  LGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K    + L          Q+  G+ Y+   N 
Sbjct: 70  V------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 181

Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 217

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.1 bits (158), Expect = 7e-12
 Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 9/202 (4%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHEN 90
           +  ++ IG+G++G V   ++  T + VAIK I+   E   D +  ++ E+ +L       
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           V       +   +     ++++ E +       +  +           L ++L+GL YLH
Sbjct: 64  VTKYYGSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S   +HRD+K  N+L++   D+K+ DFG+A            +V T ++ APE++     
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ-QSA 177

Query: 211 YGTSIDVWSVGCIFAELLGRKP 232
           Y +  D+WS+G    EL   +P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.7 bits (158), Expect = 7e-12
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 47/222 (21%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT----------LRELKLLRH 85
           K +G G++G+V     R        K I  A    V  L++          L+E  ++  
Sbjct: 1   KKLGDGSFGVV----RRGEWSTSGGKVIPVA----VKCLKSDKLSDIMDDFLKEAAIMHS 52

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYE------LMDTDLHQIIKSSQALTNDHCQYFL 139
           L HEN+I L  V++         + +V E      L+D  L +       ++   C Y +
Sbjct: 53  LDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDR-LRKDALGHFLIST-LCDYAV 104

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEY--VV 195
            Q+  G++YL S   +HRDL   N+L+ ++  +KI DFGL R    N  +  M E+  V 
Sbjct: 105 -QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163

Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKP 232
             W  APE L       T   + DVW  G    E+   G +P
Sbjct: 164 FAWC-APESL----RTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 25/162 (15%)

Query: 76  TLRELKLLRHLQHENVIALKDV---------MMPSHRRNFKDVYLVYELMDTDLHQIIKS 126
           ++ E +LLR L H  V+AL DV         ++P +R +    YL   L    L Q+   
Sbjct: 207 SVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLY-TYLGARLRPLGLAQVTAV 265

Query: 127 SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK 186
           ++            QLL  + Y+H   I+HRD+K  N+LVN   D+ + DFG A  + G 
Sbjct: 266 AR------------QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 187 NQFMTEYVV--TRWYRAPELLLCCDNYGTSIDVWSVGCIFAE 226
                 Y +  T    APE +L  D Y  S+D+WS G +  E
Sbjct: 314 WSTPFHYGIAGTVDTNAPE-VLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 54/196 (27%), Positives = 83/196 (42%), Gaps = 43/196 (21%)

Query: 58  VAIKKINNAFENRVDALRT-----LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV 112
           VA+K +      R DA        L+E+K+L  L   N+  L  V           + ++
Sbjct: 49  VAVKVL------RPDASDNAREDFLKEVKILSRLSDPNIARLLGVC-----TVDPPLCMI 97

Query: 113 YELMDT-DLHQIIKSSQALTNDHCQYFLF-----------QLLRGLKYLHSANILHRDLK 160
            E M+  DL+Q ++   A T+                   Q+  G++YL S N +HRDL 
Sbjct: 98  MEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157

Query: 161 PGNLLVNANCDLKICDFGLARTSNGKNQFMTEY--------VVTRWYRAPELLLCCDNYG 212
             N LV  N  +KI DFG++R     N + ++Y        +  RW     +LL    + 
Sbjct: 158 TRNCLVGKNYTIKIADFGMSR-----NLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFT 210

Query: 213 TSIDVWSVGCIFAELL 228
           T  DVW+ G    E+L
Sbjct: 211 TKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 44/116 (37%), Positives = 66/116 (56%), Gaps = 10/116 (8%)

Query: 127 SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK 186
           S+ LT      F +Q+ RG+++L S N +HRDL   N+L+     +KICDFGLAR     
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 187 NQFMTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           + ++++   ++  +W  APE +   DN Y T  DVWS G +  E+  LG  P +PG
Sbjct: 291 SNYVSKGSTFLPVKWM-APESIF--DNLYTTLSDVWSYGILLWEIFSLGGTP-YPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 27/209 (12%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G G +G+V     R   + VAIK I    E  +     + E K++  L HE ++ L
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQL 64

Query: 95  KDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
             V         + +Y+V E M     L+ + +  +             +  G+ YL S 
Sbjct: 65  YGVCTKQ-----RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELL 205
             +HRDL   N LV+    +K+ DFGL+R       TS+  ++F       RW   PE+L
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-----PVRW-SPPEVL 173

Query: 206 LCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           L    + +  DVW+ G +  E+  LG+ P
Sbjct: 174 LYS-KFSSKSDVWAFGVLMWEVYSLGKMP 201

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 38/227 (16%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           FEI      +K IGRGA+G            +VA+ K+ N    +V A++ L + ++L+ 
Sbjct: 3   FEI------LKVIGRGAFG------------EVAVVKMKNT--GQVYAMKILNKWEMLKR 42

Query: 86  LQHENVIALKDVMMPSHRR-------NFKDVYLVYELMD----TDLHQII-KSSQALTND 133
            +       +DV++   RR        F+D   +Y +MD     DL  ++ K    L  D
Sbjct: 43  AETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED 102

Query: 134 HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY 193
             +++L +++  +  +H    +HRD+KP N+L++ N  +++ DFG            +  
Sbjct: 103 MARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV 162

Query: 194 VV-TRWYRAPELLLCCDN----YGTSIDVWSVG-CIFAELLGRKPIF 234
            V T  Y +PE+L   ++    YG   D WS+G C++  L G  P +
Sbjct: 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 38/124 (30%), Positives = 70/124 (56%), Gaps = 4/124 (3%)

Query: 111 LVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
            + +LM+  DLH  +      +    +++  +++ GL+++H+  +++RDLKP N+L++ +
Sbjct: 74  FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH 133

Query: 170 CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL- 228
             ++I D GLA   + K    +  V T  Y APE+L     Y +S D +S+GC+  +LL 
Sbjct: 134 GHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191

Query: 229 GRKP 232
           G  P
Sbjct: 192 GHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 42/109 (38%), Positives = 56/109 (51%), Gaps = 18/109 (16%)

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-TSNGKNQFMTEYVV- 195
           F  Q+ +G+ +L S N +HRD+   N+L+      KICDFGLAR   N  N     YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-----YVVK 271

Query: 196 ------TRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
                  +W  APE +  C  Y    DVWS G +  E+  LG+ P +PG
Sbjct: 272 GNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 27/213 (12%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G G +G V       +  KVA+K +     + V A   L E  L++ LQH+ ++ L
Sbjct: 11  VKKLGAGQFGEVWMGYYNNST-KVAVKTLKPGTMS-VQAF--LEEANLMKTLQHDKLVRL 66

Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHS 151
             V+        + +Y++ E M    L   +KS +   +       F  Q+  G+ Y+  
Sbjct: 67  YAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YVVTRWYRAPELLLCC 208
            N +HRDL+  N+LV+ +   KI DFGLAR     N++          +W  APE +   
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKW-TAPEAI--- 176

Query: 209 DNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            N+G+     DVWS G +  E++  G+ P +PG
Sbjct: 177 -NFGSFTIKSDVWSFGILLYEIVTYGKIP-YPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 44/130 (33%), Positives = 67/130 (51%), Gaps = 7/130 (5%)

Query: 108 DVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN 167
           D YL      T    +I  S AL+      F +Q+  G+++L S N +HRDL   N+L+ 
Sbjct: 214 DQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273

Query: 168 ANCDLKICDFGLARTSNGKNQFMTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIF 224
               +KICDFGLAR     + ++++   ++  +W  APE +   + Y T  DVWS G + 
Sbjct: 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIF-NNLYTTLSDVWSFGILL 331

Query: 225 AEL--LGRKP 232
            E+  LG  P
Sbjct: 332 WEIFTLGGTP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 15/211 (7%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHE 89
           Y  +K IGRGA+G V   V  ++++KV   K+ + FE   R D+     E  ++      
Sbjct: 45  YDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            V+ L         ++ K +Y+V E M   DL  ++ S+  +     +++  +++  L  
Sbjct: 104 WVVQLFCAF-----QDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDA 157

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLC 207
           +HS  ++HRD+KP N+L++ +  LK+ DFG     +       +  V T  Y +PE+L  
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217

Query: 208 CDN---YGTSIDVWSVGC-IFAELLGRKPIF 234
                 YG   D WSVG  +F  L+G  P +
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 66/242 (27%), Positives = 108/242 (44%), Gaps = 52/242 (21%)

Query: 38  IGRGAYGIV----CSSVNRETNEK-VAIKKINNAFEN-RVDALRTLRELKLLRHLQHENV 91
           +G GA+G V    C ++  E ++  VA+K +  A E+ R D     RE +LL  LQH+++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD---FQREAELLTVLQHQHI 69

Query: 92  IALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQ---------------ALTNDHC 135
           +    V         + + +V+E M   DL++ ++S                  LT    
Sbjct: 70  VRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY-- 193
                Q+  G+ YL S + +HRDL   N LV     +KI DFG++R     + + T+Y  
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYR 179

Query: 194 ------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF-----PGTECL 240
                 +  RW   PE +L    + T  D+WS G +  E+   G++P +        EC+
Sbjct: 180 VGGRTMLPIRWM-PPESIL-YRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237

Query: 241 NQ 242
            Q
Sbjct: 238 TQ 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 17/211 (8%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHENVIA 93
           +  +G+G++G V  +  + T+E  AIK +      + D +  T+ E         + V+A
Sbjct: 5   LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVE---------KRVLA 55

Query: 94  LKD-----VMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           L         + S  +    +Y V E ++  DL   I+        H  ++  ++  GL 
Sbjct: 56  LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           +LHS  I++RDLK  N+++++   +KI DFG+ + +         +  T  Y APE ++ 
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE-IIA 174

Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTE 238
              YG S+D W+ G +  E+L  +  F G +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)

Query: 38  IGRGAYGIVCSSVNRETN---EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +G+G +G V  +  +  +   +KVA+K +     +  D    LRE   ++   H NVI L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 95  KDVMMPSHRRNFKDVYLVYE--LMDTDLHQIIKSSQ------ALTNDHCQYFLFQLLRGL 146
             V + S  +    + +V    +   DLH  +  S+       L       F+  +  G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRAPE 203
           +YL S N +HRDL   N ++N N  + + DFGL++   + +   Q     +  +W     
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186

Query: 204 LLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
           L    DN Y T  DVW+ G    E+   G+ P + G E
Sbjct: 187 L---ADNVYTTHSDVWAFGVTMWEIMTRGQTP-YAGVE 220

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 68/274 (24%), Positives = 112/274 (40%), Gaps = 74/274 (27%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +V IK +G GA+G VC +   +T+   A+K              TLR+  +L   Q  +V
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMK--------------TLRKKDVLNRNQVAHV 48

Query: 92  IALKDVMMPSHRR-------NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLF 140
            A +D++  +          +F+D   +Y +MD     D+  ++   +       ++++ 
Sbjct: 49  KAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGK---------- 186
           +L   ++ +H    +HRD+KP N+L++ +  +K+ DFGL      T N K          
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQ 168

Query: 187 ------------------NQFMT---------------EYVVTRWYRAPELLLCCDNYGT 213
                             ++  T                 V T  Y APE+LL    Y  
Sbjct: 169 DSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQ 227

Query: 214 SIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLI 246
             D WSVG I  E+L G+ P    T    QLK+I
Sbjct: 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.9 bits (150), Expect = 6e-11
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 23/220 (10%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G +G V        N KVA+K +       +     L E ++++ L+H+ ++ L
Sbjct: 11  IKKLGNGQFGEVWMGT-WNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQL 66

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHS 151
             V+      + + +Y+V E M    L   +K    +AL   +      Q+  G+ Y+  
Sbjct: 67  YAVV------SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCD 209
            N +HRDL+  N+LV      KI DFGLAR    N            +W  APE  L   
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YG 178

Query: 210 NYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
            +    DVWS G +  EL+  GR P +PG    E L Q++
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP-YPGMNNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 31/219 (14%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IGRGA+G               ++ + +    +V A++ L + ++++       
Sbjct: 45  YEVVKVIGRGAFG--------------EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 90

Query: 92  IALKDVMMPSHRR-------NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLF 140
              +D+M  ++          F+D   +Y+V E M   DL  ++ S+  +     +++  
Sbjct: 91  WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTA 149

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWY 199
           +++  L  +HS   +HRD+KP N+L++ +  LK+ DFG     N +     +  V T  Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209

Query: 200 RAPELLLCCDN---YGTSIDVWSVGCIFAELL-GRKPIF 234
            +PE+L        YG   D WSVG    E+L G  P +
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 47/150 (31%), Positives = 68/150 (45%), Gaps = 23/150 (15%)

Query: 96  DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
           D        ++ D  +  E+++ D         AL  +    F +Q+ +G+ +L S N +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED-------ELALDTEDLLSFSYQVAKGMSFLASKNCI 236

Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-------TRWYRAPELLLCC 208
           HRDL   N+L+      KICDFGLAR         + YVV        +W  APE +  C
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRND----SNYVVKGNARLPVKWM-APESIFNC 291

Query: 209 DNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             Y    DVWS G +  E+  LG  P +PG
Sbjct: 292 -VYTFESDVWSYGILLWEIFSLGSSP-YPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 29/218 (13%)

Query: 34  PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHENVI 92
            +  +G+G++G V  +  + T+E  AIK +      + D +  T+ E         + V+
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVE---------KRVL 54

Query: 93  ALKD-----VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGL 146
           AL+D       + S  +    +Y V E ++  DL   I+           ++  ++  GL
Sbjct: 55  ALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGL 114

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW------YR 200
            +LH   I++RDLK  N+++++   +KI DFG+ +        M + V TR       Y 
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH------MVDGVTTRTFCGTPDYI 168

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE 238
           APE ++    YG S+D W+ G +  E+L  +P F G +
Sbjct: 169 APE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 34/192 (17%)

Query: 58  VAIKKINNAFENRVDALRT-----LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV 112
           VA+K +      R D  +T     L+E+K++  L++ N+I L  V +         + ++
Sbjct: 47  VAVKML------RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMI 95

Query: 113 YELMDT-DLHQI-----IKSSQALTND-------HCQYFLFQLLRGLKYLHSANILHRDL 159
            E M+  DL+Q      I+S+    N+       +  Y   Q+  G+KYL S N +HRDL
Sbjct: 96  TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL 155

Query: 160 KPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YVVTRWYRAPELLLCCDNYGTSID 216
              N LV  +  +KI DFG++R     + +  +    +  RW     +LL    + T+ D
Sbjct: 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASD 213

Query: 217 VWSVGCIFAELL 228
           VW+ G    E+ 
Sbjct: 214 VWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 8e-11
 Identities = 65/301 (21%), Positives = 118/301 (39%), Gaps = 82/301 (27%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K IG+GA+G           E   ++K +     ++ A++TL + ++ +  Q  +V A 
Sbjct: 6   VKVIGKGAFG-----------EVRLVQKKDTG---KIYAMKTLLKSEMFKKDQLAHVKAE 51

Query: 95  KDVMMPSHR-------RNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLL 143
           +DV+  S          +F+D   +Y +M+     DL  ++      + D  ++++ + +
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA----------------------R 181
             ++ +H    +HRD+KP N+L++    +K+ DFGL+                       
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKN 171

Query: 182 TSNGKNQFMTEYV---------VTRW----------------YRAPELLLCCDNYGTSID 216
             + +N    + +         +  W                Y APE+ L    YG   D
Sbjct: 172 RIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL-QQGYGQECD 230

Query: 217 VWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN----PKARKYIKS 272
            WS+G I  E L   P F         + IIN       E L F D+     +A   I+ 
Sbjct: 231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINW-----RETLYFPDDIHLSVEAEDLIRR 285

Query: 273 L 273
           L
Sbjct: 286 L 286

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 27/236 (11%)

Query: 12  RSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV 71
           +   K Y+        I         +G GA G V  +      E  A+K ++    +  
Sbjct: 28  KEQAKKYW--------ISRV------LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA 73

Query: 72  DALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSS 127
           D  R   E+  L +    +++   +       RN ++V ++  ++D     DL Q IKS 
Sbjct: 74  DKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKS- 132

Query: 128 QALTN----DHCQYFLF-QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR- 181
           +A TN    +H    LF Q+L  + ++HS +++HRD+K  N+L+ +N  +K+ DFG ++ 
Sbjct: 133 RAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192

Query: 182 -TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
             +   +     +  T +Y APE+      Y    D++S+G +  ELL  K  F G
Sbjct: 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDG 247

Length = 496

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 47/228 (20%)

Query: 35  IKPIGRGAYGIV-------CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           I+ +G+G++G+V             ET  +VAIK   N   +  + +  L E  +++   
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPET--RVAIK-TVNENASMRERIEFLNEASVMKEFN 67

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHC--------QYF 138
             +V+ L  V+            +V ELM   DL   ++S +    ++         Q F
Sbjct: 68  CHHVVRLLGVVSTGQP-----TLVVMELMAKGDLKSYLRSRRP-EAENNPGLGPPTLQKF 121

Query: 139 L---FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY-- 193
           +    ++  G+ YL +   +HRDL   N +V  +  +KI DFG+ R     + + T+Y  
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYR 176

Query: 194 ------VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKP 232
                 +  RW  APE L   D  + T  DVWS G +  E+  L  +P
Sbjct: 177 KGGKGLLPVRWM-APESLK--DGVFTTKSDVWSFGVVLWEMATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 54/202 (26%), Positives = 82/202 (40%), Gaps = 29/202 (14%)

Query: 53  ETNEKVAIKKINNAFENRVDALRTLRELKLLR-------HLQHENVIALKDVMMPSHRRN 105
            T  +VAIK +      R DA     +    R        L H N++AL D         
Sbjct: 1   MTGHEVAIKLL------RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL- 53

Query: 106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNL 164
              ++ V+E +    L +++ +  AL        + Q+L  L   H+  I+HRDLKP N+
Sbjct: 54  ---LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNI 110

Query: 165 LVNANCD---LKICDFGLARTSNGKNQFM-------TEYVVTRWYRAPELLLCCDNYGTS 214
           +V+        K+ DFG+     G            TE + T  Y APE L        S
Sbjct: 111 MVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS 170

Query: 215 IDVWSVGCIFAELLGRKPIFPG 236
            D+++ G IF E L  + +  G
Sbjct: 171 -DLYAWGLIFLECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 38/124 (30%), Positives = 70/124 (56%), Gaps = 4/124 (3%)

Query: 111 LVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
            + +LM+  DLH  +      +    +++  +++ GL+++H+  +++RDLKP N+L++ +
Sbjct: 74  FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 133

Query: 170 CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL- 228
             ++I D GLA   + K    +  V T  Y APE+L     Y +S D +S+GC+  +LL 
Sbjct: 134 GHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191

Query: 229 GRKP 232
           G  P
Sbjct: 192 GHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 32/172 (18%)

Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA------ 129
           L+E+K++  L+  N+I L  V + S       + ++ E M+  DL+Q +   +       
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEK 121

Query: 130 -----LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN 184
                ++     +   Q+  G+KYL S N +HRDL   N LV  N  +KI DFG++R   
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--- 178

Query: 185 GKNQFMTEY--------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
             N +  +Y        +  RW     +LL    + T+ DVW+ G    E+L
Sbjct: 179 --NLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 74/274 (27%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +V IK +G GA+G VC +   +T    A+K              TLR+  +L   Q  +V
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMK--------------TLRKKDVLLRNQVAHV 48

Query: 92  IALKDVMMPSHRR-------NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLF 140
            A +D++  +          +F+D   +Y +MD     D+  ++        D  ++++ 
Sbjct: 49  KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGKN--------- 187
           +L   ++ +H    +HRD+KP N+L++ +  +K+ DFGL      T + K          
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQ 168

Query: 188 ---QFMTEY-------------------------------VVTRWYRAPELLLCCDNYGT 213
               F  E+                               V T  Y APE+LL    Y  
Sbjct: 169 DSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQ 227

Query: 214 SIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLI 246
             D WSVG I  E+L G+ P    T    Q+K+I
Sbjct: 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 10/113 (8%)

Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           LT +    + FQ+ +G+++L S   +HRDL   N+L++ N  +KICDFGLAR       +
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           + +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 236 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 76/353 (21%), Positives = 137/353 (38%), Gaps = 93/353 (26%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K IGRGA+G V     ++T                + A++ LR+  +L   Q  ++ A 
Sbjct: 6   LKVIGRGAFGEVRLVQKKDTGH--------------IYAMKILRKADMLEKEQVAHIRAE 51

Query: 95  KDVMMPSHR----------RNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLL 143
           +D+++ +            ++ +++YL+ E +   D+  ++     L+ +  Q+++ + +
Sbjct: 52  RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-------RTSNGKN--------- 187
             +  +H    +HRD+KP NLL++A   +K+ DFGL        RT   +N         
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171

Query: 188 -------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
                              Q     V T  Y APE+ +    Y    D WS+G I  E+L
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEML 230

Query: 229 GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDA 288
              P F         + ++N                    + ++L + P  P S      
Sbjct: 231 IGYPPFCSETPQETYRKVMN--------------------WKETLVFPPEVPISE----- 265

Query: 289 HPLAIDLLQKMLVFDPTKRI---SVTEALQHPYMSPL-YDPSSNPPAQVPIDL 337
              A DL+ +    D   RI    V E   HP+   + +      PA +PI++
Sbjct: 266 --KAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEI 315

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 60/246 (24%), Positives = 103/246 (41%), Gaps = 61/246 (24%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K IGRGA+G V     ++T                V A++ LR+  +L   Q  ++ A 
Sbjct: 6   LKVIGRGAFGEVRLVQKKDTGH--------------VYAMKILRKADMLEKEQVGHIRAE 51

Query: 95  KDVMMPSHR-------RNFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLL 143
           +D+++ +          +F+D   +YL+ E +   D+  ++     LT +  Q+++ + +
Sbjct: 52  RDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-------RTSNGKN--------- 187
             +  +H    +HRD+KP NLL+++   +K+ DFGL        RT   +N         
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 188 -------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
                              Q     V T  Y APE+ +    Y    D WS+G I  E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEML 230

Query: 229 GRKPIF 234
              P F
Sbjct: 231 IGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 40/107 (37%), Positives = 60/107 (56%), Gaps = 10/107 (9%)

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM---TEYV 194
           + FQ+ RG+++L S   +HRDL   N+L++ N  +KICDFGLAR       ++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 195 VTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
             +W  APE +   D  Y T  DVWS G +  E+  LG  P +PG +
Sbjct: 239 PLKWM-APESIF--DKVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQ 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 45/122 (36%), Positives = 64/122 (52%), Gaps = 18/122 (14%)

Query: 125 KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN 184
              + LT +    + FQ+ RG+++L S   +HRDL   N+L++ N  +KICDFGLAR   
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224

Query: 185 GKNQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIF 234
            K+    +YV         +W  APE +   D  Y T  DVWS G +  E+  LG  P +
Sbjct: 225 -KD---PDYVRKGDARLPLKWM-APESIF--DKVYTTQSDVWSFGVLLWEIFSLGASP-Y 276

Query: 235 PG 236
           PG
Sbjct: 277 PG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 12/206 (5%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVIAL 94
           +G+G++G V  +  +E+    A+K +       ++ V+   T + +  L    H  +  L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
                   R     ++ V E ++  DL   I+ S+       +++  ++   L +LH   
Sbjct: 62  YCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           I++RDLK  N+L++     K+ DFG+ +      +  + +  T  Y APE+L     YG 
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ-EMLYGP 175

Query: 214 SIDVWSVGCIFAELL-GRKPIFPGTE 238
           S+D W++G +  E+L G  P     E
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 45/232 (19%)

Query: 35  IKPIGRGAYGIV-----CSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQ 87
           ++ +G GA+G V          R +   VAIK +    EN    ++    +E +L+  LQ
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK---ENAEPKVQQEFRQEAELMSDLQ 66

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQAL 130
           H N++ L  V         +   +++E +   DLH+ +                    +L
Sbjct: 67  HPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKN 187
                 +   Q+  G++YL S + +HRDL   N LV     +KI DFGL+R   +++   
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181

Query: 188 QFMTEYVVTRWYRAPELLLCCDNYG---TSIDVWSVGCIFAELL--GRKPIF 234
                 +  RW   PE +L    YG   T  D+WS G +  E+   G +P +
Sbjct: 182 VQSKSLLPVRWM-PPEAIL----YGKFTTESDIWSFGVVLWEIFSYGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 25/222 (11%)

Query: 36  KPIGRGAYGIVCS---SVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           K +G G +G V     S +  +  KVA+K +        +    L E   ++   H NV+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 93  ALKDVMMPSHRRN-FKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL------- 143
            L  V   +          ++   M   DLH  +  S+       +    Q L       
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVDI 122

Query: 144 -RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGK--NQFMTEYVVTRWY 199
             G++YL + N +HRDL   N ++  +  + + DFGL++   +G    Q     +  +W 
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 200 RAPELLLCCDN-YGTSIDVWSVGCIFAELL--GRKPIFPGTE 238
            A E L   D  Y +  DVW+ G    E+   G+ P +PG E
Sbjct: 183 -AIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTP-YPGVE 220

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 65/302 (21%)

Query: 54  TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF---KDVY 110
           TN  VA+KKIN    ++ D     +E+   R LQH N++         +  +F    ++Y
Sbjct: 24  TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--------PYVTSFIVDSELY 75

Query: 111 LVYELMDTDLHQIIKSSQALTNDHC---------QYFLFQLLRGLKYLHSANILHRDLKP 161
           +V  LM         S + L   H           + L  +L  L Y+HS   +HR +K 
Sbjct: 76  VVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKA 129

Query: 162 GNLLVNANCDLKICDFGLART--SNGKNQ-----FMTEYVVTRWYRAPELLLCCDN---Y 211
            ++L++ +  + +     + +   +GK Q     F    V    + +PE+L    N   Y
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ--QNLQGY 187

Query: 212 GTSIDVWSVGCIFAELL-GRKPIF--PGTECLNQLKL-----------IINILGSRREED 257
               D++SVG    EL  G  P    P T+ L + K+              +      + 
Sbjct: 188 NEKSDIYSVGITACELANGHVPFKDMPATQMLLE-KVRGTVPCLLDKSTYPLYEDSMSQS 246

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
               ++P  R        +   P++R +    H      LQ+    DP  R S ++ L H
Sbjct: 247 RSSNEHPNNRD-------SVDHPYTRTFSEHFHQFVELCLQR----DPESRPSASQLLNH 295

Query: 317 PY 318
            +
Sbjct: 296 SF 297

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 45/245 (18%)

Query: 36  KPIGRGAYGIV----CSSVNRETNEK--VAIKKINN-AFENRVDALRTLRELKLLRHLQH 88
           + +G GA+G V    C +++  T +K  VA+K + +     R D     RE +LL +LQH
Sbjct: 11  RELGEGAFGKVFLAECYNLS-PTKDKMLVAVKALKDPTLAARKD---FQREAELLTNLQH 66

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIK----------------SSQALT 131
           E+++    V           + +V+E M   DL++ ++                +   L 
Sbjct: 67  EHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 132 NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT 191
                +   Q+  G+ YL S + +HRDL   N LV AN  +KI DFG++R     + +  
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 192 ---EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGT-----ECLN 241
                +  RW   PE ++    + T  DVWS G I  E+   G++P F  +     EC+ 
Sbjct: 182 GGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239

Query: 242 QLKLI 246
           Q +++
Sbjct: 240 QGRVL 244

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 70/253 (27%), Positives = 112/253 (44%), Gaps = 63/253 (24%)

Query: 36  KPIGRGAYGIVCSS----VNRETNEK---VAIK--KINNAFENRVDALRTLRELKLLRHL 86
           KP+G G +G V  +    +++   ++   VA+K  K N   ++  D +  +  +KL+   
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-- 75

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDH----------- 134
           +H+N+I L  V           +Y++ E     +L + +++ +    D+           
Sbjct: 76  KHKNIINLLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130

Query: 135 --------CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----- 181
                   C Y   Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR     
Sbjct: 131 LSFKDLVSCAY---QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187

Query: 182 -----TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPI 233
                TSNG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P 
Sbjct: 188 DYYKKTSNGR-------LPVKWM-APEALF--DRVYTHQSDVWSFGILMWEIFTLGGSP- 236

Query: 234 FPGTECLNQLKLI 246
           +PG       KL+
Sbjct: 237 YPGIPVEELFKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 45/120 (37%), Positives = 60/120 (50%), Gaps = 24/120 (20%)

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSNGKNQF 189
           +Q+ RG++YL S   +HRDL   N+LV  N  +KI DFGLAR          T+NG+   
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR--- 200

Query: 190 MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG       KL+
Sbjct: 201 ----LPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.4 bits (141), Expect = 9e-10
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 36  KPIGRGAYGIVCSSV--NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA 93
             +G G +G V   +   +++ + VA+K + N   +       LRE  +++ L +  ++ 
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 94  LKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           +  +         +   LV EL +   L++ ++ ++ +T  +    + Q+  G+KYL   
Sbjct: 61  MIGIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCD 209
           N +HRDL   N+L+      KI DFGL++       +       +W   + APE    C 
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE----CM 170

Query: 210 NY---GTSIDVWSVGCIFAELL--GRKP 232
           NY    +  DVWS G +  E    G+KP
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  KVAIK +       +     L+E ++++ L+H+ ++ L  V
Sbjct: 14  LGQGCFGEVWMGTWNGTT-KVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 70  V------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   KI DFGLAR    N            +W  APE  L    + 
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 181

Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL+  GR P +PG    E L Q++
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP-YPGMVNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 62/232 (26%), Positives = 102/232 (43%), Gaps = 28/232 (12%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEK----VAIKKINNAFENRVDALRTLRELKLLR 84
           +T++  IK +G GA+G V   +     EK    VAIK++  A   + +    L E  ++ 
Sbjct: 6   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 64

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQL 142
            + + +V  L  + + S       V L+ +LM     L  + +    + + +   +  Q+
Sbjct: 65  SVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY------VVT 196
            +G+ YL    ++HRDL   N+LV     +KI DFGLA+      +   EY      V  
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK---EYHAEGGKVPI 175

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPI--FPGTECLNQLK 244
           +W     +L     Y    DVWS G    EL+  G KP    P +E  + L+
Sbjct: 176 KWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 32/219 (14%)

Query: 36  KPIGRGAYG-IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI-- 92
           K IG G +G ++   VN        + K      +  + ++ L E +  R LQH N++  
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 93  -ALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHC-----QYFLFQLLRG 145
                 + P          LV E     DL   ++S +            Q    ++  G
Sbjct: 61  LGQCTEVTP--------YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALG 112

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YVVTRWYRAP 202
           L +LH  N +H DL   N L+ A+  +KI D+GL+     ++ ++T    +V  RW  AP
Sbjct: 113 LLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-AP 171

Query: 203 EL-------LLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           EL       LL  D    S +VWS+G    EL  LG +P
Sbjct: 172 ELVDEVHGNLLVVDQTKES-NVWSLGVTIWELFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 36/232 (15%)

Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           K +G G +G V  +       R     VA+K +     +  +    L E  LL+ + H +
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPH 64

Query: 91  VIAL-----------------KDVMMPSHRRNFKDV---YLVYELMDTDLHQIIKSSQAL 130
           VI L                 K   + S  R  + V   YL  +      +      +AL
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T      F +Q+ RG++YL    ++HRDL   N+LV     +KI DFGL+R    ++ ++
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 191 TEY---VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
                 +  +W  A E L   D+ Y T  DVWS G +  E+  LG  P +PG
Sbjct: 185 KRSKGRIPVKWM-AIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 51/175 (29%), Positives = 80/175 (45%), Gaps = 30/175 (17%)

Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQ------- 128
           L+E+K+L  L+  N+I L  V +         + ++ E M+  DL+Q + S         
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEEN 121

Query: 129 ---ALTNDHCQ---------YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD 176
              A+   HC          +   Q+  G+KYL S N +HRDL   N LV  N  +KI D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 177 FGLARTSNGKNQFMTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           FG++R     + +  +    +  RW  A E +L    + T+ DVW+ G    E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECIL-MGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 44/120 (36%), Positives = 60/120 (50%), Gaps = 24/120 (20%)

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSNGKNQF 189
           +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR          T+NG+   
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR--- 203

Query: 190 MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG       KL+
Sbjct: 204 ----LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLL 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 44/120 (36%), Positives = 60/120 (50%), Gaps = 24/120 (20%)

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSNGKNQF 189
           +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR          T+NG+   
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR--- 197

Query: 190 MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG       KL+
Sbjct: 198 ----LPVKWM-APEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPGIPVEELFKLL 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.7 bits (134), Expect = 7e-09
 Identities = 65/249 (26%), Positives = 109/249 (43%), Gaps = 34/249 (13%)

Query: 36  KPIGRGAYG-IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
             IG G +G ++    +R  ++   + K   A     + L  L+E++  R L H NV+  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQ-----LLRGLKY 148
               + S         LV E     DL   ++S++ +     Q  + Q     +  GL +
Sbjct: 61  LGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YVVTRWYRAPEL- 204
           LH A+ +H DL   N  + A+  +KI D+GLA     ++ ++T+    V  RW  APEL 
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELV 174

Query: 205 ------LLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLIINILGSRREE 256
                 LL  D    S ++WS+G    EL     +P +P       LK ++      RE+
Sbjct: 175 EIRGQDLLPKDQTKKS-NIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVV------REQ 226

Query: 257 DLEFIDNPK 265
           D++ +  P+
Sbjct: 227 DIK-LPKPQ 234

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 32/213 (15%)

Query: 39  GRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           GR  YGI+         E+V +K + ++A E +V  L  L+E  LL  L H+N++ +  V
Sbjct: 20  GRIFYGIL-IDEKPGKEEEVFVKTVKDHASEIQVTLL--LQESCLLYGLSHQNILPILHV 76

Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--------SSQALTNDHCQYFLFQLLRGLKY 148
            +      F    ++Y  M+  +L   ++        + QAL+     +   Q+  G+ Y
Sbjct: 77  CIEDGEPPF----VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-------SNGKNQFMTEYVVTRWYRA 201
           LH   ++H+D+   N +++    +KI D  L+R          G N    E    +W  A
Sbjct: 133 LHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN----ENRPVKWM-A 187

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
            E L+    Y ++ DVWS G +  EL  LG+ P
Sbjct: 188 LESLV-NKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 25/221 (11%)

Query: 38  IGRGAYGIVCSSVNRETNEKV--AIKKINNAFENRVDALRTLRELKLLRHL-QHENVIAL 94
           IG G +G V  +  ++   ++  AIK++   + ++ D      EL++L  L  H N+I L
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 95  KDVMMPSHRR------------NFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYFLF 140
                  HR             N  D      +++TD    I +S A  L++    +F  
Sbjct: 74  LGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
            + RG+ YL     +HRDL   N+LV  N   KI DFGL+R      +     +  RW  
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 191

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTEC 239
              L      Y T+ DVWS G +  E+  LG  P + G  C
Sbjct: 192 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 229

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 35/224 (15%)

Query: 38  IGRGAYGIVCSSVNR------ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +G GA+G V                +VA+K +     ++ +    L+E  L+ +  H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNI 61

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL------- 143
           + L  V + +     +  Y++ ELM+  DL   ++ ++          L +LL       
Sbjct: 62  VKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCD--LKICDFGLARTSNGKNQFMTE---YVV 195
           +G  YL   + +HRDL   N LV+    + D  +KI DFGLAR     + +  E    + 
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 196 TRWYRAPELLLCCDN-YGTSIDVWSVGCIFAELL--GRKPIFPG 236
            RW  APE LL  D  + T  DVWS G +  E+L  G++P +P 
Sbjct: 177 VRWM-APESLL--DGKFTTQSDVWSFGVLMWEILTLGQQP-YPA 216

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 25/221 (11%)

Query: 38  IGRGAYG-IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALK 95
           IG G +G ++ + + ++  +  A  K+   F +  D      EL++L  L  H N+I L 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL- 68

Query: 96  DVMMPSHRRNFKDVYLVY----ELMD-TDLHQIIKSSQALTNDHCQYFLF---QLLR--- 144
             +     R +  + + Y     L+D     +++++  A   +H         QLL+   
Sbjct: 69  --LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 145 ----GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
               G++YL     +HRDL   N+LV  N   KI DFGL+R      +     +  RW  
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTEC 239
              L      Y T  DVWS G +  E+  LG  P + G  C
Sbjct: 187 IESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTP-YCGMTC 224

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)

Query: 38  IGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           +G G +G V   V +   ++  VAIK + N  E  V     +RE +++  L +  ++ + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRMI 61

Query: 96  DVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSAN 153
            V         + + LV E+     L++ +   +  +T  +    + Q+  G+KYL   N
Sbjct: 62  GVCEA------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDN 210
            +HRDL   N+L+      KI DFGL++     + +       +W   + APE    C N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE----CIN 171

Query: 211 Y---GTSIDVWSVGCIFAELL--GRKP 232
           +    +  DVWS G    E    G+KP
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 25/161 (15%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +V +KPI RGA+G            KV + +  N   +++ A++ +++  ++       V
Sbjct: 6   FVIVKPISRGAFG------------KVYLGRKKNN--SKLYAVKVVKKADMINKNMVHQV 51

Query: 92  IALKDVMMPSHR----------RNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLF 140
            A +D +  S            ++  +VYLV E L+  D+  ++        +    ++ 
Sbjct: 52  QAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS 111

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR 181
           ++   L YLH   I+HRDLKP N+L++    +K+ DFGL++
Sbjct: 112 EVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 51/236 (21%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHE 89
           +Y  I+ IG+G  G V  + +   + +VA+KKI     EN +   R LRE K+   L H 
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM----DTDLHQIIKS---SQALTNDHCQ-----Y 137
            ++ +  +          D   VY  M       L  ++KS    ++L+ +  +      
Sbjct: 63  GIVPVYSI--------CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114

Query: 138 FL---FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF----- 189
           FL    ++   ++Y+HS  +LHRDLKP N+L+    ++ I D+G A     + +      
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 190 ----------MT---EYVVTRWYRAPELLLCCDNYGT----SIDVWSVGCIFAELL 228
                     MT   + V T  Y APE LL     G     S D++++G I  ++L
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLL-----GVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 84/311 (27%), Positives = 128/311 (41%), Gaps = 78/311 (25%)

Query: 26  FEIDTKYVPIKP-IGRGAYGIVCSSV-NRETNEK--VAIK--KINNAFENRVDALRTLRE 79
           +EI  + + +   IG G +G V   V     NEK  VA+K  K   +   R    + L+E
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE---KFLQE 57

Query: 80  LKLLRHLQHENVIALKDVM--MPSHRRNFKDVYLVYELMDT-DLHQII-KSSQALTNDHC 135
             ++R   H +++ L  V+   P        V++V EL    +L   +  +  +L     
Sbjct: 58  AYIMRQFDHPHIVKLIGVITENP--------VWIVMELAPLGELRSYLQVNKYSLDLASL 109

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---------TSNGK 186
             + +QL   L YL S   +HRD+   N+LV++   +K+ DFGL+R          S GK
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK 169

Query: 187 NQFMTEYVVTRWYRAPELLLCCDNY---GTSIDVWSVGCIFAELL--GRKPIFPGTECLN 241
                  +  +W  APE +    N+    ++ DVW  G    E+L  G KP F G +  +
Sbjct: 170 -------LPIKWM-APESI----NFRRFTSASDVWMFGVCMWEILMLGVKP-FQGVKNND 216

Query: 242 QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLV 301
            +  I N  G R                   LP  P  P   LY         L+ K   
Sbjct: 217 VIGRIEN--GER-------------------LPMPPNCP-PTLY--------SLMTKCWA 246

Query: 302 FDPTKRISVTE 312
           +DP+KR   TE
Sbjct: 247 YDPSKRPRFTE 257

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 42/226 (18%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRTLRELKLLR 84
           +T+   +K +G GA+G V   +     E V    AIK +N     + + +  + E  ++ 
Sbjct: 6   ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMA 64

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-------TDLHQIIKSSQALTNDHCQY 137
            + H +++ L  V +         + LV +LM           H+    SQ L N     
Sbjct: 65  SMDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN----- 113

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY---- 193
           +  Q+ +G+ YL    ++HRDL   N+LV +   +KI DFGLAR   G  +   EY    
Sbjct: 114 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK---EYNADG 170

Query: 194 --VVTRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKP 232
             +  +W     + L C +Y       DVWS G    EL+  G KP
Sbjct: 171 GKMPIKW-----MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 25/221 (11%)

Query: 38  IGRGAYGIVCSSVNRETNEKV-AIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALK 95
           IG G +G V  +  ++   ++ A  K    + ++ D      EL++L  L  H N+I L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL- 61

Query: 96  DVMMPSHRRNFKDVYLVY----ELMD-TDLHQIIKSSQALTNDHCQYFLF---QLLR--- 144
             +     R +  + + Y     L+D     +++++  A    +         QLL    
Sbjct: 62  --LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 145 ----GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
               G+ YL     +HRDL   N+LV  N   KI DFGL+R      +     +  RW  
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTEC 239
              L      Y T+ DVWS G +  E+  LG  P + G  C
Sbjct: 180 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 217

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 34/104 (32%), Positives = 49/104 (47%), Gaps = 17/104 (16%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY------- 193
           Q+  G+ YL     +HRDL   N LV  N  +KI DFGL+R     N +  +Y       
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSADYYKASEND 192

Query: 194 -VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
            +  RW   PE +   + Y T  DVW+ G +  E+   G +P +
Sbjct: 193 AIPIRWM-PPESIF-YNRYTTESDVWAYGVVLWEIFSYGMQPYY 234

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 58/197 (29%), Positives = 83/197 (42%), Gaps = 24/197 (12%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY-VVTRWY 199
           Q+L GL+ LH   I+HRD+KP NLLV  +  +KI DFG A        F   Y ++   Y
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376

Query: 200 RAPELLLCCDNY--GTSIDVWSVGCIFAELLGRKPIFPGTE--------CLNQLKLIINI 249
             PE L+   +     +  + ++   FA L GR  +F            C+ +L+ + NI
Sbjct: 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436

Query: 250 LGSRRE-----EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDP 304
                E      DL      K +KY  SL         R       LA  L+ K    + 
Sbjct: 437 RLFNTELRQYDNDLNRWRMYKGQKYDFSL-------LDRNKEAGWDLACKLITKRDQAN- 488

Query: 305 TKRISVTEALQHPYMSP 321
             R+SV +AL H +  P
Sbjct: 489 RGRLSVGQALSHRFFLP 505

Length = 507

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 41/224 (18%)

Query: 36  KPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           + +G+G++G+V   + +     E   +VAIK +N A   R + +  L E  +++     +
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHH 70

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLR----- 144
           V+ L  V+        +   ++ ELM   DL   ++S +    ++       L +     
Sbjct: 71  VVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125

Query: 145 -----GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY------ 193
                G+ YL++   +HRDL   N +V  +  +KI DFG+ R     + + T+Y      
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGK 180

Query: 194 --VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKP 232
             +  RW  +PE L   D  + T  DVWS G +  E+  L  +P
Sbjct: 181 GLLPVRWM-SPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 43/180 (23%), Positives = 81/180 (45%), Gaps = 30/180 (16%)

Query: 78  RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQ--IIKSSQALTN-- 132
           +E  L+  L H N++ L  V+        + V +++E ++  DLH+  I++S  +     
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 133 -----------DHCQYF--LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
                      DH  +     Q+  G++YL S   +H+DL   N+L+     +KI D GL
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 180 ARTSNGKNQFMTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIF 234
           +R     + +  +    +  RW   PE ++    + +  D+WS G +  E+   G +P +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWM-PPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 3/101 (2%)

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVV 195
             +Q++  L  +HS  ++HRDLK  N+ +     +K+ DFG ++  + +      + +  
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
           T +Y APEL      Y    D+WS+G I  ELL     F G
Sbjct: 234 TPYYLAPELWE-RKRYSKKADMWSLGVILYELLTLHRPFKG 273

Length = 478

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 35/100 (35%), Positives = 48/100 (48%), Gaps = 13/100 (13%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY------V 194
           Q+ +G+ YL    ++HRDL   N+LV +   +KI DFGLAR  +      TEY      V
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE---TEYHADGGKV 173

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
             +W     +L     +    DVWS G    EL+  G KP
Sbjct: 174 PIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 64/252 (25%), Positives = 100/252 (39%), Gaps = 52/252 (20%)

Query: 35  IKPIGRGAYGIVCSSVNRETNE-----KVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
           ++ +G GA+G V   + R  +      +VA+K +  +  +  D    L E  ++    H+
Sbjct: 11  LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQ 69

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLR---- 144
           N++ L  V      R     +++ ELM   DL   ++ ++          +  LL     
Sbjct: 70  NIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 145 ---GLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEYVVTRW 198
              G KYL   + +HRD+   N L+         KI DFG+AR     + +   Y     
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASY----- 174

Query: 199 YR------------APELLLCCDNYGTS-IDVWSVGCIFAEL--LGRKPIFPGTECLNQL 243
           YR             PE  L  D   TS  DVWS G +  E+  LG  P +PG    NQ 
Sbjct: 175 YRKGGRAMLPIKWMPPEAFL--DGIFTSKTDVWSFGVLLWEIFSLGYMP-YPG--RTNQE 229

Query: 244 KLIINILGSRRE 255
            +     G R +
Sbjct: 230 VMEFVTGGGRLD 241

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 41/225 (18%)

Query: 35  IKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
           ++ +G+G++G+V     R     E   +VA+K +N +   R + +  L E  +++     
Sbjct: 11  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCH 69

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKS----------SQALTNDHCQYF 138
           +V+ L  V+        +   +V ELM   DL   ++S              T       
Sbjct: 70  HVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY----- 193
             ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R     + + T+Y     
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGG 179

Query: 194 ---VVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKP 232
              +  RW  APE L   D  + TS D+WS G +  E+  L  +P
Sbjct: 180 KGLLPVRWM-APESLK--DGVFTTSSDMWSFGVVLWEITSLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 14/214 (6%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           E+D K + I + +G G +G +C    +  +++   VAI  +     ++      L E   
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-QRRGFLAEALT 59

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           L    H N++ L+ V+   +       Y+    +D+ L    K    L        L  L
Sbjct: 60  LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGL 116

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTRWYR 200
             G+KYL     +H+ L    +LVN++   KI  F   +    +  +  M+      W  
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW-A 175

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
           APE +    ++ ++ DVWS G +  E++  G +P
Sbjct: 176 APEAIQ-YHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 9e-05
 Identities = 59/210 (28%), Positives = 84/210 (40%), Gaps = 42/210 (20%)

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLA---RTSNGKNQFMT 191
           Q  + Q+L  L  LHS  I+HRD+KP N++ +      KI D G A   R   G N    
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRV--GINYIPK 315

Query: 192 EYVVTRWYRAPEL---------------------LLCCDNYGTSIDVWSVGCIFAELLGR 230
           E+++   Y APE                      +L   N     D++S G IF ++   
Sbjct: 316 EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM--- 372

Query: 231 KPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP--GTPFSRLYPDA 288
              FP     + L +  N    R + DL        RK ++    +P     F  L  D 
Sbjct: 373 --AFPNLRSDSNL-IQFNRQLKRNDYDLV-----AWRKLVEPRA-SPDLRRGFEVLDLDG 423

Query: 289 HPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
                +LL+ M+ F   +RIS   AL HPY
Sbjct: 424 G-AGWELLKSMMRFKGRQRISAKAALAHPY 452

Length = 566

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 26/195 (13%)

Query: 53  ETNEKVAIKKINNAFENRVDALRT-LRELKLLR-HLQHENVIALKDVMMPSHRRNFKDVY 110
           E  + VAIK + +  E     LR   +   ++R  LQH N++ L  V+      +    Y
Sbjct: 33  EQTQAVAIKTLKDKAEG---PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY 89

Query: 111 L----VYELM----------DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
                ++E +           TD  + +KS   L      + + Q+  G+++L S +++H
Sbjct: 90  CSHSDLHEFLVMRSPHSDVGSTDDDKTVKS--TLEPADFVHIVTQIAAGMEFLSSHHVVH 147

Query: 157 RDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM---TEYVVTRWYRAPELLLCCDNYGT 213
           +DL   N+LV    ++KI D GL R     + +       +  RW  +PE ++    +  
Sbjct: 148 KDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIM-YGKFSI 205

Query: 214 SIDVWSVGCIFAELL 228
             D+WS G +  E+ 
Sbjct: 206 DSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 37/161 (22%), Positives = 64/161 (39%), Gaps = 27/161 (16%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKK------INNAFENRVDALRTLRELKLLRHLQH 88
           +K I RGA   +   +      K  IK        +   + R+   RT RE +++   + 
Sbjct: 1   MKLIKRGAEAEI--YLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK 58

Query: 89  ENV----IALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLL 143
             V    +   D        NF    +V E ++   L  +I S+     +  +     + 
Sbjct: 59  AGVNVPAVYFVDP------ENFI---IVMEYIEGEPLKDLINSNGMEELELSREIGRLVG 109

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN 184
           +    LHSA I+H DL   N++++    + + DFGLA  S 
Sbjct: 110 K----LHSAGIIHGDLTTSNMILSGG-KIYLIDFGLAEFSK 145

Length = 211

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 41.0 bits (97), Expect = 3e-04
 Identities = 15/36 (41%), Positives = 22/36 (61%), Gaps = 1/36 (2%)

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN 184
           LH A I+H DL   N++V  +  L + DFGL + S+
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSD 140

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 36/134 (26%), Positives = 59/134 (44%), Gaps = 19/134 (14%)

Query: 111 LVYELMDT-DLHQIIKSSQALTNDHCQYFLFQ-----LLRGLKYLHSANILHRDLKPGNL 164
           LV+E  +  DL   +   Q    +  Q  L Q     +  G+ ++H  N LH DL   N 
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRN-SQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNC 130

Query: 165 LVNANCDLKICDFGLARTSNGKNQFMTE---YVVTRWYRAPEL-------LLCCDNYGTS 214
            + ++  +K+ D+G+  +   ++   TE    V  RW  APEL       L+  +    S
Sbjct: 131 FLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPS 189

Query: 215 IDVWSVGCIFAELL 228
            +VW++G    EL 
Sbjct: 190 -NVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 67/319 (21%), Positives = 121/319 (37%), Gaps = 53/319 (16%)

Query: 38  IGRGAYGIVCSSVNR--ETNEKVAIKKINNAF--ENRVDALRTLRELKLLRHLQHENVIA 93
           IGRG   ++  ++ R   T E V +++IN        V  L+   EL + +   H N++ 
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQG--ELHVSKLFNHPNIVP 63

Query: 94  LKDVMMPSHRRNFKDVYLVY----ELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
            +   +  +       ++ Y    +L+ T           ++     Y L  +L+ L Y+
Sbjct: 64  YRATFIADNELWVVTSFMAYGSAKDLICTHF------MDGMSELAIAYILQGVLKALDYI 117

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGL----ARTSNGKNQFMTE------YVVTRWY 199
           H    +HR +K  ++L++   D K+   GL    +  ++G+   +          V  W 
Sbjct: 118 HHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL 175

Query: 200 RAPELL-LCCDNYGTSIDVWSVGCIFAELL-GRKPI--FPGTE-----------CLNQLK 244
            +PE+L      Y    D++SVG    EL  G  P    P T+           CL    
Sbjct: 176 -SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTT 234

Query: 245 LI----INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKM 299
            I    + +  SR   +    ++        S   +   P++R + P  H      LQ+ 
Sbjct: 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQR- 293

Query: 300 LVFDPTKRISVTEALQHPY 318
              +P  R S +  L H +
Sbjct: 294 ---NPDARPSASTLLNHSF 309

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 39.9 bits (94), Expect = 0.001
 Identities = 14/28 (50%), Positives = 17/28 (60%)

Query: 290 PLAIDLLQKMLVFDPTKRISVTEALQHP 317
           P   DL++KML  DP KR S  E L+H 
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 4/88 (4%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           +++  L  LH   I+ RDL P N+L++    +++  F   R S  ++    E  V   Y 
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGE-AVENMYC 149

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELL 228
           APE+    +    + D WS+G I  ELL
Sbjct: 150 APEVGGISEE-TEACDWWSLGAILFELL 176

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 42/223 (18%)

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGKN------- 187
           LF  LRGL YLH    +HR++K  ++L++ +  + +   GL+       NG+        
Sbjct: 107 LFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDF 164

Query: 188 -QFMTEYVVTRWYRAPELLLCCDNYGTSI--DVWSVGCIFAELL-GRKPI--FPGTECLN 241
            QF T   V  W  +PELL   D YG ++  D++SVG    EL  GR P      T+ L 
Sbjct: 165 PQFSTS--VLPWL-SPELLR-QDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220

Query: 242 Q-LK------LIINIL---GSRREEDLEFIDNPKARKYIKSLPYTP------GTPFSRLY 285
           Q LK      L I       SR +     +D+      + +            TP S+ +
Sbjct: 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF 280

Query: 286 PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
               P   +L++  L  DP KR S +  L H +   + + +  
Sbjct: 281 S---PAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQG 320

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 38/161 (23%), Positives = 62/161 (38%), Gaps = 29/161 (18%)

Query: 34  PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-------RTLRELKLLRHL 86
           P   IG+GA   +      E   + A+ K       R   L       RT  E +LL   
Sbjct: 337 PDHLIGKGAEADI---KKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA 393

Query: 87  QHENVIA--LKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLL 143
           +   V    + DV       + ++  +V E +   DL  +++ +  L           + 
Sbjct: 394 RRAGVPTPVIYDV-------DPEEKTIVMEYIGGKDLKDVLEGNPELVRK--------VG 438

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN 184
             +  LH A I+H DL   N +V  +  L + DFGL + S+
Sbjct: 439 EIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSD 478

Length = 535

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.8 bits (88), Expect = 0.003
 Identities = 25/121 (20%), Positives = 39/121 (32%), Gaps = 17/121 (14%)

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW 198
             Q L  L+ LH        L   + L+           G       +      Y +   
Sbjct: 23  CLQCLGALRELHRQAKSGNILLTWDGLLKL--------DGSVAFKTPEQSRPDPYFM--- 71

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
             APE++     Y    D++S+G    E L  +   P  E   +L  I+ IL +    D 
Sbjct: 72  --APEVIQGQS-YTEKADIYSLGITLYEALDYEL--PYNE-ERELSAILEILLNGMPADD 125

Query: 259 E 259
            
Sbjct: 126 P 126

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 3/90 (3%)

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRW 198
           Q+ +G+ YL    ++HR+L   N+L+ ++  ++I DFG+A     + K  F +E+     
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           + A E +L    Y    DVWS G    E++
Sbjct: 177 WMALESIL-FGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	373
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10345	210	hypothetical protein; Provisional	99.89
smart00090	237	RIO RIO-like kinase.	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.78
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.76
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.69
KOG1243	690	consensus Protein kinase [General function predict	99.61
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.59
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.59
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.58
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.42
KOG3087	229	consensus Serine/threonine protein kinase [General	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.29
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.26
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.22
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.22
COG4248	637	Uncharacterized protein with protein kinase and he	99.16
PRK09902	216	hypothetical protein; Provisional	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.09
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.04
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.77
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.69
PF01636	239	APH: Phosphotransferase enzyme family This family	98.66
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.65
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.64
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.54
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.51
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.45
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.4
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.36
PLN02876	822	acyl-CoA dehydrogenase	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.07
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.0
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.93
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.9
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.9
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.76
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.74
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.73
PRK05231	319	homoserine kinase; Provisional	97.67
PRK10593	297	hypothetical protein; Provisional	97.63
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.57
KOG2270	520	consensus Serine/threonine protein kinase involved	97.56
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.53
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.44
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.43
PLN02236	344	choline kinase	97.32
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.25
PRK12396	409	5-methylribose kinase; Reviewed	97.23
PLN02756	418	S-methyl-5-thioribose kinase	97.2
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.0
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.8
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.61
PTZ00384	383	choline kinase; Provisional	96.52
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.47
PRK06148	1013	hypothetical protein; Provisional	96.17
PRK11768	325	serine/threonine protein kinase; Provisional	96.11
PTZ00296	442	choline kinase; Provisional	95.77
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.43
PHA03111	444	Ser/Thr kinase; Provisional	95.37
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	95.36
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.18
PRK10271	188	thiK thiamine kinase; Provisional	95.01

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-74  Score=501.37  Aligned_cols=346  Identities=62%  Similarity=1.068  Sum_probs=325.7

Q ss_pred             eeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeecee
Q 017334           18 YYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV   97 (373)
Q Consensus        18 ~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   97 (373)
                      .+..+...+++.++|..++.||+|+||.|+.|.++.+|+.||||++...+.+....++.+||+++|+.++|+||+.+.++
T Consensus        10 ~~~~~~~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di   89 (359)
T KOG0660|consen   10 DYEVFGELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI   89 (359)
T ss_pred             EEEeeeeEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence            45678899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ecCCCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEccc
Q 017334           98 MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (373)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Df  177 (373)
                      +..+.....+.+|+|+|+|+.+|.++++++..+++..++.+++||+.||+|+|+.||+||||||.|+|++.++.+|||||
T Consensus        90 ~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   90 FRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             cccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccc
Confidence            98866677889999999999999999999888999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCC--CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          178 GLARTSNG--KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       178 g~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      |+|+....  ....++.++.|.||+|||++.....|+.+.||||+|||++||++|++.|+|.+..+++..|...+|.+.+
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            99987643  3556789999999999999999899999999999999999999999999999999999999999999999


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPI  335 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~  335 (373)
                      +....+.+..++.++.+.+..++.+|...+|++++.+.|||.+||.+||.+|+|++|+|+||||+++.+++.+|.++...
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~  329 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIF  329 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999877766


Q ss_pred             CCCcccccCHHHHHHHHHHHHHhcCcccc
Q 017334          336 DLDMDEESGEEMIREMMLKEMLHYHPEAI  364 (373)
Q Consensus       336 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  364 (373)
                      .. .+.....+.+++++.+|+..++|...
T Consensus       330 ~~-~~~~~~~~~~r~~i~~e~~~~~~~~~  357 (359)
T KOG0660|consen  330 DS-FEHELTEEELRELIYKEILDFHPDVS  357 (359)
T ss_pred             cc-ccccccHHHHHHHHHHHHHhhCcccc
Confidence            54 33337799999999999999998753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.8e-66  Score=435.06  Aligned_cols=288  Identities=36%  Similarity=0.690  Sum_probs=253.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +.|+.+.++|+|+||+|++|+++.||+.||||++..+..+..-..-.+||+++|++++|||+|.++++|     .....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            679999999999999999999999999999999987777777777788999999999999999999999     566889


Q ss_pred             EEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++|+|||+.++.+-+... ..+++..++.+++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.......
T Consensus        77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd  156 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD  156 (396)
T ss_pred             EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence            999999998877777654 5799999999999999999999999999999999999999999999999999999887888


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC-hhHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN-PKAR  267 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~  267 (373)
                      .++.++.|.||+|||.+.|...|+.++||||+||++.||++|.|.|++.++.+++..|...+|...+.....+.. +.+.
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            899999999999999999988999999999999999999999999999999999999999999887765443322 2211


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      . +.--......+..+-+|.++..+.||+++||+.||.+|++.+++|.||||..+.
T Consensus       237 G-v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  237 G-VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             e-eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            1 111111222355666788999999999999999999999999999999996553

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.7e-64  Score=419.20  Aligned_cols=285  Identities=44%  Similarity=0.745  Sum_probs=255.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+|..++.||+|.||+||+|++..||+.||||+++.......-....+||++.|+.++|+||+.++++|     .+...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            589999999999999999999999999999999987655544455678999999999999999999999     566789


Q ss_pred             EEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      .||+||++.+|...++.. ..++..+++.|+.+++.||+|||++.|+||||||.|+|++++|.+||+|||+|+.....+.
T Consensus        77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            999999999999999865 4699999999999999999999999999999999999999999999999999999887777


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      .....+.|.||+|||.+.|.+.|+..+||||.|||++||+.|.|.|+|.++.+++..|.+.+|.+.++.|+....-..-.
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            66666899999999999999999999999999999999999999999999999999999999999999888765432222


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .+...   +..+...+++.++..+.||+.+||..||.+|+++.|+|+|+||+..
T Consensus       237 ~~~~~---P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  237 KIQQF---PKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             HHhcC---CCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence            22233   3344455889999999999999999999999999999999999863

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-64  Score=451.64  Aligned_cols=290  Identities=37%  Similarity=0.675  Sum_probs=259.5

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCC
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHR  103 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  103 (373)
                      ...+.++|.++++||.|+||.||+|+.+.+|..||||++++....-.+. .-+||+..|++++ ||||+++.+++.+.+ 
T Consensus         5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~-   82 (538)
T KOG0661|consen    5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND-   82 (538)
T ss_pred             ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC-
Confidence            3456799999999999999999999999999999999999877664333 3469999999999 999999999996542 


Q ss_pred             CCcceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          104 RNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                         +.+|+|||||+.+|+++++.+ +.|++..++.|++||++||+|+|++|+.|||+||+|||+.....+||+|||+|+.
T Consensus        83 ---~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   83 ---RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             ---ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence               389999999999999999865 5699999999999999999999999999999999999999988999999999998


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ..+ ...++.|+.|+||+|||+++....|+.+.||||+|||++|+++-+|.|+|.++.+++..|..++|.+....+... 
T Consensus       160 v~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-  237 (538)
T KOG0661|consen  160 VRS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-  237 (538)
T ss_pred             ccc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-
Confidence            754 445788999999999999999889999999999999999999999999999999999999999999987765542 


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      .......--.+|+..+.++..+.+.+++++.+||.+||.+||.+||||.++|+||||+.
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~  296 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQV  296 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence            12223344467888888999999999999999999999999999999999999999974

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-64  Score=439.32  Aligned_cols=262  Identities=33%  Similarity=0.554  Sum_probs=223.8

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-----HHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-----VDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      +...|.+.+.||+|+||.|-+|..++||+.||||++++.....     .....+.+|+++|++|+|||||+++++|    
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence            6789999999999999999999999999999999998764322     2233457999999999999999999999    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CCeEEcccC
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFG  178 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~---~~~kL~Dfg  178 (373)
                       +.....|+||||++ |+|++.+-.++.+.+...+.+++||+.|+.|||++||+||||||+|||++.+   ..+||+|||
T Consensus       246 -~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  246 -EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             -ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence             55567899999996 7999999999999999999999999999999999999999999999999877   679999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHhCCCCh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLN-QLKLIINILGSRRE  255 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~  255 (373)
                      +|+..+ ....+.+.||||.|.|||++.+..  .+..++|||||||+||-+++|.|||.+..... ...+|.+.-     
T Consensus       325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~-----  398 (475)
T KOG0615|consen  325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR-----  398 (475)
T ss_pred             hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc-----
Confidence            999875 667788999999999999997532  24458999999999999999999998765443 444443310     


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       ++..     ...|..+|.++.+||.+||..||++|||++|+|+||||+..
T Consensus       399 -----------------y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  399 -----------------YAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             -----------------cccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                             0111     12346689999999999999999999999999999999854

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.6e-62  Score=416.49  Aligned_cols=289  Identities=37%  Similarity=0.642  Sum_probs=254.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +.|+.+.+|++|+||.||+|+++.|++.||+|+++.......-....+|||.+|.+++|||||.+.++....+.   +.+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~i  152 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DKI  152 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---cee
Confidence            68999999999999999999999999999999998665444334456799999999999999999999866533   669


Q ss_pred             EEEeecCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      |+|||||+.+|.+++.+.+ +|.+.+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+..++...
T Consensus       153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK  232 (419)
T ss_pred             eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence            9999999999999998765 899999999999999999999999999999999999999999999999999999888878


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      .++..+.|.||+|||.+++...|+.++|+||+|||+.||++++|.|+|....+++..|.+.+|.+.+..|+-+......+
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence            88899999999999999999999999999999999999999999999999999999999999999998888766544332


Q ss_pred             HHHhCCCCCCCCccccCCC--CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPD--AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~--~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .. .++..+-..+...++.  +|....+|+.++|..||.+|.||.|.|+|.||...
T Consensus       313 ~~-~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  313 KM-TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             cc-ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            11 2233333334444444  45899999999999999999999999999999863

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-61  Score=442.73  Aligned_cols=261  Identities=31%  Similarity=0.522  Sum_probs=234.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+.. .......++.+||+|.+.|+|||||+++++|     ++.++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            57999999999999999999999999999999997653 3445566788999999999999999999999     77799


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|||.|+|. ++|..+++.++.++|.+++.+++||+.||.|||+++|+|||||..|++++++.+|||+|||+|.......
T Consensus        93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999996 8999999999999999999999999999999999999999999999999999999999999999887666


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ..-.+.||||.|.|||++.. ..++..+||||+|||||.||.|+|||...+..+.+..|...-                 
T Consensus       173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-----------------  234 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-----------------  234 (592)
T ss_pred             cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-----------------
Confidence            77788999999999999986 789999999999999999999999999988888887775410                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSS  327 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~  327 (373)
                                    -..+..+|.++++||.+||+.||.+|||+++||.|+||+.-+.|..
T Consensus       235 --------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~  280 (592)
T KOG0575|consen  235 --------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPAR  280 (592)
T ss_pred             --------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCC
Confidence                          0123468899999999999999999999999999999965444443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-61  Score=433.84  Aligned_cols=287  Identities=39%  Similarity=0.646  Sum_probs=249.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -.+.|+.+++||+|.||.||+|++..+|+.||+|++...........-..|||.||++|.||||+++.++....   ...
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~  191 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSG  191 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCc
Confidence            45789999999999999999999999999999999987765566666677999999999999999999998654   236


Q ss_pred             eEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+|+|||+.+|.-++... -.|++.++++++.||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+.....
T Consensus       192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            89999999999999998764 48999999999999999999999999999999999999999999999999999965543


Q ss_pred             -CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          187 -NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       187 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                       ...+++.+.|.||+|||.++|...|+.++|+||+||||.||++|+|.|++.++.+++..|.+++|.+.+..|....-+.
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence             3447888999999999999999999999999999999999999999999999999999999999999998877332221


Q ss_pred             HHHHHHhCCCCC-CCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          266 ARKYIKSLPYTP-GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       266 ~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ...+   .+..+ +..+.+.+..++..+.+|+..||..||.+|.||.++|+|+||.
T Consensus       352 ~~~~---kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  352 ATIF---KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cccc---CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            1111   11111 2334455677899999999999999999999999999999994

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-61  Score=417.94  Aligned_cols=258  Identities=26%  Similarity=0.464  Sum_probs=230.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++|++++.||+|+||+|+.++.++|++.||+|++++.... .........|..+|..++||+||+++..|     ++..
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccCC
Confidence            48999999999999999999999999999999999876543 34556678999999999999999999999     7778


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ++|+|+||+. |+|+..|.+.+.|++..++.++..|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....
T Consensus        99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999995 699999999999999999999999999999999999999999999999999999999999999876666


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....+.|||+.|||||++.+ .+|+.++|+||||+++|+|++|.+||.+.+.......|.+.-                
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k----------------  241 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK----------------  241 (357)
T ss_pred             CCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----------------
Confidence            666677899999999999988 689999999999999999999999999998777777665411                


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC----CHHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI----SVTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~----t~~eil~hp~~~~~  322 (373)
                                    .......++.++++||+++|+.||++|.    .+.+|-+||||.++
T Consensus       242 --------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  242 --------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             --------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence                          0111233789999999999999999996    68899999999864

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-60  Score=412.73  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=221.4

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc-eE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK-DV  109 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~-~~  109 (373)
                      +.+.++.||+|..|+||+|+|+.|++.+|+|++.. ..+.....++.+|+++++.++|||||++|++|...     + .+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~i  153 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEI  153 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceE
Confidence            67778999999999999999999999999999943 34556667889999999999999999999999544     4 59


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||+ |+|.++++..++++|.....++.+|++||.|||. ++|+||||||+||||+..|.|||||||.+...... 
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            99999997 7999999988999999999999999999999995 99999999999999999999999999999876433 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCC--CchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT--ECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                       ...+++||..|||||.+.+ ..|+.++||||||+.++|+++|+.||...  .....+..+..++..+++          
T Consensus       233 -~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP----------  300 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP----------  300 (364)
T ss_pred             -hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC----------
Confidence             5688999999999999988 68999999999999999999999999874  223333333333332221          


Q ss_pred             HHHHHHhCCCCCCCCccccCCC-CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       +++.+ +|+++++||..||++||.+|+++.|+++|||++..
T Consensus       301 -----------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  301 -----------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             -----------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence                             22233 89999999999999999999999999999999865

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-58  Score=403.47  Aligned_cols=293  Identities=42%  Similarity=0.718  Sum_probs=252.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC-eeeeceeecCCC-CCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN-VIALKDVMMPSH-RRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~-~~~~  106 (373)
                      ...|..+++||+|+||+||+|+++.+|+.||+|++......+.......||+.+++.++|+| |+.+++++...+ .+..
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            36788899999999999999999999999999999876554334445679999999999999 999999996543 1233


Q ss_pred             ceEEEEeecCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          107 KDVYLVYELMDTDLHQIIKSSQ----ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ..+++|+||++.+|.+++....    .++...++.+++||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            5799999999999999997654    577889999999999999999999999999999999999999999999999997


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ..-.....+..++|.+|+|||++.+...|+...||||+|||++||+++++.|++.+..+++..|.+.+|.+....|+...
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~  249 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS  249 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence            76566667888999999999999998899999999999999999999999999999999999999999999998887654


Q ss_pred             ChhHHHHHHhCCCCC-CCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTP-GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      .-...+  ...+... ...+....+..++...+++.+||+.+|.+|.|++.+|+||||....
T Consensus       250 ~~~~~k--~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  250 SLPDYK--APFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             cccccc--ccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            321111  1233333 4455566677778999999999999999999999999999998763

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-58  Score=402.97  Aligned_cols=288  Identities=39%  Similarity=0.688  Sum_probs=249.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      =.|...+.+|.|+||.||.|....+++.||||++-....      --.+|+.+|+.+.|||||++..+|......+.-.+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            468889999999999999999999999999999843321      11269999999999999999999877654434577


Q ss_pred             EEEeecCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CCeEEcccCcccccC
Q 017334          110 YLVYELMDTDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSN  184 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-~~~kL~Dfg~a~~~~  184 (373)
                      .+|||||+-+|.+.++.    +.+++.-+++-+.+||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus        98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            88999999999998874    5789999999999999999999999999999999999999987 899999999999875


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      .+.+ ..++..|+.|+|||.+.|...|+.+.||||.||+++||+-|+|.|+|.+..+++.+|.+++|.+..++.......
T Consensus       178 ~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  178 KGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             cCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            4443 478899999999999999999999999999999999999999999999999999999999999999888766544


Q ss_pred             hHHHHHHhCCCCCCCCccc-cCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSR-LYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSS  327 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~  327 (373)
                      ..   ....+.....+|.+ .....++++.+|+.++|..+|.+|.++.|++.||||..+.++..
T Consensus       257 y~---~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~  317 (364)
T KOG0658|consen  257 YT---EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNT  317 (364)
T ss_pred             cc---cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCc
Confidence            32   22344444556656 56778999999999999999999999999999999998776643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-58  Score=415.51  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=228.3

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHH-HHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD-ALRTLRELKLLRHL-QHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  105 (373)
                      -..+|...+.||.|+|++|++|+++.+++.||||++.+....+.. ..-+.+|-.+|.+| .||.|++++..|     ++
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD  145 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD  145 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence            346899999999999999999999999999999999877544333 23345789999999 699999999999     77


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ...+|+|+||+. |+|.++|++.+.|++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||.|+.+.
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            788999999995 8999999999999999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC-----------c--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC
Q 017334          185 GKN-----------Q--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILG  251 (373)
Q Consensus       185 ~~~-----------~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  251 (373)
                      ...           .  ...+++||..|.+||++.. ...++++|||+||||+|+|+.|.|||.+.+..-.+..|+.+.-
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y  304 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY  304 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc
Confidence            311           1  1256899999999999976 6789999999999999999999999999999999888877422


Q ss_pred             CCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          252 SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                                     .+.+++++.++|||+++|..||.+|+|+.+|.+||||..+
T Consensus       305 -------------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  305 -------------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             -------------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence                                           2336678999999999999999999999999999999864

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.7e-56  Score=411.85  Aligned_cols=331  Identities=50%  Similarity=0.924  Sum_probs=271.2

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++.+.||+|+||.||+|++..+|..||||++............+.+|+.+++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            69999999999999999999999999999999875544444555678999999999999999999998665444456799


Q ss_pred             EEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC---C
Q 017334          111 LVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK---N  187 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~---~  187 (373)
                      +||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......   .
T Consensus        81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  160 (338)
T cd07859          81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA  160 (338)
T ss_pred             EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998754221   1


Q ss_pred             ccccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          188 QFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....+.+.......+.....
T Consensus       161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  240 (338)
T cd07859         161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA  240 (338)
T ss_pred             ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence            223456789999999998642 4688999999999999999999999999988888888888888888777666655555


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCC--C-ccccc
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDL--D-MDEES  343 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~--~-~~~~~  343 (373)
                      ..+...+......++...++.+++.+.++|.+||+.||++|||+.++++||||+........+..++....  . .....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (338)
T cd07859         241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL  320 (338)
T ss_pred             HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence            55555555555555666677889999999999999999999999999999999876543333322222111  1 12255


Q ss_pred             CHHHHHHHHHHHHHhcCc
Q 017334          344 GEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       344 ~~~~~~~~~~~e~~~~~~  361 (373)
                      ..+.+++.+..+...++|
T Consensus       321 ~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         321 TKEDVRELIYREILEYHP  338 (338)
T ss_pred             CHHHHHHHHHHHHHhcCC
Confidence            678888888888888876

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-57  Score=383.48  Aligned_cols=253  Identities=26%  Similarity=0.476  Sum_probs=226.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|+.++.||.|+||.|.+++++.+|..||+|++++... ..........|..+|+.+.||+++++.+.+     .+.++
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~~  118 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNSN  118 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCCe
Confidence            899999999999999999999999999999999987543 333444567899999999999999999999     66688


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ |.|++++++.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+...+. 
T Consensus       119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            999999996 799999999999999999999999999999999999999999999999999999999999999987443 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                        ..+.||||.|+|||++.. ++|+.++|+|||||++|||+.|.+||.+.+.......|...-                 
T Consensus       198 --T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-----------------  257 (355)
T KOG0616|consen  198 --TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-----------------  257 (355)
T ss_pred             --EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-----------------
Confidence              467899999999999987 789999999999999999999999999998888887776521                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                    -..++.+++.+++||+++|+.|-.+|.     ...+|..||||+.+
T Consensus       258 --------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  258 --------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             --------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence                          123456899999999999999999994     56899999999864

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7e-57  Score=396.07  Aligned_cols=259  Identities=30%  Similarity=0.480  Sum_probs=226.6

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .-++|.+.+.||+|+||+||+|+++.++..||||.+.+.............|+++|+.++|||||.+++++     +..+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            34899999999999999999999999999999999988776777777788999999999999999999999     5557


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC------CCeEEcccCcc
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN------CDLKICDFGLA  180 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~------~~~kL~Dfg~a  180 (373)
                      ++|+|||||+ |+|.+++++++.+++..++.++.||+.||++||+++||||||||+|||++..      -.+||+|||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            8999999997 7999999999999999999999999999999999999999999999999775      35899999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      +... ......+.||+|.|||||++.. +.|+.++|+||+|+|+|+|++|++||...+..+.+..+.+.-...       
T Consensus       163 R~L~-~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~-------  233 (429)
T KOG0595|consen  163 RFLQ-PGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV-------  233 (429)
T ss_pred             hhCC-chhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc-------
Confidence            9874 4556778899999999999976 689999999999999999999999999988877776554311110       


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                           .......++.+.+|+...|..+|..|.+..+-+.|+++..
T Consensus       234 ---------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  234 ---------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ---------------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                                 0111234555779999999999999999999999999864

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-55  Score=408.05  Aligned_cols=335  Identities=73%  Similarity=1.237  Sum_probs=294.1

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+.++|++.+.||.|+||+||+|.+..+|+.||||.+............+.+|+.+++.++|+||+++++++........
T Consensus         2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            56789999999999999999999999999999999987654444445567789999999999999999998865543444


Q ss_pred             ceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          107 KDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..+|+|+||++++|.+++...+.+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          82 NDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             CcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            67999999999999999988889999999999999999999999999999999999999999999999999999765443


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      ........++..|+|||.+.....++.++|||||||++|+|++|++||.+.+.......+....+.+.............
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence            33344567889999999987645688999999999999999999999999988888999999999998888888787777


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCccc-ccCH
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDE-ESGE  345 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  345 (373)
                      ..+....+..+...+....+.+++.+.+||++||+.||++|||+.++++||||..+.++...+..+.+++.++++ +...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTE  321 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhcCH
Confidence            777777776666666666778999999999999999999999999999999999988888888888888888777 5678


Q ss_pred             HHHHHHHHHHHHhcCc
Q 017334          346 EMIREMMLKEMLHYHP  361 (373)
Q Consensus       346 ~~~~~~~~~e~~~~~~  361 (373)
                      +++++.+..||..++|
T Consensus       322 ~~~~~~~~~~~~~~~~  337 (337)
T cd07858         322 EDIKELIYNEMLAYHP  337 (337)
T ss_pred             HHHHHHHHHHHhhcCC
Confidence            8999999999998886

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-56  Score=409.87  Aligned_cols=260  Identities=34%  Similarity=0.498  Sum_probs=225.6

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC---hHHHHHHHHHHHHHhhCC-CCCeeeeceeecCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN---RVDALRTLRELKLLRHLQ-HENVIALKDVMMPS  101 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  101 (373)
                      ....+.|++.+.||+|+||+|+.|.+..+|..||+|++.+....   ......+.+|+.+++.+. ||||+++++++   
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~---   89 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF---   89 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE---
Confidence            35568999999999999999999999999999999988764221   123345568999999999 99999999999   


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CCeEEcccCc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGL  179 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-~~~kL~Dfg~  179 (373)
                        .....+|+||||+. |+|++++...+++.|.+++.+|+||+.|++|||++||+||||||+|||++.+ +++||+|||+
T Consensus        90 --~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   90 --ATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             --ecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence              44466999999996 6999999999999999999999999999999999999999999999999999 9999999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      +...........+.|||+.|+|||++.+.. ..+.++||||+||+||.|++|+.||...+.......|.+.         
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~---------  238 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG---------  238 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC---------
Confidence            987754556778899999999999998855 4468999999999999999999999987766666654431         


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCC-CHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDA-HPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                            .-.++..+ |+++++||.+||..||.+|+|+.++++||||+.
T Consensus       239 ----------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 ----------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             ----------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                                  01122345 899999999999999999999999999999986

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-56  Score=404.83  Aligned_cols=260  Identities=27%  Similarity=0.469  Sum_probs=223.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -++|++++.||+|+||.||+|+.+.||..||+|++++... .......+..|-.+|....+|+||+++..|     ++..
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~~  214 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDKE  214 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCCC
Confidence            3789999999999999999999999999999999988654 334455667899999998999999999999     7778


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC-
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG-  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~-  185 (373)
                      ++||||||++ |++..+|...+.+++..++.++.+++.|++.||+.|++||||||+|+|||..|++||+|||++.-... 
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999996 79999999999999999999999999999999999999999999999999999999999999831110 


Q ss_pred             ----------------------CCc------------------------cccceeeccccCchhhhhcCCCCCchhhhHH
Q 017334          186 ----------------------KNQ------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWS  219 (373)
Q Consensus       186 ----------------------~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws  219 (373)
                                            ...                        ...+.+|||.|+|||++.+ .+|+..+|+||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS  373 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS  373 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence                                  000                        0123489999999999998 67999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhh
Q 017334          220 VGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM  299 (373)
Q Consensus       220 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~  299 (373)
                      ||||+||||.|.|||.+.+..+..+.|.+.-..                    +..+..       ..++++++|||.+|
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------------l~fP~~-------~~~s~eA~DLI~rl  426 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------------LKFPEE-------VDLSDEAKDLITRL  426 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------------ccCCCc-------CcccHHHHHHHHHH
Confidence            999999999999999999999999888763211                    111111       23668999999999


Q ss_pred             cCcCCCCCCC---HHHHhCCCCCCCC
Q 017334          300 LVFDPTKRIS---VTEALQHPYMSPL  322 (373)
Q Consensus       300 L~~dP~~R~t---~~eil~hp~~~~~  322 (373)
                      |. ||++|+.   ++||.+||||+.+
T Consensus       427 l~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  427 LC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             hc-CHHHhcCcccHHHHhcCCccccC
Confidence            99 9999984   8999999999865

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-57  Score=380.03  Aligned_cols=247  Identities=29%  Similarity=0.458  Sum_probs=218.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+|+++++||+|+||.||++++..+|..+|.|.++-...+....+....|+.+|++|+|||||++++.-+.   ++..-+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence            78999999999999999999999999999999999777788888888999999999999999999883222   222459


Q ss_pred             EEEeecCC-ccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          110 YLVYELMD-TDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLHS--AN--ILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~--~~--ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      +||||+|+ |+|.++++    .++.++|..+|.++.|++.||.+||+  .+  |+||||||.||+++.+|.+||+|||++
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            99999997 89999885    34679999999999999999999999  45  999999999999999999999999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      +..........+++|||.||+||++.+ .+|+.+|||||+||++|||+.-++||.+.+-.+....|.+.           
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg-----------  243 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-----------  243 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC-----------
Confidence            999888888899999999999999987 68999999999999999999999999999777777666552           


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccC-CCCCHHHHHHHHhhcCcCCCCCCCH
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISV  310 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~ll~~~L~~dP~~R~t~  310 (373)
                                         .++.++ ..+|..+..||.-|+..||+.||+.
T Consensus       244 -------------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  244 -------------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             -------------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence                               111122 3467889999999999999999985

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-56  Score=410.37  Aligned_cols=258  Identities=31%  Similarity=0.453  Sum_probs=230.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccc-ccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      +-|++.+.||.|+.|.|.+|++..||+..|||++.+. .........+.+|+-+|+.+.|||++++++++     ++..+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence            6799999999999999999999999999999999876 34445566788999999999999999999999     66789


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+|.||++ |.|++++..++++++.++.++++||+.|+.|||..+|+||||||+|+|++..+++||+|||+|... ..+
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~g  165 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE-VPG  165 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-cCC
Confidence            999999995 799999999999999999999999999999999999999999999999999999999999999765 456


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ..+.+.||+|.|.|||++.|....+.++||||+|||||.||+|+.||.+.+....+..+.+..                 
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-----------------  228 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-----------------  228 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-----------------
Confidence            678889999999999999997777899999999999999999999998766555555554411                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                                    -+.+..+++++++||++||..||++|+|.+||++|||+...-.
T Consensus       229 --------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  229 --------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             --------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence                          1233568999999999999999999999999999999987643

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-57  Score=375.01  Aligned_cols=262  Identities=31%  Similarity=0.469  Sum_probs=229.2

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ..+.++|.+.+.||+|.|+.|+++.+..||+.+|+|+++.........+++.+|++|.+.|+||||+++.+.+     ..
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~   81 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QE   81 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cc
Confidence            4567999999999999999999999999999999999987666666777888999999999999999999998     55


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEcccCccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~kL~Dfg~a~  181 (373)
                      ....|+|+|+|+ ++|..-|-.+--++|..+..+++||++||.|+|.+||||||+||+|+|+-+..   -+||+|||+|.
T Consensus        82 ~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   82 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence            578999999997 58865555546789999999999999999999999999999999999996543   59999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ... ......+.+|||.|||||++.. .+|+..+|||+.|||||-|+.|.+||.+.+.......|...--.         
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd---------  230 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD---------  230 (355)
T ss_pred             EeC-CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC---------
Confidence            876 5566778899999999999976 68999999999999999999999999998877777777652111         


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                        -....|+.+++++++|+++||..||.+|+|+.|+|+|||+..
T Consensus       231 ------------------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  231 ------------------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             ------------------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                              112356889999999999999999999999999999999864

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-54  Score=401.26  Aligned_cols=333  Identities=48%  Similarity=0.868  Sum_probs=271.1

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      +....+.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++....
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07878           8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT   87 (343)
T ss_pred             HHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence            44556789999999999999999999999999999999999765544445556778999999999999999999885432


Q ss_pred             -CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          103 -RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       103 -~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                       .......|+++++++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          88 SIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             cccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence             123356899999999999888764 579999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .....   .....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+.......+
T Consensus       167 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07878         167 QADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI  243 (343)
T ss_pred             ecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            65332   345678999999999977567899999999999999999999999998888888888888888777666555


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDE  341 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  341 (373)
                      .......+...++..+...+...+...++.+.+||.+||+.||++|||+.++++||||.....+...+............
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~  323 (343)
T cd07878         244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDESPENK  323 (343)
T ss_pred             chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCccccchhhh
Confidence            55555566666666555556666677889999999999999999999999999999999876655444333222222333


Q ss_pred             ccCHHHHHHHHHHHHHhc
Q 017334          342 ESGEEMIREMMLKEMLHY  359 (373)
Q Consensus       342 ~~~~~~~~~~~~~e~~~~  359 (373)
                      ....+++++.+..+...+
T Consensus       324 ~~~~~~~~~~~~~~~~~~  341 (343)
T cd07878         324 ERTIEEWKELTYEEVSSF  341 (343)
T ss_pred             hccHHHHHHHHHHHHHhc
Confidence            555677777777665443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.7e-56  Score=403.73  Aligned_cols=256  Identities=31%  Similarity=0.528  Sum_probs=234.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|-+.+.||+|+||.||+|+.+.+.+.||||.+.+..........+.+|++|++.++||||+.+++.|     +...++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            689999999999999999999999999999999998888888888889999999999999999999999     777899


Q ss_pred             EEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          110 YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      ++|+||+.|+|+.++...+.++|+.++.++.|++.||.|||+++|.|||+||.|||+...|.+||||||+|+........
T Consensus        77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998888888


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      .+...|||.|||||++.+ +.|+..+|+||||||+|||+.|+|||...+.......|..   .+                
T Consensus       157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~---d~----------------  216 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK---DP----------------  216 (808)
T ss_pred             eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---CC----------------
Confidence            888999999999999986 7999999999999999999999999988766555555543   10                


Q ss_pred             HHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                  ...++.+|..+..||+.+|.+||.+|+|..+++.|||.++-
T Consensus       217 ------------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  217 ------------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ------------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                        11224678899999999999999999999999999998753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-54  Score=403.45  Aligned_cols=283  Identities=33%  Similarity=0.564  Sum_probs=233.5

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-C-----CCeeeeceeec
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-H-----ENVIALKDVMM   99 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~   99 (373)
                      ..|..+|.+++.||+|+||.|.+|.+..|++.||||++++..   .-..+...|+.+|..++ |     -|+|+++++| 
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-  257 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-  257 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-
Confidence            345569999999999999999999999999999999997643   22334567999999986 3     4799999999 


Q ss_pred             CCCCCCcceEEEEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC--CeEEc
Q 017334          100 PSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC--DLKIC  175 (373)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~--~~kL~  175 (373)
                          ...+++|||+|.++-+|+++++.+.  .++...++.++.||+.||.+||+.||||+|||||||||..-+  .|||+
T Consensus       258 ----~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVI  333 (586)
T KOG0667|consen  258 ----YFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVI  333 (586)
T ss_pred             ----ccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEE
Confidence                5558999999999999999998764  689999999999999999999999999999999999997644  69999


Q ss_pred             ccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      |||.+.....   ...+++.++.|+|||+++| .+|+.+.||||||||++||++|.|+|+|.++.++++.|..++|.++.
T Consensus       334 DFGSSc~~~q---~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  334 DFGSSCFESQ---RVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             ecccccccCC---cceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            9999987633   2348899999999999999 68999999999999999999999999999999999999999999887


Q ss_pred             hhhcccCChhHHHHHHh----------------------------CC----CC-CCCCccccCC-CCCHHHHHHHHhhcC
Q 017334          256 EDLEFIDNPKARKYIKS----------------------------LP----YT-PGTPFSRLYP-DAHPLAIDLLQKMLV  301 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~----------------------------~~----~~-~~~~~~~~~~-~~s~~~~~ll~~~L~  301 (373)
                      ..+......  ..+...                            ..    .. ....+....+ .....+.|||++||.
T Consensus       410 ~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~  487 (586)
T KOG0667|consen  410 KMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE  487 (586)
T ss_pred             HHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence            765543221  111111                            00    00 1112222222 234567999999999


Q ss_pred             cCCCCCCCHHHHhCCCCCCCC
Q 017334          302 FDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       302 ~dP~~R~t~~eil~hp~~~~~  322 (373)
                      +||.+|+|+.++|+||||...
T Consensus       488 ~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  488 WDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             cCchhcCCHHHHhcCcccccc
Confidence            999999999999999999854

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-56  Score=348.54  Aligned_cols=287  Identities=42%  Similarity=0.702  Sum_probs=254.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+|.-.++||+|.||+||+|+++.+++.||+|.++....++......++|+-+++.++|.|||+++++.     ...+.+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkkl   76 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCcee
Confidence            467778999999999999999999999999999987777666667889999999999999999999998     555789


Q ss_pred             EEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      -+|+|||+.+|..+..+ ++.+..+.++.++.|++.||.|+|++++.||||||.|.||+.+|.+||+|||+++..+-...
T Consensus        77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            99999999999988875 57799999999999999999999999999999999999999999999999999998876665


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      -++..+.|.||++|.++.|.+-|+...|+||.|||+.|+. .|+|.|++.+..+++..|.+.+|.+.+.+|+.+....  
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp--  234 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP--  234 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC--
Confidence            6667788999999999999889999999999999999998 8999999999999999999999999998887654321  


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      ++..--.+.+...|+++.|.++..-+||++++|..+|.+|++++++++||||.+..
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            11111123344578888899999999999999999999999999999999998653

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6e-54  Score=388.25  Aligned_cols=282  Identities=38%  Similarity=0.691  Sum_probs=235.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||.|+||+||+|+++.+++.||+|+++..... .....+.+|+.+++.++||||+++++++     ...+..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            6899999999999999999999999999999998654322 1223466899999999999999999998     444679


Q ss_pred             EEEeecCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      |+||||++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        79 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          79 TLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            9999999999999887644 578999999999999999999999999999999999999999999999999976544444


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh-hHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP-KAR  267 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~  267 (373)
                      ......+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.+..+.+...... ...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            4455678999999999877667899999999999999999999999999988999999999988887766554322 111


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .+  ..+.....+.....+.+++++++||++||+.||.+|||++|+++||||
T Consensus       239 ~~--~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SY--LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cc--ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            11  112222223334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.3e-52  Score=391.87  Aligned_cols=333  Identities=43%  Similarity=0.749  Sum_probs=258.8

Q ss_pred             EecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeec
Q 017334           20 SMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMM   99 (373)
Q Consensus        20 ~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   99 (373)
                      ......+.+.++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~   93 (364)
T cd07875          14 EIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   93 (364)
T ss_pred             ecCcchhchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence            34445566789999999999999999999999999999999999876555555667789999999999999999999885


Q ss_pred             CCC-CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccC
Q 017334          100 PSH-RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       100 ~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      ... ......+|+||||++++|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875          94 PQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             ccccccccCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            432 123356899999999999888753  58899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ++..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...++.+.....
T Consensus       172 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         172 LARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CccccCC-CCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9976533 223345678999999999976 67899999999999999999999999999888888888887777665443


Q ss_pred             cccCChhHHHHHHhCCCCCCCCcccc------------CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRL------------YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS  326 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  326 (373)
                      .... .....+....+......+...            ....+..+++||.+||+.||.+|||+.++|+||||..++++.
T Consensus       250 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         250 KKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS  328 (364)
T ss_pred             Hhhh-HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence            3322 122223333222221111111            122456789999999999999999999999999998776665


Q ss_pred             CCCCCCCCC-C-CCcccccCHHHHHHHHHHHHH
Q 017334          327 SNPPAQVPI-D-LDMDEESGEEMIREMMLKEML  357 (373)
Q Consensus       327 ~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~e~~  357 (373)
                      ..+...+.. + .....+...+.+++.+.+|+.
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (364)
T cd07875         329 EAEAPPPKIPDKQLDEREHTIEEWKELIYKEVM  361 (364)
T ss_pred             cCCCCCCCCCCccchhhhccHHHHHHHHHHHHH
Confidence            544332222 1 112235566778888887764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.7e-53  Score=392.72  Aligned_cols=305  Identities=46%  Similarity=0.810  Sum_probs=242.2

Q ss_pred             eeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeecee
Q 017334           18 YYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV   97 (373)
Q Consensus        18 ~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   97 (373)
                      .+++.+..+.+.++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||++++++
T Consensus         9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   88 (359)
T cd07876           9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV   88 (359)
T ss_pred             eecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence            33444555567799999999999999999999999999999999998765555556677899999999999999999999


Q ss_pred             ecCCCC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcc
Q 017334           98 MMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (373)
Q Consensus        98 ~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~D  176 (373)
                      +..... .....+|+||||++++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          89 FTPQKSLEEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             eccCCCccccceeEEEEeCCCcCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEec
Confidence            864421 2335689999999998888775  3588999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChh
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE  256 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (373)
                      ||++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+...++.+...
T Consensus       167 fg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         167 FGLARTACT-NFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             CCCcccccc-CccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            999875432 223345688999999999976 678999999999999999999999999988888877777777766654


Q ss_pred             hhcccCChhHHHHHHhCCCCCCCCccccC------------CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          257 DLEFIDNPKARKYIKSLPYTPGTPFSRLY------------PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                      ...... .....+....+..+...+.+.+            ...++.+++||.+||+.||++|||+.|+|+||||..+++
T Consensus       245 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         245 FMNRLQ-PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHHH-HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence            332211 1122222222222222222211            224678999999999999999999999999999987665


Q ss_pred             CCC
Q 017334          325 PSS  327 (373)
Q Consensus       325 ~~~  327 (373)
                      +..
T Consensus       324 ~~~  326 (359)
T cd07876         324 PAE  326 (359)
T ss_pred             ccc
Confidence            543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-54  Score=401.54  Aligned_cols=255  Identities=25%  Similarity=0.441  Sum_probs=226.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~  107 (373)
                      ++|++++.||+|+||+|++|..+.+++.||||++++.. ....+....+.|.+++.... ||.++.++..|     +...
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT~~  442 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QTKE  442 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----ccCC
Confidence            78999999999999999999999999999999998864 34445556778999988886 99999999999     6678


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ++|+||||+. |++ -.+...+.|++..++.|+..|+.||+|||++||||||||.+|||+|.+|++||+|||+++.....
T Consensus       443 ~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            9999999996 573 34445578999999999999999999999999999999999999999999999999999987666


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....+.||||.|+|||++.+ ..|+.++|+|||||+||||+.|.+||++.+..+....|.+.                 
T Consensus       522 g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-----------------  583 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-----------------  583 (694)
T ss_pred             CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            667889999999999999988 78999999999999999999999999999999998888651                 


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                    -..++..+|.++.++|+++|..||++|+.     +.+|.+||||..+
T Consensus       584 --------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  584 --------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             --------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence                          11233568999999999999999999995     5899999999864

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.2e-52  Score=390.31  Aligned_cols=290  Identities=49%  Similarity=0.840  Sum_probs=239.5

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+++.++||||+++++++..........+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            47889999999999999999999999999999976555555566788999999999999999999998655333334799


Q ss_pred             EEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC-Ccc
Q 017334          111 LVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK-NQF  189 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-~~~  189 (373)
                      +||||++++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus        81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~  160 (372)
T cd07853          81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH  160 (372)
T ss_pred             EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999999764322 222


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      .....+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+.+.+|.+..+....... .....
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~  239 (372)
T cd07853         161 MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GARAH  239 (372)
T ss_pred             CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HHHHH
Confidence            34457889999999998766689999999999999999999999999999999999999999887665443321 12222


Q ss_pred             HHhCCCCCCC--CccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          270 IKSLPYTPGT--PFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       270 ~~~~~~~~~~--~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      +...+..+..  .........++++.+||.+||+.||++|||+.++++||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence            2222221111  111233556889999999999999999999999999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.5e-52  Score=387.79  Aligned_cols=331  Identities=44%  Similarity=0.769  Sum_probs=253.0

Q ss_pred             EecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeec
Q 017334           20 SMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMM   99 (373)
Q Consensus        20 ~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   99 (373)
                      .+....+.+.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   86 (355)
T cd07874           7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT   86 (355)
T ss_pred             ccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeee
Confidence            33444556679999999999999999999999999999999999876655556667789999999999999999999986


Q ss_pred             CCCC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccC
Q 017334          100 PSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       100 ~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      .... ......|+||||++++|.+.+..  .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          87 PQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             ccccccccceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence            4421 23356899999999998887754  58899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      +++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...++.+..+..
T Consensus       165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTS-FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCc-cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99765332 23345688999999999976 57899999999999999999999999998888888887777776655543


Q ss_pred             cccCChhHHHHHHhCCCCCCCCc------------cccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPF------------SRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS  326 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  326 (373)
                      .... +....+....+......+            .......+..+++||.+||..||++|||+.|+|+||||...+++.
T Consensus       243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~  321 (355)
T cd07874         243 KKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPA  321 (355)
T ss_pred             Hhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChh
Confidence            3322 112222222221111110            111223466789999999999999999999999999998776654


Q ss_pred             CCCCCCCCC---CCCcccccCHHHHHHHHHHHH
Q 017334          327 SNPPAQVPI---DLDMDEESGEEMIREMMLKEM  356 (373)
Q Consensus       327 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~e~  356 (373)
                      ........+   +.+ ......+.+++.+.+++
T Consensus       322 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  353 (355)
T cd07874         322 EVEAPPPQIYDKQLD-EREHTIEEWKELIYKEV  353 (355)
T ss_pred             hccCCCccccccchh-hhhccHHHHHHHHHHHh
Confidence            333322221   111 12334555666666665

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-54  Score=383.12  Aligned_cols=264  Identities=28%  Similarity=0.419  Sum_probs=218.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc------------ChHHHHHHHHHHHHHhhCCCCCeeeec
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE------------NRVDALRTLRELKLLRHLQHENVIALK   95 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~hpniv~~~   95 (373)
                      .-++|++++.||+|.||+|.+|++..+++.||||++.+...            ......+..+||.+|++|.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            34789999999999999999999999999999999975321            111224678999999999999999999


Q ss_pred             eeecCCCCCCcceEEEEeecCC-ccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeE
Q 017334           96 DVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (373)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~k  173 (373)
                      ++.-.+   ...++|+|+|||. |.+. +....+. +++.+++.|+++++.||+|||.+||+||||||+|+||+.+|++|
T Consensus       175 EvLDDP---~s~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  175 EVLDDP---ESDKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             EeecCc---ccCceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence            998443   4478999999997 5543 3333344 99999999999999999999999999999999999999999999


Q ss_pred             EcccCcccccC-----CCCccccceeeccccCchhhhhcC---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q 017334          174 ICDFGLARTSN-----GKNQFMTEYVVTRWYRAPELLLCC---DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL  245 (373)
Q Consensus       174 L~Dfg~a~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  245 (373)
                      |+|||.+....     +....+...+|||.|+|||.+.+.   ...+.+.||||+||.||.|+.|+.||-+....+....
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            99999997652     233345567999999999998763   2356899999999999999999999998888888877


Q ss_pred             HHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          246 IINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                      |.+.--..                             ...+.+++.++|||.+||.+||++|+++.+|..|||.....+
T Consensus       331 Ivn~pL~f-----------------------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  331 IVNDPLEF-----------------------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             HhcCcccC-----------------------------CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            76521110                             112456788999999999999999999999999999976533

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-52  Score=384.72  Aligned_cols=329  Identities=53%  Similarity=0.981  Sum_probs=270.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......++.+|+.+++.++||||+++++++........
T Consensus         2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            46789999999999999999999999999999999986432 22334456789999999999999999998765544455


Q ss_pred             ceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          107 KDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ...|+|+||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            67999999999999888754 57999999999999999999999999999999999999999999999999998754322


Q ss_pred             C---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          187 N---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       187 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .   .......|++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+...++.+..+.......
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            1   1223457899999999987656789999999999999999999999999888888888888888877776665555


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCC--CCCCCccc
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQV--PIDLDMDE  341 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~--~~~~~~~~  341 (373)
                      .....+....+.....++....+..++.+.+||.+||+.||++|||+.++++||||..+.++...+..+.  +.+++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFD  319 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhcccc
Confidence            5555666666655555555566778899999999999999999999999999999999988766665533  44444445


Q ss_pred             ccCHHHHHHHHHHHHH
Q 017334          342 ESGEEMIREMMLKEML  357 (373)
Q Consensus       342 ~~~~~~~~~~~~~e~~  357 (373)
                      ....+..++.+..|++
T Consensus       320 ~~~~~~~~~~~~~~~~  335 (336)
T cd07849         320 DLPKEKLKELIFEEIM  335 (336)
T ss_pred             ccCHHHHHHHHHHHhc
Confidence            5567777777776654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.4e-52  Score=385.69  Aligned_cols=327  Identities=54%  Similarity=0.993  Sum_probs=277.8

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+.++|++.+.||+|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.... ...
T Consensus         2 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~   80 (334)
T cd07855           2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADF   80 (334)
T ss_pred             chhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCC
Confidence            4678999999999999999999999999999999999765444444556778999999999999999999875543 344


Q ss_pred             ceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          107 KDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..+|+||||++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          81 KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             ceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            67999999999999999988788999999999999999999999999999999999999999999999999998654322


Q ss_pred             C----ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          187 N----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       187 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .    .......++..|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..+....|.++........
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            1    122345788999999998765568999999999999999999999999998888889999999988877666555


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCccc-
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDE-  341 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~-  341 (373)
                      ...........+.....++....+..++.+.++|++||+.||.+||++.++++||||.....+...+....+.+.+.+. 
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAI  320 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCCChhhh
Confidence            5555556666666666666777788899999999999999999999999999999999998888888888888887776 


Q ss_pred             ccCHHHHHHHHHH
Q 017334          342 ESGEEMIREMMLK  354 (373)
Q Consensus       342 ~~~~~~~~~~~~~  354 (373)
                      +...+.+.+.+.+
T Consensus       321 ~~~~~~~~~~~~~  333 (334)
T cd07855         321 ELSREQLKEAIVK  333 (334)
T ss_pred             hcChhhHHHHhhc
Confidence            3667766666654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-52  Score=381.08  Aligned_cols=287  Identities=34%  Similarity=0.600  Sum_probs=223.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++....... ....+.+|+.+++.++||||+++++++     ....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~   76 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDII-----HTKE   76 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCC
Confidence            4588999999999999999999999999999999987543222 223467899999999999999999998     4446


Q ss_pred             eEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..|+||||++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        77 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          77 TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             eEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            79999999999998888654 57899999999999999999999999999999999999999999999999998765443


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCChhhhcccCChh
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC-LNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+... .+.+..+...++.+....+...... 
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  235 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL-  235 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc-
Confidence            33445567899999999987766789999999999999999999999987543 3455666666665543332211100 


Q ss_pred             HHHHH-HhCCCCCCCCccccC--CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          266 ARKYI-KSLPYTPGTPFSRLY--PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~-~~~~~~~~~~~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                       ..+. ..........+...+  ...++.+.+||++||+.||++|||+.++++||||..+
T Consensus       236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         236 -PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             -cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence             0000 000000000011111  1245779999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=388.54  Aligned_cols=257  Identities=29%  Similarity=0.519  Sum_probs=225.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -...|...++||+|+.|.||.|+...+++.||||.+.........  -++.|+.+|+..+|+|||.+++.|...     .
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke--LilnEi~Vm~~~~H~NiVnfl~Sylv~-----d  343 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE--LLLNEILVMRDLHHPNIVNFLDSYLVG-----D  343 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh--hhHHHHHHHHhccchHHHHHHHHhccc-----c
Confidence            456889999999999999999999999999999999876655433  477999999999999999999999554     6


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+++||||++ |+|.+++.. ..++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|......
T Consensus       344 eLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            6999999997 698888876 46999999999999999999999999999999999999999999999999999887766


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....+.+|||+|||||++.. ..|++++||||||+++.||+.|+|||-..+....+.+|..-                 
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-----------------  484 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-----------------  484 (550)
T ss_pred             cCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-----------------
Confidence            666788899999999999876 78999999999999999999999999877666666655431                 


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                 +.+-.+....+|+.++|||.+||+.|+++|++|.++|+||||+.
T Consensus       485 -----------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  485 -----------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             -----------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                       12223334678999999999999999999999999999999953

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.9e-54  Score=359.81  Aligned_cols=261  Identities=33%  Similarity=0.545  Sum_probs=223.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-----Ch-HHHHHHHHHHHHHhhCC-CCCeeeeceeecCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-----NR-VDALRTLRELKLLRHLQ-HENVIALKDVMMPS  101 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-----~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  101 (373)
                      -+.|...+.||+|..++|.++.++.+|..+|+|++.....     +. .-.....+|+.||+++. ||+|+++.++|   
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y---   92 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY---   92 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec---
Confidence            3778889999999999999999999999999999964321     11 11223358999999996 99999999999   


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                        +....+++|+|.|. |.|+|++.+.-.+++.+.+.+++|+++|+.|||.++||||||||+|||++++.++||+|||++
T Consensus        93 --es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   93 --ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             --cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence              66678999999996 899999999899999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLC-----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      .... ....+...||||+|.|||.+.+     ..+|+..+|+||+|||||.|+.|.|||......-.++.|+..--... 
T Consensus       171 ~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~-  248 (411)
T KOG0599|consen  171 CQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR-  248 (411)
T ss_pred             eccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC-
Confidence            8774 3455678899999999999864     34689999999999999999999999987766666666665222211 


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                                +..|.++|..++|||.+||+.||.+|+|++|+|+||||.++
T Consensus       249 --------------------------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  249 --------------------------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             --------------------------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence                                      12346688889999999999999999999999999999654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-53  Score=374.64  Aligned_cols=261  Identities=28%  Similarity=0.451  Sum_probs=213.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..+|...+.||+|+||.||++.+.++|...|||.+.......  ...+.+|+.+|+.++|||||++++......  . ..
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~   90 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DE   90 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-ee
Confidence            367888999999999999999999999999999997652222  555779999999999999999999753321  1 46


Q ss_pred             EEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~  185 (373)
                      +++.|||+. |+|.+++...+ .+++..++.+.+||++||+|||++||+|+||||+|||++. ++.+||+|||++.....
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999996 79999999876 7999999999999999999999999999999999999999 79999999999987653


Q ss_pred             ---CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          186 ---KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       186 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                         .........||+.|||||++..+.....++|||||||++.||+||.+||...  .+....+..+....         
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~---------  239 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED---------  239 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC---------
Confidence               1223446789999999999975333446999999999999999999999763  12222222211110         


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       ....++..+|+++++||.+||..||++||||.++|+|||....
T Consensus       240 -----------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  240 -----------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             -----------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence                             1114456789999999999999999999999999999999754

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-51  Score=380.06  Aligned_cols=336  Identities=49%  Similarity=0.913  Sum_probs=282.4

Q ss_pred             ecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           21 MWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        21 ~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      +.+..+.+.++|++.+.||+|++|.||+|++..+++.||+|++............+.+|+.+++.+.|||++++++++..
T Consensus         6 ~~~~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851           6 LNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             hccceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            45667788999999999999999999999999999999999987654444455567789999999999999999998754


Q ss_pred             CCC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          101 SHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       101 ~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                      ... ......|+|+||++++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          86 ASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence            422 23346999999999999998876 5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      +......   .....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+.+....
T Consensus       165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            8765332   3445778899999998765568899999999999999999999999988888888888888877777666


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCc
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDM  339 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  339 (373)
                      .........+....+......+...++..++.+.+||.+||+.||++|||+.++++||||.....+...+. ....+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~-~~~~~~~~  320 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV-APPYDQSF  320 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc-ccccCcch
Confidence            66666666777777766666666666778999999999999999999999999999999998766654443 34445555


Q ss_pred             cc-ccCHHHHHHHHHHHHHhcCc
Q 017334          340 DE-ESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       340 ~~-~~~~~~~~~~~~~e~~~~~~  361 (373)
                      .. +...+.+++++.+||+.+.|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         321 ESRDLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             hhhhcCHHHHHHHhHHHHHhccC
Confidence            44 66889999999999998765

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.4e-52  Score=375.27  Aligned_cols=284  Identities=37%  Similarity=0.678  Sum_probs=225.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++     .....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            479999999999999999999999999999999976544444455677899999999999999999998     445789


Q ss_pred             EEEeecCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC-
Q 017334          110 YLVYELMDTDLHQIIK-SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN-  187 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-  187 (373)
                      |+||||+++++.+.+. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... 
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9999999875555554 44679999999999999999999999999999999999999999999999999997653322 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC-ChhH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID-NPKA  266 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~  266 (373)
                      .......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.+..+..+........ ++..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            22344578999999999976 568999999999999999999999999988877777777777766544333211 1111


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .....................+|+.+.+||++||+.||++|||++++|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00000000000111122234578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.9e-52  Score=374.76  Aligned_cols=284  Identities=40%  Similarity=0.660  Sum_probs=227.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCC-CCcEEEEEEccccccChHHHHHHHHHHHHHhhC---CCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRE-TNEKVAIKKINNAFENRVDALRTLRELKLLRHL---QHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~-~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~  105 (373)
                      ++|++++.||+|+||.||+|++.. +|+.||+|++..............+|+.+++.+   .||||+++++++.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 578899999875543333333455677777665   6999999999986443334


Q ss_pred             cceEEEEeecCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ...+++||||++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            5679999999999999998753  45899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.....
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             cCC-cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            332 23345678999999999876 5788999999999999999999999999988888888888777665544322110


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ..    .......+..+.....+.+++.+++||.+||+.||++|||+.++|+||||
T Consensus       239 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cc----chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            00    00111222334445557788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-51  Score=376.72  Aligned_cols=288  Identities=37%  Similarity=0.671  Sum_probs=238.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|+++.+++.||+|+++...... ....+.+|+.+++.++||||+++++++     ...+.
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~   78 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIV-----HTDKS   78 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEE-----eeCCe
Confidence            378999999999999999999999999999999987543222 223456899999999999999999998     44467


Q ss_pred             EEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          79 LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            9999999999998888654 458999999999999999999999999999999999999999999999999987654433


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.+.++.+....+.........
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            33445578999999999877667899999999999999999999999999988899999999988877766544332111


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      .. ...+.....++....+.+++++++||.+||+.||.+|||+.|+++||||..+.
T Consensus       239 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KN-YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hh-hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            11 12222222333344567899999999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-53  Score=378.37  Aligned_cols=259  Identities=28%  Similarity=0.453  Sum_probs=232.4

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .|.+-|.+.+.||+|.|++|.+|+|.-||.+||||++.+...+......++.|++.|+.++|||||++|+++     ...
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ   89 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ   89 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence            356789999999999999999999999999999999999988888888899999999999999999999999     555


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-cCCCCeEEcccCccccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV-NANCDLKICDFGLARTS  183 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill-~~~~~~kL~Dfg~a~~~  183 (373)
                      ..+|+|+|+-+ |+|+++|.++ ..++|..+++|+.||+.|+.|+|+..+|||||||+||.+ ..-|-|||+|||++...
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            78999999996 6999999765 579999999999999999999999999999999999987 45688999999999876


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      . ....+.+.||+..|.|||+++|.....+++||||||||||.|.+|++||+..+..+.+..|+..-             
T Consensus       170 ~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-------------  235 (864)
T KOG4717|consen  170 Q-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-------------  235 (864)
T ss_pred             C-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-------------
Confidence            3 34557788999999999999997666789999999999999999999999999888888876521             


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                        -.++..+|.++++||..||..||.+|.+.++|..|+|+++.
T Consensus       236 ------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  236 ------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             ------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence                              12335688999999999999999999999999999999875

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-53  Score=370.34  Aligned_cols=259  Identities=24%  Similarity=0.454  Sum_probs=233.0

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      -++.-+|++.+.||+|.||+|-+|.+...|+.||||.|++.. .+..+...+.+|++||..|+||||++++++|     +
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----E  123 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----E  123 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----c
Confidence            457789999999999999999999999999999999998764 4667777889999999999999999999999     7


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      +...+.|||||.. |.|++++...+.+++.+++.+++||.+|+.|+|+++++|||||.+|||+|.++++||+|||++...
T Consensus       124 NkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  124 NKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             CCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence            7789999999995 899999999999999999999999999999999999999999999999999999999999999766


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                       .....++++||+|.|.+||++.|...-++.+|.||||++||.|..|..||.|.+....+++|.+..-.           
T Consensus       204 -~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-----------  271 (668)
T KOG0611|consen  204 -ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-----------  271 (668)
T ss_pred             -ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-----------
Confidence             45567889999999999999998766789999999999999999999999999888877777552110           


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                           -|.-+..+.-||+.||-.||++|.|+.+|-.|=|+..-
T Consensus       272 ---------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  272 ---------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             ---------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence                                 13344568899999999999999999999999998643

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.9e-51  Score=374.59  Aligned_cols=324  Identities=57%  Similarity=0.999  Sum_probs=275.3

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCC--CcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRET--NEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~--g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~  107 (373)
                      +|++.+.||+|+||.||++++..+  +..||+|++............+.+|+.+++.+. ||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            588999999999999999999888  999999998755444444556778999999995 999999998754321 2335


Q ss_pred             eEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          108 DVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .+|+++|+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            68999999999999999888889999999999999999999999999999999999999999999999999997543221


Q ss_pred             ----ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          188 ----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       188 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                          .......|++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..+...++.+..........
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS  239 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence                1223457899999999987656789999999999999999999999999988899999999999887776665555


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES  343 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (373)
                      .....+.......+...+....+..+..+.+|+.+||+.||++|||+.+++.||||..+.++...+.+..+.+..++.|.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (332)
T cd07857         240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESED  319 (332)
T ss_pred             hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccccc
Confidence            55555555555555555666667788999999999999999999999999999999998888888889999999999999


Q ss_pred             CHHHHHHHHHHH
Q 017334          344 GEEMIREMMLKE  355 (373)
Q Consensus       344 ~~~~~~~~~~~e  355 (373)
                      ..+.++.++.+|
T Consensus       320 ~~~~~~~~~~~~  331 (332)
T cd07857         320 SMEELRDMIIEE  331 (332)
T ss_pred             cHHHHHHHHhhc
Confidence            999999988876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.3e-51  Score=390.16  Aligned_cols=288  Identities=35%  Similarity=0.595  Sum_probs=228.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC---C
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR---R  104 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~  104 (373)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++.....      ...+|+.+++.++||||+++++++.....   .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            34689999999999999999999999999999998854321      23469999999999999999988754321   2


Q ss_pred             CcceEEEEeecCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCc
Q 017334          105 NFKDVYLVYELMDTDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGL  179 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~  179 (373)
                      ....+++||||++++|.+++.    ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus       138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence            224578999999998877764    346799999999999999999999999999999999999999765 699999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ++...... ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+..+...
T Consensus       218 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        218 AKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             chhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            98654322 23456789999999998876679999999999999999999999999998888999999888887665443


Q ss_pred             ccCChhHHHHHHhCCCCCCCCcccc-CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRL-YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      ..... ...  ..++......+... ....++++++||.+||..||.+|||+.|+|+||||..+.++
T Consensus       297 ~~~~~-~~~--~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~  360 (440)
T PTZ00036        297 EMNPN-YAD--IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP  360 (440)
T ss_pred             Hhchh-hhc--ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence            22110 000  00111111111122 23477899999999999999999999999999999876543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-51  Score=365.08  Aligned_cols=267  Identities=25%  Similarity=0.357  Sum_probs=221.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ...|++...||.|..++||+|+...+++.||||+++.+..+.. ...+.+|+..++.++||||++++..|...     ..
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~   98 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SE   98 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec-----ce
Confidence            4789999999999999999999999999999999987766554 56788999999999999999999999544     67


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +|+||.||. |++.++++..  ..++|..|..++++++.||.|||++|.+|||||+.||||+.+|.|||+|||.+.....
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999996 8999999753  4699999999999999999999999999999999999999999999999998765433


Q ss_pred             CCc----cccceeeccccCchhh-hhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          186 KNQ----FMTEYVVTRWYRAPEL-LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       186 ~~~----~~~~~~gt~~y~aPE~-~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...    .+++.+||++|||||+ .....+|+.++||||||+...||.+|..||........+..-  +.+.++--....
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~t~~  256 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLLTSG  256 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCccccc
Confidence            221    1266799999999999 455568999999999999999999999999877665544332  223332111111


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .+..                   ....++..++.+|..||..||.+|||++++|+|+||+..
T Consensus       257 ~~~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  257 LDKD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             CChH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence            1111                   112355679999999999999999999999999999754

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.4e-51  Score=368.90  Aligned_cols=283  Identities=39%  Similarity=0.637  Sum_probs=226.3

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC---CCCCeeeeceeecCCCCCCcc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL---QHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +|++++.||+|+||.||+|+++.+|+.||+|.+..............+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58999999999999999999999999999999875433322222344666666555   699999999998654434456


Q ss_pred             eEEEEeecCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .+++||||+.++|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~  160 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC  160 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence            79999999999999988754  3589999999999999999999999999999999999999999999999999876532


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      . .......+|..|+|||++.+ ..++.++||||+||++|+|++|.+||.+....+.+..+....+.+....+.......
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         161 Q-MALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             c-ccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            2 22344578999999999876 578999999999999999999999999888888888888877765544332211000


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                          ................+.++..+.+||.+||+.||++|||+.+++.||||
T Consensus       239 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 ----RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ----ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                01112222334445567788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-51  Score=383.51  Aligned_cols=281  Identities=26%  Similarity=0.347  Sum_probs=220.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|.+..+++.||+|+...        ..+.+|+.+++.++||||+++++++.     ....
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~  157 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFT-----YNKF  157 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCe
Confidence            3689999999999999999999999999999997532        23568999999999999999999983     3467


Q ss_pred             EEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC-CC
Q 017334          109 VYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG-KN  187 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~-~~  187 (373)
                      .++|+|++.++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus       158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999999865322 22


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCC-------CchHHHHHHHHHhCCCChhhhcc
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT-------ECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||-..       +...++..+....|..+......
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            23345689999999999876 57899999999999999999999766433       23346666777666654332111


Q ss_pred             cCChhHHH-H---HHhCCCCCC-C-CccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          261 IDNPKARK-Y---IKSLPYTPG-T-PFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       261 ~~~~~~~~-~---~~~~~~~~~-~-~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      . ...... +   .......+. . .+.. ...++.++.+||.+||+.||++|||+.|+|+||||..+..+
T Consensus       317 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        317 A-QANLDEIYIGLAKKSSRKPGSRPLWTN-LYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             h-hHHHHHHHHHHHhccCCCCCCCCCHHH-HhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            1 111111 1   111111110 0 1111 12356789999999999999999999999999999876444

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-51  Score=376.47  Aligned_cols=324  Identities=61%  Similarity=1.088  Sum_probs=278.2

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++.+.||.|++|.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++........+.+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            68999999999999999999999999999999976554445556788999999999999999999998665433445799


Q ss_pred             EEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC---
Q 017334          111 LVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN---  187 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---  187 (373)
                      +||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......   
T Consensus        81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~  160 (330)
T cd07834          81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK  160 (330)
T ss_pred             EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence            99999999999999887899999999999999999999999999999999999999999999999999998664432   


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+....+....+.+....+.........
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  240 (330)
T cd07834         161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR  240 (330)
T ss_pred             ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence            22445578999999999987547899999999999999999999999999999999999999998888877766666677


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCC--cccccCH
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLD--MDEESGE  345 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  345 (373)
                      .+..........++....+.+++.+.+||.+||+.||++||++.++++||||..+..+....+...+.++.  ......+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (330)
T cd07834         241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTE  320 (330)
T ss_pred             hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcCH
Confidence            77777777777777777888999999999999999999999999999999999988888887777777662  2225556


Q ss_pred             HHHHHHHHH
Q 017334          346 EMIREMMLK  354 (373)
Q Consensus       346 ~~~~~~~~~  354 (373)
                      +..++++.+
T Consensus       321 ~~~~~~~~~  329 (330)
T cd07834         321 EELKELIYE  329 (330)
T ss_pred             HHHhHHhhc
Confidence            666666544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-52  Score=364.80  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=221.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      +++++++.||.|.-|+||+|+.+.++..+|+|++.+.... .....++..|-+||..+.||.++.+|+.|     +....
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccce
Confidence            6789999999999999999999999999999999887544 45566778899999999999999999999     66688


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .|+|||||. |+|..+++++  +.|++..++.++..|+.||+|||-.|||+|||||+||||..+|+|.|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999995 7999988754  5799999999999999999999999999999999999999999999999998732110


Q ss_pred             -----------------------------------C---------------------CccccceeeccccCchhhhhcCC
Q 017334          186 -----------------------------------K---------------------NQFMTEYVVTRWYRAPELLLCCD  209 (373)
Q Consensus       186 -----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~  209 (373)
                                                         .                     .....+.+||-.|.|||++.| .
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~  310 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-E  310 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-C
Confidence                                               0                     011234588999999999988 6


Q ss_pred             CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCC
Q 017334          210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH  289 (373)
Q Consensus       210 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  289 (373)
                      +.+.++|+|+||+++|||+.|..||.|.+..+.+..|+.   .+.    .                     +.. .+.++
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---~~l----~---------------------Fp~-~~~vs  361 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---QPL----K---------------------FPE-EPEVS  361 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---CCC----c---------------------CCC-CCcch
Confidence            789999999999999999999999999998888776654   110    0                     011 13577


Q ss_pred             HHHHHHHHhhcCcCCCCCCC----HHHHhCCCCCCCC
Q 017334          290 PLAIDLLQKMLVFDPTKRIS----VTEALQHPYMSPL  322 (373)
Q Consensus       290 ~~~~~ll~~~L~~dP~~R~t----~~eil~hp~~~~~  322 (373)
                      ..++|||+++|.+||.+|+.    |.||-+||||+++
T Consensus       362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV  398 (459)
T KOG0610|consen  362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV  398 (459)
T ss_pred             hHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence            88999999999999999998    9999999999865

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-51  Score=376.79  Aligned_cols=263  Identities=34%  Similarity=0.522  Sum_probs=229.6

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCC
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQ-HENVIALKDVMMPSH  102 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  102 (373)
                      ...+...|++.+.||+|.||+||.|+++.||+.+|+|++.+.... ......+.+|+.+|++++ ||||++++++|    
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~----  105 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF----  105 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence            356778999999999999999999999999999999999876542 234456779999999999 99999999999    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC----CCeEEccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN----CDLKICDF  177 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~----~~~kL~Df  177 (373)
                       +....+++|||++. |.|++.+... .+++.++..++.||+.|++|||+.||+||||||+|+|+...    +.+|++||
T Consensus       106 -e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  106 -EDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             -EcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence             55578999999996 7999999876 59999999999999999999999999999999999999654    47999999


Q ss_pred             CcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      |++..... .......+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+.......|...--      
T Consensus       184 Gla~~~~~-~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------  255 (382)
T KOG0032|consen  184 GLAKFIKP-GERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------  255 (382)
T ss_pred             CCceEccC-CceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------
Confidence            99998766 667888999999999999976 6899999999999999999999999999887776665544111      


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                           .-....|+.+|..+++||++||..||.+|+|+.++|+|||++..
T Consensus       256 ---------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  256 ---------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ---------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence                                 01123467889999999999999999999999999999998764

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.7e-50  Score=374.80  Aligned_cols=335  Identities=44%  Similarity=0.750  Sum_probs=255.2

Q ss_pred             cceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeec
Q 017334           16 KHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK   95 (373)
Q Consensus        16 ~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   95 (373)
                      .+.+.+.+..+.+.++|++++.||+|+||.||+|.+..+|+.||+|++.+..........+.+|+.+++.++||||++++
T Consensus         2 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   81 (353)
T cd07850           2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL   81 (353)
T ss_pred             ceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCccee
Confidence            34556666667788999999999999999999999999999999999976555555556677899999999999999999


Q ss_pred             eeecCCC-CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEE
Q 017334           96 DVMMPSH-RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (373)
Q Consensus        96 ~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL  174 (373)
                      +++.... ..+....|+||||++++|.+.+...  +++..++.++.||+.||+|||++||+||||||+||+++.++.+||
T Consensus        82 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          82 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             eeeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEE
Confidence            9886432 1233568999999999999888653  899999999999999999999999999999999999999999999


Q ss_pred             cccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      +|||++....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+...++.+.
T Consensus       160 ~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (353)
T cd07850         160 LDFGLARTAGTSF-MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS  237 (353)
T ss_pred             ccCccceeCCCCC-CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999997654322 2334567899999999977 6789999999999999999999999999888888888888888776


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCcccc-------------CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRL-------------YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ......... ....+....+.....++...             ....++.+++||.+||+.||++|||+.++|+||||..
T Consensus       238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         238 DEFMSRLQP-TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             HHHHHHhhh-hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence            544333221 11222222222111112111             1134567899999999999999999999999999987


Q ss_pred             CCCCCCCCC-CCCCCCCCcc-cccCHHHHHHHHHHH
Q 017334          322 LYDPSSNPP-AQVPIDLDMD-EESGEEMIREMMLKE  355 (373)
Q Consensus       322 ~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~e  355 (373)
                      ++.+..... .....+...+ .+...+.+++.+.+|
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T cd07850         317 WYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKE  352 (353)
T ss_pred             ccCCccCCCCCCCccccccccccccHHHHHHHHHhh
Confidence            666544333 2222222211 144445555554443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-52  Score=351.87  Aligned_cols=261  Identities=30%  Similarity=0.449  Sum_probs=216.4

Q ss_pred             eeecCceeeee-eeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCC
Q 017334           26 FEIDTKYVPIK-PIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHR  103 (373)
Q Consensus        26 ~~~~~~Y~~~~-~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  103 (373)
                      ..|.++|.+-. .||-|-.|+|..+.++.||+++|+|++..       ..+..+|+++.-..+ |||||.++++|.... 
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-  128 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSY-  128 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-
Confidence            45788998875 79999999999999999999999999843       335678999887775 999999999996553 


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCCeEEccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDF  177 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~---~~~~kL~Df  177 (373)
                      .+...+.+|||.|+ |.|++.+..++.  |+|.++..|++||..|+.|||+.+|.||||||+|+|...   +..+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence            45578999999996 699999988765  999999999999999999999999999999999999965   446999999


Q ss_pred             CcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHHHhCCC
Q 017334          178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL----NQLKLIINILGSR  253 (373)
Q Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~  253 (373)
                      |+|+.... ...+.+.|-||+|.|||++.. ..|+..+|+||+||++|-|++|.|||......    ...+.|....-.+
T Consensus       209 GFAK~t~~-~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  209 GFAKETQE-PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccCC-CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            99987643 345667799999999999854 67999999999999999999999999765432    2222222211111


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      +                           ...|..+|..++|+|+++|..+|++|+|+.+++.|||+.+..
T Consensus       287 P---------------------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  287 P---------------------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             C---------------------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            1                           123456889999999999999999999999999999998653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5e-52  Score=354.40  Aligned_cols=332  Identities=44%  Similarity=0.779  Sum_probs=278.2

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-  102 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-  102 (373)
                      +.|.+..+|.-++.+|.|.- .|..|.|.-+++.||+|++..+..+.....+..+|..++..+.|+||++++.+|.... 
T Consensus        11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT   89 (369)
T ss_pred             cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence            66788899999999999998 8999999999999999999888877777888999999999999999999999997642 


Q ss_pred             CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          103 RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      .+....+|+|||+|+.+|.+.+.  -.+....++++++|++.|++|||+.||+||||||+||+++.++.+||.|||+|+.
T Consensus        90 l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   90 LEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence            23446799999999999998887  4678889999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .... -..+.++.|..|+|||++.+. .|...+||||+|||+.||++|...|+|.+..++..++...+|.+.+.......
T Consensus       168 e~~~-~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  168 EDTD-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cCcc-cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            6433 467889999999999999984 59999999999999999999999999999999999999999999887655433


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCC------------CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPD------------AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP  330 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~  330 (373)
                       +..+.+....+......+.+.+|+            -+..+++|+.+||..||++|.+++++|+|||++-++++.....
T Consensus       246 -~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~a  324 (369)
T KOG0665|consen  246 -PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEA  324 (369)
T ss_pred             -HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccC
Confidence             233444445555555555555443            2456899999999999999999999999999985544443332


Q ss_pred             CCCC-CCCCcc-cccCHHHHHHHHHHHHHhcCc
Q 017334          331 AQVP-IDLDMD-EESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       331 ~~~~-~~~~~~-~~~~~~~~~~~~~~e~~~~~~  361 (373)
                      ++++ .+...+ ++..-+++++.+.+|+..+.+
T Consensus       325 p~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  325 PPPEIYDKQLDEREHTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             CCCchhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence            2222 333332 355689999999999999887

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-51  Score=369.35  Aligned_cols=253  Identities=24%  Similarity=0.389  Sum_probs=214.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++     .+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence            479999999999999999999999999999999865432 223344567899999999999999999888     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            999999996 699999998889999999999999999999999999999999999999999999999999998765332 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                        ....+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...  .               
T Consensus       155 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~---------------  214 (291)
T cd05612         155 --TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--K---------------  214 (291)
T ss_pred             --cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C---------------
Confidence              234578999999999876 57899999999999999999999999887655544443320  0               


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                    ......+++.+++||++||+.||.+|++     +.++++||||..+
T Consensus       215 --------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         215 --------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             --------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence                          0112346788999999999999999995     9999999999753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-50  Score=370.41  Aligned_cols=335  Identities=47%  Similarity=0.853  Sum_probs=274.0

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      ..++..+.++|.+++.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            45667788999999999999999999999999999999999976544444455677899999999999999999987543


Q ss_pred             C-CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          102 H-RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       102 ~-~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      . .......|+++++++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          89 RSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             ccccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence            2 123356899999999999888765 46999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .....   ......++..|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+....+.+.......
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         168 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             ccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            75432   223457789999999987655688999999999999999999999998888888888888888887777766


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCC-Cc
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDL-DM  339 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~-~~  339 (373)
                      ......+.+....+..+...+.......++.+.+||.+||+.||.+||++.++++||||.....+...+.+. +.+. ..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~-~~~~~~~  323 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSFE  323 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCC-CccCcch
Confidence            666666666666666665555555566789999999999999999999999999999999887776666443 2322 22


Q ss_pred             ccccCHHHHHHHHHHHHHhcCc
Q 017334          340 DEESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       340 ~~~~~~~~~~~~~~~e~~~~~~  361 (373)
                      .++...+++...+.+|+-.+.|
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~  345 (345)
T cd07877         324 SRDLLIDEWKSLTYDEVISFVP  345 (345)
T ss_pred             hcccCHHHHHHHHHHHHHhcCC
Confidence            2344457777778888765544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.8e-51  Score=375.15  Aligned_cols=250  Identities=26%  Similarity=0.458  Sum_probs=212.0

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      +.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     ...+.+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            469999999999999999999999999976432 233445677899999999999999999998     44578999999


Q ss_pred             cCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccce
Q 017334          115 LMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY  193 (373)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  193 (373)
                      |+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  155 (323)
T cd05571          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence            996 6999999888899999999999999999999999999999999999999999999999999987543333444567


Q ss_pred             eeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhC
Q 017334          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL  273 (373)
Q Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      +||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...                        
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------------------------  210 (323)
T cd05571         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------------  210 (323)
T ss_pred             ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------------------------
Confidence            89999999999876 67899999999999999999999999876654444333210                        


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                             .......+++.+.+||++||+.||++||     ++.++++||||...
T Consensus       211 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         211 -------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                   0012245788999999999999999999     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7e-52  Score=352.06  Aligned_cols=290  Identities=40%  Similarity=0.672  Sum_probs=235.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCc----EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNE----KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      -..|++++.||+|.||.||+|..++++.    .||||+++.+.....-.....||+.+++.++|||++.+..+|...   
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---   99 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---   99 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence            3679999999999999999997665543    689999986654444445677999999999999999999999753   


Q ss_pred             CcceEEEEeecCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC----CCeEEc
Q 017334          105 NFKDVYLVYELMDTDLHQIIKSS-----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN----CDLKIC  175 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~----~~~kL~  175 (373)
                       +..+++++||.+.+|..+|+.+     ..++...++.+++||+.|+.|||++.|+||||||.||||..+    |.|||+
T Consensus       100 -d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 -DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             -CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence             3789999999999999999643     368999999999999999999999999999999999999888    899999


Q ss_pred             ccCcccccCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---------chHHH
Q 017334          176 DFGLARTSNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE---------CLNQL  243 (373)
Q Consensus       176 Dfg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~  243 (373)
                      |||+++.....-.   .....+.|.||+|||.++|...|+++.|+||.|||+.||++-.|.|.+..         ..+++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            9999997754322   23456789999999999999999999999999999999999999997653         24688


Q ss_pred             HHHHHHhCCCChhhhcccCChh-HHHHHHhCC--CCCC---CCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q 017334          244 KLIINILGSRREEDLEFIDNPK-ARKYIKSLP--YTPG---TPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP  317 (373)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~---~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp  317 (373)
                      ..|++++|.+....|+...... ....+..+.  +...   ..+-.....-++.+.+||.+||..||.+|+|++++|+|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            9999999999998887654321 111122111  1111   111222233456688999999999999999999999999


Q ss_pred             CCCCC
Q 017334          318 YMSPL  322 (373)
Q Consensus       318 ~~~~~  322 (373)
                      ||...
T Consensus       339 yF~~d  343 (438)
T KOG0666|consen  339 YFTED  343 (438)
T ss_pred             ccccC
Confidence            99754

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-50  Score=370.09  Aligned_cols=336  Identities=45%  Similarity=0.815  Sum_probs=271.0

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      ..++..+.++|++++.||+|+||.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++...
T Consensus         7 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (343)
T cd07880           7 NKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD   86 (343)
T ss_pred             hhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence            45566789999999999999999999999999999999999876544444455677999999999999999999998543


Q ss_pred             CC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          102 HR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       102 ~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      .. ......++||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        87 ~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          87 LSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            21 12245799999998899888765 57999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ......   .....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+....+.........
T Consensus       166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         166 RQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             cccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            765322   23446788999999987645688999999999999999999999998887777777777766666555544


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMD  340 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  340 (373)
                      ........+...++......+....+.+++.+.++|.+||+.||++|||+.++++||||+........+....-.+.-..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDE  322 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCccccHHh
Confidence            44444555555555554445555567789999999999999999999999999999999987665544433332222233


Q ss_pred             cccCHHHHHHHHHHHHHhcCc
Q 017334          341 EESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       341 ~~~~~~~~~~~~~~e~~~~~~  361 (373)
                      .+...++++.+...|+..+.|
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         323 VDQSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             hccchHHHHHHHHHHHHhcCC
Confidence            367789999999999887765

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.2e-50  Score=385.23  Aligned_cols=295  Identities=24%  Similarity=0.380  Sum_probs=226.2

Q ss_pred             eEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC------CCCee
Q 017334           19 YSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ------HENVI   92 (373)
Q Consensus        19 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv   92 (373)
                      ....+.+....++|++++.||+|+||+||+|.+..+++.||||+++....   .......|+.+++.++      |.+++
T Consensus       118 ~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~  194 (467)
T PTZ00284        118 VVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLM  194 (467)
T ss_pred             EecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCccee
Confidence            33344444557899999999999999999999999999999999964321   1223345666666654      45588


Q ss_pred             eeceeecCCCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCC-
Q 017334           93 ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANC-  170 (373)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~-  170 (373)
                      ++++++...    ..++|+|||+++++|.+++...+.+++.+++.++.||+.||+|||+ .||+||||||+|||++.++ 
T Consensus       195 ~i~~~~~~~----~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        195 KIQRYFQNE----TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDT  270 (467)
T ss_pred             eeEEEEEcC----CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCc
Confidence            888887432    2579999999999999999888899999999999999999999998 5999999999999998765 


Q ss_pred             ---------------CeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 017334          171 ---------------DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFP  235 (373)
Q Consensus       171 ---------------~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  235 (373)
                                     .+||+|||.+....   ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                           49999999876432   22345689999999999987 579999999999999999999999999


Q ss_pred             CCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCC----CCCcccc-----C--CCCCHHHHHHHHhhcCcCC
Q 017334          236 GTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP----GTPFSRL-----Y--PDAHPLAIDLLQKMLVFDP  304 (373)
Q Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-----~--~~~s~~~~~ll~~~L~~dP  304 (373)
                      +.+..+.+..+...+|..+..............+........    ...+...     .  ...++.+.|||.+||++||
T Consensus       347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            999889999999998887765543322222222222111100    0000000     0  0124668899999999999


Q ss_pred             CCCCCHHHHhCCCCCCCCCC
Q 017334          305 TKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       305 ~~R~t~~eil~hp~~~~~~~  324 (373)
                      ++|||+.|+|+||||...+.
T Consensus       427 ~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        427 QKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             hhCCCHHHHhcCccccccCC
Confidence            99999999999999987644

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.6e-50  Score=365.93  Aligned_cols=287  Identities=38%  Similarity=0.661  Sum_probs=232.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||.|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++     ...+..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence            78999999999999999999999999999999986543222 223456899999999999999999998     444679


Q ss_pred             EEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++||||++++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++........
T Consensus        80 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             EEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            999999999999888653 5689999999999999999999999999999999999999999999999999876543333


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+...++.+....+......... 
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  238 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF-  238 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc-
Confidence            3445567899999999877667889999999999999999999999998888888888888877665544332111000 


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      .....+...........+.+++.+++||.+||+.||.+|||++++++||||..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            0001111111112233456788999999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-52  Score=339.66  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=224.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChH-HHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV-DALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|.||.||+|+.+.++..||+|++-++..... ....+.||+++...|+||||++++++|     .+...
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~~r   96 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDSKR   96 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----eccce
Confidence            789999999999999999999999999999999976543322 233566899999999999999999999     45577


Q ss_pred             EEEEeecCC-ccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +|+++||.. |+++..+.  ...++++...+.++.|++.||.|+|.++|+||||||+|+|++..+.+|++|||.+.... 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999995 89999998  66789999999999999999999999999999999999999999999999999987664 


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                       .....+.|||..|.|||+..+ ..++..+|+|++|++.||++.|.+||...+..+..+.|.++--              
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--------------  239 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--------------  239 (281)
T ss_pred             -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc--------------
Confidence             344577899999999999877 6899999999999999999999999999888888888766311              


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                       ..+..++..++|||.+||..+|.+|++..|++.|||+..
T Consensus       240 -----------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  240 -----------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             -----------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                             122568889999999999999999999999999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-50  Score=372.58  Aligned_cols=253  Identities=25%  Similarity=0.424  Sum_probs=214.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     ...+.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCCE
Confidence            789999999999999999999999999999999975432 223344577899999999999999999998     44477


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            999999996 699999998889999999999999999999999999999999999999999999999999999765332 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                        ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..   ..              
T Consensus       172 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~---~~--------------  231 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA---GR--------------  231 (329)
T ss_pred             --cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc---CC--------------
Confidence              234578999999999976 5688999999999999999999999987665444433321   00              


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                    ......++..+++||++||+.||.+|++     ++++++||||...
T Consensus       232 --------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        232 --------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             --------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence                          0112346788999999999999999997     7999999999763

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-49  Score=359.81  Aligned_cols=282  Identities=39%  Similarity=0.678  Sum_probs=230.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||+|++|.||+|.++.+|..||+|++............+.+|+.+++.++||||+++++++     .....+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence            58999999999999999999999999999999876544333344567899999999999999999998     4446799


Q ss_pred             EEeecCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          111 LVYELMDTDLHQIIKSS---QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +||||+.++|.+++...   ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            99999999998888642   468999999999999999999999999999999999999999999999999987654333


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||++.+...++.++|+|||||++|+|++|++||.+.........+...++.+....+.....  ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  233 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LP  233 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh--hH
Confidence            3334456789999999987766678999999999999999999999998877777777766666655444433221  22


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .+....+.............+++++.+||++||+.||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            2333333333333334455689999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-52  Score=354.41  Aligned_cols=298  Identities=24%  Similarity=0.417  Sum_probs=244.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++|..++.||+|.||+|-+++.+.+|+.||||++++... .+......+.|-++|+..+||.+..+...|     +...
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence            4789999999999999999999999999999999987643 444555677899999999999999988888     5557


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||+. |.|+-.+...+.|++..++.+...|+.||.|||+++||+||||.+|.|+|.+|++||+|||+++.....
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            8999999996 799988888889999999999999999999999999999999999999999999999999999877777


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....+.||||.|.|||++.. ..|+.++|+|.+||++|||++|+.||.+.+.......|.-.       +         
T Consensus       322 g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------d---------  384 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------D---------  384 (516)
T ss_pred             cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------h---------
Confidence            777889999999999999976 68999999999999999999999999998877777766431       0         


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC-CCCCCCCCCCCCCCCCcc
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL-YDPSSNPPAQVPIDLDMD  340 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~-~~~~~~~~~~~~~~~~~~  340 (373)
                                     .+.+..++++++.||..+|..||.+|+     .+.+|.+|+||..+ +.........+|+..+..
T Consensus       385 ---------------~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt  449 (516)
T KOG0690|consen  385 ---------------LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT  449 (516)
T ss_pred             ---------------ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence                           123356899999999999999999998     47899999999864 111111122223333344


Q ss_pred             cccCHHHHHHHHHHHHHhcCccc
Q 017334          341 EESGEEMIREMMLKEMLHYHPEA  363 (373)
Q Consensus       341 ~~~~~~~~~~~~~~e~~~~~~~~  363 (373)
                      .+.+.....+....+.....|.+
T Consensus       450 SetDTryFD~EFT~q~v~lTPP~  472 (516)
T KOG0690|consen  450 SETDTRYFDEEFTSQPVTLTPPD  472 (516)
T ss_pred             cccchhhhhhhhhcceeEecCCC
Confidence            44444444444444444444443

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-49  Score=367.31  Aligned_cols=333  Identities=47%  Similarity=0.836  Sum_probs=263.9

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ..+..+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.+..........+.+|+.+++.++||||+++++++....
T Consensus         8 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~   87 (342)
T cd07879           8 KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV   87 (342)
T ss_pred             hhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence            34456778999999999999999999999999999999999765433333445778999999999999999999985432


Q ss_pred             -CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          103 -RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       103 -~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                       ......+|+|+||+..+|.+++.  ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          88 SGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             cCCCCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence             12335679999999888877653  468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ....   ......+++.|+|||++.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+........
T Consensus       166 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         166 HADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            5432   2234577899999999876556889999999999999999999999998888888888888887777666555


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDE  341 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  341 (373)
                      .+.....+....+..+...+...++.+++.+.+||.+||+.||++||++.+++.||||..+......+. ..+.+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~-~~~~~~~~~~  321 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE-QQPYDDSLEN  321 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCC-CCcccchhhh
Confidence            555445555555555555566666788999999999999999999999999999999998755433332 3333333322


Q ss_pred             -ccCHHHHHHHHHHHHHhcCc
Q 017334          342 -ESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       342 -~~~~~~~~~~~~~e~~~~~~  361 (373)
                       +...+++..-+.+|...++|
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~  342 (342)
T cd07879         322 EKLSVDEWKKHIYKEVKSFSP  342 (342)
T ss_pred             hhCCHHHHHHHhhhhhhccCC
Confidence             44456666666666554443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.4e-49  Score=363.42  Aligned_cols=325  Identities=49%  Similarity=0.911  Sum_probs=267.2

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      .+.++.+.++|++++.||.|+||.||+|.+..+|+.||+|++.+..........+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   81 (328)
T cd07856           2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP   81 (328)
T ss_pred             CcceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence            35667889999999999999999999999999999999999876544444445677899999999999999999988432


Q ss_pred             CCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          102 HRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                          ....|+++||++++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.+||+|||.+.
T Consensus        82 ----~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          82 ----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             ----CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence                246899999999999888764 568899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ....   ......+++.|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......+.+.++.+..+.....
T Consensus       157 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         157 IQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             ccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            5432   2234567889999999866567899999999999999999999999988887788888888888877665554


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDE  341 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  341 (373)
                      .......+....+.....+.....+.+++.+.++|++||+.+|++||++.+++.||||.....+...+.....+++..++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFND  313 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhc
Confidence            44444445555554444555566677889999999999999999999999999999999887777776666666665555


Q ss_pred             -ccCHHHHHHHHHH
Q 017334          342 -ESGEEMIREMMLK  354 (373)
Q Consensus       342 -~~~~~~~~~~~~~  354 (373)
                       +...+.|+-+|..
T Consensus       314 ~~~~~~~~~~~~~~  327 (328)
T cd07856         314 ADLPVDTWKVMMYS  327 (328)
T ss_pred             ccCCHHHHHHHhcC
Confidence             4456777766653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.8e-50  Score=360.97  Aligned_cols=282  Identities=42%  Similarity=0.689  Sum_probs=225.7

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||+|+||.||+|+++.+|+.+|+|++............+.+|+.+++.++||||+++++++     .+...++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            58999999999999999999999999999999975433333334567899999999999999999998     4446799


Q ss_pred             EEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          111 LVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      +|+||++++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus        76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence            9999999999888865 467999999999999999999999999999999999999999999999999999765443333


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPI-FPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      .....+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+....+..+.+.++.+....+.......  .
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  233 (284)
T cd07839         156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP--D  233 (284)
T ss_pred             cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc--c
Confidence            44456789999999987756678999999999999999987755 66666667777777777766544332211100  0


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      +...........+.+..+.+++.+.+||++||+.||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            000001111122344456789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-49  Score=366.39  Aligned_cols=261  Identities=24%  Similarity=0.442  Sum_probs=218.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++     .....
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            4799999999999999999999999999999999765332 22344577899999999999999999998     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999996 69999998888899999999999999999999999999999999999999999999999999876533  


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                       .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+........             
T Consensus       154 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------------  218 (333)
T cd05600         154 -YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ-------------  218 (333)
T ss_pred             -ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc-------------
Confidence             2345688999999999977 5789999999999999999999999988766555544433111000             


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                              .+  ........+++++.+||.+||..+|.+||++.++++||||...
T Consensus       219 --------~~--~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         219 --------RP--VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             --------CC--CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence                    00  0000013468899999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-50  Score=366.46  Aligned_cols=248  Identities=29%  Similarity=0.495  Sum_probs=209.6

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecC
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM  116 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~  116 (373)
                      ||+|+||.||+|++..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++     ...+..|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999987543 2333445677899999999999999999988     4447899999999


Q ss_pred             C-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceee
Q 017334          117 D-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV  195 (373)
Q Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  195 (373)
                      . |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|
T Consensus        76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g  155 (312)
T cd05585          76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG  155 (312)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence            6 699999988889999999999999999999999999999999999999999999999999998754333334455689


Q ss_pred             ccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCC
Q 017334          196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPY  275 (373)
Q Consensus       196 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (373)
                      |+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..   .                       
T Consensus       156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~---~-----------------------  208 (312)
T cd05585         156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ---E-----------------------  208 (312)
T ss_pred             CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc---C-----------------------
Confidence            999999999976 6789999999999999999999999987665444333321   0                       


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC---CHHHHhCCCCCCCC
Q 017334          276 TPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SVTEALQHPYMSPL  322 (373)
Q Consensus       276 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~---t~~eil~hp~~~~~  322 (373)
                           .......+++.+.+||.+||..||++||   ++.++++||||...
T Consensus       209 -----~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         209 -----PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence                 0112345788899999999999999997   58999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.9e-50  Score=372.50  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=211.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++.+... .......+.+|+.++..++||||+++++.+     ++...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            479999999999999999999999999999999975432 223334567899999999999999999998     45578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||+. |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999996 6999999888899999999999999999999999999999999999999999999999999986432110


Q ss_pred             -----------------------------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCC
Q 017334          188 -----------------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP  232 (373)
Q Consensus       188 -----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  232 (373)
                                                         ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCC
Confidence                                               01124589999999999976 578999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCC---CCCC
Q 017334          233 IFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPT---KRIS  309 (373)
Q Consensus       233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~---~R~t  309 (373)
                      ||.+.+..+....+.......                          .+.. ...+++.+++||.+|+. +|.   .||+
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~~--------------------------~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~  286 (363)
T cd05628         235 PFCSETPQETYKKVMNWKETL--------------------------IFPP-EVPISEKAKDLILRFCC-EWEHRIGAPG  286 (363)
T ss_pred             CCCCCCHHHHHHHHHcCcCcc--------------------------cCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence            998877655555443311000                          0000 12367889999999875 444   4589


Q ss_pred             HHHHhCCCCCCCC
Q 017334          310 VTEALQHPYMSPL  322 (373)
Q Consensus       310 ~~eil~hp~~~~~  322 (373)
                      ++++++||||+..
T Consensus       287 ~~ei~~hp~f~~~  299 (363)
T cd05628         287 VEEIKTNPFFEGV  299 (363)
T ss_pred             HHHHhCCCCCCCC
Confidence            9999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.4e-50  Score=369.42  Aligned_cols=250  Identities=25%  Similarity=0.450  Sum_probs=210.4

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      +.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++     .....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            469999999999999999999999999976432 223344567899999999999999999998     44467999999


Q ss_pred             cCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccce
Q 017334          115 LMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY  193 (373)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  193 (373)
                      |++ |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~  155 (323)
T cd05595          76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF  155 (323)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence            996 6999999888889999999999999999999999999999999999999999999999999987543333334456


Q ss_pred             eeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhC
Q 017334          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL  273 (373)
Q Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      .||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...                        
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------------------------  210 (323)
T cd05595         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------------  210 (323)
T ss_pred             cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------------
Confidence            79999999999876 57899999999999999999999999876654444333210                        


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                             .......+++.+.+||.+||..||.+|+     ++.++++||||...
T Consensus       211 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         211 -------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence                   0012245788999999999999999998     89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-50  Score=368.73  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=214.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCC-cEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETN-EKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g-~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      -++|++++.||+|+||.||+|.++.++ ..||+|++.+... .......+.+|+.+++.++||||+++++++     ...
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            368999999999999999999876655 6899999865432 223344677899999999999999999998     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +.+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            77999999995 79999999888999999999999999999999999999999999999999999999999999976533


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+....               
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------------  244 (340)
T PTZ00426        184 R---TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------------  244 (340)
T ss_pred             C---cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------------
Confidence            2   245689999999999976 578899999999999999999999998776544444432200               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                      ....+.+++.+.++|++||+.||++|+     +++++++||||..+
T Consensus       245 ----------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        245 ----------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                            012245678899999999999999995     89999999999864

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.5e-50  Score=367.12  Aligned_cols=250  Identities=25%  Similarity=0.450  Sum_probs=210.5

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      +.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++.+     .....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            468999999999999999999999999976432 233445677899999999999999999988     44578999999


Q ss_pred             cCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccce
Q 017334          115 LMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY  193 (373)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  193 (373)
                      |++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~  155 (328)
T cd05593          76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF  155 (328)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence            996 6999999888889999999999999999999999999999999999999999999999999987543333334556


Q ss_pred             eeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhC
Q 017334          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL  273 (373)
Q Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      +||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..   .                     
T Consensus       156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~---~---------------------  210 (328)
T cd05593         156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---E---------------------  210 (328)
T ss_pred             cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---C---------------------
Confidence            89999999999876 5789999999999999999999999987654443333211   0                     


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                             ...+...+++.+.+||++||..||++|+     ++.++++||||...
T Consensus       211 -------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         211 -------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             -------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                   0012245788999999999999999997     89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-50  Score=373.17  Aligned_cols=259  Identities=26%  Similarity=0.446  Sum_probs=212.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+... .......+.+|+.+++.++||||+++++.+     .....
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            479999999999999999999999999999999975432 223344567899999999999999999998     45578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999996 7999999888889999999999999999999999999999999999999999999999999986432111


Q ss_pred             c--------------------------------------cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh
Q 017334          188 Q--------------------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG  229 (373)
Q Consensus       188 ~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  229 (373)
                      .                                      ...+.+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhc
Confidence            0                                      1123469999999999876 678999999999999999999


Q ss_pred             CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC
Q 017334          230 RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS  309 (373)
Q Consensus       230 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t  309 (373)
                      |.+||.+.+..+....+......                    ..      .. ....+++.+.+||++||. +|.+|++
T Consensus       235 G~~Pf~~~~~~~~~~~i~~~~~~--------------------~~------~~-~~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         235 GYPPFCSDNPQETYRKIINWKET--------------------LQ------FP-DEVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCc--------------------cC------CC-CCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            99999877655444433221000                    00      00 012468899999999997 9999998


Q ss_pred             ---HHHHhCCCCCCCC
Q 017334          310 ---VTEALQHPYMSPL  322 (373)
Q Consensus       310 ---~~eil~hp~~~~~  322 (373)
                         +.++++||||+..
T Consensus       287 ~~~~~~ll~h~~~~~~  302 (364)
T cd05599         287 NNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCHHHHhcCCCcCCC
Confidence               9999999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-49  Score=374.05  Aligned_cols=259  Identities=27%  Similarity=0.427  Sum_probs=211.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+|++++.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.+++.++||||+++++.+     .....
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~   75 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN   75 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCE
Confidence            368999999999999999999999999999999975432 223344677899999999999999999999     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC-
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK-  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-  186 (373)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999996 699999988888999999999999999999999999999999999999999999999999997422100 


Q ss_pred             ----------------------------------------------CccccceeeccccCchhhhhcCCCCCchhhhHHH
Q 017334          187 ----------------------------------------------NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSV  220 (373)
Q Consensus       187 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  220 (373)
                                                                    .....+.+||+.|+|||++.+ ..++.++|||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSl  234 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSV  234 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEec
Confidence                                                          001123578999999999876 578999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhc
Q 017334          221 GCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML  300 (373)
Q Consensus       221 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L  300 (373)
                      ||++|+|++|++||.+.+..+....+.......                        ..   .....+++++.++|.+|+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------~~---p~~~~~s~~~~~li~~l~  287 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSL------------------------HI---PPQAKLSPEASDLIIKLC  287 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc------------------------CC---CCcccCCHHHHHHHHHHc
Confidence            999999999999998876554444333210000                        00   011357889999999976


Q ss_pred             CcCCCCCCC---HHHHhCCCCCCCC
Q 017334          301 VFDPTKRIS---VTEALQHPYMSPL  322 (373)
Q Consensus       301 ~~dP~~R~t---~~eil~hp~~~~~  322 (373)
                       .+|++|++   +.++++||||+..
T Consensus       288 -~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         288 -RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             -cCHhHcCCCCCHHHHhcCCCcCCc
Confidence             59999997   9999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-52  Score=366.80  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=221.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -...|..++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|.+++++||.++|+.|...     .
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g-----~   84 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----T   84 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeec-----c
Confidence            346788889999999999999999999999999999866433 2344677899999999999999999999654     6


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .++++||||+ |++.++++....+.+.++..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+......
T Consensus        85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence            6999999996 799999998777899999999999999999999999999999999999999999999999999877665


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....+.+|||.|||||++.+ ..|+.++||||||++.+||++|.||+........+..|                    
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI--------------------  223 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI--------------------  223 (467)
T ss_pred             hhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec--------------------
Confidence            555688999999999999985 78999999999999999999999999776542222111                    


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                             +   +.....+-..+|+.+++|+..||+.||+.||+|.++|+|+|++.
T Consensus       224 -------p---k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  224 -------P---KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             -------c---CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence                   1   11222333468899999999999999999999999999999975

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-49  Score=357.67  Aligned_cols=258  Identities=23%  Similarity=0.365  Sum_probs=210.8

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .|++++.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.+++.++|+||+++++++     ...+..
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            378899999999999999999999999999998754322 22234567899999999999999999998     444679


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ++||||+. |+|.+.+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999996 6898777543  46899999999999999999999999999999999999999999999999999765322


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+......              
T Consensus       156 -~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--------------  219 (285)
T cd05631         156 -ETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--------------  219 (285)
T ss_pred             -CeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--------------
Confidence             22345578999999999976 57899999999999999999999999876543322222211100              


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                   ........+++.+.+||++||+.||++||+     ++++++||||...
T Consensus       220 -------------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         220 -------------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             -------------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence                         001223457889999999999999999997     8999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3e-49  Score=371.21  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=210.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..|++++.||+|+||+||+|+++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++     .....
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~   75 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCE
Confidence            36899999999999999999999999999999997543 2333445677899999999999999999999     44477


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC-
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK-  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-  186 (373)
                      +|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++...... 
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999996 699999988888999999999999999999999999999999999999999999999999987532100 


Q ss_pred             ----------------------------------------------CccccceeeccccCchhhhhcCCCCCchhhhHHH
Q 017334          187 ----------------------------------------------NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSV  220 (373)
Q Consensus       187 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  220 (373)
                                                                    .....+.+||+.|+|||++.+ ..++.++|||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSl  234 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSV  234 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeeh
Confidence                                                          001124579999999999876 578999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhc
Q 017334          221 GCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML  300 (373)
Q Consensus       221 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L  300 (373)
                      ||++|+|++|.+||.+.+..+....+.......                        .   ......+++++.+||.+|+
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------~---~~~~~~~s~~~~dli~~ll  287 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTL------------------------H---IPPQVKLSPEAVDLITKLC  287 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc------------------------C---CCCCCCCCHHHHHHHHHHc
Confidence            999999999999998766544333332100000                        0   0011347889999999966


Q ss_pred             C--cCCCCCCCHHHHhCCCCCCCC
Q 017334          301 V--FDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       301 ~--~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .  .+|..|+++.++++||||...
T Consensus       288 ~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         288 CSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             cCcccccCCCCHHHHhcCcccCCC
Confidence            4  455559999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.1e-50  Score=368.18  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=209.8

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      +.||+|+||.||+|.+..+|+.||+|++.+... .........+|+.+++.++||||+++++++     .....+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            469999999999999999999999999976432 223345567899999999999999999988     44478999999


Q ss_pred             cCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          115 LMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      |++ |+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++............
T Consensus        76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            996 6999998888889999999999999999999997 79999999999999999999999999998754333333445


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      ..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------------  211 (325)
T cd05594         156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------------  211 (325)
T ss_pred             ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------------
Confidence            679999999999876 57899999999999999999999999876654443333210                       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                              .......+++.+.+||.+||+.||++|+     ++.++++||||...
T Consensus       212 --------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         212 --------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence                    0012245788999999999999999997     89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.6e-49  Score=362.95  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=213.4

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCC-CCeeeeceeecCCCCCCcce
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQH-ENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~  108 (373)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+... .......+..|..++..+.| ++|+++++++     ...+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            58999999999999999999999999999999976432 22334556789999999975 5588888888     44467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999996 7999999888889999999999999999999999999999999999999999999999999987543333


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+....+....                 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------------  217 (324)
T cd05587         156 KTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------------  217 (324)
T ss_pred             CceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            33455679999999999976 578999999999999999999999998876555544443200                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-----TEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~eil~hp~~~~~  322 (373)
                                    ......+++.+.++|++||..||.+|++.     .++++||||...
T Consensus       218 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         218 --------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                          01224578889999999999999999976     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-49  Score=370.40  Aligned_cols=259  Identities=29%  Similarity=0.455  Sum_probs=216.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+..... .....+.+|+.++..++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            47999999999999999999999999999999997543222 3344567899999999999999999988     45578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999996 6999999888899999999999999999999999999999999999999999999999999987654332


Q ss_pred             -----------------------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 017334          188 -----------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE  238 (373)
Q Consensus       188 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  238 (373)
                                                   .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                         22345578999999999977 578999999999999999999999998876


Q ss_pred             chHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-HHHHhCCC
Q 017334          239 CLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-VTEALQHP  317 (373)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-~~eil~hp  317 (373)
                      .......+.......                        ..   .....+++.+.+||.+||. ||.+|++ +.++++||
T Consensus       235 ~~~~~~~i~~~~~~~------------------------~~---p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         235 LQETYNKIINWKESL------------------------RF---PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             HHHHHHHHhccCCcc------------------------cC---CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            554444433210000                        00   0012368899999999998 9999999 99999999


Q ss_pred             CCCCC
Q 017334          318 YMSPL  322 (373)
Q Consensus       318 ~~~~~  322 (373)
                      ||...
T Consensus       287 ~~~~~  291 (350)
T cd05573         287 FFKGI  291 (350)
T ss_pred             CcCCC
Confidence            99864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.6e-49  Score=363.06  Aligned_cols=250  Identities=24%  Similarity=0.400  Sum_probs=209.7

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|+++.+++.||+|++.+... .......+..|..++..+ +||||+++++++     ...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            469999999999999999999999999975432 223344566788888876 599999999998     4447799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (320)
T cd05590          76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST  155 (320)
T ss_pred             cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence            9996 699999988889999999999999999999999999999999999999999999999999998754333334455


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      ..||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+...   .                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~---~-------------------  212 (320)
T cd05590         156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND---E-------------------  212 (320)
T ss_pred             cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC---C-------------------
Confidence            689999999999876 57899999999999999999999999887765554444320   0                   


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH------HHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV------TEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~------~eil~hp~~~~~  322 (373)
                               ......+++.+.+||++||+.||++|+++      +++++||||..+
T Consensus       213 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         213 ---------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence                     01123467889999999999999999998      999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.7e-49  Score=358.12  Aligned_cols=289  Identities=39%  Similarity=0.670  Sum_probs=231.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||.|+||.||+|.++.+|+.||+|++..............+|+.+++.++|+||+++++++...   ..+.+
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~~   83 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDSI   83 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCeE
Confidence            789999999999999999999999999999999865433322233456799999999999999999998543   22568


Q ss_pred             EEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++||||++++|.+++.. ...+++.+++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||.+........
T Consensus        84 ~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          84 FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            99999999999888875 36799999999999999999999999999999999999999999999999999986654333


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+..........
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            33444568889999998776678999999999999999999999999999889999888888876655443222111000


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .. .....+...+....+..++.+.+||++||+.||++|||+.++++||||...
T Consensus       244 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         244 KF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            00 001111111222334568899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.8e-49  Score=359.37  Aligned_cols=278  Identities=37%  Similarity=0.618  Sum_probs=211.6

Q ss_pred             eeeeeccCceEEEEEEeC--CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEE
Q 017334           35 IKPIGRGAYGIVCSSVNR--ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      .++||+|+||.||+|+++  .+++.||+|.+......    ..+.+|+.+++.++||||+++++++...   ....+|++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv   78 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLL   78 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEE
Confidence            357999999999999975  46789999998654322    2456899999999999999999988543   23679999


Q ss_pred             eecCCccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCCeEEcccCc
Q 017334          113 YELMDTDLHQIIKSS---------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGL  179 (373)
Q Consensus       113 ~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill----~~~~~~kL~Dfg~  179 (373)
                      |||++++|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+
T Consensus        79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            999999998887532         258999999999999999999999999999999999999    4567899999999


Q ss_pred             ccccCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc---------hHHHHHHH
Q 017334          180 ARTSNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC---------LNQLKLII  247 (373)
Q Consensus       180 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~  247 (373)
                      +.......   .......+|+.|+|||++.+...++.++||||+||++|+|++|++||.+...         ..++..+.
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            97654322   2234567899999999998766789999999999999999999999975432         35567777


Q ss_pred             HHhCCCChhhhcccCCh-----hHHHHHHhCCCCC--CCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          248 NILGSRREEDLEFIDNP-----KARKYIKSLPYTP--GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      +.+|.+....+......     ....+........  ...........+..+.+||++||+.||.+|||++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            77777666554432211     0011110000000  000011112345678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-49  Score=371.50  Aligned_cols=259  Identities=24%  Similarity=0.403  Sum_probs=210.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+++.++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            479999999999999999999999999999999865432 223344567899999999999999999999     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999995 7999999888899999999999999999999999999999999999999999999999999985321100


Q ss_pred             ------------c-----------------------------------cccceeeccccCchhhhhcCCCCCchhhhHHH
Q 017334          188 ------------Q-----------------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSV  220 (373)
Q Consensus       188 ------------~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  220 (373)
                                  .                                   .....+||+.|+|||++.+ ..++.++|||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSl  234 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSL  234 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEec
Confidence                        0                                   0012479999999999876 678999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhc
Q 017334          221 GCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML  300 (373)
Q Consensus       221 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L  300 (373)
                      ||++|+|++|.+||.+.+..+....+......                    .      .+. -...+++.+.+||.+||
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------------~------~~p-~~~~~s~~~~dli~~lL  287 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIINWRET--------------------L------YFP-DDIHLSVEAEDLIRRLI  287 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHccCCc--------------------c------CCC-CCCCCCHHHHHHHHHHh
Confidence            99999999999999877665554444321000                    0      000 01246788999999999


Q ss_pred             CcCCCCC---CCHHHHhCCCCCCCC
Q 017334          301 VFDPTKR---ISVTEALQHPYMSPL  322 (373)
Q Consensus       301 ~~dP~~R---~t~~eil~hp~~~~~  322 (373)
                      . +|.+|   +++.++++||||.+.
T Consensus       288 ~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         288 T-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             c-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            8 77765   599999999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-48  Score=353.07  Aligned_cols=282  Identities=40%  Similarity=0.696  Sum_probs=230.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||.|++|.||+|++..+|+.||||++............+.+|+++++.++||||+++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            48999999999999999999999999999999875544333445677899999999999999999998     4446799


Q ss_pred             EEeecCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          111 LVYELMDTDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      +||||+.++|.+++..  ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus        76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            9999999899888865  35689999999999999999999999999999999999999999999999999876543333


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+.....  ...
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--LPD  233 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH--HHH
Confidence            334446788999999987655678899999999999999999999998887777777777777665443322111  122


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      +....+......+....+.+++.++++|.+||+.||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            222333333333444456688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.4e-49  Score=363.68  Aligned_cols=260  Identities=24%  Similarity=0.369  Sum_probs=209.7

Q ss_pred             ceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEcccccc--ChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRR  104 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  104 (373)
                      +|++++.||+|+||.||+|++.   .+|+.||+|++.+...  .......+.+|+.+++.++ ||||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            5899999999999999998874   5789999999875422  2223345678999999995 99999999988     4


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ..+.+|+||||+. |+|.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            4477999999996 699999988888999999999999999999999999999999999999999999999999998754


Q ss_pred             CCC-CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          184 NGK-NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       184 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......+||+.|+|||++.+...++.++|||||||++|+|++|..||...........+....            
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~------------  223 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI------------  223 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH------------
Confidence            322 2223356799999999999775568899999999999999999999997543222111111100            


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                             ....        ....+.+++.+.+||.+||+.||++||     +++++++||||...
T Consensus       224 -------~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         224 -------LKCD--------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             -------hcCC--------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                   0000        012245788899999999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-51  Score=337.75  Aligned_cols=303  Identities=35%  Similarity=0.569  Sum_probs=251.6

Q ss_pred             eeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeecee
Q 017334           18 YYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV   97 (373)
Q Consensus        18 ~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   97 (373)
                      +.+++...-...+.|+-+.+||+|.||.||+|+.+++|++||+|++-.......-....++|+++|..++|+|++.++++
T Consensus         5 ~~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEi   84 (376)
T KOG0669|consen    5 KDSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI   84 (376)
T ss_pred             hhcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHH
Confidence            34555566667789999999999999999999999999999999875433333333456799999999999999999998


Q ss_pred             ecCC---CCCCcceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeE
Q 017334           98 MMPS---HRRNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (373)
Q Consensus        98 ~~~~---~~~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~k  173 (373)
                      +...   ...+...+|+||.+|+.+|.-++.+. .+++..+++.++.+++.||.|+|++.|+|||+||+|+||+.+|.+|
T Consensus        85 c~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   85 CRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             HhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEE
Confidence            7543   22344679999999999999999765 6899999999999999999999999999999999999999999999


Q ss_pred             EcccCcccccCC----CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017334          174 ICDFGLARTSNG----KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       174 L~Dfg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  249 (373)
                      |+|||+++.+..    ....++..+.|.+|++||.++|.+.|+++.|||..|||+.+|.++.|.|++.+...++..|...
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            999999965432    2344666788999999999999999999999999999999999999999999999999999999


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccC-----CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY-----PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      +|....+-|+..++..+.+.+..-| -++..++.+.     -.-.+++.||+.++|..||.+|+.++++++|.||..
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~eP-l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEP-LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCC-CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            9999888888777665554442222 1111111111     113567899999999999999999999999999965

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.9e-48  Score=351.73  Aligned_cols=285  Identities=36%  Similarity=0.669  Sum_probs=223.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|++|.||+|.++.+|+.||+|++............+.+|+.+++.++|||++++++++     ......
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            479999999999999999999999999999999865433322333467899999999999999999998     444679


Q ss_pred             EEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++||||+++ .|..++.....+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........
T Consensus        76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999999985 5555666666799999999999999999999999999999999999999999999999999986654433


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+.................
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            33445678899999998775668899999999999999999999999888777776666665554332222111100000


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ...........+.....+.++..+.+||.+||+.||++||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            000000011111223345678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-48  Score=360.95  Aligned_cols=300  Identities=48%  Similarity=0.886  Sum_probs=247.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  105 (373)
                      .+.++|++.+.||+|+||.||+|.+..+|+.+|+|++............+.+|+.+++++ +||||+++++++...   +
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~   80 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---N   80 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---C
Confidence            356899999999999999999999999999999999865544444445677899999999 899999999987442   2


Q ss_pred             cceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          106 FKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ....|+||||++++|.+++... .+++...+.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          81 DKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             CceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            3568999999999999998775 789999999999999999999999999999999999999999999999999875433


Q ss_pred             CC-----ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          186 KN-----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       186 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ..     .....+.++..|+|||.+.+...++.++|+|||||++|+|++|++||.+....+....+....+......+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            22     2334567899999999987656788999999999999999999999999888888888888877776655554


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP  330 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~  330 (373)
                      .........................+.++..+.++|.+||+.||++|||+.++++||||..+..+...+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~  309 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPV  309 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCC
Confidence            4444344444444444444555556678999999999999999999999999999999987755544443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.2e-49  Score=371.79  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=211.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++||||+++++.+     ...+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence            479999999999999999999999999999999865432 222344567899999999999999999998     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC--
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG--  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~--  185 (373)
                      +|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....  
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999996 79999998888899999999999999999999999999999999999999999999999999742210  


Q ss_pred             -----------------------------------------CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHH
Q 017334          186 -----------------------------------------KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIF  224 (373)
Q Consensus       186 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  224 (373)
                                                               ........+||+.|+|||++.+ ..++.++|||||||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil  234 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVIL  234 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeecccee
Confidence                                                     0001123579999999999976 6789999999999999


Q ss_pred             HHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCC
Q 017334          225 AELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDP  304 (373)
Q Consensus       225 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP  304 (373)
                      |+|++|++||.+.+..+....+......                    .    .   ......+++.+.+||.+|+ .+|
T Consensus       235 yell~G~~Pf~~~~~~~~~~~i~~~~~~--------------------~----~---~~~~~~~s~~~~~li~~l~-~~p  286 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLKVINWETT--------------------L----H---IPSQAKLSREASDLILRLC-CGA  286 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHHHhccCcc--------------------c----c---CCCCCCCCHHHHHHHHHHh-cCH
Confidence            9999999999887655443333210000                    0    0   0011357888999999976 599


Q ss_pred             CCCC---CHHHHhCCCCCCCC
Q 017334          305 TKRI---SVTEALQHPYMSPL  322 (373)
Q Consensus       305 ~~R~---t~~eil~hp~~~~~  322 (373)
                      .+|+   ++.++++||||..+
T Consensus       287 ~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         287 EDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhcCCCCCHHHHhCCCCcCCC
Confidence            9999   99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-50  Score=363.43  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=230.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|..++.+|+|+||.+++++++..++.|++|++............+..|+.++++++|||||.+.+.|...    ...+
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~----~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED----GQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC----CceE
Confidence            789999999999999999999999999999999988776666666788999999999999999999999433    2349


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +|||+||+ |+|.+.+...  ..|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|+.....
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999996 6999998754  46999999999999999999999999999999999999999999999999999998777


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....+.+||+.|+.||++.+ .+|+.++|||||||++|||++-+++|.+.+....+..|.+....+             
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P-------------  225 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP-------------  225 (426)
T ss_pred             hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC-------------
Confidence            767889999999999999987 789999999999999999999999999999888888887643222             


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                       +....+.+++.||+.||..+|+.||++.++|.+|.+..
T Consensus       226 -----------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  226 -----------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             -----------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence                             23457888999999999999999999999999998764

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.7e-49  Score=360.05  Aligned_cols=253  Identities=25%  Similarity=0.415  Sum_probs=209.0

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHH---hhCCCCCeeeeceeecCCCCCCcc
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLL---RHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      |++++.||+|+||.||+|.+..+|+.||||++++... .......+.+|+.++   +.++||||+++++++     ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            7889999999999999999999999999999975432 222334455666555   566799999999998     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..|+||||+. ++|...+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            8999999996 688877754 57999999999999999999999999999999999999999999999999998754333


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .......+|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....                
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------------  217 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------------  217 (324)
T ss_pred             CCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            334456789999999999876 578999999999999999999999998876555444433200                


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                     ......+++.+.++|.+||+.||.+||     ++.++++||||...
T Consensus       218 ---------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         218 ---------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence                           012245688899999999999999999     69999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-48  Score=359.03  Aligned_cols=255  Identities=23%  Similarity=0.397  Sum_probs=213.5

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcce
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~  108 (373)
                      +|++++.||+|+||.||+|++..+++.||+|++.+... ..........|..++..+. |++|+++++++     ...+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            58899999999999999999999999999999976432 2223344567888888775 89999999988     44467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ |+|.+.+...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999996 7999999888889999999999999999999999999999999999999999999999999987543333


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....                 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------------  217 (323)
T cd05616         156 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------------  217 (323)
T ss_pred             CccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence            33455689999999999976 678999999999999999999999998877655554443210                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-----TEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~eil~hp~~~~~  322 (373)
                                    ......+++.+.+|+.+||+.||++|++.     .++++||||...
T Consensus       218 --------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         218 --------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             --------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence                          01123578889999999999999999974     899999999753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.7e-48  Score=352.08  Aligned_cols=288  Identities=44%  Similarity=0.746  Sum_probs=231.8

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC---hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN---RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +|++.+.||+|++|.||+|.+..+|+.||||++......   ......+..|+.+++.++|+||+++++++.     ..+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            588999999999999999999999999999999765433   223345668999999999999999999994     347


Q ss_pred             eEEEEeecCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..++||||++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            799999999889999998765 7999999999999999999999999999999999999999999999999999866544


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      ........+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+....+...++.+....+....... 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-  234 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc-
Confidence            3333444667889999998765678899999999999999999999999888777777777666655544332211110 


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS  326 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  326 (373)
                       .+. .....+..+........+..+.++|.+||..||++|||+.++++||||.....+.
T Consensus       235 -~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 -DYV-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             -ccc-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence             010 1111122233344566788999999999999999999999999999998765444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.1e-49  Score=362.00  Aligned_cols=259  Identities=23%  Similarity=0.390  Sum_probs=206.1

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|.++.+++.||+|++++.... ......+.+|..+++.+ +||||+++++++     ...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            4689999999999999999999999999765332 23344567899999988 599999999998     4447799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (329)
T cd05588          76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence            9996 699999988889999999999999999999999999999999999999999999999999998753333334456


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+ ..++.++|+|||||++|+|++|++||......+..          .    .. ......+.+..
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~----------~----~~-~~~~~~~~~~~  219 (329)
T cd05588         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP----------D----QN-TEDYLFQVILE  219 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccc----------c----cc-chHHHHHHHHc
Confidence            689999999999976 67899999999999999999999999642111000          0    00 00000000000


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC------HHHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS------VTEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t------~~eil~hp~~~~~  322 (373)
                      .       .......+++.+.+||++||+.||.+|++      +.++++||||...
T Consensus       220 ~-------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         220 K-------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             C-------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            0       01123457889999999999999999997      7899999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9e-49  Score=359.82  Aligned_cols=250  Identities=25%  Similarity=0.398  Sum_probs=209.9

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|.++.+|+.||+|++.+... .......+..|..++..+ +||||+++++++     ...+.+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            469999999999999999999999999976432 223344566788888866 699999999999     4446799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||++ |+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9996 699999988888999999999999999999999999999999999999999999999999998764433444456


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....                      
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------------  212 (321)
T cd05591         156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------------  212 (321)
T ss_pred             cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence            689999999999876 578999999999999999999999998877655554443200                      


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-------CHHHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-------SVTEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-------t~~eil~hp~~~~~  322 (373)
                               ......+++++.+||.+||+.||++|+       ++.++++||||...
T Consensus       213 ---------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         213 ---------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence                     011234678899999999999999999       89999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-48  Score=359.66  Aligned_cols=251  Identities=28%  Similarity=0.476  Sum_probs=209.0

Q ss_pred             eeeeeccCceEEEEEEeC---CCCcEEEEEEcccccc--ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           35 IKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++.||+|+||.||+|++.   .+|+.||+|++.+...  .......+.+|+.+++.++||||+++++++     ...+.+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence            467999999999999863   5789999999875422  223334566899999999999999999998     444679


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      |+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999996 69999998888899999999999999999999999999999999999999999999999999875433333


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+...                   
T Consensus       156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------------------  215 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------------------  215 (323)
T ss_pred             cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence            3445679999999999876 56889999999999999999999999877654444333220                   


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                  ...+.+.+++.+.+||++||+.||++||     ++.++++||||...
T Consensus       216 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         216 ------------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence                        0112345788899999999999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.5e-48  Score=357.46  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|.++.+|+.||+|++++.... .........|..++... +||||+++++++     ...+.+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            4699999999999999999999999999764321 12333456778887755 799999999998     4457899999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||+. |+|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05620          76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST  155 (316)
T ss_pred             CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence            9996 699999988888999999999999999999999999999999999999999999999999998754333333456


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-----------------------  211 (316)
T cd05620         156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-----------------------  211 (316)
T ss_pred             cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence            689999999999976 57899999999999999999999999877654443333210                       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH-HHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-TEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-~eil~hp~~~~~  322 (373)
                      .        ......++..+++||++||+.||++|+++ +++++||||...
T Consensus       212 ~--------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         212 T--------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence            0        01123467889999999999999999998 589999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-48  Score=354.62  Aligned_cols=252  Identities=27%  Similarity=0.383  Sum_probs=209.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcE-EEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~-~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .....+.+.||+|+||+||++.++  |+. ||+|++............+.+|+.+|.+++|||||++++++..+.    .
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~  113 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----G  113 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----C
Confidence            344556677999999999999887  666 999999876655555778889999999999999999999995442    1


Q ss_pred             eEEEEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceEEcCCC-CeEEcccCcccc
Q 017334          108 DVYLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANC-DLKICDFGLART  182 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~  182 (373)
                      .++|||||+. |+|.+++..  .+.++...+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            6999999996 899999987  578999999999999999999999999 99999999999999998 999999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhc-CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ........+...||+.|||||++.+ ...|+.++||||+|+++|||+||+.||.+.........+... +.+        
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~-~~R--------  264 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG-GLR--------  264 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-CCC--------
Confidence            6543334455789999999999984 367999999999999999999999999988874444443321 111        


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                          ..+...+++.+..|+.+||+.||++||++.+++.
T Consensus       265 --------------------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  265 --------------------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --------------------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                0112236788999999999999999999988765

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.3e-48  Score=355.62  Aligned_cols=282  Identities=22%  Similarity=0.365  Sum_probs=216.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|++..+|..+|+|++.... .......+.+|+++++.++||||+++++++.     ..+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCE
Confidence            589999999999999999999999999999999987543 2334456789999999999999999999984     4467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +++||||++ ++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999997 69999998888899999999999999999999986 6999999999999999999999999998755322


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc-------
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE-------  259 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------  259 (373)
                        ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.............       
T Consensus       158 --~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence              2345578999999999976 578999999999999999999999998766544322211100000000000       


Q ss_pred             ------------ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          260 ------------FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       260 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                  ....................  ..-...+++++++||.+||..||++|||+.++++||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPP--KLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCc--CCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                        00000001111111000000  0001246789999999999999999999999999999974

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-48  Score=357.94  Aligned_cols=250  Identities=25%  Similarity=0.428  Sum_probs=209.0

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||+||+|.++.+++.||+|++.+... .......+.+|..+++.+ +||||+++++++     ...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            469999999999999999999999999976532 223344566888899888 599999999998     4456799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||+. |+|...+...+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (318)
T cd05570          76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST  155 (318)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence            9996 699999988889999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...                       
T Consensus       156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------------  211 (318)
T cd05570         156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------------  211 (318)
T ss_pred             eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            679999999999976 57899999999999999999999999876654443333210                       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-----TEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~eil~hp~~~~~  322 (373)
                      .        ......+++.+.+||++||+.||++||++     .++++||||...
T Consensus       212 ~--------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         212 E--------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             C--------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            0        01123467889999999999999999999     999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-48  Score=359.57  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=207.4

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHH-HHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELK-LLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||+||+|+++.+|+.||+|++.+... .......+++|.. +++.++||||+++++.+     ...+..|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            469999999999999999999999999975432 2223334555555 46788999999999998     4447799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||+. |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (323)
T cd05575          76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST  155 (323)
T ss_pred             cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence            9996 699999988889999999999999999999999999999999999999999999999999998754333344455


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..   .                    
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~--------------------  211 (323)
T cd05575         156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN---K--------------------  211 (323)
T ss_pred             ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc---C--------------------
Confidence            679999999999876 6789999999999999999999999987765544443322   0                    


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV----TEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~eil~hp~~~~~  322 (373)
                              .....+.+++.+.++|++||+.||.+||++    .++++||||...
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         212 --------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence                    012235578889999999999999999987    699999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.3e-49  Score=361.87  Aligned_cols=260  Identities=24%  Similarity=0.362  Sum_probs=214.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|.+.+.||+|+||+||+|.++.+|+.||+|++++... .......+.+|+.+++.++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            479999999999999999999999999999999976533 223344567899999999999999999988     44477


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .|+||||++ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999995 7999999875 68999999999999999999999999999999999999999999999999999765432


Q ss_pred             Cc-cccceeeccccCchhhhhc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          187 NQ-FMTEYVVTRWYRAPELLLC-----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       187 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .. ......||+.|+|||++..     ...++.++|||||||++|+|++|..||...+.......+.+....        
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~--------  227 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF--------  227 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc--------
Confidence            22 2233478999999999863     345788999999999999999999999877655554444321000        


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                        ..+ ...+.+++.+.+||++||+ ||.+||++.++++||||...
T Consensus       228 ------------------~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         228 ------------------LKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             ------------------cCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence                              000 0113578889999999998 99999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.9e-48  Score=349.08  Aligned_cols=284  Identities=40%  Similarity=0.710  Sum_probs=232.3

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++     ......|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            58999999999999999999999999999999976554444455678999999999999999999998     4457799


Q ss_pred             EEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC-c
Q 017334          111 LVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN-Q  188 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~  188 (373)
                      +|+||++++|.+++.. ...+++.+++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....... .
T Consensus        76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9999998899999864 4579999999999999999999999999999999999999999999999999987654332 1


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......++..|+|||.+.+...++.++||||+||++|+|++|.++|.+.........+...++.+....+..........
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            23445788999999998775667899999999999999999999999888888888888777776554443322211100


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      . ...+.....++....+..+..+.+||++||..||++|||++++++||||.
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 K-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             c-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            0 01122222234445567789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.1e-48  Score=360.31  Aligned_cols=254  Identities=23%  Similarity=0.418  Sum_probs=204.9

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.++..+ +||||+++++++     ...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            469999999999999999999999999976533 233344566888888777 699999999998     4447799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||+. |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (329)
T cd05618          76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST  155 (329)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence            9996 699998888889999999999999999999999999999999999999999999999999998754333333445


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-----HHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL-----NQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......     .....+.+                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~-------------------  215 (329)
T cd05618         156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ-------------------  215 (329)
T ss_pred             ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH-------------------
Confidence            689999999999976 57899999999999999999999999532110     00000000                   


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC------HHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS------VTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t------~~eil~hp~~~~~  322 (373)
                       ....       ....++..++..+.+||++||+.||++|++      +.++++||||...
T Consensus       216 -~i~~-------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         216 -VILE-------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             -HHhc-------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence             0000       001233457888999999999999999998      5799999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-48  Score=364.15  Aligned_cols=259  Identities=25%  Similarity=0.422  Sum_probs=212.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.++..++||||+++++.+     +..+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            478999999999999999999999999999999975422 223344567899999999999999999998     55578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999996 6999999888899999999999999999999999999999999999999999999999999986432110


Q ss_pred             -----------------------------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCC
Q 017334          188 -----------------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP  232 (373)
Q Consensus       188 -----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  232 (373)
                                                         ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCC
Confidence                                               01123579999999999876 678999999999999999999999


Q ss_pred             CCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC---C
Q 017334          233 IFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---S  309 (373)
Q Consensus       233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~---t  309 (373)
                      ||.+.+.......+......                    .      .+.. ...+++.+++||.+|+. ||.+|+   +
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~--------------------~------~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~  286 (360)
T cd05627         235 PFCSETPQETYRKVMNWKET--------------------L------VFPP-EVPISEKAKDLILRFCT-DSENRIGSNG  286 (360)
T ss_pred             CCCCCCHHHHHHHHHcCCCc--------------------e------ecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCC
Confidence            99887665544444321000                    0      0000 12367889999999874 999998   4


Q ss_pred             HHHHhCCCCCCCC
Q 017334          310 VTEALQHPYMSPL  322 (373)
Q Consensus       310 ~~eil~hp~~~~~  322 (373)
                      +.++++||||.+.
T Consensus       287 ~~ei~~hp~f~~~  299 (360)
T cd05627         287 VEEIKSHPFFEGV  299 (360)
T ss_pred             HHHHhcCCCCCCC
Confidence            7999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.4e-48  Score=363.30  Aligned_cols=260  Identities=26%  Similarity=0.388  Sum_probs=213.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     ...+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            4789999999999999999999999999999999965322 222333466899999999999999999988     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            8999999996 699998865 46899999999999999999999999999999999999999999999999999765432


Q ss_pred             C-ccccceeeccccCchhhhhcC---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          187 N-QFMTEYVVTRWYRAPELLLCC---DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       187 ~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      . ......+||+.|+|||++.+.   ..++.++|||||||++|+|++|.+||.+.+.......+......          
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----------  265 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS----------  265 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc----------
Confidence            2 123456799999999998653   24788999999999999999999999887655544444321000          


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK--RISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~eil~hp~~~~  321 (373)
                                      ..+. ....+|..+.+||++||..+|.+  |++++++++||||..
T Consensus       266 ----------------~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         266 ----------------LTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             ----------------CCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence                            0000 01346889999999999999988  999999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.7e-48  Score=355.75  Aligned_cols=250  Identities=28%  Similarity=0.437  Sum_probs=206.6

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|.+..+++.||+|+++.... ..........|..++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            469999999999999999999999999976432 222333455677777654 799999999998     4446799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  155 (316)
T cd05592          76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST  155 (316)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence            9996 699999988889999999999999999999999999999999999999999999999999999765433344455


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------------  211 (316)
T cd05592         156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------------  211 (316)
T ss_pred             ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            689999999999976 56899999999999999999999999887655444433210                       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH-HHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-TEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-~eil~hp~~~~~  322 (373)
                      .        ......++..+.+||.+||+.||++||++ .++++||||...
T Consensus       212 ~--------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         212 R--------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence            0        01123467889999999999999999986 588899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.4e-49  Score=360.39  Aligned_cols=251  Identities=26%  Similarity=0.441  Sum_probs=210.9

Q ss_pred             eeeeeccCceEEEEEEe---CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           35 IKPIGRGAYGIVCSSVN---RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~---~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      ++.||+|+||.||++++   ..+|+.||+|++.+............+|+.++++++||||+++++++     ...+.+|+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l   75 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL   75 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence            36799999999999886   46789999999976544444445667899999999999999999998     44478999


Q ss_pred             EeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc
Q 017334          112 VYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM  190 (373)
Q Consensus       112 v~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  190 (373)
                      ||||+. |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            999996 7999999887889999999999999999999999999999999999999999999999999987654433334


Q ss_pred             cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHH
Q 017334          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI  270 (373)
Q Consensus       191 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....                    
T Consensus       156 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------------  214 (318)
T cd05582         156 YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------------  214 (318)
T ss_pred             ecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence            45688999999999876 568899999999999999999999998776554444432200                    


Q ss_pred             HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                 ......+++.+.+||++||+.||++||+     +.++++||||...
T Consensus       215 -----------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         215 -----------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence                       0122456788999999999999999999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-48  Score=363.36  Aligned_cols=264  Identities=25%  Similarity=0.351  Sum_probs=213.6

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ....++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++++     .
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~  113 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----Q  113 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----E
Confidence            3445899999999999999999999999999999999865322 222334566899999999999999999998     4


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ....+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            4578999999996 799998865 46899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC-ccccceeeccccCchhhhhcCC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          184 NGKN-QFMTEYVVTRWYRAPELLLCCD---NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       184 ~~~~-~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .... ......+||+.|+|||++.+..   .++.++|||||||++|+|++|.+||.+.+.......+.......      
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------  266 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL------  266 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc------
Confidence            3322 1234567999999999987532   37889999999999999999999998876655554443211000      


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK--RISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~eil~hp~~~~~  322 (373)
                                          .+. ....++..++++|.+||..++.+  |+++.++++||||+..
T Consensus       267 --------------------~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         267 --------------------NFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             --------------------CCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence                                000 01246788999999999865544  8999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.9e-48  Score=348.58  Aligned_cols=284  Identities=37%  Similarity=0.701  Sum_probs=225.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++     ...+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            479999999999999999999999999999999876544433344567899999999999999999998     445789


Q ss_pred             EEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      |+|+||+++ .|..+......+++.+++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            999999975 6666666666799999999999999999999999999999999999999999999999999876544444


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+.................
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence            44556788999999998765667889999999999999999999998887777777776666554332211111100000


Q ss_pred             HHHhCCC-CCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          269 YIKSLPY-TPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       269 ~~~~~~~-~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      . ...+. ....+.....+.++..+.+|+++||..||++||++.++++||||
T Consensus       236 ~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         236 G-MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             c-cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0 00000 01112223356788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.9e-48  Score=354.55  Aligned_cols=255  Identities=22%  Similarity=0.399  Sum_probs=212.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcce
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~  108 (373)
                      +|+..+.||+|+||.||+|.++.+|+.||+|++.+... .......+..|..+++.+. |++|+++++++     ...+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            47889999999999999999999999999999975432 2223345667888888886 67788888888     44467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999996 7999999888899999999999999999999999999999999999999999999999999987543333


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+.......+....                 
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------------  217 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------------  217 (323)
T ss_pred             ccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence            33445678999999999876 578999999999999999999999998876555444443200                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                    ......+++.+.+++.+||+.||.+|++     ..++++||||...
T Consensus       218 --------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         218 --------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             --------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence                          0122346788999999999999999997     4799999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-47  Score=348.03  Aligned_cols=286  Identities=42%  Similarity=0.732  Sum_probs=228.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++     ......
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            579999999999999999999999999999999876543333344567899999999999999999998     444689


Q ss_pred             EEEeecCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCCeEEcccCcccccCCC
Q 017334          110 YLVYELMDTDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~  186 (373)
                      |+||||++++|.+.+.....  +++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            99999999999888865443  578889999999999999999999999999999999985 457999999999765433


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      ........+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+..+....+....+.+....+.....  .
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  234 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--L  234 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc--c
Confidence            33334457789999999987755688999999999999999999999998887777777777766665544332111  1


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ..+....+...........+.+++.+.+++.+||+.||++||++.++++||||..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            11112222212222223346688899999999999999999999999999999764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-49  Score=336.84  Aligned_cols=277  Identities=26%  Similarity=0.395  Sum_probs=214.3

Q ss_pred             Cceeee-eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcc
Q 017334           30 TKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        30 ~~Y~~~-~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~  107 (373)
                      +-|++. +.||+|+|+.|-.+....+|..||||++.+...  -...+++||++++.+++ |+||++++++|     +++.
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~  149 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDT  149 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccc
Confidence            445554 479999999999999999999999999987633  34567899999999997 99999999999     6778


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEcccCccccc
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~kL~Dfg~a~~~  183 (373)
                      .+|+|||-|. |.|.+.|.++..|++.++..++.+|+.||.|||.+||.||||||+|||.....   -||||||.++.-.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence            8999999995 79999999999999999999999999999999999999999999999986654   4899999887422


Q ss_pred             C-------CCCccccceeeccccCchhhhh----cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          184 N-------GKNQFMTEYVVTRWYRAPELLL----CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       184 ~-------~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      .       ...+.+.+.+|+..|||||+..    ....|+.++|.||||||+|-|+.|.+||.|.-..+.        |.
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GW  301 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GW  301 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------Cc
Confidence            1       1233456779999999999863    124689999999999999999999999987521110        00


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      .+-+    ....-...++.++....-.-...-|..+|.+++||++.+|..|+..|.++.++++|||+......
T Consensus       302 drGe----~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  302 DRGE----VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             cCCC----ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            0000    00000001111111111111112346689999999999999999999999999999999876444

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-48  Score=346.38  Aligned_cols=259  Identities=32%  Similarity=0.541  Sum_probs=216.9

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      |++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++||||+++++++.     .....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence            89999999999999999999999999999999877655555545567999999999999999999994     4577999


Q ss_pred             EeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc
Q 017334          112 VYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM  190 (373)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  190 (373)
                      |||++++ +|.+++...+.+++.++..++.||+.||++||++||+|+||||+||+++.++.++|+|||.+..........
T Consensus        76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999986 999999977899999999999999999999999999999999999999999999999999997643344455


Q ss_pred             cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHH
Q 017334          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI  270 (373)
Q Consensus       191 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ....++..|+|||++.....++.++|+||||+++++|++|..||......+....+.............           
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------  224 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----------  224 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----------
Confidence            667889999999998734678999999999999999999999998875444444444432221111000           


Q ss_pred             HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                   .....++.+.++|.+||+.||++||++.++++||||
T Consensus       225 -------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                         001123679999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.1e-48  Score=350.99  Aligned_cols=286  Identities=40%  Similarity=0.704  Sum_probs=229.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||.|+||.||+|.++.+++.+|+|.++...........+.+|+.+++.++||||+++++++....   ....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            5799999999999999999999999999999999755433333345678999999999999999999885432   2679


Q ss_pred             EEEeecCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      |+|+||++++|.+++.... .+++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++........
T Consensus        82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            9999999999999887643 589999999999999999999999999999999999999999999999999886654433


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+...++.+....+..........
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            34455678899999998775567899999999999999999999999988888888888777776655444322110000


Q ss_pred             HHHhCCCCCCCCccccCCC--CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPD--AHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~--~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      . ..........+...++.  +++.+.++|++||+.||++|||+.|+++||||
T Consensus       242 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         242 K-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             c-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            0 00011111112223333  48889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.7e-47  Score=354.28  Aligned_cols=301  Identities=41%  Similarity=0.770  Sum_probs=229.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC--
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR--  104 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~--  104 (373)
                      ++.++|++.+.||.|+||.||+|.+..+|+.||+|++.....  .....+.+|+.+++.++||||+++++++......  
T Consensus         2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (342)
T cd07854           2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT   79 (342)
T ss_pred             CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence            567999999999999999999999999999999999865433  2334567899999999999999999887554321  


Q ss_pred             -------CcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCCeEEcc
Q 017334          105 -------NFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICD  176 (373)
Q Consensus       105 -------~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-~~~~kL~D  176 (373)
                             .....|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                   1246899999999999888764 57999999999999999999999999999999999999985 45789999


Q ss_pred             cCcccccCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          177 FGLARTSNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       177 fg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      ||.+.......   .......++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99987543211   112233678899999988665678899999999999999999999998887766666555544333


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPA  331 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~  331 (373)
                      ........... ..............+.....+.++.++.+||.+||+.||++|||+.++++||||+.+..+...+..
T Consensus       239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~  315 (342)
T cd07854         239 REEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVS  315 (342)
T ss_pred             ChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCC
Confidence            33222111111 011111111222233444456788999999999999999999999999999999866444444433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.1e-48  Score=348.15  Aligned_cols=281  Identities=41%  Similarity=0.734  Sum_probs=227.5

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||.|++|.||+|.+..+|..||||++...... .....+.+|+.+++.++||||+++++.+     ...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEE
Confidence            589999999999999999999999999999998754322 2233566899999999999999999998     4446799


Q ss_pred             EEeecCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          111 LVYELMDTDLHQIIKSS---QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +||||++++|.+++...   ..+++..+..++.||+.||+|||++|++||||||+||++++++.++|+|||++.......
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            99999999999888654   358999999999999999999999999999999999999999999999999997654333


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+....+.+....+....+.....  ..
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  232 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LP  232 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--Cc
Confidence            3334456788999999987756678999999999999999999999999888888888877766665544332221  11


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .+....+...........+.+++.++++|.+||+.||.+||++.++++||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            1111222222222233445678889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.3e-48  Score=353.69  Aligned_cols=250  Identities=28%  Similarity=0.423  Sum_probs=206.3

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|++..+++.||+|+++.... ..........|..++... +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            469999999999999999999999999976432 122233456677777764 799999999998     4446799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||++ |+|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (316)
T cd05619          76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT  155 (316)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence            9996 799999988788999999999999999999999999999999999999999999999999998754333333455


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      ..||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------------------  211 (316)
T cd05619         156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-----------------------  211 (316)
T ss_pred             ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence            678999999999876 57899999999999999999999999876654444333210                       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHH-HHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT-EALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~-eil~hp~~~~~  322 (373)
                      .        ......++..+++||.+||+.||++|+++. ++++||||...
T Consensus       212 ~--------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         212 N--------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             C--------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence            0        011234678899999999999999999996 99999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-47  Score=354.18  Aligned_cols=262  Identities=24%  Similarity=0.373  Sum_probs=211.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||++++..+++.||+|++.+.. ........+.+|+.+++.++|+||+++++++     ...++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            47999999999999999999999999999999997532 2223344567899999999999999999998     44578


Q ss_pred             EEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +|+||||+. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999995 799999975 467999999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc-cccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          187 NQ-FMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       187 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .. .....+||+.|+|||++.+    ...++.++||||+||++|+|++|+.||.+.+..+....+.....          
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~----------  225 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE----------  225 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            22 2223478999999999863    24578899999999999999999999987765554444332100          


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK--RISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~eil~hp~~~~~  322 (373)
                                      ...+....+.+++.+++||++||..++++  |+++.++++||||...
T Consensus       226 ----------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         226 ----------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             ----------------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence                            00111122447889999999999765544  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-47  Score=346.28  Aligned_cols=281  Identities=42%  Similarity=0.732  Sum_probs=229.0

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      |++++.||.|++|.||+|.++.+|..||+|++............+.+|+.+++.++|||++++++++     ...+..|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            6789999999999999999999999999999875543333334567899999999999999999998     34478999


Q ss_pred             EeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          112 VYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       112 v~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      +|||++++|.+++....  .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++.........
T Consensus        76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            99999999999987765  7899999999999999999999999999999999999999999999999998765433322


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      .....++..|+|||++.+...++.++|+|||||++|+|++|.+||.+.+.......+.+..+.+....+.....  ...+
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS--LPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh--chhh
Confidence            33446688999999987655678999999999999999999999998887777777777766666554433211  1122


Q ss_pred             HHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ....+...........+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            22233222233334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-47  Score=347.35  Aligned_cols=288  Identities=39%  Similarity=0.657  Sum_probs=226.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.+. ||||+++++++..........
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999999999999999998765433333345778999999996 799999999886543223345


Q ss_pred             EEEEeecCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCCeEEcccCcccc
Q 017334          109 VYLVYELMDTDLHQIIKSS-----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLART  182 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~~  182 (373)
                      .|+||||++++|.+++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            8999999999998888642     35799999999999999999999999999999999999998 88999999999875


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ............+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+...++.+....+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            53333323344678899999998765668999999999999999999999999888777777777766655544332211


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ....  .. ..+...........+.+++.+.+||.+||..||.+||++.++++||||.
T Consensus       241 ~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         241 KLRD--WH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hccc--hh-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            1100  00 0111111222333456889999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-47  Score=346.96  Aligned_cols=284  Identities=38%  Similarity=0.696  Sum_probs=220.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      -++|++.+.||+|++|.||+|.++.+|+.||||.+....... ....+.+|+.+++.++||||+++++++     .....
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   77 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDII-----HTKKT   77 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCe
Confidence            378999999999999999999999999999999986543221 122456899999999999999999998     44478


Q ss_pred             EEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          78 LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9999999999999988654 468999999999999999999999999999999999999999999999999987543222


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE-CLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .......++..|+|||++.+...++.++||||+||++|+|++|++||.+.. ..+....+.+.++.+....+........
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            222334568889999998765668899999999999999999999997765 4556666666666655443322211000


Q ss_pred             HHHHHhCCCCCCCCccccCCCCC--HHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAH--PLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s--~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      . ...........+.....+.++  ..+.++|.+||+.||++|||+.++++||||
T Consensus       238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 F-KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             c-ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0 000000011111122223344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=333.12  Aligned_cols=290  Identities=49%  Similarity=0.848  Sum_probs=249.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+.+.-+.||.|+||+||.+.|.++|+.||+|++..-..+.....++++|+++|..++|.|++..+++....+-.....+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            34455789999999999999999999999999998888888888899999999999999999999999877665556779


Q ss_pred             EEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC-CCc
Q 017334          110 YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG-KNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~-~~~  188 (373)
                      |+++|.|..+|..+|-+...++.+.++-+++||++||+|||+.||.||||||.|.|++++..+||||||+++.... ...
T Consensus       133 YV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  133 YVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            9999999999999999988999999999999999999999999999999999999999999999999999987653 334


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      .++..+.|.+|+|||++.|.+.|+.++||||.|||+.||+..+..|+..+..+++..|...+|.+..+............
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            45666789999999999999999999999999999999999999999999999999999999999988766544333233


Q ss_pred             HHHhCCCCCCCCccccCC-----CCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYP-----DAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~-----~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      .++.-+..+.  +..++.     ....+..+++.++|.+||.+|.+..+++.|++...
T Consensus       293 ~LR~~~k~Ps--~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  293 VLRAGLRAPD--TQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             hhccCCCCCC--ccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            3333332222  222222     23456889999999999999999999999999753

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.1e-48  Score=356.87  Aligned_cols=250  Identities=25%  Similarity=0.465  Sum_probs=207.0

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHH-HHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELK-LLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|.. +++.++||||+++++.+     ...+..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            469999999999999999999999999975432 2233344555655 46778999999999998     4447799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||+. |+|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  155 (325)
T cd05604          76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT  155 (325)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence            9996 699999988889999999999999999999999999999999999999999999999999998754333344456


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------------  211 (325)
T cd05604         156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------------  211 (325)
T ss_pred             ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------------
Confidence            689999999999876 57889999999999999999999999877655444433220                       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV----TEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~eil~hp~~~~~  322 (373)
                              .....+..+..+.++|++||..||.+||++    .++++||||...
T Consensus       212 --------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         212 --------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             --------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence                    011234578889999999999999999976    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-47  Score=356.68  Aligned_cols=258  Identities=27%  Similarity=0.358  Sum_probs=206.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      -.+|+.++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++|+||+++++++     ...+.
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  146 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE  146 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence            367899999999999999999999999999999986443 233345678999999999999999999998     44577


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ |+|.+    ....++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       147 ~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        147 IQVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             EEEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999999997 57653    2346788889999999999999999999999999999999999999999999997654333


Q ss_pred             ccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          188 QFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .......||..|+|||++..    ....+.++|||||||++|+|++|+.||......+....+......           
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------  291 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-----------  291 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-----------
Confidence            33345688999999998743    123456899999999999999999999743322222221111000           


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                                      ........+++.+.+||.+||+.||++||++.|+++||||....
T Consensus       292 ----------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        292 ----------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             ----------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence                            00112245788899999999999999999999999999998653

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-47  Score=345.70  Aligned_cols=252  Identities=24%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecC
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM  116 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~  116 (373)
                      ||+|+||+||++.++.+|+.||+|++.+..... .....+..|+.+++.++||||+++.+++     ......|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999987543222 2334567899999999999999999988     4446799999999


Q ss_pred             C-ccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcccc
Q 017334          117 D-TDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT  191 (373)
Q Consensus       117 ~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  191 (373)
                      + |+|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            6 68887764    235689999999999999999999999999999999999999999999999999976544433344


Q ss_pred             ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHH
Q 017334          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK  271 (373)
Q Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      ...||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||...........+...                      
T Consensus       156 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~----------------------  212 (280)
T cd05608         156 GYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----------------------  212 (280)
T ss_pred             ccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh----------------------
Confidence            5678999999999976 57889999999999999999999999765432211111110                      


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                       ....    .....+.+++.+.+++.+||+.||++||     +++++++||||+..
T Consensus       213 -~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         213 -ILND----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             -hccc----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence             0000    0122345788999999999999999999     88999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-47  Score=368.92  Aligned_cols=268  Identities=24%  Similarity=0.361  Sum_probs=220.8

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      +.....++|++.+.||+|+||+||+|++..+|+.||||++............+.+|+.++..++|+||+++++.+.....
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            33455689999999999999999999999999999999997765555666677899999999999999999887754321


Q ss_pred             ---CCcceEEEEeecCC-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEc
Q 017334          104 ---RNFKDVYLVYELMD-TDLHQIIKSS----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       104 ---~~~~~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                         .....+++||||+. |+|.+++...    ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence               12235789999996 7999988642    468999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCCC--CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          176 DFGLARTSNGK--NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       176 Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      |||+++.....  .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...    
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~----  260 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG----  260 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC----
Confidence            99998754322  222345689999999999976 57899999999999999999999999876654443332210    


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                                ......+.+++.+.+|+.+||+.||.+||++.++++|||++.+
T Consensus       261 --------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        261 --------------------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             --------------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                      0111235678899999999999999999999999999998754

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.3e-48  Score=354.39  Aligned_cols=250  Identities=26%  Similarity=0.453  Sum_probs=206.3

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHH-HHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELK-LLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||+||+|+++.+++.||+|++.+.... ......+.+|.. +++.++||||+++++++     ...+.+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            4699999999999999999999999999754321 222234444544 46778999999999998     4447799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~  155 (325)
T cd05602          76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST  155 (325)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence            9996 699999988888999999999999999999999999999999999999999999999999998754333334456


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...                       
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-----------------------  211 (325)
T cd05602         156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-----------------------  211 (325)
T ss_pred             ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-----------------------
Confidence            689999999999876 67899999999999999999999999877655544433220                       


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHH----HHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT----EALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~----eil~hp~~~~~  322 (373)
                              .....+.+++.+.++|.+||+.||.+|+++.    ++++|+||...
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         212 --------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             --------CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence                    0112356788999999999999999999875    89999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.5e-48  Score=354.09  Aligned_cols=254  Identities=22%  Similarity=0.402  Sum_probs=206.0

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++..+ .||||+++++++     ...+.+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            4699999999999999999999999999765332 23344567899999888 599999999998     4447799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||+. |+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (327)
T cd05617          76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST  155 (327)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence            9996 699999988888999999999999999999999999999999999999999999999999998754333334456


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchH---HHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLN---QLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......   ....+...                    
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------------  214 (327)
T cd05617         156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--------------------  214 (327)
T ss_pred             ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH--------------------
Confidence            689999999999876 678999999999999999999999996432111   00001000                    


Q ss_pred             HHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC------HHHHhCCCCCCCC
Q 017334          270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS------VTEALQHPYMSPL  322 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t------~~eil~hp~~~~~  322 (373)
                      ....       .......++..+.++|++||+.||.+|++      +.++++||||...
T Consensus       215 ~~~~-------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         215 ILEK-------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHhC-------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            0000       01123457888999999999999999998      5799999999864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-47  Score=355.25  Aligned_cols=277  Identities=28%  Similarity=0.370  Sum_probs=209.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ...|++++.||+|+||.||+|.+..+++.||+|+....        ....|+.+++.++||||+++++++.     ....
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~  131 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAI  131 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEE-----eCCe
Confidence            45799999999999999999999999999999986432        2346899999999999999999984     3467


Q ss_pred             EEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .++|||++.++|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus       132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-~  210 (357)
T PHA03209        132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-A  210 (357)
T ss_pred             eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc-C
Confidence            899999999999988865 46799999999999999999999999999999999999999999999999999875432 2


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCc---------hHHHHHHHHHhCCCChhh
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTEC---------LNQLKLIINILGSRREED  257 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~---------~~~~~~i~~~~~~~~~~~  257 (373)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|+++ .++|.....         ...+..+...++..+...
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             cccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence            22345678999999999876 5789999999999999999965 455554322         123333334444333222


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCcccc----CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRL----YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ...........+..... ....++...    ...++..+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       290 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        290 PRDPGSRLVRGFIEYAS-LERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCCCccHHHHHHHhhcc-cCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            11111111222222111 111111110    1245677889999999999999999999999999975

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-48  Score=359.29  Aligned_cols=261  Identities=27%  Similarity=0.408  Sum_probs=231.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -.+.|.+++.||+|.|++|.+|++..+|..||||++++...+.....++.+|+++|+.++|||||+++.+.     +...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eecc
Confidence            34789999999999999999999999999999999999988888888899999999999999999999999     5557


Q ss_pred             eEEEEeecC-CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||+ +|.+++++.+++++.+.+++.++.|+.+|++|||+++|+|||||++|||++.+.++||+|||++.... .
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~  207 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-Y  207 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-c
Confidence            899999999 58999999999999999999999999999999999999999999999999999999999999998875 5


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....++||++.|.|||++.+....++.+|+||+|+++|.|+.|..||.+.+-.+.-.....                  
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~------------------  269 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR------------------  269 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee------------------
Confidence            66778899999999999999987788999999999999999999999988653332221111                  


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                                   .--+++-.++-++.+||+++|..+|.+|++.+++..|.|.......
T Consensus       270 -------------gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 -------------GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             -------------eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                         0012223467789999999999999999999999999999866544

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-49  Score=342.59  Aligned_cols=286  Identities=31%  Similarity=0.551  Sum_probs=227.0

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC--CCC----eeeec
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ--HEN----VIALK   95 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpn----iv~~~   95 (373)
                      ++..-.+.++|.+++.+|+|.||.|..+.++.++..||||+++.-.   ......+-|+++|+++.  -|+    ++++.
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            4555667899999999999999999999999999999999996431   11223456999999994  233    67777


Q ss_pred             eeecCCCCCCcceEEEEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-----
Q 017334           96 DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-----  168 (373)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-----  168 (373)
                      ++|     ...++.|||+|.++.+++++++.+.  +++...++.+.+||+.+++|||+.+++|.||||+|||+.+     
T Consensus       158 ~wF-----dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  158 DWF-----DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hhh-----hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence            777     6668999999999999999998754  6899999999999999999999999999999999999832     


Q ss_pred             ---------------CCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCC
Q 017334          169 ---------------NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPI  233 (373)
Q Consensus       169 ---------------~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  233 (373)
                                     +..|+|+|||.|.......   +..+.|..|+|||++++ -+++.++||||+||||+|+++|...
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeecccee
Confidence                           3459999999998764333   66789999999999998 6899999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh-CCC--------------CCCCCccccCCCC---CHHHHHH
Q 017334          234 FPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS-LPY--------------TPGTPFSRLYPDA---HPLAIDL  295 (373)
Q Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--------------~~~~~~~~~~~~~---s~~~~~l  295 (373)
                      |+..+..+.+..+..++|..+........   ..++... ...              .+..+...+....   -..+.||
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            99999999999999999976655443321   1111110 000              0011111111111   2247899


Q ss_pred             HHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          296 LQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       296 l~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      |++||.+||.+|+|+.|+|.||||+..
T Consensus       386 l~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HHHHHccCccccccHHHHhcCHHhhcC
Confidence            999999999999999999999999864

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5e-47  Score=346.45  Aligned_cols=290  Identities=37%  Similarity=0.593  Sum_probs=225.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC---CC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR---RN  105 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~  105 (373)
                      -++|++++.||+|+||.||+|.+..+|+.||||++..............+|+.+++.++||||+++++++.....   ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            368999999999999999999999999999999986543333333345689999999999999999998754321   23


Q ss_pred             cceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ....++||||++++|.+.+... ..+++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence            3568999999999998888654 378999999999999999999999999999999999999999999999999987543


Q ss_pred             CCC----ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 GKN----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...    .......++..|+|||.+.+...++.++||||+|+++|+|++|.+||.+.+.......+..+.+..+......
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (310)
T cd07865         171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG  250 (310)
T ss_pred             CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            221    1223446788899999987755678999999999999999999999999888888888888777666554333


Q ss_pred             cCChhHHHHHHhCCCCCCCCc-ccc-CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPF-SRL-YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .......... ..+....... ..+ ....++.+.+||.+||..||++|||++++++||||
T Consensus       251 ~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         251 VDKLELFKKM-ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccchhhhhhc-cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            2211111100 0111100000 011 11246778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-48  Score=358.49  Aligned_cols=250  Identities=24%  Similarity=0.428  Sum_probs=205.1

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC---CCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL---QHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      ||+|+||+||+|++..+|+.||+|++.+... ..........|..++..+   .||||+++++.+     .....+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            7999999999999999999999999865422 222333455677777655   699999999998     4457799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~  155 (330)
T cd05586          76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT  155 (330)
T ss_pred             cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence            9996 699999988889999999999999999999999999999999999999999999999999998764433344456


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...  ..                   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~-------------------  214 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG--KV-------------------  214 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC--CC-------------------
Confidence            689999999999976556899999999999999999999999876654444333210  00                   


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC----CHHHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI----SVTEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~----t~~eil~hp~~~~~  322 (373)
                             .+.  ...+++.+.+||++||+.||.+||    ++.++++||||...
T Consensus       215 -------~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         215 -------RFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             -------CCC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence                   000  023678899999999999999998    78999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.4e-48  Score=353.10  Aligned_cols=250  Identities=24%  Similarity=0.442  Sum_probs=205.1

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHH-HHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELK-LLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|++..+|+.||+|++.+... .......+.+|.. +++.++||||+++++.+     ...+..|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            469999999999999999999999999975432 2222334555554 57889999999999988     4446799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||++ |+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05603          76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST  155 (321)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence            9996 699988888788999999999999999999999999999999999999999999999999998754333333455


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+..   .+                   
T Consensus       156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~-------------------  212 (321)
T cd05603         156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH---KP-------------------  212 (321)
T ss_pred             ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc---CC-------------------
Confidence            688999999999876 5789999999999999999999999987764443333221   00                   


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV----TEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~eil~hp~~~~~  322 (373)
                               ....+..+..+.++|.+||+.||.+|+++    .++++|+||...
T Consensus       213 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         213 ---------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence                     11234567889999999999999999975    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-47  Score=357.93  Aligned_cols=261  Identities=26%  Similarity=0.358  Sum_probs=211.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++.+... .......+.+|+.+++.++||||+++++.+     ...
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  115 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            34899999999999999999999999999999999865322 223334466899999999999999999998     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            78999999996 699998865 4689999999999999999999999999999999999999999999999999976543


Q ss_pred             CC-ccccceeeccccCchhhhhcCC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          186 KN-QFMTEYVVTRWYRAPELLLCCD---NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       186 ~~-~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .. ......+||+.|+|||++.+..   .++.++|||||||++|+|++|.+||.+.+.......+.......        
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------  266 (371)
T cd05622         195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--------  266 (371)
T ss_pred             CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcc--------
Confidence            22 1234567999999999986532   37889999999999999999999998876655544443211000        


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK--RISVTEALQHPYMSP  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~eil~hp~~~~  321 (373)
                                        .+. ..+.++..+++||.+||..++.+  |+++.++++||||+.
T Consensus       267 ------------------~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         267 ------------------TFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             ------------------cCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence                              000 12357889999999999844443  789999999999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-47  Score=357.09  Aligned_cols=281  Identities=24%  Similarity=0.323  Sum_probs=217.8

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeC--CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNR--ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .+..+|++++.||.|+||.||+|...  .++..||+|.+....       ...+|+.+++.++||||+++++++     .
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~-----~  156 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAY-----R  156 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeE-----e
Confidence            45678999999999999999999764  456889999885431       234799999999999999999998     4


Q ss_pred             CcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          105 NFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ....+|+|||++.++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       157 ~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        157 WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             eCCEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            44679999999999999999877889999999999999999999999999999999999999999999999999987554


Q ss_pred             CCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHhCCCChhhhc
Q 017334          185 GKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC---LNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       185 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...   ...+..+.+.++..+.....
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             cccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            322  22234578999999999876 5789999999999999999999999976543   44556666655544332111


Q ss_pred             ccCChhHHHHHHhCCCCCCC--Ccccc--CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGT--PFSRL--YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      . ..................  .....  ....+..+++||++||..||++|||+.++|+||||..
T Consensus       316 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~  380 (392)
T PHA03207        316 N-GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK  380 (392)
T ss_pred             c-cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence            1 111111111111111111  11111  1235678999999999999999999999999999974

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-47  Score=343.38  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=210.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .|++.+.||+|+||.||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++.+     .....+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            488999999999999999999999999999998654322 22234467899999999999999999998     444679


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ++||||+. |+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999996 6898887543  46899999999999999999999999999999999999999999999999998765322


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                       ......+|++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.......+.......             
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  220 (285)
T cd05605         156 -ETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED-------------  220 (285)
T ss_pred             -CccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc-------------
Confidence             22234578999999999876 578899999999999999999999998765433333222211000             


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSP  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~  321 (373)
                                    .....+.+++.+.+||.+||..||++||     +++++++||||..
T Consensus       221 --------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         221 --------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             --------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence                          0112245788899999999999999999     8999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.8e-47  Score=351.47  Aligned_cols=262  Identities=23%  Similarity=0.387  Sum_probs=211.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+++++.+++.||+|++.+... .......+.+|+.++..++|+||+++++.+     .....
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            479999999999999999999999999999999865322 222233466889999999999999999998     44578


Q ss_pred             EEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +|+||||+. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999995 799999976 467999999999999999999999999999999999999999999999999998754322


Q ss_pred             C-ccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          187 N-QFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       187 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      . ......+||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+.+..+....+...   ..       
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~---~~-------  225 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH---KE-------  225 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---Cc-------
Confidence            2 22234579999999999863    345789999999999999999999999877655554444321   00       


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK--RISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~eil~hp~~~~~  322 (373)
                                      ...+......+++.+.+||++||..++.+  |+++.++++||||..+
T Consensus       226 ----------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         226 ----------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             ----------------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence                            00111222457899999999999765554  6899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.1e-47  Score=347.12  Aligned_cols=277  Identities=38%  Similarity=0.646  Sum_probs=208.0

Q ss_pred             eeeeccCceEEEEEEeCC--CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRE--TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~--~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      .+||+|+||.||+|.++.  ++..||+|.+......    ..+.+|+.+++.++||||+++++++...   ....+++||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~   79 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLF   79 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEE
Confidence            579999999999999754  6688999998654222    2456899999999999999999988543   236789999


Q ss_pred             ecCCccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCCeEEcccCcc
Q 017334          114 ELMDTDLHQIIKSS---------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLA  180 (373)
Q Consensus       114 e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill----~~~~~~kL~Dfg~a  180 (373)
                      ||++++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            99999998887521         248899999999999999999999999999999999999    56678999999999


Q ss_pred             cccCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc---------hHHHHHHHH
Q 017334          181 RTSNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC---------LNQLKLIIN  248 (373)
Q Consensus       181 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~i~~  248 (373)
                      +......   .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.....         ..++..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            7654322   1234567899999999997756789999999999999999999999975432         245566666


Q ss_pred             HhCCCChhhhcccCCh----hHHHHHHhCCCCCC---CCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          249 ILGSRREEDLEFIDNP----KARKYIKSLPYTPG---TPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       249 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .++.+....+......    ..............   ..........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            6676555443322110    00000000000000   00011112346678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-47  Score=360.13  Aligned_cols=279  Identities=26%  Similarity=0.329  Sum_probs=211.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ....|.+.+.||+|+||.||+|.+..+++.||||....        ....+|+++++.++|+||+++++++.     ..+
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~  233 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRV-----VGG  233 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEE-----ECC
Confidence            45689999999999999999999999999999996432        13457999999999999999999883     346


Q ss_pred             eEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..++|||++.++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            78999999999999888754 46999999999999999999999999999999999999999999999999999765332


Q ss_pred             C--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCC-CCCCCC------chHHHHHHHHHhCCCChhh
Q 017334          187 N--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP-IFPGTE------CLNQLKLIINILGSRREED  257 (373)
Q Consensus       187 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~~------~~~~~~~i~~~~~~~~~~~  257 (373)
                      .  .......||+.|+|||++.+ ..++.++|||||||++|+|++|.. +|....      ....+..+.+..+......
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            1  12234578999999999977 578999999999999999998774 444322      1233444443333222111


Q ss_pred             hcccCChhHHHHHH-----hCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          258 LEFIDNPKARKYIK-----SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       258 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ...........+..     ..+......|.++ ..+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            11111111111111     1111222223222 246778999999999999999999999999999964

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-47  Score=350.31  Aligned_cols=280  Identities=22%  Similarity=0.365  Sum_probs=214.6

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||.|+||.||+|.+..+|..+|+|++.... .......+.+|+++++.++||||+++++++.     ..+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~   76 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDG   76 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECC
Confidence            3589999999999999999999999999999999987543 2334456789999999999999999999984     346


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .+++||||+. |+|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            7999999996 69999998888899999999999999999999975 799999999999999999999999999875432


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC---
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID---  262 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~---  262 (373)
                      .  ......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.........    ...+...........   
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         157 S--MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE----LMFGCPVEGDPAESETSP  229 (333)
T ss_pred             h--ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH----HHhcCcccCCccccccCc
Confidence            2  2234578999999999876 57899999999999999999999999766543222    112111110000000   


Q ss_pred             ------------------ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          263 ------------------NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       263 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                        ..................  .....+++++++||.+||+.||++|||+.++++||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPK--LPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCcc--CCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                              000000000000000000  0012367889999999999999999999999999999743

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.3e-47  Score=340.69  Aligned_cols=280  Identities=38%  Similarity=0.699  Sum_probs=221.9

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcceEE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      |++++.||+|+||.||+|.+..+++.||+|+++....... .....+|+.+++++. |+|++++++++...   ..+..+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~   76 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA   76 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence            7889999999999999999999999999999876533322 224457899999886 99999999998543   125789


Q ss_pred             EEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          111 LVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      +||||++++|.+.+... ..+++.+++.++.||+.||+|||+.|++||||||+||+++. +.+||+|||++....... .
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~  154 (282)
T cd07831          77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-P  154 (282)
T ss_pred             EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-C
Confidence            99999999999888764 57899999999999999999999999999999999999999 999999999997654322 2


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      .....++..|+|||.+.....++.++||||+||++|+|++|.+||.+.+..+....+....+.+............... 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  233 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN-  233 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc-
Confidence            2345678999999987665667899999999999999999999999988888888888877766654322111100000 


Q ss_pred             HHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                       ...+...........+.++..+.+||.+||..||++||++.++++||||
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 -YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             -ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence             0011111111222335678999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5e-47  Score=342.81  Aligned_cols=284  Identities=40%  Similarity=0.713  Sum_probs=224.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++...........+.+|+++++.++|+||+++++++..     .+..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence            47999999999999999999999999999999987654444445567899999999999999999999843     4679


Q ss_pred             EEEeecCCccHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLH-QIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~-~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++||||+++++. .+..+...+++.+++.++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus        76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            999999986554 4455556799999999999999999999999999999999999999999999999999876544332


Q ss_pred             -cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          189 -FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       189 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                       ......++..|+|||++.+...++.++|+||||+++|+|++|++||.+....+.+..+...++................
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence             3345678899999999987547899999999999999999999999988777777777776665554332221110000


Q ss_pred             HHHHhCC-CCCCCCccccCC-CCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLP-YTPGTPFSRLYP-DAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~-~~~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .- ...+ ..........++ .+++.+.+||++||..+|++||++.++++||||
T Consensus       236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         236 AG-VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cc-cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            00 0000 000011111122 348889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.2e-47  Score=348.63  Aligned_cols=289  Identities=38%  Similarity=0.650  Sum_probs=230.1

Q ss_pred             eeecCceeee-eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHH------------HHHHHHHHHHHhhCCCCCee
Q 017334           26 FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD------------ALRTLRELKLLRHLQHENVI   92 (373)
Q Consensus        26 ~~~~~~Y~~~-~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~------------~~~~~~E~~~l~~l~hpniv   92 (373)
                      +.+.++|..+ +.||+|+||+||+|.+..+|+.||+|++.........            ...+.+|+.+++.++||||+
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            3567889765 6799999999999999999999999998654322100            11356899999999999999


Q ss_pred             eeceeecCCCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334           93 ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                      ++++++.     .....++||||++|+|.+++.....+++..+..++.||+.||+|||++||+|+||+|+||+++.++.+
T Consensus        84 ~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         84 GLVDVYV-----EGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             eeeEEEe-----cCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence            9999984     44679999999999999999888889999999999999999999999999999999999999999999


Q ss_pred             EEcccCcccccC--------------CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 017334          173 KICDFGLARTSN--------------GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE  238 (373)
Q Consensus       173 kL~Dfg~a~~~~--------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  238 (373)
                      ||+|||.+....              ..........+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999987554              111222334568889999998775567899999999999999999999999998


Q ss_pred             chHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          239 CLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                      ..+.+..+...++.+....+......  ..+. ..............+..+..+.++|.+||+.+|++||++++++.|||
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        239 EIDQLGRIFELLGTPNEDNWPQAKKL--PLYT-EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHHHHHHHHHHhCCCchhhCcchhhc--cccc-ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            88888888887777665433221100  0000 00011112222334567888999999999999999999999999999


Q ss_pred             CCCC
Q 017334          319 MSPL  322 (373)
Q Consensus       319 ~~~~  322 (373)
                      |...
T Consensus       316 ~~~~  319 (335)
T PTZ00024        316 FKSD  319 (335)
T ss_pred             cCCC
Confidence            9865

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.1e-47  Score=348.57  Aligned_cols=262  Identities=23%  Similarity=0.371  Sum_probs=211.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||++++..+++.||+|++.+.. ........+.+|+.++..++|+||+++++++     ...+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            47999999999999999999999999999999987532 2222333466789999999999999999998     45578


Q ss_pred             EEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .|+||||+. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999995 799999976 467999999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc-cccceeeccccCchhhhhcC----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          187 NQ-FMTEYVVTRWYRAPELLLCC----DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       187 ~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .. .....+||+.|+|||++.+.    ..++.++||||+||++|+|++|+.||.+.+..+....+.....          
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----------  225 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE----------  225 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC----------
Confidence            22 12335789999999998642    3578899999999999999999999987665544443322100          


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK--RISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~eil~hp~~~~~  322 (373)
                                      ..++......+++.+++||.+||..++.+  |++++++++||||...
T Consensus       226 ----------------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         226 ----------------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             ----------------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence                            00111222457889999999999876654  5689999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=378.33  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=225.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      -.++|.+++.||+|+||.|.+++++.|++.||+|++++-.. ......-|..|-.+|...+.+-|++++.+|     ++.
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~  147 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE  147 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence            35789999999999999999999999999999999976322 233344566788899888999999999999     777


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC-
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN-  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~-  184 (373)
                      +++|+||||+. |+|..++.+.+++++..++.|+..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|-... 
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            99999999995 7999999988899999999999999999999999999999999999999999999999999998776 


Q ss_pred             CCCccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ++.-.....+|||.|.+||++..    ...|+..+|+||+||++|||+.|..||.+.+-.+.+..|++.-..     +. 
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~-----l~-  301 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES-----LS-  301 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh-----cC-
Confidence            34444567799999999999853    246899999999999999999999999999888888888874111     11 


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC---HHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~eil~hp~~~~~  322 (373)
                                  +|        . -..+|+++++||+++|. +|+.|+.   ++++.+||||.++
T Consensus       302 ------------FP--------~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  302 ------------FP--------D-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             ------------CC--------c-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence                        11        0 03489999999999887 5888987   9999999999864

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-50  Score=338.18  Aligned_cols=254  Identities=24%  Similarity=0.448  Sum_probs=216.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +-|.++++||+|+||.||+|.|+.+|+.+|||.+...    .+.+++.+|+.+++++..|++|++|+.|+-.     ..+
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDL  103 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDL  103 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccC-----Cce
Confidence            4577899999999999999999999999999998643    4566889999999999999999999998644     459


Q ss_pred             EEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +||||||+ |++.++++. ++.+++.++..+++.-+.||+|||..+-+|||||..|||++.+|..||+|||.|....+.-
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            99999997 899999974 4689999999999999999999999999999999999999999999999999998776655


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ...++..|||.|||||++.. -+|+..+||||||+...||..|+|||..-....   .|                     
T Consensus       184 AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AI---------------------  238 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AI---------------------  238 (502)
T ss_pred             HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccc---ee---------------------
Confidence            55678899999999999987 579999999999999999999999996543211   11                     


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                         ..+|..+...+.. +...|.++.||+++||..+|++|-|+.++++|||++.
T Consensus       239 ---FMIPT~PPPTF~K-PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn  288 (502)
T KOG0574|consen  239 ---FMIPTKPPPTFKK-PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN  288 (502)
T ss_pred             ---EeccCCCCCCCCC-hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence               1222222222211 2235778999999999999999999999999999974

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.6e-46  Score=343.27  Aligned_cols=290  Identities=37%  Similarity=0.628  Sum_probs=226.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC---CC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR---RN  105 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~  105 (373)
                      .++|++.+.||+|+||.||+|.++.+|+.+|+|++..............+|+++++.++||||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            389999999999999999999999999999999986543322222345689999999999999999998765421   23


Q ss_pred             cceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ...+++|+||+++++...+.. ...+++.+++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++....
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            456899999999988887764 3579999999999999999999999999999999999999999999999999987543


Q ss_pred             CCC-----------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          185 GKN-----------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       185 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      ...           .......+++.|+|||.+.+...++.++||||+||++|+|++|++||.+.+.......+....+.+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP  246 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            221           112334678899999998765668899999999999999999999999988888888888877766


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .+..+........... ..............+..+++.+.++|.+||..||++|||+.++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         247 TEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             Chhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            5443322110000000 0000011111222334566789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-46  Score=337.72  Aligned_cols=282  Identities=49%  Similarity=0.818  Sum_probs=232.2

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      |++.+.||.|++|.||+|.+..+|+.+++|.+............+.+|+.+++.++|+||+++++++.     .....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            67889999999999999999999999999998766554444556778999999999999999999984     4477999


Q ss_pred             EeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc
Q 017334          112 VYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM  190 (373)
Q Consensus       112 v~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  190 (373)
                      |+||++++|.+.+... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+..........
T Consensus        76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence            9999999998888763 589999999999999999999999999999999999999999999999999987665443233


Q ss_pred             cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHH
Q 017334          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI  270 (373)
Q Consensus       191 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+..+....+...++.+....+....... ....
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  234 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA-RNYK  234 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh-hhhh
Confidence            445678899999998775578999999999999999999999999998888888887777776655444433211 1111


Q ss_pred             HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ...+...........+.++..+.++|.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            1222222222334456688999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.9e-46  Score=329.77  Aligned_cols=254  Identities=29%  Similarity=0.484  Sum_probs=211.3

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      .|++++.||.|++|.||++.++.+++.||+|++............+.+|+.+++.++|+|++++++.+..    ....+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence            4899999999999999999999999999999997655555555567889999999999999999887632    224689


Q ss_pred             EEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          111 LVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++|||+. ++|.+++..  ...+++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||++.......
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999996 699998875  3458999999999999999999999999999999999999999999999999997664443


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||++.+ ..++.++|+||+||++++|++|+.||...+.......+..  +.               
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--~~---------------  218 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--GK---------------  218 (257)
T ss_pred             CccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cC---------------
Confidence            34445678899999999876 5788999999999999999999999976654333222211  00               


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                   .......+++.+.++|.+||+.||++||++.++++||||
T Consensus       219 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 -------------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                         001123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-46  Score=337.82  Aligned_cols=281  Identities=43%  Similarity=0.741  Sum_probs=232.9

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      |++.+.||+|++|.||+|.+..+++.||+|++............+..|+.+++.++|+|++++++++.     .....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            67788999999999999999999999999999866433333455678999999999999999999984     3467999


Q ss_pred             EeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc
Q 017334          112 VYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM  190 (373)
Q Consensus       112 v~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  190 (373)
                      |+||++++|.+++... ..+++..++.++.|++.||+|||++||+||||+|+||+++.++.+||+|||.+..........
T Consensus        76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            9999999999999876 579999999999999999999999999999999999999999999999999987654433333


Q ss_pred             cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHH
Q 017334          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI  270 (373)
Q Consensus       191 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ....++..|+|||.+.+...++.++|+|||||++++|++|.+||.+.+..+.+..+...++.+....+....+..  .+.
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYK  233 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--ccc
Confidence            445567889999998775578999999999999999999999999988888888888888877666554332221  111


Q ss_pred             HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ...+...........+.++..+.++|.+||..||++||++.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            1222222333334456678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.4e-46  Score=337.34  Aligned_cols=283  Identities=36%  Similarity=0.649  Sum_probs=216.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|.+..+|..||+|++....... ....+.+|+.+++.++|+||+++++++     .....
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDII-----HTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-CcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence            478999999999999999999999999999999986543221 122456899999999999999999998     34467


Q ss_pred             EEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||++++|.+.+.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          78 LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             EEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            999999999888877754 3568889999999999999999999999999999999999999999999999987654333


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC-LNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+. .+.+..+...++.+..........  .
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  235 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK--L  235 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh--c
Confidence            3334456789999999987655688899999999999999999999976543 345555555555544432221110  0


Q ss_pred             HHHHHh-CCCCCCCCccccCC--CCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          267 RKYIKS-LPYTPGTPFSRLYP--DAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       267 ~~~~~~-~~~~~~~~~~~~~~--~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ..+... .+..........+.  ..++.+.+++.+||..||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            000000 00000111111111  135779999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-46  Score=373.07  Aligned_cols=266  Identities=26%  Similarity=0.368  Sum_probs=215.3

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ......++|++++.||+|+||+||+|.+..++..+|+|++............+..|+.+++.++||||++++++|...  
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de--   84 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK--   84 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec--
Confidence            344455899999999999999999999999999999999976655555666788999999999999999999988543  


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCceEEcC---
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSA-------NILHRDLKPGNLLVNA---  168 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-------~ivH~Dlkp~Nill~~---  168 (373)
                       ....+||||||++ |+|.++|..    .+.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.   
T Consensus        85 -~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         85 -ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             -CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence             2357999999997 699998864    35799999999999999999999985       4999999999999964   


Q ss_pred             --------------CCCeEEcccCcccccCCCCccccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCC
Q 017334          169 --------------NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPI  233 (373)
Q Consensus       169 --------------~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p  233 (373)
                                    .+.+||+|||++...... ......+||+.|+|||++.+. ..++.++||||||||||+|++|.+|
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                          234899999999765322 223455789999999998642 4578999999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHH
Q 017334          234 FPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA  313 (373)
Q Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~ei  313 (373)
                      |...+....+.....   .                    .+.       ...+..++.+.+||.+||..+|.+||++.++
T Consensus       243 F~~~~~~~qli~~lk---~--------------------~p~-------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Ql  292 (1021)
T PTZ00266        243 FHKANNFSQLISELK---R--------------------GPD-------LPIKGKSKELNILIKNLLNLSAKERPSALQC  292 (1021)
T ss_pred             CCcCCcHHHHHHHHh---c--------------------CCC-------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence            976554333222111   0                    000       0013457889999999999999999999999


Q ss_pred             hCCCCCCCCC
Q 017334          314 LQHPYMSPLY  323 (373)
Q Consensus       314 l~hp~~~~~~  323 (373)
                      |.|||+....
T Consensus       293 L~h~~ik~i~  302 (1021)
T PTZ00266        293 LGYQIIKNVG  302 (1021)
T ss_pred             hccHHHhhcC
Confidence            9999997553

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-46  Score=331.52  Aligned_cols=255  Identities=28%  Similarity=0.465  Sum_probs=210.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC---hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN---RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      +.|++.+.||+|++|.||.|.+..+|+.+|+|.+......   ......+.+|+.++++++||||+++++++     ...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            5789999999999999999999999999999998654322   22334567899999999999999999999     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ...++|+||+. ++|.+++...+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.+++++|+|||++.....
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            68999999996 69999998888899999999999999999999999999999999999999999999999999875432


Q ss_pred             CCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          186 KNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       186 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ...   ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+..   .          
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~----------  222 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---Q----------  222 (263)
T ss_pred             cccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc---c----------
Confidence            211   1133567889999999977 5688999999999999999999999976544333222111   0          


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                      .........++..+.++|++||..+|.+|||+.++++||||
T Consensus       223 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         223 ----------------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ----------------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                            00012234577889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-46  Score=359.18  Aligned_cols=254  Identities=23%  Similarity=0.354  Sum_probs=210.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCC-CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRET-NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~-g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..|.+.+.||+|++|.||+|.+..+ +..||+|.+...  .......+.+|+.+++.++||||+++++.+     ...+.
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~  139 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDK  139 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCE
Confidence            4599999999999999999998877 788999987433  233344566899999999999999999998     44478


Q ss_pred             EEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          109 VYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      +|+||||+. |+|.+++..    ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            999999996 799887753    356899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          184 NGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       184 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ....  ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+..  +.         
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~--~~---------  287 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY--GK---------  287 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CC---------
Confidence            4322  12345679999999999876 6789999999999999999999999987665444443322  00         


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                         .......+++.+.+||.+||..||++||++.+++.|+|++.
T Consensus       288 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        288 -------------------YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence                               00112346788999999999999999999999999999863

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.1e-45  Score=328.16  Aligned_cols=253  Identities=27%  Similarity=0.430  Sum_probs=212.9

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|.+.+.||+|++|.||+|.++.+|+.|++|.+............+.+|+.+++.++||||+++++.+.     ..+..|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            488899999999999999999999999999998765555566667889999999999999999999984     446799


Q ss_pred             EEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          111 LVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +||||+. ++|.+++...  ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999996 6999998764  578999999999999999999999999999999999999999999999999987665444


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+...                  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------  216 (256)
T cd08529         156 NFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG------------------  216 (256)
T ss_pred             chhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------------
Confidence            33445578899999999876 56889999999999999999999999776643333322210                  


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                  ........++..+.++|.+||+.+|++||++.++++|||+
T Consensus       217 ------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         217 ------------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ------------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                        0001112467789999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-46  Score=340.68  Aligned_cols=286  Identities=41%  Similarity=0.674  Sum_probs=216.2

Q ss_pred             ceeeeeeeeccCceEEEEEEeCC--CCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRE--TNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~--~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +|++.+.||+|++|.||+|.++.  +|+.||+|.+.... ........+.+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            58899999999999999999988  89999999997643 1122223467899999999999999999998543   226


Q ss_pred             eEEEEeecCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC----CCCeEEcccC
Q 017334          108 DVYLVYELMDTDLHQIIKSS-----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA----NCDLKICDFG  178 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~----~~~~kL~Dfg  178 (373)
                      .+++||||++++|.+++...     ..+++..++.++.||+.||+|||+++|+||||||+|||++.    ++.+||+|||
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            79999999998888877532     36899999999999999999999999999999999999999    8999999999


Q ss_pred             cccccCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch---------HHHHHH
Q 017334          179 LARTSNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL---------NQLKLI  246 (373)
Q Consensus       179 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i  246 (373)
                      ++........   ......++..|+|||++.+...++.++|||||||++|+|++|++||.+....         ..+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9876533221   2234577899999999877667899999999999999999999999865532         244555


Q ss_pred             HHHhCCCChhhhcccCC-hhHHHHHHhCC--CCCCCC---ccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          247 INILGSRREEDLEFIDN-PKARKYIKSLP--YTPGTP---FSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~---~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ...++.+....+..... +......+...  ..+...   +.......+..+.++|.+||+.||++|||+.++++||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            55565544433221111 01111000000  000000   001112567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5e-46  Score=335.95  Aligned_cols=258  Identities=25%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||+++++.+     ...+..
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence            378889999999999999999999999999998654322 22234466899999999999999999998     444679


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      |+||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus        76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999996 6998888543  35899999999999999999999999999999999999999999999999998755322


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      . ......|+..|+|||++.+ ..++.++||||+||++|+|++|++||.+..............                
T Consensus       156 ~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~----------------  217 (285)
T cd05630         156 Q-TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----------------  217 (285)
T ss_pred             c-cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh----------------
Confidence            2 2234578999999999976 568999999999999999999999997653221111111100                


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                          ....       ......+++.+.+||++||+.||++|||     +.++++||||...
T Consensus       218 ----~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         218 ----KEVQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             ----hhhh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence                0000       0122456788999999999999999999     9999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8e-46  Score=337.34  Aligned_cols=291  Identities=38%  Similarity=0.625  Sum_probs=228.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-----
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-----  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----  102 (373)
                      ..++|++.+.||.|+||.||+|.++.+|+.||+|+++...........+.+|+.+++.++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            457899999999999999999999999999999999754333333345668999999999999999999885432     


Q ss_pred             CCCcceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          103 RRNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      ......+++|+||+++++.+.+... ..+++.+++.++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence            1123479999999999888887754 468999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          182 TSNGKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...... .......++..|+|||.+.+...++.++|||||||++++|++|++||...+..+.+..+....+.+....+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD  244 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            654332 1222335678899999987655678999999999999999999999998888888888888777766554432


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .............. .........+..+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         245 VIKLPYFNTMKPKK-QYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccc-ccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            21110000000000 00011122334578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-46  Score=340.41  Aligned_cols=267  Identities=28%  Similarity=0.405  Sum_probs=210.9

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecC
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMP  100 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  100 (373)
                      .+.+..-+..|++++.||+||.+.||++.... ...||+|++.....+......+..|+..|.+|+ |.+|++++++-..
T Consensus       353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~  431 (677)
T KOG0596|consen  353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT  431 (677)
T ss_pred             CeeEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence            34556677889999999999999999998753 456888888777777788888999999999997 9999999999854


Q ss_pred             CCCCCcceEEEEeecCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          101 SHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                           ++.+|+||||=+.+|..+|++... ++.-.++.|..||+.|+.++|++||||.||||.|+|+-. |.+||+|||+
T Consensus       432 -----d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGI  505 (677)
T KOG0596|consen  432 -----DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGI  505 (677)
T ss_pred             -----CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeech
Confidence                 478999999999999999987654 444689999999999999999999999999999999864 6999999999


Q ss_pred             ccccCCC--CccccceeeccccCchhhhhcCC----------CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017334          180 ARTSNGK--NQFMTEYVVTRWYRAPELLLCCD----------NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLII  247 (373)
Q Consensus       180 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  247 (373)
                      |.....+  .....+-+||+.||+||.+....          ..+.++||||||||||+|+.|++||..-  ......+.
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~  583 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLH  583 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHH
Confidence            9865433  22334569999999999986421          1567899999999999999999999432  11222222


Q ss_pred             HHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          248 NILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .+...                       ..+..+..+.+  ..++.++++.||..||.+||++.++|+|||++..
T Consensus       584 aI~~P-----------------------~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  584 AITDP-----------------------NHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             hhcCC-----------------------CccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            11111                       11112222221  1238999999999999999999999999999763

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-46  Score=334.37  Aligned_cols=284  Identities=41%  Similarity=0.689  Sum_probs=226.0

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      |++++.||+|++|.||+|.+..+|+.+|+|++............+.+|+.+++.++|||++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            78899999999999999999999999999999866433334456778999999999999999999984331   267999


Q ss_pred             EeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC-cc
Q 017334          112 VYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN-QF  189 (373)
Q Consensus       112 v~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  189 (373)
                      |+||++++|.+++... ..+++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus        78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            9999999999988765 579999999999999999999999999999999999999999999999999997654332 12


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+.......+....+.+....+...........
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23346688899999887656688999999999999999999999999888888888887777665554433222100000


Q ss_pred             HHhCCCCCCCCccccCCC-CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          270 IKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ... .............. .++.+.++|++||+.||.+||++.++++||||
T Consensus       238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            000 00000111122233 38889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5e-46  Score=342.56  Aligned_cols=282  Identities=19%  Similarity=0.270  Sum_probs=206.3

Q ss_pred             eeeeeecc--CceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           34 PIKPIGRG--AYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        34 ~~~~lg~G--~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      +++.||+|  +|++||++.++.+|+.||+|++............+.+|+.+++.++||||+++++++.     ..+..|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence            56789999  6789999999999999999999766544444556678999999999999999999984     4467999


Q ss_pred             EeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC-
Q 017334          112 VYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN-  187 (373)
Q Consensus       112 v~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-  187 (373)
                      ||||++ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+....... 
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999996 7999998653  468999999999999999999999999999999999999999999999998654322111 


Q ss_pred             ------ccccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChh-hhc
Q 017334          188 ------QFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE-DLE  259 (373)
Q Consensus       188 ------~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~  259 (373)
                            .......++..|+|||++.+. ..++.++||||+||++|+|++|.+||..............  +..+.. ...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccccccc
Confidence                  111223567789999998753 3588999999999999999999999976554332222211  111000 000


Q ss_pred             ccCChhHH-------------HHH---HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKAR-------------KYI---KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~-------------~~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ........             ...   ...+.............+++.+.+||++||+.||++|||++++++||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence            00000000             000   0000000011111223467889999999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.7e-46  Score=333.03  Aligned_cols=252  Identities=22%  Similarity=0.346  Sum_probs=199.7

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecC
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM  116 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~  116 (373)
                      ||+|+||.||+++++.+|+.||+|++....... .....+..|+++++.++||||+++++.+     +....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999986543221 2233455799999999999999999998     4457899999999


Q ss_pred             C-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccce
Q 017334          117 D-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY  193 (373)
Q Consensus       117 ~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  193 (373)
                      . ++|.+++....  .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... .....
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~  154 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQR  154 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeecc
Confidence            6 69988875433  58889999999999999999999999999999999999999999999999987654322 22345


Q ss_pred             eeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhC
Q 017334          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL  273 (373)
Q Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      .|++.|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.........+....                      .
T Consensus       155 ~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~----------------------~  211 (277)
T cd05607         155 AGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT----------------------L  211 (277)
T ss_pred             CCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh----------------------h
Confidence            78899999999877 458999999999999999999999997643221111111100                      0


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCC
Q 017334          274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV----TEALQHPYMSPL  322 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~eil~hp~~~~~  322 (373)
                      ..    ........+++++++||++||+.||++||++    +++++||||..+
T Consensus       212 ~~----~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         212 ED----EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             cc----ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence            00    0000113468889999999999999999999    678899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=353.04  Aligned_cols=260  Identities=27%  Similarity=0.449  Sum_probs=215.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -.+.|.|+..||.|+||+||+|..+.++..-|.|+|...  .......++-||.||..+.||+||++++.|+..     +
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----n  102 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----N  102 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----C
Confidence            456789999999999999999999999999999998543  344556788899999999999999999999544     7


Q ss_pred             eEEEEeecCCc-cHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMDT-DLHQIIK-SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .++|+.|||+| ....++. -...+++.+++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+.....
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence            79999999975 5544443 346799999999999999999999999999999999999999999999999999876655


Q ss_pred             CCccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          186 KNQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ......+++|||+|||||+..+    ..+|+.++||||||+.|.+|..+.||-...+....+-.|.+   ..+       
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SeP-------  252 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEP-------  252 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCC-------
Confidence            5555678899999999999754    46799999999999999999999999766655444443332   111       


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                   +..     -.+...+..+.|+|.+||..||..||++.++|+||||...
T Consensus       253 -------------PTL-----lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  253 -------------PTL-----LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             -------------Ccc-----cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                         111     1123456678999999999999999999999999999753

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.9e-46  Score=342.50  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=197.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEe-----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVN-----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSH  102 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP-   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence            37899999999999999999975     3456789999987432 233345678999999999 799999999987432 


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhc------------------------------------------------------
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSS------------------------------------------------------  127 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------------  127 (373)
                         ...+++||||++ |+|.+++...                                                      
T Consensus        84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence               246899999996 7999988642                                                      


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc--cccceeecc
Q 017334          128 --------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTR  197 (373)
Q Consensus       128 --------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~  197 (373)
                              ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ......++.
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    2477888899999999999999999999999999999999999999999999975432211  112234567


Q ss_pred             ccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCC
Q 017334          198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYT  276 (373)
Q Consensus       198 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (373)
                      .|+|||++.+ ..++.++|||||||++|+|++ |.+||.+............  ..                        
T Consensus       241 ~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~--~~------------------------  293 (338)
T cd05102         241 KWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK--DG------------------------  293 (338)
T ss_pred             cccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh--cC------------------------
Confidence            8999999876 578999999999999999996 9999987654332221111  00                        


Q ss_pred             CCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          277 PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       277 ~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                         ........+++.+.+|+.+||+.||++|||+.++++
T Consensus       294 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         294 ---TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               000112356788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.1e-45  Score=333.05  Aligned_cols=262  Identities=26%  Similarity=0.423  Sum_probs=211.9

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ....+.|++++.||+|+||.||+|.+..+++.+++|.+...  .......+.+|+.+++.++||||+++++.+.     .
T Consensus         8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   80 (292)
T cd06644           8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFY-----W   80 (292)
T ss_pred             cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----e
Confidence            34568899999999999999999999999999999998643  3334556778999999999999999999984     3


Q ss_pred             cceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .+..|+||||++ ++|..++.+ ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            467999999997 577777654 457899999999999999999999999999999999999999999999999998754


Q ss_pred             CCCCccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ...........+++.|+|||++.+    ...++.++|+|||||++|+|++|.+||...+.......+..   ..      
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~------  231 (292)
T cd06644         161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SE------  231 (292)
T ss_pred             cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CC------
Confidence            333333345578899999999853    23467899999999999999999999976553332222211   00      


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                         .+.......++..+.++|++||..||++||++.++++||||..+
T Consensus       232 -------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         232 -------------------PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             -------------------CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                               00011123467789999999999999999999999999999765

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-45  Score=333.14  Aligned_cols=253  Identities=28%  Similarity=0.499  Sum_probs=213.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++..... .......+.+|+++++.++||||+++++++     ...+.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            479999999999999999999999999999999865432 223345677899999999999999999998     44477


Q ss_pred             EEEEeecC-CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||+ +++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...... 
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            99999999 5799999988889999999999999999999999999999999999999999999999999998765433 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                        .....+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+..   ..              
T Consensus       155 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~--------------  214 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE---GK--------------  214 (290)
T ss_pred             --CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC--------------
Confidence              234468899999999876 5678999999999999999999999977663333332221   00              


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                    ..+...+++.++++|++||..||.+|+     ++.++++||||..+
T Consensus       215 --------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         215 --------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             --------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence                          011234578899999999999999999     89999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-45  Score=330.29  Aligned_cols=260  Identities=22%  Similarity=0.407  Sum_probs=208.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCC-CC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHR-RN  105 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~-~~  105 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++......   ...+..|+.+++.+ +||||+++++.+..... ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            457899999999999999999999999999999998654322   23567899999998 59999999999865422 12


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ...+|+||||++ ++|.+++...  ..+++..++.++.|++.||+|||+++|+|+||||+||+++.++.+||+|||++..
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            357899999996 6999988763  4689999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ............|+..|+|||++.+    ...++.++|+||+||++|+|++|.+||...........+..          
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~----------  230 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----------  230 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc----------
Confidence            5433333445678999999999863    23578899999999999999999999965433222211100          


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                    ..   ..  ......++..+.+||.+||..||.+|||+.++++||||
T Consensus       231 --------------~~---~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         231 --------------NP---AP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             --------------CC---CC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                          00   00  01123467889999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.9e-46  Score=330.77  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=208.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++....  .....+.+|+.+++.++||||+++++.+     ...+.
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~   80 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDK   80 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCE
Confidence            4689999999999999999999999999999999865422  2334566899999999999999999998     44467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||++ ++|.+++...+.+++.+++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            999999997 6999999888899999999999999999999999999999999999999999999999999987654333


Q ss_pred             ccccceeeccccCchhhhh--cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 QFMTEYVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .......|+..|+|||++.  ....++.++|+|||||++|+|++|.+||...........+..  ...            
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~~------------  226 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SNF------------  226 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cCC------------
Confidence            3334557899999999974  224578899999999999999999999865443222211111  000            


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                              .   ...+ .....++..+.++|.+||..||++||++.++++|||
T Consensus       227 --------~---~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         227 --------Q---PPKL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             --------C---CCcc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                    0   0000 011235678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=338.15  Aligned_cols=260  Identities=25%  Similarity=0.381  Sum_probs=216.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .+.|+.-+.||+||||.||-++.+.||+.||+|++.+..... ......+.|-.+|.+++.+.||.+-.+|     +...
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd  258 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD  258 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence            367888899999999999999999999999999987543322 2233467899999999999999998888     6667


Q ss_pred             eEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+|+|+..|+ |+|.-.|-+.+  .|++..++.++.+|+-||++||+.+||+|||||+|||+|+.|+++|+|+|+|....
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            8999999996 69988887655  89999999999999999999999999999999999999999999999999998775


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ... ...+.+||.+|||||++.+ ..|+...|+|||||++|+|+.|+.||........-..+.+..              
T Consensus       339 ~g~-~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~--------------  402 (591)
T KOG0986|consen  339 EGK-PIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT--------------  402 (591)
T ss_pred             CCC-ccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH--------------
Confidence            433 3455699999999999987 459999999999999999999999997654322222222111              


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                            .       ....++...+|+++++|.+.+|+.||++|+     +++++.+||||+.+
T Consensus       403 ------~-------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  403 ------L-------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             ------h-------cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence                  0       011233456899999999999999999998     56799999999864

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.6e-45  Score=331.26  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=210.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .|+..+.||+|+||+||+|.+..+|+.+|+|++...... ......+.+|+.+++.++|+||+++.+.+     ...+..
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence            478889999999999999999999999999998654322 22234467899999999999999999988     444679


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ++||||+. ++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            99999996 6888877543  46999999999999999999999999999999999999999999999999998654322


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                       .......|+..|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.........+.......             
T Consensus       156 -~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~-------------  220 (285)
T cd05632         156 -ESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-------------  220 (285)
T ss_pred             -CcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc-------------
Confidence             22344578999999999876 578999999999999999999999998765443333322211100             


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                    .....+.+++.+.+|+.+||+.||++||+     +.++++|+||...
T Consensus       221 --------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         221 --------------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             --------------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence                          00122457788999999999999999999     8899999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=331.44  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=212.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||.|+||.||++.+..++..+|+|.+...  .......+.+|+.+++.++||||+++++.+.     ....
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENK   76 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCe
Confidence            36799999999999999999999989999999998643  3344456778999999999999999999984     3467


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .|+||||++ ++|.+++... ..+++.+++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            999999997 5998888764 56999999999999999999999999999999999999999999999999998765444


Q ss_pred             CccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          187 NQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ........+++.|+|||.+..    ...++.++|+|||||++|+|++|++||.+.+.......+..   ...        
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--------  225 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEP--------  225 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCC--------
Confidence            433445678999999999853    23467899999999999999999999977654333322211   000        


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       +.......++..+.++|.+||+.||.+||++.++++||||...
T Consensus       226 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         226 -----------------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             -----------------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                             0001123467889999999999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-47  Score=331.75  Aligned_cols=257  Identities=24%  Similarity=0.410  Sum_probs=224.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~  106 (373)
                      -.+|..+..||+|+||+|.+|..+.+.+.||||++++... +..+..-.+.|-++|.... -|.+++++..|     +.-
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm  422 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM  422 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence            3678999999999999999999999999999999987642 2223333456777777765 78899999999     555


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..+|+||||+. |+|.-.+++-++|.|..+..++..|+.||-+||++||++||||.+|||++++|++||+|||+++..--
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            67999999996 79999999999999999999999999999999999999999999999999999999999999986655


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ......+.||||.|+|||++.. ++|+.++|+||+||+||||+.|++||.+.+..+..+.|....               
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------------  566 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------------  566 (683)
T ss_pred             CCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---------------
Confidence            6667788999999999999976 799999999999999999999999999999999998887521               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-----TEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~eil~hp~~~~~  322 (373)
                                      ..++..+|.++.++.+.+|...|.+|+.+     .+|-.||||..+
T Consensus       567 ----------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  567 ----------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             ----------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence                            12335688999999999999999999854     689999999754

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.4e-45  Score=323.45  Aligned_cols=253  Identities=29%  Similarity=0.500  Sum_probs=215.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||.|+||.|+.+++..+++.+++|.+...........++.+|+.++++++|+||+++++++.     .....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence            699999999999999999999999999999998766555555667889999999999999999999994     446799


Q ss_pred             EEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          111 LVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++|||++ ++|.+++...  ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            9999996 6999999764  468999999999999999999999999999999999999999999999999987654443


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||.+.+ ..++.++|+|||||++++|++|..||...+..+....+..  +.               
T Consensus       156 ~~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~---------------  217 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GN---------------  217 (256)
T ss_pred             ccccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CC---------------
Confidence            33445678999999999876 4578899999999999999999999987665544444322  10               


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                   +....+.++..+.++|.+||..+|.+||++.++++|||+
T Consensus       218 -------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         218 -------------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -------------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                         011124567889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.8e-45  Score=324.92  Aligned_cols=253  Identities=25%  Similarity=0.458  Sum_probs=211.6

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||+|+||.||++.+..+|+.||+|.+............+.+|+.+++.++||||+++++.+     ...+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            58999999999999999999999999999999876544444555778999999999999999999998     4457899


Q ss_pred             EEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          111 LVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||+. ++|.+.+...  ..+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999996 6999988754  357899999999999999999999999999999999999999999999999997654433


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||++.+ ..++.++|+||+||++++|++|..||...+..+....+..  +..              
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~--------------  218 (256)
T cd08218         156 ELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSY--------------  218 (256)
T ss_pred             hhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCC--------------
Confidence            33334567889999999876 5688899999999999999999999976654444333321  100              


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                    .......+..+.++|.+||+.+|++||++.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 --------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             --------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                          01123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-45  Score=329.27  Aligned_cols=257  Identities=25%  Similarity=0.372  Sum_probs=206.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++......  ....+.+|+.+++.++||||+++++.+.     ....
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~   80 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREK   80 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCE
Confidence            46899999999999999999999999999999998644222  2335678999999999999999999984     3467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999997 6999999887889999999999999999999999999999999999999999999999999997654333


Q ss_pred             ccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 QFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .......+++.|+|||.+.+  ...++.++|+||+||++|+|++|.+||...........+..                 
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-----------------  223 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-----------------  223 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-----------------
Confidence            22344578899999999753  24477899999999999999999999855432211111100                 


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                            ...   ..+.......++..+.+||++||+.||++|||++++++|+|
T Consensus       224 ------~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         224 ------SNF---QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ------CCC---CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                  000   00000111346788999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-45  Score=329.32  Aligned_cols=282  Identities=42%  Similarity=0.678  Sum_probs=221.2

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC---CCCCeeeeceeecCCCCCCcce
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL---QHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      |++.+.||.|+||.||+|.++.+|+.||+|++............+.+|+.+++++   .|||++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7889999999999999999998999999999975544333334556787777666   5999999999986654333445


Q ss_pred             EEEEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ++++|||++++|.+++....  .+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~  160 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE  160 (287)
T ss_pred             eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence            99999999999998887643  5899999999999999999999999999999999999999999999999998765332


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      . ......++..|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+..+....+....+......+........
T Consensus       161 ~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         161 M-ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             c-ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            2 2233457889999999976 5688999999999999999999999998887777777766555433322211110000


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                          ...+...........+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus       239 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 ----SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ----hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                0111122222334445677889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.8e-45  Score=333.18  Aligned_cols=282  Identities=23%  Similarity=0.372  Sum_probs=213.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|+||.||++.+..+|..+|+|.+.... .......+.+|+++++.++||||+++++++     ...+.+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEE
Confidence            47999999999999999999999999999999986542 233345677899999999999999999998     444689


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      |+||||++ ++|.+++...+.+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||++...... 
T Consensus        75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            99999996 6999999888889999999999999999999997 59999999999999999999999999998654322 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh------ccc
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL------EFI  261 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------~~~  261 (373)
                       ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+............      ...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence             2244578899999999866 56889999999999999999999999766533222211110000000000      000


Q ss_pred             C---ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 D---NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .   ...............  +...-...+++.+.+|+.+||..||++||++.++++||||...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEP--PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CccchhhHHHHHHHHhcCC--CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            0   000011111111000  0000012367889999999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.1e-45  Score=331.76  Aligned_cols=258  Identities=26%  Similarity=0.451  Sum_probs=211.7

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      +...+|++++.||+|+||.||+|.+..+++.||+|.+......  ....+.+|+.+++.+.|||++++++.+..     .
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~   89 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV-----G   89 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----C
Confidence            4568999999999999999999999999999999998754333  23457789999999999999999999843     4


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ...|+||||+. ++|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            67999999996 699998865 5689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .........+++.|+|||.+.+ ..++.++|+||+||++|+|++|++||...+.......+.. .+              
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~--------------  232 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NG--------------  232 (296)
T ss_pred             cccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CC--------------
Confidence            3333344578899999999876 5678999999999999999999999976554322221110 00              


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                   .+.......+++.+.++|.+||..||++||++.++++||||..
T Consensus       233 -------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~  275 (296)
T cd06654         233 -------------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (296)
T ss_pred             -------------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence                         0001112346788999999999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.3e-45  Score=324.67  Aligned_cols=255  Identities=30%  Similarity=0.507  Sum_probs=213.8

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||.|+||.||+|.+..+|..+|+|++............+..|+.+++.++||||+++++.+...   .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            58999999999999999999999999999999976655556666788999999999999999999987543   235689


Q ss_pred             EEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          111 LVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLH-----SANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-----~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      ++|||++ ++|.+++..    ...+++..++.++.||+.||+|||     +.+++|+||||+||+++.++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999996 699988865    357899999999999999999999     899999999999999999999999999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ..............+++.|+|||++.+ ..++.++|+||||+++++|++|..||...+.......+..            
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  224 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE------------  224 (265)
T ss_pred             ccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc------------
Confidence            876544433445678999999999876 5688999999999999999999999987663333222211            


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                        ..........+..+.+++.+||..+|++||++.++++|||+
T Consensus       225 ------------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         225 ------------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ------------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                              00112234567889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.5e-45  Score=332.42  Aligned_cols=259  Identities=26%  Similarity=0.456  Sum_probs=212.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++..+|++++.||+|+||.||+|.+..+|+.||+|.+......  ....+.+|+.+++.++||||+++++.+.     ..
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~   88 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYL-----VG   88 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cC
Confidence            4568999999999999999999999999999999998654332  2345678999999999999999999984     44


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ...|+||||++ ++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.....
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            67999999996 699988865 5689999999999999999999999999999999999999999999999999876544


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .........+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+.......+.. .               
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~---------------  230 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-N---------------  230 (297)
T ss_pred             CccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-C---------------
Confidence            3333345578899999999876 6788999999999999999999999976543222111100 0               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                  ..+.......+++.+.+|+.+||..||++||++.++++||||...
T Consensus       231 ------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         231 ------------GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             ------------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence                        000011123467889999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.4e-45  Score=329.72  Aligned_cols=267  Identities=25%  Similarity=0.385  Sum_probs=212.5

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPS  101 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  101 (373)
                      ..+....++|.+.+.||+|+||.||+|.+..+|+.+|+|++.....   ....+.+|+.+++.+ +|||++++++++...
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            4455567999999999999999999999999999999999864321   223456799999998 699999999998654


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~D  176 (373)
                      .....+..|+||||++ ++|.+++..    ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence            3334467999999996 699888752    45789999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCCCCccccceeeccccCchhhhhcCC----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD----NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      ||++..............++..|+|||++....    .++.++||||+||++|+|++|++||...+....+..+.+   .
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~  248 (291)
T cd06639         172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---N  248 (291)
T ss_pred             cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---C
Confidence            999876543332233456889999999986432    367899999999999999999999976554333322211   0


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ..                    .     ........+..+.+||.+||+.||++||++.++++||||+
T Consensus       249 ~~--------------------~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         249 PP--------------------P-----TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CC--------------------C-----CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            00                    0     0001123567799999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.9e-45  Score=329.01  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=208.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +.|++++.||.|+||.||++.+..++..+++|.+....  ......+.+|+.+++.++|||++++++.+..     .+..
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~   77 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNL   77 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEE
Confidence            44789999999999999999999999999999986432  3344567789999999999999999999843     4679


Q ss_pred             EEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      |+|+||++ ++|..++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus        78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            99999997 588777654 4679999999999999999999999999999999999999999999999999987654333


Q ss_pred             ccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          188 QFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .......++..|+|||++..    ...++.++|+||+||++|+|++|.+||...+..+....+.....            
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~------------  225 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP------------  225 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC------------
Confidence            33345578899999999842    24567899999999999999999999977654443333322100            


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                      +.......++..+.+||.+||+.||.+||++.++++||||..
T Consensus       226 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  267 (282)
T cd06643         226 ----------------PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV  267 (282)
T ss_pred             ----------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence                            000112346778999999999999999999999999999974

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-45  Score=332.91  Aligned_cols=258  Identities=27%  Similarity=0.449  Sum_probs=212.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++.+     .....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            47999999999999999999999999999999997654332 3445678899999999999999999998     44477


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .|+||||+. ++|.+++...  ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999996 6999998754  5789999999999999999999999999999999999999999999999999864322


Q ss_pred             CCc-----------------------------cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 017334          186 KNQ-----------------------------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG  236 (373)
Q Consensus       186 ~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  236 (373)
                      ...                             ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            110                             1123467889999999876 5688999999999999999999999987


Q ss_pred             CCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC----HHH
Q 017334          237 TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS----VTE  312 (373)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t----~~e  312 (373)
                      .+.......+..   ..                         ..+. ....+++.+.++|.+||..||++||+    +++
T Consensus       235 ~~~~~~~~~~~~---~~-------------------------~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~  285 (316)
T cd05574         235 SNRDETFSNILK---KE-------------------------VTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE  285 (316)
T ss_pred             CchHHHHHHHhc---CC-------------------------ccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence            765444333221   00                         0000 01226788999999999999999999    999


Q ss_pred             HhCCCCCCCC
Q 017334          313 ALQHPYMSPL  322 (373)
Q Consensus       313 il~hp~~~~~  322 (373)
                      +++||||+..
T Consensus       286 ll~~~~~~~~  295 (316)
T cd05574         286 IKQHPFFRGV  295 (316)
T ss_pred             HHcCchhhcC
Confidence            9999999864

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-47  Score=345.38  Aligned_cols=255  Identities=27%  Similarity=0.427  Sum_probs=216.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      -...|.-++.||+|+||.||-|++..+.+.||||++.... .....+..+++|+..|++++|||++.+.++|.-.     
T Consensus        24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----   98 (948)
T KOG0577|consen   24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----   98 (948)
T ss_pred             HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----
Confidence            3456788899999999999999999999999999997653 4456677899999999999999999999999654     


Q ss_pred             ceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ...|+|||||=|+-.|++.- .+++.+.+|..|..+.+.||+|||+++.||||||..|||++..|.|||+|||.|.... 
T Consensus        99 ~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-  177 (948)
T KOG0577|consen   99 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-  177 (948)
T ss_pred             chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-
Confidence            45899999998877777754 3689999999999999999999999999999999999999999999999999997653 


Q ss_pred             CCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                         ..++++|||+|||||+++.  .+.|+-++||||||+...+|...+||+-+.+....+..|..-              
T Consensus       178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN--------------  240 (948)
T KOG0577|consen  178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------------  240 (948)
T ss_pred             ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc--------------
Confidence               3467899999999999864  356999999999999999999999998777766655555430              


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                              .-|.-       -.+..|..++.|+..||++-|.+|||.+++|+|+|+.
T Consensus       241 --------esPtL-------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  241 --------ESPTL-------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             --------CCCCC-------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence                    00000       0244577799999999999999999999999999975

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.6e-45  Score=329.98  Aligned_cols=258  Identities=27%  Similarity=0.476  Sum_probs=212.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..+|++++.||.|++|.||+|.+..+|+.||+|.+......  ....+.+|+.+++.++||||+++++.+.     ....
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~   90 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFL-----VGDE   90 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCce
Confidence            35799999999999999999999999999999998654332  2345678999999999999999999983     3467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+|+||+. ++|.+++.. ..+++.++..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            999999996 688888765 468999999999999999999999999999999999999999999999999987654433


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+.......+... +                
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~----------------  231 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G----------------  231 (296)
T ss_pred             ccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C----------------
Confidence            33344578899999999876 56889999999999999999999999876654433322110 0                


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                                 .+.......+++.+.++|++||..||++||++.++++||||....
T Consensus       232 -----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         232 -----------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             -----------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                       000111245778899999999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.9e-45  Score=324.30  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=211.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+     ...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEE
Confidence            47999999999999999999999899999999987554333 455678999999999999999999988     444779


Q ss_pred             EEEeecCC-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          110 YLVYELMD-TDLHQIIKSS---QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      |+|+|++. ++|.+++...   ..+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999996 6999998763   4589999999999999999999999999999999999999999999999999875543


Q ss_pred             CCcc----ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          186 KNQF----MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       186 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ....    .....++..|+|||++.....++.++|+|||||++++|++|+.||...+.......+..   ...       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~-------  224 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---NDP-------  224 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CCC-------
Confidence            3221    23446889999999987654788999999999999999999999976554332222211   100       


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                     +.......+..+++.+.+++.+||..||++||++.++++||||
T Consensus       225 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 ---------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ---------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                           0000011124577889999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-45  Score=327.83  Aligned_cols=255  Identities=24%  Similarity=0.405  Sum_probs=211.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++.+.     .....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeE
Confidence            479999999999999999999999999999999875432 233445678999999999999999999884     33679


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      |+|+||+. ++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus        75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999996 6999998764 899999999999999999999999999999999999999999999999999977654433


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+.......+...                   
T Consensus       154 ~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------------------  213 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-------------------  213 (274)
T ss_pred             ccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-------------------
Confidence            3445578889999999977 45899999999999999999999999765533322222110                   


Q ss_pred             HHHhCCCCCCCCccccCCC-CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                          .+       ...... +++.+.++|.+||..||++|||++++++||||...
T Consensus       214 ----~~-------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         214 ----NP-------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             ----CC-------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence                00       001112 67789999999999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-44  Score=323.85  Aligned_cols=257  Identities=27%  Similarity=0.436  Sum_probs=206.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc---ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE---NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+|++.+.||+|+||.||+|.+..+|..||+|++.....   .......+.+|+.+++.++||||+++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            478999999999999999999999999999999865432   223344567899999999999999999987432   23


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..+++++||++ ++|.+++...+.+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||++.....
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            57899999996 69999998878899999999999999999999999999999999999999999999999999875432


Q ss_pred             C---CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          186 K---NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       186 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .   ........++..|+|||.+.+ ..++.++|+||+||++|+|++|++||...+.......+..   ..         
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~---------  225 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QP---------  225 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CC---------
Confidence            1   111223457889999999876 5788999999999999999999999976543332222111   00         


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                  .     .......+++.+.++| +||..+|++||+++++++||||+
T Consensus       226 ------------~-----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         226 ------------T-----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ------------C-----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                        0     0111234577788999 67778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-45  Score=328.46  Aligned_cols=280  Identities=41%  Similarity=0.716  Sum_probs=224.5

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcceEE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      |++.+.||+|++|+||+|....+++.|+||.+...... .......+|+..++.++ |||++++++++.     ..+..|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEE
Confidence            77899999999999999999999999999998765433 22334457999999999 999999999984     347799


Q ss_pred             EEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          111 LVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       111 lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      +||||++|+|.+.+....  .+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~  153 (283)
T cd07830          75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-P  153 (283)
T ss_pred             EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-C
Confidence            999999999999887654  7899999999999999999999999999999999999999999999999998765432 2


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......++..|+|||++.+...++.++|+||||+++++|++|++||++.+..+....+...++.+....+...... ...
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  232 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL-ASK  232 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh-hcc
Confidence            2344567889999999866566889999999999999999999999999888888888888777665432211000 000


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ....++...........+..+..+.++|++||+.||++|||+.|++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            000111111112223334557889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-44  Score=324.07  Aligned_cols=253  Identities=28%  Similarity=0.490  Sum_probs=207.2

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-------HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-------VDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+.......       .....+.+|+.+++.++||||+++++++.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            4788899999999999999999999999999886543221       12234668999999999999999999983    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                       .....++||||++ ++|.+++...+.+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+..
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          77 -DADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             -eCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence             3467899999996 59999998888899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCC------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChh
Q 017334          183 SNGKN------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE  256 (373)
Q Consensus       183 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (373)
                      .....      .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+..   .    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~----  227 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---N----  227 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---c----
Confidence            54211      11123457889999999876 5678999999999999999999999987544332222111   0    


Q ss_pred             hhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                             ........++..+.++|++||+.||.+||++.++++||||
T Consensus       228 -----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 -----------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -----------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                   0011223467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-45  Score=326.07  Aligned_cols=261  Identities=26%  Similarity=0.438  Sum_probs=210.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCC-CC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHR-RN  105 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~-~~  105 (373)
                      ..++|++.+.||.|++|.||+|.++.+++.+++|++.....   ....+.+|+.+++.+ .|+||+++++++..... ..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            35899999999999999999999999999999999865432   234577899999999 59999999999865432 23


Q ss_pred             cceEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      ...+|+||||++ ++|.+++..    ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence            467999999997 588888764    357999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCccccceeeccccCchhhhhcC----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChh
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCC----DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE  256 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (373)
                      ..............++..|+|||++.+.    ..++.++|||||||++|+|++|.+||...........+..   ...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--  235 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPP--  235 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCC--
Confidence            7654433334456789999999997542    3467899999999999999999999976543333322211   000  


Q ss_pred             hhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                        .    . .......+..+.+||++||..||++|||+.++++|||+
T Consensus       236 ------------------~----~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 ------------------P----T-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ------------------C----C-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                              0    0 00112357789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=322.64  Aligned_cols=257  Identities=28%  Similarity=0.427  Sum_probs=209.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++......  ....+.+|+.+++.++||||+++++.+     .....
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   74 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDK   74 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCE
Confidence            37899999999999999999999999999999999654332  445677899999999999999999988     34467


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +|++|||++ ++|.+++... ..+++.+++.++.|++.||+|||++||+|+||||+||+++.++.+||+|||++......
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            999999997 5999888765 78999999999999999999999999999999999999999999999999998765433


Q ss_pred             CccccceeeccccCchhhhhcC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 NQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ........++..|+|||.+.+.  ..++.++|+|||||++|+|++|.+||...+.......+... +...          
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-~~~~----------  223 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS-NFPP----------  223 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCC----------
Confidence            3233445788899999998652  26788999999999999999999999776544333222110 0000          


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                                     .........+..+.++|++||..+|.+|||+.+++.|+|
T Consensus       224 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         224 ---------------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ---------------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                           000011234677999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.8e-45  Score=328.69  Aligned_cols=258  Identities=25%  Similarity=0.432  Sum_probs=209.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++||||+++++.+.     ..+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   74 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAV   74 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeE
Confidence            47999999999999999999999999999999986542 3334456789999999999999999999884     44789


Q ss_pred             EEEeecCC-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          110 YLVYELMD-TDLHQIIKSS---QALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      |+||||++ ++|.+++...   ..+++..++.++.||+.||.|||+ .||+|+||||+||+++.++.+||+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999997 5888888753   379999999999999999999996 599999999999999999999999999987543


Q ss_pred             CCCccccceeeccccCchhhhhcCC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ..  ......+++.|+|||.+.+..     .++.++|+|||||++|+|++|..||...........+..+...       
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------  225 (286)
T cd06622         155 AS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG-------  225 (286)
T ss_pred             CC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhc-------
Confidence            22  223346788999999985422     3578999999999999999999999765443333222221111       


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                          ......+.+++.+.++|.+||..+|++||++.++++||||...
T Consensus       226 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         226 --------------------DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             --------------------CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence                                0112334578889999999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-44  Score=326.59  Aligned_cols=262  Identities=24%  Similarity=0.407  Sum_probs=209.1

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCC-C
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSH-R  103 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~-~  103 (373)
                      ..-.+.|++.+.||.|+||.||+|.+..+++.+|+|++....   .....+..|+.+++.+ +|+||+++++++.... .
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            345589999999999999999999999999999999985432   2334566889999988 5999999999986432 1


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      ......|++|||++ |+|.+++...  ..+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence            23467999999997 6999988653  45888899999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChh
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE  256 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (373)
                      ..............|++.|+|||++..    ...++.++|+|||||++|+|++|.+||...........+.+        
T Consensus       169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--------  240 (282)
T cd06636         169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--------  240 (282)
T ss_pred             hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh--------
Confidence            755433333345678999999999853    24578899999999999999999999966543222221111        


Q ss_pred             hhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                     ..      ........++..+.+||.+||+.||.+||++.++++||||
T Consensus       241 ---------------~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         241 ---------------NP------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ---------------CC------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                           00      0001113467889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=339.90  Aligned_cols=261  Identities=32%  Similarity=0.513  Sum_probs=221.3

Q ss_pred             eeecCceeee--eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           26 FEIDTKYVPI--KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        26 ~~~~~~Y~~~--~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .+|..-|++.  +.||+|.||+||-|+++++|+.||||+|.+.............|+.||+.+.||.||.+--.|     
T Consensus       558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----  632 (888)
T KOG4236|consen  558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----  632 (888)
T ss_pred             hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----
Confidence            3566777775  689999999999999999999999999998776666667788999999999999999998888     


Q ss_pred             CCcceEEEEeecCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEcccC
Q 017334          104 RNFKDVYLVYELMDTDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFG  178 (373)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~kL~Dfg  178 (373)
                      +....+++|||-+.|++.+.|.+  .+++++...+.++.||+.||.|||.+||+|.||||+|||+.+..   ++||||||
T Consensus       633 ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  633 ETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             cCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccc
Confidence            55577999999999999888854  47899999999999999999999999999999999999997764   59999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      +|+..+ ......+.+|||.|.|||++.. ++|...-|+||.|||+|.-+.|..||....+  .-.+|.+.         
T Consensus       713 fARiIg-EksFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNA---------  779 (888)
T KOG4236|consen  713 FARIIG-EKSFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNA---------  779 (888)
T ss_pred             ceeecc-hhhhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccc--hhHHhhcc---------
Confidence            999874 3445667899999999999987 7899999999999999999999999964432  22222221         


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                    .-..+..+|    ..+++.+.|||..+|+..-.+|.|.+..|.|||++.+
T Consensus       780 --------------aFMyPp~PW----~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  780 --------------AFMYPPNPW----SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             --------------ccccCCCch----hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence                          011223344    4578899999999999999999999999999999864

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.2e-44  Score=325.32  Aligned_cols=266  Identities=26%  Similarity=0.414  Sum_probs=210.6

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPS  101 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  101 (373)
                      .......++|++++.||+|+||.||+|.+..+|+.+|+|++.....   ....+.+|+.+++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            4445677999999999999999999999999999999998764321   123456799999999 599999999988654


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~D  176 (373)
                      ..+..+..++||||++ ++|.+++.    ....+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence            4345578999999996 68988764    235688999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCCCCccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      ||++..............|++.|+|||++..    ...++.++||||+||++|+|++|++||...........+..   .
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~  244 (286)
T cd06638         168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---N  244 (286)
T ss_pred             CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---c
Confidence            9998765433333344578999999999753    23478899999999999999999999976543222211110   0


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .                    .     +........+..+.+||.+||+.||++|||+.++++|+||
T Consensus       245 ~--------------------~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 P--------------------P-----PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             C--------------------C-----CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            0                    0     0000112346779999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-44  Score=321.40  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=207.2

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC----hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN----RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      +|++.+.||+|+||.||+|.+ .+|+.+|+|.+......    ......+.+|+.+++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            588999999999999999986 47889999998644321    22334567899999999999999999998     344


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ...++|+||+. ++|.+++.+.+.+++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            78999999996 69999998878899999999999999999999999999999999999999999999999999875421


Q ss_pred             ------CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          186 ------KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       186 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                            .........++..|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.......+....         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---------  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR---------  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc---------
Confidence                  1112234568899999999876 568899999999999999999999997654333222221100         


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                         .........++..+.++|++||+.+|++||++.++++||||
T Consensus       225 -------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         225 -------------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -------------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                               00112234578889999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.5e-44  Score=325.92  Aligned_cols=257  Identities=28%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHH-HhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|.++.+|+.||||++........ ..++..|+.+ ++.+.||||+++++++.     ..+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALF-----REGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCc
Confidence            479999999999999999999999999999999876543332 3345566665 56678999999999984     3366


Q ss_pred             EEEEeecCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          109 VYLVYELMDTDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .|++|||++|+|.+++..    ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999998887753    24689999999999999999999997 9999999999999999999999999998755


Q ss_pred             CCCCccccceeeccccCchhhhhcC---CCCCchhhhHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCChhhhc
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCC---DNYGTSIDVWSVGCIFAELLGRKPIFPGTE-CLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ... .......++..|+|||.+.+.   ..++.++|+||+||++|+|++|+.||.... ..+.+..+..   ..      
T Consensus       155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~------  224 (283)
T cd06617         155 VDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EP------  224 (283)
T ss_pred             ccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh---cC------
Confidence            322 112234678899999988642   346889999999999999999999996432 1122221111   00      


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                    .  +    ......++..+.++|.+||..+|.+||++.++++||||...
T Consensus       225 --------------~--~----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         225 --------------S--P----QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             --------------C--C----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence                          0  0    00012367889999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-44  Score=321.01  Aligned_cols=253  Identities=27%  Similarity=0.477  Sum_probs=208.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||.|+||.||+|.+..+++.+++|.+.....    ...+.+|+.+++.++||||+++++.+.     ....
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~   72 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTD   72 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCc
Confidence            3789999999999999999999999899999999864422    456789999999999999999999984     3467


Q ss_pred             EEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .|+++||++ ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            999999997 699999875 457899999999999999999999999999999999999999999999999998865443


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      ........++..|+|||++.+ ..++.++||||+||++|+|++|++||...+.......+..   .              
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~--------------  214 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---K--------------  214 (256)
T ss_pred             ccccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---C--------------
Confidence            323344567889999999876 5788999999999999999999999976543322211100   0              


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                 ..........++..+.++|.+||+.||++|||+.++++||||
T Consensus       215 -----------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         215 -----------PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             -----------CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                       000011123467789999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.2e-45  Score=330.43  Aligned_cols=264  Identities=26%  Similarity=0.472  Sum_probs=214.7

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ....+.|.....||.|+||.||++.+..++..||||.+....  ......+.+|+.+++.++||||+++++.+.     .
T Consensus        18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~   90 (292)
T cd06658          18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYL-----V   90 (292)
T ss_pred             CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----c
Confidence            455677787889999999999999999999999999986432  233445778999999999999999999984     3


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+..|+||||++ ++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus        91 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (292)
T cd06658          91 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS  169 (292)
T ss_pred             CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence            467999999996 588887754 578999999999999999999999999999999999999999999999999987554


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..........++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+.......           
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  237 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-----------  237 (292)
T ss_pred             cccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------
Confidence            33333345678999999999865 578899999999999999999999998765544433332211000           


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS  326 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  326 (373)
                                       .......+..+.++|.+||..||++|||+.++++||||.....++
T Consensus       238 -----------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         238 -----------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             -----------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence                             001124677899999999999999999999999999998654444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.9e-45  Score=322.98  Aligned_cols=254  Identities=28%  Similarity=0.450  Sum_probs=210.7

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.... ......+.+|++++++++||||+++++.+     ......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            589999999999999999999999999999999765432 24456778999999999999999999998     445789


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++|+||+. ++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999996 6999999877789999999999999999999999999999999999999999999999999987654332 


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+... ...+......                
T Consensus       155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~----------------  216 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRAKQET----------------  216 (258)
T ss_pred             cccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHHHHHhcc----------------
Confidence            2234567889999999876 568899999999999999999999998765321 1111110000                


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH--HHHhCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV--TEALQHPYM  319 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~--~eil~hp~~  319 (373)
                                 ......+..+..+.++|++||..||.+||++  .++++||||
T Consensus       217 -----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 -----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             -----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                       0011224467889999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-44  Score=325.32  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=202.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+.     ..+..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   74 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRI   74 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEE
Confidence            46889999999999999999999999999999986543 2333456788999999999999999999984     34678


Q ss_pred             EEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++||||+++ +|..+    ..+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++......  
T Consensus        75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            999999974 66433    35789999999999999999999999999999999999999999999999998755322  


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHH---HHHHHHhCCCChhhhcccCChh
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQL---KLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .....+++..|+|||++.+ ..++.++|+|||||++|+|++|..||.........   ........              
T Consensus       149 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  213 (279)
T cd06619         149 IAKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV--------------  213 (279)
T ss_pred             cccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh--------------
Confidence            2344578999999999876 56899999999999999999999999653211100   00000000              


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                           ...+      ........++.+.++|.+||+.||++||++.++++||||...
T Consensus       214 -----~~~~------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         214 -----DEDP------PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             -----ccCC------CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence                 0000      000113467889999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.9e-44  Score=320.12  Aligned_cols=257  Identities=27%  Similarity=0.447  Sum_probs=207.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc---cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+|++.+.||+|+||.||.+.+..+|..||||.+....   ........+.+|+.+++.+.||||+++++++....   .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence            57999999999999999999999999999999886432   12233456778999999999999999999874321   2


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..++++|||++ ++|.+++...+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            56899999996 69999998877899999999999999999999999999999999999999999999999999875432


Q ss_pred             C---CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          186 K---NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       186 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .   ........++..|+|||++.+ ..++.++|+|||||++|+|++|++||...+.......+   ...+.        
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~--------  226 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQPT--------  226 (265)
T ss_pred             ccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH---hcCCC--------
Confidence            1   112233467889999999876 56889999999999999999999999765433322211   11100        


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                        .....+.++..+.++|++|+. +|++||+++++++|||+.
T Consensus       227 ------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                              011224567789999999995 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-44  Score=322.84  Aligned_cols=258  Identities=28%  Similarity=0.459  Sum_probs=209.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC----hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN----RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      +|+..+.||+|+||.||++.+..+|+.+|+|++......    ......+.+|+.+++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            478889999999999999999999999999998754321    22345677899999999999999999998     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~  184 (373)
                      +..++|+||+. ++|.+++...+.+++..+..++.||+.||+|||++|++|+||+|+||+++.++ .+||+|||.+....
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            78999999997 69999998888899999999999999999999999999999999999998876 59999999987553


Q ss_pred             CCC----ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 GKN----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...    .......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+......        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  226 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--------  226 (268)
T ss_pred             cccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc--------
Confidence            321    11123467889999999876 57889999999999999999999999755433322222211100        


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                        .........+++.+.+++.+||..||++||++.++++||||.
T Consensus       227 ------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 ------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                              000112245678899999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-45  Score=351.09  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=204.8

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceee-cC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVM-MP  100 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~-~~  100 (373)
                      +.+..=.-+++|.+.|.+|||+.||+|++...|.+||+|++-..  ++.....+.+||.+|+.|+ |+|||.+++.. ..
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            44445566889999999999999999999988899999998654  5555666789999999998 99999999943 33


Q ss_pred             CCCCC-cceEEEEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCCCeEE
Q 017334          101 SHRRN-FKDVYLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKI  174 (373)
Q Consensus       101 ~~~~~-~~~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~~~~~kL  174 (373)
                      ....+ ...+.|+||||. |+|.+++..  ..+|++.++.+|++|+++|+++||..+  |||||||-|||||+.+|+.||
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence            22233 356899999997 799999974  356999999999999999999999998  999999999999999999999


Q ss_pred             cccCcccccCCCCccc---------cceeeccccCchhhhh--cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHH
Q 017334          175 CDFGLARTSNGKNQFM---------TEYVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQL  243 (373)
Q Consensus       175 ~Dfg~a~~~~~~~~~~---------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  243 (373)
                      ||||.|..........         -....|+.|+|||++.  .+...+.++|||+|||+||-|+....||...-....+
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl  267 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL  267 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE
Confidence            9999986432111000         0124589999999973  3457899999999999999999999999765211111


Q ss_pred             HHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          244 KLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      ..           ..             .+|         -++.++..+.+||+.||+.||.+||++.+++.+
T Consensus       268 ng-----------~Y-------------~~P---------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  268 NG-----------NY-------------SFP---------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             ec-----------cc-------------cCC---------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence            00           00             001         025678889999999999999999999888764

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-45  Score=352.26  Aligned_cols=287  Identities=25%  Similarity=0.331  Sum_probs=203.4

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCC-cEEEEEEc--------------ccc-ccChHHHHHHHHHHHHHhhCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETN-EKVAIKKI--------------NNA-FENRVDALRTLRELKLLRHLQHEN   90 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g-~~~aiK~~--------------~~~-~~~~~~~~~~~~E~~~l~~l~hpn   90 (373)
                      .+.++|++++.||+|+||+||+|..+... ...++|.+              .+. .........+.+|+.+++.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            45689999999999999999998765432 22222211              111 112223345678999999999999


Q ss_pred             eeeeceeecCCCCCCcceEEEEeecCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 017334           91 VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS-----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL  165 (373)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nil  165 (373)
                      |+++++++     ......|+|+++++++|.+++...     ......+++.++.||+.||+|||++||+||||||+|||
T Consensus       225 Iv~l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL  299 (501)
T PHA03210        225 ILKIEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF  299 (501)
T ss_pred             cCcEeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            99999998     444678999999999988877532     23456778899999999999999999999999999999


Q ss_pred             EcCCCCeEEcccCcccccCCCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCC-CCCCC--CchH
Q 017334          166 VNANCDLKICDFGLARTSNGKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP-IFPGT--ECLN  241 (373)
Q Consensus       166 l~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~~--~~~~  241 (373)
                      ++.++.+||+|||++....... ......+||..|+|||++.+ ..++.++|||||||++|+|++|.. |+.+.  ....
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9999999999999997654332 22334689999999999977 578999999999999999998874 44332  2334


Q ss_pred             HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCC-CCcccc--CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          242 QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPG-TPFSRL--YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                      .+..+...++....+...  .......++........ ......  ...++..+.++|.+||+.||.+|||+.|+|+|||
T Consensus       379 ~~~~~~~~~~~~~~~~p~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPD--PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHHhcccChhhcCC--cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            444444444432221110  00112222221111000 000000  1135667889999999999999999999999999


Q ss_pred             CCC
Q 017334          319 MSP  321 (373)
Q Consensus       319 ~~~  321 (373)
                      |..
T Consensus       457 f~~  459 (501)
T PHA03210        457 FSA  459 (501)
T ss_pred             hhc
Confidence            975

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.1e-44  Score=326.65  Aligned_cols=258  Identities=28%  Similarity=0.392  Sum_probs=209.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+     .....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            4799999999999999999999999999999998754322 23344667899999999999999999998     44467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ ++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999996 6999999888889999999999999999999999999999999999999999999999999886321100


Q ss_pred             ---------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          188 ---------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       188 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                                     .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....+..... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~-  233 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-  233 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence                           01112356788999999876 5789999999999999999999999987654443333222100 


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC---HHHHhCCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEALQHPYMSP  321 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~eil~hp~~~~  321 (373)
                                                 .+....+.+++.+.++|.+||+.||++||+   +.++++||||..
T Consensus       234 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         234 ---------------------------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ---------------------------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence                                       000111246788999999999999999997   799999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=322.52  Aligned_cols=310  Identities=29%  Similarity=0.447  Sum_probs=236.4

Q ss_pred             CCCCCCCCCCCCcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHH
Q 017334            4 PVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL   83 (373)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l   83 (373)
                      -.|.+.+|+.+|.|.+.+....  -.++|.++++||.|.|++||+|.|..+.+.||+|+++..   .......+.||++|
T Consensus        54 eqE~~~dY~kGGYHpV~IGD~F--~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL  128 (590)
T KOG1290|consen   54 EQEDPEDYRKGGYHPVRIGDVF--NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLL  128 (590)
T ss_pred             cccChhhhhcCCCceeeccccc--cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHH
Confidence            3578899999999999884433  138999999999999999999999999999999998643   22233457899999


Q ss_pred             hhCC-----C---CCeeeeceeecCCCCCCcceEEEEeecCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-C
Q 017334           84 RHLQ-----H---ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHS-A  152 (373)
Q Consensus        84 ~~l~-----h---pniv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~-~  152 (373)
                      ++++     |   ..||++++.|.... .+..++|+|+|+++.+|..+|...  +.++...++.|++||+.||.|||. .
T Consensus       129 ~~v~~~Dp~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec  207 (590)
T KOG1290|consen  129 QQVREGDPNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC  207 (590)
T ss_pred             HHHHhcCCCCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc
Confidence            9884     2   35999999997654 567899999999999999999754  579999999999999999999996 4


Q ss_pred             CccccCCCCCceEEcC----------------------------------------------------------------
Q 017334          153 NILHRDLKPGNLLVNA----------------------------------------------------------------  168 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~----------------------------------------------------------------  168 (373)
                      ||+|.||||+|||+..                                                                
T Consensus       208 gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~  287 (590)
T KOG1290|consen  208 GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEAS  287 (590)
T ss_pred             CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhh
Confidence            9999999999999820                                                                


Q ss_pred             --------------------------------------------------------------------------------
Q 017334          169 --------------------------------------------------------------------------------  168 (373)
Q Consensus       169 --------------------------------------------------------------------------------  168 (373)
                                                                                                      
T Consensus       288 l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s  367 (590)
T KOG1290|consen  288 LAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSS  367 (590)
T ss_pred             hcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------CCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHH
Q 017334          169 ----------------------NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAE  226 (373)
Q Consensus       169 ----------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~  226 (373)
                                            +-++||+|||-|...   ...++.-+.|..|+|||++++ ..|+..+||||++|+++|
T Consensus       368 ~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~---~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FE  443 (590)
T KOG1290|consen  368 PSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWV---HKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFE  443 (590)
T ss_pred             cCCccccccccccCCCCCCCccceeEEEeeccchhhh---hhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHH
Confidence                                  002455666655443   222344466888999999998 689999999999999999


Q ss_pred             HHhCCCCCCCC------CchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccC-------------CC
Q 017334          227 LLGRKPIFPGT------ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY-------------PD  287 (373)
Q Consensus       227 ll~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~  287 (373)
                      |+||..+|...      ...+.++.|+..+|..+......-  ..-++|++....-....-.+.|             ..
T Consensus       444 LaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~G--k~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e  521 (590)
T KOG1290|consen  444 LATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGG--KYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEE  521 (590)
T ss_pred             hhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcC--cchHhhhccccceecccccCCCcHHHHHHHHhCCCHH
Confidence            99999999654      355789999999998665433211  1122333322111111101111             11


Q ss_pred             CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          288 AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       288 ~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      ...++.+||.-||+.+|++|+||.++|+|||+.+...+
T Consensus       522 ~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  522 DAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             HHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            23457899999999999999999999999999977554

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-44  Score=318.01  Aligned_cols=254  Identities=27%  Similarity=0.475  Sum_probs=209.3

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc---ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE---NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +|+..+.||+|++|.||+|.+..+++.|++|.+.....   .......+.+|+.+++.++|+||+++++++     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            57888999999999999999998999999999865432   233445677899999999999999999988     4446


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..|+++||++ ++|.+++...+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||.+......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            7999999996 599999988778999999999999999999999999999999999999999999999999998765332


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      . ......++..|+|||.+.....++.++|+|||||++|+|++|.+||...........+...                 
T Consensus       156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-----------------  217 (258)
T cd06632         156 S-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS-----------------  217 (258)
T ss_pred             c-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-----------------
Confidence            2 2344568899999999866334889999999999999999999999765432222211110                 


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                  .......+.+++.+.+++++||+.+|.+||++.++++|||+
T Consensus       218 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         218 ------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                        00112234578889999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.4e-44  Score=317.91  Aligned_cols=252  Identities=29%  Similarity=0.448  Sum_probs=209.3

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++++.||+|+||.||+|.+..+++.+|+|.+............+.+|+.+++.++|||++++++.+     ...+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence            58999999999999999999999999999999976554445556778999999999999999999988     3446799


Q ss_pred             EEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCcccccCCC
Q 017334          111 LVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGK  186 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  186 (373)
                      +||||++ ++|.+++...  ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||.+......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            9999996 5999999763  3589999999999999999999999999999999999998655 5799999999765433


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      . ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+...                 
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-----------------  216 (256)
T cd08220         156 S-KAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-----------------  216 (256)
T ss_pred             c-cccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-----------------
Confidence            2 2233567889999999876 56889999999999999999999999776544433332210                 


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                   ........+++.+.+++.+||..||++|||+.++++||||
T Consensus       217 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         217 -------------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             -------------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                         0011223467889999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.7e-44  Score=318.55  Aligned_cols=258  Identities=29%  Similarity=0.442  Sum_probs=214.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||.|++|.||+|.+..+|+.|++|++...... .....+.+|+..+..++|+|++++++++.     ..+..
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeE
Confidence            4789999999999999999999999999999998765432 44556789999999999999999999984     34779


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++||||++ ++|.+++.....+++..+..++.||+.||+|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999997 7999999888889999999999999999999999 999999999999999999999999999988665444


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...........+..+....              
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------  219 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--------------  219 (264)
T ss_pred             CcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC--------------
Confidence            43345678899999999876 578899999999999999999999997764211111121111100              


Q ss_pred             HHHHhCCCCCCCCccccCCC-CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                   ....... ++..+.++|++||..+|++||++.++++||||+.
T Consensus       220 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         220 -------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             -------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence                         0011223 6788999999999999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=334.41  Aligned_cols=246  Identities=27%  Similarity=0.382  Sum_probs=204.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+.+++++.||+|.||.||.|..+.+ .+||+|.++.....   ...+.+|+++|++|+|+|||++++++.     ....
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~p  275 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEP  275 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCc
Confidence            45677899999999999999998633 47999998754222   235679999999999999999999994     3346


Q ss_pred             EEEEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +|||||||. |+|.++++.  ++.++..+...++.||++|++||+++++|||||-..||||+++..+||+|||+|+...+
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence            999999996 999999986  56799999999999999999999999999999999999999999999999999994432


Q ss_pred             CCc-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KNQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ..- ...+..-..-|.|||.+.. ..++.+||||||||+|+||+ .|+.||++.+..+.+..+.+....+.         
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------  425 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------  425 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------
Confidence            211 1111122455999999976 57999999999999999998 68899999999888888766332221         


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHh
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL  314 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil  314 (373)
                                           ++.+++++-+++..||+.+|++|||++.+.
T Consensus       426 ---------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  426 ---------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ---------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                                 256889999999999999999999998654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.1e-46  Score=302.65  Aligned_cols=283  Identities=33%  Similarity=0.618  Sum_probs=229.0

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  104 (373)
                      +.-.++|++++++|+|.|+.||.|+...+.++++||+++.     ....++.||+.||+.|. ||||++++++..++.. 
T Consensus        34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S-  107 (338)
T KOG0668|consen   34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES-  107 (338)
T ss_pred             ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc-
Confidence            4456899999999999999999999999999999999853     44567889999999998 9999999999976543 


Q ss_pred             CcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCcccc
Q 017334          105 NFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~  182 (373)
                        ....+|+||++. +...+.   ..++.-+++.++.+++.||.|||++||.|||+||.|++||... .++|+|+|+|..
T Consensus       108 --ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  108 --KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             --cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence              567899999975 544443   4688999999999999999999999999999999999998754 699999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHhCCCChhhhc--
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDLE--  259 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~--  259 (373)
                      -... ...+-.+.+..|--||.+..-+.|+.+-|+|||||+++.|+..+ |+|.|.+..+++-.|.+++|...-....  
T Consensus       183 YHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  183 YHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             cCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            6433 33455677899999999988888999999999999999998665 7789999999999999999974322111  


Q ss_pred             --ccCChhHHHHHHhCCCCCCCCccccCC-----CCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          260 --FIDNPKARKYIKSLPYTPGTPFSRLYP-----DAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       260 --~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                        ..-++.   +..-+......+|.+...     -+++++.|||.++|..|-.+|+||.|++.||||.+..
T Consensus       262 Y~i~Ldp~---~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  262 YQIDLDPQ---FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             HccCCChh---HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence              011122   112222333344443332     2579999999999999999999999999999998654

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.7e-44  Score=317.90  Aligned_cols=253  Identities=27%  Similarity=0.475  Sum_probs=208.9

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|.+.+.||+|+||.||++.++.+|..+|+|.+............+.+|+.+++.++|+||+++++.+     ......|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            58899999999999999999999999999999876533333445667899999999999999999988     4446799


Q ss_pred             EEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC-eEEcccCcccccCCC
Q 017334          111 LVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGK  186 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~-~kL~Dfg~a~~~~~~  186 (373)
                      +|+||+. ++|.+++....  .+++..+..++.||+.||.|||+.+++|+||||+||+++.++. +||+|||.+......
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999996 69999886543  4789999999999999999999999999999999999998865 699999998766544


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      ........|++.|+|||++.+ ..++.++|+||+||++++|++|..||...+.......+..   .              
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~--------------  217 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ---G--------------  217 (257)
T ss_pred             cccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---c--------------
Confidence            333344568899999999866 5688999999999999999999999976554333322211   0              


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                   ......+.++..+.++|.+||..+|++|||+.++++||||
T Consensus       218 -------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         218 -------------YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             -------------cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                         0111234567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.3e-44  Score=322.33  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=197.4

Q ss_pred             eeeccCceEEEEEEeCCCCcEEEEEEccccccChH-HHHHHHHHHHHHh---hCCCCCeeeeceeecCCCCCCcceEEEE
Q 017334           37 PIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV-DALRTLRELKLLR---HLQHENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~---~l~hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      .||+|+||.||++.+..+|+.+|+|.+.+...... ......+|..+++   ...||||+.+++.+.     ..+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence            48999999999999999999999999875433211 1222334444333   346999999999984     34679999


Q ss_pred             eecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcccc
Q 017334          113 YELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT  191 (373)
Q Consensus       113 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  191 (373)
                      |||+. ++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......  ..
T Consensus        76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~  153 (279)
T cd05633          76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH  153 (279)
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--cc
Confidence            99996 6999999888889999999999999999999999999999999999999999999999999986543222  23


Q ss_pred             ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHH
Q 017334          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK  271 (373)
Q Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      ...|+..|+|||.+.+...++.++||||+||++|+|++|..||......... .+....                    .
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~--------------------~  212 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT--------------------L  212 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh--------------------h
Confidence            3478999999999865456889999999999999999999999754322111 111100                    0


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                      .       ......+.+++.+.++|++||..||++|+     ++.++++||||+.+
T Consensus       213 ~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         213 T-------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             c-------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            0       00122345788999999999999999999     69999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-44  Score=323.13  Aligned_cols=257  Identities=28%  Similarity=0.469  Sum_probs=209.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|++|.||+|.++.+++.+|+|.+...... .....+.+|+.+++.++||||+++++.+.     ..+..
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   74 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDI   74 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEE
Confidence            4688899999999999999999999999999998765433 44556789999999999999999999983     34789


Q ss_pred             EEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ++++||++ ++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999998 6999999876 789999999999999999999999 99999999999999999999999999998654322


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC--LNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..  ....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.  ......+........          
T Consensus       155 ~~--~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------  221 (265)
T cd06605         155 LA--KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP----------  221 (265)
T ss_pred             Hh--hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC----------
Confidence            11  12577889999999876 5789999999999999999999999865421  111111111111000          


Q ss_pred             hHHHHHHhCCCCCCCCccccCCC-CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       ...... +++.+.++|.+||..||++|||+.++++||||+.+
T Consensus       222 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 -----------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             -----------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                             011112 67889999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.8e-44  Score=317.12  Aligned_cols=257  Identities=29%  Similarity=0.476  Sum_probs=210.6

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++|+||+++++..     .....++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            68999999999999999999999999999999976655545667788999999999999999999987     4446799


Q ss_pred             EEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          111 LVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      +|+||++ ++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999996 699999988778999999999999999999999999999999999999999999999999998765433221


Q ss_pred             ----ccceeeccccCchhhhhcCC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          190 ----MTEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       190 ----~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                          .....++..|+|||++.+..  .++.++||||+||++++|++|..||...+........... +.           
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~-----------  223 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH-----------  223 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC-----------
Confidence                12356788999999987632  3788999999999999999999999765422211111110 00           


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                  .+.   ......+++.+.++|++||+.+|.+||++.++++|||+
T Consensus       224 ------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         224 ------------KPP---IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             ------------CCC---CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                        000   00112357889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=335.87  Aligned_cols=257  Identities=23%  Similarity=0.432  Sum_probs=227.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+.+.+..||-|+||.|-++..+.....+|+|++++.. .+......+..|-++|..++.|.||++|..|     .+..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            56778889999999999999877665569999998754 3445556778999999999999999999999     66688


Q ss_pred             EEEEeecC-CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|++||-| +|.|+..++.++.|.+..++.++..+++|++|||++|||+|||||+|.|++.+|-+||.|||+|+......
T Consensus       495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            99999999 78999999999999999999999999999999999999999999999999999999999999999886554


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      . ..++||||.|.|||++++ ++.+.++|.||||+++|||++|.|||.+.+....+..|.+.+...              
T Consensus       575 K-TwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------------  638 (732)
T KOG0614|consen  575 K-TWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------------  638 (732)
T ss_pred             c-eeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------
Confidence            4 456899999999999988 688999999999999999999999999999999999988754321              


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                     .++..++..+.+||+++...+|.+|+.     +.+|-+|.||.++
T Consensus       639 ---------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  639 ---------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             ---------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence                           122456778999999999999999995     8999999999754

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=343.09  Aligned_cols=250  Identities=28%  Similarity=0.489  Sum_probs=209.3

Q ss_pred             eeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecC
Q 017334           37 PIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM  116 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~  116 (373)
                      .||+|.||+||.|+++.|...+|||.+...  +....+-...|+.+.++|+|.|||++++.+     ...+++-|.||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence            599999999999999999999999999543  333344566899999999999999999998     4447899999999


Q ss_pred             C-ccHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCCeEEcccCcccccCCCCcccc
Q 017334          117 D-TDLHQIIKSS-QAL--TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSNGKNQFMT  191 (373)
Q Consensus       117 ~-g~L~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~  191 (373)
                      + |+|.+++++. +++  +|..+-.+..||++||.|||++.|||||||-+|+||+. .|-+||+|||-++...+-++...
T Consensus       655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            6 7999999865 666  88999999999999999999999999999999999974 78999999999998888788888


Q ss_pred             ceeeccccCchhhhh-cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHH
Q 017334          192 EYVVTRWYRAPELLL-CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI  270 (373)
Q Consensus       192 ~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ++.||..|||||++. |.++|+.++|||||||.+.||.||+|||........  .+.++ |.                 .
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkV-Gm-----------------y  794 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKV-GM-----------------Y  794 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhh-cc-----------------e
Confidence            899999999999985 446799999999999999999999999965432221  11111 00                 0


Q ss_pred             HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      +..|        .++..+|.+++.||.+|+.+||.+||+|.++|+.||++.
T Consensus       795 KvHP--------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~  837 (1226)
T KOG4279|consen  795 KVHP--------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH  837 (1226)
T ss_pred             ecCC--------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence            0001        123457788999999999999999999999999999974

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3e-44  Score=323.07  Aligned_cols=255  Identities=23%  Similarity=0.383  Sum_probs=210.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+.|+.++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.+.||||+++++.+     .....
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   76 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTK   76 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCE
Confidence            4678899999999999999999999999999999875432 23445677899999999999999999998     44467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||++ ++|.+++.. +.+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            999999996 699998865 578999999999999999999999999999999999999999999999999997654433


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......++..|+|||++.+ ...+.++|+|||||++|+|++|.+||...+.......+..                   
T Consensus       156 ~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------------------  215 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK-------------------  215 (277)
T ss_pred             cccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-------------------
Confidence            33344567889999999876 5688999999999999999999999976553322221100                   


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                 .........++..+.+++.+||+.+|++||++.++++|+||..
T Consensus       216 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  258 (277)
T cd06640         216 -----------NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK  258 (277)
T ss_pred             -----------CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence                       0001122345677999999999999999999999999999964

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=298.79  Aligned_cols=272  Identities=23%  Similarity=0.318  Sum_probs=211.1

Q ss_pred             cceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeec
Q 017334           16 KHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK   95 (373)
Q Consensus        16 ~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   95 (373)
                      +.++.-..++..-++||++.+.||.|||+.|+++....++..||+|++....  ..+....++|++..++++|||+++++
T Consensus         7 ~l~~c~~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~   84 (302)
T KOG2345|consen    7 NLCVCRRGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLV   84 (302)
T ss_pred             ceeEeCCCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHH
Confidence            3344445666667899999999999999999999999999999999996543  45566788999999999999999999


Q ss_pred             eeecCCCCCCcceEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcC
Q 017334           96 DVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNA  168 (373)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~  168 (373)
                      +.............||+++|.. |+|.+.+..    +..+++.++..|+.+|++||++||+..  ++||||||.|||+++
T Consensus        85 dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~  164 (302)
T KOG2345|consen   85 DHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD  164 (302)
T ss_pred             HHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC
Confidence            9876553334567999999995 899988853    237999999999999999999999998  999999999999999


Q ss_pred             CCCeEEcccCcccccCCCCc---------cccceeeccccCchhhhhcC--CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 017334          169 NCDLKICDFGLARTSNGKNQ---------FMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAELLGRKPIFPGT  237 (373)
Q Consensus       169 ~~~~kL~Dfg~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~  237 (373)
                      ++.++|.|||.+....-.-.         ....-..|..|+|||.+...  ...+.++|||||||+||.|+.|..||...
T Consensus       165 ~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~  244 (302)
T KOG2345|consen  165 SGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI  244 (302)
T ss_pred             CCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence            99999999999865431110         11122458889999998542  24578999999999999999999999432


Q ss_pred             CchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      -         . .|.    .+...            .......+.+. ..+|..+.+||+.||+.||.+||++.+++.+
T Consensus       245 ~---------~-~Gg----SlaLA------------v~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  245 Y---------Q-QGG----SLALA------------VQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             h---------h-cCC----eEEEe------------eeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1         0 000    00000            00001111122 2278899999999999999999999999864

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-43  Score=320.75  Aligned_cols=258  Identities=25%  Similarity=0.484  Sum_probs=210.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+|...+.||+|++|.||++.+..+++.+++|++....  ......+.+|+.+++.++||||+++++.+..     .+..
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~   91 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDEL   91 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeE
Confidence            45666789999999999999999999999999885432  2234457789999999999999999998843     4678


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++|+||+. ++|.+++.. +++++.++..++.||+.||+|||++|++||||+|+||+++.++.++|+|||.+........
T Consensus        92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            99999996 699998877 6799999999999999999999999999999999999999999999999998875543333


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......|++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+.......+...   .               
T Consensus       171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~---------------  231 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---L---------------  231 (285)
T ss_pred             ccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---C---------------
Confidence            3344568899999999876 56889999999999999999999999776544443333221   0               


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                           +     +.......++..+.++|++||+.+|++||++.++++||||....+
T Consensus       232 -----~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         232 -----P-----PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             -----C-----CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                 0     000111336788999999999999999999999999999987544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.7e-44  Score=318.51  Aligned_cols=249  Identities=24%  Similarity=0.432  Sum_probs=205.2

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecC
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM  116 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~  116 (373)
                      ||.|++|.||+|.+..+++.+|+|++.+... .......+.+|+.+++.++||||+++++.+     .....+|+|+||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            6899999999999999999999999976433 233445678999999999999999999988     4446799999999


Q ss_pred             C-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceee
Q 017334          117 D-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV  195 (373)
Q Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  195 (373)
                      + ++|.+++.+...+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~  154 (262)
T cd05572          76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCG  154 (262)
T ss_pred             CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccC
Confidence            6 6999999887889999999999999999999999999999999999999999999999999997664332 2233477


Q ss_pred             ccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhC
Q 017334          196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC--LNQLKLIINILGSRREEDLEFIDNPKARKYIKSL  273 (373)
Q Consensus       196 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      ++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||.....  ......+..  +.                     
T Consensus       155 ~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---------------------  210 (262)
T cd05572         155 TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--GN---------------------  210 (262)
T ss_pred             CcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--cC---------------------
Confidence            899999999865 5688999999999999999999999977652  222222211  00                     


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                            .........++.+.++|.+||..||++|++     +.|+++||||+++
T Consensus       211 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         211 ------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             ------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence                  000112334778999999999999999999     9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.4e-44  Score=319.16  Aligned_cols=259  Identities=27%  Similarity=0.466  Sum_probs=206.7

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC--------hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN--------RVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+......        ......+.+|+.+++.++|||++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            588999999999999999999999999999988642111        11123466899999999999999999988    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                       ...+..++||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence             34467999999996 6999999888889999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCC--ccccceeeccccCchhhhhcCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          182 TSNGKN--QFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       182 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ......  .......++..|+|||.+.... .++.++|+||||+++++|++|..||...+.......+..   ..     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~-----  228 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---KR-----  228 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---cc-----
Confidence            543211  1123446788999999987533 478999999999999999999999965443322221110   00     


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                      .. ........+.++..+.++|.+||..+|.+||++.++++||||
T Consensus       229 ----------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 ----------------SA-PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----------------cC-CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                            00 000112234578889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-43  Score=323.77  Aligned_cols=257  Identities=24%  Similarity=0.312  Sum_probs=198.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC----------------CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCee
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE----------------TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI   92 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~----------------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   92 (373)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++.... .......+.+|+.+++.++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence            4789999999999999999998643                34479999987542 333455678999999999999999


Q ss_pred             eeceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 017334           93 ALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ-------------------ALTNDHCQYFLFQLLRGLKYLHSA  152 (373)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~  152 (373)
                      ++++++..     .+..++||||+. |+|.+++....                   .+++..+..++.||+.||.|||++
T Consensus        83 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  157 (304)
T cd05096          83 RLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL  157 (304)
T ss_pred             EEEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            99999843     356999999996 69999886432                   367788999999999999999999


Q ss_pred             CccccCCCCCceEEcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-
Q 017334          153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-  229 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  229 (373)
                      ||+||||||+|||++.++.+||+|||++........  ......++..|+|||++.+ ..++.++|||||||++|+|++ 
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999875432221  1122345778999999876 568999999999999999985 


Q ss_pred             -CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC
Q 017334          230 -RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI  308 (373)
Q Consensus       230 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~  308 (373)
                       +..||...+..+....+........                       ........+.++..+.+|+.+||..||++||
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP  293 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQG-----------------------RQVYLFRPPPCPQGLYELMLQCWSRDCRERP  293 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhcc-----------------------ccccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence             5678876654443333222110000                       0000111245678899999999999999999


Q ss_pred             CHHHHhC
Q 017334          309 SVTEALQ  315 (373)
Q Consensus       309 t~~eil~  315 (373)
                      |+.++.+
T Consensus       294 s~~~i~~  300 (304)
T cd05096         294 SFSDIHA  300 (304)
T ss_pred             CHHHHHH
Confidence            9999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.3e-44  Score=316.16  Aligned_cols=249  Identities=28%  Similarity=0.451  Sum_probs=206.1

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++.+.||.|+||.||++.+..+++.+|+|.++.... ......+.+|+.+++.++||||+++++.+     ...+.+|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence            58999999999999999999999999999999865432 23445677899999999999999999998     4457899


Q ss_pred             EEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          111 LVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +||||++ ++|.+++..  ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999996 699888864  2458999999999999999999999999999999999999999999999999987664444


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||++.+ ..++.++|+||+|+++|+|++|.+||...+.......+..  +.               
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~~---------------  216 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--GS---------------  216 (255)
T ss_pred             cccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--CC---------------
Confidence            33445678899999999876 5688999999999999999999999977654333322211  00               


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                   .......++..+.+||.+||+.||++||++.++++-
T Consensus       217 -------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -------------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                         011123467789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.7e-44  Score=320.85  Aligned_cols=253  Identities=32%  Similarity=0.537  Sum_probs=211.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~  107 (373)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++ ||||+++++++     ...+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            479999999999999999999999999999999876432 3333456778999999998 99999999998     4446


Q ss_pred             eEEEEeecC-CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..++|||++ +++|.+++...+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            799999999 5799999998889999999999999999999999999999999999999999999999999998755432


Q ss_pred             C--------------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017334          187 N--------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI  246 (373)
Q Consensus       187 ~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  246 (373)
                      .                    .......++..|+|||++.+ ..++.++|+|||||+++++++|.+||...+.......+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            2                    11223456889999999876 56889999999999999999999999877643333322


Q ss_pred             HHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH----HHHhCCCCC
Q 017334          247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV----TEALQHPYM  319 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~eil~hp~~  319 (373)
                      ...                               .......+++.+.+||++||+.||++||++    .++++||||
T Consensus       235 ~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         235 LKL-------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             Hhc-------------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            210                               001224467889999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-43  Score=314.57  Aligned_cols=253  Identities=30%  Similarity=0.500  Sum_probs=213.9

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|.+.+.||.|+||.||++.+..++..+|+|++............+.+|+++++.++|||++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            5899999999999999999999999999999997765555666678899999999999999999999843     37799


Q ss_pred             EEeecCC-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          111 LVYELMD-TDLHQIIKSS----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +|+|+++ ++|.+.+...    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            9999997 5999988763    6799999999999999999999999999999999999999999999999999976654


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .........+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+..........   .             
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~-------------  218 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK---G-------------  218 (258)
T ss_pred             CcceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc---C-------------
Confidence            4434455678999999999876 5688999999999999999999999976653332222211   0             


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                    ........++..+.+++++||..+|++|||+.++|+||||
T Consensus       219 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         219 --------------QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                          0111223567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-44  Score=325.14  Aligned_cols=256  Identities=24%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ...|+.++.||+|+||.||+|.+..+|..||+|.+...... .....+.+|+.+++.++||||+++++.+.     ..+.
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTK   76 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCc
Confidence            46788899999999999999999999999999998754332 23456778999999999999999999984     3467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        77 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          77 LWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             eEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            999999997 688888764 578999999999999999999999999999999999999999999999999987654433


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+..                   
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------------------  215 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK-------------------  215 (277)
T ss_pred             hhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc-------------------
Confidence            33334467889999999876 5788999999999999999999999865433222211100                   


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                 .........++..+.++|.+||+.+|++||++.++++||||..+
T Consensus       216 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         216 -----------NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             -----------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence                       00011123467789999999999999999999999999998643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-44  Score=319.73  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=208.3

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC---CCCeeeeceeecCCCCCCcc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ---HENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~~~  107 (373)
                      .|++++.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.+.   |||++++++++.     ...
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCC
Confidence            58889999999999999999999999999999875432 223345678999999886   999999999883     346


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..|+||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            7999999996 599988865 47899999999999999999999999999999999999999999999999999766544


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      ........|+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+..   .              
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~--------------  217 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---S--------------  217 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---C--------------
Confidence            43344557889999999987656678999999999999999999999976543222111100   0              


Q ss_pred             HHHHHhCCCCCCCCccccCC-CCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYP-DAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                   ....+.. .++..+.+++.+||+.||++||++.++++|+||+..
T Consensus       218 -------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         218 -------------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             -------------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence                         0001111 267789999999999999999999999999999754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.9e-44  Score=324.30  Aligned_cols=259  Identities=24%  Similarity=0.453  Sum_probs=210.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ...|.....||+|+||.||+|.+..+++.||+|++......  ....+.+|+.+++.+.||||+++++.+.     ..+.
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~   92 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEE   92 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCe
Confidence            34556667899999999999999999999999998643322  2345678999999999999999999984     3467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+|+||++ ++|.+++.. ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        93 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          93 LWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999999997 588877654 578999999999999999999999999999999999999999999999999987554333


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......++..|+|||++.+ ..++.++|+||+||++|+|++|++||...+..+....+..   ..              
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~--------------  233 (297)
T cd06659         172 PKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SP--------------  233 (297)
T ss_pred             ccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cC--------------
Confidence            33345678999999999876 5689999999999999999999999976654443332211   00              


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                                 .........+++.+.++|.+||+.+|.+||++.++++||||.....
T Consensus       234 -----------~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         234 -----------PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             -----------CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence                       0011122456788999999999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.5e-44  Score=322.60  Aligned_cols=261  Identities=24%  Similarity=0.416  Sum_probs=204.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+|...+.||+|+||.||++.+..+|+.+|+|.+...... .....+.+|+.++.++. ||||+++++++..     .+.
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~   77 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGD   77 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCc
Confidence            4677788999999999999999999999999998754333 34456778999999996 9999999998843     366


Q ss_pred             EEEEeecCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          109 VYLVYELMDTDLHQIIK-----SSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      .+++|||+++++.++..     ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++..
T Consensus        78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            89999999876655432     236799999999999999999999975 999999999999999999999999999875


Q ss_pred             cCCCCccccceeeccccCchhhhhcC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...... .....++..|+|||++.+.  ..++.++||||+||++|+|++|++||....  .....+........      
T Consensus       158 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~------  228 (288)
T cd06616         158 LVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDP------  228 (288)
T ss_pred             hccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCC------
Confidence            432221 1233678899999998764  368899999999999999999999997543  11122211111000      


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       ..........++..+.+||.+||+.||++|||+.++++||||...
T Consensus       229 -----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         229 -----------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             -----------------CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence                             000011123478889999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-43  Score=318.86  Aligned_cols=245  Identities=20%  Similarity=0.218  Sum_probs=199.4

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHH-HHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD-ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      ..||+|++|.||+|..  +|+.||||++......... ...+.+|+.++++++||||+++++++.... .....+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5689999999999987  6899999999765433322 345679999999999999999999985421 22356899999


Q ss_pred             cCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          115 LMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      |++ |+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......   ..
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---cc
Confidence            997 6999999888889999999999999999999998 499999999999999999999999999987653321   23


Q ss_pred             eeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHH
Q 017334          193 YVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK  271 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      ..++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......                   
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------------  240 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS-------------------  240 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC-------------------
Confidence            4678999999998652 46899999999999999999999999877655544433221000                   


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                .......++.+++||.+||+.||++|||+.++++
T Consensus       241 ----------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        241 ----------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ----------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                      0111246788999999999999999999999985

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-43  Score=324.08  Aligned_cols=257  Identities=28%  Similarity=0.426  Sum_probs=209.6

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ....+|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++..     
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----   86 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----   86 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----
Confidence            44578999999999999999999999999999999986443 233444567899999999999999999999843     


Q ss_pred             cceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ....|+|+||+.|++.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....
T Consensus        87 ~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          87 EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             CCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            466899999999998887764 4578999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ..    ....+++.|+|||++.+  ...++.++||||+|+++|+|++|.+||.+.+.......+..  +..         
T Consensus       167 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~---------  231 (307)
T cd06607         167 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NDS---------  231 (307)
T ss_pred             CC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--CCC---------
Confidence            22    23467889999998752  34578899999999999999999999977654333222211  000         


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                        ........+..+.++|.+||..||++||++.++++||||..
T Consensus       232 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         232 ------------------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             ------------------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                              00001225677999999999999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=312.06  Aligned_cols=253  Identities=30%  Similarity=0.505  Sum_probs=214.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+............+.+|+++++.++|||++++++++     ...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence            58899999999999999999999999999999987655445566788999999999999999999998     3346799


Q ss_pred             EEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          111 LVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      ++|||++ ++|.+++.....+++..++.++.|++.||.+||++||+||||||+||+++.++.++|+|||.+.........
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999997 599999988888999999999999999999999999999999999999999999999999999876544443


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...+.......+..                     
T Consensus       156 ~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------------  213 (254)
T cd06627         156 DASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---------------------  213 (254)
T ss_pred             ccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---------------------
Confidence            445578899999999876 4588999999999999999999999976543222221110                     


Q ss_pred             HHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                               .......+.++..+.+++.+||..+|++||++.++++||||
T Consensus       214 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         214 ---------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ---------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                     00112234567889999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=8.9e-44  Score=319.97  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=202.5

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecC
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM  116 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~  116 (373)
                      ||+|+||+||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++     +..+..|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            68999999999999999999999998654322 22334556899999999999999999998     4446799999999


Q ss_pred             C-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccce
Q 017334          117 D-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY  193 (373)
Q Consensus       117 ~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~  193 (373)
                      + ++|.+++....  .+++.+++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||.+..... .......
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~  154 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGR  154 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccc
Confidence            7 69999987655  799999999999999999999999999999999999999999999999999875532 2223345


Q ss_pred             eeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhC
Q 017334          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL  273 (373)
Q Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (373)
                      .++..|+|||++.+ ..++.++|+||+||++|+|++|+.||...........+....                       
T Consensus       155 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------  210 (277)
T cd05577         155 AGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-----------------------  210 (277)
T ss_pred             cCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-----------------------
Confidence            67889999999876 458899999999999999999999997654321111111100                       


Q ss_pred             CCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                      .    .......+.+++.+.++|.+||+.||++||     ++.++++||||..+
T Consensus       211 ~----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         211 L----EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             c----cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence            0    001112345688999999999999999999     88999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.7e-43  Score=318.24  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=197.8

Q ss_pred             eeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHH---HHHHhhCCCCCeeeeceeecCCCCCCcceEEEE
Q 017334           37 PIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRE---LKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E---~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      .||+|+||.||+|.+..+|+.||+|.+.+..... ........|   +.+++...||||+++++.+     ......|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            4899999999999999999999999987543221 111122233   3445556799999999998     444679999


Q ss_pred             eecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcccc
Q 017334          113 YELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT  191 (373)
Q Consensus       113 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  191 (373)
                      |||+. ++|.+++...+.+++.+++.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++.......  ..
T Consensus        76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~  153 (278)
T cd05606          76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PH  153 (278)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--Cc
Confidence            99996 6999999887889999999999999999999999999999999999999999999999999987543222  23


Q ss_pred             ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHH
Q 017334          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK  271 (373)
Q Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      ...|+..|+|||++.+...++.++||||+||++|+|++|+.||.+.............                     .
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------------~  212 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------------------L  212 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh---------------------h
Confidence            4578999999999876556889999999999999999999999765322111110000                     0


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                      .       .........++.+.++|.+||..||.+|+     ++.++++||||...
T Consensus       213 ~-------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         213 T-------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             c-------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            0       00112234678899999999999999999     99999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-43  Score=319.57  Aligned_cols=250  Identities=23%  Similarity=0.363  Sum_probs=202.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCC-----cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETN-----EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ++|++++.||+|+||.||+|.+...+     ..+|+|.+.... .......+.+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----   78 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----   78 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----
Confidence            57999999999999999999876555     679999986443 2333446778999999999999999999983     


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                      .....|++|||++ ++|.+++...                ..+++.++..++.||+.||+|||++|++|+||||+||+++
T Consensus        79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~  158 (283)
T cd05048          79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG  158 (283)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence            3466899999996 7999998754                4578889999999999999999999999999999999999


Q ss_pred             CCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017334          168 ANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLK  244 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  244 (373)
                      .++.+||+|||++.......  .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999987543221  12234456788999999876 568999999999999999997 999998766544433


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+...                              ........+++.+.+|+.+||+.||.+||++.+++++
T Consensus       238 ~i~~~------------------------------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSR------------------------------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcC------------------------------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33210                              0001124578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.6e-44  Score=332.92  Aligned_cols=251  Identities=25%  Similarity=0.362  Sum_probs=196.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCC-----cEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETN-----EKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSH  102 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|++..+|     ..||+|++...... .....+.+|+.+++.+ +|+||+++++.+.   
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACT---  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEec---
Confidence            357999999999999999999865443     57999999754332 2345677899999999 7999999999984   


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhc------------------------------------------------------
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSS------------------------------------------------------  127 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------------  127 (373)
                        ....+++||||+. |+|.+++...                                                      
T Consensus       113 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         113 --HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             --CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence              4467999999996 7999888532                                                      


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc--c
Q 017334          128 ----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ--F  189 (373)
Q Consensus       128 ----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~  189 (373)
                                      .++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                            2477888999999999999999999999999999999999999999999999875432211  1


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...........+...                   
T Consensus       271 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~-------------------  330 (374)
T cd05106         271 KGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR-------------------  330 (374)
T ss_pred             ccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc-------------------
Confidence            112234567999999876 578999999999999999996 99999765433322222110                   


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                         ...       ......+++++.++|.+||+.||++|||+.++++
T Consensus       331 ---~~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         331 ---GYQ-------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ---ccC-------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               000       0011235788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-43  Score=321.80  Aligned_cols=258  Identities=27%  Similarity=0.468  Sum_probs=210.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|.+++.||+|+||.||++.+..++..||+|.+.....  .....+.+|+.+++.++|||++++++.+.     ..+.
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~   90 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYL-----VGDE   90 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCc
Confidence            4799999999999999999999998999999999864322  23345778999999999999999999984     3467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+|+||++ ++|.+++.+ ..+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            999999996 699998875 468899999999999999999999999999999999999999999999999887554433


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......+++.|+|||.+.+ ..++.++|+||+||++|++++|.+||...+.......+..  +                
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~----------------  230 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--N----------------  230 (293)
T ss_pred             cccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--C----------------
Confidence            33344578889999999876 5688999999999999999999999976543322211100  0                


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                                ..+.......++..+.++|++||..+|++||++.+++.|+||....
T Consensus       231 ----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         231 ----------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ----------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                      0000011234577899999999999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-43  Score=319.70  Aligned_cols=265  Identities=24%  Similarity=0.344  Sum_probs=209.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||++.+..+|+.||+|++..... ......+.+|+++++.++||||+++++.+.     ..+.+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEE
Confidence            689999999999999999999999999999998865422 333456789999999999999999999984     44779


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++||||++ ++|.+++...+.+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... 
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            99999996 6999998887889999999999999999999997 69999999999999999999999999998654221 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                       ......|+..|+|||++.+ ..++.++|+||+||++|+|++|..||............                .....
T Consensus       158 -~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~----------------~~~~~  219 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD----------------PMGIL  219 (284)
T ss_pred             -ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh----------------hhHHH
Confidence             1234578999999999876 57889999999999999999999999765432110000                00000


Q ss_pred             HHHHhCCCCCCCCccccC-CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~-~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ...........   .... ..++..+.+||.+||+.||++|||+.++++|+||...
T Consensus       220 ~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         220 DLLQQIVQEPP---PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHHHhhccC---CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            00000000000   0011 1256789999999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=335.46  Aligned_cols=244  Identities=27%  Similarity=0.464  Sum_probs=204.6

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..+.|.+...+|.|+|+.|..+.+..+++.+++|++.+...+      ..+|+.++... +||||+++.+++     .+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~-----~~~  388 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVY-----EDG  388 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeeccee-----cCC
Confidence            568899999999999999999999999999999999876322      22477666655 599999999999     666


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-cCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV-NANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill-~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+.|+|||.+. +.+.+.+...+.+. .++..|+++|+.|+.|||++|+|||||||+|||+ ++.++++|+|||.++...
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            88999999997 56777776656566 8888999999999999999999999999999999 699999999999998664


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..   ..+.+-|..|.|||++.. ..|+.++||||||++||+|++|+.||........   +...++.+.          
T Consensus       468 ~~---~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~----------  530 (612)
T KOG0603|consen  468 RS---CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPK----------  530 (612)
T ss_pred             hh---hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCc----------
Confidence            33   445577899999999974 7999999999999999999999999987655411   211111111          


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                         ....+|+.+++||++||++||.+|+++.+++.||||
T Consensus       531 -------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 -------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                               114589999999999999999999999999999999

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2e-43  Score=315.74  Aligned_cols=249  Identities=18%  Similarity=0.260  Sum_probs=199.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.++.... ......+.+|+.+++.++||||+++++++.     ..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   78 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RG   78 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cC
Confidence            57999999999999999999765   4567899999876432 233456789999999999999999999984     34


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +..++||||++ |+|.+++... ..+++.+++.++.||+.||+|||++|++||||||+|||++.++.+||+|||.+....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            67999999997 6899888764 578999999999999999999999999999999999999999999999999875432


Q ss_pred             CCCc-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKNQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .... ......++..|+|||.+.+ ..++.++||||+||++|+++ +|.+||.+.+..+....+.+...           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-----------  226 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-----------  226 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-----------
Confidence            2111 1112234578999999876 67899999999999999977 59999987765544443321000           


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                         ....+.++..+.+++.+||+.+|.+||++.++++
T Consensus       227 -------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         227 -------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                               0112446778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.8e-43  Score=313.60  Aligned_cols=250  Identities=28%  Similarity=0.435  Sum_probs=199.6

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      ...||+|+||.||+|.+..++..||+|.+....  ......+.+|+.+++.++|+||+++++++.     ..+..++|+|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   85 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFME   85 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEe
Confidence            457999999999999999999999999886542  233456779999999999999999999983     3467999999


Q ss_pred             cCC-ccHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCCeEEcccCcccccCCCCcc
Q 017334          115 LMD-TDLHQIIKSS-QAL--TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       115 ~~~-g~L~~~l~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      |+. ++|.+++... ..+  ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||.+.........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            996 6999998764 445  88889999999999999999999999999999999976 678999999998765433333


Q ss_pred             ccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          190 MTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|.+||................                  
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~------------------  227 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF------------------  227 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh------------------
Confidence            3445678999999998653 347899999999999999999999986543211110000000                  


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                .....+...+++.+.+|+++||+.+|.+|||+.+++.||||
T Consensus       228 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         228 ----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                      00011234577889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-43  Score=332.29  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=196.5

Q ss_pred             CceeeeeeeeccCceEEEEEEe-----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVN-----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHR  103 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  103 (373)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|+++.... ......+.+|+.+++.+ +||||+++++++     
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            4799999999999999999974     45677899999864432 23345677899999999 799999999998     


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcC------------------------------------------------------
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQ------------------------------------------------------  128 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~------------------------------------------------------  128 (373)
                      ......++||||++ |+|.+++....                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            44467899999996 79998886421                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          129 ---------------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       129 ---------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                                           .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                                 46788899999999999999999999999999999999999999999999997653322


Q ss_pred             cc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          188 QF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       188 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..  .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...............               
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---------------  332 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE---------------  332 (375)
T ss_pred             cccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh---------------
Confidence            11  112234567999999976 578999999999999999997 88999765433322222110               


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                             ...       .......+.++.+||.+||+.||++||++.++++.
T Consensus       333 -------~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         333 -------GYR-------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -------Ccc-------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                   000       00112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.4e-43  Score=311.38  Aligned_cols=251  Identities=25%  Similarity=0.429  Sum_probs=210.2

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|++.+.||+|+||.||++.+..+|+.+|+|.+...........++.+|+.+++.++|+||+++++++..     ....|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            5899999999999999999999999999999997665555556677899999999999999999999843     37799


Q ss_pred             EEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          111 LVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +|+||++ ++|.+++..    ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            9999996 599888865    35689999999999999999999999999999999999999999999999999976643


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .  ......+++.|+|||.+.+ ..++.++|+||||+++++|++|++||...+.......+..                 
T Consensus       156 ~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----------------  215 (256)
T cd08530         156 N--MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-----------------  215 (256)
T ss_pred             C--CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------
Confidence            3  2334567899999999876 6788999999999999999999999987654332222211                 


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                   ..+.......+..++++|.+||+.+|++||++.++++||++
T Consensus       216 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         216 -------------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -------------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                         00111223467789999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-43  Score=311.54  Aligned_cols=256  Identities=26%  Similarity=0.442  Sum_probs=208.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc---cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+....   ........+.+|+.+++.++|+||+++++.+...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence            57999999999999999999999999999999875432   1223445677899999999999999999987442   22


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..+++++||+. ++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            56899999996 69999998877899999999999999999999999999999999999999999999999999975432


Q ss_pred             C---CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          186 K---NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       186 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .   ........++..|+|||.+.+ ...+.++|+|||||++|+|++|++||...........+   ...+         
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~---------  225 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQP---------  225 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCC---------
Confidence            1   112234568899999999876 56889999999999999999999999765433322221   1110         


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                       ......+.+++.+.++|.+||. +|.+||++.++++|||.
T Consensus       226 -----------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         226 -----------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             -----------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                             0012235678899999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-44  Score=330.31  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=211.7

Q ss_pred             Ccee-eeeeeeccCceEEEEEEeCCCCcEEEEEEccccc--cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYV-PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF--ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~-~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|- ....||+|+|-+||+|.|..+|..||.-.++...  .......++..|+.+|+.|+||||+++++.+.....   
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---  115 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---  115 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---
Confidence            4443 3457999999999999999999999977665433  344555788999999999999999999999976543   


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCC-CCeEEcccCcccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNAN-CDLKICDFGLART  182 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~~-~~~kL~Dfg~a~~  182 (373)
                      ..+.+|+|.+. |+|..++++.++++...++.|++||+.||.|||++.  |+|||||-+||+|+.+ |.|||+|+|+|..
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            67999999995 899999999999999999999999999999999996  9999999999999865 7899999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ....  .....+|||.|||||++.  ..|+..+||||||++++||+|+..||..-....+  ...++.....+..+..+ 
T Consensus       196 ~r~s--~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~kV-  268 (632)
T KOG0584|consen  196 LRKS--HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALSKV-  268 (632)
T ss_pred             hhcc--ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhhcc-
Confidence            6433  345589999999999986  4699999999999999999999999865443333  23333333332222222 


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                               -.|++++||.+||.. .++|+|+.|+|+||||..
T Consensus       269 -------------------------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  269 -------------------------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             -------------------------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                                     357799999999999 999999999999999975

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-43  Score=317.01  Aligned_cols=256  Identities=23%  Similarity=0.394  Sum_probs=210.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+-|++++.||+|+||.||+|.+..++..+|+|++..... ......+.+|+.+++.++||||+++++.+.     ....
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~   76 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTK   76 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCe
Confidence            4568889999999999999999999999999999864432 233456778999999999999999999983     4467


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .|+||||++ ++|.+++.. ..+++..+..++.|++.|+.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        77 ~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            999999997 588888865 578999999999999999999999999999999999999999999999999987654433


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......++..|+|||.+.+ ...+.++|+||+||++|+|++|.+||...........+..   .               
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~---------------  216 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---N---------------  216 (277)
T ss_pred             hhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc---C---------------
Confidence            33344567889999999876 5678899999999999999999999976543322222111   0               


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                  ........++..+.++|.+||+.+|.+||++.++++||||...
T Consensus       217 ------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         217 ------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ------------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                        0011223467889999999999999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-42  Score=314.57  Aligned_cols=265  Identities=25%  Similarity=0.387  Sum_probs=206.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|+.++.||.|++|.||+|.+..+++.+|+|.+...... ....++.+|+++++.++||||+++++++...   ..+.+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~   76 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI   76 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence            4789999999999999999999999999999998754332 3445678999999999999999999988543   23578


Q ss_pred             EEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          110 YLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      |+||||++ ++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999996 688877643    3568999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc--hHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC--LNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ...  .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.....  .................      
T Consensus       157 ~~~--~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  227 (287)
T cd06621         157 NSL--AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE------  227 (287)
T ss_pred             ccc--cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh------
Confidence            222  123457888999999876 5788999999999999999999999976532  11111111111100000      


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                ..   ..  ...-...++.+.++|.+||..||++|||+.|+++||||...
T Consensus       228 ----------~~---~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         228 ----------LK---DE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             ----------hc---cC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence                      00   00  00001245679999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=301.37  Aligned_cols=257  Identities=23%  Similarity=0.395  Sum_probs=209.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcceE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +.+.+..||+|+-|+|++++.+.+|...|||.+.+. .+....++++..+.++.... +|+||+.+++|..+     ..+
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV  166 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDV  166 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chH
Confidence            345678899999999999999999999999999865 55566678888888877665 99999999999765     458


Q ss_pred             EEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|.||.|..-+..+++. .++++|.-+=++...++.||.||.. +||+|||+||+|||+|..|++||||||++....+. 
T Consensus       167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-  245 (391)
T KOG0983|consen  167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-  245 (391)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc-
Confidence            89999998655555543 3679999999999999999999985 58999999999999999999999999999765332 


Q ss_pred             ccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHHHhCCCChhhhcccCCh
Q 017334          188 QFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTE-CLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ...+...|-+.|||||.+..  ...|+.++||||||+.++||.||+.||.+.+ ..+.+..+.+   .            
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~------------  310 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---E------------  310 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---c------------
Confidence            22344577899999999853  3468999999999999999999999998853 4455555544   1            


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                              .|     +....-.++|+.+++|+..||.+|+.+||.-.++|+|||+..+
T Consensus       311 --------eP-----P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  311 --------EP-----PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             --------CC-----CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence                    11     1111113478999999999999999999999999999998754

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1e-42  Score=314.91  Aligned_cols=257  Identities=24%  Similarity=0.416  Sum_probs=201.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC-----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE-----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~-----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||.||+|.++.     .+..||+|.+..... ......+.+|+.+++.++||||+++++++.    
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----   79 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS----   79 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            4789999999999999999997652     355899998865432 233445778999999999999999999984    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS----------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                       .....|+||||+. |+|.+++...          ..++...+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence             3356899999996 7999999652          234567888999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017334          173 KICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  249 (373)
                      ||+|||+++........  .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.. 
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-  236 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD-  236 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-
Confidence            99999998754322111  112234677999999876 568999999999999999997 7889977654443332211 


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC------CCCCCCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ------HPYMSPL  322 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~------hp~~~~~  322 (373)
                       +.                            ........++.+.+++.+||+.||++|||+.++++      ||||.++
T Consensus       237 -~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         237 -GG----------------------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             -CC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence             00                            00111345678999999999999999999999987      9999764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-42  Score=308.84  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=212.7

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|.+.+.||+|++|.||+|.+..+++.+++|++............+.+|+.++++++||||+++++.+....   ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            588899999999999999999999999999999766544455667789999999999999999999984331   26799


Q ss_pred             EEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc-
Q 017334          111 LVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ-  188 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-  188 (373)
                      +++||++ ++|.+++.....+++.+++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999995 79999998877999999999999999999999999999999999999999999999999999886654332 


Q ss_pred             -cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          189 -FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       189 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                       ......++..|+|||.+.+ ...+.++|+||||+++++|++|..||...+.  ....+.....                
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~----------------  218 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS----------------  218 (260)
T ss_pred             ccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc----------------
Confidence             1334567889999999876 4588999999999999999999999977651  1111111100                


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                ...........+..+.++|.+||..||.+||++.++++||||
T Consensus       219 ----------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 ----------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             ----------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                      011112234457889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.4e-43  Score=313.04  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=202.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|++..+|+.||||.+.... ........+.+|+.+++.++||||+++++.+.     ..+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence            58999999999999999999999999999999886532 33444456778999999999999999999984     3367


Q ss_pred             EEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          109 VYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .++|+||++ ++|.+++..    ...+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            999999997 699888752    345899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ...........+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...... .......+ .            
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~-~------------  221 (267)
T cd08228         157 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKI-E------------  221 (267)
T ss_pred             cchhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHH-h------------
Confidence            443333344578889999999876 56889999999999999999999998654321 11111110 0            


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                              .....     .......+..+.++|.+||+.+|++||++.++++.
T Consensus       222 --------~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         222 --------QCDYP-----PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             --------cCCCC-----CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence                    00000     00112356779999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-43  Score=325.41  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=198.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSH  102 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++.... .......+.+|+.+++++ +|+||+++++++... 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence            368999999999999999999753     345789999987543 223345677899999999 699999999987432 


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhc------------------------------------------------------
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSS------------------------------------------------------  127 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------------  127 (373)
                         ...++++|||+. ++|.+++...                                                      
T Consensus        84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (337)
T cd05054          84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE  160 (337)
T ss_pred             ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence               256899999996 6998888542                                                      


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc--cccceeeccc
Q 017334          128 -------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRW  198 (373)
Q Consensus       128 -------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~  198 (373)
                             ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  ......++..
T Consensus       161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                   2578899999999999999999999999999999999999999999999999976532221  1223345678


Q ss_pred             cCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCC
Q 017334          199 YRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP  277 (373)
Q Consensus       199 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (373)
                      |+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+........                      ...   
T Consensus       241 y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~----------------------~~~---  294 (337)
T cd05054         241 WMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE----------------------GTR---  294 (337)
T ss_pred             ccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc----------------------cCC---
Confidence            999999876 678999999999999999997 99999775433322221110                      000   


Q ss_pred             CCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       278 ~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                          .......++.+.+++.+||+.+|++||++.++++|
T Consensus       295 ----~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 ----MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                01123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9.8e-43  Score=313.18  Aligned_cols=252  Identities=22%  Similarity=0.383  Sum_probs=198.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ..++|++.+.||+|+||.||+|.++     .++..||+|++.... .......+.+|+.+++.++||||+++++++    
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE----
Confidence            4688999999999999999999864     245679999986432 223445678999999999999999999998    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQ----------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD  171 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~  171 (373)
                       ......++||||+. ++|.+++....          .++...+..++.|++.||+|||+.|++|+||||+||+++.++.
T Consensus        79 -~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          79 -SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             -cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence             34467999999996 69999986532          3567788999999999999999999999999999999999999


Q ss_pred             eEEcccCcccccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017334          172 LKICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIIN  248 (373)
Q Consensus       172 ~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  248 (373)
                      ++|+|||++.........  .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998754322111  112244678999999876 568999999999999999998 7899977654443332221


Q ss_pred             HhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .                              .........++.+.+++.+||+.||++|||+.+++++
T Consensus       237 ~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 G------------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             C------------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                              0001123467789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.7e-43  Score=318.97  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=209.7

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ...+.|...+.||+|+||+||+|.+..+|..|++|++..... .......+.+|+.+++.++|||++++++++.     .
T Consensus        18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   92 (313)
T cd06633          18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----K   92 (313)
T ss_pred             CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----e
Confidence            345668888999999999999999999999999999865433 2333456778999999999999999999984     4


Q ss_pred             cceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ....|+||||+.|++.+++.. ...+++.++..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus        93 ~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          93 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            467999999999998888765 4568999999999999999999999999999999999999999999999999886432


Q ss_pred             CCCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .    .....++..|+|||.+..  ...++.++|+|||||++|+|++|.+||...+.......+...  .          
T Consensus       173 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~----------  236 (313)
T cd06633         173 P----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D----------  236 (313)
T ss_pred             C----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--C----------
Confidence            2    234578889999999852  245788999999999999999999999776544444332210  0          


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                .+       ....+.++..+++|+.+||+.+|.+||++.++++||||..
T Consensus       237 ----------~~-------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~  278 (313)
T cd06633         237 ----------SP-------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR  278 (313)
T ss_pred             ----------CC-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence                      00       0112345677999999999999999999999999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-43  Score=312.30  Aligned_cols=250  Identities=29%  Similarity=0.437  Sum_probs=199.6

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHH-hhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLL-RHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||.|+||.||+|.+..+|+.||+|++.+.... .........|..++ ....|+|++++++++     ...+..|+|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            5699999999999999999999999998754322 22222334455444 445799999999998     4446799999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      ||++ ++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....    ...
T Consensus        77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~  152 (260)
T cd05611          77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKK  152 (260)
T ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----ccc
Confidence            9996 69999998888899999999999999999999999999999999999999999999999999875432    223


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      ..++..|+|||.+.+ ..++.++||||+|+++|+|++|.+||...+.......+.....                     
T Consensus       153 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------  210 (260)
T cd05611         153 FVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI---------------------  210 (260)
T ss_pred             CCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc---------------------
Confidence            467889999999877 4588999999999999999999999987665443333221000                     


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC---HHHHhCCCCCCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEALQHPYMSPL  322 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~eil~hp~~~~~  322 (373)
                        .    ........+++.+.++|.+||+.||++||+   ++|+++||||...
T Consensus       211 --~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         211 --N----WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             --C----CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence              0    000112356788999999999999999995   5799999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=311.01  Aligned_cols=261  Identities=22%  Similarity=0.409  Sum_probs=214.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~  107 (373)
                      ++|.+++.||+|+|++|.+++.++|.+.||+|++++...+. .+..-...|-.+..+.. ||.+|.++.+|     +...
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qtes  324 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTES  324 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----cccc
Confidence            78999999999999999999999999999999998875433 33333456777777764 99999999999     5557


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+++|.||++ |+|.-.+++++.++++.++.+...|+.||.|||++||++||||.+|+|+++.|++||+|+|.++..-..
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            7999999996 699888888899999999999999999999999999999999999999999999999999999877677


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCC--CCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG--TECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ....++.||||.|.|||++.+ ..|+..+|+|+|||+++||+.|+.||.-  .+..+                      .
T Consensus       405 gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d----------------------~  461 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD----------------------M  461 (593)
T ss_pred             CcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcc----------------------c
Confidence            778889999999999999988 7899999999999999999999999952  11110                      0


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC------HHHHhCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS------VTEALQHPYMSP  321 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t------~~eil~hp~~~~  321 (373)
                      +-++++-++.-.   ...+++..+|-.+..+|+..|++||.+|+.      ..++-.|+||..
T Consensus       462 ntedylfqvile---kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  462 NTEDYLFQVILE---KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             chhHHHHHHHhh---hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            001111110000   001233456777889999999999999974      689999999974

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.7e-43  Score=316.74  Aligned_cols=260  Identities=30%  Similarity=0.506  Sum_probs=214.9

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      +..+.|++.+.||.|++|.||+|.+..++..+++|++.....   ....+.+|+.+++.++|+|++++++.+..     .
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   87 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV-----G   87 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----C
Confidence            456789999999999999999999998999999999965433   34567789999999999999999999843     3


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ...|+|+||++ ++|.+++.... .+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            67999999997 79999998876 89999999999999999999999999999999999999999999999999887554


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+...  .            
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~------------  232 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--G------------  232 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--C------------
Confidence            33333334467889999999876 56889999999999999999999999766544333322210  0            


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                              .      +.......++..+.++|++||+.+|.+||++.++++|+||....
T Consensus       233 --------~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         233 --------I------PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             --------C------CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                    0      00011123677899999999999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.9e-43  Score=312.91  Aligned_cols=246  Identities=25%  Similarity=0.368  Sum_probs=196.5

Q ss_pred             Cceeeeeee--eccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPI--GRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~l--g~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|.+.+.+  |+|+||.||++.++.+|..+|+|.+.......       .|+.....+ +||||+++++.+..     .
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~-----~   81 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT-----L   81 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec-----C
Confidence            567777766  99999999999999999999999986542221       122222223 69999999999943     3


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~  184 (373)
                      +..|+||||+. ++|.+++.....+++.+++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            67999999996 79999998877999999999999999999999999999999999999999998 99999999987653


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCChhhhcccCC
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQ-LKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ..    ....++..|+|||++.+ ..++.++|+||+||++|+|++|..||........ ...+..               
T Consensus       162 ~~----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------  221 (267)
T PHA03390        162 TP----SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK---------------  221 (267)
T ss_pred             CC----ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH---------------
Confidence            32    23467889999999976 5688999999999999999999999975432221 111111               


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-HHHHhCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-VTEALQHPYMS  320 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-~~eil~hp~~~  320 (373)
                              ...     ......+..++.+.+||.+||+.||.+|++ ++++|+||||.
T Consensus       222 --------~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        222 --------RQQ-----KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             --------hhc-----ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence                    000     001122357889999999999999999996 69999999996

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.9e-43  Score=316.90  Aligned_cols=258  Identities=26%  Similarity=0.479  Sum_probs=209.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ..|.-...||+|+||.||++..+.+|+.+|+|++....  ......+.+|+.+++.++|+||+++++.+.     ..+..
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~   92 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDEL   92 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEE
Confidence            34444578999999999999999999999999985432  233445778999999999999999999984     44679


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++||||++ ++|.+++.. +.+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~  171 (292)
T cd06657          93 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  171 (292)
T ss_pred             EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence            99999996 588887654 5789999999999999999999999999999999999999999999999998875543332


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+.......+....                  
T Consensus       172 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~------------------  232 (292)
T cd06657         172 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------------  232 (292)
T ss_pred             cccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC------------------
Confidence            3344578899999998865 567899999999999999999999998765544433332210                  


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                           +.    .+ .....+++.+.+++.+||+.||.+||++.++++||||.....
T Consensus       233 -----~~----~~-~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         233 -----PP----KL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             -----Cc----cc-CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                 00    00 012346788999999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-42  Score=309.47  Aligned_cols=247  Identities=24%  Similarity=0.392  Sum_probs=201.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+|.+.+.||+|+||.||+|.++.+++.+|+|++....   .....+.+|+.+++.++||||+++++++.     ....+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   77 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCc
Confidence            56899999999999999999999999999999986432   23446778999999999999999999983     34678


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +++|||++ ++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999996 7999998653  35889999999999999999999999999999999999999999999999998765432


Q ss_pred             Ccc-ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 NQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....              
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------------  222 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------------  222 (263)
T ss_pred             eeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------------
Confidence            211 111223567999999876 578899999999999999997 999998765544333322100              


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                      .......+++.+.++|.+||+.||++||++.++++
T Consensus       223 ----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 ----------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                            00112456788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-42  Score=317.19  Aligned_cols=257  Identities=27%  Similarity=0.440  Sum_probs=209.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .....|...+.||+|+||.||+|.+..+|..+|+|++..... .......+.+|+.+++.++|||++++++++.     .
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   96 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----R   96 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----e
Confidence            345668999999999999999999999999999999865432 2334456788999999999999999999984     3


Q ss_pred             cceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ....++||||+.|+|.+.+.. ...+++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus        97 ~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635          97 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             CCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            467899999999988887754 4568999999999999999999999999999999999999999999999999886543


Q ss_pred             CCCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ..    ....+++.|+|||.+.+  ...++.++|+||+||++|+|++|.+||...+.......+.....           
T Consensus       177 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-----------  241 (317)
T cd06635         177 PA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----------  241 (317)
T ss_pred             Cc----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC-----------
Confidence            22    23467889999999742  24578899999999999999999999876554443333322100           


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                 +       .......++.++++|.+||+.+|.+||++.++++|+|+..
T Consensus       242 -----------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 -----------P-------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -----------C-------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                       0       0011245678999999999999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9e-43  Score=313.76  Aligned_cols=249  Identities=25%  Similarity=0.369  Sum_probs=200.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCC-----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRE-----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ++|.+.+.||+|+||.||+|.+..     ++..||+|++...... .....+.+|+++++.++||||+++++++..    
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTE----   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEec----
Confidence            679999999999999999998753     4678999998754332 234567899999999999999999999843    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS--------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~  169 (373)
                       ....++||||+. ++|.+++...              ..+++.++..++.||+.||+|||++|++||||||+||+++.+
T Consensus        80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~  158 (280)
T cd05049          80 -GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD  158 (280)
T ss_pred             -CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence             367999999996 6999998754              247888999999999999999999999999999999999999


Q ss_pred             CCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 017334          170 CDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLI  246 (373)
Q Consensus       170 ~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  246 (373)
                      +.+||+|||++.......  .......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            999999999987542211  11223345678999999876 578999999999999999998 99999776654443333


Q ss_pred             HHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ...                              ........++..+.+++++||+.||++||++.|+++
T Consensus       238 ~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQG------------------------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcC------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            210                              000112346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-42  Score=345.01  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=198.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++..... ......++.+|+.+++.++||||+++++++     ...+.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence            689999999999999999999999999999999976433 233455678999999999999999999998     44467


Q ss_pred             EEEEeecCC-ccHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcc
Q 017334          109 VYLVYELMD-TDLHQIIKSS-----------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~D  176 (373)
                      .|+||||++ |+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence            999999996 6999888631           2345667889999999999999999999999999999999999999999


Q ss_pred             cCcccccCCCC------------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 017334          177 FGLARTSNGKN------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE  238 (373)
Q Consensus       177 fg~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  238 (373)
                      ||++.......                  ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            99997542110                  01123478999999999876 578999999999999999999999997643


Q ss_pred             chHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          239 CLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .......  .....                       ...  . .-...+++.+.+++.+||..||++|++..+.+.
T Consensus       236 ~~ki~~~--~~i~~-----------------------P~~--~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        236 GRKISYR--DVILS-----------------------PIE--V-APYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhhhhh--hhccC-----------------------hhh--c-cccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            3221110  00000                       000  0 001356788999999999999999987655543

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.9e-43  Score=310.50  Aligned_cols=250  Identities=34%  Similarity=0.537  Sum_probs=204.4

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecC
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM  116 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~  116 (373)
                      ||.|+||.||+|.+..+|+.+++|++..... .......+.+|+.+++.++||||+++++.+     ......|+++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            6899999999999999999999999865432 223445677899999999999999999888     4457799999999


Q ss_pred             C-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc-------
Q 017334          117 D-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ-------  188 (373)
Q Consensus       117 ~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-------  188 (373)
                      . ++|.+++.+.+.+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........       
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            6 69999998877899999999999999999999999999999999999999999999999999875432211       


Q ss_pred             -cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          189 -FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       189 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                       ......++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+..  +.               
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~---------------  217 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GK---------------  217 (265)
T ss_pred             ccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC---------------
Confidence             2234467889999999876 4588999999999999999999999977654443333221  00               


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH---HHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV---TEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~---~eil~hp~~~~~  322 (373)
                                 ..+.. ....++.+.+++++||+.+|.+|||+   .++++||||+.+
T Consensus       218 -----------~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         218 -----------IEWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             -----------cCCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                       00000 01147889999999999999999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.7e-43  Score=346.60  Aligned_cols=262  Identities=29%  Similarity=0.474  Sum_probs=201.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc--
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF--  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~--  106 (373)
                      -.+|+.++.||+||||.||+|+++-+|+.||||+|.... ......++++|+..|.+|+|||||+++..+.+......  
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            467789999999999999999999999999999998776 66677789999999999999999998775543211000  


Q ss_pred             --------------------------------------------------------------------------------
Q 017334          107 --------------------------------------------------------------------------------  106 (373)
Q Consensus       107 --------------------------------------------------------------------------------  106 (373)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------ceEEEEeecCCccH-HHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 017334          107 --------------------------------KDVYLVYELMDTDL-HQIIKSSQAL-TNDHCQYFLFQLLRGLKYLHSA  152 (373)
Q Consensus       107 --------------------------------~~~~lv~e~~~g~L-~~~l~~~~~~-~~~~~~~i~~qi~~aL~~LH~~  152 (373)
                                                      ..+||-||||+.++ .+++..+... ....+++++++|++||.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                            24789999998655 5555544333 3788999999999999999999


Q ss_pred             CccccCCCCCceEEcCCCCeEEcccCcccccC------------------CCCccccceeeccccCchhhhhcCC--CCC
Q 017334          153 NILHRDLKPGNLLVNANCDLKICDFGLARTSN------------------GKNQFMTEYVVTRWYRAPELLLCCD--NYG  212 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~--~~~  212 (373)
                      |||||||||.||++++++.|||+|||+|....                  ......++.+||-.|+|||++.+..  .|+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999999999999999997511                  1122456779999999999998765  699


Q ss_pred             chhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHH
Q 017334          213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLA  292 (373)
Q Consensus       213 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  292 (373)
                      .++|+||||+||+||+.   ||...  .+-...+.+.-.    ...               |..     ..++..--+.-
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~----g~i---------------P~~-----~~f~~~~~~~e  847 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRK----GSI---------------PEP-----ADFFDPEHPEE  847 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhccc----CCC---------------CCC-----cccccccchHH
Confidence            99999999999999983   35332  222222222111    000               000     11111222345


Q ss_pred             HHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          293 IDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       293 ~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ..+|+.||+.||++||||.|+|++.||-
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            6899999999999999999999999986

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.9e-42  Score=313.07  Aligned_cols=248  Identities=25%  Similarity=0.358  Sum_probs=199.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .+|.+.+.||+|+||.||++.+.     .++..+|+|.+...  .......+.+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   77 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----   77 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            57899999999999999999853     34567999988653  2333456788999999999999999999983     


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQ-------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC  170 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~  170 (373)
                      ..+..++||||+. ++|.+++...+             .+++..++.++.||+.||+|||++|++||||||+|||++.++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            3467999999996 79999987543             489999999999999999999999999999999999999999


Q ss_pred             CeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q 017334          171 DLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLII  247 (373)
Q Consensus       171 ~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  247 (373)
                      .+||+|||++........  ......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...........+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            999999999875432211  1122345678999999876 578899999999999999998 999997766544433332


Q ss_pred             HHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          248 NILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..  .                            ........++.+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~--~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         237 QG--R----------------------------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cC--C----------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            20  0                            00112346778999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=310.59  Aligned_cols=254  Identities=22%  Similarity=0.315  Sum_probs=201.3

Q ss_pred             eeeeeeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC-CCcc
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR-RNFK  107 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~  107 (373)
                      |++.+.||+|+||.||+|....+   +..||+|++............+.+|+..++.++||||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            57889999999999999987653   4789999997655555555678899999999999999999998765432 3335


Q ss_pred             eEEEEeecCC-ccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          108 DVYLVYELMD-TDLHQIIKSS------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      ..++++||+. |+|..++...      ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            6899999996 7998887432      36899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          181 RTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       181 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      +........  .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..   .     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~---~-----  231 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH---G-----  231 (273)
T ss_pred             eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---C-----
Confidence            765332211  111234567999999865 678999999999999999998 8899977654443332221   0     


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                            ........+++.+.+++.+||+.||++||++.+++++
T Consensus       232 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         232 ----------------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ----------------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  0011224567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.8e-43  Score=322.84  Aligned_cols=283  Identities=19%  Similarity=0.214  Sum_probs=202.0

Q ss_pred             eeeecc--CceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRG--AYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G--~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      ..||+|  +||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.     .....++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            456666  9999999999999999999998765544445566778999999999999999999994     446799999


Q ss_pred             ecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc-
Q 017334          114 ELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF-  189 (373)
Q Consensus       114 e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~-  189 (373)
                      ||+. ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+......... 
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9997 6999988764  35899999999999999999999999999999999999999999999999865432111100 


Q ss_pred             ------ccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          190 ------MTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       190 ------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                            .....++..|+|||++.+. ..++.++||||+||++|+|++|.+||.+.........+.......+.....+..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                  0111345679999998753 347899999999999999999999998766544333222211000000000000


Q ss_pred             C--------hhHH-----HHHH-hCCCCCC-CCc-cccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          263 N--------PKAR-----KYIK-SLPYTPG-TPF-SRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       263 ~--------~~~~-----~~~~-~~~~~~~-~~~-~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      .        ....     .... ....... ... ......+++.+.+||++||+.||++|||+.++++||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence            0        0000     0000 0000000 000 001123577899999999999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.9e-42  Score=304.07  Aligned_cols=251  Identities=29%  Similarity=0.506  Sum_probs=207.4

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +|.+.+.||+|++|.||++.+..+|+.+++|++.....  .....+.+|+.+++.++|+|++++++.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence            48889999999999999999999999999999976533  344567789999999999999999999843     36799


Q ss_pred             EEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          111 LVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      +++||++ ++|.+++... ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            9999998 6999998775 6899999999999999999999999999999999999999999999999999876644332


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+..  ...               
T Consensus       154 -~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~---------------  214 (253)
T cd05122         154 -RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGP---------------  214 (253)
T ss_pred             -ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCC---------------
Confidence             345578899999999876 4588999999999999999999999976643333222211  000               


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                              +..   .....++..+.++|.+||+.||++|||+.++++|||
T Consensus       215 --------~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         215 --------PGL---RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             --------CCc---CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                    000   001123678999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-42  Score=307.55  Aligned_cols=242  Identities=21%  Similarity=0.346  Sum_probs=196.6

Q ss_pred             eeeccCceEEEEEEe--CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           37 PIGRGAYGIVCSSVN--RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~--~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      .||+|+||.||+|.+  ..++..+|+|+++...........+.+|+.+++.+.||||+++++++..      ...++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence            589999999999964  4577899999987665555556677899999999999999999988621      35789999


Q ss_pred             cCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc---c
Q 017334          115 LMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF---M  190 (373)
Q Consensus       115 ~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~---~  190 (373)
                      |++ |+|.+++...+.+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||++.........   .
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            997 689999988788999999999999999999999999999999999999999999999999998765433221   1


Q ss_pred             cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       191 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.+..                   
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------------  215 (257)
T cd05116         156 THGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------------  215 (257)
T ss_pred             CCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------------
Confidence            12233578999999865 568899999999999999997 999998765544443332100                   


Q ss_pred             HHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                 .....+.+++.+.++|.+||+.||++||++.+|.+
T Consensus       216 -----------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         216 -----------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                       00122457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.4e-42  Score=311.61  Aligned_cols=250  Identities=20%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             CceeeeeeeeccCceEEEEEEe----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVN----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .+|++.+.||+|+||+||+|..    ..++..+|+|.+.... .......+.+|+.+++.++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~   78 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----Q   78 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----c
Confidence            5789999999999999999985    3456789999987532 2334456778999999999999999999983     3


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS-----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                      ....|+||||+. ++|.+++...                 ..+++.++..++.||+.||+|||++|++||||||+|||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~  158 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence            466899999996 6999988532                 2477888999999999999999999999999999999999


Q ss_pred             CCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017334          168 ANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLK  244 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  244 (373)
                      .++.+||+|||++.......  .......++..|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+......
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999997643221  11233345677999999876 568999999999999999998 999997765433333


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+..   .                           ........+++.+.+++.+||+.||++||++.+++++
T Consensus       238 ~~~~---~---------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRK---R---------------------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHc---C---------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2221   0                           0001223467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.6e-42  Score=317.72  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=198.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcE----EEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEK----VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~----~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..+|++++.||+|+||.||+|.+..+|..    ||+|++... .......++.+|+.+++.++||||+++++++..    
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~----   80 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT----   80 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC----
Confidence            36799999999999999999998766654    899998643 223344567789999999999999999998843    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        ...++++||+. |+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 --~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          81 --STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             --CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence              23679999996 7999998764 4688999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .......  .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+.. .+....         
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~---------  227 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKG---------  227 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCC---------
Confidence            5432221  122234667999999876 678999999999999999987 99999765433322 111100         


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                    .   .   ....+.++..+.+++.+||..||++||++.+++.+
T Consensus       228 --------------~---~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         228 --------------E---R---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             --------------C---C---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                          0   0   00123456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-42  Score=307.06  Aligned_cols=244  Identities=27%  Similarity=0.411  Sum_probs=202.8

Q ss_pred             eeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEE
Q 017334           36 KPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      +.||+|+||.||+|.+...   +..|++|.+....... ....+.+|+..++.++|+||+++++++..     ...+++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence            4689999999999999866   8999999997654443 45667899999999999999999999843     4679999


Q ss_pred             eecC-CccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          113 YELM-DTDLHQIIKSS---------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       113 ~e~~-~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      |||+ +++|.+++...         ..+++.+++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+..
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence            9999 57999999875         7899999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .....  .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..  +        
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~--------  223 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--G--------  223 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--C--------
Confidence            64332  22334466888999999876 478999999999999999998 6999987755444433322  0        


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                          ........+++.+.+++.+||+.||++|||+.+++++
T Consensus       224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 --------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                0011224567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.7e-43  Score=320.42  Aligned_cols=271  Identities=21%  Similarity=0.280  Sum_probs=199.1

Q ss_pred             CceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCC-ccH
Q 017334           42 AYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDL  120 (373)
Q Consensus        42 ~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L  120 (373)
                      ++|.||.+++..+|+.||+|++............+.+|+.+++.++|+||+++++++.     .....+++|||++ |+|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence            4566777777779999999999766445556667889999999999999999999984     3467999999997 789


Q ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC-------cccc
Q 017334          121 HQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN-------QFMT  191 (373)
Q Consensus       121 ~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-------~~~~  191 (373)
                      .+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.......       ....
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence            9988753  468999999999999999999999999999999999999999999999999886432211       1123


Q ss_pred             ceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHH
Q 017334          192 EYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI  270 (373)
Q Consensus       192 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ...++..|+|||++.+. ..++.++|+||+||++++|++|.+||..........  ....+..... ..   ........
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~-~~---~~~~~~~~  240 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCL-LD---KSTYPLYE  240 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccc-cc---cCchhhhc
Confidence            34567889999998653 358899999999999999999999998765433221  1222111100 00   00000000


Q ss_pred             HhCC---------CCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          271 KSLP---------YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       271 ~~~~---------~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      ....         .............++..+.+|+.+||..||++|||+.++|+||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            0000         0000000111223567789999999999999999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.3e-42  Score=315.55  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=208.3

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ....|...+.||+|+||.||+|+++.++..+|+|.+.... .......++.+|+.+++.++|+|++++++++..     .
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   87 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----E   87 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----C
Confidence            3466888999999999999999999999999999986432 233344567789999999999999999999843     3


Q ss_pred             ceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ...++||||+.|++.+++.. ...+++.++..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            67899999999988887754 45689999999999999999999999999999999999999999999999999875432


Q ss_pred             CCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .    ....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+...  .           
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~-----------  230 (308)
T cd06634         168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--E-----------  230 (308)
T ss_pred             c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc--C-----------
Confidence            2    23467889999999853  245788999999999999999999998765443333222110  0           


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                               .+       ......++..+.+||++||..+|++||++.++++|||+...
T Consensus       231 ---------~~-------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         231 ---------SP-------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             ---------CC-------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                     00       00113467789999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.9e-42  Score=305.71  Aligned_cols=243  Identities=25%  Similarity=0.358  Sum_probs=192.4

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeec
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYEL  115 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~  115 (373)
                      +.||+|+||.||+|.++.+|+.+|+|.+.... .......+.+|+++++.++||||+++++++.     .....++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEee
Confidence            46899999999999999999999999886443 2333456789999999999999999999983     44679999999


Q ss_pred             CC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc--c
Q 017334          116 MD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM--T  191 (373)
Q Consensus       116 ~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~--~  191 (373)
                      +. ++|.+++... ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........  .
T Consensus        75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            96 6999998754 468999999999999999999999999999999999999999999999999987543211100  0


Q ss_pred             ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHH
Q 017334          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI  270 (373)
Q Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...........+...                     
T Consensus       155 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~---------------------  212 (252)
T cd05084         155 MKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---------------------  212 (252)
T ss_pred             CCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC---------------------
Confidence            1122356999999876 568899999999999999997 88998665433322222110                     


Q ss_pred             HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                        ..       .......+..+.+|+.+||+.||++|||+.++++
T Consensus       213 --~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         213 --VR-------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             --CC-------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              00       0112345778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.2e-42  Score=308.91  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             eeeeeeeccCceEEEEEEeCCCCc--EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-CCCcceE
Q 017334           33 VPIKPIGRGAYGIVCSSVNRETNE--KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-RRNFKDV  109 (373)
Q Consensus        33 ~~~~~lg~G~~g~V~~a~~~~~g~--~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~  109 (373)
                      .+.+.||+|+||.||+|.+..++.  .+|+|.++...........+.+|+.+++.++||||+++++.+.... .......
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467889999999999999887775  6999998766555555667788999999999999999999765432 1223468


Q ss_pred             EEEeecCC-ccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          110 YLVYELMD-TDLHQIIKS------SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      +++|||+. |+|.+++..      ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            99999996 799887742      23488999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .......  .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+.+.          
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~----------  230 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG----------  230 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----------
Confidence            5332211  112245678999999876 578999999999999999998 89999876543333222110          


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                    .      .....+.++..+.++|.+||+.||++|||+.+++++
T Consensus       231 --------------~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         231 --------------N------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             --------------C------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                          0      001124567789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.6e-42  Score=309.53  Aligned_cols=251  Identities=22%  Similarity=0.377  Sum_probs=199.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC-----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE-----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~-----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++|.+.+.||+|++|.||+|.+..     ++..||+|.+.... .......+.+|+.+++.++|+||+++++++..   
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence            3679999999999999999999987     77899999886432 23334567889999999999999999998843   


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---Ce
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQ-------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DL  172 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~  172 (373)
                        ....++||||+. ++|.+++...+       .+++..+..++.||+.||+|||+++++||||||+||+++.++   .+
T Consensus        81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          81 --RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             --CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence              356799999995 69999987643       488999999999999999999999999999999999998765   59


Q ss_pred             EEcccCcccccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017334          173 KICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  249 (373)
                      ||+|||++.........  ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.. 
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-  236 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-  236 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence            99999998765322110  111223467999999976 568999999999999999996 9999987665443332211 


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                        ...                           ......++..+.+++.+||+.||++||++.++++|
T Consensus       237 --~~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         237 --GGR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             --CCc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence              000                           01124467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.4e-42  Score=312.79  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=197.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCc--EEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNE--KVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~--~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||.||+|..+.+|.  .+++|.++.. ........+.+|+.++.++ +||||+++++++     ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~   75 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENR   75 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccC
Confidence            579999999999999999999887765  4688887632 2333445678899999999 699999999998     334


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~  169 (373)
                      +..|+|+||+. ++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence            66999999996 79999986532                47889999999999999999999999999999999999999


Q ss_pred             CCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017334          170 CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIIN  248 (373)
Q Consensus       170 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  248 (373)
                      +.+||+|||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus       156 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             CeEEECCcCCCccccceec-cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            9999999999864321111 111122456999999876 568999999999999999997 9999987765544333221


Q ss_pred             HhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      ..                              .......+++.+.+||.+||..||.+||++.++++.
T Consensus       234 ~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GY------------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00                              001123477889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-42  Score=309.30  Aligned_cols=253  Identities=27%  Similarity=0.414  Sum_probs=202.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|++|.||+|++..+|+.+|+|.+.... ........+.+|+.+++.++||||+++++.+..     .+.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            57899999999999999999999999999999886532 233344567889999999999999999999843     367


Q ss_pred             EEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          109 VYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .+++|||+. ++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            999999997 599888763    356899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ...........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.... .......+              
T Consensus       157 ~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~--------------  220 (267)
T cd08229         157 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKI--------------  220 (267)
T ss_pred             ccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhh--------------
Confidence            444333445578899999999876 56889999999999999999999998654321 11110000              


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                             ..... +    ......+++.+.++|.+||+.||++|||+.+|++
T Consensus       221 -------~~~~~-~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         221 -------EQCDY-P----PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -------hcCCC-C----CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                   00000 0    0011246788999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.6e-42  Score=342.00  Aligned_cols=147  Identities=27%  Similarity=0.465  Sum_probs=132.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++     .....
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            78999999999999999999999999999999997543 2333445677899999999999999999888     44468


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      +|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999995 6999999887889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=325.87  Aligned_cols=237  Identities=27%  Similarity=0.376  Sum_probs=199.2

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      -++-||+|+.|.||+++.+  ++.||||+++..         -..+|+-|++|+||||+.+.+++     .....+||||
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiM  191 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIM  191 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeee-----cCCceeEEee
Confidence            3667999999999999776  789999998421         12478889999999999999999     4457899999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE  192 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~  192 (373)
                      |||. |.|..+++....++......|..+|+.|+.|||.++|||||||.-||||..+..|||+|||-++..... ...-+
T Consensus       192 EfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS  270 (904)
T KOG4721|consen  192 EFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS  270 (904)
T ss_pred             eccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence            9996 999999999999999999999999999999999999999999999999999999999999999876544 44556


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      ++||..|||||++.+ .+.+.++|||||||+|||||||..||.+-+...    |.+..|....                .
T Consensus       271 FaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVGsNsL----------------~  329 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVGSNSL----------------H  329 (904)
T ss_pred             hhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchhe----eEEeccCCcc----------------c
Confidence            899999999999987 789999999999999999999999997654322    2222222110                0


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP  317 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp  317 (373)
                               .-.+..+++-++-||++||+-.|..||++.++|.|-
T Consensus       330 ---------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  330 ---------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             ---------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence                     011234667788999999999999999999999994

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.6e-42  Score=314.40  Aligned_cols=249  Identities=25%  Similarity=0.345  Sum_probs=196.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcE--EEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~--~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||.||+|.++.+|..  +++|.+... ........+.+|+.++.++ +||||+++++++     ...
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            5889999999999999999999888764  577766532 2233445677899999999 799999999998     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~  169 (373)
                      +..|+||||+. ++|.+++...+                .+++..++.++.||+.||+|||++|++||||||+|||++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            67999999996 79999986532                57889999999999999999999999999999999999999


Q ss_pred             CCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017334          170 CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIIN  248 (373)
Q Consensus       170 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  248 (373)
                      +.+||+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             CcEEeCccccCcccchhhh-cccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            9999999999863321111 111123567999999866 568899999999999999997 9999977654433322211


Q ss_pred             HhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                         ..                           .......+++.+.+||.+||+.+|++||++.+++++
T Consensus       239 ---~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 ---GY---------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             ---CC---------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               00                           000112357789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.9e-42  Score=305.86  Aligned_cols=246  Identities=23%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|+++++||+|+||.||+|.+. ++..||+|.+....   .....+.+|+.+++.++|+||+++++.+     ...+..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPI   76 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCc
Confidence            68999999999999999999865 56779999876432   2345677899999999999999999988     344668


Q ss_pred             EEEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +++|||+. ++|.+++..  ...++...+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            99999995 799999865  356888999999999999999999999999999999999999999999999999765432


Q ss_pred             Cc-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 NQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      .. ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.........+.....             
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------------  222 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-------------  222 (261)
T ss_pred             ceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence            21 1222345677999999876 568899999999999999998 9999987654443333321100             


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                       ......++..+.+++.+||..+|++||+++++++
T Consensus       223 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         223 -----------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                             0112346788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-42  Score=307.32  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=200.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC-----CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET-----NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-----g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||.||+|.++..     +..||+|.+.... .......+.+|+.+++.++||||+++++++.    
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc----
Confidence            47899999999999999999988644     4789999986443 2233456778999999999999999999984    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS----------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                       .....++||||+. |+|.+++...          ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+
T Consensus        80 -~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          80 -TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             -CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence             3467999999996 7999998643          236778899999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017334          173 KICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  249 (373)
                      ||+|||+++.......  ......++..|+|||.+.+ ..++.++|||||||++|++++ |.+||.+.+..+....+.. 
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-  236 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-  236 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-
Confidence            9999999875432211  1123345778999999876 568899999999999999997 9999987665443333221 


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                       +.                            ........+..+.++|.+||+.+|++|||+.++++
T Consensus       237 -~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 -GG----------------------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             -CC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             00                            00112335788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4e-42  Score=323.18  Aligned_cols=252  Identities=27%  Similarity=0.360  Sum_probs=197.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCC-----CcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRET-----NEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPS  101 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~-----g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  101 (373)
                      -.++|++.+.||+|+||.||+|.+...     +..||||++.... .......+.+|+.+++.+. ||||+++++++   
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~---  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGAC---  110 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE---
Confidence            357888999999999999999987433     3579999996542 2334456789999999996 99999999998   


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhc-----------------------------------------------------
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSS-----------------------------------------------------  127 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~-----------------------------------------------------  127 (373)
                        .....+|+||||+. |+|.+++...                                                     
T Consensus       111 --~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         111 --TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             --ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence              44467999999996 7998887542                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 017334          128 -------------------------------------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNL  164 (373)
Q Consensus       128 -------------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Ni  164 (373)
                                                                 ..+++.++..++.||+.||+|||++||+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                       2367788899999999999999999999999999999


Q ss_pred             EEcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchH
Q 017334          165 LVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLN  241 (373)
Q Consensus       165 ll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  241 (373)
                      |++.++.+||+|||++........  ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.......
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            999999999999999875432221  1223346678999999876 578999999999999999996 889987654332


Q ss_pred             HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          242 QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .......  .                    ...       ......++..+.+++.+||+.||++||++.++.+
T Consensus       348 ~~~~~~~--~--------------------~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 TFYNKIK--S--------------------GYR-------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHh--c--------------------CCC-------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            2221111  0                    000       0112346788999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=360.02  Aligned_cols=269  Identities=25%  Similarity=0.388  Sum_probs=223.0

Q ss_pred             eEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceee
Q 017334           19 YSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVM   98 (373)
Q Consensus        19 ~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   98 (373)
                      .++...+..+.-+|+-..+||.|.||.||.|.+..+|+..|+|.++-..........+.+|+.++..++|||+|+++++-
T Consensus      1224 ~kla~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1224 NKLASSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE 1303 (1509)
T ss_pred             HHHHHHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee
Confidence            34455566777889999999999999999999999999999999976544444445567899999999999999999997


Q ss_pred             cCCCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEccc
Q 017334           99 MPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Df  177 (373)
                           -+...++|.||||+ |+|.+++...+-..+...+.+..|++.|++|||++|||||||||+||+++.+|-+|++||
T Consensus      1304 -----vHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1304 -----VHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred             -----ecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecc
Confidence                 34467999999996 799999998888899999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC----CccccceeeccccCchhhhhcCC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC
Q 017334          178 GLARTSNGK----NQFMTEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILG  251 (373)
Q Consensus       178 g~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  251 (373)
                      |.|......    ....+.+.||+.|||||++.+..  +...++|||||||++.||+||+.||...+..-++..-+-. |
T Consensus      1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-g 1457 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-G 1457 (1509)
T ss_pred             cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-c
Confidence            999765433    23456789999999999997643  4668999999999999999999999765543322211111 0


Q ss_pred             CCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          252 SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      .                            -.+++..+|++.+|||..||..||++|.++.|+++|.|-+.
T Consensus      1458 h----------------------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1458 H----------------------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             C----------------------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            0                            01223448899999999999999999999999999998653

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.3e-42  Score=303.53  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=198.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|+||.||++..+ .+..+|+|.+......   ...+.+|+.+++.++||||+++++++     ......
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   74 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPL   74 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCE
Confidence            57899999999999999999875 4568999988644322   33577899999999999999999998     334679


Q ss_pred             EEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++||||++ |+|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+.......
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99999996 7999988753 568999999999999999999999999999999999999999999999999987543221


Q ss_pred             c-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 Q-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      . ......++..|+|||++.+ ..++.++|+||+||++|+|++ |++||...+..+....+.+...              
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~--------------  219 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR--------------  219 (256)
T ss_pred             eeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC--------------
Confidence            1 1122234567999999876 578899999999999999998 8999987765555444432100              


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                      .......+..+.+++.+||+.||.+||++.++++
T Consensus       220 ----------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         220 ----------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                            0001224677999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.3e-42  Score=307.95  Aligned_cols=248  Identities=24%  Similarity=0.356  Sum_probs=203.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..+|++++.||.|+||.||+|.+.. +..+|+|++.....  .....+.+|+.+++.++||||+++++++     .....
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   76 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEP   76 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCC
Confidence            4679999999999999999999987 88999999865432  2334577899999999999999999988     34466


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .++||||++ ++|.+++...  ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||.+.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999996 6999999753  4689999999999999999999999999999999999999999999999999976543


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      .........++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....             
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------  222 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-------------  222 (261)
T ss_pred             ccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-------------
Confidence            3222223345678999999876 578899999999999999997 8999987765444444332000             


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                       ......+++.+.+++.+||+.||.+|||+.++++
T Consensus       223 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         223 -----------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                             0112456788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.8e-42  Score=310.73  Aligned_cols=260  Identities=23%  Similarity=0.370  Sum_probs=206.2

Q ss_pred             ceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEcccccc--ChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRR  104 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  104 (373)
                      +|++.+.||.|+||.||.|.+.   .+|..||+|++.....  .......+.+|+.+++.+. |+||+++++.+     +
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4889999999999999999875   4789999999865422  1223345678999999995 99999999888     4


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ....+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++...
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            4467999999997 699999988888999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC-ccccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          184 NGKN-QFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       184 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .... .......|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.....          
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~----------  225 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL----------  225 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh----------
Confidence            3322 222345688999999998653 2467899999999999999999999964332221111111100          


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                               ...        ....+.+++.+.+++++||..||++|+     ++.+++.||||...
T Consensus       226 ---------~~~--------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         226 ---------KSE--------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             ---------ccC--------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence                     000        011234678899999999999999997     89999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=324.63  Aligned_cols=254  Identities=21%  Similarity=0.290  Sum_probs=206.3

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ...++..+...||+|.||+||+|++..   .||||+++....+....+.+..|+..+++-+|.||+-+.+++..+     
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-----  460 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-----  460 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-----
Confidence            345777888999999999999999873   399999998888888888899999999999999999999998543     


Q ss_pred             ceEEEEeecCCc-cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMDT-DLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      . +.||+-+|+| +|+.+++-. .+|.+...+.|++||+.|+.|||.++|+|||||..||++.++++|||+|||++....
T Consensus       461 ~-~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 P-LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             c-eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            3 4999999986 999998643 579999999999999999999999999999999999999999999999999986432


Q ss_pred             --CCCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 --GKNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 --~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                        .........-|...|||||++..  ..+|++.+||||+||++|||++|..||........+..+-+..+.        
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~--------  611 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM--------  611 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC--------
Confidence              22333444567888999999863  346899999999999999999999999844333222222111111        


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        ..........+.++++|+..||.+++++||.+.+||.
T Consensus       612 ------------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  612 ------------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ------------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                              1112223456668999999999999999999998886

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-41  Score=304.63  Aligned_cols=252  Identities=28%  Similarity=0.441  Sum_probs=202.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++... ........+.+|+.++++++|+|++++++.+..     .+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            68999999999999999999999999999999986432 233335567899999999999999999999843     367


Q ss_pred             EEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          109 VYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .++||||++ ++|.+++..    ...+++..++.++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence            899999996 699988853    345899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ...........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .........             
T Consensus       157 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-------------  221 (267)
T cd08224         157 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE-------------  221 (267)
T ss_pred             cCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhh-------------
Confidence            443333344578899999999876 57889999999999999999999998654311 000000000             


Q ss_pred             hhHHHHHHhCCCCCCCCcccc-CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          264 PKARKYIKSLPYTPGTPFSRL-YPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                             ..       ..... ...++..+.++|.+||..+|++|||+.++++
T Consensus       222 -------~~-------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         222 -------KC-------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -------cC-------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                   00       00001 1246678999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-42  Score=305.72  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=200.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||+||+|.+..+   ...+|+|++.... .......+.+|+.+++.++||||+++++.+.     ..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   77 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KS   77 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cC
Confidence            6799999999999999999998654   4579999987543 3334456778999999999999999999883     34


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +..++||||+. ++|.+++... +.+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++....
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            66899999996 6999998754 478999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCcccc--ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          185 GKNQFMT--EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       185 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .......  ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+....           
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------  225 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-----------  225 (266)
T ss_pred             ccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            2222111  2234567999999876 578999999999999999997 999987655443333332100           


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                  .    .   ......++.+.+|+.+||+.+|++||++.+++++
T Consensus       226 ------------~----~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         226 ------------R----L---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ------------C----C---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                        0    0   0113467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.5e-43  Score=319.32  Aligned_cols=292  Identities=32%  Similarity=0.545  Sum_probs=231.2

Q ss_pred             ceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC------CCC
Q 017334           17 HYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ------HEN   90 (373)
Q Consensus        17 ~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpn   90 (373)
                      .||.. +....++.+|.+....|+|-||+|..|.+...|..||||+|.+.   ......=++|+++|++|+      --|
T Consensus       420 GYYrv-~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  420 GYYRV-RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             ceEEE-ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhH
Confidence            35544 66788999999999999999999999999999999999999753   222333468999999995      246


Q ss_pred             eeeeceeecCCCCCCcceEEEEeecCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334           91 VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ---ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                      ++.++..|     .+.+++|+|+|-+.-+|.++++.-+   .+....++.|+.|++.||..|...||+|.||||+||||+
T Consensus       496 clrl~r~F-----~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  496 CLRLFRHF-----KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN  570 (752)
T ss_pred             HHHHHHHh-----hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec
Confidence            88888777     5568999999999999999998654   588899999999999999999999999999999999999


Q ss_pred             CCC-CeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017334          168 ANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI  246 (373)
Q Consensus       168 ~~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  246 (373)
                      ... .+||||||.|...+..  ..+.|..+..|+|||+++| -.|+...|+||.||.||||.||+..|+|.+....+...
T Consensus       571 E~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             cCcceeeeccCccccccccc--cccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            875 4899999999876433  3567788999999999998 68999999999999999999999999999999999999


Q ss_pred             HHHhCCCChhhhcccCChhHHHHHH----------hC---------CC-CCCCCccc-c-----C----CCCCHHHHHHH
Q 017334          247 INILGSRREEDLEFIDNPKARKYIK----------SL---------PY-TPGTPFSR-L-----Y----PDAHPLAIDLL  296 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---------~~-~~~~~~~~-~-----~----~~~s~~~~~ll  296 (373)
                      +.+-|..+...+....-.. ..|-.          .+         .. .|...+.. +     +    +.+-..+.+||
T Consensus       648 me~KGk~p~KmlRKgqF~d-qHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL  726 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKD-QHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL  726 (752)
T ss_pred             HHhcCCCcHHHhhhcchhh-hhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence            9998887755433211000 00000          00         00 00000000 0     0    11223588999


Q ss_pred             HhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          297 QKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       297 ~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      .+||..||++|.|+.++|+||||..
T Consensus       727 dkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  727 DKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHhccChhhcCCHHHHhcCCcccC
Confidence            9999999999999999999999963

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.4e-42  Score=311.45  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=199.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC-----CcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET-----NEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSH  102 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-----g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||++.++..     ...+|+|.+..... ......+.+|+.+++.+ +|+||+++++++    
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~----   85 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVC----   85 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence            37899999999999999999987644     37899999875433 33445678999999999 799999999998    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKS----------------SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL  165 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~----------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nil  165 (373)
                       ...+.++++|||+. |+|.+++..                .+.+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence             33467999999995 799999854                246889999999999999999999999999999999999


Q ss_pred             EcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHH
Q 017334          166 VNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQ  242 (373)
Q Consensus       166 l~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  242 (373)
                      ++.++.+||+|||+++.......  ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            99999999999999976533211  1112234567999999866 578899999999999999996 9999987654443


Q ss_pred             HHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          243 LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      ...+....                              ........+..+.+|+.+||..||++|||+.+++++
T Consensus       244 ~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEGY------------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33221100                              001123467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.2e-42  Score=311.37  Aligned_cols=257  Identities=23%  Similarity=0.304  Sum_probs=201.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCC----------------cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCee
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETN----------------EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI   92 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g----------------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   92 (373)
                      .++|++++.||+|+||.||+|.+..++                ..||+|.+..... ......+.+|+.+++.++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence            378999999999999999999876544                4589999875432 23455678899999999999999


Q ss_pred             eeceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017334           93 ALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ-----------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLK  160 (373)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  160 (373)
                      ++++++.     .....+++||++. ++|.+++....           .+++..++.++.|++.||+|||++||+|+|||
T Consensus        83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk  157 (296)
T cd05051          83 RLLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA  157 (296)
T ss_pred             EEEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            9999983     3367999999996 69999987655           68999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh--CCCCCCC
Q 017334          161 PGNLLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG--RKPIFPG  236 (373)
Q Consensus       161 p~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~  236 (373)
                      |+||+++.++.++|+|||++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++  +..||..
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            999999999999999999987543221  11223345678999999876 568999999999999999987  6788876


Q ss_pred             CCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          237 TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .+..+.+...........                       ........+.++.++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDDG-----------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhcccccc-----------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            554443333322111000                       00001112446788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.1e-42  Score=306.14  Aligned_cols=252  Identities=27%  Similarity=0.485  Sum_probs=202.1

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc---cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +|.+.+.||+|+||.||++.+..++..+++|+++...   ........+.+|+.+++.++||||+++++.+.     ...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            6899999999999999999998887777777765322   22233445668999999999999999999984     335


Q ss_pred             eEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          108 DVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ..++|+||+. ++|.+++..    ...+++.+++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence            6899999996 688887753    457999999999999999999999999999999999999975 5799999999876


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ............+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+..   ..         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~---------  221 (260)
T cd08222         155 LMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GP---------  221 (260)
T ss_pred             cCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CC---------
Confidence            5443333344567889999999865 5678899999999999999999999976544333322211   00         


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                        .......++..+.++|.+||..||++||++.++++||||
T Consensus       222 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         222 ------------------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             ------------------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                              011123467789999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-43  Score=325.31  Aligned_cols=259  Identities=26%  Similarity=0.446  Sum_probs=210.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .-|..++.||-|+||.|++++..+|...||+|.+.+.. ...........|-.||..-.++-||++|..|     ++..+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence            44778899999999999999999999999999997653 3334445566799999999999999999999     77789


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC---
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN---  184 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~---  184 (373)
                      +|+||+|+. |++..+|-+.+-|.|..++.++..|..|+++.|..|+|||||||+|||||.+|++||+|||+|.-+.   
T Consensus       704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999995 7999999999999999999999999999999999999999999999999999999999999984210   


Q ss_pred             -------CC--------------------------------CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHH
Q 017334          185 -------GK--------------------------------NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA  225 (373)
Q Consensus       185 -------~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~  225 (373)
                             +.                                .......+||+.|+|||++.. .+|+..+|+||.|||||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHH
Confidence                   00                                001234588999999999987 68999999999999999


Q ss_pred             HHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCC
Q 017334          226 ELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPT  305 (373)
Q Consensus       226 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~  305 (373)
                      +|+.|++||-+....+.-..+.+                 ++.++. +         .....+|+++.+||.++. .+++
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~n-----------------w~~~l~-~---------~~~~~ls~e~~~li~kLc-~sad  914 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVIN-----------------WRNFLH-I---------PYQGNLSKEALDLIQKLC-CSAD  914 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeee-----------------hhhccc-c---------ccccccCHHHHHHHHHHh-cChh
Confidence            99999999977665443332222                 011110 0         112458899999999854 5688


Q ss_pred             CCC---CHHHHhCCCCCCCC
Q 017334          306 KRI---SVTEALQHPYMSPL  322 (373)
Q Consensus       306 ~R~---t~~eil~hp~~~~~  322 (373)
                      .|+   .++++..||||+.+
T Consensus       915 ~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  915 SRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             hhhcccchhhhhcCcccccc
Confidence            888   47889999999865

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.3e-42  Score=312.11  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=198.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC-------CCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE-------TNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~-------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      .++|.+.+.||+|+||.||+|.+..       ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++. 
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-
Confidence            4789999999999999999998643       23579999987542 233445677899999999 6999999999983 


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                          .....|+||||+. |+|.+++....                .++..++..++.||+.||+|||++|++||||||+|
T Consensus        95 ----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  170 (307)
T cd05098          95 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN  170 (307)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence                3467999999996 69999997532                47888999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      |+++.++.+||+|||.+.........  .....+++.|+|||++.+ ..++.++|+|||||++|+|++ |.+||.+.+..
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence            99999999999999998754322111  111223467999999876 568999999999999999997 88999765543


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      +....+...                              ........++..+.+||.+||..+|.+||++.+++++
T Consensus       250 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         250 ELFKLLKEG------------------------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHcC------------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            333222110                              0011223567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-42  Score=303.06  Aligned_cols=245  Identities=29%  Similarity=0.508  Sum_probs=204.8

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecC
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM  116 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~  116 (373)
                      ||.|+||.||++.+..+++.+|+|++.+.... ......+..|+.+++.++||||+++++.+     +.....|+||||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            68999999999999989999999998765332 23445677899999999999999999988     5557899999999


Q ss_pred             -CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceee
Q 017334          117 -DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV  195 (373)
Q Consensus       117 -~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g  195 (373)
                       +++|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||.+..............+
T Consensus        76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (250)
T cd05123          76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG  155 (250)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence             5799999988778999999999999999999999999999999999999999999999999998765443333345577


Q ss_pred             ccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCC
Q 017334          196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPY  275 (373)
Q Consensus       196 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (373)
                      +..|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+..  +                        
T Consensus       156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~------------------------  208 (250)
T cd05123         156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D------------------------  208 (250)
T ss_pred             CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C------------------------
Confidence            889999999876 5678899999999999999999999976654332222211  0                        


Q ss_pred             CCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH---HHHhCCCCC
Q 017334          276 TPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV---TEALQHPYM  319 (373)
Q Consensus       276 ~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~---~eil~hp~~  319 (373)
                           ........+..+.++|++||..||++||++   .++++||||
T Consensus       209 -----~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         209 -----PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                 001223357789999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-42  Score=303.31  Aligned_cols=242  Identities=21%  Similarity=0.317  Sum_probs=194.9

Q ss_pred             eeeeccCceEEEEEEeCCCC---cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEE
Q 017334           36 KPIGRGAYGIVCSSVNRETN---EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      +.||+|+||.||+|....++   ..+|+|.+...... .....+.+|+.+++.+.||||+++++++..      ...++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence            46999999999999876554   78999998765443 344567889999999999999999998632      357999


Q ss_pred             eecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcccc
Q 017334          113 YELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT  191 (373)
Q Consensus       113 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  191 (373)
                      |||+. |+|.+++.....+++..+..++.|++.||+|||+.|++|+||||+|||++.++.+||+|||++...........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99996 69999998877899999999999999999999999999999999999999999999999999876543322211


Q ss_pred             c---eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          192 E---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       192 ~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .   ..++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+...   .              
T Consensus       154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~---~--------------  215 (257)
T cd05060         154 ATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG---E--------------  215 (257)
T ss_pred             cccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC---C--------------
Confidence            1   122457999999866 568999999999999999997 99999776544433332210   0              


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                   .......+++.+.++|.+||..||++||++.++++
T Consensus       216 -------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 -------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             -------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                         00122446788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-41  Score=302.99  Aligned_cols=247  Identities=22%  Similarity=0.304  Sum_probs=197.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||.||+|.... +..+|+|.+......   ...+.+|+.+++.++||||+++++++.     .....
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   74 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPI   74 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCc
Confidence            579999999999999999997753 456999998654322   345778999999999999999999983     33568


Q ss_pred             EEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++||||+. |+|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||.+.......
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            99999996 6999998764 468999999999999999999999999999999999999999999999999987543322


Q ss_pred             c-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 Q-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      . ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.+....             
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------  220 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-------------  220 (256)
T ss_pred             eeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-------------
Confidence            1 1112234567999999876 568899999999999999998 99999766544433333221000             


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                       ......+..+.+++.+||+.||++||++.+++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                             0112356789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-41  Score=306.81  Aligned_cols=249  Identities=24%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCc----EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNE----KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..+|++++.||.|+||+||+|.+..+|.    .||+|++.... .......+.+|+.+++.+.||||+++++++..    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC----
Confidence            4789999999999999999999877776    48999886543 23334567789999999999999999998843    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        ...++++||+. |+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 --~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          81 --STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             --CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence              34689999996 7999998763 5699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .......  .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...........+..           
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----------  226 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-----------  226 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-----------
Confidence            5432211  112234677999999876 578999999999999999997 8999976543332222211           


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                   ...      ....+..++.+.+++.+||..||++||++.++++
T Consensus       227 -------------~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         227 -------------GER------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -------------CCc------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         000      0112346788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=6.2e-42  Score=308.91  Aligned_cols=250  Identities=20%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCC-----CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRET-----NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~-----g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .+|++++.||.|+||.||+|.+..+     +..||+|+++.... ......+.+|+.++..++||||+++++++.     
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----   78 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----   78 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            4688999999999999999987543     57899999975432 223345678999999999999999999983     


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                      .....++++||+. ++|.+++...                ..+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF  158 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence            3456899999996 6898888531                3478888999999999999999999999999999999999


Q ss_pred             CCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017334          168 ANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLK  244 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  244 (373)
                      .++.+||+|||+++......  .......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+...
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE  237 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999987543222  11223345678999999876 568899999999999999997 888998765544444


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+.+..                              .......++..+.+|+.+||+.+|.+||++.++++.
T Consensus       238 ~i~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQ------------------------------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCC------------------------------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            333210                              001124577889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-41  Score=308.44  Aligned_cols=248  Identities=25%  Similarity=0.360  Sum_probs=197.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ++|.+.+.||+|+||.||+|.+.     .++..+++|.+....  ......+.+|+.+++.++||||+++++++.     
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   77 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCG-----   77 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----
Confidence            57899999999999999999854     345669999885432  233345778999999999999999999984     


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                      .....++||||++ ++|.+++...+                .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~  157 (291)
T cd05094          78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG  157 (291)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence            3466999999996 79999986532                378899999999999999999999999999999999999


Q ss_pred             CCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017334          168 ANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLK  244 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  244 (373)
                      .++.++|+|||++.......  .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+...
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999987543221  11223456788999999876 578899999999999999998 999987665444333


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .+..  +                            .+.......+..+.+++.+||+.||++||++.++++
T Consensus       237 ~~~~--~----------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQ--G----------------------------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhC--C----------------------------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            2211  0                            001112345778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-41  Score=309.23  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=203.8

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~  106 (373)
                      --++|++.+.||+|+||.||+|.+..+|+.||+|.++..... .....+.+|+.++.... ||||+++++++.     ..
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~   86 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TD   86 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeee-----cC
Confidence            347899999999999999999999999999999999754322 23345667777666665 999999999984     44


Q ss_pred             ceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ...|++|||+++++.+++.. .+.+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus        87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            67999999999888877765 4578999999999999999999997 599999999999999999999999999987553


Q ss_pred             CCCccccceeeccccCchhhhhcC---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCChhhhcc
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCC---DNYGTSIDVWSVGCIFAELLGRKPIFPGTECL-NQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .... .....++..|+|||.+.+.   ..++.++|||||||++|+|++|+.||...... +.+..+   .....      
T Consensus       167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~------  236 (296)
T cd06618         167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI---LQEEP------  236 (296)
T ss_pred             CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH---hcCCC------
Confidence            2221 2233567889999998653   24788999999999999999999999653221 111111   11100      


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                   +   ..+   ....++..+.+||.+||..||.+||++.++++||||...
T Consensus       237 -------------~---~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         237 -------------P---SLP---PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             -------------C---CCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence                         0   000   011367789999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=303.46  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=198.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.++.....   ...+.+|+.+++.++||||+++++++     ...+.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEP   75 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEE-----ecCCC
Confidence            478999999999999999999875 4578999998654322   34577899999999999999999988     34467


Q ss_pred             EEEEeecC-CccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELM-DTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~-~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .|+||||+ +++|.+++....  .+++..+..++.|++.||.+||++|++||||||+||+++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            89999999 579999997644  689999999999999999999999999999999999999999999999999976542


Q ss_pred             CCc-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KNQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... .......+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||.+.+.......+.+...            
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------  222 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------  222 (261)
T ss_pred             CcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            211 1111222457999999876 578899999999999999998 9999987654444433321000            


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        .......+..+.+++.+||+.+|.+||++.++++
T Consensus       223 ------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         223 ------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                              0011346778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.6e-41  Score=302.91  Aligned_cols=246  Identities=25%  Similarity=0.351  Sum_probs=197.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.++||+|+||.||+|.+..+ ..||+|++......   ...+.+|+.+++.++||||+++++.+..      ..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~   74 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP   74 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence            47899999999999999999988755 46999998754332   2356789999999999999999987622      34


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .|+||||+. |+|.+++...  ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||.+.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            799999996 6999999753  3578999999999999999999999999999999999999999999999999975533


Q ss_pred             CCc-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KNQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... ......++..|+|||...+ ..++.++|+|||||++|+|++ |.+||.+....+....+....             
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------  220 (262)
T cd05071         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------  220 (262)
T ss_pred             cccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-------------
Confidence            221 1123345678999998865 568999999999999999998 889998765444333322100             


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                .       ......++..+.+++.+||+.||++||++.++++
T Consensus       221 ----------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         221 ----------R-------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             ----------C-------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                      0       0012346778999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=307.84  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=199.8

Q ss_pred             eecCceeeeeeeeccCceEEEEEEe-----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVN-----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      ...++|.+.+.||+|+||.||+|.+     ..++..+|+|.++.... ......+.+|+.+++++ +||||+++++.+. 
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-  109 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACT-  109 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEe-
Confidence            3457899999999999999999975     33556899999875432 23345677899999999 7999999999983 


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEccc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Df  177 (373)
                          ..+..|+||||+. |+|.+++....  .+++.++..++.||+.||+|||+++|+|+||||+|||++.++.+||+||
T Consensus       110 ----~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         110 ----IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             ----cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence                3466999999996 79999987543  3899999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          178 GLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      |++........  ......++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+.............     
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-----  259 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-----  259 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-----
Confidence            99875533221  1112345678999999876 568899999999999999997 99999776543332222110     


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                       ...       .......++.+.+++.+||..+|++|||+.++++
T Consensus       260 -----------------~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         260 -----------------GYR-------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             -----------------CCc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                             000       0011345788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=302.25  Aligned_cols=247  Identities=21%  Similarity=0.286  Sum_probs=197.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++......   ...+.+|+.+++.++||||+++++++     ...+..
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   74 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPI   74 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCce
Confidence            46889999999999999999886 4668999998654332   23567899999999999999999988     344679


Q ss_pred             EEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      |+||||++ ++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          75 FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            99999996 6999998753 468999999999999999999999999999999999999999999999999987553221


Q ss_pred             cc-ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 QF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .. .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+..+....+.....              
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------  219 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR--------------  219 (256)
T ss_pred             ccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc--------------
Confidence            11 111123457999999876 578899999999999999998 8999976654443333221000              


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                      .......++.+.+++.+||+.+|++|||+.++++.
T Consensus       220 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ----------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                            01123467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=307.67  Aligned_cols=257  Identities=21%  Similarity=0.328  Sum_probs=198.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCC--------------cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeee
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETN--------------EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL   94 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g--------------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   94 (373)
                      .++|++.+.||+|+||.||+|++..++              ..||+|+++... .......+.+|+++++.++|||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            368999999999999999999875432              359999987542 23334567899999999999999999


Q ss_pred             ceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017334           95 KDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKP  161 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  161 (373)
                      ++++.     ..+..++||||+. ++|.+++....            .+++..+..++.|++.||+|||++|++|+||||
T Consensus        83 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp  157 (295)
T cd05097          83 LGVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT  157 (295)
T ss_pred             EEEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence            99984     3467899999996 69999885432            367888999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh--CCCCCCCC
Q 017334          162 GNLLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG--RKPIFPGT  237 (373)
Q Consensus       162 ~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~~  237 (373)
                      +||+++.++.+||+|||++........  ......++..|+|||++.+ ..++.++|+|||||++|+|++  |..||...
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            999999999999999999875432211  1122344678999999876 568999999999999999987  66788776


Q ss_pred             CchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      +..+....+........                       ........+..++.+.+|+.+||..||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         237 SDEQVIENTGEFFRNQG-----------------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ChHHHHHHHHHhhhhcc-----------------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            55444443322111000                       00001112346788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.8e-41  Score=302.07  Aligned_cols=247  Identities=23%  Similarity=0.342  Sum_probs=198.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|+++++||+|+||.||+|... +++.||+|.+......   ...+.+|+.+++.++|+||+++++++..      .
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   73 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ------E   73 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc------C
Confidence            4688999999999999999999865 5788999998754332   3457789999999999999999988621      4


Q ss_pred             eEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..+++|||+. ++|.+++...  ..++..++..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  153 (260)
T cd05067          74 PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIE  153 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence            5899999996 7999988653  468899999999999999999999999999999999999999999999999987654


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+.....           
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------  221 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-----------  221 (260)
T ss_pred             CCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-----------
Confidence            221 11223345678999999866 568899999999999999998 9999987765444333321100           


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                         .......+.++.+++.+||..+|++||+++++++
T Consensus       222 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         222 -------------------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                               0112345678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-41  Score=306.00  Aligned_cols=266  Identities=22%  Similarity=0.321  Sum_probs=197.6

Q ss_pred             cCce-eeeeeeeccCceEEEEEE----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKY-VPIKPIGRGAYGIVCSSV----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y-~~~~~lg~G~~g~V~~a~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++| ++++.||+|+||+||++.    ...++..||+|.+..... ......+.+|+.+++.++||||+++++++...  
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   78 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--   78 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence            3566 999999999999998764    345788999999875432 23345677899999999999999999987432  


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                       ....+++||||+. ++|.+++.. ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        79 -~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          79 -GGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             -CCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence             2356899999996 699998876 4699999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCCcc---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKNQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .......   .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......  ...+.   ....    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~---~~~~----~  226 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMI---GPKQ----G  226 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhh---cccc----c
Confidence            5432211   122244567999999876 56889999999999999999999988654311  11111   0000    0


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ...............   .   ......++..+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         227 QMTVVRLIELLERGM---R---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ccchhhhhhhhhcCC---C---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000001111111100   0   0112456788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-41  Score=305.24  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=197.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ..+|++.++||+|+||.||+|...     .++..+|+|.+...  .......+.+|+++++.++|+||+++++++.    
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   77 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCT----   77 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEe----
Confidence            367889999999999999999743     35678999987643  3334456788999999999999999999883    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQ---------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                       .....+++|||+. ++|.+++...+               .+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus        78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~  156 (280)
T cd05092          78 -EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG  156 (280)
T ss_pred             -cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence             3356899999996 79999987543               478899999999999999999999999999999999999


Q ss_pred             CCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017334          168 ANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLK  244 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  244 (373)
                      .++.+||+|||++........  ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+...
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  235 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE  235 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence            999999999999875432211  1122344678999999876 568999999999999999997 899997655444333


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .+....                       .       ......+++.+.+||.+||+.||.+||++.++++
T Consensus       236 ~~~~~~-----------------------~-------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         236 CITQGR-----------------------E-------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHcCc-----------------------c-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            222100                       0       0112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.3e-41  Score=301.37  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=197.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++++.||+|+||.||+|.+. ++..+|+|.+......   ...+.+|+.+++.++|+|++++++++..      .
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~   73 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE------E   73 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC------C
Confidence            3578999999999999999999875 5667999998754333   2357789999999999999999988621      3


Q ss_pred             eEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..|++|||+. ++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            4799999996 6999998753  458999999999999999999999999999999999999999999999999997653


Q ss_pred             CCCc-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKNQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....            
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------------  220 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY------------  220 (260)
T ss_pred             CcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence            3221 1122334567999999866 568899999999999999998 899998765544444332100            


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                 .       .......+..+.+|+.+||..||++|||+.++.+
T Consensus       221 -----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         221 -----------R-------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             -----------C-------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                       0       0112346778999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.3e-42  Score=304.47  Aligned_cols=246  Identities=29%  Similarity=0.428  Sum_probs=194.1

Q ss_pred             eeeeeeeccCceEEEEEEeC----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           33 VPIKPIGRGAYGIVCSSVNR----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        33 ~~~~~lg~G~~g~V~~a~~~----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+.+.||.|.||.||+|...    ..+..|+||.++. .........+.+|++.+++++||||+++++++..     .+.
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~   75 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEP   75 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSS
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc-----ccc
Confidence            46789999999999999987    4567899999954 3344446778899999999999999999999963     245


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .++|+||+. |+|.+++...  ..+++..+..++.||+.||.|||+++++|+||+++||+++.++.+||+|||++.....
T Consensus        76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999996 7999999886  6899999999999999999999999999999999999999999999999999976622


Q ss_pred             CC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          186 KN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       186 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ..  ...........|+|||.+.+ ..++.++||||||+++||+++ |+.||...+..+....+.+..            
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~------------  222 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ------------  222 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE------------
T ss_pred             cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc------------
Confidence            11  12233456788999999876 458999999999999999999 789998776555444442210            


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        .......++..+.++|.+||..||++||++.++++
T Consensus       223 ------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 ------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             ------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                              00112346788999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.7e-41  Score=303.47  Aligned_cols=249  Identities=24%  Similarity=0.339  Sum_probs=199.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCc---EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||.||+|.++.++.   .+|+|.++.... ......+.+|+.+++.++||||+++++++.     ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   77 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KS   77 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            689999999999999999999865543   799999875433 233456788999999999999999999983     34


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +..|+||||++ ++|.+++... +.++..++..++.|++.||+|||++|++||||||+|||++.++.++|+|||++....
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            67999999996 6999998764 468999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCccc---cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 GKNQFM---TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ......   ....++..|+|||.+.+ ..++.++|+|||||++|++++ |..||...+..+....+.+...         
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---------  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR---------  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc---------
Confidence            322111   11223467999999876 568999999999999999885 9999977654443333321100         


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                           ......+++.+.+++.+||+.+|.+||++.++++
T Consensus       228 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 ---------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                 0012346778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-41  Score=299.80  Aligned_cols=243  Identities=25%  Similarity=0.373  Sum_probs=199.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||.|+||.||+|...  |+.||+|.+.....   ...++.+|+.+++.++|+||+++++++..     ...
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   74 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP   74 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence            368999999999999999999875  88999999975533   44567889999999999999999999843     466


Q ss_pred             EEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .++||||++ ++|.+++....  .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence            999999997 69999997655  699999999999999999999999999999999999999999999999999876532


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ...   ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+...               
T Consensus       155 ~~~---~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------------  215 (256)
T cd05039         155 GQD---SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------------  215 (256)
T ss_pred             ccc---cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------------
Confidence            221   2334567999999875 568899999999999999996 99999766543332222110               


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                              .       .......+++.+.++|.+||..+|++||++.++++
T Consensus       216 --------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 --------Y-------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             --------C-------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                    0       00112346788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.3e-41  Score=308.73  Aligned_cols=250  Identities=25%  Similarity=0.395  Sum_probs=197.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC-------CCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE-------TNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~-------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      .++|.+.+.||+|+||.||+|.+..       .+..+|+|.+..... ......+.+|+.+++.+ +||||+++++++. 
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCT-   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence            4789999999999999999998632       345699999875432 33455677899999999 5999999999983 


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                          ..+.+|++|||+. |+|.+++...                ..++..++..++.||+.||.|||++|++||||||+|
T Consensus        89 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N  164 (314)
T cd05099          89 ----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN  164 (314)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence                3366999999996 7999999653                247888999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      ||++.++.+||+|||+++........  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999755322111  111233467999999876 578999999999999999998 88999776544


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      +....+...                              ........++..+.+++.+||..||++|||+.++++
T Consensus       244 ~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         244 ELFKLLREG------------------------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHHHcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            444332210                              000112456778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-41  Score=315.17  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=195.5

Q ss_pred             CceeeeeeeeccCceEEEEEEe-----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVN-----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHR  103 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  103 (373)
                      ++|++.+.||+|+||.||+|++     ..+++.||||+++.... ......+.+|+.++..+ +||||+++++++...  
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            6899999999999999999984     35678999999975432 23345677899999999 589999999987432  


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc-------------------------------------------------------
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS-------------------------------------------------------  127 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-------------------------------------------------------  127 (373)
                        ...+++||||++ |+|.+++...                                                       
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              246899999996 7999988642                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc--cccce
Q 017334          128 ------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ--FMTEY  193 (373)
Q Consensus       128 ------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~  193 (373)
                                  ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  .....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                        1367778889999999999999999999999999999999999999999999876432211  11122


Q ss_pred             eeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh
Q 017334          194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS  272 (373)
Q Consensus       194 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (373)
                      .++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..............  .                    .
T Consensus       242 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~--------------------~  298 (343)
T cd05103         242 RLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--E--------------------G  298 (343)
T ss_pred             CCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh--c--------------------c
Confidence            34567999999876 578999999999999999996 9999976543222211110  0                    0


Q ss_pred             CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                       .      ........++.+.+++.+||+.||++||++.++++|
T Consensus       299 -~------~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         299 -T------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -C------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             0      001112356789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=299.91  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=199.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|.+......   ...+.+|+.+++.++|+||+++++++     ....
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   74 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEE   74 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeee-----ecCC
Confidence            3589999999999999999999976 4578999998754332   34577899999999999999999988     3345


Q ss_pred             eEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..++||||++ ++|.+++...  ..++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus        75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            6899999996 6999999764  368999999999999999999999999999999999999999999999999987653


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......++..|+|||.+.+ ..++.++|+||+||++|+|++ |++||.+.+.......+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------  223 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            211 11112233567999999876 568899999999999999998 99999876655444443221000          


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                          ......+..+.+++.+||+.+|++||++.++++
T Consensus       224 --------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 --------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             --------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                011234678999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.1e-41  Score=299.09  Aligned_cols=242  Identities=25%  Similarity=0.391  Sum_probs=195.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+|++.+.||+|+||.||++...  |..+|+|.+....    ....+.+|+.+++.++|+|++++++++..    ..+..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~   75 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL   75 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCce
Confidence            57999999999999999999764  7889999986432    23457789999999999999999987643    22568


Q ss_pred             EEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      |+||||++ ++|.+++....  .+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999996 69999987643  4789999999999999999999999999999999999999999999999998754332


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .   ....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+.+.                
T Consensus       156 ~---~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~----------------  215 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------------  215 (256)
T ss_pred             C---CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----------------
Confidence            2   22344567999999866 578899999999999999997 99999765543333322110                


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                             .       .....+.+++.+.+++.+||+.+|++|||+.++++
T Consensus       216 -------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         216 -------Y-------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -------C-------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                   0       00122456788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.7e-41  Score=327.80  Aligned_cols=274  Identities=23%  Similarity=0.311  Sum_probs=181.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC----CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-C
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET----NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-R  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~----g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~  103 (373)
                      .++|++.+.||+|+||.||+|.+..+    +..||+|++........    ...+  .++...+.++..+...+.... .
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            47899999999999999999999988    99999998764321111    1111  122222333333333322211 1


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQA--------------------LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPG  162 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  162 (373)
                      ......++|+||++ ++|.+++.....                    .....++.++.||+.||+|||++||+||||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            34467999999997 689988865321                    123456789999999999999999999999999


Q ss_pred             ceEEcC-CCCeEEcccCcccccCCC-CccccceeeccccCchhhhhcCC---------------------CCCchhhhHH
Q 017334          163 NLLVNA-NCDLKICDFGLARTSNGK-NQFMTEYVVTRWYRAPELLLCCD---------------------NYGTSIDVWS  219 (373)
Q Consensus       163 Nill~~-~~~~kL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Diws  219 (373)
                      |||++. ++.+||+|||++...... .......++++.|+|||.+....                     .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986 579999999999754322 22335568899999999764321                     2344669999


Q ss_pred             HHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCc---cccCCCCCHHHHHHH
Q 017334          220 VGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPF---SRLYPDAHPLAIDLL  296 (373)
Q Consensus       220 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~~ll  296 (373)
                      +||++|+|+++..++  .+....+..+....+.....            +............   ............+||
T Consensus       365 lGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi  430 (566)
T PLN03225        365 AGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVA------------WRKLVEPRASPDLRRGFEVLDLDGGAGWELL  430 (566)
T ss_pred             HHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHH------------HHHhhccccchhhhhhhhhccccchHHHHHH
Confidence            999999999865443  33333333222222211111            1111110000000   011122344567999


Q ss_pred             HhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          297 QKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       297 ~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .+||+.||++|||+.++|+||||...
T Consensus       431 ~~mL~~dP~kR~ta~e~L~Hpff~~~  456 (566)
T PLN03225        431 KSMMRFKGRQRISAKAALAHPYFDRE  456 (566)
T ss_pred             HHHccCCcccCCCHHHHhCCcCcCCC
Confidence            99999999999999999999999864

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-41  Score=306.98  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=199.6

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeC-------CCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeec
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNR-------ETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMM   99 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~-------~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~   99 (373)
                      ...+|.+.+.||+|+||.||+|++.       .++..+|+|.+.... .......+.+|+.+++.+ +||||+++++.+ 
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-   90 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-   90 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEE-
Confidence            4588999999999999999999752       234579999986542 233445678999999999 799999999998 


Q ss_pred             CCCCCCcceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 017334          100 PSHRRNFKDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPG  162 (373)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  162 (373)
                          ......|+||||+. |+|.+++...                ..++...+..++.||+.||+|||++|++||||||+
T Consensus        91 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  166 (304)
T cd05101          91 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR  166 (304)
T ss_pred             ----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence                34467899999996 6999998753                24677889999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEcccCcccccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCc
Q 017334          163 NLLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTEC  239 (373)
Q Consensus       163 Nill~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  239 (373)
                      ||+++.++.+||+|||++.........  .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  245 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  245 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            999999999999999999765432211  122344677999999876 568999999999999999997 7889877654


Q ss_pred             hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+....+...   .                           .......++..+.+||.+||..+|.+||++.++++.
T Consensus       246 ~~~~~~~~~~---~---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 EELFKLLKEG---H---------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHcC---C---------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            4433332210   0                           001123467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.2e-41  Score=305.01  Aligned_cols=260  Identities=23%  Similarity=0.344  Sum_probs=204.0

Q ss_pred             ceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEcccccc--ChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRR  104 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  104 (373)
                      +|++.+.||+|++|.||++.+.   .+++.||+|++.+...  .......+.+|+.+++.++ ||||+++++.+     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4889999999999999999864   4678899999875422  1223345678999999995 99999999888     4


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .....|+||||+. ++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            4467999999996 699999987788999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCc-cccceeeccccCchhhhhcCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          184 NGKNQ-FMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       184 ~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ..... ......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+.            
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------  223 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR------------  223 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH------------
Confidence            33221 122346789999999986532 3678999999999999999999999643322111111110            


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC---HHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t---~~eil~hp~~~~~  322 (373)
                             .....        ......+++.+.++|.+||+.||++|||   +.++|+||||+.+
T Consensus       224 -------~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         224 -------ILKSK--------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             -------HHccC--------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence                   00000        0112346788999999999999999998   5678999999865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-41  Score=311.10  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=198.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC-------CcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET-------NEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-------g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      ..+|++.+.||+|+||.||+|++...       +..+|+|.+.... .......+.+|+.+++++ +||||+++++++. 
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc-
Confidence            46899999999999999999986432       2368999886432 233445678899999999 7999999999983 


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                          ..+.+++++||+. |+|.+++....                .++..++..++.||+.||+|||++|++||||||+|
T Consensus        89 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          89 ----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence                3467999999996 69999986532                36778889999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      ||++.++.+||+|||+++........  .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999998765332211  112233467999999876 678899999999999999997 88999876654


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP  317 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp  317 (373)
                      +....+....                              ........+..+.+|+.+||+.+|++||++.+++++-
T Consensus       244 ~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         244 ELFKLLKEGH------------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            4433332100                              0011234677899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.7e-41  Score=301.60  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=195.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCc----EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNE----KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ++|++++.||+|+||+||+|.+..+|.    ++++|.+... .......++..|+.+++.+.||||+++++++..     
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence            689999999999999999999987776    4777776432 222333456778889999999999999998632     


Q ss_pred             cceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                       ...++++||+. |+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++..
T Consensus        81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence             34788999996 799999975 457899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          184 NGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       184 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ....  .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..  +.        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~--------  228 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK--GE--------  228 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--CC--------
Confidence            3221  12233456778999999876 568999999999999999997 9999977654332222211  00        


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                    .   .   ......+..+.+++.+||..||++|||+.++++
T Consensus       229 --------------~---~---~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         229 --------------R---L---AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             --------------c---C---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                          0   0   001124567889999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.9e-41  Score=297.89  Aligned_cols=241  Identities=21%  Similarity=0.341  Sum_probs=191.0

Q ss_pred             eeeccCceEEEEEEeC--CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           37 PIGRGAYGIVCSSVNR--ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      .||+|+||.||+|.++  .++..||+|++.... .......+.+|+.++++++||||+++++++..      ...++|||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e   74 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME   74 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence            3899999999999765  456679999986543 23344567799999999999999999998721      35899999


Q ss_pred             cCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc--
Q 017334          115 LMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM--  190 (373)
Q Consensus       115 ~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~--  190 (373)
                      |++ ++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++..........  
T Consensus        75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            996 699998874 4578999999999999999999999999999999999999999999999999987543322211  


Q ss_pred             -cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          191 -TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       191 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                       ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+...  .                
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~----------------  215 (257)
T cd05115         155 RSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--K----------------  215 (257)
T ss_pred             cCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--C----------------
Confidence             11223567999999876 568899999999999999995 99999876554433322210  0                


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                  .....+..++++.++|.+||..||++||++.++.+
T Consensus       216 ------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         216 ------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        00122456788999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.8e-41  Score=297.76  Aligned_cols=243  Identities=23%  Similarity=0.320  Sum_probs=195.8

Q ss_pred             eeeeccCceEEEEEEeCC-CCc--EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEE
Q 017334           36 KPIGRGAYGIVCSSVNRE-TNE--KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~-~g~--~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      +.||+|++|.||+|.+.. +++  .+|||.+...... .....+.+|+.++++++||||+++++.+.     . ...++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEE
Confidence            468999999999999865 333  6999999765443 45567789999999999999999999983     3 678999


Q ss_pred             eecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          113 YELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       113 ~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      |||++ ++|.+++....  .+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99996 79999997654  6899999999999999999999999999999999999999999999999998765432211


Q ss_pred             ---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          190 ---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       190 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                         .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....              
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------  218 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE--------------  218 (257)
T ss_pred             eecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--------------
Confidence               112346778999999866 578999999999999999998 9999976655544443322000              


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                .     .......+..+.+++.+||+.+|++||++.++++
T Consensus       219 ----------~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         219 ----------R-----LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ----------c-----CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                      0     0011245678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.1e-41  Score=300.16  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=198.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCc---EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||.||+|.++.+|+   .||+|.+.... .......+..|+.+++.++||||+++++++     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~   77 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKS   77 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCC
Confidence            579999999999999999999887765   59999987543 333455678999999999999999999998     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ...++||||++ ++|.+++... +.+++.+++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++....
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            67899999996 6999888753 568999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCc--ccccee---eccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          185 GKNQ--FMTEYV---VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       185 ~~~~--~~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ....  ......   .+..|+|||.+.+ ..++.++||||+||++|+|++ |.+||...+..+....+.....       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~-------  229 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR-------  229 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-------
Confidence            2211  111111   2357999999876 578999999999999999885 9999977654443333321000       


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                          .   ...+.++..+.+++.+||..+|.+||++.++++
T Consensus       230 --------------------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         230 --------------------L---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             --------------------C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                0   011346778999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.2e-41  Score=303.22  Aligned_cols=264  Identities=17%  Similarity=0.175  Sum_probs=194.4

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHH---------HHHHHHHHHHhhCCCCCeeee
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDA---------LRTLRELKLLRHLQHENVIAL   94 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~   94 (373)
                      ...++|++.+.||+|+||+||+|.+..+   +..+|+|+...........         .....++..+..+.|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3458999999999999999999998877   6778888654322111111         112234455666789999999


Q ss_pred             ceeecCCCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEE
Q 017334           95 KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL  174 (373)
                      ++...... ......++++|++..++.+.+......++..++.++.|++.||+|||+++|+||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            98764332 12235688899988888777776666789999999999999999999999999999999999999999999


Q ss_pred             cccCcccccCCCC-------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017334          175 CDFGLARTSNGKN-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLII  247 (373)
Q Consensus       175 ~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  247 (373)
                      +|||+|+......       .......||+.|+|||+..+ ..++.++|||||||++|+|++|.+||.+...........
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999997543211       11123468999999999876 678999999999999999999999998764322211111


Q ss_pred             HHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          248 NILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .                  .++...+....     ...+..++.+.++++.|+..+|++||+..++++
T Consensus       247 ~------------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 K------------------CDFIKRLHEGK-----IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             H------------------HHHHHHhhhhh-----hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1                  00111111000     012345688999999999999999999999875

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5e-41  Score=304.09  Aligned_cols=248  Identities=25%  Similarity=0.374  Sum_probs=195.1

Q ss_pred             ceeeeeeeeccCceEEEEEEeCC-----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRE-----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~-----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+..... ......+.+|+.+++.++||||+++++.+.     .
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   74 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACS-----Q   74 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----c
Confidence            57889999999999999998753     235789988865432 233456778999999999999999999883     3


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS------------------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLK  160 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  160 (373)
                      ....++++||+. ++|.+++...                        ..+++..+..++.|++.||+|||++|++|||||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik  154 (290)
T cd05045          75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA  154 (290)
T ss_pred             CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence            466899999996 7999887642                        247788899999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEcccCcccccCCCCcc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 017334          161 PGNLLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGT  237 (373)
Q Consensus       161 p~Nill~~~~~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  237 (373)
                      |+|||+++++.+||+|||++.........  .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999998754322211  122244678999999866 578999999999999999998 99999776


Q ss_pred             CchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ........+....                         .     ......++..+.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~~~~~-------------------------~-----~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         234 APERLFNLLKTGY-------------------------R-----MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CHHHHHHHHhCCC-------------------------C-----CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            5433322221100                         0     0112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.3e-41  Score=298.78  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=199.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCc---EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|...+.||+|+||.||+|.+..++.   .+|+|.+..... ......+..|+.+++.++||||+++.+++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF   78 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence            578889999999999999999876665   799999865432 33345677899999999999999999998     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +..|+||||++ ++|.+++... +.+++.++..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            67899999997 6999988753 578999999999999999999999999999999999999999999999999987553


Q ss_pred             CCCcc-cc--ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 GKNQF-MT--EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~~~~~-~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ..... ..  ....+..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......        
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~--------  229 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL--------  229 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC--------
Confidence            22111 11  1122456999999876 568899999999999999987 99999776654444443221000        


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                         +   ....++..+.+++.+||+.+|++||++.++++
T Consensus       230 -------------------~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         230 -------------------P---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             -------------------C---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                               0   01235678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-40  Score=296.96  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=196.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....   ....+.+|+.+++.++|||++++++++..      ..
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~   74 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP   74 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence            47899999999999999999987655 4699998864332   22356789999999999999999988621      34


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            789999997 6999999754  3478899999999999999999999999999999999999999999999999976533


Q ss_pred             CC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .. .......++..|+|||...+ ..++.++|||||||++|+|++ |.+||.+....+....+.+..             
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  220 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-------------  220 (260)
T ss_pred             CcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            22 11223345678999998865 568899999999999999998 899998765544333322100             


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                .       .......+..+.+++++||..||++||+++++++
T Consensus       221 ----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         221 ----------R-------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ----------C-------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                      0       0112346778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8.1e-41  Score=297.07  Aligned_cols=247  Identities=27%  Similarity=0.417  Sum_probs=200.0

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCC----cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETN----EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +++.+.||.|+||.||++.+..++    ..+|+|++...... .....+..|+.+++.++|+||+++++.+..     .+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~   74 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EE   74 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CC
Confidence            356789999999999999998766    89999999654322 245567789999999999999999999843     36


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..+++|||+. ++|.+++.....  +++..+..++.||+.||++||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            7999999996 699999976544  9999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccc-ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKNQFMT-EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ....... ...+++.|+|||.+.+ ..++.++|+|||||++++|++ |.+||...+.......+.+..            
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~------------  221 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY------------  221 (258)
T ss_pred             cccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------
Confidence            3311111 1236788999999855 678999999999999999997 889997765544444332200            


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        ........+..+.+++.+||+.||++|||+.++++
T Consensus       222 ------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 ------------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             ------------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                              00112336788999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.4e-41  Score=303.54  Aligned_cols=257  Identities=22%  Similarity=0.310  Sum_probs=195.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC----------------CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCee
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE----------------TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI   92 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~----------------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   92 (373)
                      .++|++.+.||+|+||.||+|.+..                ++..+|+|++.... .......+.+|+.+++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            3679999999999999999986432                34579999986542 333445678999999999999999


Q ss_pred             eeceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017334           93 ALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ-----------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLK  160 (373)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  160 (373)
                      ++++++..     ....++||||+. ++|.+++....           .+++..+..++.||+.||+|||++|++|+|||
T Consensus        83 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk  157 (296)
T cd05095          83 RLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA  157 (296)
T ss_pred             eEEEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence            99999843     356899999996 69999987542           36677899999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh--CCCCCCC
Q 017334          161 PGNLLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG--RKPIFPG  236 (373)
Q Consensus       161 p~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--g~~pf~~  236 (373)
                      |+|||++.++.++|+|||++........  ......++..|+|||...+ ..++.++|+|||||++|+|++  |..||..
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            9999999999999999999875432211  1112234577999998776 568999999999999999997  7788876


Q ss_pred             CCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          237 TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .+..+..........                    ....   .......+.+++.+.+|+.+||+.||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~--------------------~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         237 LSDEQVIENTGEFFR--------------------DQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             cChHHHHHHHHHHHh--------------------hccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            554433322211100                    0000   0000112346688999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.6e-41  Score=315.27  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=197.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSH  102 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  102 (373)
                      .++|.+.+.||+|+||.||+|+++     .++..||+|+++..... .....+.+|+.++..+. ||||+++++++..  
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--  112 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTK--  112 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence            367889999999999999999864     35568999999764332 23346779999999997 9999999999843  


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcC-----------------------------------------------------
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQ-----------------------------------------------------  128 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------------------------------------  128 (373)
                         .+.+++||||+. |+|.+++...+                                                     
T Consensus       113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence               367999999996 79999886431                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334          129 ---------------------------------------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus       129 ---------------------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                                                                   .++...+..++.||+.||+|||+.+++||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         35667788899999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      ||++.++.+||+|||++........  ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            9999999999999999875432211  1123356788999999876 568899999999999999997 88998765433


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      +.......  ..                    ..       ......++.++.+|+.+||..+|.+||++.++++.
T Consensus       349 ~~~~~~~~--~~--------------------~~-------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 EQFYNAIK--RG--------------------YR-------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHH--cC--------------------CC-------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33222111  00                    00       01123467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.3e-41  Score=302.71  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=197.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++|++++.||+|+||.||+|.+.     .++..||+|++..... ......+.+|+.+++.+.||||+++++++.    
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCA----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEc----
Confidence            368999999999999999999874     3678899999875432 233456778999999999999999999883    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS----------------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLK  160 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  160 (373)
                       .....++||||++ |+|.+++...                      ..+++.++..++.||+.||+|||++|++|||||
T Consensus        79 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~  157 (288)
T cd05050          79 -VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA  157 (288)
T ss_pred             -CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence             3467899999996 6999998642                      236788899999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCC
Q 017334          161 PGNLLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGT  237 (373)
Q Consensus       161 p~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  237 (373)
                      |+||+++.++.++|+|||++.......  ........+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999987543221  11122234567999999876 578999999999999999996 88888766


Q ss_pred             CchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ...+....+...                              ........++..+.+||.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 AHEEVIYYVRDG------------------------------NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CHHHHHHHHhcC------------------------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            544433332210                              000112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-40  Score=299.84  Aligned_cols=267  Identities=23%  Similarity=0.376  Sum_probs=198.1

Q ss_pred             cCceeeeeeeeccCceEEEEEE----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSV----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..+|++++.||+|+||.||+|.    +..++..||+|++...  .......+.+|+.+++.++||||+++++++...   
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---   77 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---   77 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---
Confidence            3689999999999999999997    4567889999998643  233345677899999999999999999987543   


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      +...+++||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            2256899999996 7999998754 4689999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCcc---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKNQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .......   .....++..|+|||.+.+ ..++.++|||||||++|+|++|..++..... ..    ....+......  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~----~~~~~~~~~~~--  229 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EF----MRMMGNDKQGQ--  229 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hh----hhhcccccccc--
Confidence            5432211   111123446999999876 5688999999999999999998776543321 11    11111110000  


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                       .....+........   .   ......++..+.+|+.+||..+|++|||+.++++
T Consensus       230 -~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         230 -MIVYHLIELLKNNG---R---LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             -cchHHHHHHHhcCC---c---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             00000111111110   0   0112457788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.3e-41  Score=297.21  Aligned_cols=228  Identities=22%  Similarity=0.311  Sum_probs=185.8

Q ss_pred             cCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCC-cc
Q 017334           41 GAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TD  119 (373)
Q Consensus        41 G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~  119 (373)
                      |.+|.||+|+++.+|+.||+|++.....       ..+|...+....||||+++++.+     ......++||||+. |+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCC
Confidence            8899999999999999999999975421       22344555566799999999998     44467999999996 69


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceeecccc
Q 017334          120 LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWY  199 (373)
Q Consensus       120 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y  199 (373)
                      |.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+......   .....++..|
T Consensus        72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y  148 (237)
T cd05576          72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMY  148 (237)
T ss_pred             HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccc
Confidence            9999988778999999999999999999999999999999999999999999999999987655332   2234557789


Q ss_pred             CchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCC
Q 017334          200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGT  279 (373)
Q Consensus       200 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (373)
                      +|||.+.+ ..++.++|+||+||++|+|++|.+||......     +            ..                  .
T Consensus       149 ~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~------------------~  192 (237)
T cd05576         149 CAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT------------------H  192 (237)
T ss_pred             cCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc------------------c
Confidence            99998865 56789999999999999999999887432100     0            00                  0


Q ss_pred             CccccCCCCCHHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCC
Q 017334          280 PFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-----TEALQHPYM  319 (373)
Q Consensus       280 ~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~eil~hp~~  319 (373)
                      ......+.+++.+.++|.+||+.||++|+++     .++++||||
T Consensus       193 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         193 TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            0001224578889999999999999999986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-40  Score=298.30  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=199.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCC-----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRE-----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~-----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ++|++++.||+|+||.||+|+.+.     +.+.+++|.+.... .......+.+|++++++++|+||+++++++     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~   78 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLC-----R   78 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEE-----C
Confidence            689999999999999999999754     34679999886432 222345678899999999999999999988     3


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEE
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQ---------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI  174 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL  174 (373)
                      .....++||||++ |+|.+++....         .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence            3466899999997 79999997655         6899999999999999999999999999999999999999999999


Q ss_pred             cccCcccccCCC-CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCC
Q 017334          175 CDFGLARTSNGK-NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       175 ~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      +|||++...... ........++..|+|||.+.+ ...+.++|||||||++|+|++ |..||...........+...  .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~  235 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--K  235 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--C
Confidence            999998643221 112234466778999999876 467899999999999999997 78898765443333222110  0


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                                ..+ .....++..+.+++.+||+.||++||++.++++.
T Consensus       236 --------------------------~~~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         236 --------------------------LEL-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             --------------------------cCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                      000 0123467889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=298.95  Aligned_cols=242  Identities=26%  Similarity=0.350  Sum_probs=189.5

Q ss_pred             eeeeccCceEEEEEEeCCCCc--EEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcceEEEE
Q 017334           36 KPIGRGAYGIVCSSVNRETNE--KVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~--~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      +.||+|+||.||+|.++.+|.  .+++|.+... ........+.+|+.++..+ +||||+++++++.     ..+..|+|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv   74 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLA   74 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEE
Confidence            368999999999999988876  4688887643 2233444677899999999 6999999999984     33568999


Q ss_pred             eecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEc
Q 017334          113 YELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       113 ~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      |||+. |+|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+
T Consensus        75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence            99996 79999987532                47889999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      |||++........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...     
T Consensus       155 dfgl~~~~~~~~~-~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-----  227 (270)
T cd05047         155 DFGLSRGQEVYVK-KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-----  227 (270)
T ss_pred             CCCCccccchhhh-ccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-----
Confidence            9999853221111 111223567999999865 578999999999999999996 99999776544433322110     


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                               .........+..+.+|+.+||..||.+|||+.++++
T Consensus       228 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         228 -------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             -------------------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                     000112346678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-41  Score=295.64  Aligned_cols=242  Identities=27%  Similarity=0.390  Sum_probs=193.3

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeec
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYEL  115 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~  115 (373)
                      ++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.++++++|+||+++++++     ......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEc
Confidence            468999999999999887 999999998765433 3445678899999999999999999998     444679999999


Q ss_pred             CC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc--c
Q 017334          116 MD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM--T  191 (373)
Q Consensus       116 ~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~--~  191 (373)
                      +. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..........  .
T Consensus        74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            96 689999865 3568899999999999999999999999999999999999999999999999987553221111  1


Q ss_pred             ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHH
Q 017334          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI  270 (373)
Q Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  270 (373)
                      ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...........+....                    
T Consensus       154 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--------------------  212 (251)
T cd05041         154 LKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------------------  212 (251)
T ss_pred             cCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------------------
Confidence            1223566999999876 578999999999999999998 889997765433222221100                    


Q ss_pred             HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                             .   .......+..+.+++.+||..+|.+|||+.++++
T Consensus       213 -------~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 -------R---MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -------C---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                   0   0011345778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-40  Score=300.96  Aligned_cols=267  Identities=22%  Similarity=0.374  Sum_probs=198.8

Q ss_pred             CceeeeeeeeccCceEEEEEEe----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVN----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ..|++++.||+|+||.||+|..    ..++..||+|.++.... ......+.+|+.+++.++||||+++++++...   .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~   79 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTED---G   79 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence            4578999999999999999974    46788999999865432 33345678999999999999999999988442   2


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ....++||||++ ++|.+++... ..+++.++..++.||+.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            256899999996 6999998654 35899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          184 NGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       184 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .....   ......++..|+|||++.+ ..++.++|||||||++|+|+++..|+.....     ......+....+.   
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~---  230 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQM---  230 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccc---
Confidence            43221   1223456678999999876 5688999999999999999998766432210     0111111110000   


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                       ...........   .   ........++..+.+|+.+||+.||.+||++.+++++
T Consensus       231 -~~~~~~~~~~~---~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         231 -TVTRLVRVLEE---G---KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             -cHHHHHHHHHc---C---ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             00000011110   0   0111234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.3e-40  Score=295.03  Aligned_cols=247  Identities=22%  Similarity=0.351  Sum_probs=197.3

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||++.+. .+..+|+|.+...   ......+.+|+.+++.++|+||+++++.+..      .
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~   73 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------E   73 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------C
Confidence            3589999999999999999999865 4567999988643   2234467789999999999999999988732      4


Q ss_pred             eEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..+++|||++ ++|.+++...  ..++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+....
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            5899999996 6999999753  457888899999999999999999999999999999999999999999999987543


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......++..|+|||++.+ ..++.++|+|||||++|++++ |.+||.+.+.......+.....           
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  221 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-----------  221 (260)
T ss_pred             CCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------
Confidence            221 11222344567999999876 568899999999999999998 9999987654443333221000           


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                         .......+..+.+++.+||+.||++||++.++++
T Consensus       222 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         222 -------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             -------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                               0112346788999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=298.16  Aligned_cols=249  Identities=25%  Similarity=0.328  Sum_probs=199.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCc----EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNE----KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..+|++.+.||+|+||+||+|.++.+|.    .+|+|.+..... ......+.+|+.+++.++||||+++++++..    
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence            4789999999999999999999877765    589998865533 3344567789999999999999999998843    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        ...++||||+. |+|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||.+..
T Consensus        81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence              46899999996 7999998764 5689999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCccc--cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKNQFM--TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ........  ....++..|+|||.+.. ..++.++|+|||||++|++++ |.+||.+....+....+...  .       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~-------  228 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG--E-------  228 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC--C-------
Confidence            54322211  11223567999999865 578899999999999999998 99999776544333322210  0       


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                           .....+..+..+.+++.+||..||++||++.++++
T Consensus       229 ---------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         229 ---------------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                 00111335677999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-40  Score=292.08  Aligned_cols=242  Identities=24%  Similarity=0.374  Sum_probs=192.0

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeec
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYEL  115 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~  115 (373)
                      +.||+|+||.||+|... ++..+|+|++..... ......+.+|+.+++.++||||+++++++.     .....++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEEC
Confidence            36899999999999864 688999999875543 233345778999999999999999999983     34568999999


Q ss_pred             CC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc-cc
Q 017334          116 MD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM-TE  192 (373)
Q Consensus       116 ~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~  192 (373)
                      +. ++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......... ..
T Consensus        74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            96 7999888653 468899999999999999999999999999999999999999999999999986543221111 11


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHH
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK  271 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      ..++..|+|||++.+ ..++.++|||||||++|++++ |..||.+.........+...   .                  
T Consensus       154 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~---~------------------  211 (250)
T cd05085         154 KQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---Y------------------  211 (250)
T ss_pred             CCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---C------------------
Confidence            233567999999866 568899999999999999998 99999776544333322110   0                  


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                               .......++..+.+++.+||+.+|++||++.++++
T Consensus       212 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 ---------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                     00112346788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.7e-40  Score=296.18  Aligned_cols=250  Identities=25%  Similarity=0.370  Sum_probs=199.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ..+|.+.+.||+|+||.||+|.+...   ...+|||....... ......+.+|+.+++.++||||+++++++..     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence            46799999999999999999987644   35699998865432 3344567889999999999999999998732     


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                       ...|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||++...
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence             34689999996 79999997643 5899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcc-ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          184 NGKNQF-MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       184 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ...... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.+..           
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----------  225 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-----------  225 (270)
T ss_pred             ccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            332211 112233467999999865 578899999999999999985 999998776544433322100           


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                         .....+.+++.+.++|.+||..+|.+|||+.+++..
T Consensus       226 -------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         226 -------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             -------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                               001224567889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.1e-40  Score=298.41  Aligned_cols=251  Identities=19%  Similarity=0.327  Sum_probs=199.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .++|++.+.||+|+||.||+|.+..    ++..+++|++... ........+.+|+.+++.++||||+++++++...   
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence            4789999999999999999999876    3578999988643 3444456678999999999999999999987543   


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS--------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                       ....++++||+. ++|.+++...        ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+
T Consensus        81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             256899999996 7999988653        458899999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCC
Q 017334          176 DFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       176 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      |||+++.......  ......++..|+|||.+.+ ..++.++|||||||++|++++ |++||...+..+....+..   .
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~  235 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---G  235 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc---C
Confidence            9999975432211  1122344667999999876 568999999999999999998 9999977654333222211   0


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .                          .+ .....+++.+.+++.+||..||++|||+.++++
T Consensus       236 ~--------------------------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         236 Y--------------------------RL-AQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             C--------------------------CC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            0                          00 011345778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.8e-41  Score=299.72  Aligned_cols=238  Identities=17%  Similarity=0.271  Sum_probs=186.9

Q ss_pred             eeeeccCceEEEEEEeCCCCc-------EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           36 KPIGRGAYGIVCSSVNRETNE-------KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~-------~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      +.||+|+||.||+|.++.++.       .+|+|.+....  ......+.+|+.+++.+.||||+++++++..     ...
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~   73 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDE   73 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCC
Confidence            468999999999999876554       38888875432  2334456789999999999999999999844     356


Q ss_pred             EEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC--------eEEcccC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD--------LKICDFG  178 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~--------~kL~Dfg  178 (373)
                      .++||||++ |+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.        ++++|||
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            899999996 69999997644 5899999999999999999999999999999999999987765        6999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      ++......    ....++..|+|||++.+...++.++|||||||++|+|++| .+||...+.........          
T Consensus       154 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~----------  219 (258)
T cd05078         154 ISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE----------  219 (258)
T ss_pred             cccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH----------
Confidence            88654321    2346788899999997656688999999999999999998 47765544322211110          


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                    ..        .......+..+.+||.+||+.||++|||++++++.
T Consensus       220 --------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         220 --------------DR--------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             --------------cc--------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                          00        01123345778999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-40  Score=297.24  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=198.4

Q ss_pred             eeeeeeeeccCceEEEEEEeCC---CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC-cc
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRE---TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN-FK  107 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~-~~  107 (373)
                      |.+.+.||+|+||.||+|....   +++.+|||++............+.+|+.+++.++||||+++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6778899999999999998643   5789999999776655566667889999999999999999999886542211 12


Q ss_pred             eEEEEeecCC-ccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          108 DVYLVYELMD-TDLHQIIKSS------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      ..++++||+. |+|.+++...      ..++...++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            3578899996 7888776422      24788999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          181 RTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      +.......  ......+++.|++||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...  .     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~-----  232 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--N-----  232 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC--C-----
Confidence            75532211  1122344577999999876 568899999999999999998 88999776543333322210  0     


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                             .....+..++.+.+++.+||+.+|++||++.+++++
T Consensus       233 -----------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 -----------------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             -----------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                   001123467789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=307.73  Aligned_cols=267  Identities=25%  Similarity=0.443  Sum_probs=213.1

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-----hHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-----RVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      .++.+|.++..||+|||+.||+|.+....+.||+|+-......     ........+|..|.+.|.||.||++|++|..+
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            4789999999999999999999999999999999986433221     12223456999999999999999999999644


Q ss_pred             CCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEc---CCCCeEEc
Q 017334          102 HRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVN---ANCDLKIC  175 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~---~~~~~kL~  175 (373)
                      .    ..+|.|+|||+| +|.-+++.++.+++.+++.|+.||+.||.||....  |+|-||||.|||+-   ..|.+||+
T Consensus       540 t----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 T----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             c----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence            2    568999999986 88889999999999999999999999999999875  99999999999994   45789999


Q ss_pred             ccCcccccCCCC-------ccccceeeccccCchhhhhcC---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q 017334          176 DFGLARTSNGKN-------QFMTEYVVTRWYRAPELLLCC---DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL  245 (373)
Q Consensus       176 Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  245 (373)
                      |||+++...+..       ...+...||.||++||.+.-.   ...+.++||||+|||+|+++.|+.||........+-.
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            999998876432       233456889999999987532   3468899999999999999999999966533222211


Q ss_pred             HHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          246 IINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      --.++...                        ...|.. -|.+++++++||++||..--++|....++-.||+|.+-
T Consensus       696 eNTIlkAt------------------------EVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  696 ENTILKAT------------------------EVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhchhcce------------------------eccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            11111100                        001100 15689999999999999999999999999999999763

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.2e-40  Score=292.46  Aligned_cols=247  Identities=23%  Similarity=0.348  Sum_probs=197.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+|++.+.||.|+||.||+|.+. ++..+|+|++......   ...+.+|++++++++|||++++++++     ......
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   74 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPI   74 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCce
Confidence            47899999999999999999875 4678999998754333   23467899999999999999999998     344678


Q ss_pred             EEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++||||+. ++|.+++... +.+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.+.......
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            99999996 6999888754 568999999999999999999999999999999999999999999999999987543221


Q ss_pred             c-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 Q-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      . ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...........+....               
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------  218 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF---------------  218 (256)
T ss_pred             ccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC---------------
Confidence            1 1112234568999999876 568899999999999999997 999997665443333321100               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                              .     .  ......+..+.+|+.+||+.+|++||++.+++++
T Consensus       219 --------~-----~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 --------R-----L--YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             --------C-----C--CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                    0     0  0012256789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5e-40  Score=294.32  Aligned_cols=248  Identities=24%  Similarity=0.295  Sum_probs=186.9

Q ss_pred             eeeeccCceEEEEEEeC--CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNR--ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|...  .++..+|+|.+...... .....+.+|+.+++.++||||+++++.+.     .....++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~   74 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVM   74 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEE
Confidence            36899999999999754  35678999998755332 33346778999999999999999999883     345689999


Q ss_pred             ecCC-ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          114 ELMD-TDLHQIIKSSQ-----ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ||++ |+|.+++....     ..++..++.++.|++.||+|||+.|++|+||||+||+++.++++||+|||++.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9996 79999986432     35667788999999999999999999999999999999999999999999986543221


Q ss_pred             c--cccceeeccccCchhhhhcCC------CCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          188 Q--FMTEYVVTRWYRAPELLLCCD------NYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       188 ~--~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      .  ......++..|+|||++.+..      .++.++||||+||++|+|++ |.+||......+.......  +..     
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~-----  227 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--EQQ-----  227 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh--ccc-----
Confidence            1  112345678899999985421      35789999999999999995 9999976554433222111  000     


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                     .   ...........++.+.+++++|+ .+|++|||+++|+.
T Consensus       228 ---------------~---~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         228 ---------------L---KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ---------------C---CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                           0   00001111235677899999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-40  Score=295.76  Aligned_cols=238  Identities=20%  Similarity=0.279  Sum_probs=184.6

Q ss_pred             eeeeccCceEEEEEEeCC------------CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           36 KPIGRGAYGIVCSSVNRE------------TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~------------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      +.||+|+||.||+|....            ....+++|++....  ......+.+|+.+++.++||||+++++++..   
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~---   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR---   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence            468999999999997532            23368899875432  2333456788999999999999999999843   


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC-------eEE
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-------LKI  174 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~-------~kL  174 (373)
                        ....++||||++ |+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.       +|+
T Consensus        76 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          76 --DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             --CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence              356799999997 577777764 356899999999999999999999999999999999999987664       899


Q ss_pred             cccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      +|||++......    ....++..|+|||.+.....++.++|||||||++|+|+ +|.+||......+.....    .. 
T Consensus       154 ~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~----~~-  224 (262)
T cd05077         154 SDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY----EG-  224 (262)
T ss_pred             CCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH----hc-
Confidence            999998654322    23467888999999875567899999999999999997 688888765432211110    00 


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                         .        .......++.+.+||.+||+.||.+||++.+|+++
T Consensus       225 -------------------~--------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 -------------------Q--------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -------------------C--------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                               0        00112235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.9e-40  Score=294.98  Aligned_cols=248  Identities=24%  Similarity=0.324  Sum_probs=186.6

Q ss_pred             eeeeccCceEEEEEEeCC--CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRE--TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~--~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|....  ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.     .....|+||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~   74 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVL   74 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEE
Confidence            358999999999996432  44578888876432 3333456778999999999999999999984     346799999


Q ss_pred             ecCC-ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          114 ELMD-TDLHQIIKSSQ-----ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ||+. |+|.+++....     ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence            9996 69999987543     24677889999999999999999999999999999999999999999999986432211


Q ss_pred             c--cccceeeccccCchhhhhc------CCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          188 Q--FMTEYVVTRWYRAPELLLC------CDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       188 ~--~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      .  ......++..|+|||++..      ...++.++|||||||++|+|++ |.+||......+....+......      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------  228 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI------  228 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc------
Confidence            1  1122345677999999753      2356789999999999999998 78898776544433332221000      


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                         ..+.......+++.+.+++..|+ .||++|||++++++
T Consensus       229 -------------------~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         229 -------------------KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             -------------------cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                               00011122456788889999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6e-40  Score=292.48  Aligned_cols=244  Identities=25%  Similarity=0.383  Sum_probs=187.9

Q ss_pred             eeeeccCceEEEEEEeCC---CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEE
Q 017334           36 KPIGRGAYGIVCSSVNRE---TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      +.||+|+||.||+|.+..   .+..+|||.+... ........+.+|+.+++.++||||+++++++...    .+..++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv   75 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVV   75 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEE
Confidence            468999999999998643   3457999988542 2333445677899999999999999999976432    2457899


Q ss_pred             eecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC---
Q 017334          113 YELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN---  187 (373)
Q Consensus       113 ~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---  187 (373)
                      |||+. |+|.+++... ...+...+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||++.......   
T Consensus        76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99996 7999998754 456778888999999999999999999999999999999999999999999987543211   


Q ss_pred             -ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 -QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                       .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.+   ..            
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---~~------------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---GR------------  219 (262)
T ss_pred             ecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---CC------------
Confidence             11122345678999999876 578899999999999999998 5778876554333222211   00            


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                              .       ......+++.+.+++.+||..+|++||++.++++
T Consensus       220 --------~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         220 --------R-------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             --------C-------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                    0       0001235678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.6e-40  Score=300.40  Aligned_cols=250  Identities=23%  Similarity=0.320  Sum_probs=197.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCc----EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNE----KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .++|+.++.||+|+||.||+|.+..+|.    .+|+|.+..... ......+.+|+.+++.++||||+++++.+..    
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLS----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcC----
Confidence            3678999999999999999999987776    478888764432 2333457789999999999999999998743    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        ...++++||+. |+|.+++.... .+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||++..
T Consensus        81 --~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          81 --PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             --CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence              23578999996 79999987643 689999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ......  ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..           
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----------  226 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-----------  226 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-----------
Confidence            543222  1223345678999999876 678999999999999999986 8899976543332222111           


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                   ....      ...+..+..+.+++.+||..+|++||++.++++.
T Consensus       227 -------------~~~~------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         227 -------------GERL------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -------------CCCC------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         0000      0113356779999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-41  Score=307.56  Aligned_cols=268  Identities=24%  Similarity=0.365  Sum_probs=200.0

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      .++....++|..-..||+|+||.||+|.-.+ |..||||++.......  ..++.+|+.++.+++|||+|++++++... 
T Consensus        68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~-  143 (361)
T KOG1187|consen   68 DELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEG-  143 (361)
T ss_pred             HHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecC-
Confidence            4555566788888999999999999998764 4899999886554432  34588999999999999999999999544 


Q ss_pred             CCCcc-eEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEEcCCCCeEEc
Q 017334          103 RRNFK-DVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSAN---ILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       103 ~~~~~-~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                          + ..+||+|||. |+|.+.+....  .+++....+|+.+++.||+|||...   |+||||||+|||+|.+.+.||+
T Consensus       144 ----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  144 ----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence                3 5999999996 89999997654  8999999999999999999999864   9999999999999999999999


Q ss_pred             ccCcccccCCCCccccce-eeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHHHhC
Q 017334          176 DFGLARTSNGKNQFMTEY-VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQ---LKLIINILG  251 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~  251 (373)
                      |||+|+............ .||.+|+|||.+.. ...+.++||||+|+++.|+++|+.+.........   .......+.
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            999996554312222222 79999999999876 5789999999999999999999988765431111   111111111


Q ss_pred             CCChhhhcccCChhHHHHHHhCCCCCCCCccccCC-CCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          252 SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYP-DAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..   ....+.++.+        ..  .   ...+ ..-..+..+..+|++.+|.+||++.++++
T Consensus       299 ~~---~~~eiiD~~l--------~~--~---~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  299 EG---KLREIVDPRL--------KE--G---EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             Cc---chhheeCCCc--------cC--C---CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11   1111111100        00  0   0000 01123667888999999999999998754

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=289.82  Aligned_cols=262  Identities=21%  Similarity=0.349  Sum_probs=205.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+.+-+..||.|+||+|++-.++.+|+..|||.++.... .....+++.|.....+- ++||||+++++.+..     +.
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----Gd  137 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GD  137 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----Cc
Confidence            455667889999999999999999999999999976544 34556777888875555 599999999998554     56


Q ss_pred             EEEEeecCCccHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          109 VYLVYELMDTDLHQIIK-----SSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~-----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      .+|.||+|+-+|..+.+     ....++|.-+-.|.-..+.||.||.. .+|+|||+||+|||++..|.+||||||++..
T Consensus       138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            89999999987765542     34679999998999999999999985 5899999999999999999999999999865


Q ss_pred             cCCCCccccceeeccccCchhhhhcCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ..+ .-..+.-.|-..|||||.+.... +|+.+||+||||+.|||+.||..|+.+.+.  ++.++..+....++.     
T Consensus       218 Lv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~-----  289 (361)
T KOG1006|consen  218 LVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPI-----  289 (361)
T ss_pred             HHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCe-----
Confidence            422 11122336778899999996544 499999999999999999999999976543  444444432221111     


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       -....-.-..+..++.+|..||.+|-+.||...+++++||+..+
T Consensus       290 -----------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  290 -----------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             -----------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence                             01111113467889999999999999999999999999999754

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-40  Score=295.89  Aligned_cols=237  Identities=20%  Similarity=0.253  Sum_probs=183.6

Q ss_pred             eeeccCceEEEEEEeCCC------------------------CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCee
Q 017334           37 PIGRGAYGIVCSSVNRET------------------------NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI   92 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~------------------------g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   92 (373)
                      .||+|+||.||+|....+                        ...+++|++....  ......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            589999999999875322                        2358899885432  22334567889999999999999


Q ss_pred             eeceeecCCCCCCcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q 017334           93 ALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC  170 (373)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~  170 (373)
                      ++++++..     ....++||||++ |+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus        80 ~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          80 FVHGVCVR-----GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             eEEEEEEe-----CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence            99999843     356899999997 688888865 46789999999999999999999999999999999999997654


Q ss_pred             -------CeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHH
Q 017334          171 -------DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQ  242 (373)
Q Consensus       171 -------~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~  242 (373)
                             .+||+|||.+......    ....++..|+|||.+.+...++.++|||||||++|+|+ +|.+||.+....+.
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                   3899999987543221    22356788999999876566899999999999999985 79999976543322


Q ss_pred             HHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          243 LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      ......                       . .        ......++.+.++|.+||+.+|++|||+.+++++
T Consensus       231 ~~~~~~-----------------------~-~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         231 ERFYEK-----------------------K-H--------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHh-----------------------c-c--------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            111100                       0 0        0112234678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-42  Score=319.67  Aligned_cols=208  Identities=29%  Similarity=0.418  Sum_probs=176.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-CCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-RRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~  108 (373)
                      .-|..-+.||+|+||.||+++++.+|+.||||.++... .........+|+++|++++|||||+++++-.+.. .-....
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            45666788999999999999999999999999998654 4455556779999999999999999998863321 011356


Q ss_pred             EEEEeecCC-ccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--CCCC--eEEcccCcc
Q 017334          109 VYLVYELMD-TDLHQIIKS---SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN--ANCD--LKICDFGLA  180 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~--~~~~--~kL~Dfg~a  180 (373)
                      ..+|||||. |+|+..+.+   ...+++.++..++.++..||.|||++||+||||||.||++-  .+|+  .||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            789999995 799999964   45799999999999999999999999999999999999984  3344  799999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC  239 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  239 (373)
                      +...++ ....+.+||+.|.+||++...+.|+..+|.||+||++|+++||..||.....
T Consensus       172 rel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  172 RELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            987544 4788899999999999997557899999999999999999999999965443

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.4e-40  Score=292.75  Aligned_cols=250  Identities=25%  Similarity=0.455  Sum_probs=198.9

Q ss_pred             ceeeeeeeeccCceEEEEEEeCC-CCcEEEEEEccccc--------cChHHHHHHHHHHHHHhh-CCCCCeeeeceeecC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRE-TNEKVAIKKINNAF--------ENRVDALRTLRELKLLRH-LQHENVIALKDVMMP  100 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~-~g~~~aiK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~  100 (373)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+....        .......++.+|+.++.. ++||||+++++.+  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            48889999999999999999987 78899999886432        122333456678888865 6899999999998  


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEE
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKI  174 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL  174 (373)
                         ...+..+++|||+. ++|.+++.    ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence               34467999999996 58888774    23568999999999999999999996 68999999999999999999999


Q ss_pred             cccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      +|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...+.......+......  
T Consensus       156 ~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  231 (269)
T cd08528         156 TDFGLAKQKQPES-KLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--  231 (269)
T ss_pred             ecccceeeccccc-ccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--
Confidence            9999997654332 3445678899999999976 56899999999999999999999999765544333332210000  


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                               +.  .....++.+.++|++||+.||++||++.++..+
T Consensus       232 -------------------------~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         232 -------------------------PL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -------------------------cC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                     00  012356789999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.3e-40  Score=291.09  Aligned_cols=240  Identities=25%  Similarity=0.388  Sum_probs=193.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|+||.||++.  .+++.+|+|++....    ....+.+|+.+++.++|||++++++++..      +..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~   73 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGL   73 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCc
Confidence            679999999999999999985  468899999986432    23457789999999999999999998743      237


Q ss_pred             EEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ++||||+. ++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            99999996 69999997643  5789999999999999999999999999999999999999999999999998754322


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                         ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||.+.+..+....+.+.                
T Consensus       154 ---~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------------  213 (254)
T cd05083         154 ---VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG----------------  213 (254)
T ss_pred             ---CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC----------------
Confidence               122234567999999865 568899999999999999996 99999876544333222110                


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                             ..       ......+++.+.+++++||+.+|.+||++.++++
T Consensus       214 -------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         214 -------YR-------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -------CC-------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   00       0012346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.9e-40  Score=291.91  Aligned_cols=235  Identities=20%  Similarity=0.284  Sum_probs=185.7

Q ss_pred             eeeeccCceEEEEEEeCCCC----------cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           36 KPIGRGAYGIVCSSVNRETN----------EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g----------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +.||+|+||.||+|.+..++          ..+++|.+......   ...+.+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-----   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence            46899999999999998777          35788876543221   4567789999999999999999998843     


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-------CeEEcc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-------DLKICD  176 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-------~~kL~D  176 (373)
                       ...++||||+. |+|.+++.... .++...+..++.||+.||+|||++||+||||||+|||++.++       .+||+|
T Consensus        73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence             34699999996 79999998665 789999999999999999999999999999999999999888       799999


Q ss_pred             cCcccccCCCCccccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      ||++.....    .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..........      
T Consensus       152 fg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~------  221 (259)
T cd05037         152 PGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD------  221 (259)
T ss_pred             CCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc------
Confidence            999876533    1233566789999998764 368899999999999999998 5777766542221111100      


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        ..        .........+.++|.+||..+|.+|||+.++++
T Consensus       222 ------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         222 ------------------QH--------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ------------------CC--------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              00        000112267899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=307.96  Aligned_cols=253  Identities=24%  Similarity=0.327  Sum_probs=205.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCc---E-EEEEEccc-cccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNE---K-VAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~---~-~aiK~~~~-~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      -.++-.+.++||+|+||.||+|..+..+.   . ||+|..+. .........++++|.+++++++|||||+++++...  
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--  232 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--  232 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--
Confidence            45566677999999999999998865432   3 89999875 33667777889999999999999999999999843  


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                         ...++||||+|. |+|.++++..+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||++
T Consensus       233 ---~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  233 ---EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ---CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence               466999999996 79999999876 4999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      +.............-...|+|||.+.. ..++.++||||+||++||+.+ |..||.+....+....|..-.-        
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~--------  380 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY--------  380 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc--------
Confidence            765311111101123567999999987 489999999999999999985 7889999987776666633000        


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                           ........+..+..++.+|+..||++||++.++.+
T Consensus       381 ---------------------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  381 ---------------------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ---------------------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                                 00112345667889999999999999999988765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=315.82  Aligned_cols=263  Identities=25%  Similarity=0.440  Sum_probs=219.7

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  105 (373)
                      +-.+.|++.+.||.|.+|+||+++++.+|+..|+|+.........   ++..|+++|+... |||++.++++|.......
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---EIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---HHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            445789999999999999999999999999999999875543332   4556899999886 999999999998665567


Q ss_pred             cceEEEEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      .+.+++|||||+ |+..|++++  ..++.|..+.+|++.++.||.+||.+.++|||||=.|||++.++.|||+|||.+..
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            788999999996 799999875  45799999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCccccceeeccccCchhhhhcCC----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCD----NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      .........+.+|||.|||||++.+..    .|+.++|+||||++..||..|.||+-.......+-.             
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-------------  239 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------------  239 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-------------
Confidence            877777778899999999999997643    367899999999999999999999866543221111             


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                    ++..|... ...+...+.++.++|..||..|-++||+..++|+|||+.
T Consensus       240 --------------IpRNPPPk-Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  240 --------------IPRNPPPK-LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             --------------CCCCCCcc-ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence                          11111111 111234577899999999999999999999999999986

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-39  Score=292.08  Aligned_cols=243  Identities=25%  Similarity=0.372  Sum_probs=190.6

Q ss_pred             eeeeccCceEEEEEEeCCCC------cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           36 KPIGRGAYGIVCSSVNRETN------EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +.||+|+||.||+|.+...+      ..+|||.+..... ......+.+|+.+++.++||||+++++++..     ....
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   74 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQ   74 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCe
Confidence            36899999999999886544      6899998865422 2334467789999999999999999999843     3569


Q ss_pred             EEEeecCC-ccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-----CeEEcc
Q 017334          110 YLVYELMD-TDLHQIIKSS-------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-----DLKICD  176 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-----~~kL~D  176 (373)
                      ++||||+. ++|.+++...       ..+++.++..++.||+.||+|||+++++|+||||+||+++.++     .++|+|
T Consensus        75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999996 6999988642       3478899999999999999999999999999999999999887     899999


Q ss_pred             cCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCC
Q 017334          177 FGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       177 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      ||++........  ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+...    
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----  229 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG----  229 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC----
Confidence            999875432211  1112244678999999876 568999999999999999997 99999766544433322110    


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                                ........++..+.++|.+||..+|.+||++.++++
T Consensus       230 --------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         230 --------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                      000112346778999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-39  Score=292.86  Aligned_cols=266  Identities=24%  Similarity=0.360  Sum_probs=198.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeC----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNR----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .+|++++.||+|+||.||+|...    .++..+|+|++...... .....+.+|+.+++.++||||+++++++...   .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~   79 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP---G   79 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC---C
Confidence            57889999999999999999864    34789999999765443 3455678999999999999999999887442   2


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ....++||||+. ++|.+++.... .+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            357999999996 69999997654 6899999999999999999999999999999999999999999999999999766


Q ss_pred             CCCCccc---cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          184 NGKNQFM---TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       184 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .......   ....++..|+|||.+.+ ..++.++|||||||++++|++|..||.......     ....+.....    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~----  229 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQ----  229 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccccc----
Confidence            4222111   12234566999999876 578899999999999999999998875532211     0001100000    


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..............   ..   .....++..+.+|+.+||+.+|.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~---~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         230 MIVTRLLELLKEGE---RL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ccHHHHHHHHHcCC---cC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            00001111111100   00   012345678999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3e-40  Score=315.59  Aligned_cols=252  Identities=26%  Similarity=0.381  Sum_probs=208.0

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCC-----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRE-----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~-----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      --..+-+..+.||+|.||+||+|+-..     ....||||.++.. .+.....+|.||++++..++|||||++++++   
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC---  558 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVC---  558 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE---
Confidence            345677788999999999999997532     3357999998755 3344566899999999999999999999999   


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQ--------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV  166 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill  166 (373)
                        ...+.+|+|+|||. |||.++|+.+.              +++..+...|+.||+.|+.||-++.+|||||-.+|+||
T Consensus       559 --~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  559 --REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV  636 (774)
T ss_pred             --ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence              44477999999997 99999996432              27889999999999999999999999999999999999


Q ss_pred             cCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHH
Q 017334          167 NANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQL  243 (373)
Q Consensus       167 ~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~  243 (373)
                      +++..|||+|||+++..-+.+  .......-...|||||.++. ..++.+|||||+||+|||++ .|..||.+.+..+.+
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            999999999999997542211  11112233577999999987 68999999999999999998 788999999988888


Q ss_pred             HHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          244 KLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..|...                              ..-..+.+++.++.+|+..||+.+|++||+++||-.
T Consensus       716 e~i~~g------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  716 ECIRAG------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             HHHHcC------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            887651                              111233568889999999999999999999998754

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.1e-39  Score=287.62  Aligned_cols=247  Identities=20%  Similarity=0.247  Sum_probs=185.0

Q ss_pred             eeeccCceEEEEEEeCCC--CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEee
Q 017334           37 PIGRGAYGIVCSSVNRET--NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~--g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      .||+|+||.||++....+  ...+++|.+..... ......+.+|+.+++.++||||+++++.+.     .....|+|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE   75 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence            589999999999975433  34566776654322 233456789999999999999999999984     3466899999


Q ss_pred             cCC-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC--
Q 017334          115 LMD-TDLHQIIKSS----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN--  187 (373)
Q Consensus       115 ~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--  187 (373)
                      |+. |+|.+++...    ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++.......  
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            997 6999998753    345677888999999999999999999999999999999999999999999875422111  


Q ss_pred             ccccceeeccccCchhhhhcC------CCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          188 QFMTEYVVTRWYRAPELLLCC------DNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ......+++..|+|||++...      ..++.++|||||||++|+|++ |.+||...+..+.+..+.+....        
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~--------  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV--------  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc--------
Confidence            112345678899999997431      235789999999999999985 57888766554444433221000        


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                       ..........+++.+.+++..|+ .+|.+||++.++++
T Consensus       228 -----------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 -----------------KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             -----------------ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                             00001112346778999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=312.05  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=205.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCC-----cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETN-----EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ...-...+.||+|.||.||.|......     ..||||.+.+. .+......+++|..+|+.++|||||+++++....  
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--
Confidence            355667889999999999999875433     34999998754 4456677899999999999999999999999764  


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS-------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                         ...+|++|||. |+|..+|+..       ..++..+...++.||+.|++||+++++|||||-.+|+|++....+||+
T Consensus       768 ---~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 ---GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             ---CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence               56899999996 7999999865       358999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCCCCccccc--eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCC
Q 017334          176 DFGLARTSNGKNQFMTE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      |||+|+..-...-....  ..-...|||||.+.. ..++.++|||||||++||++ .|..||++.+..+.+......-  
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--  921 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--  921 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence            99999843221110011  122356999999987 68999999999999999998 7889999998877776554411  


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                                  ....++.++..+.+++..||+.+|++||++..|++
T Consensus       922 ----------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 ----------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ----------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                                        01123567788999999999999999999999887

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.2e-39  Score=286.80  Aligned_cols=288  Identities=30%  Similarity=0.466  Sum_probs=217.9

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCC---CCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceee
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRE---TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVM   98 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~   98 (373)
                      +.+-.+.+.|.++++||.|+|++||+|.+..   .++.||+|.+....    ...++..|+++|..+. +.||+++.+++
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~  104 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCF  104 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhh
Confidence            3344577899999999999999999999887   78899999996543    2346889999999997 99999999999


Q ss_pred             cCCCCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CCeEEcc
Q 017334           99 MPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICD  176 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-~~~kL~D  176 (373)
                           .+.+.+.+|+||++. +-.++..   .++-.+++.+++.++.||+++|.+|||||||||.|+|.+.. ++-.|+|
T Consensus       105 -----rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  105 -----RNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             -----ccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEe
Confidence                 566789999999984 6566654   47789999999999999999999999999999999999865 5789999


Q ss_pred             cCcccccC---------C-------C----------------C------------ccccceeeccccCchhhhhcCCCCC
Q 017334          177 FGLARTSN---------G-------K----------------N------------QFMTEYVVTRWYRAPELLLCCDNYG  212 (373)
Q Consensus       177 fg~a~~~~---------~-------~----------------~------------~~~~~~~gt~~y~aPE~~~~~~~~~  212 (373)
                      ||+|....         .       .                .            .......||++|+|||++...+..+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99985100         0       0                0            0001236799999999999888889


Q ss_pred             chhhhHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCChhhhcccCC-------------hhHHHHHHhC-----
Q 017334          213 TSIDVWSVGCIFAELLGRKPI-FPGTECLNQLKLIINILGSRREEDLEFIDN-------------PKARKYIKSL-----  273 (373)
Q Consensus       213 ~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~-----  273 (373)
                      +++||||.|+|+.-+++++.| |...+..+.+..+..++|...-........             +....-...+     
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~  336 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI  336 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence            999999999999999988755 677778888888888887543222111111             1111111111     


Q ss_pred             CCCCC--CCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          274 PYTPG--TPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       274 ~~~~~--~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .....  ..........+..+.|||.+||..||.+|+|++++|+||||.+.
T Consensus       337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            11000  11111223345689999999999999999999999999999743

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=292.85  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=204.9

Q ss_pred             CCCCCCcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCC--C--cEEEEEEccccccChHHHHHHHHHHHHHhh
Q 017334           10 GIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRET--N--EKVAIKKINNAFENRVDALRTLRELKLLRH   85 (373)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~--g--~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~   85 (373)
                      +|..|+-..|.+..      +...+.+.||.|-||.||.|.....  |  -.||||.-+..... .+...++.|..+|+.
T Consensus       375 ty~~P~~rnyel~R------e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrn  447 (974)
T KOG4257|consen  375 TYSTPTVRNYELRR------ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRN  447 (974)
T ss_pred             cccCCCCCcceeeh------hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHh
Confidence            34445544554422      3344557899999999999986432  3  35889987765443 446789999999999


Q ss_pred             CCCCCeeeeceeecCCCCCCcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334           86 LQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus        86 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                      +.||||+++++++..      ...+||||++. |.|..+++.+ ..++......+++||+.||+|||+.++|||||-..|
T Consensus       448 fdHphIikLIGv~~e------~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRN  521 (974)
T KOG4257|consen  448 FDHPHIIKLIGVCVE------QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARN  521 (974)
T ss_pred             CCCcchhheeeeeec------cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhh
Confidence            999999999999954      45899999997 9999999865 578999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCCccccceee--ccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKNQFMTEYVV--TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~  240 (373)
                      ||+.+...|||+|||+++...+.. .+....|  ..-|||||.+.- +.++.++|||.|||.+||++ .|..||.+-...
T Consensus       522 iLVsSp~CVKLaDFGLSR~~ed~~-yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs  599 (974)
T KOG4257|consen  522 ILVSSPQCVKLADFGLSRYLEDDA-YYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS  599 (974)
T ss_pred             eeecCcceeeecccchhhhccccc-hhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcccccccc
Confidence            999999999999999998775433 1221122  455999999865 67999999999999999987 889999887665


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHH
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA  313 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~ei  313 (373)
                      +.+..+.+.                              .....++.+++.+..|+.+||..+|.+||++.++
T Consensus       600 DVI~~iEnG------------------------------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  600 DVIGHIENG------------------------------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             ceEEEecCC------------------------------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence            555444331                              1112347789999999999999999999987654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3.9e-37  Score=270.28  Aligned_cols=243  Identities=41%  Similarity=0.670  Sum_probs=196.8

Q ss_pred             CceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCCc-cH
Q 017334           42 AYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DL  120 (373)
Q Consensus        42 ~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L  120 (373)
                      +||.||+|.+..+|+.+|+|++........ ...+.+|+..++.++|+|++++++.+..     ....++++|++++ +|
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCH
Confidence            589999999999999999999976543322 4567789999999999999999999843     3679999999975 99


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceeeccccC
Q 017334          121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR  200 (373)
Q Consensus       121 ~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~  200 (373)
                      .+++.....++...+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|+
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~  153 (244)
T smart00220       75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM  153 (244)
T ss_pred             HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence            9999876669999999999999999999999999999999999999999999999999997664332 334456788999


Q ss_pred             chhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCC
Q 017334          201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTP  280 (373)
Q Consensus       201 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (373)
                      |||.+.+ ..++.++|+||+|+++++|++|..||..............   ..                        ...
T Consensus       154 ~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---~~------------------------~~~  205 (244)
T smart00220      154 APEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG---KP------------------------KPP  205 (244)
T ss_pred             CHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh---cc------------------------CCC
Confidence            9999875 5678899999999999999999999976332222211111   00                        000


Q ss_pred             ccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          281 FSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       281 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .......++..+.+++.+||..+|++||++.++++||||
T Consensus       206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            011111166789999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-37  Score=294.02  Aligned_cols=275  Identities=20%  Similarity=0.288  Sum_probs=185.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC----------------CCCcEEEEEEccccccChHH------------HHHHHHHH
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR----------------ETNEKVAIKKINNAFENRVD------------ALRTLREL   80 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~----------------~~g~~~aiK~~~~~~~~~~~------------~~~~~~E~   80 (373)
                      .++|++.++||+|+||+||+|...                ..++.||||.+.........            ......|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            579999999999999999999752                34567999998643221100            01123466


Q ss_pred             HHHhhCCCCCe-----eeeceeecCCC---CCCcceEEEEeecCC-ccHHHHHHhcC-----------------------
Q 017334           81 KLLRHLQHENV-----IALKDVMMPSH---RRNFKDVYLVYELMD-TDLHQIIKSSQ-----------------------  128 (373)
Q Consensus        81 ~~l~~l~hpni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------  128 (373)
                      .++..++|.++     +++++++....   ....+..++|+||++ ++|.+++....                       
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     55666654321   112356899999996 69988886321                       


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc-cccceeeccccCchhhhh
Q 017334          129 -ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ-FMTEYVVTRWYRAPELLL  206 (373)
Q Consensus       129 -~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~  206 (373)
                       .+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........ ......+++.|+|||.+.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence             234567889999999999999999999999999999999999999999999865432211 111123478999999975


Q ss_pred             cCCC-------------------C--CchhhhHHHHHHHHHHHhCCC-CCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          207 CCDN-------------------Y--GTSIDVWSVGCIFAELLGRKP-IFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       207 ~~~~-------------------~--~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ....                   +  ....|+||+||++|+|++|.. ||.+.......   .....            .
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~------------~  448 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYD------------N  448 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhcc------------c
Confidence            4211                   1  124799999999999999874 66443211110   00000            0


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCC---CCCCCHHHHhCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDP---TKRISVTEALQHPYMSP  321 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP---~~R~t~~eil~hp~~~~  321 (373)
                      ....+....  .....+. .+...++.++||+.+||..+|   .+|+|+.|+|+||||.+
T Consensus       449 ~~~~~r~~~--~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        449 DLNRWRMYK--GQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hHHHHHhhc--ccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            000000000  0011121 245678999999999999866   68999999999999965

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=300.14  Aligned_cols=254  Identities=26%  Similarity=0.353  Sum_probs=215.4

Q ss_pred             eeecCcee-eeeeeeccCceEEEEEEeCCCCc---EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           26 FEIDTKYV-PIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        26 ~~~~~~Y~-~~~~lg~G~~g~V~~a~~~~~g~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      .+|+-.|. |.+.||.|.||.|++++-+..|+   .||||.++.. ........|+.|..||-++.||||+++-++.   
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV---  699 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV---  699 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE---
Confidence            34555554 56689999999999999988774   5999999755 3445566899999999999999999999998   


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                        ...+-+.||+|||+ |+|..+|+.+ +.|+.-++.-+++.|+.|++||-++|+|||||-..|||||.+-.+|++|||+
T Consensus       700 --Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL  777 (996)
T KOG0196|consen  700 --TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL  777 (996)
T ss_pred             --ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence              44577999999996 8999999865 6799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccceee---ccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          180 ARTSNGKNQFMTEYVV---TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       180 a~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      ++...++.....+..|   ...|.|||.+.- +.++.++|+||+|++|||.+ .|..||...+..+.+..|......+++
T Consensus       778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP  856 (996)
T KOG0196|consen  778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP  856 (996)
T ss_pred             eeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC
Confidence            9977555433322222   467999999976 68999999999999999976 899999999999999998875544332


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                                    .+++..+.+|+..||++|-.+||.+.||+.+
T Consensus       857 ------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  857 ------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             ------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence                                          4577889999999999999999999887763

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=302.80  Aligned_cols=245  Identities=31%  Similarity=0.431  Sum_probs=188.4

Q ss_pred             eeeeeeccCce-EEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcceEEE
Q 017334           34 PIKPIGRGAYG-IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        34 ~~~~lg~G~~g-~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      -.+.+|.|+.| .||+|...  |+.||||.+-....     ..+.||+..|+.-. ||||++++..-     ++....||
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~-----~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YI  580 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFF-----DFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYI  580 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhH-----HHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEE
Confidence            34668999988 56889775  88999998854322     24568999999986 99999988775     66688999


Q ss_pred             EeecCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CC--CeEEcccCcccc
Q 017334          112 VYELMDTDLHQIIKSSQA----LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NC--DLKICDFGLART  182 (373)
Q Consensus       112 v~e~~~g~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~---~~--~~kL~Dfg~a~~  182 (373)
                      ..|.|..+|.+++...+.    ...-+.+.++.|++.||++||+.+||||||||.||||+.   ++  +++|+|||+++.
T Consensus       581 alELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  581 ALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             EehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            999999999999987411    122456889999999999999999999999999999976   34  689999999998


Q ss_pred             cCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ...+..   ...+..||.+|+|||++.. ...+.++|||||||++|..++| .+||...-..  -..|..   ..     
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~---~~-----  729 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILT---GN-----  729 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhc---Cc-----
Confidence            765432   3456789999999999987 4557799999999999887755 8999654211  111111   00     


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                          .....+.+.-..++.|||.+||+++|..||+|.++|.||+|-.
T Consensus       730 --------------------~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  730 --------------------YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             --------------------cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence                                0011111212227999999999999999999999999999964

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=281.54  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=204.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -++...+.++||+|-||.|.+|.-. .+.+||+|+++.. .+......+.+|+++|.+|+||||+.+++++..+     +
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----e  608 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----D  608 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----C
Confidence            3566778899999999999999764 4699999998754 3334456789999999999999999999999544     5


Q ss_pred             eEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+++|+|||+ |+|.+++..+.  .........++.||++|++||.+.++|||||.+.|+|++.++++||+|||.++..-
T Consensus       609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence            6999999996 89999998763  23445566799999999999999999999999999999999999999999998553


Q ss_pred             CCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH--hCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 GKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ++.  ......+-...|||+|.++. ..++.++|+|++|+.+||++  +...||......+.......++.....     
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~-----  762 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR-----  762 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc-----
Confidence            322  12223345678999999876 57999999999999999986  778898777665555444333322211     


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                        .-....++-++..+.+|+.+|+..+-++||+++++..|
T Consensus       763 ------------------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  763 ------------------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             ------------------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence                              11222335577889999999999999999999998653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=248.68  Aligned_cols=215  Identities=27%  Similarity=0.439  Sum_probs=174.6

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  105 (373)
                      .-.+....+..||+|+||.|-+.++..+|...|+|.+.....+ ....+.++|+.+.... .||++|.+++.++.     
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-----  116 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-----  116 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----
Confidence            3445566678899999999999999999999999999866443 4455677899887766 49999999998843     


Q ss_pred             cceEEEEeecCCccHHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          106 FKDVYLVYELMDTDLHQI----IKSSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~----l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      ...++|.||.|+.+|..+    ++..+.++|..+=+++..++.||.|||++ .++|||+||+|||+|.+|++|+||||.+
T Consensus       117 egdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  117 EGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             cccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccc
Confidence            367999999999888654    45667899999999999999999999976 8999999999999999999999999998


Q ss_pred             cccCCCCccccceeeccccCchhhhhc---CCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHH
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLC---CDNYGTSIDVWSVGCIFAELLGRKPIFPGT-ECLNQLKLIIN  248 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~  248 (373)
                      ....+.- ..+--.|-..|||||.+..   ...|+.++||||||+.+.||.+++.||... +..+++.+++.
T Consensus       197 G~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  197 GYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            7653221 1111356678999999853   236899999999999999999999998653 45566665543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=282.86  Aligned_cols=205  Identities=28%  Similarity=0.429  Sum_probs=178.9

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHH--H----HHHHHHHHHhhCC---CCCeeee
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA--L----RTLRELKLLRHLQ---HENVIAL   94 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~--~----~~~~E~~~l~~l~---hpniv~~   94 (373)
                      ....--..|..++.+|.|+||.|++|.++.+...|+||.|.++..-...+  .    .+-.|+.||..++   |+||+++
T Consensus       555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            33344467999999999999999999999999999999997653211111  1    2336999999997   9999999


Q ss_pred             ceeecCCCCCCcceEEEEeecCC-c-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334           95 KDVMMPSHRRNFKDVYLVYELMD-T-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                      +++|     ++.+++||+||--+ | +|+++|..+..++|.+++.|++||+.|+++||+.||||||||-+|+.++.+|.+
T Consensus       635 LdfF-----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  635 LDFF-----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             hhee-----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeE
Confidence            9999     77789999999885 5 999999999999999999999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCC
Q 017334          173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFP  235 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  235 (373)
                      ||+|||.+....  +..+..++||..|.|||++.|....+..-|||+||++||.++....||.
T Consensus       710 klidfgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999987653  3345678999999999999987778899999999999999998888874

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=278.38  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=204.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+..+.++||.|.||.||.+.+++-...||||.++..   .....++++|..+|+.++|||+|++++++.     ....+
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPF  338 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPF  338 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCe
Confidence            4556678999999999999999998899999998643   455668999999999999999999999994     44669


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      |||+|||. |+|.++++..  ..++.-...+++.||.+|++||..+++|||||-..|+|+..+..||++|||+++.+.++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            99999995 9999999854  35777778899999999999999999999999999999999999999999999987543


Q ss_pred             Cccccceee---ccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          187 NQFMTEYVV---TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       187 ~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .  ++.-.|   ..-|.|||-+.. ..++.++|||+|||+|||+. .|-.||++-+-.+.+..+.+....          
T Consensus       419 T--YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM----------  485 (1157)
T KOG4278|consen  419 T--YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM----------  485 (1157)
T ss_pred             c--eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc----------
Confidence            2  222222   455999999866 57899999999999999998 577999998877666665542111          


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                          .-+.++++.+.+|++.||+++|.+||++.|+-+
T Consensus       486 --------------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  486 --------------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             --------------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence                                113568889999999999999999999988754

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=280.21  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=207.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCC-C--cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRET-N--EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~-g--~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      -.++..+.++||+|+||+|++|.+... |  ..||||.++...... ....+++|+.+|..|+|||++++|++..+    
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~----  182 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD----  182 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc----
Confidence            346777889999999999999988653 3  359999997655443 56679999999999999999999999854    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                        ..+.+|||++. |+|.+.++.  ...|.......|+.||+.|+.||.++++|||||-..|+|+-....|||+|||+.+
T Consensus       183 --qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  183 --QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             --chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence              34789999997 899999976  3568888899999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCcccc---ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          182 TSNGKNQFMT---EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       182 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      ..+.....+.   ...-...|.|||.+.. ..++.++|+|++||.+|||+ .|+.||.|......+..|...        
T Consensus       261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------  331 (1039)
T KOG0199|consen  261 ALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------  331 (1039)
T ss_pred             ccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--------
Confidence            8765544331   1122456999999976 68999999999999999998 678999998877777665421        


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP  317 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp  317 (373)
                                            ......+.++..+.++++.||..+|.+|||+..|.+.-
T Consensus       332 ----------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  332 ----------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ----------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                                  00112356788899999999999999999998886443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=286.13  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=213.8

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      +-.++|+++..+|+|.||.||+|+++.+++..|+|+++......  ..-+..|+-+++.++||||+.+++.+...     
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~-----   84 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----   84 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhh-----
Confidence            45689999999999999999999999999999999998765443  33456799999999999999999999554     


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..++|.||||+ |+|.+.-.-.+.+++.++.++.+..+.+|+|||++|=+|||||=.|||+++.|.+||+|||.+.....
T Consensus        85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence            55999999997 69998888889999999999999999999999999999999999999999999999999999876655


Q ss_pred             CCccccceeeccccCchhhhh--cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KNQFMTEYVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .-....+..||++|||||+..  ....|...+|||++|+...|+-.-+||.-.......+..+.+               
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk---------------  229 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK---------------  229 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc---------------
Confidence            555567789999999999853  235689999999999999999877777433333222222221               


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                              +....+...   --...++.+.+|++.+|..+|++||+++.+|+|||...
T Consensus       230 --------S~~qpp~lk---Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  230 --------SGFQPPTLK---DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             --------cCCCCCccc---CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                    111111110   01234677999999999999999999999999999864

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=260.41  Aligned_cols=193  Identities=27%  Similarity=0.374  Sum_probs=158.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHh--hCCCCCeeeeceeecCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR--HLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~--~l~hpniv~~~~~~~~~~~~  104 (373)
                      .+.++.++++.||+|.||.||+|.++  |+.||||++....     ....+||.+|.+  .|+|+||+.+++.=..+. .
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-g  279 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDN-G  279 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCC-C
Confidence            36788999999999999999999988  9999999996432     223456666665  458999999988765443 3


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEcCCCCeEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA--------NILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      ....++||++|-+ |+|+|++.. ..++...+.+++..++.||++||-.        .|.|||||..||||.+++.+-|+
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            4467999999997 999999987 6799999999999999999999953        39999999999999999999999


Q ss_pred             ccCcccccCCC----CccccceeeccccCchhhhhcCCCC-----CchhhhHHHHHHHHHHH
Q 017334          176 DFGLARTSNGK----NQFMTEYVVTRWYRAPELLLCCDNY-----GTSIDVWSVGCIFAELL  228 (373)
Q Consensus       176 Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~ll  228 (373)
                      |+|+|..-...    +...+..+||..|||||++...-..     -..+||||||.++||++
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence            99999654322    2345667999999999998653221     14699999999999997

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-35  Score=307.42  Aligned_cols=254  Identities=19%  Similarity=0.264  Sum_probs=184.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ...|...+.||+|+||.||+|.+..+|..||+|++......      ...|+..+++++||||+++++++..     ...
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~  757 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS-----EKG  757 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc-----CCC
Confidence            35567778999999999999999999999999998643221      1246888999999999999999943     356


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH---SANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .|+||||++ |+|.++++   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||......
T Consensus       758 ~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             CEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            899999996 79999986   3889999999999999999999   6699999999999999999887775 55543221


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCChhhhcccCC
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL-NQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .    .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .......+..-..          
T Consensus       834 ~----~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------  898 (968)
T PLN00113        834 T----DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD----------  898 (968)
T ss_pred             c----CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc----------
Confidence            1    123367899999999876 67899999999999999999999998532211 1111111100000          


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .....+..  + ..... .........++.+++.+||+.||++|||+.++++.
T Consensus       899 ~~~~~~~~--~-~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        899 CHLDMWID--P-SIRGD-VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cchhheeC--c-cccCC-CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00000000  0 00000 00001112357789999999999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=246.43  Aligned_cols=263  Identities=21%  Similarity=0.345  Sum_probs=200.7

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSH  102 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  102 (373)
                      .+.++.+.|.|.+.||.|.||.+-+|+|+.++..+++|.+.++...   ..++.+|...--.|. |.||+.-|++-+   
T Consensus        18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaF---   91 (378)
T KOG1345|consen   18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAF---   91 (378)
T ss_pred             cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHh---
Confidence            3467889999999999999999999999999999999999876443   446788988877776 999999888754   


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--CCCeEEcccCc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGL  179 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~--~~~~kL~Dfg~  179 (373)
                       +..+.+++++||++ |+|.+-+.. ..+-|...+.++.|+++|+.|||++++||||||.+||||-.  ..+|||||||.
T Consensus        92 -qt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen   92 -QTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             -hcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence             33467899999998 899988866 46889999999999999999999999999999999999943  34799999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcC----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCC----DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      .+..+....   ..--+..|.+||++...    -...+.+|+|.||+++|.+++|.+||+.....               
T Consensus       170 t~k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---------------  231 (378)
T KOG1345|consen  170 TRKVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---------------  231 (378)
T ss_pred             ccccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---------------
Confidence            876543322   22235668999987532    23567899999999999999999999743211               


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCC---CCHHHHhCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR---ISVTEALQHPYMS  320 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R---~t~~eil~hp~~~  320 (373)
                             ++....+...... ......+.+..+|+.+..+.++-|..+|++|   -++.......|..
T Consensus       232 -------d~~Y~~~~~w~~r-k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  232 -------DKPYWEWEQWLKR-KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             -------CchHHHHHHHhcc-cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence                   1111111111100 0112223455688999999999999999999   4555666666753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=252.29  Aligned_cols=196  Identities=28%  Similarity=0.342  Sum_probs=157.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhh--CCCCCeeeeceeecCCCCCCcc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH--LQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ...++++.||+|.||.||+|...  ++.||||++..     ...+.+..|-+|...  ++|+||++++.+-.... ....
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCC-cccc
Confidence            55677899999999999999654  69999999853     233445566666654  56999999988754332 1245


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEEcCCCCeEEccc
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA---------NILHRDLKPGNLLVNANCDLKICDF  177 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------~ivH~Dlkp~Nill~~~~~~kL~Df  177 (373)
                      .++||++|.+ |+|.++++. ..+++.+..+++..|++||+|||+-         .|+|||||..||||.+|++..|+||
T Consensus       282 eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            7999999996 899999987 4789999999999999999999963         4999999999999999999999999


Q ss_pred             CcccccCCCC--ccccceeeccccCchhhhhcCCCCC-----chhhhHHHHHHHHHHHhCCCCC
Q 017334          178 GLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYG-----TSIDVWSVGCIFAELLGRKPIF  234 (373)
Q Consensus       178 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll~g~~pf  234 (373)
                      |+|.......  .....-+||..|||||++.+.-+..     .+.||||+|.+||||++....+
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            9998664321  1223469999999999998754444     4689999999999999765444

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.9e-32  Score=234.84  Aligned_cols=212  Identities=39%  Similarity=0.632  Sum_probs=182.7

Q ss_pred             eeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCC
Q 017334           38 IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD  117 (373)
Q Consensus        38 lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~  117 (373)
                      ||+|++|.||++.+..+|+.+++|++....... ....+.+|+..++.++|++++++++++..     ....++++|+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCC
Confidence            689999999999998889999999997654332 34567799999999999999999999843     367999999998


Q ss_pred             -ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCCeEEcccCcccccCCCCcccccee
Q 017334          118 -TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSNGKNQFMTEYV  194 (373)
Q Consensus       118 -g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~  194 (373)
                       ++|.+++... ..++...++.++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+..............
T Consensus        75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence             7999998765 57899999999999999999999999999999999999999 89999999999976644332234456


Q ss_pred             eccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCC
Q 017334          195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLP  274 (373)
Q Consensus       195 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (373)
                      +...|++||.+.....++.++|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            788899999987633788999999999999998                                               


Q ss_pred             CCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q 017334          275 YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP  317 (373)
Q Consensus       275 ~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp  317 (373)
                                     ..+.+++.+|++.||++||++.++++|+
T Consensus       188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                           1167999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-33  Score=271.67  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=197.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeC---C----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNR---E----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPS  101 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~---~----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  101 (373)
                      ++..+.+.||+|.||.|++|.-.   .    ....||+|..+..... .....+..|+++|+.+. |+||+.+++++.. 
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~-  373 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ-  373 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence            33456779999999999998742   1    1456999998766555 66777889999999996 9999999999844 


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNL  164 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Ni  164 (373)
                          .+.+++|+||+. |+|.++++..+                .++..+...++.||+.|++||++.+++||||-.+||
T Consensus       374 ----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  374 ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             ----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence                477999999996 89999998755                388999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEcccCcccccCCCCccc-cceee--ccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCC-c
Q 017334          165 LVNANCDLKICDFGLARTSNGKNQFM-TEYVV--TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTE-C  239 (373)
Q Consensus       165 ll~~~~~~kL~Dfg~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~-~  239 (373)
                      |+..+..+|++|||+|+......... ....+  ...|||||.+.. ..|+.++||||+|++|||++ .|..||++-. .
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999998543322211 11122  234999999987 78999999999999999998 6789998744 2


Q ss_pred             hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .+....+..  |                            .....+..+++++.++++.||+.+|++||++.++.+
T Consensus       529 ~~l~~~l~~--G----------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  529 EELLEFLKE--G----------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHhc--C----------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            222222211  0                            011223457888999999999999999999988764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=260.26  Aligned_cols=248  Identities=25%  Similarity=0.307  Sum_probs=199.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCc----EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNE----KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ...+..+.||+|+||+||++.+...|+    +||||++... .......++++|+-+|..+.|||++++++++..+.   
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---  771 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---  771 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---
Confidence            345567899999999999999876665    5888887643 33344567889999999999999999999996542   


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                         +-||++|++ |.|.++++.+ ..+..++...|..||++||.|||.++++||||-.+||||..-..+|+.|||+++..
T Consensus       772 ---~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  772 ---LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             ---HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence               789999997 8999999864 57899999999999999999999999999999999999999999999999999877


Q ss_pred             CCCCccccceee--ccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          184 NGKNQFMTEYVV--TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       184 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...........|  .+-|||=|.+.. ..|+.++||||+||.+||++ .|..|+.+....+.-..+....          
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge----------  917 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE----------  917 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc----------
Confidence            654443333222  455888888876 68999999999999999998 6888888776554443332200          


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                 .         ...+|..+-++.-++.+||..|+..||+++++..
T Consensus       918 -----------R---------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  918 -----------R---------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             -----------c---------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence                       0         1123567788899999999999999999987654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-31  Score=230.72  Aligned_cols=199  Identities=36%  Similarity=0.608  Sum_probs=171.5

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+..     ....++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEE
Confidence            66789999999999999999988999999999765433 244567789999999999999999998843     366999


Q ss_pred             EeecCCc-cHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC-c
Q 017334          112 VYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN-Q  188 (373)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~  188 (373)
                      ++|++++ +|.+++..... +++..+..++.+++.++.+||+++++|+||+|.||+++.++.++|+|||.+....... .
T Consensus        75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999975 99999987666 8999999999999999999999999999999999999999999999999987654332 1


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG  236 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  236 (373)
                      ......++..|++||.+.+...++.++|+||||+++++|++|++||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            234457788899999984446678899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=1e-32  Score=281.33  Aligned_cols=205  Identities=18%  Similarity=0.220  Sum_probs=147.1

Q ss_pred             hCCC-CCeeeeceeecCC--CCCCcceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017334           85 HLQH-ENVIALKDVMMPS--HRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLK  160 (373)
Q Consensus        85 ~l~h-pniv~~~~~~~~~--~~~~~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  160 (373)
                      .++| +||+.+++.+...  +......++.++|+++++|.+++.. ...+++.+++.+++||+.||+|||++||+|||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            3445 5777777776322  1122346888999999999999975 3569999999999999999999999999999999


Q ss_pred             CCceEEcCC-------------------CCeEEcccCcccccCCCC----------------ccccceeeccccCchhhh
Q 017334          161 PGNLLVNAN-------------------CDLKICDFGLARTSNGKN----------------QFMTEYVVTRWYRAPELL  205 (373)
Q Consensus       161 p~Nill~~~-------------------~~~kL~Dfg~a~~~~~~~----------------~~~~~~~gt~~y~aPE~~  205 (373)
                      |+||||+..                   +.+|++|||+++......                ......+||++|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   445666666654321100                001124678999999998


Q ss_pred             hcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccC
Q 017334          206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY  285 (373)
Q Consensus       206 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (373)
                      .+ ..++.++|||||||+||||++|.+|+....  .....+....                      .+..        .
T Consensus       188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~----------------------~~~~--------~  234 (793)
T PLN00181        188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV----------------------LPPQ--------I  234 (793)
T ss_pred             cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh----------------------cChh--------h
Confidence            77 578999999999999999999988874321  1111111100                      0000        0


Q ss_pred             CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          286 PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       286 ~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ....+.+.+++.+||++||.+||++.++++||||...
T Consensus       235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            0113456789999999999999999999999999753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.4e-31  Score=260.02  Aligned_cols=269  Identities=28%  Similarity=0.332  Sum_probs=203.8

Q ss_pred             eeecCce-eeeeeeeccCceEEEEEEeCCCCcEEEEEEccc---cccChHH-HHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           26 FEIDTKY-VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN---AFENRVD-ALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        26 ~~~~~~Y-~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~---~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      ..+...| .....+|.|++|.|+.+......+.++.|.+..   ....... ...+..|+-+-..+.|||++.....+..
T Consensus       313 ~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~  392 (601)
T KOG0590|consen  313 IGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE  392 (601)
T ss_pred             cccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh
Confidence            3334556 456789999999999888887777777776542   1122222 2226678888889999999888777743


Q ss_pred             CCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          101 SHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      .     ...+-+||||+++|+.++...+.++..++..++.||+.||+|||++||.||||||+|+++..+|.+||+|||.+
T Consensus       393 ~-----~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  393 I-----DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             c-----ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcc
Confidence            3     23344499998899999998889999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCC--C--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHH-HHHHHhCCCCh
Q 017334          181 RTSNGK--N--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK-LIINILGSRRE  255 (373)
Q Consensus       181 ~~~~~~--~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~i~~~~~~~~~  255 (373)
                      ......  .  ....+.+|+..|+|||++.+...-....||||.|+++..|++|+.||......+... .....      
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~------  541 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS------  541 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc------
Confidence            754422  2  446678999999999999885445567999999999999999999997654332211 00000      


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       ...........++..++...+.+|.+||++||.+|.|+++|++.+||+.+
T Consensus       542 -----------------~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  542 -----------------DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             -----------------cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence                             00000111122334456678999999999999999999999999999865

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3e-30  Score=215.99  Aligned_cols=165  Identities=21%  Similarity=0.285  Sum_probs=127.0

Q ss_pred             ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceeec
Q 017334          118 TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT  196 (373)
Q Consensus       118 g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  196 (373)
                      |+|.+++..+ ..+++.+++.++.||+.||+|||+++      ||+|||++.++.+|+  ||.+.......     ..||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence            6899999864 56999999999999999999999999      999999999999999  99987654322     2688


Q ss_pred             cccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCC
Q 017334          197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL-NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPY  275 (373)
Q Consensus       197 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (373)
                      +.|+|||++.+ ..++.++||||+||++|+|++|++||...... ..+..+...........                  
T Consensus        68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------  128 (176)
T smart00750       68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD------------------  128 (176)
T ss_pred             ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc------------------
Confidence            99999999977 67899999999999999999999999665432 22222221111000000                  


Q ss_pred             CCCCCccccCCCCCH--HHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          276 TPGTPFSRLYPDAHP--LAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       276 ~~~~~~~~~~~~~s~--~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                            ......++.  .+.++|.+||..||.+||++.++++|+|+.
T Consensus       129 ------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      129 ------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                  000011222  589999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=216.73  Aligned_cols=253  Identities=17%  Similarity=0.246  Sum_probs=198.6

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCC-----cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETN-----EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      .-+.|++....+-+|.||.||.|.++...     +.+.+|.++. .........++.|--.+..+.|||+.++.++..+.
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            34567888889999999999999776433     3466666653 34455666778899999999999999999988653


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKS--------SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                          ....++++.+++ |+|..++..        ...++..++..++.|++.|++|||++|++|.||-..|.+|++.-++
T Consensus       360 ----~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  360 ----YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             ----cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence                255788899998 899999861        2357788888999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCC--CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHH
Q 017334          173 KICDFGLARTSNGK--NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       173 kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~  249 (373)
                      ||+|=.+++..-..  +.....-.....||+||.+.. ..|+.++|+||||++||||+ .|+.|+..-+..+....+...
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            99999888754221  111111122456999999987 68999999999999999998 688999887777766655442


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ...                              ..+-++++++..++.-||..+|++||+.+|+..
T Consensus       515 yRl------------------------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 YRL------------------------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cee------------------------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            110                              112357889999999999999999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.9e-28  Score=222.82  Aligned_cols=177  Identities=19%  Similarity=0.261  Sum_probs=133.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCC-CCcEEEEEEcccccc---ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRE-TNEKVAIKKINNAFE---NRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~-~g~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      .+.++|.+.+.||+|+||+||+|+++. +|+.+|||++.....   .......+.+|+++|+.++|+|+++.+..+    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            456899999999999999999999876 778889998753311   223345578999999999999998533222    


Q ss_pred             CCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEEcCCCCeEEcccCcc
Q 017334          103 RRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDL-KPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl-kp~Nill~~~~~~kL~Dfg~a  180 (373)
                          +..|+||||++| +|. .+..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus        91 ----~~~~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             ----CCcEEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence                347999999975 675 2211   11   2568899999999999999999999 999999999999999999999


Q ss_pred             cccCCCCc--------cccceeeccccCchhhhhcCC-----CCCchhhhH
Q 017334          181 RTSNGKNQ--------FMTEYVVTRWYRAPELLLCCD-----NYGTSIDVW  218 (373)
Q Consensus       181 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~-----~~~~~~Diw  218 (373)
                      +.......        ......+++.|+|||.+....     ..+..+|-|
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            86543221        123456788899999985422     123446666

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=2.9e-26  Score=210.09  Aligned_cols=262  Identities=34%  Similarity=0.515  Sum_probs=204.0

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChH-HHHHHHHHHHHHhhCCCC-CeeeeceeecCCCCCCcceE
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV-DALRTLRELKLLRHLQHE-NVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~~~~~  109 (373)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+........ ....+.+|+.++..+.|+ +++++.+.+.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            788999999999999999987   7899999987655543 556788999999999988 7999999993     23448


Q ss_pred             EEEeecCC-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCcccccC
Q 017334          110 YLVYELMD-TDLHQIIKSSQ---ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSN  184 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~  184 (373)
                      +++++++. +++.+++....   .+++.....++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+....
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999997 58887777654   799999999999999999999999999999999999999998 69999999987544


Q ss_pred             CCCc------cccceeeccccCchhhhhcC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHhCCC
Q 017334          185 GKNQ------FMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAELLGRKPIFPGTEC---LNQLKLIINILGSR  253 (373)
Q Consensus       185 ~~~~------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~  253 (373)
                      ....      ......|+..|+|||.+.+.  ..+....|+||+|++++++++|..||.....   .............+
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            3321      34677999999999999763  4788999999999999999999999877654   22222222211111


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                        ........   .........+.+++.+++..+|..|.+..+...++|....
T Consensus       234 ------------------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         234 ------------------SLASPLSP---SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             ------------------ccccccCc---cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence                              00000000   0001123468899999999999999999999988776543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-29  Score=234.12  Aligned_cols=239  Identities=24%  Similarity=0.365  Sum_probs=196.7

Q ss_pred             eeeccCceEEEEEEe---CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcceEEEE
Q 017334           37 PIGRGAYGIVCSSVN---RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~---~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      .+|.|+||.|++++.   ...|..||+|+.++.............|..++...+ ||.+++++..+     +....++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence            379999999987754   446788999998765433332224456888888887 99999999999     556789999


Q ss_pred             eecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcccc
Q 017334          113 YELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT  191 (373)
Q Consensus       113 ~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  191 (373)
                      +++.. |+|...+.....+.+...+.+...++.|++++|+.+|+|||+|++||+++.+|++++.|||+++..-....   
T Consensus        76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            99995 69999998888999999999999999999999999999999999999999999999999999986543322   


Q ss_pred             ceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHH
Q 017334          192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK  271 (373)
Q Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (373)
                       .|||..|||||++.   ....++|+||+|+++++|++|..||.+    +....|.+.--                    
T Consensus       153 -~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~--------------------  204 (612)
T KOG0603|consen  153 -ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL--------------------  204 (612)
T ss_pred             -cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc--------------------
Confidence             29999999999986   478899999999999999999999977    44444433100                    


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                 ..+...+..+++++..++..+|..|..     +.++++|+||+.+
T Consensus       205 -----------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i  249 (612)
T KOG0603|consen  205 -----------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSI  249 (612)
T ss_pred             -----------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheee
Confidence                       112345677999999999999999985     4799999999754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-25  Score=205.28  Aligned_cols=203  Identities=24%  Similarity=0.295  Sum_probs=163.1

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCC-cEEEEEEccccccChHHHHHHHHHHHHHhhCC----CCCeeeeceeecCCCCCC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETN-EKVAIKKINNAFENRVDALRTLRELKLLRHLQ----HENVIALKDVMMPSHRRN  105 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g-~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~----hpniv~~~~~~~~~~~~~  105 (373)
                      +|++.+.||+|+||.||.|.+..++ ..+|+|...........  .+..|+.++..+.    .+++..+++...    ..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~   92 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST   92 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence            8999999999999999999998775 67888887654222211  3445777777776    368888888773    13


Q ss_pred             cceEEEEeecCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-----CCeEEcccC
Q 017334          106 FKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-----CDLKICDFG  178 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-----~~~kL~Dfg  178 (373)
                      ...-|+||+.++.+|.++....  +.++...+..++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||
T Consensus        93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            3568999999999999988644  589999999999999999999999999999999999999865     359999999


Q ss_pred             ccc--ccCCCC-----cc---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch
Q 017334          179 LAR--TSNGKN-----QF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL  240 (373)
Q Consensus       179 ~a~--~~~~~~-----~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  240 (373)
                      +++  ......     ..   .....||..|.++.+-.+ ...+.+.|+||++.++.+++.|..||.+....
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~  243 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMT  243 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence            998  321111     01   223569999999998877 67899999999999999999999999776543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-26  Score=189.62  Aligned_cols=216  Identities=23%  Similarity=0.305  Sum_probs=172.5

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSH  102 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  102 (373)
                      .-+...+.|+++++||+|+||.+|.|....+|+.||||+-.......    ....|.++.+.|+ ...|..+..+.    
T Consensus         9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~----   80 (341)
T KOG1163|consen    9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYG----   80 (341)
T ss_pred             hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhc----
Confidence            33456799999999999999999999999999999999875543332    3556888888887 66777776666    


Q ss_pred             CCCcceEEEEeecCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CCeEEcccC
Q 017334          103 RRNFKDVYLVYELMDTDLHQIIK-SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFG  178 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~---~~~kL~Dfg  178 (373)
                       .+..+-.+||+..+.+|.++.. ..+.|+...+.-++-|++.-++|+|.++++||||||+|+|..-+   .++.|+|||
T Consensus        81 -~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   81 -TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             -cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence             3346678999999999999886 34689999999999999999999999999999999999998644   359999999


Q ss_pred             cccccCCCC-------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017334          179 LARTSNGKN-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       179 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  249 (373)
                      +|+..-+..       ..-....||..|.+--...+ ...+.+.|+=|+|.+|..+..|..||++............+
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI  236 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI  236 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence            997643321       22345678999988766655 45678999999999998899999999987665544444433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=9.2e-27  Score=227.07  Aligned_cols=223  Identities=32%  Similarity=0.446  Sum_probs=172.6

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ...+|..++.|..|+||.||.++|+.+.+.+|+| +++..       .++|-  ++.....|.                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------lilRn--ilt~a~npf-----------------  133 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------LILRN--ILTFAGNPF-----------------  133 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------hhhhc--cccccCCcc-----------------
Confidence            4578999999999999999999999999999995 43321       11111  111112222                 


Q ss_pred             eEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC-
Q 017334          108 DVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK-  186 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-  186 (373)
                         .|     |+-..+++..+.++...        +.|++|||+-||+|||+||+|.+|..-|++|++|||+++..... 
T Consensus       134 ---vv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  134 ---VV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ---ee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence               22     66666777766666544        78999999999999999999999999999999999998643210 


Q ss_pred             --------------CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          187 --------------NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       187 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                                    .-.....||||.|+|||++.. ++|++.+|+|++|+|+|+.+-|..||-+....+.+..+......
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                          011234589999999999987 78999999999999999999999999998888887777664333


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC---CHHHHhCCCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SVTEALQHPYMSPL  322 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~---t~~eil~hp~~~~~  322 (373)
                      .+++                            -....++++++|.++|..+|..|.   .+.++.+|+||..+
T Consensus       277 wpE~----------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  277 WPEE----------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             cccc----------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            3222                            234678899999999999999997   56789999999754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=226.17  Aligned_cols=251  Identities=22%  Similarity=0.329  Sum_probs=186.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc--cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF--ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +..+|...+-||++.|=+|.+|++. .|. |+||++-+..  ..-....+.++|++ ...+++||.+++.-+.     ..
T Consensus        21 ~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t   92 (1431)
T KOG1240|consen   21 LSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VT   92 (1431)
T ss_pred             CccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----Hh
Confidence            4447888999999999999999886 444 9999986543  33344445556666 6677899999988776     44


Q ss_pred             cceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc--c
Q 017334          106 FKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--S  183 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~--~  183 (373)
                      ....|+|-+|+..+|+|.+..+..+..-+-+.|+.||+.||.-+|..||+|||||.+||||++=..+.|+||..-+-  .
T Consensus        93 ~kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen   93 DKAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             hHHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC
Confidence            47789999999999999999888899999999999999999999999999999999999999988999999975431  1


Q ss_pred             CCCCc-----cccceeeccccCchhhhhcCC----------CCCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHH
Q 017334          184 NGKNQ-----FMTEYVVTRWYRAPELLLCCD----------NYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLII  247 (373)
Q Consensus       184 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~  247 (373)
                      ..+++     .+.+....-+|.|||.+....          ..+++-||||+||+++||+ .|+|||.-.    ++-...
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr  248 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYR  248 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHh
Confidence            11111     112223346799999986522          1467899999999999997 679999432    111111


Q ss_pred             HHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          248 NILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      +.-...            ....+..+.              +..++.||..|++.||++|.+|++.|+.
T Consensus       249 ~~~~~~------------~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  249 SGNADD------------PEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCccC------------HHHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            110000            111111111              1237899999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.93  E-value=7e-26  Score=193.01  Aligned_cols=176  Identities=15%  Similarity=0.202  Sum_probs=133.8

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHH-HHH------HHHHHHHHhhCCCCCeeeeceeecC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD-ALR------TLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~-~~~------~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      +.++|++++.||.|+||.||++.+  ++..+|||++......... ...      +.+|+..+.++.|++|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            789999999999999999999765  4668999999755433222 222      4589999999999999999888654


Q ss_pred             CCCC---CcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcc
Q 017334          101 SHRR---NFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (373)
Q Consensus       101 ~~~~---~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~D  176 (373)
                      ....   ..+..++||||++| +|.++.    .+++    ....+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            3211   13468999999987 787763    2333    3466999999999999999999999999999998 99999


Q ss_pred             cCcccccCCCCccccceeeccccCchh-hhhcCCCCCchhhhHHHHHHHHHHH
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPE-LLLCCDNYGTSIDVWSVGCIFAELL  228 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE-~~~~~~~~~~~~DiwslG~il~~ll  228 (373)
                      ||.........             |-+ .++. +.++.++|+||||+.+..+.
T Consensus       178 fg~~~~~~e~~-------------a~d~~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRK-------------AKDRIDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchh-------------hHHHHHHH-hHhcccccccceeEeehHHH
Confidence            99876442111             111 2233 45778999999999877653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-24  Score=187.12  Aligned_cols=215  Identities=21%  Similarity=0.269  Sum_probs=174.0

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  104 (373)
                      ....-.|++.++||.|+||+.+.+.+.-+++.||||.-......    -.+..|.+..+.|. .++|..++.+.     +
T Consensus        24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFG-----q   94 (449)
T KOG1165|consen   24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFG-----Q   94 (449)
T ss_pred             eEecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeec-----c
Confidence            45678999999999999999999999999999999976433222    23445777777775 89999887665     4


Q ss_pred             CcceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-----CeEEcccC
Q 017334          105 NFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-----DLKICDFG  178 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-----~~kL~Dfg  178 (373)
                      ...+-.+|+|+++.+|.|+..- .++|+...+.-++.|++.-++|+|++.+|+|||||+|+||...+     .|.++|||
T Consensus        95 eG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen   95 EGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             ccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence            4466789999999999888864 46799999999999999999999999999999999999997654     38999999


Q ss_pred             cccccCCCC-------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017334          179 LARTSNGKN-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL  250 (373)
Q Consensus       179 ~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  250 (373)
                      +|+...+..       ....+..||..||+=-.-+| +.-+.+.|+=|||-++..+|-|..||++......-....++-
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG  252 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG  252 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence            997543321       22356688999999777666 567899999999999999999999999876555544444433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=1e-24  Score=191.35  Aligned_cols=239  Identities=21%  Similarity=0.271  Sum_probs=149.4

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCC----------CCCeeeeceeec
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQ----------HENVIALKDVMM   99 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~----------hpniv~~~~~~~   99 (373)
                      .+.....||.|+++.||.+.+..||+.+|+|++....... .....+.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4556778999999999999999999999999986543222 23334444443333322          112333333222


Q ss_pred             CCC---------CCCcc---eEEEEeecCCccHHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017334          100 PSH---------RRNFK---DVYLVYELMDTDLHQIIK---SSQAL----TNDHCQYFLFQLLRGLKYLHSANILHRDLK  160 (373)
Q Consensus       100 ~~~---------~~~~~---~~~lv~e~~~g~L~~~l~---~~~~~----~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  160 (373)
                      ...         .....   +.+++|+-+.++|.+++.   .....    .......+..|++..+++||+.|++|+|||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            110         00111   357889999888887763   22222    122233455899999999999999999999


Q ss_pred             CCceEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcC-------CCCCchhhhHHHHHHHHHHHhCCCC
Q 017334          161 PGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC-------DNYGTSIDVWSVGCIFAELLGRKPI  233 (373)
Q Consensus       161 p~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~p  233 (373)
                      |+|++++.+|.++|+||+.....+....   ....+..|.+||.....       -.++.+.|.|+||+++|.|.+|..|
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            9999999999999999998876533211   12345789999987442       2468899999999999999999999


Q ss_pred             CCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCC
Q 017334          234 FPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR  307 (373)
Q Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R  307 (373)
                      |.........                                  ...+.... +++..+++||+++|+.||.+|
T Consensus       250 f~~~~~~~~~----------------------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADP----------------------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTS----------------------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccc----------------------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9754321100                                  00233333 678889999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=2.1e-25  Score=187.97  Aligned_cols=140  Identities=19%  Similarity=0.240  Sum_probs=108.4

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHH------------------------HHHHHHHHHHHhhCCCCC
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD------------------------ALRTLRELKLLRHLQHEN   90 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~hpn   90 (373)
                      ...||+|++|.||+|.+. +|+.||||+++........                        .....+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999987 8999999999754221111                        112235999999998777


Q ss_pred             eeeeceeecCCCCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEEcC
Q 017334           91 VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYL-HSANILHRDLKPGNLLVNA  168 (373)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~ivH~Dlkp~Nill~~  168 (373)
                      +.....+..       ...++||||++| ++.......+.+++.++..++.|++.+|.+| |+.||+||||||+|||++ 
T Consensus        81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            643332221       123899999986 4544434456899999999999999999999 799999999999999998 


Q ss_pred             CCCeEEcccCccccc
Q 017334          169 NCDLKICDFGLARTS  183 (373)
Q Consensus       169 ~~~~kL~Dfg~a~~~  183 (373)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            578999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.3e-24  Score=190.19  Aligned_cols=199  Identities=25%  Similarity=0.377  Sum_probs=144.0

Q ss_pred             CCCCeeeeceeecCCC----------------------CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHH
Q 017334           87 QHENVIALKDVMMPSH----------------------RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR  144 (373)
Q Consensus        87 ~hpniv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~  144 (373)
                      +|||||.+..+|.++-                      ......+|+||--...+|..++-. ...+....+-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-RHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-CCCchHHHHHHHHHHHH
Confidence            5999999988875431                      123357999999999999999976 45677778889999999


Q ss_pred             HHHHHHhCCccccCCCCCceEEc--CCC--CeEEcccCcccccCCC------CccccceeeccccCchhhhhcCCCC---
Q 017334          145 GLKYLHSANILHRDLKPGNLLVN--ANC--DLKICDFGLARTSNGK------NQFMTEYVVTRWYRAPELLLCCDNY---  211 (373)
Q Consensus       145 aL~~LH~~~ivH~Dlkp~Nill~--~~~--~~kL~Dfg~a~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~---  211 (373)
                      |+.|||++||.|||+|.+|||+.  +|+  .+.|+|||.+-.-...      .....+.-|.-..||||+.......   
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999984  333  4899999987432211      1112233567778999998543221   


Q ss_pred             --CchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCC
Q 017334          212 --GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH  289 (373)
Q Consensus       212 --~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  289 (373)
                        -.++|.|+.|.+.||+++...||.+.-....                   +.   +.+.       +.....++..++
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------------~~---r~Yq-------e~qLPalp~~vp  483 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------------DT---RTYQ-------ESQLPALPSRVP  483 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchhee-------------------ch---hhhh-------hhhCCCCcccCC
Confidence              2579999999999999999999876321100                   00   0010       111223345688


Q ss_pred             HHHHHHHHhhcCcCCCCCCCH---HHHhC
Q 017334          290 PLAIDLLQKMLVFDPTKRISV---TEALQ  315 (373)
Q Consensus       290 ~~~~~ll~~~L~~dP~~R~t~---~eil~  315 (373)
                      +.+++|+..+|+.||++|+++   ..+|+
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999999999985   45554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=5.6e-24  Score=179.92  Aligned_cols=142  Identities=18%  Similarity=0.180  Sum_probs=110.7

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh------------------------HHHHHHHHHHHHHhhCCCC
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR------------------------VDALRTLRELKLLRHLQHE   89 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~------------------------~~~~~~~~E~~~l~~l~hp   89 (373)
                      +.+.||+|++|.||+|.+. +|+.||||+++......                        .......+|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 89999999987542110                        0011234789999999998


Q ss_pred             CeeeeceeecCCCCCCcceEEEEeecCCcc-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEc
Q 017334           90 NVIALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVN  167 (373)
Q Consensus        90 niv~~~~~~~~~~~~~~~~~~lv~e~~~g~-L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~  167 (373)
                      ++.....+...       ..|+||||++|. +.........++..++..++.|++.+|.+||+ .||+||||||+|||++
T Consensus        80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~  152 (190)
T cd05145          80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence            87544443311       138999999863 43332334678889999999999999999999 9999999999999999


Q ss_pred             CCCCeEEcccCcccccC
Q 017334          168 ANCDLKICDFGLARTSN  184 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~  184 (373)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             8899999999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.3e-23  Score=173.81  Aligned_cols=185  Identities=17%  Similarity=0.110  Sum_probs=137.0

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh--HHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcceEE
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR--VDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      +...|++|+||+|+.+..  .+.+++.+.+.......  .....+.+|+++|++|. |+++++++++         +..+
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~~   74 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGRH   74 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCEE
Confidence            567899999999997755  67889888776544321  12224678999999996 6889988875         2369


Q ss_pred             EEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          111 LVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDL-KPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       111 lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl-kp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++|||+.| +|.+.+..       ....++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|........
T Consensus        75 lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             EEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            99999976 66543321       12357889999999999999999999 79999999999999999999985543221


Q ss_pred             c----c---------cceeeccccCchhhhhcCCCCC-chhhhHHHHHHHHHHHhCCCCCCC
Q 017334          189 F----M---------TEYVVTRWYRAPELLLCCDNYG-TSIDVWSVGCIFAELLGRKPIFPG  236 (373)
Q Consensus       189 ~----~---------~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~  236 (373)
                      .    .         .-...++.|++|+.-.--...+ .+.++++.|+.+|.++|+..|+-+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            1    0         0012467788888643222233 678999999999999999987643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.3e-24  Score=181.38  Aligned_cols=242  Identities=16%  Similarity=0.189  Sum_probs=189.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+..++.+|.....|..|+++++  |..++.|+++...........+..|.-.|+.+.||||+.+++.+     ....++
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnl  262 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNL  262 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCc
Confidence            44556778899999999999887  66788999887666666666778899999999999999999999     555789


Q ss_pred             EEEeecCC-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCCCeEEc--ccCcccc
Q 017334          110 YLVYELMD-TDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKIC--DFGLART  182 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~~~~~kL~--Dfg~a~~  182 (373)
                      .++..||+ |+|+..+.....  ....++.+++.+|+.|++|||+..  |.---|....++||.+.+.+|.  |--++..
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq  342 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ  342 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence            99999998 899999986543  577889999999999999999985  4444689999999998776553  4222211


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCC--CCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .       .+..-.|.|++||.+...+.  .-.++|+||+++++|||.|...||...+..+.-..|.-            
T Consensus       343 e-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial------------  403 (448)
T KOG0195|consen  343 E-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL------------  403 (448)
T ss_pred             c-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh------------
Confidence            1       12244689999999976433  23689999999999999999999988776654433321            


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHh
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL  314 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil  314 (373)
                                       +.....++|++++.+..|+.-|++.||.+||.++.++
T Consensus       404 -----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 -----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             -----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                             1122345688999999999999999999999987664

>PRK10345 hypothetical protein; Provisional

Probab=99.89  E-value=1.9e-22  Score=171.51  Aligned_cols=134  Identities=23%  Similarity=0.307  Sum_probs=105.3

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-----CCCCeeeeceeecCCCCCCcceE
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-----QHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      .+.||+|+||.||.  +..++.+ +||++......  ....+.+|+.+++.+     .||||+++++++.++.  ..+.+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v   79 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV   79 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence            57899999999995  7777776 69998653222  334578999999999     5799999999996542  22344


Q ss_pred             E-EEeecCC---ccHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCceEEcCC----CCeEEcccC
Q 017334          110 Y-LVYELMD---TDLHQIIKSSQALTNDHCQYFLFQLLRGL-KYLHSANILHRDLKPGNLLVNAN----CDLKICDFG  178 (373)
Q Consensus       110 ~-lv~e~~~---g~L~~~l~~~~~~~~~~~~~i~~qi~~aL-~~LH~~~ivH~Dlkp~Nill~~~----~~~kL~Dfg  178 (373)
                      + +|+||.+   |+|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            4 7899954   699999976 456665  45688888888 99999999999999999999743    379999954

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=6.9e-22  Score=172.18  Aligned_cols=146  Identities=16%  Similarity=0.096  Sum_probs=112.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEE-eCCCCcEEEEEEccccccCh--------------------H--HHHHHHHHHHHHh
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSV-NRETNEKVAIKKINNAFENR--------------------V--DALRTLRELKLLR   84 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~-~~~~g~~~aiK~~~~~~~~~--------------------~--~~~~~~~E~~~l~   84 (373)
                      -..-|.+.+.||+|++|.||+|. +..+|+.||+|+++......                    .  ....+.+|+.+++
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            34468999999999999999999 67799999999987542110                    0  1123457999999


Q ss_pred             hCCCCC--eeeeceeecCCCCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCC
Q 017334           85 HLQHEN--VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN-ILHRDLK  160 (373)
Q Consensus        85 ~l~hpn--iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-ivH~Dlk  160 (373)
                      .+.+..  ++++++.         ...++||||++| +|.........+...++..++.||+.+|++||++| |+|||||
T Consensus       106 ~L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik  176 (237)
T smart00090      106 RLYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS  176 (237)
T ss_pred             HHHhcCCCCCeeeEe---------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence            997532  3333332         124899999987 56555444456677778899999999999999999 9999999


Q ss_pred             CCceEEcCCCCeEEcccCccccc
Q 017334          161 PGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       161 p~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      |+||+++ ++.++|+|||.+...
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhcc
Confidence            9999999 889999999988644

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.5e-21  Score=194.22  Aligned_cols=194  Identities=21%  Similarity=0.279  Sum_probs=153.9

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC---CCCeeeeceeecCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ---HENVIALKDVMMPSHR  103 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~  103 (373)
                      .-...|.|-+.||+|+||+||.|.+.+ |+.||+|+-+.+...+     ++-=.+++.+|+   -+-|..+..++...  
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~--  766 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQ--  766 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccC--
Confidence            345678899999999999999999987 9999999876543221     111122233333   34455555555332  


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-------CCeEEc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-------CDLKIC  175 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-------~~~kL~  175 (373)
                         +.-++|+||.+ |+|.+++...+.+++.-+..+..|++..++.||..+|||+||||+|+||...       --++|+
T Consensus       767 ---~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  767 ---NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ---CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence               45789999997 9999999988899999999999999999999999999999999999999532       349999


Q ss_pred             ccCcccccC--CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCC
Q 017334          176 DFGLARTSN--GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP  232 (373)
Q Consensus       176 Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  232 (373)
                      |||.+-.+.  .....+...++|-.+-.+|+..| +.+++.+|.|.|+.+++.|+.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence            999986433  23345677788999999999877 789999999999999999998873

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=6e-22  Score=181.47  Aligned_cols=253  Identities=24%  Similarity=0.329  Sum_probs=165.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeece-------e
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKD-------V   97 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-------~   97 (373)
                      -...+.+.+..+.++++.+....-..+   ..-++-+..+.  ..........+++..+....|.+..-+.+       .
T Consensus       242 ~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~--d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~  319 (516)
T KOG1033|consen  242 ESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV--DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES  319 (516)
T ss_pred             ccccccccccccccccCCchhhhhcccchhhhhccchhhhc--cchhhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence            344555566666666666654433322   12222222211  11133334556776666666544443333       1


Q ss_pred             ecCCCCCCcceEEEEeecCC-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeE
Q 017334           98 MMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ---ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (373)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~k  173 (373)
                      +.........++||.|++|. .+|.+|+..+.   ..+...+..++.|+..|++|   +|.+|+|+||.||....+..+|
T Consensus       320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence            11111122346999999996 79999997543   46778899999999999999   9999999999999999999999


Q ss_pred             EcccCcccccCCCC------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 017334          174 ICDFGLARTSNGKN------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLI  246 (373)
Q Consensus       174 L~Dfg~a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  246 (373)
                      |.|||+........      ...+...||.+||+||.+.+ +.|+.++||||||+||+|++. -...|.   .......+
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~  472 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDI  472 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhh
Confidence            99999987654332      23455689999999999988 789999999999999999985 222111   01111111


Q ss_pred             HHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .+       ..                       +...+..-.|.-.+||.+||...|.+||++.+.--|+|.
T Consensus       473 r~-------g~-----------------------ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 RD-------GI-----------------------IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hc-------CC-----------------------CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            10       00                       000001112345699999999999999988888777775

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=3.2e-20  Score=159.89  Aligned_cols=137  Identities=26%  Similarity=0.279  Sum_probs=109.6

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccC------hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN------RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++.||+|++|.||+|.+  +|..+++|+.......      .....+..+|+.++..+.|+++.....++..     ...
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~   73 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PEN   73 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CCC
Confidence            35799999999999987  6788999986533211      1122356689999999999988766666532     245


Q ss_pred             EEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          109 VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       109 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .++||||++| +|.+++.....    ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+...
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            7899999975 89888865332    7888999999999999999999999999999999 789999999998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=3.7e-22  Score=194.45  Aligned_cols=262  Identities=25%  Similarity=0.362  Sum_probs=204.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~  106 (373)
                      ...|.+.+.||+|+|+.|-.+... .+...+|.|.+............+..|..+-+.+. |+|++.+++..     .+.
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence            478999999999999999888764 34456777777655433334445556888888887 99999999988     555


Q ss_pred             ceEEEEeecCC-ccHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEcCCC-CeEEcccCccc
Q 017334          107 KDVYLVYELMD-TDLHQII-KSSQ-ALTNDHCQYFLFQLLRGLKYLH-SANILHRDLKPGNLLVNANC-DLKICDFGLAR  181 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l-~~~~-~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~  181 (373)
                      ...++++++.. +++++.+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++.++ .+++.|||+|.
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence            77899999986 5888887 5544 7788889999999999999999 99999999999999999999 99999999997


Q ss_pred             ccCC---CCccccceee-ccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          182 TSNG---KNQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       182 ~~~~---~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      ....   ........+| ++.|+|||...+.....+..|+||+|+++.-+++|..|+.........              
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------  239 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------  239 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------
Confidence            5543   2334556688 999999999987556778999999999999999999887544321100              


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ..            .+.......-...+..++..+.+++.++|..+|+.|.+.+++-.+||+..
T Consensus       240 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  240 YS------------SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ce------------eecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            00            00000001112234567788999999999999999999999999999987

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.1e-19  Score=154.81  Aligned_cols=139  Identities=21%  Similarity=0.195  Sum_probs=105.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh--------------------HHHHHHHHHHHHHhhCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR--------------------VDALRTLRELKLLRHLQHE   89 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~hp   89 (373)
                      ..|.+.+.||+|+||.||++... +|+.+|||++.......                    .......+|+.++..+.++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            34888999999999999999875 79999999876432100                    0111245788899888777


Q ss_pred             C--eeeeceeecCCCCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017334           90 N--VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV  166 (373)
Q Consensus        90 n--iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill  166 (373)
                      +  ++.+++.         ...++||||++| +|..+...      .....++.+++.++.++|+.||+||||||+||++
T Consensus        94 ~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill  158 (198)
T cd05144          94 GFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV  158 (198)
T ss_pred             CCCCCceeec---------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE
Confidence            4  3333221         235899999975 66544321      3456789999999999999999999999999999


Q ss_pred             cCCCCeEEcccCcccccC
Q 017334          167 NANCDLKICDFGLARTSN  184 (373)
Q Consensus       167 ~~~~~~kL~Dfg~a~~~~  184 (373)
                      +.++.++|+|||.+....
T Consensus       159 ~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCcEEEEECCccccCC
Confidence            999999999999986553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=3e-19  Score=152.40  Aligned_cols=132  Identities=27%  Similarity=0.328  Sum_probs=101.7

Q ss_pred             eeeccCceEEEEEEeCCCCcEEEEEEccccc-cC-----hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           37 PIGRGAYGIVCSSVNRETNEKVAIKKINNAF-EN-----RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      .||+|++|.||++..  +|..+++|+..... ..     .....++.+|+++++.+.|+++....-++...     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            389999999999984  57889999864321 11     11234566899999999887655443333222     3468


Q ss_pred             EEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          111 LVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      +||||++ ++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+...
T Consensus        74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999997 588887754321       7899999999999999999999999999999 889999999998654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=3.6e-19  Score=166.13  Aligned_cols=207  Identities=25%  Similarity=0.335  Sum_probs=150.7

Q ss_pred             HhhCCCCCeeeeceeecCCCCCCcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCC
Q 017334           83 LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANI-LHRDL  159 (373)
Q Consensus        83 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i-vH~Dl  159 (373)
                      |+.+.|.|+.++++.....     ...++|.+||. |+|.+.+.. .-.++......++++|+.||+|||...| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            4568899999999999654     67999999997 899999987 3467788888999999999999998876 99999


Q ss_pred             CCCceEEcCCCCeEEcccCcccccCC--CCccccceeeccccCchhhhhcCCC------CCchhhhHHHHHHHHHHHhCC
Q 017334          160 KPGNLLVNANCDLKICDFGLARTSNG--KNQFMTEYVVTRWYRAPELLLCCDN------YGTSIDVWSVGCIFAELLGRK  231 (373)
Q Consensus       160 kp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~ll~g~  231 (373)
                      ++.|.+++....+||+|||+......  .........-..-|.|||.+.+...      .+.+.||||+|++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999876532  1111111223456999999876311      467799999999999999999


Q ss_pred             CCCCCCCchHH-HHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH
Q 017334          232 PIFPGTECLNQ-LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV  310 (373)
Q Consensus       232 ~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~  310 (373)
                      .||........ ...+..+.+...                     .+..|.-.......+++..++.+||..+|++||++
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~---------------------~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGS---------------------NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCC---------------------CCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence            99976432211 111211111000                     00000000001345578899999999999999999


Q ss_pred             HHHhC
Q 017334          311 TEALQ  315 (373)
Q Consensus       311 ~eil~  315 (373)
                      +++-.
T Consensus       215 ~~i~~  219 (484)
T KOG1023|consen  215 EQIRS  219 (484)
T ss_pred             HHHHh
Confidence            88764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2.3e-18  Score=168.22  Aligned_cols=140  Identities=24%  Similarity=0.331  Sum_probs=108.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcc-cccc-----ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFE-----NRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~-~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      ....|...+.||+|+||+||++...  +..+++|+.. +...     ......++.+|+++++.++|++++....+....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3455677899999999999999875  3344554432 1111     112234567899999999999988766555322


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                           ...++||||++ ++|.+++.        ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||++
T Consensus       409 -----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        409 -----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             -----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence                 34689999997 58988775        356789999999999999999999999999999 6789999999998


Q ss_pred             ccc
Q 017334          181 RTS  183 (373)
Q Consensus       181 ~~~  183 (373)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.78  E-value=1.4e-18  Score=146.70  Aligned_cols=136  Identities=24%  Similarity=0.265  Sum_probs=96.4

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHH----------------------HHHHHHHHhhCCCCC--
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR----------------------TLRELKLLRHLQHEN--   90 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~hpn--   90 (373)
                      .+.||+|+||+||+|.+. +|+.||||++............                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999987 8999999998654322111111                      124555565554332  


Q ss_pred             eeeeceeecCCCCCCcceEEEEeecCCc-cHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEc
Q 017334           91 VIALKDVMMPSHRRNFKDVYLVYELMDT-DLH-QIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVN  167 (373)
Q Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~-~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~  167 (373)
                      +.+++..         ...++||||++| ++. ..+.... . ..+++.++.+++.++.++|. .||+|+||||+||+++
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence            3333332         235899999976 221 1121111 1 16788999999999999999 9999999999999999


Q ss_pred             CCCCeEEcccCccccc
Q 017334          168 ANCDLKICDFGLARTS  183 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~  183 (373)
                       ++.++|+|||.+...
T Consensus       150 -~~~~~liDfg~a~~~  164 (187)
T cd05119         150 -DGKVYIIDVPQAVEI  164 (187)
T ss_pred             -CCcEEEEECcccccc
Confidence             889999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=8.7e-19  Score=163.71  Aligned_cols=254  Identities=24%  Similarity=0.251  Sum_probs=200.5

Q ss_pred             ecCceeeeeeeec--cCceEEEEEEe--CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCC
Q 017334           28 IDTKYVPIKPIGR--GAYGIVCSSVN--RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSH  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~--G~~g~V~~a~~--~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  102 (373)
                      ..+.+.+.+.+|.  |.+|.||.+..  +.++..+|+|.-+..........+-++|+...+.+. |+|.++.+..+    
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~----  187 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW----  187 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc----
Confidence            4567778889999  99999999998  889999999997666555555555668888888887 99999977776    


Q ss_pred             CCCcceEEEEeecCCccHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCceEEcCC-CCeEEcc
Q 017334          103 RRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLR----GLKYLHSANILHRDLKPGNLLVNAN-CDLKICD  176 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~----aL~~LH~~~ivH~Dlkp~Nill~~~-~~~kL~D  176 (373)
                       +..+..++-+|+++.+|.++...... +++..++..+.+...    ||.++|+.+++|-|+||+||+...+ ...+++|
T Consensus       188 -e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  188 -EGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             -ccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence             55578999999999999888876544 899999999999999    9999999999999999999999999 7899999


Q ss_pred             cCcccccCCCCccc-----cceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCC--CchHHHHHHHHH
Q 017334          177 FGLARTSNGKNQFM-----TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT--ECLNQLKLIINI  249 (373)
Q Consensus       177 fg~a~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~~i~~~  249 (373)
                      ||+.......+-..     ....|..-|++||.+.+  -++...||++||.++.+..++..+....  +...+++.+   
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---  341 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---  341 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---
Confidence            99998765543221     12256677999999865  5889999999999999988887655433  111111100   


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                                   ....++....+..+...+..|++.+|-.|+++..+++|+++.
T Consensus       342 -----------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  342 -----------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             -----------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence                                         011122334556677799999999999999999999999986

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.76  E-value=1.5e-17  Score=145.16  Aligned_cols=139  Identities=16%  Similarity=0.245  Sum_probs=103.9

Q ss_pred             eeee-ccCceEEEEEEeCCCCcEEEEEEccccc-----------cChHHHHHHHHHHHHHhhCCCCCe--eeeceeecCC
Q 017334           36 KPIG-RGAYGIVCSSVNRETNEKVAIKKINNAF-----------ENRVDALRTLRELKLLRHLQHENV--IALKDVMMPS  101 (373)
Q Consensus        36 ~~lg-~G~~g~V~~a~~~~~g~~~aiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~~  101 (373)
                      ..|| .||.|+||.+...  +..+++|.+....           .......++.+|+.++..+.|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3577 8888999988764  7789999885321           112333467789999999998775  5666554322


Q ss_pred             CCCCcceEEEEeecCCc--cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          102 HRRNFKDVYLVYELMDT--DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                      . ......++|||+++|  +|.+++.. ..+++.    .+.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            1 111234699999974  88888765 455554    367899999999999999999999999999999999999998


Q ss_pred             ccc
Q 017334          180 ART  182 (373)
Q Consensus       180 a~~  182 (373)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=1.9e-16  Score=128.42  Aligned_cols=131  Identities=24%  Similarity=0.246  Sum_probs=106.3

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCC--CCeeeeceeecCCCCCCcceEEE
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH--ENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      +++.||+|.++.||++...  +..+++|.+.....    ...+.+|+.+++.+++  .++++++...     ...+..++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYL   70 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEE
Confidence            4678999999999999875  37899999865433    3456789999999975  5888887776     33366899


Q ss_pred             EeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          112 VYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA---NILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      +|||++| .+..+       +......++.+++.+|+.||..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9999976 44322       5566677899999999999985   699999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.69  E-value=1.4e-17  Score=163.52  Aligned_cols=259  Identities=23%  Similarity=0.275  Sum_probs=192.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..+.+.+.+.+|+++.++.+.-..+|...++|+...... ...+...+..+-.++-...+|.++.....+     .....
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP  878 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSP  878 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCC
Confidence            455667789999999999998888887777776643321 111122222333333333456665443332     23356


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC-
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK-  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-  186 (373)
                      .+++++|++ ++|...+++.+..+..-++.++..+..++++||...+.|+|++|.|+|+..+++.+++|||.....+.. 
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            899999996 699999998888888899999999999999999999999999999999999999999999843221100 


Q ss_pred             ----------------------------C--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 017334          187 ----------------------------N--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG  236 (373)
Q Consensus       187 ----------------------------~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  236 (373)
                                                  .  ..-....+|+.|.+||.+.+ ...+.++|+|+.|+++++.++|.+||..
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                        0  01123467999999999988 5778999999999999999999999988


Q ss_pred             CCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHH---HH
Q 017334          237 TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT---EA  313 (373)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~---ei  313 (373)
                      .........|.+.                            ..+|..-....++.+++++.++|..+|.+|..+.   ++
T Consensus      1038 ~tpq~~f~ni~~~----------------------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~ 1089 (1205)
T KOG0606|consen 1038 ETPQQIFENILNR----------------------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEV 1089 (1205)
T ss_pred             cchhhhhhccccC----------------------------CCCCCCCccccChhhhhhhhhhhccCchhccCccccccc
Confidence            7655544333221                            1233333345678899999999999999999887   89


Q ss_pred             hCCCCCCCC
Q 017334          314 LQHPYMSPL  322 (373)
Q Consensus       314 l~hp~~~~~  322 (373)
                      -.|+||++.
T Consensus      1090 k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1090 KGHPFFQDV 1098 (1205)
T ss_pred             ccCCccCCC
Confidence            999999864

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.61  E-value=2e-14  Score=136.04  Aligned_cols=169  Identities=23%  Similarity=0.377  Sum_probs=129.2

Q ss_pred             EEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCCccHHHHHHhc
Q 017334           48 SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS  127 (373)
Q Consensus        48 ~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~  127 (373)
                      .|..+.++.++.|.+++....  .....+.+.++.|+.++||||+++++.+     +..+.+|||+|.+.. |..+++. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~-  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE-  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH-
Confidence            456677889999998876544  3344566888999999999999999998     555789999999853 1122222 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhh
Q 017334          128 QALTNDHCQYFLFQLLRGLKYLH-SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL  206 (373)
Q Consensus       128 ~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  206 (373)
                        ++...+..-++||+.||.||| +.+++|++|.-..|+|+..|..||++|.++....+.+........--.|..|+.+.
T Consensus       101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID  178 (690)
T ss_pred             --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence              236778889999999999997 67899999999999999999999999999876544433222233334467777653


Q ss_pred             cCCCCCchhhhHHHHHHHHHHHhC
Q 017334          207 CCDNYGTSIDVWSVGCIFAELLGR  230 (373)
Q Consensus       207 ~~~~~~~~~DiwslG~il~~ll~g  230 (373)
                      .   ..-..|.|.|||++++++.|
T Consensus       179 ~---s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 P---SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c---cccchhhhhHHHHHHHHhCc
Confidence            2   22567999999999999988

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=4.1e-16  Score=135.29  Aligned_cols=204  Identities=21%  Similarity=0.229  Sum_probs=141.8

Q ss_pred             HHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q 017334           82 LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSAN--I  154 (373)
Q Consensus        82 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--i  154 (373)
                      .|-++-|.|||+++.++.....++...+.++.|||. |++.++|+.    +..+....-++|+-||+.||.|||+..  |
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            345556999999999987665556677899999996 899998864    346888889999999999999999885  9


Q ss_pred             cccCCCCCceEEcCCCCeEEcccCcc--cc-cCCC-CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC
Q 017334          155 LHRDLKPGNLLVNANCDLKICDFGLA--RT-SNGK-NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR  230 (373)
Q Consensus       155 vH~Dlkp~Nill~~~~~~kL~Dfg~a--~~-~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  230 (373)
                      +|+++..+.|++..+|-+|+.---..  .. .... .....-..+-++|.|||.-.. ...+.++|||++|....+|..+
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHh
Confidence            99999999999999988887532111  00 0000 000111234678999987433 4567799999999999999877


Q ss_pred             CCC-CCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC
Q 017334          231 KPI-FPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS  309 (373)
Q Consensus       231 ~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t  309 (373)
                      ..- -.+.+....-..+.++.                        .          ..-++.-++++.+||+..|..||+
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i------------------------~----------~len~lqr~~i~kcl~~eP~~rp~  324 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVI------------------------I----------GLENGLQRGSITKCLEGEPNGRPD  324 (458)
T ss_pred             eeccCCCcceeehhhhhhhhe------------------------e----------eccCccccCcCcccccCCCCCCcc
Confidence            632 22222111111111100                        0          001112347899999999999999


Q ss_pred             HHHHhCCCCCC
Q 017334          310 VTEALQHPYMS  320 (373)
Q Consensus       310 ~~eil~hp~~~  320 (373)
                      +.+++.||-+-
T Consensus       325 ar~llfHpllf  335 (458)
T KOG1266|consen  325 ARLLLFHPLLF  335 (458)
T ss_pred             hhhhhcCceee
Confidence            99999999764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.59  E-value=1.2e-14  Score=121.61  Aligned_cols=138  Identities=18%  Similarity=0.221  Sum_probs=100.1

Q ss_pred             eeeeeccCceEEEEEEeCC------CCcEEEEEEcccccc-----------C---------hHHHHH----HHHHHHHHh
Q 017334           35 IKPIGRGAYGIVCSSVNRE------TNEKVAIKKINNAFE-----------N---------RVDALR----TLRELKLLR   84 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~------~g~~~aiK~~~~~~~-----------~---------~~~~~~----~~~E~~~l~   84 (373)
                      ...||.|--+.||.|....      .+..+|||+.+....           +         ......    ..+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3568999999999998654      357899998852210           0         011111    237999999


Q ss_pred             hCC--CCCeeeeceeecCCCCCCcceEEEEeecCCcc-HH-HHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCC
Q 017334           85 HLQ--HENVIALKDVMMPSHRRNFKDVYLVYELMDTD-LH-QIIKSSQALTNDHCQYFLFQLLRGLKYL-HSANILHRDL  159 (373)
Q Consensus        85 ~l~--hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g~-L~-~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~ivH~Dl  159 (373)
                      ++.  .-++++++++.         .-+|||||++++ +. ..++ ...+++.++..+..+++.+|..| |+.||+|+||
T Consensus        82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            985  35666666542         247999999863 32 2222 23456667788899999999998 8999999999


Q ss_pred             CCCceEEcCCCCeEEcccCccccc
Q 017334          160 KPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       160 kp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ++.|||++ ++.+.|+|||.+...
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeC
Confidence            99999997 468999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=2.2e-15  Score=141.07  Aligned_cols=254  Identities=21%  Similarity=0.183  Sum_probs=190.0

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeC-CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCC
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNR-ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSH  102 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~-~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  102 (373)
                      .-....++..+..||.|.|+.|+.+..+ .++..|++|...+..........-+.|+.+...+. |.+++.....+.   
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---  336 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---  336 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc---
Confidence            4456688999999999999999987766 68889999999887777776666778999888886 999998877773   


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CCeEEcccCcc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLA  180 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-~~~kL~Dfg~a  180 (373)
                        .....|+-.|||+ +++...+.-...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.+
T Consensus       337 --~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  337 --QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             --ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccc
Confidence              3355779999996 4554444434568888999999999999999999999999999999999886 78899999988


Q ss_pred             cccCCCCccccceeeccccC-chhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          181 RTSNGKNQFMTEYVVTRWYR-APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .......   ......-++. .+|++.....+..+.|++|||.-+.+.+++.+.-......   ..|..           
T Consensus       415 t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~-----------  477 (524)
T KOG0601|consen  415 TRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRS-----------  477 (524)
T ss_pred             cccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeec-----------
Confidence            6422111   1112233344 3677766678889999999999999999998754332110   00000           


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                         .. ....+.....++.+.+.++..++..|+.+.++..|.-|.
T Consensus       478 -------------------~~-~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  478 -------------------GD-TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             -------------------cc-ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                               00 001123335678899999999999999999999887654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.56  E-value=4.5e-15  Score=142.25  Aligned_cols=143  Identities=18%  Similarity=0.316  Sum_probs=96.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh--------------------------------HHH----
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR--------------------------------VDA----   73 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~--------------------------------~~~----   73 (373)
                      ..|.. +.||+|++|.||+|+.+.+|+.||||+++......                                .-.    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 78999999999999999889999999997432110                                000    


Q ss_pred             --HHHHHHHHHHhhCC----CCCeeeeceeecCCCCCCcceEEEEeecCCc-cHHHH--HHhcC----CCCHHHHHHHHH
Q 017334           74 --LRTLRELKLLRHLQ----HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQI--IKSSQ----ALTNDHCQYFLF  140 (373)
Q Consensus        74 --~~~~~E~~~l~~l~----hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~--l~~~~----~~~~~~~~~i~~  140 (373)
                        ..+.+|...+.++.    +.+.+.+-.++..    .....++||||++| .+.++  +...+    .+.+..+..++.
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence              11234444444442    3333444444421    12457899999975 77653  33333    355555666666


Q ss_pred             HHHHHHHHHHhCCccccCCCCCceEEcCCC----CeEEcccCcccccC
Q 017334          141 QLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDFGLARTSN  184 (373)
Q Consensus       141 qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~----~~kL~Dfg~a~~~~  184 (373)
                      |++       ..|++|+|+||.||+++.++    +++++|||++...+
T Consensus       275 Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        275 QVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            665       48999999999999999988    99999999987653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=4.4e-14  Score=133.90  Aligned_cols=141  Identities=22%  Similarity=0.298  Sum_probs=94.8

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHH--------------------------------------HHHHH
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD--------------------------------------ALRTL   77 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~--------------------------------------~~~~~   77 (373)
                      +.||+|++|.||+|+.+ +|+.||||+.+........                                      ...+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999875 7899999998643211000                                      00123


Q ss_pred             HHHHHHhhC----CCCCeeeeceeecCCCCCCcceEEEEeecCCc-cHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHH
Q 017334           78 RELKLLRHL----QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS-QALTNDHCQYFLFQLLR-GLKYLH  150 (373)
Q Consensus        78 ~E~~~l~~l----~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~~~~~~~~~i~~qi~~-aL~~LH  150 (373)
                      +|...+..+    ++.+-+.+-.++...    ....++||||++| +|.++.... ...   ....++.+++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence            455555444    333333333344211    1346999999975 777665421 122   23445566665 467899


Q ss_pred             hCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       151 ~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..|++|+|+||.||+++.+++++|+|||++....
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=7.5e-14  Score=115.79  Aligned_cols=127  Identities=22%  Similarity=0.219  Sum_probs=92.5

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCee-eeceeecCCCCCCcceEEEEe
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI-ALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      ++.|+.|.++.||++...  |..|++|+.......   .....+|+.+++.+.+.+++ +++...     .  ..-++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEE
Confidence            567899999999999864  788999987544321   12345788888888654443 444332     1  1247999


Q ss_pred             ecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          114 ELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANI-----LHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       114 e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i-----vH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ||++| ++.+.        ......++.+++.+|+.||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99986 54322        11124467899999999999985     9999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.42  E-value=7.2e-12  Score=115.51  Aligned_cols=216  Identities=13%  Similarity=0.181  Sum_probs=155.0

Q ss_pred             ceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCC--ccH
Q 017334           43 YGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD--TDL  120 (373)
Q Consensus        43 ~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~--g~L  120 (373)
                      -.+.|+|....+|..|++|.++......  ..+...-+++++++.|+|+|++.++|.+.. -++..+++|++|.+  ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchH
Confidence            4588999999999999999994322111  112335678899999999999999997443 23467999999997  488


Q ss_pred             HHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          121 HQIIK---------------SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       121 ~~~l~---------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .++--               .+...+|..+|.++.||..||.++|+.|+..+-|.|.+||++.+.+++|+..|.......
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            77652               123577899999999999999999999999999999999999999999998887765432


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      +.            .  |.+.+    ..+-|.=.||.+++.|.+|..--...+.....                      
T Consensus       446 d~------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s----------------------  485 (655)
T KOG3741|consen  446 DP------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS----------------------  485 (655)
T ss_pred             CC------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH----------------------
Confidence            21            0  11222    24678899999999999996321111111000                      


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                    ....+.+.+|.+++++|.-+...++.+ -++.+++.+
T Consensus       486 --------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  486 --------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                          001122456777888888888888876 667776654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.41  E-value=2.8e-12  Score=103.28  Aligned_cols=143  Identities=21%  Similarity=0.287  Sum_probs=103.9

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEcc-c----c-ccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-N----A-FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~-~----~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .+..|-+|+-+.|+++...  |+.+.||.-- +    + ........+..+|.++|.++.--.|.-..-++.+.     +
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y   83 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence            5678889999999999765  8888888532 2    1 22334445667899999888533333222233222     3


Q ss_pred             eEEEEeecCCc--cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC---eEEcccCcc
Q 017334          108 DVYLVYELMDT--DLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLA  180 (373)
Q Consensus       108 ~~~lv~e~~~g--~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~---~kL~Dfg~a  180 (373)
                      .-.|+|||++|  ++.+++....  ...+.....++.+|-+.+.-||.++|+|+||..+||++.+++.   +.|+|||++
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            35799999998  8888886542  2333334789999999999999999999999999999987763   689999998


Q ss_pred             ccc
Q 017334          181 RTS  183 (373)
Q Consensus       181 ~~~  183 (373)
                      ...
T Consensus       164 ~~s  166 (229)
T KOG3087|consen  164 SVS  166 (229)
T ss_pred             hcc
Confidence            643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=3.1e-12  Score=103.49  Aligned_cols=131  Identities=24%  Similarity=0.309  Sum_probs=94.2

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEc-cccc-----cChHHHHHHHHHHHHHhhCC--CCCeeeeceeecCCCCCCcc
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAF-----ENRVDALRTLRELKLLRHLQ--HENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~-~~~~-----~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..+++|+-+.++.+...  |.++++|.= .+..     .......+..+|.+++.++.  --+.+.++++..       .
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-------~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-------D   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-------C
Confidence            35789999999988653  555666653 2222     22233345568999998885  333444444431       3


Q ss_pred             eEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          108 DVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ...|+|||++| .|.+.+...       .-.+++.+-..+.-||..||+|+||.++||+++.++ +.++|||++...
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            46799999998 556677654       145777888888899999999999999999998774 999999998743

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.29  E-value=1.2e-10  Score=102.97  Aligned_cols=134  Identities=13%  Similarity=0.110  Sum_probs=91.8

Q ss_pred             EEEEEeCCCCcEEEEEEccccccCh---------HHHHHHHHHHHHHhhCCCCCee--eeceeecCCCCCCcceEEEEee
Q 017334           46 VCSSVNRETNEKVAIKKINNAFENR---------VDALRTLRELKLLRHLQHENVI--ALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        46 V~~a~~~~~g~~~aiK~~~~~~~~~---------~~~~~~~~E~~~l~~l~hpniv--~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      |+++..  .|+.|.||.........         .....+.+|+..+..|..-+|.  +++++............++|||
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            445433  47789999764322110         1111366888888887533333  3333332111111245789999


Q ss_pred             cCCc--cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-------CCCeEEcccCccc
Q 017334          115 LMDT--DLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-------NCDLKICDFGLAR  181 (373)
Q Consensus       115 ~~~g--~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-------~~~~kL~Dfg~a~  181 (373)
                      ++++  +|.+++..  ....+......++.+++..+.-||.+||+|+|+++.|||++.       +..+.|+||+.+.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9986  78888753  345667788899999999999999999999999999999975       4679999999774

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=2.9e-11  Score=104.76  Aligned_cols=143  Identities=18%  Similarity=0.232  Sum_probs=100.4

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCC--CCeeeeceeecCCCCCCcceEEEE
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH--ENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      ++.|+.|..+.||++.... |..+++|+....... .....+.+|+.+++.+.+  .++.+++.+....  ...+..++|
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v   78 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYV   78 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEE
Confidence            3678999999999998753 688999997654321 123356689999999875  3456666554321  112356899


Q ss_pred             eecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 017334          113 YELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS----------------------------------------  151 (373)
Q Consensus       113 ~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~----------------------------------------  151 (373)
                      |||++| ++.+.+.. ..+++.+...++.+++.+|..||+                                        
T Consensus        79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999986 55443321 346666677777777777777773                                        


Q ss_pred             ----------------CCccccCCCCCceEEcC--CCCeEEcccCcccc
Q 017334          152 ----------------ANILHRDLKPGNLLVNA--NCDLKICDFGLART  182 (373)
Q Consensus       152 ----------------~~ivH~Dlkp~Nill~~--~~~~kL~Dfg~a~~  182 (373)
                                      ..++|+|++|.|||++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                            23689999999999998  56689999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.26  E-value=4.6e-11  Score=99.66  Aligned_cols=127  Identities=25%  Similarity=0.263  Sum_probs=82.6

Q ss_pred             EEEEEEeCCCCcEEEEEEccccc------------------------cChHHHHHHHHHHHHHhhCCCC--Ceeeeceee
Q 017334           45 IVCSSVNRETNEKVAIKKINNAF------------------------ENRVDALRTLRELKLLRHLQHE--NVIALKDVM   98 (373)
Q Consensus        45 ~V~~a~~~~~g~~~aiK~~~~~~------------------------~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~   98 (373)
                      .||.|.. .+|..+|+|+.+...                        ..........+|.+.|..+..-  ++++++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3788876 367789999875210                        0111222446899999999744  566776553


Q ss_pred             cCCCCCCcceEEEEeecCC--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCceEEcCCCCeEEc
Q 017334           99 MPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY-LHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~-LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                               .-+|||||++  |.....+... .++..+...++.+++..+.. +|+.||+|+||.+.|||++.+ .+.++
T Consensus        80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence                     2379999998  7333333321 22255677888899996555 579999999999999999988 99999


Q ss_pred             ccCccccc
Q 017334          176 DFGLARTS  183 (373)
Q Consensus       176 Dfg~a~~~  183 (373)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=4.6e-12  Score=120.71  Aligned_cols=154  Identities=25%  Similarity=0.373  Sum_probs=112.9

Q ss_pred             HHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcccccCCCCccc---------cceeeccccCchhhhhcCCC
Q 017334          141 QLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM---------TEYVVTRWYRAPELLLCCDN  210 (373)
Q Consensus       141 qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~  210 (373)
                      ++..|+.|+|.. ++||++|.|++|.++..+..||+.|+++....+.....         .-......|.|||.+.+ ..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence            344999999955 89999999999999999999999999986554422211         01123566999999987 67


Q ss_pred             CCchhhhHHHHHHHHHHH-hCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCC
Q 017334          211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH  289 (373)
Q Consensus       211 ~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  289 (373)
                      .+.++|+||+||++|.+. +|+..+.+.........-....+.                           ........++
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~---------------------------~~~~~s~~~p  238 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA---------------------------GAFGYSNNLP  238 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc---------------------------ccccccccCc
Confidence            889999999999999998 677666554322222211110000                           0011224578


Q ss_pred             HHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          290 PLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       290 ~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      +++++=|.++|..++..||++..++..|||.+.
T Consensus       239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             HHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            899999999999999999999999999999754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.22  E-value=1.4e-10  Score=99.25  Aligned_cols=128  Identities=23%  Similarity=0.262  Sum_probs=92.1

Q ss_pred             CCcEEEEEEccccc-----cChHHHHHHHHHHHHHhhCC--CCCeeeeceeecCCCCCCcceEEEEeecCCc--cHHHHH
Q 017334           54 TNEKVAIKKINNAF-----ENRVDALRTLRELKLLRHLQ--HENVIALKDVMMPSHRRNFKDVYLVYELMDT--DLHQII  124 (373)
Q Consensus        54 ~g~~~aiK~~~~~~-----~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g--~L~~~l  124 (373)
                      .++.|.+|......     .......+..+|...+..|.  .-..++++++..... ......++|+|+++|  +|.+++
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~  109 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLL  109 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHH
Confidence            45566666543211     11133446678888887775  333344444443221 111457899999976  799998


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEcccCcccc
Q 017334          125 KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGLART  182 (373)
Q Consensus       125 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~kL~Dfg~a~~  182 (373)
                      ......+......++.+++..++-||.+||+|+|+++.|||++.++   .+.|+||+.++.
T Consensus       110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            8755577888899999999999999999999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.16  E-value=9.4e-10  Score=99.47  Aligned_cols=193  Identities=14%  Similarity=0.110  Sum_probs=129.4

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeee----eceeecCCCCCCcce
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIA----LKDVMMPSHRRNFKD  108 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~----~~~~~~~~~~~~~~~  108 (373)
                      ..+.||+|+.+.+|..-..   ...+.|++..+.......     -+..|... .||-+-.    ..+.....  ....-
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq-----k~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~   84 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ-----KVAELAATPDAPLLNYRVAWPQATLHGG--RRGKV   84 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHHHH-----HHHHhccCCCCcchhhhhcccHHHhhCC--Cccce
Confidence            4567999999999966433   224678887654322211     12223322 3554322    11111111  11123


Q ss_pred             EEEEeecCCc--cHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          109 VYLVYELMDT--DLHQIIK------SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       109 ~~lv~e~~~g--~L~~~l~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      +.+.|..+.|  .+..+..      +...+.+..+.++.+.|+.|.+-||.+|.+-+|++++|+|+++++.|.|.|=..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            7888998865  4444442      2235678889999999999999999999999999999999999999999985433


Q ss_pred             cccCCCCccccceeeccccCchhhhh-c---CCCCCchhhhHHHHHHHHHHHhC-CCCCCCC
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLL-C---CDNYGTSIDVWSVGCIFAELLGR-KPIFPGT  237 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~~DiwslG~il~~ll~g-~~pf~~~  237 (373)
                      ..- .........+|...|.+||.-. +   +-.-+...|.|.||+++++++.| ++||.+-
T Consensus       165 qi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         165 QIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            222 2333445568899999999843 1   12356789999999999999855 9999764

>PRK09902 hypothetical protein; Provisional

Probab=99.13  E-value=1.5e-09  Score=91.02  Aligned_cols=140  Identities=16%  Similarity=0.138  Sum_probs=101.4

Q ss_pred             eccCceEEEEEEeCCCCcEEEEEEccccc----cChHHHHHHHHHHHHHhhCCC--CCeeeeceeecCCCCCCcceEEEE
Q 017334           39 GRGAYGIVCSSVNRETNEKVAIKKINNAF----ENRVDALRTLRELKLLRHLQH--ENVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        39 g~G~~g~V~~a~~~~~g~~~aiK~~~~~~----~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      |+||-+.|+.....  |+.+-+|.-....    ........+.+|+..++.|..  -.++++. ++...........+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            66888999887543  4578888764211    112234467889999988863  3344444 2211111223458899


Q ss_pred             eecCCc--cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC--eEEcccCccc
Q 017334          113 YELMDT--DLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD--LKICDFGLAR  181 (373)
Q Consensus       113 ~e~~~g--~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~--~kL~Dfg~a~  181 (373)
                      +|-++|  +|.+++...  .+.+..+...++.+++.++.-||+.|+.|+|+-+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            998874  999988653  35677778899999999999999999999999999999987777  9999998664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.09  E-value=8.8e-10  Score=94.67  Aligned_cols=137  Identities=23%  Similarity=0.221  Sum_probs=102.1

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccc------------------c--cChHHHHHHHHHHHHHhhCCCC-
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA------------------F--ENRVDALRTLRELKLLRHLQHE-   89 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~------------------~--~~~~~~~~~~~E~~~l~~l~hp-   89 (373)
                      -+.+...||-|--|.||.|.+. .|.++|||.=+..                  .  ........+.+|.++|+.|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3456788999999999999886 7889999964210                  0  0112233456899999999744 


Q ss_pred             -CeeeeceeecCCCCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334           90 -NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus        90 -niv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                       .+++.++.         +.-.+|||+++| .|...     ++....+..++..|+.-+.-+-..||||+|+++-||+++
T Consensus       171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~  236 (304)
T COG0478         171 VKVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence             66666655         345799999998 44321     224556677777888877777799999999999999999


Q ss_pred             CCCCeEEcccCcccc
Q 017334          168 ANCDLKICDFGLART  182 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~  182 (373)
                      .+|.+.++||-.+..
T Consensus       237 ~dg~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCCCEEEEeCccccc
Confidence            999999999976643

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.04  E-value=4.2e-09  Score=88.72  Aligned_cols=143  Identities=19%  Similarity=0.191  Sum_probs=91.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHH-HHH------HHHHHHHHhhC---CCCCeeeecee
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD-ALR------TLRELKLLRHL---QHENVIALKDV   97 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~-~~~------~~~E~~~l~~l---~hpniv~~~~~   97 (373)
                      +.++|.+++.+-......|.+..-  +|..+++|..+........ ...      ..+++..+..+   ..-....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            688999999998888888877654  5789999987643211111 111      12333333333   22333332222


Q ss_pred             ecCCCCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcc
Q 017334           98 MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (373)
Q Consensus        98 ~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~D  176 (373)
                      ..-....-....+++|||++| .|.+...    +++    .+...|.+++.-||+.|++|+|.+|.|++++.+ .++++|
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence            211111222456789999988 5544321    222    244677888999999999999999999999965 599999


Q ss_pred             cCccc
Q 017334          177 FGLAR  181 (373)
Q Consensus       177 fg~a~  181 (373)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            97553

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.77  E-value=8.3e-08  Score=81.87  Aligned_cols=144  Identities=19%  Similarity=0.154  Sum_probs=98.6

Q ss_pred             ecCceeeee---eeeccCceEEEEEEeCCCCcEEEEEEccccccChHH--------------------H--HHHHHHHHH
Q 017334           28 IDTKYVPIK---PIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD--------------------A--LRTLRELKL   82 (373)
Q Consensus        28 ~~~~Y~~~~---~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~--------------------~--~~~~~E~~~   82 (373)
                      +..+..+..   .|..|--+.||+|.. .++..+|+|+++........                    .  .-..+|+..
T Consensus        43 L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~N  121 (268)
T COG1718          43 LLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRN  121 (268)
T ss_pred             HhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHH
Confidence            344444444   455666678999875 46889999998643211111                    0  112468888


Q ss_pred             HhhCC--CCCeeeeceeecCCCCCCcceEEEEeecCCccH--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccc
Q 017334           83 LRHLQ--HENVIALKDVMMPSHRRNFKDVYLVYELMDTDL--HQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHR  157 (373)
Q Consensus        83 l~~l~--hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g~L--~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~  157 (373)
                      |+++.  +-.+.+.+.+.         .-.|||||++...  .-.|+. -.+...++..+..++++.+.-|-. .++||+
T Consensus       122 L~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHg  191 (268)
T COG1718         122 LKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHG  191 (268)
T ss_pred             HHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccc
Confidence            88885  55555665554         2479999997431  111111 233344788889999999998877 899999


Q ss_pred             CCCCCceEEcCCCCeEEcccCccccc
Q 017334          158 DLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       158 Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ||+.=|||+. ++.+.++|||.|...
T Consensus       192 DLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         192 DLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             cchhhheEEE-CCeEEEEECcccccc
Confidence            9999999999 889999999988654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.69  E-value=1.7e-07  Score=89.92  Aligned_cols=141  Identities=23%  Similarity=0.376  Sum_probs=88.3

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccChH--------------------------------------HHHHHH
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV--------------------------------------DALRTL   77 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~--------------------------------------~~~~~~   77 (373)
                      +.|+.++-|.||+|+-+ +|+.||||+.+.......                                      ....+.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            57999999999999986 499999999853211000                                      001123


Q ss_pred             HHHHHHhhC----CCCCeeeeceeecCCCCCCcceEEEEeecCCc-cHHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 017334           78 RELKLLRHL----QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQI--IKSSQALTNDHCQYFLFQLLRGLKYLH  150 (373)
Q Consensus        78 ~E~~~l~~l----~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~--l~~~~~~~~~~~~~i~~qi~~aL~~LH  150 (373)
                      +|...+.++    +...-+.+=.++.    +..+.-.++|||++| .+.+.  ++. ..++...+...+.++.  +.-+=
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~w----e~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYW----EYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeeh----hccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH
Confidence            455555554    2222333333442    222457899999988 56555  444 3444333322222211  12222


Q ss_pred             hCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       151 ~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..|++|.|.+|.||+++.+|++.+.|||+....+
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            3899999999999999999999999999986553

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.66  E-value=4.6e-07  Score=78.90  Aligned_cols=139  Identities=24%  Similarity=0.289  Sum_probs=78.6

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCC--CeeeeceeecCCCCCCcceEEEE
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE--NVIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      ++.|+.|..+.||.+....  ..+++|.....    .....+.+|..+++.+...  .+.+++......  ......+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~   73 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL   73 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence            5789999999999998764  48999987543    3344566788888887522  345555533221  222458999


Q ss_pred             eecCCc-cHHH----------------HH---Hhc----CCCCHHH------HHHH---------------HHHHHH-HH
Q 017334          113 YELMDT-DLHQ----------------II---KSS----QALTNDH------CQYF---------------LFQLLR-GL  146 (373)
Q Consensus       113 ~e~~~g-~L~~----------------~l---~~~----~~~~~~~------~~~i---------------~~qi~~-aL  146 (373)
                      |++++| .+..                .+   ...    ..+....      ....               ...+.. .+
T Consensus        74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            999986 4444                11   111    0111000      0000               011222 23


Q ss_pred             HHHH-------hCCccccCCCCCceEEc-CCCCeEEcccCccc
Q 017334          147 KYLH-------SANILHRDLKPGNLLVN-ANCDLKICDFGLAR  181 (373)
Q Consensus       147 ~~LH-------~~~ivH~Dlkp~Nill~-~~~~~kL~Dfg~a~  181 (373)
                      +.++       ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3333       23599999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.65  E-value=3.5e-07  Score=79.25  Aligned_cols=133  Identities=21%  Similarity=0.239  Sum_probs=78.1

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC--eeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN--VIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      ..||+|..+.||+.    .|..+++|......    ....+.+|.++++.+..-.  +.+++++.     +..+...+||
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence            56899999999974    25568899876432    1223567999998886332  45556555     2234578899


Q ss_pred             ecCCcc--HHHHH---------------------Hhc--CCCCHHH-HHHHHH----------HHHHH-HHHHH----hC
Q 017334          114 ELMDTD--LHQII---------------------KSS--QALTNDH-CQYFLF----------QLLRG-LKYLH----SA  152 (373)
Q Consensus       114 e~~~g~--L~~~l---------------------~~~--~~~~~~~-~~~i~~----------qi~~a-L~~LH----~~  152 (373)
                      |+++|.  +...+                     +.-  ....... ...+..          .+... ..+|.    ..
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            999873  11111                     100  0111111 001100          01111 12222    12


Q ss_pred             CccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          153 NILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      .++|+|+.|.||+++.++ +.++||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            468999999999999888 99999997753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.64  E-value=3.3e-07  Score=92.86  Aligned_cols=204  Identities=21%  Similarity=0.259  Sum_probs=140.2

Q ss_pred             HHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc-eEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 017334           74 LRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK-DVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS  151 (373)
Q Consensus        74 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~-~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  151 (373)
                      .....|+..+....|+|++.++.+....-  ..+ -+.+..+++.+ ++...+..-+..+....+.+..+++.||.++|+
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~--~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERL--FRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhh--cchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            33446778888889999999988875542  112 23445667764 888888888899999999999999999999999


Q ss_pred             CCccccCCCCC---ceEEcCCCCeEEc--ccCcccccCCCCccccceeeccccCchhhhhcCCCCC--chhhhHHHHHHH
Q 017334          152 ANILHRDLKPG---NLLVNANCDLKIC--DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG--TSIDVWSVGCIF  224 (373)
Q Consensus       152 ~~ivH~Dlkp~---Nill~~~~~~kL~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwslG~il  224 (373)
                      ....|.-+...   +--.+.++.+..+  ||+.+.......... .......+.+||.... ..+.  ...|+|++|...
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCcccccccccccc-ccchhhhhhHHHHHHHHH
Confidence            96655555444   4444555666666  888877654433222 2234566788887654 2333  346999999999


Q ss_pred             HHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCC-HHHHHHHHhhcCcC
Q 017334          225 AELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFD  303 (373)
Q Consensus       225 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~~~~ll~~~L~~d  303 (373)
                      ..+..|...-..      ...+...+                                   +..+ ....+++.+|+.-+
T Consensus       383 ~~~~~~~~i~~~------~~~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~~  421 (1351)
T KOG1035|consen  383 LQLSQGEDISEK------SAVPVSLL-----------------------------------DVLSTSELLDALPKCLDED  421 (1351)
T ss_pred             hhhhhcCccccc------ccchhhhh-----------------------------------ccccchhhhhhhhhhcchh
Confidence            999876643211      01111110                                   1111 14678999999999


Q ss_pred             CCCCCCHHHHhCCCCCCCC
Q 017334          304 PTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       304 P~~R~t~~eil~hp~~~~~  322 (373)
                      +++|+++.+++.|+|.+..
T Consensus       422 ~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  422 SEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hhhccchhhhhhchhcccc
Confidence            9999999999999998643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.54  E-value=1.1e-08  Score=97.25  Aligned_cols=247  Identities=17%  Similarity=0.111  Sum_probs=162.4

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC-eeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN-VIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~  105 (373)
                      +...-|...+-+++|+++++++.+...+...+ .+.+...       ....-++++|.+++||| .+..++-+     +.
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~  305 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY-----DG  305 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC-----Cc
Confidence            44466777888999999999999877665544 6665432       23345889999999999 43333333     55


Q ss_pred             cceEEEEeecCCcc--HHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          106 FKDVYLVYELMDTD--LHQII-KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       106 ~~~~~lv~e~~~g~--L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      +...+++++++++.  ....+ ...-.+.+-+...+.+.-+.++++||+.-=+|+|    ||+..+ +..|+.||+....
T Consensus       306 E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  306 EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcc
Confidence            57789999999642  22111 1112344555666777888899999998778998    777655 6899999998765


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ..... ..++..+++.++|||+... ..+....|.|++|+--.+|.-|.+|-.....  ..    ...|..+       .
T Consensus       381 L~~~~-~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~----~~~g~~p-------~  445 (829)
T KOG0576|consen  381 LTRTM-KPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VL----PMIGNGP-------N  445 (829)
T ss_pred             cCccc-ccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCcc--cc----CCCCCCC-------C
Confidence            54332 3456788999999999876 5688899999999887888888777543110  00    0000000       0


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      .+.+..         +..|...      .-.++...|+..-|..|+....++.|.+|..
T Consensus       446 s~~L~~---------~~aw~~~------~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  446 SPMLTD---------KSAWSPV------FHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             ccccch---------hhhcCcc------cccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            000000         0001100      0114677899999999999999999988864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.51  E-value=7.2e-07  Score=72.09  Aligned_cols=131  Identities=21%  Similarity=0.211  Sum_probs=91.3

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      .-++.+.|++|.+|.||++...  |..+|+|+-..+.    ....+..|.++|+.++..++.+=+-.+        +...
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~   88 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFY--------GEDF   88 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc--CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEe--------chhh
Confidence            3456788999999999999876  6689999865432    233466799999988866654322222        2345


Q ss_pred             EEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCceEEcCCCCeEEcccCcccc
Q 017334          111 LVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLK-PGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       111 lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk-p~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      +.|||++| .|.++-...       -+.-+..++++---|-..||-|+.|. |..+++-.++.+.|+||..|+.
T Consensus        89 i~me~i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          89 IRMEYIDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            66999987 776654321       13345566777666778899999985 5555555556999999998874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.45  E-value=3.5e-06  Score=70.38  Aligned_cols=132  Identities=23%  Similarity=0.268  Sum_probs=91.1

Q ss_pred             CceeeeeeeeccCc-eEEEEEEeCCCCcEEEEEEccc---c--------ccC-h-------HHHHHHHHHHHHHhhC---
Q 017334           30 TKYVPIKPIGRGAY-GIVCSSVNRETNEKVAIKKINN---A--------FEN-R-------VDALRTLRELKLLRHL---   86 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~-g~V~~a~~~~~g~~~aiK~~~~---~--------~~~-~-------~~~~~~~~E~~~l~~l---   86 (373)
                      ..++.++.||.|.. |.||++...  |+.||+|++..   .        ... .       ....-+..|-++.-+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 999999765  88999999321   1        000 0       1112344565555444   


Q ss_pred             CCCCe--eeeceeecCCC-C------------CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 017334           87 QHENV--IALKDVMMPSH-R------------RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS  151 (373)
Q Consensus        87 ~hpni--v~~~~~~~~~~-~------------~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~  151 (373)
                      .+.++  |+++++..-.. .            .......||.||+...-        .++..    -+.+|++-|..+|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~----~~~~~~~dl~~~~k  182 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIR----DIPQMLRDLKILHK  182 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchh----HHHHHHHHHHHHHH
Confidence            56666  88988875431 0            12234678888886432        22322    35677888888999


Q ss_pred             CCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          152 ANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      .||+-+|+++.|..     .-||+|||.+
T Consensus       183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  183 LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             CCeeeccCcccccc-----CCEEEecccC
Confidence            99999999999997     6799999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=3.3e-06  Score=80.97  Aligned_cols=139  Identities=21%  Similarity=0.308  Sum_probs=86.2

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccccChH-----------------------------------HHHHHHHHH
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV-----------------------------------DALRTLREL   80 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~-----------------------------------~~~~~~~E~   80 (373)
                      +.||..+.|.|++|+-+. |+.||||+-+.......                                   ....+.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999875 99999998763321110                                   001223444


Q ss_pred             HHHhh----CCCCC---eeeeceeecCCCCCCcceEEEEeecCCc----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-
Q 017334           81 KLLRH----LQHEN---VIALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLLRGLKY-  148 (373)
Q Consensus        81 ~~l~~----l~hpn---iv~~~~~~~~~~~~~~~~~~lv~e~~~g----~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~-  148 (373)
                      +...+    +.|-+   -|.+-.++..    ....-+++||||+|    ++ +.+.+. .++..++..   .+.++... 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~----~st~RVLtME~~~G~~i~Dl-~~i~~~-gi~~~~i~~---~l~~~~~~q  316 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD----LSTKRVLTMEYVDGIKINDL-DAIDKR-GISPHDILN---KLVEAYLEQ  316 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh----cCcceEEEEEecCCccCCCH-HHHHHc-CCCHHHHHH---HHHHHHHHH
Confidence            43333    33444   1222223321    12457999999986    44 455543 455544333   33333222 


Q ss_pred             HHhCCccccCCCCCceEEcC----CCCeEEcccCcccccC
Q 017334          149 LHSANILHRDLKPGNLLVNA----NCDLKICDFGLARTSN  184 (373)
Q Consensus       149 LH~~~ivH~Dlkp~Nill~~----~~~~kL~Dfg~a~~~~  184 (373)
                      +=..|++|.|-+|.||+++.    ++.+.+-|||+.....
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            22568999999999999984    6689999999987653

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.40  E-value=6.8e-06  Score=69.25  Aligned_cols=132  Identities=23%  Similarity=0.292  Sum_probs=89.4

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccc--------------cChHHHHHHHHHHHHHhhCC------CCCeeee
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF--------------ENRVDALRTLRELKLLRHLQ------HENVIAL   94 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------hpniv~~   94 (373)
                      ...||+|+.-.||.  |.. ....+||+.....              ..........+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            45799999999994  333 3457799987654              01112234445666555554      8889999


Q ss_pred             ceeecCCCCCCcceEEEEeecC---Cc----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334           95 KDVMMPSHRRNFKDVYLVYELM---DT----DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~---~g----~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                      ++...++     -...+|+|.+   +|    +|.+++.. +.+++ ++   ...+-+-..||-+++|+.+|++|.||++.
T Consensus        83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence            9998443     5578888887   23    68888855 45665 33   33444556678899999999999999996


Q ss_pred             CCC----CeEEcc-cCc
Q 017334          168 ANC----DLKICD-FGL  179 (373)
Q Consensus       168 ~~~----~~kL~D-fg~  179 (373)
                      ...    .+.|+| ||.
T Consensus       153 ~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             ecCCCceEEEEEeCCCC
Confidence            433    578888 453

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.36  E-value=4.6e-06  Score=73.35  Aligned_cols=70  Identities=17%  Similarity=0.095  Sum_probs=45.3

Q ss_pred             eeeccCc-eEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcceEEEEee
Q 017334           37 PIGRGAY-GIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        37 ~lg~G~~-g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      .|..|.+ +.||++...  +..+.+|+.....     .....+|+.+++.+. +-.+.+++.....     .+..++|||
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e   72 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTS   72 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEE
Confidence            3445555 789988653  4678899875432     224557888888875 4445566665522     245789999


Q ss_pred             cCCc
Q 017334          115 LMDT  118 (373)
Q Consensus       115 ~~~g  118 (373)
                      +++|
T Consensus        73 ~i~G   76 (244)
T cd05150          73 AVPG   76 (244)
T ss_pred             eeCC
Confidence            9987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=1.7e-05  Score=81.88  Aligned_cols=83  Identities=14%  Similarity=0.161  Sum_probs=54.4

Q ss_pred             eeeeeeccCceEEEEEEeCCCC--cEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCe--eeeceeecCCCCCCcce
Q 017334           34 PIKPIGRGAYGIVCSSVNRETN--EKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENV--IALKDVMMPSHRRNFKD  108 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g--~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~~~~~~~~~~~~~~~~  108 (373)
                      .++.|+.|.++.+|+......+  ..+++|+....... .....+.+|+++++.+. |.++  ++++.++...  ...+.
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~  118 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT  118 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence            3677899999999998765432  46888876432211 11234668999999996 6664  5556555332  22345


Q ss_pred             EEEEeecCCcc
Q 017334          109 VYLVYELMDTD  119 (373)
Q Consensus       109 ~~lv~e~~~g~  119 (373)
                      .|+||||++|.
T Consensus       119 ~flVME~v~G~  129 (822)
T PLN02876        119 AFYIMEYLEGR  129 (822)
T ss_pred             ceEEEEecCCc
Confidence            78999999873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=1.5e-05  Score=69.61  Aligned_cols=30  Identities=40%  Similarity=0.550  Sum_probs=25.2

Q ss_pred             CccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          153 NILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      +++|+|+.|.|||++.++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            489999999999998765567999997753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.07  E-value=6e-07  Score=93.10  Aligned_cols=153  Identities=15%  Similarity=0.073  Sum_probs=112.4

Q ss_pred             HHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC
Q 017334           78 RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ----ALTNDHCQYFLFQLLRGLKYLHSA  152 (373)
Q Consensus        78 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~  152 (373)
                      .|..-++...|+++.....-....   .....|.+++++. |.+++.|.++-    .+...-+.....+.+.+..-+|+.
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            444455566899988766555332   2255789999996 89999886531    222333333333447777777754


Q ss_pred             C-----ccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHH
Q 017334          153 N-----ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL  227 (373)
Q Consensus       153 ~-----ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  227 (373)
                      .     .+|++||+.|.+|..+.++|+.++|+.+.............+++.|++|++... -.++.++|+|+.|+.+|..
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence            2     789999999999999999999999999855444444555677889999998765 5677889999999999999


Q ss_pred             HhCCCCC
Q 017334          228 LGRKPIF  234 (373)
Q Consensus       228 l~g~~pf  234 (373)
                      ..|.++|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            9888876

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.00  E-value=7.3e-05  Score=65.25  Aligned_cols=72  Identities=21%  Similarity=0.288  Sum_probs=44.8

Q ss_pred             eeeeeccCceEEEEEEeCC-CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC-eeeeceeecCCCCCCcceEEEE
Q 017334           35 IKPIGRGAYGIVCSSVNRE-TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN-VIALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~-~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~~~~~~lv  112 (373)
                      ++.|..|-...+|++.... .+..|++|+........   ....+|+.+++.+...+ .++++...     .    -.++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~---~d~~~E~~~~~~l~~~gl~P~v~~~~-----~----~~~l   70 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI---IDRERELRIHKLLSKHGLAPKLYATF-----Q----NGLI   70 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce---ecHHHHHHHHHHHHhCCCCCeEEEEe-----C----CcEE
Confidence            5678888888999986543 35789999775432111   12336888888885333 34444332     1    1379


Q ss_pred             eecCCc
Q 017334          113 YELMDT  118 (373)
Q Consensus       113 ~e~~~g  118 (373)
                      |||++|
T Consensus        71 ~e~i~G   76 (235)
T cd05157          71 YEFIPG   76 (235)
T ss_pred             EEeeCC
Confidence            999976

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.93  E-value=4.1e-05  Score=71.90  Aligned_cols=176  Identities=26%  Similarity=0.350  Sum_probs=113.4

Q ss_pred             HHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 017334           73 ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA  152 (373)
Q Consensus        73 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~  152 (373)
                      ...++....+++.+.|+|..+++++....+    ....+|||+++-+|.+.+..+. +-....       +       .+
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~-------~-------~~   86 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESL-------L-------AH   86 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhh-------c-------cc
Confidence            345677888999999999999988875543    3389999999999999987643 211111       1       22


Q ss_pred             CccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCC
Q 017334          153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP  232 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  232 (373)
                      |+.|     -|++       +.+|    ...       +       |. |-      ..++++||||+|.++.++.-|..
T Consensus        87 ~~~~-----~~~~-------~~td----~~~-------t-------~~-~~------~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   87 GVLH-----LNII-------YITD----HFL-------T-------KY-PS------PIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             ccce-----ehhh-------hccc----ccc-------c-------cC-CC------CCCcchhhhhHHHHHHHHHHhhH
Confidence            2222     2222       2233    000       0       00 11      11249999999999999999998


Q ss_pred             CCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHH
Q 017334          233 IFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE  312 (373)
Q Consensus       233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e  312 (373)
                      .+......+....+..+...+..- ....    ..+.+              .-.++....+++.+|+-..|..||...+
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~-~~~a----~e~~~--------------~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQEL-LSTA----MEHLI--------------QLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhH-HHHH----HHHHH--------------HHhhhHhHHHHhccCCccccccccchhH
Confidence            887777777777666643332211 1100    00000              1123455789999999999999999999


Q ss_pred             HhCCCCCCCCC
Q 017334          313 ALQHPYMSPLY  323 (373)
Q Consensus       313 il~hp~~~~~~  323 (373)
                      +.+++-|...+
T Consensus       191 ~~k~~i~~ev~  201 (725)
T KOG1093|consen  191 LSKRCSFTEVY  201 (725)
T ss_pred             HhcCccHHHHH
Confidence            99999987653

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.90  E-value=0.00029  Score=65.84  Aligned_cols=77  Identities=18%  Similarity=0.129  Sum_probs=51.4

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccc----c-ChHHHHHHHHHHHHHhhCC---CCCeeeeceeecCCCCCCc
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF----E-NRVDALRTLRELKLLRHLQ---HENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~----~-~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~~  106 (373)
                      .+.||.|....||++.....++.++||.-....    . ......+...|.+.|+.+.   ..++++++.+-     .  
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~--  103 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E--  103 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C--
Confidence            467899999999999986444689999853110    1 1123445667888888763   24566666653     1  


Q ss_pred             ceEEEEeecCCc
Q 017334          107 KDVYLVYELMDT  118 (373)
Q Consensus       107 ~~~~lv~e~~~g  118 (373)
                      ...++|||++++
T Consensus       104 ~~~~lVME~L~~  115 (401)
T PRK09550        104 ELAVTVMEDLSD  115 (401)
T ss_pred             CCCEEEEecCCC
Confidence            346899999964

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.90  E-value=4.6e-05  Score=67.55  Aligned_cols=133  Identities=19%  Similarity=0.218  Sum_probs=74.1

Q ss_pred             eeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCe-eeeceeecCCCCCCcceEEEEeec
Q 017334           37 PIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV-IALKDVMMPSHRRNFKDVYLVYEL  115 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~~~~~~lv~e~  115 (373)
                      .+..|-.+.+|+..  .+|..+++|.........  .....+|..+++.+....+ .+++...     .    -++|+||
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~   69 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW   69 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence            35668788999886  457789999764332111  0123468888888863323 2333332     1    2689999


Q ss_pred             CCc-cHH--------------HHHH---hcC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCcc
Q 017334          116 MDT-DLH--------------QIIK---SSQ----ALTN-DHCQYFLFQL---------LRGLKYLHS--------ANIL  155 (373)
Q Consensus       116 ~~g-~L~--------------~~l~---~~~----~~~~-~~~~~i~~qi---------~~aL~~LH~--------~~iv  155 (373)
                      ++| .+.              +.+.   +..    +++. ..+..+..++         ...+..+-.        ..++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            976 321              1111   111    1111 1222222121         111222211        2489


Q ss_pred             ccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          156 HRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       156 H~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      |+|+.|.||+++.++ +.|+||+.+...
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            999999999999877 899999987543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.76  E-value=9.8e-05  Score=66.91  Aligned_cols=140  Identities=16%  Similarity=0.082  Sum_probs=78.9

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC--eeeeceeecCC-CCCCcceEEE
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN--VIALKDVMMPS-HRRNFKDVYL  111 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~-~~~~~~~~~l  111 (373)
                      ++.|..|....+|++..  ++..+++|+...  ..   ...+..|+.+++.+.+.+  +++++...... .....+..++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            66788888889998854  345799998754  11   223556777777775322  34443321000 0012245789


Q ss_pred             EeecCCc-cHH-----------HHH---Hh-cCCCCH--------HHHH------------HHHHHHHHHHHHHHh----
Q 017334          112 VYELMDT-DLH-----------QII---KS-SQALTN--------DHCQ------------YFLFQLLRGLKYLHS----  151 (373)
Q Consensus       112 v~e~~~g-~L~-----------~~l---~~-~~~~~~--------~~~~------------~i~~qi~~aL~~LH~----  151 (373)
                      |+++++| .+.           ..+   +. ...+..        ....            .....+..++.++.+    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9999976 211           111   00 000000        0000            011112334444443    


Q ss_pred             ---CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 ---ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 ---~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                         .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence               469999999999999988777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.74  E-value=3.7e-05  Score=68.32  Aligned_cols=136  Identities=17%  Similarity=0.166  Sum_probs=95.4

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccc--------------------ccChHHHHHHHHHHHHHhhCC-CC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA--------------------FENRVDALRTLRELKLLRHLQ-HE   89 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~--------------------~~~~~~~~~~~~E~~~l~~l~-hp   89 (373)
                      -|-+...||-|.-+-||.+-+. .|++.++|.-+..                    .+-........+|+..|+.|. |-
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4667788999999999999774 6788888853210                    011112223458999999886 33


Q ss_pred             -CeeeeceeecCCCCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334           90 -NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus        90 -niv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                       -+++.++.         +.-++|||+++| .|.+.-.      ...+..+...++.-+--|-.+|+||+|..-=||++.
T Consensus       172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCCcccc---------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence             24444444         346899999987 5543321      123445666777777788899999999999999999


Q ss_pred             CCCCeEEcccCcccc
Q 017334          168 ANCDLKICDFGLART  182 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~  182 (373)
                      .++.++++||-.+..
T Consensus       237 dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVS  251 (465)
T ss_pred             cCCCEEEeechHhhc
Confidence            999999999976543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.73  E-value=0.00012  Score=61.47  Aligned_cols=97  Identities=25%  Similarity=0.211  Sum_probs=76.8

Q ss_pred             HHHHHHhhCCC-CCeeeeceeecCCCCCCcceEEEEeecCC-ccHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 017334           78 RELKLLRHLQH-ENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQI---IKSSQALTNDHCQYFLFQLLRGLKYLHS-  151 (373)
Q Consensus        78 ~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~---l~~~~~~~~~~~~~i~~qi~~aL~~LH~-  151 (373)
                      .|.-+++.+++ ++++++++.+        +. .+|.||.+ +++...   +..-...++....+++.+++..+.+|+. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C--------G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC--------GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC--------CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            58888999985 6999999998        33 56888887 555321   1111346888999999999999999987 


Q ss_pred             --CCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          152 --ANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       152 --~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                        ..+.-.|++|+|+-++++|++|++|.+.+...
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence              45788899999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=97.67  E-value=0.0013  Score=60.19  Aligned_cols=30  Identities=27%  Similarity=0.328  Sum_probs=25.7

Q ss_pred             CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      .+++|+|++|.|||++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999966556899999774

>PRK10593 hypothetical protein; Provisional

Probab=97.63  E-value=0.0015  Score=59.12  Aligned_cols=78  Identities=13%  Similarity=0.068  Sum_probs=51.7

Q ss_pred             eeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCC---CCeeeeceeecCCCCCCcceE
Q 017334           33 VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH---ENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        33 ~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~~~~~~~~~~  109 (373)
                      .-.+.||.|..+.||.....  +..+.+|..+. ...   ...+..|...|+.+..   -.++++++++...  ...+..
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~   88 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS--QGNPMPLMARS-FST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPD   88 (297)
T ss_pred             heeeecCCccceeEEEEEcC--CCCEEEEEecc-ccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCe
Confidence            34677999999999988543  23577777432 111   1245678888888852   3577777765332  223558


Q ss_pred             EEEeecCCc
Q 017334          110 YLVYELMDT  118 (373)
Q Consensus       110 ~lv~e~~~g  118 (373)
                      ++|||+++|
T Consensus        89 ~LVmE~i~G   97 (297)
T PRK10593         89 VLLLERLRG   97 (297)
T ss_pred             EEEEeccCC
Confidence            999999975

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.57  E-value=0.0013  Score=59.51  Aligned_cols=31  Identities=29%  Similarity=0.589  Sum_probs=28.1

Q ss_pred             CccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          153 NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .++|+|+++.|++++.++.+-+.||+.+...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            3799999999999999999999999998754

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.56  E-value=0.00068  Score=61.54  Aligned_cols=137  Identities=22%  Similarity=0.307  Sum_probs=93.2

Q ss_pred             eeeeccCceEEEEEEeCCCCcEEEEEEccccc----------------------cChHHH--HHHHHHHHHHhhCCCCCe
Q 017334           36 KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF----------------------ENRVDA--LRTLRELKLLRHLQHENV   91 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~----------------------~~~~~~--~~~~~E~~~l~~l~hpni   91 (373)
                      ..|.-|--+.||.|.. .+|..+|||+++...                      .++...  .-+.+|++-|+++....|
T Consensus       150 GCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  150 GCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             cccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3566677788999875 477889999986321                      111111  123478888888865554


Q ss_pred             eeeceeecCCCCCCcceEEEEeecCCcc--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEEcC
Q 017334           92 IALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKYL-HSANILHRDLKPGNLLVNA  168 (373)
Q Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~g~--L~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~ivH~Dlkp~Nill~~  168 (373)
                      .-.--+..       ..-+|||+|++++  -.-.|+ ...++...+..+-.|++.-+.-| |..++||.||.-=|+|+- 
T Consensus       229 P~PePIlL-------k~hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  229 PCPEPILL-------KNHVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCCceee-------ecceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence            32222221       2347999999742  222222 24678888888888888888877 567999999999999985 


Q ss_pred             CCCeEEcccCcccc
Q 017334          169 NCDLKICDFGLART  182 (373)
Q Consensus       169 ~~~~kL~Dfg~a~~  182 (373)
                      +|.+.++|.+.+..
T Consensus       300 dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVE  313 (520)
T ss_pred             CCEEEEEEcccccc
Confidence            46999999987643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.53  E-value=0.0013  Score=59.92  Aligned_cols=142  Identities=16%  Similarity=0.144  Sum_probs=78.5

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC--eeeeceeecCC-CCCCcceEE
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN--VIALKDVMMPS-HRRNFKDVY  110 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~-~~~~~~~~~  110 (373)
                      .++.++.|....+|++... +| .+++|+......    ...+..|+++++.|....  +++++...... .....+..+
T Consensus        26 ~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             eccccCCccccceEEEEeC-CC-cEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            3667778877899988642 33 688998754211    123445667777664222  33433321100 001235678


Q ss_pred             EEeecCCc-cH-----H------HHH---Hh-cCCCCH-------HHHH----------------HHHHHHHHHHHHHHh
Q 017334          111 LVYELMDT-DL-----H------QII---KS-SQALTN-------DHCQ----------------YFLFQLLRGLKYLHS  151 (373)
Q Consensus       111 lv~e~~~g-~L-----~------~~l---~~-~~~~~~-------~~~~----------------~i~~qi~~aL~~LH~  151 (373)
                      ++++|++| .+     .      ..+   .. ...++.       ...+                .....+...++++..
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            99999976 21     1      111   10 011100       0000                001123334555532


Q ss_pred             -------CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 -------ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 -------~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                             .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                   579999999999999998777899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.44  E-value=0.0018  Score=59.42  Aligned_cols=81  Identities=14%  Similarity=0.043  Sum_probs=51.1

Q ss_pred             eeeccCceEEEEEEeCCCCcEEEEEEccc-----cccChHHHHHHHHHHHHHhhCC--CCC-eeeeceeecCCCCCCcce
Q 017334           37 PIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVDALRTLRELKLLRHLQ--HEN-VIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~g~~~aiK~~~~-----~~~~~~~~~~~~~E~~~l~~l~--hpn-iv~~~~~~~~~~~~~~~~  108 (373)
                      .||.|.-..||++.+...++.++||.-..     .........+...|...|+...  .|. +++++.+-       ...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence            47999999999999864446799996531     1122344445667888887764  453 44444432       134


Q ss_pred             EEEEeecCCc--cHHHHH
Q 017334          109 VYLVYELMDT--DLHQII  124 (373)
Q Consensus       109 ~~lv~e~~~g--~L~~~l  124 (373)
                      ..+|||+++.  .|.+.+
T Consensus        75 ~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        75 AVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             ceehHhhCccchHHHHHH
Confidence            5699999853  454444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.43  E-value=0.0012  Score=59.88  Aligned_cols=29  Identities=34%  Similarity=0.494  Sum_probs=25.9

Q ss_pred             CccccCCCCCceEEcCC----CCeEEcccCccc
Q 017334          153 NILHRDLKPGNLLVNAN----CDLKICDFGLAR  181 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~----~~~kL~Dfg~a~  181 (373)
                      .++|+|+.|.|||++.+    +.+.|+||..|.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999985    889999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02236 choline kinase

Probab=97.32  E-value=0.0032  Score=58.26  Aligned_cols=139  Identities=17%  Similarity=0.217  Sum_probs=77.1

Q ss_pred             ceeeeeeeeccCceEEEEEEeCC----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCe-eeeceeecCCCCCC
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRE----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV-IALKDVMMPSHRRN  105 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~  105 (373)
                      ...-++.|..|-...+|++....    +++.|++|+........   .....|..+++.+..-++ .++++.+     .+
T Consensus        37 ~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~---idR~~E~~~~~~l~~~gl~P~~~~~~-----~~  108 (344)
T PLN02236         37 EALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF---FDRDDEIRTFECMSRHGQGPRLLGRF-----PN  108 (344)
T ss_pred             CcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee---echHHHHHHHHHHHHcCCCCceEEEE-----CC
Confidence            34445567668888999986422    34789999886532211   122468888887753333 2344444     11


Q ss_pred             cceEEEEeecCCc-cHH-----------HH---H---HhcC----C-C-CHHHHHHHHHHH-----------------HH
Q 017334          106 FKDVYLVYELMDT-DLH-----------QI---I---KSSQ----A-L-TNDHCQYFLFQL-----------------LR  144 (373)
Q Consensus       106 ~~~~~lv~e~~~g-~L~-----------~~---l---~~~~----~-~-~~~~~~~i~~qi-----------------~~  144 (373)
                          ..|.+|++| ++.           .+   +   ++..    . + ....+..++.++                 ..
T Consensus       109 ----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~  184 (344)
T PLN02236        109 ----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED  184 (344)
T ss_pred             ----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence                147888764 321           11   1   1100    0 1 122333333222                 11


Q ss_pred             HHHHH----H----hCCccccCCCCCceEEcC-CCCeEEcccCccc
Q 017334          145 GLKYL----H----SANILHRDLKPGNLLVNA-NCDLKICDFGLAR  181 (373)
Q Consensus       145 aL~~L----H----~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~  181 (373)
                      .+..|    .    ...++|+|+++.|||++. ++.+.|+||..+.
T Consensus       185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11111    1    225899999999999986 4679999998775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.25  E-value=0.0028  Score=56.70  Aligned_cols=31  Identities=26%  Similarity=0.601  Sum_probs=25.7

Q ss_pred             CccccCCCCCceEEcCCCC-eEEcccCccccc
Q 017334          153 NILHRDLKPGNLLVNANCD-LKICDFGLARTS  183 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~-~kL~Dfg~a~~~  183 (373)
                      .++|+|++|.|||++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997565 469999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.23  E-value=0.003  Score=58.73  Aligned_cols=83  Identities=19%  Similarity=0.101  Sum_probs=54.2

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEcc----ccccChHHHHHHHHHHHHHhhCC--CCC-eeeeceeecCCCCCCcc
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLLRHLQ--HEN-VIALKDVMMPSHRRNFK  107 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~----~~~~~~~~~~~~~~E~~~l~~l~--hpn-iv~~~~~~~~~~~~~~~  107 (373)
                      ++.||.|.-..||++.+...++.++||.-.    ..........+..-|..+|+.+.  .|. +++++.+=       ..
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D-------~e  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD-------SV  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-------cH
Confidence            667899999999999885445679998642    12222445556677888888774  554 44454332       24


Q ss_pred             eEEEEeecCCc--cHHHHH
Q 017334          108 DVYLVYELMDT--DLHQII  124 (373)
Q Consensus       108 ~~~lv~e~~~g--~L~~~l  124 (373)
                      ...+|||+++.  .|.+.+
T Consensus       107 ~~~~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        107 MNCCVMEDLSDHTILRTAL  125 (409)
T ss_pred             HhhHHHHhCcccHHHHHHH
Confidence            46789999853  455544

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.20  E-value=0.0056  Score=57.28  Aligned_cols=76  Identities=17%  Similarity=0.150  Sum_probs=49.4

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccc-----cccChHHHHHHHHHHHHHhhCC---CCCeeeeceeecCCCCCC
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVDALRTLRELKLLRHLQ---HENVIALKDVMMPSHRRN  105 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~-----~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~  105 (373)
                      ..+.||.|.-..||++.+.  +..++||.-..     .........+...|...|+.+.   -.++++++.+..      
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------  107 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------  107 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence            3667899999999998863  45688997641     1111123344556777777664   246777777652      


Q ss_pred             cceEEEEeecCCc
Q 017334          106 FKDVYLVYELMDT  118 (373)
Q Consensus       106 ~~~~~lv~e~~~g  118 (373)
                       ...+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             335788999965

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.00  E-value=0.0048  Score=56.79  Aligned_cols=29  Identities=34%  Similarity=0.534  Sum_probs=25.2

Q ss_pred             ccccCCCCCceEEcC-CCCeEEcccCcccc
Q 017334          154 ILHRDLKPGNLLVNA-NCDLKICDFGLART  182 (373)
Q Consensus       154 ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~~  182 (373)
                      ++|.|+.+.|||++. ++.++|+||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            789999999999975 46899999998753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.80  E-value=0.0085  Score=51.31  Aligned_cols=29  Identities=41%  Similarity=0.762  Sum_probs=20.7

Q ss_pred             CccccCCCCCceEE-cCCCCeEEcccCccc
Q 017334          153 NILHRDLKPGNLLV-NANCDLKICDFGLAR  181 (373)
Q Consensus       153 ~ivH~Dlkp~Nill-~~~~~~kL~Dfg~a~  181 (373)
                      -++|+|+.|.|||+ +.++.++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            47899999999999 888999999998774

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.61  E-value=0.0072  Score=54.98  Aligned_cols=104  Identities=19%  Similarity=0.293  Sum_probs=72.2

Q ss_pred             ceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .+.|++|++-++.|...    ..-...++..++++.+..+.-+..+ ..-|||+...||||+ +|+|.|+||-+++...+
T Consensus       299 ~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         299 LYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             eEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            56888999888766422    2235677888888888888777655 588999999999999 99999999999985433


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHH
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGC  222 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  222 (373)
                      ++....     ...--|-.+.|.  -+..-+||-+--
T Consensus       374 q~~isy-----~rldhp~lF~G~--dd~QFeIYrlMr  403 (488)
T COG5072         374 QGIISY-----NRLDHPDLFNGV--DDYQFEIYRLMR  403 (488)
T ss_pred             Cceeec-----cccCchhhhcCc--cceeeeHHHHHH
Confidence            332221     122345555542  356667776533

>PTZ00384 choline kinase; Provisional

Probab=96.52  E-value=0.034  Score=52.17  Aligned_cols=29  Identities=28%  Similarity=0.245  Sum_probs=24.1

Q ss_pred             CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      ..++|.|+-+.|||.+. +.+.++||..|.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            45799999999999764 469999998764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.47  E-value=0.026  Score=50.65  Aligned_cols=73  Identities=15%  Similarity=0.120  Sum_probs=42.8

Q ss_pred             eeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC---CCCeeeeceeecCCCCCCcceE
Q 017334           33 VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ---HENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        33 ~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +-.+.++.|.-..+|+..  .+++.+.+|+-......     .+..|..-|+.|.   .-.+++++.+....     +.-
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~-----~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~~~   87 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRD-----MFEGEAEGLKALAEANPIRVPKVIAWGEYD-----DDA   87 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCC-----HHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----SCC
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHH-----HHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----CCc
Confidence            346678989999999886  56788999987532222     3446777777773   44566777776332     335


Q ss_pred             EEEeecCC
Q 017334          110 YLVYELMD  117 (373)
Q Consensus       110 ~lv~e~~~  117 (373)
                      ++||||++
T Consensus        88 fLlle~l~   95 (288)
T PF03881_consen   88 FLLLEFLE   95 (288)
T ss_dssp             EEEEE---
T ss_pred             eEEEEeec
Confidence            99999985

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=96.17  E-value=0.13  Score=54.55  Aligned_cols=31  Identities=35%  Similarity=0.551  Sum_probs=26.2

Q ss_pred             CCccccCCCCCceEEcCCC--CeE-EcccCcccc
Q 017334          152 ANILHRDLKPGNLLVNANC--DLK-ICDFGLART  182 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~--~~k-L~Dfg~a~~  182 (373)
                      .++||+|+.+.|||++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999875  555 999998753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.11  E-value=0.17  Score=46.52  Aligned_cols=28  Identities=36%  Similarity=0.479  Sum_probs=23.6

Q ss_pred             CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      .+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            3689999999999995 4 67899999764

>PTZ00296 choline kinase; Provisional

Probab=95.77  E-value=0.15  Score=48.85  Aligned_cols=28  Identities=25%  Similarity=0.454  Sum_probs=23.4

Q ss_pred             CccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          153 NILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      .++|.|+-+.|||.+.+ .++|+||..|.
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg  312 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYSG  312 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeecccc
Confidence            47899999999998655 49999998763

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.43  E-value=0.023  Score=51.03  Aligned_cols=90  Identities=23%  Similarity=0.274  Sum_probs=66.6

Q ss_pred             HHHHHHhhC-----CCCCeeeeceeecCCCCCCcceEEEEeecCCc-cH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHH-
Q 017334           78 RELKLLRHL-----QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DL-HQIIKSSQALTNDHCQYFLFQLLRGLKYL-  149 (373)
Q Consensus        78 ~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L-~~~l~~~~~~~~~~~~~i~~qi~~aL~~L-  149 (373)
                      +|+.-|.++     .+|.+|.+.            .-.+||.|++. .+ .--++ ...++..+.+..-.|+..++.-| 
T Consensus       334 kEmhNL~RMq~~GlpcP~vV~lk------------khvLVMsFiGd~~~aAPkLK-~v~l~d~E~~~aY~q~~~~M~~lY  400 (531)
T KOG2269|consen  334 KEMHNLSRMQKHGLPCPQVVKLK------------KHVLVMSFIGDQGLAAPKLK-NVELTDDERRNAYDQVQSIMCRLY  400 (531)
T ss_pred             HHHHHHHHHHhcCCCCCceeeee------------cceEEEEeecCCCCCCcccc-ccccChHHHHHHHHHHHHHHHHHH
Confidence            455545444     377777653            34699999963 22 22222 34699999999999999999877 


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          150 HSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       150 H~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      |..-+||-|+.--|+|+..+ .+-++|...+.
T Consensus       401 ~Ec~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv  431 (531)
T KOG2269|consen  401 KECLLVHADLSEYNLLWTPG-KVWVIDVSQSV  431 (531)
T ss_pred             HhhheeecchhhhhheecCC-ceEEEechhcc
Confidence            67789999999999999886 99999987654

>PHA03111 Ser/Thr kinase; Provisional

Probab=95.37  E-value=0.014  Score=52.35  Aligned_cols=77  Identities=18%  Similarity=0.290  Sum_probs=46.8

Q ss_pred             eEEEEeecCCccHHH----HHHhcCCCC-HHHHHHHHHHHHHHHHHH---H-hCCccccCCCCCceEEcCC---------
Q 017334          108 DVYLVYELMDTDLHQ----IIKSSQALT-NDHCQYFLFQLLRGLKYL---H-SANILHRDLKPGNLLVNAN---------  169 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~----~l~~~~~~~-~~~~~~i~~qi~~aL~~L---H-~~~ivH~Dlkp~Nill~~~---------  169 (373)
                      .-.||++.+-++-..    .....|-.+ .+-++.++.||+.-.-.+   - ..+++|-||||+|||+-++         
T Consensus       249 GnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~  328 (444)
T PHA03111        249 GNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLK  328 (444)
T ss_pred             CcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEEC
Confidence            345777776442211    112223333 344677888887755333   2 4579999999999998432         


Q ss_pred             ---------CCeEEcccCcccccC
Q 017334          170 ---------CDLKICDFGLARTSN  184 (373)
Q Consensus       170 ---------~~~kL~Dfg~a~~~~  184 (373)
                               -.++|.||.+++..+
T Consensus       329 ~~~~vF~Epi~~~LnDFDfSqv~~  352 (444)
T PHA03111        329 DATYVFNEPIKACLNDFDFSQVAN  352 (444)
T ss_pred             CeEEEeccchhhhhcccCHHHHcc
Confidence                     236778888876543

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=95.36  E-value=0.013  Score=52.85  Aligned_cols=76  Identities=20%  Similarity=0.320  Sum_probs=45.8

Q ss_pred             EEEEeecCCccHHHH---H-HhcCCCC-HHHHHHHHHHHHHHHHH---HH-hCCccccCCCCCceEEcCC----------
Q 017334          109 VYLVYELMDTDLHQI---I-KSSQALT-NDHCQYFLFQLLRGLKY---LH-SANILHRDLKPGNLLVNAN----------  169 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~---l-~~~~~~~-~~~~~~i~~qi~~aL~~---LH-~~~ivH~Dlkp~Nill~~~----------  169 (373)
                      -.||++.+-++-..+   . ...|-.+ ..-++.++.||+.-.--   |- ..+.+|-||||+|||+-++          
T Consensus       246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~  325 (434)
T PF05445_consen  246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN  325 (434)
T ss_pred             cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence            357888775432211   1 1112222 23466777887654311   22 4579999999999998332          


Q ss_pred             --------CCeEEcccCcccccC
Q 017334          170 --------CDLKICDFGLARTSN  184 (373)
Q Consensus       170 --------~~~kL~Dfg~a~~~~  184 (373)
                              -.++|.||.+++..+
T Consensus       326 ~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  326 RNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             eEEEecccceeeecccCHHHhcc
Confidence                    247888999887654

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.18  E-value=0.038  Score=50.30  Aligned_cols=29  Identities=21%  Similarity=0.394  Sum_probs=25.5

Q ss_pred             CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      .+++|+|+++.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999988 678999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.01  E-value=0.02  Score=47.62  Aligned_cols=29  Identities=34%  Similarity=0.543  Sum_probs=25.6

Q ss_pred             ccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          154 ILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       154 ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .+|+|+.|.||+++.++ ++|+||+.+...
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            69999999999998877 999999988643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	373
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-96
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-96
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-96
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-96
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-96
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-96
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-96
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-96
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-96
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-96
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-96
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-96
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-96
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-96
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-95
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-95
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-95
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-95
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-95
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-95
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-95
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-95
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-94
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-94
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-94
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-94
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-93
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-92
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-92
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-87
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-87
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-87
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-87
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-87
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-87
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-87
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-87
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-87
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-87
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-87
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-87
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-87
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-87
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-87
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-87
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-87
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-87
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-87
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-87
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-87
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-87
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-87
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-87
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-87
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-87
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-87
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-87
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-87
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-87
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-87
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-87
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-87
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-87
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-87
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-87
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-87
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-87
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-87
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-87
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-87
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-87
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-86
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-86
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-86
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-86
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-86
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-86
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-86
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-86
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-86
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-86
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-86
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-86
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-86
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-86
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-86
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-86
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-86
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-86
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-86
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-86
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-86
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-86
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-79
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-73
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-73
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-72
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-72
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-72
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-72
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-72
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-72
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-72
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-72
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-72
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-72
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-72
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-72
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-72
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-72
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-72
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-72
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-72
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-72
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-72
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-72
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-72
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-72
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-71
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-71
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-71
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-71
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-71
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-70
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-70
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-70
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-69
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-69
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-68
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-67
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-64
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-64
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-60
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-54
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-54
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-54
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-53
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-53
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-53
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-53
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-53
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-53
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-53
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-53
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-53
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-53
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-53
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-53
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-53
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-53
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-53
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-53
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-53
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-53
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-53
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-53
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-53
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-53
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-53
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-53
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-52
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-52
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-52
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-52
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-52
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-52
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-52
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-52
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-52
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-52
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-52
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-52
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-52
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-50
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-50
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-50
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-50
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-49
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-49
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-48
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-48
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-47
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-47
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-46
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-45
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-45
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-45
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-45
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-44
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-44
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-43
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-43
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-43
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-43
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-43
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-43
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-43
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-43
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-43
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-43
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-43
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-43
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-42
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-42
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-42
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-42
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-42
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-42
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-42
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-42
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-42
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-42
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-42
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-41
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-40
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-38
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-38
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-32
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-30
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-30
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-30
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-30
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-30
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-30
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-28
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		3e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-28
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-27
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-27
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-27
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-27
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-27
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-27
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-27
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		7e-27
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		7e-27
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-27
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		8e-27
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-26
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-26
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-26
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-26
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-26
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-26
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-26
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-26
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-26
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-26
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-26
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-26
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-26
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-26
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-26
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-26
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-26
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-26
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-25
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-25
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-25
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		8e-25
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-25
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-24
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-24
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-24
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-24
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-24
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-24
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-24
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-24
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-24
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-24
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-24
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-24
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-24
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-24
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-24
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-24
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-24
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-24
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-24
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-24
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-24
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-24
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-24
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-24
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-24
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-24
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-24
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-24
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-24
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-24
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-24
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-24
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-24
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-24
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-24
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-23
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-23
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-23
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-23
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-23
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-23
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-23
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-23
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-23
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-23
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-23
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-23
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-23
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-23
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-23
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-23
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-23
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-23
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-23
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-23
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-23
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-22
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-22
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-22
3soa_A	444	Full-Length Human Camkii Length = 444		1e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-22
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-22
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-22
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-22
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-22
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-22
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-22
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-22
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-22
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-22
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-22
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-22
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-22
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-22
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-22
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-22
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-22
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-21
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-21
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-21
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-21
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-21
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-21
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-21
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-21
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-21
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-21
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-21
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-21
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-20
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-20
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-20
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-20
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-20
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-20
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-20
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-20
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-19
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-19
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-19
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-19
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-18
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-18
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-18
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-18
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-18
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-18
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-18
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-18
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-18
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-18
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-18
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-18
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-18
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-17
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-17
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-17
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-17
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-17
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-17
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-17
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-17
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-17
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-17
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-17
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-17
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-17
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-17
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-17
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-16
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-16
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-16
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-16
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-16
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-16
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-15
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-15
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-15
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-15
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-15
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-15
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-15
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-15
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-15
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-15
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-15
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-15
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-15
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-15
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-15
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		8e-15
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-15
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		9e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-15
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		9e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-14
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-14
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-14
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-14
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-14
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-14
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-14
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-14
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-14
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-14
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-14
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-14
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-14
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-14
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-14
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-14
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-13
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-13
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-13
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-12
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-12
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-12
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-12
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		7e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		8e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-11
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-11
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		8e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-08

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  349 bits (896), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 239/341 (70%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 78
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 137
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY++ 
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 318 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  349 bits (895), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 96
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 155
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 336 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 376

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  349 bits (895), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 74
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 133
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCI 253
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 314 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 354

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 26  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 84
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 85  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 143
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 263
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 264 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 323
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 324 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 78
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 137
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 257
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 317
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 318 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 16  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 74
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 75  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 133
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 253
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 254 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 313
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 314 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 354

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 81
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 140
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 321 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 24  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 82
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 83  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 141
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 261
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 262 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 321
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 322 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 15  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 73
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 74  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 132
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 252
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 253 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 312
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 313 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  348 bits (894), Expect = 2e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  347 bits (891), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 171/341 (50%), Positives = 238/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAI+KI+  FE++    RTLRE+K+L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  347 bits (891), Expect = 5e-96,   Method: Compositional matrix adjust.
 Identities = 172/341 (50%), Positives = 237/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K  Q L+NDH  YFL+Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  346 bits (887), Expect = 1e-95,   Method: Compositional matrix adjust.
 Identities = 171/341 (50%), Positives = 237/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  345 bits (886), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 170/345 (49%), Positives = 238/345 (68%), Gaps = 6/345 (1%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK 81
           +   F++  +Y  I+ IG GAYG+V S+  R T ++VAIKKI NAF+   +A RTLRELK
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 105
Query: 82  LLRHLQHENVIALKDVMMPS-HRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF 140
           +L+H +H+N+IA+KD++ P+     FK VY+V +LM++DLHQII SSQ LT +H +YFL+
Sbjct: 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLY 165
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQ-FMTEYVVT 196
           QLLRGLKY+HSA ++HRDLKP NLLVN NC+LKI DFG+AR   TS  ++Q FMTEYV T
Sbjct: 166 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
           RWYRAPEL+L    Y  +ID+WSVGCIF E+L R+ +FPG   ++QL+LI+ +LG+    
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285
Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
            ++ +   + R YI+SLP     P+  +YP A   A+ LL +ML F+P+ RIS   AL+H
Sbjct: 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345
Query: 317 PYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYH 360
           P+++  +DP   P    P D   D E+   E I+E ++ E+  +H
Sbjct: 346 PFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFH 390

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  345 bits (885), Expect = 2e-95,   Method: Compositional matrix adjust.
 Identities = 171/341 (50%), Positives = 237/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  345 bits (884), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 170/345 (49%), Positives = 238/345 (68%), Gaps = 6/345 (1%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK 81
           +   F++  +Y  I+ IG GAYG+V S+  R T ++VAIKKI NAF+   +A RTLRELK
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK 106
Query: 82  LLRHLQHENVIALKDVMMPS-HRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF 140
           +L+H +H+N+IA+KD++ P+     FK VY+V +LM++DLHQII SSQ LT +H +YFL+
Sbjct: 107 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLY 166
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQ-FMTEYVVT 196
           QLLRGLKY+HSA ++HRDLKP NLLVN NC+LKI DFG+AR   TS  ++Q FMTEYV T
Sbjct: 167 QLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
           RWYRAPEL+L    Y  +ID+WSVGCIF E+L R+ +FPG   ++QL+LI+ +LG+    
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 286
Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
            ++ +   + R YI+SLP     P+  +YP A   A+ LL +ML F+P+ RIS   AL+H
Sbjct: 287 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 346
Query: 317 PYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYH 360
           P+++  +DP   P    P D   D E+   E I+E ++ E+  +H
Sbjct: 347 PFLAKYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFH 391

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  345 bits (884), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 171/341 (50%), Positives = 237/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYXQRTLREIKILL 80
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  345 bits (884), Expect = 3e-95,   Method: Compositional matrix adjust.
 Identities = 171/341 (50%), Positives = 237/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  343 bits (881), Expect = 7e-95,   Method: Compositional matrix adjust.
 Identities = 170/341 (49%), Positives = 236/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 80
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 139
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+ E V TRWYRA
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 320 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  343 bits (881), Expect = 7e-95,   Method: Compositional matrix adjust.
 Identities = 170/341 (49%), Positives = 236/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 23  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 81
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 82  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 140
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++  +    F+ E V TRWYRA
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 260
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 261 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 320
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 321 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 361

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  343 bits (880), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 170/341 (49%), Positives = 237/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 20  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 78
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 79  AFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 137
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL   
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCG 257
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY++ 
Sbjct: 258 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQ 317
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 318 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  342 bits (878), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 171/341 (50%), Positives = 234/341 (68%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 38  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 96
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVYLV  LM  DL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 97  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILR 155
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKICDFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 275
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 276 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 335
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 336 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 376

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  342 bits (877), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 170/341 (49%), Positives = 236/341 (69%), Gaps = 6/341 (1%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L 
Sbjct: 18  VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILL 76
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
             +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+NDH  YFL+Q+LR
Sbjct: 77  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILR 135
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRA 201
           GLKY+HSAN+LHRDLKP NLL+N   DLKI DFGLAR ++  +    F+TEYV TRWYRA
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+  
Sbjct: 256 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 315
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P
Sbjct: 316 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  342 bits (877), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 167/345 (48%), Positives = 239/345 (69%), Gaps = 6/345 (1%)
Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F++  +Y  ++ IG GAYG+V S+ +     +VAIKKI+  FE++    RTLRE+++L  
Sbjct: 39  FDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKIS-PFEHQTYCQRTLREIQILLR 97
Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            +HENVI ++D++  S     +DVY+V +LM+TDL++++KS Q L+NDH  YFL+Q+LRG
Sbjct: 98  FRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFLYQILRG 156
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---FMTEYVVTRWYRAP 202
           LKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR ++ ++    F+TE V TRWYRAP
Sbjct: 157 LKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  I 
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
           N KAR Y++SLP      +++L+P +   A+DLL +ML F+P KRI+V EAL HPY+   
Sbjct: 277 NMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQY 336
Query: 323 YDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHPEAITA 366
           YDP+  P A+ P    M+ ++  +E ++E++ +E   + P  + A
Sbjct: 337 YDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEA 381

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  337 bits (864), Expect = 7e-93,   Method: Compositional matrix adjust.
 Identities = 158/306 (51%), Positives = 217/306 (70%), Gaps = 13/306 (4%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G GAYG+VCS+ ++ T E VAIKKI   F+  + ALRTLRE+K+L+H +HEN+I + ++
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
             P    NF +VY++ ELM TDLH++I S+Q L++DH QYF++Q LR +K LH +N++HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSN----------GKNQFMTEYVVTRWYRAPELLLC 207
           DLKP NLL+N+NCDLK+CDFGLAR  +          G+   MTEYV TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLT 196
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS-RREEDLEFIDNPKA 266
              Y  ++DVWS GCI AEL  R+PIFPG +  +QL LI  I+G+   + DL  I++P+A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS 326
           R+YIKSLP  P  P  +++P  +P  IDLLQ+MLVFDP KRI+  EAL+HPY+   +DP+
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 327 SNPPAQ 332
             P  +
Sbjct: 317 DEPEGE 322

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  333 bits (855), Expect = 6e-92,   Method: Compositional matrix adjust.
 Identities = 157/306 (51%), Positives = 216/306 (70%), Gaps = 13/306 (4%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G GAYG+VCS+ ++ T E VAIKKI   F+  + ALRTLRE+K+L+H +HEN+I + ++
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
             P    NF +VY++ ELM TDLH++I S+Q L++DH QYF++Q LR +K LH +N++HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSN----------GKNQFMTEYVVTRWYRAPELLLC 207
           DLKP NLL+N+NCDLK+CDFGLAR  +          G+   MTE V TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLT 196
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS-RREEDLEFIDNPKA 266
              Y  ++DVWS GCI AEL  R+PIFPG +  +QL LI  I+G+   + DL  I++P+A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS 326
           R+YIKSLP  P  P  +++P  +P  IDLLQ+MLVFDP KRI+  EAL+HPY+   +DP+
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 327 SNPPAQ 332
             P  +
Sbjct: 317 DEPEGE 322

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  333 bits (855), Expect = 7e-92,   Method: Compositional matrix adjust.
 Identities = 156/306 (50%), Positives = 216/306 (70%), Gaps = 13/306 (4%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G GAYG+VCS+ ++ T E VAIKKI   F+  + ALRTLRE+K+L+H +HEN+I + ++
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
             P    NF +VY++ ELM TDLH++I S+Q L++DH QYF++Q LR +K LH +N++HR
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHR 136
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSN----------GKNQFMTEYVVTRWYRAPELLLC 207
           DLKP NLL+N+NCDLK+CDFGLAR  +          G+   M E+V TRWYRAPE++L 
Sbjct: 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS-RREEDLEFIDNPKA 266
              Y  ++DVWS GCI AEL  R+PIFPG +  +QL LI  I+G+   + DL  I++P+A
Sbjct: 197 SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRA 256
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS 326
           R+YIKSLP  P  P  +++P  +P  IDLLQ+MLVFDP KRI+  EAL+HPY+   +DP+
Sbjct: 257 REYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 327 SNPPAQ 332
             P  +
Sbjct: 317 DEPEGE 322

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  320 bits (819), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 160/341 (46%), Positives = 233/341 (68%), Gaps = 7/341 (2%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +   ++P+G GAYG VCS+ +    +KVA+KK++  F++ + A RT REL+L
Sbjct: 13  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 72
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+HL+HENVI L DV  P+    +F +VYLV  LM  DL+ I+K  QAL+++H Q+ ++Q
Sbjct: 73  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQ 131
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           LLRGLKY+HSA I+HRDLKP N+ VN +C+L+I DFGLAR ++ +   MT YV TRWYRA
Sbjct: 132 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE---MTGYVATRWYRA 188
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  K +FPG++ ++QLK I+ ++G+   E L  I
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKI 248
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SLP  P    S ++  A+PLAIDLL +MLV D  +R+S  EAL H Y S 
Sbjct: 249 SSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ 308
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHP 361
            +DP   P A+ P D  ++ +E   E  +E+  +E+L + P
Sbjct: 309 YHDPEDEPEAE-PYDESVEAKERTLEEWKELTYQEVLSFKP 348

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 210
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 331 YHDPDDEPVA 340

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  319 bits (818), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 143
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 144 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 200
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 260
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 261 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 320
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 321 YHDPDDEPVA 330

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  319 bits (817), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 152
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 209
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 270 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 329
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 330 YHDPDDEPVA 339

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  319 bits (817), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 257 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 317 YHDPDDEPVA 326

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  319 bits (817), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  318 bits (816), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  318 bits (816), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 307 YHDPDDEPVA 316

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 318 YHDPDDEPVA 327

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 317 YHDPDDEPVA 326

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 202
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 323 YHDPDDEPVA 332

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 155/315 (49%), Positives = 221/315 (70%), Gaps = 6/315 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPAQVPID 336
            +DP   P A  P D
Sbjct: 311 YHDPDDEPVAD-PFD 324

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 313 YHDPDDEPVA 322

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 202
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 323 YHDPDDEPVA 332

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 145
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 146 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 202
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 262
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 263 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 322
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 323 YHDPDDEPVA 332

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 144
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 201
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 322 YHDPDDEPVA 331

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 313 YHDPDDEPVA 322

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  318 bits (815), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 156
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 213
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 334 YHDPDDEPVA 343

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 317 YHDPDDEPVA 326

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 316 YHDPDDEPVA 325

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 158/329 (48%), Positives = 225/329 (68%), Gaps = 8/329 (2%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +  +   MT YV TRWYRA
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 322 LYDPSSNPPAQVPIDLDMDEESGEEMIRE 350
            +DP   P A      D   ES + +I E
Sbjct: 318 YHDPDDEPVAD---PYDQSSESRDLLIDE 343

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 316 YHDPDDEPVA 325

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 132
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 133 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 189
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 249
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 250 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 309
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 310 YHDPDDEPVA 319

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 210
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 271 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 331 YHDPDDEPVA 340

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  318 bits (814), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 152
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 153 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 209
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 269
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 270 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 329
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 330 YHDPDDEPVA 339

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  317 bits (813), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 220/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K ++ LT+DH Q+ ++Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQ 129
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 307 YHDPDDEPVA 316

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  317 bits (813), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 130
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 187
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 308 YHDPDDEPVA 317

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  317 bits (813), Expect = 5e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 313 YHDPDDEPVA 322

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  317 bits (813), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 153/311 (49%), Positives = 219/311 (70%), Gaps = 5/311 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VCSS + ++  K+A+KK++  F++ + A RT REL+L
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 162
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 163 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 219
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ +NQL+ I+ + G+     +  +
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRM 279
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            + +AR YI SLP  P   F+ ++  A+PLA+DLL+KMLV D  KRI+ +EAL HPY S 
Sbjct: 280 PSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQ 339
Query: 322 LYDPSSNPPAQ 332
            +DP   P ++
Sbjct: 340 YHDPDDEPESE 350

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  317 bits (813), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 130
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 131 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 187
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 247
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 248 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 307
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 308 YHDPDDEPVA 317

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  317 bits (813), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 307 YHDPDDEPVA 316

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  317 bits (813), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +  +   MT YV TRWYRA
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 318 YHDPDDEPVA 327

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  317 bits (813), Expect = 6e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  317 bits (812), Expect = 7e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 140
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR +  +   MT YV TRWYRA
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVATRWYRA 197
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 318 YHDPDDEPVA 327

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  317 bits (812), Expect = 7e-87,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 131
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 132 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRA 188
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 248
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 249 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 308
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 309 YHDPDDEPVA 318

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  317 bits (811), Expect = 8e-87,   Method: Compositional matrix adjust.
 Identities = 159/339 (46%), Positives = 232/339 (68%), Gaps = 7/339 (2%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +   ++P+G GAYG VCS+ +    +KVA+KK++  F++ + A RT REL+L
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 80
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+HL+HENVI L DV  P+    +F +VYLV  LM  DL+ I+KS QAL+++H Q+ ++Q
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           LLRGLKY+HSA I+HRDLKP N+ VN + +L+I DFGLAR ++ +   MT YV TRWYRA
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE---MTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  K +FPG++ ++QLK I+ ++G+   E L  I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKI 256
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SLP  P    S ++  A+PLAIDLL +MLV D  +R+S  EAL H Y S 
Sbjct: 257 SSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ 316
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHY 359
            +DP   P A+ P D  ++ +E   E  +E+  +E+L +
Sbjct: 317 YHDPEDEPEAE-PYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  316 bits (810), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 156
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   M  YV TRWYRA
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MXGYVATRWYRA 213
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 273
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 274 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 333
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 334 YHDPDDEPVA 343

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  316 bits (810), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 219/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D+GLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  316 bits (810), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 158/353 (44%), Positives = 229/353 (64%), Gaps = 7/353 (1%)
Query: 11  IRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR 70
           IR  G +   + +T +E+   YV    +G GAYG VCS++++ + EKVAIKK++  F++ 
Sbjct: 23  IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 82
Query: 71  VDALRTLRELKLLRHLQHENVIALKDVMMP-SHRRNFKDVYLVYELMDTDLHQIIKSSQA 129
           + A R  REL LL+H+QHENVI L DV  P S  RNF D YLV   M TDL +I+     
Sbjct: 83  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GME 140
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
            + +  QY ++Q+L+GLKY+HSA ++HRDLKPGNL VN +C+LKI DFGLAR ++ +   
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 197
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
           MT YVVTRWYRAPE++L   +Y  ++D+WSVGCI AE+L  K +F G + L+QL  I+ +
Sbjct: 198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 257
Query: 250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
            G    E ++ +++  A+ YI+SLP TP   F++L+P A P A DLL+KML  D  KR++
Sbjct: 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317
Query: 310 VTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHP 361
             +AL HP+  P  DP     AQ P D  ++ E    +  ++ + KE++++ P
Sbjct: 318 AAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  316 bits (810), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 151/310 (48%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   M  +V TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  316 bits (810), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 151/310 (48%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   M  +V TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 158/353 (44%), Positives = 229/353 (64%), Gaps = 7/353 (1%)
Query: 11  IRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR 70
           IR  G +   + +T +E+   YV    +G GAYG VCS++++ + EKVAIKK++  F++ 
Sbjct: 5   IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 64
Query: 71  VDALRTLRELKLLRHLQHENVIALKDVMMP-SHRRNFKDVYLVYELMDTDLHQIIKSSQA 129
           + A R  REL LL+H+QHENVI L DV  P S  RNF D YLV   M TDL +I+     
Sbjct: 65  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLK 122
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
            + +  QY ++Q+L+GLKY+HSA ++HRDLKPGNL VN +C+LKI DFGLAR ++ +   
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 179
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
           MT YVVTRWYRAPE++L   +Y  ++D+WSVGCI AE+L  K +F G + L+QL  I+ +
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
            G    E ++ +++  A+ YI+SLP TP   F++L+P A P A DLL+KML  D  KR++
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 310 VTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHP 361
             +AL HP+  P  DP     AQ P D  ++ E    +  ++ + KE++++ P
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  315 bits (808), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  315 bits (808), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DF LAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 151/310 (48%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 129
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   M  +V TRWYRA
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MAGFVATRWYRA 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 247 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 307 YHDPDDEPVA 316

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  315 bits (807), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI  FGLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  315 bits (807), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D GLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 153/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + PIG GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 316 YHDPDDEPVA 325

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 135
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 136 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE---MTGYVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 252
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 253 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 312
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 313 YHDPDDEPVA 322

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  315 bits (806), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+KS Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGL R ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  315 bits (806), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE---MTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 256
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 257 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 316
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 317 YHDPDDEPVA 326

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D GLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  314 bits (805), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   MT  V TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGXVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  314 bits (805), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 133
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI D GLAR ++ +   MT YV TRWYRA
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE---MTGYVATRWYRA 190
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 311 YHDPDDEPVA 320

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  314 bits (805), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 144
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 145 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRA 201
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 261
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 262 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 321
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 322 YHDPDDEPVA 331

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  314 bits (805), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 152/310 (49%), Positives = 218/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 138
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN + +LKI DFGLAR ++ +   MT YV TRWYRA
Sbjct: 139 ILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---MTGYVATRWYRA 195
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 255
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 256 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 315
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 316 YHDPDDEPVA 325

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  314 bits (804), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 151/310 (48%), Positives = 217/310 (70%), Gaps = 5/310 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A RT REL+L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P+     F DVYLV  LM  DL+ I+K  Q LT+DH Q+ ++Q
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQ 153
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++ +   M   V TRWYRA
Sbjct: 154 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MXGXVATRWYRA 210
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+   E L+ I
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 270
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +AL H Y + 
Sbjct: 271 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 330
Query: 322 LYDPSSNPPA 331
            +DP   P A
Sbjct: 331 YHDPDDEPVA 340

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  314 bits (804), Expect = 6e-86,   Method: Compositional matrix adjust.
 Identities = 158/339 (46%), Positives = 231/339 (68%), Gaps = 7/339 (2%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T++E+  +   ++P+G GAYG VCS+ +    +KVA+KK++  F++ + A RT REL+L
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 80
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+HL+HENVI L DV  P+    +F +VYLV  LM  DL+ I+K  QAL+++H Q+ ++Q
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQ 139
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           LLRGLKY+HSA I+HRDLKP N+ VN + +L+I DFGLAR ++ +   MT YV TRWYRA
Sbjct: 140 LLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE---MTGYVATRWYRA 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L   +Y  ++D+WSVGCI AELL  K +FPG++ ++QLK I+ ++G+   E L  I
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKI 256
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            +  AR YI+SLP  P    S ++  A+PLAIDLL +MLV D  +R+S  EAL H Y S 
Sbjct: 257 SSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQ 316
Query: 322 LYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHY 359
            +DP   P A+ P D  ++ +E   E  +E+  +E+L +
Sbjct: 317 YHDPEDEPEAE-PYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  292 bits (747), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 146/340 (42%), Positives = 218/340 (64%), Gaps = 5/340 (1%)
Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +T +E+   Y  ++P+G GAYG VCS+V+  T  KVAIKK+   F++ + A R  REL+L
Sbjct: 18  KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 77
Query: 83  LRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L+H++HENVI L DV  P     +F D YLV   M TDL +++K  + L  D  Q+ ++Q
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQ 136
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +L+GL+Y+H+A I+HRDLKPGNL VN +C+LKI DFGLAR ++ +   M   VVTRWYRA
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MXGXVVTRWYRA 193
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++L    Y  ++D+WSVGCI AE++  K +F G++ L+QLK I+ + G+   E ++ +
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
            + +A+ Y+K LP      F+ +  +A PLA++LL+KMLV D  +R++  EAL HPY   
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
Query: 322 LYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHP 361
           L+D    P  Q   D   D +   +  + +  KE+L + P
Sbjct: 314 LHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 353

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  271 bits (693), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 152/404 (37%), Positives = 221/404 (54%), Gaps = 64/404 (15%)
Query: 19  YSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR 78
           +S WQ    I  +Y     IG G+YG VC + ++     VAIKKI   FE+ +D  R LR
Sbjct: 46  HSDWQ----IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR 101
Query: 79  ELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYF 138
           E+ +L  L H++V+ + D+++P     F ++Y+V E+ D+D  ++ ++   LT  H +  
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTL 161
Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART----SNGKNQF----- 189
           L+ LL G+KY+HSA ILHRDLKP N LVN +C +K+CDFGLART     NG +Q      
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 190 ------------------MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-- 229
                             +T +VVTRWYRAPEL+L  +NY  +IDVWS+GCIFAELL   
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 230 ---------RKPIFPGTECL--------------------NQLKLIINILGSRREEDLEF 260
                    R P+FPG+ C                     +QL +I NILG+  EED+E 
Sbjct: 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA 341
Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           ++   A++YI+  P   GT  +  +P +   AI LL++MLVF+P KRI++ E L HP+  
Sbjct: 342 LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK 401
Query: 321 P--LYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHPE 362
              + +  +N   +V +  +      E  +R   +KE+  YHPE
Sbjct: 402 EVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  271 bits (692), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 151/350 (43%), Positives = 219/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  270 bits (690), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 151/350 (43%), Positives = 219/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  269 bits (688), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 152/350 (43%), Positives = 216/350 (61%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VA+KK++  F+N+  A R  REL LL
Sbjct: 16  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLL 75
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I     L ++   Y L+Q+
Sbjct: 76  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQM 133
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART++  N  MT YVVTR+YRAP
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS-TNFMMTPYVVTRYYRAP 192
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  EL+    IF GT+ ++Q   +I  LG+   E +  + 
Sbjct: 193 EVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL- 250
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPD------------AHPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P  PG  F  L+PD                A DLL KMLV DP KRISV
Sbjct: 251 QPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISV 310
Query: 311 TEALQHPYMSPLYDP--SSNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EAL+HPY++  YDP  +  PP Q+  D  ++E E   E  +E++ KE++
Sbjct: 311 DEALRHPYITVWYDPAEAEAPPPQI-YDAQLEEREHAIEEWKELIYKEVM 359

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  269 bits (688), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 150/350 (42%), Positives = 218/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  269 bits (688), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 173
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 232
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 233 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 290
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 351 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 400

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  269 bits (687), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 56  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 173
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 232
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 233 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 290
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 351 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 400

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  268 bits (686), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 78
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 136
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 195
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 196 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 253
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 254 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 313
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 314 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 363

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  268 bits (686), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 313 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 362

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  268 bits (686), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 17  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 76
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 77  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 134
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 135 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 193
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 194 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 251
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 252 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 311
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 312 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 361

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  268 bits (686), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 151/350 (43%), Positives = 219/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 78
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 136
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 195
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 196 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL- 253
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 314 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 362

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  268 bits (686), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 78
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 136
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 195
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 196 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 253
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 254 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 313
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 314 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 363

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  268 bits (685), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 150/350 (42%), Positives = 218/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  268 bits (685), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 313 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 362

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  268 bits (685), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 151/350 (43%), Positives = 219/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  268 bits (685), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQM 128
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 187
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 188 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 245
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 355

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  268 bits (684), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 71
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQM 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 189 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 246
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 247 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 306
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 307 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 356

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  268 bits (684), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 151/351 (43%), Positives = 222/351 (63%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 71
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQM 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 189 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 246
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 247 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 306
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 307 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 356

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  268 bits (684), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 152/352 (43%), Positives = 216/352 (61%), Gaps = 22/352 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VA+KK++  F+N+  A R  REL LL
Sbjct: 18  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLL 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I     L ++   Y L+Q+
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+   N  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-CTNFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  EL+    IF GT+ ++Q   +I  LG+   E +  + 
Sbjct: 195 EVILGM-GYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPD------------AHPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P  PG  F  L+PD                A DLL KMLV DP KRISV
Sbjct: 253 QPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISV 312
Query: 311 TEALQHPYMSPLYDP--SSNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLHY 359
            EAL+HPY++  YDP  +  PP Q+  D  ++E E   E  +E++ KE++ +
Sbjct: 313 DEALRHPYITVWYDPAEAEAPPPQI-YDAQLEEREHAIEEWKELIYKEVMDW 363

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  268 bits (684), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 150/351 (42%), Positives = 221/351 (62%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 313 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 362

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  267 bits (683), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 150/350 (42%), Positives = 218/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  267 bits (682), Expect = 8e-72,   Method: Compositional matrix adjust.
 Identities = 150/351 (42%), Positives = 221/351 (62%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 313 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 362

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  267 bits (682), Expect = 8e-72,   Method: Compositional matrix adjust.
 Identities = 151/350 (43%), Positives = 219/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 23  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 82
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 83  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 140
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 141 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 199
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 200 EVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 257
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 258 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 317
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 318 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 366

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  267 bits (682), Expect = 8e-72,   Method: Compositional matrix adjust.
 Identities = 150/351 (42%), Positives = 221/351 (62%), Gaps = 22/351 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME--LDHERMSYLLYQM 128
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 129 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 187
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 188 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 245
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+    PP Q+  D  +DE E   E  +E++ KE+++
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQI-YDKQLDEREHTIEEWKELIYKEVMN 355

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  266 bits (681), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 151/350 (43%), Positives = 219/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 71
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 72  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 130 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 189 EVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 246
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 247 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 306
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 307 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 355

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  266 bits (680), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 149/350 (42%), Positives = 217/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVG I  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  265 bits (678), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 151/359 (42%), Positives = 223/359 (62%), Gaps = 24/359 (6%)
Query: 17  HYYS--MWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL 74
           ++YS  +  + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A 
Sbjct: 11  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK 70
Query: 75  RTLRELKLLRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTND 133
           R  REL L++ + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++
Sbjct: 71  RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHE 128
Query: 134 HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY 193
              Y L+Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  M  +
Sbjct: 129 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMVPF 187
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
           VVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+ 
Sbjct: 188 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 246
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLV 301
             E ++ +  P  R Y+++ P   G  F +L+PD                A DLL KMLV
Sbjct: 247 CPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 305
Query: 302 FDPTKRISVTEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            D +KRISV EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 306 IDASKRISVDEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 363

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  265 bits (677), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 154/369 (41%), Positives = 225/369 (60%), Gaps = 24/369 (6%)
Query: 17  HYYS--MWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL 74
           ++YS  +  + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A 
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK 68
Query: 75  RTLRELKLLRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTND 133
           R  REL L++ + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++
Sbjct: 69  RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHE 126
Query: 134 HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY 193
              Y L+Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPE 185
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
           VVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   +I  LG+ 
Sbjct: 186 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLV 301
             E ++ +  P  R Y+++ P   G  F +L+PD                A DLL KMLV
Sbjct: 245 CPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLV 303
Query: 302 FDPTKRISVTEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLH 358
            D +KRISV EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++ 
Sbjct: 304 IDASKRISVDEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVMD 362
Query: 359 YHPEAITAN 367
                 T N
Sbjct: 363 LPKRPTTLN 371

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  263 bits (673), Expect = 8e-71,   Method: Compositional matrix adjust.
 Identities = 148/350 (42%), Positives = 216/350 (61%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIV ++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVG I  E++    +FPGT+ ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  261 bits (667), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 149/350 (42%), Positives = 217/350 (62%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  M   VVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMEPEVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  261 bits (666), Expect = 7e-70,   Method: Compositional matrix adjust.
 Identities = 142/379 (37%), Positives = 211/379 (55%), Gaps = 52/379 (13%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRG+YG V  + ++ T + VAIKK+N  FE+ +D  R LRE+ +L  L+ + +I L D+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
           ++P     F ++Y+V E+ D+DL ++ K+   LT +H +  L+ LL G  ++H + I+HR
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGK----------------------NQFMTEYVV 195
           DLKP N L+N +C +K+CDFGLART N +                       + +T +VV
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-----------GRKPIFPGTECL---- 240
           TRWYRAPEL+L  +NY  SID+WS GCIFAELL            R P+FPG+ C     
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273
Query: 241 -------------NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPD 287
                        +QL +I NI+G+  E+DL+ I+ P+  KYIK  P+       + YP 
Sbjct: 274 DRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333
Query: 288 AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES--GE 345
                I+LL+ ML F+P KRI++ +AL HPY+  +        +   I L  D+     E
Sbjct: 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSE 393
Query: 346 EMIREMMLKEMLHYHPEAI 364
             +R + LKE+  +HPE +
Sbjct: 394 TQLRYIFLKEVQSFHPELV 412

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  260 bits (665), Expect = 8e-70,   Method: Compositional matrix adjust.
 Identities = 146/348 (41%), Positives = 216/348 (62%), Gaps = 25/348 (7%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 311 TEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLH 358
            +ALQHPY++  YDP+           D  E + EE  +E++ KE+++
Sbjct: 313 DDALQHPYINVWYDPAXXXXX------DEREHTIEEW-KELIYKEVMN 353

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  260 bits (664), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 148/350 (42%), Positives = 216/350 (61%), Gaps = 22/350 (6%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  M   VVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMEPEVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+     ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD                A DLL KMLV D +KRISV
Sbjct: 253 QPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 312
Query: 311 TEALQHPYMSPLYDPS--SNPPAQVPIDLDMDE-ESGEEMIREMMLKEML 357
            EALQHPY++  YDPS    PP ++P D  +DE E   E  +E++ KE++
Sbjct: 313 DEALQHPYINVWYDPSEAEAPPPKIP-DKQLDEREHTIEEWKELIYKEVM 361

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  259 bits (662), Expect = 2e-69,   Method: Compositional matrix adjust.
 Identities = 142/337 (42%), Positives = 205/337 (60%), Gaps = 42/337 (12%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HE 89
           KY  +K +G+GAYGIV  S++R T E VA+KKI +AF+N  DA RT RE+ +L  L  HE
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           N++ L +V+   + R   DVYLV++ M+TDLH +I+++  L   H QY ++QL++ +KYL
Sbjct: 70  NIVNLLNVLRADNDR---DVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYL 125
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLART----------------SNGKN-----Q 188
           HS  +LHRD+KP N+L+NA C +K+ DFGL+R+                 N +N      
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
            +T+YV TRWYRAPE+LL    Y   ID+WS+GCI  E+L  KPIFPG+  +NQL+ II 
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 249 ILGSRREEDLEFIDNPKARKYIKSLPYTPG----------TPFSRLY------PDAHPLA 292
           ++     ED+E I +P A+  I+SL               T +  L        D +  A
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 293 IDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNP 329
           +DLL K+L F+P KRIS  +AL+HP++S  ++P+  P
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEP 342

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  256 bits (655), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 143/382 (37%), Positives = 206/382 (53%), Gaps = 55/382 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRG+YG V  + ++  N+ VAIKK+N  FE+ +D  R LRE+ +L  L+ + +I L D+
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
           ++P     F ++Y+V E+ D+DL ++ K+   LT  H +  L+ LL G K++H + I+HR
Sbjct: 96  IIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHR 155
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQF-------------------------MTE 192
           DLKP N L+N +C +KICDFGLART N                              +T 
Sbjct: 156 DLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTS 215
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-----------GRKPIFPGTECL- 240
           +VVTRWYRAPEL+L  +NY  SID+WS GCIFAELL            R P+FPG+ C  
Sbjct: 216 HVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFP 275
Query: 241 ----------------NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRL 284
                           +QL +I N++G+  EEDL+ I   +  KYIK  P   G   S+ 
Sbjct: 276 LSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKK 335
Query: 285 YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES- 343
           Y       IDLL+ ML F+  KRI++ +AL HPY+  +   +    +   I L  D+   
Sbjct: 336 YSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIILPFDDWMV 395
Query: 344 -GEEMIREMMLKEMLHYHPEAI 364
             E  +R + LKE+  +H + I
Sbjct: 396 LSETQLRYIFLKEIQSFHADLI 417

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  253 bits (646), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 137/313 (43%), Positives = 199/313 (63%), Gaps = 18/313 (5%)
Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A R  REL L+
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 77
Query: 84  RHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L ++   Y L+Q+
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQM 135
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L G+K+LHSA I+HRDLKP N++V ++  LKI DFGLART+ G +  MT YVVTR+YRAP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAP 194
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+   E ++ + 
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL- 252
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISV 310
            P  R Y+++ P   G  F +L+PD+               A DLL KMLV DP KRISV
Sbjct: 253 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 312
Query: 311 TEALQHPYMSPLY 323
            +ALQHPY++  Y
Sbjct: 313 DDALQHPYINVWY 325

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  241 bits (614), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 124/312 (39%), Positives = 183/312 (58%), Gaps = 13/312 (4%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN--RVDAL-------R 75
           L  + + Y   + I  G+YG VC+ V+ E    VAIK++ N   +   V+ L       R
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 76  TLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ-ALTNDH 134
            LRE++LL H  H N++ L+D+ +         +YLV ELM TDL Q+I   +  ++  H
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYV 194
            QYF++ +L GL  LH A ++HRDL PGN+L+  N D+ ICDF LAR         T YV
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-KTHYV 194
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR 254
             RWYRAPEL++    +   +D+WS GC+ AE+  RK +F G+   NQL  I+ ++G+ +
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 255 EEDLEFIDNPKARKYIK-SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            ED+    +P AR Y++ SL   P   ++ + P A P+A+DL+ KML F+P +RIS  +A
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 314 LQHPYMSPLYDP 325
           L+HPY   L+DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  240 bits (613), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 124/312 (39%), Positives = 183/312 (58%), Gaps = 13/312 (4%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN--RVDAL-------R 75
           L  + + Y   + I  G+YG VC+ V+ E    VAIK++ N   +   V+ L       R
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 76  TLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ-ALTNDH 134
            LRE++LL H  H N++ L+D+ +         +YLV ELM TDL Q+I   +  ++  H
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYV 194
            QYF++ +L GL  LH A ++HRDL PGN+L+  N D+ ICDF LAR         T YV
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN-KTHYV 194
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR 254
             RWYRAPEL++    +   +D+WS GC+ AE+  RK +F G+   NQL  I+ ++G+ +
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 255 EEDLEFIDNPKARKYIK-SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            ED+    +P AR Y++ SL   P   ++ + P A P+A+DL+ KML F+P +RIS  +A
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 314 LQHPYMSPLYDP 325
           L+HPY   L+DP
Sbjct: 315 LRHPYFESLFDP 326

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  227 bits (579), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 124/317 (39%), Positives = 192/317 (60%), Gaps = 17/317 (5%)
Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F++ ++Y+ +KP+G G  G+V S+V+ + +++VAIKKI     +       LRE+K++R 
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRR 64
Query: 86  LQHENVIALKDVMMPSHRRNFKDV---------YLVYELMDTDLHQIIKSSQALTNDHCQ 136
           L H+N++ + +++ PS  +   DV         Y+V E M+TDL  +++    L  +H +
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG-PLLEEHAR 123
Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSN---GKNQFMTE 192
            F++QLLRGLKY+HSAN+LHRDLKP NL +N  +  LKI DFGLAR  +        ++E
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
            +VT+WYR+P LLL  +NY  +ID+W+ GCIFAE+L  K +F G   L Q++LI+  +  
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
             EED + + +     YI++    P  P ++L P     A+D L+++L F P  R++  E
Sbjct: 244 VHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302
Query: 313 ALQHPYMSPLYDPSSNP 329
           AL HPYMS    P   P
Sbjct: 303 ALSHPYMSIYSFPMDEP 319

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  210 bits (534), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 124/297 (41%), Positives = 169/297 (56%), Gaps = 9/297 (3%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ IG G YG V  + NRET+E VA+K++    ++       LRE+ LL+ L+H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYL 149
           ++ L DV+        K + LV+E  D DL +   S    L  +  + FLFQLL+GL + 
Sbjct: 63  IVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           HS N+LHRDLKP NLL+N N +LK+ DFGLAR      +  +  VVT WYR P++L    
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 210 NYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
            Y TSID+WS GCIFAEL    +P+FPG +  +QLK I  +LG+  EE  ++    K   
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEE--QWPSMTKLPD 235
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           Y     Y   T    + P  +    DLLQ +L  +P +RIS  EALQHPY S    P
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 124/308 (40%), Positives = 174/308 (56%), Gaps = 14/308 (4%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV-DALR--TLRELKLLRHLQ 87
           +Y  +  +G G +  V  + ++ TN+ VAIKKI     +   D +    LRE+KLL+ L 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIK-SSQALTNDHCQYFLFQLLRGL 146
           H N+I L D     H+ N   + LV++ M+TDL  IIK +S  LT  H + ++   L+GL
Sbjct: 71  HPNIIGLLDAF--GHKSN---ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +YLH   ILHRDLKP NLL++ N  LK+ DFGLA++    N+     VVTRWYRAPELL 
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
               YG  +D+W+VGCI AELL R P  PG   L+QL  I   LG+  EE  ++ D    
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE--QWPDMCSL 243
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS 326
             Y+ +    PG P   ++  A    +DL+Q + +F+P  RI+ T+AL+  Y S    P 
Sbjct: 244 PDYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS--NRPG 300
Query: 327 SNPPAQVP 334
             P  Q+P
Sbjct: 301 PTPGCQLP 308

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  207 bits (528), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 123/297 (41%), Positives = 169/297 (56%), Gaps = 9/297 (3%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ IG G YG V  + NRET+E VA+K++    ++       LRE+ LL+ L+H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYL 149
           ++ L DV+        K + LV+E  D DL +   S    L  +  + FLFQLL+GL + 
Sbjct: 63  IVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           HS N+LHRDLKP NLL+N N +LK+ +FGLAR      +  +  VVT WYR P++L    
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 210 NYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
            Y TSID+WS GCIFAEL    +P+FPG +  +QLK I  +LG+  EE  ++    K   
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE--QWPSMTKLPD 235
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           Y     Y   T    + P  +    DLLQ +L  +P +RIS  EALQHPY S    P
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 75  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 246
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 69  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 67  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 72  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 243
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 67  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  205 bits (521), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 167/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +D DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 71  LDVI---HTEN--KLYLVFEHVDQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  204 bits (519), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 71  LDVI---HTEN--KLYLVFEFLSMDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 70  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 241
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 69  LDVI---HTEN--KLYLVFEFLSMDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 72  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 185
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 243
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 244 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 67  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 71  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 70  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 241
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 67  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+ KI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 71  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+ KI    E        +RE+ LL+ L H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 67  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  204 bits (518), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 69  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 70  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 241
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 116/305 (38%), Positives = 172/305 (56%), Gaps = 25/305 (8%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ +G G YG+V  + + +    VA+K+I    E+       +RE+ LL+ L H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYL 149
           +++L DV+        + + LV+E M+ DL +++  ++  L +   + +L+QLLRG+ + 
Sbjct: 81  IVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   ILHRDLKP NLL+N++  LK+ DFGLAR      +  T  VVT WYRAP++L+   
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            Y TS+D+WS+GCIFAE++  KP+FPG    +QL  I +ILG+          NP+    
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT---------PNPREWPQ 246
Query: 270 IKSLPYTP--------GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
           ++ LP             P+S + P      IDLL  ML FDP KRIS  +A+ HPY   
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 322 LYDPS 326
           L DP 
Sbjct: 307 L-DPQ 310

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 69  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 165/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL   + +S ALT       + +LFQLL+GL + HS
Sbjct: 70  LDVI---HTEN--KLYLVFEFLSMDLKDFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 241
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 242 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 116/304 (38%), Positives = 172/304 (56%), Gaps = 25/304 (8%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ +G G YG+V  + + +    VA+K+I    E+       +RE+ LL+ L H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYL 149
           +++L DV+        + + LV+E M+ DL +++  ++  L +   + +L+QLLRG+ + 
Sbjct: 81  IVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   ILHRDLKP NLL+N++  LK+ DFGLAR      +  T  VVT WYRAP++L+   
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            Y TS+D+WS+GCIFAE++  KP+FPG    +QL  I +ILG+          NP+    
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT---------PNPREWPQ 246
Query: 270 IKSLPYTP--------GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
           ++ LP             P+S + P      IDLL  ML FDP KRIS  +A+ HPY   
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 322 LYDP 325
           L DP
Sbjct: 307 L-DP 309

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 69  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 240
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 241 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 165/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL   + +S ALT       + +LFQLL+GL + HS
Sbjct: 71  LDVI---HTEN--KLYLVFEFLSMDLKDFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  203 bits (516), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 165/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL   + +S ALT       + +LFQLL+GL + HS
Sbjct: 71  LDVI---HTEN--KLYLVFEFLHQDLKTFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 242
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  203 bits (516), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 118/294 (40%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL   + +S ALT       + +LFQLL+GL + HS
Sbjct: 67  LDVI---HTEN--KLYLVFEHVHQDLKTFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C  Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 238
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  202 bits (515), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 165/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL   + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKDFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  202 bits (514), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 75  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL    Y
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 246
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 247 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  202 bits (514), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 116/288 (40%), Positives = 164/288 (56%), Gaps = 11/288 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +     VVT WYRAPE+LL C  Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           S P      FS++ P        LL +ML +DP KRIS   AL HP+ 
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  202 bits (513), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 117/294 (39%), Positives = 166/294 (56%), Gaps = 11/294 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N++ L
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHS 151
            DV+   H  N   +YLV+E +  DL + + +S ALT       + +LFQLL+GL + HS
Sbjct: 68  LDVI---HTEN--KLYLVFEFLHQDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL    Y
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
            T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+   +++ +        Y  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVVWPGVTSMPDYKP 239
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
           S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 112/290 (38%), Positives = 161/290 (55%), Gaps = 9/290 (3%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ IG G YG+V  + N    E  A+KKI    E+      T+RE+ +L+ L+H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYL 149
           ++ L DV+    R     + LV+E +D DL +++   +  L +   + FL QLL G+ Y 
Sbjct: 62  IVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  VVT WYRAP++L+   
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  ILG+   ++  + +  +  KY
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKY 234
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +       P+           IDLL KML  DP +RI+  +AL+H Y 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  195 bits (495), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 112/290 (38%), Positives = 161/290 (55%), Gaps = 9/290 (3%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ IG G YG+V  + N    E  A+KKI    E+      T+RE+ +L+ L+H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYL 149
           ++ L DV+    R     + LV+E +D DL +++   +  L +   + FL QLL G+ Y 
Sbjct: 62  IVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  VVT WYRAP++L+   
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  ILG+   ++  + +  +  KY
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKY 234
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +       P+           IDLL KML  DP +RI+  +AL+H Y 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  194 bits (494), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 111/290 (38%), Positives = 161/290 (55%), Gaps = 9/290 (3%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ IG G YG+V  + N    E  A+KKI    E+      T+RE+ +L+ L+H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYL 149
           ++ L DV+    R     + LV+E +D DL +++   +  L +   + FL QLL G+ Y 
Sbjct: 62  IVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  +VT WYRAP++L+   
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  ILG+   ++  + +  +  KY
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKY 234
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +       P+           IDLL KML  DP +RI+  +AL+H Y 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  194 bits (492), Expect = 9e-50,   Method: Compositional matrix adjust.
 Identities = 123/320 (38%), Positives = 175/320 (54%), Gaps = 19/320 (5%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLL 83
           L   D +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 84  RHLQ---HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS--SQALTNDHCQYF 138
           RHL+   H NV+ L DV   S       + LV+E +D DL   +       +  +  +  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125
Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +FQLLRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR  + +   +T  VVT W
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLW 184
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           YRAPE+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I++++G   EED 
Sbjct: 185 YRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243
Query: 259 -EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
              +  P+   + KS       P  +   D   L  DLL K L F+P KRIS   AL HP
Sbjct: 244 PRDVALPRQAFHSKS-----AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 318 YMSPLYDPSSN-----PPAQ 332
           Y   L     N     PP+Q
Sbjct: 299 YFQDLERCKENLDSHLPPSQ 318

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  192 bits (488), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 118/301 (39%), Positives = 169/301 (56%), Gaps = 14/301 (4%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           D +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +LRHL+
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 88  ---HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS--SQALTNDHCQYFLFQL 142
              H NV+ L DV   S       + LV+E +D DL   +       +  +  +  +FQL
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           LRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR  + +   +T  VVT WYRAP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFI 261
           E+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I++++G   EED    +
Sbjct: 189 EVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
             P+   + KS       P  +   D   L  DLL K L F+P KRIS   AL HPY   
Sbjct: 248 ALPRQAFHSKS-----AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 322 L 322
           L
Sbjct: 303 L 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  191 bits (486), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 117/298 (39%), Positives = 168/298 (56%), Gaps = 14/298 (4%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           D +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +LRHL+
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 88  ---HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS--SQALTNDHCQYFLFQL 142
              H NV+ L DV   S       + LV+E +D DL   +       +  +  +  +FQL
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           LRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR  + +   +T  VVT WYRAP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWYRAP 188
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFI 261
           E+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I++++G   EED    +
Sbjct: 189 EVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             P+   + KS       P  +   D   L  DLL K L F+P KRIS   AL HPY 
Sbjct: 248 ALPRQAFHSKS-----AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 109/293 (37%), Positives = 156/293 (53%), Gaps = 10/293 (3%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y+ +  +G G Y  V    ++ T+  VA+K+I    E        +RE+ LL+ L+H N+
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC-TAIREVSLLKDLKHANI 62
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH-CQYFLFQLLRGLKYLH 150
           + L D++        K + LV+E +D DL Q +     + N H  + FLFQLLRGL Y H
Sbjct: 63  VTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              +LHRDLKP NLL+N   +LK+ DFGLAR  +   +     VVT WYR P++LL   +
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDNPKARKY 269
           Y T ID+W VGCIF E+   +P+FPG+    QL  I  ILG+  EE     + N + + Y
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
             + P           P       DLL K+L F+   RIS  +A++HP+   L
Sbjct: 238 --NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  187 bits (475), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 115/309 (37%), Positives = 168/309 (54%), Gaps = 19/309 (6%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
           +++  ++ +G G Y  V   +N+ T   VA+K++    E    +   +RE+ L++ L+HE
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS-TAIREISLMKELKHE 63
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS------QALTNDHCQYFLFQLL 143
           N++ L DV+   H  N   + LV+E MD DL + + S       + L  +  +YF +QLL
Sbjct: 64  NIVRLYDVI---HTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           +GL + H   ILHRDLKP NLL+N    LK+ DFGLAR         +  VVT WYRAP+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           +L+    Y TSID+WS GCI AE++  KP+FPGT    QLKLI +I+G+  E     +  
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 264 -PKARKYIKSLPYTPGTPFSRLYPDA-HPL---AIDLLQKMLVFDPTKRISVTEALQHPY 318
            PK    I+  P  P      L P    PL    +D L  +L  +P  R+S  +AL HP+
Sbjct: 239 LPKYNPNIQQRP--PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
Query: 319 MSPLYDPSS 327
            +  Y  +S
Sbjct: 297 FAEYYHHAS 305

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 106/299 (35%), Positives = 163/299 (54%), Gaps = 12/299 (4%)
Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F+   KY  +  +G G+YG+V    N++T   VAIKK   + ++++     +RE+KLL+ 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN--DH--CQYFLFQ 141
           L+HEN++ L +V     R      YLV+E +D   H I+   +   N  D+   Q +LFQ
Sbjct: 81  LRHENLVNLLEVCKKKKRW-----YLVFEFVD---HTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           ++ G+ + HS NI+HRD+KP N+LV+ +  +K+CDFG ART     +   + V TRWYRA
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PELL+    YG ++DVW++GC+  E+   +P+FPG   ++QL  I+  LG+      E  
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           +       ++        P  R YP    + IDL +K L  DP KR    E L H +  
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 117/315 (37%), Positives = 170/315 (53%), Gaps = 14/315 (4%)
Query: 12  RSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV 71
           + PG    S   +   ID +Y  I  +G G YG V  +++  TNE VAIK+I    E   
Sbjct: 17  QGPGSMSVSAAPSATSID-RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG 75
Query: 72  DALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALT 131
                +RE+ LL+ LQH N+I LK V+  +HR     ++L++E  + DL + +  +  ++
Sbjct: 76  VPGTAIREVSLLKELQHRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVS 130
Query: 132 NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-----LKICDFGLARTSNGK 186
               + FL+QL+ G+ + HS   LHRDLKP NLL++ +       LKI DFGLAR     
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI 246
            +  T  ++T WYR PE+LL   +Y TS+D+WS+ CI+AE+L + P+FPG   ++QL  I
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250
Query: 247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSR-LYPDAHPLAIDLLQKMLVFDPT 305
             +LG    +D  +        + +S P   G    R L        +DLL  ML  DP 
Sbjct: 251 FEVLG--LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV 308
Query: 306 KRISVTEALQHPYMS 320
           KRIS   AL+HPY S
Sbjct: 309 KRISAKNALEHPYFS 323

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 100/291 (34%), Positives = 160/291 (54%), Gaps = 6/291 (2%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  I  IG G+YG+V    NR+T + VAIKK   + ++ V     LRE+++L+ L+H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L +V      R  + ++LV+E  D T LH++ +  + +     +   +Q L+ + + 
Sbjct: 64  LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H  N +HRD+KP N+L+  +  +K+CDFG AR   G + +  + V TRWYR+PELL+   
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            YG  +DVW++GC+FAELL   P++PG   ++QL LI   LG       +     +    
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           +K        P    +P+    A+ LL+  L  DPT+R++  + L HPY  
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 113/299 (37%), Positives = 160/299 (53%), Gaps = 16/299 (5%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI---NNAFENRVDALRTLRELKLLRHL 86
           ++Y P+  IG GAYG V  + +  +   VA+K +   N         + T+RE+ LLR L
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 87  Q---HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQ 141
           +   H NV+ L DV   S       V LV+E +D DL   +  +    L  +  +  + Q
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
            LRGL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR  +     +T  VVT WYRA
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALTPVVVTLWYRA 187
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EF 260
           PE+LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I +++G   E+D    
Sbjct: 188 PEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 246
Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           +  P+      + P     P   + P+       LL +ML F+P KRIS   ALQH Y+
Sbjct: 247 VSLPRG-----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 111/296 (37%), Positives = 158/296 (53%), Gaps = 13/296 (4%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-- 87
           ++Y P+  IG GAYG V  + +  +   VA+K +          + T+RE+ LLR L+  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 88  -HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLR 144
            H NV+ L DV   S       V LV+E +D DL   +  +    L  +  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           GL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR  +     +   VVT WYRAPE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALAPVVVTLWYRAPEV 182
Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDN 263
           LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I +++G   E+D    +  
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           P+      + P     P   + P+       LL +ML F+P KRIS   ALQH Y+
Sbjct: 242 PRG-----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  178 bits (451), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 111/296 (37%), Positives = 158/296 (53%), Gaps = 13/296 (4%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-- 87
           ++Y P+  IG GAYG V  + +  +   VA+K +          + T+RE+ LLR L+  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 88  -HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLR 144
            H NV+ L DV   S       V LV+E +D DL   +  +    L  +  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           GL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR  +     +   VVT WYRAPE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALDPVVVTLWYRAPEV 182
Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDN 263
           LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I +++G   E+D    +  
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           P+      + P     P   + P+       LL +ML F+P KRIS   ALQH Y+
Sbjct: 242 PRG-----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 111/296 (37%), Positives = 158/296 (53%), Gaps = 13/296 (4%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-- 87
           ++Y P+  IG GAYG V  + +  +   VA+K +          + T+RE+ LLR L+  
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAF 63
Query: 88  -HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLR 144
            H NV+ L DV   S       V LV+E +D DL   +  +    L  +  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           GL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR  + +       VVT WYRAPE+
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP-VVVTLWYRAPEV 182
Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDN 263
           LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I +++G   E+D    +  
Sbjct: 183 LLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 241
Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           P+      + P     P   + P+       LL +ML F+P KRIS   ALQH Y+
Sbjct: 242 PRG-----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 175/312 (56%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+    AF+NR        EL+++R L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKL 70
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++  + P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 249 EM-NPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 306 FDELRDPNVKLP 317

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 107/312 (34%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+    AF+NR        EL+++R L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKL 70
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 249 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 306 FDELRDPNVKLP 317

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 47  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 99  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 158 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 216
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 276
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 277 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 333
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 334 FDELRDPNVKLP 345

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 113/316 (35%), Positives = 166/316 (52%), Gaps = 9/316 (2%)
Query: 13  SPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD 72
            P K Y S+     +  +KY  +  IG+G +G V  + +R+T +KVA+KK+    E    
Sbjct: 1   GPAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 60
Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPS---HRRNFKDVYLVYELMDTDLHQIIKSSQA 129
            +  LRE+K+L+ L+HENV+ L ++       + R    +YLV++  + DL  ++ +   
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 120
Query: 130 -LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKN 187
             T    +  +  LL GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR  S  KN
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 188 QFMTEY---VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK 244
                Y   VVT WYR PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL 
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFD 303
           LI  + GS   E    +DN +  + ++ +         RL      P A+DL+ K+LV D
Sbjct: 241 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 300
Query: 304 PTKRISVTEALQHPYM 319
           P +RI   +AL H + 
Sbjct: 301 PAQRIDSDDALNHDFF 316

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 104
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 105 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 222
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 283 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 340 FDELRDPNVKLP 351

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 55  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 106
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 107 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 166 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 224
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 284
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 285 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 341
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 342 FDELRDPNVKLP 353

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 24  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 75
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 76  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 135 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 193
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 253
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 254 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 310
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 311 FDELRDPNVKLP 322

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 98  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 149
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 150 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 209 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 267
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 327
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 328 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 384
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 385 FDELRDPNVKLP 396

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 57  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 108
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 109 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 168 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 226
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 286
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 287 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 343
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 344 FDELRDPNVKLP 355

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+    AF+NR        EL+++R L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKL 70
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++  + P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 249 EM-NPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 306 FDELRDPNVKLP 317

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 113/316 (35%), Positives = 166/316 (52%), Gaps = 9/316 (2%)
Query: 13  SPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD 72
            P K Y S+     +  +KY  +  IG+G +G V  + +R+T +KVA+KK+    E    
Sbjct: 1   GPAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 60
Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPS---HRRNFKDVYLVYELMDTDLHQIIKSSQA 129
            +  LRE+K+L+ L+HENV+ L ++       + R    +YLV++  + DL  ++ +   
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV 120
Query: 130 -LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKN 187
             T    +  +  LL GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR  S  KN
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 188 QFMTEY---VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK 244
                Y   VVT WYR PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL 
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFD 303
           LI  + GS   E    +DN +  + ++ +         RL      P A+DL+ K+LV D
Sbjct: 241 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 300
Query: 304 PTKRISVTEALQHPYM 319
           P +RI   +AL H + 
Sbjct: 301 PAQRIDSDDALNHDFF 316

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 32  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 83
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 84  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 143 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 201
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 261
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 262 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 318
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 319 FDELRDPNVKLP 330

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  172 bits (435), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 113/316 (35%), Positives = 166/316 (52%), Gaps = 9/316 (2%)
Query: 13  SPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD 72
            P K Y S+     +  +KY  +  IG+G +G V  + +R+T +KVA+KK+    E    
Sbjct: 1   GPAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 60
Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPS---HRRNFKDVYLVYELMDTDLHQIIKSSQA 129
            +  LRE+K+L+ L+HENV+ L ++       + R    +YLV++  + DL  ++ +   
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 120
Query: 130 -LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKN 187
             T    +  +  LL GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR  S  KN
Sbjct: 121 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 188 QFMTEY---VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK 244
                Y   VVT WYR PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL 
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 240
Query: 245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFD 303
           LI  + GS   E    +DN +  + ++ +         RL      P A+DL+ K+LV D
Sbjct: 241 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 300
Query: 304 PTKRISVTEALQHPYM 319
           P +RI   +AL H + 
Sbjct: 301 PAQRIDSDDALNHDFF 316

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 106/312 (33%), Positives = 174/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 70
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 249 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 306 FDELRDPNVKLP 317

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 109/299 (36%), Positives = 160/299 (53%), Gaps = 9/299 (3%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
           +KY  +  IG+G +G V  + +R+T +KVA+KK+    E     +  LRE+K+L+ L+HE
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 90  NVIALKDVMMPS---HRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRG 145
           NV+ L ++       + R    +YLV++  + DL  ++ +     T    +  +  LL G
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKNQFMTEY---VVTRWYRA 201
           L Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR  S  KN     Y   VVT WYR 
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + GS   E    +
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 256
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           DN +  + ++ +         RL      P A+DL+ K+LV DP +RI   +AL H + 
Sbjct: 257 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 104
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 105 DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 222
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 283 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 340 FDELRDPNVKLP 351

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 82
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 83  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 200
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 260
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 261 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 318 FDELRDPNVKLP 329

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 82
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 83  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 142 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 200
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 260
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 261 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 318 FDELRDPNVKLP 329

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 106/313 (33%), Positives = 173/313 (55%), Gaps = 25/313 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 70
Query: 87  QHENVIALKDVMMPSHRRNFKDVY---LVYELMDTDLHQIIK----SSQALTNDHCQYFL 139
            H N++ L+     S  +  KDV    LV + +   ++++ +    + Q L   + + ++
Sbjct: 71  DHCNIVRLRYFFYSSGEK--KDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRW 198
           +QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRY 187
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           YRAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
             + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H 
Sbjct: 248 REM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
Query: 318 YMSPLYDPSSNPP 330
           +   L DP+   P
Sbjct: 305 FFDELRDPNVKLP 317

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 70
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 249 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 306 FDELRDPNVKLP 317

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 38  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 89
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 90  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 149 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 207
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 267
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 268 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 324
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 325 FDELRDPNVKLP 336

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 23  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 74
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 75  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 134 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 192
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 252
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 253 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 309
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 310 FDELRDPNVKLP 321

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 27  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 78
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 79  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 138 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 196
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 256
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 257 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 313
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 314 FDELRDPNVKLP 325

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 70
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 71  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 188
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 249 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 306 FDELRDPNVKLP 317

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 105/312 (33%), Positives = 173/312 (55%), Gaps = 23/312 (7%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHL 86
           +  Y   K IG G++G+V  +   ++ E VAIKK+  +  F+NR        EL+++R L
Sbjct: 20  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR--------ELQIMRKL 71
Query: 87  QHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIK----SSQALTNDHCQYFLF 140
            H N++ L+     S  +   +VYL  V + +   ++++ +    + Q L   + + +++
Sbjct: 72  DHCNIVRLRYFFYSSGEKK-DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWY 199
           QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +     + +R+Y
Sbjct: 131 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSXICSRYY 189
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           RAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E + 
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 249
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            + NP   ++    P     P+++++ P   P AI L  ++L + PT R++  EA  H +
Sbjct: 250 EM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 306
Query: 319 MSPLYDPSSNPP 330
              L DP+   P
Sbjct: 307 FDELRDPNVKLP 318

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 117/369 (31%), Positives = 194/369 (52%), Gaps = 25/369 (6%)
Query: 4   PVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI 63
           P++ PN +    K   S  +T  + +  Y   K IG G++G+V  +   E++E VAIKK+
Sbjct: 17  PLDDPNKVI---KVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV 72
Query: 64  --NNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN---FKDVYLVY--ELM 116
             +  F+NR        EL+++R ++H NV+ LK     +  +    F ++ L Y  E +
Sbjct: 73  LQDKRFKNR--------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124
Query: 117 DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKIC 175
                   K  Q +     + +++QLLR L Y+HS  I HRD+KP NLL++     LK+ 
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI 184
Query: 176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFP 235
           DFG A+        ++  + +R+YRAPEL+    NY T+ID+WS GC+ AEL+  +P+FP
Sbjct: 185 DFGSAKILIAGEPNVSX-ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243
Query: 236 GTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAID 294
           G   ++QL  II +LG+   E ++ + NP   ++    P     PFS+++ P   P AID
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTM-NPNYMEH--KFPQIRPHPFSKVFRPRTPPDAID 300
Query: 295 LLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLK 354
           L+ ++L + P+ R++  EAL HP+   L    +  P    +    +    E  +R  ++ 
Sbjct: 301 LISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLIS 360
Query: 355 EMLHYHPEA 363
            ++  H EA
Sbjct: 361 RLVPQHAEA 369

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 115/317 (36%), Positives = 173/317 (54%), Gaps = 28/317 (8%)
Query: 39  GRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRTLRELKLLRHLQHENVIALKD 96
           G+G +G V     + T   VAIKK+  +  F NR   L+ +++L +L    H N++ L+ 
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--ELQIMQDLAVL---HHPNIVQLQS 86
Query: 97  VMMPSHRRNFKDVYL--VYELMDTDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLH 150
                  R+ +D+YL  V E +   LH+  ++      A      + FLFQL+R +  LH
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 151 --SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
             S N+ HRD+KP N+LVN A+  LK+CDFG A+  +  ++    Y+ +R+YRAPEL+  
Sbjct: 147 LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICSRYYRAPELIFG 205
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
             +Y T++D+WSVGCIFAE++  +PIF G     QL  I+ +LG    E L  + NP   
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL-NPSHT 264
Query: 268 KYIKSLPYTPGTPFSRLYPDAHPL-----AIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
                L  + G P+S ++ D H L     A DLL  +L + P +R+   EAL HPY   L
Sbjct: 265 DV--DLYNSKGIPWSNVFSD-HSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321
Query: 323 YDPSSNPP--AQVPIDL 337
           +DP++  P    +P DL
Sbjct: 322 HDPATKLPNNKDLPEDL 338

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 115/322 (35%), Positives = 167/322 (51%), Gaps = 43/322 (13%)
Query: 38  IGRGAYGIV--CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           +GRG YG V      + + ++  A+K+I    E    ++   RE+ LLR L+H NVI+L+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 84
Query: 96  DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA---------LTNDHCQYFLFQLLRGL 146
            V +    R    V+L+++  + DL  IIK  +A         L     +  L+Q+L G+
Sbjct: 85  KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 147 KYLHSANILHRDLKPGNLLVNANC----DLKICDFGLARTSNGKNQFMTE---YVVTRWY 199
            YLH+  +LHRDLKP N+LV         +KI D G AR  N   + + +    VVT WY
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE---------CLNQLKLIINIL 250
           RAPELLL   +Y  +ID+W++GCIFAELL  +PIF   +           +QL  I N++
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261
Query: 251 GSRREEDLEFIDN-PKARKYIKSLPYTPGTPFSRL-YPDAHPL-----AIDLLQKMLVFD 303
           G   ++D E I   P+    +K       T  S + Y + H +     A  LLQK+L  D
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321
Query: 304 PTKRISVTEALQHPYMSPLYDP 325
           P KRI+  +A+Q PY   L DP
Sbjct: 322 PIKRITSEQAMQDPYF--LEDP 341

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 103/331 (31%), Positives = 173/331 (52%), Gaps = 49/331 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   K +G G++GIVC   + E+ ++ A+KK+        D     REL +++ L H N
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVN 61
Query: 91  VIALKDVM--------------------------MPSHRRNF-------KDVYLVYELMD 117
           +I L D                            + +H ++        K + ++ E + 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 118 TDLHQI----IKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-L 172
             LH++    I+S +++  +    +++QL R + ++HS  I HRD+KP NLLVN+  + L
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP 232
           K+CDFG A+     ++     + +R+YRAPEL+L    Y  SID+WS+GC+F EL+  KP
Sbjct: 182 KLCDFGSAKKLI-PSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 233 IFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHP-L 291
           +F G   ++QL  II I+G+  +E +  + NP   +     P      + ++ P+  P L
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRM-NPHYTEV--RFPTLKAKDWRKILPEGTPSL 297
Query: 292 AIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
           AIDLL+++L ++P  RI+  EA+ HP+   L
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/307 (30%), Positives = 167/307 (54%), Gaps = 40/307 (13%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           Y  ++ +GRG Y  V  ++N   NEKV +K +    +N++      RE+K+L +L+   N
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIK-----REIKILENLRGGPN 93
Query: 91  VIALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           +I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y 
Sbjct: 94  IITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 150 HSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           HS  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDY 206
Query: 209 DNYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID---- 262
             Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID    
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNI 263
Query: 263 --NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
             +P+        +RK  +   ++             P A+D L K+L +D   R++  E
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTARE 317
Query: 313 ALQHPYM 319
           A++HPY 
Sbjct: 318 AMEHPYF 324

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 147/294 (50%), Gaps = 41/294 (13%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +  +G+G++G V    +R T ++ A+K IN A     D    LRE++LL+ L H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++ L +++  S        Y+V EL        +IIK  +   +D  +  + Q+  G+ Y
Sbjct: 83  IMKLFEILEDSS-----SFYIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITY 136
Query: 149 LHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           +H  NI+HRDLKP N+L+ +   +CD+KI DFGL+ T   +N  M + + T +Y APE+L
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
                Y    DVWS G I   LL   P F G    + LK +                  +
Sbjct: 196 RGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------------------E 235
Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             KY   LP      +  +  DA     DL++KML F P+ RI+ T+ L+HP++
Sbjct: 236 TGKYAFDLP-----QWRTISDDAK----DLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 147/294 (50%), Gaps = 41/294 (13%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +  +G+G++G V    +R T ++ A+K IN A     D    LRE++LL+ L H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++ L +++  S        Y+V EL        +IIK  +   +D  +  + Q+  G+ Y
Sbjct: 83  IMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITY 136
Query: 149 LHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           +H  NI+HRDLKP N+L+ +   +CD+KI DFGL+ T   +N  M + + T +Y APE+L
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
                Y    DVWS G I   LL   P F G    + LK +                  +
Sbjct: 196 R--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------------------E 235
Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             KY   LP      +  +  DA     DL++KML F P+ RI+ T+ L+HP++
Sbjct: 236 TGKYAFDLP-----QWRTISDDAK----DLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/294 (32%), Positives = 147/294 (50%), Gaps = 41/294 (13%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +  +G+G++G V    +R T ++ A+K IN A     D    LRE++LL+ L H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++ L +++  S        Y+V EL        +IIK  +   +D  +  + Q+  G+ Y
Sbjct: 83  IMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAAR-IIKQVFSGITY 136
Query: 149 LHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           +H  NI+HRDLKP N+L+ +   +CD+KI DFGL+ T   +N  M + + T +Y APE+L
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-TCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
                Y    DVWS G I   LL   P F G    + LK +                  +
Sbjct: 196 R--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------------------E 235
Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             KY   LP      +  +  DA     DL++KML F P+ RI+ T+ L+HP++
Sbjct: 236 TGKYAFDLP-----QWRTISDDAK----DLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 92/326 (28%), Positives = 166/326 (50%), Gaps = 42/326 (12%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           +  +Y  +K IG+G++G V  + + + ++ VA+K + N       A   +R L+ LR   
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRG 145
            +N + +  ++     RN   + + +EL+  +L+++IK +  Q  +    + F   +L+ 
Sbjct: 155 KDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 146 LKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           L  LH   I+H DLKP N+L+       +K+ DFG   +S  ++Q +   + +R+YRAPE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTXIQSRFYRAPE 269
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           ++L    YG  ID+WS+GCI AELL   P+ PG +  +QL  +I +LG   ++ L+   +
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD--AS 326
Query: 264 PKARKYIKSLPY-------------------------TPGTPFSRLYPDA-----HPLAI 293
            +A+ ++    Y                           G P SR + +A      PL +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 294 DLLQKMLVFDPTKRISVTEALQHPYM 319
           D L++ L +DP  R++  +AL+HP++
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 92/326 (28%), Positives = 166/326 (50%), Gaps = 42/326 (12%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           +  +Y  +K IG+G++G V  + + + ++ VA+K + N       A   +R L+ LR   
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRG 145
            +N + +  ++     RN   + + +EL+  +L+++IK +  Q  +    + F   +L+ 
Sbjct: 155 KDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 146 LKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           L  LH   I+H DLKP N+L+       +K+ DFG   +S  ++Q +   + +R+YRAPE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTXIQSRFYRAPE 269
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           ++L    YG  ID+WS+GCI AELL   P+ PG +  +QL  +I +LG   ++ L+   +
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD--AS 326
Query: 264 PKARKYIKSLPY-------------------------TPGTPFSRLYPDA-----HPLAI 293
            +A+ ++    Y                           G P SR + +A      PL +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 294 DLLQKMLVFDPTKRISVTEALQHPYM 319
           D L++ L +DP  R++  +AL+HP++
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  127 bits (320), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 92/326 (28%), Positives = 165/326 (50%), Gaps = 42/326 (12%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           +  +Y  +K IG+G +G V  + + + ++ VA+K + N       A   +R L+ LR   
Sbjct: 95  VAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRG 145
            +N + +  ++     RN   + + +EL+  +L+++IK +  Q  +    + F   +L+ 
Sbjct: 155 KDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 146 LKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           L  LH   I+H DLKP N+L+       +K+ DFG   +S  ++Q +   + +R+YRAPE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYXXIQSRFYRAPE 269
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           ++L    YG  ID+WS+GCI AELL   P+ PG +  +QL  +I +LG   ++ L+   +
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLD--AS 326
Query: 264 PKARKYIKSLPY-------------------------TPGTPFSRLYPDA-----HPLAI 293
            +A+ ++    Y                           G P SR + +A      PL +
Sbjct: 327 KRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386
Query: 294 DLLQKMLVFDPTKRISVTEALQHPYM 319
           D L++ L +DP  R++  +AL+HP++
Sbjct: 387 DFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 164/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKVA+K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N+L++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 93/315 (29%), Positives = 162/315 (51%), Gaps = 32/315 (10%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NE+V +K +      +    R ++ L+ LR     N+
Sbjct: 40  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPV--KKKKIKREVKILENLR--GGTNI 95
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D +        K   LV+E ++ TD  Q+    Q LT+   ++++++LL+ L Y H
Sbjct: 96  IKLIDTVKDPVS---KTPALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDYCH 149
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR-VASRYFKGPELLVDYQ 208
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRR----------EEDL 258
            Y  S+D+WS+GC+ A ++ R+ P F G +  +QL  I  +LG+            + D 
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDP 268
Query: 259 EFID--NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
            F D     +RK  ++  ++             P A+DLL K+L +D  +R++  EA++H
Sbjct: 269 HFNDILGQHSRKRWENFIHSENRHL------VSPEALDLLDKLLRYDHQQRLTAKEAMEH 322
Query: 317 PYMSPLYDPSSNPPA 331
           PY  P+    S P A
Sbjct: 323 PYFYPVVKEQSQPSA 337

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 96/318 (30%), Positives = 168/318 (52%), Gaps = 38/318 (11%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYMSPLYDPSSNPPA 331
           ++HPY  P+    S P A
Sbjct: 319 MEHPYFYPVVKEQSQPCA 336

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 146/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVD-ALRTLRELKLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+            D AL    E+++L+
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
            L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + +Q+L
Sbjct: 77  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 130
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T  Y 
Sbjct: 131 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYL 189
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE+L+      Y  ++D WS+G I    L   P F                 S     +
Sbjct: 190 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHRTQV 232
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              D   + KY     + P      ++ +    A+DL++K+LV DP  R +  EAL+HP+
Sbjct: 233 SLKDQITSGKY----NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 283
Query: 319 M 319
           +
Sbjct: 284 L 284

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 155/306 (50%), Gaps = 32/306 (10%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V   +N   NEK  IK +    +             L   +   N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLMGGPNI 88
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED-- 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ H
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 317 PYMSPL 322
           PY   +
Sbjct: 316 PYFQQV 321

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 146/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVD-ALRTLRELKLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+            D AL    E+++L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
            L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + +Q+L
Sbjct: 71  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T  Y 
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYL 183
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE+L+      Y  ++D WS+G I    L   P F                 S     +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHRTQV 226
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              D   + KY     + P      ++ +    A+DL++K+LV DP  R +  EAL+HP+
Sbjct: 227 SLKDQITSGKY----NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 319 M 319
           +
Sbjct: 278 L 278

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 146/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVD-ALRTLRELKLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+            D AL    E+++L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
            L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + +Q+L
Sbjct: 71  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T  Y 
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYL 183
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE+L+      Y  ++D WS+G I    L   P F                 S     +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHRTQV 226
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              D   + KY     + P      ++ +    A+DL++K+LV DP  R +  EAL+HP+
Sbjct: 227 SLKDQITSGKY----NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 319 M 319
           +
Sbjct: 278 L 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 146/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVD-ALRTLRELKLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+            D AL    E+++L+
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
            L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + +Q+L
Sbjct: 70  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 123
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T  Y 
Sbjct: 124 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYL 182
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE+L+      Y  ++D WS+G I    L   P F                 S     +
Sbjct: 183 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHRTQV 225
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              D   + KY     + P      ++ +    A+DL++K+LV DP  R +  EAL+HP+
Sbjct: 226 SLKDQITSGKY----NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 276
Query: 319 M 319
           +
Sbjct: 277 L 277

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 146/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVD-ALRTLRELKLLR 84
           +Y+  K +G GA G V  +  R+T +KVAIK I+            D AL    E+++L+
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
            L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + +Q+L
Sbjct: 71  KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T  Y 
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYL 183
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE+L+      Y  ++D WS+G I    L   P F                 S     +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHRTQV 226
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              D   + KY     + P      ++ +    A+DL++K+LV DP  R +  EAL+HP+
Sbjct: 227 SLKDQITSGKY----NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277
Query: 319 M 319
           +
Sbjct: 278 L 278

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 91/312 (29%), Positives = 160/312 (51%), Gaps = 32/312 (10%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NE+V +K +      +    R ++ L+ LR     N+
Sbjct: 45  YQLVRKLGRGKYSEVFEAINITNNERVVVKILKPV--KKKKIKREVKILENLR--GGTNI 100
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D +        K   LV+E ++ TD  Q+    Q LT+   ++++++LL+ L Y H
Sbjct: 101 IKLIDTVKDPVS---KTPALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDYCH 154
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR-VASRYFKGPELLVDYQ 213
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRR----------EEDL 258
            Y  S+D+WS+GC+ A ++ R+ P F G +  +QL  I  +LG+            + D 
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDP 273
Query: 259 EFID--NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
            F D     +RK  ++  ++             P A+DLL K+L +D  +R++  EA++H
Sbjct: 274 HFNDILGQHSRKRWENFIHSENRHL------VSPEALDLLDKLLRYDHQQRLTAKEAMEH 327
Query: 317 PYMSPLYDPSSN 328
           PY  P+    S 
Sbjct: 328 PYFYPVVKEQSQ 339

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 162/307 (52%), Gaps = 34/307 (11%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           Y  ++ +GRG Y  V   +N   NEK  IK +           +  RE+K+L++L    N
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVK-----KKKIKREIKILQNLXGGPN 87
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++ L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y H
Sbjct: 88  IVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 151 SANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQ 201
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED- 257
           +Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 258 -LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ 
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 316 HPYMSPL 322
           HPY   +
Sbjct: 315 HPYFQQV 321

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 162/307 (52%), Gaps = 34/307 (11%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           Y  ++ +GRG Y  V   +N   NEK  IK +           +  RE+K+L++L    N
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVK-----KKKIKREIKILQNLXGGPN 88
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++ L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y H
Sbjct: 89  IVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCH 143
Query: 151 SANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQ 202
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED- 257
           +Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D 
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 258 -LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ 
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMT 315
Query: 316 HPYMSPL 322
           HPY   +
Sbjct: 316 HPYFQQV 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 162/307 (52%), Gaps = 34/307 (11%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           Y  ++ +GRG Y  V   +N   NEK  IK +           +  RE+K+L++L    N
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVK-----KKKIKREIKILQNLXGGPN 87
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++ L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y H
Sbjct: 88  IVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 151 SANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQ 201
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED- 257
           +Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 258 -LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ 
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 316 HPYMSPL 322
           HPY   +
Sbjct: 315 HPYFQQV 321

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 162/307 (52%), Gaps = 34/307 (11%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           Y  ++ +GRG Y  V   +N   NEK  IK +           +  RE+K+L++L    N
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVK-----KKKIKREIKILQNLXGGPN 87
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++ L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y H
Sbjct: 88  IVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCH 142
Query: 151 SANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQ 201
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED- 257
           +Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 258 -LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ 
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMT 314
Query: 316 HPYMSPL 322
           HPY   +
Sbjct: 315 HPYFQQV 321

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 162/307 (52%), Gaps = 34/307 (11%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           Y  ++ +GRG Y  V   +N   NEK  IK +           +  RE+K+L++L    N
Sbjct: 54  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVK-----KKKIKREIKILQNLXGGPN 108
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++ L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y H
Sbjct: 109 IVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCH 163
Query: 151 SANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 164 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQ 222
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED- 257
           +Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D 
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDP 282
Query: 258 -LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ 
Sbjct: 283 QLEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMT 335
Query: 316 HPYMSPL 322
           HPY   +
Sbjct: 336 HPYFQQV 342

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 154/306 (50%), Gaps = 32/306 (10%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V   +N   NEK  IK +    +             L       N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 88
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED-- 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ H
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 317 PYMSPL 322
           PY   +
Sbjct: 316 PYFQQV 321

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 154/306 (50%), Gaps = 32/306 (10%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V   +N   NEK  IK +    +             L       N+
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 89
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y HS
Sbjct: 90  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 144
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   +
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 203
Query: 211 YGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED-- 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D  
Sbjct: 204 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 263
Query: 258 LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ H
Sbjct: 264 LEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 317 PYMSPL 322
           PY   +
Sbjct: 317 PYFQQV 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 154/306 (50%), Gaps = 32/306 (10%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V   +N   NEK  IK +    +             L       N+
Sbjct: 35  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 90
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y HS
Sbjct: 91  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 145
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   +
Sbjct: 146 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 204
Query: 211 YGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED-- 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D  
Sbjct: 205 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 264
Query: 258 LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ H
Sbjct: 265 LEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMTH 317
Query: 317 PYMSPL 322
           PY   +
Sbjct: 318 PYFQQV 323

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/306 (29%), Positives = 154/306 (50%), Gaps = 32/306 (10%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V   +N   NEK  IK +    +             L       N+
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNI 88
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
           + L D++   H    K   L++E ++    +++  +  LT+   +Y++++LL+ L Y HS
Sbjct: 89  VKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYCHS 143
Query: 152 ANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
             I+HRD+KP N++++     L++ D+GLA   +   ++    V +R+++ PELL+   +
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPELLVDLQD 202
Query: 211 YGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGS----------RREED-- 257
           Y  S+D+WS+GC+FA ++ RK P F G +  +QL  I  +LG+          R E D  
Sbjct: 203 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQ 262
Query: 258 LEFIDNPKARK-YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           LE +    +RK ++K +        S       P AID L K+L +D  +R++  EA+ H
Sbjct: 263 LEALVGRHSRKPWLKFMNADNQHLVS-------PEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 317 PYMSPL 322
           PY   +
Sbjct: 316 PYFQQV 321

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 93
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 94  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 147
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 206
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 263
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 317
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 318 MEHPYF 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 94
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 95  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 148
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 207
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 319 MEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 44  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 99
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 100 ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 153
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 212
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 269
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 270 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 323
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 324 MEHPYF 329

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 93
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 94  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 147
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 206
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 263
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 317
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 318 MEHPYF 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 92/306 (30%), Positives = 163/306 (53%), Gaps = 38/306 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +GRG Y  V  ++N   NEKV +K +    + +    R ++ L+ LR     N+
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLR--GGPNI 92
Query: 92  IALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D++     R      LV+E + +TD  Q+    Q LT+   +++++++L+ L Y H
Sbjct: 93  ITLADIVKDPVSRTPA---LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 151 SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           S  I+HRD+KP N++++  +  L++ D+GLA   +   ++    V +R+++ PELL+   
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-VASRYFKGPELLVDYQ 205
Query: 210 NYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDL-EFID----- 262
            Y  S+D+WS+GC+ A ++ RK P F G +  +QL  I  +LG+   EDL ++ID     
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 262
Query: 263 -NPK--------ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            +P+        +RK  +   ++             P A+D L K+L +D   R++  EA
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHL------VSPEALDFLDKLLRYDHQSRLTAREA 316
Query: 314 LQHPYM 319
           ++HPY 
Sbjct: 317 MEHPYF 322

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 146/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVD-ALRTLRELKLLR 84
           +Y+  K +G GA G V  +  R+T +KVAI+ I+            D AL    E+++L+
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
            L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + +Q+L
Sbjct: 210 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 263
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T  Y 
Sbjct: 264 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYL 322
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE+L+      Y  ++D WS+G I    L   P F                 S     +
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHRTQV 365
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              D   + KY     + P      ++ +    A+DL++K+LV DP  R +  EAL+HP+
Sbjct: 366 SLKDQITSGKY----NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 416
Query: 319 M 319
           +
Sbjct: 417 L 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 146/301 (48%), Gaps = 45/301 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-----AFENRVD-ALRTLRELKLLR 84
           +Y+  K +G GA G V  +  R+T +KVAI+ I+            D AL    E+++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
            L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + +Q+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T  Y 
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYL 308
Query: 201 APELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE+L+      Y  ++D WS+G I    L   P F                 S     +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF-----------------SEHRTQV 351
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              D   + KY     + P      ++ +    A+DL++K+LV DP  R +  EAL+HP+
Sbjct: 352 SLKDQITSGKY----NFIP-----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402
Query: 319 M 319
           +
Sbjct: 403 L 403

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 142/292 (48%), Gaps = 42/292 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA-LRTLRELKLLRHLQHEN 90
           Y+  + +G G++G V  + + +T +KVA+K I+     + D  +R  RE+  L+ L+H +
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +I L DV+         D+ +V E    +L   I   + +T D  + F  Q++  ++Y H
Sbjct: 71  IIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH 125
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLKP NLL++ N ++KI DFGL+      N F+     +  Y APE++     
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVINGKLY 184
Query: 211 YGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            G  +DVWS G + +  L+GR P                        D EFI  P   K 
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPF-----------------------DDEFI--PNLFKK 219
Query: 270 IKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           + S  Y        + PD   P A  L+++M+V DP +RI++ E  + P+ +
Sbjct: 220 VNSCVY--------VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 138/297 (46%), Gaps = 43/297 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K +G GAYG V    ++ T+ + AIK I     +     + L E+ +L+ L H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 92  IALKDVMMPSHRRNFKDVYLVY---ELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           + L D      +RN+  V   Y   EL D  +H++               + Q+L G+ Y
Sbjct: 99  MKLYDFF--EDKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTY 151
Query: 149 LHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           LH  NI+HRDLKP NLL+ +   +  +KI DFGL+     + + M E + T +Y APE+L
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPEVL 210
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
                Y    DVWS+G I   LL   P F G                         D   
Sbjct: 211 R--KKYDEKCDVWSIGVILFILLAGYPPFGGQ-----------------------TDQEI 245
Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
            RK  K   YT  +P    + +    A DL+++ML FD  +RIS  +AL+HP++  +
Sbjct: 246 LRKVEKG-KYTFDSP---EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 91/332 (27%), Positives = 155/332 (46%), Gaps = 45/332 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHL 86
           +  +Y  +  +G GA+G V   ++ +   + VA+K + N  +   +A R+  E+++L HL
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHL 68
Query: 87  QHEN-VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL--TNDHCQYFLFQLL 143
              +     + V M     +   + +V+EL+    +  IK +  L    DH +   +Q+ 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA-------------------NCDLKICDFGLARTSN 184
           + + +LHS  + H DLKP N+L                      N D+K+ DFG   ++ 
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SAT 185
Query: 185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK 244
             ++  +  V TR YRAPE++L    +    DVWS+GCI  E      +FP  +    L 
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 245 LIINILG---------SRR-----EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHP 290
           ++  ILG         +R+      + L++ ++  A +Y+ S    P   F       H 
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV-SRACKPLKEFMLSQDVEHE 303
Query: 291 LAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
              DL+QKML +DP KRI++ EAL+HP+   L
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 101/351 (28%), Positives = 170/351 (48%), Gaps = 61/351 (17%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN--AFENRVDALRTLRE 79
           W   +EID+       IG+G++G V  + +R   E VAIK I N  AF N+        E
Sbjct: 33  WMDRYEIDS------LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----E 81
Query: 80  LKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQ 136
           ++LL  + +H+  +    V +  H      + LV+E++  +L+ +++++  + ++ +  +
Sbjct: 82  VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR 141
Query: 137 YFLFQLLRGLKYLHS--ANILHRDLKPGNLLVN--ANCDLKICDFGLARTSNGKNQFMTE 192
            F  Q+   L +L +   +I+H DLKP N+L+       +KI DFG   +S    Q + +
Sbjct: 142 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQ 198
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
            + +R+YR+PE+LL    Y  +ID+WS+GCI  E+   +P+F G   ++Q+  I+ +LG 
Sbjct: 199 XIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 257
Query: 253 RREEDLEFIDNPKARKYIKSLP---------------YTP--------------GTPFSR 283
                L+    PKARK+ + LP               Y P              G P  R
Sbjct: 258 PPAHILD--QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 315
Query: 284 LYPDA-HPLA-----IDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
              ++ H +A      DL+ +ML +DP  RI    ALQH +     D  +N
Sbjct: 316 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGTN 366

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/332 (27%), Positives = 154/332 (46%), Gaps = 45/332 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHL 86
           +  +Y  +  +G GA+G V   ++ +   + VA+K + N  +   +A R+  E+++L HL
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHL 68
Query: 87  QHEN-VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL--TNDHCQYFLFQLL 143
              +     + V M     +   + +V+EL+    +  IK +  L    DH +   +Q+ 
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA-------------------NCDLKICDFGLARTSN 184
           + + +LHS  + H DLKP N+L                      N D+K+ DFG   ++ 
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SAT 185
Query: 185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK 244
             ++  +  V  R YRAPE++L    +    DVWS+GCI  E      +FP  +    L 
Sbjct: 186 YDDEHHSTLVXXRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 245 LIINILG---------SRR-----EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHP 290
           ++  ILG         +R+      + L++ ++  A +Y+ S    P   F       H 
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV-SRACKPLKEFMLSQDVEHE 303
Query: 291 LAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
              DL+QKML +DP KRI++ EAL+HP+   L
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 142/306 (46%), Gaps = 37/306 (12%)
Query: 18  YYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL 77
           Y+    T       Y   + +G+GA+ +V   V +   ++ A K IN    +  D  +  
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 78  RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQ 136
           RE ++ R L+H N++ L D +       F   YLV++L+   +L + I + +  +     
Sbjct: 79  REARICRLLKHPNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADAS 133
Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEY 193
           + + Q+L  + ++H  +I+HRDLKP NLL+ + C    +K+ DFGLA    G+ Q    +
Sbjct: 134 HCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGF 193
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
             T  Y +PE+L   D YG  +D+W+ G I   LL   P F                   
Sbjct: 194 AGTPGYLSPEVLR-KDPYGKPVDIWACGVILYILLVGYPPFWDE---------------- 236
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                   D  K  + IK+  Y   +P    +    P A +L+ +ML  +P KRI+  +A
Sbjct: 237 --------DQHKLYQQIKAGAYDFPSP---EWDTVTPEAKNLINQMLTINPAKRITADQA 285
Query: 314 LQHPYM 319
           L+HP++
Sbjct: 286 LKHPWV 291

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 100/347 (28%), Positives = 168/347 (48%), Gaps = 61/347 (17%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN--AFENRVDALRTLRE 79
           W   +EID+       IG+G++G V  + +R   E VAIK I N  AF N+        E
Sbjct: 52  WMDRYEIDS------LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----E 100
Query: 80  LKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQ 136
           ++LL  + +H+  +    V +  H      + LV+E++  +L+ +++++  + ++ +  +
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR 160
Query: 137 YFLFQLLRGLKYLHS--ANILHRDLKPGNLLVN--ANCDLKICDFGLARTSNGKNQFMTE 192
            F  Q+   L +L +   +I+H DLKP N+L+       +KI DFG   +S    Q + +
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQ 217
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
            + +R+YR+PE+LL    Y  +ID+WS+GCI  E+   +P+F G   ++Q+  I+ +LG 
Sbjct: 218 XIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276
Query: 253 RREEDLEFIDNPKARKYIKSLP---------------YTP--------------GTPFSR 283
                L+    PKARK+ + LP               Y P              G P  R
Sbjct: 277 PPAHILD--QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGR 334
Query: 284 LYPDA-HPLA-----IDLLQKMLVFDPTKRISVTEALQHPYMSPLYD 324
              ++ H +A      DL+ +ML +DP  RI    ALQH +     D
Sbjct: 335 RAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 101/350 (28%), Positives = 170/350 (48%), Gaps = 67/350 (19%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN--AFENRVDALRTLRE 79
           W   +EID+       IG+G++G V  + +R   E VAIK I N  AF N+        E
Sbjct: 52  WMDRYEIDS------LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----E 100
Query: 80  LKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQ 136
           ++LL  + +H+  +    V +  H      + LV+E++  +L+ +++++  + ++ +  +
Sbjct: 101 VRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR 160
Query: 137 YFLFQLLRGLKYLHS--ANILHRDLKPGNLLVNANCD-----LKICDFGLARTSNGKNQF 189
            F  Q+   L +L +   +I+H DLKP N+L+   C+     +KI DFG   +S    Q 
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILL---CNPKRXAIKIVDFG---SSCQLGQR 214
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
           + + + +R+YR+PE+LL    Y  +ID+WS+GCI  E+   +P+F G   ++Q+  I+ +
Sbjct: 215 IYQXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273
Query: 250 LGSRREEDLEFIDNPKARKYIKSLP---------------YTP--------------GTP 280
           LG      L+    PKARK+ + LP               Y P              G P
Sbjct: 274 LGIPPAHILD--QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGP 331
Query: 281 FSRLYPDA-HPLA-----IDLLQKMLVFDPTKRISVTEALQHPYMSPLYD 324
             R   ++ H +A      DL+ +ML +DP  RI    ALQH +     D
Sbjct: 332 GGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 143/312 (45%), Gaps = 48/312 (15%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE----NRVDALR-- 75
           W    E   KY P   IGRG   +V   V+R T  + A+K +    E     +++ +R  
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 76  TLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTND 133
           T RE  +LR +  H ++I L D    S   +F  ++LV++LM   +L   +    AL+  
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESS---SF--MFLVFDLMRKGELFDYLTEKVALSEK 200
Query: 134 HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-RTSNGKNQFMTE 192
             +  +  LL  + +LH+ NI+HRDLKP N+L++ N  +++ DFG +     G+   + E
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRE 258
Query: 193 YVVTRWYRAPELLLCCDN-----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLII 247
              T  Y APE+L C  +     YG  +D+W+ G I   LL   P F     +  L++I+
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318
Query: 248 NILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
                               +Y  S P          + D      DL+ ++L  DP  R
Sbjct: 319 E------------------GQYQFSSPE---------WDDRSSTVKDLISRLLQVDPEAR 351
Query: 308 ISVTEALQHPYM 319
           ++  +ALQHP+ 
Sbjct: 352 LTAEQALQHPFF 363

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 273
Query: 328 NP 329
            P
Sbjct: 274 RP 275

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 227 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 328 NP 329
            P
Sbjct: 275 RP 276

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 273
Query: 328 NP 329
            P
Sbjct: 274 RP 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 68  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 181
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 182 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 234
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 235 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 270
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 271 HPWIKP 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 68  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 181
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 182 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 234
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 235 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 270
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 271 HPWIKP 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPA 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 227 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 328 NP 329
            P
Sbjct: 275 RP 276

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 227 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 328 NP 329
            P
Sbjct: 275 RP 276

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 227 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 328 NP 329
            P
Sbjct: 275 RP 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 227 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 328 NP 329
            P
Sbjct: 275 RP 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 96/307 (31%), Positives = 144/307 (46%), Gaps = 51/307 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRR 254
           + APE++    NY   G   D+WS+G I   LL G  P                 LG  +
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASP----------------FLGDTK 222
Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
           +E L    N  A  Y     Y         + +   LA D ++++LV DP KR+++ ++L
Sbjct: 223 QETLA---NVSAVNYEFEDEY---------FSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 315 QHPYMSP 321
           QHP++ P
Sbjct: 271 QHPWIKP 277

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 93/306 (30%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENR-VDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A   IKK       R V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +KI DFGLA   +  N+F   +  T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPE 182
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F G     + + + N+     E
Sbjct: 183 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 235
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            + E+  N  A                        LA D ++++LV DP KR+++ ++LQ
Sbjct: 236 FEDEYFSNTSA------------------------LAKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 316 HPYMSP 321
           HP++ P
Sbjct: 272 HPWIKP 277

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 273
Query: 328 NP 329
            P
Sbjct: 274 RP 275

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 273
Query: 328 NP 329
            P
Sbjct: 274 RP 275

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 227 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
Query: 328 NP 329
            P
Sbjct: 275 RP 276

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 273
Query: 328 NP 329
            P
Sbjct: 274 RP 275

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 91/302 (30%), Positives = 141/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 68  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 224
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 225 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 272
Query: 328 NP 329
            P
Sbjct: 273 RP 274

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 142/300 (47%), Gaps = 40/300 (13%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           +   +DVWS G +   +L  +   P  +  +  +              E+ D  + + Y+
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQ--------------EYSDWKEKKTYL 227
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSSNP 329
                    P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   +  P
Sbjct: 228 --------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 275

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 89/310 (28%), Positives = 144/310 (46%), Gaps = 51/310 (16%)
Query: 17  HYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT 76
           ++ SM+Q LFE          +G+GA+ +V   V     ++ A K IN    +  D  + 
Sbjct: 19  YFQSMYQ-LFE---------ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL 68
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHC 135
            RE ++ R L+H N++ L D +           YL+++L+   +L + I + +  +    
Sbjct: 69  EREARICRLLKHPNIVRLHDSISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADA 123
Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTE 192
            + + Q+L  + + H   ++HRDLKP NLL+ +      +K+ DFGLA    G+ Q    
Sbjct: 124 SHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 183
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
           +  T  Y +PE+L   D YG  +D+W+ G I   LL   P                    
Sbjct: 184 FAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILLVGYP-------------------- 222
Query: 253 RREEDLEFIDNPKARKY--IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
                  F D  + R Y  IK+  Y   +P    +    P A DL+ KML  +P+KRI+ 
Sbjct: 223 ------PFWDEDQHRLYQQIKAGAYDFPSP---EWDTVTPEAKDLINKMLTINPSKRITA 273
Query: 311 TEALQHPYMS 320
            EAL+HP++S
Sbjct: 274 AEALKHPWIS 283

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 43/282 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITI 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 43/282 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITI 255

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 43/282 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++
Sbjct: 227 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITI 256

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 43/282 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITI 255

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 43/282 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITI 255

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 43/282 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITI 255

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 37/293 (12%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y   + IG+GA+ +V   V   T  + A K IN    +  D  +  RE ++ R L+H N
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSN 64
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L D +       F   YLV++L+   +L + I + +  +     + + Q+L  + + 
Sbjct: 65  IVRLHDSIS---EEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 150 HSANILHRDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           H   ++HRDLKP NLL+ + C    +K+ DFGLA    G  Q    +  T  Y +PE+L 
Sbjct: 120 HQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             + YG  +D+W+ G I   LL   P F                           D  K 
Sbjct: 180 -KEAYGKPVDIWACGVILYILLVGYPPFWDE------------------------DQHKL 214
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            + IK+  Y   +P    +    P A +L+ +ML  +P KRI+  EAL+HP++
Sbjct: 215 YQQIKAGAYDFPSP---EWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 38/289 (13%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHEN 90
           Y  +K +G G++G V  + +  T +KVA+K IN     + D   R  RE+  LR L+H +
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +I L DV+     ++  ++ +V E    +L   I     ++    + F  Q++  ++Y H
Sbjct: 66  IIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLKP NLL++ + ++KI DFGL+      N F+     +  Y APE++     
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVISGKLY 179
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS G I   +L R+  F                      D E I  P   K I
Sbjct: 180 AGPEVDVWSCGVILYVMLCRRLPF----------------------DDESI--PVLFKNI 215
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            +  YT     S       P A  L+++ML+ +P  RIS+ E +Q  + 
Sbjct: 216 SNGVYTLPKFLS-------PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 257

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 38/289 (13%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHEN 90
           Y  +K +G G++G V  + +  T +KVA+K IN     + D   R  RE+  LR L+H +
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +I L DV+     ++  ++ +V E    +L   I     ++    + F  Q++  ++Y H
Sbjct: 70  IIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLKP NLL++ + ++KI DFGL+      N F+     +  Y APE++     
Sbjct: 125 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVISGKLY 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS G I   +L R+  F                      D E I  P   K I
Sbjct: 184 AGPEVDVWSCGVILYVMLCRRLPF----------------------DDESI--PVLFKNI 219
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            +  YT     S       P A  L+++ML+ +P  RIS+ E +Q  + 
Sbjct: 220 SNGVYTLPKFLS-------PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 261

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 138/295 (46%), Gaps = 41/295 (13%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y   + +G+GA+ +V   +   T ++ A K IN    +  D  +  RE ++ R L+H N
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L D +       F   YLV++L+   +L + I + +  +     + + Q+L  + + 
Sbjct: 65  IVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 150 HSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           H   I+HRDLKP NLL+   +    +K+ DFGLA    G  Q    +  T  Y +PE+L 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             D YG  +D+W+ G I   LL   P                           F D  + 
Sbjct: 180 -KDPYGKPVDMWACGVILYILLVGYP--------------------------PFWDEDQH 212
Query: 267 RKY--IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           R Y  IK+  Y   +P    +    P A DL+ KML  +P KRI+ +EAL+HP++
Sbjct: 213 RLYQQIKAGAYDFPSP---EWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 38/289 (13%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHEN 90
           Y  +K +G G++G V  + +  T +KVA+K IN     + D   R  RE+  LR L+H +
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +I L DV+     ++  ++ +V E    +L   I     ++    + F  Q++  ++Y H
Sbjct: 76  IIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLKP NLL++ + ++KI DFGL+      N F+     +  Y APE++     
Sbjct: 131 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVISGKLY 189
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS G I   +L R+  F                      D E I  P   K I
Sbjct: 190 AGPEVDVWSCGVILYVMLCRRLPF----------------------DDESI--PVLFKNI 225
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            +  YT     S       P A  L+++ML+ +P  RIS+ E +Q  + 
Sbjct: 226 SNGVYTLPKFLS-------PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 267

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 138/295 (46%), Gaps = 41/295 (13%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y   + +G+GA+ +V   +   T ++ A K IN    +  D  +  RE ++ R L+H N
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPN 64
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L D +       F   YLV++L+   +L + I + +  +     + + Q+L  + + 
Sbjct: 65  IVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 150 HSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           H   I+HRDLKP NLL+   +    +K+ DFGLA    G  Q    +  T  Y +PE+L 
Sbjct: 120 HLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             D YG  +D+W+ G I   LL   P                           F D  + 
Sbjct: 180 -KDPYGKPVDMWACGVILYILLVGYP--------------------------PFWDEDQH 212
Query: 267 RKY--IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           R Y  IK+  Y   +P    +    P A DL+ KML  +P KRI+ +EAL+HP++
Sbjct: 213 RLYQQIKAGAYDFPSP---EWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 38/289 (13%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHEN 90
           Y  +K +G G++G V  + +  T +KVA+K IN     + D   R  RE+  LR L+H +
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +I L DV+     ++  ++ +V E    +L   I     ++    + F  Q++  ++Y H
Sbjct: 75  IIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLKP NLL++ + ++KI DFGL+      N F+     +  Y APE++     
Sbjct: 130 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSCGSPNYAAPEVISGKLY 188
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS G I   +L R+  F                      D E I  P   K I
Sbjct: 189 AGPEVDVWSCGVILYVMLCRRLPF----------------------DDESI--PVLFKNI 224
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            +  YT     S       P A  L+++ML+ +P  RIS+ E +Q  + 
Sbjct: 225 SNGVYTLPKFLS-------PGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 133/282 (47%), Gaps = 43/282 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GAYG V  +VNR T E VA+K ++   +  VD    ++ E+ +   L HENV+ 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINAMLNHENVVK 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 70  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 226
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++
Sbjct: 227 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITI 256

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/320 (28%), Positives = 148/320 (46%), Gaps = 51/320 (15%)
Query: 13  SPGKHYYSMWQTLFEIDT-----KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-A 66
            PG H ++      +  T     +Y   + +G+G++G V    ++ T ++ A+K I+   
Sbjct: 27  GPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 86
Query: 67  FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD---VYLVYEL-MDTDLHQ 122
            + + D    LRE++LL+ L H N++ L +         F+D    YLV E+    +L  
Sbjct: 87  VKQKTDKESLLREVQLLKQLDHPNIMKLYEF--------FEDKGYFYLVGEVYTGGELFD 138
Query: 123 IIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL 179
            I S +  +       + Q+L G+ Y+H   I+HRDLKP NLL+ +   + +++I DFGL
Sbjct: 139 EIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 198
Query: 180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC 239
           + T    ++ M + + T +Y APE+L     Y    DVWS G I   LL   P F G   
Sbjct: 199 S-THFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANE 255
Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
            + LK +                  +  KY   LP          +      A DL++KM
Sbjct: 256 YDILKKV------------------EKGKYTFELPQ---------WKKVSESAKDLIRKM 288
Query: 300 LVFDPTKRISVTEALQHPYM 319
           L + P+ RIS  +AL H ++
Sbjct: 289 LTYVPSMRISARDALDHEWI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 91/320 (28%), Positives = 148/320 (46%), Gaps = 51/320 (15%)
Query: 13  SPGKHYYSMWQTLFEIDT-----KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-A 66
            PG H ++      +  T     +Y   + +G+G++G V    ++ T ++ A+K I+   
Sbjct: 28  GPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 87
Query: 67  FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD---VYLVYEL-MDTDLHQ 122
            + + D    LRE++LL+ L H N++ L +         F+D    YLV E+    +L  
Sbjct: 88  VKQKTDKESLLREVQLLKQLDHPNIMKLYEF--------FEDKGYFYLVGEVYTGGELFD 139
Query: 123 IIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL 179
            I S +  +       + Q+L G+ Y+H   I+HRDLKP NLL+ +   + +++I DFGL
Sbjct: 140 EIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 199
Query: 180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC 239
           + T    ++ M + + T +Y APE+L     Y    DVWS G I   LL   P F G   
Sbjct: 200 S-THFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANE 256
Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
            + LK +                  +  KY   LP          +      A DL++KM
Sbjct: 257 YDILKKV------------------EKGKYTFELPQ---------WKKVSESAKDLIRKM 289
Query: 300 LVFDPTKRISVTEALQHPYM 319
           L + P+ RIS  +AL H ++
Sbjct: 290 LTYVPSMRISARDALDHEWI 309

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 141/297 (47%), Gaps = 46/297 (15%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHE 89
           +Y   + +G+G++G V    ++ T ++ A+K I+    + + D    LRE++LL+ L H 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 90  NVIALKDVMMPSHRRNFKD---VYLVYEL-MDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
           N++ L +         F+D    YLV E+    +L   I S +  +       + Q+L G
Sbjct: 87  NIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + Y+H   I+HRDLKP NLL+ +   + +++I DFGL+ T    ++ M + + T +Y AP
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAP 197
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+L     Y    DVWS G I   LL   P F G    + LK +                
Sbjct: 198 EVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 239
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +  KY   LP          +      A DL++KML + P+ RIS  +AL H ++
Sbjct: 240 --EKGKYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 87/296 (29%), Positives = 137/296 (46%), Gaps = 44/296 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           YV  + IG G+Y      V++ TN + A+K I+ +  +  + +  L     LR+ QH N+
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL-----LRYGQHPNI 83
Query: 92  IALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I LKDV       + K VYLV ELM   +L   I   +  +     + L  + + ++YLH
Sbjct: 84  ITLKDVY-----DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 151 SANILHRDLKPGNLLV-----NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           S  ++HRDLKP N+L      N  C L+ICDFG A+    +N  +     T  + APE+L
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 206 LCCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
                Y    D+WS+G  ++  L G  P   G    +  + I+  +GS +          
Sbjct: 198 K-RQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSGK---------- 244
Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                      + G      +      A DL+ KML  DP +R++  + LQHP+++
Sbjct: 245 --------FTLSGGN-----WNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           YV  + IG G+Y      V++ TN + A+K I+ +  +  + +  L     LR+ QH N+
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL-----LRYGQHPNI 83
Query: 92  IALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I LKDV       + K VYLV ELM   +L   I   +  +     + L  + + ++YLH
Sbjct: 84  ITLKDVY-----DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 151 SANILHRDLKPGNLLV-----NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           S  ++HRDLKP N+L      N  C L+ICDFG A+    +N  +     T  + APE+L
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 197
Query: 206 LCCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
                Y    D+WS+G  ++  L G  P   G                  EE L  I + 
Sbjct: 198 K-RQGYDEGCDIWSLGILLYTMLAGYTPFANGPS-------------DTPEEILTRIGSG 243
Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           K          + G      +      A DL+ KML  DP +R++  + LQHP+++
Sbjct: 244 K-------FTLSGGN-----WNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 140/302 (46%), Gaps = 44/302 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIA 93
           ++ +G GA G V  +VNR T E VA+K ++   +  VD    ++ E+ + + L HENV+ 
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   HRR     YL  E     +L   I+    +     Q F  QL+ G+ YLH  
Sbjct: 69  FY-----GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL   + 
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF--PGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           +   +DVWS G +   +L  +  +  P   C                   E+ D  + + 
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------------------QEYSDWKEKKT 225
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPYMSPLYDPSS 327
           Y+         P+ ++  D+ PLA  LL K+LV +P+ RI++ +  +   Y  PL   + 
Sbjct: 226 YL--------NPWKKI--DSAPLA--LLHKILVENPSARITIPDIKKDRWYNKPLKKGAK 273
Query: 328 NP 329
            P
Sbjct: 274 RP 275

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 141/297 (47%), Gaps = 46/297 (15%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHE 89
           +Y   + +G+G++G V    ++ T ++ A+K I+    + + D    LRE++LL+ L H 
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 90  NVIALKDVMMPSHRRNFKD---VYLVYEL-MDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
           N++ L +         F+D    YLV E+    +L   I S +  +       + Q+L G
Sbjct: 93  NIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 144
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + Y+H   I+HRDLKP NLL+ +   + +++I DFGL+ T    ++ M + + T +Y AP
Sbjct: 145 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKMKDKIGTAYYIAP 203
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+L     Y    DVWS G I   LL   P F G    + LK +                
Sbjct: 204 EVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 245
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +  KY   LP          +      A DL++KML + P+ RIS  +AL H ++
Sbjct: 246 --EKGKYTFELPQ---------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 141/293 (48%), Gaps = 45/293 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT---LRELKLLRHLQHENVIAL 94
           IG+GA+ +V   +NRET ++ A+K ++ A       L T    RE  +   L+H +++ L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 95  KDVMMPSHRRNFKDVYLVYELMD-TDL-HQIIKSSQA---LTNDHCQYFLFQLLRGLKYL 149
            +            +Y+V+E MD  DL  +I+K + A    +     +++ Q+L  L+Y 
Sbjct: 92  LETYSSDGM-----LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           H  NI+HRD+KP N+L+ +   +  +K+ DFG+A             V T  + APE++ 
Sbjct: 147 HDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             + YG  +DVW  G I   LL     F GT    + +L   I+  +      +  NP+ 
Sbjct: 207 -REPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGK------YKMNPRQ 255
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +I                     A DL+++ML+ DP +RI+V EAL HP++
Sbjct: 256 WSHISE------------------SAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIALKD 96
           +G+G +       + +T E  A K +  +   +      +  E+ + R L H++V+    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 97  VMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                    F+D   V++V EL     L ++ K  +ALT    +Y+L Q++ G +YLH  
Sbjct: 89  F--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRDLK GNL +N + ++KI DFGLA       +       T  Y APE +L    + 
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHS 199
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +DVWS+GCI   LL  KP F  T CL +  L I                 K  +Y  S
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI-----------------KKNEY--S 239
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNP 329
           +P              +P+A  L+QKML  DPT R ++ E L   + +  Y P+  P
Sbjct: 240 IP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 285

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIALKD 96
           +G+G +       + +T E  A K +  +   +      +  E+ + R L H++V+    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 97  VMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                    F+D   V++V EL     L ++ K  +ALT    +Y+L Q++ G +YLH  
Sbjct: 85  F--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRDLK GNL +N + ++KI DFGLA       +       T  Y APE +L    + 
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHS 195
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +DVWS+GCI   LL  KP F  T CL +  L I                 K  +Y  S
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI-----------------KKNEY--S 235
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNP 329
           +P              +P+A  L+QKML  DPT R ++ E L   + +  Y P+  P
Sbjct: 236 IP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 281

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIALKD 96
           +G+G +       + +T E  A K +  +   +      +  E+ + R L H++V+    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 97  VMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                    F+D   V++V EL     L ++ K  +ALT    +Y+L Q++ G +YLH  
Sbjct: 85  F--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRDLK GNL +N + ++KI DFGLA       +       T  Y APE +L    + 
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKGHS 195
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +DVWS+GCI   LL  KP F  T CL +  L I                 K  +Y  S
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI-----------------KKNEY--S 235
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNP 329
           +P              +P+A  L+QKML  DPT R ++ E L   + +  Y P+  P
Sbjct: 236 IP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 281

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIALKD 96
           +G+G +       + +T E  A K +  +   +      +  E+ + R L H++V+    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 97  VMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                    F+D   V++V EL     L ++ K  +ALT    +Y+L Q++ G +YLH  
Sbjct: 109 F--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRDLK GNL +N + ++KI DFGLA       +       T  Y APE +L    + 
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHS 219
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +DVWS+GCI   LL  KP F  T CL +  L I                 K  +Y  S
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI-----------------KKNEY--S 259
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNP 329
           +P              +P+A  L+QKML  DPT R ++ E L   + +  Y P+  P
Sbjct: 260 IPK-----------HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 305

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/339 (24%), Positives = 150/339 (44%), Gaps = 52/339 (15%)
Query: 6   EPPNGIRSPGKHYYSMWQTLFEIDTKYV--PIKP---------IGRGAYGIVCSSVNRET 54
           E P G RSP +    +    F    + V  P  P         IG G+ GIVC +  R +
Sbjct: 116 EKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSS 175
Query: 55  NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE 114
            + VA+KK++   + R + L    E+ ++R  QHENV+ + +  +        ++++V E
Sbjct: 176 GKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVME 228
Query: 115 LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
            ++      I +   +  +        +L+ L  LH+  ++HRD+K  ++L+  +  +K+
Sbjct: 229 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL 288
Query: 175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
            DFG     + +       V T ++ APEL+     YG  +D+WS+G +  E++  +P +
Sbjct: 289 SDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPY 347
Query: 235 PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAID 294
                L  +K+I + L             P+ +   K  P   G                
Sbjct: 348 FNEPPLKAMKMIRDNL------------PPRLKNLHKVSPSLKG---------------- 379
Query: 295 LLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQV 333
            L ++LV DP +R +  E L+HP+++      + PPA +
Sbjct: 380 FLDRLLVRDPAQRATAAELLKHPFLA-----KAGPPASI 413

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIALKD 96
           +G+G +       + +T E  A K +  +   +      +  E+ + R L H++V+    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 97  VMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                    F+D   V++V EL     L ++ K  +ALT    +Y+L Q++ G +YLH  
Sbjct: 107 F--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRDLK GNL +N + ++KI DFGLA       +       T  Y APE +L    + 
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHS 217
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +DVWS+GCI   LL  KP F  T CL +  L I                 K  +Y  S
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI-----------------KKNEY--S 257
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNP 329
           +P              +P+A  L+QKML  DPT R ++ E L   + +  Y P+  P
Sbjct: 258 IP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 303

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 96/302 (31%), Positives = 138/302 (45%), Gaps = 50/302 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL 86
           +  +Y  +K +G GAYG V    ++ T  + AIK I  ++     ++   L E+ +L+ L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            H N++ L +      +RN+   YLV E+    +L   I   Q  +       + Q+L G
Sbjct: 79  DHPNIMKLYEFF--EDKRNY---YLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSG 133
Query: 146 LKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR--TSNGKNQFMTEYVVTRWYR 200
             YLH  NI+HRDLKP NLL+ +      +KI DFGL+      GK   M E + T +Y 
Sbjct: 134 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTAYYI 190
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE+L     Y    DVWS G I   LL   P F G      LK         R E  +F
Sbjct: 191 APEVLR--KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILK---------RVEKGKF 239
Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPL---AIDLLQKMLVFDPTKRISVTEALQHP 317
             +P                     PD   +   A  L++ ML ++P+KRIS  EAL HP
Sbjct: 240 SFDP---------------------PDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHP 278
Query: 318 YM 319
           ++
Sbjct: 279 WI 280

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/303 (29%), Positives = 140/303 (46%), Gaps = 47/303 (15%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFE-NRVDALR--TLRELKLLR 84
           Y P + +GRG   +V   +++ T ++ A+K I+     +F    V  LR  TL+E+ +LR
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 85  HLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
            +  H N+I LKD         F   +LV++LM   +L   +     L+    +  +  L
Sbjct: 66  KVSGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +   +   + + E   T  Y AP
Sbjct: 121 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLAP 179
Query: 203 ELLLCCDN-----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
           E++ C  N     YG  +D+WS G I   LL   P F   + +  L++I+          
Sbjct: 180 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM---------- 229
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                         S  Y  G+P    Y D      DL+ + LV  P KR +  EAL HP
Sbjct: 230 --------------SGNYQFGSPEWDDYSDT---VKDLVSRFLVVQPQKRYTAEEALAHP 272
Query: 318 YMS 320
           +  
Sbjct: 273 FFQ 275

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 140/302 (46%), Gaps = 47/302 (15%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFE-NRVDALR--TLRELKLLR 84
           Y P + +GRG   +V   +++ T ++ A+K I+     +F    V  LR  TL+E+ +LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 85  HLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
            +  H N+I LKD         F   +LV++LM   +L   +     L+    +  +  L
Sbjct: 79  KVSGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +   +   + + E   T  Y AP
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLAP 192
Query: 203 ELLLCCDN-----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
           E++ C  N     YG  +D+WS G I   LL   P F   + +  L++I+          
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM---------- 242
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                         S  Y  G+P    Y D      DL+ + LV  P KR +  EAL HP
Sbjct: 243 --------------SGNYQFGSPEWDDYSDT---VKDLVSRFLVVQPQKRYTAEEALAHP 285
Query: 318 YM 319
           + 
Sbjct: 286 FF 287

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 135/297 (45%), Gaps = 45/297 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIALKD 96
           +G+G +       + +T E  A K +  +   +      +  E+ + R L H++V+    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 97  VMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                    F+D   V++V EL     L ++ K  +ALT    +Y+L Q++ G +YLH  
Sbjct: 83  F--------FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRDLK GNL +N + ++KI DFGLA       +       T  Y APE +L    + 
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHS 193
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +DVWS+GCI   LL  KP F  T CL +  L I                 K  +Y  S
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRI-----------------KKNEY--S 233
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNP 329
           +P              +P+A  L+QKML  DPT R ++ E L   + +  Y P+  P
Sbjct: 234 IP-----------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 279

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 82/339 (24%), Positives = 150/339 (44%), Gaps = 52/339 (15%)
Query: 6   EPPNGIRSPGKHYYSMWQTLFEIDTKYV--PIKP---------IGRGAYGIVCSSVNRET 54
           E P G RSP +    +    F    + V  P  P         IG G+ GIVC +  R +
Sbjct: 39  EKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSS 98
Query: 55  NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE 114
            + VA+KK++   + R + L    E+ ++R  QHENV+ + +  +        ++++V E
Sbjct: 99  GKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVME 151
Query: 115 LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
            ++      I +   +  +        +L+ L  LH+  ++HRD+K  ++L+  +  +K+
Sbjct: 152 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL 211
Query: 175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
            DFG     + +       V T ++ APEL+     YG  +D+WS+G +  E++  +P +
Sbjct: 212 SDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPY 270
Query: 235 PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAID 294
                L  +K+I + L             P+ +   K  P   G                
Sbjct: 271 FNEPPLKAMKMIRDNL------------PPRLKNLHKVSPSLKG---------------- 302
Query: 295 LLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQV 333
            L ++LV DP +R +  E L+HP+++      + PPA +
Sbjct: 303 FLDRLLVRDPAQRATAAELLKHPFLA-----KAGPPASI 336

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 142/307 (46%), Gaps = 49/307 (15%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++  Y   + +G G + IV     + T ++ A K I     ++    V      RE+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
           R ++H N+I L D+       N  DV L+ EL+   +L   +   ++LT D    FL Q+
Sbjct: 63  REIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +K+ DFG+A      N+F   +  T  
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPE 176
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           + APE++    NY   G   D+WS+G I   LL     F               LG  ++
Sbjct: 177 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPF---------------LGETKQ 217
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
           E L    N  A  Y     Y         + +   LA D ++++LV DP +R+++ ++L+
Sbjct: 218 ETL---TNISAVNYDFDEEY---------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 316 HPYMSPL 322
           H ++  +
Sbjct: 266 HSWIKAI 272

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 141/310 (45%), Gaps = 60/310 (19%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN------------------------NAFENRVDA 73
           IG+G+YG+V  + N   N   A+K ++                           + R   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 74  LRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTND 133
            +  +E+ +L+ L H NV+ L +V+      N   +Y+V+EL++      + + + L+ D
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 134 HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY 193
             +++   L++G++YLH   I+HRD+KP NLLV  +  +KI DFG++    G +  ++  
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 194 VVTRWYRAPELLLCCDNY--GTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINIL 250
           V T  + APE L        G ++DVW++G  ++  + G+ P           + I+ + 
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD--------ERIMCLH 249
Query: 251 GSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV 310
              + + LEF D P   + +K                      DL+ +ML  +P  RI V
Sbjct: 250 SKIKSQALEFPDQPDIAEDLK----------------------DLITRMLDKNPESRIVV 287
Query: 311 TEALQHPYMS 320
            E   HP+++
Sbjct: 288 PEIKLHPWVT 297

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           KP+G G++ I    V++++N+  A+K I+   E   +  + +  LKL     H N++ L 
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME--ANTQKEITALKLCE--GHPNIVKLH 72
Query: 96  DVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
           +V        F D    +LV EL++  +L + IK  +  +     Y + +L+  + ++H 
Sbjct: 73  EV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 152 ANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
             ++HRDLKP NLL    N N ++KI DFG AR     NQ +     T  Y APE LL  
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-LLNQ 183
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           + Y  S D+WS+G I   +L  +  F   +        + I+   ++ D  F        
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-------- 235
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                    G  +  +  +A     DL+Q +L  DP KR+ ++    + ++      SSN
Sbjct: 236 --------EGEAWKNVSQEAK----DLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283
Query: 329 P 329
           P
Sbjct: 284 P 284

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 41/296 (13%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y   + +G+GA+ +V   V     ++ A   IN    +  D  +  RE ++ R L+H N
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L D +           YL+++L+   +L + I + +  +     + + Q+L  + + 
Sbjct: 72  IVRLHDSISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           H   ++HR+LKP NLL+ +      +K+ DFGLA    G+ Q    +  T  Y +PE+L 
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             D YG  +D+W+ G I   LL   P                           F D  + 
Sbjct: 187 -KDPYGKPVDLWACGVILYILLVGYP--------------------------PFWDEDQH 219
Query: 267 RKY--IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           R Y  IK+  Y   +P    +    P A DL+ KML  +P+KRI+  EAL+HP++S
Sbjct: 220 RLYQQIKAGAYDFPSP---EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 94/299 (31%), Positives = 138/299 (46%), Gaps = 50/299 (16%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           +Y  +K +G GAYG V    ++ T  + AIK I  ++     ++   L E+ +L+ L H 
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           N++ L +      +RN+   YLV E+    +L   I   Q  +       + Q+L G  Y
Sbjct: 65  NIMKLYEFF--EDKRNY---YLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTY 119
Query: 149 LHSANILHRDLKPGNLLVNANCD---LKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPE 203
           LH  NI+HRDLKP NLL+ +      +KI DFGL+      GK   M E + T +Y APE
Sbjct: 120 LHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTAYYIAPE 176
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           +L     Y    DVWS G I   LL   P F G                  + D E +  
Sbjct: 177 VLR--KKYDEKCDVWSCGVILYILLCGYPPFGG------------------QTDQEILKR 216
Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPL---AIDLLQKMLVFDPTKRISVTEALQHPYM 319
            +  K+     + P        PD   +   A  L++ ML ++P+KRIS  EAL HP++
Sbjct: 217 VEKGKF----SFDP--------PDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/306 (28%), Positives = 142/306 (46%), Gaps = 51/306 (16%)
Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKL 82
           +++  Y   + +G G + IV     + T ++ A K I     ++    V      RE+ +
Sbjct: 9   DVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 68
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQ 141
           LR ++H N+I L D+       N  DV L+ EL+   +L   +   ++LT D    FL Q
Sbjct: 69  LREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ 123
Query: 142 LLRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTR 197
           +L G+ YLHS  I H DLKP N +L++ N     +K+ DFG+A      N+F   +  T 
Sbjct: 124 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTP 182
Query: 198 WYRAPELLLCCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSR 253
            + APE++    NY   G   D+WS+G I   LL G  P                 LG  
Sbjct: 183 EFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASP----------------FLGET 222
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
           ++E L    N  A  Y     Y         + +   LA D ++++LV DP +R+ + ++
Sbjct: 223 KQETL---TNISAVNYDFDEEY---------FSNTSELAKDFIRRLLVKDPKRRMXIAQS 270
Query: 314 LQHPYM 319
           L+H ++
Sbjct: 271 LEHSWI 276

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 88/308 (28%), Positives = 141/308 (45%), Gaps = 51/308 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN----AFENRVDALRTLRELKLL 83
           ++  Y   + +G G + IV     + T ++ A K I      +    V      RE+ +L
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
           R ++H N+I L D+       N  DV L+ EL+   +L   +   ++LT D    FL Q+
Sbjct: 84  REIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 143 LRGLKYLHSANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N +L++ N     +K+ DFG+A      N+F   +  T  
Sbjct: 139 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPE 197
Query: 199 YRAPELLLCCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRR 254
           + APE++    NY   G   D+WS+G I   LL G  P                 LG  +
Sbjct: 198 FVAPEIV----NYEPLGLEADMWSIGVITYILLSGASP----------------FLGETK 237
Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
           +E L    N  A  Y     Y         + +   LA D ++++LV DP +R+ + ++L
Sbjct: 238 QETL---TNISAVNYDFDEEY---------FSNTSELAKDFIRRLLVKDPKRRMXIAQSL 285
Query: 315 QHPYMSPL 322
           +H ++  +
Sbjct: 286 EHSWIKAI 293

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 139/300 (46%), Gaps = 51/300 (17%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKI----NNAFENRVDALRTLRELKLLRHLQHENV 91
           + +G G + IV     + T  + A K I    + A    V      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L DV       N  DV L+ EL+   +L   +   ++L+ +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +  I H DLKP N +L++ N     +K+ DFGLA       +F   +  T  + APE++ 
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIV- 190
Query: 207 CCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
              NY   G   D+WS+G I   LL G  P                 LG  ++E L    
Sbjct: 191 ---NYEPLGLEADMWSIGVITYILLSGASP----------------FLGDTKQETL---- 227
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
                  I S+ Y     F   +     LA D ++K+LV +  KR+++ EAL+HP+++P+
Sbjct: 228 -----ANITSVSYDFDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQ 87
           +Y+  + +G+G +       + +T E  A K +  +     ++ + + T  E+ + + L 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKSLD 100
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLL 143
           + +V+             F+D   VY +++      L ++ K  +A+T    +YF+ Q +
Sbjct: 101 NPHVVGFHGF--------FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           +G++YLH+  ++HRDLK GNL +N + D+KI DFGLA       +   +   T  Y APE
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE 212
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
            +LC   +   +D+WS+GCI   LL  KP F  T CL +  + I                
Sbjct: 213 -VLCKKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRI---------------- 254
Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY 323
            K  +Y  S+P              +P+A  L+++ML  DPT R SV E L   + +  Y
Sbjct: 255 -KKNEY--SVPR-----------HINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGY 300
Query: 324 DPSSNP 329
            P   P
Sbjct: 301 APMRLP 306

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 136/293 (46%), Gaps = 36/293 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  R + + VA+KK++   + R + L    E+ ++R  QHENV+ + + 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 94
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   +  +        +L+ L  LH+  ++HR
Sbjct: 95  YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 149
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG     + +       V T ++ APEL+     YG  +D+
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 208
Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP 277
           WS+G +  E++  +P +     L  +K+I + L             P+ +   K  P   
Sbjct: 209 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPRLKNLHKVSPSLK 256
Query: 278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           G                 L ++LV DP +R +  E L+HP+++    P+S  P
Sbjct: 257 G----------------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 293

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 136/293 (46%), Gaps = 36/293 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  R + + VA+KK++   + R + L    E+ ++R  QHENV+ + + 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 96
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   +  +        +L+ L  LH+  ++HR
Sbjct: 97  YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 151
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG     + +       V T ++ APEL+     YG  +D+
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 210
Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP 277
           WS+G +  E++  +P +     L  +K+I + L             P+ +   K  P   
Sbjct: 211 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPRLKNLHKVSPSLK 258
Query: 278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           G                 L ++LV DP +R +  E L+HP+++    P+S  P
Sbjct: 259 G----------------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 295

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 95/305 (31%), Positives = 143/305 (46%), Gaps = 61/305 (20%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKI----NNAFENRVDALRTLRELKLLRHLQHENV 91
           + +G G + IV     + T  + A K I    + A    V      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L DV       N  DV L+ EL+   +L   +   ++L+ +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSNG---KNQFMT-EYVVTRWYRA 201
           +  I H DLKP N +L++ N     +K+ DFGLA    +G   KN F T E+V      A
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV------A 186
Query: 202 PELLLCCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREED 257
           PE++    NY   G   D+WS+G I   LL G  P                 LG  ++E 
Sbjct: 187 PEIV----NYEPLGLEADMWSIGVITYILLSGASP----------------FLGDTKQET 226
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
           L           I S+ Y     F   +     LA D ++K+LV +  KR+++ EAL+HP
Sbjct: 227 L---------ANITSVSYDFDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 318 YMSPL 322
           +++P+
Sbjct: 275 WITPV 279

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 143/306 (46%), Gaps = 49/306 (16%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQ 87
           +Y+  + +G+G +       + +T E  A K +  +     ++ + + T  E+ + + L 
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKSLD 84
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLL 143
           + +V+             F+D   VY +++      L ++ K  +A+T    +YF+ Q +
Sbjct: 85  NPHVVGFHGF--------FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 136
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           +G++YLH+  ++HRDLK GNL +N + D+KI DFGLA       +   +   T  Y APE
Sbjct: 137 QGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE 196
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
            +LC   +   +D+WS+GCI   LL  KP F  T CL +  + I                
Sbjct: 197 -VLCKKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRI---------------- 238
Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY 323
            K  +Y  S+P              +P+A  L+++ML  DPT R SV E L   + +  Y
Sbjct: 239 -KKNEY--SVPR-----------HINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGY 284
Query: 324 DPSSNP 329
            P   P
Sbjct: 285 APMRLP 290

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 136/293 (46%), Gaps = 36/293 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  R + + VA+KK++   + R + L    E+ ++R  QHENV+ + + 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 89
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   +  +        +L+ L  LH+  ++HR
Sbjct: 90  YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 144
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG     + +       V T ++ APEL+     YG  +D+
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 203
Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP 277
           WS+G +  E++  +P +     L  +K+I + L             P+ +   K  P   
Sbjct: 204 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPRLKNLHKVSPSLK 251
Query: 278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           G                 L ++LV DP +R +  E L+HP+++    P+S  P
Sbjct: 252 G----------------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 288

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 136/293 (46%), Gaps = 36/293 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  R + + VA+KK++   + R + L    E+ ++R  QHENV+ + + 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYNS 85
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   +  +        +L+ L  LH+  ++HR
Sbjct: 86  YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHR 140
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG     + +       V T ++ APEL+     YG  +D+
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP-YGPEVDI 199
Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP 277
           WS+G +  E++  +P +     L  +K+I + L             P+ +   K  P   
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPRLKNLHKVSPSLK 247
Query: 278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           G                 L ++LV DP +R +  E L+HP+++    P+S  P
Sbjct: 248 G----------------FLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 284

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 96/305 (31%), Positives = 143/305 (46%), Gaps = 61/305 (20%)
Query: 36  KPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           + +G G + IV  C   S   E   K   K+ + A    V      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L DV       N  DV L+ EL+   +L   +   ++L+ +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSNG---KNQFMT-EYVVTRWYRA 201
           +  I H DLKP N +L++ N     +K+ DFGLA    +G   KN F T E+V      A
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV------A 186
Query: 202 PELLLCCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREED 257
           PE++    NY   G   D+WS+G I   LL G  P                 LG  ++E 
Sbjct: 187 PEIV----NYEPLGLEADMWSIGVITYILLSGASP----------------FLGDTKQET 226
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
           L           I S+ Y     F   +     LA D ++K+LV +  KR+++ EAL+HP
Sbjct: 227 L---------ANITSVSYDFDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 318 YMSPL 322
           +++P+
Sbjct: 275 WITPV 279

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 139/302 (46%), Gaps = 47/302 (15%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFE-NRVDALR--TLRELKLLR 84
           Y P + +GRG   +V   +++ T ++ A+K I+     +F    V  LR  TL+E+ +LR
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 85  HLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
            +  H N+I LKD         F   +LV++LM   +L   +     L+    +  +  L
Sbjct: 79  KVSGHPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +   +   + +     T  Y AP
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LRSVCGTPSYLAP 192
Query: 203 ELLLCCDN-----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
           E++ C  N     YG  +D+WS G I   LL   P F   + +  L++I+          
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM---------- 242
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                         S  Y  G+P    Y D      DL+ + LV  P KR +  EAL HP
Sbjct: 243 --------------SGNYQFGSPEWDDYSDT---VKDLVSRFLVVQPQKRYTAEEALAHP 285
Query: 318 YM 319
           + 
Sbjct: 286 FF 287

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 95/305 (31%), Positives = 143/305 (46%), Gaps = 61/305 (20%)
Query: 36  KPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           + +G G + IV  C   S   E   K   K+ + A    V      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L DV       N  DV L+ EL+   +L   +   ++L+ +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSNG---KNQFMT-EYVVTRWYRA 201
           +  I H DLKP N +L++ N     +K+ DFGLA    +G   KN F T E+V      A
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV------A 186
Query: 202 PELLLCCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREED 257
           PE++    NY   G   D+WS+G I   LL G  P                 LG  ++E 
Sbjct: 187 PEIV----NYEPLGLEADMWSIGVITYILLSGASP----------------FLGDTKQET 226
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
           L           I ++ Y     F   +     LA D ++K+LV +  KR+++ EAL+HP
Sbjct: 227 L---------ANITAVSYDFDEEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 318 YMSPL 322
           +++P+
Sbjct: 275 WITPV 279

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 142/306 (46%), Gaps = 49/306 (16%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQ 87
           +Y+  + +G+G +       + +T E  A K +  +     ++ + + T  E+ + + L 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKSLD 100
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLL 143
           + +V+             F+D   VY +++      L ++ K  +A+T    +YF+ Q +
Sbjct: 101 NPHVVGFHGF--------FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           +G++YLH+  ++HRDLK GNL +N + D+KI DFGLA       +       T  Y APE
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE 212
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
            +LC   +   +D+WS+GCI   LL  KP F  T CL +  + I                
Sbjct: 213 -VLCKKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRI---------------- 254
Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY 323
            K  +Y  S+P              +P+A  L+++ML  DPT R SV E L   + +  Y
Sbjct: 255 -KKNEY--SVPR-----------HINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGY 300
Query: 324 DPSSNP 329
            P   P
Sbjct: 301 APMRLP 306

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 95/305 (31%), Positives = 143/305 (46%), Gaps = 61/305 (20%)
Query: 36  KPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           + +G G + IV  C   S   E   K   K+ + A    V      RE+ +LR + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L DV       N  DV L+ EL+   +L   +   ++L+ +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSNG---KNQFMT-EYVVTRWYRA 201
           +  I H DLKP N +L++ N     +K+ DFGLA    +G   KN F T E+V      A
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV------A 186
Query: 202 PELLLCCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREED 257
           PE++    NY   G   D+WS+G I   LL G  P                 LG  ++E 
Sbjct: 187 PEIV----NYEPLGLEADMWSIGVITYILLSGASP----------------FLGDTKQET 226
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
           L           I ++ Y     F   +     LA D ++K+LV +  KR+++ EAL+HP
Sbjct: 227 L---------ANITAVSYDFDEEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 318 YMSPL 322
           +++P+
Sbjct: 275 WITPV 279

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 142/306 (46%), Gaps = 49/306 (16%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQ 87
           +Y+  + +G+G +       + +T E  A K +  +     ++ + + T  E+ + + L 
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMST--EIAIHKSLD 100
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLL 143
           + +V+             F+D   VY +++      L ++ K  +A+T    +YF+ Q +
Sbjct: 101 NPHVVGFHGF--------FEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI 152
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           +G++YLH+  ++HRDLK GNL +N + D+KI DFGLA       +       T  Y APE
Sbjct: 153 QGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE 212
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
            +LC   +   +D+WS+GCI   LL  KP F  T CL +  + I                
Sbjct: 213 -VLCKKGHSFEVDIWSLGCILYTLLVGKPPFE-TSCLKETYIRI---------------- 254
Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY 323
            K  +Y  S+P              +P+A  L+++ML  DPT R SV E L   + +  Y
Sbjct: 255 -KKNEY--SVPR-----------HINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGY 300
Query: 324 DPSSNP 329
            P   P
Sbjct: 301 APMRLP 306

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/312 (28%), Positives = 141/312 (45%), Gaps = 41/312 (13%)
Query: 14  PGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVD 72
           PG      W+   +I   Y     +G GA+  V  + ++ T + VAIK I   A E +  
Sbjct: 2   PGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG 61
Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALT 131
           ++    E+ +L  ++H N++AL D+           +YL+ +L+   +L   I      T
Sbjct: 62  SMEN--EIAVLHKIKHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYT 114
Query: 132 NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSNGKNQ 188
                  +FQ+L  +KYLH   I+HRDLKP NLL   ++ +  + I DFGL++  +    
Sbjct: 115 ERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGS 173
Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
            ++    T  Y APE+L     Y  ++D WS+G I   LL   P F      N  KL   
Sbjct: 174 VLSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQ 229
Query: 249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI 308
           IL +  E D                     +P+   + D    A D ++ ++  DP KR 
Sbjct: 230 ILKAEYEFD---------------------SPY---WDDISDSAKDFIRHLMEKDPEKRF 265
Query: 309 SVTEALQHPYMS 320
           +  +ALQHP+++
Sbjct: 266 TCEQALQHPWIA 277

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 41/304 (13%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLREL 80
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I   A E +  ++    E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EI 67
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            +L  ++H N++AL D+           +YL+ +L+   +L   I      T       +
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSNGKNQFMTEYVVT 196
           FQ+L  +KYLH   I+HRDLKP NLL   ++ +  + I DFGL++  +     ++    T
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGT 181
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
             Y APE+L     Y  ++D WS+G I   LL   P F      N  KL   IL +  E 
Sbjct: 182 PGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEF 237
Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           D                     +P+   + D    A D ++ ++  DP KR +  +ALQH
Sbjct: 238 D---------------------SPY---WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 273
Query: 317 PYMS 320
           P+++
Sbjct: 274 PWIA 277

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 41/304 (13%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLREL 80
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I   A E +  ++    E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EI 67
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            +L  ++H N++AL D+           +YL+ +L+   +L   I      T       +
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSNGKNQFMTEYVVT 196
           FQ+L  +KYLH   I+HRDLKP NLL   ++ +  + I DFGL++  +     ++    T
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGT 181
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
             Y APE+L     Y  ++D WS+G I   LL   P F      N  KL   IL +  E 
Sbjct: 182 PGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEF 237
Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           D                     +P+   + D    A D ++ ++  DP KR +  +ALQH
Sbjct: 238 D---------------------SPY---WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 273
Query: 317 PYMS 320
           P+++
Sbjct: 274 PWIA 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 41/304 (13%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLREL 80
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I   A E +  ++    E+
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMEN--EI 67
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            +L  ++H N++AL D+           +YL+ +L+   +L   I      T       +
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLI 122
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSNGKNQFMTEYVVT 196
           FQ+L  +KYLH   I+HRDLKP NLL   ++ +  + I DFGL++  +     ++    T
Sbjct: 123 FQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGT 181
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
             Y APE+L     Y  ++D WS+G I   LL   P F      N  KL   IL +  E 
Sbjct: 182 PGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEF 237
Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           D                     +P+   + D    A D ++ ++  DP KR +  +ALQH
Sbjct: 238 D---------------------SPY---WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 273
Query: 317 PYMS 320
           P+++
Sbjct: 274 PWIA 277

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 92/322 (28%), Positives = 140/322 (43%), Gaps = 66/322 (20%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV--DALRTLRELKLLRHLQH 88
           KY+    +G G+YG V   ++ ET  + A+K +      R+        +E++LLR L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQY--FLFQLLRGL 146
           +NVI L DV+    ++    +Y+V E     + +++ S        CQ   +  QL+ GL
Sbjct: 66  KNVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLA------------RTSNGKNQFMTEYV 194
           +YLHS  I+H+D+KPGNLL+     LKI   G+A            RTS G   F     
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF----- 177
Query: 195 VTRWYRAPELLLCCDNY-GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
                + PE+    D + G  +D+WS G     +      F G    N  KL  NI    
Sbjct: 178 -----QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYKLFENI---- 225
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                         K   ++P   G P S           DLL+ ML ++P KR S+ + 
Sbjct: 226 -------------GKGSYAIPGDCGPPLS-----------DLLKGMLEYEPAKRFSIRQI 261
Query: 314 LQHPYMSPLYDPSSNPPAQVPI 335
            QH +         +PPA+ P+
Sbjct: 262 RQHSWFR-----KKHPPAEAPV 278

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 137/291 (47%), Gaps = 48/291 (16%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+Y +    +++ TN + A+K I+ +  +  + +  L     LR+ QH N+I LKDV
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL-----LRYGQHPNIITLKDV 84
Query: 98  MMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
                  + K VY+V ELM   +L   I   +  +       LF + + ++YLH+  ++H
Sbjct: 85  Y-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 157 RDLKPGNLL-VNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           RDLKP N+L V+ + +   ++ICDFG A+    +N  +     T  + APE+L     Y 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE-RQGYD 198
Query: 213 TSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK---ARK 268
            + D+WS+G  ++  L G  P   G +                EE L  I + K   +  
Sbjct: 199 AACDIWSLGVLLYTMLTGYTPFANGPD-------------DTPEEILARIGSGKFSLSGG 245
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           Y  S+  T               A DL+ KML  DP +R++    L+HP++
Sbjct: 246 YWNSVSDT---------------AKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/344 (25%), Positives = 152/344 (44%), Gaps = 49/344 (14%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNE-KVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +  +Y  +  +G G +G V   ++    + +VA+K I N  + R  A   +  LK ++  
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 76
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLR 144
             EN      V+M         + + +EL+  +  + +K +  Q     H ++  +QL  
Sbjct: 77  DKENKFLC--VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 145 GLKYLHSANILHRDLKPGNLL-VNA------------------NCDLKICDFGLARTSNG 185
            L++LH   + H DLKP N+L VN+                  N  +++ DFG   ++  
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATF 191
Query: 186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL 245
            ++  T  V TR YR PE++L    +    DVWS+GCI  E      +F   E    L +
Sbjct: 192 DHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250
Query: 246 IINILG---------SRREE-----DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPL 291
           +  ILG         +R+++      L + +N    +Y+K     P   +       H  
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE-NCKPLKSYMLQDSLEHVQ 309
Query: 292 AIDLLQKMLVFDPTKRISVTEALQHPYMSPL------YDPSSNP 329
             DL+++ML FDP +RI++ EAL HP+ + L      +  S NP
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 148/331 (44%), Gaps = 43/331 (12%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNE-KVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +  +Y  +  +G G +G V   ++    + +VA+K I N  + R  A   +  LK ++  
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 108
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLR 144
             EN      V+M         + + +EL+  +  + +K +  Q     H ++  +QL  
Sbjct: 109 DKENKFLC--VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 166
Query: 145 GLKYLHSANILHRDLKPGNLL-VNA------------------NCDLKICDFGLARTSNG 185
            L++LH   + H DLKP N+L VN+                  N  +++ DFG   ++  
Sbjct: 167 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATF 223
Query: 186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL 245
            ++  T  V TR YR PE++L    +    DVWS+GCI  E      +F   E    L +
Sbjct: 224 DHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 282
Query: 246 IINILG---------SRREE-----DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPL 291
           +  ILG         +R+++      L + +N    +Y+K     P   +       H  
Sbjct: 283 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE-NCKPLKSYMLQDSLEHVQ 341
Query: 292 AIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
             DL+++ML FDP +RI++ EAL HP+ + L
Sbjct: 342 LFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 89/308 (28%), Positives = 140/308 (45%), Gaps = 44/308 (14%)
Query: 20  SMWQTLFEIDTKYVPIKP-IGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTL 77
           S W+   E   K    K  +G GA+  V  +  + T +  A+K I   A + +  ++   
Sbjct: 11  SSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIEN- 69
Query: 78  RELKLLRHLQHENVIALKDVM-MPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHC 135
            E+ +LR ++HEN++AL+D+   P+H      +YLV +L+   +L   I      T    
Sbjct: 70  -EIAVLRKIKHENIVALEDIYESPNH------LYLVMQLVSGGELFDRIVEKGFYTEKDA 122
Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTE 192
              + Q+L  + YLH   I+HRDLKP NLL    +    + I DFGL++   GK   M+ 
Sbjct: 123 STLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVMST 181
Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
              T  Y APE+L     Y  ++D WS+G I   LL   P F      N  KL   IL +
Sbjct: 182 ACGTPGYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDSKLFEQILKA 237
Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
             E D                     +P+   + D    A D ++ ++  DP KR +  +
Sbjct: 238 EYEFD---------------------SPY---WDDISDSAKDFIRNLMEKDPNKRYTCEQ 273
Query: 313 ALQHPYMS 320
           A +HP+++
Sbjct: 274 AARHPWIA 281

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/331 (25%), Positives = 148/331 (44%), Gaps = 43/331 (12%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNE-KVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +  +Y  +  +G G +G V   ++    + +VA+K I N  + R  A   +  LK ++  
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 85
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLR 144
             EN      V+M         + + +EL+  +  + +K +  Q     H ++  +QL  
Sbjct: 86  DKENKFLC--VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 143
Query: 145 GLKYLHSANILHRDLKPGNLL-VNA------------------NCDLKICDFGLARTSNG 185
            L++LH   + H DLKP N+L VN+                  N  +++ DFG   ++  
Sbjct: 144 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATF 200
Query: 186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL 245
            ++  T  V TR YR PE++L    +    DVWS+GCI  E      +F   E    L +
Sbjct: 201 DHEHHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 259
Query: 246 IINILG---------SRREE-----DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPL 291
           +  ILG         +R+++      L + +N    +Y+K     P   +       H  
Sbjct: 260 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE-NCKPLKSYMLQDSLEHVQ 318
Query: 292 AIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
             DL+++ML FDP +RI++ EAL HP+ + L
Sbjct: 319 LFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 141/295 (47%), Gaps = 43/295 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +K IG G +G+     ++++NE VA+K I      ++D     RE+   R L+H N
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKIDE-NVKREIINHRSLRHPN 75
Query: 91  VIALKDVMM-PSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K+V++ P+H      + +V E     +L + I ++   + D  ++F  QL+ G+ Y
Sbjct: 76  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKICDFG +++S   +Q  +  V T  Y APE+LL
Sbjct: 130 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 188
Query: 207 CCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
             +  G   DVWS G  ++  L+G  P     E  N  K I  IL  +            
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 237
Query: 266 ARKYIKSLP-YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                 ++P Y   +P  R           L+ ++ V DP KRIS+ E   H + 
Sbjct: 238 ------AIPDYVHISPECR----------HLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 143/305 (46%), Gaps = 61/305 (20%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKI----NNAFENRVDALRTLRELKLLRHLQHENV 91
           + +G G + IV     + T  + A K I    + A    V      RE+ +LR + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L DV       N  DV L+ EL+   +L   +   ++L+ +    F+ Q+L G+ YLH
Sbjct: 78  ITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 151 SANILHRDLKPGN-LLVNANC---DLKICDFGLA-RTSNG---KNQFMT-EYVVTRWYRA 201
           +  I H DLKP N +L++ N     +K+ DFGLA    +G   KN F T E+V      A
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV------A 186
Query: 202 PELLLCCDNY---GTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREED 257
           PE++    NY   G   D+WS+G I   LL G  P                 LG  ++E 
Sbjct: 187 PEIV----NYEPLGLEADMWSIGVITYILLSGASP----------------FLGDTKQET 226
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
           L           I ++ Y     F   +     LA D ++K+LV +  KR+++ EAL+HP
Sbjct: 227 L---------ANITAVSYDFDEEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274
Query: 318 YMSPL 322
           +++P+
Sbjct: 275 WITPV 279

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 140/295 (47%), Gaps = 43/295 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +K IG G +G+     ++++NE VA+K I    +    A    RE+   R L+H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI---AANVKREIINHRSLRHPN 76
Query: 91  VIALKDVMM-PSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K+V++ P+H      + +V E     +L + I ++   + D  ++F  QL+ G+ Y
Sbjct: 77  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKICDFG +++S   +Q  +  V T  Y APE+LL
Sbjct: 131 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 189
Query: 207 CCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
             +  G   DVWS G  ++  L+G  P     E  N  K I  IL  +            
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 238
Query: 266 ARKYIKSLP-YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                 ++P Y   +P  R           L+ ++ V DP KRIS+ E   H + 
Sbjct: 239 ------AIPDYVHISPECR----------HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 142/302 (47%), Gaps = 51/302 (16%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
            FE++++      +GRGA  IV     + T +  A+K +    + ++  +RT  E+ +L 
Sbjct: 54  FFEVESE------LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRT--EIGVLL 103
Query: 85  HLQHENVIALKDVM-MPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQL 142
            L H N+I LK++   P+      ++ LV EL+   +L   I      +       + Q+
Sbjct: 104 RLSHPNIIKLKEIFETPT------EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           L  + YLH   I+HRDLKP NLL      +  LKI DFGL++        M     T  Y
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVCGTPGY 216
Query: 200 RAPELLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
            APE+L  C  YG  +D+WSVG I +  L G +P +                   R +  
Sbjct: 217 CAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFY-----------------DERGDQF 258
Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            F       + I +  Y   +P+   + +    A DL++K++V DP KR++  +ALQHP+
Sbjct: 259 MF-------RRILNCEYYFISPW---WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308
Query: 319 MS 320
           ++
Sbjct: 309 VT 310

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 46/297 (15%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHE 89
           +Y   + +G+G++G V    ++ T ++ A+K I+    + + D    LRE++LL+ L H 
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 90  NVIALKDVMMPSHRRNFKD---VYLVYEL-MDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
           N+  L +         F+D    YLV E+    +L   I S +  +       + Q+L G
Sbjct: 87  NIXKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 146 LKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + Y H   I+HRDLKP NLL+ +   + +++I DFGL+ T    ++   + + T +Y AP
Sbjct: 139 ITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-THFEASKKXKDKIGTAYYIAP 197
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+L     Y    DVWS G I   LL   P F G    + LK +                
Sbjct: 198 EVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV---------------- 239
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +  KY   LP          +      A DL++K L + P+ RIS  +AL H ++
Sbjct: 240 --EKGKYTFELPQ---------WKKVSESAKDLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 134/293 (45%), Gaps = 36/293 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  + T ++VA+KK++   + R + L    E+ ++R   H+NV+ +   
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHDNVVDMYSS 110
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +        ++++V E ++      I +   +  +        +LR L YLH+  ++HR
Sbjct: 111 YLVG-----DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 165
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+ ++  +K+ DFG     + +       V T ++ APE++     YGT +D+
Sbjct: 166 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP-YGTEVDI 224
Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTP 277
           WS+G +  E++  +P +     L  ++ I + L  R +      D  K    ++      
Sbjct: 225 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVK------DLHKVSSVLRG----- 273
Query: 278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
                             L  MLV +P++R +  E L HP++     PS   P
Sbjct: 274 -----------------FLDLMLVREPSQRATAQELLGHPFLKLAGPPSCIVP 309

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 138/293 (47%), Gaps = 45/293 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT---LRELKLLRHLQHENVIAL 94
           IG+G + +V   +NRET ++ A+K ++ A       L T    RE  +   L+H +++ L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 95  KDVMMPSHRRNFKDVYLVYELMD-TDL-HQIIKSSQA---LTNDHCQYFLFQLLRGLKYL 149
            +            +Y+V+E MD  DL  +I+K + A    +     +++ Q+L  L+Y 
Sbjct: 94  LETYSSDGM-----LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           H  NI+HRD+KP  +L+ +   +  +K+  FG+A             V T  + APE++ 
Sbjct: 149 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 208
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             + YG  +DVW  G I   LL     F GT    + +L   I+  +      +  NP+ 
Sbjct: 209 -REPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGK------YKMNPRQ 257
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +I                     A DL+++ML+ DP +RI+V EAL HP++
Sbjct: 258 WSHISE------------------SAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 138/293 (47%), Gaps = 45/293 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT---LRELKLLRHLQHENVIAL 94
           IG+G + +V   +NRET ++ A+K ++ A       L T    RE  +   L+H +++ L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 95  KDVMMPSHRRNFKDVYLVYELMD-TDL-HQIIKSSQA---LTNDHCQYFLFQLLRGLKYL 149
            +            +Y+V+E MD  DL  +I+K + A    +     +++ Q+L  L+Y 
Sbjct: 92  LETYSSDGM-----LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 150 HSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           H  NI+HRD+KP  +L+ +   +  +K+  FG+A             V T  + APE++ 
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK 206
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             + YG  +DVW  G I   LL     F GT    + +L   I+  +      +  NP+ 
Sbjct: 207 -REPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGK------YKMNPRQ 255
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +I                     A DL+++ML+ DP +RI+V EAL HP++
Sbjct: 256 WSHISE------------------SAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN--AFENRVDALRTLRELKLLRHLQH 88
           +Y  +K IG G +G+     ++ T E VA+K I    A +  V      RE+   R L+H
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-----REIINHRSLRH 75
Query: 89  ENVIALKDVMM-PSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGL 146
            N++  K+V++ P+H      + ++ E     +L++ I ++   + D  ++F  QLL G+
Sbjct: 76  PNIVRFKEVILTPTH------LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129
Query: 147 KYLHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
            Y HS  I HRDLK  N L++ +    LKICDFG +++S   +Q  +  V T  Y APE+
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 188
Query: 205 LLCCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           LL  +  G   DVWS G  ++  L+G  P                           F D 
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYP---------------------------FEDP 221
Query: 264 PKARKYIKSLPYTPGTPFSRLYPD---AHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            + R Y K++       +S   PD     P    L+ ++ V DP  RIS+ E   H + 
Sbjct: 222 EEPRDYRKTIQRILSVKYS--IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 140/295 (47%), Gaps = 43/295 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +K IG G +G+     ++++NE VA+K I      ++D     RE+   R L+H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKIDE-NVKREIINHRSLRHPN 76
Query: 91  VIALKDVMM-PSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K+V++ P+H      + +V E     +L + I ++   + D  ++F  QL+ G+ Y
Sbjct: 77  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKIC FG +++S   +Q   + V T  Y APE+LL
Sbjct: 131 CHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ-PKDTVGTPAYIAPEVLL 189
Query: 207 CCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
             +  G   DVWS G  ++  L+G  P     E  N  K I  IL  +            
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 238
Query: 266 ARKYIKSLP-YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                 ++P Y   +P  R           L+ ++ V DP KRIS+ E   H + 
Sbjct: 239 ------AIPDYVHISPECR----------HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/294 (28%), Positives = 138/294 (46%), Gaps = 41/294 (13%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +K IG G +G+     ++++NE VA+K I      ++D     RE+   R L+H N
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG--EKIDE-NVKREIINHRSLRHPN 76
Query: 91  VIALKDVMM-PSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K+V++ P+H      + +V E     +L + I ++   + D  ++F  QL+ G+ Y
Sbjct: 77  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKIC FG +++S   +Q  +  V T  Y APE+LL
Sbjct: 131 CHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 189
Query: 207 CCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
             +  G   DVWS G  ++  L+G  P     E  N  K I  IL  +            
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY----------- 238
Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                 ++P          Y    P    L+ ++ V DP KRIS+ E   H + 
Sbjct: 239 ------AIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 48/291 (16%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+Y +    +++ TN + A+K I+ +  +  + +  L     LR+ QH N+I LKDV
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEIL-----LRYGQHPNIITLKDV 84
Query: 98  MMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
                  + K VY+V EL    +L   I   +  +       LF + + ++YLH+  ++H
Sbjct: 85  Y-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 157 RDLKPGNLL-VNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           RDLKP N+L V+ + +   ++ICDFG A+    +N  +     T  + APE+L     Y 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLE-RQGYD 198
Query: 213 TSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK---ARK 268
            + D+WS+G  ++  L G  P   G +                EE L  I + K   +  
Sbjct: 199 AACDIWSLGVLLYTXLTGYTPFANGPD-------------DTPEEILARIGSGKFSLSGG 245
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           Y  S+  T               A DL+ K L  DP +R++    L+HP++
Sbjct: 246 YWNSVSDT---------------AKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+GA+ +V   V++ T  + A K IN    +  D  +  RE ++ R LQH N++ L D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 98  MMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +      +F   YLV++L+   +L + I + +  +     + + Q+L  + Y HS  I+H
Sbjct: 74  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 157 RDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           R+LKP NLL+ +      +K+ DFGLA   N    +   +  T  Y +PE+L   D Y  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLK-KDPYSK 186
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY--IK 271
            +D+W+ G I   LL   P                           F D  + R Y  IK
Sbjct: 187 PVDIWACGVILYILLVGYP--------------------------PFWDEDQHRLYAQIK 220
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           +  Y   +P    +    P A  L+  ML  +P KRI+  +AL+ P++
Sbjct: 221 AGAYDYPSP---EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G YGIV +  +     ++AIK+I          L    E+ L +HL+H+N++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQY--- 84
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQ---YFLFQLLRGLKYLHSANI 154
            + S   N      + ++    L  +++S      D+ Q   ++  Q+L GLKYLH   I
Sbjct: 85  -LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 155 LHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL-LCCDNYG 212
           +HRD+K  N+L+N     LKI DFG ++   G N     +  T  Y APE++      YG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 213 TSIDVWSVGCIFAELLGRKPIF 234
            + D+WS+GC   E+   KP F
Sbjct: 204 KAADIWSLGCTIIEMATGKPPF 225

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+GA+ +V   V++ T  + A K IN    +  D  +  RE ++ R LQH N++ L D 
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 98  MMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +      +F   YLV++L+   +L + I + +  +     + + Q+L  + Y HS  I+H
Sbjct: 73  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 127
Query: 157 RDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           R+LKP NLL+ +      +K+ DFGLA   N    +   +  T  Y +PE+L   D Y  
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLK-KDPYSK 185
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY--IK 271
            +D+W+ G I   LL   P                           F D  + R Y  IK
Sbjct: 186 PVDIWACGVILYILLVGYP--------------------------PFWDEDQHRLYAQIK 219
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           +  Y   +P    +    P A  L+  ML  +P KRI+  +AL+ P++
Sbjct: 220 AGAYDYPSP---EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+GA+ +V   V++ T  + A K IN    +  D  +  RE ++ R LQH N++ L D 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 98  MMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +      +F   YLV++L+   +L + I + +  +     + + Q+L  + Y HS  I+H
Sbjct: 74  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 128
Query: 157 RDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           R+LKP NLL+ +      +K+ DFGLA   N    +   +  T  Y +PE+L   D Y  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLK-KDPYSK 186
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY--IK 271
            +D+W+ G I   LL   P                           F D  + R Y  IK
Sbjct: 187 PVDIWACGVILYILLVGYP--------------------------PFWDEDQHRLYAQIK 220
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           +  Y   +P    +    P A  L+  ML  +P KRI+  +AL+ P++
Sbjct: 221 AGAYDYPSP---EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G YGIV +  +     ++AIK+I          L    E+ L +HL+H+N++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQ---- 69
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF---QLLRGLKYLHSANI 154
            + S   N      + ++    L  +++S      D+ Q   F   Q+L GLKYLH   I
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 129
Query: 155 LHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL-LCCDNYG 212
           +HRD+K  N+L+N     LKI DFG ++   G N     +  T  Y APE++      YG
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 213 TSIDVWSVGCIFAELLGRKPIF 234
            + D+WS+GC   E+   KP F
Sbjct: 190 KAADIWSLGCTIIEMATGKPPF 211

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 42/288 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+GA+ +V   V++ T  + A K IN    +  D  +  RE ++ R LQH N++ L D 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 98  MMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +      +F   YLV++L+   +L + I + +  +     + + Q+L  + Y HS  I+H
Sbjct: 97  I---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVH 151
Query: 157 RDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           R+LKP NLL+ +      +K+ DFGLA   N    +   +  T  Y +PE+L   D Y  
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTPGYLSPEVLK-KDPYSK 209
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY--IK 271
            +D+W+ G I   LL   P                           F D  + R Y  IK
Sbjct: 210 PVDIWACGVILYILLVGYP--------------------------PFWDEDQHRLYAQIK 243
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           +  Y   +P    +    P A  L+  ML  +P KRI+  +AL+ P++
Sbjct: 244 AGAYDYPSP---EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 138/295 (46%), Gaps = 43/295 (14%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +K IG G +G+     +++ NE VA+K I      ++D     RE+   R L+H N
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG--EKIDE-NVKREIINHRSLRHPN 76
Query: 91  VIALKDVMM-PSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K+V++ P+H      + +V E     +L + I ++   + D  ++F  QL+ G+ Y
Sbjct: 77  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 149 LHSANILHRDLKPGNLLVNANCD--LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            H+  + HRDLK  N L++ +    LKI DFG ++ S   +Q  +  V T  Y APE+LL
Sbjct: 131 AHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA-VGTPAYIAPEVLL 189
Query: 207 CCDNYGTSIDVWSVGC-IFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
             +  G   DVWS G  ++  L+G  P     E  N  K I  IL  +            
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQ------------ 237
Query: 266 ARKYIKSLP-YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                 ++P Y   +P  R           L+ ++ V DP KRIS+ E   H + 
Sbjct: 238 -----YAIPDYVHISPECR----------HLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 43/297 (14%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           I   ++ ++ +G GA+  V     R T +  A+K I  +   R  +L    E+ +L+ ++
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN--EIAVLKKIK 64
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGL 146
           HEN++ L+D+   +        YLV +L+   +L   I      T       + Q+L  +
Sbjct: 65  HENIVTLEDIYESTTH-----YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 147 KYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           KYLH   I+HRDLKP NLL      N  + I DFGL++    +N  M+    T  Y APE
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTACGTPGYVAPE 177
Query: 204 LLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
            +L    Y  ++D WS+G I +  L G  P +  TE                        
Sbjct: 178 -VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------------------------ 212
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             K  + IK   Y   +PF   + D    A D +  +L  DP +R +  +AL HP++
Sbjct: 213 -SKLFEKIKEGYYEFESPF---WDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 115/231 (49%), Gaps = 19/231 (8%)
Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F+   KYV ++ IG G++G      + E   +  IK+IN +  +  +   + RE+ +L +
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQAL--TNDHCQYFL 139
           ++H N++         +R +F++   +Y +MD     DL + I + + +    D    + 
Sbjct: 80  MKHPNIV--------QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
            Q+   LK++H   ILHRD+K  N+ +  +  +++ DFG+AR  N   +     + T +Y
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 200 RAPELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
            +PE+   C+N  Y    D+W++GC+  EL   K  F      N +  II+
Sbjct: 192 LSPEI---CENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 16/214 (7%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAI-KKINNAFENRVDALRTLRELKLLRHLQHEN 90
           Y  +  IG G+YG  C  + R+++ K+ + K+++       +    + E+ LLR L+H N
Sbjct: 8   YEVLYTIGTGSYG-RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII----KSSQALTNDHCQYFLFQLLRG 145
           ++   D ++    R    +Y+V E  +  DL  +I    K  Q L  +     + QL   
Sbjct: 67  IVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 146 LKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           LK  H  +     +LHRDLKP N+ ++   ++K+ DFGLAR  N    F  E+V T +Y 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
           +PE +    +Y    D+WS+GC+  EL    P F
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 130/283 (45%), Gaps = 38/283 (13%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G+ GIVC +  + +  +VA+K ++   + R + L    E+ ++R  QH NV+ +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHFNVVEMYKS 110
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
            +       ++++++ E +       I S   L  +        +L+ L YLH+  ++HR
Sbjct: 111 YLVG-----EELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDV 217
           D+K  ++L+  +  +K+ DFG     +         V T ++ APE ++    Y T +D+
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDI 224
Query: 218 WSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP-KARKYIKSLPYT 276
           WS+G +  E++  +P +                         F D+P +A K ++  P  
Sbjct: 225 WSLGIMVIEMVDGEPPY-------------------------FSDSPVQAMKRLRDSP-- 257
Query: 277 PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
              P  +      P+  D L++MLV DP +R +  E L HP++
Sbjct: 258 --PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 93/358 (25%), Positives = 149/358 (41%), Gaps = 73/358 (20%)
Query: 13  SPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV- 71
           S  ++ Y    +L E+  KY     IG+G+YG+V  ++  +T    AIK +N     ++ 
Sbjct: 9   SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 72  --DALRTLRELKLLRHLQHENVIALKDV----------MMPSHRRNFKDVYLVY------ 113
             D  R   E++L++ L H N+  L +V          M   H  +  D   V+      
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 114 -------------------ELMDTDLHQIIKSSQALTNDH-CQYFLFQLLRGLKYLHSAN 153
                              E ++  +H   +S   +  +      + Q+   L YLH+  
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 154 ILHRDLKPGNLLVNAN--CDLKICDFGLART----SNGKNQFMTEYVVTRWYRAPELL-L 206
           I HRD+KP N L + N   ++K+ DFGL++     +NG+   MT    T ++ APE+L  
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             ++YG   D WS G +   LL     FPG    + +  ++N       + L F +NP  
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCF-ENPN- 299
Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD 324
                             Y    PLA DLL  +L  +  +R     ALQHP++S   D
Sbjct: 300 ------------------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHENVIALKD 96
           +G+G++  V  + +  T  +VAIK I+     +   + R   E+K+   L+H +++ L +
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 97  VMMPSHRRNFKDVYLVYELM-DTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANI 154
               S+      VYLV E+  + ++++ +K+  +  + +  ++F+ Q++ G+ YLHS  I
Sbjct: 79  YFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           LHRDL   NLL+  N ++KI DFGLA      ++       T  Y +PE +     +G  
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRSAHGLE 192
Query: 215 IDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLP 274
            DVWS+GC+F  LL  +P F      N L  +  +L          I+            
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIE------------ 238
Query: 275 YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                            A DL+ ++L  +P  R+S++  L HP+MS
Sbjct: 239 -----------------AKDLIHQLLRRNPADRLSLSSVLDHPFMS 267

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 143/321 (44%), Gaps = 46/321 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           I  +G GA+G V  + N+ET+   A K I+   E  ++    + E+ +L    H N++ L
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKL 99
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANI 154
            D     +       +     +D  + ++    + LT    Q    Q L  L YLH   I
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN---- 210
           +HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           Y    DVWS+G    E+   +P  P  E LN +++++ I                     
Sbjct: 217 YDYKADVWSLGITLIEMAEIEP--PHHE-LNPMRVLLKI--------------------A 253
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           KS P T   P SR   +      D L+K L  +   R + ++ LQHP+++      SN P
Sbjct: 254 KSEPPTLAQP-SRWSSNFK----DFLKKCLEKNVDARWTTSQLLQHPFVT----VDSNKP 304
Query: 331 -----AQVPIDLDMDEESGEE 346
                A+   ++  + E G+E
Sbjct: 305 IRELIAEAKAEVTEEVEDGKE 325

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 143/321 (44%), Gaps = 46/321 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           I  +G GA+G V  + N+ET+   A K I+   E  ++    + E+ +L    H N++ L
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKL 99
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANI 154
            D     +       +     +D  + ++    + LT    Q    Q L  L YLH   I
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN---- 210
           +HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           Y    DVWS+G    E+   +P  P  E LN +++++ I                     
Sbjct: 217 YDYKADVWSLGITLIEMAEIEP--PHHE-LNPMRVLLKI--------------------A 253
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           KS P T   P SR   +      D L+K L  +   R + ++ LQHP+++      SN P
Sbjct: 254 KSEPPTLAQP-SRWSSNFK----DFLKKCLEKNVDARWTTSQLLQHPFVT----VDSNKP 304
Query: 331 -----AQVPIDLDMDEESGEE 346
                A+   ++  + E G+E
Sbjct: 305 IRELIAEAKAEVTEEVEDGKE 325

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/321 (26%), Positives = 143/321 (44%), Gaps = 46/321 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           I  +G GA+G V  + N+ET+   A K I+   E  ++    + E+ +L    H N++ L
Sbjct: 42  IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY--MVEIDILASCDHPNIVKL 99
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANI 154
            D     +       +     +D  + ++    + LT    Q    Q L  L YLH   I
Sbjct: 100 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKI 156
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN---- 210
           +HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  +    
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           Y    DVWS+G    E+   +P  P  E LN +++++ I                     
Sbjct: 217 YDYKADVWSLGITLIEMAEIEP--PHHE-LNPMRVLLKI--------------------A 253
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           KS P T   P SR   +      D L+K L  +   R + ++ LQHP+++      SN P
Sbjct: 254 KSEPPTLAQP-SRWSSNFK----DFLKKCLEKNVDARWTTSQLLQHPFVT----VDSNKP 304
Query: 331 -----AQVPIDLDMDEESGEE 346
                A+   ++  + E G+E
Sbjct: 305 IRELIAEAKAEVTEEVEDGKE 325

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/307 (28%), Positives = 134/307 (43%), Gaps = 45/307 (14%)
Query: 19  YSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR 78
           Y    T  +I+  Y     IGRG++G V  +V + T  + A KKI   F   VD  +  +
Sbjct: 15  YFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--Q 72
Query: 79  ELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYEL-MDTDLHQIIKSSQALTNDHCQY 137
           E+++++ L H N+I L +        +  D+YLV EL    +L + +   +         
Sbjct: 73  EIEIMKSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR 127
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGL-ARTSNGKNQFMTEY 193
            +  +L  + Y H  N+ HRDLKP N L    + +  LK+ DFGL AR   GK   M   
Sbjct: 128 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTK 185
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGS 252
           V T +Y +P++L     YG   D WS G +   LL G  P    T+    LK+       
Sbjct: 186 VGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI------- 236
Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
            RE    F +                      + +  P A  L++++L   P +RI+  +
Sbjct: 237 -REGTFTFPEKD--------------------WLNVSPQAESLIRRLLTKSPKQRITSLQ 275
Query: 313 ALQHPYM 319
           AL+H + 
Sbjct: 276 ALEHEWF 282

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 132/299 (44%), Gaps = 45/299 (15%)
Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +I+  Y     IGRG++G V  +V + T  + A KKI   F   VD  +  +E+++++ L
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSL 63
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYEL-MDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            H N+I L +        +  D+YLV EL    +L + +   +          +  +L  
Sbjct: 64  DHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 146 LKYLHSANILHRDLKPGNLLV---NANCDLKICDFGL-ARTSNGKNQFMTEYVVTRWYRA 201
           + Y H  N+ HRDLKP N L    + +  LK+ DFGL AR   GK   M   V T +Y +
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVS 176
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           P++L     YG   D WS G +   LL G  P    T+    LK+        RE    F
Sbjct: 177 PQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKI--------REGTFTF 226
Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            +                      + +  P A  L++++L   P +RI+  +AL+H + 
Sbjct: 227 PEKD--------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           +  ++ IG G++G V  + +   +E VAIKK++ + +   +  +  ++E++ L+ L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 91  VIALKDVMMPSHRRNFKDVYLVYEL---MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            I  +   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 116 TIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 168
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L++    +K+ DFG A      N F    V T ++ APE++L 
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILA 224
Query: 208 CD--NYGTSIDVWSVGCIFAELLGRKP 232
            D   Y   +DVWS+G    EL  RKP
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/342 (24%), Positives = 154/342 (45%), Gaps = 46/342 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVN-RETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +  +Y  +  +G G +G V   V+ R    +VA+K I N  + +  A   +  L+ +   
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEK 90
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN--DHCQYFLFQLLR 144
             +N      V M         + + +EL+       +K +  L       ++  FQL +
Sbjct: 91  DPDNKNLC--VQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQ 148
Query: 145 GLKYLHSANILHRDLKPGNLL-VNANCDL------------------KICDFGLARTSNG 185
            +K+LH   + H DLKP N+L VN++ +L                  ++ DFG   ++  
Sbjct: 149 AVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG---SATF 205
Query: 186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL 245
            ++  +  V TR YRAPE++L    +    DVWS+GCI  E      +F   +    L +
Sbjct: 206 DHEHHSTIVSTRHYRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 246 IINILG---------SRREE-----DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPL 291
           +  ILG         +R+++      L++ +N  A +Y++     P   +     + H  
Sbjct: 265 MERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRE-NCKPLRRYLTSEAEEHHQ 323
Query: 292 AIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQV 333
             DL++ ML ++P KR+++ EALQHP+ + L    + PP ++
Sbjct: 324 LFDLIESMLEYEPAKRLTLGEALQHPFFARL---RAEPPNKL 362

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 16/214 (7%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAI-KKINNAFENRVDALRTLRELKLLRHLQHEN 90
           Y  +  IG G+YG  C  + R+++ K+ + K+++       +    + E+ LLR L+H N
Sbjct: 8   YEVLYTIGTGSYG-RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII----KSSQALTNDHCQYFLFQLLRG 145
           ++   D ++    R    +Y+V E  +  DL  +I    K  Q L  +     + QL   
Sbjct: 67  IVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 146 LKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           LK  H  +     +LHRDLKP N+ ++   ++K+ DFGLAR  N    F   +V T +Y 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
           +PE +    +Y    D+WS+GC+  EL    P F
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 16/214 (7%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAI-KKINNAFENRVDALRTLRELKLLRHLQHEN 90
           Y  +  IG G+YG  C  + R+++ K+ + K+++       +    + E+ LLR L+H N
Sbjct: 8   YEVLYTIGTGSYG-RCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII----KSSQALTNDHCQYFLFQLLRG 145
           ++   D ++    R    +Y+V E  +  DL  +I    K  Q L  +     + QL   
Sbjct: 67  IVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 146 LKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           LK  H  +     +LHRDLKP N+ ++   ++K+ DFGLAR  N    F   +V T +Y 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
           +PE +    +Y    D+WS+GC+  EL    P F
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 17/207 (8%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           +  ++ IG G++G V  + +   +E VAIKK++ + +   +  +  ++E++ L+ L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 91  VIALKDVMMPSHRRNFKDVYLVYEL---MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            I  +   +  H       +LV E      +DL ++ K  + L            L+GL 
Sbjct: 77  TIQYRGCYLREH-----TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS N++HRD+K GN+L++    +K+ DFG A      N F    V T ++ APE++L 
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF----VGTPYWMAPEVILA 185
Query: 208 CD--NYGTSIDVWSVGCIFAELLGRKP 232
            D   Y   +DVWS+G    EL  RKP
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 96/333 (28%), Positives = 148/333 (44%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 66
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 67  QCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N  +TE   T +Y 
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEPCYTPYYV 184
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 185 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 223
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 224 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 279
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 280 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 310

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 138/303 (45%), Gaps = 51/303 (16%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           ID  ++  + +G GA+G V     R +  +  IK IN    ++V   +   E+++L+ L 
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLD 78
Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQA----LTNDHCQYFL 139
           H N+I + +V        F+D + +Y +M+T    +L + I S+QA    L+  +    +
Sbjct: 79  HPNIIKIFEV--------FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLL---VNANCDLKICDFGLARTSNGKNQFMTEYVVT 196
            Q++  L Y HS +++H+DLKP N+L    + +  +KI DFGLA      ++  T    T
Sbjct: 131 KQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAAGT 189
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
             Y APE+     +     D+WS G +   LL        T CL          G+  EE
Sbjct: 190 ALYMAPEVF--KRDVTFKCDIWSAGVVMYFLL--------TGCL-------PFTGTSLEE 232
Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
             +     +    ++  P TP              A+DLL++ML  DP +R S  + L H
Sbjct: 233 VQQKATYKEPNYAVECRPLTPQ-------------AVDLLKQMLTKDPERRPSAAQVLHH 279
Query: 317 PYM 319
            + 
Sbjct: 280 EWF 282

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 131/289 (45%), Gaps = 44/289 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G +G V       T  K+A K I        D      E+ ++  L H N+I L D 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 98  MMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
               +     D+ LV E +D      +II  S  LT      F+ Q+  G++++H   IL
Sbjct: 155 FESKN-----DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 156 HRDLKPGNLL-VNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           H DLKP N+L VN +   +KI DFGLAR    + +    +  T  + APE ++  D    
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPE-VVNYDFVSF 267
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE-EDLEFID-NPKARKYIK 271
             D+WSVG I   LL     F G    N  + + NIL  R + ED EF D + +A+++I 
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGD---NDAETLNNILACRWDLEDEEFQDISEEAKEFI- 323
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                                     K+L+ + + RIS +EAL+HP++S
Sbjct: 324 -------------------------SKLLIKEKSWRISASEALKHPWLS 347

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G GA+G+V     R T    A K +    E+  + +R  +E++ +  L+H  ++ L D 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPTLVNLHDA 222
Query: 98  MMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
                  +  ++ ++YE M       ++      ++ D    ++ Q+ +GL ++H  N +
Sbjct: 223 F-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 156 HRDLKPGNLLVNA--NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           H DLKP N++     + +LK+ DFGL    + K Q +     T  + APE+       G 
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEG-KPVGY 335
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL 273
             D+WSVG +   LL     F G                  E D E + N      +KS 
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGG------------------ENDDETLRN------VKSC 371
Query: 274 PYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQ 332
            +    + FS +  D      D ++K+L+ DP  R+++ +AL+HP+++P   P  +  +Q
Sbjct: 372 DWNMDDSAFSGISEDGK----DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD--SQ 425
Query: 333 VP 334
           +P
Sbjct: 426 IP 427

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
           + +  I  +G+GA+G V  + N   +   AIKKI +  E ++  +  L E+ LL  L H+
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTI--LSEVMLLASLNHQ 62
Query: 90  NVIALKDVMMPSHRRNF----------KDVYLVYELMDTDLHQIIKSSQALTNDHCQYF- 138
            V+      +   RRNF            +++  E  +      +  S+ L     +Y+ 
Sbjct: 63  YVVRYYAAWL--ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 139 LF-QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN------------- 184
           LF Q+L  L Y+HS  I+HRDLKP N+ ++ + ++KI DFGLA+  +             
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 185 -GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQL 243
            G +  +T  + T  Y A E+L    +Y   ID++S+G IF E++   P   G E +N L
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNIL 238
Query: 244 K 244
           K
Sbjct: 239 K 239

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 130/289 (44%), Gaps = 44/289 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ +G G+YG V  ++++ET + VAIK++        D    ++E+ +++     +V+  
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK-SSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 S+ +N  D+++V E      +  II+  ++ LT D     L   L+GL+YLH  
Sbjct: 90  ----YGSYFKN-TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
             +HRD+K GN+L+N     K+ DFG+A             + T ++ APE++     Y 
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEI-GYN 203
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
              D+WS+G    E+   KP +     +  + +I                          
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-------------------------- 237
Query: 273 LPYTPGTPFSR--LYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            P  P   F +  L+ D      D +++ LV  P +R + T+ LQHP++
Sbjct: 238 -PTNPPPTFRKPELWSDNF---TDFVKQCLVKSPEQRATATQLLQHPFV 282

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G GA+G+V     R T    A K +    E+  + +R  +E++ +  L+H  ++ L D 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPTLVNLHDA 116
Query: 98  MMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
                  +  ++ ++YE M       ++      ++ D    ++ Q+ +GL ++H  N +
Sbjct: 117 F-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 156 HRDLKPGNLLVNA--NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           H DLKP N++     + +LK+ DFGL    + K Q +     T  + APE+       G 
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEG-KPVGY 229
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL 273
             D+WSVG +   LL     F G                  E D E + N      +KS 
Sbjct: 230 YTDMWSVGVLSYILLSGLSPFGG------------------ENDDETLRN------VKSC 265
Query: 274 PYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQ 332
            +    + FS +  D      D ++K+L+ DP  R+++ +AL+HP+++P   P  +  +Q
Sbjct: 266 DWNMDDSAFSGISEDGK----DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD--SQ 319
Query: 333 VP 334
           +P
Sbjct: 320 IP 321

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 43/292 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHEN 90
           Y+    +G G +G V    +  T  KVA+K +N      +D + +  RE++ L+  +H +
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 91  VIALKDVM-MPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           +I L  V+  PS      D+++V E +   +L   I  +  L     +    Q+L G+ Y
Sbjct: 78  IIKLYQVISTPS------DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLAR-TSNGKNQFMTEYVVTRWYRAPELLLC 207
            H   ++HRDLKP N+L++A+ + KI DFGL+   S+G  +F+     +  Y APE++  
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRXSCGSPNYAAPEVISG 189
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
               G  +D+WS G I   LL     F         K I +                   
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD------------------- 230
Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                + YTP           +P  I LL+ ML  DP KR ++ +  +H + 
Sbjct: 231 ----GIFYTPQY--------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 73
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 74  QCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 132
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 133 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 191
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 192 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 230
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 231 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 286
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 287 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 317

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
           + +  I  +G+GA+G V  + N   +   AIKKI +  E ++  +  L E+ LL  L H+
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTI--LSEVMLLASLNHQ 62
Query: 90  NVIALKDVMMPSHRRNF----------KDVYLVYELMDTDLHQIIKSSQALTNDHCQYF- 138
            V+      +   RRNF            +++  E  +      +  S+ L     +Y+ 
Sbjct: 63  YVVRYYAAWL--ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 139 LF-QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN------------- 184
           LF Q+L  L Y+HS  I+HRDLKP N+ ++ + ++KI DFGLA+  +             
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 185 -GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQL 243
            G +  +T  + T  Y A E+L    +Y   ID++S+G IF E++   P   G E +N L
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNIL 238
Query: 244 K 244
           K
Sbjct: 239 K 239

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 67
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 68  QCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 126
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 127 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 185
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 186 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 224
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 225 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 280
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 281 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 311

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 74
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 75  QCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 133
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 134 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 192
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 193 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 231
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 232 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 287
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 288 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 318

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 82
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 83  QCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 141
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 142 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 200
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 201 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 239
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 240 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 295
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 296 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 326

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 66
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 67  QCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 125
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 126 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 184
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 185 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 223
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 224 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 279
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 280 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 310

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 72
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 73  QCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 131
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 132 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 190
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 191 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 229
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 230 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 285
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 286 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 316

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 91/324 (28%), Positives = 142/324 (43%), Gaps = 57/324 (17%)
Query: 27  EIDTKYVPIKPIGRGAYG--IVCSSVNRETNEKVAIKKINNAFENRV-DALRTLR----- 78
           +I   Y  ++ +G GAYG  ++C   N  + + + + K +   + R  D  + +      
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 79  ---ELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTND 133
              E+ LL+ L H N+I L DV         K  YLV E  +      QII   +    D
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDK-----KYFYLVTEFYEGGELFEQIINRHKF---D 144
Query: 134 HCQY--FLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQ 188
            C     + Q+L G+ YLH  NI+HRD+KP N+L+   N+  ++KI DFGL+ +   K+ 
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDY 203
Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
            + + + T +Y APE+L     Y    DVWS G I   LL   P F G            
Sbjct: 204 KLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGG------------ 249
Query: 249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI 308
                 + D + I   +  KY     Y     +  +  +A     +L++ ML +D  KR 
Sbjct: 250 ------QNDQDIIKKVEKGKY-----YFDFNDWKNISDEAK----ELIKLMLTYDYNKRC 294
Query: 309 SVTEALQHPYMSPLYDPSSNPPAQ 332
           +  EAL   ++   Y  + N   Q
Sbjct: 295 TAEEALNSRWIKK-YANNINKSDQ 317

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 140/305 (45%), Gaps = 38/305 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+++++ L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLK  NLL++A+ ++KI DFG +      N+  T +  +  Y APEL      
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQGKKY 189
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS+G I   L+     F G + L +L+              E +   K R   
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR--------------ERVLRGKYR--- 231
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
             +P+   T              +LL+K L+ +P+KR ++ + ++  +M+  ++     P
Sbjct: 232 --IPFYMSTDCE-----------NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKP 278
Query: 331 AQVPI 335
              P+
Sbjct: 279 YVAPL 283

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 118
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 119 QCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 177
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 178 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 236
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 237 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 275
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 276 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 331
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 332 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 362

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 112
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 113 QCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 230
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 231 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 269
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 270 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 325
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 326 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 356

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 68
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 69  QCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 186
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 187 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 225
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 226 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 281
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 282 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 312

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 95/333 (28%), Positives = 146/333 (43%), Gaps = 45/333 (13%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 68
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 69  QCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 186
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 187 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 225
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 226 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 281
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 282 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 312

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 141/305 (46%), Gaps = 38/305 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T ++VA++ I+    N     +  RE+++++ L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLK  NLL++A+ ++KI DFG +      N+ + E+  +  Y APEL      
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDEFCGSPPYAAPELFQGKKY 189
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS+G I   L+     F G + L +L+              E +   K R   
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR--------------ERVLRGKYR--- 231
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
             +P+   T              +LL+K L+ +P+KR ++ + ++  +M+  ++     P
Sbjct: 232 --IPFYMSTDCE-----------NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKP 278
Query: 331 AQVPI 335
              P+
Sbjct: 279 YVEPL 283

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 140/305 (45%), Gaps = 38/305 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+++++ L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLK  NLL++A+ ++KI DFG +      N+  T +  +  Y APEL      
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQGKKY 189
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS+G I   L+     F G + L +L+              E +   K R   
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR--------------ERVLRGKYR--- 231
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
             +P+   T              +LL+K L+ +P+KR ++ + ++  +M+  ++     P
Sbjct: 232 --IPFYMSTDCE-----------NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKP 278
Query: 331 AQVPI 335
              P+
Sbjct: 279 YVEPL 283

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/341 (24%), Positives = 149/341 (43%), Gaps = 55/341 (16%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T  +VAIK I+    N     +  RE+++++ L H N+
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YL+ E     ++   + +   +     +    Q++  ++Y H
Sbjct: 74  VKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCC 208
              I+HRDLK  NLL++A+ ++KI DFG +   T  GK   +  +  +  Y APEL    
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDTFCGSPPYAAPELFQGK 185
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
              G  +DVWS+G I   L+     F G + L +L+              E +   K R 
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR--------------ERVLRGKYR- 229
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ------------- 315
               +P+   T              +LL++ LV +P KR ++ + ++             
Sbjct: 230 ----IPFYMSTDCE-----------NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 274
Query: 316 HPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEM 356
            P++ P  D S      + + +   +E  +E + +M   E+
Sbjct: 275 KPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEI 315

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 140/305 (45%), Gaps = 38/305 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+++++ L H N+
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 69  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH 123
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLK  NLL++A+ ++KI DFG +      N+  T +  +  Y APEL      
Sbjct: 124 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQGKKY 182
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS+G I   L+     F G + L +L+              E +   K R   
Sbjct: 183 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR--------------ERVLRGKYR--- 224
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
             +P+   T              +LL+K L+ +P+KR ++ + ++  +M+  ++     P
Sbjct: 225 --IPFYMSTDCE-----------NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKP 271
Query: 331 AQVPI 335
              P+
Sbjct: 272 YVEPL 276

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 130/289 (44%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + + + +  + E+ ++R  ++ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPN 78
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG       +    +E V T ++ APE++     
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV-TRKA 192
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------------- 229
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                T GTP  +       +  D L + L  D  KR S  E LQH ++
Sbjct: 230 -----TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/341 (24%), Positives = 148/341 (43%), Gaps = 55/341 (16%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T  +VAIK I+    N     +  RE+++++ L H N+
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YL+ E     ++   + +   +     +    Q++  ++Y H
Sbjct: 77  VKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCC 208
              I+HRDLK  NLL++A+ ++KI DFG +   T  GK   +  +     Y APEL    
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGK 188
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
              G  +DVWS+G I   L+     F G + L +L+              E +   K R 
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR--------------ERVLRGKYR- 232
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ------------- 315
               +P+   T              +LL++ LV +P KR ++ + ++             
Sbjct: 233 ----IPFYMSTDCE-----------NLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277
Query: 316 HPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEM 356
            P++ P  D S      + + +   +E  +E + +M   E+
Sbjct: 278 KPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEI 318

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/318 (26%), Positives = 130/318 (40%), Gaps = 65/318 (20%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R   EL     L    ++ L   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 134
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +     R    V +  EL++   L Q++K    L  D   Y+L Q L GL+YLHS  ILH
Sbjct: 135 V-----REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 189
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSNGKNQFMTEYV-VTRWYRAPELLL--CC 208
            D+K  N+L++++     +CDFG    L     GK+    +Y+  T  + APE++L   C
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           D     +DVWS  C+   +L      P T                     +F   P   K
Sbjct: 250 D---AKVDVWSSCCMMLHML--NGCHPWT---------------------QFFRGPLCLK 283
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE-------------ALQ 315
                P     P   + P   PL    +Q+ L  +P  R+S  E              L+
Sbjct: 284 IASEPP-----PVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLK 338
Query: 316 HPYMSPLYDPSSNPPAQV 333
            P+     +P   PP Q 
Sbjct: 339 SPWRGEYKEPRHPPPNQA 356

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 140/305 (45%), Gaps = 38/305 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T ++VA++ I+    N     +  RE+++++ L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLK  NLL++A+ ++KI DFG +      N+  T +  +  Y APEL      
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQGKKY 189
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS+G I   L+     F G + L +L+              E +   K R   
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR--------------ERVLRGKYR--- 231
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
             +P+   T              +LL+K L+ +P+KR ++ + ++  +M+  ++     P
Sbjct: 232 --IPFYMSTDCE-----------NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKP 278
Query: 331 AQVPI 335
              P+
Sbjct: 279 YVEPL 283

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 46/295 (15%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  ++ +G GA+G+V   V + T      K IN  +   +D      E+ ++  L H  +
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKL 110
Query: 92  IALKDVMMPSHRRNFKDVY---LVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGL 146
           I L D         F+D Y   L+ E +       +I      ++      ++ Q   GL
Sbjct: 111 INLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 162
Query: 147 KYLHSANILHRDLKPGNLLVNAN--CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           K++H  +I+H D+KP N++        +KI DFGLA   N  ++ +     T  + APE 
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPE- 220
Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
           ++  +  G   D+W++G +   LL     F G + L  L+ +       +  D EF ++ 
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------KRCDWEFDED- 272
Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                           FS + P+A     +LLQK    +P KR++V +AL+HP++
Sbjct: 273 ---------------AFSSVSPEAKDFIKNLLQK----EPRKRLTVHDALEHPWL 308

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 124/283 (43%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 98
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 99  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 213
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I      + E D      PKAR  
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII------KLEYDFPAAFFPKAR-- 265
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                                   DL++K+LV D TKR+   E
Sbjct: 266 ------------------------DLVEKLLVLDATKRLGCEE 284

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII----------KLEY-DFPE---- 255
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 256 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 281

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 139/305 (45%), Gaps = 38/305 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+++++ L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLK  NLL++A+ ++KI DFG +      N+ +  +     Y APEL      
Sbjct: 131 QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKY 189
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            G  +DVWS+G I   L+     F G + L +L+              E +   K R   
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR--------------ERVLRGKYR--- 231
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
             +P+   T              +LL+K L+ +P+KR ++ + ++  +M+  ++     P
Sbjct: 232 --IPFYMSTDCE-----------NLLKKFLILNPSKRGTLEQIMKDRWMNVGHEDDELKP 278
Query: 331 AQVPI 335
              P+
Sbjct: 279 YVEPL 283

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 13/219 (5%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHL 86
           I+ +Y  +  +G G    V  + +   N KVAIK I      + + L+   RE+     L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 87  QHENVIALKDVMMPSHRRNFKD--VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
            H+N++++ DV       + +D   YLV E ++   L + I+S   L+ D    F  Q+L
Sbjct: 69  SHQNIVSMIDV-------DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQIL 121
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAP 202
            G+K+ H   I+HRD+KP N+L+++N  LKI DFG+A+  +  +   T +V+ T  Y +P
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLN 241
           E     +      D++S+G +  E+L  +P F G   ++
Sbjct: 182 E-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS 219

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 24  TLFEIDTKYVPIKPI-GRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +L  ID K + ++ + GRGA+G+VC +  R  +  VAIK+I +  E +      + EL+ 
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESESERKA----FIVELRQ 54
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQAL---TNDHCQYF 138
           L  + H N++ L    +         V LV E  +   L+ ++  ++ L   T  H   +
Sbjct: 55  LSRVNHPNIVKLYGACL-------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 139 LFQLLRGLKYLHSAN---ILHRDLKPGN-LLVNANCDLKICDFGLARTSNGKNQFMTEYV 194
             Q  +G+ YLHS     ++HRDLKP N LLV     LKICDFG   T+      MT   
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG---TACDIQTHMTNNK 164
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
            +  + APE+     NY    DV+S G I  E++ R+  F
Sbjct: 165 GSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 26/220 (11%)
Query: 24  TLFEIDTKYVPIKPI-GRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +L  ID K + ++ + GRGA+G+VC +  R  +  VAIK+I +  E +      + EL+ 
Sbjct: 2   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESESERKA----FIVELRQ 55
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQAL---TNDHCQYF 138
           L  + H N++ L    +         V LV E  +   L+ ++  ++ L   T  H   +
Sbjct: 56  LSRVNHPNIVKLYGACL-------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 108
Query: 139 LFQLLRGLKYLHSAN---ILHRDLKPGN-LLVNANCDLKICDFGLARTSNGKNQFMTEYV 194
             Q  +G+ YLHS     ++HRDLKP N LLV     LKICDFG   T+      MT   
Sbjct: 109 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG---TACDIQTHMTNNK 165
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
            +  + APE+     NY    DV+S G I  E++ R+  F
Sbjct: 166 GSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII----------KLEY-DFPE---- 255
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 256 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 281

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 115/241 (47%), Gaps = 33/241 (13%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
           + +  I  +G+GA+G V  + N   +   AIKKI +  E ++  +  L E+ LL  L H+
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTI--LSEVXLLASLNHQ 62
Query: 90  NVIALKDVMMPSHRRNF----------KDVYLVYELMDTDLHQIIKSSQALTNDHCQYF- 138
            V+      +   RRNF            +++  E  +      +  S+ L     +Y+ 
Sbjct: 63  YVVRYYAAWL--ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 139 LF-QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN------------- 184
           LF Q+L  L Y+HS  I+HR+LKP N+ ++ + ++KI DFGLA+  +             
Sbjct: 121 LFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 185 -GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQL 243
            G +  +T  + T  Y A E+L    +Y   ID +S+G IF E +   P   G E +N L
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI--YPFSTGXERVNIL 238
Query: 244 K 244
           K
Sbjct: 239 K 239

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 96
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 211
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 256
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 257 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 282

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 136/296 (45%), Gaps = 45/296 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +  +G GA+G V  + N+ET    A K I    E  ++    + E+++L    H  ++ L
Sbjct: 24  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDHPYIVKL 81
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQII--KSSQALTNDHCQYFLFQLLRGLKYLHSA 152
               + ++  + K ++++ E         I  +  + LT    Q    Q+L  L +LHS 
Sbjct: 82  ----LGAYYHDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN-- 210
            I+HRDLK GN+L+    D+++ DFG++  +    Q    ++ T ++ APE+++C     
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 211 --YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y    D+WS+G    E+   +P  P  E LN +++++ I                   
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVLLKI------------------- 234
Query: 269 YIKSLPYTPGTP--FSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
             KS P T  TP  +S  + D   +A+D        +P  R S  + L+HP++S +
Sbjct: 235 -AKSDPPTLLTPSKWSVEFRDFLKIALDK-------NPETRPSAAQLLEHPFVSSI 282

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 73
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 74  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 188
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 189 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 233
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 234 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 259

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 96
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 211
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 256
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 257 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 282

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 86/335 (25%), Positives = 144/335 (42%), Gaps = 61/335 (18%)
Query: 3   TPVEPPNGIRSPGKHYYSMWQTLFEIDTKYV-PIKPIGRGAYGIVCSSVNRETNEKVAIK 61
           T   PP  + S  K   S+    FE+    + PI  +GRGAYG+V    +  + + +A+K
Sbjct: 25  TSSTPPRDLDS--KACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVK 82
Query: 62  KINNAFENRVDALRTLRELKL-LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           +I  A  N  +  R L +L + +R +     +     +         DV++  ELMDT L
Sbjct: 83  RIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----DVWICMELMDTSL 136
Query: 121 ----HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKIC 175
                Q+I   Q +  D        +++ L++LHS  +++HRD+KP N+L+NA   +K+C
Sbjct: 137 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 196
Query: 176 DFGLARTSNGKNQFMTEYVVT------RWYRAPELL---LCCDNYGTSIDVWSVGCIFAE 226
           DFG++        ++ + V        + Y APE +   L    Y    D+WS+G    E
Sbjct: 197 DFGIS-------GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 249
Query: 227 L-LGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY 285
           L + R P         QLK              + ++ P         P  P   FS  +
Sbjct: 250 LAILRFPYDSWGTPFQQLK--------------QVVEEPS--------PQLPADKFSAEF 287
Query: 286 PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                  +D   + L  +  +R +  E +QHP+ +
Sbjct: 288 -------VDFTSQCLKKNSKERPTYPELMQHPFFT 315

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 93
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 253
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 254 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 279

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 255
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 256 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 281

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 72
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 73  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 187
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 188 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 232
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 233 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 258

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 255
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 256 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 281

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 136/296 (45%), Gaps = 45/296 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +  +G GA+G V  + N+ET    A K I    E  ++    + E+++L    H  ++ L
Sbjct: 16  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE--DYIVEIEILATCDHPYIVKL 73
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQII--KSSQALTNDHCQYFLFQLLRGLKYLHSA 152
               + ++  + K ++++ E         I  +  + LT    Q    Q+L  L +LHS 
Sbjct: 74  ----LGAYYHDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN-- 210
            I+HRDLK GN+L+    D+++ DFG++  +    Q    ++ T ++ APE+++C     
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 211 --YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y    D+WS+G    E+   +P  P  E LN +++++ I                   
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVLLKI------------------- 226
Query: 269 YIKSLPYTPGTP--FSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
             KS P T  TP  +S  + D   +A+D        +P  R S  + L+HP++S +
Sbjct: 227 -AKSDPPTLLTPSKWSVEFRDFLKIALDK-------NPETRPSAAQLLEHPFVSSI 274

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 93
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE-LLTEKS 208
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 253
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 254 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 279

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 93
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 253
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 254 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 279

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 255
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 256 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 281

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 70
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 71  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 185
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 186 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 230
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 231 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 256

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 92
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 207
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 252
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 253 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 278

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV--TRERDVMSRLDHPFFV 71
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 72  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 186
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 231
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 232 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 257

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 127/289 (43%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E+ ++R  ++ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG       +    +  V T ++ APE++     
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-TRKA 192
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------------- 229
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                T GTP  +       +  D L + L  D  KR S  E LQH ++
Sbjct: 230 -----TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 92
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 207
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 252
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 253 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 278

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 77
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 78  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 192
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 237
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 238 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 263

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 127/289 (43%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E+ ++R  ++ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG       +    +  V T ++ APE++     
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKA 192
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------------- 229
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                T GTP  +       +  D L + L  D  KR S  E LQH ++
Sbjct: 230 -----TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 100
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 101 KLYFCFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 215
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 260
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 261 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 286

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++  V  +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 95
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      +  L + I+   +      +++  +++  L+YLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYA----KNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKS 210
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 255
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 256 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 281

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   TE   T  Y  PE++     + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTELCGTLDYLPPEMIE-GRMHD 184
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 224
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 225 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 127/289 (43%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E+ ++R  ++ N
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 79
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 80  IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 134
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG       +    +  V T ++ APE++     
Sbjct: 135 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV-TRKA 193
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA----------------------- 230
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                T GTP  +       +  D L + L  D  KR S  E +QH ++
Sbjct: 231 -----TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    +R +   +A K    +I  A  N++     +REL++L 
Sbjct: 15  DDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLH 69
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K ++ +  +        +L
Sbjct: 70  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVL 124
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           RGL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y AP
Sbjct: 125 RGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMAP 182
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP 235
           E L    +Y    D+WS+G    EL +GR PI P
Sbjct: 183 ERLQGT-HYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 121/284 (42%), Gaps = 52/284 (18%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R   EL     L    ++ L   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRA-EELMACAGLTSPRIVPLYGA 153
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +     R    V +  EL++   L Q++K    L  D   Y+L Q L GL+YLHS  ILH
Sbjct: 154 V-----REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILH 208
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSNGKNQFMTEYV-VTRWYRAPELLL--CC 208
            D+K  N+L++++     +CDFG    L     GK+    +Y+  T  + APE++L   C
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           D     +DVWS  C+   +L      P T                     +F   P   K
Sbjct: 269 D---AKVDVWSSCCMMLHML--NGCHPWT---------------------QFFRGPLCLK 302
Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                P     P   + P   PL    +Q+ L  +P  R+S  E
Sbjct: 303 IASEPP-----PVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAE 341

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQHENVIA 93
           K IGRG +  V  +        VA+KK+   +  + +  A   ++E+ LL+ L H NVI 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLNHPNVIK 96
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK----SSQALTNDHCQYFLFQLLRGLKY 148
                +  +  N     +V EL D  DL ++IK      + +       +  QL   L++
Sbjct: 97  YYASFIEDNELN-----IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           +HS  ++HRD+KP N+ + A   +K+ D GL R  + K       V T +Y +PE +   
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-E 210
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPG 236
           + Y    D+WS+GC+  E+   +  F G
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYG 238

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 45/283 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVI 92
           K +G G++     +    T+ + AIK +       EN+V  +   RE  ++  L H   +
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFFV 93
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
            L        +  F   Y      + +L + I+   +      +++  +++  L+YLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYA----KNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PE LL   +
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE-LLTEKS 208
Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
              S D+W++GCI  +L+ G  P   G E L   K+I           LE+ D P+    
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----------KLEY-DFPE---- 253
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                        + +P A     DL++K+LV D TKR+   E
Sbjct: 254 -------------KFFPKAR----DLVEKLLVLDATKRLGCEE 279

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT-LRELKLLRHLQHENVIALKD 96
           +G+G +G      +RET E + +K++    E   +  RT L+E+K++R L+H NV+    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 97  VMMPSHRRNFKDVYLVYELMDTDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANI 154
           V+    R NF   Y+        L  IIKS  SQ   +     F   +  G+ YLHS NI
Sbjct: 75  VLYKDKRLNFITEYI----KGGTLRGIIKSMDSQYPWSQRVS-FAKDIASGMAYLHSMNI 129
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVVTR--WYR 200
           +HRDL   N LV  N ++ + DFGLAR             S  K      Y V    ++ 
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGR 230
           APE ++   +Y   +DV+S G +  E++GR
Sbjct: 190 APE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 7/202 (3%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           K IG+G +  V  + +  T  +VA+K I+    N     +  RE+++++ L H N++ L 
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 96  DVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +V+        K +YLV E     ++   + +   +     +    Q++  ++Y H   I
Sbjct: 81  EVIETE-----KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYI 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           +HRDLK  NLL++ + ++KI DFG +      N+  T +  +  Y APEL       G  
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-FCGSPPYAAPELFQGKKYDGPE 194
Query: 215 IDVWSVGCIFAELLGRKPIFPG 236
           +DVWS+G I   L+     F G
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDG 216

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 15/229 (6%)
Query: 6   EPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN- 64
           EPP  +   G     +     E   KY  + P+G GA+G V ++V++E N++V +K I  
Sbjct: 5   EPPKAVELEG-----LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKK 59
Query: 65  -----NAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD 119
                + +       +   E+ +L  ++H N+I + D+      + F  + +       D
Sbjct: 60  EKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLD 116
Query: 120 LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L   I     L      Y   QL+  + YL   +I+HRD+K  N+++  +  +K+ DFG 
Sbjct: 117 LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS 176
Query: 180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           A        F T +  T  Y APE+L+     G  +++WS+G     L+
Sbjct: 177 AAYLERGKLFYT-FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 94/335 (28%), Positives = 142/335 (42%), Gaps = 51/335 (15%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQ-------DCPKARREVELHWRAS 112
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T          + 
Sbjct: 113 QCPHIVRIVDVYENLYA-GRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIG 171
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYYV 230
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D WS+G I   LL   P F     L                    
Sbjct: 231 APE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL-------------------- 269
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R ++TE   HP++
Sbjct: 270 AISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKT----EPTQRXTITEFXNHPWI 325
Query: 320 SPLYDPSSNPPAQVPID----LDMDEESGEEMIRE 350
                  S    Q P+     L  D+E  E++  E
Sbjct: 326 X-----QSTKVPQTPLHTSRVLKEDKERWEDVKEE 355

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 31/242 (12%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y  +K IG+G +  V  + +  T ++VA+K I+    N     +  RE+++ + L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L +V+        K +YLV E     ++   + +         +    Q++  ++Y H
Sbjct: 76  VKLFEVIETE-----KTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I+HRDLK  NLL++A+ ++KI DFG +      N+ +  +     Y APEL      
Sbjct: 131 QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKY 189
Query: 211 YGTSIDVWSVGCIFAELLG----------------------RKPIFPGTECLNQLK--LI 246
            G  +DVWS+G I   L+                       R P +  T+C N LK  LI
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLI 249
Query: 247 IN 248
           +N
Sbjct: 250 LN 251

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 132/303 (43%), Gaps = 58/303 (19%)
Query: 34  PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHLQHENVI 92
           PI  +GRGAYG+V    +  + + +A+K+I  A  N  +  R L +L + +R +     +
Sbjct: 11  PIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDL----HQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                +         DV++  ELMDT L     Q+I   Q +  D        +++ L++
Sbjct: 70  TFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 149 LHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRA 201
           LHS  +++HRD+KP N+L+NA   +K+CDFG++        ++ + V        + Y A
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS-------GYLVDDVAKDIDAGCKPYMA 177
Query: 202 PELL---LCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREED 257
           PE +   L    Y    D+WS+G    EL + R P         QLK             
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK------------- 224
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
            + ++ P         P  P   FS  +       +D   + L  +  +R +  E +QHP
Sbjct: 225 -QVVEEPS--------PQLPADKFSAEF-------VDFTSQCLKKNSKERPTYPELMQHP 268
Query: 318 YMS 320
           + +
Sbjct: 269 FFT 271

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK IG G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E M   D+   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK IG G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E M   D+   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHENVIA 93
           ++ IG+G++G VC     +T +  A+K +N      R +     +EL++++ L+H  ++ 
Sbjct: 20  LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 94  LKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           L         ++ +D+++V +L+   DL   ++ +     +  + F+ +L+  L YL + 
Sbjct: 80  LWYSF-----QDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I+HRD+KP N+L++ +  + I DF +A     + Q +T    T+ Y APE+       G
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEMFSSRKGAG 193
Query: 213 TS--IDVWSVGCIFAELL-GRKP 232
            S  +D WS+G    ELL GR+P
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 95  KDVMMPSHRRNFKDVYLV--YELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+  Y  + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 153
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE++     + 
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIE-GRMHD 210
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 250
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 251 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 295

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 130/296 (43%), Gaps = 43/296 (14%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
                 + R     VYL+ E     ++++ ++            ++ +L   L Y HS  
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE++     +  
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIE-GRMHDE 190
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL 273
            +D+WS+G +  E L  KP F         K I  +         EF             
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT------------ 229
Query: 274 PYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                      +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 230 -----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 132
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T+   T  Y  PE++     + 
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIE-GRMHD 189
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 229
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 230 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 128
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T+   T  Y  PE++     + 
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEMIE-GRMHD 185
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 225
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 226 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T+   T  Y  PE ++    + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPE-MIEGRMHD 184
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 224
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 225 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T+   T  Y  PE ++    + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPE-MIEGRMHD 184
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 224
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 225 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/289 (22%), Positives = 129/289 (44%), Gaps = 36/289 (12%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + + + +  + E+ ++R  ++ N
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPN 79
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D  +        ++++V E +       + +   +          + L+ L++LH
Sbjct: 80  IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 134
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HR++K  N+L+  +  +K+ DFG       +    +  V T ++ APE++     
Sbjct: 135 SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKA 193
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------------------ 229
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                T GTP  +       +  D L + L  D  KR S  E +QH ++
Sbjct: 230 ----ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 130
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE++     + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIE-GRMHD 187
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 227
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 228 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 128
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE ++    + 
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGW--SCHAPSSRRTTLSGTLDYLPPE-MIEGRMHD 185
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 225
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 226 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 144
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE++     + 
Sbjct: 145 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIE-GRMHD 201
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 241
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 242 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 286

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 132
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE++     + 
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIE-GRMHD 189
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 229
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 230 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 131/305 (42%), Gaps = 54/305 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHEN 90
           + P   +G GA G +        N  VA+K+I     +  D     RE++LLR   +H N
Sbjct: 26  FCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPN 79
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYL 149
           VI           R F+  Y+  EL    L + ++    A         L Q   GL +L
Sbjct: 80  VIRY---FCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 150 HSANILHRDLKPGNLLV---NANCDLK--ICDFGLART-SNGKNQFMTEYVV--TRWYRA 201
           HS NI+HRDLKP N+L+   NA+  +K  I DFGL +  + G++ F     V  T  + A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 202 PELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           PE+L   C +N   ++D++S GC+F  ++       G     Q  +++            
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG----------- 243
Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHP--LAIDLLQKMLVFDPTKRISVTEALQHP 317
                                   L+P+ H   +A +L++KM+  DP KR S    L+HP
Sbjct: 244 ------------------ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 318 YMSPL 322
           +   L
Sbjct: 286 FFWSL 290

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE++     + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIE-GRMHD 184
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 224
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 225 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/312 (25%), Positives = 136/312 (43%), Gaps = 46/312 (14%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           K +G+G++G V  +  ++TN+  AIK +        D +      K +  L  E+     
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 96  DVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                  + N   ++ V E ++  DL   I+S          ++  +++ GL++LHS  I
Sbjct: 84  MFCTFQTKEN---LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 140
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTS 214
           ++RDLK  N+L++ +  +KI DFG+ + +   +    E+  T  Y APE+LL    Y  S
Sbjct: 141 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL-GQKYNHS 199
Query: 215 IDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLP 274
           +D WS G +  E+L  +  F G    ++ +L  +I           +DNP   ++++   
Sbjct: 200 VDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIR----------MDNPFYPRWLEK-- 244
Query: 275 YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL-QHPYMSPL---------YD 324
                            A DLL K+ V +P KR+ V   + QHP    +          D
Sbjct: 245 ----------------EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 288
Query: 325 PSSNPPAQVPID 336
           P   P  + P D
Sbjct: 289 PPFRPKVKSPFD 300

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 130/297 (43%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 132
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE +     + 
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEXIE-GRXHD 189
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 229
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 230 ------------FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITANSSKPSN 274

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 89/334 (26%), Positives = 149/334 (44%), Gaps = 59/334 (17%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   TL E ++L++ +H  + A
Sbjct: 13  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 72
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS- 151
           LK       R  F     V E  +  +L   +   +  + D  +++  +++  L YLHS 
Sbjct: 73  LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 127
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D Y
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-Y 186
Query: 212 GTSIDVWSVGCIFAELL-GRKPIF-PGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           G ++D W +G +  E++ GR P +    E L +L L+         E++ F         
Sbjct: 187 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EEIRF--------- 228
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL-- 322
               P T G       P+A  L   LL+K    DP +R+        E +QH + + +  
Sbjct: 229 ----PRTLG-------PEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVW 273
Query: 323 ---YDPSSNPP--AQVPIDLD---MDEESGEEMI 348
              Y+   +PP   QV  + D    DEE   +MI
Sbjct: 274 QHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMI 307

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 43/296 (14%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
                 + R     VYL+ E     ++++ ++            ++ +L   L Y HS  
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           ++HRD+KP NLL+ +  +LKI DFG +  +    +      +   Y  PE ++    +  
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLD--YLPPE-MIEGRMHDE 190
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL 273
            +D+WS+G +  E L  KP F         K I  +         EF             
Sbjct: 191 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT------------ 229
Query: 274 PYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                      +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 230 -----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 89/334 (26%), Positives = 149/334 (44%), Gaps = 59/334 (17%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   TL E ++L++ +H  + A
Sbjct: 14  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 73
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS- 151
           LK       R  F     V E  +  +L   +   +  + D  +++  +++  L YLHS 
Sbjct: 74  LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D Y
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-Y 187
Query: 212 GTSIDVWSVGCIFAELL-GRKPIF-PGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           G ++D W +G +  E++ GR P +    E L +L L+         E++ F         
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EEIRF--------- 229
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL-- 322
               P T G       P+A  L   LL+K    DP +R+        E +QH + + +  
Sbjct: 230 ----PRTLG-------PEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVW 274
Query: 323 ---YDPSSNPP--AQVPIDLD---MDEESGEEMI 348
              Y+   +PP   QV  + D    DEE   +MI
Sbjct: 275 QHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMI 308

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE ++    + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTXLCGTLDYLPPE-MIEGRMHD 184
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 224
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 225 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 131
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE ++    + 
Sbjct: 132 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPE-MIEGRMHD 188
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 228
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 229 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 265

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 95  KDVMMPSHRRNFKDVYLV--YELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+  Y  + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 153
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +    +   T  Y  PE++     + 
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEMIE-GRMHD 210
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 250
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 251 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 295

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 126
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE ++    + 
Sbjct: 127 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPE-MIEGRMHD 183
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 223
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 224 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 260

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 89/334 (26%), Positives = 149/334 (44%), Gaps = 59/334 (17%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   TL E ++L++ +H  + A
Sbjct: 15  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 74
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS- 151
           LK       R  F     V E  +  +L   +   +  + D  +++  +++  L YLHS 
Sbjct: 75  LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D Y
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND-Y 188
Query: 212 GTSIDVWSVGCIFAELL-GRKPIF-PGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           G ++D W +G +  E++ GR P +    E L +L L+         E++ F         
Sbjct: 189 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EEIRF--------- 230
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL-- 322
               P T G       P+A  L   LL+K    DP +R+        E +QH + + +  
Sbjct: 231 ----PRTLG-------PEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVW 275
Query: 323 ---YDPSSNPP--AQVPIDLD---MDEESGEEMI 348
              Y+   +PP   QV  + D    DEE   +MI
Sbjct: 276 QHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMI 309

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 130
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE ++    + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPE-MIEGRMHD 187
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 227
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 228 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 10/218 (4%)
Query: 35  IKPIGRGAYGIV--CSSVNR-ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +K +G+G++G V     V R ++    A+K +  A     D +RT  E  +L  + H  V
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFV 92
Query: 92  IALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L        +     +YL+ + +   DL   +      T +  +++L +L  GL +LH
Sbjct: 93  VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  I++RDLKP N+L++    +K+ DFGL++ +    +    +  T  Y APE ++    
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQG 206
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
           +  S D WS G +  E+L     F G +    + LI+ 
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILK 244

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 49/291 (16%)
Query: 36  KPIGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVI 92
           +P+G+G +G V   + RE N K  +A+K +  A   +      LR E+++  HL+H N++
Sbjct: 14  RPLGKGKFGNVY--LAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 71
Query: 93  ALKDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
            L      S R     VYL+ E   + T   ++ K S+         ++ +L   L Y H
Sbjct: 72  RLYGYFHDSTR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH 125
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+KP NLL+ +  +LKI DFG   + +  +        T  Y  PE ++    
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPE-MIEGRM 182
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           +   +D+WS+G +  E L  KP F      +  K I  +         EF          
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV---------EFT--------- 224
Query: 271 KSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                         +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 225 --------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHENVIALKD 96
           IG GA  +V ++      EKVAIK+IN    +  +D L  L+E++ +    H N++    
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQCHHPNIV---- 76
Query: 97  VMMPSHRRNF---KDVYLVYELM------DTDLHQIIKS---SQALTNDHCQYFLFQLLR 144
               S+  +F    +++LV +L+      D   H + K    S  L        L ++L 
Sbjct: 77  ----SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNG---KNQFMTEYVVTRWY 199
           GL+YLH    +HRD+K GN+L+  +  ++I DFG++    + G   +N+    +V T  +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEL 227
            APE++     Y    D+WS G    EL
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIEL 220

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   T+ E ++L++ +H  + A
Sbjct: 15  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 74
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           LK       R  F     V E  +  +L   +   +  T +  +++  +++  L+YLHS 
Sbjct: 75  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 129
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 130 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YG 188
Query: 213 TSIDVWSVGCIFAELL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFY 211

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   T+ E ++L++ +H  + A
Sbjct: 13  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 72
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           LK       R  F     V E  +  +L   +   +  T +  +++  +++  L+YLHS 
Sbjct: 73  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 128 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YG 186
Query: 213 TSIDVWSVGCIFAELL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFY 209

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 130
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +        T  Y  PE++     + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEMIE-GRMHD 187
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 227
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 228 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   T+ E ++L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           LK       R  F     V E  +  +L   +   +  T +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAELL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   T+ E ++L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           LK       R  F     V E  +  +L   +   +  T +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAELL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 129/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 130
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +    +   T  Y  PE ++    + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPE-MIEGRMHD 187
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 227
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 228 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHENVIALKD 96
           IG GA  +V ++      EKVAIK+IN    +  +D L  L+E++ +    H N++    
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQCHHPNIV---- 71
Query: 97  VMMPSHRRNF---KDVYLVYELM------DTDLHQIIKS---SQALTNDHCQYFLFQLLR 144
               S+  +F    +++LV +L+      D   H + K    S  L        L ++L 
Sbjct: 72  ----SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNG---KNQFMTEYVVTRWY 199
           GL+YLH    +HRD+K GN+L+  +  ++I DFG++    + G   +N+    +V T  +
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAEL 227
            APE++     Y    D+WS G    EL
Sbjct: 188 MAPEVMEQVRGYDFKADIWSFGITAIEL 215

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   T+ E ++L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           LK       R  F     V E  +  +L   +   +  T +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAELL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   T+ E ++L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           LK       R  F     V E  +  +L   +   +  T +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAELL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   T+ E ++L++ +H  + A
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           LK       R  F     V E  +  +L   +   +  T +  +++  +++  L+YLHS 
Sbjct: 70  LKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YG 183
Query: 213 TSIDVWSVGCIFAELL-GRKPIF 234
            ++D W +G +  E++ GR P +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 129
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI +FG   + +  +   T    T  Y  PE++     + 
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEMIE-GRMHD 186
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 226
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 227 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 72
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 129
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR----WYRAPEL 204
           L +   +HRDL   N+LV     +KI DFGL +      +F            WY APE 
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APE- 187
Query: 205 LLCCDNYGTSIDVWSVGCIFAELL 228
            L    +  + DVWS G +  EL 
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELF 211

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 130
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI +FG   + +  +   T    T  Y  PE ++    + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPE-MIEGRMHD 187
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 227
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 228 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  ++    +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 124
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +   T    T  Y  PE ++    + 
Sbjct: 125 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPE-MIEGRMHD 181
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 221
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 222 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 258

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 148/333 (44%), Gaps = 59/333 (17%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   TL E ++L++ +H  + A
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS- 151
           LK       R  F     V E  +  +L   +   +  + D  +++  +++  L YLHS 
Sbjct: 213 LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N+++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D Y
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-Y 326
Query: 212 GTSIDVWSVGCIFAELL-GRKPIF-PGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           G ++D W +G +  E++ GR P +    E L +L L+         E++ F         
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EEIRF--------- 368
Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL-- 322
               P T G       P+A  L   LL+K    DP +R+        E +QH + + +  
Sbjct: 369 ----PRTLG-------PEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVW 413
Query: 323 ---YDPSSNPP--AQVPIDLD---MDEESGEEM 347
              Y+   +PP   QV  + D    DEE   +M
Sbjct: 414 QHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQM 446

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 130/288 (45%), Gaps = 45/288 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  R++   +A+K +      +      LR E+++  HL+H N++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCHSK 131
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +N +LKI DFG   + +  +   T    T  Y  PE ++    + 
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPE-MIEGRMHD 188
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L   P F                              +A  Y ++
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPF------------------------------EAHTYQET 218
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                   F+  +PD     A DL+ ++L  + ++R+++ E L+HP++
Sbjct: 219 YRRISRVEFT--FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 129
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +        T  Y  PE++     + 
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEMIE-GRMHD 186
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 226
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 227 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +        T  Y  PE ++    + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPE-MIEGRMHD 184
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 224
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 225 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 141/320 (44%), Gaps = 52/320 (16%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIA 93
           +K +G+G +G V     + T    A+K +       + +   TL E ++L++ +H  + A
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-A 152
           LK       R  F   Y        +L   +   +  + D  +++  +++  L YLHS  
Sbjct: 216 LKYSFQTHDRLCFVMEYA----NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           N+++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+L   D YG
Sbjct: 272 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YG 330
Query: 213 TSIDVWSVGCIFAELL-GRKPIF-PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
            ++D W +G +  E++ GR P +    E L +L L+         E++ F          
Sbjct: 331 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------EEIRF---------- 371
Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL--- 322
              P T G       P+A  L   LL+K    DP +R+        E +QH + + +   
Sbjct: 372 ---PRTLG-------PEAKSLLSGLLKK----DPKQRLGGGSEDAKEIMQHRFFAGIVWQ 417
Query: 323 --YDPSSNPPAQVPIDLDMD 340
             Y+   +PP +  +  + D
Sbjct: 418 HVYEKKLSPPFKPQVTSETD 437

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK IG G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTIGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 130/298 (43%), Gaps = 46/298 (15%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 24  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 78
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K +  +           ++
Sbjct: 79  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 133
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y +P
Sbjct: 134 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 191
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           E L    +Y    D+WS+G    E+ +GR PI  G+  +   +L            L++I
Sbjct: 192 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFEL------------LDYI 238
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            N          P  P   FS  +        D + K L+ +P +R  + + + H ++
Sbjct: 239 VNEPP-------PKLPSGVFSLEFQ-------DFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/319 (24%), Positives = 136/319 (42%), Gaps = 52/319 (16%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           ++  K +G+G++G V  +  ++TN+  AIK +        D +      K +  L  E+ 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
                      + N   ++ V E ++  DL   I+S          ++  +++ GL++LH
Sbjct: 79  FLTHMFCTFQTKEN---LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  I++RDLK  N+L++ +  +KI DFG+ + +   +     +  T  Y APE+LL    
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL-GQK 194
Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF---IDNPKAR 267
           Y  S+D WS G +  E+L  +  F G +                EE+L     +DNP   
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQD----------------EEELFHSIRMDNPFYP 238
Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL-QHPYMSPL---- 322
           ++++                    A DLL K+ V +P KR+ V   + QHP    +    
Sbjct: 239 RWLEK------------------EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 280
Query: 323 -----YDPSSNPPAQVPID 336
                 DP   P  + P D
Sbjct: 281 LERKEIDPPFRPKVKSPFD 299

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 127
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +        T  Y  PE ++    + 
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPE-MIEGRMHD 184
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 224
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 225 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 261

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 45/297 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 128
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +        T  Y  PE++     + 
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEMIE-GRMHD 185
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 225
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                       +PD     A DL+ ++L  +P++R  + E L+HP+++      SN
Sbjct: 226 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  +++   +A+K +  A   +      LR E+++  HL+H N++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSK 130
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +  +LKI DFG   + +  +        T  Y  PE ++    + 
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPE-MIEGRMHD 187
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L  KP F         K I  +         EF            
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------EFT----------- 227
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                       +PD     A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 228 ------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 264

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ +G G YG V    + +T +  AIK ++   +   +  + +  LK   H  H N+   
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATY 86
Query: 95  KDVMMPSHRRNFKD-VYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLH 150
               +  +     D ++LV E      +  +IK+++   L  +   Y   ++LRGL +LH
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLA----RTSNGKNQFMTEYVVTRWYRAPELLL 206
              ++HRD+K  N+L+  N ++K+ DFG++    RT   +N F    + T ++ APE++ 
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----IGTPYWMAPEVIA 202
Query: 207 CCDN----YGTSIDVWSVGCIFAELLGRKP 232
           C +N    Y    D+WS+G    E+    P
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 142/298 (47%), Gaps = 43/298 (14%)
Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           E+  KY+  + +GRG +GIV   V   + +    K +        D +   +E+ +L   
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIA 58
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTND-HCQYFLFQLLR 144
           +H N++ L +        + +++ +++E +   D+ + I +S    N+     ++ Q+  
Sbjct: 59  RHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 145 GLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
            L++LHS NI H D++P N++     +  +KI +FG AR     + F   +    +Y AP
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY-AP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           E +   D   T+ D+WS+G +   LL G  P    T   NQ ++I NI+ +      E+ 
Sbjct: 173 E-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQ-QIIENIMNA------EYT 221
Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            + +A K I S+                  A+D + ++LV +   R++ +EALQHP++
Sbjct: 222 FDEEAFKEI-SIE-----------------AMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQHEN 90
           YV    +G G +G V    ++ T  KVA+K +N      +D +  + RE++ L+  +H +
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           +I L  V+         D ++V E +   +L   I     +     +    Q+L  + Y 
Sbjct: 73  IIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   ++HRDLKP N+L++A+ + KI DFGL+   +   +F+ +   +  Y APE++    
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGSPNYAAPEVISGRL 186
Query: 210 NYGTSIDVWSVGCIFAELL 228
             G  +D+WS G I   LL
Sbjct: 187 YAGPEVDIWSCGVILYALL 205

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMP---SHRRNFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P       +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMP---SHRRNFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P       +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 38  IGRGAYGIVCSS--VNRETNE-KVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIA 93
           IG+G +G+V     +++  N  + AIK ++   E  +V+A   LRE  L+R L H NV+A
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF--LREGLLMRGLNHPNVLA 86
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSA 152
           L  +M+P        V L Y +   DL Q I+S Q   T      F  Q+ RG++YL   
Sbjct: 87  LIGIMLPP--EGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN-- 210
             +HRDL   N +++ +  +K+ DFGLAR    +  +  +    R  R P      ++  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ--HRHARLPVKWTALESLQ 201
Query: 211 ---YGTSIDVWSVGCIFAELLGR 230
              + T  DVWS G +  ELL R
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTR 224

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKETGNHFAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMP---SHRRNFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P       +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 88
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 89  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 148
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 204
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 67  IKTLGTGSFGRVMLVKHKETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 116
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 117 QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 176
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 232
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHKETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 75
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRGLKY 148
           ++  K V   + RRN K   L+ E +     +    + A   DH +   +  Q+ +G++Y
Sbjct: 76  IVKYKGVCYSAGRRNLK---LIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEY 132
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 190
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 191 -SLTESKFSVASDVWSFGVVLYELF 214

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 105/223 (47%), Gaps = 10/223 (4%)
Query: 30  TKYVPIKPIGRGAYG---IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +++  +K +G+G++G   +V      +  +  A+K +  A     D +RT  E  +L  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            H  ++ L        +     +YL+ + +   DL   +      T +  +++L +L   
Sbjct: 84  NHPFIVKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L +LHS  I++RDLKP N+L++    +K+ DFGL++ S    +    +  T  Y APE +
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-V 197
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
           +    +  S D WS G +  E+L     F G +    + +I+ 
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 16  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 73
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 130
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR-------WYRA 201
           L +   +HR+L   N+LV     +KI DFGL +      ++   Y V         WY A
Sbjct: 131 LGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEY---YKVKEPGESPIFWY-A 186
Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELL 228
           PE  L    +  + DVWS G +  EL 
Sbjct: 187 PE-SLTESKFSVASDVWSFGVVLYELF 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKEIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +K+ DFGLA+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 112/221 (50%), Gaps = 21/221 (9%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
              Y  ++D W++G +  E+    P F   E +   + I++
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVS 252

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 8/199 (4%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQHEN 90
           YV    +G G +G V    ++ T  KVA+K +N      +D +  + RE++ L+  +H +
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           +I L  V+         D ++V E +   +L   I     +     +    Q+L  + Y 
Sbjct: 73  IIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   ++HRDLKP N+L++A+ + KI DFGL+   +   +F+     +  Y APE++    
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVISGRL 186
Query: 210 NYGTSIDVWSVGCIFAELL 228
             G  +D+WS G I   LL
Sbjct: 187 YAGPEVDIWSCGVILYALL 205

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 15/222 (6%)
Query: 35  IKPIGRGAYGIVCSS---VNRETNEKVAIKKINNAF--ENRVDALRTLRELKLLRHLQHE 89
           ++ +G+G YG V          T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            ++ L        +     +YL+ E L   +L   ++       D   ++L ++   L +
Sbjct: 82  FIVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LH   I++RDLKP N+++N    +K+ DFGL + S         +  T  Y APE+L+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL 250
             +  ++D WS+G +  ++L   P F G    N+ K I  IL
Sbjct: 197 -GHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKIL 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 39  IKTLGTGSFGRVMLVKHKETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 88
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 89  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 148
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 204
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 15/222 (6%)
Query: 35  IKPIGRGAYGIVCSS---VNRETNEKVAIKKINNAF--ENRVDALRTLRELKLLRHLQHE 89
           ++ +G+G YG V          T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            ++ L        +     +YL+ E L   +L   ++       D   ++L ++   L +
Sbjct: 82  FIVDLIYAFQTGGK-----LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LH   I++RDLKP N+++N    +K+ DFGL + S         +  T  Y APE+L+  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL 250
             +  ++D WS+G +  ++L   P F G    N+ K I  IL
Sbjct: 197 -GHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKIL 234

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 127/303 (41%), Gaps = 58/303 (19%)
Query: 34  PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHLQHENVI 92
           PI  +GRGAYG+V    +  + +  A+K+I  A  N  +  R L +L +  R +     +
Sbjct: 38  PIXELGRGAYGVVEKXRHVPSGQIXAVKRIR-ATVNSQEQKRLLXDLDISXRTVDCPFTV 96
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTDL----HQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                +         DV++  EL DT L     Q+I   Q +  D        +++ L++
Sbjct: 97  TFYGALFREG-----DVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 151
Query: 149 LHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRA 201
           LHS  +++HRD+KP N+L+NA   +K CDFG++        ++ + V        + Y A
Sbjct: 152 LHSKLSVIHRDVKPSNVLINALGQVKXCDFGIS-------GYLVDDVAKDIDAGCKPYXA 204
Query: 202 PELL---LCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREED 257
           PE +   L    Y    D+WS+G    EL + R P         QLK             
Sbjct: 205 PERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLK------------- 251
Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
            + ++ P         P  P   FS  +       +D   + L  +  +R +  E  QHP
Sbjct: 252 -QVVEEPS--------PQLPADKFSAEF-------VDFTSQCLKKNSKERPTYPELXQHP 295
Query: 318 YMS 320
           + +
Sbjct: 296 FFT 298

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 103
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 160
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 218
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 219 -SLTESKFSVASDVWSFGVVLYELF 242

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 18  YYSMWQTLFEI-DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVD 72
           + +  Q + E+ D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++ 
Sbjct: 55  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI- 113
Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALT 131
               +REL++L       ++               ++ +  E MD   L Q++K +  + 
Sbjct: 114 ----IRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIP 164
Query: 132 NDHCQYFLFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
                     +++GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +   
Sbjct: 165 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMA 222
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP 235
             +V TR Y +PE L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 223 NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI-- 92
           I+ +G G++G V    ++ET    A+K ++          + + +LK + H  +E  I  
Sbjct: 47  IRTLGTGSFGRVMLVKHKETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRIQQ 97
Query: 93  ALKDVMMPSHRRNFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           A+    +     +FKD   +Y+V E     ++   ++     +  H +++  Q++   +Y
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LHS ++++RDLKP NLL++    +K+ DFG A+   G+   +     T  Y APE++L  
Sbjct: 158 LHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-S 213
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIF 234
             Y  ++D W++G +  E+    P F
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 136/337 (40%), Gaps = 63/337 (18%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK--------------------KINNAFE 68
           D +Y+ ++ +G G +  V  + +   N  VA+K                    ++N+A  
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 69  NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIK--S 126
            + D++     LKLL H  H+               N   V +V+E++  +L  +IK   
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGP-------------NGVHVVMVFEVLGENLLALIKKYE 124
Query: 127 SQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNAN------CDLKICDFGL 179
            + +   + +    QLL GL Y+H    I+H D+KP N+L+           +KI D G 
Sbjct: 125 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG- 183
Query: 180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC 239
              +   ++  T  + TR YR+PE+LL    +G   D+WS  C+  EL+    +F   E 
Sbjct: 184 --NACWYDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 240 L------NQLKLIINILGS-------RREEDLEFIDNPKARKYIKSLPYTPG----TPFS 282
                  + +  II +LG          +    F ++    + I  L + P     T   
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 300
Query: 283 RLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           +   D      D L  ML  DP KR      + HP++
Sbjct: 301 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/288 (24%), Positives = 129/288 (44%), Gaps = 45/288 (15%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR-ELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  R++   +A+K +      +      LR E+++  HL+H N++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 95  KDVMMPSHRRNFKDVYLVYEL--MDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                 + R     VYL+ E   + T   ++ K S+         ++ +L   L Y HS 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCHSK 131
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            ++HRD+KP NLL+ +N +LKI DFG   + +  +        T  Y  PE ++    + 
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPE-MIEGRMHD 188
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+WS+G +  E L   P F                              +A  Y ++
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPF------------------------------EAHTYQET 218
Query: 273 LPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                   F+  +PD     A DL+ ++L  + ++R+++ E L+HP++
Sbjct: 219 YRRISRVEFT--FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 81/337 (24%), Positives = 136/337 (40%), Gaps = 63/337 (18%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK--------------------KINNAFE 68
           D +Y+ ++ +G G +  V  + +   N  VA+K                    ++N+A  
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 69  NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIK--S 126
            + D++     LKLL H  H+    +  VM             V+E++  +L  +IK   
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVM-------------VFEVLGENLLALIKKYE 124
Query: 127 SQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNAN------CDLKICDFGL 179
            + +   + +    QLL GL Y+H    I+H D+KP N+L+           +KI D G 
Sbjct: 125 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG- 183
Query: 180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC 239
              +   ++  T  + TR YR+PE+LL    +G   D+WS  C+  EL+    +F   E 
Sbjct: 184 --NACWYDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 240 L------NQLKLIINILGS-------RREEDLEFIDNPKARKYIKSLPYTPG----TPFS 282
                  + +  II +LG          +    F ++    + I  L + P     T   
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 300
Query: 283 RLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           +   D      D L  ML  DP KR      + HP++
Sbjct: 301 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 75
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 132
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 190
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 191 -SLTESKFSVASDVWSFGVVLYELF 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 70
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 127
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 128 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 185
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 186 -SLTESKFSVASDVWSFGVVLYELF 209

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 19  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 76
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 133
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 134 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 191
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 192 -SLTESKFSVASDVWSFGVVLYELF 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 20  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 77
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 134
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 135 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 192
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 193 -SLTESKFSVASDVWSFGVVLYELF 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 21  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 78
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 135
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 136 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 193
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 194 -SLTESKFSVASDVWSFGVVLYELF 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 105/223 (47%), Gaps = 10/223 (4%)
Query: 30  TKYVPIKPIGRGAYG---IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +++  +K +G+G++G   +V      +  +  A+K +  A     D +RT  E  +L  +
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            H  ++ L        +     +YL+ + +   DL   +      T +  +++L +L   
Sbjct: 85  NHPFIVKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 139
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L +LHS  I++RDLKP N+L++    +K+ DFGL++ S    +    +  T  Y APE +
Sbjct: 140 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-V 198
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
           +    +  S D WS G +  E+L     F G +    + +I+ 
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 241

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 105/223 (47%), Gaps = 10/223 (4%)
Query: 30  TKYVPIKPIGRGAYG---IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +++  +K +G+G++G   +V      +  +  A+K +  A     D +RT  E  +L  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            H  ++ L        +     +YL+ + +   DL   +      T +  +++L +L   
Sbjct: 84  NHPFIVKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L +LHS  I++RDLKP N+L++    +K+ DFGL++ S    +    +  T  Y APE +
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-V 197
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
           +    +  S D WS G +  E+L     F G +    + +I+ 
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 22  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 79
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 136
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 137 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 194
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 195 -SLTESKFSVASDVWSFGVVLYELF 218

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 71
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 128
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 129 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 186
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 187 -SLTESKFSVASDVWSFGVVLYELF 210

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 72
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 129
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 187
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 188 -SLTESKFSVASDVWSFGVVLYELF 211

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 24/200 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R + EL     L    ++ L   
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 134
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +     R    V +  EL++   L Q+IK    L  D   Y+L Q L GL+YLH+  ILH
Sbjct: 135 V-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSNGKNQFMTEYV-VTRWYRAPELLLC--C 208
            D+K  N+L++++     +CDFG    L     GK+    +Y+  T  + APE+++   C
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 249
Query: 209 DNYGTSIDVWSVGCIFAELL 228
           D     +D+WS  C+   +L
Sbjct: 250 D---AKVDIWSSCCMMLHML 266

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 72
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 129
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 187
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 188 -SLTESKFSVASDVWSFGVVLYELF 211

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 33  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 82
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 83  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 142
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 143 YLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 198
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 90
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 147
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 148 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 205
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 206 -SLTESKFSVASDVWSFGVVLYELF 229

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 18  LRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 75
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLF--QLLRGLK 147
           ++  K V   + RRN K   L+ E +    L + ++  +    DH +   +  Q+ +G++
Sbjct: 76  IVKYKGVCYSAGRRNLK---LIMEFLPYGSLREYLQKHKERI-DHIKLLQYTSQICKGME 131
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAP 202
           YL +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY AP
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-AP 189
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELL 228
           E  L    +  + DVWS G +  EL 
Sbjct: 190 E-SLTESKFSVASDVWSFGVVLYELF 214

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++ +G+G +G V  C    +   T E VA+KK+ ++ E  +      RE+++L+ LQH+N
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE--REIEILKSLQHDN 90
Query: 91  VIALKDVMMPSHRRNFKDV--YLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++  K V   + RRN K +  YL Y  +   L    K  + + +     +  Q+ +G++Y
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEY 147
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-----SNGKNQFMTEYVVTRWYRAPE 203
           L +   +HRDL   N+LV     +KI DFGL +         K +   E  +  WY APE
Sbjct: 148 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF-WY-APE 205
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
             L    +  + DVWS G +  EL 
Sbjct: 206 -SLTESKFSVASDVWSFGVVLYELF 229

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 24/200 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R + EL     L    ++ L   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 118
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +     R    V +  EL++   L Q+IK    L  D   Y+L Q L GL+YLH+  ILH
Sbjct: 119 V-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSNGKNQFMTEYV-VTRWYRAPELLLC--C 208
            D+K  N+L++++     +CDFG    L     GK+    +Y+  T  + APE+++   C
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 209 DNYGTSIDVWSVGCIFAELL 228
           D     +D+WS  C+   +L
Sbjct: 234 D---AKVDIWSSCCMMLHML 250

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 21/221 (9%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ +G G++G V    +R      A+K +      R         LK + H   E ++ L
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---------LKQVEHTNDERLM-L 60
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
             V  P   R    F+D   ++ +MD     +L  +++ SQ   N   +++  ++   L+
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS +I++RDLKP N+L++ N  +KI DFG A+        +     T  Y APE ++ 
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCG---TPDYIAPE-VVS 176
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
              Y  SID WS G +  E+L     F  +  +   + I+N
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP 235
           E L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++        H +++  Q++   +
Sbjct: 97  QAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 32  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 81
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 82  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 141
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 142 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL- 197
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKEIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +++ DFGLA+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP 235
           E L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP 235
           E L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 18  YYSMWQTLFEI-DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVD 72
           + +  Q + E+ D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++ 
Sbjct: 20  FLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI- 78
Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALT 131
               +REL++L       ++               ++ +  E MD   L Q++K +  + 
Sbjct: 79  ----IRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIP 129
Query: 132 NDHCQYFLFQLLRGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
                     +++GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +   
Sbjct: 130 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMA 187
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP 235
             +V TR Y +PE L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 188 NSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 116
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 117 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 176
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 232
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G +G V   ++++T E+VAIK+       + +  R   E+++++ L H NV++ ++V
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 98  MMPSHRRNFKDV-YLVYELMDT-DLHQIIKSSQ---ALTNDHCQYFLFQLLRGLKYLHSA 152
                +    D+  L  E  +  DL + +   +    L     +  L  +   L+YLH  
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 153 NILHRDLKPGNLLVNANCDL---KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
            I+HRDLKP N+++         KI D G A+  + + +  TE+V T  Y APELL    
Sbjct: 142 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPELLE-QK 199
Query: 210 NYGTSIDVWSVGCI-FAELLGRKPIFP 235
            Y  ++D WS G + F  + G +P  P
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G +G V   ++++T E+VAIK+       + +  R   E+++++ L H NV++ ++V
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 98  MMPSHRRNFKDV-YLVYELMDT-DLHQIIKSSQ---ALTNDHCQYFLFQLLRGLKYLHSA 152
                +    D+  L  E  +  DL + +   +    L     +  L  +   L+YLH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 153 NILHRDLKPGNLLVNANCDL---KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
            I+HRDLKP N+++         KI D G A+  + + +  TE+V T  Y APELL    
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPELLE-QK 198
Query: 210 NYGTSIDVWSVGCI-FAELLGRKPIFP 235
            Y  ++D WS G + F  + G +P  P
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 128/289 (44%), Gaps = 43/289 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIA 93
           ++P+G+G +G V  +  ++    +A+K +  +  E      +  RE+++  HL+H N++ 
Sbjct: 19  VRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 94  LKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           + +     H R  K +YL+ E     +L++ ++            F+ +L   L Y H  
Sbjct: 79  MYNYF---HDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLA-RTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            ++HRD+KP NLL+    +LKI DFG +    + + + M     T  Y  PE ++    +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCG---TLDYLPPE-MIEGKTH 189
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
              +D+W  G +  E L   P F         + I+N+       DL+F           
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------DLKF----------- 231
Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                   PF     D    + DL+ K+L + P +R+ +   ++HP++ 
Sbjct: 232 -------PPF---LSDG---SKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 8   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 62
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K +  +           ++
Sbjct: 63  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 117
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    ++   E+V TR Y +P
Sbjct: 118 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDEMANEFVGTRSYMSP 175
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKP 232
           E L    +Y    D+WS+G    E+ +GR P
Sbjct: 176 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 137/333 (41%), Gaps = 66/333 (19%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL-LRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L  R  
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 68
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I  +  QA T       +  + 
Sbjct: 69  QCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ + G               
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--------------- 172
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
                   + Y  S D+WS+G I   LL   P F     L                    
Sbjct: 173 --------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------------- 204
Query: 261 IDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY- 318
             +P  +  I+   Y  P   +S +  +   L  +LL+     +PT+R+++TE + HP+ 
Sbjct: 205 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----EPTQRMTITEFMNHPWI 260
Query: 319 MSPLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
           M     P +  P      L  D+E  E++  EM
Sbjct: 261 MQSTKVPQT--PLHTSRVLKEDKERWEDVKEEM 291

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++        H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +K+ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 41  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 90
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 91  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 150
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 151 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 206
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 24/200 (12%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R + EL     L    ++ L   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 132
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
           +     R    V +  EL++   L Q+IK    L  D   Y+L Q L GL+YLH+  ILH
Sbjct: 133 V-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 157 RDLKPGNLLVNANCD-LKICDFG----LARTSNGKNQFMTEYV-VTRWYRAPELLLC--C 208
            D+K  N+L++++     +CDFG    L     GK+    +Y+  T  + APE+++   C
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 247
Query: 209 DNYGTSIDVWSVGCIFAELL 228
           D     +D+WS  C+   +L
Sbjct: 248 D---AKVDIWSSCCMMLHML 264

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP 235
           E L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK----KINNAFENRVDALRTLRELKLLR 84
           D  +  I  +G G  G+V    ++ +   +A K    +I  A  N++     +REL++L 
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI-----IRELQVLH 59
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
                 ++               ++ +  E MD   L Q++K +  +           ++
Sbjct: 60  ECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI 114
Query: 144 RGLKYLHSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +GL YL   + I+HRD+KP N+LVN+  ++K+CDFG+  +    +     +V TR Y +P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSP 172
Query: 203 ELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFP 235
           E L    +Y    D+WS+G    E+ +GR PI P
Sbjct: 173 ERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 47  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 96
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 97  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 156
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++        H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 67  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 116
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 117 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 176
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G    +     T  Y APE++L 
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCG---TPEYLAPEIIL- 232
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  ++    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    + ET    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHMETGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y +M+     ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +++ DFG A+   G+   +     T  Y APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 111/262 (42%), Gaps = 49/262 (18%)
Query: 25  LFEIDTKYVPIKPIGRGAYGIV---CSSVNRETNEKVAIKKINNAFENRVDALRTLRELK 81
           +F+I+ K      IG G +  V    + +     EK+A+K +          + T   ++
Sbjct: 22  VFKIEDK------IGEGTFSSVYLATAQLQVGPEEKIALKHL----------IPTSHPIR 65
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           +   LQ   V   +D +M       K+ ++V  +   +    +    +L+    + ++  
Sbjct: 66  IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLN 125
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSN---------------- 184
           L + LK +H   I+HRD+KP N L N       + DFGLA+ ++                
Sbjct: 126 LFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQ 185
Query: 185 ------------GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRK 231
                        + Q +     T  +RAPE+L  C N  T+ID+WS G IF  LL GR 
Sbjct: 186 ERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245
Query: 232 PIFPGTECLNQLKLIINILGSR 253
           P +  ++ L  L  I+ I GSR
Sbjct: 246 PFYKASDDLTALAQIMTIRGSR 267

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NL+++    +++ DFG A+   G+   +     T  Y APE+++ 
Sbjct: 156 YLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIII- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 127/288 (44%), Gaps = 43/288 (14%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  ++    +A+K +  +  E      +  RE+++  HL+H N++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
            +     H R  K +YL+ E     +L++ ++            F+ +L   L Y H   
Sbjct: 81  YNYF---HDR--KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 135
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLA-RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           ++HRD+KP NLL+    +LKI DFG +    + + + M     T  Y  PE ++    + 
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCG---TLDYLPPE-MIEGKTHD 191
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
             +D+W  G +  E L   P F         + I+N+       DL+F            
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------DLKF------------ 232
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                  PF     D    + DL+ K+L + P +R+ +   ++HP++ 
Sbjct: 233 ------PPF---LSDG---SKDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 135/293 (46%), Gaps = 47/293 (16%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE---NVIAL 94
           +G G  G V    +R T +K A+K + ++ + R +         +  H Q     +++ +
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE---------VDHHWQASGGPHIVCI 87
Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLLRGLKYLHS 151
            DV    H    + + ++ E M+  +L   I  +  QA T       +  +   +++LHS
Sbjct: 88  LDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 152 ANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
            NI HRD+KP NLL  +   +  LK+ DFG A+ +  +N   T    T +Y APE +L  
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTP-CYTPYYVAPE-VLGP 203
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           + Y  S D+WS+G I   LL   P F      N  + I                +P  ++
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYS----NTGQAI----------------SPGMKR 243
Query: 269 YIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
            I+   Y  P   +S +  DA      L++ +L  DPT+R+++T+ + HP+++
Sbjct: 244 RIRLGQYGFPNPEWSEVSEDAK----QLIRLLLKTDPTERLTITQFMNHPWIN 292

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T  Y AP ++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPAIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 85/325 (26%), Positives = 148/325 (45%), Gaps = 50/325 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE---NVIAL 94
           +G G  G V    +R T +K A+K + ++ + R +         +  H Q     +++ +
Sbjct: 18  LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE---------VDHHWQASGGPHIVCI 68
Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQII--KSSQALTNDHCQYFLFQLLRGLKYLHS 151
            DV    H    + + ++ E M+  +L   I  +  QA T       +  +   +++LHS
Sbjct: 69  LDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 127
Query: 152 ANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
            NI HRD+KP NLL  +   +  LK+ DFG A+ +  +N   T    T +Y APE +L  
Sbjct: 128 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-QNALQTP-CYTPYYVAPE-VLGP 184
Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           + Y  S D+WS+G I   LL   P F      N  + I                +P  ++
Sbjct: 185 EKYDKSCDMWSLGVIMYILLCGFPPFYS----NTGQAI----------------SPGMKR 224
Query: 269 YIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS-PLYDPS 326
            I+   Y  P   +S +  DA      L++ +L  DPT+R+++T+ + HP+++  +  P 
Sbjct: 225 RIRLGQYGFPNPEWSEVSEDAK----QLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 280
Query: 327 SNPPAQVPIDLDMDEESGEEMIREM 351
           +  P      L  D++  +E+  EM
Sbjct: 281 T--PLHTARVLQEDKDHWDEVKEEM 303

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 27  EIDTKYVPIKP-IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           EID  YV I+  IG G +G VC    +   +K   VAIK +   +  R      L E  +
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 70
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQ 141
           +   +H N+I L+ V+      N   V ++ E M+   L   ++      ND  Q+ + Q
Sbjct: 71  MGQFEHPNIIRLEGVVT-----NSMPVMILTEFMENGALDSFLR-----LNDG-QFTVIQ 119
Query: 142 LL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
           L+        G++YL   + +HRDL   N+LVN+N   K+ DFGL+R     +   TE  
Sbjct: 120 LVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETS 179
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
                +  RW  APE  +    + ++ D WS G +  E++  G +P +
Sbjct: 180 SLGGKIPIRWT-APE-AIAFRKFTSASDAWSYGIVMWEVMSFGERPYW 225

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/344 (22%), Positives = 146/344 (42%), Gaps = 57/344 (16%)
Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK 81
           W+    ++  ++ I+ +G G +G V    + +  +  A+K + N  +    A     E  
Sbjct: 27  WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EAD 83
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFL 139
           +L+ +Q++++     V        +  + L++E +   L++II  +       +  + + 
Sbjct: 84  ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYC 143
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVN-------------------------ANCDLKI 174
            ++L+ L YL   ++ H DLKP N+L++                          +  +K+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
            DFG A     K+ +    + TR YRAPE++L    +  S D+WS GC+ AEL     +F
Sbjct: 204 IDFGCA---TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLF 259
Query: 235 PGTECLNQLKLIINIL---------------GSRR----EEDLEFIDNPKARKYIKSLPY 275
              E +  L ++ +I+               GS+     E  L + +N  +   IK +  
Sbjct: 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK- 318
Query: 276 TPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
               P  ++    H L  D L  +L  DPT R S  E L+H ++
Sbjct: 319 -KCLPLYKII--KHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 27  EIDTKYVPIKP-IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           EID  YV I+  IG G +G VC    +   +K   VAIK +   +  R      L E  +
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTER-QRREFLSEASI 68
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQ 141
           +   +H N+I L+ V+      N   V ++ E M+   L   ++      ND  Q+ + Q
Sbjct: 69  MGQFEHPNIIRLEGVVT-----NSMPVMILTEFMENGALDSFLR-----LNDG-QFTVIQ 117
Query: 142 LL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTE 192
           L+        G++YL   + +HRDL   N+LVN+N   K+ DFGL+R    N  +   T 
Sbjct: 118 LVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTS 177
Query: 193 Y----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
                +  RW  APE  +    + ++ D WS G +  E++  G +P +
Sbjct: 178 SLGGKIPIRW-TAPE-AIAFRKFTSASDAWSYGIVMWEVMSFGERPYW 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 27/223 (12%)
Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQH 88
           T + PI+ +GRG +G+V  + N+  +   AIK+I     NR  A  + +RE+K L  L+H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAKLEH 62
Query: 89  ENVIALKDVMMPSH-----RRNFKDVYLVYELM---DTDLHQIIKSSQALTNDH---CQY 137
             ++   +  +  +     + +   VYL  ++      +L   +     +       C +
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL--ARTSNGKNQFM----- 190
              Q+   +++LHS  ++HRDLKP N+    +  +K+ DFGL  A   + + Q +     
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 191 -----TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
                T  V T+ Y +PE  +  ++Y   +D++S+G I  ELL
Sbjct: 183 AYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G++G V    ++E+    A+K ++          + + +LK + H  +E  I L
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDK---------QKVVKLKQIEHTLNEKRI-L 95
Query: 95  KDVMMPSHRR---NFKD---VYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + V  P   +   +FKD   +Y+V E +   ++   ++     +  H +++  Q++   +
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +     T    APE++L 
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEALAPEIIL- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W++G +  E+    P F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 129/303 (42%), Gaps = 45/303 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQ-HENVIALK 95
           +G GAY  V  +V+ +  ++ A+K I   A  +R    R  RE++ L   Q ++N++ L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS---RVFREVETLYQCQGNKNILELI 77
Query: 96  DVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      R      YLV+E L    +   I+  +          +  +   L +LH+  I
Sbjct: 78  EFFEDDTR-----FYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGI 132
Query: 155 LHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQF-------MTEYVVTRWYRAPEL 204
            HRDLKP N+L  +      +KICDF L       N         +T    +  Y APE+
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEV 192
Query: 205 LLCCDN----YGTSIDVWSVGCIFAELLGRKPIFPG---TECLNQLKLIINILGSRREED 257
           +    +    Y    D+WS+G +   +L   P F G    +C           G  R E 
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADC-----------GWDRGEV 241
Query: 258 LEFIDNPKARKYIKSLPYT-PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                N K  + I+   Y  P   ++ +  +A     DL+ K+LV D  +R+S  + LQH
Sbjct: 242 CRVCQN-KLFESIQEGKYEFPDKDWAHISSEAK----DLISKLLVRDAKQRLSAAQVLQH 296
Query: 317 PYM 319
           P++
Sbjct: 297 PWV 299

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K IG+G++G V  + ++      A+K +           + + + K  +H+  E  + L
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQK---------KAILKKKEEKHIMSERNVLL 93
Query: 95  KDVMMP---SHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           K+V  P       +F+    +Y ++D     +L   ++  +       +++  ++   L 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           YLHS NI++RDLKP N+L+++   + + DFGL + +   N   + +  T  Y APE +L 
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLH 212
Query: 208 CDNYGTSIDVWSVGCIFAELLGRKPIF 234
              Y  ++D W +G +  E+L   P F
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 74  LRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTN 132
           LR  RE +    L H  ++A+ D    +        Y+V E +D   L  I+ +   +T 
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFM 190
                 +    + L + H   I+HRD+KP N+L++A   +K+ DFG+AR    +G +   
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 191 TEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
           T  V+ T  Y +PE     D+     DV+S+GC+  E+L  +P F G
Sbjct: 176 TAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVA---IKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           K +GRG + +V   +++ T ++ A   +KK     + R + L  +  L+L +      VI
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR--VI 92
Query: 93  ALKDVMMPSHRRNFKDVYLVYELM-DTDLHQII--KSSQALTNDHCQYFLFQLLRGLKYL 149
            L +V       N  ++ L+ E     ++  +   + ++ ++ +     + Q+L G+ YL
Sbjct: 93  NLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 150 HSANILHRDLKPGNLLVNAN---CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           H  NI+H DLKP N+L+++     D+KI DFG++R   G    + E + T  Y APE +L
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPE-IL 205
Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             D   T+ D+W++G I   LL     F G                         DN + 
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSPFVGE------------------------DNQET 241
Query: 267 RKYIK--SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
              I   ++ Y+  T     +     LA D +Q +LV +P KR +    L H ++
Sbjct: 242 YLNISQVNVDYSEET-----FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK IGRGA+G            +VA+ K+ N    R+ A++ L + ++L+  +       
Sbjct: 79  IKVIGRGAFG------------EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREE 124
Query: 95  KDVM-------MPSHRRNFKDVYLVYELMD----TDLHQII-KSSQALTNDHCQYFLFQL 142
           +DV+       + +    F+D   +Y +MD     DL  ++ K    L  D  ++++ ++
Sbjct: 125 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 184
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRA 201
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG     N      +   V T  Y +
Sbjct: 185 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 244
Query: 202 PELLLCCDN----YGTSIDVWSVG-CIFAELLGRKPIF 234
           PE+L   ++    YG   D WS+G C++  L G  P +
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 109/227 (48%), Gaps = 18/227 (7%)
Query: 12  RSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR- 70
           R  GK   S+    F++      ++ IGRG+Y  V     ++T+   A+K +     N  
Sbjct: 8   RESGKASSSLGLQDFDL------LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD 61
Query: 71  --VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS 127
             +D ++T + +   +   H  ++ L        R     ++ V E ++  DL   ++  
Sbjct: 62  EDIDWVQTEKHV-FEQASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQ 115
Query: 128 QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN 187
           + L  +H +++  ++   L YLH   I++RDLK  N+L+++   +K+ D+G+ +      
Sbjct: 116 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 175
Query: 188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPI 233
              + +  T  Y APE+L   D YG S+D W++G +  E++ GR P 
Sbjct: 176 DTTSXFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR---VDALRTLRELKLLRHLQHENV 91
           ++ IGRG+Y  V     ++T+   A+K +     N    +D ++T + +   +   H  +
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 72
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L        R     ++ V E ++  DL   ++  + L  +H +++  ++   L YLH
Sbjct: 73  VGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   D 
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED- 186
Query: 211 YGTSIDVWSVGCIFAELL-GRKPI 233
           YG S+D W++G +  E++ GR P 
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 44/223 (19%)
Query: 36  KPIGRGAYGIVCSSVNRETNEK----VAIKKINNAF--ENRVDALRTLRELKLLRHLQHE 89
           K IG G +G V   + + ++ K    VAIK +   +  + RVD    L E  ++    H 
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD---FLGEAGIMGQFSHH 106
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRG--- 145
           N+I L+ V+       +K + ++ E M+   L + ++       +     L  +LRG   
Sbjct: 107 NIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAA 158
Query: 146 -LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-----------TSNGKNQFMTEY 193
            +KYL + N +HRDL   N+LVN+N   K+ DFGL+R           TS GK       
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK------- 211
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           +  RW  APE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 212 IPIRW-TAPE-AISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR---VDALRTLRELKLLRHLQHENV 91
           ++ IGRG+Y  V     ++T+   A+K +     N    +D ++T + +   +   H  +
Sbjct: 10  LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFL 68
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           + L        R     ++ V E ++  DL   ++  + L  +H +++  ++   L YLH
Sbjct: 69  VGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y APE+L   D 
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED- 182
Query: 211 YGTSIDVWSVGCIFAELL-GRKPI 233
           YG S+D W++G +  E++ GR P 
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 32/218 (14%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK IGRGA+G            +VA+ K+ N    R+ A++ L + ++L+  +       
Sbjct: 95  IKVIGRGAFG------------EVAVVKMKNT--ERIYAMKILNKWEMLKRAETACFREE 140
Query: 95  KDVM-------MPSHRRNFKDVYLVYELMD----TDLHQII-KSSQALTNDHCQYFLFQL 142
           +DV+       + +    F+D   +Y +MD     DL  ++ K    L  D  ++++ ++
Sbjct: 141 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 200
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRA 201
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG     N      +   V T  Y +
Sbjct: 201 VLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 260
Query: 202 PELLLCCDN----YGTSIDVWSVG-CIFAELLGRKPIF 234
           PE+L   ++    YG   D WS+G C++  L G  P +
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  +  IG+G++G V   ++  T E VAIK I+            L E +       + +
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIID------------LEEAEDEIEDIQQEI 68
Query: 92  IALKDVMMPSHRRNFKD------VYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
             L     P   R F        ++++ E +       +     L   +    L ++L+G
Sbjct: 69  TVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG 128
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L YLHS   +HRD+K  N+L++   D+K+ DFG+A            +V T ++ APE++
Sbjct: 129 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI 188
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKP 232
                Y    D+WS+G    EL   +P
Sbjct: 189 KQS-AYDFKADIWSLGITAIELAKGEP 214

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 61/311 (19%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQ-HENVIAL 94
           +G GA+  V + +N  T+++ A+K I    E +   +R+   RE+++L   Q H NV+ L
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKII----EKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
            +      R      YLV+E M    +   I   +          +  +   L +LH+  
Sbjct: 77  IEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 154 ILHRDLKPGNLLV---NANCDLKICDFGLAR-----------------TSNGKNQFMTEY 193
           I HRDLKP N+L    N    +KICDFGL                   T  G  ++M   
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
           VV  +     +      Y    D+WS+G I   LL   P F G                R
Sbjct: 192 VVEAFSEEASI------YDKRCDLWSLGVILYILLSGYPPFVG----------------R 229
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPD---AH--PLAIDLLQKMLVFDPTKRI 308
              D  + D  +A    +++ +         +PD   AH    A DL+ K+LV D  +R+
Sbjct: 230 CGSDCGW-DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL 288
Query: 309 SVTEALQHPYM 319
           S  + LQHP++
Sbjct: 289 SAAQVLQHPWV 299

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 32/230 (13%)
Query: 27  EIDTKYVPIKP-IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           EID   V I+  IG G +G VCS   +   ++   VAIK + + +  +      L E  +
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 87
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           +    H NVI L+ V+  S       V ++ E M+            L  +  Q+ + QL
Sbjct: 88  MGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENG-----SLDSFLRQNDGQFTVIQL 137
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-----TSNGK-NQF 189
           +        G+KYL   N +HRDL   N+LVN+N   K+ DFGL+R     TS+      
Sbjct: 138 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGT 237
           +   +  RW  APE +     + ++ DVWS G +  E++  G +P +  T
Sbjct: 198 LGGKIPIRW-TAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 245

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 109/227 (48%), Gaps = 18/227 (7%)
Query: 12  RSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR- 70
           R  GK   S+    F++      ++ IGRG+Y  V     ++T+   A++ +     N  
Sbjct: 40  RESGKASSSLGLQDFDL------LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD 93
Query: 71  --VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS 127
             +D ++T + +   +   H  ++ L        R     ++ V E ++  DL   ++  
Sbjct: 94  EDIDWVQTEKHV-FEQASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQ 147
Query: 128 QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN 187
           + L  +H +++  ++   L YLH   I++RDLK  N+L+++   +K+ D+G+ +      
Sbjct: 148 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207
Query: 188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPI 233
              + +  T  Y APE+L   D YG S+D W++G +  E++ GR P 
Sbjct: 208 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 101/225 (44%), Gaps = 12/225 (5%)
Query: 8   PNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF 67
           P  ++ PG     M   + + +  +  ++ IG+G++G V   ++  T + VAIK I+   
Sbjct: 6   PVAVQVPG-----MQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID-LE 59
Query: 68  ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS 127
           E   +     +E+ +L       V       +   +     ++++ E +       +  +
Sbjct: 60  EAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSK-----LWIIMEYLGGGSALDLLRA 114
Query: 128 QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN 187
                      L ++L+GL YLHS   +HRD+K  N+L++   D+K+ DFG+A       
Sbjct: 115 GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 174
Query: 188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP 232
                +V T ++ APE++     Y +  D+WS+G    EL   +P
Sbjct: 175 IKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEP 218

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGLAR    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 36  KPIGRGAYGIVC-SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           K +G G +G V  ++ N+ T  KVA+K +       V+A   L E  +++ LQH+ ++ L
Sbjct: 21  KKLGAGQFGEVWMATYNKHT--KVAVKTMKPG-SMSVEAF--LAEANVMKTLQHDKLVKL 75
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLF--QLLRGLKYLHS 151
             V+        + +Y++ E M    L   +KS +       +   F  Q+  G+ ++  
Sbjct: 76  HAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 129
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+A+   KI DFGLAR          E      +W  APE +    
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 184
Query: 210 NYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
           N+G+     DVWS G +  E++  GR P +PG
Sbjct: 185 NFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 74  LRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTN 132
           LR  RE +    L H  ++A+ D    +        Y+V E +D   L  I+ +   +T 
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFM 190
                 +    + L + H   I+HRD+KP N++++A   +K+ DFG+AR    +G +   
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 191 TEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
           T  V+ T  Y +PE     D+     DV+S+GC+  E+L  +P F G
Sbjct: 176 TAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 34/210 (16%)
Query: 36  KPIGRGAYGIVC-SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           K +G G +G V  ++ N+ T  KVA+K +       V+A   L E  +++ LQH+ ++ L
Sbjct: 188 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPG-SMSVEAF--LAEANVMKTLQHDKLVKL 242
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLF--QLLRGLKYLHS 151
             V+        + +Y++ E M    L   +KS +       +   F  Q+  G+ ++  
Sbjct: 243 HAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 296
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL+  N+LV+A+   KI DFGLAR      +F  ++       APE +    N+
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFGLARVG---AKFPIKWT------APEAI----NF 343
Query: 212 GT---SIDVWSVGCIFAELL--GRKPIFPG 236
           G+     DVWS G +  E++  GR P +PG
Sbjct: 344 GSFTIKSDVWSFGILLMEIVTYGRIP-YPG 372

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 7/203 (3%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHENVIALKD 96
           +G+G++G V  +  + T E  AIK +      + D +  T+ E ++L  L     +    
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLT--- 83
Query: 97  VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
             + S  +    +Y V E ++  DL   I+           ++  ++  GL +LH   I+
Sbjct: 84  -QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGII 142
Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           +RDLK  N+++++   +KI DFG+ +          E+  T  Y APE ++    YG S+
Sbjct: 143 YRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPE-IIAYQPYGKSV 201
Query: 216 DVWSVGCIFAELLGRKPIFPGTE 238
           D W+ G +  E+L  +P F G +
Sbjct: 202 DWWAYGVLLYEMLAGQPPFDGED 224

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 74  LRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTN 132
           LR  RE +    L H  ++A+ D    +        Y+V E +D   L  I+ +   +T 
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFM 190
                 +    + L + H   I+HRD+KP N++++A   +K+ DFG+AR    +G +   
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 191 TEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
           T  V+ T  Y +PE     D+     DV+S+GC+  E+L  +P F G
Sbjct: 176 TAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 74  LRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTN 132
           LR  RE +    L H  ++A+ D    +        Y+V E +D   L  I+ +   +T 
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFM 190
                 +    + L + H   I+HRD+KP N++++A   +K+ DFG+AR    +G +   
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 191 TEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
           T  V+ T  Y +PE     D+     DV+S+GC+  E+L  +P F G
Sbjct: 176 TAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 36  KPIGRGAYGIVC-SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           K +G G +G V  ++ N+ T  KVA+K +       V+A   L E  +++ LQH+ ++ L
Sbjct: 194 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPG-SMSVEAF--LAEANVMKTLQHDKLVKL 248
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLF--QLLRGLKYLHS 151
             V+        + +Y++ E M    L   +KS +       +   F  Q+  G+ ++  
Sbjct: 249 HAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+A+   KI DFGLAR          E      +W  APE +    
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 357
Query: 210 NYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
           N+G+     DVWS G +  E++  GR P +PG
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 90
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y++   DL++       L
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFL 145
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       ++
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 206 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 81
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y++   DL++       L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFL 136
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       ++
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 197 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 246

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 81
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y++   DL++       L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFL 136
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       ++
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 197 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 246

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 70  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 127
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y++   DL++       L
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFL 182
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       ++
Sbjct: 183 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 242
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 243 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 292

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E M+   DL   I    AL  +  + F 
Sbjct: 66  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 121 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 178
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEXMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 95
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 144
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 145 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 204
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 205 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 250

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEXMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 10  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 65
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K+     LT +    
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E     
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 179
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 180 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 68/131 (51%), Gaps = 5/131 (3%)
Query: 110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA 168
           Y+V E +D   L  I+ +   +T       +    + L + H   I+HRD+KP N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 169 NCDLKICDFGLAR--TSNGKNQFMTEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
              +K+ DFG+AR    +G +   T  V+ T  Y +PE     D+     DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLY 210
Query: 226 ELLGRKPIFPG 236
           E+L  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 6/167 (3%)
Query: 74  LRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTN 132
           LR  RE +    L H  ++A+ D    +        Y+V E +D   L  I+ +   +T 
Sbjct: 74  LRFRREAQNAAALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 132
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFM 190
                 +    + L + H   I+HRD+KP N++++A   +K+ DFG+AR    +G +   
Sbjct: 133 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 191 TEYVV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
           T  V+ T  Y +PE     D+     DV+S+GC+  E+L  +P F G
Sbjct: 193 TAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           I+ +G G +G V  C        T E+VA+K +   +  N +  L+  +E+++LR+L HE
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHE 83
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQY-FLFQLLRGLK 147
           N++  K +         K   L+ E + +  L + +  ++   N   Q  +  Q+ +G+ 
Sbjct: 84  NIVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT----EYVVTRWYRAPE 203
           YL S   +HRDL   N+LV +   +KI DFGL +      +  T          WY APE
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APE 199
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
            L+    Y  S DVWS G    ELL
Sbjct: 200 CLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 12  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 67
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K+     LT +    
Sbjct: 68  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 121
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E     
Sbjct: 122 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 181
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 182 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 85
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 86  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 134
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 135 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 194
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 195 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 240

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 97
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 146
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL R    + +  + 
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 207 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 13  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 68
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K+     LT +    
Sbjct: 69  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 122
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E     
Sbjct: 123 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 182
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 183 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 222

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 68
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEXMENGSLDSFLRKHDA------QFTV 117
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 118 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 178 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 223

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 36/228 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS   +  ++K   VAIK  K+    + R D L    E 
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EA 68
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A      Q+ +
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDA------QFTV 117
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 118 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 177
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T    +  RW  +PE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 178 TRGGKIPIRW-TSPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 223

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 59
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K  S   LT +    
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E     
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 174 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 37/231 (16%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 14  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 69
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K+     LT +    
Sbjct: 70  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 123
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFM 190
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR       T+    +F 
Sbjct: 124 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 183
Query: 191 TEYVVTRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            ++       APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 184 IKWT------APEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 223

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 6   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 61
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K  S   LT +    
Sbjct: 62  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 115
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E     
Sbjct: 116 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 175
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 176 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  ++ IG+G++G V   ++  T + VAIK I +  E   +     +E+ +L       V
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                    S+ ++ K ++++ E +       +     L        L ++L+GL YLHS
Sbjct: 83  TK----YYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 137
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++ + ++K+ DFG+A            +V T ++ APE++     Y
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS-AY 196
Query: 212 GTSIDVWSVGCIFAELLGRKP 232
            +  D+WS+G    EL   +P
Sbjct: 197 DSKADIWSLGITAIELARGEP 217

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 34/219 (15%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K IGRGA+G            +VA+ K+ NA  ++V A++ L + ++L+  +       
Sbjct: 79  LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 124
Query: 95  KDVMMPSHRR-------NFKDVYLVYELMD----TDLHQII-KSSQALTNDHCQYFLFQL 142
           +DV++    +        F+D   +Y +MD     DL  ++ K    L  +  +++L ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG--LARTSNGKNQFMTEYVVTRWYR 200
           +  +  +H  + +HRD+KP N+L++ N  +++ DFG  L    +G  Q  +  V T  Y 
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYI 243
Query: 201 APELLLCCDN----YGTSIDVWSVG-CIFAELLGRKPIF 234
           +PE+L   +     YG   D WS+G C++  L G  P +
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 37/231 (16%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 9   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 64
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K  S   LT +    
Sbjct: 65  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 118
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFM 190
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR       T+    +F 
Sbjct: 119 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 178
Query: 191 TEYVVTRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            ++       APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 179 IKWT------APEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 218

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  ++ IG+G++G V   ++  T + VAIK I+   E   +     +E+ +L       V
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                    S+ ++ K ++++ E +       +     L        L ++L+GL YLHS
Sbjct: 88  TK----YYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 142
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++ + ++K+ DFG+A            +V T ++ APE ++    Y
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAY 201
Query: 212 GTSIDVWSVGCIFAELLGRKP 232
            +  D+WS+G    EL   +P
Sbjct: 202 DSKADIWSLGITAIELARGEP 222

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 37/231 (16%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 10  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 65
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K  S   LT +    
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFM 190
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR       T+    +F 
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 179
Query: 191 TEYVVTRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            ++       APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 180 IKWT------APEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 90
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y++   DL++       L
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFL 145
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR        +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 206 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 5   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 60
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K  S   LT +    
Sbjct: 61  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 114
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E     
Sbjct: 115 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 174
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 175 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 214

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +        +   KVA+K + + A  +  +AL  + ELK++ HL QH
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY-----------ELMDTDLHQIIKSSQALTNDHCQY 137
           EN++ L               Y  Y            +++TD    I +S A T D   +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD-LLH 168
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YV 194
           F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR     + ++ +    +
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G +  E+  LG  P +PG
Sbjct: 229 PVKW-MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 269

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 59
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K  S   LT +    
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E     
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFP 173
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 174 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           I+ +G G +G V  C        T E+VA+K +   +  N +  L+  +E+++LR+L HE
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHE 71
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQY-FLFQLLRGLK 147
           N++  K +         K   L+ E + +  L + +  ++   N   Q  +  Q+ +G+ 
Sbjct: 72  NIVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 128
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT----EYVVTRWYRAPE 203
           YL S   +HRDL   N+LV +   +KI DFGL +      +  T          WY APE
Sbjct: 129 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APE 187
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
            L+    Y  S DVWS G    ELL
Sbjct: 188 CLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 81
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y++   DL++       L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFL 136
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR        +
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 197 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 246

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 81
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y++   DL++       L
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFL 136
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR        +
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 196
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 197 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 246

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  ++ IG+G++G V   ++  T + VAIK I +  E   +     +E+ +L       V
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                    S+ ++ K ++++ E +       +     L        L ++L+GL YLHS
Sbjct: 68  TK----YYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++ + ++K+ DFG+A            +V T ++ APE ++    Y
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAY 181
Query: 212 GTSIDVWSVGCIFAELLGRKP 232
            +  D+WS+G    EL   +P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 7/201 (3%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  ++ IG+G++G V   ++  T + VAIK I +  E   +     +E+ +L       V
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIK-IIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                    S+ ++ K ++++ E +       +     L        L ++L+GL YLHS
Sbjct: 68  TK----YYGSYLKDTK-LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
              +HRD+K  N+L++ + ++K+ DFG+A            +V T ++ APE ++    Y
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAY 181
Query: 212 GTSIDVWSVGCIFAELLGRKP 232
            +  D+WS+G    EL   +P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 111/239 (46%), Gaps = 11/239 (4%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRG++  V   ++ ET  +VA  ++ +    + +  R   E + L+ LQH N++   D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD- 92
Query: 98  MMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--I 154
              S  +  K + LV EL  +  L   +K  +       + +  Q+L+GL++LH+    I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 155 LHRDLKPGNLLVNA-NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           +HRDLK  N+ +      +KI D GLA     +  F    + T  + APE     + Y  
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFXAPEXYE--EKYDE 208
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
           S+DV++ G    E    +  +P +EC N  ++   +    +    + +  P+ ++ I+ 
Sbjct: 209 SVDVYAFGXCXLEXATSE--YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 37/231 (16%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G +G V        + KVA+K +        DA   L E 
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 59
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K  S   LT +    
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFM 190
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR       T+    +F 
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 191 TEYVVTRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            ++       APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 174 IKWT------APEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 90
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y++   DL++       L
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-----DFL 145
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR        +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXV 205
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 206 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 92
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y+    DL++       L
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK-----DFL 147
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       ++
Sbjct: 148 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 208 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 257

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 53/304 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH- 88
           Y  +K IG G    V   +N E  +  AIK +N   A    +D+ R   E+  L  LQ  
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 89  -ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            + +I L D  +         +Y+V E  + DL+  +K  +++     + +   +L  + 
Sbjct: 115 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
                + E            DVWS+GCI   +   K   P  + +NQ+  +  I+    E
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHE 286
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             +EF D P+     K L                    D+L+  L  DP +RIS+ E L 
Sbjct: 287 --IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELLA 320
Query: 316 HPYM 319
           HPY+
Sbjct: 321 HPYV 324

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 25  LFEIDTKYVPIKPI-GRGAYGIVCSS--VNRETNEKVAIKKINNAFENRVDALRTLRELK 81
           L EID   + ++ I G G +G V  +  +  E   K A    +      ++ +R  +E K
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVR--QEAK 58
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L   L+H N+IAL+ V +        ++ LV E         + S + +  D    +  Q
Sbjct: 59  LFAMLKHPNIIALRGVCLKE-----PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ 113
Query: 142 LLRGLKYLHSAN---ILHRDLKPGNLLV--------NANCDLKICDFGLARTSNGKNQFM 190
           + RG+ YLH      I+HRDLK  N+L+         +N  LKI DFGLAR  + +   M
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKM 172
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
           +      W  APE++     +    DVWS G +  ELL  +  F G + L
Sbjct: 173 SAAGAYAWM-APEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 36/231 (15%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRVDALRTLREL 80
           EI+   + I + IG G +G VCS   +   ++   VAIK  K+    + R D    L E 
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD---FLGEA 74
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
            ++    H N+I L+ V+  S     K V +V E M+   L   +K +        Q+ +
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDTFLKKNDG------QFTV 123
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFM 190
            QL+        G+KYL     +HRDL   N+L+N+N   K+ DFGL+R    + +  + 
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT 183
Query: 191 TE--YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGT 237
           T    +  RW  APE  +    + ++ DVWS G +  E++  G +P +  T
Sbjct: 184 TRGGKIPIRW-TAPE-AIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMT 232

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 127/311 (40%), Gaps = 61/311 (19%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQ-HENVIAL 94
           +G GA+  V + +N  T+++ A+K I    E +   +R+   RE+++L   Q H NV+ L
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKII----EKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
            +      R      YLV+E M    +   I   +          +  +   L +LH+  
Sbjct: 77  IEFFEEEDR-----FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 154 ILHRDLKPGNLLV---NANCDLKICDFGLAR-----------------TSNGKNQFMTEY 193
           I HRDLKP N+L    N    +KICDF L                   T  G  ++M   
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
           VV  +     +      Y    D+WS+G I   LL   P F G                R
Sbjct: 192 VVEAFSEEASI------YDKRCDLWSLGVILYILLSGYPPFVG----------------R 229
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPD---AH--PLAIDLLQKMLVFDPTKRI 308
              D  + D  +A    +++ +         +PD   AH    A DL+ K+LV D  +R+
Sbjct: 230 CGSDCGW-DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL 288
Query: 309 SVTEALQHPYM 319
           S  + LQHP++
Sbjct: 289 SAAQVLQHPWV 299

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 53/304 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH- 88
           Y  +K IG G    V   +N E  +  AIK +N   A    +D+ R   E+  L  LQ  
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 86
Query: 89  -ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            + +I L D  +         +Y+V E  + DL+  +K  +++     + +   +L  + 
Sbjct: 87  SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 142 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
                + E            DVWS+GCI   +   K   P  + +NQ+  +  I+    E
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHE 258
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             +EF D P+     K L                    D+L+  L  DP +RIS+ E L 
Sbjct: 259 --IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELLA 292
Query: 316 HPYM 319
           HPY+
Sbjct: 293 HPYV 296

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 53/304 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH- 88
           Y  +K IG G    V   +N E  +  AIK +N   A    +D+ R   E+  L  LQ  
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 86
Query: 89  -ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            + +I L D  +         +Y+V E  + DL+  +K  +++     + +   +L  + 
Sbjct: 87  SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 142 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAI 200
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
                + E            DVWS+GCI   +   K   P  + +NQ+  +  I+    E
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHE 258
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             +EF D P+     K L                    D+L+  L  DP +RIS+ E L 
Sbjct: 259 --IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELLA 292
Query: 316 HPYM 319
           HPY+
Sbjct: 293 HPYV 296

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 53/304 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH- 88
           Y  +K IG G    V   +N E  +  AIK +N   A    +D+ R   E+  L  LQ  
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 89  -ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            + +I L D  +         +Y+V E  + DL+  +K  +++     + +   +L  + 
Sbjct: 115 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
                + E            DVWS+GCI   +   K   P  + +NQ+  +  I+    E
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHE 286
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             +EF D P+     K L                    D+L+  L  DP +RIS+ E L 
Sbjct: 287 --IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELLA 320
Query: 316 HPYM 319
           HPY+
Sbjct: 321 HPYV 324

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 53/304 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH- 88
           Y  +K IG G    V   +N E  +  AIK +N   A    +D+ R   E+  L  LQ  
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 114
Query: 89  -ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            + +I L D  +         +Y+V E  + DL+  +K  +++     + +   +L  + 
Sbjct: 115 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 170 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
                + E            DVWS+GCI   +   K   P  + +NQ+  +  I+    E
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHE 286
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             +EF D P+     K L                    D+L+  L  DP +RIS+ E L 
Sbjct: 287 --IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELLA 320
Query: 316 HPYM 319
           HPY+
Sbjct: 321 HPYV 324

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ +G G +G V        + KVA+K +        DA   L E  L++ LQH+ ++ L
Sbjct: 13  VERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEANLMKQLQHQRLVRL 68
Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHS 151
             V+        + +Y++ E M+   L   +K  S   LT +       Q+  G+ ++  
Sbjct: 69  YAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 122
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+     KI DFGLAR          E      +W  APE +    
Sbjct: 123 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEAI---- 177
Query: 210 NYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
           NYGT     DVWS G +  E++  GR P +PG
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 208

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 22  WQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLREL 80
           W+  +E+  + +  ++ +G G  G V        + KVA+K +        DA   L E 
Sbjct: 4   WEDAWEVPRETLKLVERLGAGQAGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAF--LAEA 59
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
            L++ LQH+ ++ L  V+        + +Y++ E M+   L   +K  S   LT +    
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-- 195
              Q+  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E     
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFP 173
Query: 196 TRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
            +W  APE +    NYGT     DVWS G +  E++  GR P +PG
Sbjct: 174 IKW-TAPEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           EID   + I K IG G +G VCS   +   ++   VAIK +   + ++      L E  +
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 83
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLF 140
           +    H N+I L+ V+        K V ++ E M+   L   ++ +    T       L 
Sbjct: 84  MGQFDHPNIIHLEGVVTKC-----KPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 138
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTE--YVVT 196
            +  G+KYL   + +HRDL   N+LVN+N   K+ DFG++R    + +  + T    +  
Sbjct: 139 GIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 198
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           RW  APE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 199 RWT-APE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 236

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 53/304 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH- 88
           Y  +K IG G    V   +N E  +  AIK +N   A    +D+ R   E+  L  LQ  
Sbjct: 14  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 70
Query: 89  -ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            + +I L D  +         +Y+V E  + DL+  +K  +++     + +   +L  + 
Sbjct: 71  SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 125
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 126 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
                + E            DVWS+GCI   +   K   P  + +NQ+  +  I+    E
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHE 242
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             +EF D P+     K L                    D+L+  L  DP +RIS+ E L 
Sbjct: 243 --IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELLA 276
Query: 316 HPYM 319
           HPY+
Sbjct: 277 HPYV 280

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 53/304 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH- 88
           Y  +K IG G    V   +N E  +  AIK +N   A    +D+ R   E+  L  LQ  
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 67
Query: 89  -ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            + +I L D  +         +Y+V E  + DL+  +K  +++     + +   +L  + 
Sbjct: 68  SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 123 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
                + E            DVWS+GCI   +   K   P  + +NQ+  +  I+    E
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHE 239
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             +EF D P+     K L                    D+L+  L  DP +RIS+ E L 
Sbjct: 240 --IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELLA 273
Query: 316 HPYM 319
           HPY+
Sbjct: 274 HPYV 277

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 125/304 (41%), Gaps = 53/304 (17%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH- 88
           Y  +K IG G    V   +N E  +  AIK +N   A    +D+ R   E+  L  LQ  
Sbjct: 10  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRN--EIAYLNKLQQH 66
Query: 89  -ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            + +I L D  +         +Y+V E  + DL+  +K  +++     + +   +L  + 
Sbjct: 67  SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 121
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMTEYVV 195
            +H   I+H DLKP N L+  +  LK+ DFG+A             +  G   +M    +
Sbjct: 122 TIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
                + E            DVWS+GCI   +   K   P  + +NQ+  +  I+    E
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHE 238
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             +EF D P+     K L                    D+L+  L  DP +RIS+ E L 
Sbjct: 239 --IEFPDIPE-----KDLQ-------------------DVLKCCLKRDPKQRISIPELLA 272
Query: 316 HPYM 319
           HPY+
Sbjct: 273 HPYV 276

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 52/297 (17%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRGAYG V   V++ + + +A+K+I +  + +      +    ++R      ++     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHC-----QYFLFQLLRGLKYL-HS 151
           +         D ++  ELM T   +  K   ++ +D              ++ L +L  +
Sbjct: 90  LFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW-----YRAPELL- 205
             I+HRD+KP N+L++ + ++K+CDFG++       Q +     TR      Y APE + 
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGIS------GQLVDSIAKTRDAGCRPYMAPERID 198
Query: 206 --LCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
                  Y    DVWS+G    EL  GR P        +QL  ++       + D   + 
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-------KGDPPQLS 251
Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           N + R++                    P  I+ +   L  D +KR    E L+HP++
Sbjct: 252 NSEEREF-------------------SPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IK +G G +G V        N KVAIK +       +     L E ++++ L+H+ ++ L
Sbjct: 14  IKRLGNGQFGEVWMGT-WNGNTKVAIKTLKPG---TMSPESFLEEAQIMKKLKHDKLVQL 69
Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHS 151
             V+      + + +Y+V E M+   L   +K  +  AL   +      Q+  G+ Y+  
Sbjct: 70  YAVV------SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCD 209
            N +HRDL+  N+LV      KI DFGLAR    N            +W  APE  L   
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL-YG 181
Query: 210 NYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
            +    DVWS G +  EL+  GR P +PG    E L Q++
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVP-YPGMNNREVLEQVE 220

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 32/230 (13%)
Query: 27  EIDTKYVPIKP-IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           EID   V I+  IG G +G VCS   +   ++   VAIK + + +  +      L E  +
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 61
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           +    H NVI L+ V+  S       V ++ E M+            L  +  Q+ + QL
Sbjct: 62  MGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENG-----SLDSFLRQNDGQFTVIQL 111
Query: 143 L-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-----TSNGK-NQF 189
           +        G+KYL   N +HR L   N+LVN+N   K+ DFGL+R     TS+      
Sbjct: 112 VGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 171
Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGT 237
           +   +  RW  APE +     + ++ DVWS G +  E++  G +P +  T
Sbjct: 172 LGGKIPIRW-TAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 219

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  I+ IG G +G V  + +R   +   IK++    E      +  RE+K L  L H N+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHVNI 66
Query: 92  IALKDVM-----------MPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYF- 138
           +                   S R   K +++  E  D   L Q I+  +    D      
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 139 LF-QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           LF Q+ +G+ Y+HS  +++RDLKP N+ +     +KI DFGL  +     +        R
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLR 186
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
            Y +PE +   D YG  +D++++G I AELL
Sbjct: 187 -YMSPEQISSQD-YGKEVDLYALGLILAELL 215

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           EID   + I K IG G +G VCS   +   ++   VAIK +   + ++      L E  +
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 62
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLF 140
           +    H N+I L+ V+        K V ++ E M+   L   ++ +    T       L 
Sbjct: 63  MGQFDHPNIIHLEGVVTKC-----KPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 117
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTE--YVVT 196
            +  G+KYL   + +HRDL   N+LVN+N   K+ DFG++R    + +  + T    +  
Sbjct: 118 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           RW  APE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 178 RW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 215

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 20/220 (9%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           EID   + I K IG G +G VCS   +   ++   VAIK +   + ++      L E  +
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASI 68
Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLF 140
           +    H N+I L+ V+        K V ++ E M+   L   ++ +    T       L 
Sbjct: 69  MGQFDHPNIIHLEGVVTKC-----KPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR 123
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTE--YVVT 196
            +  G+KYL   + +HRDL   N+LVN+N   K+ DFG++R    + +  + T    +  
Sbjct: 124 GIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           RW  APE  +    + ++ DVWS G +  E++  G +P +
Sbjct: 184 RW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 221

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 101 KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 213
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 67  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 179
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           I+ +G G +G V        N  T E VA+K +      ++ +    RE+++LR L HE+
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRS-GWQREIEILRTLYHEH 72
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHC----QYFLF--QLLR 144
           ++  K        +  K V LV E +       + S +     HC    Q  LF  Q+  
Sbjct: 73  IVKYKGC---CEDQGEKSVQLVMEYVP------LGSLRDYLPRHCVGLAQLLLFAQQICE 123
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR------- 197
           G+ YLH+ + +HR L   N+L++ +  +KI DFGLA+     +++   Y V         
Sbjct: 124 GMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVF 180
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           WY APE L  C  Y  S DVWS G    ELL
Sbjct: 181 WY-APECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 89  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 143
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 144 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 201
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           I+ +G G +G V        N  T E VA+K +      ++ +    RE+++LR L HE+
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRS-GWQREIEILRTLYHEH 71
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHC----QYFLF--QLLR 144
           ++  K        +  K V LV E +       + S +     HC    Q  LF  Q+  
Sbjct: 72  IVKYKGC---CEDQGEKSVQLVMEYVP------LGSLRDYLPRHCVGLAQLLLFAQQICE 122
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR------- 197
           G+ YLH+ + +HR L   N+L++ +  +KI DFGLA+     +++   Y V         
Sbjct: 123 GMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVF 179
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           WY APE L  C  Y  S DVWS G    ELL
Sbjct: 180 WY-APECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 107/245 (43%), Gaps = 59/245 (24%)
Query: 109 VYLVYELMDTDLHQIIKSSQALTND---HCQY----FLFQLLRGLKYLHSANILHRDLKP 161
           +Y+  EL + +L  +++S      +     +Y     L Q+  G+ +LHS  I+HRDLKP
Sbjct: 84  LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 143
Query: 162 GNLLVNA-------------NCDLKICDFGLART-SNGKNQFMTEY---VVTRWYRAPEL 204
            N+LV+              N  + I DFGL +   +G++ F T       T  +RAPEL
Sbjct: 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL 203
Query: 205 LLCCDNYGT------SIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRREE 256
           L   +N  T      SID++S+GC+F  +L  G+ P   G +   +  +I  I       
Sbjct: 204 LEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKYSRESNIIRGIFS----- 256
Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
            L+ +     R  I                     A DL+ +M+  DP KR +  + L+H
Sbjct: 257 -LDEMKCLHDRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 317 PYMSP 321
           P   P
Sbjct: 297 PLFWP 301

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 108/251 (43%), Gaps = 47/251 (18%)
Query: 8   PNGIRSPGKHYYSMWQTLFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKI 63
           P+    PG+   S  +   EI+   + I K IG G  G VC    R   ++   VAIK +
Sbjct: 29  PHTYEEPGRAGRSFTR---EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL 85
Query: 64  NNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQI 123
              +  R      L E  ++    H N+I L+ V+           Y+    +DT L   
Sbjct: 86  KAGYTER-QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-- 142
Query: 124 IKSSQALTNDHCQYFLFQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICD 176
                  T+D  Q+ + QL+        G++YL     +HRDL   N+LV++N   K+ D
Sbjct: 143 -------THD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 177 FGLAR-----------TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
           FGL+R           T+ GK       +  RW  APE  +    + ++ DVWS G +  
Sbjct: 195 FGLSRVLEDDPDAAXTTTGGK-------IPIRWT-APE-AIAFRTFSSASDVWSFGVVMW 245
Query: 226 ELL--GRKPIF 234
           E+L  G +P +
Sbjct: 246 EVLAYGERPYW 256

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 81  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 135
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 136 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 193
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 82  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 136
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 194
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 82  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 136
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 194
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 82  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 136
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 194
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 81  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 135
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 136 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 193
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 67  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 179
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 95  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 149
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 207
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 94  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 148
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 206
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 94  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 148
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 206
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 95  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 149
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 207
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 94  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 148
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 206
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 108/251 (43%), Gaps = 47/251 (18%)
Query: 8   PNGIRSPGKHYYSMWQTLFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKI 63
           P+    PG+   S  +   EI+   + I K IG G  G VC    R   ++   VAIK +
Sbjct: 29  PHTYEEPGRAGRSFTR---EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL 85
Query: 64  NNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQI 123
              +  R      L E  ++    H N+I L+ V+           Y+    +DT L   
Sbjct: 86  KAGYTER-QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-- 142
Query: 124 IKSSQALTNDHCQYFLFQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICD 176
                  T+D  Q+ + QL+        G++YL     +HRDL   N+LV++N   K+ D
Sbjct: 143 -------THD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 177 FGLAR-----------TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
           FGL+R           T+ GK       +  RW  APE  +    + ++ DVWS G +  
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGK-------IPIRWT-APE-AIAFRTFSSASDVWSFGVVMW 245
Query: 226 ELL--GRKPIF 234
           E+L  G +P +
Sbjct: 246 EVLAYGERPYW 256

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 95  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 149
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 207
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 54  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 114 KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 168
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 169 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 226
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 113/240 (47%), Gaps = 38/240 (15%)
Query: 36  KPIGRGAYGIV----CSSVNRETNE-KVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           + +G GA+G V    C ++  E ++  VA+K + +A +N        RE +LL +LQHE+
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH--REAELLTNLQHEH 76
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSS-------------QALTNDHCQ 136
           ++    V +         + +V+E M   DL++ +++                LT     
Sbjct: 77  IVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT---EY 193
           +   Q+  G+ YL S + +HRDL   N LV  N  +KI DFG++R     + +       
Sbjct: 132 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 191
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGT-----ECLNQLKLI 246
           +  RW   PE ++    + T  DVWS+G +  E+   G++P +  +     EC+ Q +++
Sbjct: 192 LPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 249

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 109 KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 163
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 221
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 67  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 179
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 66  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 120
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 121 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 178
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 95  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 149
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 207
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 94  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 148
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 206
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRG +G V S   R  N  VA+K         + A + L+E ++L+   H N++ L  V
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLIGV 180
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANIL 155
                    + +Y+V EL+   D    +++  A L        +     G++YL S   +
Sbjct: 181 CTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 156 HRDLKPGNLLVNANCDLKICDFGLAR--------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           HRDL   N LV     LKI DFG++R         S G  Q     V  +W  APE L  
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQ-----VPVKW-TAPEAL-- 287
Query: 208 CDNYG---TSIDVWSVGCIFAEL--LGRKP 232
             NYG   +  DVWS G +  E   LG  P
Sbjct: 288 --NYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 100/389 (25%), Positives = 155/389 (39%), Gaps = 82/389 (21%)
Query: 6   EPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINN 65
           E PN     G H   +   LF  + +Y  I+ +G G +  V  S + +  + VA+K + +
Sbjct: 16  EDPNDYCKGGYHLVKI-GDLF--NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS 72
Query: 66  AFENRVDALRTLRELKLLRHL-----QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL 120
           A      AL  +R LK +R+        E V+ L D    S   N   + +V+E++   L
Sbjct: 73  AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS-GVNGTHICMVFEVLGHHL 131
Query: 121 -HQIIKSS-QALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNAN-------- 169
              IIKS+ Q L     +  + Q+L+GL YLH+   I+H D+KP N+L++ N        
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 170 -----------------------------------------CDLKICDFGLARTSNGKNQ 188
                                                      +KI D G    +   ++
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG---NACWVHK 248
Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF---PGTECL---NQ 242
             TE + TR YR+ E+L+    Y T  D+WS  C+  EL     +F    G E     + 
Sbjct: 249 HFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
Query: 243 LKLIINILGS-------RREEDLEFIDNPKARKYIKSL-PYTPGTPFSRLYPDAHPLA-- 292
           + LII +LG          +   EF       K+I  L P+         Y  +   A  
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 293 -IDLLQKMLVFDPTKRISVTEALQHPYMS 320
             D L  ML   P KR +  E L+HP+++
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPWLN 396

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 132/293 (45%), Gaps = 64/293 (21%)
Query: 52  RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL 111
           +  N+K++IK   + F+N         EL+++  +++E  +  + ++      N+ +VY+
Sbjct: 75  KSNNDKISIKSKYDDFKN---------ELQIITDIKNEYCLTCEGIIT-----NYDEVYI 120
Query: 112 VYELMDTDLHQIIKSSQALTNDHCQYFLF-----------QLLRGLKYLHS-ANILHRDL 159
           +YE M+ D   I+K  +        Y  F            +L    Y+H+  NI HRD+
Sbjct: 121 IYEYMEND--SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 160 KPGNLLVNANCDLKICDFGLA--------RTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
           KP N+L++ N  +K+ DFG +        + S G  +FM           PE      +Y
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM----------PPEFFSNESSY 228
Query: 212 -GTSIDVWSVG-CIFAELLGRKPIFPGTECLNQLKL-IINILGSRREEDLEFIDNPKARK 268
            G  +D+WS+G C++       P          LK+ ++ +  + R +++E+   P  R 
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPF--------SLKISLVELFNNIRTKNIEY---PLDRN 277
Query: 269 -YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
            ++  L     T  +    +     ID L+  L  +P +RI+  +AL+H +++
Sbjct: 278 HFLYPLTNKKSTCSNNFLSNED---IDFLKLFLRKNPAERITSEDALKHEWLA 327

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 92/210 (43%), Gaps = 31/210 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRG +G V S   R  N  VA+K         + A + L+E ++L+   H N++ L  V
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLIGV 180
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANIL 155
                    + +Y+V EL+   D    +++  A L        +     G++YL S   +
Sbjct: 181 CTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 156 HRDLKPGNLLVNANCDLKICDFGLAR--------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           HRDL   N LV     LKI DFG++R         S G  Q     V  +W  APE L  
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ-----VPVKW-TAPEAL-- 287
Query: 208 CDNYG---TSIDVWSVGCIFAEL--LGRKP 232
             NYG   +  DVWS G +  E   LG  P
Sbjct: 288 --NYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 109 KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 163
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 221
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 42/232 (18%)
Query: 36  KPIGRGAYGIVCSS----VNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           KP+GRGA+G V  +    +++    +    K+        +    + ELK+L H+ H  N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 91  VIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
           V+ L                  K   + ++ R+ ++ ++ Y+ +  D          LT 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF---------LTL 143
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       ++ +
Sbjct: 144 EHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 204 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 251

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIALKD 96
           +G+GA   V    +++T +  AIK  NN +F   VD    +RE ++L+ L H+N++ L  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFA 74
Query: 97  VMMPSHRRNFKDVYLVYELMD-TDLHQIIK---SSQALTNDHCQYFLFQLLRGLKYLHSA 152
           +   +  R+     L+ E      L+ +++   ++  L        L  ++ G+ +L   
Sbjct: 75  IEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 153 NILHRDLKPGNLL----VNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL---- 204
            I+HR++KPGN++     +     K+ DFG AR      QF++ Y  T  Y  P++    
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYERA 190
Query: 205 LLCCDN---YGTSIDVWSVGCIF 224
           +L  D+   YG ++D+WS+G  F
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTF 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 6/192 (3%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G++G V  +    ++  V I    +    RV+    LRE+ +++ L+H N++     
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEF--LREVAIMKRLRHPNIVLFMGA 102
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--IL 155
           +      +    YL    +   LH+     Q L         + + +G+ YLH+ N  I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           HRDLK  NLLV+    +K+CDFGL+R              T  + APE+L    +   S 
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS- 220
Query: 216 DVWSVGCIFAEL 227
           DV+S G I  EL
Sbjct: 221 DVYSFGVILWEL 232

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 131/284 (46%), Gaps = 41/284 (14%)
Query: 35  IKPIGRGAYG---IVCSSVNRETNEKVAIKKINNA--FENRVDALRTLRELKLLRHLQHE 89
           +K +G GAYG   +V      +T +  A+K +  A   +       T  E ++L H++  
Sbjct: 59  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
             +        +  +    ++L+ + ++  +L   +   +  T    Q ++ +++  L++
Sbjct: 119 PFLVTLHYAFQTETK----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKNQFMTEYVVTRWYRAPELLLC 207
           LH   I++RD+K  N+L+++N  + + DFGL++     + +   ++  T  Y AP+++  
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 208 CDN-YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
            D+ +  ++D WS+G +  ELL G  P     E  +Q ++                    
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------------------- 274
Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
           +R+ +KS P  P         +   LA DL+Q++L+ DP KR+ 
Sbjct: 275 SRRILKSEPPYP--------QEMSALAKDLIQRLLMKDPKKRLG 310

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 39/237 (16%)
Query: 23  QTLFEIDTKY----VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLR 78
           +T + +D ++      I+ IG G +G V  + +R   +   I+++    E      +  R
Sbjct: 1   ETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE------KAER 54
Query: 79  ELKLLRHLQHENVIALKDVM------------------------MPSHRRNFKDVYLVYE 114
           E+K L  L H N++                                S R   K +++  E
Sbjct: 55  EVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQME 114
Query: 115 LMDTD-LHQIIKSSQALTNDHCQYF-LF-QLLRGLKYLHSANILHRDLKPGNLLVNANCD 171
             D   L Q I+  +    D      LF Q+ +G+ Y+HS  ++HRDLKP N+ +     
Sbjct: 115 FCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ 174
Query: 172 LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           +KI DFGL  TS   +   T    T  Y +PE +   D YG  +D++++G I AELL
Sbjct: 175 VKIGDFGLV-TSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELL 229

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 45/295 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA-LRTLRELKLLRHLQHENVIALKD 96
           +G+G +G VC+   R T +  A KK+      +       L E ++L  +    V++L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-- 249
Query: 97  VMMPSHRRNFKDVY-LVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
               ++    KD   LV  LM   D   H               ++  ++  GL+ LH  
Sbjct: 250 ----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++ +  ++I D GLA     + Q +   V T  Y APE++   + Y 
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVK-NERYT 363
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
            S D W++GC+  E++       G     Q K  I     +REE           + +K 
Sbjct: 364 FSPDWWALGCLLYEMIA------GQSPFQQRKKKI-----KREE---------VERLVKE 403
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL 322
           +P      FS       P A  L  ++L  DP +R+     S  E  +HP    L
Sbjct: 404 VPEEYSERFS-------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 62  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 117 WQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 174
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +        +   KVA+K + + A  +  +AL  + ELK++ HL QH
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY-----------ELMDTDLHQIIKSSQALTNDHCQY 137
           EN++ L               Y  Y            +++TD    I +S   T D   +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD-LLH 168
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YV 194
           F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR     + ++ +    +
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +W  APE +  C  Y    DVWS G +  E+  LG  P +PG
Sbjct: 229 PVKW-MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 269

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 64
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 65  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 119
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 120 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 177
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKD- 96
           +G+G++G V  S  + T+E  A+K +      + D +           +  + V+AL   
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT--------MVEKRVLALPGK 79
Query: 97  ----VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                 + S  +    +Y V E ++  DL   I+        H  ++  ++  GL +L S
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+++++   +KI DFG+ + +         +  T  Y APE ++    Y
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPE-IIAYQPY 198
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTE 238
           G S+D W+ G +  E+L  +  F G +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGED 225

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ +G G +G V        + KVA+K +        DA   L E  L++ LQH+ ++ L
Sbjct: 14  VERLGAGQFGEVWMGY-YNGHTKVAVKSLKQG-SMSPDAF--LAEANLMKQLQHQRLVRL 69
Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHS 151
             V+        + +Y++ E M+   L   +K  S   LT +       Q+  G+ ++  
Sbjct: 70  YAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 123
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV--TRWYRAPELLLCCD 209
            N +HR+L+  N+LV+     KI DFGLAR          E      +W  APE +    
Sbjct: 124 RNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPEAI---- 178
Query: 210 NYGT---SIDVWSVGCIFAELL--GRKPIFPG 236
           NYGT     DVWS G +  E++  GR P +PG
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 209

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 127/289 (43%), Gaps = 41/289 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           ++  + +GRG +G V +   + T +  A KK+N     +    +  + E K+L  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD-----LHQIIKSSQALTNDHCQYFLFQLLRG 145
           +++L             D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 247 IVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA            Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           L  + Y  S+D +++G    E++  +  F                 +R E+    ++N +
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPFR----------------ARGEK----VENKE 400
Query: 266 ARKYIKSLPYTPGTPFSRLYPDA-HPLAIDLLQKMLVFDPTKRISVTEA 313
            ++ +     T        YPD   P + D  + +L  DP KR+   + 
Sbjct: 401 LKQRVLEQAVT--------YPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 127/289 (43%), Gaps = 41/289 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           ++  + +GRG +G V +   + T +  A KK+N     +    +  + E K+L  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD-----LHQIIKSSQALTNDHCQYFLFQLLRG 145
           +++L             D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 247 IVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA            Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           L  + Y  S+D +++G    E++  +  F                 +R E+    ++N +
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPFR----------------ARGEK----VENKE 400
Query: 266 ARKYIKSLPYTPGTPFSRLYPDA-HPLAIDLLQKMLVFDPTKRISVTEA 313
            ++ +     T        YPD   P + D  + +L  DP KR+   + 
Sbjct: 401 LKQRVLEQAVT--------YPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 62  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 174
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 127/289 (43%), Gaps = 41/289 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           ++  + +GRG +G V +   + T +  A KK+N     +    +  + E K+L  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD-----LHQIIKSSQALTNDHCQYFLFQLLRG 145
           +++L             D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 247 IVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA            Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           L  + Y  S+D +++G    E++  +  F                 +R E+    ++N +
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPFR----------------ARGEK----VENKE 400
Query: 266 ARKYIKSLPYTPGTPFSRLYPDA-HPLAIDLLQKMLVFDPTKRISVTEA 313
            ++ +     T        YPD   P + D  + +L  DP KR+   + 
Sbjct: 401 LKQRVLEQAVT--------YPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 45/295 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA-LRTLRELKLLRHLQHENVIALKD 96
           +G+G +G VC+   R T +  A KK+      +       L E ++L  +    V++L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-- 249
Query: 97  VMMPSHRRNFKDVY-LVYELM---DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
               ++    KD   LV  LM   D   H               ++  ++  GL+ LH  
Sbjct: 250 ----AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLKP N+L++ +  ++I D GLA     + Q +   V T  Y APE++   + Y 
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRVGTVGYMAPEVVK-NERYT 363
Query: 213 TSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
            S D W++GC+  E++       G     Q K  I     +REE           + +K 
Sbjct: 364 FSPDWWALGCLLYEMIA------GQSPFQQRKKKI-----KREE---------VERLVKE 403
Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL 322
           +P      FS       P A  L  ++L  DP +R+     S  E  +HP    L
Sbjct: 404 VPEEYSERFS-------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 127/289 (43%), Gaps = 41/289 (14%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHEN 90
           ++  + +GRG +G V +   + T +  A KK+N     +    +  + E K+L  +    
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD-----LHQIIKSSQALTNDHCQYFLFQLLRG 145
           +++L             D+ LV  +M+       ++ + + +         ++  Q++ G
Sbjct: 247 IVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L++LH  NI++RDLKP N+L++ + +++I D GLA            Y  T  + APELL
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           L  + Y  S+D +++G    E++  +  F                 +R E+    ++N +
Sbjct: 362 L-GEEYDFSVDYFALGVTLYEMIAARGPFR----------------ARGEK----VENKE 400
Query: 266 ARKYIKSLPYTPGTPFSRLYPDA-HPLAIDLLQKMLVFDPTKRISVTEA 313
            ++ +     T        YPD   P + D  + +L  DP KR+   + 
Sbjct: 401 LKQRVLEQAVT--------YPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHE 89
           Y  +K IGRGA+G V   V  ++  KV   K+ + FE   R D+     E  ++      
Sbjct: 76  YEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            V+ L              +Y+V E M   DL  ++ S+  +     +++  +++  L  
Sbjct: 135 WVVQLFYAFQDDRY-----LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDA 188
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLC 207
           +HS   +HRD+KP N+L++ +  LK+ DFG     N +     +  V T  Y +PE+L  
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 208 CDN---YGTSIDVWSVGCIFAELL-GRKPIFPGT 237
                 YG   D WSVG    E+L G  P +  +
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 84  RHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 62  KKVSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 174
Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           Y  PE +     +G S  VWS+G +  +++
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  L+H N++ L
Sbjct: 198 LQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL  
Sbjct: 252 LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + ++      T  +  +W  APE L     +
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALR-EKKF 363
Query: 212 GTSIDVWSVGCIFAEL--LGRKP 232
            T  DVWS G +  E+   GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 93/367 (25%), Positives = 147/367 (40%), Gaps = 79/367 (21%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL- 86
            + +Y  I+ +G G +  V  S + +  + VA+K + +A      AL  +R LK +R+  
Sbjct: 19  FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSD 78
Query: 87  ----QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL-HQIIKSS-QALTNDHCQYFLF 140
                 E V+ L D    S   N   + +V+E++   L   IIKS+ Q L     +  + 
Sbjct: 79  PNDPNREMVVQLLDDFKIS-GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 137
Query: 141 QLLRGLKYLHS-ANILHRDLKPGNLLVNAN------------------------------ 169
           Q+L+GL YLH+   I+H D+KP N+L++ N                              
Sbjct: 138 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 197
Query: 170 -------------------CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
                                +KI D G    +   ++  TE + TR YR+ E+L+    
Sbjct: 198 PATAGNFLVNPLEPKNAEKLKVKIADLG---NACWVHKHFTEDIQTRQYRSLEVLI-GSG 253
Query: 211 YGTSIDVWSVGCIFAELLGRKPIF---PGTECL---NQLKLIINILGS-------RREED 257
           Y T  D+WS  C+  EL     +F    G E     + + LII +LG          +  
Sbjct: 254 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 313
Query: 258 LEFIDNPKARKYIKSL-PYTPGTPFSRLYPDAHPLA---IDLLQKMLVFDPTKRISVTEA 313
            EF       K+I  L P+         Y  +   A    D L  ML   P KR +  E 
Sbjct: 314 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 373
Query: 314 LQHPYMS 320
           L+HP+++
Sbjct: 374 LRHPWLN 380

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHE 89
           Y  +K IGRGA+G V   V  ++  KV   K+ + FE   R D+     E  ++      
Sbjct: 76  YEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            V+ L              +Y+V E M   DL  ++ S+  +     +++  +++  L  
Sbjct: 135 WVVQLFYAFQDDRY-----LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDA 188
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLC 207
           +HS   +HRD+KP N+L++ +  LK+ DFG     N +     +  V T  Y +PE+L  
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 248
Query: 208 CDN---YGTSIDVWSVGCIFAELL-GRKPIFPGT 237
                 YG   D WSVG    E+L G  P +  +
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 282

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHE 89
           Y  +K IGRGA+G V   V  ++  KV   K+ + FE   R D+     E  ++      
Sbjct: 71  YEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            V+ L              +Y+V E M   DL  ++ S+  +     +++  +++  L  
Sbjct: 130 WVVQLFYAFQDDRY-----LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDA 183
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLC 207
           +HS   +HRD+KP N+L++ +  LK+ DFG     N +     +  V T  Y +PE+L  
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 208 CDN---YGTSIDVWSVGCIFAELL-GRKPIFPGT 237
                 YG   D WSVG    E+L G  P +  +
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 50/235 (21%)
Query: 27  EIDTKYVPI-KPIGRGAYGIVCSS---VNRETNEKVAIK--KINNAFENRVDALRTLREL 80
           E+D   + I + IG G +G VCS    +  + +  VAIK  K+    + R D    L E 
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD---FLCEA 95
Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH-CQYFL 139
            ++    H NV+ L+ V+        K V +V E M+        +  A    H  Q+ +
Sbjct: 96  SIMGQFDHPNVVHLEGVVTRG-----KPVMIVIEFMENG------ALDAFLRKHDGQFTV 144
Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------- 181
            QL+        G++YL     +HRDL   N+LVN+N   K+ DFGL+R           
Sbjct: 145 IQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYT 204
Query: 182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           T+ GK       +  RW  APE +     + ++ DVWS G +  E++  G +P +
Sbjct: 205 TTGGK-------IPVRW-TAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYW 250

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 40/232 (17%)
Query: 36  KPIGRGAYGIVCSS----VNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           KP+GRGA+G V  +    +++    +    K+        +    + ELK+L H+ H  N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 91  VIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
           V+ L                  K   + ++ R+ ++ ++ Y+    DL++       LT 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK--PEDLYK-----DFLTL 147
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR        + +
Sbjct: 148 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 193 ---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 208 GDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 15/214 (7%)
Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHE 89
           Y  +K IGRGA+G V   V  + ++KV   K+ + FE   R D+     E  ++      
Sbjct: 77  YDVVKVIGRGAFGEV-QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            V+ L         ++ K +Y+V E M   DL  ++ S+  +     +++  +++  L  
Sbjct: 136 WVVQLFCAF-----QDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDA 189
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLC 207
           +HS  ++HRD+KP N+L++ +  LK+ DFG     +       +  V T  Y +PE+L  
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKS 249
Query: 208 CDN---YGTSIDVWSVGC-IFAELLGRKPIFPGT 237
                 YG   D WSVG  +F  L+G  P +  +
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 283

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  L+H N++ L
Sbjct: 26  LQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL  
Sbjct: 80  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + ++      T  +  +W  APE L     +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALR-EKKF 191
Query: 212 GTSIDVWSVGCIFAEL--LGRKP 232
            T  DVWS G +  E+   GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 25/246 (10%)
Query: 10  GIRSPGKHYYSMWQTLFEIDTKYVPIK-PIGRGAYGIVCSSVNRETNEKVAIKKINNAFE 68
           G   P    Y  W    E++   + +K  +G G YG V   V ++ +  VA+K +    E
Sbjct: 1   GAMDPSSPNYDKW----EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---E 53
Query: 69  NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIK-- 125
           + ++    L+E  +++ ++H N++ L  V            Y++ E M   +L   ++  
Sbjct: 54  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC 108
Query: 126 SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG 185
           + Q ++     Y   Q+   ++YL   N +HRDL   N LV  N  +K+ DFGL+R   G
Sbjct: 109 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 168
Query: 186 KNQFMTEYVVTRW---YRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTECL 240
                T +   ++   + APE  L  + +    DVW+ G +  E+   G  P +PG +  
Sbjct: 169 DT--YTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLS 224
Query: 241 NQLKLI 246
              +L+
Sbjct: 225 QVYELL 230

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  L+H N++ L
Sbjct: 17  LQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL  
Sbjct: 71  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + ++      T  +  +W  APE L     +
Sbjct: 127 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALREA-AF 182
Query: 212 GTSIDVWSVGCIFAEL--LGRKP 232
            T  DVWS G +  E+   GR P
Sbjct: 183 STKSDVWSFGILLWEIYSFGRVP 205

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINN-AFENRVDALRTLRELKLLRHLQHENVIALKD 96
           +G+GA   V    +++T +  AIK  NN +F   VD    +RE ++L+ L H+N++ L  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFA 74
Query: 97  VMMPSHRRNFKDVYLVYELMD-TDLHQIIK---SSQALTNDHCQYFLFQLLRGLKYLHSA 152
           +   +  R+     L+ E      L+ +++   ++  L        L  ++ G+ +L   
Sbjct: 75  IEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 153 NILHRDLKPGNLL----VNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL---- 204
            I+HR++KPGN++     +     K+ DFG AR      QF+  Y  T  Y  P++    
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY-GTEEYLHPDMYERA 190
Query: 205 LLCCDN---YGTSIDVWSVGCIF 224
           +L  D+   YG ++D+WS+G  F
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTF 213

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKD- 96
           +G+G++G V  S  + T+E  A+K +      + D +           +  + V+AL   
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT--------MVEKRVLALPGK 400
Query: 97  ----VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                 + S  +    +Y V E ++  DL   I+        H  ++  ++  GL +L S
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 460
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             I++RDLK  N+++++   +KI DFG+ + +         +  T  Y APE ++    Y
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPE-IIAYQPY 519
Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTE 238
           G S+D W+ G +  E+L  +  F G +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGED 546

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IG+G +G V     R    KVA+K I    +N   A   L E  ++  L+H N++ L
Sbjct: 11  LQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHS 151
             V++         +Y+V E M    L   ++S     L  D    F   +   ++YL  
Sbjct: 65  LGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
            N +HRDL   N+LV+ +   K+ DFGL + ++      T  +  +W  APE L     +
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKW-TAPEALR-EKKF 176
Query: 212 GTSIDVWSVGCIFAEL--LGRKP 232
            T  DVWS G +  E+   GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 76  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAPE-SLAYNKF 187
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               DVW+ G +  E+   G  P +PG +
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 92  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 206
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 260

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 82  V------SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 110/246 (44%), Gaps = 25/246 (10%)
Query: 10  GIRSPGKHYYSMWQTLFEIDTKYVPIK-PIGRGAYGIVCSSVNRETNEKVAIKKINNAFE 68
           G   P    Y  W    E++   + +K  +G G YG V   V ++ +  VA+K +    E
Sbjct: 1   GAMDPSSPNYDKW----EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---E 53
Query: 69  NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIK-- 125
           + ++    L+E  +++ ++H N++ L  V            Y++ E M   +L   ++  
Sbjct: 54  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC 108
Query: 126 SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG 185
           + Q +      Y   Q+   ++YL   N +HRDL   N LV  N  +K+ DFGL+R   G
Sbjct: 109 NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 168
Query: 186 KNQFMTEYVVTRW---YRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTECL 240
                T +   ++   + APE  L  + +    DVW+ G +  E+   G  P +PG +  
Sbjct: 169 DTX--TAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLS 224
Query: 241 NQLKLI 246
              +L+
Sbjct: 225 QVYELL 230

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 76  CTRE-----PPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE-SLAYNKF 187
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               DVW+ G +  E+   G  P +PG +
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 115 LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 229
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 283

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 116 LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 230
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 284

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 89  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 203
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 257

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 78  CTRE-----PPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 125/287 (43%), Gaps = 43/287 (14%)
Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +P+G+G +G V  +  ++++  VA+K +  +  E      +  RE+++  HL H N++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
            +      R     +YL+ E     +L++ ++ S           + +L   L Y H   
Sbjct: 89  YNYFYDRRR-----IYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           ++HRD+KP NLL+    +LKI DFG   + +  +        T  Y  PE++     +  
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGW--SVHAPSLRRKTMCGTLDYLPPEMIE-GRMHNE 200
Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL 273
            +D+W +G +  ELL   P F         + I+ +       DL+F             
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV-------DLKF------------- 240
Query: 274 PYTPGTPFSRLYPDAHPL-AIDLLQKMLVFDPTKRISVTEALQHPYM 319
                       P + P  A DL+ K+L  +P++R+ + +   HP++
Sbjct: 241 ------------PASVPTGAQDLISKLLRHNPSERLPLAQVSAHPWV 275

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 95  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 151
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 209
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 263

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 94  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 208
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 262

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 97  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 211
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 265

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 96  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 210
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 264

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 6/192 (3%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IG G++G V  +    ++  V I    +    RV+    LRE+ +++ L+H N++     
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEF--LREVAIMKRLRHPNIVLFMGA 102
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--IL 155
           +      +    YL    +   LH+     Q L         + + +G+ YLH+ N  I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           HR+LK  NLLV+    +K+CDFGL+R              T  + APE+L    +   S 
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS- 220
Query: 216 DVWSVGCIFAEL 227
           DV+S G I  EL
Sbjct: 221 DVYSFGVILWEL 232

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 19  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 75  V------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 128
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+    +F  ++       APE  L 
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 181
Query: 208 CDNYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 222

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 97  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K  +         +  +W     L    
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ--T 211
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 265

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 78  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 10/209 (4%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKD 96
           +G G+YG V    ++E     A+K+  + F    D  R L E+     + QH   + L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 97  VMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANIL 155
                       +YL  EL    L Q  ++   +L       +L   L  L +LHS  ++
Sbjct: 125 AW-----EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSI 215
           H D+KP N+ +      K+ DFGL            +    R Y APELL    +YGT+ 
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQ--GSYGTAA 236
Query: 216 DVWSVGCIFAELLGRKPIFPGTECLNQLK 244
           DV+S+G    E+     +  G E   QL+
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGWQQLR 265

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 78  CTRE-----PPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 78  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 15  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 71  V------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 124
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+    +F  ++       APE  L 
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 177
Query: 208 CDNYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 218

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 23  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M+   L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 79  V------SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+    +F  ++       APE  L 
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWT------APEAAL- 185
Query: 208 CDNYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 226

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 110/246 (44%), Gaps = 25/246 (10%)
Query: 10  GIRSPGKHYYSMWQTLFEIDTKYVPIK-PIGRGAYGIVCSSVNRETNEKVAIKKINNAFE 68
           G   P    Y  W    E++   + +K  +G G YG V   V ++ +  VA+K +    E
Sbjct: 1   GAMDPSSPNYDKW----EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---E 53
Query: 69  NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIK-- 125
           + ++    L+E  +++ ++H N++ L  V            Y++ E M   +L   ++  
Sbjct: 54  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC 108
Query: 126 SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG 185
           + Q +      Y   Q+   ++YL   N +HRDL   N LV  N  +K+ DFGL+R   G
Sbjct: 109 NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 168
Query: 186 KNQFMTEYVVTRW---YRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTECL 240
                T +   ++   + APE  L  + +    DVW+ G +  E+   G  P +PG +  
Sbjct: 169 DT--YTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLS 224
Query: 241 NQLKLI 246
              +L+
Sbjct: 225 QVYELL 230

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 23  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M+   L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 79  V------SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+    +F  ++       APE  L 
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 185
Query: 208 CDNYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 226

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 17  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 73  V------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 126
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+    +F  ++       APE  L 
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 179
Query: 208 CDNYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 220

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 38  IGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           +G G +G V   V R   ++  VAIK +    E + D    +RE +++  L +  ++ L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 96  DVMMPSHRRNFKDVYLVYELMDTD-LHQ-IIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
            V         + + LV E+     LH+ ++   + +   +    L Q+  G+KYL   N
Sbjct: 77  GVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDN 210
            +HRDL   N+L+      KI DFGL++     + + T     +W   + APE    C N
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE----CIN 186
Query: 211 ---YGTSIDVWSVGCIFAELL--GRKP 232
              + +  DVWS G    E L  G+KP
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 59/245 (24%)
Query: 109 VYLVYELMDTDLHQIIKSSQALTND---HCQY----FLFQLLRGLKYLHSANILHRDLKP 161
           +Y+  EL + +L  +++S      +     +Y     L Q+  G+ +LHS  I+HRDLKP
Sbjct: 84  LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 143
Query: 162 GNLLVNA-------------NCDLKICDFGLART-SNGKNQF---MTEYVVTRWYRAPEL 204
            N+LV+              N  + I DFGL +   +G+  F   +     T  +RAPEL
Sbjct: 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPEL 203
Query: 205 LLCCDNYGT------SIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRREE 256
           L   +N  T      SID++S+GC+F  +L  G+ P   G +   +  +I  I       
Sbjct: 204 LEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKYSRESNIIRGIFS----- 256
Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
            L+ +     R  I                     A DL+ +M+  DP KR +  + L+H
Sbjct: 257 -LDEMKCLHDRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 317 PYMSP 321
           P   P
Sbjct: 297 PLFWP 301

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 79  CTRE-----PPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE-SLAYNKF 190
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 191 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 226

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           IGRG +G V      +T +  A+K ++    + +      L E  +L      ++++  D
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML------SLVSTGD 250
Query: 97  ----VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
               V M         +  + +LM+  DLH  +      +    +++  +++ GL+++H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +++RDLKP N+L++ +  ++I D GLA   + K    +  V T  Y APE+L     Y
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAY 368
Query: 212 GTSIDVWSVGCIFAELL-GRKPI 233
            +S D +S+GC+  +LL G  P 
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 82  V------SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 83  CTRE-----PPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 194
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 230

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           IGRG +G V      +T +  A+K ++    + +      L E  +L      ++++  D
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML------SLVSTGD 249
Query: 97  ----VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
               V M         +  + +LM+  DLH  +      +    +++  +++ GL+++H+
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +++RDLKP N+L++ +  ++I D GLA   + K    +  V T  Y APE+L     Y
Sbjct: 310 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAY 367
Query: 212 GTSIDVWSVGCIFAELL-GRKPI 233
            +S D +S+GC+  +LL G  P 
Sbjct: 368 DSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 82  V------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 83  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 194
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 230

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           IGRG +G V      +T +  A+K ++    + +      L E  +L      ++++  D
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML------SLVSTGD 250
Query: 97  ----VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
               V M         +  + +LM+  DLH  +      +    +++  +++ GL+++H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +++RDLKP N+L++ +  ++I D GLA   + K    +  V T  Y APE+L     Y
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAY 368
Query: 212 GTSIDVWSVGCIFAELL-GRKPI 233
            +S D +S+GC+  +LL G  P 
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTLRELKLLRHLQHENVIALKD 96
           IGRG +G V      +T +  A+K ++    + +      L E  +L      ++++  D
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML------SLVSTGD 250
Query: 97  ----VMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
               V M         +  + +LM+  DLH  +      +    +++  +++ GL+++H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNY 211
             +++RDLKP N+L++ +  ++I D GLA   + K    +  V T  Y APE+L     Y
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAY 368
Query: 212 GTSIDVWSVGCIFAELL-GRKPI 233
            +S D +S+GC+  +LL G  P 
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 82  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 136
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 193
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 229

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 82  V------SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 38  IGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           +G G +G V   V R   ++  VAIK +    E + D    +RE +++  L +  ++ L 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 96  DVMMPSHRRNFKDVYLVYELMDTD-LHQ-IIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
            V         + + LV E+     LH+ ++   + +   +    L Q+  G+KYL   N
Sbjct: 403 GVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDN 210
            +HR+L   N+L+      KI DFGL++     + + T     +W   + APE    C N
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE----CIN 512
Query: 211 ---YGTSIDVWSVGCIFAELL--GRKP 232
              + +  DVWS G    E L  G+KP
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 43/234 (18%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           KP+GRGA+G V  +         T   VA+K +   A  +   AL  + ELK+L H+ H 
Sbjct: 34  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 91
Query: 90  -NVIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQAL 130
            NV+ L                  K   + ++ R+ ++ ++ Y+  + DL++       L
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE-DLYK-----DFL 145
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR        +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 191 TE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
            +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 206 RKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 255

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           I  +G+G +G V  C    +   T   VA+K++ ++  ++    +  RE+++L+ L  + 
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDF 73
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRGLKY 148
           ++  + V     R++ +   LV E + +   +          D  +  L+  Q+ +G++Y
Sbjct: 74  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 130
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR--------WYR 200
           L S   +HRDL   N+LV +   +KI DFGLA+          +Y V R        WY 
Sbjct: 131 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDYYVVREPGQSPIFWY- 185
Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAELL 228
           APE L   DN +    DVWS G +  EL 
Sbjct: 186 APESL--SDNIFSRQSDVWSFGVVLYELF 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 78  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               DVW+ G +  E+   G  P +PG +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 36/238 (15%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           I  +G+G +G V  C    +   T   VA+K++ ++  ++    +  RE+++L+ L  + 
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDF 72
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRGLKY 148
           ++  + V     R++ +   LV E + +   +          D  +  L+  Q+ +G++Y
Sbjct: 73  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 129
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR--------WYR 200
           L S   +HRDL   N+LV +   +KI DFGLA+          +Y V R        WY 
Sbjct: 130 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDYYVVREPGQSPIFWY- 184
Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAELLG--RKPIFPGTECLNQLKLIINILGSRRE 255
           APE L   DN +    DVWS G +  EL     K   P  E        + ++GS R+
Sbjct: 185 APESL--SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE-------FLRMMGSERD 233

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 80  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 191
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 82  V------SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 78  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 189
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               DVW+ G +  E+   G  P +PG +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP-YPGID 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 91  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 202
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 203 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 238

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 275 LGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 331 V------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 442
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 478

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 80  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 191
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 192 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           I  +G+G +G V  C    +   T   VA+K++ ++  ++    +  RE+++L+ L  + 
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDF 85
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRGLKY 148
           ++  + V     R++ +   LV E + +   +          D  +  L+  Q+ +G++Y
Sbjct: 86  IVKYRGVSYGPGRQSLR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 142
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR--------WYR 200
           L S   +HRDL   N+LV +   +KI DFGLA+          +Y V R        WY 
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDYYVVREPGQSPIFWY- 197
Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAELL 228
           APE L   DN +    DVWS G +  EL 
Sbjct: 198 APESL--SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 82  V------SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 5   VEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKP-IGRGAYGIVCSSVNRETNEKVAIKKI 63
            +  N IR  G+   S +   +EI+   V +   IG G++G V        +  V I K+
Sbjct: 13  TQEKNKIRPRGQRDSSYY---WEIEASEVMLSTRIGSGSFGTVYKG-KWHGDVAVKILKV 68
Query: 64  NNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQI 123
            +    +  A R   E+ +LR  +H N++     M        KD   +       + Q 
Sbjct: 69  VDPTPEQFQAFRN--EVAVLRKTRHVNILLFMGYMT-------KDNLAI-------VTQW 112
Query: 124 IKSSQALTNDHCQ---YFLFQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLK 173
            + S    + H Q   + +FQL+       +G+ YLH+ NI+HRD+K  N+ ++    +K
Sbjct: 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVK 172
Query: 174 ICDFGLA--RTSNGKNQFMTEYVVTRWYRAPELLLCCDN--YGTSIDVWSVGCIFAELL 228
           I DFGLA  ++    +Q + +   +  + APE++   DN  +    DV+S G +  EL+
Sbjct: 173 IGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 98  MMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHR 157
                       Y+ Y  +   L +   + + +T     Y   Q+   ++YL   N +HR
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLREC--NREEVTAVVLLYMATQISSAMEYLEKKNFIHR 154
Query: 158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNYGTS 214
           DL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +   
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNTFSIK 211
Query: 215 IDVWSVGCIFAEL--LGRKPIFPGTE 238
            DVW+ G +  E+   G  P +PG +
Sbjct: 212 SDVWAFGVLLWEIATYGMSP-YPGID 236

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 40/231 (17%)
Query: 36  KPIGRGAYGIVCSS----VNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE-N 90
           KP+GRGA+G V  +    +++    +    K+        +    + ELK+L H+ H  N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 91  VIAL------------------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
           V+ L                  K   + ++ R+ ++ ++ Y+ +  D          LT 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF---------LTL 143
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
           +H   + FQ+ +G+++L S   +HRDL   N+L++    +KI DFGLAR       ++ +
Sbjct: 144 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 193 ---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               +  +W  APE +     Y    DVWS G +  E+  LG  P +PG +
Sbjct: 204 GDARLPLKWM-APETIF-DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 251

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ ++HE ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 82  V------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G +G V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 76  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HRDL   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE-SLAYNKF 187
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               DVW+ G +  E+   G  P +PG +
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSP-YPGID 215

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 192 LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 248 V------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+    +F  ++       APE  L 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 354
Query: 208 CDNYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 395

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 26  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 82  V------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL   N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 193
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 229

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 192 LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 248 V------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLC 207
           +HRDL+  N+LV  N   K+ DFGLAR       T+    +F  ++       APE  L 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT------APEAAL- 354
Query: 208 CDNYGTSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              +    DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 395

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 19/237 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+KYL S  
Sbjct: 96  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-----YVVTRWYRAPELLLCC 208
            +HRDL   N +++    +K+ DFGLAR    K            +  +W     L    
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ--T 210
Query: 209 DNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
             + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 264

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 95/365 (26%), Positives = 146/365 (40%), Gaps = 77/365 (21%)
Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL- 86
            + +Y  I+ +G G +  V    + +    VA+K + +A      AL  ++ LK +R   
Sbjct: 29  FNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESD 88
Query: 87  ----QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL-HQIIKSS-QALTNDHCQYFLF 140
                 + V+ L D    S   N   V +V+E++   L   IIKS+ Q L     +  + 
Sbjct: 89  PSDPNKDMVVQLIDDFKIS-GMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIR 147
Query: 141 QLLRGLKYLHS-ANILHRDLKPGN------------------------------------ 163
           Q+L+GL YLHS   I+H D+KP N                                    
Sbjct: 148 QVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTA 207
Query: 164 ----LLVN----ANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
               LLVN     N D   +KI D G    +   ++  TE + TR YR+ E+L+    Y 
Sbjct: 208 PAADLLVNPLDPRNADKIRVKIADLG---NACWVHKHFTEDIQTRQYRSIEVLIGA-GYS 263
Query: 213 TSIDVWSVGCIFAELLGRKPIFPG------TECLNQLKLIINILGS-------RREEDLE 259
           T  D+WS  C+  EL     +F        +   + +  II +LGS         +   E
Sbjct: 264 TPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSRE 323
Query: 260 FIDNPKARKYIKSL-PYTPGTPFSRLYPDAHPLA---IDLLQKMLVFDPTKRISVTEALQ 315
           F +     ++I  L P++        Y   H  A    D L  ML   P KR S  E L+
Sbjct: 324 FFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLR 383
Query: 316 HPYMS 320
           HP+++
Sbjct: 384 HPWLN 388

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 192 LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 248 V------SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 359
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 395

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +        +   KVA+K + + A  +  +AL  + ELK++ HL QH
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 101
Query: 89  ENVIAL-------KDVMMPSHRRNFKDVY-LVYELMDTDLHQIIKSSQALTNDHCQYFLF 140
           EN++ L         V++ +    + D+   +    + DL +  +  + L      +F  
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK--EDGRPLELRDLLHFSS 159
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YVVTR 197
           Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR     + ++ +    +  +
Sbjct: 160 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           W  APE +  C  Y    DVWS G +  E+  LG  P +PG
Sbjct: 220 W-MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 257

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q ++     Y   Q+   ++YL   N 
Sbjct: 285 CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HR+L   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 396
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 432

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 45/247 (18%)
Query: 4   PVEPPNGIRSPGKHYYSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKK 62
           P+   N   + G  Y S     +EID K +  +K +G G +G+V     R   + VAIK 
Sbjct: 2   PLGSKNAPSTAGLGYGS-----WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKM 55
Query: 63  INNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT---- 118
           I    E  +     + E K++ +L HE ++ L  V         + ++++ E M      
Sbjct: 56  IK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLL 107
Query: 119 ----DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
               ++    ++ Q L  + C+     +   ++YL S   LHRDL   N LVN    +K+
Sbjct: 108 NYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161
Query: 175 CDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL 227
            DFGL+R       TS+  ++F       RW  +P  +L    + +  D+W+ G +  E+
Sbjct: 162 SDFGLSRYVLDDEETSSVGSKF-----PVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEI 214
Query: 228 --LGRKP 232
             LG+ P
Sbjct: 215 YSLGKMP 221

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 45/247 (18%)
Query: 4   PVEPPNGIRSPGKHYYSMWQTLFEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKK 62
           P+   N   + G  Y S     +EID K +  +K +G G +G+V     R   + VAIK 
Sbjct: 2   PLGSKNAPSTAGLGYGS-----WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKM 55
Query: 63  INNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT---- 118
           I    E  +     + E K++ +L HE ++ L  V         + ++++ E M      
Sbjct: 56  IK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLL 107
Query: 119 ----DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
               ++    ++ Q L  + C+     +   ++YL S   LHRDL   N LVN    +K+
Sbjct: 108 NYLREMRHRFQTQQLL--EMCK----DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161
Query: 175 CDFGLAR-------TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL 227
            DFGL+R       TS+  ++F       RW  +P  +L    + +  D+W+ G +  E+
Sbjct: 162 SDFGLSRYVLDDEYTSSVGSKF-----PVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEI 214
Query: 228 --LGRKP 232
             LG+ P
Sbjct: 215 YSLGKMP 221

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +        +   KVA+K + + A  +  +AL  + ELK++ HL QH
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109
Query: 89  ENVIAL-------KDVMMPSHRRNFKDVY-LVYELMDTDLHQIIKSSQALTNDHCQYFLF 140
           EN++ L         V++ +    + D+   +    + DL +  +  + L      +F  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDK--EDGRPLELRDLLHFSS 167
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE---YVVTR 197
           Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR     + ++ +    +  +
Sbjct: 168 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           W  APE +  C  Y    DVWS G +  E+  LG  P +PG
Sbjct: 228 W-MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 265

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 21/238 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+K+L S  
Sbjct: 156 LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    K +F + +  T      +W     L   
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVKWMALESLQ-- 269
Query: 208 CDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
              + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 324

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G G +G V       +  KVA+K +     + V A   L E  L++ LQH+ ++ L
Sbjct: 18  VKRLGAGQFGEVWMGYYNNST-KVAVKTLKPGTMS-VQAF--LEEANLMKTLQHDKLVRL 73
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHS 151
             V+          +Y++ E M    L   +KS +   +       F  Q+  G+ Y+  
Sbjct: 74  YAVVTREE-----PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 128
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+ +   KI DFGLAR          E      +W  APE +    
Sbjct: 129 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 183
Query: 210 NYG---TSIDVWSVGCIFAELL--GRKPIFPG 236
           N+G      DVWS G +  E++  G+ P +PG
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVTYGKIP-YPG 214

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 99  KHKNIITLLGACTQDG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           +T        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLK 244
              T   +   + APE L   D  Y    DVWS G +  E+  LG  P +PG       K
Sbjct: 214 KKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 245 LI 246
           L+
Sbjct: 271 LL 272

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 25/212 (11%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G G +G V       +  KVA+K +       +     L E  L++ LQH+ ++ L
Sbjct: 17  VKKLGAGQFGEVWMGYYNNST-KVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRL 72
Query: 95  KDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHS 151
             V+          +Y++ E M    L   +KS +   +       F  Q+  G+ Y+  
Sbjct: 73  YAVVTKEE-----PIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 127
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV--TRWYRAPELLLCCD 209
            N +HRDL+  N+LV+ +   KI DFGLAR          E      +W  APE +    
Sbjct: 128 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPEAI---- 182
Query: 210 NYG---TSIDVWSVGCIFAELL--GRKPIFPG 236
           N+G      +VWS G +  E++  G+ P +PG
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIP-YPG 213

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVI---A 93
           +  G +  V  + +  +  + A+K++ +  E +  A+  ++E+  ++ L  H N++   +
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHPNIVQFCS 93
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA---LTNDHCQYFLFQLLRGLKYLH 150
              +          +  L+ EL    L + +K  ++   L+ D      +Q  R ++++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 151 SAN--ILHRDLKPGNLLVNANCDLKICDFGLARTS--------NGKNQFMTEYVVTR--- 197
                I+HRDLK  NLL++    +K+CDFG A T         + + + + E  +TR   
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 198 -WYRAPELLLCCDNY--GTSIDVWSVGCIFAELLGRKPIF 234
             YR PE++    N+  G   D+W++GCI   L  R+  F
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V       +               H +  S              Q  RG+ Y
Sbjct: 89  STAPQLAIVTQWCEGSSL-------------YHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 194
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILG 251
              D+  Y    DV++ G +  EL+ G+ P       +N    II ++G
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPY----SNINNRDQIIEMVG 239

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 80  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL   N LV  N  +K+ DFGL+R   G             +W  APE  L  + + 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPE-SLAYNKFS 192
Query: 213 TSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
              DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 79  CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL   N LV  N  +K+ DFGL+R   G             +W  APE  L  + + 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW-TAPE-SLAYNKFS 191
Query: 213 TSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
              DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 226

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 16  LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---TMSPEAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + + +V E M    L   +K  + + L          Q+  G+ Y+   N 
Sbjct: 72  V------SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 125
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGLAR    N            +W  APE  L    + 
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW-TAPEAAL-YGRFT 183
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 184 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 219

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 21/238 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+K+L S  
Sbjct: 97  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    K +F + +  T      +W     L   
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVKWMALESLQ-- 210
Query: 208 CDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
              + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 265

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 21/238 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+K+L S  
Sbjct: 102 LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 158
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    K +F + +  T      +W     L   
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVKWMALESLQ-- 215
Query: 208 CDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
              + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 270

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 97/202 (48%), Gaps = 8/202 (3%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLRHLQHENVIA 93
           I+ +G+G++G V  +  +ET +  A+K +      + D +  T+ E ++L   ++   + 
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                  +  R    ++ V E ++  DL   I+ S+       +++  +++  L +LH  
Sbjct: 88  QLFCCFQTPDR----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
            I++RDLK  N+L++     K+ DFG+ +           +  T  Y APE+L     YG
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYG 202
Query: 213 TSIDVWSVGCIFAELL-GRKPI 233
            ++D W++G +  E+L G  P 
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPF 224

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ ++H N++ L  V
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANI 154
                       Y++ E M   +L   ++  + Q +      Y   Q+   ++YL   N 
Sbjct: 324 CTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY 211
           +HR+L   N LV  N  +K+ DFGL+R   G     T +   ++   + APE  L  + +
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE-SLAYNKF 435
Query: 212 GTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
               DVW+ G +  E+   G  P +PG +     +L+
Sbjct: 436 SIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 471

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 26  FEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +EID K +  +K +G G +G+V     R   + VAIK I    E  +     + E K++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 59
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT--------DLHQIIKSSQAL--TNDH 134
           +L HE ++ L  V         + ++++ E M          ++    ++ Q L    D 
Sbjct: 60  NLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 114
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKN 187
           C+         ++YL S   LHRDL   N LVN    +K+ DFGL+R       TS+  +
Sbjct: 115 CE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGS 166
Query: 188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           +F       RW  +P  +L    + +  D+W+ G +  E+  LG+ P
Sbjct: 167 KF-----PVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 21/238 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+K+L S  
Sbjct: 95  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 151
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    K +F + +  T      +W     L   
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVKWMALESLQ-- 208
Query: 208 CDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
              + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 263

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 23/217 (10%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G +G V       T  +VAIK +       +     L+E ++++ L+HE ++ L  V
Sbjct: 193 LGQGCFGEVWMGTWNGTT-RVAIKTLKPG---NMSPEAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANI 154
           +      + + +Y+V E M    L   +K      L          Q+  G+ Y+   N 
Sbjct: 249 V------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 302
Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYG 212
           +HRDL+  N+LV  N   K+ DFGL R    N            +W  APE  L    + 
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW-TAPEAAL-YGRFT 360
Query: 213 TSIDVWSVGCIFAELL--GRKPIFPGT---ECLNQLK 244
              DVWS G +  EL   GR P +PG    E L+Q++
Sbjct: 361 IKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVE 396

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 21/238 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+K+L S  
Sbjct: 97  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    K +F + +  T      +W     L   
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVKWMALESLQ-- 210
Query: 208 CDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
              + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 265

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 117/245 (47%), Gaps = 47/245 (19%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 91
Query: 87  QHENVIALKD----------VMMPSHRRNFKDVYLVYE--LMDTDLHQIIKSSQALTNDH 134
           +H+N+I L            ++  + + N ++     E   ++   +      + L++  
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSN 184
                +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR          T+N
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 185 GKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLN 241
           G+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG     
Sbjct: 212 GR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEE 260
Query: 242 QLKLI 246
             KL+
Sbjct: 261 LFKLL 265

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 21/238 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+K+L S  
Sbjct: 98  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    K +F + +  T      +W     L   
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK-EFDSVHNKTGAKLPVKWMALESLQ-- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
              + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 266

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V       +               H +  S              Q  RG+ Y
Sbjct: 77  STKPQLAIVTQWCEGSSL-------------YHHLHASETKFEMKKLIDIARQTARGMDY 123
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 124 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 182
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILG 251
              D+  Y    DV++ G +  EL+ G+ P       +N    II ++G
Sbjct: 183 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPY----SNINNRDQIIEMVG 227

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 60/111 (54%), Gaps = 3/111 (2%)
Query: 119 DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDF 177
           DL   I    AL  +  + F +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL 228
           G       K+   T++  TR Y  PE +     +G S  VWS+G +  +++
Sbjct: 203 GSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 26  FEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +EID K +  +K +G G +G+V     R   + VAIK I    E  +     + E K++ 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 58
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT--------DLHQIIKSSQAL--TNDH 134
           +L HE ++ L  V         + ++++ E M          ++    ++ Q L    D 
Sbjct: 59  NLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 113
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKN 187
           C+         ++YL S   LHRDL   N LVN    +K+ DFGL+R       TS+  +
Sbjct: 114 CE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 165
Query: 188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           +F       RW  +P  +L    + +  D+W+ G +  E+  LG+ P
Sbjct: 166 KF-----PVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 205

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 26  FEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +EID K +  +K +G G +G+V     R   + VAIK I    E  +     + E K++ 
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 65
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT--------DLHQIIKSSQAL--TNDH 134
           +L HE ++ L  V         + ++++ E M          ++    ++ Q L    D 
Sbjct: 66  NLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 120
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKN 187
           C+         ++YL S   LHRDL   N LVN    +K+ DFGL+R       TS+  +
Sbjct: 121 CE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 172
Query: 188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           +F       RW  +P  +L    + +  D+W+ G +  E+  LG+ P
Sbjct: 173 KF-----PVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V   +       +Y    +++T    I     A           Q  +G+ Y
Sbjct: 73  STAPQLAIV---TQWCEGSSLYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 119
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 178
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 113/243 (46%), Gaps = 43/243 (17%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 99  KHKNIIHLLGACTQDG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           +T        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 190 ---MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQL 243
                  +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG       
Sbjct: 214 KKTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELF 269
Query: 244 KLI 246
           KL+
Sbjct: 270 KLL 272

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 99  KHKNIINLLGACTQDG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           +T        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLK 244
              T   +   + APE L   D  Y    DVWS G +  E+  LG  P +PG       K
Sbjct: 214 KKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 245 LI 246
           L+
Sbjct: 271 LL 272

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 41/242 (16%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 99  KHKNIINLLGACTQDG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           +T        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 190 --MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLK 244
              T   +   + APE L   D  Y    DVWS G +  E+  LG  P +PG       K
Sbjct: 214 KNTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFK 270
Query: 245 LI 246
           L+
Sbjct: 271 LL 272

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 37/240 (15%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKD----------VMMPSHRRNFKDVYLVYEL-----MDTDLHQIIKSSQALT 131
           +H+N+I L            ++  + + N ++ YL            D++++    + +T
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLRE-YLRARRPPGMEYSYDINRV--PEEQMT 155
Query: 132 NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF-- 189
                   +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +  
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 190 MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
            T   +   + APE L   D  Y    DVWS G +  E+  LG  P +PG       KL+
Sbjct: 216 TTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 272

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 26  FEIDTKYVP-IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +EID K +  +K +G G +G+V     R   + VAIK I    E  +     + E K++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMM 59
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT--------DLHQIIKSSQAL--TNDH 134
           +L HE ++ L  V         + ++++ E M          ++    ++ Q L    D 
Sbjct: 60  NLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 114
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKN 187
           C+         ++YL S   LHRDL   N LVN    +K+ DFGL+R       TS+  +
Sbjct: 115 CE--------AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 166
Query: 188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           +F       RW  +P  +L    + +  D+W+ G +  E+  LG+ P
Sbjct: 167 KF-----PVRW--SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 206

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 55/241 (22%)
Query: 109 VYLVYELMDTDLHQIIKSSQALTND---HCQY----FLFQLLRGLKYLHSANILHRDLKP 161
           +Y+  EL + +L  +++S      +     +Y     L Q+  G+ +LHS  I+HRDLKP
Sbjct: 102 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 161
Query: 162 GNLLVNA-------------NCDLKICDFGLART-SNGKNQF---MTEYVVTRWYRAPEL 204
            N+LV+              N  + I DFGL +   +G+  F   +     T  +RAPEL
Sbjct: 162 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPEL 221
Query: 205 L--LCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           L          SID++S+GC+F  +L  G+ P   G +   +  +I  I        L+ 
Sbjct: 222 LEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKYSRESNIIRGIFS------LDE 273
Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           +     R  I                     A DL+ +M+  DP KR +  + L+HP   
Sbjct: 274 MKCLHDRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHPLFW 314
Query: 321 P 321
           P
Sbjct: 315 P 315

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGIV--CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           ++ IG G +G+V     +N++   KVAIK I     +  D    + E +++  L H  ++
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIREGAMSEED---FIEEAEVMMKLSHPKLV 65
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQAL-TNDHCQYFLFQLLRGLKYLH 150
            L  V +         + LV+E M+   L   +++ + L   +        +  G+ YL 
Sbjct: 66  QLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPE 203
            A+++HRDL   N LV  N  +K+ DFG+ R       TS+   +F  ++       +PE
Sbjct: 121 EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 174
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 175 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 112/243 (46%), Gaps = 43/243 (17%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 99  KHKNIINLLGACTQDG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG---K 186
           +T        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 187 NQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQL 243
            +     +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG       
Sbjct: 214 KKTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELF 269
Query: 244 KLI 246
           KL+
Sbjct: 270 KLL 272

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 55/241 (22%)
Query: 109 VYLVYELMDTDLHQIIKSSQALTND---HCQY----FLFQLLRGLKYLHSANILHRDLKP 161
           +Y+  EL + +L  +++S      +     +Y     L Q+  G+ +LHS  I+HRDLKP
Sbjct: 102 LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKP 161
Query: 162 GNLLVNA-------------NCDLKICDFGLART-SNGKNQF---MTEYVVTRWYRAPEL 204
            N+LV+              N  + I DFGL +   +G+  F   +     T  +RAPEL
Sbjct: 162 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPEL 221
Query: 205 L--LCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           L          SID++S+GC+F  +L  G+ P   G +   +  +I  I        L+ 
Sbjct: 222 LEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKYSRESNIIRGIFS------LDE 273
Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           +     R  I                     A DL+ +M+  DP KR +  + L+HP   
Sbjct: 274 MKCLHDRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHPLFW 314
Query: 321 P 321
           P
Sbjct: 315 P 315

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V       +               H +  S              Q  RG+ Y
Sbjct: 89  STKPQLAIVTQWCEGSSL-------------YHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 194
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILG 251
              D+  Y    DV++ G +  EL+ G+ P       +N    II ++G
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPY----SNINNRDQIIEMVG 239

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 112/243 (46%), Gaps = 43/243 (17%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 99  KHKNIINLLGACTQDG-----PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG---K 186
           +T        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 187 NQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQL 243
            +     +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG       
Sbjct: 214 KKTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELF 269
Query: 244 KLI 246
           KL+
Sbjct: 270 KLL 272

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 21/238 (8%)
Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N    +  +  + L E  +++   H NV++L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
             + + S       V L Y +   DL   I++ +   T      F  Q+ +G+K+L S  
Sbjct: 98  LGICLRSEGSPL--VVLPY-MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------RWYRAPELLLC 207
            +HRDL   N +++    +K+ DFGLAR    K +F + +  T      +W     L   
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDK-EFDSVHNKTGAKLPVKWMALESLQ-- 211
Query: 208 CDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
              + T  DVWS G +  EL+ R  P +P    +N   + + +L  RR    E+  +P
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP 266

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 58/113 (51%), Gaps = 10/113 (8%)
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF---MTEYVVT 196
           +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +       +  
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
           +W  APE L   D  Y    DVWS G +  E+  LG  P +PG       KL+
Sbjct: 270 KWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 318

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 113/250 (45%), Gaps = 47/250 (18%)
Query: 36  KPIGRGAYGIVCSSVNRETNE-----KVAIKKIN-NAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V ++     ++     +VA+K +   A  +  +AL  + ELK++  L  H
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL--MSELKMMTQLGSH 108
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSS-QALTNDHCQY--------- 137
           EN++ L      S       +YL++E     DL   ++S  +  + D  +Y         
Sbjct: 109 ENIVNLLGACTLSG-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 138 -------------FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN 184
                        F +Q+ +G+++L   + +HRDL   N+LV     +KICDFGLAR   
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 185 GKNQFMTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTEC 239
             + ++      +  +W  APE L     Y    DVWS G +  E+  LG  P +PG   
Sbjct: 224 SDSNYVVRGNARLPVKW-MAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPV 280
Query: 240 -LNQLKLIIN 248
             N  KLI N
Sbjct: 281 DANFYKLIQN 290

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 114/241 (47%), Gaps = 39/241 (16%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS----------------SQAL 130
           +H+N+I L    + +  ++     +V      +L + +++                 + +
Sbjct: 99  KHKNIINL----LGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF- 189
           T        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 190 -MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKL 245
             T   +   + APE L   D  Y    DVWS G +  E+  LG  P +PG       KL
Sbjct: 215 KTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKL 271
Query: 246 I 246
           +
Sbjct: 272 L 272

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 57/250 (22%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 84
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 85  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------- 181
           L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 199
Query: 182 --TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 200 KKTTNGR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 248
Query: 237 TECLNQLKLI 246
                  KL+
Sbjct: 249 VPVEELFKLL 258

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +        +   KVA+K + + A  +  +AL  + ELK++ HL QH
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 109
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS----------------QALTN 132
           EN++ L               Y  Y     DL   ++                  + L++
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCY----GDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
               +F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR     + ++ +
Sbjct: 166 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 193 ---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
               +  +W  APE +  C  Y    DVWS G +  E+  LG  P +PG
Sbjct: 226 GNARLPVKW-MAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 271

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 57/250 (22%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 132
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 133 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------- 181
           L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 182 --TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 248 KKTTNGR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 296
Query: 237 TECLNQLKLI 246
                  KL+
Sbjct: 297 VPVEELFKLL 306

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 57/250 (22%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 91
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 92  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------- 181
           L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 182 --TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 207 KKTTNGR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 255
Query: 237 TECLNQLKLI 246
                  KL+
Sbjct: 256 VPVEELFKLL 265

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 36  KPIGRGAYGIVCSS-----VNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +     +  +    VA+K +  +A     +AL  + ELK+L +L  H
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGNH 109
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY-ELMD-----TDLHQIIKSSQALTNDHCQY----- 137
            N++ L               Y  Y +L++      D     K+S A+  D         
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 138 ---FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-- 192
              F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR     + ++ +  
Sbjct: 170 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 193 -YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +  +W  APE +  C  Y    DVWS G    EL  LG  P +PG
Sbjct: 230 ARLPVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 57/250 (22%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 91
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 92  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------- 181
           L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXX 206
Query: 182 --TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 207 KKTTNGR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 255
Query: 237 TECLNQLKLI 246
                  KL+
Sbjct: 256 VPVEELFKLL 265

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V   +       +Y    +++T    I     A           Q  +G+ Y
Sbjct: 78  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 124
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 183
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 36  KPIGRGAYGIVCSS-----VNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +     +  +    VA+K +  +A     +AL  + ELK+L +L  H
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGNH 104
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY-ELMD-----TDLHQIIKSSQALTNDHCQY----- 137
            N++ L               Y  Y +L++      D     K+S A+  D         
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 164
Query: 138 ---FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-- 192
              F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR     + ++ +  
Sbjct: 165 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 193 -YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +  +W  APE +  C  Y    DVWS G    EL  LG  P +PG
Sbjct: 225 ARLPVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 18  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V   +       +Y    +++T    I     A           Q  +G+ Y
Sbjct: 75  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 121
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 122 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 180
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 181 RMQDKNPYSFQSDVYAFGIVLYELM 205

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V   +       +Y    +++T    I     A           Q  +G+ Y
Sbjct: 73  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 119
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 178
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 57/250 (22%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 91
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 92  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------- 181
           L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 206
Query: 182 --TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 207 KKTTNGR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 255
Query: 237 TECLNQLKLI 246
                  KL+
Sbjct: 256 VPVEELFKLL 265

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 36  KPIGRGAYGIVCSS-----VNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +     +  +    VA+K +  +A     +AL  + ELK+L +L  H
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGNH 86
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY-ELMD-----TDLHQIIKSSQALTNDHCQY----- 137
            N++ L               Y  Y +L++      D     K+S A+  D         
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 138 ---FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-- 192
              F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR     + ++ +  
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 193 -YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +  +W  APE +  C  Y    DVWS G    EL  LG  P +PG
Sbjct: 207 ARLPVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 250

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 36  KPIGRGAYGIVCSS-----VNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +     +  +    VA+K +  +A     +AL  + ELK+L +L  H
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGNH 102
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY-ELMD-----TDLHQIIKSSQALTNDHCQY----- 137
            N++ L               Y  Y +L++      D     K+S A+  D         
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 162
Query: 138 ---FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-- 192
              F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR     + ++ +  
Sbjct: 163 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 193 -YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +  +W  APE +  C  Y    DVWS G    EL  LG  P +PG
Sbjct: 223 ARLPVKW-MAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSP-YPG 266

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 45/245 (18%)
Query: 36  KPIGRGAYGIV----CSSVNRETNEK--VAIKKINN-AFENRVDALRTLRELKLLRHLQH 88
           + +G GA+G V    C +++  T +K  VA+K + +     R D     RE +LL +LQH
Sbjct: 21  RELGEGAFGKVFLAECYNLS-PTKDKMLVAVKALKDPTLAARKD---FQREAELLTNLQH 76
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS-------------SQA---LT 131
           E+++    V       +   + +V+E M   DL++ +++              QA   L 
Sbjct: 77  EHIVKFYGVC-----GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 132 NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT 191
                +   Q+  G+ YL S + +HRDL   N LV AN  +KI DFG++R     + +  
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 192 ---EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGT-----ECLN 241
                +  RW   PE ++    + T  DVWS G I  E+   G++P F  +     EC+ 
Sbjct: 192 GGHTMLPIRWM-PPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249
Query: 242 QLKLI 246
           Q +++
Sbjct: 250 QGRVL 254

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 57/250 (22%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 80
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 81  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------- 181
           L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 195
Query: 182 --TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 196 KKTTNGR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 244
Query: 237 TECLNQLKLI 246
                  KL+
Sbjct: 245 VPVEELFKLL 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 58/112 (51%), Gaps = 8/112 (7%)
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTR 197
           +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +   T   +  
Sbjct: 153 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 212
Query: 198 WYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
            + APE L   D  Y    DVWS G +  E+  LG  P +PG       KL+
Sbjct: 213 KWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 261

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 58/112 (51%), Gaps = 8/112 (7%)
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTR 197
           +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +   T   +  
Sbjct: 156 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 215
Query: 198 WYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
            + APE L   D  Y    DVWS G +  E+  LG  P +PG       KL+
Sbjct: 216 KWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 264

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V   +       +Y    +++T    I     A           Q  +G+ Y
Sbjct: 78  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 124
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 183
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 184 RMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/107 (40%), Positives = 59/107 (55%), Gaps = 10/107 (9%)
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           + FQ+ RG+++L S   +HRDL   N+L++ N  +KICDFGLAR    KN        TR
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIY-KNPDYVRKGDTR 262
Query: 198 W---YRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
               + APE +   D  Y T  DVWS G +  E+  LG  P +PG +
Sbjct: 263 LPLKWMAPESIF--DKIYSTKSDVWSYGVLLWEIFSLGGSP-YPGVQ 306

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 43/243 (17%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  +V  + ++      VA+K + ++A E  +  L  + E+++++ + 
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIG 98
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 99  KHKNIINLLGACTQDG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           +T        +QL RG++YL S   +HRDL   N+LV  N  ++I DFGLAR  N  + +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYY 213
Query: 190 ---MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQL 243
                  +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG       
Sbjct: 214 KKTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELF 269
Query: 244 KLI 246
           KL+
Sbjct: 270 KLL 272

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 57/250 (22%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 83
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 84  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------- 181
           L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 198
Query: 182 --TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 199 KKTTNGR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 247
Query: 237 TECLNQLKLI 246
                  KL+
Sbjct: 248 VPVEELFKLL 257

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/112 (39%), Positives = 58/112 (51%), Gaps = 8/112 (7%)
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF--MTEYVVTR 197
           +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N  + +   T   +  
Sbjct: 151 YQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 210
Query: 198 WYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLI 246
            + APE L   D  Y    DVWS G +  E+  LG  P +PG       KL+
Sbjct: 211 KWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLL 259

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 36  KPIGRGAYGIVCSS-----VNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +     +  +    VA+K +  +A     +AL  + ELK+L +L  H
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGNH 109
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY-ELMD-----TDLHQIIKSSQALTNDHCQY----- 137
            N++ L               Y  Y +L++      D     K+S A+  D         
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 169
Query: 138 ---FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE-- 192
              F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR     + ++ +  
Sbjct: 170 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 193 -YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +  +W  APE +  C  Y    DVWS G    EL  LG  P +PG
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 117/250 (46%), Gaps = 57/250 (22%)
Query: 36  KPIGRGAYG--IVCSSVNRETNE-----KVAIKKI-NNAFENRVDALRTLRELKLLRHL- 86
           KP+G GA+G  ++  ++  + ++     KVA+K + ++A E  +  L  + E+++++ + 
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIG 76
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS----------------SQA 129
           +H+N+I L              +Y++ E     +L + +++                 + 
Sbjct: 77  KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------- 181
           L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLAR        
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 182 --TSNGKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             T+NG+       +  +W  APE L   D  Y    DVWS G +  E+  LG  P +PG
Sbjct: 192 KKTTNGR-------LPVKWM-APEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 240
Query: 237 TECLNQLKLI 246
                  KL+
Sbjct: 241 VPVEELFKLL 250

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V   +       +Y    +++T    I     A           Q  +G+ Y
Sbjct: 73  STKPQLAIV---TQWCEGSSLYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 119
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 178
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 38  IGRGAYGIVCSS-VNRETNEKVAIKKINNAFENRVDALRTL--RELKLLRHLQHENVIAL 94
           +G G +G+V    VN   N  VA+KK+    +   + L+    +E+K++   QHEN++ L
Sbjct: 39  MGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 95  KDVMMPSHRRNFKDVYLVY------ELMDT----------DLHQIIKSSQALTNDHCQYF 138
                     +  D+ LVY       L+D             H   K +Q   N      
Sbjct: 96  -----LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN------ 144
Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN--GKNQFMTEYVVT 196
                 G+ +LH  + +HRD+K  N+L++     KI DFGLAR S    +    +  V T
Sbjct: 145 ------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGT 198
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP 232
             Y APE L          D++S G +  E++   P
Sbjct: 199 TAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLP 232

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 43/217 (19%)
Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K +G G +G+V     R   + VAIK I    E  +     + E K++ +L HE ++ L
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYD-VAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 95  KDVMMPSHRRNFKDVYLVYELMDT--------DLHQIIKSSQAL--TNDHCQYFLFQLLR 144
             V         + ++++ E M          ++    ++ Q L    D C+        
Sbjct: 65  YGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE-------- 111
Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTR 197
            ++YL S   LHRDL   N LVN    +K+ DFGL+R       TS+  ++F       R
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-----PVR 166
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKP 232
           W  +P  +L    + +  D+W+ G +  E+  LG+ P
Sbjct: 167 W--SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 201

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V       +   +Y    +++T    I     A           Q  +G+ Y
Sbjct: 100 STKPQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 146
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 147 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 205
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 206 RMQDKNPYSFQSDVYAFGIVLYELM 230

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V       +   +Y    +++T    I     A           Q  +G+ Y
Sbjct: 101 STKPQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 147
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM-APEVI 206
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGIV--CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           ++ IG G +G+V     +N++   KVAIK I     +  D    + E +++  L H  ++
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIREGAMSEED---FIEEAEVMMKLSHPKLV 68
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQAL-TNDHCQYFLFQLLRGLKYLH 150
            L  V +         + LV+E M+   L   +++ + L   +        +  G+ YL 
Sbjct: 69  QLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 123
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS+   +F  ++       +PE
Sbjct: 124 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 177
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 178 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 206

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGIV--CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           ++ IG G +G+V     +N++   KVAIK I     +  D    + E +++  L H  ++
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIREGAMSEED---FIEEAEVMMKLSHPKLV 65
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQAL-TNDHCQYFLFQLLRGLKYLH 150
            L  V +         + LV+E M+   L   +++ + L   +        +  G+ YL 
Sbjct: 66  QLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS+   +F  ++       +PE
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 174
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 175 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 203

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGIV--CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           ++ IG G +G+V     +N++   KVAIK I     +  D    + E +++  L H  ++
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIREGAMSEED---FIEEAEVMMKLSHPKLV 63
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQAL-TNDHCQYFLFQLLRGLKYLH 150
            L  V +         + LV+E M+   L   +++ + L   +        +  G+ YL 
Sbjct: 64  QLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS+   +F  ++       +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 172
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 173 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIK--KINNAFENRVDALRTLRELKLLRHLQH 88
           I+ +G G +G V        N  T E VA+K  K +   ++R       +E+ +LR L H
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYH 75
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRGL 146
           E++I  K        ++ + V + Y  + +    + + S  L     Q  LF  Q+  G+
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLV-MEYVPLGSLRDYLPRHSIGLA----QLLLFAQQICEGM 130
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR-------WY 199
            YLHS + +HR+L   N+L++ +  +KI DFGLA+     +++   Y V         WY
Sbjct: 131 AYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWY 187
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELL 228
            APE L     Y  S DVWS G    ELL
Sbjct: 188 -APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 36  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V       +   +Y    +++T    I     A           Q  +G+ Y
Sbjct: 93  STKPQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 139
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 140 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 198
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 199 RMQDKNPYSFQSDVYAFGIVLYELM 223

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 31/205 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKIN---------NAFENRVDALRTLRELKLLRHLQH 88
           IG G++G V      + +  VA+K +N          AF+N V  LR  R + +L  + +
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
                L  V       +   +Y    +++T    I     A           Q  +G+ Y
Sbjct: 101 STKPQLAIVTQWCEGSS---LYHHLHIIETKFEMIKLIDIAR----------QTAQGMDY 147
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQFMTEYVVTRWYRAPELL 205
           LH+ +I+HRDLK  N+ ++ +  +KI DFGLA      +G +QF        W  APE++
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM-APEVI 206
Query: 206 LCCDN--YGTSIDVWSVGCIFAELL 228
              D   Y    DV++ G +  EL+
Sbjct: 207 RMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 35  IKPIGRGAYGIVCSSVNRETN-EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA 93
           ++ IG G +G+V   +    N +KVAIK I     +  D    + E +++  L H  ++ 
Sbjct: 32  VQEIGSGQFGLV--HLGYWLNKDKVAIKTIKEGSMSEDD---FIEEAEVMMKLSHPKLVQ 86
Query: 94  LKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQAL-TNDHCQYFLFQLLRGLKYLHS 151
           L  V +         + LV+E M+   L   +++ + L   +        +  G+ YL  
Sbjct: 87  LYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 141
Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPEL 204
           A ++HRDL   N LV  N  +K+ DFG+ R       TS+   +F  ++       +PE 
Sbjct: 142 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE- 194
Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPI 233
           +     Y +  DVWS G +  E+     I
Sbjct: 195 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 223

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 38  IGRGAYGIVCSS-VNRETNEKVAIKKINNAFENRVDALRTL--RELKLLRHLQHENVIAL 94
           +G G +G+V    VN   N  VA+KK+    +   + L+    +E+K++   QHEN++ L
Sbjct: 33  MGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 95  KDVMMPSHRRNFKDVYLVY------ELMDT----------DLHQIIKSSQALTNDHCQYF 138
                     +  D+ LVY       L+D             H   K +Q   N      
Sbjct: 90  -----LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN------ 138
Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM--TEYVVT 196
                 G+ +LH  + +HRD+K  N+L++     KI DFGLAR S    Q +     V T
Sbjct: 139 ------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGT 192
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP 232
             Y APE L          D++S G +  E++   P
Sbjct: 193 TAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHC 135
           L E  ++  + + +V  L  + + S  +    +     L+D    H+    SQ L N   
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLN--- 121
Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY-- 193
             +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY  
Sbjct: 122 --WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHA 176
Query: 194 ----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
               V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 177 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           I+ +G G +G V        N  T E VA+K +  +A        +  +E+ +LR L HE
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK--QEIDILRTLYHE 93
Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRGLK 147
           ++I  K     +   + + V + Y  + +    + + S  L     Q  LF  Q+  G+ 
Sbjct: 94  HIIKYKGCCEDAGAASLQLV-MEYVPLGSLRDYLPRHSIGLA----QLLLFAQQICEGMA 148
Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLART-SNGKNQFMTEY---VVTRWYRAPE 203
           YLH+ + +HRDL   N+L++ +  +KI DFGLA+    G   +           WY APE
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APE 207
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL 228
            L     Y  S DVWS G    ELL
Sbjct: 208 CLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 38  IGRGAYGIVCSS-VNRETNEKVAIKKINNAFENRVDALRTL--RELKLLRHLQHENVIAL 94
           +G G +G+V    VN   N  VA+KK+    +   + L+    +E+K++   QHEN++ L
Sbjct: 39  MGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 95  KDVMMPSHRRNFKDVYLVY------ELMDT----------DLHQIIKSSQALTNDHCQYF 138
                     +  D+ LVY       L+D             H   K +Q   N      
Sbjct: 96  -----LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN------ 144
Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN--GKNQFMTEYVVT 196
                 G+ +LH  + +HRD+K  N+L++     KI DFGLAR S    +       V T
Sbjct: 145 ------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGT 198
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP 232
             Y APE L          D++S G +  E++   P
Sbjct: 199 TAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLP 232

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 35  IKPIGRGAYGIV--C--SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           I  +G+G +G V  C    +   T   VA+K++ ++  ++    +  RE+++L+ L  + 
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ--REIQILKALHSDF 69
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRGLKY 148
           ++  + V     R   +   LV E + +   +          D  +  L+  Q+ +G++Y
Sbjct: 70  IVKYRGVSYGPGRPELR---LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY 126
Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR--------WYR 200
           L S   +HRDL   N+LV +   +KI DFGLA+          +  V R        WY 
Sbjct: 127 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP----LDKDXXVVREPGQSPIFWY- 181
Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAELL 228
           APE L   DN +    DVWS G +  EL 
Sbjct: 182 APESL--SDNIFSRQSDVWSFGVVLYELF 208

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 7   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 65
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHC 135
           L E  ++  + + +V  L  + + S  +    +     L+D    H+    SQ L N   
Sbjct: 66  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLN--- 122
Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY-- 193
             +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY  
Sbjct: 123 --WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHA 177
Query: 194 ----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
               V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 178 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 10  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 68
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 69  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 122
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 123 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 179
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 180 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 9   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 67
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 121
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 122 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 178
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 7   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 65
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 66  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 119
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 120 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 176
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 177 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIK--KINNAFENRVDALRTLRELKLLRHLQH 88
           I+ +G G +G V        N  T E VA+K  K +   ++R       +E+ +LR L H
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYH 75
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF--QLLRGL 146
           E++I  K        ++ + V + Y  + +    + + S  L     Q  LF  Q+  G+
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLV-MEYVPLGSLRDYLPRHSIGLA----QLLLFAQQICEGM 130
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR-------WY 199
            YLH+ + +HR+L   N+L++ +  +KI DFGLA+     +++   Y V         WY
Sbjct: 131 AYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWY 187
Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELL 228
            APE L     Y  S DVWS G    ELL
Sbjct: 188 -APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 10  GIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINN 65
           GIRS      ++ + L E  T++  IK +G GA+G V   +     EKV    AIK++  
Sbjct: 4   GIRSGEAPNQALLRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 66  AFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQI 123
           A   + +    L E  ++  + + +V  L  + + S       V L+ +LM     L  +
Sbjct: 62  ATSPKANK-EILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYV 114
Query: 124 IKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS 183
            +    + + +   +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+  
Sbjct: 115 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174
Query: 184 NGKNQFMTEY------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
             + +   EY      V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 175 GAEEK---EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 9   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 67
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 121
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 122 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 178
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 12  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 70
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 71  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 124
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 125 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 181
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 182 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 21/223 (9%)
Query: 28  IDTK-YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           ID K Y+ I+ +G G +  V            A+K+I      + D     RE  + R  
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMHRLF 83
Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMD-----TDLHQIIKSSQALTNDHCQYFLFQ 141
            H N++ L    +   R    + +L+           ++ ++      LT D   + L  
Sbjct: 84  NHPNILRLVAYCL-RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS----NGKNQFMT--EYVV 195
           + RGL+ +H+    HRDLKP N+L+       + D G    +     G  Q +T  ++  
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 196 TRW---YRAPELLLCCDN--YGTSIDVWSVGCI-FAELLGRKP 232
            R    YRAPEL     +       DVWS+GC+ +A + G  P
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 31  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 89
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 90  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 143
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 144 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 200
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 201 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 9   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 67
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 121
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 122 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 178
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 9   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 67
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 121
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 122 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 178
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 179 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 16  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 74
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 75  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 128
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 129 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 185
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 186 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 38  IGRGAYGIVCSSVNRETNEKV--AIKKINNAFENRVDALRTLRELKLLRHLQHE-NVIAL 94
           IG G +G V  +  ++   ++  AIK++   + ++ D      EL++L  L H  N+I L
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 95  KDVMMPSHRR------------NFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYFLF 140
             +    HR             N  D      +++TD    I +S A  L++    +F  
Sbjct: 82  --LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
            + RG+ YL     +HRDL   N+LV  N   KI DFGL+R      +     +  RW  
Sbjct: 140 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 199
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTEC 239
              L      Y T+ DVWS G +  E+  LG  P + G  C
Sbjct: 200 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 237

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 38  IGRGAYGIVCSSVNRETNEKV--AIKKINNAFENRVDALRTLRELKLLRHLQHE-NVIAL 94
           IG G +G V  +  ++   ++  AIK++   + ++ D      EL++L  L H  N+I L
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 95  KDVMMPSHRR------------NFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYFLF 140
             +    HR             N  D      +++TD    I +S A  L++    +F  
Sbjct: 92  --LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
            + RG+ YL     +HRDL   N+LV  N   KI DFGL+R      +     +  RW  
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 209
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTEC 239
              L      Y T+ DVWS G +  E+  LG  P + G  C
Sbjct: 210 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 247

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 176 AEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G  G V     R+T   +A+K++  +  N+ +  R L +L               DV
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDL---------------DV 76
Query: 98  MMPSHRRNF-----------KDVYLVYELMDTDLHQIIKSSQA-LTNDHCQYFLFQLLRG 145
           ++ SH   +            DV++  ELM T   ++ K  Q  +           +++ 
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 146 LKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLA-RTSNGKNQFMTEYVVTRWYRAPE 203
           L YL     ++HRD+KP N+L++    +K+CDFG++ R  + K +  +       Y APE
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA--YMAPE 194
Query: 204 LLLCCD----NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL 250
            +   D    +Y    DVWS+G    EL   +  FP   C    +++  +L
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FPYKNCKTDFEVLTKVL 243

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 43/215 (20%)
Query: 39  GRGAYGIVCSS-VNRETNEKVAIKKINNAFENRVDALRTL--RELKLLRHLQHENVIALK 95
           G G +G+V    VN   N  VA+KK+    +   + L+    +E+K+    QHEN++ L 
Sbjct: 31  GEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL- 86
Query: 96  DVMMPSHRRNFKDVYLVY------ELMDT----------DLHQIIKSSQALTNDHCQYFL 139
                    +  D+ LVY       L+D             H   K +Q   N       
Sbjct: 87  ----LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAAN------- 135
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM--TEYVVTR 197
                G+ +LH  + +HRD+K  N+L++     KI DFGLAR S    Q +  +  V T 
Sbjct: 136 -----GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP 232
            Y APE L          D++S G +  E++   P
Sbjct: 191 AYXAPEALR--GEITPKSDIYSFGVVLLEIITGLP 223

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 35  IKPIGRGAYGIV--CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           ++ IG G +G+V     +N++   KVAIK I     +  D    + E +++  L H  ++
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKD---KVAIKTIREGAMSEED---FIEEAEVMMKLSHPKLV 66
Query: 93  ALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQAL-TNDHCQYFLFQLLRGLKYLH 150
            L  V +         + LV E M+   L   +++ + L   +        +  G+ YL 
Sbjct: 67  QLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYRAPE 203
            A ++HRDL   N LV  N  +K+ DFG+ R       TS+   +F  ++       +PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPE 175
Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPI 233
            +     Y +  DVWS G +  E+     I
Sbjct: 176 -VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRTLRELKLLR 84
           +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    L E  ++ 
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQL 142
            + + +V  L  + + S       V L+ +LM     L  + +    + + +   +  Q+
Sbjct: 67  SVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY------VVT 196
            +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY      V  
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPI 177
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
           +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 178 KWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 45/194 (23%)
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT--- 191
           C +   Q+   +++LHS  ++HRDLKP N+    +  +K+ DFGL    +   +  T   
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 192 ---------EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQ 242
                      V T+ Y +PE  +  +NY   +D++S+G I  ELL     +  +  + +
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELL-----YSFSTQMER 279
Query: 243 LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVF 302
           +++I ++       +L+F             P      F++ YP  H     ++Q ML  
Sbjct: 280 VRIITDV------RNLKF-------------PLL----FTQKYPQEHM----MVQDMLSP 312
Query: 303 DPTKRISVTEALQH 316
            PT+R   T+ +++
Sbjct: 313 SPTERPEATDIIEN 326

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 36/232 (15%)
Query: 36  KPIGRGAYGIVCSSV-----NRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHL-QH 88
           K +G GA+G V  +        +   KVA+K + + A  +  +AL  + ELK++ HL QH
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQH 94
Query: 89  ENVIALKDVMMPSHRRNFKDVYLVY----ELMDTDLHQIIKSSQALTND----------- 133
           EN++ L               Y  Y      +      ++  S A   D           
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 134 ----HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
                  +F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR     + +
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 214
Query: 190 MTE---YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           + +    +  +W  APE +  C  Y    DVWS G +  E+  LG  P +PG
Sbjct: 215 IVKGNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPG 263

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRTLRELKLLR 84
           +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    L E  ++ 
Sbjct: 11  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 69
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQL 142
            + + +V  L  + + S       V L+ +LM     L  + +    + + +   +  Q+
Sbjct: 70  SVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 123
Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY------VVT 196
             G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY      V  
Sbjct: 124 AEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPI 180
Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
           +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 181 KWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 8   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 66
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQY 137
            +R   H +++ L  V+  +       V+++ EL          Q+ K S  L +     
Sbjct: 67  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLDLAS--LIL 118
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVV 195
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +      + 
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 178
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSR 253
            +W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R
Sbjct: 179 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER 233
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                              LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 234 -------------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 264

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 33  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 91
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQY 137
            +R   H +++ L  V+  +       V+++ EL          Q+ K S  L +     
Sbjct: 92  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLDLAS--LIL 143
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVV 195
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +      + 
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 203
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSR 253
            +W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R
Sbjct: 204 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER 258
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                              LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 259 -------------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 289

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 60
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQY 137
            +R   H +++ L  V+  +       V+++ EL          Q+ K S  L +     
Sbjct: 61  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLDLAS--LIL 112
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVV 195
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +      + 
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSR 253
            +W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R
Sbjct: 173 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER 227
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                              LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 228 -------------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 258

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEAL 63
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQY 137
            +R   H +++ L  V+  +       V+++ EL          Q+ K S  L +     
Sbjct: 64  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLDLAS--LIL 115
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVV 195
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +      + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSR 253
            +W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER 230
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                              LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 231 -------------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 261

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 50/297 (16%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEAL 443
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF- 140
            +R   H +++ L  V+  +       V+++ EL      +     +  + D     L+ 
Sbjct: 444 TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 141 -QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVVTR 197
            QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +      +  +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRRE 255
           W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R  
Sbjct: 558 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER-- 610
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                            LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 611 -----------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 641

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+    + +   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 7   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 65
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQY 137
            +R   H +++ L  V+  +       V+++ EL          Q+ K S  L +     
Sbjct: 66  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLDLAS--LIL 117
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVV 195
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +      + 
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 177
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSR 253
            +W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R
Sbjct: 178 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER 232
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                              LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 233 -------------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 263

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 10  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 68
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 69  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 122
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+    + +   EY 
Sbjct: 123 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 179
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 180 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 68
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQY 137
            +R   H +++ L  V+  +       V+++ EL          Q+ K S  L +     
Sbjct: 69  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLDLAS--LIL 120
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVV 195
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +      + 
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSR 253
            +W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R
Sbjct: 181 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER 235
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                              LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 236 -------------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 266

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 63
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQY 137
            +R   H +++ L  V+  +       V+++ EL          Q+ K S  L +     
Sbjct: 64  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLDLAS--LIL 115
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVV 195
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +      + 
Sbjct: 116 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 175
Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSR 253
            +W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R
Sbjct: 176 IKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER 230
Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                              LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 231 -------------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 261

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+    + +   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 10/115 (8%)
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           LT +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       +
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
           + +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 255 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 305

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 10  GIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINN 65
           GIRS      ++ + L E  T++  IK +  GA+G V   +     EKV    AIK++  
Sbjct: 4   GIRSGEAPNQALLRILKE--TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 66  AFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQI 123
           A   + +    L E  ++  + + +V  L  + + S       V L+ +LM     L  +
Sbjct: 62  ATSPKANK-EILDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYV 114
Query: 124 IKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS 183
            +    + + +   +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+  
Sbjct: 115 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174
Query: 184 NGKNQFMTEY------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
             + +   EY      V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 175 GAEEK---EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 38  IGRGAYGIVCSSVNRETNEKV--AIKKINNAFENRVDALRTLRELKLLRHLQHE-NVIAL 94
           IG G +G V  +  ++   ++  AIK++   + ++ D      EL++L  L H  N+I L
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 95  KDVMMPSHRR------------NFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYFLF 140
             +    HR             N  D      +++TD    I +S A  L++    +F  
Sbjct: 89  --LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
            + RG+ YL     +HR+L   N+LV  N   KI DFGL+R      +     +  RW  
Sbjct: 147 DVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 206
Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTEC 239
              L      Y T+ DVWS G +  E+  LG  P + G  C
Sbjct: 207 IESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTP-YCGMTC 244

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 12/116 (10%)
Query: 128 QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN 187
           +ALT      F +Q+ +G++YL    ++HRDL   N+LV     +KI DFGL+R    ++
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 188 QFMTEYVVTRWYRAPELLLCCDN-----YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
                YV     R P   +  ++     Y T  DVWS G +  E+  LG  P +PG
Sbjct: 205 S----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 255

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 10/115 (8%)
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           LT +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       +
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
           + +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 257 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 307

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 8   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 66
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTS------TVQLIMQLMPFGCLLDYVREHKDNIGSQY 120
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+    + +   EY 
Sbjct: 121 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 177
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 178 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 10/115 (8%)
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           LT +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       +
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
           + +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 250 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 300

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 10  GIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINN 65
           GIRS      ++ + L E  T++  IK +G GA+G V   +     EKV    AIK++  
Sbjct: 4   GIRSGEAPNQALLRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 66  AFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQI 123
           A   + +    L E  ++  + + +V  L  + + S       V L+ +LM     L  +
Sbjct: 62  ATSPKANK-EILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYV 114
Query: 124 IKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS 183
            +    + + +   +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+  
Sbjct: 115 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 174
Query: 184 NGKNQFMTEY------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
             + +   EY      V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 175 GAEEK---EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 10/115 (8%)
Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           LT +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR       +
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 190 MTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTE 238
           + +    +  +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +
Sbjct: 248 VRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVK 298

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AI ++  A   + +    
Sbjct: 40  QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK-EI 98
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 99  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 152
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 153 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 209
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 210 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +G GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFG A+    + +   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 10  GIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINN 65
           GIRS      ++ + L E  T++  IK +  GA+G V   +     EKV    AIK++  
Sbjct: 4   GIRSGEAPNQALLRILKE--TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 66  AFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQI 123
           A   + +    L E  ++  + + +V  L  + + S       V L+ +LM     L  +
Sbjct: 62  ATSPKANK-EILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYV 114
Query: 124 IKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS 183
            +    + + +   +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+  
Sbjct: 115 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 174
Query: 184 NGKNQFMTEY------VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
             + +   EY      V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 175 GAEEK---EYHAEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 38  IGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +G+G +G V  +  ++ +    KVA+K +        D    LRE   ++   H +V  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 95  KDVMMPSHRRNFKDVYLVYE--LMDTDLHQIIKSSQALTN------DHCQYFLFQLLRGL 146
             V + S  +    + +V    +   DLH  + +S+   N           F+  +  G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRAPE 203
           +YL S N +HRDL   N ++  +  + + DFGL+R   + +   Q     +  +W     
Sbjct: 151 EYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALES 210
Query: 204 LLLCCDN-YGTSIDVWSVGCIFAELLGR 230
           L    DN Y    DVW+ G    E++ R
Sbjct: 211 L---ADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 23  QTLFEI--DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRT 76
           Q L  I  +T++  IK +  GA+G V   +     EKV    AIK++  A   + +    
Sbjct: 6   QALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EI 64
Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDH 134
           L E  ++  + + +V  L  + + S       V L+ +LM     L  + +    + + +
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY- 193
              +  Q+ +G+ YL    ++HRDL   N+LV     +KI DFGLA+    + +   EY 
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYH 175
Query: 194 -----VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKP 232
                V  +W     +L     Y    DVWS G    EL+  G KP
Sbjct: 176 AEGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 122/304 (40%), Gaps = 64/304 (21%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEAL 63
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF- 140
            +R   H +++ L  V+  +       V+++ EL      +     +  + D     L+ 
Sbjct: 64  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 141 -QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---------TSNGKNQFM 190
            QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R          S GK    
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGK---- 173
Query: 191 TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIIN 248
              +  +W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N
Sbjct: 174 ---LPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN 227
Query: 249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI 308
             G R                   LP  P  P         P    L+ K   +DP++R 
Sbjct: 228 --GER-------------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRP 257
Query: 309 SVTE 312
             TE
Sbjct: 258 RFTE 261

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 119/297 (40%), Gaps = 50/297 (16%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 5   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEAL 63
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF- 140
            +R   H +++ L  V+  +       V+++ EL      +     +  + D     L+ 
Sbjct: 64  TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 141 -QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVVTR 197
            QL   L YL S   +HRD+   N+LV+A   +K+ DFGL+R       +      +  +
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRRE 255
           W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R  
Sbjct: 178 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER-- 230
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                            LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 231 -----------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 261

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 119/297 (40%), Gaps = 50/297 (16%)
Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI  + + + + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEAL 443
Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLF- 140
            +R   H +++ L  V+  +       V+++ EL      +     +  + D     L+ 
Sbjct: 444 TMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 141 -QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVVTR 197
            QL   L YL S   +HRD+   N+LV+A   +K+ DFGL+R       +      +  +
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRRE 255
           W  APE  +    + ++ DVW  G    E+L  G KP F G +  + +  I N  G R  
Sbjct: 558 WM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRIEN--GER-- 610
Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                            LP  P  P         P    L+ K   +DP++R   TE
Sbjct: 611 -----------------LPMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTE 641

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 42/226 (18%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRTLRELKLLR 84
           +T+   +K +G GA+G V   +     E V    AIK +N     + + +  + E  ++ 
Sbjct: 37  ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMA 95
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL-------HQIIKSSQALTNDHCQY 137
            + H +++ L  V +         + LV +LM           H+    SQ L N     
Sbjct: 96  SMDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN----- 144
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY---- 193
           +  Q+ +G+ YL    ++HRDL   N+LV +   +KI DFGLAR   G  +   EY    
Sbjct: 145 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK---EYNADG 201
Query: 194 --VVTRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKP 232
             +  +W     + L C +Y       DVWS G    EL+  G KP
Sbjct: 202 GKMPIKW-----MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH--LQHENVIALK 95
           +G+G YG V     +   E VA+K     F +R D     RE +L     L+HEN++   
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVK----IFSSR-DEKSWFRETELYNTVMLRHENILGFI 68
Query: 96  DVMMPSHRRNFKDVYLV--YELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH--- 150
              M S R +   ++L+  Y  M + L+  ++ +  L    C   +  +  GL +LH   
Sbjct: 69  ASDMTS-RHSSTQLWLITHYHEMGS-LYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 151 -----SANILHRDLKPGNLLVNANCDLKICDFGLA----RTSNGKNQFMTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA    +++N  +      V T+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 202 PELL------LCCDNYGTSIDVWSVGCIFAELLGR 230
           PE+L       C D+Y   +D+W+ G +  E+  R
Sbjct: 186 PEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARR 219

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH--LQHENVIALK 95
           +G+G YG V     +   E VA+K     F +R D     RE +L     L+HEN++   
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVK----IFSSR-DEKSWFRETELYNTVMLRHENILGFI 68
Query: 96  DVMMPSHRRNFKDVYLV--YELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH--- 150
              M S R +   ++L+  Y  M + L+  ++ +  L    C   +  +  GL +LH   
Sbjct: 69  ASDMTS-RHSSTQLWLITHYHEMGS-LYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 151 -----SANILHRDLKPGNLLVNANCDLKICDFGLA----RTSNGKNQFMTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA    +++N  +      V T+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 202 PELL------LCCDNYGTSIDVWSVGCIFAELLGR 230
           PE+L       C D+Y   +D+W+ G +  E+  R
Sbjct: 186 PEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARR 219

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 98/226 (43%), Gaps = 42/226 (18%)
Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRTLRELKLLR 84
           +T+   +K +G GA+G V   +     E V    AIK +N     + + +  + E  ++ 
Sbjct: 14  ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMA 72
Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL-------HQIIKSSQALTNDHCQY 137
            + H +++ L  V +         + LV +LM           H+    SQ L N     
Sbjct: 73  SMDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN----- 121
Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY---- 193
           +  Q+ +G+ YL    ++HRDL   N+LV +   +KI DFGLAR   G  +   EY    
Sbjct: 122 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK---EYNADG 178
Query: 194 --VVTRWYRAPELLLCCDNYGT---SIDVWSVGCIFAELL--GRKP 232
             +  +W     + L C +Y       DVWS G    EL+  G KP
Sbjct: 179 GKMPIKW-----MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH--LQHENVIALK 95
           +G+G YG V     +   E VA+K     F +R D     RE +L     L+HEN++   
Sbjct: 45  VGKGRYGEVWRGSWQ--GENVAVK----IFSSR-DEKSWFRETELYNTVMLRHENILGFI 97
Query: 96  DVMMPSHRRNFKDVYLV--YELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH--- 150
              M S R +   ++L+  Y  M + L+  ++ +  L    C   +  +  GL +LH   
Sbjct: 98  ASDMTS-RHSSTQLWLITHYHEMGS-LYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 151 -----SANILHRDLKPGNLLVNANCDLKICDFGLA----RTSNGKNQFMTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA    +++N  +      V T+ Y A
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 202 PELL------LCCDNYGTSIDVWSVGCIFAELLGR 230
           PE+L       C D+Y   +D+W+ G +  E+  R
Sbjct: 215 PEVLDETIQVDCFDSY-KRVDIWAFGLVLWEVARR 248

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 38  IGRGAYGIV----CSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           +G GA+G V    C ++  E ++  VA+K +  A E+     +  RE +LL  LQH++++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAELLTMLQHQHIV 106
Query: 93  ALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQA---------------LTNDHCQ 136
               V         + + +V+E M   DL++ ++S                  L      
Sbjct: 107 RFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT---EY 193
               Q+  G+ YL   + +HRDL   N LV     +KI DFG++R     + +       
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF 234
           +  RW   PE +L    + T  DVWS G +  E+   G++P +
Sbjct: 222 LPIRWM-PPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 40/236 (16%)
Query: 38  IGRGAYGIV----CSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           +G GA+G V    C ++  E ++  VA+K +  A E+     +  RE +LL  LQH++++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAELLTMLQHQHIV 83
Query: 93  ALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQA---------------LTNDHCQ 136
               V         + + +V+E M   DL++ ++S                  L      
Sbjct: 84  RFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 138
Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT---EY 193
               Q+  G+ YL   + +HRDL   N LV     +KI DFG++R     + +       
Sbjct: 139 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF-----PGTECLNQ 242
           +  RW   PE +L    + T  DVWS G +  E+   G++P +        +C+ Q
Sbjct: 199 LPIRWM-PPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 252

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 40/236 (16%)
Query: 38  IGRGAYGIV----CSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHLQHENVI 92
           +G GA+G V    C ++  E ++  VA+K +  A E+     +  RE +LL  LQH++++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--REAELLTMLQHQHIV 77
Query: 93  ALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKSSQA---------------LTNDHCQ 136
               V         + + +V+E M   DL++ ++S                  L      
Sbjct: 78  RFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 132
Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT---EY 193
               Q+  G+ YL   + +HRDL   N LV     +KI DFG++R     + +       
Sbjct: 133 AVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIF-----PGTECLNQ 242
           +  RW   PE +L    + T  DVWS G +  E+   G++P +        +C+ Q
Sbjct: 193 LPIRWM-PPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 246

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 10/115 (8%)
Query: 128 QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN 187
           +ALT      F +Q+ +G++YL   +++HRDL   N+LV     +KI DFGL+R    ++
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 188 QFMTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +      +  +W     L    D+ Y T  DVWS G +  E+  LG  P +PG
Sbjct: 205 SXVKRSQGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 255

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 36  KPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           + +G+G++G+V   V +     E   +VAIK +N A   R + +  L E  +++     +
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHH 89
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ-ALTND---------HCQYFL 139
           V+ L  V+        +   ++ ELM   DL   ++S + A+ N+               
Sbjct: 90  VVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY------ 193
            ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R     + + T+Y      
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGK 199
Query: 194 --VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL 227
             +  RW  +PE  L    + T  DVWS G +  E+
Sbjct: 200 GLLPVRWM-SPE-SLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 22/220 (10%)
Query: 36  KPIGRGAYGIVCSSVNRE---TNEKVAIK--KINNAFENRVDALRTLRELKLLRHLQHEN 90
           K +G G +G V     ++   T+ KVA+K  K++N+ +  ++    L E   ++   H N
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF--LSEAACMKDFSHPN 97
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTN------DHCQYFLFQLL 143
           VI L  V +    +      ++   M   DLH  +  S+  T            F+  + 
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV---TRWYR 200
            G++YL + N LHRDL   N ++  +  + + DFGL++     + +    +     +W  
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 201 APELLLCCDN-YGTSIDVWSVGCIFAELLGRKPI-FPGTE 238
              L    D  Y +  DVW+ G    E+  R    +PG +
Sbjct: 218 IESL---ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 58/115 (50%), Gaps = 10/115 (8%)
Query: 128 QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN 187
           +ALT      F +Q+ +G++YL    ++HRDL   N+LV     +KI DFGL+R    ++
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 188 QFMTE---YVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
             +      +  +W     L    D+ Y T  DVWS G +  E+  LG  P +PG
Sbjct: 205 SXVKRSQGRIPVKWMAIESLF---DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 255

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    + Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 505
Query: 170 CDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++       +       +W   + APE    C NY    +  DVWS G +
Sbjct: 506 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 561
Query: 224 FAELL--GRKP 232
             E    G+KP
Sbjct: 562 MWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    + Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 447 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 506
Query: 170 CDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++       +       +W   + APE    C NY    +  DVWS G +
Sbjct: 507 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 562
Query: 224 FAELL--GRKP 232
             E    G+KP
Sbjct: 563 MWEAFSYGQKP 573

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 120 LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L++ ++ ++ + + +    + Q+  G+KYL  +N +HRDL   N+L+      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 180 ARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCIFAELL--GRK 231
           ++       +       +W   + APE    C NY    +  DVWS G +  E    G+K
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVLMWEAFSYGQK 229
Query: 232 P 232
           P
Sbjct: 230 P 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 12/121 (9%)
Query: 120 LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L++ ++ ++ + + +    + Q+  G+KYL  +N +HRDL   N+L+      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 180 ARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCIFAELL--GRK 231
           ++       +       +W   + APE    C NY    +  DVWS G +  E    G+K
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVLMWEAFSYGQK 229
Query: 232 P 232
           P
Sbjct: 230 P 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    + Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 102 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 161
Query: 170 CDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++       +       +W   + APE    C NY    +  DVWS G +
Sbjct: 162 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 217
Query: 224 FAELL--GRKP 232
             E    G+KP
Sbjct: 218 MWEAFSYGQKP 228

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 37/216 (17%)
Query: 36  KPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           + +G+G++G+V   V +     E   +VAIK +N A   R + +  L E  +++     +
Sbjct: 21  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHH 79
Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ-ALTND---------HCQYFL 139
           V+ L  V+        +   ++ ELM   DL   ++S + A+ N+               
Sbjct: 80  VVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 134
Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY------ 193
            ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R     + + T+Y      
Sbjct: 135 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGK 189
Query: 194 --VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL 227
             +  RW  +PE  L    + T  DVWS G +  E+
Sbjct: 190 GLLPVRWM-SPE-SLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 111 LVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN 169
           LV E+ +   L++ ++ ++ + + +    + Q+  G+KYL  +N +HRDL   N+L+   
Sbjct: 94  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 153
Query: 170 CDLKICDFGLARTSNGKNQFMTEYVVTRW---YRAPELLLCCDNY---GTSIDVWSVGCI 223
              KI DFGL++       +       +W   + APE    C NY    +  DVWS G +
Sbjct: 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE----CINYYKFSSKSDVWSFGVL 209
Query: 224 FAELL--GRKP 232
             E    G+KP
Sbjct: 210 MWEAFSYGQKP 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 106/239 (44%), Gaps = 30/239 (12%)
Query: 31  KYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           K   ++ +G+G++G+V     R     E   +VA+K +N +   R + +  L E  +++ 
Sbjct: 15  KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKG 73
Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELM-DTDLHQIIKS--SQALTN--------DH 134
               +V+ L  V+        +   +V ELM   DL   ++S   +A  N          
Sbjct: 74  FTCHHVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 128
Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMT 191
                 ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R    ++   +   
Sbjct: 129 MIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGK 188
Query: 192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKLIIN 248
             +  RW  APE  L    + TS D+WS G +  E+  L  +P + G      LK +++
Sbjct: 189 GLLPVRWM-APE-SLKDGVFTTSSDMWSFGVVLWEITSLAEQP-YQGLSNEQVLKFVMD 244
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	373
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	0.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	0.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	0.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	0.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	0.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	0.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	0.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	0.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	0.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	0.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	0.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-171
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-170
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-169
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-163
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-162
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-143
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-134
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-114
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-112
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-112
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-111
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-111
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-110
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-109
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-109
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-107
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-107
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-105
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-66
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-65
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-64
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-63
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-63
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-62
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-61
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-61
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-60
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-60
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-60
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-59
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-59
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-59
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-59
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-58
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-58
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-58
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-58
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-57
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-57
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-57
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-57
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-56
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-56
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-56
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-56
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-56
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-55
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-55
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-55
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-55
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-55
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-55
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-55
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-55
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-55
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-55
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-54
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-54
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-54
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-54
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-54
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-54
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-54
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-53
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-53
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-53
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-53
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-52
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-52
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-52
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-51
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-51
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-51
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-51
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-50
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-50
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-50
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-49
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-49
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-49
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-49
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-48
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-48
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-48
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-47
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-46
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-46
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-46
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-46
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-45
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-45
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-45
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-45
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-45
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-45
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-44
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-43
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-43
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-42
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-42
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-40
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-38
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-38
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-37
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-37
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-37
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-37
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-36
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-35
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-35
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-35
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-34
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-34
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-33
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-32
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-32
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-28
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-27
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-27
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-27
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-26
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-26
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-25
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-24
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-24
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-23
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-22
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-21
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-11
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-05

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  593 bits (1531), Expect = 0.0
 Identities = 172/355 (48%), Positives = 238/355 (67%), Gaps = 6/355 (1%)

Query: 13  SPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD 72
           +       +   +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++  
Sbjct: 10  AAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTY 68

Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
             RTLRE+K+L   +HEN+I + D++        KDVY+V +LM+TDL++++K+ Q L+N
Sbjct: 69  CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSN 127

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS---NGKNQF 189
           DH  YFL+Q+LRGLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR +   +    F
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
           +TEYV TRWYRAPE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ I
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247

Query: 250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
           LGS  +EDL  I N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI 
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307

Query: 310 VTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHPEA 363
           V +AL HPY+   YDPS  P A+ P   DM+ +   +E ++E++ +E   + P  
Sbjct: 308 VEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 362

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  592 bits (1527), Expect = 0.0
 Identities = 144/412 (34%), Positives = 219/412 (53%), Gaps = 52/412 (12%)

Query: 5   VEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN 64
           +   +   S  ++ Y        +   Y+    IGRG+YG V  + ++ T + VAIKK+N
Sbjct: 1   MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60

Query: 65  NAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQII 124
             FE+ +D  R LRE+ +L  L+ + +I L D+++P     F ++Y+V E+ D+DL ++ 
Sbjct: 61  RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120

Query: 125 KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-- 182
           K+   LT +H +  L+ LL G  ++H + I+HRDLKP N L+N +C +K+CDFGLART  
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 183 --------------------SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGC 222
                               +    + +T +VVTRWYRAPEL+L  +NY  SID+WS GC
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240

Query: 223 IFAELL-----------GRKPIFPGTEC-----------------LNQLKLIINILGSRR 254
           IFAELL            R P+FPG+ C                  +QL +I NI+G+  
Sbjct: 241 IFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPT 300

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
           E+DL+ I+ P+  KYIK  P+       + YP      I+LL+ ML F+P KRI++ +AL
Sbjct: 301 EDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQAL 360

Query: 315 QHPYMSPLYDPSSNPPAQVPIDLDMDEES--GEEMIREMMLKEMLHYHPEAI 364
            HPY+  +        +   I L  D+     E  +R + LKE+  +HPE +
Sbjct: 361 DHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELV 412

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  583 bits (1505), Expect = 0.0
 Identities = 157/353 (44%), Positives = 228/353 (64%), Gaps = 7/353 (1%)

Query: 11  IRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR 70
           IR  G +   + +T +E+   YV    +G GAYG VCS++++ + EKVAIKK++  F++ 
Sbjct: 5   IRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE 64

Query: 71  VDALRTLRELKLLRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQA 129
           + A R  REL LL+H+QHENVI L DV  P+   RNF D YLV   M TDL +I+     
Sbjct: 65  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LK 122

Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
            + +  QY ++Q+L+GLKY+HSA ++HRDLKPGNL VN +C+LKI DFGLAR ++     
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD---AE 179

Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
           MT YVVTRWYRAPE++L   +Y  ++D+WSVGCI AE+L  K +F G + L+QL  I+ +
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239

Query: 250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
            G    E ++ +++  A+ YI+SLP TP   F++L+P A P A DLL+KML  D  KR++
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299

Query: 310 VTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLHYHP 361
             +AL HP+  P  DP     AQ P D  ++ E    +  ++ + KE++++ P
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  579 bits (1496), Expect = 0.0
 Identities = 159/351 (45%), Positives = 233/351 (66%), Gaps = 18/351 (5%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           + ++ I + +     +G GAYG+VCS+ ++ T E VAIKKI   F+  + ALRTLRE+K+
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKI 62

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           L+H +HEN+I + ++  P    NF +VY++ ELM TDLH++I + Q L++DH QYF++Q 
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQT 121

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART----------SNGKNQFMTE 192
           LR +K LH +N++HRDLKP NLL+N+NCDLK+CDFGLAR             G+   M E
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
           +V TRWYRAPE++L    Y  ++DVWS GCI AEL  R+PIFPG +  +QL LI  I+G+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 253 -RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT 311
              + DL  I++P+AR+YIKSLP  P  P  +++P  +P  IDLLQ+MLVFDP KRI+  
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301

Query: 312 EALQHPYMSPLYDPSSNPPAQ----VPIDLDMDEES-GEEMIREMMLKEML 357
           EAL+HPY+   +DP+  P  +       + D  +E+   + +++++  E+ 
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  580 bits (1496), Expect = 0.0
 Identities = 126/364 (34%), Positives = 196/364 (53%), Gaps = 16/364 (4%)

Query: 10  GIRSPGKHY-YSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA-- 66
           G+++ G+     +   L  + + Y   + I  G+YG VC+ V+      VAIK++ N   
Sbjct: 1   GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVS 59

Query: 67  -------FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD 119
                    +     R LRE++LL H  H N++ L+D+ +         +YLV ELM TD
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD 119

Query: 120 LHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG 178
           L Q+I   +  ++  H QYF++ +L GL  LH A ++HRDL PGN+L+  N D+ ICDF 
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179

Query: 179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE 238
           LAR     +   T YV  RWYRAPEL++    +   +D+WS GC+ AE+  RK +F G+ 
Sbjct: 180 LAREDT-ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

Query: 239 CLNQLKLIINILGSRREEDLEFIDNPKARKYIK-SLPYTPGTPFSRLYPDAHPLAIDLLQ 297
             NQL  I+ ++G+ + ED+    +P AR Y++ SL   P   ++ + P A P+A+DL+ 
Sbjct: 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298

Query: 298 KMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEM 356
           KML F+P +RIS  +AL+HPY   L+DP              DE       + ++   E+
Sbjct: 299 KMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERFHFDESVTDVYDMHKIFTAEV 357

Query: 357 LHYH 360
             ++
Sbjct: 358 ERFN 361

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  580 bits (1496), Expect = 0.0
 Identities = 153/365 (41%), Positives = 228/365 (62%), Gaps = 12/365 (3%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           M++P  PP      G +   + +T +E+   Y  ++P+G GAYG VCS+V+  T  KVAI
Sbjct: 1   MSSP--PPA---RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAI 55

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-RRNFKDVYLVYELMDTD 119
           KK+   F++ + A R  REL+LL+H++HENVI L DV  P     +F D YLV   M TD
Sbjct: 56  KKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD 115

Query: 120 LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L +++K  + L  D  Q+ ++Q+L+GL+Y+H+A I+HRDLKPGNL VN +C+LKI DFGL
Sbjct: 116 LGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174

Query: 180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC 239
           AR ++     MT YVVTRWYRAPE++L    Y  ++D+WSVGCI AE++  K +F G++ 
Sbjct: 175 ARQAD---SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231

Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
           L+QLK I+ + G+   E ++ + + +A+ Y+K LP      F+ +  +A PLA++LL+KM
Sbjct: 232 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 291

Query: 300 LVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLH 358
           LV D  +R++  EAL HPY   L+D    P  Q   D   D+     +  + +  KE+L 
Sbjct: 292 LVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLS 350

Query: 359 YHPEA 363
           + P  
Sbjct: 351 FKPPR 355

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  577 bits (1489), Expect = 0.0
 Identities = 161/366 (43%), Positives = 237/366 (64%), Gaps = 8/366 (2%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
           MA      +  R P  +   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+
Sbjct: 1   MAHHHHHHSQER-PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 59

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR-RNFKDVYLVYELMDTD 119
           KK++  F++ + A RT REL+LL+H++HENVI L DV  P+     F DVYLV  LM  D
Sbjct: 60  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD 119

Query: 120 LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
           L+ I+K  Q LT+DH Q+ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGL
Sbjct: 120 LNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178

Query: 180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC 239
           AR +      MT YV TRWYRAPE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ 
Sbjct: 179 ARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235

Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
           ++QLKLI+ ++G+   E L+ I +  AR YI+SL   P   F+ ++  A+PLA+DLL+KM
Sbjct: 236 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 295

Query: 300 LVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES-GEEMIREMMLKEMLH 358
           LV D  KRI+  +AL H Y +  +DP   P A  P D  ++      +  + +   E++ 
Sbjct: 296 LVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVIS 354

Query: 359 YHPEAI 364
           + P  +
Sbjct: 355 FVPPPL 360

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  579 bits (1494), Expect = 0.0
 Identities = 147/410 (35%), Positives = 217/410 (52%), Gaps = 60/410 (14%)

Query: 13  SPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD 72
           S          + ++I  +Y     IG G+YG VC + ++     VAIKKI   FE+ +D
Sbjct: 36  SKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID 95

Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
             R LRE+ +L  L H++V+ + D+++P     F ++Y+V E+ D+D  ++ ++   LT 
Sbjct: 96  CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE 155

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART---------- 182
            H +  L+ LL G+KY+HSA ILHRDLKP N LVN +C +K+CDFGLART          
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 183 -----------------SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
                            +    + +T +VVTRWYRAPEL+L  +NY  +IDVWS+GCIFA
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275

Query: 226 ELLG-----------RKPIFPGTECL--------------------NQLKLIINILGSRR 254
           ELL            R P+FPG+ C                     +QL +I NILG+  
Sbjct: 276 ELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS 335

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
           EED+E ++   A++YI+  P   GT  +  +P +   AI LL++MLVF+P KRI++ E L
Sbjct: 336 EEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECL 395

Query: 315 QHPYMSPLYDPSSNPPAQVPIDLDMDEES--GEEMIREMMLKEMLHYHPE 362
            HP+   +        A   + L  ++     E  +R   +KE+  YHPE
Sbjct: 396 AHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  565 bits (1457), Expect = 0.0
 Identities = 144/382 (37%), Positives = 215/382 (56%), Gaps = 44/382 (11%)

Query: 23  QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +    +  KY  +K +G+GAYGIV  S++R T E VA+KKI +AF+N  DA RT RE+ +
Sbjct: 2   RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI 61

Query: 83  LRHLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQ 141
           L  L  HEN++ L +V+      N +DVYLV++ M+TDLH +I++   L   H QY ++Q
Sbjct: 62  LTELSGHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQ 117

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART------------------- 182
           L++ +KYLHS  +LHRD+KP N+L+NA C +K+ DFGL+R+                   
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 183 --SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL 240
              +     +T+YV TRWYRAPE+LL    Y   ID+WS+GCI  E+L  KPIFPG+  +
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237

Query: 241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY--------------- 285
           NQL+ II ++     ED+E I +P A+  I+SL        S                  
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297

Query: 286 -PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES- 343
             D +  A+DLL K+L F+P KRIS  +AL+HP++S  ++P+  P     I + +++   
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVK 357

Query: 344 -GEEMIREMMLKEMLHYHPEAI 364
              +  R ++  E+     E I
Sbjct: 358 HSIDDYRNLVYSEISRRKRELI 379

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  542 bits (1399), Expect = 0.0
 Identities = 125/323 (38%), Positives = 192/323 (59%), Gaps = 17/323 (5%)

Query: 20  SMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRE 79
           SM    F++ ++Y+ +KP+G G  G+V S+V+ + +++VAIKKI     +       LRE
Sbjct: 1   SMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALRE 58

Query: 80  LKLLRHLQHENVIALKDVMMPSHRR---------NFKDVYLVYELMDTDLHQIIKSSQAL 130
           +K++R L H+N++ + +++ PS  +             VY+V E M+TDL  +++    L
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPL 117

Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTS---NGK 186
             +H + F++QLLRGLKY+HSAN+LHRDLKP NL +N  +  LKI DFGLAR        
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177

Query: 187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI 246
              ++E +VT+WYR+P LLL  +NY  +ID+W+ GCIFAE+L  K +F G   L Q++LI
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK 306
           +  +    EED + + +     YI++    P  P ++L P     A+D L+++L F P  
Sbjct: 238 LESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296

Query: 307 RISVTEALQHPYMSPLYDPSSNP 329
           R++  EAL HPYMS    P   P
Sbjct: 297 RLTAEEALSHPYMSIYSFPMDEP 319

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  539 bits (1390), Expect = 0.0
 Identities = 147/371 (39%), Positives = 215/371 (57%), Gaps = 20/371 (5%)

Query: 7   PPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA 66
                R    +   +  + F +  +Y  +KPIG GA GIVC++ +      VAIKK++  
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 61

Query: 67  FENRVDALRTLRELKLLRHLQHENVIALKDVMMP-SHRRNFKDVYLVYELMDTDLHQIIK 125
           F+N+  A R  REL L++ + H+N+I L +V  P      F+DVY+V ELMD +L Q+I+
Sbjct: 62  FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 121

Query: 126 SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG 185
               L ++   Y L+Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G
Sbjct: 122 --MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-G 178

Query: 186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL 245
            +  MT YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++    +FPGT+ ++Q   
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 237

Query: 246 IINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH------------PLAI 293
           +I  LG+   E ++ +  P  R Y+++ P   G  F +L+PD                A 
Sbjct: 238 VIEQLGTPCPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 296

Query: 294 DLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEES--GEEMIREM 351
           DLL KMLV D +KRISV EALQHPY++  YDPS        I     +E     E  +E+
Sbjct: 297 DLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKEL 356

Query: 352 MLKEMLHYHPE 362
           + KE++     
Sbjct: 357 IYKEVMDLEHH 367

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  541 bits (1396), Expect = 0.0
 Identities = 149/375 (39%), Positives = 223/375 (59%), Gaps = 20/375 (5%)

Query: 14  PGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA 73
              +   +  + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A
Sbjct: 46  NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 105

Query: 74  LRTLRELKLLRHLQHENVIALKDVMMPSH-RRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
            R  REL L++ + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+    L +
Sbjct: 106 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDH 163

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
           +   Y L+Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLART+ G +  MT 
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTP 222

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
           YVVTR+YRAPE++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+
Sbjct: 223 YVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281

Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH------------PLAIDLLQKML 300
              E ++ +  P  R Y+++ P   G  F +L+PD+               A DLL KML
Sbjct: 282 PCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340

Query: 301 VFDPTKRISVTEALQHPYMSPLYDPS-SNPPAQVPIDLDMDEES-GEEMIREMMLKEMLH 358
           V DP KRISV +ALQHPY++  YDP+    P     D  +DE     E  +E++ KE+++
Sbjct: 341 VIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 400

Query: 359 YHPEAITANTEVCSS 373
              +      +   S
Sbjct: 401 SEEKTKNGVVKGQPS 415

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  481 bits (1241), Expect = e-171
 Identities = 109/346 (31%), Positives = 174/346 (50%), Gaps = 21/346 (6%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
            +   ++   +  G+G +G V     + T   VAIKK+    ++     R L+ ++ L  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAV 75

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYL--VYELMDTDLHQIIKS----SQALTNDHCQYFL 139
           L H N++ L+        R+ +D+YL  V E +   LH+  ++      A      + FL
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 140 FQLLRGLKYLH--SANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVT 196
           FQL+R +  LH  S N+ HRD+KP N+LVN A+  LK+CDFG A+  +  ++    Y+ +
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICS 194

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
           R+YRAPEL+    +Y T++D+WSVGCIFAE++  +PIF G     QL  I+ +LG    E
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLY----PDAHPLAIDLLQKMLVFDPTKRISVTE 312
            L  ++          L  + G P+S ++          A DLL  +L + P +R+   E
Sbjct: 255 VLRKLNPSHTDVD---LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311

Query: 313 ALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEM-IREMMLKEML 357
           AL HPY   L+DP++  P    +  D+      E+ +     K  L
Sbjct: 312 ALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKL 357

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  478 bits (1232), Expect = e-170
 Identities = 115/370 (31%), Positives = 191/370 (51%), Gaps = 21/370 (5%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAI 60
              P++ PN +    K   S  +T  + +  Y   K IG G++G+V  +   E++E VAI
Sbjct: 14  KLNPLDDPNKVI---KVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAI 69

Query: 61  KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMP-SHRRNFKDVYLVYELMDTD 119
           KK+        D     REL+++R ++H NV+ LK        +++   + LV E +   
Sbjct: 70  KKV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123

Query: 120 LHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKI 174
           +++  +      Q +     + +++QLLR L Y+HS  I HRD+KP NLL++     LK+
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL 183

Query: 175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
            DFG A+      +    Y+ +R+YRAPEL+    NY T+ID+WS GC+ AEL+  +P+F
Sbjct: 184 IDFGSAKILI-AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

Query: 235 PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAI 293
           PG   ++QL  II +LG+   E ++ + NP         P     PFS+++ P   P AI
Sbjct: 243 PGESGIDQLVEIIKVLGTPSREQIKTM-NP--NYMEHKFPQIRPHPFSKVFRPRTPPDAI 299

Query: 294 DLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMML 353
           DL+ ++L + P+ R++  EAL HP+   L    +  P    +    +    E  +R  ++
Sbjct: 300 DLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLI 359

Query: 354 KEMLHYHPEA 363
             ++  H EA
Sbjct: 360 SRLVPQHAEA 369

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  479 bits (1234), Expect = e-169
 Identities = 108/363 (29%), Positives = 180/363 (49%), Gaps = 21/363 (5%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK 81
                  +  Y   K IG G++G+V  +   ++ E VAIKK+        D     REL+
Sbjct: 46  QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQ 99

Query: 82  LLRHLQHENVIALKDVMMPS-HRRNFKDVYLVYELMDTDLHQIIK----SSQALTNDHCQ 136
           ++R L H N++ L+     S  +++   + LV + +   ++++ +    + Q L   + +
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYVV 195
            +++QL R L Y+HS  I HRD+KP NLL++ +   LK+CDFG A+    + +    Y+ 
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYIC 218

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           +R+YRAPEL+    +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278

Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSR-LYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
           E +  + NP   ++    P     P+++   P   P AI L  ++L + PT R++  EA 
Sbjct: 279 EQIREM-NPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335

Query: 315 QHPYMSPLYDPSSNPPAQVPI----DLDMDEESGEEMIREMMLKEMLHYHPEAITANTEV 370
            H +   L DP+   P         +    E S    +  +++         A T     
Sbjct: 336 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNAT 395

Query: 371 CSS 373
            +S
Sbjct: 396 AAS 398

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  457 bits (1179), Expect = e-163
 Identities = 89/326 (27%), Positives = 159/326 (48%), Gaps = 20/326 (6%)

Query: 9   NGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE 68
           N  R      Y      +     Y  ++ +GRG Y  V  ++N   NEKV +K +     
Sbjct: 15  NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--- 71

Query: 69  NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS 127
             V   +  RE+K+L +L+   N+I L D++      +     +   + +TD  Q+    
Sbjct: 72  --VKKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY--- 124

Query: 128 QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGK 186
           Q LT+   +++++++L+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA   +  
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-P 183

Query: 187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKL 245
            Q     V +R+++ PELL+    Y  S+D+WS+GC+ A ++ RK P F G +  +QL  
Sbjct: 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243

Query: 246 IINILGSRREED-LEFIDNPKARKYIKSLPYTPGTPFSRLYPD-----AHPLAIDLLQKM 299
           I  +LG+    D ++  +     ++   L       + R           P A+D L K+
Sbjct: 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303

Query: 300 LVFDPTKRISVTEALQHPYMSPLYDP 325
           L +D   R++  EA++HPY   +   
Sbjct: 304 LRYDHQSRLTAREAMEHPYFYTVVKD 329

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  459 bits (1182), Expect = e-162
 Identities = 100/344 (29%), Positives = 171/344 (49%), Gaps = 49/344 (14%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
              KY   K +G G++GIVC   + E+ ++ A+KK+        D     REL +++ L 
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMKVLD 58

Query: 88  HENVIALKDVM---------------------------------MPSHRRNFKDVYLVYE 114
           H N+I L D                                   +  +    K + ++ E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 115 LMDTDLHQII----KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC 170
            +   LH+++    +S +++  +    +++QL R + ++HS  I HRD+KP NLLVN+  
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178

Query: 171 D-LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG 229
           + LK+CDFG A+     ++    Y+ +R+YRAPEL+L    Y  SID+WS+GC+F EL+ 
Sbjct: 179 NTLKLCDFGSAKKLI-PSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237

Query: 230 RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH 289
            KP+F G   ++QL  II I+G+  +E +  ++           P      + ++ P+  
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR---FPTLKAKDWRKILPEGT 294

Query: 290 P-LAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQ 332
           P LAIDLL+++L ++P  RI+  EA+ HP+   L +   +    
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKN 338

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  408 bits (1052), Expect = e-143
 Identities = 97/301 (32%), Positives = 158/301 (52%), Gaps = 6/301 (1%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  I  IG G+YG+V    NR+T + VAIKK   + ++ V     LRE+++L+ L+H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYL 149
           ++ L +V      R  + ++LV+E  D  +   +    + +     +   +Q L+ + + 
Sbjct: 64  LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H  N +HRD+KP N+L+  +  +K+CDFG AR   G + +  + V TRWYR+PELL+   
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            YG  +DVW++GC+FAELL   P++PG   ++QL LI   LG       +     +    
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNP 329
           +K        P    +P+    A+ LL+  L  DPT+R++  + L HPY   + +     
Sbjct: 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA 298

Query: 330 P 330
            
Sbjct: 299 K 299

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  386 bits (995), Expect = e-134
 Identities = 103/294 (35%), Positives = 161/294 (54%), Gaps = 6/294 (2%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           F+   KY  +  +G G+YG+V    N++T   VAIKK   + ++++     +RE+KLL+ 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLR 144
           L+HEN++ L +V      +  K  YLV+E +D  +   ++     L     Q +LFQ++ 
Sbjct: 81  LRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           G+ + HS NI+HRD+KP N+LV+ +  +K+CDFG ART     +   + V TRWYRAPEL
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
           L+    YG ++DVW++GC+  E+   +P+FPG   ++QL  I+  LG+      E  +  
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
                ++        P  R YP    + IDL +K L  DP KR    E L H +
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  335 bits (861), Expect = e-114
 Identities = 125/327 (38%), Positives = 177/327 (54%), Gaps = 17/327 (5%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI--NNAFENRVDALRT-LRELKLLRHLQ 87
           +Y  +  +G G +  V  + ++ TN+ VAIKKI   +  E +    RT LRE+KLL+ L 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGL 146
           H N+I L D     H+ N   + LV++ M+TDL  IIK  S  LT  H + ++   L+GL
Sbjct: 71  HPNIIGLLDAFG--HKSN---ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +YLH   ILHRDLKP NLL++ N  LK+ DFGLA++    N+  T  VVTRWYRAPELL 
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDNPK 265
               YG  +D+W+VGCI AELL R P  PG   L+QL  I   LG+  EE   +    P 
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY--MSPL- 322
                 +    PG P   ++  A    +DL+Q + +F+P  RI+ T+AL+  Y    P  
Sbjct: 246 Y----VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301

Query: 323 YDPSSNPPAQVPIDLDMDEESGEEMIR 349
                 P    P++   ++ +    I+
Sbjct: 302 TPGCQLPRPNCPVETLKEQSNPALAIK 328

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  328 bits (844), Expect = e-112
 Identities = 112/333 (33%), Positives = 168/333 (50%), Gaps = 14/333 (4%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y+ +  +G G Y  V    ++ T+  VA+K+I    E        +RE+ LL+ L+H N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-CTAIREVSLLKDLKHAN 61

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYL 149
           ++ L D++        K + LV+E +D DL Q +      +   + + FLFQLLRGL Y 
Sbjct: 62  IVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LK+ DFGLAR  +   +     VVT WYR P++LL   
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFIDNPKARK 268
           +Y T ID+W VGCIF E+   +P+FPG+    QL  I  ILG+  EE     + N + + 
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
           Y  + P           P       DLL K+L F+   RIS  +A++HP+   L      
Sbjct: 237 Y--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL----GE 290

Query: 329 PPAQVPIDLDMDEESGEEMIREMMLKEMLHYHP 361
              ++P    +      ++ +E  L+   H+H 
Sbjct: 291 RIHKLPDTTSIFALKEIQLQKEASLRSAHHHHH 323

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  326 bits (837), Expect = e-111
 Identities = 112/296 (37%), Positives = 160/296 (54%), Gaps = 23/296 (7%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR------TLRELKLLR 84
           KY  ++ IG G YG+V  + N    E  A+KKI      R++         T+RE+ +L+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI------RLEKEDEGIPSTTIREISILK 55

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLL 143
            L+H N++ L DV+        K + LV+E +D DL +++      L +   + FL QLL
Sbjct: 56  ELKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL 110

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
            G+ Y H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  +VT WYRAP+
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFID 262
           +L+    Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  ILG+   ++     +
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            P   KY  +       P+           IDLL KML  DP +RI+  +AL+H Y
Sbjct: 231 LP---KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  326 bits (837), Expect = e-111
 Identities = 115/329 (34%), Positives = 170/329 (51%), Gaps = 28/329 (8%)

Query: 3   TPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKK 62
                    + PG    S   +   ID +Y  I  +G G YG V  +++  TNE VAIK+
Sbjct: 8   HMGTLEAQTQGPGSMSVSAAPSATSID-RYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66

Query: 63  INNAFENRVDALR------TLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM 116
           I      R++          +RE+ LL+ LQH N+I LK V+  +HR     ++L++E  
Sbjct: 67  I------RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-----LHLIFEYA 115

Query: 117 DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD----- 171
           + DL + +  +  ++    + FL+QL+ G+ + HS   LHRDLKP NLL++ +       
Sbjct: 116 ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175

Query: 172 LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK 231
           LKI DFGLAR      +  T  ++T WYR PE+LL   +Y TS+D+WS+ CI+AE+L + 
Sbjct: 176 LKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

Query: 232 PIFPGTECLNQLKLIINILGSRREEDL-EFIDNPKARKYIKSLPYTPGTPFSRLYPDA-H 289
           P+FPG   ++QL  I  +LG   +         P    + +S P   G    R+      
Sbjct: 236 PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP---DWKQSFPKFRGKTLKRVLGALLD 292

Query: 290 PLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              +DLL  ML  DP KRIS   AL+HPY
Sbjct: 293 DEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  322 bits (829), Expect = e-110
 Identities = 112/296 (37%), Positives = 167/296 (56%), Gaps = 22/296 (7%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR------TLRELKLLR 84
           KY  ++ +G G YG+V  + +      VA+K+I      R+DA         +RE+ LL+
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI------RLDAEDEGIPSTAIREISLLK 74

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLL 143
            L H N+++L DV+          + LV+E M+ DL +++      L +   + +L+QLL
Sbjct: 75  ELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           RG+ + H   ILHRDLKP NLL+N++  LK+ DFGLAR      +  T  VVT WYRAP+
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-EFID 262
           +L+    Y TS+D+WS+GCIFAE++  KP+FPG    +QL  I +ILG+    +  +  +
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            P  ++   +       P+S + P      IDLL  ML FDP KRIS  +A+ HPY
Sbjct: 250 LPLWKQR--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  321 bits (826), Expect = e-109
 Identities = 122/297 (41%), Positives = 168/297 (56%), Gaps = 23/297 (7%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR------TLRELKLLR 84
           KY  ++ IG G YG V  + NRET+E VA+K++      R+D          LRE+ LL+
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLK 56

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLL 143
            L+H+N++ L DV+    +     + LV+E  D DL +   S +  L  +  + FLFQLL
Sbjct: 57  ELKHKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           +GL + HS N+LHRDLKP NLL+N N +LK+ +FGLAR      +  +  VVT WYR P+
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDL-EFI 261
           +L     Y TSID+WS GCIFAEL    +P+FPG +  +QLK I  +LG+  EE      
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
             P  + Y     Y   T    + P  +    DLLQ +L  +P +RIS  EALQHPY
Sbjct: 232 KLPDYKPYPM---YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  321 bits (824), Expect = e-109
 Identities = 113/299 (37%), Positives = 156/299 (52%), Gaps = 20/299 (6%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-----TLRELKLLRH 85
           +Y P+  IG GAYG V  + +  +   VA+K +     N           T+RE+ LLR 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLRR 67

Query: 86  LQ---HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYFLF 140
           L+   H NV+ L DV   S       V LV+E +D DL   +  +    L  +  +  + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           Q LRGL +LH+  I+HRDLKP N+LV +   +K+ DFGLAR        +T  VVT WYR
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMALTPVVVTLWYR 186

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-E 259
           APE+LL    Y T +D+WSVGCIFAE+  RKP+F G    +QL  I +++G   E+D   
Sbjct: 187 APEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            +  P+      + P     P   + P+       LL +ML F+P KRIS   ALQH Y
Sbjct: 246 DVSLPRG-----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  316 bits (812), Expect = e-107
 Identities = 119/324 (36%), Positives = 170/324 (52%), Gaps = 26/324 (8%)

Query: 31  KYVPIKPIGRGAYGIVCSSVN-RETNEKVAIKKINNAFENRVDALR------TLRELKLL 83
           +Y  +  IG GAYG V  + + +     VA+K++      RV          T+RE+ +L
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVL 65

Query: 84  RHLQ---HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYF 138
           RHL+   H NV+ L DV   S       + LV+E +D DL   +       +  +  +  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 125

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +FQLLRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR        +T  VVT W
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLW 184

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           YRAPE+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I++++G   EED 
Sbjct: 185 YRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243

Query: 259 -EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
              +  P+      +       P  +   D   L  DLL K L F+P KRIS   AL HP
Sbjct: 244 PRDVALPRQ-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298

Query: 318 YMSPLYDPSSNPPAQVPIDLDMDE 341
           Y   L     N  + +P   +  E
Sbjct: 299 YFQDLERCKENLDSHLPPSQNTSE 322

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  315 bits (809), Expect = e-107
 Identities = 108/317 (34%), Positives = 164/317 (51%), Gaps = 31/317 (9%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA-----LRTLRELKLLRH 85
           ++  ++ +G G Y  V   +N+ T   VA+K++      ++D+        +RE+ L++ 
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKE 59

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS------QALTNDHCQYFL 139
           L+HEN++ L DV+          + LV+E MD DL + + S       + L  +  +YF 
Sbjct: 60  LKHENIVRLYDVIHTE-----NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           +QLL+GL + H   ILHRDLKP NLL+N    LK+ DFGLAR         +  VVT WY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL- 258
           RAP++L+    Y TSID+WS GCI AE++  KP+FPGT    QLKLI +I+G+  E    
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAH-----PLAIDLLQKMLVFDPTKRISVTEA 313
                P   KY  ++   P     ++             +D L  +L  +P  R+S  +A
Sbjct: 235 SVTKLP---KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 314 LQHPYMSPLYDPSSNPP 330
           L HP+ +  Y  +S   
Sbjct: 292 LHHPWFAEYYHHASMGG 308

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  311 bits (800), Expect = e-105
 Identities = 108/316 (34%), Positives = 155/316 (49%), Gaps = 20/316 (6%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR--TLRELKLLRHLQH 88
           KY  +  IG+G +G V  + +R+T +KVA+KK+    EN  +      LRE+K+L+ L+H
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLKH 75

Query: 89  ENVIALKDVMM---PSHRRNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLR 144
           ENV+ L ++       + R    +YLV++  + DL  ++ +     T    +  +  LL 
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 135

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART----SNGKNQFMTEYVVTRWYR 200
           GL Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR      N +    T  VVT WYR
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL-E 259
            PELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + GS   E    
Sbjct: 196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAH--PLAIDLLQKMLVFDPTKRISVTEALQHP 317
             +     K    L                  P A+DL+ K+LV DP +RI   +AL H 
Sbjct: 256 VDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313

Query: 318 Y--MSPL-YDPSSNPP 330
           +    P+  D      
Sbjct: 314 FFWSDPMPSDLKGMLS 329

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  294 bits (754), Expect = 3e-97
 Identities = 112/333 (33%), Positives = 163/333 (48%), Gaps = 43/333 (12%)

Query: 38  IGRGAYGIV--CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           +GRG YG V      + + ++  A+K+I         +    RE+ LLR L+H NVI+L+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMS--ACREIALLRELKHPNVISLQ 84

Query: 96  DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQA---------LTNDHCQYFLFQLLRGL 146
            V +       + V+L+++  + DL  IIK  +A         L     +  L+Q+L G+
Sbjct: 85  KVFL---SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 147 KYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSNGKNQFMTEY---VVTRWY 199
            YLH+  +LHRDLKP N+LV         +KI D G AR  N   + + +    VVT WY
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE---------CLNQLKLIINIL 250
           RAPELLL   +Y  +ID+W++GCIFAELL  +PIF   +           +QL  I N++
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261

Query: 251 GSRREEDLEFIDN-PKARKYIKSLPYTPGTPFS------RLYPDAHPLAIDLLQKMLVFD 303
           G   ++D E I   P+    +K       T  S      +        A  LLQK+L  D
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321

Query: 304 PTKRISVTEALQHPY--MSPLYDPSSNPPAQVP 334
           P KRI+  +A+Q PY    PL         Q+P
Sbjct: 322 PIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIP 354

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  211 bits (539), Expect = 4e-66
 Identities = 76/324 (23%), Positives = 125/324 (38%), Gaps = 53/324 (16%)

Query: 20  SMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRE 79
             +Q++      Y  +K IG G    V   +N E  +  AIK +N    +         E
Sbjct: 18  LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNE 76

Query: 80  LKLLRHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQY 137
           +  L  LQ   + +I L D  +       + +Y+V E  + DL+  +K  +++     + 
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKS 131

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART--SNGKNQFMTEYVV 195
           +   +L  +  +H   I+H DLKP N L+  +  LK+ DFG+A     +  +      V 
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 196 TRWYRAPELLLCCDN----------YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLK 244
           T  Y  PE +    +               DVWS+GCI   +  G+ P       +++L 
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250

Query: 245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFD 303
            II+                            P       +PD       D+L+  L  D
Sbjct: 251 AIID----------------------------PNHEIE--FPDIPEKDLQDVLKCCLKRD 280

Query: 304 PTKRISVTEALQHPYMSPLYDPSS 327
           P +RIS+ E L HPY+     P +
Sbjct: 281 PKQRISIPELLAHPYVQIQTHPVN 304

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  211 bits (539), Expect = 6e-65
 Identities = 90/346 (26%), Positives = 165/346 (47%), Gaps = 51/346 (14%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           +  +Y  +K IG+G++G V  + + + ++ VA+K + N    +    +   E+++L HL+
Sbjct: 95  VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLR 151

Query: 88  HE------NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFL 139
            +      NVI + +      R +   + + +EL+  +L+++IK +  Q  +    + F 
Sbjct: 152 KQDKDNTMNVIHMLENFT--FRNH---ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVN--ANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
             +L+ L  LH   I+H DLKP N+L+       +K+ DFG +   +   Q +  Y+ +R
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQSR 263

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILG------ 251
           +YRAPE++L    YG  ID+WS+GCI AELL   P+ PG +  +QL  +I +LG      
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL 322

Query: 252 ----------------------SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH 289
                                 +   +    ++  ++R+     P       + L     
Sbjct: 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDD 382

Query: 290 PLAIDLLQKMLVFDPTKRISVTEALQHPYMS-PLYDPSSNPPAQVP 334
           PL +D L++ L +DP  R++  +AL+HP++   L  P +     V 
Sbjct: 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVK 428

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  207 bits (529), Expect = 5e-64
 Identities = 81/361 (22%), Positives = 139/361 (38%), Gaps = 50/361 (13%)

Query: 14  PGKHY-YSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVD 72
           PG ++     +     D +Y+ ++ +G G +  V  + +   N  VA+K +         
Sbjct: 4   PGGYHPAFKGEPY--KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 61

Query: 73  ALRTLRELKLLRHLQ-----------HENVIALKDVMMPSHRRNFKD-VYLVYELMDTDL 120
           A     E+KLL+ +              +++ L D     H+      V +V+E++  +L
Sbjct: 62  AED---EIKLLQRVNDADNTKEDSMGANHILKLLDHFN--HKGPNGVHVVMVFEVLGENL 116

Query: 121 HQIIKSS--QALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCD------ 171
             +IK    + +   + +    QLL GL Y+H    I+H D+KP N+L+           
Sbjct: 117 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176

Query: 172 LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK 231
           +KI D G A   +   +  T  + TR YR+PE+LL    +G   D+WS  C+  EL+   
Sbjct: 177 IKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGD 232

Query: 232 PIFPGTEC------LNQLKLIINILG-------SRREEDLEFIDNPKARKYIKSLPYTPG 278
            +F   E        + +  II +LG          +    F ++    + I  L + P 
Sbjct: 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 292

Query: 279 TPFSR----LYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVP 334
                       D      D L  ML  DP KR      + HP++               
Sbjct: 293 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRE 352

Query: 335 I 335
           +
Sbjct: 353 L 353

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  204 bits (520), Expect = 2e-63
 Identities = 60/308 (19%), Positives = 116/308 (37%), Gaps = 28/308 (9%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
            +  ++    +G+GA   V    +++T +  AIK  NN    R      +RE ++L+ L 
Sbjct: 7   SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLN 65

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII---KSSQALTNDHCQYFLFQLL 143
           H+N++ L  +         +   L+ E      L+ ++    ++  L        L  ++
Sbjct: 66  HKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSNGKNQFMTEYVVTRWY 199
            G+ +L    I+HR++KPGN++     D     K+ DFG AR     ++       T  Y
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEY 181

Query: 200 RAPELL-------LCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILG 251
             P++             YG ++D+WS+G  F     G  P  P        +++  I+ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 252 SRREEDLEFIDNPK--ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
            +    +  +   +     +   +P +       L      L   +L  +L  D  K   
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSC-----SLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 310 VTEALQHP 317
             +     
Sbjct: 297 FDQFFAET 304

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  204 bits (522), Expect = 3e-63
 Identities = 73/317 (23%), Positives = 117/317 (36%), Gaps = 51/317 (16%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH 88
              Y  +K IG G    V   +N E  +  AIK +N    +         E+  L  LQ 
Sbjct: 8   GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66

Query: 89  --ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGL 146
             + +I L D  +       + +Y+V E  + DL+  +K  +++     + +   +L  +
Sbjct: 67  HSDKIIRLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPEL 204
             +H   I+H DLKP N L+  +  LK+ DFG+A     +  +      V T  Y  PE 
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 205 LL----------CCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSR 253
           +                    DVWS+GCI   +  G+ P       +++L  II+     
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID----- 235

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                                  P                D+L+  L  DP +RIS+ E 
Sbjct: 236 -----------------------PNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 314 LQHPYMSPLYDPSSNPP 330
           L HPY+     P +   
Sbjct: 272 LAHPYVQIQTHPVNQMA 288

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  204 bits (520), Expect = 2e-62
 Identities = 76/343 (22%), Positives = 121/343 (35%), Gaps = 51/343 (14%)

Query: 7   PPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA 66
           P  G     K   S  + +      Y  +K IG G    V   +N E  +  AIK +N  
Sbjct: 33  PDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLE 91

Query: 67  FENRVDALRTLRELKLLRHLQH--ENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQII 124
             +         E+  L  LQ   + +I L D  +       + +Y+V E  + DL+  +
Sbjct: 92  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQYIYMVMECGNIDLNSWL 146

Query: 125 KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART-- 182
           K  +++     + +   +L  +  +H   I+H DLKP N L+  +  LK+ DFG+A    
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205

Query: 183 SNGKNQFMTEYVVTRWYRAPELLL----------CCDNYGTSIDVWSVGCIFAELLGRKP 232
            +  +      V    Y  PE +                    DVWS+GCI   +   K 
Sbjct: 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

Query: 233 IFPG-TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPL 291
            F      +++L  II+                            P              
Sbjct: 266 PFQQIINQISKLHAIID----------------------------PNHEI-EFPDIPEKD 296

Query: 292 AIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVP 334
             D+L+  L  DP +RIS+ E L HPY+     P +       
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 339

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  198 bits (505), Expect = 3e-61
 Identities = 72/320 (22%), Positives = 124/320 (38%), Gaps = 56/320 (17%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            +  I  +G+GA+G V  + N   +   AIKKI +           L E+ LL  L H+ 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQY 63

Query: 91  VIALKDV--------MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTN-DHCQYFLF 140
           V+                +  +    +++  E  +   L+ +I S       D       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN--------------GK 186
           Q+L  L Y+HS  I+HRDLKP N+ ++ + ++KI DFGLA+  +              G 
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI 246
           +  +T  + T  Y A E+L    +Y   ID++S+G IF E++   P   G E +N LK +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241

Query: 247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK 306
            ++                               F         +   +++ ++  DP K
Sbjct: 242 RSV------------------------SIEFPPDFDDNKM---KVEKKIIRLLIDHDPNK 274

Query: 307 RISVTEALQHPYMSPLYDPS 326
           R      L   ++   +   
Sbjct: 275 RPGARTLLNSGWLPVKHQDE 294

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  200 bits (509), Expect = 4e-61
 Identities = 54/341 (15%), Positives = 90/341 (26%), Gaps = 57/341 (16%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKL 82
            L + + K   ++P+  G   +V    + E  E  A+K      EN    L  L      
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115

Query: 83  LRHLQHENVIALK---------DVMMPSHRRNF------------KDVYLVYELMDTDLH 121
              L  E+    +         D +    +  F             +  L+      DL 
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175

Query: 122 QIIK-------SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
            +                        QL+R    L S  ++H    P NL +  +  L +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLML 235

Query: 175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAELLGRKPI 233
            D                  V   Y   E L      +  +++ W +G     +      
Sbjct: 236 GDVSALWKV---GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

Query: 234 FPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAI 293
           F       +       L     + L F                   P             
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPGTDSLAF-------------GSCTPLP---------DFVK 330

Query: 294 DLLQKMLVFDPTKRISVTEALQHPYMSPLYD--PSSNPPAQ 332
            L+ + L FD  +R+   EA++ P    L +   SS    Q
Sbjct: 331 TLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  199 bits (507), Expect = 1e-60
 Identities = 88/338 (26%), Positives = 152/338 (44%), Gaps = 61/338 (18%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRH 85
              +Y     IG+G++G V  + +R   E VAIK I N       A       E++LL  
Sbjct: 52  WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLEL 106

Query: 86  LQHE------NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQY 137
           +          ++ LK   M   R +   + LV+E++  +L+ +++++  + ++ +  + 
Sbjct: 107 MNKHDTEMKYYIVHLKRHFM--FRNH---LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 161

Query: 138 FLFQLLRGLKYLHS--ANILHRDLKPGNLLV--NANCDLKICDFGLARTSNGKNQFMTEY 193
           F  Q+   L +L +   +I+H DLKP N+L+       +KI DFG   +S    Q + +Y
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQY 218

Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILG-- 251
           + +R+YR+PE+LL    Y  +ID+WS+GCI  E+   +P+F G   ++Q+  I+ +LG  
Sbjct: 219 IQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

Query: 252 -------------------------SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYP 286
                                     + ++       P  RK    L    G P  R   
Sbjct: 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337

Query: 287 DAHPLA------IDLLQKMLVFDPTKRISVTEALQHPY 318
           ++           DL+ +ML +DP  RI    ALQH +
Sbjct: 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSF 375

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  199 bits (507), Expect = 3e-60
 Identities = 76/305 (24%), Positives = 116/305 (38%), Gaps = 58/305 (19%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHE 89
            + P   +G GA G +        N  VA+K+I     +  D     RE++LLR   +H 
Sbjct: 25  SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78

Query: 90  NVIALKDVMMPSHRRNFKD---VYLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRG 145
           NVI              KD    Y+  EL    L + ++    A         L Q   G
Sbjct: 79  NVIRYFCT--------EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130

Query: 146 LKYLHSANILHRDLKPGNLLV-----NANCDLKICDFGLAR---TSNGKNQFMTEYVVTR 197
           L +LHS NI+HRDLKP N+L+     +      I DFGL +            +    T 
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 198 WYRAPELLLCCDN--YGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRR 254
            + APE+L          ++D++S GC+F  ++      F  +      +   NIL    
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-----QRQANIL--LG 243

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
              L+ +                             +A +L++KM+  DP KR S    L
Sbjct: 244 ACSLDCLHPE---------------------KHEDVIARELIEKMIAMDPQKRPSAKHVL 282

Query: 315 QHPYM 319
           +HP+ 
Sbjct: 283 KHPFF 287

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  196 bits (501), Expect = 6e-60
 Identities = 71/342 (20%), Positives = 142/342 (41%), Gaps = 65/342 (19%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRH 85
           ++  ++ I+ +G G +G V    + +  +  A+K + N     +         E  +L+ 
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKK 87

Query: 86  LQHE-----NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYF 138
           +Q++     N++      M  +  +   + L++E +   L++II  +       +  + +
Sbjct: 88  IQNDDINNNNIVKYHGKFM--YYDH---MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLY 142

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVN-------------------------ANCDLK 173
             ++L+ L YL   ++ H DLKP N+L++                          +  +K
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 174 ICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPI 233
           + DFG    +  K+ +    + TR YRAPE++L    +  S D+WS GC+ AEL     +
Sbjct: 203 LIDFG---CATFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLL 258

Query: 234 FPGTECLNQLKLIINILG---------SRREEDLEFIDN-------PKARKYIKSLPYTP 277
           F   E +  L ++ +I+          + +    ++++        P+    I S+ +  
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318

Query: 278 GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                      H L  D L  +L  DPT R S  E L+H ++
Sbjct: 319 KCLPLYKIIK-HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  197 bits (502), Expect = 2e-59
 Identities = 87/306 (28%), Positives = 145/306 (47%), Gaps = 45/306 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN------NAFENRVDALRTLREL 80
            +  +Y+  K +G GA G V  +  R+T +KVAI+ I+       +      AL    E+
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191

Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
           ++L+ L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + 
Sbjct: 192 EILKKLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVT 196
           +Q+L  ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T
Sbjct: 246 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGT 304

Query: 197 RWYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR 254
             Y APE+L+      Y  ++D WS+G I    L   P F       Q+ L   I     
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR--TQVSLKDQI----- 357

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
                      + KY               + +    A+DL++K+LV DP  R +  EAL
Sbjct: 358 ----------TSGKYNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEAL 398

Query: 315 QHPYMS 320
           +HP++ 
Sbjct: 399 RHPWLQ 404

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  193 bits (493), Expect = 3e-59
 Identities = 88/306 (28%), Positives = 144/306 (47%), Gaps = 45/306 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN------NAFENRVDALRTLREL 80
            +  +Y+  K +G GA G V  +  R+T +KVAIK I+       +      AL    E+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
           ++L+ L H  +I +K+        + +D Y+V ELM+  +L   +  ++ L    C+ + 
Sbjct: 67  EILKKLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVT 196
           +Q+L  ++YLH   I+HRDLKP N+L+++   +C +KI DFG ++   G+   M     T
Sbjct: 121 YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGT 179

Query: 197 RWYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR 254
             Y APE+L+      Y  ++D WS+G I    L   P F       Q+ L   I     
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR--TQVSLKDQITSG-- 235

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
                FI                       + +    A+DL++K+LV DP  R +  EAL
Sbjct: 236 --KYNFIPEV--------------------WAEVSEKALDLVKKLLVVDPKARFTTEEAL 273

Query: 315 QHPYMS 320
           +HP++ 
Sbjct: 274 RHPWLQ 279

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  194 bits (494), Expect = 4e-59
 Identities = 89/344 (25%), Positives = 144/344 (41%), Gaps = 63/344 (18%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETN-EKVAIKKINNAFENRVDALRT--LRELKLLR 84
           +  +Y  +  +G GA+G V   ++ +     VA+K + N     VD        E+++L 
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLE 66

Query: 85  HLQHE------NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQ 136
           HL           + + +     H  +   + +V+EL+    +  IK +       DH +
Sbjct: 67  HLNTTDPNSTFRCVQMLEWFE--HHGH---ICIVFELLGLSTYDFIKENGFLPFRLDHIR 121

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVN-------------------ANCDLKICDF 177
              +Q+ + + +LHS  + H DLKP N+L                      N D+K+ DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT 237
           G   ++   ++  +  V TR YRAPE++L    +    DVWS+GCI  E      +FP  
Sbjct: 182 G---SATYDDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTH 237

Query: 238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS--LPYTPGTPFSRLYPDA------- 288
           +    L ++  ILG         I   + RKY     L +   +   R    A       
Sbjct: 238 DSKEHLAMMERILGPL---PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294

Query: 289 -------HPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
                  H    DL+QKML +DP KRI++ EAL+HP+   L   
Sbjct: 295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  195 bits (496), Expect = 7e-59
 Identities = 60/307 (19%), Positives = 116/307 (37%), Gaps = 28/307 (9%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
            +  ++    +G+GA   V    +++T +  AIK  NN    R      +RE ++L+ L 
Sbjct: 7   SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLN 65

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII---KSSQALTNDHCQYFLFQLL 143
           H+N++ L  +         +   L+ E      L+ ++    ++  L        L  ++
Sbjct: 66  HKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSNGKNQFMTEYVVTRWY 199
            G+ +L    I+HR++KPGN++     D     K+ DFG AR     ++       T  Y
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLYGTEEY 181

Query: 200 RAPELL-------LCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILG 251
             P++             YG ++D+WS+G  F     G  P  P        +++  I+ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 252 SRREEDLEFIDNPK--ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
            +    +  +   +     +   +P +       L      L   +L  +L  D  K   
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSC-----SLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 310 VTEALQH 316
             +    
Sbjct: 297 FDQFFAE 303

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  190 bits (485), Expect = 2e-58
 Identities = 67/304 (22%), Positives = 112/304 (36%), Gaps = 57/304 (18%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  I+ IG G +G V  + +R   +   IK++    E         RE+K L  L H N+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHVNI 66

Query: 92  IALKD-----------VMMPSHRRNFKDVYLVYELMDT-DLHQIIK--SSQALTNDHCQY 137
           +                   S R   K +++  E  D   L Q I+    + L       
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
              Q+ +G+ Y+HS  +++RDLKP N+ +     +KI DFGL  +     +       T 
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR-SKGTL 185

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            Y +PE +    +YG  +D++++G I AELL         E       + +         
Sbjct: 186 RYMSPEQIS-SQDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRDG-------- 234

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                                   S ++         LLQK+L   P  R + +E L+  
Sbjct: 235 ----------------------IISDIFDKK---EKTLLQKLLSKKPEDRPNTSEILRTL 269

Query: 318 YMSP 321
            +  
Sbjct: 270 TVWK 273

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  191 bits (487), Expect = 5e-58
 Identities = 83/356 (23%), Positives = 144/356 (40%), Gaps = 68/356 (19%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSV-NRETNEKVAIKKINNAFENRVDALRT--LRELKLLR 84
           +  +Y  +  +G G +G V   + +     +VA+K I N     V   R     E+ +L+
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLK 71

Query: 85  HLQHE------NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQ 136
            ++ +        + + D        +   + + +EL+  +  + +K +  Q     H +
Sbjct: 72  KIKEKDKENKFLCVLMSDWFN--FHGH---MCIAFELLGKNTFEFLKENNFQPYPLPHVR 126

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVN-------------------ANCDLKICDF 177
           +  +QL   L++LH   + H DLKP N+L                      N  +++ DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT 237
           G A   +   +  T  V TR YR PE++L    +    DVWS+GCI  E      +F   
Sbjct: 187 GSATFDH---EHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTH 242

Query: 238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS--LPYTPGTPFSRLYPDA------- 288
           E    L ++  ILG         I   + +KY     L +   +   R   +        
Sbjct: 243 ENREHLVMMEKILGP---IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY 299

Query: 289 -------HPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP-----SSNPPAQ 332
                  H    DL+++ML FDP +RI++ EAL HP+ + L        +S  P++
Sbjct: 300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  194 bits (496), Expect = 5e-58
 Identities = 84/336 (25%), Positives = 143/336 (42%), Gaps = 48/336 (14%)

Query: 8   PNGIRSPGKHYYSMWQTLF--EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN- 64
           P  +         M+          +Y   + +G+G++G V    ++ T ++ A+K I+ 
Sbjct: 2   PGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK 61

Query: 65  NAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDL 120
              + + D    LRE++LL+ L H N++ L +         F+D    YLV E+    +L
Sbjct: 62  RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF--------FEDKGYFYLVGEVYTGGEL 113

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDF 177
              I S +  +       + Q+L G+ Y+H   I+HRDLKP NLL+   + + +++I DF
Sbjct: 114 FDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDF 173

Query: 178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT 237
           GL+      ++ M + + T +Y APE+L     Y    DVWS G I   LL   P F G 
Sbjct: 174 GLSTHFE-ASKKMKDKIGTAYYIAPEVLH--GTYDEKCDVWSTGVILYILLSGCPPFNGA 230

Query: 238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQ 297
              N+  ++  +     +    F                        +      A DL++
Sbjct: 231 ---NEYDILKKVE----KGKYTFELPQ--------------------WKKVSESAKDLIR 263

Query: 298 KMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQV 333
           KML + P+ RIS  +AL H ++        +     
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPS 299

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  188 bits (480), Expect = 9e-58
 Identities = 80/314 (25%), Positives = 137/314 (43%), Gaps = 38/314 (12%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +    Y   + +G+GA+ +V   V++ T  + A K IN    +  D  +  RE ++ R L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRG 145
           QH N++ L D +     +     YLV++L+   +L + I + +  +     + + Q+L  
Sbjct: 63  QHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117

Query: 146 LKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + Y HS  I+HR+LKP NLL+ +      +K+ DFGLA      ++    +  T  Y +P
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSP 176

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+L   D Y   +D+W+ G I   LL   P F      +Q +L   I         ++  
Sbjct: 177 EVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAG----AYDYPS 228

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
                                 +    P A  L+  ML  +P KRI+  +AL+ P++   
Sbjct: 229 PE--------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268

Query: 323 YDPSSNPPAQVPID 336
              +S    Q  +D
Sbjct: 269 ERVASAIHRQDTVD 282

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  197 bits (503), Expect = 1e-57
 Identities = 75/341 (21%), Positives = 137/341 (40%), Gaps = 27/341 (7%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            +   + +G G +G V   ++++T E+VAIK+      +  +  R   E+++++ L H N
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73

Query: 91  VIALKDVM-MPSHRRNFKDVYLVYELMDT-DLHQIIKSSQ---ALTNDHCQYFLFQLLRG 145
           V++ ++V              L  E  +  DL + +   +    L     +  L  +   
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 146 LKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L+YLH   I+HRDLKP N+++         KI D G A+  + + +  TE+V T  Y AP
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAP 192

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           ELL     Y  ++D WS G +  E + G +P  P       ++    +     E  + + 
Sbjct: 193 ELLE-QKKYTVTVDYWSFGTLAFECITGFRPFLPNW---QPVQWHGKVREKSNEHIVVYD 248

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
           D   A K+   LP       + L           LQ ML++   +R +  +         
Sbjct: 249 DLTGAVKFSSVLPTP-----NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303

Query: 322 LYDPSS-------NPPAQVPIDLDMDEESGEEMIREMMLKE 355
           L    S       N  +       + E    + ++  + ++
Sbjct: 304 LDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQD 344

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  193 bits (493), Expect = 2e-57
 Identities = 88/316 (27%), Positives = 134/316 (42%), Gaps = 46/316 (14%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           +   Y  +K +G GAYG V    ++ T+ + AIK I     +     + L E+ +L+ L 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94

Query: 88  HENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLL 143
           H N++ L D         F+D    YLV E     +L   I              + Q+L
Sbjct: 95  HPNIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL 146

Query: 144 RGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
            G+ YLH  NI+HRDLKP NLL+     +  +KI DFGL+       + M E + T +Y 
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKMKERLGTAYYI 205

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE+L     Y    DVWS+G I   LL   P F G       +++  +     +    F
Sbjct: 206 APEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQEILRKVE----KGKYTF 256

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                                   + +    A DL+++ML FD  +RIS  +AL+HP++ 
Sbjct: 257 DSPE--------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296

Query: 321 PLYDPSSNPPAQVPID 336
                      ++P  
Sbjct: 297 -EMCSKKESGIELPSL 311

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  187 bits (477), Expect = 4e-57
 Identities = 81/310 (26%), Positives = 135/310 (43%), Gaps = 53/310 (17%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-------NAFENRVDALRTLRE 79
                Y P + +GRG   +V   +++ T ++ A+K I+       +A E +     TL+E
Sbjct: 14  GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 80  LKLLRHL-QHENVIALKDVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDH 134
           + +LR +  H N+I LKD         ++     +LV++LM   +L   +     L+   
Sbjct: 74  VDILRKVSGHPNIIQLKDT--------YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125

Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYV 194
            +  +  LL  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +       + + E  
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVC 184

Query: 195 VTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
            T  Y APE++ C        YG  +D+WS G I   LL   P F       Q+ ++  I
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---KQMLMLRMI 241

Query: 250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
           +      + +F                        + D      DL+ + LV  P KR +
Sbjct: 242 M----SGNYQFGSPE--------------------WDDYSDTVKDLVSRFLVVQPQKRYT 277

Query: 310 VTEALQHPYM 319
             EAL HP+ 
Sbjct: 278 AEEALAHPFF 287

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  187 bits (476), Expect = 6e-57
 Identities = 69/326 (21%), Positives = 126/326 (38%), Gaps = 57/326 (17%)

Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
           T + PI+ +GRG +G+V  + N+  +   AIK+I       +   + +RE+K L  L+H 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHP 63

Query: 90  NVIALKDV-------MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTN---DHCQYF 138
            ++   +                   +Y+  +L    +L   +     +       C + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGK 186
             Q+   +++LHS  ++HRDLKP N+    +  +K+ DFGL              T    
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI 246
               T  V T+ Y +PE +   ++Y   +D++S+G I  ELL   P     E        
Sbjct: 184 YARHTGQVGTKLYMSPEQIH-GNSYSHKVDIFSLGLILFELL--YPFSTQME----RVRT 236

Query: 247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK 306
           +                      +++L + P   F++ YP  +     ++Q ML   P +
Sbjct: 237 LTD--------------------VRNLKFPPL--FTQKYPCEY----VMVQDMLSPSPME 270

Query: 307 RISVTEALQHPYMSPLYDPSSNPPAQ 332
           R      +++     L  P      Q
Sbjct: 271 RPEAINIIENAVFEDLDFPGKTVLRQ 296

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  191 bits (487), Expect = 1e-56
 Identities = 89/316 (28%), Positives = 142/316 (44%), Gaps = 46/316 (14%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
              +Y  +  +G+G++G V    +R T ++ A+K IN A     D    LRE++LL+ L 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79

Query: 88  HENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLL 143
           H N++ L ++         +D    Y+V EL    +L   I   +  +       + Q+ 
Sbjct: 80  HPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF 131

Query: 144 RGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
            G+ Y+H  NI+HRDLKP N+L+     +CD+KI DFGL+     +N  M + + T +Y 
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYI 190

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE+L     Y    DVWS G I   LL   P F G    N+  ++  +          F
Sbjct: 191 APEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVE----TGKYAF 241

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                                   +      A DL++KML F P+ RI+ T+ L+HP++ 
Sbjct: 242 DLPQ--------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

Query: 321 PLYDPSSNPPAQVPID 336
             Y   +   + +P  
Sbjct: 282 -KYSSETPTISDLPSL 296

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  187 bits (477), Expect = 2e-56
 Identities = 83/337 (24%), Positives = 142/337 (42%), Gaps = 44/337 (13%)

Query: 7   PPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA 66
              G +  G+    M     +    Y   + +G+GA+ +V   V++ T  + A K IN  
Sbjct: 6   SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65

Query: 67  FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD---VYLVYELMDT-DLHQ 122
             +  D  +  RE ++ R LQH N++ L D          ++    YLV++L+   +L +
Sbjct: 66  KLSARDFQKLEREARICRKLQHPNIVRLHDS--------IQEESFHYLVFDLVTGGELFE 117

Query: 123 IIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGL 179
            I + +  +     + + Q+L  + Y HS  I+HR+LKP NLL+ +      +K+ DFGL
Sbjct: 118 DIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177

Query: 180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC 239
           A      ++    +  T  Y +PE+L   D Y   +D+W+ G I   LL   P F     
Sbjct: 178 AIEV-NDSEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDE-- 233

Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
            +Q +L   I         ++                        +    P A  L+  M
Sbjct: 234 -DQHRLYAQIKAG----AYDYPSPE--------------------WDTVTPEAKSLIDSM 268

Query: 300 LVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPID 336
           L  +P KRI+  +AL+ P++      +S    Q  +D
Sbjct: 269 LTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 305

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  184 bits (469), Expect = 4e-56
 Identities = 73/303 (24%), Positives = 119/303 (39%), Gaps = 48/303 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y  +  IG G+YG       +   + +  K+++       +    + E+ LLR L+H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA----LTNDHCQYFLFQLLRG 145
           ++   D +     R    +Y+V E  +  DL  +I         L  +     + QL   
Sbjct: 67  IVRYYDRI---IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 146 LKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           LK  H  +     +LHRDLKP N+ ++   ++K+ DFGLAR  N    F   +V T +Y 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 201 APELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           +PE     +   Y    D+WS+GC+  EL    P F      +Q +L   I   +     
Sbjct: 184 SPEQ---MNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKFR--- 234

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
                                     Y D      +++ +ML      R SV E L++P 
Sbjct: 235 ---------------------RIPYRYSDE---LNEIITRMLNLKDYHRPSVEEILENPL 270

Query: 319 MSP 321
           +  
Sbjct: 271 ILE 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  186 bits (473), Expect = 5e-56
 Identities = 65/299 (21%), Positives = 130/299 (43%), Gaps = 49/299 (16%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KYV ++ IG G++G      + E   +  IK+IN +  +  +   + RE+ +L +++H N
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 91  VIALKDVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKS--SQALTNDHCQYFLFQLLR 144
           ++  ++        +F++   +Y+V +  +  DL + I +        D    +  Q+  
Sbjct: 85  IVQYRE--------SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
            LK++H   ILHRD+K  N+ +  +  +++ DFG+AR  N   +     + T +Y +PE+
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196

Query: 205 LLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
              C+N  Y    D+W++GC+  EL   K  F      +   L++ I+            
Sbjct: 197 ---CENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKII------------ 238

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
                     +       +S            L+ ++   +P  R SV   L+  +++ 
Sbjct: 239 ----SGSFPPVSLH----YS-------YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  183 bits (468), Expect = 7e-56
 Identities = 87/301 (28%), Positives = 137/301 (45%), Gaps = 45/301 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
               +Y  +  +G+G++G V    +R T ++ A+K IN A     D    LRE++LL+ L
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 87  QHENVIALKDVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
            H N++ L ++         +D    Y+V EL    +L   I   +  +       + Q+
Sbjct: 79  DHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130

Query: 143 LRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
             G+ Y+H  NI+HRDLKP N+L+     +CD+KI DFGL+     +N  M + + T +Y
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKDRIGTAYY 189

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
            APE+L     Y    DVWS G I   LL   P F G    N+  ++  +          
Sbjct: 190 IAPEVLR--GTYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETG----KYA 240

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           F                        +      A DL++KML F P+ RI+ T+ L+HP++
Sbjct: 241 FDLPQ--------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

Query: 320 S 320
            
Sbjct: 281 Q 281

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  183 bits (467), Expect = 1e-55
 Identities = 83/318 (26%), Positives = 132/318 (41%), Gaps = 47/318 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
            I   ++ ++ +G GA+  V     R T +  A+K I  +   R  +L    E+ +L+ +
Sbjct: 6   NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKI 63

Query: 87  QHENVIALKDVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
           +HEN++ L+D+        ++     YLV +L+   +L   I      T       + Q+
Sbjct: 64  KHENIVTLEDI--------YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV 115

Query: 143 LRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           L  +KYLH   I+HRDLKP NLL      N  + I DFGL++    +N  M+    T  Y
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTPGY 173

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
            APE+L     Y  ++D WS+G I   LL   P F       + KL   I         E
Sbjct: 174 VAPEVLA-QKPYSKAVDCWSIGVITYILLCGYPPFYEE---TESKLFEKIKEG----YYE 225

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           F                        + D    A D +  +L  DP +R +  +AL HP++
Sbjct: 226 FESPF--------------------WDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

Query: 320 SPLYDPSSNPPAQVPIDL 337
                   +    V + +
Sbjct: 266 DGNTALHRDIYPSVSLQI 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  183 bits (468), Expect = 1e-55
 Identities = 82/321 (25%), Positives = 140/321 (43%), Gaps = 43/321 (13%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKL 82
           +++  Y   + +G G + IV     + T  + A K I      A    V      RE+ +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQ 141
           LR + H NVI L DV       N  DV L+ EL+   +L   +   ++L+ +    F+ Q
Sbjct: 69  LRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 142 LLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           +L G+ YLH+  I H DLKP N+++         +K+ DFGLA               T 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTP 182

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            + APE++   +  G   D+WS+G I   LL     F G     + + + NI        
Sbjct: 183 EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANIT----SVS 234

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
            +F +                      +     LA D ++K+LV +  KR+++ EAL+HP
Sbjct: 235 YDFDEEF--------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 318 YMSPLYDPSSNPPAQVPIDLD 338
           +++P+ +  +    +  ++L+
Sbjct: 275 WITPVDNQQAMVRRESVVNLE 295

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  182 bits (465), Expect = 1e-55
 Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 43/303 (14%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++  Y   + +G G + IV     + T ++ A K I     ++    V      RE+ +L
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
           R ++H N+I L D+       N  DV L+ EL+   +L   +   ++LT D    FL Q+
Sbjct: 63  REIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117

Query: 143 LRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N+++      N  +K+ DFG+A               T  
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGTPE 176

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           + APE++   +  G   D+WS+G I   LL     F G     + + + NI       + 
Sbjct: 177 FVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGE---TKQETLTNISAV----NY 228

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           +F +                      + +   LA D ++++LV DP +R+++ ++L+H +
Sbjct: 229 DFDEEY--------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

Query: 319 MSP 321
           +  
Sbjct: 269 IKA 271

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  186 bits (475), Expect = 2e-55
 Identities = 79/329 (24%), Positives = 123/329 (37%), Gaps = 77/329 (23%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
            +    V  K +G G+ G V           VA+K++   F +         E+KLL   
Sbjct: 12  SLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIAL-----MEIKLLTES 65

Query: 87  -QHENVIALKDVMMPSHRRNFKD---VYLVYELMDTDLHQIIKS-------SQALTNDHC 135
             H NVI                   +Y+  EL + +L  +++S        +     + 
Sbjct: 66  DDHPNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLV-------------NANCDLKICDFGLART 182
              L Q+  G+ +LHS  I+HRDLKP N+LV               N  + I DFGL + 
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 183 -SNGKNQF---MTEYVVTRWYRAPELLLCCDN------YGTSIDVWSVGCIFAELL--GR 230
             +G++ F   +     T  +RAPELL   +N         SID++S+GC+F  +L  G+
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 231 KPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHP 290
            P                           F D       I    ++              
Sbjct: 238 HP---------------------------FGDKYSRESNIIRGIFSLDEMKCLHDRSLIA 270

Query: 291 LAIDLLQKMLVFDPTKRISVTEALQHPYM 319
            A DL+ +M+  DP KR +  + L+HP  
Sbjct: 271 EATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  183 bits (466), Expect = 3e-55
 Identities = 67/293 (22%), Positives = 103/293 (35%), Gaps = 42/293 (14%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-Q 87
              +  +  +G G+YG V    ++E     A+K+  + F    D  R L E+     + Q
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQII-KSSQALTNDHCQYFLFQLLRGL 146
           H   + L+     +       +YL  EL    L Q       +L       +L   L  L
Sbjct: 116 HPCCVRLEQ----AWEEG-GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            +LHS  ++H D+KP N+ +      K+ DFGL                   Y APELL 
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPELLQ 229

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
              +YGT+ DV+S+G    E+     +  G E   QL+                      
Sbjct: 230 --GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------------------- 268

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                     P    + L  +       +L  ML  DP  R +    L  P +
Sbjct: 269 ---------LPPEFTAGLSSELR----SVLVMMLEPDPKLRATAEALLALPVL 308

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  184 bits (469), Expect = 3e-55
 Identities = 82/306 (26%), Positives = 132/306 (43%), Gaps = 46/306 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN------NAFENRVDALRTLREL 80
           E   KY P   IGRG   +V   V+R T  + A+K +       +  +       T RE 
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150

Query: 81  KLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYF 138
            +LR +  H ++I L D    S       ++LV++LM   +L   +    AL+    +  
Sbjct: 151 HILRQVAGHPHIITLIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +  LL  + +LH+ NI+HRDLKP N+L++ N  +++ DFG +       + + E   T  
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRELCGTPG 264

Query: 199 YRAPELLLCC-----DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
           Y APE+L C        YG  +D+W+ G I   LL   P F       Q+ ++  I+   
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR---RQILMLRMIMEG- 320

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                +F                        + D      DL+ ++L  DP  R++  +A
Sbjct: 321 ---QYQFSSPE--------------------WDDRSSTVKDLISRLLQVDPEARLTAEQA 357

Query: 314 LQHPYM 319
           LQHP+ 
Sbjct: 358 LQHPFF 363

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  186 bits (474), Expect = 4e-55
 Identities = 82/317 (25%), Positives = 138/317 (43%), Gaps = 43/317 (13%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
               +Y   + +G+GA+ +V   V     ++ A   IN    +  D  +  RE ++ R L
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67

Query: 87  QHENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQL 142
           +H N++ L D           +    YL+++L+   +L + I + +  +     + + Q+
Sbjct: 68  KHPNIVRLHDS--------ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI 119

Query: 143 LRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           L  + + H   ++HR+LKP NLL+        +K+ DFGLA    G+ Q    +  T  Y
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
            +PE+L   D YG  +D+W+ G I   LL   P F      +Q +L   I         +
Sbjct: 180 LSPEVLR-KDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAG----AYD 231

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           F                        +    P A DL+ KML  +P+KRI+  EAL+HP++
Sbjct: 232 FPSPE--------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

Query: 320 SPLYDPSSNPPAQVPID 336
           S     +S    Q  +D
Sbjct: 272 SHRSTVASCMHRQETVD 288

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  183 bits (467), Expect = 6e-55
 Identities = 81/321 (25%), Positives = 139/321 (43%), Gaps = 43/321 (13%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKL 82
           +++  Y   + +G G + IV     + T  + A K I      A    V      RE+ +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQ 141
           LR + H N+I L DV       N  DV L+ EL+   +L   +   ++L+ +    F+ Q
Sbjct: 69  LRQVLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123

Query: 142 LLRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           +L G+ YLH+  I H DLKP N+++         +K+ DFGLA               T 
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTP 182

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            + APE++   +  G   D+WS+G I   LL     F G     + + + NI        
Sbjct: 183 EFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITAV----S 234

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
            +F +                      +     LA D ++K+LV +  KR+++ EAL+HP
Sbjct: 235 YDFDEEF--------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHP 274

Query: 318 YMSPLYDPSSNPPAQVPIDLD 338
           +++P+    +    +  ++L+
Sbjct: 275 WITPVDTQQAMVRRESVVNLE 295

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  186 bits (475), Expect = 8e-55
 Identities = 84/329 (25%), Positives = 133/329 (40%), Gaps = 56/329 (17%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-----------NAFENRVDALR 75
           +I   Y  ++ +G GAYG V     +  + + AIK I            +          
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92

Query: 76  TLRELKLLRHLQHENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDLHQIIKSSQALT 131
              E+ LL+ L H N+I L DV        F+D    YLV E  +  +L + I +     
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFD 144

Query: 132 NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQ 188
                  + Q+L G+ YLH  NI+HRD+KP N+L+   N+  ++KI DFGL+     K+ 
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDY 203

Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN 248
            + + + T +Y APE+L     Y    DVWS G I   LL   P F G    N   +I  
Sbjct: 204 KLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQDIIKK 258

Query: 249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI 308
           +     +    F                    +  +  +A     +L++ ML +D  KR 
Sbjct: 259 VE----KGKYYF----------------DFNDWKNISDEA----KELIKLMLTYDYNKRC 294

Query: 309 SVTEALQHPYMSPLYDPSSNPPAQVPIDL 337
           +  EAL   ++    +  +    +     
Sbjct: 295 TAEEALNSRWIKKYANNINKSDQKTLCGA 323

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  182 bits (465), Expect = 8e-55
 Identities = 77/324 (23%), Positives = 139/324 (42%), Gaps = 51/324 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENR--VDALRTLRELKLL 83
             +  Y   + IG+G + +V   +NRET ++ A+K ++   F +   +      RE  + 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 84  RHLQHENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDL-HQIIK---SSQALTNDHC 135
             L+H +++ L +         +     +Y+V+E MD  DL  +I+K   +    +    
Sbjct: 81  HMLKHPHIVELLET--------YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTE 192
            +++ Q+L  L+Y H  NI+HRD+KP  +L+     +  +K+  FG+A            
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
            V T  + APE++   + YG  +DVW  G I   LL     F GT+     +L   I+  
Sbjct: 193 RVGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGII-- 245

Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
             +   +                         +      A DL+++ML+ DP +RI+V E
Sbjct: 246 --KGKYKMNPRQ--------------------WSHISESAKDLVRRMLMLDPAERITVYE 283

Query: 313 ALQHPYMSPLYDPSSNPPAQVPID 336
           AL HP++      +        ++
Sbjct: 284 ALNHPWLKERDRYAYKIHLPETVE 307

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  180 bits (459), Expect = 1e-54
 Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 41/298 (13%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +I+  Y     IGRG++G V  +V + T  + A KKI   F   VD  +  +E+++++ L
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSL 63

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRG 145
            H N+I L +        +  D+YLV EL    +L + +   +          +  +L  
Sbjct: 64  DHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 146 LKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + Y H  N+ HRDLKP N L    + +  LK+ DFGLA       + M   V T +Y +P
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRTKVGTPYYVSP 177

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           ++L     YG   D WS G +   LL   P F         ++++ I          F +
Sbjct: 178 QVLE--GLYGPECDEWSAGVMMYVLLCGYPPFSAP---TDSEVMLKIREG----TFTFPE 228

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                                 + +  P A  L++++L   P +RI+  +AL+H +  
Sbjct: 229 KD--------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  182 bits (463), Expect = 1e-54
 Identities = 89/356 (25%), Positives = 136/356 (38%), Gaps = 83/356 (23%)

Query: 16  KHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA---FENRVD 72
           ++ Y    +L E+  KY     IG+G+YG+V  ++  +T    AIK +N       N  D
Sbjct: 12  ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71

Query: 73  ALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM---------------- 116
             R   E++L++ L H N+  L +V       + + + LV EL                 
Sbjct: 72  VERIKTEVRLMKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDS 126

Query: 117 -------------------------DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
                                     +                    + Q+   L YLH+
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186

Query: 152 ANILHRDLKPGNLLV--NANCDLKICDFGLAR----TSNGKNQFMTEYVVTRWYRAPELL 205
             I HRD+KP N L   N + ++K+ DFGL++     +NG+   MT    T ++ APE+L
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246

Query: 206 LCCD-NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
              + +YG   D WS G +   LL     FPG    N    I  +L     + L F +  
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV---NDADTISQVL----NKKLCFENPN 299

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                               Y    PLA DLL  +L  +  +R     ALQHP++S
Sbjct: 300 --------------------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  180 bits (459), Expect = 3e-54
 Identities = 84/303 (27%), Positives = 135/303 (44%), Gaps = 43/303 (14%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           +D  Y   + +G G + +V     + T  + A K I      +    V      RE+ +L
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQL 142
           + +QH NVI L +V       N  DV L+ EL+   +L   +   ++LT +    FL Q+
Sbjct: 69  KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 143 LRGLKYLHSANILHRDLKPGNLLV----NANCDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           L G+ YLHS  I H DLKP N+++         +KI DFGLA   +           T  
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPE 182

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           + APE++   +  G   D+WS+G I   LL     F G     + + + N+       + 
Sbjct: 183 FVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVS----AVNY 234

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
           EF D                      + +   LA D ++++LV DP KR+++ ++LQHP+
Sbjct: 235 EFEDEY--------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

Query: 319 MSP 321
           + P
Sbjct: 275 IKP 277

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  179 bits (456), Expect = 3e-54
 Identities = 73/302 (24%), Positives = 133/302 (44%), Gaps = 47/302 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRH 85
            ID  ++  + +G GA+G V     R +  +  IK IN +  +  ++ +    E+++L+ 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--AEIEVLKS 76

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQA---LTNDHCQYFLF 140
           L H N+I + +V       ++ ++Y+V E  +    L +I+ +      L+  +    + 
Sbjct: 77  LDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           Q++  L Y HS +++H+DLKP N+L    + +  +KI DFGLA      ++  T    T 
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTNAAGTA 190

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            Y APE+     +     D+WS G +   LL     F GT   +  ++           +
Sbjct: 191 LYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGT---SLEEVQQKATYK----E 241

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
             +    +              P +       P A+DLL++ML  DP +R S  + L H 
Sbjct: 242 PNYAVECR--------------PLT-------PQAVDLLKQMLTKDPERRPSAAQVLHHE 280

Query: 318 YM 319
           + 
Sbjct: 281 WF 282

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  180 bits (459), Expect = 5e-54
 Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 48/312 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           +    Y   + IG G+Y +    +++ TN + A+K I+ +            E+++L   
Sbjct: 19  QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS------KRDPTEEIEILLRY 72

Query: 87  -QHENVIALKDVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQ 141
            QH N+I LKDV        + D   VY+V ELM   +L   I   +  +       LF 
Sbjct: 73  GQHPNIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT 124

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCD----LKICDFGLARTSNGKNQFMTEYVVTR 197
           + + ++YLH+  ++HRDLKP N+L          ++ICDFG A+    +N  +     T 
Sbjct: 125 ITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA 184

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            + APE+L     Y  + D+WS+G +   +L     F         +++  I        
Sbjct: 185 NFVAPEVLE-RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG----K 239

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                                      +      A DL+ KML  DP +R++    L+HP
Sbjct: 240 FSLSGGY--------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279

Query: 318 YMSPLYDPSSNP 329
           ++          
Sbjct: 280 WIVHWDQLPQYQ 291

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  186 bits (473), Expect = 6e-54
 Identities = 72/311 (23%), Positives = 133/311 (42%), Gaps = 46/311 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
            +   Y   + +G GA+G+V     R T    A K +    E+  + +R  +E++ +  L
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVL 211

Query: 87  QHENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDL-HQIIKSSQALTNDHCQYFLFQ 141
           +H  ++ L D         F+D   + ++YE M   +L  ++      ++ D    ++ Q
Sbjct: 212 RHPTLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263

Query: 142 LLRGLKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           + +GL ++H  N +H DLKP N++     + +LK+ DFGL    +   Q +     T  +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEF 322

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
            APE+       G   D+WSVG +   LL     F G    N  + + N+       D  
Sbjct: 323 AAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVK----SCDWN 374

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             D+                     +        D ++K+L+ DP  R+++ +AL+HP++
Sbjct: 375 MDDSA--------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

Query: 320 SPLYDPSSNPP 330
           +P   P  +  
Sbjct: 415 TPGNAPGRDSQ 425

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  181 bits (461), Expect = 8e-54
 Identities = 71/310 (22%), Positives = 134/310 (43%), Gaps = 46/310 (14%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
            +   Y  ++ +G GA+G+V   V + T      K IN  +      ++   E+ ++  L
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK--NEISIMNQL 105

Query: 87  QHENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDLH-QIIKSSQALTNDHCQYFLFQ 141
            H  +I L D         F+D   + L+ E +   +L  +I      ++      ++ Q
Sbjct: 106 HHPKLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157

Query: 142 LLRGLKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
              GLK++H  +I+H D+KP N++        +KI DFGLA   N  ++ +     T  +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEF 216

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
            APE++   +  G   D+W++G +   LL     F G    + L+ + N+       D E
Sbjct: 217 AAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVK----RCDWE 268

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           F ++                     +    P A D ++ +L  +P KR++V +AL+HP++
Sbjct: 269 FDEDA--------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308

Query: 320 SPLYDPSSNP 329
              +   ++ 
Sbjct: 309 KGDHSNLTSR 318

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  179 bits (456), Expect = 1e-53
 Identities = 69/309 (22%), Positives = 131/309 (42%), Gaps = 47/309 (15%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           E+  KY+  + +GRG +GIV   V   + +    K +     ++V   +   E+ +L   
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIA 58

Query: 87  QHENVIALKDVMMPSHRRNFKD---VYLVYELMD-TDLH-QIIKSSQALTNDHCQYFLFQ 141
           +H N++ L +         F+    + +++E +   D+  +I  S+  L       ++ Q
Sbjct: 59  RHRNILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           +   L++LHS NI H D++P N++     +  +KI +FG AR                 Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEY 169

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE 259
            APE+    D   T+ D+WS+G +   LL     F         ++I NI+ +    +  
Sbjct: 170 YAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNA----EYT 221

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           F +                      + +    A+D + ++LV +   R++ +EALQHP++
Sbjct: 222 FDEEA--------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

Query: 320 SPLYDPSSN 328
               +  S 
Sbjct: 262 KQKIERVST 270

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  178 bits (453), Expect = 2e-53
 Identities = 77/329 (23%), Positives = 122/329 (37%), Gaps = 57/329 (17%)

Query: 2   ATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK 61
             P   P     P   Y ++          +   K IGRG +  V  +        VA+K
Sbjct: 12  PVPQFQPQKALRPDMGYNTL--------ANFRIEKKIGRGQFSEVYRAACLLDGVPVALK 63

Query: 62  KIN-NAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD---VYLVYELMD 117
           K+      +       ++E+ LL+ L H NVI            +F +   + +V EL D
Sbjct: 64  KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA--------SFIEDNELNIVLELAD 115

Query: 118 T-DLHQIIKSSQA----LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL 172
             DL ++IK  +     +       +  QL   L+++HS  ++HRD+KP N+ + A   +
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVV 175

Query: 173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN--YGTSIDVWSVGCIFAELLGR 230
           K+ D GL R  + K       V T +Y +PE         Y    D+WS+GC+  E+   
Sbjct: 176 KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER---IHENGYNFKSDIWSLGCLLYEMAAL 232

Query: 231 KPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHP 290
           +  F G + +N   L   I                 +     LP       S  Y +   
Sbjct: 233 QSPFYG-DKMNLYSLCKKIE----------------QCDYPPLP-------SDHYSEE-- 266

Query: 291 LAIDLLQKMLVFDPTKRISVTEALQHPYM 319
               L+   +  DP KR  VT        
Sbjct: 267 -LRQLVNMCINPDPEKRPDVTYVYDVAKR 294

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  178 bits (454), Expect = 2e-53
 Identities = 81/306 (26%), Positives = 137/306 (44%), Gaps = 42/306 (13%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HEN 90
            +  KP+G G++ I    V++++N+  A+K I+   E         +E+  L+  + H N
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----KEITALKLCEGHPN 67

Query: 91  VIALKDVMMPSHRRNFKD---VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGL 146
           ++ L +V        F D    +LV EL++  +L + IK  +  +     Y + +L+  +
Sbjct: 68  IVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119

Query: 147 KYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
            ++H   ++HRDLKP NLL    N N ++KI DFG AR     NQ +     T  Y APE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           LL   + Y  S D+WS+G I   +L  +  F   +        + I+   ++ D  F   
Sbjct: 180 LLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY 323
                                + +    A DL+Q +L  DP KR+ ++    + ++    
Sbjct: 239 A--------------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278

Query: 324 DPSSNP 329
             SSNP
Sbjct: 279 QLSSNP 284

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  177 bits (450), Expect = 9e-53
 Identities = 72/315 (22%), Positives = 134/315 (42%), Gaps = 48/315 (15%)

Query: 27  EIDTKY-VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
             +  Y +  K +GRG + +V   +++ T ++ A K +      +      L E+ +L  
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84

Query: 86  LQH-ENVIALKDVMMPSHRRNFKD---VYLVYELMDT-DL-HQII-KSSQALTNDHCQYF 138
            +    VI L +V        +++   + L+ E     ++    + + ++ ++ +     
Sbjct: 85  AKSCPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL 136

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVV 195
           + Q+L G+ YLH  NI+H DLKP N+L+       D+KI DFG++R   G    + E + 
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMG 195

Query: 196 TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE 255
           T  Y APE+L   D   T+ D+W++G I   LL     F G    +  +  +NI      
Sbjct: 196 TPEYLAPEILN-YDPITTATDMWNIGIIAYMLLTHTSPFVGE---DNQETYLNISQV--- 248

Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            ++++ +                      +     LA D +Q +LV +P KR +    L 
Sbjct: 249 -NVDYSEET--------------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287

Query: 316 HPYMSPLYDPSSNPP 330
           H ++      +   P
Sbjct: 288 HSWLQQWDFENLFHP 302

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  176 bits (448), Expect = 2e-52
 Identities = 91/357 (25%), Positives = 148/357 (41%), Gaps = 43/357 (12%)

Query: 2   ATPVEPPNGIRSPGKHYYSMWQTLFEIDT--KYVPIKPIGRGAYGIVCSSVNRETNEKVA 59
             P     G  +       + + L +  +  +YV  + +G+G +       + +T E  A
Sbjct: 11  GVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFA 70

Query: 60  IKKIN-NAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT 118
            K +  +         +   E+ + R L H++V+            +   V++V EL   
Sbjct: 71  GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDNDFVFVVLELCRR 125

Query: 119 -DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF 177
             L ++ K  +ALT    +Y+L Q++ G +YLH   ++HRDLK GNL +N + ++KI DF
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 185

Query: 178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT 237
           GLA       +       T  Y APE +L    +   +DVWS+GCI   LL  KP F  T
Sbjct: 186 GLATKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE-T 243

Query: 238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQ 297
            CL +                           IK   Y+     +       P+A  L+Q
Sbjct: 244 SCLKET-----------------------YLRIKKNEYSIPKHIN-------PVAASLIQ 273

Query: 298 KMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPA--QVPIDLDMDEESGEEMIREMM 352
           KML  DPT R ++ E L   + +  Y P+  P     +P    +   S +   R+ +
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  174 bits (444), Expect = 2e-52
 Identities = 85/302 (28%), Positives = 132/302 (43%), Gaps = 39/302 (12%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           +YV  + +G+G +       + +T E  A K +  +         +   E+ + R L H+
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           +V+            +   V++V EL     L ++ K  +ALT    +Y+L Q++ G +Y
Sbjct: 76  HVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LH   ++HRDLK GNL +N + ++KI DFGLA       +       T  Y APE +L  
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSK 189

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             +   +DVWS+GCI   LL  KP F  T CL +                          
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKET-----------------------YL 225

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
            IK   Y+     +       P+A  L+QKML  DPT R ++ E L   + +  Y P+  
Sbjct: 226 RIKKNEYSIPKHIN-------PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

Query: 329 PP 330
           P 
Sbjct: 279 PI 280

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  175 bits (447), Expect = 3e-52
 Identities = 88/326 (26%), Positives = 131/326 (40%), Gaps = 47/326 (14%)

Query: 2   ATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIK 61
           +       G  S    Y+        +   +     +GRGA  IV     + T +  A+K
Sbjct: 25  SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84

Query: 62  KINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD---VYLVYELMDT 118
            +       VD      E+ +L  L H N+I LK++        F+    + LV EL+  
Sbjct: 85  VLKK----TVDKKIVRTEIGVLLRLSHPNIIKLKEI--------FETPTEISLVLELVTG 132

Query: 119 -DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKI 174
            +L   I      +       + Q+L  + YLH   I+HRDLKP NLL      +  LKI
Sbjct: 133 GELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKI 192

Query: 175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF 234
            DFGL++        M     T  Y APE+L  C  YG  +D+WSVG I   LL     F
Sbjct: 193 ADFGLSKI-VEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPF 250

Query: 235 PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAID 294
                     +   IL      +  FI                       + +    A D
Sbjct: 251 YDER--GDQFMFRRILNC----EYYFISPW--------------------WDEVSLNAKD 284

Query: 295 LLQKMLVFDPTKRISVTEALQHPYMS 320
           L++K++V DP KR++  +ALQHP+++
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVT 310

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  174 bits (443), Expect = 1e-51
 Identities = 74/323 (22%), Positives = 132/323 (40%), Gaps = 42/323 (13%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIAL 94
           + +G G  G V    +R T +K A+K +        D+ +  +E+          +++ +
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCI 87

Query: 95  KDVMMPSHRRNFKDVYLVYELMDTD--LHQII-KSSQALTNDHCQYFLFQLLRGLKYLHS 151
            DV    H    + + ++ E M+      +I  +  QA T       +  +   +++LHS
Sbjct: 88  LDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146

Query: 152 ANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
            NI HRD+KP NLL      +  LK+ DFG A+ +      +     T +Y APE+L   
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPCYTPYYVAPEVLG-P 203

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           + Y  S D+WS+G I   LL   P F          +   +    R     F +      
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSN---TGQAISPGMKRRIRLGQYGFPNPE---- 256

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
                           + +    A  L++ +L  DPT+R+++T+ + HP+++        
Sbjct: 257 ----------------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ-SMVVPQ 299

Query: 329 PPAQVPIDLDMDEESGEEMIREM 351
            P      L  D++  +E+  EM
Sbjct: 300 TPLHTARVLQEDKDHWDEVKEEM 322

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  174 bits (444), Expect = 2e-51
 Identities = 82/290 (28%), Positives = 124/290 (42%), Gaps = 46/290 (15%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G G +G V       T  K+A K I        + ++   E+ ++  L H N+I L D 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK--NEISVMNQLDHANLIQLYDA 154

Query: 98  MMPSHRRNF---KDVYLVYELMDT-DLH-QIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
                   F    D+ LV E +D  +L  +II  S  LT      F+ Q+  G++++H  
Sbjct: 155 --------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 153 NILHRDLKPGNLLV--NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
            ILH DLKP N+L        +KI DFGLAR      + +     T  + APE++   D 
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEVVN-YDF 264

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
                D+WSVG I   LL     F G    N  + + NIL        +  D        
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGD---NDAETLNNILAC----RWDLEDEE------ 311

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                         + D    A + + K+L+ + + RIS +EAL+HP++S
Sbjct: 312 --------------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  174 bits (442), Expect = 6e-51
 Identities = 93/362 (25%), Positives = 145/362 (40%), Gaps = 43/362 (11%)

Query: 2   ATPVEPPNGIRSPGKHYYSMWQTLFE--IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVA 59
                PP   + P  H  S  Q      ID   V  + +G G  G V    N+ T EK A
Sbjct: 32  PAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA 91

Query: 60  IKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMD- 117
           +K +        D  +  RE++L        +++ + DV    +    K + +V E +D 
Sbjct: 92  LKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDG 143

Query: 118 -TDLHQII-KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDL 172
                +I  +  QA T       +  +   ++YLHS NI HRD+KP NLL      N  L
Sbjct: 144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 203

Query: 173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKP 232
           K+ DFG A+ +   N   T    T +Y APE+L   + Y  S D+WS+G I   LL   P
Sbjct: 204 KLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYP 261

Query: 233 IFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLA 292
            F      + L +   +    R    EF +                      + +     
Sbjct: 262 PFYSN---HGLAISPGMKTRIRMGQYEFPNPE--------------------WSEVSEEV 298

Query: 293 IDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMM 352
             L++ +L  +PT+R+++TE + HP++          P      L  D+E  E++  EM 
Sbjct: 299 KMLIRNLLKTEPTQRMTITEFMNHPWIMQ-STKVPQTPLHTSRVLKEDKERWEDVKEEMT 357

Query: 353 LK 354
             
Sbjct: 358 SA 359

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  171 bits (435), Expect = 7e-51
 Identities = 88/335 (26%), Positives = 138/335 (41%), Gaps = 61/335 (18%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA--FENRVDALRTLRELKLLRHLQH 88
           KY+    +G G+YG V   ++ ET  + A+K +                +E++LLR L+H
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 89  ENVIALKDVMMPSHRRNFKDVYLV--------YELMDTDLHQIIKSSQALTNDHCQYFLF 140
           +NVI L DV+    +   + +Y+V         E++D+   +     QA       YF  
Sbjct: 66  KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA-----HGYFC- 116

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW-- 198
           QL+ GL+YLHS  I+H+D+KPGNLL+     LKI   G+   +   + F  +        
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGV---AEALHPFAADDTCRTSQG 173

Query: 199 ---YRAPELLLCCDNY-GTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSR 253
              ++ PE+    D + G  +D+WS G   +    G  P F G           NI    
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGD----------NI---- 218

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                      K  + I    Y    P      D  P   DLL+ ML ++P KR S+ + 
Sbjct: 219 ----------YKLFENIGKGSYA--IP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQI 261

Query: 314 LQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMI 348
            QH +    + P+  P    P     D      ++
Sbjct: 262 RQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVV 296

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  169 bits (430), Expect = 4e-50
 Identities = 79/325 (24%), Positives = 138/325 (42%), Gaps = 78/325 (24%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN------------------------NA 66
           +Y     IG+G+YG+V  + N   N   A+K ++                          
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 67  FENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYE------LMDTDL 120
            + R    +  +E+ +L+ L H NV+ L +V+   +  +   +Y+V+E      +M+   
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVME--- 127

Query: 121 HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
              + + + L+ D  +++   L++G++YLH   I+HRD+KP NLLV  +  +KI DFG++
Sbjct: 128 ---VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 181 RTSNGKNQFMTEYVVTRWYRAPELLL-CCDNY-GTSIDVWSVGCI-FAELLGRKPIFPGT 237
               G +  ++  V T  + APE L      + G ++DVW++G   +  + G+ P     
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP----- 239

Query: 238 ECLNQLKLIINILGSRREEDLEFIDN--PKARKYIKSLPYT-PGTPFSRLYPDAHPLAID 294
                                 F+D         IKS     P        PD      D
Sbjct: 240 ----------------------FMDERIMCLHSKIKSQALEFPD------QPDIAEDLKD 271

Query: 295 LLQKMLVFDPTKRISVTEALQHPYM 319
           L+ +ML  +P  RI V E   HP++
Sbjct: 272 LITRMLDKNPESRIVVPEIKLHPWV 296

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  169 bits (431), Expect = 4e-50
 Identities = 59/304 (19%), Positives = 104/304 (34%), Gaps = 49/304 (16%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y+ I+ +G G +  V            A+K+I    +   +  +  RE  + R   H N
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ--READMHRLFNHPN 87

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA----LTNDHCQYFLFQLLRG 145
           ++ L    +       +  +L+        L   I+  +     LT D   + L  + RG
Sbjct: 88  ILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV---------T 196
           L+ +H+    HRDLKP N+L+       + D G    +    +   + +          T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 197 RWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGT-ECLNQLKLIINILGSR 253
             YRAPEL             DVWS+GC+   ++  +  +    +  + + L +      
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----- 261

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                         +   S+P        R           LL  M+  DP +R  +   
Sbjct: 262 -------------NQL--SIP-----QSPRHSSALW----QLLNSMMTVDPHQRPHIPLL 297

Query: 314 LQHP 317
           L   
Sbjct: 298 LSQL 301

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  167 bits (426), Expect = 8e-50
 Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 48/308 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQHE 89
            +     +G+G++  V  + +  T  +VAIK I+     +   ++ +  E+K+   L+H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71

Query: 90  NVIALKDVMMPSHRRNFKDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLFQLL 143
           +++ L +        +   VYLV       E+       +    +  + +  ++F+ Q++
Sbjct: 72  SILELYNYF-----EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMHQII 122

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
            G+ YLHS  ILHRDL   NLL+  N ++KI DFGLA      ++       T  Y +PE
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
            +     +G   DVWS+GC+F  LL  +P F                    + D      
Sbjct: 183 -IATRSAHGLESDVWSLGCMFYTLLIGRPPF--------------------DTD----TV 217

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY 323
                 +    Y   +  S         A DL+ ++L  +P  R+S++  L HP+MS   
Sbjct: 218 KNTLNKVVLADYEMPSFLS-------IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270

Query: 324 DPSSNPPA 331
              S    
Sbjct: 271 STKSKDEG 278

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  167 bits (426), Expect = 2e-49
 Identities = 82/332 (24%), Positives = 139/332 (41%), Gaps = 51/332 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
            +  ++ +G GAYG V  +VNR T E VA+K ++     +  + ++  +E+ + + L HE
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHE 65

Query: 90  NVIALKDVMMPSHRRNFKDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLFQLL 143
           NV+           R     YL   Y    EL D      I+    +     Q F  QL+
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLM 115

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRA 201
            G+ YLH   I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 202 PELLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           PELL   + +   +DVWS G +  A L G  P    ++   +                  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------- 222

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
               + + Y+         P+ ++        + LL K+LV +P+ RI++ +  +  + +
Sbjct: 223 ----EKKTYL--------NPWKKIDSA----PLALLHKILVENPSARITIPDIKKDRWYN 266

Query: 321 PLYDPSSNPPAQVPIDLDMDEESGEEMIREMM 352
                 +  P      +        + I+  +
Sbjct: 267 KPLKKGAKRPRVTSGGVSESPSGFSKHIQSNL 298

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  168 bits (427), Expect = 2e-49
 Identities = 68/334 (20%), Positives = 127/334 (38%), Gaps = 53/334 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN------NAFENRVDALRTLRELKLLR 84
           KY  + P+G GA+G V ++V++E N++V +K I       + +       +   E+ +L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT--DLHQIIKSSQALTNDHCQYFLFQL 142
            ++H N+I + D+       N     LV E   +  DL   I     L      Y   QL
Sbjct: 85  RVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           +  + YL   +I+HRD+K  N+++  +  +K+ DFG A        F T +  T  Y AP
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAP 198

Query: 203 ELLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           E+L+     G  +++WS+G   +  +    P                           F 
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENP---------------------------FC 231

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
           +     +        P    S          + L+  +L   P +R ++ + +  P+++ 
Sbjct: 232 E----LEETVEAAIHPPYLVS-------KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

Query: 322 LYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKE 355
             + +     +V      +         EM  + 
Sbjct: 281 PVNLADYTWEEVFRVNKPESGVLSAASLEMGNRS 314

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  167 bits (426), Expect = 2e-49
 Identities = 78/305 (25%), Positives = 121/305 (39%), Gaps = 43/305 (14%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIAL 94
             +G GA+  V + +N  T+++ A+K I     +    +   RE+++L   Q H NV+ L
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGHRNVLEL 76

Query: 95  KDVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
            +         F++    YLV+E M    +   I   +          +  +   L +LH
Sbjct: 77  IEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 151 SANILHRDLKPGNLLV---NANCDLKICDFGLAR-------TSNGKNQFMTEYVVTRWYR 200
           +  I HRDLKP N+L    N    +KICDF L          S      +     +  Y 
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 201 APELLLCCD----NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
           APE++         Y    D+WS+G I   LL   P F G  C +             + 
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-RCGSDCGWDRGEACPACQN 247

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            L F       + I+   Y     F           A DL+ K+LV D  +R+S  + LQ
Sbjct: 248 ML-F-------ESIQEGKYE----FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295

Query: 316 HPYMS 320
           HP++ 
Sbjct: 296 HPWVQ 300

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  166 bits (422), Expect = 9e-49
 Identities = 76/343 (22%), Positives = 145/343 (42%), Gaps = 45/343 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y  +K IG+G +  V  + +  T  +VAIK I+    N     +  RE+++++ L H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L +V+        K +YL+ E     ++   + +   +     +    Q++  ++Y 
Sbjct: 76  IVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   I+HRDLK  NLL++A+ ++KI DFG +         +  +     Y APEL     
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAFCGAPPYAAPELFQGKK 189

Query: 210 NYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             G  +DVWS+G I +  + G  P F G                         +  + R+
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLP-FDGQ------------------------NLKELRE 224

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
            +    Y      S           +LL++ LV +P KR ++ + ++  +++  ++    
Sbjct: 225 RVLRGKYRIPFYMS-------TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277

Query: 329 PPAQVPIDLDMDEESGEEMI-----REMMLKEMLHYHPEAITA 366
            P   P     D++  + M+     +E + + +     + ITA
Sbjct: 278 KPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITA 320

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  164 bits (418), Expect = 1e-48
 Identities = 82/310 (26%), Positives = 133/310 (42%), Gaps = 51/310 (16%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
            +  ++ +G GAYG V  +VNR T E VA+K ++     +  + ++  +E+ + + L HE
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHE 65

Query: 90  NVIALKDVMMPSHRRNFKDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLFQLL 143
           NV+           R     YL   Y    EL D      I+    +     Q F  QL+
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLM 115

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA--RTSNGKNQFMTEYVVTRWYRA 201
            G+ YLH   I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y A
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 202 PELLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           PELL   + +   +DVWS G +  A L G  P    ++   +                  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                 +K      Y    P+ ++        + LL K+LV +P+ RI++ +  +  + +
Sbjct: 224 ------KKT-----YLN--PWKKIDSA----PLALLHKILVENPSARITIPDIKKDRWYN 266

Query: 321 PLYDPSSNPP 330
                 +  P
Sbjct: 267 KPLKKGAKRP 276

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  163 bits (414), Expect = 5e-48
 Identities = 69/309 (22%), Positives = 133/309 (43%), Gaps = 59/309 (19%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQH 88
            +   +P+G+G +G V  +  +++   +A+K +      +  V+  +  RE+++  HL+H
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH 68

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            N++ L      + R     VYL+ E      +++ ++            ++ +L   L 
Sbjct: 69  PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT----EYVVTRWYRAPE 203
           Y HS  ++HRD+KP NLL+ +  +LKI DFG +  +    +       +Y+       PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           ++     +   +D+WS+G +  E L G+ P                           F  
Sbjct: 178 MIEGRM-HDEKVDLWSLGVLCYEFLVGKPP---------------------------FEA 209

Query: 263 NPKARKY--IKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
           N     Y  I  + +T        +PD     A DL+ ++L  +P++R  + E L+HP++
Sbjct: 210 NTYQETYKRISRVEFT--------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

Query: 320 SPLYDPSSN 328
           +      SN
Sbjct: 262 TANSSKPSN 270

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  165 bits (419), Expect = 7e-48
 Identities = 85/327 (25%), Positives = 135/327 (41%), Gaps = 43/327 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           +Y  +K IG G +G+     ++ T E VA+K I              RE+   R L+H N
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++  K+V++         + ++ E     +L++ I ++   + D  ++F  QLL G+ Y 
Sbjct: 78  IVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132

Query: 150 HSANILHRDLKPGNLLV--NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           HS  I HRDLK  N L+  +    LKICDFG +++S   +Q  +  V T  Y APE+LL 
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLR 191

Query: 208 CDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
            +  G   DVWS G   +  L+G  P F   E     +                    K 
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPRDYR--------------------KT 230

Query: 267 RKYIKSLPYT--PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD 324
            + I S+ Y+       S       P    L+ ++ V DP  RIS+ E   H +      
Sbjct: 231 IQRILSVKYSIPDDIRIS-------PECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283

Query: 325 PSSNPPAQVPIDLDMDEESGEEMIREM 351
                 +         E+  + +   M
Sbjct: 284 ADLMNESNTGSQFQEPEQPMQSLDTIM 310

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  162 bits (412), Expect = 9e-47
 Identities = 50/363 (13%), Positives = 110/363 (30%), Gaps = 84/363 (23%)

Query: 14  PGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA 73
                + +   L E     V    +G+        + ++ET E   +           +A
Sbjct: 57  NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 116

Query: 74  LRTLRE----LKLLRHLQHENVIALK-------------------DVMMPSHRRNFKDVY 110
           ++ ++E    L+LLR ++++    +                     V +          +
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176

Query: 111 LVYELMDTD-------LHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN 163
            +Y  M ++       L     + ++L +        Q++R L  LH   ++H  L+P +
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 236

Query: 164 LLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN----------YGT 213
           ++++    + +  F        ++       V+R +  PEL                   
Sbjct: 237 IVLDQRGGVFLTGFEHLV----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292

Query: 214 SIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS 272
           S D W++G +   +     P       L   + I                     +  K+
Sbjct: 293 SFDAWALGLVIYWIWCADLP-ITKDAALGGSEWIF--------------------RSCKN 331

Query: 273 LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQ 332
           +P                    LL+  L +    R+   +A++ P    L        A 
Sbjct: 332 IP---------------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL---SAA 373

Query: 333 VPI 335
           +P+
Sbjct: 374 LPL 376

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  159 bits (405), Expect = 1e-46
 Identities = 60/319 (18%), Positives = 103/319 (32%), Gaps = 67/319 (21%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL- 86
             T++  ++ IG G +G V   V R      AIK+        VD    LRE+     L 
Sbjct: 9   YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIK----SSQALTNDHCQYFLFQ 141
           QH +V+        +   +   + +  E  +   L   I               +  L Q
Sbjct: 69  QHSHVVRYFS----AWAEDDH-MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNAN-------------------CDLKICDFGLART 182
           + RGL+Y+HS +++H D+KP N+ ++                        KI D G    
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQ 242
            +              + A E+L     +    D++++        G +P+       +Q
Sbjct: 184 ISSPQVE----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQ 236

Query: 243 LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVF 302
              I                          LP  P    S           +LL+ M+  
Sbjct: 237 WHEIRQ----------------------GRLPRIPQV-LS-------QEFTELLKVMIHP 266

Query: 303 DPTKRISVTEALQHPYMSP 321
           DP +R S    ++H  +  
Sbjct: 267 DPERRPSAMALVKHSVLLS 285

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  159 bits (405), Expect = 2e-46
 Identities = 70/314 (22%), Positives = 116/314 (36%), Gaps = 55/314 (17%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLLRHL 86
           +Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL+ +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 87  QHE--NVIALKDVMMPSHRRNFKDVYLVYELMDT--DLHQIIKSSQALTNDHCQYFLFQL 142
                 VI L D              L+ E  +   DL   I    AL  +  + F +Q+
Sbjct: 104 SSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR Y  
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSP 216

Query: 202 PELLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           PE +     +G S  VWS+G + +  + G  P                           F
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------------------------F 249

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
             + +    I           S            L++  L   P+ R +  E   HP+M 
Sbjct: 250 EHDEE----IIRGQVFFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

Query: 321 PLYDPSSNPPAQVP 334
            +  P       + 
Sbjct: 299 DVLLPQETAEIHLH 312

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  160 bits (407), Expect = 3e-46
 Identities = 59/318 (18%), Positives = 125/318 (39%), Gaps = 56/318 (17%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN---------------NAFENRVDALR 75
            Y  I+ + +G +  +   +  + N+  A+KK                 +    +     
Sbjct: 32  DYRIIRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 76  TLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLV--Y----ELMDTDLHQ---IIKS 126
              EL+++  +++E  +  + ++      N+ +VY++  Y     ++  D +        
Sbjct: 90  FKNELQIITDIKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144

Query: 127 SQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNG 185
           +  +     +  +  +L    Y+H+  NI HRD+KP N+L++ N  +K+ DFG +     
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

Query: 186 KNQFMT-----EYVVTRWYRAPELLLCCDNY-GTSIDVWSVGCIFAELLGRKPIFPGTEC 239
             +        E++       PE      +Y G  +D+WS+G     +      F     
Sbjct: 205 -KKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI- 256

Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
            + ++L  NI      +++E+   P  R +         +  S  +       ID L+  
Sbjct: 257 -SLVELFNNIR----TKNIEY---PLDRNHFLYPLTNKKSTCSNNF--LSNEDIDFLKLF 306

Query: 300 LVFDPTKRISVTEALQHP 317
           L  +P +RI+  +AL+H 
Sbjct: 307 LRKNPAERITSEDALKHE 324

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  158 bits (401), Expect = 6e-46
 Identities = 81/331 (24%), Positives = 127/331 (38%), Gaps = 62/331 (18%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL- 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++L     
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 68

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQII-KSSQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D      +I  +  QA T       +  + 
Sbjct: 69  QCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127

Query: 144 RGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL      N  LK+ DFG                      
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------- 166

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           A E     + Y  S D+WS+G I   LL   P F     L     +   +   R    EF
Sbjct: 167 AKETTG--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMGQYEF 221

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
            +                      + +       L++ +L  +PT+R+++TE + HP++ 
Sbjct: 222 PNPE--------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261

Query: 321 PLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
                    P      L  D+E  E++  EM
Sbjct: 262 Q-STKVPQTPLHTSRVLKEDKERWEDVKEEM 291

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  156 bits (397), Expect = 1e-45
 Identities = 60/314 (19%), Positives = 126/314 (40%), Gaps = 54/314 (17%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNA--FENRVDALRTLRELKLLRHLQH 88
            +   +P+G+G +G V  +  ++    +A+K +  +   +  V+  +  RE+++  HL+H
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLRH 73

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            N++ + +      R     +YL+ E     +L++ ++            F+ +L   L 
Sbjct: 74  PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMT----EYVVTRWYRAPE 203
           Y H   ++HRD+KP NLL+    +LKI DFG +  +    +       +Y+       PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           ++     +   +D+W  G +  E L   P F                    +       +
Sbjct: 183 MIEGKT-HDEKVDLWCAGVLCYEFLVGMPPF--------------------DSP----SH 217

Query: 264 PKARKYIKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
            +  + I ++           +P      + DL+ K+L + P +R+ +   ++HP++   
Sbjct: 218 TETHRRIVNVDLK--------FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK-A 268

Query: 323 YDPSSNPPAQVPID 336
                 PP      
Sbjct: 269 NSRRVLPPVYQSTQ 282

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  158 bits (401), Expect = 2e-45
 Identities = 72/306 (23%), Positives = 123/306 (40%), Gaps = 48/306 (15%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +GRG++G V    +++T  + A+KK+      R++  R + EL     L    ++ L   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYG- 117

Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILH 156
              + R     V +  EL++   L Q+IK    L  D   Y+L Q L GL+YLH+  ILH
Sbjct: 118 ---AVREGPW-VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173

Query: 157 RDLKPGNLLVNAN-CDLKICDFG----LARTSNGKNQFMTEYVV-TRWYRAPELLLCCDN 210
            D+K  N+L++++     +CDFG    L     GK+    +Y+  T  + APE+++    
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM-GKP 232

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
               +D+WS  C+   +L     +       +  L + I                    I
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKI--------------ASEPPPI 275

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           + +P           P   PL    +Q+ L  +P  R S  E  +    +         P
Sbjct: 276 REIP-----------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324

Query: 331 AQVPID 336
            +    
Sbjct: 325 WKGEYK 330

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  158 bits (401), Expect = 2e-45
 Identities = 87/328 (26%), Positives = 142/328 (43%), Gaps = 51/328 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
            Y+  + +G G++G V  + + +T +KVA+K I+    +     +R  RE+  L+ L+H 
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++I L DV+         D+ +V E    +L   I   + +T D  + F  Q++  ++Y 
Sbjct: 70  HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW-----YRAPEL 204
           H   I+HRDLKP NLL++ N ++KI DFGL+      N   T            Y APE+
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT------SCGSPNYAAPEV 178

Query: 205 LLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           +      G  +DVWS G + +  L+GR P F              I              
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLP-FDDE----------FI-------------- 213

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY 323
           P   K + S  Y      S       P A  L+++M+V DP +RI++ E  + P+ +   
Sbjct: 214 PNLFKKVNSCVYVMPDFLS-------PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266

Query: 324 DPSSNPPAQVPIDLDMDEESGEEMIREM 351
            P    P +       D     ++   M
Sbjct: 267 -PDYLRPMEEVQGSYADSRIVSKLGEAM 293

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  156 bits (397), Expect = 4e-45
 Identities = 71/361 (19%), Positives = 127/361 (35%), Gaps = 102/361 (28%)

Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-- 87
           T + PI+ +GRG +G+V  + N+  +   AIK+I       +   + +RE+K L  L+  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHP 64

Query: 88  --------------------------------------------------HENVIALKDV 97
                                                              +       V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 98  MMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTN---DHCQYFLFQLLRGLKYLHSAN 153
                      +Y+  +L    +L   +    +L +     C +   Q+   +++LHS  
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF------------MTEYVVTRWYRA 201
           ++HRDLKP N+    +  +K+ DFGL    +   +              T  V T+ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE  +  +NY   +D++S+G I  ELL         E       II              
Sbjct: 245 PE-QIHGNNYSHKVDIFSLGLILFELL--YSFSTQME----RVRIITD------------ 285

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
                   +++L +     F++ YP  H     ++Q ML   PT+R   T+ +++     
Sbjct: 286 --------VRNLKFPL--LFTQKYPQEH----MMVQDMLSPSPTERPEATDIIENAIFEN 331

Query: 322 L 322
           L
Sbjct: 332 L 332

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  156 bits (396), Expect = 5e-45
 Identities = 65/316 (20%), Positives = 110/316 (34%), Gaps = 57/316 (18%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRE---LKLL 83
           +Y     +G+G +G V +        +VAIK I       +    D++    E   L  +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 84  RH-LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT--DLHQIIKSSQALTNDHCQYFLF 140
                H  VI L D          +   LV E      DL   I     L     + F  
Sbjct: 92  GAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           Q++  +++ HS  ++HRD+K  N+L++      K+ DFG        ++  T++  TR Y
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRVY 204

Query: 200 RAPELLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
             PE +     +     VWS+G + +  + G  P                          
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIP-------------------------- 238

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
            F  + +    I           S       P    L+++ L   P+ R S+ E L  P+
Sbjct: 239 -FERDQE----ILEAELHFPAHVS-------PDCCALIRRCLAPKPSSRPSLEEILLDPW 286

Query: 319 MSPLYDPSSNPPAQVP 334
           M    +     P++  
Sbjct: 287 MQTPAEDVPLNPSKGG 302

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  156 bits (396), Expect = 8e-45
 Identities = 76/368 (20%), Positives = 140/368 (38%), Gaps = 65/368 (17%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEIDT-KYVPIKPIGRGAYGIVCSSVNRETNEKVA 59
           MA P          G+          E+   +    + +  G +  V  + +  +  + A
Sbjct: 1   MAGPGSLGGA---SGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYA 57

Query: 60  IKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMD- 117
           +K++ +  E +  A+   +E+  ++ L  H N++            +         L + 
Sbjct: 58  LKRLLSNEEEKNRAII--QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL 115

Query: 118 ---TDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANC 170
                +  + K      L+ D      +Q  R ++++H     I+HRDLK  NLL++   
Sbjct: 116 CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175

Query: 171 DLKICDFGLART--------SNGKNQFMTEYVVTR----WYRAPELLLCCDN--YGTSID 216
            +K+CDFG A T         + + + + E  +TR     YR PE++    N   G   D
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235

Query: 217 VWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYT 276
           +W++GCI   L  R+  F       +L+ I+N                   KY  S+P  
Sbjct: 236 IWALGCILYLLCFRQHPFEDG---AKLR-IVN------------------GKY--SIP-- 269

Query: 277 PGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPID 336
              P    Y   H     L++ ML  +P +R+S+ E +           + N   + PI 
Sbjct: 270 ---PHDTQYTVFH----SLIRAMLQVNPEERLSIAEVVHQLQEIA---AARNVNPKSPIT 319

Query: 337 LDMDEESG 344
             +++  G
Sbjct: 320 ELLEQNGG 327

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  154 bits (391), Expect = 1e-44
 Identities = 64/286 (22%), Positives = 121/286 (42%), Gaps = 37/286 (12%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           IGRG++  V   ++ ET  +VA  ++ +    + +  R   E ++L+ LQH N++   D 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 98  MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--I 154
              + +   K + LV ELM +  L   +K  + +     + +  Q+L+GL++LH+    I
Sbjct: 94  WESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152

Query: 155 LHRDLKPGNLLVNA-NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT 213
           +HRDLK  N+ +      +KI D GLA        F    + T  + APE  +  + Y  
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPE--MYEEKYDE 208

Query: 214 SIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSL 273
           S+DV++ G    E+   +  +   +   Q+   +                          
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-------------------------- 242

Query: 274 PYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             T G   +     A P   ++++  +  +  +R S+ + L H + 
Sbjct: 243 --TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  151 bits (383), Expect = 2e-43
 Identities = 73/299 (24%), Positives = 116/299 (38%), Gaps = 41/299 (13%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDV 97
           +G+G YGIV +  +     ++AIK+I          L    E+ L +HL+H+N++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGS 87

Query: 98  MMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQA---LTNDHCQYFLFQLLRGLKYLHSAN 153
              +       + +  E +    L  +++S             ++  Q+L GLKYLH   
Sbjct: 88  FSENGF-----IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142

Query: 154 ILHRDLKPGNLLVNA-NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE-LLLCCDNY 211
           I+HRD+K  N+L+N  +  LKI DFG ++   G N     +  T  Y APE +      Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK 271
           G + D+WS+GC   E+   KP  P  E       +  +                     K
Sbjct: 203 GKAADIWSLGCTIIEMATGKP--PFYELGEPQAAMFKVGMF------------------K 242

Query: 272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
             P  P +  S         A   + K    DP KR    + L   ++          P
Sbjct: 243 VHPEIPES-MS-------AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  150 bits (380), Expect = 4e-43
 Identities = 72/307 (23%), Positives = 119/307 (38%), Gaps = 51/307 (16%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
            YV    +G G +G V    ++ T  KVA+K +N     +     +  RE++ L+  +H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++I L  V+         D ++V E +   +L   I     +     +    Q+L  + Y
Sbjct: 72  HIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW-----YRAPE 203
            H   ++HRDLKP N+L++A+ + KI DFGL+   +      T            Y APE
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPE 180

Query: 204 LLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           ++      G  +D+WS G I +A L G  P F             ++             
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP-FDDE----------HV------------- 216

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
            P   K I+   +      +            LL  ML  DP KR ++ +  +H +    
Sbjct: 217 -PTLFKKIRGGVFYIPEYLN-------RSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268

Query: 323 YDPSSNP 329
                 P
Sbjct: 269 LPSYLFP 275

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  152 bits (385), Expect = 1e-42
 Identities = 41/337 (12%), Positives = 91/337 (27%), Gaps = 72/337 (21%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRE----LKLLRHLQHE-- 89
             +G+        + ++ET E   +           +A++ ++E    L+LLR ++++  
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 90  -----------------NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKS------ 126
                                +  V +          + +Y  M ++L    +       
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 127 -SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG 185
             ++L +        Q++R L  LH   ++H  L+P +++++    + +  F        
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 186 KNQFM-TEYVVTRWYRAPELLLCCD----NYGTSIDVWSVGCIFAELL-GRKPIFPGTEC 239
                           A  +L            + D W++G     +     P       
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP------- 316

Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
                                 D+                P              LL+  
Sbjct: 317 --------------------NTDDAALGGSEWIFRSCKNIP---------QPVRALLEGF 347

Query: 300 LVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPID 336
           L +    R+   +A++ P    L    S        D
Sbjct: 348 LRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTD 384

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  152 bits (386), Expect = 3e-42
 Identities = 79/333 (23%), Positives = 133/333 (39%), Gaps = 51/333 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
            Y+    +G G +G V    +  T  KVA+K +N     +     +  RE++ L+  +H 
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++I L  V+         D+++V E +   +L   I  +  L     +    Q+L G+ Y
Sbjct: 77  HIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW-----YRAPE 203
            H   ++HRDLKP N+L++A+ + KI DFGL+   +      T            Y APE
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPE 185

Query: 204 LLLCCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           ++      G  +D+WS G I +A L G  P F                     + +    
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLP-FDD-------------------DHV---- 221

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
            P   K I    +      +       P  I LL+ ML  DP KR ++ +  +H +    
Sbjct: 222 -PTLFKKICDGIFYTPQYLN-------PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273

Query: 323 YDPSSNPPAQVPIDLDMDEESGEEMIREMMLKE 355
                 P         +D+E+ +E+  +    E
Sbjct: 274 LPKYLFPEDPSYSSTMIDDEALKEVCEKFECSE 306

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  145 bits (367), Expect = 4e-40
 Identities = 83/369 (22%), Positives = 138/369 (37%), Gaps = 83/369 (22%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
            + +Y  I+ +G G +  V  S + +  + VA+K + +A      AL    E++LL+ ++
Sbjct: 35  FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVR 91

Query: 88  HENVIALKDVMMPSHRRNFKD-------VYLVYELMDTDLHQIIKSS--QALTNDHCQYF 138
           + +       M+     +FK        + +V+E++   L + I  S  Q L     +  
Sbjct: 92  NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151

Query: 139 LFQLLRGLKYLHS-ANILHRDLKPGNLLVNAN---------------------------- 169
           + Q+L+GL YLH+   I+H D+KP N+L++ N                            
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 170 ---------------------CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
                                  +KI D G A   +      TE + TR YR+ E+L+  
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGS 268

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK------LIINILG-------SRRE 255
             Y T  D+WS  C+  EL     +F         +      LII +LG          +
Sbjct: 269 G-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327

Query: 256 EDLEFIDNPKARKYIKSLPYTP----GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT 311
              EF       K+I  L                 +      D L  ML   P KR +  
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387

Query: 312 EALQHPYMS 320
           E L+HP+++
Sbjct: 388 ECLRHPWLN 396

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  137 bits (348), Expect = 6e-38
 Identities = 71/302 (23%), Positives = 124/302 (41%), Gaps = 50/302 (16%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK-LLRHLQHEN 90
              +  IGRGAYG V   V++ + + +A+K+I  +  +  +  + L +L  ++R      
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPY 82

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN-----DHCQYFLFQLLRG 145
           ++     +         D ++  ELM T   +  K   ++ +     +         ++ 
Sbjct: 83  IVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 146 LKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRA 201
           L +L     I+HRD+KP N+L++ + ++K+CDFG++     S  K +        R Y A
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD----AGCRPYMA 193

Query: 202 PELLLC---CDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREED 257
           PE +        Y    DVWS+G    EL  GR P        +QL  ++          
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--------- 244

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
               D P+       L  +    FS       P  I+ +   L  D +KR    E L+HP
Sbjct: 245 ---GDPPQ-------LSNSEEREFS-------PSFINFVNLCLTKDESKRPKYKELLKHP 287

Query: 318 YM 319
           ++
Sbjct: 288 FI 289

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  136 bits (345), Expect = 8e-38
 Identities = 76/301 (25%), Positives = 125/301 (41%), Gaps = 52/301 (17%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK-LLRHLQHEN 90
             PI  +GRGAYG+V    +  + + +A+K+I  A  N  +  R L +L   +R +    
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLLRGL 146
            +     +         DV++  ELMDT       Q+I   Q +  D        +++ L
Sbjct: 68  TVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 147 KYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRAP 202
           ++LHS  +++HRD+KP N+L+NA   +K+CDFG++        K+         + Y AP
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKPYMAP 178

Query: 203 ELLLCCDN---YGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           E +    N   Y    D+WS+G    EL + R P         QLK ++           
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE---------- 228

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              +           P  P   FS          +D   + L  +  +R +  E +QHP+
Sbjct: 229 ---EPS---------PQLPADKFS-------AEFVDFTSQCLKKNSKERPTYPELMQHPF 269

Query: 319 M 319
            
Sbjct: 270 F 270

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  137 bits (347), Expect = 1e-37
 Identities = 69/311 (22%), Positives = 121/311 (38%), Gaps = 40/311 (12%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  I  +G G  G+V    ++ +   +A K I+          + +REL++L       +
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPYI 93

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           +               ++ +  E MD   L Q++K +  +           +++GL YL 
Sbjct: 94  VGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 151 SA-NILHRDLKPGNLLVNANCDLKICDFG--------LARTSNGKNQFMTEYVVTRWYRA 201
               I+HRD+KP N+LVN+  ++K+CDFG        +A +  G          TR Y +
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG----------TRSYMS 198

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAEL-LGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           PE L    +Y    D+WS+G    E+ +GR PI P      +L     + G   E     
Sbjct: 199 PERLQ-GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLY--PDAHP----------LAIDLLQKMLVFDPTKRI 308
               +           P   F  L    +  P             D + K L+ +P +R 
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317

Query: 309 SVTEALQHPYM 319
            + + + H ++
Sbjct: 318 DLKQLMVHAFI 328

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  135 bits (343), Expect = 3e-37
 Identities = 66/322 (20%), Positives = 118/322 (36%), Gaps = 50/322 (15%)

Query: 9   NGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE 68
           +  +  G       +   EI+     +  +G G  G V     R+T   +A+K++  +  
Sbjct: 5   SSGKQTGYLTIGGQRYQAEIN-DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63

Query: 69  NRVDALRTLRELK-LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS 127
              +  R L +L  +L+      ++      + +      DV++  ELM T   ++ K  
Sbjct: 64  KEENK-RILMDLDVVLKSHDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRM 117

Query: 128 QA-LTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLAR---T 182
           Q  +           +++ L YL     ++HRD+KP N+L++    +K+CDFG++     
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177

Query: 183 SNGKNQFMTEYVVTRWYRAPELLLCCDN----YGTSIDVWSVGCIFAEL-LGRKPIFPGT 237
              K++          Y APE +   D     Y    DVWS+G    EL  G+ P     
Sbjct: 178 DKAKDRS----AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

Query: 238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQ 297
                L  ++              + P        LP      FS             ++
Sbjct: 234 TDFEVLTKVLQ-------------EEP------PLLP--GHMGFS-------GDFQSFVK 265

Query: 298 KMLVFDPTKRISVTEALQHPYM 319
             L  D  KR    + L+H ++
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFI 287

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  136 bits (344), Expect = 3e-37
 Identities = 72/298 (24%), Positives = 125/298 (41%), Gaps = 46/298 (15%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQ 87
           +  +  ++ IG G++G V  + +   +E VAIKK++ + +   +  + + +E++ L+ L+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGL 146
           H N I  +      + R     +LV E        +++  +  L            L+GL
Sbjct: 113 HPNTIQYRG----CYLRE-HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            YLHS N++HRD+K GN+L++    +K+ DFG A      N F    V T ++ APE++L
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----VGTPYWMAPEVIL 223

Query: 207 CCDN--YGTSIDVWSVGCIFA-ELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
             D   Y   +DVWS+G I   EL  RKP       ++ L  I                 
Sbjct: 224 AMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI----------------- 265

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
            +             +P   L          + +   L   P  R +    L+H ++ 
Sbjct: 266 AQN-----------ESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  135 bits (341), Expect = 4e-37
 Identities = 71/228 (31%), Positives = 106/228 (46%), Gaps = 26/228 (11%)

Query: 24  TLFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           +L  ID K + + + +GRGA+G+VC +  R   + VAIK+I +  E+   A     EL+ 
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFI--VELRQ 54

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII---KSSQALTNDHCQYF 138
           L  + H N++ L    +         V LV E  +   L+ ++   +     T  H   +
Sbjct: 55  LSRVNHPNIVKLYGACL-------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107

Query: 139 LFQLLRGLKYLHSAN---ILHRDLKPGNLLVNANCD-LKICDFGLARTSNGKNQFMTEYV 194
             Q  +G+ YLHS     ++HRDLKP NLL+ A    LKICDFG A         MT   
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD---IQTHMTNNK 164

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQ 242
            +  + APE+     NY    DV+S G I  E++ R+  F        
Sbjct: 165 GSAAWMAPEVFE-GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  134 bits (340), Expect = 5e-37
 Identities = 68/299 (22%), Positives = 133/299 (44%), Gaps = 52/299 (17%)

Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
            KY   + IG+GA G V ++++  T ++VAI+++N   + + + +  + E+ ++R  ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRG 145
           N++   D    S+     ++++V E +     TD    + +   +          + L+ 
Sbjct: 78  NIVNYLD----SYLVG-DELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQA 128

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEYVVTRWYRA 201
           L++LHS  ++HRD+K  N+L+  +  +K+ DFG    +    + ++      V T ++ A
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----VGTPYWMA 184

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++     YG  +D+WS+G +  E++  +P +     L  L LI               
Sbjct: 185 PEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--------------- 228

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                           GTP  +       +  D L + L  D  KR S  E LQH ++ 
Sbjct: 229 --ATN-----------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  133 bits (337), Expect = 1e-36
 Identities = 74/308 (24%), Positives = 127/308 (41%), Gaps = 61/308 (19%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH 88
           +  +  +  +G GA+G V  + N+ET    A K I    E  ++    + E+++L    H
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY--IVEIEILATCDH 75

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLR 144
             ++ L              ++++ E         +   +     LT    Q    Q+L 
Sbjct: 76  PYIVKLLGAYYHDG-----KLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLE 128

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFM-TEYVVTRWY 199
            L +LHS  I+HRDLK GN+L+    D+++ DFG      +T   ++ F+ T Y    W 
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY----WM 184

Query: 200 RAPELLLCCDN----YGTSIDVWSVGCIFA-ELLGRKPIFPGTECLNQLKLIINILGSRR 254
            APE+++C       Y    D+WS+G I   E+   +P  P  E LN +++++ I     
Sbjct: 185 -APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP--PHHE-LNPMRVLLKI----- 234

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH--PLAIDLLQKMLVFDPTKRISVTE 312
                     K+             P   L   +       D L+  L  +P  R S  +
Sbjct: 235 ---------AKS-----------DPP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272

Query: 313 ALQHPYMS 320
            L+HP++S
Sbjct: 273 LLEHPFVS 280

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  132 bits (335), Expect = 3e-36
 Identities = 67/307 (21%), Positives = 117/307 (38%), Gaps = 51/307 (16%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHEN 90
           Y   + IG GA  +V ++      EKVAIK+IN    +  +D L   +E++ +    H N
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL--KEIQAMSQCHHPN 74

Query: 91  VIA-----LKD----VMMPSHRRNFKDVYL----VYELMDTDLHQIIKSSQALTNDHCQY 137
           +++     +      ++M           L    V +++   + +    S  L       
Sbjct: 75  IVSYYTSFVVKDELWLVMK---------LLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEY 193
            L ++L GL+YLH    +HRD+K GN+L+  +  ++I DFG    LA   +     + + 
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

Query: 194 VV-TRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
            V T  + APE++     Y    D+WS G    EL      +     +  L L +     
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---- 241

Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
                     N                 + + +         ++   L  DP KR +  E
Sbjct: 242 ----------NDPPSLETGVQDKEMLKKYGKSF-------RKMISLCLQKDPEKRPTAAE 284

Query: 313 ALQHPYM 319
            L+H + 
Sbjct: 285 LLRHKFF 291

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  132 bits (334), Expect = 6e-36
 Identities = 66/299 (22%), Positives = 132/299 (44%), Gaps = 52/299 (17%)

Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
                   IG G+ GIVC +  + +  +VA+K ++   + R + L    E+ ++R  QH 
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHF 102

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRG 145
           NV+ +      S+    ++++++ E +     TD   I+   + L  +        +L+ 
Sbjct: 103 NVVEMYK----SYLVG-EELWVLMEFLQGGALTD---IVSQVR-LNEEQIATVCEAVLQA 153

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEYVVTRWYRA 201
           L YLH+  ++HRD+K  ++L+  +  +K+ DFG    +++    +       V T ++ A
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL----VGTPYWMA 209

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE++     Y T +D+WS+G +  E++  +P +     +  +K +               
Sbjct: 210 PEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------------- 253

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
               +             P  +      P+  D L++MLV DP +R +  E L HP++ 
Sbjct: 254 --RDS-----------PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  130 bits (330), Expect = 9e-36
 Identities = 48/228 (21%), Positives = 92/228 (40%), Gaps = 26/228 (11%)

Query: 25  LFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNA-FENRVDALRTL----R 78
           L  +    +   K IG+G +G+V      +    VAIK +     E   + +       R
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72

Query: 79  ELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQII-KSSQALTNDHCQ 136
           E+ ++ +L H N++ L  +M            +V E +   DL+  +   +  +      
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMH-------NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125

Query: 137 YFLFQLLRGLKYLHSAN--ILHRDLKPGNLLV-----NANCDLKICDFGLARTSNGKNQF 189
             +  +  G++Y+ + N  I+HRDL+  N+ +     NA    K+ DFGL++        
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHS 182

Query: 190 MTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAELLGRKPIFPG 236
           ++  +    + APE +   +  Y    D +S   I   +L  +  F  
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  132 bits (334), Expect = 1e-35
 Identities = 44/312 (14%), Positives = 84/312 (26%), Gaps = 69/312 (22%)

Query: 31  KYVPIKPIGRGAYGIV-----CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
                  +G GA+  V         + +  +K  +K    A           + ++ L+ 
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT--QLMERLKP 123

Query: 86  LQHENVIALKDVMMPSHRRNFKD-VYLVYELMD-TDLHQIIK-----SSQALTNDHCQYF 138
                 +      +      F++   LV EL     L   I        + +       F
Sbjct: 124 SMQHMFMKFYSAHL------FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVN-----------ANCDLKICDFGLARTSN--G 185
             ++L  ++ +H   I+H D+KP N ++             +  L + D G +       
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL 245
           K    T    T  ++  E+L     +   ID + V      +L    +    E       
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNE------- 289

Query: 246 IINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPT 305
                                          P   F RL      +  +    ML     
Sbjct: 290 --------------------------GGECKPEGLFRRLP--HLDMWNEFFHVMLNIPDC 321

Query: 306 KRISVTEALQHP 317
             +   + L+  
Sbjct: 322 HHLPSLDLLRQK 333

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  130 bits (330), Expect = 2e-35
 Identities = 67/302 (22%), Positives = 128/302 (42%), Gaps = 45/302 (14%)

Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QH 88
             +  ++ +G G YG V    + +T +  AIK ++   +   +     +E+ +L+    H
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE---IKQEINMLKKYSHH 80

Query: 89  ENVIALKDVMMPSHRRNFKD-VYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLL 143
            N+       +  +     D ++LV E       TDL +  K    L  +   Y   ++L
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREIL 139

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
           RGL +LH   ++HRD+K  N+L+  N ++K+ DFG++   +        ++ T ++ APE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 204 LLLCCDN----YGTSIDVWSVGCIFA-ELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           ++ C +N    Y    D+WS+G I A E+    P       +  L LI            
Sbjct: 200 VIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
               NP         P      +S+ +          ++  LV + ++R +  + ++HP+
Sbjct: 249 ----NPA--------PRLKSKKWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPF 289

Query: 319 MS 320
           + 
Sbjct: 290 IR 291

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  131 bits (331), Expect = 5e-35
 Identities = 59/324 (18%), Positives = 114/324 (35%), Gaps = 45/324 (13%)

Query: 30  TKYVPIKPIGRGA--YGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRH 85
             Y  +  IG+G      V  +  + T E V +++IN        V  L+   EL + + 
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ--GELHVSKL 82

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLFQL 142
             H N++  +   +  +     ++++V   M       +I +     +      Y L  +
Sbjct: 83  FNHPNIVPYRATFIADN-----ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGV 137

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA-------RTSNGKNQFMTEYVV 195
           L+ L Y+H    +HR +K  ++L++ +  + +             +     + F    V 
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 196 TRWYRAPELLLCCDN-YGTSIDVWSVGCIFAELL-GRKPIF----------------PG- 236
              + +PE+L      Y    D++SVG    EL  G  P                  P  
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 237 TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDL 295
            +        + +  SR   +    D+        S   +P  P+ R + P  H      
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH----HF 313

Query: 296 LQKMLVFDPTKRISVTEALQHPYM 319
           +++ L  +P  R S +  L H + 
Sbjct: 314 VEQCLQRNPDARPSASTLLNHSFF 337

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  128 bits (325), Expect = 5e-35
 Identities = 60/289 (20%), Positives = 111/289 (38%), Gaps = 43/289 (14%)

Query: 27  EIDTKYVPIKP-IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           EI    + +   IG G++G V        +  VA+K +N              E+ +LR 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 76

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLL 143
            +H N++                + +V +  +   L+  + +S+             Q  
Sbjct: 77  TRHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRA 201
           RG+ YLH+ +I+HRDLK  N+ ++ +  +KI DFGLA   +    +    +   +  + A
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

Query: 202 PELLLCCDN--YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDL 258
           PE++   D+  Y    DV++ G +  EL+ G+ P +     +N    II ++G       
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN---INNRDQIIEMVG------- 239

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
                   R  +   P            +       L+ + L     +R
Sbjct: 240 --------RGSLS--PDLSKVR-----SNCPKRMKRLMAECLKKKRDER 273

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  129 bits (327), Expect = 5e-35
 Identities = 65/245 (26%), Positives = 100/245 (40%), Gaps = 26/245 (10%)

Query: 27  EIDTKYVPIKP-IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
                 +     +G+G +G      +RET E + +K++    E        L+E+K++R 
Sbjct: 6   IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF--LKEVKVMRC 63

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS-SQALTNDHCQYFLFQLL 143
           L+H NV+    V+        K +  + E +    L  IIKS            F   + 
Sbjct: 64  LEHPNVLKFIGVLYKD-----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQFMT 191
            G+ YLHS NI+HRDL   N LV  N ++ + DFGLAR             S  K     
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 192 EYVVTRWYR--APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
            Y V       APE++    +Y   +DV+S G +  E++GR    P           +N+
Sbjct: 179 RYTVVGNPYWMAPEMIN-GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM-DFGLNV 236

Query: 250 LGSRR 254
            G   
Sbjct: 237 RGFLD 241

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  128 bits (324), Expect = 1e-34
 Identities = 72/301 (23%), Positives = 133/301 (44%), Gaps = 58/301 (19%)

Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
             +  ++ +G G+YG V  ++++ET + VAIK++    E+ +  +  ++E+ +++     
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEI--IKEISIMQQCDSP 84

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRG 145
           +V+        S+ +N  D+++V E       +D+ ++   +  LT D     L   L+G
Sbjct: 85  HVVKYYG----SYFKN-TDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKG 137

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEYVVTRWYRA 201
           L+YLH    +HRD+K GN+L+N     K+ DFG    L  T   +N      + T ++ A
Sbjct: 138 LEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV----IGTPFWMA 193

Query: 202 PELLLCCDNYGTSIDVWSVGCIFA-ELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           PE++     Y    D+WS+G I A E+   KP +     +  + +I              
Sbjct: 194 PEVIQ-EIGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMI-------------- 237

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAH--PLAIDLLQKMLVFDPTKRISVTEALQHPY 318
              P               P               D +++ LV  P +R + T+ LQHP+
Sbjct: 238 ---PTN-----------PPP--TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281

Query: 319 M 319
           +
Sbjct: 282 V 282

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  128 bits (324), Expect = 1e-34
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 17/219 (7%)

Query: 26  FEIDTKYVPIKP-IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
            +I    + IK  IG G++G V  +        VA+K +     +       LRE+ +++
Sbjct: 32  MDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMK 89

Query: 85  HLQHENVIALKDVMM-PSHRRNFKDVYLVYELMD-TDLHQIIKSSQA---LTNDHCQYFL 139
            L+H N++     +  P +      + +V E +    L++++  S A   L         
Sbjct: 90  RLRHPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143

Query: 140 FQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           + + +G+ YLH+ N  I+HR+LK  NLLV+    +K+CDFGL+R              T 
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP 203

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
            + APE +L  +      DV+S G I  EL   +  +  
Sbjct: 204 EWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  123 bits (310), Expect = 5e-33
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 28/228 (12%)

Query: 25  LFEIDTKYVPIKP-IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELK 81
           L EID   + ++  IG G +G V  +      ++VA+K   +  +  +        +E K
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAK 58

Query: 82  LLRHLQHENVIALKDV-MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFL 139
           L   L+H N+IAL+ V +   +      + LV E      L++++   + +  D    + 
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPN------LCLVMEFARGGPLNRVLSGKR-IPPDILVNWA 111

Query: 140 FQLLRGLKYLHSAN---ILHRDLKPGNLLVN--------ANCDLKICDFGLARTSNGKNQ 188
            Q+ RG+ YLH      I+HRDLK  N+L+         +N  LKI DFGLAR  + +  
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTT 170

Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
            M+      W  APE++     +    DVWS G +  ELL  +  F G
Sbjct: 171 KMSAAGAYAW-MAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  123 bits (311), Expect = 7e-33
 Identities = 72/307 (23%), Positives = 138/307 (44%), Gaps = 55/307 (17%)

Query: 30  TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQH 88
             +  ++ IG+G++G V   ++  T + VAIK I+    E+ ++ ++  +E+ +L     
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDS 79

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLR 144
             V         S+ ++ K ++++ E +      DL +       L        L ++L+
Sbjct: 80  PYVTKYYG----SYLKDTK-LWIIMEYLGGGSALDLLE----PGPLDETQIATILREILK 130

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFG----LARTSNGKNQFMTEYVVTRWYR 200
           GL YLHS   +HRD+K  N+L++ + ++K+ DFG    L  T   +N F    V T ++ 
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF----VGTPFWM 186

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE++     Y +  D+WS+G    EL   +P  P +E L+ +K++  I           
Sbjct: 187 APEVIK-QSAYDSKADIWSLGITAIELARGEP--PHSE-LHPMKVLFLIP---------- 232

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                     K+ P T    +S+          + ++  L  +P+ R +  E L+H ++ 
Sbjct: 233 ----------KNNPPTLEGNYSKPL-------KEFVEACLNKEPSFRPTAKELLKHKFIL 275

Query: 321 PLYDPSS 327
                +S
Sbjct: 276 RNAKKTS 282

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  122 bits (309), Expect = 2e-32
 Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 27/228 (11%)

Query: 26  FEIDTKYVPIKP-IGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           ++I  + + I   IG+G +G V           VAI+ I+   +N        RE+   R
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYR 84

Query: 85  HLQHENVIALKDVMM-PSHRRNFKDVYLVYELMDT-DLHQIIKS-SQALTNDHCQYFLFQ 141
             +HENV+      M P H      + ++  L     L+ +++     L  +  +    +
Sbjct: 85  QTRHENVVLFMGACMSPPH------LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-----TSNGKNQFMTEYVVT 196
           +++G+ YLH+  ILH+DLK  N+  + N  + I DFGL        +  +   +      
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 197 RWYRAPELL--------LCCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
             + APE++             +    DV+++G I+ EL  R+  F  
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  123 bits (312), Expect = 2e-32
 Identities = 69/305 (22%), Positives = 134/305 (43%), Gaps = 51/305 (16%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR-TLRELKLLR 84
           FEI      ++ IG+G++G VC     +T +  A+K +N       + +R   +EL++++
Sbjct: 17  FEI------LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70

Query: 85  HLQHENVIALKDVMMPSHRRNFKD---VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLF 140
            L+H  ++ L          +F+D   +++V +L+   DL   ++ +     +  + F+ 
Sbjct: 71  GLEHPFLVNL--------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC 122

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           +L+  L YL +  I+HRD+KP N+L++ +  + I DF +A     + Q  T    T+ Y 
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYM 181

Query: 201 APELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE+        Y  ++D WS+G    ELL  +  +      +  +++           +
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTVV 237

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HP 317
            +   P                            + LL+K+L  +P +R S    +Q  P
Sbjct: 238 TY---P---------------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP 273

Query: 318 YMSPL 322
           YM+ +
Sbjct: 274 YMNDI 278

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  118 bits (299), Expect = 2e-31
 Identities = 38/219 (17%), Positives = 72/219 (32%), Gaps = 18/219 (8%)

Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
             ID K +     +     G +     +     + +K +     +   +     E   LR
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQY--FLFQ 141
              H NV+ +          +     L+   M    L+ ++        D  Q   F   
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119

Query: 142 LLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           + RG+ +LH+    I    L   +++++ +   +I    +  +     +         W 
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA----PAWV 175

Query: 200 RAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPG 236
            APE L     D    S D+WS   +  EL+ R+  F  
Sbjct: 176 -APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  118 bits (298), Expect = 6e-31
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 51/283 (18%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENV 91
            K +G G++  V  +    T+ + AIK +       EN+V      RE  ++  L H   
Sbjct: 35  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP--YVTRERDVMSRLDHPFF 92

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + L           F+D   +Y  +      +L + I+   +      +++  +++  L+
Sbjct: 93  VKLY--------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 144

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY--VVTRWYRAPELL 205
           YLH   I+HRDLKP N+L+N +  ++I DFG A+  + +++       V T  Y +PELL
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204

Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
                   S D+W++GCI  +L+   P F      N+  +   I+    + + +F   P 
Sbjct: 205 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKII----KLEYDF---P- 252

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI 308
                                   P A DL++K+LV D TKR+
Sbjct: 253 --------------------EKFFPKARDLVEKLLVLDATKRL 275

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (296), Expect = 2e-30
 Identities = 67/299 (22%), Positives = 104/299 (34%), Gaps = 34/299 (11%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +K IG+G YG V     R   EKVA+K             R   E+     ++HEN++  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFT--TEEASWFRE-TEIYQTVLMRHENILGF 96

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN 153
               +         +YL+ +  +   L+  +KS   L         +  + GL +LH+  
Sbjct: 97  IAADIKGTGSW-TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 154 --------ILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGKNQFMTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA      +N  +      V T+ Y  
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 202 PELLLCCDN-----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
           PE+L    N          D++S G I  E+  R       E        +       E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
             E +   K R         P  P      +       L+ +    +P  R++     +
Sbjct: 275 MREIVCIKKLR---------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  115 bits (289), Expect = 1e-29
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 27/223 (12%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA- 93
           ++ +G+G YG V     +   E VA+K  ++   +     R   EL     L+HEN++  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSS--RDEKSWFRE-TELYNTVMLRHENILGF 67

Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA 152
           +   M   H      ++L+    +   L+  ++    L    C   +  +  GL +LH  
Sbjct: 68  IASDMTSRHSST--QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 153 --------NILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGKNQFMTEYVVTRWYR 200
                    I HRDLK  N+LV  N    I D GLA     ++N  +      V T+ Y 
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 201 APELL-----LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE 238
           APE+L     + C +    +D+W+ G +  E+  R       E
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  113 bits (284), Expect = 1e-28
 Identities = 63/303 (20%), Positives = 109/303 (35%), Gaps = 37/303 (12%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
            + IG+G +G V     R   E+VA+K  ++         R   E+     L+HEN++  
Sbjct: 47  QESIGKGRFGEVWRGKWR--GEEVAVKIFSS--REERSWFRE-AEIYQTVMLRHENILGF 101

Query: 95  KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA- 152
                      +  ++LV +  +   L   +     +T +           GL +LH   
Sbjct: 102 IAADN-KDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 153 -------NILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGKNQFMTEYVVTRWYRA 201
                   I HRDLK  N+LV  N    I D GLA      ++  +      V T+ Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 202 PELLLCCDN-----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
           PE+L    N          D++++G +F E+  R  I    E        +       EE
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEA 313
             + +   K R         P  P      +A  +   ++++    +   R++   + + 
Sbjct: 280 MRKVVCEQKLR---------PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 314 LQH 316
           L  
Sbjct: 331 LSQ 333

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  110 bits (278), Expect = 5e-28
 Identities = 69/313 (22%), Positives = 117/313 (37%), Gaps = 38/313 (12%)

Query: 25  LFEIDT-KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
                +     ++   RG +G V  +     NE VA+K           + +   E+  L
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF---PIQDKQSWQNEYEVYSL 72

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
             ++HEN++               D++L+    +   L   +K+   ++ +   +    +
Sbjct: 73  PGMKHENILQFIGAEKRG-TSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETM 130

Query: 143 LRGLKYLHSA----------NILHRDLKPGNLLVNANCDLKICDFGLART-SNGKNQFMT 191
            RGL YLH             I HRD+K  N+L+  N    I DFGLA     GK+   T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 192 EYVV-TRWYRAPELL----LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI 246
              V TR Y APE+L        +    ID++++G +  EL  R     G      L   
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 247 INILGSRREEDL-EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPT 305
             I      ED+ E + + K R  ++   +      + L         + +++    D  
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDY-WQKHAGMAML--------CETIEECWDHDAE 301

Query: 306 KRIS---VTEALQ 315
            R+S   V E + 
Sbjct: 302 ARLSAGCVGERIT 314

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  109 bits (275), Expect = 2e-27
 Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 32/236 (13%)

Query: 27  EIDTKYVP-IKPIGRGAYGIVC----SSVNRETNEKVAIKKINNAFENRVDALRTLRELK 81
             + +++  I  +G+G +G V       +   T   VA+K++ ++  ++       RE++
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF--QREIQ 76

Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFL 139
           +L+ L  + ++  + V     R++   + LV E + +  L   ++  +A L       + 
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT--- 196
            Q+ +G++YL S   +HRDL   N+LV +   +KI DFGLA+           YVV    
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYVVREPG 190

Query: 197 ----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPGTECLNQL 243
                WY APE L    +    S   DVWS G +  EL     K   P  E L  +
Sbjct: 191 QSPIFWY-APESL----SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  112 bits (282), Expect = 2e-27
 Identities = 63/301 (20%), Positives = 121/301 (40%), Gaps = 59/301 (19%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
            + IGRG +G V      +T +  A+K ++            ++  +      +E ++ L
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKK---------RIKMKQGETLALNERIM-L 243

Query: 95  KDVMMPSHRRNF-----------KDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
             V        F             +  + +LM+  DLH  +      +    +++  ++
Sbjct: 244 SLVSTGDCP--FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 301

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + GL+++H+  +++RDLKP N+L++ +  ++I D GLA   + K       V T  Y AP
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGTHGYMAP 359

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+L     Y +S D +S+GC+  +LL     F   +  ++ ++    L       +E  D
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TMAVELPD 415

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHP 317
           +                 FS       P    LL+ +L  D  +R+        E  + P
Sbjct: 416 S-----------------FS-------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP 451

Query: 318 Y 318
           +
Sbjct: 452 F 452

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  109 bits (275), Expect = 2e-27
 Identities = 61/284 (21%), Positives = 123/284 (43%), Gaps = 58/284 (20%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENV 91
           IK +G G++G V    ++E+    A+K ++        +++   TL E ++L+ +    +
Sbjct: 46  IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE--HTLNEKRILQAVNFPFL 103

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT----DLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           + L+         +FKD   +Y +M+     ++   ++     +  H +++  Q++   +
Sbjct: 104 VKLE--------FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE 155

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM---TEYVVTRWYRAPEL 204
           YLHS ++++RDLKP NLL++    +++ DFG A+   G+   +    E +      APE+
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEI 209

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
           +L    Y  ++D W++G +  E+    P F        +++   I+       + F   P
Sbjct: 210 ILSKG-YNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIV----SGKVRF---P 258

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI 308
                                        DLL+ +L  D TKR 
Sbjct: 259 ---------------------SHFSSDLKDLLRNLLQVDLTKRF 281

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (272), Expect = 2e-27
 Identities = 61/236 (25%), Positives = 109/236 (46%), Gaps = 32/236 (13%)

Query: 27  EIDTKYVP-IKPIGRGAYGIVC----SSVNRETNEKVAIKKINNAFENRVDALRTLRELK 81
           + + +++  ++ +G+G +G V       +   T E VA+KK+ ++ E  +      RE++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF--EREIE 63

Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFL 139
           +L+ LQH+N++  K V   + RRN   + L+ E +    L   ++  +  + +     + 
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT--- 196
            Q+ +G++YL +   +HRDL   N+LV     +KI DFGL +      +    + V    
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---FFKVKEPG 177

Query: 197 ----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAELL--GRKPIFPGTECLNQL 243
                WY APE L         S+  DVWS G +  EL     K   P  E +  +
Sbjct: 178 ESPIFWY-APESL----TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 4e-27
 Identities = 64/261 (24%), Positives = 111/261 (42%), Gaps = 36/261 (13%)

Query: 2   ATPVEPPNGIRSPGKHYYSMWQTLFEIDTKYVP-IKPIGRGAYGIVC----SSVNRETNE 56
            T      G                + + +++  ++ +G+G +G V       +   T E
Sbjct: 16  TTENLYFQGAMGSAFEDRDPT----QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGE 71

Query: 57  KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM 116
            VA+KK+ ++ E  +      RE+++L+ LQH+N++  K V   + RRN   + L+ E +
Sbjct: 72  VVAVKKLQHSTEEHLRDF--EREIEILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYL 126

Query: 117 DT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
               L   ++  +  + +     +  Q+ +G++YL +   +HRDL   N+LV     +KI
Sbjct: 127 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186

Query: 175 CDFGLARTSNGKNQFMTEYVVT-------RWYRAPELLLCCDNYGT-SI--DVWSVGCIF 224
            DFGL +      +    Y V         WY APE L         S+  DVWS G + 
Sbjct: 187 GDFGLTKVLPQDKE---YYKVKEPGESPIFWY-APESL----TESKFSVASDVWSFGVVL 238

Query: 225 AELL--GRKPIFPGTECLNQL 243
            EL     K   P  E +  +
Sbjct: 239 YELFTYIEKSKSPPAEFMRMI 259

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  109 bits (275), Expect = 6e-27
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 51/296 (17%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHENVIA 93
           +K IGRGA+G V    ++ T +  A+K ++      R D+     E  ++       V+ 
Sbjct: 74  VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 94  LKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           L           F+D   +Y +M+     DL  ++ S+  +     +++  +++  L  +
Sbjct: 134 LF--------YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAI 184

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLCC 208
           HS   +HRD+KP N+L++ +  LK+ DFG     N +     +  V T  Y +PE+L   
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 209 D---NYGTSIDVWSVG-CIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
                YG   D WSVG  ++  L+G  P +      + +     I+  +    L F D+ 
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHK--NSLTFPDD- 297

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SVTEALQHP 317
                                 D    A +L+   L  D   R+    V E  +H 
Sbjct: 298 ---------------------NDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHL 331

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  109 bits (274), Expect = 9e-27
 Identities = 67/306 (21%), Positives = 121/306 (39%), Gaps = 55/306 (17%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLR 84
           FEI      +K IGRGA+G V     +  ++  A+K +N      R +      E  +L 
Sbjct: 76  FEI------LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMD----TDL-HQIIKSSQALTNDHCQYFL 139
           +   + +  L           F+D   +Y +MD     DL   + K    L  +  +++L
Sbjct: 130 NGDSKWITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRW 198
            +++  +  +H  + +HRD+KP N+L++ N  +++ DFG            +   V T  
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 199 YRAPELLLCCDN----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR 254
           Y +PE+L   +     YG   D WS+G    E+L  +  F      + ++    I+    
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIM---- 294

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SVT 311
                   N K R             F     D    A DL+++++      R+    + 
Sbjct: 295 --------NHKER-----------FQFPTQVTDVSENAKDLIRRLIC-SREHRLGQNGIE 334

Query: 312 EALQHP 317
           +  +HP
Sbjct: 335 DFKKHP 340

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  106 bits (267), Expect = 1e-26
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 32/228 (14%)

Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHE 89
           I+ +G G +G V           T E+VA+K +   +  N +  L   +E+++LR+L HE
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL--KKEIEILRNLYHE 83

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQ-IIKSSQALTNDHCQYFLFQLLRGLK 147
           N++  K +           + L+ E + +  L + + K+   +       +  Q+ +G+ 
Sbjct: 84  NIVKYKGICTEDGGNG---IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYR 200
           YL S   +HRDL   N+LV +   +KI DFGL +      +    Y V         WY 
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE---YYTVKDDRDSPVFWY- 196

Query: 201 APELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPGTECLNQL 243
           APE    C       I  DVWS G    EL         P    L  +
Sbjct: 197 APE----CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  109 bits (273), Expect = 2e-26
 Identities = 72/330 (21%), Positives = 133/330 (40%), Gaps = 55/330 (16%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIA 93
            + +GRG +G V +   + T +  A KK+N    + R      + E K+L  +    +++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 94  LKDVMMPSHRRNFKDVYLVYELMD-----TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           L             D+ LV  +M+       ++ + + +         ++  Q++ GL++
Sbjct: 250 LA-----YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LH  NI++RDLKP N+L++ + +++I D GLA            Y  T  + APELLL  
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL-G 363

Query: 209 DNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
           + Y  S+D +++G    E++  R P     E +   +L   +L    E+ + +   P   
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL----EQAVTY---PDK- 415

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL 322
                        FS       P + D  + +L  DP KR+     S      HP    +
Sbjct: 416 -------------FS-------PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455

Query: 323 ---------YDPSSNPPAQVPIDLDMDEES 343
                      P   P ++     ++ +  
Sbjct: 456 SWRQLEAGMLTPPFVPDSRTVYAKNIQDVG 485

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  108 bits (271), Expect = 4e-26
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 29/223 (13%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           E++   + +   +G G YG V   V ++ +  VA+K +        +    L+E  +++ 
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKE 272

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLFQL 142
           ++H N++ L  V            Y++ E M   +L   ++    Q ++     Y   Q+
Sbjct: 273 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------ 196
              ++YL   N +HR+L   N LV  N  +K+ DFGL+R   G       Y         
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFP 382

Query: 197 -RWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
            +W  APE L   + +    DVW+ G +  E+   G  P +PG
Sbjct: 383 IKWT-APESLA-YNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 422

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  108 bits (272), Expect = 4e-26
 Identities = 47/217 (21%), Positives = 88/217 (40%), Gaps = 22/217 (10%)

Query: 28  IDTKYVPIKPIGRGAYGIV----CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           +  +Y     I  G  G +      +VN      V +K + ++  +       + E + L
Sbjct: 78  VAGQYEVKGCIAHGGLGWIYLALDRNVNGRP---VVLKGLVHS-GDAEAQAMAMAERQFL 133

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQL 142
             + H +++ + + +  + R      Y+V E +    L +     Q L       +L ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEI 191

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L  L YLHS  +++ DLKP N+++     LK+ D G     N           T  ++AP
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----GTPGFQAP 246

Query: 203 ELLLCCDNYGTSI--DVWSVGCIFAELLGRKPIFPGT 237
           E++      G ++  D+++VG   A L    P   G 
Sbjct: 247 EIVR----TGPTVATDIYTVGRTLAALTLDLPTRNGR 279

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  107 bits (268), Expect = 4e-26
 Identities = 58/300 (19%), Positives = 114/300 (38%), Gaps = 51/300 (17%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIA 93
           +K IGRGA+  V     ++T +  A+K +N      R +      E  +L +     +  
Sbjct: 66  LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 94  LKDVMMPSHRRNFKDVYLVYELMD----TDL-HQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           L           F+D   +Y +M+     DL   + K  + +  +  +++L +++  +  
Sbjct: 126 LH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLL- 206
           +H    +HRD+KP N+L++    +++ DFG            +   V T  Y +PE+L  
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 207 -----CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
                   +YG   D W++G    E+   +  F      +  +    I+    +E L   
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAETYGKIV--HYKEHLSLP 292

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI---SVTEALQHPY 318
              +                  +  +A     D +Q++L   P  R+      +   HP+
Sbjct: 293 LVDEG-----------------VPEEAR----DFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  104 bits (261), Expect = 7e-26
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 35/226 (15%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           E++   + +   +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++ 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKE 65

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLFQL 142
           ++H N++ L  V            Y++ E M   +L   ++    Q ++     Y   Q+
Sbjct: 66  IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------ 196
              ++YL   N +HRDL   N LV  N  +K+ DFGL+R   G       Y         
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFP 175

Query: 197 -RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
            +W  APE L     Y   SI  DVW+ G +  E+   G  P +PG
Sbjct: 176 IKWT-APESL----AYNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 215

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  103 bits (258), Expect = 2e-25
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 32/228 (14%)

Query: 26  FEIDTKYVPI--KPIGRGAYGIVCSSV--NRETNEKVAIKKINNAFENRVDALRTLRELK 81
             +D K + +  K +G G +G V       ++  + VA+K + N   +       L E  
Sbjct: 11  VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 70

Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLF 140
           +++ L +  ++ +  +             LV E+ +   L++ ++ ++ + + +    + 
Sbjct: 71  VMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 124

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT---- 196
           Q+  G+KYL  +N +HRDL   N+L+      KI DFGL++           Y       
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE---NYYKAQTHGK 181

Query: 197 ---RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAELL--GRKPIFPG 236
              +WY APE    C NY   S   DVWS G +  E    G+KP + G
Sbjct: 182 WPVKWY-APE----CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRG 223

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  104 bits (262), Expect = 2e-25
 Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 37/228 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLL 83
            ++ + + + + IGRG +G V S   R  N  VA+K      E     L+   L+E ++L
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARIL 166

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKS-SQALTNDHCQYFLFQ 141
           +   H N++ L  V         + +Y+V EL+   D    +++    L        +  
Sbjct: 167 KQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT----- 196
              G++YL S   +HRDL   N LV     LKI DFG++R           Y  +     
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGGLRQ 276

Query: 197 ---RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
              +W  APE L    NYG  S   DVWS G +  E   LG  P +P 
Sbjct: 277 VPVKWT-APEAL----NYGRYSSESDVWSFGILLWETFSLGASP-YPN 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  103 bits (259), Expect = 3e-25
 Identities = 53/247 (21%), Positives = 93/247 (37%), Gaps = 35/247 (14%)

Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
             +D   + + + IGRG YG V           VA+K  + A           + +  + 
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR---QNFINEKNIYRVP 62

Query: 85  HLQHENVIAL--KDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQ 141
            ++H+N+      D  + +  R      LV E      L + +    +     C+     
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEY--LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-S 119

Query: 142 LLRGLKYLHSA---------NILHRDLKPGNLLVNANCDLKICDFGLART--------SN 184
           + RGL YLH+           I HRDL   N+LV  +    I DFGL+            
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179

Query: 185 GKNQFMTEYVVTRWYRAPELL------LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE 238
            ++      V T  Y APE+L         ++    +D++++G I+ E+  R       E
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239

Query: 239 CLNQLKL 245
            + + ++
Sbjct: 240 SVPEYQM 246

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  102 bits (257), Expect = 3e-25
 Identities = 68/217 (31%), Positives = 109/217 (50%), Gaps = 19/217 (8%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHL 86
           I+ +Y  +  +G G    V  + +   N KVAIK I      + + L R  RE+     L
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            H+N++++ DV            YLV E ++   L + I+S   L+ D    F  Q+L G
Sbjct: 69  SHQNIVSMIDVDEEDDC-----YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPEL 204
           +K+ H   I+HRD+KP N+L+++N  LKI DFG+A+  +  +   T +V+ T  Y +PE 
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183

Query: 205 LLCCDNYGTSI----DVWSVGCIFAELL-GRKPIFPG 236
                  G +     D++S+G +  E+L G  P F G
Sbjct: 184 AK-----GEATDECTDIYSIGIVLYEMLVGEPP-FNG 214

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  102 bits (256), Expect = 6e-25
 Identities = 61/227 (26%), Positives = 93/227 (40%), Gaps = 32/227 (14%)

Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIKKI-NNAFENRVDALRTLRELKLLRHLQHE 89
           I+ +G G +G V        N  T E VA+K +  +A           +E+ +LR L HE
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW--KQEIDILRTLYHE 93

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++I  K     +   +   + LV E +    L   +     +       F  Q+  G+ Y
Sbjct: 94  HIIKYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYRA 201
           LH+ + +HRDL   N+L++ +  +KI DFGLA+     ++    Y V         WY A
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---YYRVREDGDSPVFWY-A 205

Query: 202 PELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPGTECLNQL 243
           PE    C          DVWS G    EL         P T+ L  +
Sbjct: 206 PE----CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  101 bits (255), Expect = 8e-25
 Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 58/283 (20%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENV 91
           ++ +G G++G V    +R      A+K +         +V+   T  E  +L  + H  +
Sbjct: 11  LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE--HTNDERLMLSIVTHPFI 68

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMD----TDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
           I +           F+D   ++ +MD     +L  +++ SQ   N   +++  ++   L+
Sbjct: 69  IRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM---TEYVVTRWYRAPEL 204
           YLHS +I++RDLKP N+L++ N  +KI DFG A+        +    +Y+      APE+
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEV 174

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
           +     Y  SID WS G +  E+L     F  +   N +K    IL      +L F   P
Sbjct: 175 VSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKIL----NAELRF---P 223

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
                                P  +    DLL +++  D ++R
Sbjct: 224 ---------------------PFFNEDVKDLLSRLITRDLSQR 245

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  100 bits (252), Expect = 1e-24
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 35/225 (15%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
            ID   +   + IG G +G+V        + KVAIK I     +  D    + E +++  
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEED---FIEEAEVMMK 59

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLL 143
           L H  ++ L  V +         + LV E M+   L   +++ +     +        + 
Sbjct: 60  LSHPKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------- 196
            G+ YL  A ++HRDL   N LV  N  +K+ DFG+ R          +Y  +       
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-----DQYTSSTGTKFPV 169

Query: 197 RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
           +W  +PE+     ++   S   DVWS G +  E+   G+ P +  
Sbjct: 170 KWA-SPEVF----SFSRYSSKSDVWSFGVLMWEVFSEGKIP-YEN 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  100 bits (252), Expect = 1e-24
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 41/226 (18%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLL 83
            ++ K + + + IG+G +G V     R    KVA+K I N      DA     L E  ++
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKN------DATAQAFLAEASVM 68

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLF 140
             L+H N++ L  V++         +Y+V E M    L   ++S     L  D    F  
Sbjct: 69  TQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-----TSNGKNQFMTEYVV 195
            +   ++YL   N +HRDL   N+LV+ +   K+ DFGL +        GK       + 
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-------LP 177

Query: 196 TRWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
            +W  APE L         S   DVWS G +  E+   GR P +P 
Sbjct: 178 VKWT-APEAL----REKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 217

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  102 bits (257), Expect = 2e-24
 Identities = 67/249 (26%), Positives = 104/249 (41%), Gaps = 45/249 (18%)

Query: 4   PVEPPNGIRSPGKHYYSMWQTLFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKK 62
           P      + +  + Y S W     ++ K + + + IG+G +G V     R    KVA+K 
Sbjct: 170 PKVMEGTVAAQDEFYRSGW----ALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKC 223

Query: 63  INNAFENRVDALRT--LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-D 119
           I      + DA     L E  ++  L+H N++ L  V++         +Y+V E M    
Sbjct: 224 I------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGS 273

Query: 120 LHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF 177
           L   ++S     L  D    F   +   ++YL   N +HRDL   N+LV+ +   K+ DF
Sbjct: 274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 333

Query: 178 GLAR-----TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL-- 227
           GL +        GK       +  +W  APE L         S   DVWS G +  E+  
Sbjct: 334 GLTKEASSTQDTGK-------LPVKWT-APEAL----REKKFSTKSDVWSFGILLWEIYS 381

Query: 228 LGRKPIFPG 236
            GR P +P 
Sbjct: 382 FGRVP-YPR 389

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  100 bits (251), Expect = 2e-24
 Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 19/213 (8%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHEN 90
           Y   + +GRG  G V  + +      VA+K ++    +      R  RE +    LQ  +
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           V+ + D      +     +Y+   L++  DL  +++    L        + Q+   L   
Sbjct: 96  VVPIHDFGEIDGQ-----LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAA 150

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYRAPELLLCC 208
           H+A   HRD+KP N+LV+A+    + DFG+A  +  +        V T +Y APE     
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS-- 208

Query: 209 DNYGTSI----DVWSVGCIFAELL-GRKPIFPG 236
               +      D++++ C+  E L G  P + G
Sbjct: 209 ---ESHATYRADIYALTCVLYECLTGSPP-YQG 237

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (255), Expect = 4e-24
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 37/226 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           EI  + + + K +G G +G V  +   +   KVA+K +     +       L E  +++ 
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEA---FLAEANVMKT 239

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLFQL 142
           LQH+ ++ L  V+          +Y++ E M    L   +KS             F  Q+
Sbjct: 240 LQHDKLVKLHAVVTKEP------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------ 196
             G+ ++   N +HRDL+  N+LV+A+   KI DFGLAR          EY         
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-----NEYTAREGAKFP 348

Query: 197 -RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
            +W  APE +    N+G+ +I  DVWS G +  E+   GR P +PG
Sbjct: 349 IKWT-APEAI----NFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 99.2 bits (248), Expect = 4e-24
 Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 40/236 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSV-NRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           E+  + + + K +G G +G+V       +    VA+K I     +  +     +E + + 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDE---FFQEAQTMM 58

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS-QALTNDHCQYFLFQL 142
            L H  ++    V           +Y+V E +    L   ++S  + L         + +
Sbjct: 59  KLSHPKLVKFYGVCSKE-----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------ 196
             G+ +L S   +HRDL   N LV+ +  +K+ DFG+ R          +YV +      
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-----DQYVSSVGTKFP 168

Query: 197 -RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG---TECLNQL 243
            +W  APE+     +Y   S   DVW+ G +  E+  LG+ P +     +E + ++
Sbjct: 169 VKWS-APEVF----HYFKYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV 218

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  102 bits (256), Expect = 4e-24
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 21/218 (9%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           EI  + + +   +G+G +G V          +VAIK +     +       L+E ++++ 
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEA---FLQEAQVMKK 318

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQL 142
           L+HE ++ L  V+          +Y+V E M    L   +K    + L          Q+
Sbjct: 319 LRHEKLVQLYAVVSEEP------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY--VVTRWYR 200
             G+ Y+   N +HRDL+  N+LV  N   K+ DFGLAR          +      +W  
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 431

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           APE       +    DVWS G +  EL   GR P +PG
Sbjct: 432 APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 467

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  102 bits (255), Expect = 4e-24
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 21/218 (9%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           EI  + + +   +G+G +G V          +VAIK +     +       L+E ++++ 
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEA---FLQEAQVMKK 235

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQL 142
           L+HE ++ L  V+          +Y+V E M    L   +K    + L          Q+
Sbjct: 236 LRHEKLVQLYAVVSEEP------IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY--VVTRWYR 200
             G+ Y+   N +HRDL+  N+LV  N   K+ DFGLAR          +      +W  
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 348

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           APE  L    +    DVWS G +  EL   GR P +PG
Sbjct: 349 APEAAL-YGRFTIKSDVWSFGILLTELTTKGRVP-YPG 384

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  100 bits (250), Expect = 4e-24
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 25/223 (11%)

Query: 28  IDTKYVPIKPIGRGAYGIV----CSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKL 82
           +  +Y   + +G G    V        +R+    VA+K +            R  RE + 
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQN 65

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQ 141
              L H  ++A+ D    +        Y+V E +D   L  I+ +   +T       +  
Sbjct: 66  AAALNHPAIVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE--YVV-TRW 198
             + L + H   I+HRD+KP N++++A   +K+ DFG+AR        +T+   V+ T  
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184

Query: 199 YRAPELLLCCDNYGTSI----DVWSVGCIFAELL-GRKPIFPG 236
           Y +PE        G S+    DV+S+GC+  E+L G  P F G
Sbjct: 185 YLSPEQAR-----GDSVDARSDVYSLGCVLYEVLTGEPP-FTG 221

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.8 bits (247), Expect = 7e-24
 Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 35/225 (15%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           EID K +   K +G G +G+V     R     VAIK I     +  +    + E K++ +
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSEDE---FIEEAKVMMN 75

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLL 143
           L HE ++ L  V         + ++++ E M    L   ++  +              + 
Sbjct: 76  LSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------- 196
             ++YL S   LHRDL   N LVN    +K+ DFGL+R          EY  +       
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-----DEYTSSVGSKFPV 185

Query: 197 RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
           RW   PE+L     Y   S   D+W+ G +  E+  LG+ P +  
Sbjct: 186 RWS-PPEVL----MYSKFSSKSDIWAFGVLMWEIYSLGKMP-YER 224

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 99.6 bits (249), Expect = 8e-24
 Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 43/224 (19%)

Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           IK +G GA+G V          +    VAIK++           +  L E  ++  + + 
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI--LDEAYVMASVDNP 77

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLK 147
           +V  L  + + S       V L+ +LM    L   ++  +  + + +   +  Q+ +G+ 
Sbjct: 78  HVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSNGKNQFMTEYVVTR 197
           YL    ++HRDL   N+LV     +KI DFGLA+             GK       V  +
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-------VPIK 184

Query: 198 WYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
           W  A E +     +   +   DVWS G    EL   G KP + G
Sbjct: 185 WM-ALESI----LHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (254), Expect = 9e-24
 Identities = 77/322 (23%), Positives = 127/322 (39%), Gaps = 52/322 (16%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIA 93
            + +G+G +G VC+   R T +  A KK+     + R      L E ++L  +    V++
Sbjct: 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DL-HQIIKSSQA-LTNDHCQYFLFQLLRGLKYLH 150
           L              + LV  LM+  DL   I    QA        ++  ++  GL+ LH
Sbjct: 249 LAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              I++RDLKP N+L++ +  ++I D GLA     + Q +   V T  Y APE++   + 
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGRVGTVGYMAPEVVK-NER 361

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           Y  S D W++GC+  E++  +  F       +      +    +E   E+ +        
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQR---KKKIKREEVERLVKEVPEEYSER------- 411

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL--- 322
                     FS       P A  L  ++L  DP +R+     S  E  +HP    L   
Sbjct: 412 ----------FS-------PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454

Query: 323 ------YDPSSNPPAQVPIDLD 338
                  +P   P  Q     D
Sbjct: 455 RLGAGMLEPPFKPDPQAIYCKD 476

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 39/240 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCS----SVNRETNEKVAIKKINNAFENRVDALRT--LRE 79
           EI    V   K IG G +G V      + + +    VAIK +        +  R   L E
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGE 96

Query: 80  LKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQY 137
             ++    H N+I L+ V+          + ++ E M+   L + ++      +      
Sbjct: 97  AGIMGQFSHHNIIRLEGVISKYKP-----MMIITEYMENGALDKFLREKDGEFSVLQLVG 151

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT- 196
            L  +  G+KYL + N +HRDL   N+LVN+N   K+ DFGL+R    ++     Y  + 
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSG 209

Query: 197 -----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG---TECLNQL 243
                RW  APE +    +Y   +   DVWS G +  E+   G +P +      E +  +
Sbjct: 210 GKIPIRWT-APEAI----SYRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)

Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIK--KINNAFENRVDALRTLRE 79
             ID   + + K +G G +G V     ++ +    KVA+K  K++N+ +  ++    L E
Sbjct: 29  VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEF--LSE 86

Query: 80  LKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS------QALTN 132
              ++   H NVI L  V +    +      ++   M   DLH  +  S      + +  
Sbjct: 87  AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
                F+  +  G++YL + N LHRDL   N ++  +  + + DFGL++     +     
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD----Y 202

Query: 193 YVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           Y          +W  A E L   D  Y +  DVW+ G    E+   G  P +PG
Sbjct: 203 YRQGRIAKMPVKWI-AIESLA--DRVYTSKSDVWAFGVTMWEIATRGMTP-YPG 252

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 36/238 (15%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCS---SVNRETNEKVAIKKINNAFENRVDALRTLRELKL 82
           EI+   + I K IG G  G VC     V  + +  VAIK +   +  R      L E  +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASI 103

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLF 140
           +    H N+I L+ V+            +V E M+   L   +++     T       L 
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRL-----AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT---- 196
            +  G++YL     +HRDL   N+LV++N   K+ DFGL+R              T    
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD---AAYTTTGGK 215

Query: 197 ---RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG---TECLNQL 243
              RW  APE +     + T S   DVWS G +  E+   G +P +      + ++ +
Sbjct: 216 IPIRWT-APEAI----AFRTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV 267

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 37/226 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
           E+  + + + + +G G +G V          KVA+K +     +       L E  L++ 
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDA---FLAEANLMKQ 64

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS--QALTNDHCQYFLFQL 142
           LQH+ ++ L  V+          +Y++ E M+   L   +K+     LT +       Q+
Sbjct: 65  LQHQRLVRLYAVVTQEP------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------ 196
             G+ ++   N +HRDL+  N+LV+     KI DFGLAR          EY         
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-----NEYTAREGAKFP 173

Query: 197 -RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
            +W  APE +    NYGT +I  DVWS G +  E+   GR P +PG
Sbjct: 174 IKWT-APEAI----NYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 36/230 (15%)

Query: 35  IKPIGRGAYGIVCS---SVNRETNEKVAIKKINNAFENRVDALRT-LRELKLLRHLQHEN 90
           ++ +G G++G+V              VA+K +     ++ +A+   +RE+  +  L H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLKY 148
           +I L  V++         + +V EL     L   ++  Q          +  Q+  G+ Y
Sbjct: 83  LIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 136

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYRA 201
           L S   +HRDL   NLL+     +KI DFGL R     +     YV+         W  A
Sbjct: 137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD---HYVMQEHRKVPFAWC-A 192

Query: 202 PELLLCCDNYGT-SI--DVWSVGCIFAELL--GRKPIFPG---TECLNQL 243
           PE         T S   D W  G    E+   G++P + G   ++ L+++
Sbjct: 193 PE----SLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 237

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 43/241 (17%)

Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE---KVAIK--KINNAFENRVDALRTLRE 79
           +EI  + + + + IG G +G V   +          VAIK  K   +   R   L+   E
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---E 66

Query: 80  LKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQY 137
              +R   H +++ L  V+  +       V+++ EL    +L   ++  +  L       
Sbjct: 67  ALTMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKYSLDLASLIL 120

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT- 196
           + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R         + Y    
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-----STYYKAS 175

Query: 197 ------RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG---TECLNQ 242
                 +W  APE +    N+   +   DVW  G    E+   G KP F G    + + +
Sbjct: 176 KGKLPIKWM-APESI----NFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGR 229

Query: 243 L 243
           +
Sbjct: 230 I 230

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.0 bits (242), Expect = 6e-23
 Identities = 45/230 (19%), Positives = 87/230 (37%), Gaps = 38/230 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVC----SSVNRETNEKVAIKKIN-NAFENRVDALRTLREL 80
                 +   K +G G +G V               V IK I   +      A+     +
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV--TDHM 66

Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYF 138
             +  L H +++ L  +   S       + LV + +    L   ++  +  L       +
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-- 196
             Q+ +G+ YL    ++HR+L   N+L+ +   +++ DFG+A      +    + ++   
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD----KQLLYSE 176

Query: 197 -----RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
                +W  A E +    ++G  +   DVWS G    EL   G +P + G
Sbjct: 177 AKTPIKWM-ALESI----HFGKYTHQSDVWSYGVTVWELMTFGAEP-YAG 220

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 37/230 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCS---SVNRETNEKVAIK--KINNAFENRVDALRTLREL 80
           E+D   + I K +G G +G VCS    +  +    VAIK  K+    + R D    L E 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD---FLGEA 97

Query: 81  KLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYF 138
            ++    H N+I L+ V+  S     K V +V E M+   L   ++   A  T       
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152

Query: 139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-- 196
           L  +  G+KYL     +HRDL   N+L+N+N   K+ DFGL R      +       T  
Sbjct: 153 LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE---AAYTTRG 209

Query: 197 -----RWYRAPELLLCCDNYG---TSIDVWSVGCIFAEL--LGRKPIFPG 236
                RW  +PE +     Y    ++ DVWS G +  E+   G +P +  
Sbjct: 210 GKIPIRWT-SPEAI----AYRKFTSASDVWSYGIVLWEVMSYGERP-YWE 253

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)

Query: 35  IKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
            + +G+G +G V  +  ++ +    KVA+K +        D    LRE   ++   H +V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 92  IALKDVMMPSH-RRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQ------YFLFQLL 143
             L  V + S  +       ++   M   DLH  + +S+   N           F+  + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT------- 196
            G++YL S N +HRDL   N ++  +  + + DFGL+R     +     Y          
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD----YYRQGCASKLPV 203

Query: 197 RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           +W  A E L   DN Y    DVW+ G    E+   G+ P + G
Sbjct: 204 KWL-ALESLA--DNLYTVHSDVWAFGVTMWEIMTRGQTP-YAG 242

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 36/217 (16%)

Query: 38  IGRGAYGIVCSSV--NRETNEKVAIK--KINNAFENRVDALRTLRELKLLRHLQHENVIA 93
           +G G +G V   V   R+    VAIK  K      +  + +R   E +++  L +  ++ 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYIVR 74

Query: 94  LKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHS 151
           L  V         + + LV E+     LH+ +   +  +   +    L Q+  G+KYL  
Sbjct: 75  LIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYRAPEL 204
            N +HRDL   N+L+      KI DFGL++     +   + Y          +WY APE 
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWPLKWY-APE- 183

Query: 205 LLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
              C N+   S   DVWS G    E    G+KP +  
Sbjct: 184 ---CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKK 216

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.9 bits (234), Expect = 6e-22
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 24/216 (11%)

Query: 35  IKPIGRGAYGIVCSSV---NRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHEN 90
            + IG+G +G+V         +   + AIK ++      +V+A   LRE  L+R L H N
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF--LREGLLMRGLNHPN 83

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS-QALTNDHCQYFLFQLLRGLKY 148
           V+AL  +M+P         +++   M   DL Q I+S  +  T      F  Q+ RG++Y
Sbjct: 84  VLALIGIMLPPEGL----PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-----RWYRAPE 203
           L     +HRDL   N +++ +  +K+ DFGLAR    +  +  +         +W  A E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALE 198

Query: 204 LLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
            L      + T  DVWS G +  EL   G  P +  
Sbjct: 199 SLQ--TYRFTTKSDVWSFGVLLWELLTRGAPP-YRH 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 94.6 bits (236), Expect = 6e-22
 Identities = 71/297 (23%), Positives = 128/297 (43%), Gaps = 59/297 (19%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
            K +G+G++G V  +  ++TN+  AIK               L++  +L     E  +  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIK--------------ALKKDVVLMDDDVECTMVE 67

Query: 95  KDVMMPSHRRNF-----------KDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
           K V+  +    F           ++++ V E ++  DL   I+S          ++  ++
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           + GL++LHS  I++RDLK  N+L++ +  +KI DFG+ + +   +     +  T  Y AP
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 187

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+LL    Y  S+D WS G +  E+L  +  F G    ++ +L  +I      ++  +  
Sbjct: 188 EILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIR----MDNPFY-- 237

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ-HPY 318
            P                           A DLL K+ V +P KR+ V   ++ HP 
Sbjct: 238 -P---------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 94.2 bits (235), Expect = 6e-22
 Identities = 71/298 (23%), Positives = 130/298 (43%), Gaps = 58/298 (19%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENV 91
           +K +G+G +G V     + T    A+K +       ++ V    T+ E ++L++ +H  +
Sbjct: 10  LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA--HTVTESRVLQNTRHPFL 67

Query: 92  IALKDVMMPSHRRNFKDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            ALK       R     +  V  Y    EL     H  +   +  T +  +++  +++  
Sbjct: 68  TALKYAFQTHDR-----LCFVMEYANGGELF---FH--LSRERVFTEERARFYGAEIVSA 117

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
           L+YLHS ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE+L
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
              D YG ++D W +G +  E++  +  F      +  +L   IL     E++ F   P 
Sbjct: 178 EDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELIL----MEEIRF---P- 225

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPY 318
                ++L                P A  LL  +L  DP +R+        E ++H +
Sbjct: 226 -----RTLS---------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 93.9 bits (234), Expect = 8e-22
 Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 43/224 (19%)

Query: 35  IKPIGRGAYGIVC----SSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQHE 89
           IK +G GA+G V          +    VAIK++           +  L E  ++  + + 
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI--LDEAYVMASVDNP 77

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLK 147
           +V  L  + + S       V L+ +LM    L   ++  +  + + +   +  Q+ +G+ 
Sbjct: 78  HVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----------TSNGKNQFMTEYVVTR 197
           YL    ++HRDL   N+LV     +KI DFGLA+             GK       V  +
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-------VPIK 184

Query: 198 WYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG 236
           W  A E +     +   +   DVWS G    EL   G KP + G
Sbjct: 185 WM-ALESI----LHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.0 bits (232), Expect = 8e-22
 Identities = 51/243 (20%), Positives = 103/243 (42%), Gaps = 47/243 (19%)

Query: 26  FEIDTKYVPI-KPIGRGAYGIVCSSV---NRETNEKVAIK--KINNAFENRVDALRTLRE 79
           + I  + V + + +G G +G V   V   ++     VA+K  K +   +N+      + E
Sbjct: 7   YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSE 63

Query: 80  LKLLRHLQHENVIALKDVMM--PSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHC 135
             ++++L H +++ L  ++   P         +++ EL    +L   ++ ++  L     
Sbjct: 64  AVIMKNLDHPHIVKLIGIIEEEP--------TWIIMELYPYGELGHYLERNKNSLKVLTL 115

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV 195
             +  Q+ + + YL S N +HRD+   N+LV +   +K+ DFGL+R          +Y  
Sbjct: 116 VLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYK 170

Query: 196 T-------RWYRAPELLLCCDNYGT-SI--DVWSVGCIFAEL--LGRKPIFPG---TECL 240
                   +W  +PE +    N+   +   DVW       E+   G++P F      + +
Sbjct: 171 ASVTRLPIKWM-SPESI----NFRRFTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVI 224

Query: 241 NQL 243
             L
Sbjct: 225 GVL 227

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 37/231 (16%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
              +  V   + IGRG +G V      + + K    A+K +N   +   +  + L E  +
Sbjct: 21  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGII 79

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQ-IIKSSQALTNDHCQYFLF 140
           ++   H NV++L  + + S         +V   M   DL   I   +   T      F  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 135

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR------------TSNGKNQ 188
           Q+ +G+KYL S   +HRDL   N +++    +K+ DFGLAR             +  K  
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK-- 193

Query: 189 FMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
                +  +W  A E L      + T  DVWS G +  EL   G  P +P 
Sbjct: 194 -----LPVKWM-ALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPP-YPD 235

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 39/229 (17%)

Query: 36  KPIGRGAYGIVCSSVNRETNE--KVAIK--KINNAFENRVDALRTLRELKLLRHLQHENV 91
             +G G +G V   V R   +   VAIK  K      +  + +R   E +++  L +  +
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYI 398

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYL 149
           + L  V           + LV E+     LH+ +   +  +   +    L Q+  G+KYL
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYRAP 202
              N +HR+L   N+L+      KI DFGL++     +   + Y          +WY AP
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWPLKWY-AP 508

Query: 203 ELLLCCDNYGT-SI--DVWSVGCIFAELL--GRKPIFPG---TECLNQL 243
           E    C N+   S   DVWS G    E L  G+KP +      E +  +
Sbjct: 509 E----CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 552

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 59/287 (20%)

Query: 35  IKPIGRGAYG---IVCSSVNRETNEKVAIKKINNAF--ENRVDALRTLRELKLLRHLQHE 89
           ++ +G+G YG    V       T +  A+K +  A    N  D   T  E  +L  ++H 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHP 81

Query: 90  NVIALKDVMMPSHRRNF---KDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLF 140
            ++ L           F     +YL+  Y    EL    +   ++       D   ++L 
Sbjct: 82  FIVDLI--------YAFQTGGKLYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLA 128

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           ++   L +LH   I++RDLKP N+++N    +K+ DFGL + S         +  T  Y 
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE+L+    +  ++D WS+G +  ++L   P F G    N+ K I  IL    +  L  
Sbjct: 189 APEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDKIL----KCKLNL 240

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
              P                   L  +A     DLL+K+L  +   R
Sbjct: 241 ---PP-----------------YLTQEAR----DLLKKLLKRNAASR 263

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 66/293 (22%), Positives = 128/293 (43%), Gaps = 63/293 (21%)

Query: 35  IKPIGRGAYG---IVCSSVNRETNEKVAIKKINNAF--ENRVDALRTLRELKLLRHLQHE 89
           +K +G GAYG   +V      +T +  A+K +  A   +       T  E ++L H++  
Sbjct: 59  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 90  NVIALKDVMMPSHRRNFKDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLFQLL 143
             +    V +    +    ++L+  Y    EL     H  +   +  T    Q ++ +++
Sbjct: 119 PFL----VTLHYAFQTETKLHLILDYINGGELF---TH--LSQRERFTEHEVQIYVGEIV 169

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRW----- 198
             L++LH   I++RD+K  N+L+++N  + + DFGL++      +F+ +     +     
Sbjct: 170 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVADETERAYDFCGT 223

Query: 199 --YRAPELLLCCDN-YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRR 254
             Y AP+++   D+ +  ++D WS+G +  ELL G  P     E  +Q ++   IL    
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL---- 279

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
           + +  +   P                      +   LA DL+Q++L+ DP KR
Sbjct: 280 KSEPPY---P---------------------QEMSALAKDLIQRLLMKDPKKR 308

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 92.5 bits (230), Expect = 4e-21
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 33/229 (14%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
              +  V   + IGRG +G V      + + K    A+K +N   +   +  + L E  +
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGII 143

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQ-ALTNDHCQYFLF 140
           ++   H NV++L  + + S         +V   M   DL   I++     T      F  
Sbjct: 144 MKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT---- 196
           Q+ +G+K+L S   +HRDL   N +++    +K+ DFGLAR     + +  E+       
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKT 254

Query: 197 ------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
                 +W  A E L      + T  DVWS G +  EL   G  P +P 
Sbjct: 255 GAKLPVKWM-ALESLQ--TQKFTTKSDVWSFGVLLWELMTRGAPP-YPD 299

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 90.8 bits (226), Expect = 5e-21
 Identities = 41/234 (17%), Positives = 84/234 (35%), Gaps = 36/234 (15%)

Query: 25  LFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNE-------KVAIKKINNAFENRVDALRT 76
             +I  + +   + +G+G +  +   V RE  +       +V +K ++ A  N  ++   
Sbjct: 2   FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF-- 59

Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQ-ALTNDH 134
                ++  L H++++    V +           LV E +    L   +K ++  +    
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDE-----NILVQEFVKFGSLDTYLKKNKNCINILW 114

Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL--------KICDFGLARTSNGK 186
                 QL   + +L    ++H ++   N+L+    D         K+ D G++ T    
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP- 173

Query: 187 NQFMTEYVVT--RWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG 236
                + +     W   PE +    N   + D WS G    E+   G KP    
Sbjct: 174 ----KDILQERIPWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSA 221

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 93.4 bits (232), Expect = 6e-21
 Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 37/247 (14%)

Query: 18  YYSMWQTLFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIK--KINNAFENRV 71
           Y       +EI  + + + + IG G +G V   +          VAIK  K   +   R 
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436

Query: 72  DALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQA- 129
                L+E   +R   H +++ L  V+  +       V+++ EL    +L   ++  +  
Sbjct: 437 K---FLQEALTMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKFS 487

Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
           L       + +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R        
Sbjct: 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---- 543

Query: 190 MTEYVVT-------RWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG---T 237
            + Y          +W  APE +     + ++ DVW  G    E+   G KP F G    
Sbjct: 544 -STYYKASKGKLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNN 599

Query: 238 ECLNQLK 244
           + + +++
Sbjct: 600 DVIGRIE 606

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 91.1 bits (227), Expect = 7e-21
 Identities = 64/285 (22%), Positives = 114/285 (40%), Gaps = 57/285 (20%)

Query: 35  IKPIGRGAYG---IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +K +G+G++G   +V      +  +  A+K +  A     D +RT  E  +L  + H  +
Sbjct: 29  LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 92  IALKDVMMPSHRRNF---KDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLFQL 142
           + L           F     +YL+  +    +L        +      T +  +++L +L
Sbjct: 89  VKLH--------YAFQTEGKLYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAEL 135

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
              L +LHS  I++RDLKP N+L++    +K+ DFGL++ S    +    +  T  Y AP
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E++     +  S D WS G +  E+L     F G    ++ + +  IL    +  L    
Sbjct: 196 EVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMIL----KAKLGM-- 245

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
            P                         P A  LL+ +   +P  R
Sbjct: 246 -P---------------------QFLSPEAQSLLRMLFKRNPANR 268

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 91.1 bits (227), Expect = 8e-21
 Identities = 57/286 (19%), Positives = 113/286 (39%), Gaps = 51/286 (17%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IGRG+Y  V     ++T+   A+K               +++  +      + V   
Sbjct: 14  LRVIGRGSYAKVLLVRLKKTDRIYAMK--------------VVKKELVNDDEDIDWVQTE 59

Query: 95  KDVMMPSHRRNF-----------KDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
           K V   +    F             ++ V E ++  DL   ++  + L  +H +++  ++
Sbjct: 60  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
              L YLH   I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y AP
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 179

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+L   D YG S+D W++G +  E++  +  F      +          +  +   + I 
Sbjct: 180 EILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVIL 232

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA-HPLAIDLLQKMLVFDPTKR 307
             + R                  P +    A  +L+  L  DP +R
Sbjct: 233 EKQIR-----------------IPRSLSVKAASVLKSFLNKDPKER 261

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 76/299 (25%), Positives = 129/299 (43%), Gaps = 59/299 (19%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENV 91
           +K +G+G +G V     + T    A+K +       ++ V    TL E ++L++ +H  +
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA--HTLTENRVLQNSRHPFL 210

Query: 92  IALKDVMMPSHRRNFKDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLFQLLRG 145
            ALK       R     +  V  Y    EL     H  +   +  + D  +++  +++  
Sbjct: 211 TALKYSFQTHDR-----LCFVMEYANGGELF---FH--LSRERVFSEDRARFYGAEIVSA 260

Query: 146 LKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
           L YLHS  N+++RDLK  NL+++ +  +KI DFGL +        M  +  T  Y APE+
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

Query: 205 LLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
           L   D YG ++D W +G +  E++  +  F      +  KL   IL     E++ F   P
Sbjct: 321 LEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELIL----MEEIRF---P 369

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPY 318
                 ++L                P A  LL  +L  DP +R+        E +QH +
Sbjct: 370 ------RTLG---------------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 59/290 (20%), Positives = 114/290 (39%), Gaps = 68/290 (23%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           I+ +G+G++G V  +  +ET +  A+K               L++  +L+    E  +  
Sbjct: 28  IRVLGKGSFGKVMLARVKETGDLYAVK--------------VLKKDVILQDDDVECTMTE 73

Query: 95  KDVMMPSHRRNF-----------KDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQY 137
           K ++  +    F             ++ V  +    +LM    H  I+ S+       ++
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLM---FH--IQKSRRFDEARARF 128

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           +  +++  L +LH   I++RDLK  N+L++     K+ DFG+ +           +  T 
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTP 188

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            Y APE+L     YG ++D W++G +  E+L     F      N+  L   IL     ++
Sbjct: 189 DYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAIL----NDE 240

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
           + +   P                        H  A  +L+  +  +PT R
Sbjct: 241 VVY---P---------------------TWLHEDATGILKSFMTKNPTMR 266

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 56/286 (19%), Positives = 113/286 (39%), Gaps = 51/286 (17%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           ++ IGRG+Y  V     ++T+   A++               +++  +      + V   
Sbjct: 57  LRVIGRGSYAKVLLVRLKKTDRIYAMR--------------VVKKELVNDDEDIDWVQTE 102

Query: 95  KDVMMPSHRRNF-----------KDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQL 142
           K V   +    F             ++ V E ++  DL   ++  + L  +H +++  ++
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
              L YLH   I++RDLK  N+L+++   +K+ D+G+ +         + +  T  Y AP
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+L   D YG S+D W++G +  E++  +  F      +          +  +   + I 
Sbjct: 223 EILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------QNTEDYLFQVIL 275

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDA-HPLAIDLLQKMLVFDPTKR 307
             + R                  P +    A  +L+  L  DP +R
Sbjct: 276 EKQIR-----------------IPRSLSVKAASVLKSFLNKDPKER 304

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 88.4 bits (220), Expect = 5e-20
 Identities = 67/249 (26%), Positives = 95/249 (38%), Gaps = 49/249 (19%)

Query: 35  IKPIGRGAYGIV-----CSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHLQH 88
            K +G G +G V          R     VA+K +  NA  + +  L  L E  +L+ + H
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL--LSEFNVLKQVNH 85

Query: 89  ENVIALKDV------------MMPS--------HRRNFKDVYLVYELMDTDLHQIIKSSQ 128
            +VI L                             R     YL                +
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 129 ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ 188
           ALT      F +Q+ +G++YL    ++HRDL   N+LV     +KI DFGL+R    ++ 
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED- 204

Query: 189 FMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG-- 236
               YV         +W  A E L   D+ Y T  DVWS G +  E+  LG  P +PG  
Sbjct: 205 ---SYVKRSQGRIPVKWM-AIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPGIP 257

Query: 237 -TECLNQLK 244
                N LK
Sbjct: 258 PERLFNLLK 266

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.4 bits (220), Expect = 8e-20
 Identities = 61/306 (19%), Positives = 121/306 (39%), Gaps = 73/306 (23%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +  +G+G++G V  S  + T+E  A+K               L++  +++    E  +  
Sbjct: 25  LMVLGKGSFGKVMLSERKGTDELYAVK--------------ILKKDVVIQDDDVECTMVE 70

Query: 95  KDVMMPSHRRNF-----------KDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQY 137
           K V+    +  F             +Y V  Y    +LM    H  I+        H  +
Sbjct: 71  KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVF 125

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           +  ++  GL +L S  I++RDLK  N+++++   +KI DFG+ + +         +  T 
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 185

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            Y APE++     YG S+D W+ G +  E+L  +  F G    ++ +L  +I+    E +
Sbjct: 186 DYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIM----EHN 237

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTE 312
           + +   P                           A+ + + ++   P KR+        +
Sbjct: 238 VAY---P---------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERD 273

Query: 313 ALQHPY 318
             +H +
Sbjct: 274 IKEHAF 279

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 88.1 bits (219), Expect = 9e-20
 Identities = 72/281 (25%), Positives = 112/281 (39%), Gaps = 57/281 (20%)

Query: 11  IRSPGKHYYSMWQTLFEIDTKY-VP------IKPIGRGAYGIV-----CSSVNRETNEKV 58
             S    Y+ +    +E D K+  P       K +G GA+G V             + +V
Sbjct: 19  TGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV 78

Query: 59  AIKKIN-NAFENRVDALRTLRELKLLRHL-QHENVIAL-----KD-----VM--MP---- 100
           A+K +   A  +  +AL  + ELK++  L  HEN++ L            +         
Sbjct: 79  AVKMLKEKADSSEREAL--MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136

Query: 101 -----SHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANIL 155
                S R  F +  + YE  +    +  +    LT +    F +Q+ +G+++L   + +
Sbjct: 137 LNYLRSKREKFSEDEIEYE--NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194

Query: 156 HRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYRAPELLLCC 208
           HRDL   N+LV     +KICDFGLAR     +     YVV        +W  APE L   
Sbjct: 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWM-APESLFEG 249

Query: 209 DNYGTSIDVWSVGCIFAEL--LGRKP---IFPGTECLNQLK 244
             Y    DVWS G +  E+  LG  P   I         ++
Sbjct: 250 -IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 289

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 69/300 (23%), Positives = 125/300 (41%), Gaps = 54/300 (18%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELK-LLRHLQHENVI 92
           +K IG+G++G V  + ++      A+K +       + +    + E   LL++++H  ++
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 93  ALKDVMMPSHRRNFKDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGL 146
            L         +    +Y V  Y    EL     H  ++  +       +++  ++   L
Sbjct: 103 GLH-----FSFQTADKLYFVLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASAL 152

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
            YLHS NI++RDLKP N+L+++   + + DFGL + +   N   + +  T  Y APE+L 
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLH 212

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
               Y  ++D W +G +  E+L   P F      N  ++  NIL     + L+       
Sbjct: 213 KQP-YDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNIL----NKPLQL---K-- 259

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI----SVTEALQHPYMSPL 322
                              P+    A  LL+ +L  D TKR+       E   H + S +
Sbjct: 260 -------------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 61/273 (22%), Positives = 104/273 (38%), Gaps = 55/273 (20%)

Query: 3   TPVEPPNGIRSPGKHY------YSMWQTLFEIDTKYVPI-KPIGRGAYGIVC-----SSV 50
           + + P  G  S  + +      Y     +  I  + + +   +G GA+G V      + +
Sbjct: 7   SSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLL 66

Query: 51  NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY 110
             +    VA+K +  A E+        RE +LL  LQH++++    V         + + 
Sbjct: 67  PEQDKMLVAVKALKEASESARQDF--QREAELLTMLQHQHIVRFFGVCTEG-----RPLL 119

Query: 111 LVYELMDT-DLHQ---------------IIKSSQALTNDHCQYFLFQLLRGLKYLHSANI 154
           +V+E M   DL++                  +   L          Q+  G+ YL   + 
Sbjct: 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF 179

Query: 155 LHRDLKPGNLLVNANCDLKICDFGLAR--------TSNGKNQFMTEYVVTRWYRAPELLL 206
           +HRDL   N LV     +KI DFG++R           G+          RW   PE +L
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-----PIRWM-PPESIL 233

Query: 207 CCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
                + T  DVWS G +  E+   G++P +  
Sbjct: 234 --YRKFTTESDVWSFGVVLWEIFTYGKQP-WYQ 263

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 64/256 (25%), Positives = 92/256 (35%), Gaps = 59/256 (23%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSV--NRETNEKVAIKKIN-NAFENRVDALRTLRELKL 82
            +D   +     IG G +G V  +           AIK++   A ++         EL++
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF--AGELEV 78

Query: 83  LRHL-QHENVIALKDV---MMPSHRRNFKDVYLVYELM-----------------DTDLH 121
           L  L  H N+I L                 +YL  E                   D    
Sbjct: 79  LCKLGHHPNIINLLGACEHRGY--------LYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130

Query: 122 QIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR 181
               ++  L++    +F   + RG+ YL     +HRDL   N+LV  N   KI DFGL+R
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

Query: 182 TSNGKNQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRK 231
                      YV         RW  A E L    + Y T+ DVWS G +  E+  LG  
Sbjct: 191 GQE-------VYVKKTMGRLPVRWM-AIESLN--YSVYTTNSDVWSYGVLLWEIVSLGGT 240

Query: 232 PIFPG---TECLNQLK 244
           P + G    E   +L 
Sbjct: 241 P-YCGMTCAELYEKLP 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 58/235 (24%), Positives = 93/235 (39%), Gaps = 49/235 (20%)

Query: 35  IKPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE 89
            + +G GA+G V      +    +    VA+K + +            RE +LL +LQHE
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF--QREAELLTNLQHE 77

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQ----------------IIKSSQALTN 132
           +++    V           + +V+E M   DL++                  ++   L  
Sbjct: 78  HIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--------TSN 184
               +   Q+  G+ YL S + +HRDL   N LV AN  +KI DFG++R           
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192

Query: 185 GKNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG 236
           G           RW   PE ++     + T  DVWS G I  E+   G++P +  
Sbjct: 193 GHTML-----PIRWM-PPESIM--YRKFTTESDVWSFGVILWEIFTYGKQP-WFQ 238

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 60/290 (20%), Positives = 116/290 (40%), Gaps = 68/290 (23%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           +  +G+G++G V  S  + T+E  A+K               L++  +++    E  +  
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVK--------------ILKKDVVIQDDDVECTMVE 391

Query: 95  KDVMMPSHRRNF-----------KDVYLV--Y----ELMDTDLHQIIKSSQALTNDHCQY 137
           K V+    +  F             +Y V  Y    +LM    H  I+        H  +
Sbjct: 392 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLM---YH--IQQVGRFKEPHAVF 446

Query: 138 FLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           +  ++  GL +L S  I++RDLK  N+++++   +KI DFG+ + +         +  T 
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            Y APE++     YG S+D W+ G +  E+L  +  F G    ++ +L  +I+    E +
Sbjct: 507 DYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIM----EHN 558

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
           + +   P                           A+ + + ++   P KR
Sbjct: 559 VAY---P---------------------KSMSKEAVAICKGLMTKHPGKR 584

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 55/248 (22%)

Query: 35  IKPIGRGAYGIV-----CSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-Q 87
            K +G GA+G V           +   KVA+K +   A  +  +AL  + ELK++ HL Q
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL--MSELKIMSHLGQ 108

Query: 88  HENVIALKDV---MMPSHRRNFKDVYLVYELM---------------DTDLHQIIKSSQA 129
           HEN++ L        P        V ++ E                          ++  
Sbjct: 109 HENIVNLLGACTHGGP--------VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 130 LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF 189
            +     +F  Q+ +G+ +L S N +HRD+   N+L+      KI DFGLAR     +  
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-- 218

Query: 190 MTEYVVT-------RWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKPIFPG---- 236
              Y+V        +W  APE +  C  Y    DVWS G +  E+  LG  P +PG    
Sbjct: 219 --NYIVKGNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNP-YPGILVN 273

Query: 237 TECLNQLK 244
           ++    +K
Sbjct: 274 SKFYKLVK 281

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 85.4 bits (212), Expect = 6e-19
 Identities = 67/243 (27%), Positives = 101/243 (41%), Gaps = 48/243 (19%)

Query: 35  IKPIGRGAYGIV-----CSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-Q 87
            KP+GRGA+G V            T   VA+K +   A  +   AL  + ELK+L H+  
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGH 89

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELM-----------------DTDLHQIIKSSQAL 130
           H NV+ L         +    + ++ E                      +         L
Sbjct: 90  HLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM 190
           T +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR         
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP--- 202

Query: 191 TEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECL 240
            +YV         +W  APE +   D  Y    DVWS G +  E+  LG  P +PG +  
Sbjct: 203 -DYVRKGDARLPLKWM-APETIF--DRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKID 257

Query: 241 NQL 243
            + 
Sbjct: 258 EEF 260

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 85.0 bits (211), Expect = 8e-19
 Identities = 58/246 (23%), Positives = 98/246 (39%), Gaps = 57/246 (23%)

Query: 35  IKPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQ 87
            + +G+G++G+V        V  E   +VAIK +N   E      R   L E  +++   
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFN 86

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSS----------QALTNDHCQ 136
             +V+ L  V+            ++ ELM   DL   ++S              +     
Sbjct: 87  CHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT 196
               ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R     + + T+Y   
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDY--- 193

Query: 197 RWYR------------APELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG---TE 238
             YR            +PE L   D  + T  DVWS G +  E+  L  +P + G    +
Sbjct: 194 --YRKGGKGLLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQ 248

Query: 239 CLNQLK 244
            L  + 
Sbjct: 249 VLRFVM 254

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 84.6 bits (210), Expect = 8e-19
 Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 51/247 (20%)

Query: 25  LFEIDTKYVPI-KPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRT-- 76
           L EI    V   + +G   +G V           E  + VAIK +    +     LR   
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEF 59

Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQ------------- 122
             E  L   LQH NV+ L  V+        + + +++      DLH+             
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114

Query: 123 ---IIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
                    AL      + + Q+  G++YL S +++H+DL   N+LV    ++KI D GL
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174

Query: 180 ARTSNGKNQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LG 229
            R     +     Y +        RW  APE ++     +    D+WS G +  E+   G
Sbjct: 175 FREVYAAD----YYKLLGNSLLPIRWM-APEAIM--YGKFSIDSDIWSYGVVLWEVFSYG 227

Query: 230 RKPIFPG 236
            +P + G
Sbjct: 228 LQP-YCG 233

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.8 bits (208), Expect = 2e-18
 Identities = 66/251 (26%), Positives = 98/251 (39%), Gaps = 57/251 (22%)

Query: 35  IKPIGRGAYGIV-----CSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-Q 87
            K +G GA+G V        +  +    VA+K +  +A     +AL  + ELK+L +L  
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL--MSELKVLSYLGN 85

Query: 88  HENVIALKDV---MMPSHRRNFKDVYLVYELM-------------------DTDLHQIIK 125
           H N++ L        P          ++ E                      T    +  
Sbjct: 86  HMNIVNLLGACTIGGP--------TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 126 SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG 185
              AL  +    F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGLAR    
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 186 KNQFMTEYVVT-------RWYRAPELLLCCDNYGTSIDVWSVGCIFAEL--LGRKP---I 233
            +     YVV        +W  APE +  C  Y    DVWS G    EL  LG  P   +
Sbjct: 198 DS----NYVVKGNARLPVKWM-APESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 234 FPGTECLNQLK 244
              ++    +K
Sbjct: 252 PVDSKFYKMIK 262

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 83.8 bits (206), Expect = 3e-18
 Identities = 50/344 (14%), Positives = 95/344 (27%), Gaps = 68/344 (19%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKI---------------NNA 66
           +      + K    + IG G +G V  ++    +  VAIK I                  
Sbjct: 13  FSHCLPTE-KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEE 69

Query: 67  FENRVDALRTLRELKLLRHLQHENVIALKDVMM-------------------------PS 101
               +   + L  L      + E  I L  V                             
Sbjct: 70  ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129

Query: 102 HRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLK 160
                  +++V E     +      ++  +    +  L QL   L    ++    HRDL 
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189

Query: 161 PGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSV 220
            GN+L+      K+         NGK+  +    +          +   +Y  S      
Sbjct: 190 WGNVLLKKTSLKKLHYTL-----NGKSSTIPSCGLQ---------VSIIDYTLSRLERDG 235

Query: 221 GCIFAELLGRKPIFPGTECLN-QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGT 279
             +F ++   + +F G       +  ++    + R  +     N     Y+        T
Sbjct: 236 IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 280 PFSRLYPDAHPLAI----DLLQKMLVFDPTKRISVTEALQHPYM 319
             ++    A         +  + ML F      S T+ L    +
Sbjct: 296 FKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 52/222 (23%), Positives = 75/222 (33%), Gaps = 45/222 (20%)

Query: 35  IKPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQ 87
           ++ IG GA+G V        +  E    VA+K +    E     ++    RE  L+    
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFD 108

Query: 88  HENVIALKDV------------MMP--------SHRRNFKDVYLVYELMDTDLHQIIKSS 127
           + N++ L  V             M                   L +  + T         
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 128 QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN 187
             L+         Q+  G+ YL     +HRDL   N LV  N  +KI DFGL+R     +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 188 QFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVG 221
                Y          RW   PE +    N Y T  DVW+ G
Sbjct: 229 ----YYKADGNDAIPIRWM-PPESIF--YNRYTTESDVWAYG 263

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 57/241 (23%)

Query: 35  IKPIGRGAYGIV-------CSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL 86
            KP+G G +G V             +    VA+K +  +A E  +  L  + E+++++ +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMI 143

Query: 87  -QHENVIALKDV---MMPSHRRNFKDVYLVYELM-----------------DTDLHQIIK 125
            +H+N+I L        P        +Y++ E                   +        
Sbjct: 144 GKHKNIINLLGACTQDGP--------LYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195

Query: 126 SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG 185
             + +T        +QL RG++YL S   +HRDL   N+LV  N  +KI DFGLAR  N 
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 186 KNQFMTEYVVT-------RWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFP 235
            +     Y  T       +W  APE L   D  Y    DVWS G +  E+  LG  P +P
Sbjct: 256 ID----YYKKTTNGRLPVKWM-APEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YP 307

Query: 236 G 236
           G
Sbjct: 308 G 308

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 54/245 (22%), Positives = 92/245 (37%), Gaps = 55/245 (22%)

Query: 35  IKPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQ 87
           I+ +G GA+G V         N  +  +VA+K +    E   +      L E  ++    
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFN 91

Query: 88  HENVIALKDV---MMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
           H+N++    V    +P         +++ ELM   DL   ++ ++   +      +  LL
Sbjct: 92  HQNIVRCIGVSLQSLP--------RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 144 -------RGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR--------TSNG 185
                   G +YL   + +HRD+   N L+         KI DFG+AR           G
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203

Query: 186 KNQFMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG---TEC 239
                      +W   PE  +  +  + +  D WS G +  E+  LG  P +P     E 
Sbjct: 204 CAML-----PVKWM-PPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQEV 254

Query: 240 LNQLK 244
           L  + 
Sbjct: 255 LEFVT 259

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 73/286 (25%), Positives = 111/286 (38%), Gaps = 74/286 (25%)

Query: 15  GKHYYSMWQTLFEIDTKYVP--------------IKPIGRGAYGIV-------CSSVNRE 53
             H++S    L  +    +P               KP+G GA+G V             +
Sbjct: 6   HHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPK 65

Query: 54  TNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QHENVIALKDV---MMPSHRRNFKD 108
               VA+K +  +A E  +  L  + E+++++ + +H+N+I L        P        
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDL--VSEMEMMKMIGKHKNIINLLGACTQDGP-------- 115

Query: 109 VYLVYELM-----------------DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS 151
           +Y++ E                   +          + +T        +QL RG++YL S
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 152 ANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYRAPEL 204
              +HRDL   N+LV  N  +KI DFGLAR  N  +     Y  T       +W  APE 
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----YYKKTTNGRLPVKWM-APEA 230

Query: 205 LLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG---TECLNQLK 244
           L   D  Y    DVWS G +  E+  LG  P +PG    E    LK
Sbjct: 231 LF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLK 273

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 63/345 (18%), Positives = 118/345 (34%), Gaps = 91/345 (26%)

Query: 35  IKPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLLRHLQ 87
           I+ +G GA+G V         N  +  +VA+K +    E   +      L E  ++    
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFN 132

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL--- 143
           H+N++    V + S        +++ ELM   DL   ++ ++   +      +  LL   
Sbjct: 133 HQNIVRCIGVSLQS-----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 144 ----RGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR--------TSNGKNQ 188
                G +YL   + +HRD+   N L+         KI DFG+AR           G   
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 189 FMTEYVVTRWYRAPELLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPGTECLNQLKL 245
                   +W   PE  +  +  + +  D WS G +  E+  LG  P +P          
Sbjct: 248 L-----PVKWM-PPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMP-YPS--------- 289

Query: 246 IINILGSRREEDLEFIDNPKARKYIKS---LPYTPGTPFSRLYPDAHPLAIDLLQKML-- 300
                            N +  +++ S   +      P   +Y           + M   
Sbjct: 290 ---------------KSNQEVLEFVTSGGRMDPPKNCP-GPVY-----------RIMTQC 322

Query: 301 -VFDPTKRIS---VTEALQHPYMSPLYDPSSNPPAQVPIDLDMDE 341
               P  R +   + E +++    P    ++ P    P+  + ++
Sbjct: 323 WQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEK 367

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 72/287 (25%), Positives = 115/287 (40%), Gaps = 61/287 (21%)

Query: 1   MATPVEPPNGIRSPGKHYYSMWQTLFEID-TKYVPIKPIGRGAYGIV-------CSSVNR 52
             T      G+ +    Y       +E+   + V  KP+G GA+G V             
Sbjct: 39  PTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKP 98

Query: 53  ETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QHENVIALKDV---MMPSHRRNFK 107
               KVA+K +  +A E  +  L  + E+++++ + +H+N+I L        P       
Sbjct: 99  NRVTKVAVKMLKSDATEKDLSDL--ISEMEMMKMIGKHKNIINLLGACTQDGP------- 149

Query: 108 DVYLVYELM-----------------DTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
            +Y++ E                   +   +      + L++       +Q+ RG++YL 
Sbjct: 150 -LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 208

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT-------RWYRAPE 203
           S   +HRDL   N+LV  +  +KI DFGLAR  +  +     Y  T       +W  APE
Sbjct: 209 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYKKTTNGRLPVKWM-APE 263

Query: 204 LLLCCDN-YGTSIDVWSVGCIFAEL--LGRKPIFPG---TECLNQLK 244
            L   D  Y    DVWS G +  E+  LG  P +PG    E    LK
Sbjct: 264 ALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFKLLK 307

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 34/283 (12%), Positives = 74/283 (26%), Gaps = 63/283 (22%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHL 86
            + +Y  +   G         +++   + +VA+  ++            TL     L  +
Sbjct: 29  ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRG 145
               V  + DV+            +V E +    L ++  +  + +       +  L   
Sbjct: 89  DKPGVARVLDVVHTRAG-----GLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAA 141

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
               H A +      P  + V+ + D+ +        +N ++                  
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD------------------ 183

Query: 206 LCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP 264
                     D+  +G     LL  R P  P     + L                     
Sbjct: 184 ----------DIRGIGASLYALLVNRWP-LPEAGVRSGL--------------------A 212

Query: 265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR 307
            A +     P  P    + +  D       +  + +  D   R
Sbjct: 213 PAERDTAGQPIEP----ADIDRDIPFQISAVAARSVQGDGGIR 251

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 73.7 bits (182), Expect = 6e-15
 Identities = 58/242 (23%), Positives = 88/242 (36%), Gaps = 68/242 (28%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRT--LRELKLL 83
           F+     V    +G G +G+V       T   VA+KK+    +   + L+    +E+K++
Sbjct: 27  FDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVM 84

Query: 84  RHLQHENVIAL-----KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYF 138
              QHEN++ L                     LVY  M               N      
Sbjct: 85  AKCQHENLVELLGFSSDG----DDL------CLVYVYM--------------PNGSLLDR 120

Query: 139 LFQLL------------------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
           L  L                    G+ +LH  + +HRD+K  N+L++     KI DFGLA
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 181 RTS-NGKNQFMTEYVV-TRWYRAPELLLCCDNYGT------SIDVWSVGCIFAELL-GRK 231
           R S       MT  +V T  Y APE                S D++S G +  E++ G  
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPE-------ALRGEITPKS-DIYSFGVVLLEIITGLP 232

Query: 232 PI 233
            +
Sbjct: 233 AV 234

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 75/233 (32%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA-------FENRVDALRTLRELKLLRHLQHEN 90
           IG G +G V   V R+   KVA+K+           FE          E++ L   +H +
Sbjct: 47  IGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFET---------EIETLSFCRHPH 96

Query: 91  VIAL------KDVMMPSHRRNFKDVYLVYELMDTD-----LHQIIKSSQALTNDHCQYFL 139
           +++L      ++ M+           L+Y+ M+       L+     + +++ +      
Sbjct: 97  LVSLIGFCDERNEMI-----------LIYKYMENGNLKRHLYGSDLPTMSMSWE------ 139

Query: 140 FQLL-------RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
            Q L       RGL YLH+  I+HRD+K  N+L++ N   KI DFG+++     +Q    
Sbjct: 140 -QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ---T 195

Query: 193 YVVTRW-----YRAPELLLCCDNYGTSI------DVWSVGCIFAELL-GRKPI 233
           ++ T       Y  PE       Y          DV+S G +  E+L  R  I
Sbjct: 196 HLSTVVKGTLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 35/167 (20%), Positives = 63/167 (37%), Gaps = 19/167 (11%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           ++V  K IG G +G++  +      EK A   +    E + +      ELK  + +  ++
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQ-ENGPLFSELKFYQRVAKKD 94

Query: 91  VIALKDVMMPSHRRNFKDVY--------------LVYELMDTDLHQIIKSSQALTNDHCQ 136
            I                 Y              +V E +  DL +I   +         
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL 154

Query: 137 YFLFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCD-LKICDFGLAR 181
               ++L  L+Y+H    +H D+K  NLL+   N D + + D+GL+ 
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 50/249 (20%)

Query: 38  IGRGAYGIVCSSVNRETNEKVAIKKINNA--------FENRVDALRTLRELKLLRHLQHE 89
           +GRG +G V           VA+K++           F+          E++++    H 
Sbjct: 38  LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT---------EVEMISMAVHR 87

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELM-----DTDLHQIIKSSQALTNDHCQYFLFQLLR 144
           N++ L+   M    R      LVY  M      + L +  +S   L     Q       R
Sbjct: 88  NLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142

Query: 145 GLKYLH---SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV-TRWYR 200
           GL YLH      I+HRD+K  N+L++   +  + DFGLA+  + K+  +T  V  T  + 
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHI 202

Query: 201 APELLLCCDNYGTS------IDVWSVGCIFAELL-GRKPI----FPGTECLNQLKLIINI 249
           APE       Y ++       DV+  G +  EL+ G++          + +  L  +  +
Sbjct: 203 APE-------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 250 LGSRREEDL 258
           L  ++ E L
Sbjct: 256 LKEKKLEAL 264

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 22/164 (13%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHL 86
           +   +   K IG G +G +    N  TNE VAIK      E        L  E +  + L
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQL 61

Query: 87  QHENVIALKDVMMPSHR---RNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQL 142
              + I       P         K   +V EL+   L  +     +  +         QL
Sbjct: 62  GSGDGI-------PQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQL 114

Query: 143 LRGLKYLHSANILHRDLKPGNLLV--NANCDLKIC---DFGLAR 181
           +  ++Y+HS N+++RD+KP N L+    N   ++    DF LA+
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.5 bits (175), Expect = 6e-14
 Identities = 41/133 (30%), Positives = 62/133 (46%), Gaps = 16/133 (12%)

Query: 113 YELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL 172
              ++ +          LT +H   + FQ+ +G+++L S   +HRDL   N+L++    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 173 KICDFGLARTSNGKNQFMTEYVVT-------RWYRAPELLLCCDNYGTSIDVWSVGCIFA 225
           KICDFGLAR          +YV         +W  APE +     Y    DVWS G +  
Sbjct: 233 KICDFGLARDIYKDP----DYVRKGDARLPLKWM-APETIFDR-VYTIQSDVWSFGVLLW 286

Query: 226 EL--LGRKPIFPG 236
           E+  LG  P +PG
Sbjct: 287 EIFSLGASP-YPG 298

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 36/181 (19%), Positives = 69/181 (38%), Gaps = 18/181 (9%)

Query: 36  KPIGRGAYGIVC-----SSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRHL-QH 88
           KP+GRGA+G V            T   VA+K +   A  +   AL  + ELK+L H+  H
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL--MSELKILIHIGHH 85

Query: 89  ENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
            NV+ L         +    + ++ E     +L   ++S +     +      +  +G  
Sbjct: 86  LNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG-ARFRQGKD 140

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC 207
           Y+     +  DLK     + ++       F   ++ +   +      + + +   E L+C
Sbjct: 141 YV---GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197

Query: 208 C 208
            
Sbjct: 198 Y 198

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 20/162 (12%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHL 86
           +  +Y   + IG G++G +    +    E+VAIK      E        L  E K+ + +
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMM 61

Query: 87  QHENVIALKDVMMPSHR---RNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQL 142
           Q    I       P+ R          +V EL+   L  +    S+  +         Q+
Sbjct: 62  QGGVGI-------PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 114

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR 181
           +  ++Y+HS N +HRD+KP N L+        + I DFGLA+
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 20/162 (12%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHL 86
           +  K+   + IG G++G +    N +TNE+VAIK      EN       L  E K+ R L
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRIL 59

Query: 87  QHENVIALKDVMMPSHR---RNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQL 142
           Q    I       P+ R          LV +L+   L  +    S+ L+         Q+
Sbjct: 60  QGGTGI-------PNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 112

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR 181
           +  ++++HS + LHRD+KP N L+        + I DFGLA+
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 22/164 (13%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHL 86
           +   Y   + IG G++G++    N   N++VAIK     FE R      L  E +  + L
Sbjct: 8   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLL 62

Query: 87  QHENVIALKDVMMPSHR---RNFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQL 142
                I       P+     +      LV +L+   L  ++    +  +         Q+
Sbjct: 63  AGCTGI-------PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM 115

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLK-----ICDFGLAR 181
           L  ++ +H  ++++RD+KP N L+            + DFG+ +
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.1 bits (155), Expect = 3e-11
 Identities = 48/397 (12%), Positives = 112/397 (28%), Gaps = 107/397 (26%)

Query: 16  KHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALR 75
            +Y  +   +     K    +P       +     +R  N+     K N    +R+    
Sbjct: 89  INYKFLMSPI-----KTEQRQPSMM--TRMYIEQRDRLYNDNQVFAKYN---VSRLQPYL 138

Query: 76  TLRELKLLRHLQHENVIAL-------KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ 128
            LR  + L  L+    + +       K  +      ++K    V   MD  +  +     
Sbjct: 139 KLR--QALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK----VQCKMDFKIFWL----- 187

Query: 129 ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ 188
            L N +    + ++L+ L Y    N   R     N+ +  +  ++              +
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH-SIQ----------AELRR 236

Query: 189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC----LNQLK 244
            +      + Y     LL         +V +     A        F    C      + K
Sbjct: 237 LLKS----KPY--ENCLLVLL------NVQNAKAWNA--------F-NLSCKILLTTRFK 275

Query: 245 LIINILGSRREEDLEFIDNPKA----------RKYIKSLPYTPGTPFSRLYPDA---HPL 291
            + + L +     +    +              KY+             L  +    +P 
Sbjct: 276 QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL-------DCRPQDLPREVLTTNPR 328

Query: 292 AIDLLQKMLVFDP--------------TKRISVT-EALQHPYMSPLYD------PSSNPP 330
            + ++ + +                  T  I  +   L+      ++D      PS++ P
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP 388

Query: 331 AQVPIDL--DMDEESGEEMIREMMLKEMLHYHPEAIT 365
             +   +  D+ +     ++ ++    ++   P+  T
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 24/179 (13%), Positives = 51/179 (28%), Gaps = 40/179 (22%)

Query: 31  KYVPIKPIGRGAYGIV--------CSSVNRETNEKVAIK--------KINNAFENRVDAL 74
           ++       R   GI+         +  +    +K ++K             F  R    
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102

Query: 75  RTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDH 134
             + + K L       +       +   +  F    LV   +   L   +        D 
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF----LVLPSLGRSLQSAL--------DV 150

Query: 135 CQYFLF----------QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI--CDFGLAR 181
               +           +LL  L++LH    +H ++   N+ V+     ++    +G A 
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 28/173 (16%)

Query: 31  KYVPIKPIGRGAYGIV-----CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
            +    PIG+G +G +      SS +  ++    +K          D      ELK  + 
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK------VEPSDNGPLFTELKFYQR 89

Query: 86  LQHENVIA-------LKDVMMP------SHRRNFKDV-YLVYELMDTDLHQIIKS-SQAL 130
                 I        LK + +P       H +N K   +++ +   +DL +I ++ ++  
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149

Query: 131 TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCD-LKICDFGLAR 181
           +         ++L  L+Y+H    +H D+K  NLL+N  N D + + D+GLA 
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 31/170 (18%), Positives = 67/170 (39%), Gaps = 24/170 (14%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIV--CSSVNRETNEKVAIKKI--NNAFENRVDALRTL 77
           W    +   + +P   IG+GA   +   S ++ +   K  +KK   +   +  +   RT 
Sbjct: 328 WIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTA 387

Query: 78  RELKLLRHLQHENVIA--LKDVMMPSHRRNFKDVYLVYE-LMDTDLHQIIKSSQALTNDH 134
           RE + L  ++   + A  + DV       +  +  ++   +       +I+ +  +    
Sbjct: 388 REARYLALVKDFGIPAPYIFDV-------DLDNKRIMMSYINGKLAKDVIEDNLDIAYK- 439

Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN 184
                  +   +  LH  +++H DL   N + + +  +   DFGL + SN
Sbjct: 440 -------IGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI--IDFGLGKISN 480

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	373
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.9
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.81
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.25
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.78
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.72
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.44
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.34
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.23
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.11
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.07
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.92
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.79
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.66
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.56
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.43
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.42
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.4
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.29
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.29
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.23
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.74
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.88
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.12

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-73  Score=529.10  Aligned_cols=336  Identities=49%  Similarity=0.894  Sum_probs=297.3

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-CC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-RR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~  104 (373)
                      +.+.++|++++.||+|+||+||+|+++.+|+.||||++++.........++.+|+.+|+.++|||||++++++.... ..
T Consensus        50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            45778999999999999999999999999999999999877777777778899999999999999999999986532 24


Q ss_pred             CcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          105 NFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +.+++|||||||+|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus       130 ~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          130 EFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             TCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             cCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            55789999999999999999998999999999999999999999999999999999999999999999999999998653


Q ss_pred             C----CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 G----KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .    ......+.+||++|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..|....|.+....+..
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            2    223456789999999999998867789999999999999999999999999999999999999999999888887


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMD  340 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  340 (373)
                      ........+....+.....++...++.++++++|||++||..||++|||+.|+|+||||+...++...+....+++...+
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~~~~~~~  369 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPFDFAFD  369 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSSCCCCHHH
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCCCCCCccc
Confidence            77777888888999888889999999999999999999999999999999999999999998888877777777776654


Q ss_pred             c-ccCHHHHHHHHHHHHHhcCc
Q 017334          341 E-ESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       341 ~-~~~~~~~~~~~~~e~~~~~~  361 (373)
                      . +...+.+++.+.+|+..+++
T Consensus       370 ~~~~~~~~~k~~i~~ei~~~~~  391 (398)
T 4b99_A          370 REALTRERIKEAIVAEIEDFHA  391 (398)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhhcCHHHHHHHHHHHHHHHHH
Confidence            4 45678899999999887654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.1e-68  Score=470.67  Aligned_cols=255  Identities=31%  Similarity=0.486  Sum_probs=208.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++..... ....++.+|+.+++.++||||+++++++     ++.+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence            68999999999999999999999999999999997654332 2345678999999999999999999999     45578


Q ss_pred             EEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          109 VYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      +|+||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.... ..
T Consensus        88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~  166 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-GN  166 (275)
T ss_dssp             EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-CC
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999986543 33


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ...+.+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..                  
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------------  228 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------------  228 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------------
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            34567999999999999875556789999999999999999999999887666665554310                  


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                   ...+..+|+++++||++||+.||++|||++|+++||||+.
T Consensus       229 -------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          229 -------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             -------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                         0122457899999999999999999999999999999963

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.3e-68  Score=476.90  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=225.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+++|+.++|||||+++++|     ++.+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~  105 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE  105 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            4689999999999999999999999999999999976432 222345678999999999999999999999     5557


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC-
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG-  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~-  185 (373)
                      .+|+|||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.... 
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            8999999996 69999999989999999999999999999999999999999999999999999999999999987643 


Q ss_pred             -CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          186 -KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       186 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                       ......+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+.-              
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--------------  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--------------  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------------
T ss_pred             CCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------
Confidence             2334567899999999999987 679999999999999999999999999988777776665410              


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHH------HhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE------ALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e------il~hp~~~~~  322 (373)
                                       ..++..+|+++++||++||+.||++|||++|      +++||||+.+
T Consensus       251 -----------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          251 -----------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             -----------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence                             0122457899999999999999999999987      5899999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.1e-68  Score=484.17  Aligned_cols=256  Identities=25%  Similarity=0.440  Sum_probs=221.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+|+.++|||||++++++     ++.+.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence            799999999999999999999999999999999987766666677889999999999999999999999     455789


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      |||||||+ |+|.+++...  ..+++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.....
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999996 6999999754  35799999999999999999999999999999999999999999999999999876544


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.  .              
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~--------------  241 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--S--------------  241 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--C--------------
T ss_pred             cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC--C--------------
Confidence            444566789999999999987 68999999999999999999999999998877777666541  0              


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                    +...+..+|+++++||.+||+.||++|||+.|+|+||||+.
T Consensus       242 --------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          242 --------------FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             --------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                          11223568899999999999999999999999999999964

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-67  Score=478.96  Aligned_cols=257  Identities=26%  Similarity=0.483  Sum_probs=224.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++.......  ...+.+|+.+|+.++|||||++++++     ++.+.
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~  145 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSY-----LVGDE  145 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence            467999999999999999999999999999999997553332  23467899999999999999999999     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|||||||+ |+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+......
T Consensus       146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999996 699998876 679999999999999999999999999999999999999999999999999998876665


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.....                
T Consensus       225 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~----------------  287 (346)
T 4fih_A          225 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----------------  287 (346)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC----------------
T ss_pred             CcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC----------------
Confidence            66678899999999999876 6799999999999999999999999998887776666544110                


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                  +....+..+|+++++||.+||+.||++|||+.|+|+||||+..
T Consensus       288 ------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          288 ------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             ------------CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ------------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence                        0011234578999999999999999999999999999999754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.3e-67  Score=471.67  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=216.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|++++.||+|+||+||+|++.   .+++.||||++++.........++.+|+.+|+.++|||||++++++     ++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            68999999999999999999884   4688999999976543333333577899999999999999999999     455


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +.+|+|||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            78999999996 79999999989999999999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ......+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+..               
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------------  242 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK---------------  242 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------------
Confidence            5555667899999999999987 689999999999999999999999999988777777665410               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                      ...+..+|+++++||++||+.||++|||     ++|+++||||+.+
T Consensus       243 ----------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          243 ----------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence                            0123458899999999999999999998     5799999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.4e-66  Score=480.48  Aligned_cols=257  Identities=26%  Similarity=0.483  Sum_probs=225.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++.......  ...+.+|+.+|+.++|||||+++++|     ...+.
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~  222 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSY-----LVGDE  222 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEE-----EECCE
Confidence            467999999999999999999999999999999997553332  23577999999999999999999999     44478


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|||||||+ |+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus       223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999996 699998875 579999999999999999999999999999999999999999999999999998776665


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ....+.+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.....                
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~----------------  364 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----------------  364 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC----------------
T ss_pred             ccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC----------------
Confidence            66678899999999999976 6799999999999999999999999998887777666644110                


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                  +....+..+|+++++||.+||..||++|||+.|+|+||||+..
T Consensus       365 ------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          365 ------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                        0112235689999999999999999999999999999999754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.3e-65  Score=457.54  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=219.8

Q ss_pred             eecCce-eeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKY-VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y-~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ...++| ++.+.||+|+||+||+|.++.+|..||+|++...........++.+|+.+++.++|||||++++++.... ..
T Consensus        22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~  100 (290)
T 3fpq_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG  100 (290)
T ss_dssp             CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TT
T ss_pred             CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CC
Confidence            345566 6778899999999999999999999999999877666667778899999999999999999999985432 23


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcC-CCCeEEcccCccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNA-NCDLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~  181 (373)
                      ...+|||||||+ |+|.+++...+.+++.+++.++.||+.||+|||++|  |+||||||+|||++. ++.+||+|||+|+
T Consensus       101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            467999999996 799999998899999999999999999999999999  999999999999985 7999999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ....  ....+.+||+.|||||++.+  .|+.++|||||||++|+|++|++||.+.+....+.....  ....       
T Consensus       181 ~~~~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~--~~~~-------  247 (290)
T 3fpq_A          181 LKRA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGVK-------  247 (290)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--TTCC-------
T ss_pred             eCCC--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH--cCCC-------
Confidence            6433  33456799999999999864  599999999999999999999999987654443322211  1100       


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                         ........++++++||.+||+.||++|||+.|+|+||||+.
T Consensus       248 -------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          248 -------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                               01122457889999999999999999999999999999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.4e-65  Score=462.16  Aligned_cols=256  Identities=26%  Similarity=0.380  Sum_probs=218.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++.....       .+|+.+++.++|||||++++++     ++.+.+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~-----~~~~~~  125 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAV-----REGPWV  125 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            5689999999999999999999999999999999764322       3699999999999999999999     445789


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~  187 (373)
                      |||||||+ |+|.++++..+.+++.+++.++.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+......
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999996 69999999889999999999999999999999999999999999999999998 69999999998654321


Q ss_pred             c-----cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          188 Q-----FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       188 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .     .....+||+.|||||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|.+.             
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-------------  271 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-------------  271 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-------------
T ss_pred             cccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-------------
Confidence            1     1234589999999999987 68999999999999999999999999887766555555431             


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHH-------------hCCCCCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA-------------LQHPYMSPLYDPS  326 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~ei-------------l~hp~~~~~~~~~  326 (373)
                                     ..++..+++.+++.+.+||.+||+.||++|||+.|+             |+|||+.....|.
T Consensus       272 ---------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          272 ---------------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             ---------------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             ---------------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                           112234567899999999999999999999999997             6899998775554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-62  Score=471.13  Aligned_cols=340  Identities=43%  Similarity=0.796  Sum_probs=284.3

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ..+.+.++|++++.||+|+||+||+|+++.+|+.||||++.+.........++.+|+.+|+.++||||+++++++.....
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            34567899999999999999999999999999999999998777777777888999999999999999999999976655


Q ss_pred             CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          104 RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      +....+|+||||++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       127 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          127 EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             TTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             ccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            56678999999999999999998889999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC---------------------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-------
Q 017334          184 NGKN---------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-------  229 (373)
Q Consensus       184 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-------  229 (373)
                      ....                           ......+||++|+|||++.....++.++|||||||++|+|++       
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence            3211                           234567889999999988666789999999999999999998       


Q ss_pred             ----CCCCCCCCCc--------------------hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccC
Q 017334          230 ----RKPIFPGTEC--------------------LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY  285 (373)
Q Consensus       230 ----g~~pf~~~~~--------------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (373)
                          |.++|++.+.                    .+++..|.+++|.+..+.+..........+....+......+...+
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                8888987653                    5788899999999999999999999999999999988888999999


Q ss_pred             CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCc--ccccCHHHHHHHHHHHHHhcCccc
Q 017334          286 PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDM--DEESGEEMIREMMLKEMLHYHPEA  363 (373)
Q Consensus       286 ~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~e~~~~~~~~  363 (373)
                      +.+++.+.+||++||..||++|||++|+|+||||+.+..+..++....+.....  ......+.+++.+.+|+.+++|+.
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  446 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEI  446 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCTTC
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCccc
Confidence            999999999999999999999999999999999998866655544433333332  346678999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.9e-62  Score=462.67  Aligned_cols=340  Identities=42%  Similarity=0.768  Sum_probs=294.8

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .+.+.++|++++.||+|+||.||+|+++.+|+.||||++...........++.+|+.+++.++||||+++++++......
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence            36788999999999999999999999999999999999987777777778889999999999999999999999765444


Q ss_pred             CcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          105 NFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ....+|+||||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       101 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          101 KFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             TCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             cCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            45779999999999999999988889999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC----------------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-----------CC
Q 017334          185 GKN----------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-----------RK  231 (373)
Q Consensus       185 ~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-----------g~  231 (373)
                      ...                      ......+||++|+|||++.....++.++|||||||++|+|++           |.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            322                      124677899999999998666789999999999999999997           67


Q ss_pred             CCCCCCC-----------------chHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHH
Q 017334          232 PIFPGTE-----------------CLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAID  294 (373)
Q Consensus       232 ~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  294 (373)
                      |+|.+.+                 ..+++..+...+|.+..+.+..+.......++...+.....++...++.+++.+.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            7777765                 36788999999999999999999999999999999988888888888999999999


Q ss_pred             HHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCcc--cccCHHHHHHHHHHHHHhcCcccc
Q 017334          295 LLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMD--EESGEEMIREMMLKEMLHYHPEAI  364 (373)
Q Consensus       295 ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~e~~~~~~~~~  364 (373)
                      ||++||+.||++|||++|+|+||||+.+..+...+....+......  .....+.+++++.+|+..++|+..
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  412 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELV  412 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCcccc
Confidence            9999999999999999999999999988776665544433333333  467889999999999999998753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-61  Score=449.18  Aligned_cols=345  Identities=43%  Similarity=0.789  Sum_probs=292.8

Q ss_pred             CCcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeee
Q 017334           14 PGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA   93 (373)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~   93 (373)
                      .|.....+....+.+.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+++.++||||++
T Consensus         9 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~   88 (367)
T 1cm8_A            9 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG   88 (367)
T ss_dssp             CSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCC
T ss_pred             CCceEEEecCceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCC
Confidence            34445667778899999999999999999999999999999999999999877666666778889999999999999999


Q ss_pred             eceeecCCC-CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334           94 LKDVMMPSH-RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus        94 ~~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                      +++++.... ......+|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        89 l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~  167 (367)
T 1cm8_A           89 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL  167 (367)
T ss_dssp             CSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred             ceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCE
Confidence            999986542 123356899999999899999876 679999999999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      ||+|||+++....   .....++|++|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+....|.
T Consensus       168 kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~  244 (367)
T 1cm8_A          168 KILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  244 (367)
T ss_dssp             EECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999999987543   2355688999999999987667999999999999999999999999999999999999999999


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQ  332 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~  332 (373)
                      ++.+....+.......+...++......+...++.+++.+.+||.+||+.||++|||+.++|+||||+.+.++...+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~  324 (367)
T 1cm8_A          245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ  324 (367)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC
T ss_pred             CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC
Confidence            99999988888888999999999888899999999999999999999999999999999999999999887776655544


Q ss_pred             CCCCCCccc-ccCHHHHHHHHHHHHHhcCccc
Q 017334          333 VPIDLDMDE-ESGEEMIREMMLKEMLHYHPEA  363 (373)
Q Consensus       333 ~~~~~~~~~-~~~~~~~~~~~~~e~~~~~~~~  363 (373)
                       +.+...++ +...+.+++++.+|+..++|..
T Consensus       325 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (367)
T 1cm8_A          325 -KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR  355 (367)
T ss_dssp             -CCCCC-----CCHHHHHHHHHHHHHTCCC--
T ss_pred             -CCCCChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence             34444443 5678899999999999988874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-62  Score=453.63  Aligned_cols=286  Identities=29%  Similarity=0.470  Sum_probs=222.8

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      +-.+.++|++++.||+|+||+||+|+++   .+++.||||++.+...    ..++.+|+++|+.+ +||||++++++|  
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~--   89 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCF--   89 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEE--
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEE--
Confidence            3357789999999999999999999875   4678999999865422    33577899999998 599999999999  


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CCeEEcccC
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFG  178 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-~~~kL~Dfg  178 (373)
                         +..+++|+||||++ |+|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus        90 ---~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           90 ---RKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             ---EETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             ---EECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence               45578999999996 69999884   59999999999999999999999999999999999999887 799999999


Q ss_pred             cccccCCCC----------------------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC
Q 017334          179 LARTSNGKN----------------------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR  230 (373)
Q Consensus       179 ~a~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  230 (373)
                      +|+......                            ....+.+||++|+|||++.+...|+.++||||+||++|+|++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            997543221                            1234568999999999998866799999999999999999999


Q ss_pred             CCCC-CCCCchHHHHHHHHHhCCCChhhhcc-----------cCChhHHHHHHhC-------CC-----CCCCCccccCC
Q 017334          231 KPIF-PGTECLNQLKLIINILGSRREEDLEF-----------IDNPKARKYIKSL-------PY-----TPGTPFSRLYP  286 (373)
Q Consensus       231 ~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~-------~~-----~~~~~~~~~~~  286 (373)
                      ++|| .+.+..+++..|..++|.+.......           .............       +.     .........+.
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            9877 56677788999998888543221110           0001111111100       00     00111223456


Q ss_pred             CCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          287 DAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       287 ~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .+|++++|||++||+.||++|+|++|+|+||||+.+
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            789999999999999999999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.7e-61  Score=447.52  Aligned_cols=343  Identities=46%  Similarity=0.842  Sum_probs=286.3

Q ss_pred             ceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeece
Q 017334           17 HYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKD   96 (373)
Q Consensus        17 ~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   96 (373)
                      ..+.+.+..+.+.++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~   95 (367)
T 2fst_X           16 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD   95 (367)
T ss_dssp             EEEEETTEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             ceEeecCcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            34567889999999999999999999999999999999999999999877666667778889999999999999999999


Q ss_pred             eecCCC-CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEc
Q 017334           97 VMMPSH-RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus        97 ~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      ++.... ......+|+|+|+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X           96 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             EECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEe
Confidence            986531 123366899999999999998876 679999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      |||+++....   .....+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.+..
T Consensus       175 DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~  251 (367)
T 2fst_X          175 DFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  251 (367)
T ss_dssp             C------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999976532   2355689999999999987667999999999999999999999999999999999999999999999


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPI  335 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~  335 (373)
                      +.+..+.......+...++..+...+...++.+++.+.+||.+||+.||++|||+.++|+||||..+..+...+... +.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~-~~  330 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PY  330 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-CC
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-CC
Confidence            99999888888999999988888888888999999999999999999999999999999999999887776655444 45


Q ss_pred             CCCccc-ccCHHHHHHHHHHHHHhcCcccc
Q 017334          336 DLDMDE-ESGEEMIREMMLKEMLHYHPEAI  364 (373)
Q Consensus       336 ~~~~~~-~~~~~~~~~~~~~e~~~~~~~~~  364 (373)
                      +...+. +...+.+++++.+|+..++|...
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  360 (367)
T 2fst_X          331 DQSLESRDLLIDEWKSLTYDEVISFVPPPL  360 (367)
T ss_dssp             CGGGSSCCCCHHHHHHHHHHHHHHCCCCC-
T ss_pred             CcchhhccCCHHHHHHHHHHHHHHhccCcc
Confidence            544433 56789999999999999988753

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.2e-62  Score=439.41  Aligned_cols=259  Identities=24%  Similarity=0.451  Sum_probs=199.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC------
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR------  103 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------  103 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++... ......++.+|+.+|+.++|||||++++++...+.      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            46999999999999999999999999999999997543 33445578899999999999999999999865421      


Q ss_pred             -CCcceEEEEeecCC-ccHHHHHHhcCCCC---HHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccC
Q 017334          104 -RNFKDVYLVYELMD-TDLHQIIKSSQALT---NDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       104 -~~~~~~~lv~e~~~-g~L~~~l~~~~~~~---~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                       .....+|+|||||+ |+|.+++...+.++   +..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence             12346899999996 79999998765543   45688999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC------------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017334          179 LARTSNGKN------------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI  246 (373)
Q Consensus       179 ~a~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  246 (373)
                      +|+......            ...++.+||+.|||||++.+ ..|+.++|||||||++|+|++   ||.+.  .+....+
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~  237 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL  237 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence            998654321            12345689999999999987 689999999999999999996   66442  2333333


Q ss_pred             HHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ..+.....+                           ..++..++.+.+||++||+.||++|||+.|+|+||||+.+
T Consensus       238 ~~~~~~~~p---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          238 TDVRNLKFP---------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHTTCCC---------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHhcCCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            332221110                           1112345678899999999999999999999999999865

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-60  Score=448.79  Aligned_cols=333  Identities=43%  Similarity=0.768  Sum_probs=266.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  105 (373)
                      .+.++|++++.||+|+||.||+|.++.+|+.||||++...........+..+|+.+++.+. ||||+++++++...   +
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---N   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---T
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---C
Confidence            3568999999999999999999999999999999999877777777788899999999998 99999999998643   2


Q ss_pred             cceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          106 FKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ...+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           83 DRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SSCEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CCEEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence            357999999999999999976 5899999999999999999999999999999999999999999999999999975422


Q ss_pred             ---------------------CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHH
Q 017334          186 ---------------------KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLK  244 (373)
Q Consensus       186 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  244 (373)
                                           ........+||++|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                                 12234557899999999999876789999999999999999999999999999999999


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCC---CCCccccC-------------CCCCHHHHHHHHhhcCcCCCCCC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTP---GTPFSRLY-------------PDAHPLAIDLLQKMLVFDPTKRI  308 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------------~~~s~~~~~ll~~~L~~dP~~R~  308 (373)
                      .+...++.+..........+....+...++...   ...+...+             ..+++.+.+||.+||+.||++||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence            999999999988877666654444433322111   11222222             26789999999999999999999


Q ss_pred             CHHHHhCCCCCCCCCCCCCCCCCCCCCCCCcc--cccCHHHHHHHHHHHHHhcCccc
Q 017334          309 SVTEALQHPYMSPLYDPSSNPPAQVPIDLDMD--EESGEEMIREMMLKEMLHYHPEA  363 (373)
Q Consensus       309 t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~e~~~~~~~~  363 (373)
                      |+.|+|+||||+.+..+...+.....++....  .....+.+++.+.+|+.++.++-
T Consensus       322 t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  378 (388)
T 3oz6_A          322 SANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKREL  378 (388)
T ss_dssp             CHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhhhh
Confidence            99999999999988877776666555555443  35678899999999988877653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.5e-60  Score=453.10  Aligned_cols=341  Identities=43%  Similarity=0.762  Sum_probs=271.5

Q ss_pred             CcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeee
Q 017334           15 GKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL   94 (373)
Q Consensus        15 ~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   94 (373)
                      +...+...+..+.+.++|++++.||+|+||+||+|++..+|+.||||++.+.........++.+|+.+++.++||||+++
T Consensus        47 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  126 (464)
T 3ttj_A           47 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL  126 (464)
T ss_dssp             CEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             cceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            33444456677888999999999999999999999999999999999998776677777788899999999999999999


Q ss_pred             ceeecCCCC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeE
Q 017334           95 KDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (373)
Q Consensus        95 ~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~k  173 (373)
                      ++++..... +....+|+||||++++|.+.+..  .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus       127 ~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~k  204 (464)
T 3ttj_A          127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  204 (464)
T ss_dssp             SEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEE
Confidence            999965432 34467999999999999888754  599999999999999999999999999999999999999999999


Q ss_pred             EcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          174 ICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       174 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      |+|||+++.... .......+||++|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.+
T Consensus       205 l~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p  282 (464)
T 3ttj_A          205 ILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  282 (464)
T ss_dssp             ECCCCCC------CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred             EEEEEeeeecCC-CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999999986543 333566799999999999987 579999999999999999999999999999999999999999999


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCC------------CHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDA------------HPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ....+.... .....+....+......+...++..            ++.+++||.+||+.||++|||++|+|+||||+.
T Consensus       283 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          283 CPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             CHHHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             CHHHHHHcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence            887766553 4556666666655555555444432            677999999999999999999999999999997


Q ss_pred             CCCCCCCCCC-CCCCCCCcc-cccCHHHHHHHHHHHHHhcC
Q 017334          322 LYDPSSNPPA-QVPIDLDMD-EESGEEMIREMMLKEMLHYH  360 (373)
Q Consensus       322 ~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~e~~~~~  360 (373)
                      +.++...... ....+...+ .+...+.+++.+.+|+....
T Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~  402 (464)
T 3ttj_A          362 WYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE  402 (464)
T ss_dssp             GCCHHHHSCCC-----------CCCHHHHHHHHHHHHHC--
T ss_pred             ccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHHHhh
Confidence            7655432221 122222222 35567888898888876543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.2e-59  Score=436.46  Aligned_cols=339  Identities=50%  Similarity=0.926  Sum_probs=296.3

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      .+..+.+.++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...
T Consensus        19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   97 (364)
T 3qyz_A           19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAP   97 (364)
T ss_dssp             C-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             ccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence            355677889999999999999999999999999999999999743 3344456788999999999999999999999765


Q ss_pred             CCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          102 HRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      ........|+||||++|+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A           98 TIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             STTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            5455567999999999999999876 579999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          182 TSNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       182 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ......   ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+.....
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            654321   22355689999999999877667899999999999999999999999999999999999999999999988


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLD  338 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~  338 (373)
                      ..........+....+.....++...++.+++.+.+||.+||+.||++|||+.|+|+||||+..+.+...+....++..+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~  336 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD  336 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCCCCC
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCCcCCcc
Confidence            88888888888888888888888888999999999999999999999999999999999999988877777766677666


Q ss_pred             ccc-ccCHHHHHHHHHHHHHhcCcc
Q 017334          339 MDE-ESGEEMIREMMLKEMLHYHPE  362 (373)
Q Consensus       339 ~~~-~~~~~~~~~~~~~e~~~~~~~  362 (373)
                      ... +...+.+++.+.+|+.+++|+
T Consensus       337 ~~~~~~~~~~~~~~~~~e~~~~~~~  361 (364)
T 3qyz_A          337 MELDDLPKEKLKELIFEETARFQPG  361 (364)
T ss_dssp             -----CCHHHHHHHHHHHTGGGCC-
T ss_pred             cccccCCHHHHHHHHHHHHHHhhhh
Confidence            544 556889999999999888876

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-60  Score=465.46  Aligned_cols=258  Identities=24%  Similarity=0.361  Sum_probs=216.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc----ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE----NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...    .........+++.+++.++|||||+++++|     ++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f-----~~  263 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT  263 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----EE
Confidence            789999999999999999999999999999999975432    112222233456777788999999999999     55


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+.+|+|||||. |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            578999999996 7999999998999999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..  ...+.+||+.|||||++.++..|+.++|||||||++|+|++|.+||.+.+..+.......+....           
T Consensus       344 ~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-----------  410 (689)
T 3v5w_A          344 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-----------  410 (689)
T ss_dssp             SC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-----------
T ss_pred             CC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-----------
Confidence            33  24567999999999999765679999999999999999999999998754433322222211110           


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                       ...+..+|+++++||.+||+.||++|++     ++||++||||+.+
T Consensus       411 -----------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          411 -----------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             -----------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence                             1233568999999999999999999998     7999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-58  Score=431.81  Aligned_cols=350  Identities=45%  Similarity=0.811  Sum_probs=299.4

Q ss_pred             CCCCCCCCCcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC
Q 017334            7 PPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL   86 (373)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l   86 (373)
                      .-.-...+|.-........+.+.++|++.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.+
T Consensus        19 ~m~~~~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l   98 (371)
T 4exu_A           19 SMSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM   98 (371)
T ss_dssp             --CCSSCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC
T ss_pred             ceeeeccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc
Confidence            33344555665666677778999999999999999999999999999999999999987766666677888999999999


Q ss_pred             CCCCeeeeceeecCCCC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 017334           87 QHENVIALKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL  165 (373)
Q Consensus        87 ~hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nil  165 (373)
                      +||||+++++++..... ......|+||||++++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        99 ~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  176 (371)
T 4exu_A           99 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLA  176 (371)
T ss_dssp             CCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             CCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeE
Confidence            99999999999965421 1223459999999999988874  45999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHH
Q 017334          166 VNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKL  245 (373)
Q Consensus       166 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  245 (373)
                      ++.++.+||+|||++......   ....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus       177 l~~~~~~kL~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  253 (371)
T 4exu_A          177 VNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  253 (371)
T ss_dssp             ECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ECCCCCEEEEecCcccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            999999999999999765332   34567899999999998766789999999999999999999999999999999999


Q ss_pred             HHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          246 IINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      +....+.+...............+....+..+...+...++.+++.+.+||.+||+.||++|||+.|+|+||||..+..+
T Consensus       254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence            99999999999888888888888888888888888888889999999999999999999999999999999999988777


Q ss_pred             CCCCCCCCCCCCCccc-ccCHHHHHHHHHHHHHhcCc
Q 017334          326 SSNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       326 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~e~~~~~~  361 (373)
                      ........+.+..... +...+.+++.+.+|+..++|
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          334 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             GGCCCCSSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             ccccccccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            6666666566554443 55688999999999998876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.3e-59  Score=457.87  Aligned_cols=262  Identities=25%  Similarity=0.431  Sum_probs=226.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +-++|++++.||+|+||+||+|+++.+|+.||+|++.+..  ......+.+|+.+|+.++|||||+++++|     ++.+
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~  227 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDN  227 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSS
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence            3478999999999999999999999999999999996543  33455678999999999999999999999     5557


Q ss_pred             eEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC--CCeEEcccCccccc
Q 017334          108 DVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN--CDLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~--~~~kL~Dfg~a~~~  183 (373)
                      .+|+|||||+ |+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+..
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            8999999996 699999864 4689999999999999999999999999999999999999865  79999999999877


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+..|.......          
T Consensus       308 ~~-~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~----------  375 (573)
T 3uto_A          308 DP-KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM----------  375 (573)
T ss_dssp             CT-TSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC----------
T ss_pred             cC-CCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC----------
Confidence            43 344566799999999999987 689999999999999999999999999988877777665421111          


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                                       ....++.+|+.+++||++||+.||++|||+.|+|+||||+....+
T Consensus       376 -----------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          376 -----------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             -----------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             -----------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence                             112346789999999999999999999999999999999875433

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-59  Score=418.18  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=206.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+++++.++||+|+||+||+|+++.   .||||+++...........+.+|+.++++++|||||++++++..      +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            4788999999999999999998653   59999998766666667788999999999999999999998732      35


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC-
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG-  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~-  185 (373)
                      +|||||||+ |+|.+++... +.+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.... 
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            899999996 7999999754 6799999999999999999999999999999999999999999999999999986542 


Q ss_pred             -CCccccceeeccccCchhhhhcC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          186 -KNQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       186 -~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                       ........+||+.|||||++.+.  ..|+.++|||||||++|||++|++||.+.+....+..+......          
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~----------  255 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA----------  255 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC----------
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----------
Confidence             22334567899999999999752  35899999999999999999999999887665544443321000          


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                     .......++.+++.+.+|+.+||+.||++|||+.++++
T Consensus       256 ---------------~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          256 ---------------SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             ---------------CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             ---------------CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                           01122345678899999999999999999999987643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-59  Score=419.49  Aligned_cols=252  Identities=23%  Similarity=0.344  Sum_probs=209.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++|.+.+.||+|+||+||+|++.     .+|..||||+++..  .......+.+|+++|++++|||||++++++.    
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~----   85 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV----   85 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe----
Confidence            368999999999999999999875     36789999999753  3444567889999999999999999999994    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS-------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~  169 (373)
                       +.+.+|||||||+ |+|.+++...             ..+++.++..++.||+.||+|||+++|+||||||+|||++.+
T Consensus        86 -~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           86 -EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             -SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             -eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence             4467999999996 7999999754             369999999999999999999999999999999999999999


Q ss_pred             CCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 017334          170 CDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLI  246 (373)
Q Consensus       170 ~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  246 (373)
                      +.+||+|||+|+......  ......+||+.|||||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..+
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998653322  22334579999999999987 679999999999999999998 89999988777666655


Q ss_pred             HHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      .+.  ..                            ...++.+++++.+||.+||+.||++|||+.+++  +|+.
T Consensus       244 ~~~--~~----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~  285 (299)
T 4asz_A          244 TQG--RV----------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ  285 (299)
T ss_dssp             HHT--CC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred             HcC--CC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence            441  00                            112346789999999999999999999999994  4553

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.2e-57  Score=419.37  Aligned_cols=337  Identities=46%  Similarity=0.844  Sum_probs=289.0

Q ss_pred             EecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeec
Q 017334           20 SMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMM   99 (373)
Q Consensus        20 ~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   99 (373)
                      ......+.+.++|++.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           14 DVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             EETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             eecCcccccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            34556678899999999999999999999999999999999999876666666677889999999999999999999986


Q ss_pred             CCCC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccC
Q 017334          100 PSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       100 ~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      .... .....+|+||||++++|.+++.  ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             cccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecc
Confidence            5421 1223569999999999988774  359999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ++......   .....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+.....
T Consensus       172 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          172 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             CTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             cccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99765322   345688999999999977567899999999999999999999999999999999999999999998888


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLD  338 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~  338 (373)
                      ....+.....+....+..+...+...++.+++.+.+||.+||+.||++|||+.++++||||.....+........+++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~  328 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDS  328 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCCccc
Confidence            88888888888888888777778888889999999999999999999999999999999999887766665555555544


Q ss_pred             cc-cccCHHHHHHHHHHHHHhcCc
Q 017334          339 MD-EESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       339 ~~-~~~~~~~~~~~~~~e~~~~~~  361 (373)
                      .. +....+.+++.+.+|+.+++|
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          329 LEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             TTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             hhhccCCHHHHHHHHHHHHHhhcc
Confidence            33 356788999999999988776

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.5e-58  Score=418.01  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=204.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++|.+.++||+|+||+||+|+++     .+++.||||+++..  .......+.+|+++|++++|||||++++++.    
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~----  113 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCT----  113 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            367899999999999999999865     36889999999753  3445567889999999999999999999994    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS---------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                       ..+.+|||||||+ |+|.+++...               +++++.++..++.||+.||+|||+++|+||||||+||||+
T Consensus       114 -~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          114 -EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             -SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             -ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence             4467999999996 7999999753               3589999999999999999999999999999999999999


Q ss_pred             CCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017334          168 ANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLK  244 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  244 (373)
                      .++.+||+|||+|+......  ......+||+.|||||++.+ ..++.++|||||||++|||+| |++||.+.+..+.+.
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999998653322  22345689999999999987 679999999999999999998 899999887766666


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+.+.  ..                            ...++.+++++.+|+.+||+.||++|||+.||+++
T Consensus       272 ~i~~g--~~----------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQG--RE----------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHT--CC----------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcC--CC----------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            55431  00                            01234578999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-57  Score=414.43  Aligned_cols=293  Identities=38%  Similarity=0.676  Sum_probs=244.1

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      .....+.++|++++.||+|+||+||+|++. +|+.||+|++............+.+|+.+++.++||||+++++++    
T Consensus        14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----   88 (311)
T 3niz_A           14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI----   88 (311)
T ss_dssp             -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE----
Confidence            356778899999999999999999999985 589999999976655544556778999999999999999999999    


Q ss_pred             CCCcceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          103 RRNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                       ...+.+++||||++|+|.+.+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        89 -~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           89 -HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             -CCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             -ccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence             445779999999999999888764 459999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .............||+.|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+...++.+....+...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            76544445556688999999999987667899999999999999999999999999999999999999998877655544


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ....... ..........++....+.+++++.+||++||+.||++|||+.|+|+||||+.+
T Consensus       248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          248 QELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             TTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence            3321110 11222233445566677899999999999999999999999999999999865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.8e-58  Score=414.12  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=208.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .++++++.||+|+||+||+|...     .+++.||||+++..... .....+.+|+.++++++|||||++++++.     
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----   99 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-PLREEFRHEAMLRARLQHPNVVCLLGVVT-----   99 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-HHHHHHHHHHHHHHhCCCCCCCCcceEEE-----
Confidence            67899999999999999999853     46789999999754332 33456889999999999999999999994     


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                      ..+.+++|||||+ |+|.+++..+                ..+++.++..++.||+.||+|||+++|+||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            3467999999996 7999999643                3589999999999999999999999999999999999999


Q ss_pred             CCCCeEEcccCcccccCCC--CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017334          168 ANCDLKICDFGLARTSNGK--NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLK  244 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  244 (373)
                      .++.+||+|||+|+.....  .......+||+.|||||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.+.
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999765322  223445689999999999987 679999999999999999998 899999887766655


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+.+.  .                            ....++.+++.+.+|+.+||+.||++|||+.||+++
T Consensus       259 ~i~~~--~----------------------------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNR--Q----------------------------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTT--C----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcC--C----------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            54321  0                            011235678899999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-56  Score=410.57  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=228.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .-++|++++.||+|+||.||+|.+..+|+.||||++.+.........++.+|+.+++.++||||+++++++     ...+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~   87 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK   87 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            34789999999999999999999999999999999987766667777888999999999999999999999     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            8999999995 699999988889999999999999999999999999999999999999999999999999999765432


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                       ......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+....+....                
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------  230 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK----------------  230 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------------
T ss_pred             -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------
Confidence             335667899999999999885545689999999999999999999999887666555554310                


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS  326 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  326 (373)
                                     ......+++.+.+||++||..||.+|||+.|+++||||.......
T Consensus       231 ---------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~  275 (328)
T 3fe3_A          231 ---------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED  275 (328)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTC
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccc
Confidence                           011234788999999999999999999999999999998765443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.1e-57  Score=419.74  Aligned_cols=343  Identities=43%  Similarity=0.752  Sum_probs=263.5

Q ss_pred             CcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeee
Q 017334           15 GKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL   94 (373)
Q Consensus        15 ~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   94 (373)
                      +...+.+....+.+.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++
T Consensus        10 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   89 (371)
T 2xrw_A           10 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL   89 (371)
T ss_dssp             GEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccce
Confidence            33445566677788899999999999999999999999999999999998766666666778899999999999999999


Q ss_pred             ceeecCCC-CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeE
Q 017334           95 KDVMMPSH-RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (373)
Q Consensus        95 ~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~k  173 (373)
                      ++++.... ......+|+||||++++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~k  167 (371)
T 2xrw_A           90 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK  167 (371)
T ss_dssp             EEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred             EEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEE
Confidence            99986542 12335799999999999999886  4699999999999999999999999999999999999999999999


Q ss_pred             EcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          174 ICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       174 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      |+|||++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...++.+
T Consensus       168 l~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  245 (371)
T 2xrw_A          168 ILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP  245 (371)
T ss_dssp             ECCCCC-----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred             EEEeeccccccc-ccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999999976532 223455689999999999987 578999999999999999999999999999888888888888877


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCC------------CCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPD------------AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      .+...... ......+....+......+....+.            .++.+++||++||+.||++|||+.|+|+||||+.
T Consensus       246 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          246 CPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             CHHHHTTS-CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CHHHHHHh-hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence            76655443 2333444444443333333222221            1567999999999999999999999999999987


Q ss_pred             CCCCCCCC--CCCCCCCCCcccccCHHHHHHHHHHHHHhcCcc
Q 017334          322 LYDPSSNP--PAQVPIDLDMDEESGEEMIREMMLKEMLHYHPE  362 (373)
Q Consensus       322 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~  362 (373)
                      +.++....  ++..+.....+.+...+.+++.+..++.++.-+
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (371)
T 2xrw_A          325 WYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHH  367 (371)
T ss_dssp             TCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHCC-
T ss_pred             hcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHhhh
Confidence            66543221  111222222234667889999999999876544

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.5e-57  Score=407.17  Aligned_cols=287  Identities=42%  Similarity=0.697  Sum_probs=239.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++     ...+.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence            689999999999999999999999999999999987666655666788999999999999999999999     444789


Q ss_pred             EEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++||||+++++.+.+.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            99999999988777765 57899999999999999999999999999999999999999999999999999987655555


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......||+.|+|||++.+...++.++|||||||++|+|++|. |+|.+.+..+.+..+.+..+.+....+.......  
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--  234 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP--  234 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST--
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc--
Confidence            5566788999999999987666899999999999999999665 5688888888999999988887766544322100  


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      .+................+.+++.+++||++||+.||++|||++|+++||||+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            00000011112233445567899999999999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.2e-57  Score=413.92  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=209.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC-----CcEEEEEEccccccChHHHHHHHHHHHHHhhCCC-CCeeeeceeecCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET-----NEKVAIKKINNAFENRVDALRTLRELKLLRHLQH-ENVIALKDVMMPSH  102 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-----g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||++.... .......+.+|+.+|.++.| ||||++++++... 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence            46899999999999999999997654     3679999987543 33445578899999999975 9999999998433 


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL  165 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nil  165 (373)
                         .+.+|||||||+ |+|.++|+..                ..+++.++..++.||+.||+|||+++|+||||||+|||
T Consensus       141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  217 (353)
T ss_dssp             ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence               246899999996 7999999753                34899999999999999999999999999999999999


Q ss_pred             EcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHH
Q 017334          166 VNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQ  242 (373)
Q Consensus       166 l~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  242 (373)
                      ++.++.+||+|||+|+......  ....+.+||+.|||||++.+ ..|+.++|||||||++|||+| |.+||.+.+..+.
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998654332  23345689999999999987 689999999999999999997 9999988765544


Q ss_pred             HHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          243 LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      +..+..- +.                            ....+..+++++.+||.+||+.||++|||+.++++|
T Consensus       297 ~~~~i~~-g~----------------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          297 FCRRLKE-GT----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHH-TC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHc-CC----------------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4333221 00                            011234578999999999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.8e-55  Score=406.93  Aligned_cols=330  Identities=48%  Similarity=0.909  Sum_probs=274.4

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .+.+.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++......
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            456789999999999999999999999999999999999643 3344455678999999999999999999998665445


Q ss_pred             CcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          105 NFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .....|+||||++++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            5578999999999999999876 579999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc----------cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          185 GKNQ----------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       185 ~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      ....          .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            2211          123457899999999987667799999999999999999999999999998888888988888776


Q ss_pred             h-hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCC
Q 017334          255 E-EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQV  333 (373)
Q Consensus       255 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~  333 (373)
                      . .............+....+..+...+...++.+++.+.+||.+||+.||++|||+.++++||||+....+...+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~  323 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEP  323 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCC
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCC
Confidence            3 344445566677788888777777777788899999999999999999999999999999999998765544332211


Q ss_pred             -C---CC-CCcccccCHHHHHHHHHHHH
Q 017334          334 -P---ID-LDMDEESGEEMIREMMLKEM  356 (373)
Q Consensus       334 -~---~~-~~~~~~~~~~~~~~~~~~e~  356 (373)
                       +   .+ ....+....+.+++.+.+|+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (353)
T 2b9h_A          324 IPPSFFEFDHYKEALTTKDLKKLIWNEI  351 (353)
T ss_dssp             CCGGGGGGGCCSSCCCHHHHHHHHHHHH
T ss_pred             CCcceeeecchhhcCCHHHHHHHHHHHh
Confidence             1   11 13344667888898888885

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-56  Score=404.12  Aligned_cols=284  Identities=39%  Similarity=0.676  Sum_probs=232.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|++ .+|+.||+|++............+.+|+.+++.++||||+++++++.     ..+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence            6899999999999999999998 67899999999765443333346778999999999999999999994     44679


Q ss_pred             EEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      |+||||++++|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            999999999999998764 6799999999999999999999999999999999999999999999999999987654444


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+....+......  ..
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  233 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--PK  233 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TT
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc--cc
Confidence            4455688999999999977667899999999999999999999999999988888888888887665443321110  00


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      +..........++......+++.+.+||++||+.||++|||+.|+++||||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            11112222334455666788999999999999999999999999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.3e-55  Score=406.55  Aligned_cols=335  Identities=36%  Similarity=0.709  Sum_probs=268.3

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc---------ChHHHHHHHHHHHHHhhCCCCCeeee
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE---------NRVDALRTLRELKLLRHLQHENVIAL   94 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~~   94 (373)
                      .+..+.++|++.+.||+|+||.||+|.+.. |+.||||++.....         .......+.+|+.+++.++||||+++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            345678999999999999999999999865 89999999865322         22334678899999999999999999


Q ss_pred             ceeecCCCCCCcceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeE
Q 017334           95 KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~k  173 (373)
                      ++++..........+|+||||++|+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence            999876544555689999999999999988754 4799999999999999999999999999999999999999999999


Q ss_pred             EcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          174 ICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       174 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      |+|||++..... ........||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+....+.+
T Consensus       175 l~Dfg~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          175 ICDFNLAREDTA-DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             ECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEecCccccccc-ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999999975432 2233456889999999999876678999999999999999999999999999999999999999999


Q ss_pred             ChhhhcccCChhHHHHHHh-CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKS-LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQ  332 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~  332 (373)
                      ...............+... ....+...+....+..++.+.+||.+||+.||++|||+.++++||||+.++.+.......
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~  333 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL  333 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTC
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccc
Confidence            8887777666666655543 333344456666778899999999999999999999999999999999887665444332


Q ss_pred             CCCCCCcccccCHHHHHHHHHHHHHhcC
Q 017334          333 VPIDLDMDEESGEEMIREMMLKEMLHYH  360 (373)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~  360 (373)
                      .............+.+++.+.+|+.++.
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~  361 (362)
T 3pg1_A          334 SERFHFDESVTDVYDMHKIFTAEVERFN  361 (362)
T ss_dssp             CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred             ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence            2222222346677888888888887654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-55  Score=400.13  Aligned_cols=289  Identities=38%  Similarity=0.621  Sum_probs=233.7

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC---hHHHHHHHHHHHHHhhC---CCCCeeeeceeecC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN---RVDALRTLRELKLLRHL---QHENVIALKDVMMP  100 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~  100 (373)
                      .+.++|++++.||+|+||+||+|++..+|+.||+|++......   ........+|+.+++.+   .||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3568999999999999999999999999999999998643311   11112344666666655   59999999999876


Q ss_pred             CCCCCcceEEEEeecCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccC
Q 017334          101 SHRRNFKDVYLVYELMDTDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      ........+++||||++++|.+++.....  +++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             cCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            54344457899999999999999987654  9999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....+.+....+
T Consensus       166 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          166 LARIYSY-QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CTTTSTT-CCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccCC-CcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            9976543 233456688999999999977 57899999999999999999999999999999999999998888776654


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      .......    ....+.....+.....+.+++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       244 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~  302 (308)
T 3g33_A          244 PRDVSLP----RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK  302 (308)
T ss_dssp             CSSCSSC----GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred             cchhhcc----ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence            4321110    0122333334455566789999999999999999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-56  Score=407.14  Aligned_cols=289  Identities=37%  Similarity=0.652  Sum_probs=232.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++     ...+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEE
Confidence            6899999999999999999999999999999999654321 1111344799999999999999999998     444679


Q ss_pred             EEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            999999999999998765 4599999999999999999999999999999999999999999999999999986655555


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.+.++.+....+......... 
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-  234 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF-  234 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH-
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh-
Confidence            5566788999999999987677899999999999999999999999999999999999999998877655433221111 


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      .....+...........+.+++.+.+||.+||+.||++|||+.|+|+||||......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence            111222223333344557789999999999999999999999999999999876443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-55  Score=400.36  Aligned_cols=289  Identities=35%  Similarity=0.646  Sum_probs=231.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      -++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++     ...+.
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCe
Confidence            4789999999999999999999999999999999977666655566778999999999999999999999     44477


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .++||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999998 4778888877889999999999999999999999999999999999999999999999999998766555


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+...++...+............
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            55566789999999999987677899999999999999999999999999998888888888877655433221111000


Q ss_pred             HHHHhCC-CCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          268 KYIKSLP-YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       268 ~~~~~~~-~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      ... ..+ .....+....++.+++.+.+||.+||+.||++|||+.|+++||||+.+.
T Consensus       237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          237 SGV-KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             TTC-CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccC-cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            000 000 0011122233467899999999999999999999999999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.6e-56  Score=406.98  Aligned_cols=289  Identities=37%  Similarity=0.656  Sum_probs=221.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++...... .....+.+|+.+++.++||||+++++++     ...+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVI-----HTENK   77 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCe
Confidence            47899999999999999999999999999999999754322 2223567899999999999999999999     44578


Q ss_pred             EEEEeecCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          109 VYLVYELMDTDLHQIIKSS------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      +|+||||++|+|.+++...      ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            9999999999999998653      3589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ...........+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            65444445566889999999999875678999999999999999999999999999999999999988877655443221


Q ss_pred             ChhHHHHHHhCCCCCCCCc-----cccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPF-----SRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      ..  ..+............     ......+++.+.+||.+||+.||++|||+.|+|+||||+.....
T Consensus       238 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          238 KL--PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             GC--TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hh--hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            10  000000000000100     11123578899999999999999999999999999999876543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-55  Score=405.53  Aligned_cols=289  Identities=38%  Similarity=0.627  Sum_probs=226.0

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..-++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+++.++||||+++++++     ...
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HHN  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EET
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ecC
Confidence            445899999999999999999999999999999999976655544455677999999999999999999999     444


Q ss_pred             ceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-----CCCeEEcccCccc
Q 017334          107 KDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-----NCDLKICDFGLAR  181 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-----~~~~kL~Dfg~a~  181 (373)
                      ..+|+||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.     ++.+||+|||++.
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            77999999999999999999889999999999999999999999999999999999999954     4459999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ............+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....+...
T Consensus       186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            76544444566688999999999987667899999999999999999999999999999999999888887765543321


Q ss_pred             CChhHHHHHHhCCCCCCCCccc-cCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSR-LYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ...  ..+....+......... ....+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus       266 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          266 TAL--PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GGS--TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhh--hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            100  00000011111111111 111267899999999999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.2e-55  Score=401.84  Aligned_cols=256  Identities=24%  Similarity=0.449  Sum_probs=222.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++++... .......+.+|+.+++.++||||+++++++     +..+.
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCCE
Confidence            789999999999999999999999999999999975421 222344577899999999999999999999     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            999999996 6999999888899999999999999999999999999999999999999999999999999998654444


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...  .               
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~---------------  221 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--E---------------  221 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C---------------
T ss_pred             CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--C---------------
Confidence            55667899999999999876 67899999999999999999999999887766555544330  0               


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                    ......+++.+.+||.+||+.||++||     ++.++++||||..+
T Consensus       222 --------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          222 --------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence                          012245789999999999999999999     89999999999764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.5e-55  Score=405.23  Aligned_cols=263  Identities=30%  Similarity=0.483  Sum_probs=225.0

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh----HHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR----VDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      ..+.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.....    .....+.+|+.+++.++||||+++++++   
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~---   84 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY---   84 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE---
Confidence            356789999999999999999999999999999999997653321    1234677999999999999999999999   


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----CeEEcc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICD  176 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~----~~kL~D  176 (373)
                        +....+|+||||+. |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++    .+||+|
T Consensus        85 --~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           85 --ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             --ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             --EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence              44578999999995 79999998888999999999999999999999999999999999999998877    799999


Q ss_pred             cCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChh
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE  256 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (373)
                      ||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+........  
T Consensus       163 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--  238 (361)
T 2yab_A          163 FGLAHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--  238 (361)
T ss_dssp             CSSCEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--
T ss_pred             cCCceEcCCC-CccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--
Confidence            9999876432 33456789999999999876 6789999999999999999999999998877666665543211111  


Q ss_pred             hhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                               ...++.+++.+++||.+||..||++|||+.|+++||||+..
T Consensus       239 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          239 -------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             -------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             -------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence                                     12235678899999999999999999999999999999853

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-55  Score=406.48  Aligned_cols=257  Identities=23%  Similarity=0.388  Sum_probs=217.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|..+++.+ +||||+++++++     ...
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            3789999999999999999999999999999999976432 222344567899999988 699999999999     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +.+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            78999999996 69999999888999999999999999999999999999999999999999999999999999986554


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+..               
T Consensus       177 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------------  240 (353)
T 3txo_A          177 NGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE---------------  240 (353)
T ss_dssp             ---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             CCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            4555567799999999999976 578999999999999999999999999988777766665410               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH------HHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV------TEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~------~eil~hp~~~~~  322 (373)
                                      ......+++.+.+||++||+.||++||++      .++++||||+.+
T Consensus       241 ----------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          241 ----------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence                            01124478899999999999999999998      899999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1e-54  Score=413.64  Aligned_cols=263  Identities=29%  Similarity=0.451  Sum_probs=227.7

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ..+.++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++     ..
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~   81 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SE   81 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----EC
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EE
Confidence            3467899999999999999999999999999999999987665556666788999999999999999999999     45


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---CCCCeEEcccCccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN---ANCDLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~---~~~~~kL~Dfg~a~  181 (373)
                      .+..|+||||+. |+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+|||++   .++.+||+|||++.
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            578999999996 69999999889999999999999999999999999999999999999998   45789999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......        
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------  232 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF--------  232 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------
T ss_pred             EecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC--------
Confidence            77655555567789999999999976 578999999999999999999999999887766666654421111        


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                         ....++.+++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       233 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          233 -------------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             -------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             -------------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence                               11223568899999999999999999999999999999964

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-54  Score=400.62  Aligned_cols=291  Identities=40%  Similarity=0.680  Sum_probs=233.8

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChH---HHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV---DALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++........   ....+.+|+.+++.++||||+++++++     
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----   81 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----   81 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----
Confidence            445899999999999999999999999999999999975432211   123567899999999999999999999     


Q ss_pred             CCcceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          104 RNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ......++||||++++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        82 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           82 GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            444679999999999999988764 4699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ...........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            65555555667899999999999776678999999999999999999999999999999999998888877665443321


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      ...  ++ ......+..++...++.+++.+.+||++||+.||++|||+.|+|+||||.....+
T Consensus       242 ~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          242 SLP--DY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             SST--TC-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cCc--cc-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            100  00 0011112233444557788999999999999999999999999999999865433

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.7e-54  Score=407.27  Aligned_cols=297  Identities=34%  Similarity=0.595  Sum_probs=238.7

Q ss_pred             EecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeec
Q 017334           20 SMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMM   99 (373)
Q Consensus        20 ~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   99 (373)
                      +..........+|++++.||+|+||+||+|++..+++ +|+|++......      ..+|+.+++.++||||+++++++.
T Consensus        30 ~~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~  102 (394)
T 4e7w_A           30 SDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFY  102 (394)
T ss_dssp             EESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cCCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEE
Confidence            3344555677899999999999999999999987766 888887543221      126999999999999999999986


Q ss_pred             CCCC-CCcceEEEEeecCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-CCCCeE
Q 017334          100 PSHR-RNFKDVYLVYELMDTDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCDLK  173 (373)
Q Consensus       100 ~~~~-~~~~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~-~~~~~k  173 (373)
                      .... .+...+++||||+++++.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus       103 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             EESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred             ecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEE
Confidence            5432 3445689999999987766554    356899999999999999999999999999999999999999 789999


Q ss_pred             EcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          174 ICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       174 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      |+|||+++...... ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.+
T Consensus       183 L~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          183 LIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             ECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             EeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999998653332 23456889999999999876679999999999999999999999999999999999999999998


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccC-CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLY-PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSS  327 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~  327 (373)
                      ....+........   ....+.....++...+ +.+++++.+||.+||+.||++|||+.++++||||+.+.....
T Consensus       262 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          262 SREQIKTMNPNYM---EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             CHHHHHHHCGGGS---SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred             CHHHHHhhChhhh---hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence            8765543221100   0112222233333333 458999999999999999999999999999999998755443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.8e-55  Score=407.97  Aligned_cols=266  Identities=21%  Similarity=0.385  Sum_probs=216.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      -++|++++.||+|+||+||+|+++.+|+.||+|++++..... .....+.+|..+++++ +||||+++++++     +..
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence            368999999999999999999999999999999998654332 2333567899999887 799999999999     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            78999999996 69999999888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||......+....               .....
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---------------~~~~~  269 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDY  269 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------------CCHHH
T ss_pred             CCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---------------hhHHH
Confidence            4555677899999999999987 6789999999999999999999999965422110000               00000


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH------HHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV------TEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~------~eil~hp~~~~~  322 (373)
                      ....+....       ...+..+++.+++||++||+.||++||++      .++++||||+.+
T Consensus       270 ~~~~i~~~~-------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          270 LFQVILEKQ-------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             HHHHHHHCC-------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             HHHHHhccc-------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            000011100       12234678999999999999999999985      799999999865

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-54  Score=398.65  Aligned_cols=265  Identities=22%  Similarity=0.390  Sum_probs=217.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.+ +||||+++++++     ....
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeCC
Confidence            789999999999999999999999999999999986543 344455677899999988 799999999999     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            8999999996 699999988889999999999999999999999999999999999999999999999999999865444


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........               ......
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------------~~~~~~  227 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------------NTEDYL  227 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------CHHHH
T ss_pred             CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc---------------ccHHHH
Confidence            445567799999999999977 6789999999999999999999999965321110000               000000


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH------HHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV------TEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~------~eil~hp~~~~~  322 (373)
                      ...+....       ..+...+++.+++||++||+.||.+||++      .++++||||+.+
T Consensus       228 ~~~i~~~~-------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          228 FQVILEKQ-------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             HHHHHHCC-------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             HHHHHcCC-------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            00000000       11234678999999999999999999995      899999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.8e-54  Score=404.64  Aligned_cols=286  Identities=34%  Similarity=0.641  Sum_probs=230.8

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC---
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR---  103 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---  103 (373)
                      ...++|++++.||+|+||+||+|.+..+|+.||||++......      ..+|+.+++.++||||+++++++.....   
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            3568999999999999999999999999999999998654222      2369999999999999999999854321   


Q ss_pred             ------------------------------CCcceEEEEeecCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Q 017334          104 ------------------------------RNFKDVYLVYELMDTDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYL  149 (373)
Q Consensus       104 ------------------------------~~~~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~L  149 (373)
                                                    .....+++||||++|+|.+.+.    ..+.+++..++.++.||+.||+||
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                          2345689999999998877664    457899999999999999999999


Q ss_pred             HhCCccccCCCCCceEEc-CCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHH
Q 017334          150 HSANILHRDLKPGNLLVN-ANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL  228 (373)
Q Consensus       150 H~~~ivH~Dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  228 (373)
                      |++||+||||||+|||++ .++.+||+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|+
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            999999999999999998 6889999999999865433 23445688999999999987667999999999999999999


Q ss_pred             hCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCcccc-CCCCCHHHHHHHHhhcCcCCCCC
Q 017334          229 GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRL-YPDAHPLAIDLLQKMLVFDPTKR  307 (373)
Q Consensus       229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R  307 (373)
                      +|++||.+.+..+++..+.+.+|.+..+..........   ....+......+... ...+++.+.+||.+||+.||++|
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT---EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccc---cccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999999999999999999999887765433221100   001122222233332 34588999999999999999999


Q ss_pred             CCHHHHhCCCCCCCC
Q 017334          308 ISVTEALQHPYMSPL  322 (373)
Q Consensus       308 ~t~~eil~hp~~~~~  322 (373)
                      ||+.|+|+||||+.+
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.8e-54  Score=399.27  Aligned_cols=257  Identities=27%  Similarity=0.410  Sum_probs=221.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      .++|++++.||+|+||.||+|+++.+|+.||||++++... .........+|..+++.+ +||||+++++++     ++.
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~~   90 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTK   90 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----EeC
Confidence            4899999999999999999999999999999999976421 112233566889998877 899999999999     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            78999999996 69999999888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...  .             
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~-------------  234 (345)
T 1xjd_A          171 GDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N-------------  234 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C-------------
T ss_pred             CCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--C-------------
Confidence            4444567799999999999977 57899999999999999999999999988766665555431  0             


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHH-HHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT-EALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~-eil~hp~~~~~  322 (373)
                                      ......+++.+.+||.+||+.||++||++. ++++||||+.+
T Consensus       235 ----------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          235 ----------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             ----------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence                            012245789999999999999999999998 99999999865

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.2e-55  Score=402.87  Aligned_cols=257  Identities=29%  Similarity=0.456  Sum_probs=216.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -++|++.+.||+|+||.||+|.+..+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++     ...+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            389999999999999999999999999999999986542211 1123577899999999999999999999     4446


Q ss_pred             eEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          108 DVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      .+++||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus        83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-~  161 (336)
T 3h4j_B           83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-G  161 (336)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT-S
T ss_pred             EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC-C
Confidence            799999999999999998888999999999999999999999999999999999999999999999999999976543 3


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.........                      
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------------  219 (336)
T 3h4j_B          162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------------  219 (336)
T ss_dssp             BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------------
T ss_pred             cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------------
Confidence            3345668999999999998754457899999999999999999999976532211100                      


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                               ...........+++.+.+||++||+.||.+|||+.|+++||||+..
T Consensus       220 ---------i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          220 ---------VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             ---------CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             ---------HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                     0011112334578999999999999999999999999999999754

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.5e-54  Score=400.59  Aligned_cols=267  Identities=29%  Similarity=0.444  Sum_probs=226.1

Q ss_pred             ecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           21 MWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        21 ~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      +......+.++|++.+.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++  
T Consensus        20 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~--   97 (362)
T 2bdw_A           20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--   97 (362)
T ss_dssp             ----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred             eecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence            334455677899999999999999999999999999999999987666666667788999999999999999999999  


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEcc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICD  176 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~kL~D  176 (373)
                         ...+..|+||||+. |+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++   .+||+|
T Consensus        98 ---~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A           98 ---QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             ---ECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ---EeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEee
Confidence               44577999999996 69999998888999999999999999999999999999999999999998754   599999


Q ss_pred             cCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChh
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE  256 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (373)
                      ||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......+  
T Consensus       175 fG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--  250 (362)
T 2bdw_A          175 FGLAIEVNDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP--  250 (362)
T ss_dssp             CTTCBCCTTC-CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--
T ss_pred             cCcceEecCC-cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--
Confidence            9999866432 33455789999999999976 5789999999999999999999999988776665555543111100  


Q ss_pred             hhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                               ...++.+++.+.+||.+||+.||++|||+.++|+||||..
T Consensus       251 -------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          251 -------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             -------------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             -------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence                                     1123457889999999999999999999999999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.9e-54  Score=388.28  Aligned_cols=258  Identities=24%  Similarity=0.427  Sum_probs=220.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ...++|++++.||+|+||+||+|.+..+|+.||+|++.......  ...+.+|+.+++.++||||+++++++.     ..
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~   89 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYL-----VG   89 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEE-----EC
Confidence            35689999999999999999999999999999999986544333  335678999999999999999999984     34


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +.+|+||||++ |+|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            67999999995 799999876 4799999999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......             
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------  234 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-------------  234 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-------------
T ss_pred             cccccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence            5555566789999999999987 67899999999999999999999999887766555444331110             


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                     .......+++.+.+||.+||+.||++|||+.++++||||+.
T Consensus       235 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~  275 (297)
T 3fxz_A          235 ---------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI  275 (297)
T ss_dssp             ---------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ---------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence                           00112347888999999999999999999999999999974

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-54  Score=390.56  Aligned_cols=253  Identities=25%  Similarity=0.435  Sum_probs=219.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++     .+...
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCCE
Confidence            7899999999999999999999999999999999754321 12234567899999999999999999999     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            999999996 699999998889999999999999999999999999999999999999999999999999999865432 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                        ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.+..                 
T Consensus       160 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------------  219 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------------  219 (318)
T ss_dssp             --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------------
T ss_pred             --cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------
Confidence              345689999999999876 678999999999999999999999998877666655554310                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                    ....+.+++.+.+||++||..||++||     +++++++||||+.+
T Consensus       220 --------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          220 --------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence                          012245788999999999999999999     89999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=6.9e-54  Score=396.67  Aligned_cols=257  Identities=23%  Similarity=0.385  Sum_probs=221.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      -++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|..++..+ +||||+++++++     +..
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----ECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----EcC
Confidence            3789999999999999999999999999999999976432 112234567899999988 699999999999     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.....
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            78999999996 69999999888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+....               
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~---------------  237 (353)
T 2i0e_A          174 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------------  237 (353)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             CCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------------
Confidence            4445567789999999999976 678999999999999999999999999887766666554410               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                      ......+++.+.+||++||+.||.+||+     +.++++||||+.+
T Consensus       238 ----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          238 ----------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence                            0122457899999999999999999994     6999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.6e-54  Score=392.13  Aligned_cols=270  Identities=22%  Similarity=0.260  Sum_probs=193.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      |..+|.+.+.||+|+||+||+|++  +|+.||||+++...   ........|+..+..++|||||++++++...+ ....
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~   74 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT   74 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCce
Confidence            356899999999999999999987  58999999996532   11122235666677889999999999986542 2234


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEcCCCCeEEcccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA--------NILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      .+|||||||+ |+|.++++. ..+++.++..++.|++.||+|||++        +|+||||||+||||+.++++||+|||
T Consensus        75 ~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            6899999996 799999976 5699999999999999999999987        99999999999999999999999999


Q ss_pred             cccccCCCCc----cccceeeccccCchhhhhcCC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017334          179 LARTSNGKNQ----FMTEYVVTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       179 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  249 (373)
                      +|+.......    .....+||+.|||||++.+..     .++.++|||||||++|||+||.+||.........      
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p------  227 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP------  227 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT------
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc------
Confidence            9976543322    223468999999999997532     3567999999999999999999887543211100      


Q ss_pred             hCCCChhhhcccCChhHHHHHHh---CCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKS---LPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                          -.. . ....+........   -...+..+........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       228 ----~~~-~-~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          228 ----YYD-L-VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             ----TTT-T-SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ----chh-c-ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                000 0 0000001111111   01111111111111233568899999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-53  Score=395.75  Aligned_cols=293  Identities=35%  Similarity=0.568  Sum_probs=232.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC---CC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR---RN  105 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~  105 (373)
                      -++|++++.||+|+||.||+|+++.+|+.||+|++............+.+|+.+++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            489999999999999999999999999999999997655444444467789999999999999999999865321   12


Q ss_pred             cceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+.+|+||||++|+|.+.+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            4679999999999998888654 579999999999999999999999999999999999999999999999999997653


Q ss_pred             C----CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          185 G----KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       185 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .    .........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....+......+..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  255 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN  255 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence            2    222335567899999999998766789999999999999999999999999999999999999888876654443


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccC--CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLY--PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ............ ............  ...++.+.+||.+||+.||++|||+.|+|+||||...
T Consensus       256 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          256 VDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             GGGCGGGTSSCC-CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             cccchhhccccc-ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            221110000000 000000000000  0136789999999999999999999999999999764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-53  Score=390.71  Aligned_cols=261  Identities=31%  Similarity=0.500  Sum_probs=222.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh----HHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR----VDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||+|++.......    .....+.+|+.+++.++||||+++++++    
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----   83 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY----   83 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence            46689999999999999999999999999999999997543221    1245677999999999999999999999    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----CeEEccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDF  177 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~----~~kL~Df  177 (373)
                       ......|+||||++ ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++    .+||+||
T Consensus        84 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           84 -ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             -EeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence             44477999999996 69999998888999999999999999999999999999999999999999887    7999999


Q ss_pred             CcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      |++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+........   
T Consensus       163 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---  237 (326)
T 2y0a_A          163 GLAHKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE---  237 (326)
T ss_dssp             TTCEECCTT-SCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred             CCCeECCCC-CccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC---
Confidence            999876432 23445689999999999876 5789999999999999999999999988776666655543211111   


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                              ...++.+++.+.+||++||+.||++|||+.++|+||||..
T Consensus       238 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          238 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             ------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence                                    1123457888999999999999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-54  Score=396.30  Aligned_cols=290  Identities=37%  Similarity=0.648  Sum_probs=232.0

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +..-++|++++.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++     ..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   95 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KK   95 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ec
Confidence            4456999999999999999999999999999999999977666666666778999999999999999999998     44


Q ss_pred             cceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+..|+||||+++ +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            4779999999985 666666767789999999999999999999999999999999999999999999999999997665


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....+...+.........
T Consensus       176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            54444556789999999999987557899999999999999999999999999988888888888777654432211000


Q ss_pred             hHHHHHHhCC-CCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          265 KARKYIKSLP-YTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       265 ~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ..... ...+ .....+....++.+++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       256 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  312 (331)
T 4aaa_A          256 PVFAG-VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM  312 (331)
T ss_dssp             GGGTT-CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred             ccccc-ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence            00000 0000 01112233445678999999999999999999999999999999963

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-53  Score=390.27  Aligned_cols=259  Identities=25%  Similarity=0.447  Sum_probs=221.9

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++.++|++.+.||+|+||.||+|.+..+|+.||+|++...   ......+.+|+.+++.++||||+++++++     ...
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~   73 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESM   73 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EET
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecC
Confidence            4678999999999999999999999999999999998643   23344577999999999999999999999     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--CCCeEEcccCcccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLART  182 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~--~~~~kL~Dfg~a~~  182 (373)
                      +.+|+||||++ |+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++..
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            77999999997 6999999765 47999999999999999999999999999999999999987  78999999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+.......       
T Consensus       154 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------  224 (321)
T 1tki_A          154 LKPG-DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE-------  224 (321)
T ss_dssp             CCTT-CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH-------
T ss_pred             CCCC-CccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCCh-------
Confidence            6433 33456789999999999976 56899999999999999999999999988777666666542211111       


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                          ..++.+++.+.+||.+||..||.+|||+.|+|+||||+..
T Consensus       225 --------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          225 --------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             --------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             --------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                                1235678999999999999999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.8e-53  Score=390.68  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=210.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEcccccc--ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ..++|++++.||+|+||.||+|++.   .+|+.||+|++++...  .......+.+|+.+++.++||||+++++++    
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----   90 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF----   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE----
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE----
Confidence            3589999999999999999999985   6899999999976532  223344567899999999999999999999    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                       ...+.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        91 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           91 -QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             -ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             -EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence             44467999999996 6999999988899999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+....           
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-----------  237 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-----------  237 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred             ccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            65444444456689999999999976 578999999999999999999999999887666655554310           


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                          ....+.+++.+.+||.+||..||++||     ++.++++||||+.+
T Consensus       238 --------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          238 --------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence                                012245788999999999999999999     88999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.2e-54  Score=397.13  Aligned_cols=273  Identities=29%  Similarity=0.443  Sum_probs=216.8

Q ss_pred             CcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc---ChHHHHHHHHHHHHHhhCCCCCe
Q 017334           15 GKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE---NRVDALRTLRELKLLRHLQHENV   91 (373)
Q Consensus        15 ~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpni   91 (373)
                      +.....+...-..+.++|++.+.||+|+||+||+|.++.+|+.||||++.....   .......+.+|+.+++.++||||
T Consensus         9 ~g~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI   88 (351)
T 3c0i_A            9 GGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI   88 (351)
T ss_dssp             -----------CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTB
T ss_pred             CcccccccCCCCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCC
Confidence            334556666666788999999999999999999999999999999999864321   11123467799999999999999


Q ss_pred             eeeceeecCCCCCCcceEEEEeecCC-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017334           92 IALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSS----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV  166 (373)
Q Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill  166 (373)
                      +++++++     ...+.+|+||||++ ++|.+.+...    ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        89 v~~~~~~-----~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~  163 (351)
T 3c0i_A           89 VELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLL  163 (351)
T ss_dssp             CCEEEEE-----EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             CcEEEEE-----EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEE
Confidence            9999998     44477999999997 6998877542    358999999999999999999999999999999999999


Q ss_pred             cCCCC---eEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHH
Q 017334          167 NANCD---LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQL  243 (373)
Q Consensus       167 ~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  243 (373)
                      +.++.   +||+|||++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.. ....
T Consensus       164 ~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~  241 (351)
T 3c0i_A          164 ASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLF  241 (351)
T ss_dssp             CSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHH
T ss_pred             ecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHH
Confidence            87665   999999999877555444556789999999999976 578999999999999999999999998753 2223


Q ss_pred             HHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          244 KLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ..+.......                           ....++.+++.+.+||++||+.||++|||+.++|+||||+.
T Consensus       242 ~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          242 EGIIKGKYKM---------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHHHTCCCC---------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHcCCCCC---------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            3222210000                           01122467889999999999999999999999999999974

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-53  Score=403.18  Aligned_cols=289  Identities=34%  Similarity=0.623  Sum_probs=233.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC-CCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR-RNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~  107 (373)
                      ..+|++++.||+|+||+||+|++..+|+.||||++......      ..+|+.+++.++||||+++++++..... .+..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            45799999999999999999999999999999998643221      2369999999999999999999864321 2345


Q ss_pred             eEEEEeecCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CCeEEcccCcccc
Q 017334          108 DVYLVYELMDTDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLART  182 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-~~~kL~Dfg~a~~  182 (373)
                      .+++||||++++|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            678999999988877664    35679999999999999999999999999999999999999965 5689999999986


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ..... .....+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.+..+.+....
T Consensus       207 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          207 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             CCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             cccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            54322 23456889999999999876679999999999999999999999999999999999999999988766543221


Q ss_pred             ChhHHHHHHhCCCCCCCCcccc-CCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRL-YPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSS  327 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~  327 (373)
                      ... ..  ..++.....+|... .+.+++.+.+||++||..||.+|||+.|+++||||..+..+..
T Consensus       286 ~~~-~~--~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~  348 (420)
T 1j1b_A          286 PNY-TE--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV  348 (420)
T ss_dssp             SCC-CC--CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred             hhh-hh--hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence            100 00  01122222233322 3467899999999999999999999999999999987655443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.1e-53  Score=392.16  Aligned_cols=254  Identities=24%  Similarity=0.432  Sum_probs=220.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     .+..
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~  114 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCC
Confidence            4799999999999999999999999999999999965432 112334677899999999999999999999     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            8999999995 799999998889999999999999999999999999999999999999999999999999999866432


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                         ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...  .              
T Consensus       195 ---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~--------------  254 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--K--------------  254 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C--------------
T ss_pred             ---cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--C--------------
Confidence               345689999999999976 67899999999999999999999999888766666555431  0              


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                     ......+++.+.+||.+||+.||++||+     +.++++||||...
T Consensus       255 ---------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          255 ---------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence                           0122457899999999999999999998     9999999999753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-53  Score=387.39  Aligned_cols=301  Identities=41%  Similarity=0.740  Sum_probs=233.1

Q ss_pred             EecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeec
Q 017334           20 SMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMM   99 (373)
Q Consensus        20 ~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   99 (373)
                      ||.-..+.+.++|++++.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.+++.++||||+++++++.
T Consensus         1 sm~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   78 (320)
T 2i6l_A            1 SMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILG   78 (320)
T ss_dssp             -----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence            35556788999999999999999999999999999999999998643  3445567789999999999999999999875


Q ss_pred             CCCC---------CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-CC
Q 017334          100 PSHR---------RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN-AN  169 (373)
Q Consensus       100 ~~~~---------~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~-~~  169 (373)
                      ....         ......|+||||++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           79 PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED  157 (320)
T ss_dssp             TTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred             ccccccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence            4321         23467999999999999999865 6799999999999999999999999999999999999997 56


Q ss_pred             CCeEEcccCcccccCCC---CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Q 017334          170 CDLKICDFGLARTSNGK---NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLI  246 (373)
Q Consensus       170 ~~~kL~Dfg~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  246 (373)
                      +.+||+|||++......   ........+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            78999999999865321   122344567999999999877667899999999999999999999999999888888887


Q ss_pred             HHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                      ....+.............. ..+.......+..++....+.+++.+.+||++||+.||++|||+.++++||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVI-PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTS-CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             HHhcCCCchhhhhhhhhcC-cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            7766555444322211100 0111111222334455566789999999999999999999999999999999986533

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.7e-53  Score=395.34  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=214.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHH-HhhCCCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKL-LRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .++|++++.||+|+||.||+|+++.+++.||||++.+.... ......+.+|..+ ++.++||||+++++++     +..
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence            47899999999999999999999999999999999765432 2334455677776 4678899999999999     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +.+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            78999999996 69999999888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...                
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------------  254 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------------  254 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----------------
T ss_pred             CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------------
Confidence            4445567799999999999976 67999999999999999999999999988776666655431                


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH----HHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV----TEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~----~eil~hp~~~~~  322 (373)
                                     ...+.+.+++.+++||++||+.||.+||++    .++++||||+.+
T Consensus       255 ---------------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          255 ---------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             ---------------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             ---------------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence                           011235678999999999999999999986    699999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.4e-53  Score=393.95  Aligned_cols=262  Identities=30%  Similarity=0.444  Sum_probs=204.7

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ....++|++++.||+|+||+||+|+++.+|+.||+|++.......   ..+.+|+.+++.++||||+++++++.     .
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~-----~   87 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVIL-----T   87 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEe-----e
Confidence            455689999999999999999999999999999999997543332   34668999999999999999999994     4


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC--eEEcccCcccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD--LKICDFGLART  182 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~--~kL~Dfg~a~~  182 (373)
                      ...+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++..
T Consensus        88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            467999999995 699999988889999999999999999999999999999999999999988775  99999999874


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH-HhCCCChhhhccc
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN-ILGSRREEDLEFI  261 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~  261 (373)
                      ... .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.........+.. +....        
T Consensus       168 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~--------  238 (361)
T 3uc3_A          168 SVL-HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--------  238 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC--------
T ss_pred             ccc-cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC--------
Confidence            322 22334568999999999998754444559999999999999999999987654332222221 11110        


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                   ..    + .....+++.+++||++||+.||++|||+.++++||||...
T Consensus       239 -------------~~----~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          239 -------------YS----I-PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -------------CC----C-CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -------------CC----C-CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                         00    0 0113478999999999999999999999999999999654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.1e-53  Score=395.79  Aligned_cols=260  Identities=24%  Similarity=0.446  Sum_probs=217.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     ....
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   88 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE   88 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence            3889999999999999999999999999999999965431 222344677999999999999999999999     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... 
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-  167 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-  167 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC-
Confidence            7999999995 69999999888999999999999999999999999999999999999999999999999999986643 


Q ss_pred             CccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 NQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      .......+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||...........+..+..             
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-------------  234 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-------------  234 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-------------
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-------------
Confidence            334466789999999999864  24588999999999999999999999976543322222211110             


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-HHHHhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-VTEALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-~~eil~hp~~~~~  322 (373)
                             ..        ......+++.+.+||.+||+.||.+||+ ++++++||||..+
T Consensus       235 -------~~--------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          235 -------TV--------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             -------CC--------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             -------cc--------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence                   00        1123457899999999999999999998 8999999999754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.1e-53  Score=404.47  Aligned_cols=257  Identities=26%  Similarity=0.445  Sum_probs=212.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++|++++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++     ...+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence            4789999999999999999999999999999999975432 233344567899999999999999999999     4446


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            7999999996 6999999888899999999999999999999998 9999999999999999999999999999986554


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....               
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------------  365 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------------  365 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------
T ss_pred             CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC---------------
Confidence            4555667789999999999977 679999999999999999999999998887666655554310               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                      ......+++.+.+||.+||+.||.+||     ++.++++||||+.+
T Consensus       366 ----------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          366 ----------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ----------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence                            012245789999999999999999999     99999999999865

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-52  Score=376.55  Aligned_cols=264  Identities=29%  Similarity=0.440  Sum_probs=226.0

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++     ...
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE   77 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcC
Confidence            357999999999999999999999999999999999987766666667788999999999999999999998     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC---eEEcccCcccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLART  182 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~---~kL~Dfg~a~~  182 (373)
                      +..++||||+. ++|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++.   +||+|||++..
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            77999999996 699999988889999999999999999999999999999999999999987665   99999999976


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.......         
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------  226 (284)
T 3kk8_A          158 VNDS-EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY---------  226 (284)
T ss_dssp             CCSS-CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---------
T ss_pred             cccC-ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccC---------
Confidence            5432 33345688999999999976 578999999999999999999999998877666555544311110         


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                                        ....+..+++.+.+||.+||+.||++|||+.|+++||||.....
T Consensus       227 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          227 ------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             ------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             ------------------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence                              01123467899999999999999999999999999999976543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-53  Score=400.49  Aligned_cols=262  Identities=26%  Similarity=0.358  Sum_probs=219.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     .+.
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~  141 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  141 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            45789999999999999999999999999999999865321 111122356899999999999999999999     455


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++.....
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            78999999995 799999876 5799999999999999999999999999999999999999999999999999986644


Q ss_pred             CC-ccccceeeccccCchhhhhcCCC---CCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          186 KN-QFMTEYVVTRWYRAPELLLCCDN---YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       186 ~~-~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .. ....+.+||+.|+|||++.+...   ++.++|||||||++|+|++|++||.+.+..+....|.+...          
T Consensus       221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----------  290 (410)
T 3v8s_A          221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----------  290 (410)
T ss_dssp             TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----------
T ss_pred             CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc----------
Confidence            32 23346789999999999976322   78899999999999999999999998887777766654210          


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK--RISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~eil~hp~~~~~  322 (373)
                                ....       ...+.+++.+++||++||+.+|.+  |++++|+++||||+.+
T Consensus       291 ----------~~~~-------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          291 ----------SLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             ----------HCCC-------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             ----------cccC-------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence                      0000       012357899999999999999988  9999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-52  Score=396.09  Aligned_cols=283  Identities=30%  Similarity=0.580  Sum_probs=230.1

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC------CCCCeeeeceeec
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL------QHENVIALKDVMM   99 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~   99 (373)
                      ..+..+|++++.||+|+||.||+|.+..+|+.||||++...   ......+.+|+.+++.+      .|+||+++++++ 
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~-  168 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF-  168 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE-
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec-
Confidence            45778999999999999999999999999999999999753   22334456777777766      578999999998 


Q ss_pred             CCCCCCcceEEEEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC--eEEc
Q 017334          100 PSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD--LKIC  175 (373)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~--~kL~  175 (373)
                          ...+.+++||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+
T Consensus       169 ----~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          169 ----TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             ----EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             ----ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEe
Confidence                4447899999999999999997654  4999999999999999999999999999999999999999987  9999


Q ss_pred             ccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      |||++......   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+..
T Consensus       245 DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~  320 (429)
T 3kvw_A          245 DFGSSCYEHQR---VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ  320 (429)
T ss_dssp             CCTTCEETTCC---CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecccceecCCc---ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            99999765332   345688999999999987 57899999999999999999999999999999999999999998887


Q ss_pred             hhhcccCChhHHHHHHhCCCC-----------------------------CCCCccc-cCCCCCHHHHHHHHhhcCcCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYT-----------------------------PGTPFSR-LYPDAHPLAIDLLQKMLVFDPT  305 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~-~~~~~s~~~~~ll~~~L~~dP~  305 (373)
                      .........  ..+.......                             ....+.. +....++.+.+||++||+.||+
T Consensus       321 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~  398 (429)
T 3kvw_A          321 KLLDASKRA--KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA  398 (429)
T ss_dssp             HHHHTBTTH--HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred             HHHHhhhhh--hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence            755433221  1111110000                             0001111 1123478899999999999999


Q ss_pred             CCCCHHHHhCCCCCCCC
Q 017334          306 KRISVTEALQHPYMSPL  322 (373)
Q Consensus       306 ~R~t~~eil~hp~~~~~  322 (373)
                      +|||+.|+|+||||+..
T Consensus       399 ~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          399 VRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             TSCCHHHHHTSTTTC--
T ss_pred             hCCCHHHHhCChhhccC
Confidence            99999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8e-53  Score=385.69  Aligned_cols=263  Identities=28%  Similarity=0.403  Sum_probs=214.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++...... .....+.+|+.+++.++||||+++++++     ...+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~   78 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHR-----REGN   78 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence            358999999999999999999999999999999998644322 1224567899999999999999999998     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC-
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG-  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~-  185 (373)
                      ..|+||||++ |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            8999999996 69999998888899999999999999999999999999999999999999999999999999975432 


Q ss_pred             -CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          186 -KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       186 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                       ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..........                
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----------------  222 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----------------  222 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----------------
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence             223345668999999999998755557899999999999999999999977654322211111                


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                            ...      .....+..+++.+.+||.+||+.||++|||+.|+++||||.....
T Consensus       223 ------~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          223 ------EKK------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             ------TTC------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             ------ccc------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                  000      000112457888999999999999999999999999999986543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.8e-53  Score=401.54  Aligned_cols=264  Identities=22%  Similarity=0.369  Sum_probs=220.8

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++.+.... ......+.+|+.++..++||||+++++++     .+.
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  146 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDD  146 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeC
Confidence            457999999999999999999999999999999999653211 11112366899999999999999999999     455


Q ss_pred             ceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +.+|+||||+. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            78999999995 799999987 5789999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC-ccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ... ......+||+.|+|||++..    ...++.++|||||||++|+|++|++||.+.+..+....+.+...        
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------  298 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--------  298 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--------
Confidence            332 22344689999999999872    35689999999999999999999999999887777766653110        


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCC--CCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTK--RISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~--R~t~~eil~hp~~~~~  322 (373)
                                  ..      .+....+.+++.+++||++||+.+|++  |++++|+++||||+.+
T Consensus       299 ------------~~------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          299 ------------RF------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             ------------HC------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             ------------cc------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence                        00      111223558899999999999998888  9999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-52  Score=390.56  Aligned_cols=287  Identities=25%  Similarity=0.473  Sum_probs=229.2

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-----CCCeeeece
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-----HENVIALKD   96 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~~~~   96 (373)
                      ++....+.++|++++.||+|+||+||+|++..+|+.||||++...   ........+|+.+++.+.     ||||+++++
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            466677899999999999999999999999999999999999642   233445667999999986     999999999


Q ss_pred             eecCCCCCCcceEEEEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC------
Q 017334           97 VMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA------  168 (373)
Q Consensus        97 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~------  168 (373)
                      ++.     .....|+||||++++|.+++....  .+++.+++.++.||+.||+|||++||+||||||+|||++.      
T Consensus       104 ~~~-----~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          104 KFM-----YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEE-----ETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred             eee-----ECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence            984     346799999999889999998654  5999999999999999999999999999999999999975      


Q ss_pred             -------------------CCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh
Q 017334          169 -------------------NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG  229 (373)
Q Consensus       169 -------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  229 (373)
                                         ++.+||+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHH
Confidence                               788999999999865332   245688999999999987 579999999999999999999


Q ss_pred             CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHh------CCCCCC---------CCccccCCCCCHHHHH
Q 017334          230 RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKS------LPYTPG---------TPFSRLYPDAHPLAID  294 (373)
Q Consensus       230 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~---------~~~~~~~~~~s~~~~~  294 (373)
                      |++||.+.+..+.+..+....+..+..............+...      .+....         ..........++.+.+
T Consensus       255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  334 (360)
T 3llt_A          255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD  334 (360)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred             CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence            9999999999899999888887766544322111000000000      000000         0000001123577889


Q ss_pred             HHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          295 LLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       295 ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ||.+||+.||++|||+.|+|+||||+
T Consensus       335 li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          335 FLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHhcCChhhCCCHHHHhcCcccC
Confidence            99999999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.8e-52  Score=381.62  Aligned_cols=292  Identities=39%  Similarity=0.648  Sum_probs=235.9

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeC-CCCcEEEEEEccccccChHHHHHHHHHHHHHhhC---CCCCeeeeceeecCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNR-ETNEKVAIKKINNAFENRVDALRTLRELKLLRHL---QHENVIALKDVMMPS  101 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~-~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~  101 (373)
                      ....++|++++.||+|+||.||+|++. .+|+.||+|++............+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            345689999999999999999999995 6789999999875433222222344666666655   899999999998633


Q ss_pred             CCCCcceEEEEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          102 HRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                      ........++||||++|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence            223557899999999999999997643  499999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      +..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+.
T Consensus       167 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          167 ARIYSF-QMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CCCCCG-GGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccC-CCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence            976532 223445688999999999976 578999999999999999999999999999888888998888877665543


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      .......    .........+.....+.+++.+.+||.+||+.||++|||+.++++||||....
T Consensus       245 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          245 RDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             TTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence            2111000    11112223344556678999999999999999999999999999999998653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.1e-52  Score=392.82  Aligned_cols=293  Identities=18%  Similarity=0.260  Sum_probs=219.7

Q ss_pred             eecCceeeeeeeecc--CceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           27 EIDTKYVPIKPIGRG--AYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G--~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .-.++|++++.||+|  +||.||+|+++.+|+.||||++............+.+|+.+++.++||||+++++++.     
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----   96 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----   96 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----
Confidence            346899999999999  9999999999999999999999877666666667789999999999999999999994     


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      ..+.+|+||||++ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            4467999999996 7999999765  679999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCC-------CccccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          182 TSNGK-------NQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       182 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      .....       .......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....-..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            43211       1122334789999999999763 468999999999999999999999998877665554433211000


Q ss_pred             C-------hhhhccc-----CChhHHHHH---HhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          254 R-------EEDLEFI-----DNPKARKYI---KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       254 ~-------~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                      .       .......     .........   ...+.....+.......+++.+.+||++||+.||++|||+.|+|+|||
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence            0       0000000     000000000   000011111122344568999999999999999999999999999999


Q ss_pred             CCCCCC
Q 017334          319 MSPLYD  324 (373)
Q Consensus       319 ~~~~~~  324 (373)
                      |+....
T Consensus       337 f~~~~~  342 (389)
T 3gni_B          337 FKQIKR  342 (389)
T ss_dssp             GGGC--
T ss_pred             HHHHhh
Confidence            987643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.9e-53  Score=381.16  Aligned_cols=259  Identities=29%  Similarity=0.475  Sum_probs=210.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh------------------------HHHHHHHHHHHHHh
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR------------------------VDALRTLRELKLLR   84 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~------------------------~~~~~~~~E~~~l~   84 (373)
                      -++|++.+.||+|+||.||+|++..+|+.||||++.......                        .....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            389999999999999999999999999999999996543211                        11245778999999


Q ss_pred             hCCCCCeeeeceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334           85 HLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus        85 ~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                      .++||||+++++++...   ....+|+||||++ ++|.+++. .+.+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            99999999999998542   2367999999997 57776543 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCC--CCchhhhHHHHHHHHHHHhCCCCCCCCCchH
Q 017334          164 LLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLN  241 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  241 (373)
                      ||++.++.+||+|||++..............||+.|+|||++.+...  ++.++|||||||++|+|++|.+||.+.+...
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999999876555444566789999999999876432  4788999999999999999999998776544


Q ss_pred             HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          242 QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ....+...                       ....      ...+.+++.+.+||.+||+.||++|||+.|+++||||+
T Consensus       248 ~~~~~~~~-----------------------~~~~------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          248 LHSKIKSQ-----------------------ALEF------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHHC-----------------------CCCC------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHHhcc-----------------------cCCC------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            43333220                       0000      01246789999999999999999999999999999984

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-52  Score=401.49  Aligned_cols=257  Identities=28%  Similarity=0.427  Sum_probs=220.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -++|++.+.||+|+||.||+|++..+|+.||||++.+..... .....+.+|+.+++.++||||+++++++     ....
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            489999999999999999999999999999999997543211 2234677999999999999999999999     4446


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~-  168 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-  168 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT-
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc-
Confidence            7999999995 79999998888999999999999999999999999999999999999999999999999999987643 


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+....                
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------  232 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------------  232 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC----------------
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2334567899999999999875445789999999999999999999998877665555443210                


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                     ......+++.+.+||++||+.||++|||+.++++||||+..
T Consensus       233 ---------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 ---------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ---------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ---------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                           01123478899999999999999999999999999999754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-52  Score=394.75  Aligned_cols=263  Identities=22%  Similarity=0.329  Sum_probs=217.8

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++++.||+|+||.||+|+++.+|+.||+|++++... .......+.+|..++..++||||+++++++     ++.
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~  133 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE  133 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence            45899999999999999999999999999999999965321 111223456899999999999999999999     455


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +.+|+||||+. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            78999999995 7999999875 479999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCc-cccceeeccccCchhhhhc------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          185 GKNQ-FMTEYVVTRWYRAPELLLC------CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       185 ~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      .... .....+||+.|+|||++.+      ...++.++|||||||++|+|++|++||.+.+..+....+.+...      
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------  287 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE------  287 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------
Confidence            4332 2345689999999999873      24689999999999999999999999998887776666653110      


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCC---CCHHHHhCCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR---ISVTEALQHPYMSPL  322 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R---~t~~eil~hp~~~~~  322 (373)
                                    ..      .+......+++++++||++||+ +|.+|   ++++++++||||+.+
T Consensus       288 --------------~~------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          288 --------------HL------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             --------------HC------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             --------------Cc------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence                          00      0011124688999999999999 99998   589999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-52  Score=386.75  Aligned_cols=259  Identities=26%  Similarity=0.458  Sum_probs=219.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +.++|++++.||+|+||.||+|.++.+|+.||+|++....  ......+.+|+.+++.++||||+++++++     ....
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  121 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKY  121 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSS
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCC
Confidence            4578999999999999999999999999999999996543  23344677999999999999999999999     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--CCCeEEcccCccccc
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~--~~~~kL~Dfg~a~~~  183 (373)
                      .+|+||||++ |+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++...
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            7999999996 69999987654 7999999999999999999999999999999999999974  467999999999876


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+......           
T Consensus       202 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-----------  268 (387)
T 1kob_A          202 NPD-EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----------  268 (387)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             CCC-cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            433 23445689999999999976 67899999999999999999999999988766655554431100           


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                      .....+..+++.+.+||.+||+.||++|||+.++|+||||...
T Consensus       269 ----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          269 ----------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             ----------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                            0112235678999999999999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.2e-52  Score=392.74  Aligned_cols=291  Identities=36%  Similarity=0.605  Sum_probs=216.5

Q ss_pred             eeecCceeee-eeeeccCceEEEEEEeC--CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           26 FEIDTKYVPI-KPIGRGAYGIVCSSVNR--ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        26 ~~~~~~Y~~~-~~lg~G~~g~V~~a~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ..+.+.|++. ++||+|+||+||+|+++  .+++.||||++.......    .+.+|+.+++.++||||+++++++... 
T Consensus        16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l~hpniv~~~~~~~~~-   90 (405)
T 3rgf_A           16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSH-   90 (405)
T ss_dssp             CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHCCCTTBCCCCEEEEET-
T ss_pred             hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhcCCCCeeeEeeEEecC-
Confidence            3456778874 47999999999999966  578999999997553332    467899999999999999999998543 


Q ss_pred             CCCcceEEEEeecCCccHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCC
Q 017334          103 RRNFKDVYLVYELMDTDLHQIIKSS---------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV----NAN  169 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill----~~~  169 (373)
                        ....+|+||||++|+|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+    +.+
T Consensus        91 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           91 --ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             --TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred             --CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence              23679999999999999888532         249999999999999999999999999999999999999    677


Q ss_pred             CCeEEcccCcccccCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc-------
Q 017334          170 CDLKICDFGLARTSNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC-------  239 (373)
Q Consensus       170 ~~~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------  239 (373)
                      +.+||+|||++.......   ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+...       
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            899999999997654321   2345568999999999998766799999999999999999999999977654       


Q ss_pred             --hHHHHHHHHHhCCCChhhhcccCC-hhHHHHHHhCCCCCCCC------ccccCCCCCHHHHHHHHhhcCcCCCCCCCH
Q 017334          240 --LNQLKLIINILGSRREEDLEFIDN-PKARKYIKSLPYTPGTP------FSRLYPDAHPLAIDLLQKMLVFDPTKRISV  310 (373)
Q Consensus       240 --~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~  310 (373)
                        .+++..+...+|.+....+..... +................      ........++.+.+||++||+.||++|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence              478888999999887766554321 11111111111100000      001112346789999999999999999999


Q ss_pred             HHHhCCCCCCCCC
Q 017334          311 TEALQHPYMSPLY  323 (373)
Q Consensus       311 ~eil~hp~~~~~~  323 (373)
                      .|+|+||||....
T Consensus       329 ~e~L~hp~f~~~~  341 (405)
T 3rgf_A          329 EQAMQDPYFLEDP  341 (405)
T ss_dssp             HHHHTSGGGTSSS
T ss_pred             HHHhcChhhccCC
Confidence            9999999998653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.9e-52  Score=380.08  Aligned_cols=255  Identities=25%  Similarity=0.306  Sum_probs=209.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  105 (373)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++...............|+..+..+ +||||+++++++     ..
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~  128 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EE  128 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----Ee
Confidence            345899999999999999999999999999999999877666666666666777776666 799999999998     44


Q ss_pred             cceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+.+|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       129 ~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          129 GGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             CCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            5789999999999999888754 469999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      .. .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.....   .+..   ..           
T Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~---~~-----------  268 (311)
T 3p1a_A          209 TA-GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ---GY-----------  268 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT---TC-----------
T ss_pred             cC-CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc---cC-----------
Confidence            32 22344578999999999875  58999999999999999999976664432211   1100   00           


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                     ......+.+++.+.+||.+||+.||++|||+.++++||||+.
T Consensus       269 ---------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          269 ---------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ---------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ---------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                           001123457889999999999999999999999999999974

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.5e-52  Score=379.97  Aligned_cols=262  Identities=30%  Similarity=0.495  Sum_probs=222.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh----HHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR----VDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||+|++.......    .....+.+|+.+++.++||||+++++++    
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----   84 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY----   84 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE----
Confidence            45789999999999999999999999999999999997543221    1244677999999999999999999998    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----CeEEccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDF  177 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~----~~kL~Df  177 (373)
                       ......|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++    .+||+||
T Consensus        85 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           85 -ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             -ecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence             44477999999995 69999999888899999999999999999999999999999999999999888    7999999


Q ss_pred             CcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      |++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........   
T Consensus       164 g~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---  238 (321)
T 2a2a_A          164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD---  238 (321)
T ss_dssp             TTCEECCTT-CCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---
T ss_pred             ccceecCcc-ccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC---
Confidence            999866432 23345679999999999876 5789999999999999999999999988776665555443211111   


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                              ...++.+++.+.+||.+||+.||++|||+.++++||||...
T Consensus       239 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          239 ------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             ------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             ------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence                                    11224578889999999999999999999999999999754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-52  Score=405.78  Aligned_cols=261  Identities=33%  Similarity=0.549  Sum_probs=221.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+.++|++++.||+|+||+||+|.++.+|+.||||++.+..........+.+|+.+++.++||||+++++++     ...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcC
Confidence            456999999999999999999999999999999999976543333455678999999999999999999999     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---CCCCeEEcccCcccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN---ANCDLKICDFGLART  182 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~---~~~~~kL~Dfg~a~~  182 (373)
                      ..+|+||||+. |+|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            78999999996 69999998888999999999999999999999999999999999999995   456799999999976


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .... ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........        
T Consensus       174 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------  242 (486)
T 3mwu_A          174 FQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD--------  242 (486)
T ss_dssp             BCCC-----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC--------
T ss_pred             CCCC-CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            5433 33455689999999999875  489999999999999999999999999887776666554211110        


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                         ...+..+++.+++||++||+.||++|||+.++|+||||+..
T Consensus       243 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          243 -------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             -------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             -------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence                               11234578999999999999999999999999999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.5e-52  Score=384.29  Aligned_cols=258  Identities=28%  Similarity=0.474  Sum_probs=192.3

Q ss_pred             Cceeee---eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCC
Q 017334           30 TKYVPI---KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~---~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  105 (373)
                      ++|++.   +.||+|+||+||+|.++.+|+.||||++.+.     ......+|+.+++.+. ||||+++++++     .+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~   77 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVF-----HD   77 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----Ec
Confidence            567775   7899999999999999999999999998643     2234668999999997 99999999999     44


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEcccCccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~kL~Dfg~a~  181 (373)
                      ....|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            578999999996 69999999988999999999999999999999999999999999999998766   79999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchH----HHHHHHHHhCCCChhh
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLN----QLKLIINILGSRREED  257 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~  257 (373)
                      ............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+...    ....+..+..      
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~------  230 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK------  230 (325)
T ss_dssp             ECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT------
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc------
Confidence            76555555667789999999999876 678999999999999999999999997654311    1111111100      


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                        .........++.+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       231 ------------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          231 ------------------GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             ------------------TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             ------------------CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                              00001111224578999999999999999999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-52  Score=386.31  Aligned_cols=260  Identities=29%  Similarity=0.492  Sum_probs=214.4

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSH  102 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  102 (373)
                      ....+.++|++++.||+|+||+||+|.++.+|+.||+|++.+....      ..+|+.++.++ +||||+++++++    
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~----   85 (342)
T 2qr7_A           16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVY----   85 (342)
T ss_dssp             ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEE----
T ss_pred             cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEE----
Confidence            3446788999999999999999999999999999999999765332      23688888887 699999999999    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC----CCeEEccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN----CDLKICDF  177 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~----~~~kL~Df  177 (373)
                       ++...+|+||||++ |+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+|||+..+    +.+||+||
T Consensus        86 -~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           86 -DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             -EcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence             45578999999996 6999999988899999999999999999999999999999999999998543    35999999


Q ss_pred             CcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHHHhCCCC
Q 017334          178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC---LNQLKLIINILGSRR  254 (373)
Q Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~  254 (373)
                      |++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...   .+....+..  +.  
T Consensus       165 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~--~~--  239 (342)
T 2qr7_A          165 GFAKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--GK--  239 (342)
T ss_dssp             TTCEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH--CC--
T ss_pred             CCcccCcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc--CC--
Confidence            999876554445566789999999999976 5688999999999999999999999976432   222222221  00  


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                             .......++.+++.+.+||++||..||++|||+.++++||||..+
T Consensus       240 -----------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          240 -----------------------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             -----------------------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             -----------------------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                                   001112346689999999999999999999999999999999653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.3e-52  Score=404.22  Aligned_cols=263  Identities=33%  Similarity=0.493  Sum_probs=218.9

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .-.+.++|++++.||+|+||+||+|+++.+|..||+|++.+..........+.+|+.+++.++||||+++++++     .
T Consensus        32 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~  106 (494)
T 3lij_A           32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----E  106 (494)
T ss_dssp             BCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred             CCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----E
Confidence            34567789999999999999999999999999999999976544333445678999999999999999999999     4


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CCeEEcccCcc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDFGLA  180 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~---~~~kL~Dfg~a  180 (373)
                      ..+.+|+||||+. |+|.+.+.....+++.+++.++.||+.||+|||++||+||||||+|||++..   +.+||+|||++
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            4578999999996 6999999888899999999999999999999999999999999999999764   45999999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...... ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+.......       
T Consensus       187 ~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------  256 (494)
T 3lij_A          187 AVFENQ-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF-------  256 (494)
T ss_dssp             EECBTT-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred             eECCCC-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence            765433 33456689999999999854  58999999999999999999999999988777666665421111       


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                          ....++.+++.+.+||++||+.||.+|||+.++|+||||+..
T Consensus       257 --------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          257 --------------------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             --------------------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             --------------------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                112235688999999999999999999999999999999753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.6e-52  Score=387.04  Aligned_cols=296  Identities=34%  Similarity=0.571  Sum_probs=224.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC--CCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR--RNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~~  106 (373)
                      -++|++.+.||+|+||.||+|.++.+|+.||||++.......   ....+++..+..++||||+++++++.....  ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            478999999999999999999999999999999986543222   234567888888999999999999865322  233


Q ss_pred             ceEEEEeecCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEEcC-CCCeEEcccCc
Q 017334          107 KDVYLVYELMDTDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLH--SANILHRDLKPGNLLVNA-NCDLKICDFGL  179 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~  179 (373)
                      ..+++||||++++|.+.+.    ....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A           99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS  178 (360)
T ss_dssp             EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence            4589999999988766554    4567999999999999999999999  999999999999999997 89999999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      +....... ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+.+.++.+....+.
T Consensus       179 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3e3p_A          179 AKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR  257 (360)
T ss_dssp             CBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence            98664332 23455789999999999776668999999999999999999999999999999999999998888766543


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccC----CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLY----PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPA  331 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~  331 (373)
                      ........   .........++...+    ...++.+.+||.+||+.||.+|||+.|+|+||||+....+....+.
T Consensus       258 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~  330 (360)
T 3e3p_A          258 KLNPSHTD---VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPN  330 (360)
T ss_dssp             HHCTTCCC---GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTT
T ss_pred             hcccchhh---ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCC
Confidence            32211000   000011111222222    2367889999999999999999999999999999987666554433

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=382.21  Aligned_cols=260  Identities=31%  Similarity=0.452  Sum_probs=203.7

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ...+.++|++.+.||+|+||.||+|.+..+++.||||++....    ....+.+|+.+++.++||||+++++++     .
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~-----~  118 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIF-----E  118 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEE-----E
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeE-----e
Confidence            4457788999999999999999999999999999999997542    233566899999999999999999999     4


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCCeEEcccCcc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLA  180 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~---~~~~kL~Dfg~a  180 (373)
                      .....++||||++ |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++
T Consensus       119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            4467999999996 699999998888999999999999999999999999999999999999976   889999999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHhCCCChhhhc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLN-QLKLIINILGSRREEDLE  259 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  259 (373)
                      ...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+..   ..      
T Consensus       199 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~---~~------  267 (349)
T 2w4o_A          199 KIVEHQ-VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN---CE------  267 (349)
T ss_dssp             ---------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT---TC------
T ss_pred             cccCcc-cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh---CC------
Confidence            765332 23345689999999999976 578999999999999999999999997765443 2222221   00      


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                        .......++.+++.+.+||++||+.||++|||+.++|+||||...
T Consensus       268 ------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          268 ------------------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             ------------------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             ------------------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                              001112345688999999999999999999999999999999753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=381.50  Aligned_cols=264  Identities=26%  Similarity=0.340  Sum_probs=212.0

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCC--CCeeeeceeecCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH--ENVIALKDVMMPS  101 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~  101 (373)
                      .+....++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++|  |||+++++++.  
T Consensus         3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--   79 (343)
T 3dbq_A            3 CISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--   79 (343)
T ss_dssp             CEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--
T ss_pred             eeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe--
Confidence            44556788999999999999999999984 68999999998766666666778899999999986  99999999984  


Q ss_pred             CCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          102 HRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                         ....+|+|||+.+++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.
T Consensus        80 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           80 ---TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             ---CSSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             ---eCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence               447899999988899999999988999999999999999999999999999999999999997 6789999999997


Q ss_pred             ccCCCCc--cccceeeccccCchhhhhc----------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017334          182 TSNGKNQ--FMTEYVVTRWYRAPELLLC----------CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       182 ~~~~~~~--~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  249 (373)
                      .......  .....+||+.|+|||++.+          ...++.++|||||||++|+|++|++||......  ...+...
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~  233 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAI  233 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHH
Confidence            6543221  2345689999999999864          246889999999999999999999999764321  1112111


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ....                          .........++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       234 ~~~~--------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          234 IDPN--------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             HCTT--------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             hcCC--------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            1110                          0011223456789999999999999999999999999999743

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.7e-52  Score=413.36  Aligned_cols=257  Identities=23%  Similarity=0.388  Sum_probs=223.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      -++|++++.||+|+||.||+|+++.+|+.||||++++... .......+..|..++..+ +||||+++++++     +..
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~~  414 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM  414 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BCS
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----EeC
Confidence            3689999999999999999999999999999999975421 222234567899999988 599999999999     555


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++....
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            78999999996 69999999888999999999999999999999999999999999999999999999999999986544


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....|....               
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------------  558 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------------  558 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC---------------
T ss_pred             CCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC---------------
Confidence            4455667899999999999976 679999999999999999999999999988776666654310               


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH-----HHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-----TEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~-----~eil~hp~~~~~  322 (373)
                                      ..+...+++++.+||++||+.||++||++     ++|++||||+.+
T Consensus       559 ----------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          559 ----------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             ----------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence                            11234688999999999999999999997     999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-51  Score=386.29  Aligned_cols=264  Identities=25%  Similarity=0.337  Sum_probs=212.0

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC--CCCeeeeceeecCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ--HENVIALKDVMMPS  101 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~  101 (373)
                      .+.....+|++++.||+|+||+||+|.+.. |+.||||++............+.+|+.+++.++  ||||+++++++.. 
T Consensus        50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-  127 (390)
T 2zmd_A           50 CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-  127 (390)
T ss_dssp             CEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred             cccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-
Confidence            334455679999999999999999999875 899999999876666666677889999999997  5999999999843 


Q ss_pred             CCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          102 HRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                          ...+|+|||+.+++|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.
T Consensus       128 ----~~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          128 ----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             ----SSEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             ----CCEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence                46799999977889999999888999999999999999999999999999999999999995 5899999999998


Q ss_pred             ccCCCC--ccccceeeccccCchhhhhc----------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017334          182 TSNGKN--QFMTEYVVTRWYRAPELLLC----------CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       182 ~~~~~~--~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  249 (373)
                      ......  ......+||+.|+|||++.+          ...++.++|||||||++|+|++|.+||.+....  ...+..+
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~~  280 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAI  280 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHH
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHHH
Confidence            654322  12345689999999999865          135889999999999999999999999764321  1111111


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .....                          ........++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus       281 ~~~~~--------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          281 IDPNH--------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HCTTS--------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             hCccc--------------------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            11100                          001123346789999999999999999999999999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.1e-51  Score=368.17  Aligned_cols=260  Identities=29%  Similarity=0.462  Sum_probs=221.2

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      -.+.++|++.+.||+|+||.||+|.+..++..+|+|++.......  ...+.+|+.+++.++||||+++++++     ..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~   77 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETF-----ED   77 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEE-----EC
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEE-----ec
Confidence            356789999999999999999999999999999999997654332  34577899999999999999999999     44


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCCeEEcccCccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill---~~~~~~kL~Dfg~a~  181 (373)
                      ....++||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           78 NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            477999999996 6999999888889999999999999999999999999999999999999   788899999999997


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ..... .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+.......+.      
T Consensus       158 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  228 (277)
T 3f3z_A          158 RFKPG-KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE------  228 (277)
T ss_dssp             ECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH------
T ss_pred             eccCc-cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence            65432 33455689999999999865  4899999999999999999999999988776666555442111111      


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                           ..+..+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          229 ---------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             ---------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             ---------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence                                 1123578899999999999999999999999999999753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-51  Score=369.47  Aligned_cols=258  Identities=29%  Similarity=0.465  Sum_probs=209.6

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+.++|++.+.||+|+||.||+|.++.+|..+|+|++...... .....+.+|+.+++.++||||+++++++     ...
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~   92 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDY   92 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecC
Confidence            4678999999999999999999999999999999999765432 2234677899999999999999999999     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCCeEEcccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFG  178 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill---~~~~~~kL~Dfg  178 (373)
                      ...|+||||++ |+|.+.+..    ...+++..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            77999999996 599988853    3679999999999999999999999999999999999999   456789999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ++...... .......||+.|+|||++.  ..++.++|||||||++|+|++|..||.+.+..+....+....        
T Consensus       173 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--------  241 (285)
T 3is5_A          173 LAELFKSD-EHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--------  241 (285)
T ss_dssp             CCCC-----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cceecCCc-ccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--------
Confidence            99765332 2334567899999999985  358899999999999999999999998876554443332200        


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                          .........+++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       242 --------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          242 --------------------PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             --------------------CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             --------------------cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                                0011112346889999999999999999999999999999974

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.1e-52  Score=381.13  Aligned_cols=268  Identities=26%  Similarity=0.437  Sum_probs=223.6

Q ss_pred             ecceeeeecCceeee-eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceee
Q 017334           21 MWQTLFEIDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVM   98 (373)
Q Consensus        21 ~~~~~~~~~~~Y~~~-~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~   98 (373)
                      .++....+.++|.+. +.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.+. ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            456667788999999 8999999999999999999999999999876554444557789999999996 79999999999


Q ss_pred             cCCCCCCcceEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCCe
Q 017334           99 MPSHRRNFKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDL  172 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~---~~~~  172 (373)
                           ...+..|+||||+. |+|.+++...  +.+++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+
T Consensus        99 -----~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           99 -----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             -----ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCE
T ss_pred             -----EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcE
Confidence                 44577999999996 5999888543  67999999999999999999999999999999999999998   7899


Q ss_pred             EEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      ||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus       174 kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  251 (327)
T 3lm5_A          174 KIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD  251 (327)
T ss_dssp             EECCGGGCEEC----------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             EEeeCccccccCCc-cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence            99999999866432 22345689999999999976 57899999999999999999999999988776666555442211


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ..                           ...++.+++.+.+||.+||+.||.+|||++++|+||||+.+
T Consensus       252 ~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          252 YS---------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             CC---------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             cC---------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            11                           12235678899999999999999999999999999999865

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.6e-51  Score=399.27  Aligned_cols=262  Identities=30%  Similarity=0.446  Sum_probs=220.5

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-----------HHHHHHHHHHHHHhhCCCCCeeee
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-----------VDALRTLRELKLLRHLQHENVIAL   94 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~   94 (373)
                      -.+.++|++++.||+|+||+||+|.++.+++.||+|++.+.....           .....+.+|+.+++.++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            357899999999999999999999999999999999997653221           223467799999999999999999


Q ss_pred             ceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---
Q 017334           95 KDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---  170 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---  170 (373)
                      ++++     .....+|+||||++ |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   
T Consensus       112 ~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          112 FDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEE-----ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEE-----EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence            9999     45578999999996 69999998888999999999999999999999999999999999999998876   


Q ss_pred             CeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017334          171 DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL  250 (373)
Q Consensus       171 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  250 (373)
                      .+||+|||++...... ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus       187 ~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  263 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK  263 (504)
T ss_dssp             SEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             cEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            6999999999866433 33456689999999999864  58999999999999999999999999988777766665421


Q ss_pred             CCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          251 GSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .....                           ..++.+++.+++||++||+.||.+|||+.++|+||||+..
T Consensus       264 ~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          264 YYFDF---------------------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             CCCCH---------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             CCCCc---------------------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            11111                           1125678999999999999999999999999999999754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.9e-52  Score=401.13  Aligned_cols=262  Identities=31%  Similarity=0.500  Sum_probs=224.1

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..+.++|++.+.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+++.++||||+++++++     .
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~   96 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----E   96 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            4567899999999999999999999999999999999965432 223345678999999999999999999999     4


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCCeEEcccCcc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLA  180 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill---~~~~~~kL~Dfg~a  180 (373)
                      ..+.+|+||||+. |+|.+.+...+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A           97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             eCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            4578999999996 7999999988999999999999999999999999999999999999999   56789999999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...... ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........      
T Consensus       177 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------  247 (484)
T 3nyv_A          177 THFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE------  247 (484)
T ss_dssp             HHBCCC-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred             EEcccc-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            866433 23455689999999999875  589999999999999999999999999887776666654211110      


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                           ...+..+++.+++||++||+.||++|||+.++|+||||+..
T Consensus       248 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          248 ---------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             ---------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             ---------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence                                 11234578999999999999999999999999999999754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.7e-51  Score=375.97  Aligned_cols=264  Identities=30%  Similarity=0.454  Sum_probs=225.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++     ...
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecC
Confidence            46799999999999999999999999999999999976543 344555678999999999999999999999     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +..|+||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            77999999997 69999998888999999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+...                
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------------  256 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------------  256 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----------------
T ss_pred             CcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC----------------
Confidence            4444456689999999999976 57899999999999999999999999877655444433220                


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN  328 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~  328 (373)
                             .        ......+++.+.+||++||+.||++|||+.++++||||.....+...
T Consensus       257 -------~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~  304 (335)
T 2owb_A          257 -------E--------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL  304 (335)
T ss_dssp             -------C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred             -------C--------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccC
Confidence                   0        01224578889999999999999999999999999999876554433

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-51  Score=397.95  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=216.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++     +...
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  258 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT  258 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence            47899999999999999999999999999999999754322 12234577899999999999999999998     4457


Q ss_pred             eEEEEeecCC-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          108 DVYLVYELMD-TDLHQIIKSS----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      .+|+||||++ |+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence            7999999996 6999998763    3699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL----NQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~  258 (373)
                      ...........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....    .....+..          
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----------  407 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----------  407 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----------
T ss_pred             ccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----------
Confidence            6554444456699999999999987 67999999999999999999999999876422    11211111          


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                   ..        ....+.+++.+.+||++||+.||++||+     +.++++||||+.+
T Consensus       408 -------------~~--------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          408 -------------QA--------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             -------------CC--------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             -------------cc--------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence                         00        1123567899999999999999999995     5899999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.4e-51  Score=386.21  Aligned_cols=302  Identities=29%  Similarity=0.426  Sum_probs=226.1

Q ss_pred             CCCCCCCCCCcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhh
Q 017334            6 EPPNGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH   85 (373)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~   85 (373)
                      |+...|...|.+....   ...+.++|++++.||+|+||+||+|++..+|+.||||++...   ......+.+|+.+++.
T Consensus        16 e~~~~~~~~~~~~~~~---g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~   89 (397)
T 1wak_A           16 EDPNDYCKGGYHLVKI---GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKS   89 (397)
T ss_dssp             ------CC--CCSSCT---TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHH
T ss_pred             cccccCCCCCceEEeh---hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHH
Confidence            3444454445444433   334579999999999999999999999999999999999643   3334567789999998


Q ss_pred             CC--------CCCeeeeceeecCCCCCCcceEEEEeecCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q 017334           86 LQ--------HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSA-NI  154 (373)
Q Consensus        86 l~--------hpniv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-~i  154 (373)
                      ++        |+||+++++++.... .....+|+||||++++|.+.+...  +.+++..++.++.||+.||+|||++ ||
T Consensus        90 l~~~~~~~~~~~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~gi  168 (397)
T 1wak_A           90 VRNSDPNDPNREMVVQLLDDFKISG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI  168 (397)
T ss_dssp             HHHSCTTCGGGGGBCCEEEEEEEEE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred             HhhcCCCCCCcceeeeeecceeecC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence            85        788999999985321 244689999999998888887654  5699999999999999999999998 99


Q ss_pred             cccCCCCCceEEcCCC-------------------------------------------------CeEEcccCcccccCC
Q 017334          155 LHRDLKPGNLLVNANC-------------------------------------------------DLKICDFGLARTSNG  185 (373)
Q Consensus       155 vH~Dlkp~Nill~~~~-------------------------------------------------~~kL~Dfg~a~~~~~  185 (373)
                      +||||||+|||++.++                                                 .+||+|||++.....
T Consensus       169 vHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~  248 (397)
T 1wak_A          169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK  248 (397)
T ss_dssp             ECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB
T ss_pred             ecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc
Confidence            9999999999999775                                                 799999999976533


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------chHHHHHHHHHhCCCChhhhc
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE------CLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+      ....+..+...++..+.....
T Consensus       249 ~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  324 (397)
T 1wak_A          249 H---FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV  324 (397)
T ss_dssp             C---SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHH
T ss_pred             c---CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhh
Confidence            2   345688999999999987 568999999999999999999999998655      445677788888876654322


Q ss_pred             ccCChhHHHHHHhC---CCCC-CCCc---------cccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          260 FIDNPKARKYIKSL---PYTP-GTPF---------SRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       260 ~~~~~~~~~~~~~~---~~~~-~~~~---------~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ......  .+....   .... ..++         .......++.+.+||.+||+.||++|||+.|+|+||||+
T Consensus       325 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          325 AGKYSK--EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HCTTGG--GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cccccc--cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence            111000  000000   0000 0000         001122356788999999999999999999999999996

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.6e-52  Score=402.44  Aligned_cols=261  Identities=26%  Similarity=0.432  Sum_probs=216.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++++.||+|+||.||+|+++.+|+.||+|++.+... .......+.+|+.+++.++||||+++++++     +..
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~  256 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETK  256 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeC
Confidence            45789999999999999999999999999999999965422 112234567899999999999999999999     445


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ..+|+||||++ |+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++...
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            78999999995 79999998654  4999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+...              
T Consensus       337 ~~~-~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~--------------  400 (576)
T 2acx_A          337 PEG-QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--------------  400 (576)
T ss_dssp             CTT-CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH--------------
T ss_pred             ccC-ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH--------------
Confidence            433 23445689999999999976 57899999999999999999999999876432111111111              


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                            +...+       ..+...+++.+++||++||+.||++||     ++.|+++||||+.+
T Consensus       401 ------i~~~~-------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          401 ------VKEVP-------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             ------HHHCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             ------hhccc-------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence                  11111       112356789999999999999999999     78999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.6e-51  Score=378.26  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=216.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.     ..
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~  126 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----RE  126 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence            45679999999999999999999999999999999975533 3334456789999999999999999999984     34


Q ss_pred             ceEEEEeecCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMDTDLHQIIK-SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +..++||||+.|+|.+++. ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       127 ~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            6799999999999988885 456899999999999999999999999999999999999999999999999999976532


Q ss_pred             CCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                          ....+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+.+....+..+...  ..          
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~--~~----------  270 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ES----------  270 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC----------
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CC----------
Confidence                234689999999999863  356889999999999999999999999887665554443321  00          


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                +       ......+++.+.+||.+||+.||++|||+.++++||||..
T Consensus       271 ----------~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          271 ----------P-------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             ----------C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ----------C-------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence                      0       0112356888999999999999999999999999999964

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.4e-51  Score=373.31  Aligned_cols=254  Identities=24%  Similarity=0.447  Sum_probs=214.4

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      .|...+.||+|+||.||+|+++.+|+.||||++.......  ...+.+|+.+++.++||||+++++++..     .+..+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~  118 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELW  118 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEE
Confidence            4888899999999999999999999999999986543332  3456789999999999999999999843     46799


Q ss_pred             EEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          111 LVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      +||||++ ++|.+++.. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  197 (321)
T 2c30_A          119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  197 (321)
T ss_dssp             EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence            9999996 699988765 57999999999999999999999999999999999999999999999999999876554444


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.....                  
T Consensus       198 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------------------  258 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP------------------  258 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC------------------
T ss_pred             cccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence            566789999999999976 5789999999999999999999999987765554444332100                  


Q ss_pred             HHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                           .     .......+++.+.+||.+||+.||++|||+.++++||||..
T Consensus       259 -----~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  300 (321)
T 2c30_A          259 -----P-----KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ  300 (321)
T ss_dssp             -----C-----CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred             -----C-----CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence                 0     00111346788999999999999999999999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-51  Score=369.14  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=214.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -++|++.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++||||+++++++     ....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDAT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecCC
Confidence            388999999999999999999999999999999986543221 1234567899999999999999999999     4446


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..++||||++ ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            7999999997 699999988889999999999999999999999999999999999999999999999999998654322


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                        ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....               
T Consensus       163 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  224 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------------  224 (279)
T ss_dssp             -------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------------
T ss_pred             --cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC---------------
Confidence              2345688999999999876 6788999999999999999999999988776665555433110               


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                      .....+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       225 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          225 ----------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             ----------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ----------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence                            1123477889999999999999999999999999999754

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.3e-51  Score=370.17  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=199.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++..............++...++.++||||+++++++.     ..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccC
Confidence            458999999999999999999999999999999999765444444444445556688889999999999994     346


Q ss_pred             eEEEEeecCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          108 DVYLVYELMDTDLHQIIK----SSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ..++||||++|+|.+++.    ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            799999999999877765    356899999999999999999999998 999999999999999999999999999976


Q ss_pred             cCCCCccccceeeccccCchhhh---hcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELL---LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC-LNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  258 (373)
                      .... .......||+.|+|||++   .....++.++|||||||++|+|++|..||..... .........          
T Consensus       160 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------  228 (290)
T 3fme_A          160 LVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE----------  228 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH----------
T ss_pred             cccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc----------
Confidence            5332 223344789999999997   3345789999999999999999999999976332 222222211          


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                   ...      .......+++.+.+||.+||+.||++|||+.++++||||+.
T Consensus       229 -------------~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          229 -------------EPS------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             -------------SCC------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             -------------cCC------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence                         000      00112357889999999999999999999999999999964

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-50  Score=365.41  Aligned_cols=261  Identities=24%  Similarity=0.347  Sum_probs=218.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -...|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.... ....
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~  102 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK  102 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCc
Confidence            345689999999999999999999999999999999877666677778889999999999999999999885432 3347


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEc-CCCCeEEcccCccccc
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVN-ANCDLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~-~~~~~kL~Dfg~a~~~  183 (373)
                      .+++||||++ ++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++...
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            7999999996 699999998889999999999999999999999999  99999999999998 7889999999999765


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ...  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+............  ...          
T Consensus       183 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~----------  246 (290)
T 1t4h_A          183 RAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--SGV----------  246 (290)
T ss_dssp             CTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT--TTC----------
T ss_pred             ccc--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh--ccC----------
Confidence            332  2345678999999998864  489999999999999999999999987554433322111  000          


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                      .........++.+.+||.+||+.||++|||+.++++||||+.
T Consensus       247 ----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          247 ----------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                            011122346788999999999999999999999999999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7e-51  Score=367.92  Aligned_cols=263  Identities=30%  Similarity=0.458  Sum_probs=224.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++     ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   87 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----EDN   87 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----ccC
Confidence            45899999999999999999999999999999999876543 344455677899999999999999999998     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +..++||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            67999999997 69999998888999999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+...                
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------  230 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------------  230 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------------
T ss_pred             CccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------------
Confidence            4444455688999999999876 57899999999999999999999999877654443333210                


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSS  327 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~  327 (373)
                                     .......+++.+.+||.+||+.||++|||+.++++||||.....+..
T Consensus       231 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~  277 (294)
T 2rku_A          231 ---------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR  277 (294)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred             ---------------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCC
Confidence                           00122457888999999999999999999999999999986654443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.3e-52  Score=381.15  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=213.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh------HHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR------VDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      +.++|++++.||+|+||.||+|+++.+|+.||||++.......      .....+.+|+.+++.++||||+++++++   
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---   98 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---   98 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            5689999999999999999999999999999999997653211      1222456799999999999999999999   


Q ss_pred             CCCCcceEEEEeecCC-c-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          102 HRRNFKDVYLVYELMD-T-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                        ...+.+++||||+. | +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        99 --~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A           99 --ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             --ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             --eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence              44578999999985 5 9999999888999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      +...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.......                 .
T Consensus       177 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~  238 (335)
T 3dls_A          177 AAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------E  238 (335)
T ss_dssp             CEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------T
T ss_pred             ceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------h
Confidence            9866433 334556899999999999875445889999999999999999999996532100                 0


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                          ........+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       239 --------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 --------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             --------------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             --------------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                                0001123478899999999999999999999999999999753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.3e-51  Score=373.78  Aligned_cols=276  Identities=26%  Similarity=0.338  Sum_probs=206.5

Q ss_pred             ecCceeee-eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCC
Q 017334           28 IDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        28 ~~~~Y~~~-~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  105 (373)
                      +.++|++. +.||+|+||.||+|.+..+|+.||||++......  ....+.+|+.+++++ +||||+++++++     ..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~   82 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFF-----EE   82 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ee
Confidence            46889996 7899999999999999999999999999755322  234677999999985 699999999998     44


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC---eEEcccCccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~---~kL~Dfg~a~  181 (373)
                      .+.+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            478999999996 799999988889999999999999999999999999999999999999998876   9999999987


Q ss_pred             ccCCC-------CccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017334          182 TSNGK-------NQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL  250 (373)
Q Consensus       182 ~~~~~-------~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  250 (373)
                      .....       .......+||+.|+|||++.+    ...++.++|||||||++|+|++|++||.+....+......   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---  239 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG---  239 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc---
Confidence            54321       112234569999999999864    1347889999999999999999999998754321000000   


Q ss_pred             CCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          251 GSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                           ....................    .....++.+++.+++||++||+.||++|||+.++++||||+..
T Consensus       240 -----~~~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          240 -----EACPACQNMLFESIQEGKYE----FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             ------CCHHHHHHHHHHHHHCCCC----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             -----ccchhHHHHHHHHHhccCcc----cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence                 00000000000000000000    0011124578899999999999999999999999999999865

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.5e-51  Score=366.96  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=210.8

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      +.++|++++.||+|+||+||+|.+..+|+.||+|++............+.+|+..+..+ +||||+++++++.     ..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----ED   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ET
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence            46899999999999999999999999999999999987666666667788999999999 8999999999983     44


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC------------
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS----QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN------------  169 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~------------  169 (373)
                      +..++||||++ ++|.+++...    +.+++.+++.++.||+.||+|||++||+||||||+|||++.+            
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence            67999999996 5999999764    679999999999999999999999999999999999999844            


Q ss_pred             -------CCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHH
Q 017334          170 -------CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQ  242 (373)
Q Consensus       170 -------~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  242 (373)
                             ..+||+|||.+.......    ...||+.|+|||++.+...++.++|||||||++|+|++|.+++.....   
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                   479999999998664322    346899999999998755677899999999999999999988754422   


Q ss_pred             HHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          243 LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ...+..                              .........+++.+.+||.+||+.||++|||+.++++||||..
T Consensus       237 ~~~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          237 WHEIRQ------------------------------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             HHHHHT------------------------------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             HHHHHc------------------------------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence            111111                              0111233567899999999999999999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-50  Score=372.69  Aligned_cols=283  Identities=30%  Similarity=0.570  Sum_probs=221.8

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  104 (373)
                      +...++|++++.||+|+||.||+|++..+|+.||+|++....     ...+.+|+.+++.++ ||||+++++++...   
T Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---  103 (330)
T 3nsz_A           32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDP---  103 (330)
T ss_dssp             CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECT---
T ss_pred             ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccC---
Confidence            456789999999999999999999999999999999986432     235778999999997 99999999998543   


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~  182 (373)
                      .....++||||++ ++|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            2367899999997 68888774   489999999999999999999999999999999999999777 899999999986


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHHHhCCCChhhhc--
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF-PGTECLNQLKLIINILGSRREEDLE--  259 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~--  259 (373)
                      .... .......+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+...++........  
T Consensus       181 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          181 YHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            5433 23445688999999999987677999999999999999999999887 4555556666666655532211100  


Q ss_pred             --ccCChhHHHHHHhCCCCCCCCccccC-----CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          260 --FIDNPKARKYIKSLPYTPGTPFSRLY-----PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       260 --~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                        ....+......   .......+....     ..+++.+.+||.+||+.||++|||+.|+|+||||+.+.
T Consensus       260 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          260 YNIELDPRFNDIL---GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             TTCCCCTHHHHHH---CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hccccccchhhhh---hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence              00011111111   111112222221     23789999999999999999999999999999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2e-51  Score=374.56  Aligned_cols=269  Identities=22%  Similarity=0.306  Sum_probs=217.8

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      +...+.++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            345678999999999999999999999999999999999976543 3344556789999999999999999999985432


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                       ......|+||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        86 -~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           86 -PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             -TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             -CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             22235699999996 6999999988899999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          182 TSNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       182 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ......   ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.....       
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-------  236 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-------  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------
T ss_pred             cccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------
Confidence            653321   22234578999999999987 5789999999999999999999999988776555444333110       


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                          .+.....+.+++.+.+||.+||+.||++||++.++++|+|+..
T Consensus       237 --------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          237 --------------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             --------------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --------------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                                0111223567899999999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.2e-52  Score=382.82  Aligned_cols=269  Identities=31%  Similarity=0.475  Sum_probs=216.6

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc---cChHHHHHHHHHHHHHhhCCCCCeeeeceeec
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF---ENRVDALRTLRELKLLRHLQHENVIALKDVMM   99 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   99 (373)
                      .++..+.++|++++.||+|+||.||+|.+..+++.||+|++....   ........+.+|+.+++.++||||+++++++ 
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-   97 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-   97 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-
Confidence            445678899999999999999999999999999999999986542   1234455778999999999999999999999 


Q ss_pred             CCCCCCcceEEEEeecCC-ccHHHHHHh----------------------------------------cCCCCHHHHHHH
Q 017334          100 PSHRRNFKDVYLVYELMD-TDLHQIIKS----------------------------------------SQALTNDHCQYF  138 (373)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~----------------------------------------~~~~~~~~~~~i  138 (373)
                          ...+..++||||++ |+|.+++..                                        ...+++..++.+
T Consensus        98 ----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           98 ----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             ----ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ----ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence                44578999999995 799998842                                        112467888999


Q ss_pred             HHHHHHHHHHHHhCCccccCCCCCceEEcCCC--CeEEcccCcccccCC----CCccccceeeccccCchhhhhcC-CCC
Q 017334          139 LFQLLRGLKYLHSANILHRDLKPGNLLVNANC--DLKICDFGLARTSNG----KNQFMTEYVVTRWYRAPELLLCC-DNY  211 (373)
Q Consensus       139 ~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~--~~kL~Dfg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~-~~~  211 (373)
                      +.||+.||+|||++||+||||||+|||++.++  .+||+|||++.....    .........||+.|+|||++.+. ..+
T Consensus       174 ~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          174 MRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            99999999999999999999999999998777  899999999975422    11123456899999999998642 568


Q ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHH
Q 017334          212 GTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPL  291 (373)
Q Consensus       212 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  291 (373)
                      +.++|||||||++|+|++|.+||.+.+..+....+........                           ...+..+++.
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~  306 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE---------------------------NPNYNVLSPL  306 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT---------------------------SGGGGGSCHH
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC---------------------------CcccccCCHH
Confidence            8999999999999999999999998877666655544111100                           0112346889


Q ss_pred             HHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          292 AIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       292 ~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      +.+||.+||+.||.+||++.++++||||+.+.
T Consensus       307 ~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          307 ARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            99999999999999999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-51  Score=390.00  Aligned_cols=260  Identities=32%  Similarity=0.546  Sum_probs=204.6

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC------hHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN------RVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      +.++|++.+.||+|+||+||+|.++.+++.||+|++.+....      ......+.+|+.+++.++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            468899999999999999999999999999999999754321      1122246789999999999999999999722 


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEccc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDF  177 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~kL~Df  177 (373)
                           ...|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++   .+||+||
T Consensus       212 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeec
Confidence                 34799999996 69999998888999999999999999999999999999999999999997654   4999999


Q ss_pred             CcccccCCCCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHHHhCCCC
Q 017334          178 GLARTSNGKNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQL-KLIINILGSRR  254 (373)
Q Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~  254 (373)
                      |++..... .......+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||.+......+ ..+....    
T Consensus       287 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~----  361 (419)
T 3i6u_A          287 GHSKILGE-TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK----  361 (419)
T ss_dssp             STTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC----
T ss_pred             ccceecCC-CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC----
Confidence            99987643 333456789999999999853  356788999999999999999999999765433222 2221100    


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                             .......++.+++.+.+||++||+.||++|||+.++|+||||+.
T Consensus       362 -----------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          362 -----------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             -----------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             -----------------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence                                   00111223567899999999999999999999999999999964

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-50  Score=376.41  Aligned_cols=261  Identities=31%  Similarity=0.532  Sum_probs=218.3

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC------hHHHHHHHHHHHHHhhC-CCCCeeeeceeec
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN------RVDALRTLRELKLLRHL-QHENVIALKDVMM   99 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~   99 (373)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||||++......      ......+.+|+.+++.+ +||||+++++++ 
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-  169 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-  169 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE-
Confidence            3457899999999999999999999999999999998654321      11234567899999999 799999999998 


Q ss_pred             CCCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccC
Q 017334          100 PSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                          ......|+||||++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus       170 ----~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          170 ----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             ----EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ----eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence                44477999999997 5999999888899999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcC-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCC-----DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      ++...... ......+||+.|+|||++.+.     ..++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus       246 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  324 (365)
T 2y7j_A          246 FSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF  324 (365)
T ss_dssp             TCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             cccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            98766433 234557899999999998642     357889999999999999999999998877665555544311111


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      .                           ...+..+++.+.+||.+||+.||++|||+.++++||||+
T Consensus       325 ~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          325 S---------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             C---------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             C---------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            1                           011245678899999999999999999999999999996

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=366.06  Aligned_cols=256  Identities=29%  Similarity=0.466  Sum_probs=191.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh-HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR-VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++||||+++++++     ...+.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCCe
Confidence            68999999999999999999999999999999986442211 1234677899999999999999999998     44477


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .|+||||++ ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            999999996 6999999865 67999999999999999999999999999999999999999999999999999876543


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+....+.                   
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------------  225 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV-------------------  225 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------------------
T ss_pred             CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------------------
Confidence            333445688999999999876 578899999999999999999999997755332221110                   


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                  .........+++.+.+||.+||+.||++|||+.++++||||...
T Consensus       226 ------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          226 ------------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             ------------SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             ------------hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence                        00011234578899999999999999999999999999999753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-50  Score=378.57  Aligned_cols=286  Identities=30%  Similarity=0.509  Sum_probs=227.6

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CC-----Ceeeece
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HE-----NVIALKD   96 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~~   96 (373)
                      .....+.++|++.+.||+|+||+||+|.+..+|+.||||++...   ......+.+|+.+++.++ |+     +|+++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~  123 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR  123 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence            34456679999999999999999999999999999999999743   233345667888888875 55     4888888


Q ss_pred             eecCCCCCCcceEEEEeecCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEEc--CCC
Q 017334           97 VMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLH--SANILHRDLKPGNLLVN--ANC  170 (373)
Q Consensus        97 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~Nill~--~~~  170 (373)
                      ++.     ..+.+|+||||++++|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||++  .++
T Consensus       124 ~~~-----~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          124 HFM-----FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             EEE-----ETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred             eec-----cCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence            883     34789999999999999999865  46999999999999999999999  57999999999999995  477


Q ss_pred             CeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017334          171 DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL  250 (373)
Q Consensus       171 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  250 (373)
                      .+||+|||++......   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...+
T Consensus       199 ~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~  274 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR---IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL  274 (382)
T ss_dssp             CEEECCCTTCEETTCC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cEEEEeccCceecccc---cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            8999999999876432   345688999999999987 578999999999999999999999999999999999999998


Q ss_pred             CCCChhhhcccCChhHHHHHHhCCCCCC---------C--------Ccccc-----------CCC-------CCHHHHHH
Q 017334          251 GSRREEDLEFIDNPKARKYIKSLPYTPG---------T--------PFSRL-----------YPD-------AHPLAIDL  295 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~--------~~~~~-----------~~~-------~s~~~~~l  295 (373)
                      +.++........  ....+...++...-         .        .+...           ..+       .++.+++|
T Consensus       275 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  352 (382)
T 2vx3_A          275 GIPPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL  352 (382)
T ss_dssp             CSCCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred             CCCCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence            888766554322  22233222221100         0        00000           000       01468999


Q ss_pred             HHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          296 LQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       296 l~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      |.+||+.||++|||+.|+|+||||+..
T Consensus       353 i~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          353 ILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             HHHhcCCChhhCCCHHHHhcCcccccC
Confidence            999999999999999999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.2e-50  Score=365.23  Aligned_cols=267  Identities=30%  Similarity=0.478  Sum_probs=219.9

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-------ChHHHHHHHHHHHHHhhCC-CCCeeee
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-------NRVDALRTLRELKLLRHLQ-HENVIAL   94 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-------~~~~~~~~~~E~~~l~~l~-hpniv~~   94 (373)
                      .....+.++|++.+.||+|+||.||+|.++.+|+.||||++.....       .......+.+|+.+++.+. ||||+++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (298)
T 1phk_A           10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   89 (298)
T ss_dssp             -----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            4445677999999999999999999999999999999999965431       1223345678999999996 9999999


Q ss_pred             ceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeE
Q 017334           95 KDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLK  173 (373)
Q Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~k  173 (373)
                      ++++     ...+..++||||++ ++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus        90 ~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           90 KDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             EEEE-----ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred             eeee-----ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEE
Confidence            9998     44478999999997 69999999888999999999999999999999999999999999999999999999


Q ss_pred             EcccCcccccCCCCccccceeeccccCchhhhhc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 017334          174 ICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC-----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIIN  248 (373)
Q Consensus       174 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  248 (373)
                      |+|||++...... .......+++.|+|||++.+     ...++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus       165 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  243 (298)
T 1phk_A          165 LTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS  243 (298)
T ss_dssp             ECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence            9999999765432 23445678999999999862     34678999999999999999999999988766555554433


Q ss_pred             HhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      .....                           ....++.+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       244 ~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          244 GNYQF---------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             TCCCC---------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCccc---------------------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            11000                           001123578889999999999999999999999999999865

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.6e-51  Score=380.42  Aligned_cols=258  Identities=30%  Similarity=0.419  Sum_probs=211.7

Q ss_pred             ecCceee--eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           28 IDTKYVP--IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        28 ~~~~Y~~--~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +...|.+  .+.||+|+||.||+|.+..+|+.||+|++....  ......+.+|+.+++.++||||+++++++     ..
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~  157 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAF-----ES  157 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EE
Confidence            4455666  668999999999999999999999999997542  23445678999999999999999999999     44


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE--cCCCCeEEcccCccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV--NANCDLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill--~~~~~~kL~Dfg~a~  181 (373)
                      .+.+++||||++ ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||+  +.++.+||+|||++.
T Consensus       158 ~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            467999999996 6998888654 469999999999999999999999999999999999999  566789999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.......        
T Consensus       238 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~--------  307 (373)
T 2x4f_A          238 RYKPR-EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL--------  307 (373)
T ss_dssp             ECCTT-CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS--------
T ss_pred             ecCCc-cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------
Confidence            76433 23345579999999999876 578999999999999999999999999887776666655421110        


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                         ....++.+++.+++||.+||+.||.+|||+.++|+||||..
T Consensus       308 -------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          308 -------------------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             -------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             -------------------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence                               11223567899999999999999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.1e-50  Score=372.62  Aligned_cols=259  Identities=25%  Similarity=0.431  Sum_probs=204.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC-----
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR-----  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----  103 (373)
                      -++|++++.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+++.++||||+++++++.....     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            478999999999999999999999999999999997543 23344567899999999999999999998754321     


Q ss_pred             -----------------------------------------------CCcceEEEEeecCC-ccHHHHHHhcCC---CCH
Q 017334          104 -----------------------------------------------RNFKDVYLVYELMD-TDLHQIIKSSQA---LTN  132 (373)
Q Consensus       104 -----------------------------------------------~~~~~~~lv~e~~~-g~L~~~l~~~~~---~~~  132 (373)
                                                                     .....+++||||++ ++|.+++.....   .++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                           11235899999996 699999987543   455


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC------------ccccceeeccccC
Q 017334          133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN------------QFMTEYVVTRWYR  200 (373)
Q Consensus       133 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~------------~~~~~~~gt~~y~  200 (373)
                      ..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......            ......+||+.|+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            6789999999999999999999999999999999999999999999998664432            2234457999999


Q ss_pred             chhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCC
Q 017334          201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTP  280 (373)
Q Consensus       201 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (373)
                      |||++.+ ..++.++|||||||++|+|++|..|+.     +....+........                          
T Consensus       244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~--------------------------  291 (332)
T 3qd2_B          244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKF--------------------------  291 (332)
T ss_dssp             CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCC--------------------------
T ss_pred             ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCC--------------------------
Confidence            9999987 578999999999999999999876642     11111111111110                          


Q ss_pred             ccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          281 FSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       281 ~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                       ...++..++.+.+||.+||+.||++|||+.++++||||+.
T Consensus       292 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          292 -PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             -CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             -CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence             0111234567899999999999999999999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=367.09  Aligned_cols=264  Identities=28%  Similarity=0.435  Sum_probs=216.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc--ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++.....  .......+.+|+.+++.++||||+++++++...   .
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~   79 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---E   79 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---C
Confidence            45899999999999999999999999999999999975432  123445678999999999999999999998543   2


Q ss_pred             cceEEEEeecCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMDTDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ....|+||||++++|.+++..  ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           80 KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             --CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            357999999999888888865  457999999999999999999999999999999999999999999999999999765


Q ss_pred             CC--CCccccceeeccccCchhhhhcCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          184 NG--KNQFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       184 ~~--~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ..  .........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+...           
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-----------  228 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-----------  228 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------
Confidence            42  222334557899999999987532 2478999999999999999999999887655544443320           


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                                  .        ......+++.+.+||.+||+.||.+|||+.++++||||.....+
T Consensus       229 ------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          229 ------------S--------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             ------------C--------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             ------------C--------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence                        0        01224578889999999999999999999999999999765443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.3e-50  Score=372.92  Aligned_cols=287  Identities=29%  Similarity=0.517  Sum_probs=227.8

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEe-CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCC------Ceeeec
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVN-RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE------NVIALK   95 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~-~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~   95 (373)
                      +....+.++|++++.||+|+||.||+|.+ ..+|+.||+|++...   ......+.+|+.+++.++|+      ++++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            34456789999999999999999999998 568899999999643   23344567888888888655      499999


Q ss_pred             eeecCCCCCCcceEEEEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-----
Q 017334           96 DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-----  168 (373)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-----  168 (373)
                      +++     ...+..|+||||++++|.+++...+  .+++.+++.++.||+.||+|||++||+||||||+|||++.     
T Consensus        84 ~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           84 EWF-----EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             EEE-----EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred             ccc-----ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence            988     4447899999999999999998765  6899999999999999999999999999999999999987     


Q ss_pred             --------------CCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCC
Q 017334          169 --------------NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIF  234 (373)
Q Consensus       169 --------------~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  234 (373)
                                    ++.+||+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf  234 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF  234 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC
Confidence                          668999999999765332   245688999999999976 57899999999999999999999999


Q ss_pred             CCCCchHHHHHHHHHhCCCChhhhcccCCh--------------hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhc
Q 017334          235 PGTECLNQLKLIINILGSRREEDLEFIDNP--------------KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKML  300 (373)
Q Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L  300 (373)
                      .+.+..+....+....+..+..........              ....+....... ...+.......++.+.+||.+||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L  313 (339)
T 1z57_A          235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERLFDLIQKML  313 (339)
T ss_dssp             CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHHHHHHHHHh
Confidence            999988888888888887665443322110              111111110000 00111111234567899999999


Q ss_pred             CcCCCCCCCHHHHhCCCCCCCC
Q 017334          301 VFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       301 ~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      +.||.+|||+.|+++||||+.+
T Consensus       314 ~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          314 EYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             CSSTTTSCCHHHHTTSGGGGGG
T ss_pred             CcCcccccCHHHHhcCHHHHHH
Confidence            9999999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-50  Score=363.56  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=217.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++...   ....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence            4799999999999999999999999999999999987666666667788999999999999999999987532   2367


Q ss_pred             EEEEeecCC-ccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEEcCCCCeEEcccC
Q 017334          109 VYLVYELMD-TDLHQIIKSS----QALTNDHCQYFLFQLLRGLKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      +|+||||++ ++|.+++...    ..+++..++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999997 5999998653    34999999999999999999999999     9999999999999999999999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ++..............|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+...         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---------  231 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---------  231 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------
T ss_pred             hheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc---------
Confidence            99876544433445678999999999977 57899999999999999999999999887655444443321         


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                           ........+++.+.++|.+||+.||++|||+.++++|+|+.+
T Consensus       232 ---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          232 ---------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             ---------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             ---------------------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                                 001122457889999999999999999999999999999974

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.3e-51  Score=365.30  Aligned_cols=255  Identities=23%  Similarity=0.415  Sum_probs=216.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++     ...+
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence            37899999999999999999999999999999998654221 11234577899999999999999999998     4447


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      ..|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            7999999996 699999988889999999999999999999999999999999999999999999999999998765332


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                        ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+....+....                
T Consensus       168 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------------  228 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD----------------  228 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC----------------
T ss_pred             --ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc----------------
Confidence              2345678999999999876 578999999999999999999999998876555444332200                


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                     ....+.+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       229 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          229 ---------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ---------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence                           01224578899999999999999999999999999999754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.1e-50  Score=365.47  Aligned_cols=257  Identities=23%  Similarity=0.322  Sum_probs=207.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ...++|++.+.||+|+||+||+|.+  +|+.||+|++............+.+|+.++++++||||+++++++     ...
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQP  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CST
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence            4568999999999999999999977  588999999987766666677888999999999999999999999     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQA---LTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      ..+++||||++ |+|.+++...+.   +++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            67999999996 699999987553   999999999999999999999999  999999999999999999999999999


Q ss_pred             cccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ..............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....          
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~----------  255 (309)
T 3p86_A          187 RLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC----------  255 (309)
T ss_dssp             ---------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC----------
T ss_pred             ccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----------
Confidence            765444444456689999999999977 578999999999999999999999998876655444432210          


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC--CCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ--HPYMS  320 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~--hp~~~  320 (373)
                                         ........+++.+.+||.+||+.||.+|||+.++++  .++++
T Consensus       256 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          256 -------------------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             -------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -------------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                               011223567899999999999999999999999987  45554

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1e-50  Score=364.64  Aligned_cols=261  Identities=30%  Similarity=0.498  Sum_probs=216.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh----HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR----VDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      +.++|++++.||+|+||.||+|.+..+|+.||+|++.......    .....+.+|+.+++.++||||+++++++     
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----   77 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----   77 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----
Confidence            4578999999999999999999999999999999987543221    1245677999999999999999999998     


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----CeEEcccC
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDFG  178 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~----~~kL~Dfg  178 (373)
                      ......++||||++ ++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            44467999999996 79999998888999999999999999999999999999999999999998877    79999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......     
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----  230 (283)
T 3bhy_A          158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF-----  230 (283)
T ss_dssp             TCEECC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC-----
T ss_pred             cceeccCCC-cccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC-----
Confidence            998654322 2345578999999999876 578999999999999999999999998877655554443211111     


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                            ....++.+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       231 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          231 ----------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             ----------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             ----------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence                                  011234578889999999999999999999999999999754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.8e-50  Score=361.74  Aligned_cols=260  Identities=28%  Similarity=0.408  Sum_probs=214.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++     ...+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHR-----REGNI   79 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCE
Confidence            47899999999999999999999999999999998654332 2345677999999999999999999998     44477


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC-
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK-  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-  186 (373)
                      .|+||||++ ++|.+++.....+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||.+...... 
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999997 599999987778999999999999999999999999999999999999999999999999998754322 


Q ss_pred             -CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCChhhhcccCCh
Q 017334          187 -NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQ-LKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                       ........||+.|+|||++.+...++.++|||||||++|+|++|..||.+...... ...+..                
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------  223 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE----------------  223 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT----------------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh----------------
Confidence             12234567899999999997754457899999999999999999999977654321 111111                


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                             ..      .....+..+++.+.+||.+||+.||++|||+.++++||||+...
T Consensus       224 -------~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          224 -------KK------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             -------TC------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -------cc------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                   00      00011235788899999999999999999999999999998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.5e-52  Score=390.60  Aligned_cols=255  Identities=15%  Similarity=0.176  Sum_probs=201.8

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHH---HHhhCCCCCeeeeceeec----
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELK---LLRHLQHENVIALKDVMM----   99 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~---~l~~l~hpniv~~~~~~~----   99 (373)
                      ..++|++.+.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.   +++.++||||+++++.+.    
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            4588999999999999999999999999999999997542 23344556779995   455557999999984332    


Q ss_pred             ---CCCC-------CCc-----ceEEEEeecCCccHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcccc
Q 017334          100 ---PSHR-------RNF-----KDVYLVYELMDTDLHQIIKSSQALTN-------DHCQYFLFQLLRGLKYLHSANILHR  157 (373)
Q Consensus       100 ---~~~~-------~~~-----~~~~lv~e~~~g~L~~~l~~~~~~~~-------~~~~~i~~qi~~aL~~LH~~~ivH~  157 (373)
                         ....       .+.     ...|+||||++|+|.+++...+.+++       ..++.++.||+.||+|||++||+||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence               2110       001     13899999999999999987666666       7788899999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcC----------CCCCchhhhHHHHHHHHHH
Q 017334          158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC----------DNYGTSIDVWSVGCIFAEL  227 (373)
Q Consensus       158 Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~l  227 (373)
                      ||||+|||++.++.+||+|||++.....   .....+| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999999986432   3445677 999999999873          2689999999999999999


Q ss_pred             HhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCC
Q 017334          228 LGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKR  307 (373)
Q Consensus       228 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R  307 (373)
                      ++|++||.+.+.......                                   .....+.+++.+.+||.+||+.||++|
T Consensus       307 ltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R  351 (377)
T 3byv_A          307 WCADLPITKDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDR  351 (377)
T ss_dssp             HHSSCCC------CCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGC
T ss_pred             HHCCCCCcccccccchhh-----------------------------------hhhhccCCCHHHHHHHHHHcCCCchhC
Confidence            999999966432111100                                   011225678999999999999999999


Q ss_pred             CCHHHHhCCCCCCC
Q 017334          308 ISVTEALQHPYMSP  321 (373)
Q Consensus       308 ~t~~eil~hp~~~~  321 (373)
                      ||+.++++||||+.
T Consensus       352 pt~~e~l~hp~f~~  365 (377)
T 3byv_A          352 LLPLQAMETPEYEQ  365 (377)
T ss_dssp             CCHHHHHTSHHHHH
T ss_pred             CCHHHHhhChHHHH
Confidence            99999999999964

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-50  Score=381.89  Aligned_cols=258  Identities=29%  Similarity=0.420  Sum_probs=201.9

Q ss_pred             ecCceeee-eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHh-hCCCCCeeeeceeecCCCCCC
Q 017334           28 IDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR-HLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        28 ~~~~Y~~~-~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +-++|.++ +.||+|+||+||+|.++.+|+.||||++...       ....+|+.++. ..+||||+++++++.... .+
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cC
Confidence            44677776 7899999999999999999999999998532       23557888874 457999999999884321 23


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCCeEEcccCc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL  179 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~---~~~~kL~Dfg~  179 (373)
                      ...+|+||||++ |+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            467999999996 69999998653  5999999999999999999999999999999999999998   78899999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchH----HHHHHHHHhCCCCh
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLN----QLKLIINILGSRRE  255 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~  255 (373)
                      +...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.....    ....+..       
T Consensus       211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-------  281 (400)
T 1nxk_A          211 AKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-------  281 (400)
T ss_dssp             CEECC------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-------
T ss_pred             ccccCCC-CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-------
Confidence            9865432 23456789999999999866 679999999999999999999999997654321    1111111       


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                      .....    ....+..+++.+.+||++||+.||++|||+.++++||||...
T Consensus       282 ----------------~~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          282 ----------------GQYEF----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             ----------------TCCCC----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ----------------CcccC----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                            00000    011235688999999999999999999999999999999753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-50  Score=362.58  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=208.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++     ...
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STP   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecC
Confidence            448999999999999999999999999999999998654221 12234577899999999999999999998     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ...|+||||++ ++|.+++...+.+++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            67999999996 69999998888999999999999999999999999999999999999999999999999999976543


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                      . .......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.......+...                
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------  226 (276)
T 2h6d_A          164 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG----------------  226 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------------
T ss_pred             C-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC----------------
Confidence            2 22345578999999999987444578999999999999999999999877655444433220                


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                             .        ......+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       227 -------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          227 -------V--------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             -------C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             -------c--------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                   0        01123467889999999999999999999999999999754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.4e-50  Score=366.20  Aligned_cols=260  Identities=29%  Similarity=0.444  Sum_probs=218.1

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ..+.++|++.+.||+|+||.||+|++..+|+.||+|++.....  .....+.+|+.+++.++||||+++++++     ..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   77 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIY-----ES   77 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhc-----cc
Confidence            3567899999999999999999999999999999999975432  2234567899999999999999999998     44


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCCeEEcccCccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill---~~~~~~kL~Dfg~a~  181 (373)
                      ....|+||||++ ++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           78 TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            477999999996 6999999888899999999999999999999999999999999999999   778899999999987


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+......         
T Consensus       158 ~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~---------  225 (304)
T 2jam_A          158 MEQN--GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE---------  225 (304)
T ss_dssp             CCCC--BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------
T ss_pred             ecCC--CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            5432  22345578999999999876 57899999999999999999999999887765555554431100         


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                        .....++.+++.+.+||.+||..||++|||+.++++||||...
T Consensus       226 ------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          226 ------------------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ------------------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ------------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                              0012235678999999999999999999999999999999753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.7e-50  Score=362.60  Aligned_cols=262  Identities=26%  Similarity=0.356  Sum_probs=212.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .+.++|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++     ..
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~   82 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EE   82 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----EC
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----ee
Confidence            467999999999999999999999999999999999865433 344456778999999999999999999998     44


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+..|+||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            578999999996 5999999988899999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..........  ...+         
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~~---------  230 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--DSVP---------  230 (294)
T ss_dssp             ------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--SCCC---------
T ss_pred             cccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--ccCC---------
Confidence            322 22344579999999999987 5789999999999999999999999988765443322211  1100         


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                     .......+.+++.+.++|.+||..||++||+..+.+.+.|..
T Consensus       231 ---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          231 ---------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             ---------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             ---------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence                           011123456889999999999999999999766666666654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.9e-50  Score=364.32  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=212.1

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ......++|++++.||+|+||.||+|.+..+|+.||+|++......  ....+.+|+.+++.++||||+++++++..   
T Consensus        13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   87 (302)
T 2j7t_A           13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYH---   87 (302)
T ss_dssp             SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcCCCCCEeeeeeeeee---
Confidence            3456789999999999999999999999999999999998654322  23467789999999999999999999843   


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                        .+..++||||++ ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        88 --~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           88 --DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             --C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             --CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence              467999999996 589888765 4679999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCCccccceeeccccCchhhhh----cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLL----CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      .............||+.|+|||++.    ....++.++|||||||++|+|++|.+||...+.......+...  ..    
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~----  239 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--DP----  239 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC----
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc--CC----
Confidence            4321112223457899999999984    3356889999999999999999999999887655544433321  00    


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                            +.......++..+.+||.+||+.||++|||+.++++||||...
T Consensus       240 ----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          240 ----------------------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             ----------------------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             ----------------------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence                                  0001123467889999999999999999999999999999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.9e-50  Score=368.70  Aligned_cols=261  Identities=31%  Similarity=0.541  Sum_probs=210.6

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc------ChHHHHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE------NRVDALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      .+.++|++.+.||+|+||.||+|.+..+|+.||||++.....      .......+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            356899999999999999999999999999999999975432      11222346789999999999999999999832


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC---eEEcc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICD  176 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~---~kL~D  176 (373)
                            ...|+||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.   +||+|
T Consensus        87 ------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           87 ------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             ------SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             ------CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence                  23899999996 699999988889999999999999999999999999999999999999987665   99999


Q ss_pred             cCcccccCCCCccccceeeccccCchhhhh--cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchH-HHHHHHHHhCCC
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLN-QLKLIINILGSR  253 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~  253 (373)
                      ||++...... .......||+.|+|||++.  +...++.++|||||||++|+|++|.+||....... ....+.....  
T Consensus       161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--  237 (322)
T 2ycf_A          161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY--  237 (322)
T ss_dssp             CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC--
T ss_pred             Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc--
Confidence            9999866432 2334567899999999984  34568899999999999999999999997654332 2222221000  


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                               ......+..+++.+.+||.+||+.||++|||+.++++||||..
T Consensus       238 -------------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          238 -------------------------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             -------------------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             -------------------------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence                                     0011223457889999999999999999999999999999964

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-49  Score=372.12  Aligned_cols=289  Identities=27%  Similarity=0.417  Sum_probs=221.3

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-----------CCCeeeece
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-----------HENVIALKD   96 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~   96 (373)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...   ......+.+|+.+++.++           ||||+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            568999999999999999999999999999999999643   233445678898888876           899999999


Q ss_pred             eecCCCCCCcceEEEEeecCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcC-----
Q 017334           97 VMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNA-----  168 (373)
Q Consensus        97 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~-----  168 (373)
                      ++.... .+...+++|||+++++|.+++...  ..+++..++.++.||+.||+|||++ ||+||||||+|||++.     
T Consensus        94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            985432 233479999999998999999763  4699999999999999999999998 9999999999999953     


Q ss_pred             -CCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------chH
Q 017334          169 -NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE------CLN  241 (373)
Q Consensus       169 -~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~  241 (373)
                       .+.+||+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+      ...
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC---CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence             447999999999765332   344588999999999987 578999999999999999999999998654      455


Q ss_pred             HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCC-------------ccccCCCCCHHHHHHHHhhcCcCCCCCC
Q 017334          242 QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTP-------------FSRLYPDAHPLAIDLLQKMLVFDPTKRI  308 (373)
Q Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~s~~~~~ll~~~L~~dP~~R~  308 (373)
                      .+..+...++..+..........  ..+...........             .....+..++.+.+||.+||+.||++||
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHhcCCCCHHHHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            67777788887765443221110  00000000000000             0011123456789999999999999999


Q ss_pred             CHHHHhCCCCCCCCCCCC
Q 017334          309 SVTEALQHPYMSPLYDPS  326 (373)
Q Consensus       309 t~~eil~hp~~~~~~~~~  326 (373)
                      |+.|+|+||||+......
T Consensus       327 t~~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTLGME  344 (373)
T ss_dssp             CHHHHHTCGGGTTCTTCT
T ss_pred             CHHHHhhChhhhcccCcc
Confidence            999999999998764433

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.4e-50  Score=363.26  Aligned_cols=260  Identities=32%  Similarity=0.528  Sum_probs=218.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +.++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++     ....
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   94 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSS   94 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCC
Confidence            46899999999999999999999999999999999976655444456788999999999999999999998     4446


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEcccCccccc
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---DLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---~~kL~Dfg~a~~~  183 (373)
                      ..|+||||+. ++|.+.+...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++   .+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            7999999996 69999998878999999999999999999999999999999999999997644   6999999999765


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .... ......+|+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+.......          
T Consensus       175 ~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  241 (287)
T 2wei_A          175 QQNT-KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF----------  241 (287)
T ss_dssp             CCCS-SCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----------
T ss_pred             cCCC-ccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------
Confidence            4332 2344578999999999865  48899999999999999999999998877665554443310000          


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       ....+..+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       242 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          242 -----------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             -----------------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             -----------------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence                             011124578899999999999999999999999999999754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-50  Score=367.06  Aligned_cols=284  Identities=20%  Similarity=0.326  Sum_probs=213.7

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      +...+.++|++.+.||+|+||+||+|.+..+|+.||||++....... ....+.+|+.+++.++||||+++++++...  
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   79 (319)
T 4euu_A            3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEET--   79 (319)
T ss_dssp             EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECT--
T ss_pred             cccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecC--
Confidence            34556799999999999999999999999999999999997543222 234567899999999999999999998543  


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCCeEEc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQA---LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKIC  175 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill----~~~~~~kL~  175 (373)
                       .....|+||||++ ++|.+++.....   +++.+++.++.||+.||+|||++||+||||||+|||+    +.++.+||+
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           80 -TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             -TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             -CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence             2257899999996 799999976433   9999999999999999999999999999999999999    778889999


Q ss_pred             ccCcccccCCCCccccceeeccccCchhhhhc-------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchH-HHHHHH
Q 017334          176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLC-------CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLN-QLKLII  247 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~  247 (373)
                      |||++....... ......||+.|+|||++..       ...++.++|||||||++|+|++|.+||....... ....+.
T Consensus       159 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  237 (319)
T 4euu_A          159 DFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (319)
T ss_dssp             CCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred             cCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence            999998764332 3345679999999999862       3578899999999999999999999997543322 222222


Q ss_pred             HHhCCCChhhhcccCChhHH--HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q 017334          248 NILGSRREEDLEFIDNPKAR--KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP  317 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp  317 (373)
                      .++...+...+.........  .+....+     ....+...+++.+.+||++||+.||++|||++|+|+||
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHCCTTCCEEEECSTTCCEEEESSCC-----TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHhcCCCcccchhhhcccCCccccCccCC-----cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            22222221111111000000  0000000     00111223456789999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.1e-49  Score=369.23  Aligned_cols=284  Identities=26%  Similarity=0.476  Sum_probs=224.3

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCC-cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC------eeeeceee
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETN-EKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN------VIALKDVM   98 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g-~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~   98 (373)
                      ..+.++|++++.||+|+||+||+|.+..++ +.||+|++...   ......+.+|+.+++.++|++      ++.+++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            346899999999999999999999998777 68999999643   233445668999998887655      88888887


Q ss_pred             cCCCCCCcceEEEEeecCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----------
Q 017334           99 MPSHRRNFKDVYLVYELMDTDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV----------  166 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill----------  166 (373)
                           ...+..++||||++++|.+.+....  .+++.+++.++.||+.||+|||++||+||||||+|||+          
T Consensus        92 -----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           92 -----NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             -----EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             -----eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence                 4446899999999999888887653  69999999999999999999999999999999999999          


Q ss_pred             ---------cCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Q 017334          167 ---------NANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT  237 (373)
Q Consensus       167 ---------~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  237 (373)
                               +.++.+||+|||++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                     56789999999999765332   245688999999999976 57899999999999999999999999999


Q ss_pred             CchHHHHHHHHHhCCCChhhhcccCCh--------------hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcC
Q 017334          238 ECLNQLKLIINILGSRREEDLEFIDNP--------------KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFD  303 (373)
Q Consensus       238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~d  303 (373)
                      +..+....+....+..+..........              ....+....... ...........++.+.+||++||+.|
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP-LKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCc-ccccccccchhHHHHHHHHHHHhcCC
Confidence            988888888888887765543221110              011111110000 00000011223557899999999999


Q ss_pred             CCCCCCHHHHhCCCCCCCC
Q 017334          304 PTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       304 P~~R~t~~eil~hp~~~~~  322 (373)
                      |++|||+.++++||||...
T Consensus       322 P~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          322 PAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             TTTSCCHHHHTTSGGGGGC
T ss_pred             hhhCcCHHHHhcChhhcCC
Confidence            9999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-49  Score=360.50  Aligned_cols=260  Identities=22%  Similarity=0.373  Sum_probs=219.9

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ......++|++++.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++.    
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   90 (303)
T 3a7i_A           16 LKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYL----   90 (303)
T ss_dssp             CEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             CCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEe----
Confidence            3456778999999999999999999999999999999999755332 23456789999999999999999999984    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                       .....|+||||++ ++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        91 -~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A           91 -KDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ  168 (303)
T ss_dssp             -ETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             -cCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeeccccee
Confidence             3467999999997 599998865 6799999999999999999999999999999999999999999999999999977


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+...             
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------  234 (303)
T 3a7i_A          169 LTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-------------  234 (303)
T ss_dssp             CBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------
T ss_pred             cCccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-------------
Confidence            6544444456688999999999976 57889999999999999999999999876654443333220             


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                       ........+++.+.+||.+||+.||++|||+.++++||||..
T Consensus       235 -----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          235 -----------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             -----------------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             -----------------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence                             001223457889999999999999999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-50  Score=372.06  Aligned_cols=281  Identities=22%  Similarity=0.348  Sum_probs=216.8

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.     ..
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  103 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SD  103 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ET
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----EC
Confidence            45689999999999999999999999999999999997653 3444566789999999999999999999984     44


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +..|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            67999999996 59999999888999999999999999999999996 99999999999999999999999999986442


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc----
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF----  260 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----  260 (373)
                      .  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+..............    
T Consensus       184 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          184 D--SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H--HC----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             c--ccccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            1  12345688999999999977 5789999999999999999999999988765544332211111000000000    


Q ss_pred             -----------cCC---hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          261 -----------IDN---PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       261 -----------~~~---~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                 ...   .............     ......+++.+.+||++||+.||++|||+.++|+||||+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPP-----KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCC-----CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCC-----CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                       000   0011111111110     0111346889999999999999999999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=364.94  Aligned_cols=268  Identities=22%  Similarity=0.390  Sum_probs=212.1

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      ...+....++|++++.||+|+||.||+|.+..+|+.||||++......   ...+.+|+.+++.+ +||||+++++++..
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            345556789999999999999999999999999999999998654332   23567899999999 69999999999865


Q ss_pred             CCC-CCcceEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcc
Q 017334          101 SHR-RNFKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICD  176 (373)
Q Consensus       101 ~~~-~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~D  176 (373)
                      ... .....+|+||||++ ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence            321 12467999999997 5999999764  5799999999999999999999999999999999999999999999999


Q ss_pred             cCcccccCCCCccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          177 FGLARTSNGKNQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      ||++..............||+.|+|||++.+    ...++.++|||||||++|+|++|.+||.+.+.......+...   
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---  249 (326)
T 2x7f_A          173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---  249 (326)
T ss_dssp             CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---
T ss_pred             CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---
Confidence            9998765443333455688999999999863    246889999999999999999999999877655444333220   


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                           +.     .......+++.+.+||.+||..||.+||++.++++||||..
T Consensus       250 ---------------------~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~  292 (326)
T 2x7f_A          250 ---------------------PA-----PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD  292 (326)
T ss_dssp             ---------------------CC-----CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred             ---------------------cc-----ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence                                 00     00112457889999999999999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-50  Score=374.35  Aligned_cols=261  Identities=24%  Similarity=0.373  Sum_probs=210.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEcccccc--ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHR  103 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  103 (373)
                      ++|++++.||+|+||.||+|++.   .+|+.||||++++...  .......+.+|+.+++.+ +||||+++++++     
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----  128 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----  128 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE-----
Confidence            79999999999999999999984   5899999999975421  111222355799999999 599999999998     


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      .....+|+||||++ |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            44467999999996 69999999888999999999999999999999999999999999999999999999999999976


Q ss_pred             cCCC-CccccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          183 SNGK-NQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       183 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+...           
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-----------  277 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-----------  277 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-----------
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH-----------
Confidence            5322 2233456899999999999753 35789999999999999999999999764432222222110           


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                              .....        ....+.+++.+.+||.+||..||++||     ++.++++||||...
T Consensus       278 --------~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          278 --------ILKSE--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             --------HHHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             --------HhccC--------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence                    00111        112345788899999999999999999     99999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.7e-50  Score=363.21  Aligned_cols=268  Identities=25%  Similarity=0.377  Sum_probs=195.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++..     .+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   86 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-----KD   86 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES-----SS
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee-----cC
Confidence            35899999999999999999999999999999999865432 2234457789999999999999999999844     35


Q ss_pred             eEEEEeecCC-ccHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccC
Q 017334          108 DVYLVYELMD-TDLHQIIKS--------SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      ..++||||++ ++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            6999999995 699998863        4569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCC-----ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          179 LARTSNGKN-----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       179 ~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      ++.......     .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+............  +..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~  244 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDP  244 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCC
Confidence            987553221     1234457899999999987645689999999999999999999999988765544432221  110


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ...                   ............+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       245 ~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          245 PSL-------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             CCT-------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             Ccc-------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            000                   00011122345678899999999999999999999999999999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=359.92  Aligned_cols=258  Identities=26%  Similarity=0.450  Sum_probs=209.9

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.....    ...+.+|+.+++.++||||+++++++.     ..
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   96 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYF-----KN   96 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEE-----eC
Confidence            467899999999999999999999999999999999975432    235678999999999999999999984     34


Q ss_pred             ceEEEEeecCC-ccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIK-SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +..|+||||++ ++|.+++. ....+++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus        97 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A           97 TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            67999999997 59999987 45689999999999999999999999999999999999999999999999999997665


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+...   .           
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~-----------  241 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---P-----------  241 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---C-----------
T ss_pred             hhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC---C-----------
Confidence            44444456688999999999876 57899999999999999999999999876654433322210   0           


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                               +     +.......+++.+.+||.+||..||.+|||+.++++||||...
T Consensus       242 ---------~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          242 ---------P-----PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             ---------C-----CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             ---------C-----cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence                     0     0001123367889999999999999999999999999999753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.3e-49  Score=362.81  Aligned_cols=268  Identities=22%  Similarity=0.336  Sum_probs=197.5

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCc---EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      ......++|++.+.||+|+||.||+|.+..++.   .||+|++............+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            344567899999999999999999999987775   89999998765555666778899999999999999999999865


Q ss_pred             CCC-CCcceEEEEeecCC-ccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334          101 SHR-RNFKDVYLVYELMD-TDLHQIIKSSQ------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus       101 ~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                      ... ......++||||+. |+|.+++....      .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            421 11123599999996 69999986433      59999999999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHH
Q 017334          173 KICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~  249 (373)
                      ||+|||++.......  .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            999999997653322  12233456788999999977 578999999999999999999 99999887766655544321


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-------HHHHhCCCCCCCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-------VTEALQHPYMSPL  322 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-------~~eil~hp~~~~~  322 (373)
                      .                              .....+.+++.+.+||.+||+.||++|||       ++++++|||+...
T Consensus       256 ~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          256 N------------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             C------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             C------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            0                              01123567889999999999999999999       7889999999753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-49  Score=371.50  Aligned_cols=267  Identities=15%  Similarity=0.141  Sum_probs=192.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhC--CCCCeeeeceeec-------
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHL--QHENVIALKDVMM-------   99 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~-------   99 (373)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.+  +||||++++..+.       
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            459999999999999999999999999999999987654 333444556775444444  6999888653332       


Q ss_pred             CCCC------------CCcceEEEEeecCCccHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCccccCCC
Q 017334          100 PSHR------------RNFKDVYLVYELMDTDLHQIIKSS-QALTNDHC------QYFLFQLLRGLKYLHSANILHRDLK  160 (373)
Q Consensus       100 ~~~~------------~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~------~~i~~qi~~aL~~LH~~~ivH~Dlk  160 (373)
                      ....            .....+|+||||++|+|.+++... ..+++...      ..++.||+.||+|||++||+|||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik  221 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT  221 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence            1110            011558999999999999999864 34455555      5777999999999999999999999


Q ss_pred             CCceEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhc-CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 017334          161 PGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC  239 (373)
Q Consensus       161 p~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  239 (373)
                      |+|||++.++.+||+|||++......   .....+|+.|+|||++.+ ...++.++|||||||++|+|++|++||.+...
T Consensus       222 p~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          222 PDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             GGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             HHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            99999999999999999999866422   224466799999999964 24689999999999999999999999976532


Q ss_pred             hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      ...             .......         ..............+.+++.+.+||.+||+.||++|||+.++++||||
T Consensus       299 ~~~-------------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          299 GIK-------------GSWKRPS---------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             TCT-------------TCCCBCC---------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             ccc-------------cchhhhh---------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            100             0000000         000000011111235789999999999999999999999999999999


Q ss_pred             CC
Q 017334          320 SP  321 (373)
Q Consensus       320 ~~  321 (373)
                      +.
T Consensus       357 ~~  358 (371)
T 3q60_A          357 LQ  358 (371)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.3e-49  Score=358.34  Aligned_cols=266  Identities=26%  Similarity=0.338  Sum_probs=212.3

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC--CCCeeeeceeec
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ--HENVIALKDVMM   99 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~   99 (373)
                      .+.+....++|++++.||+|+||.||+|.+. +|+.||+|++............+.+|+.+++.++  ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            3566777889999999999999999999986 5889999999776666666677889999999997  599999999984


Q ss_pred             CCCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          100 PSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                           .....|+|||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+
T Consensus        99 -----~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A           99 -----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             -----CSSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             -----cCCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccc
Confidence                 4467999999778999999998889999999999999999999999999999999999999964 8999999999


Q ss_pred             ccccCCCCc--cccceeeccccCchhhhhcC----------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017334          180 ARTSNGKNQ--FMTEYVVTRWYRAPELLLCC----------DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLII  247 (373)
Q Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  247 (373)
                      +........  ......||+.|+|||++.+.          ..++.++|||||||++|+|++|..||.......  ..+.
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~  250 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLH  250 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHH
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHH
Confidence            976543221  22345789999999998651          367889999999999999999999997643221  1111


Q ss_pred             HHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          248 NILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ......                          .........++.+.+||.+||+.||.+||++.++++||||+..
T Consensus       251 ~~~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          251 AIIDPN--------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             HHHCTT--------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             HHHhcc--------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            111100                          0011223457889999999999999999999999999999753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.4e-49  Score=356.04  Aligned_cols=261  Identities=26%  Similarity=0.405  Sum_probs=203.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-----
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-----  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----  102 (373)
                      +.++|++++.||+|+||.||+|++..+|+.||||++...   ......+.+|+.+++.++||||+++++++....     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            467999999999999999999999999999999999543   334456789999999999999999999875421     


Q ss_pred             ---CCCcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEccc
Q 017334          103 ---RRNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (373)
Q Consensus       103 ---~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Df  177 (373)
                         .......|+||||++ |+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               123578999999996 6999999854 46888999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC--------------CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CchHH
Q 017334          178 GLARTSNGK--------------NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT-ECLNQ  242 (373)
Q Consensus       178 g~a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~  242 (373)
                      |++......              ........||+.|+|||++.+...++.++|||||||++|+|++   ||... +....
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            998765321              1223456789999999999875578999999999999999998   44322 11111


Q ss_pred             HHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          243 LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ...+..   .                     ..   ..........++.+.+||++||+.||.+|||+.++++||||..
T Consensus       238 ~~~~~~---~---------------------~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          238 LKKLRS---V---------------------SI---EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHS---T---------------------TC---CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHhccc---c---------------------cc---ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            111111   0                     00   0011223456788999999999999999999999999999963

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-48  Score=364.24  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=208.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-------CCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-------ETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-------~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      .++|++.+.||+|+||.||+|.+.       .++..||+|+++.. ........+.+|+.+++.+ +||||+++++++  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence            478999999999999999999874       34567999999765 3344556788999999999 799999999998  


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                         ...+.+|+||||++ |+|.+++...+                .+++.++..++.||+.||+|||++||+||||||+|
T Consensus       157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence               44467999999996 69999997643                47899999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      ||++.++.+||+|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999998654322  12233466789999999987 679999999999999999998 99999887665


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      +....+....                              .......+++.+.+||.+||+.||++||++.+++++
T Consensus       313 ~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             GHHHHHHTTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5544432210                              011234578899999999999999999999999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=351.89  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=206.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|.....||+|+||.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++.     ..+..
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~   94 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFI   94 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcE
Confidence            34555569999999999999999999999999986543  233456779999999999999999999983     44679


Q ss_pred             EEEeecCC-ccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCCeEEcccCcccccC
Q 017334          110 YLVYELMD-TDLHQIIKSS---QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSN  184 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-~~~~kL~Dfg~a~~~~  184 (373)
                      ++||||++ ++|.+++...   ..+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999996 6999999764   24678999999999999999999999999999999999988 8999999999998765


Q ss_pred             CCCccccceeeccccCchhhhhcC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCC-DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ..........|++.|+|||++.+. ..++.++|||||||++|+|++|.+||..................           
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  243 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-----------  243 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-----------
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-----------
Confidence            444444566889999999998653 24789999999999999999999999654332221111110000           


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       .......+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       244 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          244 -----------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             -----------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence                             012235678899999999999999999999999999999754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.2e-49  Score=364.19  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=212.5

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh----HHHHHHHHHHHHHhhCC--CCCeeeece
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR----VDALRTLRELKLLRHLQ--HENVIALKD   96 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hpniv~~~~   96 (373)
                      .....+.++|++.+.||+|+||.||+|.+..+|+.||||++.......    .....+.+|+.+++.++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            455668899999999999999999999999999999999997543221    11123457999999996  599999999


Q ss_pred             eecCCCCCCcceEEEEeecCC--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-CCCCeE
Q 017334           97 VMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN-ANCDLK  173 (373)
Q Consensus        97 ~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~-~~~~~k  173 (373)
                      ++     ...+..++|||++.  ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus       116 ~~-----~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          116 WF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EE-----ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred             EE-----ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEE
Confidence            99     44477999999996  69999999888999999999999999999999999999999999999999 778999


Q ss_pred             EcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          174 ICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       174 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      |+|||++......  ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+.      +..     
T Consensus       191 L~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~-----  257 (320)
T 3a99_A          191 LIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR-----  257 (320)
T ss_dssp             ECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----
T ss_pred             EeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc-----
Confidence            9999999866432  234567899999999998755557899999999999999999999965321      100     


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                                        ..        ......+++.+.+||.+||+.||++|||+.++++||||....
T Consensus       258 ------------------~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          258 ------------------GQ--------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             ------------------CC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ------------------cc--------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence                              00        012245788999999999999999999999999999998653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2e-49  Score=366.85  Aligned_cols=274  Identities=20%  Similarity=0.334  Sum_probs=213.1

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChH---------------HHHHHHHHHHHHhhCCCCCe
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV---------------DALRTLRELKLLRHLQHENV   91 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~hpni   91 (373)
                      ...++|++++.||+|+||.||+|.+  +|+.||+|++........               ....+.+|+.+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            3458999999999999999999998  899999999865432211               11567899999999999999


Q ss_pred             eeeceeecCCCCCCcceEEEEeecCC-ccHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCC
Q 017334           92 IALKDVMMPSHRRNFKDVYLVYELMD-TDLHQI------IKS--SQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKP  161 (373)
Q Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~------l~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp  161 (373)
                      +++++++.     ..+..|+||||++ ++|.++      +..  ...+++..++.++.||+.||+|||+ +||+||||||
T Consensus       106 ~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p  180 (348)
T 2pml_X          106 LTCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP  180 (348)
T ss_dssp             CCCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred             ceEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence            99999984     4468999999997 599888      655  5689999999999999999999999 9999999999


Q ss_pred             CceEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCc-hhhhHHHHHHHHHHHhCCCCCCCCCc-
Q 017334          162 GNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGT-SIDVWSVGCIFAELLGRKPIFPGTEC-  239 (373)
Q Consensus       162 ~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~-  239 (373)
                      +|||++.++.+||+|||++......  ......|++.|+|||++.+...++. ++|||||||++|+|++|.+||.+... 
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             HhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            9999999999999999999765332  3455688999999999977435655 99999999999999999999988765 


Q ss_pred             hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                      .+....+.......+.......            ............+.+++.+.+||.+||+.||.+|||+.++++||||
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f  326 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFL------------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL  326 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSST------------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHhccCcCCccchhhhh------------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence            3333333221000000000000            0000001111225688999999999999999999999999999999


Q ss_pred             CC
Q 017334          320 SP  321 (373)
Q Consensus       320 ~~  321 (373)
                      ..
T Consensus       327 ~~  328 (348)
T 2pml_X          327 AD  328 (348)
T ss_dssp             TT
T ss_pred             cC
Confidence            74

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-48  Score=362.41  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=208.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEE-----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSV-----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPS  101 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~-----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  101 (373)
                      ..++|++.+.||+|+||.||+|.     +..+++.||||+++... .......+.+|+.+++.+ +||||+++++++...
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            45899999999999999999999     56677999999997543 334455688999999999 699999999998543


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcCC---------------------------------------------------
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQA---------------------------------------------------  129 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---------------------------------------------------  129 (373)
                          ...+++||||++ |+|.+++.....                                                   
T Consensus        99 ----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           99 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             ----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence                245899999996 699999976543                                                   


Q ss_pred             ---------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC--ccccc
Q 017334          130 ---------------LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN--QFMTE  192 (373)
Q Consensus       130 ---------------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~  192 (373)
                                     +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  .....
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccc
Confidence                           8999999999999999999999999999999999999999999999999997653322  23345


Q ss_pred             eeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHH
Q 017334          193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIK  271 (373)
Q Consensus       193 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  271 (373)
                      ..||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+...............                    
T Consensus       255 ~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------------  313 (359)
T 3vhe_A          255 ARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------------------  313 (359)
T ss_dssp             CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--------------------
T ss_pred             cCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--------------------
Confidence            678999999999976 678999999999999999998 9999988765544433322110                    


Q ss_pred             hCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          272 SLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                               .......+++.+.++|.+||+.||++|||+.++++|
T Consensus       314 ---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          314 ---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                     011224578899999999999999999999999976

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.6e-48  Score=350.60  Aligned_cols=261  Identities=16%  Similarity=0.171  Sum_probs=209.2

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      .+....+.++|++.+.||+|+||.||+|.+..+|+.||+|++......    ..+.+|+.+++.+ +|+|++++++++  
T Consensus         2 s~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~--   75 (298)
T 1csn_A            2 SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFG--   75 (298)
T ss_dssp             ----CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEE--
T ss_pred             CCcCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeec--
Confidence            344556789999999999999999999999999999999998654322    2356799999999 699999999988  


Q ss_pred             CCCCCcceEEEEeecCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC-----eEE
Q 017334          101 SHRRNFKDVYLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-----LKI  174 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~-----~kL  174 (373)
                         ......++||||++++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.     +||
T Consensus        76 ---~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           76 ---QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             ---EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             ---CCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence               4447799999999889999998654 6999999999999999999999999999999999999988776     999


Q ss_pred             cccCcccccCCCCc-------cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Q 017334          175 CDFGLARTSNGKNQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLII  247 (373)
Q Consensus       175 ~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  247 (373)
                      +|||++........       ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  231 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE  231 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence            99999976543221       2345679999999999876 578999999999999999999999998754332222221


Q ss_pred             HHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          248 NILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .+....                 .      ..+.....+.+++.+.+||.+||+.||++||++.++++
T Consensus       232 ~~~~~~-----------------~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          232 RIGEKK-----------------Q------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHH-----------------H------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhhc-----------------c------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            111000                 0      01112233567889999999999999999999998875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=355.99  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=207.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCc---EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..++|++.+.||+|+||.||+|.+..+|+   .||||++.... .......+.+|+.+++.++||||+++++++     .
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  120 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T  120 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            46899999999999999999999986665   49999997543 344456788999999999999999999998     4


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ..+..|+||||++ |+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            4567999999996 6999999754 5799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ......   ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....       
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-------  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR-------  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-------
T ss_pred             cccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-------
Confidence            543221   2223345778999999976 578999999999999999998 9999988776655554432100       


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                             ......+++.+.+||.+||..||++|||+.++++
T Consensus       273 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          273 -----------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                   0122457889999999999999999999999886

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8.7e-49  Score=359.62  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=190.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHH-HHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK-LLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..++|++++.||+|+||.||+|.++.+|+.||||++...... .....+.+|+. +++.++||||+++++++.     ..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~   93 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----RE   93 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eC
Confidence            458999999999999999999999999999999999765333 33344555665 677789999999999994     34


Q ss_pred             ceEEEEeecCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          107 KDVYLVYELMDTDLHQIIKS-----SQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                      +..++||||++|+|.+++..     ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            67999999999998888763     56899999999999999999999999 9999999999999999999999999999


Q ss_pred             cccCCCCccccceeeccccCchhhhh---cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          181 RTSNGKNQFMTEYVVTRWYRAPELLL---CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       181 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      ...... .......||+.|+|||++.   ....++.++|||||||++|+|++|..||.+.....  ..+..         
T Consensus       174 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---------  241 (327)
T 3aln_A          174 GQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQ---------  241 (327)
T ss_dssp             CC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CC---------
T ss_pred             eecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHH---------
Confidence            765332 2233447899999999984   23568899999999999999999999997643210  00000         


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                    ................+++.+.+||.+||+.||++|||+.++++||||..
T Consensus       242 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          242 --------------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             --------------CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             --------------HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence                          00000000111223467899999999999999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-49  Score=365.28  Aligned_cols=257  Identities=19%  Similarity=0.282  Sum_probs=209.4

Q ss_pred             eecCceeeeeeeeccCceEEEEEE-----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSV-----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~-----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      ...++|++++.||+|+||+||+|.     +..+++.||||++... ........+.+|+.+++.++||||+++++++.  
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--  144 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL--  144 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe--
Confidence            345889999999999999999999     4567889999999643 33444556789999999999999999999984  


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQ-------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC---  170 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~---  170 (373)
                         .....|+||||++ |+|.+++...+       .+++.+++.++.||+.||+|||++||+||||||+|||++.++   
T Consensus       145 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          145 ---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             ---SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             ---cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence               4466899999995 69999997643       589999999999999999999999999999999999999665   


Q ss_pred             CeEEcccCcccccCC--CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHH
Q 017334          171 DLKICDFGLARTSNG--KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLII  247 (373)
Q Consensus       171 ~~kL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~  247 (373)
                      .+||+|||+++....  .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            499999999974321  1122234567899999999977 579999999999999999997 999998877665555443


Q ss_pred             HHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          248 NILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ....                              ......+++.+.+||.+||+.||++|||+.+++++.++.
T Consensus       301 ~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          301 SGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             TTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCC------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2100                              011245788899999999999999999999999998763

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.6e-48  Score=351.57  Aligned_cols=251  Identities=27%  Similarity=0.416  Sum_probs=205.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++..  ........+.+|+.+++.++||||+++++++.     ..+.
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   81 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKR   81 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCe
Confidence            4899999999999999999999999999999999854  34455567889999999999999999999994     4477


Q ss_pred             EEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .++||||++ |+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            999999996 699999987 567999999999999999999999999999999999999999999999999999765432


Q ss_pred             Ccc--------------ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          187 NQF--------------MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       187 ~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      ...              ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.........         
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---------  231 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---------  231 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---------
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---------
Confidence            211              114579999999999977 67899999999999999999999998654221100         


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                             .  ..........          ...+.+++.+.+||.+||+.||++|||+.++++
T Consensus       232 -------~--~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          232 -------F--GLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             -------S--SBCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------H--hhhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                   0  0001111111          112456778999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=353.14  Aligned_cols=260  Identities=20%  Similarity=0.308  Sum_probs=194.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      --++|++++.||+|+||.||+|.++.+|+.||||++............+.++..+++.++||||+++++++.     ...
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~   97 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNT   97 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCC
Confidence            358999999999999999999999999999999999765443333333445556788889999999999994     346


Q ss_pred             eEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSA-NILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..|+||||+++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus        98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A           98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            7999999997766666653 56899999999999999999999995 999999999999999999999999999875533


Q ss_pred             CCccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHHHhCCCChhhhcc
Q 017334          186 KNQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC-LNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      . .......+|+.|+|||++.+    ...++.++|||||||++|+|++|..||..... .+....+..   .        
T Consensus       178 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~--------  245 (318)
T 2dyl_A          178 D-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---E--------  245 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---S--------
T ss_pred             C-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---c--------
Confidence            2 22344578999999999852    35688999999999999999999999976432 233332222   0        


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                  .+     +.......+++.+.+||.+||+.||.+||++.++++||||+.
T Consensus       246 ------------~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          246 ------------EP-----PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             ------------CC-----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             ------------CC-----CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence                        00     000112357889999999999999999999999999999964

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-49  Score=357.89  Aligned_cols=258  Identities=24%  Similarity=0.337  Sum_probs=203.3

Q ss_pred             cceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh----HHHHHHHHHHHHHhhC----CCCCeee
Q 017334           22 WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR----VDALRTLRELKLLRHL----QHENVIA   93 (373)
Q Consensus        22 ~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l----~hpniv~   93 (373)
                      ......+.++|++.+.||+|+||.||+|.+..+|+.||+|++.......    .....+.+|+.+++.+    +||||++
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            3455677899999999999999999999999999999999997553322    1222345799999988    8999999


Q ss_pred             eceeecCCCCCCcceEEEEeec-CC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-CCC
Q 017334           94 LKDVMMPSHRRNFKDVYLVYEL-MD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN-ANC  170 (373)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~-~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~-~~~  170 (373)
                      +++++     ...+..++|||+ +. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++ .++
T Consensus       103 ~~~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          103 LLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEEEC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT
T ss_pred             EEEEE-----ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC
Confidence            99998     444678999999 54 79999999888899999999999999999999999999999999999999 789


Q ss_pred             CeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHh
Q 017334          171 DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINIL  250 (373)
Q Consensus       171 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  250 (373)
                      .+||+|||++......  ......|++.|+|||++.+....+.++|||||||++|+|++|+.||.....      +..  
T Consensus       178 ~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~--  247 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE--  247 (312)
T ss_dssp             EEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--
T ss_pred             eEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh--
Confidence            9999999999866432  234567899999999987754455699999999999999999999965311      110  


Q ss_pred             CCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          251 GSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                                           ..        ......+++.+.+||.+||+.||++|||+.++++||||+...
T Consensus       248 ---------------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          248 ---------------------AE--------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             ---------------------TC--------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ---------------------hc--------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence                                 00        012345788999999999999999999999999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-48  Score=359.53  Aligned_cols=256  Identities=21%  Similarity=0.231  Sum_probs=206.3

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  104 (373)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||||++......    ..+.+|+.+++.+ +||||+++++++     .
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~-----~   75 (330)
T 2izr_A            5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFG-----P   75 (330)
T ss_dssp             CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEE-----E
T ss_pred             EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEE-----e
Confidence            45679999999999999999999999999999999998654322    2466899999999 799999999998     4


Q ss_pred             CcceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC-----eEEcccC
Q 017334          105 NFKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-----LKICDFG  178 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~-----~kL~Dfg  178 (373)
                      .....++||||++++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.     +||+|||
T Consensus        76 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           76 CGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             ETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             cCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            4467999999998899999986 468999999999999999999999999999999999999999887     9999999


Q ss_pred             cccccCCCCc-------cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhC
Q 017334          179 LARTSNGKNQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILG  251 (373)
Q Consensus       179 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~  251 (373)
                      ++........       .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..+..
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9986533221       1246689999999999987 6789999999999999999999999988654433333222111


Q ss_pred             CCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          252 SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ....                       .+........ +.+.++|.+||+.||.+||++.++++
T Consensus       235 ~~~~-----------------------~~~~~~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          235 TKRA-----------------------TPIEVLCENF-PEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHH-----------------------SCHHHHTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hhcc-----------------------CCHHHHhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            0000                       0000111223 37999999999999999999988776

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.2e-49  Score=360.76  Aligned_cols=265  Identities=25%  Similarity=0.370  Sum_probs=185.6

Q ss_pred             eeeecCceeeee-eeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           25 LFEIDTKYVPIK-PIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        25 ~~~~~~~Y~~~~-~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .+.+.++|++++ .||+|+||+||+|.++.+|+.||||++....   ..   ..+....++.++||||+++++++.... 
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~-   95 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KA---RQEVDHHWQASGGPHIVCILDVYENMH-   95 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HH---HHHHHHHHHHTTSTTBCCEEEEEEEEE-
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HH---HHHHHHHHHhcCCCChHHHHHHHhhcc-
Confidence            356789999976 5999999999999999999999999986431   11   112233456678999999999985432 


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CCeEEccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN---CDLKICDF  177 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~---~~~kL~Df  177 (373)
                      .....+++||||++ |+|.+++...+  .+++.+++.++.||+.||.|||++||+||||||+|||++.+   +.+||+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence            22466999999996 59999998654  69999999999999999999999999999999999999864   45999999


Q ss_pred             CcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      |++.....  .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+.....      
T Consensus       176 g~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------  246 (336)
T 3fhr_A          176 GFAKETTQ--NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR------  246 (336)
T ss_dssp             TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             ccceeccc--cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh------
Confidence            99976542  22345688999999999865 5688999999999999999999999976543322111111000      


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                   ..    ........+..+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       247 -------------~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          247 -------------LG----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             -------------cc----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                         00    0000111235678999999999999999999999999999999764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=358.63  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=210.4

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCC-------CCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceee
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRE-------TNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVM   98 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~-------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~   98 (373)
                      ...++|++.+.||+|+||.||+|.+..       ++..||+|++... ........+.+|+.+++.+ +||||+++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            345899999999999999999999753       3357999999765 3444556788999999999 899999999999


Q ss_pred             cCCCCCCcceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017334           99 MPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKP  161 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  161 (373)
                           ...+..++||||++ |+|.+++....                .+++.+++.++.||+.||+|||++||+||||||
T Consensus       145 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          145 -----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             -----CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             -----ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence                 44466999999996 69999998653                499999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCC
Q 017334          162 GNLLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTE  238 (373)
Q Consensus       162 ~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  238 (373)
                      +|||++.++.+||+|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999998654322  22344567889999999987 678999999999999999998 999998876


Q ss_pred             chHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          239 CLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      ..+....+....                              .......+++.+.+||.+||+.||++|||+.+++++
T Consensus       299 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          299 VEELFKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHHTTC------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCC------------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            555444433210                              011224578899999999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.1e-48  Score=343.77  Aligned_cols=248  Identities=22%  Similarity=0.328  Sum_probs=206.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|.+. +++.||+|++.......   ..+.+|+.+++.++||||+++++++     ...+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAP   79 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSS
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCc
Confidence            479999999999999999999987 57789999997654443   3577899999999999999999998     44467


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .++||||++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            999999996 6999999654 56899999999999999999999999999999999999999999999999999765332


Q ss_pred             C-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 N-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      . .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....             
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------------  225 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------------  225 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------------
T ss_pred             ccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc-------------
Confidence            1 12233456778999999976 578999999999999999998 9999988776655544432100             


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                       .......++.+.++|.+||+.||++|||+.++++|
T Consensus       226 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                             01123467889999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9e-48  Score=350.60  Aligned_cols=252  Identities=24%  Similarity=0.344  Sum_probs=209.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEe-----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVN-----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ..++|++.+.||+|+||.||+|.+     +.++..||+|++.... .......+.+|+.+++.++||||+++++++    
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----   95 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC----   95 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE----
Confidence            358999999999999999999988     3456899999997543 344556788999999999999999999998    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQA------------------------LTNDHCQYFLFQLLRGLKYLHSANILHR  157 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~aL~~LH~~~ivH~  157 (373)
                       ...+..++||||++ ++|.+++.....                        +++.+++.++.||+.||+|||++||+||
T Consensus        96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  174 (314)
T 2ivs_A           96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR  174 (314)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence             44467999999996 799999986543                        8999999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 017334          158 DLKPGNLLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIF  234 (373)
Q Consensus       158 Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  234 (373)
                      ||||+|||++.++.+||+|||++........  ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus       175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999976543322  2233456788999999976 568999999999999999998 99999


Q ss_pred             CCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHh
Q 017334          235 PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL  314 (373)
Q Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil  314 (373)
                      .+.........+...                              ........+++.+.+||.+||+.||++|||+.+++
T Consensus       254 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~  303 (314)
T 2ivs_A          254 PGIPPERLFNLLKTG------------------------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS  303 (314)
T ss_dssp             TTCCGGGHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHhhcC------------------------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            887665544433220                              00112346789999999999999999999999998


Q ss_pred             CC
Q 017334          315 QH  316 (373)
Q Consensus       315 ~h  316 (373)
                      ++
T Consensus       304 ~~  305 (314)
T 2ivs_A          304 KD  305 (314)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-48  Score=355.14  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=208.8

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      ...++|++++.||+|+||.||+|.+.     .+++.||+|+++... .......+.+|+.+++.++||||+++++++   
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---  119 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC---  119 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE---
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE---
Confidence            45689999999999999999999987     456899999997543 334455678999999999999999999999   


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSS------------------------QALTNDHCQYFLFQLLRGLKYLHSANILH  156 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  156 (373)
                        ...+..|+||||++ |+|.+++...                        ..+++.+++.++.||+.||.|||++||+|
T Consensus       120 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH  197 (343)
T 1luf_A          120 --AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  197 (343)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             --ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence              34467999999996 6999999763                        57999999999999999999999999999


Q ss_pred             cCCCCCceEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCC
Q 017334          157 RDLKPGNLLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPI  233 (373)
Q Consensus       157 ~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p  233 (373)
                      |||||+|||++.++.+||+|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999999999999999997543221  22234567899999999876 578999999999999999998 9999


Q ss_pred             CCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHH
Q 017334          234 FPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA  313 (373)
Q Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~ei  313 (373)
                      |.+.+..+....+...                              ........+++.+.+||++||+.||++||++.++
T Consensus       277 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~  326 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDG------------------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSI  326 (343)
T ss_dssp             TTTSCHHHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCChHHHHHHHhCC------------------------------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence            9887655544443220                              0011234578899999999999999999999999


Q ss_pred             hCC
Q 017334          314 LQH  316 (373)
Q Consensus       314 l~h  316 (373)
                      +++
T Consensus       327 ~~~  329 (343)
T 1luf_A          327 HRI  329 (343)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-47  Score=341.79  Aligned_cols=249  Identities=20%  Similarity=0.257  Sum_probs=206.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++++.||+|+||.||+|.++ ++..||+|++.......   ..+.+|+.+++.++||||+++++++     ...+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   76 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVC-----SKEY   76 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence            4589999999999999999999876 56789999997654433   3577899999999999999999998     4446


Q ss_pred             eEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..++||||++ ++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            7999999996 68999997654 599999999999999999999999999999999999999999999999999976543


Q ss_pred             CC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+.......+.....            
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  223 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------------  223 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred             hhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC------------
Confidence            32 22233456778999999976 568899999999999999998 9999987766554444322100            


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                        .......++.+.++|.+||+.||++|||+.+++++
T Consensus       224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          224 ------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                              01123467889999999999999999999999976

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-47  Score=348.86  Aligned_cols=260  Identities=20%  Similarity=0.280  Sum_probs=202.7

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCC---CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRE---TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ....++|++.+.||+|+||.||+|.+..   ++..||+|++............+.+|+.+++.++||||+++++++....
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3456899999999999999999998765   5568999999876666666677889999999999999999999987654


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIK------SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      .......++||||++ |+|.+++.      ....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence            333346799999997 69999984      33569999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCC
Q 017334          176 DFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       176 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      |||++.......  .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+....  
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--  266 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH--  266 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC--
Confidence            999997653322  12233456788999999976 678999999999999999999 899998876655554433210  


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                                  .......+++.+.+||.+||..||++|||+.+++++
T Consensus       267 ----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 ----------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ----------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                        011224578899999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-47  Score=344.01  Aligned_cols=249  Identities=21%  Similarity=0.287  Sum_probs=204.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++++.||+|+||.||+|.+. ++..||+|++.......   ..+.+|+.+++.++||||+++++++     ...+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   92 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVC-----TKQR   92 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEE-----ecCC
Confidence            4589999999999999999999886 67789999997654443   3577899999999999999999999     4446


Q ss_pred             eEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..++||||++ ++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            7999999995 799999976 56799999999999999999999999999999999999999999999999999976533


Q ss_pred             CC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .. .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....            
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------  239 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------  239 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred             cccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC------------
Confidence            21 11223356788999999986 578999999999999999998 9999988776655554433110            


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                        .......++.+.+||.+||+.||++|||+.++++|
T Consensus       240 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 ------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                              01123467889999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-47  Score=342.38  Aligned_cols=254  Identities=20%  Similarity=0.263  Sum_probs=205.1

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHH-----HHHHHHHHHHhhCCCCCeeeeceeec
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA-----LRTLRELKLLRHLQHENVIALKDVMM   99 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~   99 (373)
                      .....++|++.+.||+|+||.||+|++..+++.||+|++..........     ..+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            3456789999999999999999999999999999999997543322211     46779999999999999999999984


Q ss_pred             CCCCCCcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCCC----
Q 017334          100 PSHRRNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCD----  171 (373)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~~~~----  171 (373)
                      ..       .++||||++ |+|.+.+... ..+++..++.++.||+.||+|||++|  |+||||||+|||++.++.    
T Consensus        94 ~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           94 NP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             TT-------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             CC-------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence            32       269999997 7998888654 57999999999999999999999999  999999999999988876    


Q ss_pred             -eEEcccCcccccCCCCccccceeeccccCchhhhhc-CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017334          172 -LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       172 -~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  249 (373)
                       +||+|||++.....   ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+...........
T Consensus       167 ~~kl~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~  243 (287)
T 4f0f_A          167 CAKVADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR  243 (287)
T ss_dssp             CEEECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred             eEEeCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence             99999999975432   3445688999999999843 245788999999999999999999999766543321111100


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..                      .     ........+++.+.+||.+||+.||++|||+.++++
T Consensus       244 ~~----------------------~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          244 EE----------------------G-----LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HS----------------------C-----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc----------------------C-----CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            00                      0     001223567889999999999999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-47  Score=339.59  Aligned_cols=248  Identities=15%  Similarity=0.184  Sum_probs=207.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||+|.+.  |+.||+|++............+.+|+.+++.++||||+++++++....   .+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence            478999999999999999999985  889999999877666666777889999999999999999999985432   267


Q ss_pred             EEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          109 VYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .++||||++ |+|.+++....  .+++.+++.++.||+.||+|||++|  |+||||||+|||++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            899999997 69999998765  4899999999999999999999999  999999999999999999999998887543


Q ss_pred             CCCCccccceeeccccCchhhhhcCC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ..     ....||+.|+|||++.+..  .++.++|||||||++|+|++|++||.+.+.......+....           
T Consensus       164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-----------  227 (271)
T 3kmu_A          164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-----------  227 (271)
T ss_dssp             SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred             cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC-----------
Confidence            22     2347899999999997632  23348999999999999999999998776555444332200           


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        ........+++.+.++|.+||+.||++|||+.++++
T Consensus       228 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          228 ------------------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             ------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              001223567899999999999999999999999985

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.9e-48  Score=359.66  Aligned_cols=250  Identities=25%  Similarity=0.339  Sum_probs=206.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||+|.++.+|+.||||+++... .......+.+|+.+++.++||||+++++++     ...+.
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  186 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQP  186 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCCC
Confidence            578999999999999999999999999999999987542 333444677999999999999999999999     34466


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +|+||||++ |+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            999999996 7999999765 46999999999999999999999999999999999999999999999999999764322


Q ss_pred             Ccc--ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          187 NQF--MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       187 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ...  .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....             
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  332 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-------------  332 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-------------
T ss_pred             ceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            111  112245778999999976 568999999999999999998 999998876554443332100             


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                       .......+++.+.+||.+||+.||++|||+.++++
T Consensus       333 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          333 -----------------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                             00112446788999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.5e-47  Score=342.45  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ....++|++.+.||+|+||.||+|.+..+   +..||+|++... ........+.+|+.+++.++||||+++++++..  
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--
Confidence            34568999999999999999999998654   457999998654 234445567899999999999999999999732  


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                          +..|+||||++ ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        88 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           88 ----NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             ----CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence                45899999997 59999997654 6999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCc-cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          181 RTSNGKNQ-FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ........ ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....        
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~--------  234 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------  234 (281)
T ss_dssp             ---------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred             cccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC--------
Confidence            76543221 1233456788999999976 578999999999999999996 999998877665554443210        


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                            .....+.+++.+.++|.+||+.||++|||+.+++++
T Consensus       235 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          235 ----------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                  011235678999999999999999999999999863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.3e-47  Score=343.74  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=211.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+..++..||+|++....   .....+.+|+.+++.++||||+++++++     ...+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   82 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREP   82 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence            4689999999999999999999999999999999997542   2345677999999999999999999998     4446


Q ss_pred             eEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..|+||||++ ++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            7999999997 7999999864  459999999999999999999999999999999999999999999999999998664


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+....            
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~------------  229 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------  229 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------------
T ss_pred             CCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC------------
Confidence            332 23344567889999999976 578999999999999999998 999998876655544433210            


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        .......+++.+.+||.+||..||++|||+.++++
T Consensus       230 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          230 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                              01122457889999999999999999999999976

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-47  Score=346.51  Aligned_cols=254  Identities=22%  Similarity=0.293  Sum_probs=200.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .-++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++     ...
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EID  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EET
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeC
Confidence            34889999999999999999999999999999999976543 333446678999999999999999999998     344


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +..|+||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            67999999997 59999999888899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          186 KN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       186 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      .. .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.   ..            
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~------------  250 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN---QA------------  250 (309)
T ss_dssp             ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---SC------------
T ss_pred             cccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---cC------------
Confidence            22 22345678999999999876 578899999999999999999999998765332211111   00            


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-CHHHHhC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-SVTEALQ  315 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-t~~eil~  315 (373)
                                   ........+.+++.+.++|.+||+.||++|| +++++++
T Consensus       251 -------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          251 -------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             -------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                         0011233466888999999999999999999 7887775

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.7e-47  Score=346.37  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=208.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEe-----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVN-----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPS  101 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  101 (373)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++.  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   97 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT--   97 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe--
Confidence            458999999999999999999984     4578899999997543 333455678999999999 8999999999994  


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQ------------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPG  162 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  162 (373)
                         ..+..++||||++ |+|.+++....                  .+++.+++.++.||+.||+|||++||+||||||+
T Consensus        98 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  174 (313)
T 1t46_A           98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (313)
T ss_dssp             ---SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ---cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence               4467899999996 69999997654                  4899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCc
Q 017334          163 NLLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTEC  239 (373)
Q Consensus       163 Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  239 (373)
                      |||++.++.+||+|||++........  ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+...
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            99999999999999999976543322  2334567889999999876 578999999999999999998 9999987765


Q ss_pred             hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      ......+.....                      .       ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~----------------------~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          254 DSKFYKMIKEGF----------------------R-------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SHHHHHHHHHTC----------------------C-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhHHHHHhccCC----------------------C-------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            544433322100                      0       01124578889999999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-47  Score=346.23  Aligned_cols=268  Identities=20%  Similarity=0.319  Sum_probs=203.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEE----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSV----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ..++|++++.||+|+||+||+|+    +..+|+.||+|++...  .......+.+|+.+++.++||||+++++++...  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--   83 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA--   83 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH--
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence            56899999999999999999998    6778999999998643  344455678999999999999999999998542  


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                       ....+++||||++ |+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        84 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           84 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             -HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             -CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence             2245899999995 69999997654 59999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          182 TSNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       182 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ......   .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.....     ......+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~  236 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQM  236 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccch
Confidence            654322   12223456778999999977 5789999999999999999999998865321     11111121111100


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..   ...........      .......+++.+.+||.+||+.||++|||+.++++
T Consensus       237 ~~---~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          237 IV---FHLIELLKNNG------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HH---HHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hH---HHHHHHHhccC------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            00   00111111111      01123567899999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-47  Score=352.41  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=205.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEe-----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVN-----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPS  101 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  101 (373)
                      -.++|++.+.||+|+||.||+|.+     ..++..||+|++.... .......+.+|+.+++.+ +||||+++++++.  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT--  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence            458999999999999999999997     3456789999997543 223345678999999999 7999999999984  


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSSQ-----------------------ALTNDHCQYFLFQLLRGLKYLHSANILHR  157 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  157 (373)
                         ..+..++||||++ |+|.+++....                       .+++.+++.++.||+.||+|||++||+||
T Consensus       120 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  196 (344)
T 1rjb_A          120 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR  196 (344)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             ---eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence               3467999999996 69999997643                       37899999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCC
Q 017334          158 DLKPGNLLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIF  234 (373)
Q Consensus       158 Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  234 (373)
                      ||||+|||++.++.+||+|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999997543222  22345577889999999876 578999999999999999998 99999


Q ss_pred             CCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHh
Q 017334          235 PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL  314 (373)
Q Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil  314 (373)
                      .+.........+...                      ..       .......+++.+.+||.+||+.||.+|||+.+++
T Consensus       276 ~~~~~~~~~~~~~~~----------------------~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  326 (344)
T 1rjb_A          276 PGIPVDANFYKLIQN----------------------GF-------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT  326 (344)
T ss_dssp             TTCCCSHHHHHHHHT----------------------TC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccCCcHHHHHHHHhc----------------------CC-------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            887654444333220                      00       0011245688999999999999999999999999


Q ss_pred             CCC
Q 017334          315 QHP  317 (373)
Q Consensus       315 ~hp  317 (373)
                      +|.
T Consensus       327 ~~l  329 (344)
T 1rjb_A          327 SFL  329 (344)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.3e-47  Score=342.32  Aligned_cols=258  Identities=21%  Similarity=0.290  Sum_probs=201.6

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ......++|++.+.||+|+||.||+|.+..   .+|+|+++...........+.+|+.+++.++||||++++++..    
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   90 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST----   90 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc----
Confidence            345567899999999999999999998653   5999999877667677778889999999999999999998652    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                        ....++||||++ ++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        91 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           91 --APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             --SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             --CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecc
Confidence              245899999997 699999854 4579999999999999999999999999999999999999999999999999997


Q ss_pred             ccCC--CCccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          182 TSNG--KNQFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       182 ~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      ....  .........||+.|+|||++..  ...++.++|||||||++|+|++|+.||.+....+....+......     
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----  243 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL-----  243 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC-----
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc-----
Confidence            5432  2223345678999999999862  356788999999999999999999999887665554443331111     


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                          ...+......+++.+.+||.+||+.||.+|||+.++++
T Consensus       244 --------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          244 --------------------SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             --------------------CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                11122334567899999999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.5e-48  Score=368.00  Aligned_cols=262  Identities=29%  Similarity=0.378  Sum_probs=195.8

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPS  101 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  101 (373)
                      +-...+.+.|.+.+.||+|+||+||.+ ...+|+.||||++....     ...+.+|+.+++.+ +||||+++++++   
T Consensus         8 ~~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~---   78 (434)
T 2rio_A            8 NFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSE---   78 (434)
T ss_dssp             CCSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEE---
T ss_pred             chhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEE---
Confidence            334557788888999999999999865 45679999999986432     23456899999876 799999999998   


Q ss_pred             CCCCcceEEEEeecCCccHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-----
Q 017334          102 HRRNFKDVYLVYELMDTDLHQIIKSSQAL-------TNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-----  169 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~-------~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-----  169 (373)
                        ...+.+|+||||++|+|.+++......       ++..++.++.||+.||+|||++||+||||||+|||++.+     
T Consensus        79 --~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~  156 (434)
T 2rio_A           79 --TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTA  156 (434)
T ss_dssp             --ECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHS
T ss_pred             --ecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccc
Confidence              445789999999999999999865433       233467899999999999999999999999999999764     


Q ss_pred             --------CCeEEcccCcccccCCCCc----cccceeeccccCchhhhhc------CCCCCchhhhHHHHHHHHHHHh-C
Q 017334          170 --------CDLKICDFGLARTSNGKNQ----FMTEYVVTRWYRAPELLLC------CDNYGTSIDVWSVGCIFAELLG-R  230 (373)
Q Consensus       170 --------~~~kL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g  230 (373)
                              +.+||+|||++........    .....+||+.|+|||++.+      ...++.++|||||||++|+|++ |
T Consensus       157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g  236 (434)
T 2rio_A          157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG  236 (434)
T ss_dssp             CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence                    3799999999987654322    2335689999999999865      2468899999999999999998 9


Q ss_pred             CCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH
Q 017334          231 KPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV  310 (373)
Q Consensus       231 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~  310 (373)
                      .+||.+.....  ..+..  +..                     ..+... ....+.+++++.+||.+||+.||++|||+
T Consensus       237 ~~Pf~~~~~~~--~~i~~--~~~---------------------~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~  290 (434)
T 2rio_A          237 KHPFGDKYSRE--SNIIR--GIF---------------------SLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTA  290 (434)
T ss_dssp             CCTTCSTTTHH--HHHHH--TCC---------------------CCCCCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCchhhH--HHHhc--CCC---------------------Cccccc-ccccccchHHHHHHHHHHhhCChhhCCCH
Confidence            99997654322  11111  000                     000000 00011245779999999999999999999


Q ss_pred             HHHhCCCCCCC
Q 017334          311 TEALQHPYMSP  321 (373)
Q Consensus       311 ~eil~hp~~~~  321 (373)
                      .++++||||.+
T Consensus       291 ~eil~hp~f~~  301 (434)
T 2rio_A          291 MKVLRHPLFWP  301 (434)
T ss_dssp             HHHHTSGGGSC
T ss_pred             HHHHhCCccCC
Confidence            99999999964

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.6e-47  Score=341.24  Aligned_cols=255  Identities=20%  Similarity=0.200  Sum_probs=205.7

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ..+.++|++.+.||+|+||.||+|++..+|+.||+|++.......    .+.+|+.+++.++|++++..+..+..    .
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~----~   76 (296)
T 3uzp_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGA----E   76 (296)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEE----E
T ss_pred             ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccC----C
Confidence            457899999999999999999999999999999999986543322    46789999999998887766655532    2


Q ss_pred             cceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCCeEEcccCccc
Q 017334          106 FKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill---~~~~~~kL~Dfg~a~  181 (373)
                      ....++||||++++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            367899999998899999974 4679999999999999999999999999999999999999   488899999999997


Q ss_pred             ccCCCCc-------cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHhC
Q 017334          182 TSNGKNQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL---NQLKLIINILG  251 (373)
Q Consensus       182 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~  251 (373)
                      .......       ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..   .....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            6543321       1245688999999999977 56899999999999999999999999864322   22222222100


Q ss_pred             CCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          252 SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .                          .+.....+.+++.+.+||.+||+.||++|||+.++++
T Consensus       236 ~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          236 S--------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             H--------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             C--------------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            0                          0111223557889999999999999999999998876

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.1e-47  Score=344.25  Aligned_cols=256  Identities=27%  Similarity=0.390  Sum_probs=194.9

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc-cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF-ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .-++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.     ..
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----ED  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ET
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cC
Confidence            3478999999999999999999999999999999997532 34455667789999999999999999999984     34


Q ss_pred             ceEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      +..++||||++ ++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            67999999997 599998864    4569999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .............|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ......+            
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~------------  250 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI------------  250 (310)
T ss_dssp             --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHH------------
T ss_pred             eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHh------------
Confidence            66544444455688999999999876 578999999999999999999999997643211 1111110            


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                               ......     ......+++.+.+||.+||+.||++|||+.+++++
T Consensus       251 ---------~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          251 ---------EQCDYP-----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             ---------HTTCSC-----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------hcccCC-----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                     000000     00124578899999999999999999999999863

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-47  Score=351.62  Aligned_cols=272  Identities=22%  Similarity=0.232  Sum_probs=202.3

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      --.++|++++.||+|+||+||+|++.  |+.||||++....   .......+|+.+++.++||||+++++++.... ...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~   94 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVD   94 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCC
Confidence            34579999999999999999999876  7899999996542   23334556999999999999999999986542 223


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCceEEcCCCCeEEc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA----------NILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      ..+++||||++ |+|.+++.. ..+++..++.++.||+.||+|||+.          ||+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            56899999996 699999976 4699999999999999999999999          99999999999999999999999


Q ss_pred             ccCcccccCCCC--ccccceeeccccCchhhhhcC----CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017334          176 DFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCC----DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       176 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  249 (373)
                      |||++.......  ......+||+.|+|||++.+.    ..++.++|||||||++|+|++|++||.+.............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            999997654322  223446899999999998763    23556889999999999999999999875432211111111


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccC--CCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY--PDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ...+...        ...........  .......+  ...++.+.+||.+||+.||++|||+.++++
T Consensus       254 ~~~~~~~--------~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          254 GQHPSLE--------DMQEVVVHKKK--RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CSSCCHH--------HHHHHHTTSCC--CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCchh--------hhhhhhhcccC--CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1111110        01111111110  11111111  112455899999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.6e-47  Score=347.37  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=207.3

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeC-------CCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeec
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNR-------ETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMM   99 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~-------~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~   99 (373)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++.... .......+.+|+.+++.+ +||||+++++++ 
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence            3589999999999999999999975       467889999997543 344556778999999999 799999999998 


Q ss_pred             CCCCCCcceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 017334          100 PSHRRNFKDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPG  162 (373)
Q Consensus       100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  162 (373)
                          ...+.+|+||||++ |+|.+++....                .+++.+++.++.||+.||+|||++||+||||||+
T Consensus       111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence                44467999999996 69999998654                3899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEcccCcccccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCc
Q 017334          163 NLLVNANCDLKICDFGLARTSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTEC  239 (373)
Q Consensus       163 Nill~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  239 (373)
                      |||++.++.+||+|||++........  ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            99999999999999999976543321  1233456788999999876 568999999999999999998 9999988765


Q ss_pred             hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+....+....                              .......+++.+.+||.+||+.||.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 EELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHHHTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCC------------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55544433210                              011224578899999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.6e-47  Score=347.30  Aligned_cols=256  Identities=22%  Similarity=0.359  Sum_probs=210.6

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceee
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVM   98 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   98 (373)
                      ......++|++.+.||+|+||.||+|.++     .+++.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            33456789999999999999999999886     467899999997543 334455678999999999999999999998


Q ss_pred             cCCCCCCcceEEEEeecCC-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334           99 MPSHRRNFKDVYLVYELMD-TDLHQIIKSS----------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                           ...+..++||||++ |+|.+++...          ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        98 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           98 -----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA  172 (322)
T ss_dssp             -----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred             -----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence                 44467899999996 6999998652          3578999999999999999999999999999999999999


Q ss_pred             CCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHH
Q 017334          168 ANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLK  244 (373)
Q Consensus       168 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~  244 (373)
                      .++.+||+|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+...
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            99999999999987543221  12234467889999999876 578999999999999999998 899998876555444


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+...                              ........+++.+.+||.+||+.||++|||+.++++|
T Consensus       252 ~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          252 FVMEG------------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcC------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            33220                              0011234578899999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.3e-47  Score=341.54  Aligned_cols=252  Identities=19%  Similarity=0.287  Sum_probs=205.9

Q ss_pred             eecCceeeee-eeeccCceEEEEEE--eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           27 EIDTKYVPIK-PIGRGAYGIVCSSV--NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        27 ~~~~~Y~~~~-~lg~G~~g~V~~a~--~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .-.++|++.+ .||+|+||.||+|.  +..+++.||+|++............+.+|+.+++.++||||+++++++..   
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   89 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---   89 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---
Confidence            3457899998 99999999999994  46678999999998765555556678899999999999999999999821   


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                         +..++||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        90 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           90 ---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             ---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             ---CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence               45899999997 69999999888899999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCcc---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      .......   .....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...         
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------  236 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---------  236 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT---------
T ss_pred             eccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence            5433221   122345688999999976 568899999999999999998 99999887655444333220         


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                           ......+.+++.+.++|.+||+.||++||++.++++
T Consensus       237 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          237 ---------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ---------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                 001123467889999999999999999999999885

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.3e-47  Score=337.87  Aligned_cols=248  Identities=27%  Similarity=0.367  Sum_probs=193.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh--HHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR--VDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .++|++.+.||+|+||.||+|.+.  |+.||+|++.......  .....+.+|+.+++.++||||+++++++     ...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence            478999999999999999999875  8899999987543322  2234677899999999999999999999     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEEcC--------CCCeEE
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN---ILHRDLKPGNLLVNA--------NCDLKI  174 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~Nill~~--------~~~~kL  174 (373)
                      +..++||||++ ++|.+++. .+.+++..++.++.||+.||+|||++|   |+||||||+|||++.        ++.+||
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            67999999996 68888875 468999999999999999999999999   899999999999986        678999


Q ss_pred             cccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          175 CDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      +|||++.......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..  +.  
T Consensus       158 ~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~--  230 (271)
T 3dtc_A          158 TDFGLAREWHRTT--KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM--NK--  230 (271)
T ss_dssp             CCCCC---------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT--SC--
T ss_pred             ccCCccccccccc--ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc--CC--
Confidence            9999997654322  234578999999999976 5789999999999999999999999988765444333221  00  


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                               ........+++.+.++|.+||+.||++|||+.+++++
T Consensus       231 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 -------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             -------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                     0011234578899999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.5e-47  Score=343.65  Aligned_cols=246  Identities=17%  Similarity=0.253  Sum_probs=201.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCC-------cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETN-------EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g-------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      ..++|++.+.||+|+||+||+|.++.++       ..||+|++.....  .....+.+|+.+++.++||||+++++++. 
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-   82 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCV-   82 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEEC-
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEE-
Confidence            3589999999999999999999998877       4799999865432  23346789999999999999999999994 


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC-------
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQA-LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD-------  171 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~-------  171 (373)
                          ..+..++||||++ |+|.+++...+. +++..++.++.||+.||+|||++||+||||||+|||++.++.       
T Consensus        83 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           83 ----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             ----CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             ----eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence                3466899999997 699999987654 999999999999999999999999999999999999999887       


Q ss_pred             -eEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHH
Q 017334          172 -LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       172 -~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~  249 (373)
                       +||+|||++......    ....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+.......... 
T Consensus       159 ~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-  233 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-  233 (289)
T ss_dssp             EEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-
T ss_pred             eeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-
Confidence             999999998654222    3346789999999998756789999999999999999995 566655443322221110 


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                             .        .......++.+.+||.+||+.||++|||+.++++|
T Consensus       234 -----------------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 -----------------------R--------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -----------------------T--------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -----------------------c--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                   0        01123346678999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.3e-47  Score=350.97  Aligned_cols=265  Identities=14%  Similarity=0.129  Sum_probs=201.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCC---CCcEEEEEEccccccChHHH---------HHHHHHHHHHhhCCCCCeeeec
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRE---TNEKVAIKKINNAFENRVDA---------LRTLRELKLLRHLQHENVIALK   95 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~---~g~~~aiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~~   95 (373)
                      ..++|++.+.||+|+||.||+|.+..   ++..+|+|++..........         ..+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            45799999999999999999999987   88899999987543221111         1345788899999999999999


Q ss_pred             eeecCCCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC--CeE
Q 017334           96 DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC--DLK  173 (373)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~--~~k  173 (373)
                      +++.... ......|+||||++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++  .+|
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            9986532 2357899999999889999998877999999999999999999999999999999999999999887  999


Q ss_pred             EcccCcccccCCC-------CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch--HHHH
Q 017334          174 ICDFGLARTSNGK-------NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL--NQLK  244 (373)
Q Consensus       174 L~Dfg~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~  244 (373)
                      |+|||++......       ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....  ....
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            9999999754321       112245688999999999987 57899999999999999999999999653221  1222


Q ss_pred             HHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          245 LIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .........+....            ...+          ...+++.+.+||.+||..||++||++.++++.
T Consensus       273 ~~~~~~~~~~~~~~------------~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          273 AKTNLLDELPQSVL------------KWAP----------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHTTTHHHH------------HHSC----------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHhhcccccHHHH------------hhcc----------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            22121111111100            0000          12578899999999999999999999998874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.1e-47  Score=350.45  Aligned_cols=258  Identities=19%  Similarity=0.278  Sum_probs=205.9

Q ss_pred             eeecCceeeeeeeeccCceEEEEEE-----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSV-----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~-----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      ....++|++++.||+|+||.||+|.     +..++..||+|++... ........+.+|+.+++.++||||+++++++. 
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSL-  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-
Confidence            4567999999999999999999999     5567889999999644 23444557789999999999999999999984 


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC--
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQ-------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC--  170 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~--  170 (373)
                          .....|+||||++ ++|.+++....       .+++.+++.++.||+.||.|||++||+||||||+|||++.++  
T Consensus       104 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          104 ----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             ----SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred             ----CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence                3456899999995 79999998653       489999999999999999999999999999999999998544  


Q ss_pred             -CeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHH
Q 017334          171 -DLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLI  246 (373)
Q Consensus       171 -~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i  246 (373)
                       .+||+|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+
T Consensus       180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             ceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence             59999999987432211  12233467889999999876 578999999999999999998 99999877655444433


Q ss_pred             HHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          247 INILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                      ....                              .......+++.+.+||.+||+.||.+||++.++++|.|+.
T Consensus       259 ~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          259 TSGG------------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCC------------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            2210                              0112245788999999999999999999999999998863

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-47  Score=350.73  Aligned_cols=250  Identities=20%  Similarity=0.262  Sum_probs=201.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcE----EEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEK----VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~----~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .++|++++.||+|+||+||+|.+..+|+.    ||+|.+..... ......+.+|+.+++.++||||+++++++.     
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            57899999999999999999999888876    67776643321 111224567999999999999999999873     


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                       ....++||||+. |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++..
T Consensus        86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence             245899999996 7999999764 5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .....  .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+.....        
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------  235 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER--------  235 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB--------
T ss_pred             cCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--------
Confidence            64322  23345577889999999976 578999999999999999999 9999988765554444332100        


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                            ......+++.+.+||.+||..||++|||+.+++++
T Consensus       236 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          236 ----------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ----------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ----------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                  01112356678899999999999999999999886

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=362.46  Aligned_cols=254  Identities=28%  Similarity=0.383  Sum_probs=193.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..+|.+.+.||+|+||+|+. ....+|+.||||++......     .+.+|+.+++.+ +||||+++++++     ....
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~   91 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTE-----KDRQ   91 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEE-----EETT
T ss_pred             cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEE-----ecCC
Confidence            35799999999999999763 44567899999999654332     234799999999 699999999998     4457


Q ss_pred             eEEEEeecCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-----CCeEEcccCccc
Q 017334          108 DVYLVYELMDTDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-----CDLKICDFGLAR  181 (373)
Q Consensus       108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-----~~~kL~Dfg~a~  181 (373)
                      ..|+||||++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.+     ..+||+|||++.
T Consensus        92 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           92 FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            799999999999999998654 46667788999999999999999999999999999999532     358899999998


Q ss_pred             ccCCCC---ccccceeeccccCchhhhhc--CCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          182 TSNGKN---QFMTEYVVTRWYRAPELLLC--CDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       182 ~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      ......   ......+||+.|+|||++.+  ...++.++|||||||++|+|++ |.+||....... ...+   .+....
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~---~~~~~~  247 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANIL---LGACSL  247 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHH---TTCCCC
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHH---hccCCc
Confidence            654322   23345689999999999874  3457789999999999999999 899996543222 1111   111100


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                              .........+..+.+||.+||+.||++|||+.++++||||..
T Consensus       248 ------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          248 ------------------------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             ------------------------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             ------------------------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence                                    000001123456889999999999999999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.8e-47  Score=354.59  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=195.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC---CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR---ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~---~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .++|++.+.||+|+||.||+|+++   .++..||||+++... .......+.+|+.++++++||||+++++++.     .
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~  117 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----K  117 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----e
Confidence            468999999999999999999887   567789999997543 3445567889999999999999999999983     4


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .+..++||||++ |+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            467999999995 79999998654 6999999999999999999999999999999999999999999999999999765


Q ss_pred             CCCCcc---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          184 NGKNQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       184 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ......   .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....        
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~--------  268 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR--------  268 (373)
T ss_dssp             ----------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE--------
T ss_pred             ccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence            432211   122345678999999976 578999999999999999997 9999987765554444322100        


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                            ......++..+.+||.+||+.||++||++.++++
T Consensus       269 ----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          269 ----------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ----------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                  0012346788999999999999999999988776

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.3e-47  Score=344.89  Aligned_cols=255  Identities=25%  Similarity=0.384  Sum_probs=208.7

Q ss_pred             eecCceeeeeeeeccCceEEEEEEe-----CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVN-----RETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~-----~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      ...++|++.+.||+|+||.||+|.+     ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++..
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            3468999999999999999999985     4577899999997653 334445678999999999 59999999999843


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQA----------------LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~----------------~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                      .    ...+++||||++ |+|.+++.....                +++..++.++.||+.||.|||++||+||||||+|
T Consensus       103 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A          103 P----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             T----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             C----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            2    245899999997 699999987543                8999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      ||++.++.+||+|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999999999999999997654322  22345678899999999976 578999999999999999998 99999876644


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      ...........                             .......+++.+.++|.+||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCc-----------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43332221100                             001224478899999999999999999999999976

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-47  Score=345.48  Aligned_cols=255  Identities=20%  Similarity=0.198  Sum_probs=200.1

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ..+.++|++.+.||+|+||.||+|.+..+|+.||+|++......    ..+.+|+.+++.++|++++..+..+..    .
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~----~   76 (296)
T 4hgt_A            5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGA----E   76 (296)
T ss_dssp             ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEE----E
T ss_pred             cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecC----C
Confidence            45679999999999999999999999999999999987544322    236689999999998887776665532    3


Q ss_pred             cceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCCeEEcccCccc
Q 017334          106 FKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill---~~~~~~kL~Dfg~a~  181 (373)
                      ....++||||++++|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.
T Consensus        77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            367899999998899999974 4679999999999999999999999999999999999999   788999999999997


Q ss_pred             ccCCCCc-------cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHHHhC
Q 017334          182 TSNGKNQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECL---NQLKLIINILG  251 (373)
Q Consensus       182 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~  251 (373)
                      .......       ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..   .....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            6543221       2235688999999999987 57899999999999999999999999875432   22222211100


Q ss_pred             CCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          252 SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .                          .+.......+++.+.+||.+||+.||++|||+.++++
T Consensus       236 ~--------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 S--------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             H--------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             c--------------------------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            0                          0111223457889999999999999999999998876

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-48  Score=364.06  Aligned_cols=282  Identities=20%  Similarity=0.324  Sum_probs=210.2

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ....+.++|++.+.||+|+||+||+|++..+|+.||||++...... .....+.+|+.+++.++||||+++++++.... 
T Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-   80 (396)
T 4eut_A            3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT-   80 (396)
T ss_dssp             EEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT-
T ss_pred             CCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCC-
Confidence            3455679999999999999999999999999999999999754322 22345678999999999999999999985432 


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCCeEEc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQ---ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV----NANCDLKIC  175 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill----~~~~~~kL~  175 (373)
                        ....|+||||++ |+|.+++....   .+++.+++.++.||+.||+|||++||+||||||+|||+    +.++.+||+
T Consensus        81 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           81 --TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             --TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             --CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence              257899999996 69999997543   39999999999999999999999999999999999999    777789999


Q ss_pred             ccCcccccCCCCccccceeeccccCchhhhhcC-------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCch-HHHHHHH
Q 017334          176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC-------DNYGTSIDVWSVGCIFAELLGRKPIFPGTECL-NQLKLII  247 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~  247 (373)
                      |||++...... ......+||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||.+.... .....+.
T Consensus       159 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  237 (396)
T 4eut_A          159 DFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (396)
T ss_dssp             CGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred             cCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence            99999876432 334456899999999998641       35778999999999999999999999754322 1222233


Q ss_pred             HHhCCCChhhhcccCChhHH--HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          248 NILGSRREEDLEFIDNPKAR--KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .+....+...+.........  .+....+     ....+...+++.+.++|++||..||++||++.++++
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHHSCCTTCCEEEECSTTCCEEEESSCC-----TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHhcCCCcccchhheeccCCCcccCccCC-----cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            33332222211111000000  0000000     001112234567899999999999999999998755

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.4e-47  Score=353.42  Aligned_cols=266  Identities=14%  Similarity=0.116  Sum_probs=202.3

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCC-----CcEEEEEEccccccChHHHH---------HHHHHHHHHhhCCCCCeee
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRET-----NEKVAIKKINNAFENRVDAL---------RTLRELKLLRHLQHENVIA   93 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~-----g~~~aiK~~~~~~~~~~~~~---------~~~~E~~~l~~l~hpniv~   93 (373)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||||++...........         ....|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456999999999999999999998765     58899999865432111111         2235666778889999999


Q ss_pred             eceeecCCCCCCcceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--CCC
Q 017334           94 LKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN--ANC  170 (373)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~--~~~  170 (373)
                      +++++.... ......|+||||++++|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            999986532 233668999999988999999875 6799999999999999999999999999999999999999  889


Q ss_pred             CeEEcccCcccccCCCC-------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHH
Q 017334          171 DLKICDFGLARTSNGKN-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQL  243 (373)
Q Consensus       171 ~~kL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  243 (373)
                      .+||+|||+++......       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~  270 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY  270 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence            99999999997543221       11234569999999999977 56899999999999999999999999864333222


Q ss_pred             HHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          244 KLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .........           ............         ...+++.+.+||..||..||++||++.++++
T Consensus       271 ~~~~~~~~~-----------~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          271 VRDSKIRYR-----------ENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHH-----------HCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhh-----------hhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            221110000           001111111000         1356788999999999999999999988876

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.9e-47  Score=347.94  Aligned_cols=261  Identities=22%  Similarity=0.348  Sum_probs=193.1

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPS  101 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~  101 (373)
                      +.+.....+|++.+.||+|+||.||+|++..+|+.||+|++...  .......+.+|+.+++.+. ||||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            34445567999999999999999999999999999999998543  3344556789999999996 99999999988532


Q ss_pred             C---CCCcceEEEEeecCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCCCeE
Q 017334          102 H---RRNFKDVYLVYELMDTDLHQIIKS---SQALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVNANCDLK  173 (373)
Q Consensus       102 ~---~~~~~~~~lv~e~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~~~~~~k  173 (373)
                      .   ......+++||||++|+|.+++..   .+.+++.+++.++.||+.||+|||++|  |+||||||+|||++.++.+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence            1   134467999999999999998864   467999999999999999999999999  99999999999999999999


Q ss_pred             EcccCcccccCCCCc------------cccceeeccccCchhhhh--cCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCc
Q 017334          174 ICDFGLARTSNGKNQ------------FMTEYVVTRWYRAPELLL--CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTEC  239 (373)
Q Consensus       174 L~Dfg~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  239 (373)
                      |+|||++........            ......||+.|+|||++.  ....++.++|||||||++|+|++|..||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            999999976543221            112456899999999983  235688999999999999999999999965432


Q ss_pred             hHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                      ......                          ....       ......++.+.+||.+||+.||++|||+.++++|-+
T Consensus       259 ~~~~~~--------------------------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          259 LRIVNG--------------------------KYSI-------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ---------------------------------CCC-------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHhhcC--------------------------cccC-------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            211100                          0000       011345667899999999999999999999998754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7e-47  Score=346.94  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=198.6

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEE----EEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ..++|++++.||+|+||+||+|++..+|+.+    |+|.+.... .......+.+|+.+++.++||||+++++++..   
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   88 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---   88 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---
Confidence            4688999999999999999999998887754    777765432 22334567899999999999999999999853   


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                         ...++|+||+. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++
T Consensus        89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           89 ---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ---SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             ---CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence               23788999985 799999876 4679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          182 TSNGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       182 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      .......  ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+....        
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--------  236 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------  236 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred             EccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC--------
Confidence            6543222  2233456789999999987 678999999999999999999 999998876555444332210        


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                            .....+.++..+.+++.+||+.||++||++.+++++
T Consensus       237 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          237 ----------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             ----------------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                  001124567889999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.9e-48  Score=352.75  Aligned_cols=271  Identities=23%  Similarity=0.297  Sum_probs=208.3

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ..+....++|++.+.||+|+||.||+|.++ +|+.||+|++.....  .....+.+|+.+++.++||||+++++++    
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~----  104 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFC----  104 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEEC----
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            344557799999999999999999999964 689999999875433  2345678999999999999999999998    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQ----ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDF  177 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Df  177 (373)
                       ...+..++||||++ |+|.+++....    .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus       105 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          105 -DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             -CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             -cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeec
Confidence             44467999999996 69998886543    5899999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCC--CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          178 GLARTSNGK--NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       178 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      |++......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+.........
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            999764322  222344578999999999876 56899999999999999999999999765432211111100000000


Q ss_pred             hhhcccCChhHHHHHHhCCCCC-CCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTP-GTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP  317 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp  317 (373)
                      .               .+.... ........+..+..+.+++.+||+.||++|||+.+++++.
T Consensus       263 ~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          263 G---------------QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             T---------------CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             c---------------cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            0               000000 0001112233456789999999999999999999999763

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.7e-47  Score=346.63  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=198.6

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEE----EEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKV----AIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~----aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ..++|++++.||+|+||.||+|.+..+|+.+    |+|.+.... .......+.+|+.+++.++||||+++++++...  
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--   89 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--   89 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence            4689999999999999999999998888765    666654332 222345678999999999999999999998532  


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                          ..++|+|++. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           90 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             ----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence                3788899985 799999876 4579999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          182 TSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       182 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....        
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~--------  236 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE--------  236 (327)
T ss_dssp             --------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred             EccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            654322  22233456788999999987 678999999999999999999 999998876655544432210        


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                            .....+.+++.+.+||++||+.||.+||++.++++
T Consensus       237 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          237 ----------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ----------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  01112457888999999999999999999999887

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-46  Score=333.97  Aligned_cols=248  Identities=22%  Similarity=0.325  Sum_probs=205.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.......   ..+.+|+.+++.++||||+++++++.     ..+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   77 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAP   77 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSS
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCC
Confidence            478999999999999999999986 67889999997654433   35778999999999999999999984     3467


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .++||||++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            999999996 6999999765 56899999999999999999999999999999999999999999999999999765322


Q ss_pred             C-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 N-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      . .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....             
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-------------  223 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------------  223 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------------
T ss_pred             cccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-------------
Confidence            1 11233456788999999976 578999999999999999999 8999988765554444322100             


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                       .......++.+.++|.+||+.||++|||+.+++++
T Consensus       224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                             01123467889999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=346.47  Aligned_cols=275  Identities=21%  Similarity=0.311  Sum_probs=207.5

Q ss_pred             CCCCCCCcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCC
Q 017334            9 NGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH   88 (373)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h   88 (373)
                      ....+.|....+. +......++|++++.||+|+||.||+|.+..+|+.||+|++...  .......+.+|+.+++.++|
T Consensus         9 ~~~~~~~~~~~~g-~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h   85 (317)
T 2buj_A            9 HHSSGRENLYFQG-HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNH   85 (317)
T ss_dssp             -------CCSEEE-EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCC
T ss_pred             cccccccceeecc-cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCC
Confidence            3334444444444 33344567999999999999999999999999999999998543  34455667899999999999


Q ss_pred             CCeeeeceeecCCCCCCcceEEEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334           89 ENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus        89 pniv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                      |||+++++++.... ......++||||+. |+|.+++..    ...+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        86 ~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~N  164 (317)
T 2buj_A           86 PNILRLVAYCLRER-GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN  164 (317)
T ss_dssp             TTBCCCCEEEEEEE-TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCeeeEEEEEEecc-CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence            99999999985321 23467999999997 599998875    4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCCc---------cccceeeccccCchhhhhcCC--CCCchhhhHHHHHHHHHHHhCCC
Q 017334          164 LLVNANCDLKICDFGLARTSNGKNQ---------FMTEYVVTRWYRAPELLLCCD--NYGTSIDVWSVGCIFAELLGRKP  232 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~  232 (373)
                      ||++.++.+||+|||++........         ......||+.|+|||++.+..  .++.++|||||||++|+|++|..
T Consensus       165 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  244 (317)
T 2buj_A          165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG  244 (317)
T ss_dssp             EEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred             EEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999998875432111         112345689999999986532  26889999999999999999999


Q ss_pred             CCCCCCchH-HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHH
Q 017334          233 IFPGTECLN-QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT  311 (373)
Q Consensus       233 pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~  311 (373)
                      ||....... ...                       ........      ....+.+++.+.+||.+||+.||.+|||+.
T Consensus       245 p~~~~~~~~~~~~-----------------------~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  295 (317)
T 2buj_A          245 PYDMVFQKGDSVA-----------------------LAVQNQLS------IPQSPRHSSALWQLLNSMMTVDPHQRPHIP  295 (317)
T ss_dssp             TTHHHHHTTSCHH-----------------------HHHHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             Chhhhhcccchhh-----------------------HHhhccCC------CCccccCCHHHHHHHHHHhhcChhhCCCHH
Confidence            984311000 000                       00000000      011245788999999999999999999999


Q ss_pred             HHhCC
Q 017334          312 EALQH  316 (373)
Q Consensus       312 eil~h  316 (373)
                      +++++
T Consensus       296 ~ll~~  300 (317)
T 2buj_A          296 LLLSQ  300 (317)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-46  Score=341.35  Aligned_cols=267  Identities=23%  Similarity=0.384  Sum_probs=204.2

Q ss_pred             cCceeeeeeeeccCceEEEEEE----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSV----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .++|++++.||+|+||.||+|+    +..+|+.||+|++..... ......+.+|+.+++.++||||+++++++....  
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDG--   96 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--
Confidence            4779999999999999999999    677899999999975432 223346779999999999999999999985432  


Q ss_pred             CcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                       ...+++||||++ ++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        97 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           97 -GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence             256899999996 699999954 46799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      .....   .......+|..|+|||++.+ ..++.++|||||||++|+|++|..|+...     ........+......  
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~--  247 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQM--  247 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGGG--
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCccccc--
Confidence            64433   22334567888999999977 56889999999999999999999886432     112222222211110  


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                           .............   .....+.+++.+.+||.+||+.||++|||+.++++
T Consensus       248 -----~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          248 -----TVTRLVNTLKEGK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             -----HHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             -----CHHHHHHHHhccC---CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                 0111111111100   11233568899999999999999999999999885

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.8e-47  Score=345.99  Aligned_cols=267  Identities=22%  Similarity=0.322  Sum_probs=207.1

Q ss_pred             cCceeeeeeeeccCceEEEEEE----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSV----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .++|++++.||+|+||.||+|+    +..+|+.||+|++...  .......+.+|+.+++.++||||+++++++...   
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---
Confidence            4799999999999999999999    5778999999999754  334445678999999999999999999988543   


Q ss_pred             CcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ....+|+||||++ ++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            3367999999995 799999976 45699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          183 SNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       183 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ......   ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||........     .......     
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~-----  245 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCER-----  245 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC--------
T ss_pred             cccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhccccc-----
Confidence            543322   2234467888999999876 5689999999999999999999999865432111     0000000     


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                        ...............   ......+.+++.+.+||.+||+.||++|||+.+++++
T Consensus       246 --~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          246 --DVPALSRLLELLEEG---QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ---CCHHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --ccccHHHHHHHhhcc---cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              000001111110000   0111235688999999999999999999999999653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-46  Score=344.55  Aligned_cols=256  Identities=23%  Similarity=0.295  Sum_probs=208.4

Q ss_pred             eeeecCceeeeeeeeccCceEEEEEEeCCCCc-----EEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceee
Q 017334           25 LFEIDTKYVPIKPIGRGAYGIVCSSVNRETNE-----KVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVM   98 (373)
Q Consensus        25 ~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~-----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~   98 (373)
                      .....++|++.+.||+|+||.||+|.+..+++     .||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            33456889999999999999999999977664     79999987543 334455678999999999 799999999998


Q ss_pred             cCCCCCCcceEEEEeecCC-ccHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334           99 MPSHRRNFKDVYLVYELMD-TDLHQIIKSS--------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                           ...+..|+||||++ |+|.+++...              ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus       120 -----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  194 (333)
T 2i1m_A          120 -----THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN  194 (333)
T ss_dssp             -----CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             -----ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccce
Confidence                 44467999999996 6999998642              358999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      ||++.++.+||+|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             EEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            999999999999999997543222  22334567889999999876 578999999999999999998 99999876655


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .....+.....                      .       .......++.+.+||.+||+.||.+|||+.+++++
T Consensus       274 ~~~~~~~~~~~----------------------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          274 SKFYKLVKDGY----------------------Q-------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHHHHTC----------------------C-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCC----------------------C-------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            44433332100                      0       01123467889999999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.5e-47  Score=343.90  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=196.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhh--CCCCCeeeeceeecCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH--LQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~~~  104 (373)
                      .+.++|++++.||+|+||+||+|.+  +|+.||||++....     .....+|.+++..  ++||||+++++++.... .
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSR-H   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-T
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeecccc-C
Confidence            3578999999999999999999987  58999999986432     2234556666666  78999999999875432 3


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEEcCCCCeEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH--------SANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      ....+++||||++ |+|.++++. ..+++..++.++.||+.||+|||        ++||+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence            3467999999996 699999964 57999999999999999999999        9999999999999999999999999


Q ss_pred             ccCcccccCCCCcc----ccceeeccccCchhhhhcCC-----CCCchhhhHHHHHHHHHHHhC----------CCCCCC
Q 017334          176 DFGLARTSNGKNQF----MTEYVVTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAELLGR----------KPIFPG  236 (373)
Q Consensus       176 Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g----------~~pf~~  236 (373)
                      |||++.........    .....||+.|+|||++.+..     .++.++|||||||++|+|++|          .+||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999754332221    23448999999999997642     234789999999999999999          788755


Q ss_pred             CCchH-HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          237 TECLN-QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       237 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..... ....+.....                    .....+..+........++.+.+||.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVC--------------------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TSCSSCCHHHHHHHHT--------------------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCCCCcchhhhhHHHh--------------------ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            32211 1111111110                    00001111111111224567999999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.9e-47  Score=347.99  Aligned_cols=249  Identities=25%  Similarity=0.330  Sum_probs=202.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEE--EEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKV--AIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~--aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||.||+|++..+|..+  |+|.+.... .......+.+|+.+++.+ +||||+++++++     ...
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~   98 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   98 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EET
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceee-----eeC
Confidence            79999999999999999999999998865  999886432 223344677899999999 799999999998     444


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQ----------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~  169 (373)
                      +..|+||||++ |+|.+++...+                .+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  178 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence            77999999996 69999997654                69999999999999999999999999999999999999999


Q ss_pred             CCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHH
Q 017334          170 CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIIN  248 (373)
Q Consensus       170 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~  248 (373)
                      +.+||+|||++...... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus       179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  256 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  256 (327)
T ss_dssp             GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CeEEEcccCcCcccccc-ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence            99999999998743221 11233456788999999876 568999999999999999998 9999988765544333211


Q ss_pred             HhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .                              ........+++.+.+||.+||..||.+|||+.+++++
T Consensus       257 ~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          257 G------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             T------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C------------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0                              0001224578899999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=342.56  Aligned_cols=252  Identities=22%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCC----cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETN----EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      ...+|++.+.||+|+||.||+|.+..++    ..||+|++.... .......+.+|+.+++.++||||+++++++     
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----  115 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----  115 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            3578999999999999999999987553    459999997543 334455678999999999999999999998     


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      ...+..++||||++ |+|.+++... +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            44467999999997 5999999764 679999999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          182 TSNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       182 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      .......   ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....      
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~------  268 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------  268 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------
T ss_pred             hhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc------
Confidence            6543221   1222345778999999976 578999999999999999998 9999987765554444322100      


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                              ......+++.+.+||.+||+.||++||++.+++++
T Consensus       269 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 ------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             ------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    01124577889999999999999999999998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-46  Score=363.07  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=209.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -..+|++.+.||+|+||.||+|.++.++..||||+++.....   ...+.+|+.+++.++||||+++++++.     ...
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~  289 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCT-----REP  289 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence            357899999999999999999999999999999999765333   346789999999999999999999984     446


Q ss_pred             eEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+|+||||+. |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            7999999997 7999999763  458999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....            
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------------  436 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------  436 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------------
T ss_pred             CCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------
Confidence            322 12233456788999999976 568999999999999999998 999998877655544432200            


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        .......+++.+.+||.+||+.||++|||+.++++
T Consensus       437 ------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                              00123457889999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.1e-46  Score=333.84  Aligned_cols=251  Identities=21%  Similarity=0.306  Sum_probs=203.4

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCC---CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRE---TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..++|++.+.||+|+||.||+|.+..   ++..||+|++.... .......+.+|+.+++.++||||+++++++..    
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----
Confidence            35889999999999999999998653   34569999987653 33445678899999999999999999999732    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        +..|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        85 --~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           85 --EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             --CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence              34689999997 6999999764 4699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          183 SNGKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       183 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ..... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |++||......+....+.....         
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~---------  232 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR---------  232 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC---------
T ss_pred             cccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC---------
Confidence            54322 12233456788999999976 578999999999999999998 9999987666555444332100         


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                           ......+++.+.++|.+||..||++|||+.+++++
T Consensus       233 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          233 ---------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                 01123477889999999999999999999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-46  Score=335.68  Aligned_cols=256  Identities=23%  Similarity=0.351  Sum_probs=209.7

Q ss_pred             eeeecCceeeee-eeeccCceEEEEEEeC--CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           25 LFEIDTKYVPIK-PIGRGAYGIVCSSVNR--ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        25 ~~~~~~~Y~~~~-~lg~G~~g~V~~a~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      ++...++|.+++ .||+|+||.||+|.++  .++..||+|++... ........+.+|+.+++.++||||+++++++.. 
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   81 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   81 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-
Confidence            344568888887 9999999999999864  46788999999764 334455678899999999999999999999822 


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                           +..++||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        82 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           82 -----EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             -----SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             -----CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence                 35899999997 5999998654 5699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcc---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          180 ARTSNGKNQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       180 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      +.........   .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~------  229 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------  229 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT------
T ss_pred             eeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC------
Confidence            9866433221   223356789999999976 568999999999999999998 99999887665544443220      


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY  318 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~  318 (373)
                                              ......+.+++.+.++|.+||+.||++||++.+++++.+
T Consensus       230 ------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          230 ------------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ------------------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ------------------------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                                    001223567899999999999999999999999998753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.6e-46  Score=355.79  Aligned_cols=244  Identities=25%  Similarity=0.371  Sum_probs=202.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      -.++|++++.||+|+||.||+|.+.  |+.||||+++...    ....+.+|+.+++.++||||+++++++...    ..
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~  260 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KG  260 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TS
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CC
Confidence            3578999999999999999999875  7899999997643    234678999999999999999999997443    24


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+|+||||++ |+|.+++...+.  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            6999999996 699999986543  7999999999999999999999999999999999999999999999999997543


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ...   ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....             
T Consensus       341 ~~~---~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-------------  403 (450)
T 1k9a_A          341 STQ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-------------  403 (450)
T ss_dssp             ---------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-------------
T ss_pred             ccc---cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            222   23366889999999977 679999999999999999998 999998876655554443210             


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                       .......+++.+.+||.+||+.||++|||+.++++
T Consensus       404 -----------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 -----------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                             01123457899999999999999999999999874

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=333.60  Aligned_cols=249  Identities=26%  Similarity=0.335  Sum_probs=201.4

Q ss_pred             ceeeeeeeeccCceEEEEEEeCCCCc---EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           31 KYVPIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        31 ~Y~~~~~lg~G~~g~V~~a~~~~~g~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .|++.+.||+|+||+||+|.+..++.   .+|+|++... ........+.+|+.+++.++||||+++++++....    .
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~   96 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----G   96 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----C
Confidence            56777999999999999999765554   7999998753 33445567789999999999999999999985432    3


Q ss_pred             eEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ..++||||+. |+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            3589999995 799999976 45789999999999999999999999999999999999999999999999999975432


Q ss_pred             C----CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          186 K----NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       186 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .    ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.....         
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---------  246 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---------  246 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---------
T ss_pred             CcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---------
Confidence            1    122334567899999999976 578999999999999999998 5677766655554443332100         


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                           ......+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          247 ---------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                 0112457788999999999999999999998876

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.5e-46  Score=334.88  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=201.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCC---cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETN---EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ..+|++.+.||+|+||.||+|.+..++   ..+|+|.+... ........+.+|+.+++.++||||+++++++...    
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----   98 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----   98 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----
Confidence            357999999999999999999975433   46899998753 3444556788999999999999999999986432    


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .+..++||||++ |+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            356899999997 5999999763 56899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCC----ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          184 NGKN----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       184 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ....    .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+.....       
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------  250 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------  250 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-------
T ss_pred             cccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-------
Confidence            3321    22334567889999999976 578999999999999999998 7788877765554444332100       


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                             ......+++.+.++|.+||+.||++|||+.++++
T Consensus       251 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 -----------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                   0112346788999999999999999999999886

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.6e-47  Score=339.10  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=205.5

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC----
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH----  102 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----  102 (373)
                      .+.++|++++.||+|+||.||+|.+..+|+.||+|++....      ..+.+|+.+++.++||||+++++++....    
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            35689999999999999999999999999999999996542      13558999999999999999999874310    


Q ss_pred             -------CCCcceEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334          103 -------RRNFKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus       103 -------~~~~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                             ......+++||||++ ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                   022456899999997 5999999754  579999999999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      ||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....  .....+.     
T Consensus       162 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~-----  232 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR-----  232 (284)
T ss_dssp             EECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH-----
T ss_pred             EECcchhheeccccc-cccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh-----
Confidence            999999997664332 2344578999999999976 578999999999999999999998763211  1111000     


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                        .          ......+++.+.+||.+||+.||.+|||+.++++|.|.
T Consensus       233 ------------------~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          233 ------------------D----------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             ------------------T----------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------------------c----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                              0          01123467889999999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.3e-47  Score=350.36  Aligned_cols=257  Identities=12%  Similarity=0.093  Sum_probs=199.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC--------CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET--------NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~--------g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      .++|++.+.||+|+||.||+|++..+        ++.||+|++...       ..+.+|+.+++.++||||+++++.+..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            58999999999999999999999874        889999998644       246689999999999999985433211


Q ss_pred             C-----------CCCCcceEEEEeecCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 017334          101 S-----------HRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN  167 (373)
Q Consensus       101 ~-----------~~~~~~~~~lv~e~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~  167 (373)
                      .           ........|+||||++++|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence            0           00124679999999988999999876  7899999999999999999999999999999999999999


Q ss_pred             CCC--CeEEcccCcccccCCCC-------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Q 017334          168 ANC--DLKICDFGLARTSNGKN-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE  238 (373)
Q Consensus       168 ~~~--~~kL~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  238 (373)
                      .++  .+||+|||++.......       .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            998  89999999997543221       12234588999999999976 578999999999999999999999998754


Q ss_pred             -chHHHHH-HHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          239 -CLNQLKL-IINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       239 -~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                       ....+.. ..........                    ..  .....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~--------------------~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGP--------------------FV--GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCC--------------------EE--CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHhccCChhh--------------------hh--hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence             2222222 2111111100                    00  000112356889999999999999999999998876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.7e-46  Score=356.19  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=206.0

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ...++|++.+.||+|+||.||+|.+. ++..||||+++.....   ...+.+|+.+++.++||||+++++++.      .
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~------~  254 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT------K  254 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe------C
Confidence            34678999999999999999999986 4678999999764332   446789999999999999999999973      2


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ..+|+||||+. |+|.+++...  ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            45899999996 7999999754  37899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          184 NGKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       184 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .... .......++..|+|||++.. ..++.++|||||||++|+|++ |++||.+.+..+....+......         
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  404 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---------  404 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---------
T ss_pred             CCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            4321 11223345778999999976 578999999999999999998 99999988766665554431100         


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                           .....+++.+.+||.+||+.||++|||+.++++
T Consensus       405 ---------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          405 ---------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                 012457888999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.6e-46  Score=333.05  Aligned_cols=243  Identities=25%  Similarity=0.368  Sum_probs=195.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|.+.  |+.||+|++....    ....+.+|+.+++.++||||+++++++...    .+.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~   89 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG   89 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCc
Confidence            489999999999999999999874  8899999997542    334677899999999999999999987432    246


Q ss_pred             EEEEeecCC-ccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQA--LTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .|+||||++ ++|.+++...+.  +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            899999997 599999976543  89999999999999999999999999999999999999999999999999875533


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..   ....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+...               
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---------------  230 (278)
T 1byg_A          170 TQ---DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------------  230 (278)
T ss_dssp             ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---------------
T ss_pred             cc---cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---------------
Confidence            22   23467889999999876 578999999999999999998 99999877655444333210               


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                     ........+++.+.++|.+||+.||++|||+.++++
T Consensus       231 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 ---------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                           001123467889999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.6e-46  Score=341.83  Aligned_cols=269  Identities=22%  Similarity=0.302  Sum_probs=204.9

Q ss_pred             eeecCce-eeeeeeeccCceEEEEEE----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecC
Q 017334           26 FEIDTKY-VPIKPIGRGAYGIVCSSV----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMP  100 (373)
Q Consensus        26 ~~~~~~Y-~~~~~lg~G~~g~V~~a~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  100 (373)
                      ..+.++| ++++.||+|+||+||++.    +..+|+.||||++... ........+.+|+.+++.++||||+++++++..
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            4456777 999999999999998775    4458899999999765 334455678899999999999999999999854


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                      .   ....+++||||++ |+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       105 ~---~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          105 A---GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             T---TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             C---CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence            3   2367999999996 6999998764 599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChh
Q 017334          180 ARTSNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE  256 (373)
Q Consensus       180 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (373)
                      +........   ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......     .....+.....
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~  254 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQ  254 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccc
Confidence            987644322   2334467888999999976 56889999999999999999999998653211     01111111000


Q ss_pred             hhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..    ............      .......+++.+.+||++||+.||++|||+.++++
T Consensus       255 ~~----~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          255 MT----VLRLTELLERGE------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HH----HHHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hh----HHHHHHHHhccc------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            00    000111111111      11123567899999999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.6e-47  Score=348.62  Aligned_cols=272  Identities=22%  Similarity=0.292  Sum_probs=205.8

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      .++....++|++.+.||+|+||.||+|.+. +|+.||+|++....... ....+.+|+.+++.++||||+++++++.   
T Consensus        23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~---   97 (326)
T 3uim_A           23 RELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCM---   97 (326)
T ss_dssp             HHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEEC---
T ss_pred             HHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEe---
Confidence            556677899999999999999999999854 68999999997543221 1124678999999999999999999994   


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEEcCCCCeEE
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQ----ALTNDHCQYFLFQLLRGLKYLHSA---NILHRDLKPGNLLVNANCDLKI  174 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~Nill~~~~~~kL  174 (373)
                        .....++||||++ |+|.+++....    .+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||
T Consensus        98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           98 --TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             --CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             --cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence              4466899999996 69999997643    499999999999999999999999   9999999999999999999999


Q ss_pred             cccCcccccCCC-CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----chHHHHHHHH
Q 017334          175 CDFGLARTSNGK-NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE-----CLNQLKLIIN  248 (373)
Q Consensus       175 ~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~  248 (373)
                      +|||++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....     .......+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            999999865432 233344568999999999976 568999999999999999999999995211     0011111000


Q ss_pred             HhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                         ...........+              ........+..++.+.+++.+||+.||++|||+.++++|-.-
T Consensus       255 ---~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          255 ---LLKEKKLEALVD--------------VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             ---TTSSCCSTTSSC--------------TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             ---HhhchhhhhhcC--------------hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence               000000000000              000001112234678999999999999999999999998653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.2e-46  Score=366.76  Aligned_cols=243  Identities=20%  Similarity=0.309  Sum_probs=201.2

Q ss_pred             eeeeccCceEEEEEEe--CCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVN--RETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~--~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||.||+|.+  +.+++.||||+++...........+.+|+.+++.++||||+++++++..      ...++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            4799999999999954  5677899999998766555556678899999999999999999998832      3489999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC---cc
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN---QF  189 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~  189 (373)
                      ||+. |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......   ..
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9996 6999999988899999999999999999999999999999999999999999999999999998654322   12


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+....                  
T Consensus       529 ~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------------------  589 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE------------------  589 (635)
T ss_dssp             ------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------------
T ss_pred             ccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------------------
Confidence            233456788999999976 579999999999999999998 999999887666555443310                  


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                  .......+++.+.+||.+||+.||++||++.++++
T Consensus       590 ------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          590 ------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                        01123457889999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-45  Score=330.95  Aligned_cols=247  Identities=22%  Similarity=0.339  Sum_probs=204.1

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++++.||+|+||.||+|.+. ++..||+|++......   ...+.+|+.+++.++||||+++++++..      +
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~   80 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ------E   80 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC------C
Confidence            4589999999999999999999975 5678999999755433   3457789999999999999999998732      3


Q ss_pred             eEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..++||||++ ++|.+++....  .+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            4899999995 79999987543  79999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....            
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------  227 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------  227 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc------------
Confidence            322 12234456788999999976 568899999999999999998 999998876655444432210            


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        .......+++.+.+||.+||+.||++|||+.++++
T Consensus       228 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          228 ------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              00112457889999999999999999999999876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.7e-46  Score=335.58  Aligned_cols=255  Identities=21%  Similarity=0.280  Sum_probs=197.6

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCC-CCc--EEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRE-TNE--KVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPS  101 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~-~g~--~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  101 (373)
                      ....++|++++.||+|+||.||+|.+.. +++  .||+|+++.... .......+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4456899999999999999999998643 333  699999875532 334456778999999999999999999998432


Q ss_pred             CCCCcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          102 HRRNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                            ..++||||+. ++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        94 ------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           94 ------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             ------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccc
Confidence                  3789999996 7999998764 5799999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          180 ARTSNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       180 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      +........   ......+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....     
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----  241 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG-----  241 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC-----
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC-----
Confidence            976643322   1233456788999999876 568899999999999999998 999998876655444432200     


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                              ........+++.+.++|.+||..||++|||+.+++++
T Consensus       242 ------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          242 ------------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             ------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                    0001124578899999999999999999999999873

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-46  Score=346.03  Aligned_cols=251  Identities=24%  Similarity=0.317  Sum_probs=194.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCC---cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETN---EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ..|++.+.||+|+||.||+|.+..++   ..||+|.++.. ........+.+|+.+++.++||||+++++++...    .
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~  163 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E  163 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence            35888999999999999999875433   46899998753 3334556788999999999999999999986432    2


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      +..++||||++ |+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            56899999997 6999999765 458999999999999999999999999999999999999999999999999997543


Q ss_pred             CCC----ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          185 GKN----QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       185 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      ...    .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...  .       
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~-------  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R-------  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--C-------
T ss_pred             ccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--C-------
Confidence            221    11234466788999999976 678999999999999999998 78999877655544333220  0       


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                           .......+++.+.++|.+||+.||++|||+.+++++
T Consensus       314 ---------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          314 ---------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 001124577889999999999999999999998874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=332.64  Aligned_cols=241  Identities=30%  Similarity=0.447  Sum_probs=191.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++...    .....+.+|+.+++.++||||+++++++.       +..
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~   74 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPV   74 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCc
Confidence            78999999999999999999875  789999998643    23456789999999999999999999873       237


Q ss_pred             EEEeecCC-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCceEEcCCCC-eEEcccCccc
Q 017334          110 YLVYELMD-TDLHQIIKSSQ---ALTNDHCQYFLFQLLRGLKYLHS---ANILHRDLKPGNLLVNANCD-LKICDFGLAR  181 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~Nill~~~~~-~kL~Dfg~a~  181 (373)
                      ++||||++ |+|.+++....   .++...+..++.||+.||+|||+   +||+||||||+|||++.++. +||+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            99999996 69999998654   47889999999999999999999   89999999999999999887 7999999997


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .....   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .......         
T Consensus       155 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~---------  220 (307)
T 2eva_A          155 DIQTH---MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI-MWAVHNG---------  220 (307)
T ss_dssp             -------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH-HHHHHTT---------
T ss_pred             ccccc---cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH-HHHHhcC---------
Confidence            54322   234578999999999976 578999999999999999999999997543222111 1000000         


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                        ........+++.+.+||.+||+.||++|||+.++++
T Consensus       221 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          221 ------------------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ------------------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                              001123457889999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.7e-46  Score=355.12  Aligned_cols=256  Identities=21%  Similarity=0.236  Sum_probs=202.6

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC-eeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN-VIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~  105 (373)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++.......    .+.+|+.+++.++|++ +..+..++     ..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~-----~~   74 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFG-----VE   74 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEE-----EE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEE-----ee
Confidence            46799999999999999999999999999999999886543322    3568999999998654 44444444     23


Q ss_pred             cceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCCeEEcccCccc
Q 017334          106 FKDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLAR  181 (373)
Q Consensus       106 ~~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill---~~~~~~kL~Dfg~a~  181 (373)
                      ....++||||++++|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+||||   +.++.+||+|||++.
T Consensus        75 ~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             CCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            367899999999999999975 5689999999999999999999999999999999999999   688999999999997


Q ss_pred             ccCCCCc-------cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          182 TSNGKNQ-------FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       182 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      .......       ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            6543221       1235689999999999987 5789999999999999999999999987654333332222111000


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .                       .....+...+++++.+||.+||+.||++||++.+|++
T Consensus       234 ~-----------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          234 A-----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             H-----------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             c-----------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            0                       0011122456788999999999999999999887654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-45  Score=352.13  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=202.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++.....   ...+.+|+.+++.++||||+++++++..      +
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~  251 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------E  251 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC------C
Confidence            45789999999999999999999874 467999999765433   3457899999999999999999999832      4


Q ss_pred             eEEEEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ..|+||||++ |+|.+++..  ...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            5899999996 699999964  3569999999999999999999999999999999999999999999999999997653


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......++..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+....+....+.....           
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------  399 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  399 (452)
T ss_dssp             -----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            321 12233456788999999976 578999999999999999998 9999988776655544432100           


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC--CCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ--HPYMS  320 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~--hp~~~  320 (373)
                                         ....+.+++.+.+||.+||+.||++|||+.++++  ..++.
T Consensus       400 -------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 -------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                               0112457888999999999999999999999987  35554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.2e-45  Score=335.68  Aligned_cols=263  Identities=24%  Similarity=0.309  Sum_probs=202.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccc--cChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF--ENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      ...|...+.||+|+||.||+|.+  +++.||+|++....  ........+.+|+.+++.++||||+++++++.     ..
T Consensus        30 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~  102 (307)
T 2nru_A           30 RPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DG  102 (307)
T ss_dssp             SBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred             ccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe-----cC
Confidence            34455569999999999999986  58899999987543  23344556789999999999999999999984     44


Q ss_pred             ceEEEEeecCC-ccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKS---SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      +..++||||++ ++|.+++..   ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  182 (307)
T 2nru_A          103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA  182 (307)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence            67999999995 799999863   34699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          183 SNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       183 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .....  .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.........+.........     
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  255 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK-----  255 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC-----
T ss_pred             cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh-----
Confidence            54322  22334578999999999865  4789999999999999999999999876544333333221111100     


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                          ....++..       .........+..+.++|.+||+.||++|||+.+++++
T Consensus       256 ----~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          256 ----TIEDYIDK-------KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             ----CHHHHSCS-------SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ----hhhhhccc-------cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                00111000       0011112245678999999999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=9.6e-47  Score=369.90  Aligned_cols=315  Identities=22%  Similarity=0.285  Sum_probs=222.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-CCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-RRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~  108 (373)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++.... ....+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            8999999999999999999999999999999998754 34445567889999999999999999999875421 123467


Q ss_pred             EEEEeecCC-ccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC---eEEcccCccc
Q 017334          109 VYLVYELMD-TDLHQIIKSSQ---ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCD---LKICDFGLAR  181 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~---~kL~Dfg~a~  181 (373)
                      .|+||||++ |+|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999995 69999998654   6999999999999999999999999999999999999998775   9999999998


Q ss_pred             ccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          182 TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..........   ............
T Consensus       173 ~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~  247 (676)
T 3qa8_A          173 ELDQG-ELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVY  247 (676)
T ss_dssp             BTTSC-CCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSC
T ss_pred             ccccc-cccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhh
Confidence            76433 23455689999999999876 67899999999999999999999999765322110000   000000000000


Q ss_pred             CChhHHHHHHhCCCCCC-CCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC---CCC----CCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPG-TPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY---DPS----SNPPAQV  333 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~---~~~----~~~~~~~  333 (373)
                      ....     ........ .......+.+++.+.+||.+||..||++|||+.++++||||..+.   ...    .......
T Consensus       248 ~~l~-----g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~kil~~f~~~~~~  322 (676)
T 3qa8_A          248 DDLT-----GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGR  322 (676)
T ss_dssp             CCCS-----SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCEEECCCSSSSC
T ss_pred             hhhc-----cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccccccccccccc
Confidence            0000     00000000 011223344678899999999999999999999999999996431   111    0111111


Q ss_pred             CCCCCcccccCHHHHHHHHHHH
Q 017334          334 PIDLDMDEESGEEMIREMMLKE  355 (373)
Q Consensus       334 ~~~~~~~~~~~~~~~~~~~~~e  355 (373)
                      ........+.....+++.+.++
T Consensus       323 ~~~~~i~~~~tl~~l~~~i~~~  344 (676)
T 3qa8_A          323 VHTYPVTENENLQNLKSWLQQD  344 (676)
T ss_dssp             CCEEECCTTCCHHHHHHHHHTT
T ss_pred             cceeecCCCccHHHHHHHHHHH
Confidence            1122344555666677766655

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.9e-46  Score=336.55  Aligned_cols=241  Identities=29%  Similarity=0.423  Sum_probs=188.4

Q ss_pred             ecCceeee-eeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHH-hhCCCCCeeeeceeecCCCCCC
Q 017334           28 IDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL-RHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        28 ~~~~Y~~~-~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +-++|.++ +.||+|+||.||+|.+..+|+.||+|++...       ....+|+.++ +.++||||+++++++.... ..
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~   86 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AG   86 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CC
Confidence            44778887 7899999999999999999999999998542       2355788887 5568999999999984321 22


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCCeEEcccCc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQ--ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL  179 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~---~~~~kL~Dfg~  179 (373)
                      ...+++||||++ |+|.+++....  .+++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            467999999996 59999998754  6999999999999999999999999999999999999998   78899999998


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      +....                       ...++.++|||||||++|+|++|.+||.+.........+..           
T Consensus       167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-----------  212 (299)
T 3m2w_A          167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-----------  212 (299)
T ss_dssp             CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-----------
T ss_pred             ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-----------
Confidence            86432                       13467899999999999999999999976542211100000           


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                  .............+..+++.+.+||.+||+.||++|||+.++++||||...
T Consensus       213 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          213 ------------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             ------------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             ------------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence                        000000000011124578999999999999999999999999999999764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=360.50  Aligned_cols=250  Identities=22%  Similarity=0.345  Sum_probs=200.8

Q ss_pred             ecCceeeee-eeeccCceEEEEEEeC--CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           28 IDTKYVPIK-PIGRGAYGIVCSSVNR--ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        28 ~~~~Y~~~~-~lg~G~~g~V~~a~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..++|.+.+ .||+|+||.||+|.++  .++..||||+++... .......+.+|+.+++.++||||+++++++..    
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----  407 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----  407 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----
Confidence            445666666 8999999999999875  356679999997653 22344568899999999999999999999832    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        +.+|+||||++ |+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       408 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          408 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             --SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             --CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence              34899999996 6999998754 5699999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCCcc---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      .......   .....+++.|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+..+....+....        
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~--------  556 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------  556 (613)
T ss_dssp             CC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC--------
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            5432211   122345688999999976 579999999999999999997 999999887666555443210        


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                            .....+.+++.+.+||.+||+.||++||++.++++
T Consensus       557 ----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          557 ----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ----------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  01123457899999999999999999999998754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-46  Score=356.15  Aligned_cols=253  Identities=16%  Similarity=0.168  Sum_probs=194.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCC-CCeeeece-----------
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQH-ENVIALKD-----------   96 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~~~~-----------   96 (373)
                      .+|+..+.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.++| .|...+..           
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            458889999999999999999999999999999874322 22224457789999999986 32211111           


Q ss_pred             ----------eecCCCCCCcceEEEEeecCCccHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 017334           97 ----------VMMPSHRRNFKDVYLVYELMDTDLHQIIKS-------SQALTNDHCQYFLFQLLRGLKYLHSANILHRDL  159 (373)
Q Consensus        97 ----------~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  159 (373)
                                ++..........++++|+++.++|.+++..       .+.+++..+..++.||+.||+|||++||+||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                      111111111245889999999999988841       235778889999999999999999999999999


Q ss_pred             CCCceEEcCCCCeEEcccCcccccCCCCccccceeeccccCchhhhh---------cCCCCCchhhhHHHHHHHHHHHhC
Q 017334          160 KPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL---------CCDNYGTSIDVWSVGCIFAELLGR  230 (373)
Q Consensus       160 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll~g  230 (373)
                      ||+|||++.++.+||+|||+++.....   ....+| +.|+|||++.         ....++.++|||||||++|+|++|
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            999999999999999999998765332   455677 9999999984         334578899999999999999999


Q ss_pred             CCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCH
Q 017334          231 KPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV  310 (373)
Q Consensus       231 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~  310 (373)
                      +.||.+.+.......+                                   ....+.+++.+.+||.+||+.||++||++
T Consensus       314 ~~Pf~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~  358 (413)
T 3dzo_A          314 DLPNTDDAALGGSEWI-----------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLP  358 (413)
T ss_dssp             SCCCCTTGGGSCSGGG-----------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCcchhhhHHHH-----------------------------------HhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence            9999765422111100                                   01124578899999999999999999999


Q ss_pred             HHHhCCCCCCC
Q 017334          311 TEALQHPYMSP  321 (373)
Q Consensus       311 ~eil~hp~~~~  321 (373)
                      .++++||||..
T Consensus       359 ~~~l~~~~~~~  369 (413)
T 3dzo_A          359 LQAMETPEYEQ  369 (413)
T ss_dssp             HHHTTSHHHHH
T ss_pred             HHHHhCHHHHH
Confidence            99999999964

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=338.53  Aligned_cols=277  Identities=21%  Similarity=0.262  Sum_probs=194.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      -++|++++.||+|+||.||+|.+  +|+.||||++.....   .......|+..+..++||||+++++.+..........
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            38999999999999999999976  689999999864321   1111223444455688999999998654333344567


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEEcCCCCeEEcccC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA---------NILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      +|+||||++ |+|.+++... ..++..++.++.||+.||+|||++         ||+||||||+|||++.++.+||+|||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            899999995 6999999764 458999999999999999999999         99999999999999999999999999


Q ss_pred             cccccCCC--------CccccceeeccccCchhhhhcC------CCCCchhhhHHHHHHHHHHHhCCC-CCCCCCchHHH
Q 017334          179 LARTSNGK--------NQFMTEYVVTRWYRAPELLLCC------DNYGTSIDVWSVGCIFAELLGRKP-IFPGTECLNQL  243 (373)
Q Consensus       179 ~a~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~  243 (373)
                      ++......        .......+||+.|+|||++.+.      ..++.++|||||||++|+|++|.. +|.+.......
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            99765322        1222345789999999998752      245678999999999999999964 45443322211


Q ss_pred             HHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccC---CCCCHHHHHHHHhhcCcCCCCCCCHHHHhC-----
Q 017334          244 KLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLY---PDAHPLAIDLLQKMLVFDPTKRISVTEALQ-----  315 (373)
Q Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~ll~~~L~~dP~~R~t~~eil~-----  315 (373)
                      ..+....+..+..       .............  ..+...+   ..+++.+.+||.+||+.||++|||+.++++     
T Consensus       246 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          246 MAFQTEVGNHPTF-------EDMQVLVSREKQR--PKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CTTHHHHCSSCCH-------HHHHHHHTTSCCC--CCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhhcccCCCchH-------HHHHhhhcccccC--CCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            1111111111000       0001111111111  1111111   124557999999999999999999999954     


Q ss_pred             -CCCCC
Q 017334          316 -HPYMS  320 (373)
Q Consensus       316 -hp~~~  320 (373)
                       ++|-+
T Consensus       317 l~~~~~  322 (336)
T 3g2f_A          317 MMIWER  322 (336)
T ss_dssp             HHCCCC
T ss_pred             HHHHHh
Confidence             67764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8e-46  Score=338.55  Aligned_cols=251  Identities=22%  Similarity=0.275  Sum_probs=199.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+..   .+|+|++............+.+|+.+++.++||||+++++++.     ...
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~  102 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SPP  102 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CSS
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence            45899999999999999999998863   4999999765433333334568999999999999999999984     346


Q ss_pred             eEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      .+++||||++ ++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            6999999996 69999997654 699999999999999999999999999999999999998 67999999999765421


Q ss_pred             -----CCccccceeeccccCchhhhhc--------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          186 -----KNQFMTEYVVTRWYRAPELLLC--------CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       186 -----~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                           .........|++.|+|||++.+        ...++.++|||||||++|+|++|..||.+.........+..... 
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-  260 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK-  260 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC-
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC-
Confidence                 1122334568999999999864        23578999999999999999999999987765544443322100 


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                           +       ......+++.+.++|.+||..||++|||+.++++.
T Consensus       261 ---------------------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          261 ---------------------P-------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             ---------------------C-------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             ---------------------C-------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                                 0       00112467789999999999999999999999873

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.7e-45  Score=333.26  Aligned_cols=269  Identities=20%  Similarity=0.318  Sum_probs=206.0

Q ss_pred             eecCceeeeeeeeccCceEEEEEE----eCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSV----NRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~----~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      ...++|++++.||+|+||.||+|+    +..+|+.||+|++...  .......+.+|+.+++.++||||+++++++....
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            456789999999999999999998    5678999999999753  3344556789999999999999999999885432


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA  180 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a  180 (373)
                         ...+++||||++ ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       116 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          116 ---RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             -----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ---CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence               246899999996 6999999875 46999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCcc---ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          181 RTSNGKNQF---MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       181 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      .........   .....++..|+|||++.+ ..++.++|||||||++|+|++|..||....     ....+..+......
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~  266 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQ  266 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTH
T ss_pred             hhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchh
Confidence            876433221   223456778999999876 568899999999999999999998875421     11112222211110


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ...   ......+.....      ......+++.+.+||.+||+.||++|||+.++++
T Consensus       267 ~~~---~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          267 MIV---FHLIELLKNNGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHH---HHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhH---HHHHHHhhcCCC------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            000   001111111110      1123567899999999999999999999999885

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-45  Score=336.66  Aligned_cols=260  Identities=24%  Similarity=0.311  Sum_probs=191.6

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhC--CCCCeeeeceeecCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL--QHENVIALKDVMMPSHRR  104 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~~~~~~~~~~~~  104 (373)
                      .+.++|++++.||+|+||.||+|.+.  |+.||||++....     .....+|.+++..+  +||||+++++++.... .
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGT-G  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-G
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-C
Confidence            45689999999999999999999875  8999999985432     12334555665554  8999999999985442 2


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEcCCCCeEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA--------NILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      ....+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++        ||+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            2267999999996 699999976 4799999999999999999999999        99999999999999999999999


Q ss_pred             ccCcccccCCCCcc----ccceeeccccCchhhhhcCCCCCc------hhhhHHHHHHHHHHHhC----------CCCCC
Q 017334          176 DFGLARTSNGKNQF----MTEYVVTRWYRAPELLLCCDNYGT------SIDVWSVGCIFAELLGR----------KPIFP  235 (373)
Q Consensus       176 Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~~DiwslG~il~~ll~g----------~~pf~  235 (373)
                      |||++.........    ....+||+.|+|||++.+. .++.      ++|||||||++|+|++|          ..||.
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999765432221    2345799999999999763 3333      49999999999999999          55554


Q ss_pred             CCCchH-HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHh
Q 017334          236 GTECLN-QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL  314 (373)
Q Consensus       236 ~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil  314 (373)
                      ...... ....+...                    .......+..+.......+++.+.+||.+||+.||++|||+.+++
T Consensus       264 ~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  323 (337)
T 3mdy_A          264 DLVPSDPSYEDMREI--------------------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK  323 (337)
T ss_dssp             TTSCSSCCHHHHHHH--------------------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hhcCCCCchhhhHHH--------------------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence            322110 00111110                    000000001111111123556799999999999999999999998


Q ss_pred             CC
Q 017334          315 QH  316 (373)
Q Consensus       315 ~h  316 (373)
                      +|
T Consensus       324 ~~  325 (337)
T 3mdy_A          324 KT  325 (337)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=341.65  Aligned_cols=247  Identities=17%  Similarity=0.214  Sum_probs=194.5

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEE-----EeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC---CCCeeeec
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSS-----VNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ---HENVIALK   95 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a-----~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~   95 (373)
                      ......++|++.+.||+|+||+||+|     .+..+++.||+|++....     ...+.+|+.+++.++   |+||++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            34445688999999999999999999     467789999999996542     224566777777776   99999999


Q ss_pred             eeecCCCCCCcceEEEEeecCC-ccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-
Q 017334           96 DVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS-----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-  168 (373)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-  168 (373)
                      +++..     .+..|+||||++ |+|.+++..     ...+++.+++.++.||+.||+|||++||+||||||+|||++. 
T Consensus       134 ~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~  208 (365)
T 3e7e_A          134 SAHLF-----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG  208 (365)
T ss_dssp             EEEEC-----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred             eeeec-----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence            99843     467899999996 799999973     467999999999999999999999999999999999999998 


Q ss_pred             ----------CCCeEEcccCcccccC--CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Q 017334          169 ----------NCDLKICDFGLARTSN--GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG  236 (373)
Q Consensus       169 ----------~~~~kL~Dfg~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  236 (373)
                                ++.+||+|||++....  .........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||..
T Consensus       209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                      8999999999996432  23344566789999999999987 5689999999999999999999999854


Q ss_pred             CCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          237 TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .....                .. .                ...+...  ..++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       288 ~~~~~----------------~~-~----------------~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          288 NEGGE----------------CK-P----------------EGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             EETTE----------------EE-E----------------CSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             CCCCc----------------ee-e----------------chhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            32100                00 0                0000111  235668899999999999999765555543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.1e-45  Score=354.47  Aligned_cols=252  Identities=24%  Similarity=0.352  Sum_probs=206.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++.....   ...+.+|+.+++.++||||+++++++..      +
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~------~  334 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE------E  334 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee------c
Confidence            45789999999999999999999874 467999999764433   3457899999999999999999999832      4


Q ss_pred             eEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+|+||||+. |+|.+++...  ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            5899999996 6999999743  569999999999999999999999999999999999999999999999999997653


Q ss_pred             CCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          185 GKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      ... .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....           
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------  482 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  482 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred             CCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            211 11123345778999999876 578999999999999999998 9999988776655544432100           


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC--CCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH--PYMS  320 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h--p~~~  320 (373)
                                         ......+++.+.+||.+||+.||++|||+.++++.  .+|.
T Consensus       483 -------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 -------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                               01124578889999999999999999999999873  4443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.4e-44  Score=353.97  Aligned_cols=250  Identities=25%  Similarity=0.361  Sum_probs=204.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|++... ........+.+|+.+++.++||||+++++++..    
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence            457899999999999999999998654   467999998654 233445578899999999999999999998732    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        +..|+||||++ |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       463 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          463 --NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             --CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence              35899999997 79999998654 689999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          183 SNGKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       183 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ..... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+....          
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~----------  609 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----------  609 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC----------
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC----------
Confidence            54322 12233456789999999976 578999999999999999996 999998877666555543310          


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                          .....+.+++.+.+||.+||..||++|||+.++++
T Consensus       610 --------------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          610 --------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                01123567889999999999999999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-46  Score=346.92  Aligned_cols=253  Identities=19%  Similarity=0.214  Sum_probs=187.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc------ChHHHHHHHHHHHHHhhCC---------CCCeee
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE------NRVDALRTLRELKLLRHLQ---------HENVIA   93 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------hpniv~   93 (373)
                      .++|++++.||+|+||+||+|++  +|+.||||++.....      .......+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            47899999999999999999988  689999999976532      1222345678888888775         656555


Q ss_pred             ecee-----------------ecCCC--------CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 017334           94 LKDV-----------------MMPSH--------RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLK  147 (373)
Q Consensus        94 ~~~~-----------------~~~~~--------~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~  147 (373)
                      +.++                 +....        ......+|+||||+. |++.+.+.. +.+++.+++.++.||+.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            5554                 32200        012478999999995 656555543 67899999999999999999


Q ss_pred             HHH-hCCccccCCCCCceEEcCCC--------------------CeEEcccCcccccCCCCccccceeeccccCchhhhh
Q 017334          148 YLH-SANILHRDLKPGNLLVNANC--------------------DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL  206 (373)
Q Consensus       148 ~LH-~~~ivH~Dlkp~Nill~~~~--------------------~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  206 (373)
                      ||| ++||+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|+|||++.
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhc
Confidence            999 99999999999999999987                    8999999999865432     458999999999998


Q ss_pred             cCCCCCchhhhHHHHHH-HHHHHhCCCCCCCCCchH-HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCcccc
Q 017334          207 CCDNYGTSIDVWSVGCI-FAELLGRKPIFPGTECLN-QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRL  284 (373)
Q Consensus       207 ~~~~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (373)
                      +. . +.++||||+|++ .++++.|..||.+..... ....+..                       ... .........
T Consensus       251 g~-~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~-----------------------~~~-~~~~~~~~~  304 (336)
T 2vuw_A          251 GD-G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK-----------------------QMT-FKTKCNTPA  304 (336)
T ss_dssp             CC-S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH-----------------------TCC-CSSCCCSHH
T ss_pred             CC-C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh-----------------------hhc-cCcccchhh
Confidence            64 3 889999998777 677889999884321111 1111111                       000 001111122


Q ss_pred             CCCCCHHHHHHHHhhcCcCCCCCCCHHHHh-CCCCCC
Q 017334          285 YPDAHPLAIDLLQKMLVFDPTKRISVTEAL-QHPYMS  320 (373)
Q Consensus       285 ~~~~s~~~~~ll~~~L~~dP~~R~t~~eil-~hp~~~  320 (373)
                      ++.+++++++||++||+.|     |+.|+| +||||+
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            2346788999999999987     999999 999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.5e-44  Score=329.51  Aligned_cols=261  Identities=22%  Similarity=0.297  Sum_probs=197.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhh--CCCCCeeeeceeecCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH--LQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~~~  104 (373)
                      .+.++|++.+.||+|+||.||+|.+  +|+.||||++....     ...+.+|+++++.  ++||||+++++++.... .
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~  110 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDN-G  110 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-S
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-C
Confidence            4568999999999999999999987  48999999986432     2356678888887  68999999999985542 2


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEEcCCCCeEEc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH--------SANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      ....+|+||||++ |+|.+++.. ..+++.+++.++.||+.||+|||        ++||+||||||+|||++.++.+||+
T Consensus       111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred             ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence            2247999999997 599999976 57999999999999999999999        8999999999999999999999999


Q ss_pred             ccCcccccCCCCc----cccceeeccccCchhhhhcCCC-----CCchhhhHHHHHHHHHHHhC----------CCCCCC
Q 017334          176 DFGLARTSNGKNQ----FMTEYVVTRWYRAPELLLCCDN-----YGTSIDVWSVGCIFAELLGR----------KPIFPG  236 (373)
Q Consensus       176 Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~ll~g----------~~pf~~  236 (373)
                      |||++........    ......||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||..
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~  269 (342)
T 1b6c_B          190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  269 (342)
T ss_dssp             CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence            9999976543322    2345578999999999876322     23689999999999999999          667755


Q ss_pred             CCchH-HHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          237 TECLN-QLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       237 ~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      ..... ....+.....                    .....+..+..-....+++.+.+||.+||+.||++|||+.++++
T Consensus       270 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          270 LVPSDPSVEEMRKVVC--------------------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             TSCSSCCHHHHHHHHT--------------------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cCcCcccHHHHHHHHH--------------------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            42111 1111111100                    00000000000001223457899999999999999999999987


Q ss_pred             C
Q 017334          316 H  316 (373)
Q Consensus       316 h  316 (373)
                      |
T Consensus       330 ~  330 (342)
T 1b6c_B          330 T  330 (342)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-43  Score=319.36  Aligned_cols=230  Identities=13%  Similarity=0.041  Sum_probs=186.9

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .+.++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.++..++||||+++++++     ..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~  102 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HT  102 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EE
Confidence            5678999999999999999999999999999999999866443 44556788999999999999999999998     44


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+..|+||||++ ++|.++++.  .....++..++.||+.||+|||++||+||||||+|||++.++.+||+++|      
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             CCcEEEEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            467999999997 699999864  34667889999999999999999999999999999999999999998554      


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                                    |++        .++.++|||||||++|+|++|+.||.+.+..+.+....                 
T Consensus       175 --------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-----------------  215 (286)
T 3uqc_A          175 --------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-----------------  215 (286)
T ss_dssp             --------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-----------------
T ss_pred             --------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-----------------
Confidence                          232        37889999999999999999999998765322110000                 


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                             ..............+.+++.+.+||.+||+.||++| |+.++++.
T Consensus       216 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          216 -------RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             -------BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             -------HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence                   000000111223456789999999999999999999 99998873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-44  Score=361.38  Aligned_cols=248  Identities=21%  Similarity=0.303  Sum_probs=200.0

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCC-CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRE-TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~-~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      ..+.++|++++.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+++.++||||+++++++......
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            4577999999999999999999999976 7899999998653 2334455678999999999999999999998654322


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .....|+||||++ ++|.+++..  .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++...
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            2234799999997 588887754  79999999999999999999999999999999999999885 9999999999876


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ...    ...+||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+.....          .+        . 
T Consensus       232 ~~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~--------~-  286 (681)
T 2pzi_A          232 NSF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP--------E-  286 (681)
T ss_dssp             TCC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CC--------T-
T ss_pred             ccC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc----------cc--------c-
Confidence            433    445799999999998763  5899999999999999999999986532100          00        0 


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                    ..+    ....++.+.+||.+||+.||++||+..+.+.|+|+.
T Consensus       287 --------------~~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          287 --------------DDP----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             --------------TCH----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             --------------ccc----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                          000    011346789999999999999999999888888763

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.8e-37  Score=303.20  Aligned_cols=187  Identities=20%  Similarity=0.120  Sum_probs=136.2

Q ss_pred             eeeccCceEEEEEEeCCCCcEEEEEEcccccc--------ChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCcc
Q 017334           37 PIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--------NRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        37 ~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++.|++|.+..++....|+.|++|++.+...        ......++.+|+++|+++ .|+||+++++++     ++.+
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            46788888888888888999999999975421        233445678999999999 599999999999     6668


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+||||||++ ++|.++|...+++++.   .|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            8999999997 5999999998888765   47899999999999999999999999999999999999999999877665


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCC
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPI  233 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  233 (373)
                      .....+.+||+.|+|||++.+  .+..++|+||+|++++++.++..+
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             CccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence            556677899999999999976  367789999999998887665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=6e-30  Score=248.70  Aligned_cols=186  Identities=20%  Similarity=0.264  Sum_probs=139.0

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC------hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN------RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      +...+.||+|+||.||+|.  ..+..+++|+.......      .....++.+|+++++.++||||+++..+....    
T Consensus       338 ~~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----  411 (540)
T 3en9_A          338 KIPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL----  411 (540)
T ss_dssp             ----------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET----
T ss_pred             CCCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC----
Confidence            3456789999999999994  45788999986433211      12234578999999999999999554444322    


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                       ...|+||||++ ++|.+++..        +..++.||+.||+|||++||+||||||+|||++.  ++||+|||+++...
T Consensus       412 -~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          412 -DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             -TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             -CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence             34699999996 799999875        5689999999999999999999999999999999  99999999998764


Q ss_pred             CCCc-------cccceeeccccCchhhhhc-CCCCCchhhhHHHHHHHHHHHhCCCCC
Q 017334          185 GKNQ-------FMTEYVVTRWYRAPELLLC-CDNYGTSIDVWSVGCIFAELLGRKPIF  234 (373)
Q Consensus       185 ~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf  234 (373)
                      ....       .....+||+.|+|||++.. ...|+..+|+||..+-..+...++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            4221       1246789999999999864 134778899999988887777666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=5.8e-27  Score=209.50  Aligned_cols=147  Identities=20%  Similarity=0.182  Sum_probs=116.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh----------------HHHHHHHHHHHHHhhCCCCCeee
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR----------------VDALRTLRELKLLRHLQHENVIA   93 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~hpniv~   93 (373)
                      ..|.+.+.||+|+||.||+|.+ .+|+.||+|+++......                .....+.+|+.+++.++  | ++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            4556669999999999999999 889999999996432111                13456789999999999  5 66


Q ss_pred             eceeecCCCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334           94 LKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                      +.+++..      +..|+||||++ ++|.+ +      ...+...++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus       166 v~~~~~~------~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v  231 (282)
T 1zar_A          166 VPKVYAW------EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI  231 (282)
T ss_dssp             SCCEEEE------ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred             cCeEEec------cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence            6665521      45699999996 58876 3      2234567999999999999999999999999999999 9999


Q ss_pred             EEcccCcccccCCCCccccceeeccccCchhhhhc
Q 017334          173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLC  207 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (373)
                      ||+|||+|..             +..++|||.+..
T Consensus       232 kl~DFG~a~~-------------~~~~~a~e~l~r  253 (282)
T 1zar_A          232 WIIDFPQSVE-------------VGEEGWREILER  253 (282)
T ss_dssp             EECCCTTCEE-------------TTSTTHHHHHHH
T ss_pred             EEEECCCCeE-------------CCCCCHHHHHHH
Confidence            9999999853             345789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.90  E-value=2.1e-23  Score=184.13  Aligned_cols=140  Identities=17%  Similarity=0.123  Sum_probs=109.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcE--EEEEEccccccC----------------------hHHHHHHHHHHHHHhh
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEK--VAIKKINNAFEN----------------------RVDALRTLRELKLLRH   85 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~--~aiK~~~~~~~~----------------------~~~~~~~~~E~~~l~~   85 (373)
                      .-|.+.+.||+|+||.||+|.+..+|+.  ||||+++.....                      ......+.+|+.+++.
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3478899999999999999999778999  999987543211                      0112356789999999


Q ss_pred             CCCCCe--eeeceeecCCCCCCcceEEEEeecCC--c----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccc
Q 017334           86 LQHENV--IALKDVMMPSHRRNFKDVYLVYELMD--T----DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH-SANILH  156 (373)
Q Consensus        86 l~hpni--v~~~~~~~~~~~~~~~~~~lv~e~~~--g----~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH  156 (373)
                      +.|+++  +.+++.         ...++||||++  |    +|.++...   .++.++..++.||+.||.||| +.||+|
T Consensus       127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH  194 (258)
T 1zth_A          127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH  194 (258)
T ss_dssp             HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred             HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            987764  233322         34689999995  3    67665432   346678899999999999999 999999


Q ss_pred             cCCCCCceEEcCCCCeEEcccCccccc
Q 017334          157 RDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       157 ~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.81  E-value=1.1e-19  Score=166.95  Aligned_cols=137  Identities=16%  Similarity=0.170  Sum_probs=98.9

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc---------------ChHH-----HHHHHHHHHHHhhCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE---------------NRVD-----ALRTLRELKLLRHLQHE   89 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~---------------~~~~-----~~~~~~E~~~l~~l~hp   89 (373)
                      .-|.+.+.||.|++|.||+|.+. +|+.||||+++....               ....     .....+|...|.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34999999999999999999985 699999998753211               0001     01123566677666544


Q ss_pred             Cee--eeceeecCCCCCCcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017334           90 NVI--ALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLV  166 (373)
Q Consensus        90 niv--~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill  166 (373)
                      ++.  ..++.         ...+|||||++| +|.++      ....+...++.||+.+|.+||++|||||||||.|||+
T Consensus       174 gv~vp~p~~~---------~~~~LVME~i~G~~L~~l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl  238 (397)
T 4gyi_A          174 GFPVPEPIAQ---------SRHTIVMSLVDALPMRQV------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILI  238 (397)
T ss_dssp             TCSCCCEEEE---------ETTEEEEECCSCEEGGGC------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred             CCCCCeeeec---------cCceEEEEecCCccHhhh------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEE
Confidence            332  22222         123799999986 66432      2233567789999999999999999999999999999


Q ss_pred             cCCCC----------eEEcccCcccc
Q 017334          167 NANCD----------LKICDFGLART  182 (373)
Q Consensus       167 ~~~~~----------~kL~Dfg~a~~  182 (373)
                      +.++.          +.|+||+.+..
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             eCCCCcccccccccceEEEEeCCccc
Confidence            88773          89999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=2.1e-13  Score=120.21  Aligned_cols=138  Identities=17%  Similarity=0.123  Sum_probs=105.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..|++...++.|+.+.||++...  |..+++|+........  ...+.+|+.+++.+. +..+++++++..     ..+.
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~   84 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW   84 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCc
Confidence            46889999999999999999754  6789999986432111  124668999999885 677778888773     3467


Q ss_pred             EEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 017334          109 VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS------------------------------------  151 (373)
Q Consensus       109 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~------------------------------------  151 (373)
                      .|+|||+++| +|.+.+     .+......++.++..+|..||+                                    
T Consensus        85 ~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             eEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            8999999987 776542     1223345788999999999998                                    


Q ss_pred             -----------------------CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 -----------------------ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 -----------------------~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                                             ..++|+|++|.|||++.++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                   348999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=4.3e-12  Score=111.37  Aligned_cols=133  Identities=16%  Similarity=0.053  Sum_probs=93.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC--eeeeceeecCCCCCCcc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN--VIALKDVMMPSHRRNFK  107 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~~~  107 (373)
                      ..|.+....+.|..+.||++.. .+|..+++|+......     ..+.+|+.+++.+.+.+  +.+++.+..     ..+
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~-----~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~   88 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVT-----EAG   88 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSS
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccc-----hhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCC
Confidence            4566554445666799999964 4677899998754311     23557888888886434  455777663     235


Q ss_pred             eEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 017334          108 DVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN---------------------------------  153 (373)
Q Consensus       108 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---------------------------------  153 (373)
                      ..++||||++| +| + .   ....   ...++.+++.+|..||+..                                 
T Consensus        89 ~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           89 RDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             CEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             CCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            68999999986 55 3 1   1111   2356778888888888753                                 


Q ss_pred             -------------------------ccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          154 -------------------------ILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       154 -------------------------ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                                               ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                     9999999999999877667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=2.7e-11  Score=111.69  Aligned_cols=144  Identities=14%  Similarity=0.188  Sum_probs=103.3

Q ss_pred             eeeeeeeccCceEEEEEEeCCCCcEEEEEEcc--ccccChHHHHHHHHHHHHHhhCC--CCCeeeeceeecCCCCCCcce
Q 017334           33 VPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRHLQ--HENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        33 ~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~--~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ..++.|+.|.++.||++...  +..+++|+..  .... ......+.+|+.+++.+.  +..+++++..+...  ...+.
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~  115 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGR  115 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSS
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCC
Confidence            34677899999999998764  4678999875  2211 112235668999999987  45577777776332  22255


Q ss_pred             EEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 017334          109 VYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS------------------------------------  151 (373)
Q Consensus       109 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~------------------------------------  151 (373)
                      .|+||||++| .+.+.  .-..++..+...++.+++.+|..||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            8999999987 44221  11346788888999999999999997                                    


Q ss_pred             ----------------------CCccccCCCCCceEEcCCCC--eEEcccCccccc
Q 017334          152 ----------------------ANILHRDLKPGNLLVNANCD--LKICDFGLARTS  183 (373)
Q Consensus       152 ----------------------~~ivH~Dlkp~Nill~~~~~--~kL~Dfg~a~~~  183 (373)
                                            ..++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                  35899999999999998764  699999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.25  E-value=1.1e-11  Score=111.68  Aligned_cols=183  Identities=19%  Similarity=0.215  Sum_probs=118.2

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCC--eeeeceeecCCCCCCcceEEE
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HEN--VIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~~~~~~~~~l  111 (373)
                      ++.++.|....||++.     ..+++|+....    .....+.+|..+++.+. +..  +.+++.....  .......|+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceE
Confidence            4568999999999863     46899986432    33446778999998874 333  3333333211  122234689


Q ss_pred             EeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 017334          112 VYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS---------------------------------------  151 (373)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---------------------------------------  151 (373)
                      ||++++| ++.+...  ..++..+...++.+++..|+.||+                                       
T Consensus        94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            9999987 5543322  356777888888888888888886                                       


Q ss_pred             -------------------CCccccCCCCCceEEcC--CCCeEEcccCcccccCCCCccccceeecccc---Cchhhhh-
Q 017334          152 -------------------ANILHRDLKPGNLLVNA--NCDLKICDFGLARTSNGKNQFMTEYVVTRWY---RAPELLL-  206 (373)
Q Consensus       152 -------------------~~ivH~Dlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y---~aPE~~~-  206 (373)
                                         ..++|+|++|.||+++.  .+.+.|+||+.+...........    ...+   ..|+... 
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~----~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS----LMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT----TCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH----HHhhccccCHHHHHH
Confidence                               13699999999999998  45688999998865422111000    0001   2222211 


Q ss_pred             ---cCCC---------CCchhhhHHHHHHHHHHHhCCCCC
Q 017334          207 ---CCDN---------YGTSIDVWSVGCIFAELLGRKPIF  234 (373)
Q Consensus       207 ---~~~~---------~~~~~DiwslG~il~~ll~g~~pf  234 (373)
                         ....         .....+.|++|.+++.+.+|.++|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               0000         122368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.78  E-value=1.3e-07  Score=84.99  Aligned_cols=134  Identities=22%  Similarity=0.225  Sum_probs=89.6

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCC---CeeeeceeecCCCCCCcceEEE
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHE---NVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~~~~~~~~~~~~l  111 (373)
                      ++.++.|....||+.     |..+++|+...    ......+.+|..+|+.+.+.   .+.+++.+...    ..+..++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEE
Confidence            566888988899988     56789998532    22344677899999999742   24444444421    1245789


Q ss_pred             EeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 017334          112 VYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA--------------------------------------  152 (373)
Q Consensus       112 v~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------------------------------------  152 (373)
                      |||+++| .+.+...  ..++..+...+..++...|..||+.                                      
T Consensus        91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            9999987 5544221  2344555555555555555555532                                      


Q ss_pred             ----------------------CccccCCCCCceEEcC---CCCe-EEcccCccccc
Q 017334          153 ----------------------NILHRDLKPGNLLVNA---NCDL-KICDFGLARTS  183 (373)
Q Consensus       153 ----------------------~ivH~Dlkp~Nill~~---~~~~-kL~Dfg~a~~~  183 (373)
                                            .++|+|++|.|||++.   ++.+ .|+||+.+...
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                  3589999999999987   4564 89999988654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.72  E-value=2.4e-07  Score=81.43  Aligned_cols=131  Identities=18%  Similarity=0.199  Sum_probs=90.7

Q ss_pred             eeeccCce-EEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCcceEEEEee
Q 017334           37 PIGRGAYG-IVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYLVYE  114 (373)
Q Consensus        37 ~lg~G~~g-~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~lv~e  114 (373)
                      .+..|..| .||+......+..+++|+-...     ....+.+|...|+.+. +-.+.+++.+.     ++.+..++|||
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme  100 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTT  100 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEE
Confidence            34445444 7999888777888999986432     2335668999998885 43456666666     33367899999


Q ss_pred             cCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 017334          115 LMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA-----------------------------------------  152 (373)
Q Consensus       115 ~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----------------------------------------  152 (373)
                      +++| ++.+....    ...+...+..++...|.-||+.                                         
T Consensus       101 ~l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          101 AIPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CCCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             eeCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            9987 66554432    1223345566666666666641                                         


Q ss_pred             -----------------CccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          153 -----------------NILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       153 -----------------~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                                       .++|+|+++.|||++.++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                             15899999999999987767799999775

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.44  E-value=1.1e-06  Score=81.93  Aligned_cols=78  Identities=17%  Similarity=0.092  Sum_probs=46.9

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc--C---hHHHHHHHHHHHHHhhCCC--CC-eeeeceeecCCCCCC
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE--N---RVDALRTLRELKLLRHLQH--EN-VIALKDVMMPSHRRN  105 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--pn-iv~~~~~~~~~~~~~  105 (373)
                      .++.||.|..+.||++....+++.+++|.......  .   .....+...|..+++.+..  +. +.+++.+.  .    
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~----  107 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T----  107 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence            46679999999999998766678899998642211  0   0112245678888887742  33 33444332  1    


Q ss_pred             cceEEEEeecCCc
Q 017334          106 FKDVYLVYELMDT  118 (373)
Q Consensus       106 ~~~~~lv~e~~~g  118 (373)
                       ...++|||+++|
T Consensus       108 -~~~~lvmE~l~g  119 (397)
T 2olc_A          108 -EMAVTVMEDLSH  119 (397)
T ss_dssp             -TTTEEEECCCTT
T ss_pred             -CccEEEEEeCCC
Confidence             235799999975

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.34  E-value=9.1e-06  Score=73.69  Aligned_cols=30  Identities=27%  Similarity=0.449  Sum_probs=27.3

Q ss_pred             CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.11  E-value=5.2e-05  Score=63.06  Aligned_cols=98  Identities=14%  Similarity=0.086  Sum_probs=66.8

Q ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCccccceeec
Q 017334          119 DLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLH-SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVT  196 (373)
Q Consensus       119 ~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  196 (373)
                      +|.++|.. ..+++|.++|.++.|.+.+|.-+- .+.-..+=+.|..|++..+|+|.+.+ ..+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            78999875 468999999999999999988762 22212334567999999999998875 2111            112


Q ss_pred             cccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCC
Q 017334          197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK  231 (373)
Q Consensus       197 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  231 (373)
                      ..+.|||...  ...+.+.-|+|||+++|..+--.
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            3456888763  34678899999999999998433

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.07  E-value=1.7e-05  Score=72.59  Aligned_cols=84  Identities=8%  Similarity=0.096  Sum_probs=50.1

Q ss_pred             eeeeee-eccCceEEEEEEeC--C----CCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCC-C--CCeeeeceeecCC
Q 017334           33 VPIKPI-GRGAYGIVCSSVNR--E----TNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQ-H--ENVIALKDVMMPS  101 (373)
Q Consensus        33 ~~~~~l-g~G~~g~V~~a~~~--~----~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~  101 (373)
                      ..++.| +.|..+.+|++...  .    ++..+++|+...... .......+.+|+.+++.+. +  -.+.+++.+....
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88888999987643  0    256899998654320 0000123456888877774 3  3456666665322


Q ss_pred             CCCCcceEEEEeecCCc
Q 017334          102 HRRNFKDVYLVYELMDT  118 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~g  118 (373)
                        ...+..++|||+++|
T Consensus       103 --~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 --DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             --TTTSSCEEEEECCCC
T ss_pred             --CccCCceEEEEecCC
Confidence              112456899999976

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=4.5e-05  Score=71.41  Aligned_cols=33  Identities=18%  Similarity=0.405  Sum_probs=28.6

Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       150 H~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      +...++|+|++|.|||++.++ ++|+||+.+...
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            456799999999999998876 999999988654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.92  E-value=0.00011  Score=65.51  Aligned_cols=30  Identities=20%  Similarity=0.207  Sum_probs=25.4

Q ss_pred             CccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          153 NILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       153 ~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .++|+|+.|.||| ..++.+.|+||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            3899999999999 56678999999987643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.79  E-value=0.00014  Score=65.03  Aligned_cols=73  Identities=14%  Similarity=0.047  Sum_probs=52.5

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC---CCCeeeeceeecCCCCCCcceEE
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ---HENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      -++.|+.|....+|+...  ++..+++|+....     ....+.+|...|+.+.   ...+++++....     ..+..+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~  107 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSF  107 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceE
Confidence            356799999999999875  4678999986532     1334667888888774   355667776652     235689


Q ss_pred             EEeecCCc
Q 017334          111 LVYELMDT  118 (373)
Q Consensus       111 lv~e~~~g  118 (373)
                      +|||+++|
T Consensus       108 lvme~l~G  115 (312)
T 3jr1_A          108 LLLEALNK  115 (312)
T ss_dssp             EEEECCCC
T ss_pred             EEEEeccC
Confidence            99999975

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.66  E-value=0.00018  Score=66.12  Aligned_cols=135  Identities=15%  Similarity=0.202  Sum_probs=78.5

Q ss_pred             eeeeeccCceEEEEEEeCC-------CCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCc
Q 017334           35 IKPIGRGAYGIVCSSVNRE-------TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~-------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~  106 (373)
                      ++.|..|-...+|++....       ++..|++|+.......   .....+|..+++.+. +.-..+++..+     .+ 
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~-  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG---VDSLVLESVMFAILAERSLGPQLYGVF-----PE-  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC---HHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT-
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch---HHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC-
Confidence            4567778888999987642       3578999986432111   223457888888775 33235566555     22 


Q ss_pred             ceEEEEeecCCc-cHH--------------HHH---Hhc-----CCCC--HHHHHHHHHHHHH-----------------
Q 017334          107 KDVYLVYELMDT-DLH--------------QII---KSS-----QALT--NDHCQYFLFQLLR-----------------  144 (373)
Q Consensus       107 ~~~~lv~e~~~g-~L~--------------~~l---~~~-----~~~~--~~~~~~i~~qi~~-----------------  144 (373)
                         .+||||++| .|.              +.+   ...     +...  ..++..++.++..                 
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               289999976 221              111   111     1111  3556666655422                 


Q ss_pred             --HHHHHH----hC----CccccCCCCCceEEcCC----CCeEEcccCccc
Q 017334          145 --GLKYLH----SA----NILHRDLKPGNLLVNAN----CDLKICDFGLAR  181 (373)
Q Consensus       145 --aL~~LH----~~----~ivH~Dlkp~Nill~~~----~~~kL~Dfg~a~  181 (373)
                        .+..|.    ..    .++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              233332    22    48999999999999887    789999998774

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.56  E-value=0.00059  Score=63.93  Aligned_cols=72  Identities=17%  Similarity=0.139  Sum_probs=47.0

Q ss_pred             eeeeeeccCceEEEEEEeCC-------CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC-eeeeceeecCCCCCC
Q 017334           34 PIKPIGRGAYGIVCSSVNRE-------TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN-VIALKDVMMPSHRRN  105 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~-------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~  105 (373)
                      -++.|+.|....||++....       ++..+++|+.... ..   ...+.+|..+++.+...+ .+++++.+     .+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIF-----SG  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC
Confidence            45678888889999997642       2578999988432 11   123446888888875323 35566554     21


Q ss_pred             cceEEEEeecCCc
Q 017334          106 FKDVYLVYELMDT  118 (373)
Q Consensus       106 ~~~~~lv~e~~~g  118 (373)
                          .+|+||++|
T Consensus       148 ----g~v~e~l~G  156 (429)
T 1nw1_A          148 ----GRLEEYIPS  156 (429)
T ss_dssp             ----EEEECCCCE
T ss_pred             ----CEEEEEeCC
Confidence                289999976

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.54  E-value=0.00024  Score=64.09  Aligned_cols=32  Identities=28%  Similarity=0.401  Sum_probs=27.6

Q ss_pred             CCccccCCCCCceEEcCC----CCeEEcccCccccc
Q 017334          152 ANILHRDLKPGNLLVNAN----CDLKICDFGLARTS  183 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~----~~~kL~Dfg~a~~~  183 (373)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999875    67999999988654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.43  E-value=0.0021  Score=57.64  Aligned_cols=140  Identities=16%  Similarity=0.145  Sum_probs=76.4

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCC--CCeeeeceeecCCC--CCCcceEE
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH--ENVIALKDVMMPSH--RRNFKDVY  110 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~--~~~~~~~~  110 (373)
                      +..|+ |....||++.. .+|+.+++|+.......   ...+..|..+++.+..  -.+++++..  ...  ....+..+
T Consensus        31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~  103 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYF  103 (328)
T ss_dssp             CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEE
T ss_pred             EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEE
Confidence            34566 77889998754 34667999998633222   2244567777777742  123444433  110  01134678


Q ss_pred             EEeecCCc-cH-----H------HHH---H---hcC------CCCHHHH----------------------HHHHHHHHH
Q 017334          111 LVYELMDT-DL-----H------QII---K---SSQ------ALTNDHC----------------------QYFLFQLLR  144 (373)
Q Consensus       111 lv~e~~~g-~L-----~------~~l---~---~~~------~~~~~~~----------------------~~i~~qi~~  144 (373)
                      ++|++++| .+     .      ..+   +   ...      ..+....                      ...+.+++.
T Consensus       104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  183 (328)
T 1zyl_A          104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA  183 (328)
T ss_dssp             EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence            89999976 21     1      111   1   000      1111110                      111122222


Q ss_pred             HHHHH----HhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          145 GLKYL----HSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       145 aL~~L----H~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .+.-+    ....++|+|+++.|||++ + .+.|+||+.+...
T Consensus       184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            22222    234589999999999999 4 8999999877543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.42  E-value=0.00052  Score=61.53  Aligned_cols=142  Identities=15%  Similarity=0.099  Sum_probs=74.3

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC--eeeeceeecCCC-CCCcceEE
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN--VIALKDVMMPSH-RRNFKDVY  110 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~-~~~~~~~~  110 (373)
                      -++.|+.|....+|++... +| .+++|+......    ...+..|+.+++.+...+  +.+++....... ....+..+
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            4567888888899998753 33 688998865211    113445777776664212  233332110000 01124578


Q ss_pred             EEeecCCcc-H-----------HHHH---Hh-cCCC--------CHHHHHH---------------HHHHHHHHHHHHHh
Q 017334          111 LVYELMDTD-L-----------HQII---KS-SQAL--------TNDHCQY---------------FLFQLLRGLKYLHS  151 (373)
Q Consensus       111 lv~e~~~g~-L-----------~~~l---~~-~~~~--------~~~~~~~---------------i~~qi~~aL~~LH~  151 (373)
                      +++++++|. +           ...+   +. ...+        ....-..               +-..+...++.+.+
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999762 1           0111   11 0111        0000000               00113344555542


Q ss_pred             -------CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 -------ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 -------~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                             .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                   369999999999999887656899998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.40  E-value=0.0015  Score=57.60  Aligned_cols=76  Identities=13%  Similarity=-0.007  Sum_probs=50.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCC---CCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH---ENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~~~~~~~  106 (373)
                      ....-++.+|.|..+.||++.. .+|+.|++|+........  ...+.+|...|+.+.-   -.+++++...        
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--------   83 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD--------   83 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence            3455678899999999999975 478899999865332211  1134578888888742   2233444332        


Q ss_pred             ceEEEEeecCC
Q 017334          107 KDVYLVYELMD  117 (373)
Q Consensus       107 ~~~~lv~e~~~  117 (373)
                       .-++|||+++
T Consensus        84 -~~~lv~e~l~   93 (288)
T 3f7w_A           84 -DRTLAMEWVD   93 (288)
T ss_dssp             -TTEEEEECCC
T ss_pred             -CceEEEEeec
Confidence             2378999985

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.29  E-value=0.0021  Score=60.64  Aligned_cols=73  Identities=19%  Similarity=0.183  Sum_probs=45.9

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCe-eeeceeecCCCCCCcceEEEE
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV-IALKDVMMPSHRRNFKDVYLV  112 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~~~~~~lv  112 (373)
                      -++.|+.|-...+|++.....+..+++|+.........   ...+|..+++.|...++ +++++.+     .+    ..|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i---dR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v  179 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII---NREREKKISCILYNKNIAKKIYVFF-----TN----GRI  179 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS---CHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc---CHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEE
Confidence            35678888889999998764457899998754321111   12468888888874444 4566655     11    259


Q ss_pred             eecCCc
Q 017334          113 YELMDT  118 (373)
Q Consensus       113 ~e~~~g  118 (373)
                      +||++|
T Consensus       180 ~e~I~G  185 (458)
T 2qg7_A          180 EEFMDG  185 (458)
T ss_dssp             EECCCS
T ss_pred             EEeeCC
Confidence            999975

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.27  E-value=0.0017  Score=59.40  Aligned_cols=72  Identities=13%  Similarity=0.137  Sum_probs=41.0

Q ss_pred             eeeeeccCceEEEEEEeCC--------CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCC-eeeeceeecCCCCCC
Q 017334           35 IKPIGRGAYGIVCSSVNRE--------TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN-VIALKDVMMPSHRRN  105 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~--------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~  105 (373)
                      ++.|+.|....+|++....        .+..+++|+........   .....|..+++.+...+ ..+++...     . 
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~---~~~~~E~~~l~~L~~~g~~P~~~~~~-----~-  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL---YNTISEFEVYKTMSKYKIAPQLLNTF-----N-  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT---SCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce---ecHHHHHHHHHHHHhcCCCCceEEec-----C-
Confidence            5667888888999987653        13689999875432111   11246777777775222 34555443     1 


Q ss_pred             cceEEEEeecCCc
Q 017334          106 FKDVYLVYELMDT  118 (373)
Q Consensus       106 ~~~~~lv~e~~~g  118 (373)
                         -++||||++|
T Consensus       109 ---~~~v~e~i~G  118 (369)
T 3c5i_A          109 ---GGRIEEWLYG  118 (369)
T ss_dssp             ---TEEEEECCCS
T ss_pred             ---CcEEEEEecC
Confidence               1689999976

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.23  E-value=0.0017  Score=58.81  Aligned_cols=32  Identities=25%  Similarity=0.385  Sum_probs=27.9

Q ss_pred             CCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          152 ANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            35899999999999998889999999877543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.74  E-value=0.0059  Score=56.84  Aligned_cols=73  Identities=12%  Similarity=0.064  Sum_probs=44.8

Q ss_pred             eeeeeeccCceEEEEEEeCCC-------CcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCC
Q 017334           34 PIKPIGRGAYGIVCSSVNRET-------NEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRN  105 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~-------g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  105 (373)
                      -++.|..|-...+|++.....       +..|++|+.........   ...+|..+++.+. +.-..++++.+     . 
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i---dR~~E~~~l~~L~~~gi~P~l~~~~-----~-  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY---DSKVELDVFRYLSNINIAPNIIADF-----P-  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC---CHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc---CHHHHHHHHHHHHhcCCCCCEEEEc-----C-
Confidence            356677788889999876521       57899998754221111   1236777777775 22234455433     1 


Q ss_pred             cceEEEEeecCCc
Q 017334          106 FKDVYLVYELMDT  118 (373)
Q Consensus       106 ~~~~~lv~e~~~g  118 (373)
                         -+.|+||++|
T Consensus       145 ---~~~I~efI~G  154 (424)
T 3mes_A          145 ---EGRIEEFIDG  154 (424)
T ss_dssp             ---TEEEEECCCS
T ss_pred             ---CCEEEEEeCC
Confidence               2688999976

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.88  E-value=0.055  Score=49.96  Aligned_cols=28  Identities=29%  Similarity=0.535  Sum_probs=24.0

Q ss_pred             ccccCCCCCceEE------cCCCCeEEcccCccc
Q 017334          154 ILHRDLKPGNLLV------NANCDLKICDFGLAR  181 (373)
Q Consensus       154 ivH~Dlkp~Nill------~~~~~~kL~Dfg~a~  181 (373)
                      ++|+|+.+.|||+      +.+..+.++||.+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999999      345679999999875

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.12  E-value=0.023  Score=53.56  Aligned_cols=62  Identities=10%  Similarity=0.030  Sum_probs=16.8

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEE------EEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceee
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAI------KKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVM   98 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~ai------K~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   98 (373)
                      +.+.||   ||.||++....+..+||+      |..+...........+.+|..+++.++|||+++.+.+.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            445665   999999988765567888      66543333333344567888899999999999988765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	373
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-99
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-95
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-91
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-79
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-79
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-78
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-77
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-76
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-74
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-74
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-71
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-70
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-69
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-69
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-68
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-67
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-67
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-66
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-66
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-65
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-65
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-65
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-64
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-63
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-59
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-59
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-58
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-57
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-56
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-55
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-54
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-54
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-52
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-51
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-50
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-48
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-46
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-43
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	9e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-41
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-41
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-41
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-40
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-38
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-38
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-37
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-24

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  296 bits (759), Expect = 2e-99
 Identities = 172/343 (50%), Positives = 233/343 (67%), Gaps = 6/343 (1%)

Query: 24  TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
            +F++  +Y  +  IG GAYG+VCS+ +     +VAIKKI+  FE++    RTLRE+K+L
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKIL 60

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLL 143
              +HEN+I + D++        KDVYLV  LM  DL++++K+ Q L+NDH  YFL+Q+L
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQIL 119

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYR 200
           RGLKY+HSAN+LHRDLKP NLL+N  CDLKICDFGLAR     +    F+TEYV TRWYR
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE++L    Y  SID+WSVGCI AE+L  +PIFPG   L+QL  I+ ILGS  +EDL  
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
           I N KAR Y+ SLP+    P++RL+P+A   A+DLL KML F+P KRI V +AL HPY+ 
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299

Query: 321 PLYDPSSNPPAQVPIDLDMD-EESGEEMIREMMLKEMLHYHPE 362
             YDPS  P A+ P   DM+ ++  +E ++E++ +E   + P 
Sbjct: 300 QYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 342

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  285 bits (730), Expect = 5e-95
 Identities = 149/349 (42%), Positives = 223/349 (63%), Gaps = 5/349 (1%)

Query: 14  PGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA 73
            G +   + +T +E+   Y  ++P+G GAYG VCS+V+  T  KVAIKK+   F++ + A
Sbjct: 2   SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61

Query: 74  LRTLRELKLLRHLQHENVIALKDVMMP-SHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
            R  REL+LL+H++HENVI L DV  P     +F D YLV   M TDL +++K  + L  
Sbjct: 62  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGE 120

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
           D  Q+ ++Q+L+GL+Y+H+A I+HRDLKPGNL VN +C+LKI DFGLAR ++ +   MT 
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTG 177

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
           YVVTRWYRAPE++L    Y  ++D+WSVGCI AE++  K +F G++ L+QLK I+ + G+
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
              E ++ + + +A+ Y+K LP      F+ +  +A PLA++LL+KMLV D  +R++  E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 313 ALQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEMLHYHP 361
           AL HPY   L+D    P  Q   D   D +   +  + +  KE+L + P
Sbjct: 298 ALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  276 bits (705), Expect = 3e-91
 Identities = 157/350 (44%), Positives = 231/350 (66%), Gaps = 7/350 (2%)

Query: 14  PGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDA 73
           P  +   + +T++E+  +Y  + P+G GAYG VC++ + +T  +VA+KK++  F++ + A
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 74  LRTLRELKLLRHLQHENVIALKDVM-MPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTN 132
            RT REL+LL+H++HENVI L DV         F DVYLV  LM  DL+ I+K  Q LT+
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTD 120

Query: 133 DHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTE 192
           DH Q+ ++Q+LRGLKY+HSA+I+HRDLKP NL VN +C+LKI DFGLAR ++     MT 
Sbjct: 121 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTG 177

Query: 193 YVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS 252
           YV TRWYRAPE++L   +Y  ++D+WSVGCI AELL  + +FPGT+ ++QLKLI+ ++G+
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE 312
              E L+ I +  AR YI+SL   P   F+ ++  A+PLA+DLL+KMLV D  KRI+  +
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297

Query: 313 ALQHPYMSPLYDPSSNPPAQVPIDLDMDE-ESGEEMIREMMLKEMLHYHP 361
           AL H Y +  +DP   P A  P D   +  +   +  + +   E++ + P
Sbjct: 298 ALAHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  245 bits (626), Expect = 2e-79
 Identities = 148/359 (41%), Positives = 221/359 (61%), Gaps = 22/359 (6%)

Query: 17  HYYS--MWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL 74
            +YS  +  + F +  +Y  +KPIG GA GIVC++ +   +  VAIKK++  F+N+  A 
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 75  RTLRELKLLRHLQHENVIALKDVMMP-SHRRNFKDVYLVYELMDTDLHQIIKSSQALTND 133
           R  REL L++ + H+N+I+L +V  P      F+DVYLV ELMD +L Q+I+      ++
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHE 119

Query: 134 HCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEY 193
              Y L+Q+L G+K+LHSA I+HRDLKP N++V ++C LKI DFGLAR + G +  MT Y
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPY 178

Query: 194 VVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
           VVTR+YRAPE++L    Y  ++D+WSVGCI  E++  K +FPG + ++Q   +I  LG+ 
Sbjct: 179 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH------------PLAIDLLQKMLV 301
             E ++ +  P  R Y+++ P   G  F +L+PD+               A DLL KMLV
Sbjct: 238 CPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 302 FDPTKRISVTEALQHPYMSPLYDPS--SNPPAQVPIDLDMDEESGEEMIREMMLKEMLH 358
            DP KRISV +ALQHPY++  YDP+    PP Q+      + E   E  +E++ KE+++
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 355

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (620), Expect = 4e-79
 Identities = 118/305 (38%), Positives = 165/305 (54%), Gaps = 14/305 (4%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL---RTLRELKLLRHLQHENV 91
           +  +G G +  V  + ++ TN+ VAIKKI     +          LRE+KLL+ L H N+
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           I L D           ++ LV++ M+TD    I  +S  LT  H + ++   L+GL+YLH
Sbjct: 63  IGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
              ILHRDLKP NLL++ N  LK+ DFGLA++    N+  T  VVTRWYRAPELL     
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+W+VGCI AELL R P  PG   L+QL  I   LG+  EE    + +       
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
           KS    PG P   ++  A    +DL+Q + +F+P  RI+ T+AL+  Y S    P+  P 
Sbjct: 238 KSF---PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT--PG 292

Query: 331 AQVPI 335
            Q+P 
Sbjct: 293 CQLPR 297

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (617), Expect = 2e-78
 Identities = 109/305 (35%), Positives = 158/305 (51%), Gaps = 9/305 (2%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  +  IG+G +G V  + +R+T +KVA+KK+    E     +  LRE+K+L+ L+HEN
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 91  VIALKDVM---MPSHRRNFKDVYLVYELMDTDLHQI-IKSSQALTNDHCQYFLFQLLRGL 146
           V+ L ++       + R    +YLV++  + DL  +        T    +  +  LL GL
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGKNQFMTEYVVTRWYRAP 202
            Y+H   ILHRD+K  N+L+  +  LK+ DFGLAR      N +    T  VVT WYR P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           ELLL   +YG  ID+W  GCI AE+  R PI  G    +QL LI  + GS   E    +D
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPD-AHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP 321
           N +  + ++ +         RL      P A+DL+ K+LV DP +RI   +AL H +   
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310

Query: 322 LYDPS 326
              PS
Sbjct: 311 DPMPS 315

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (612), Expect = 3e-77
 Identities = 104/332 (31%), Positives = 171/332 (51%), Gaps = 16/332 (4%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           Y   K IG G++G+V  +   ++ E VAIKK+        D     REL+++R L H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNI 75

Query: 92  IALKDVMM-PSHRRNFKDVYLVYELMDTDLHQII----KSSQALTNDHCQYFLFQLLRGL 146
           + L+        +++   + LV + +   ++++     ++ Q L   + + +++QL R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 147 KYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELL 205
            Y+HS  I HRD+KP NLL++ +   LK+CDFG A+        ++ Y+ +R+YRAPEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YICSRYYRAPELI 194

Query: 206 LCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
               +Y +SIDVWS GC+ AELL  +PIFPG   ++QL  II +LG+   E +  ++   
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
                  +   P T   R  P   P AI L  ++L + PT R++  EA  H +   L DP
Sbjct: 255 TEFKFPQIKAHPWTKVFR--PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 326 SSNPPAQVPIDLDMDEESGEEMIREMMLKEML 357
           +   P        +   + +E+     L  +L
Sbjct: 313 NVKLPNGRDTP-ALFNFTTQELSSNPPLATIL 343

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 1e-76
 Identities = 114/300 (38%), Positives = 164/300 (54%), Gaps = 9/300 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            +  ++ IG G YG+V  + N+ T E VA+KKI    E        +RE+ LL+ L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS--QALTNDHCQYFLFQLLRGLKY 148
           ++ L DV+   ++     +YLV+E +  DL + + +S    +     + +LFQLL+GL +
Sbjct: 63  IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
            HS  +LHRDLKP NLL+N    +K+ DFGLAR      +  T  VVT WYRAPE+LL C
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y T++D+WS+GCIFAE++ R+ +FPG   ++QL  I   LG+  E             
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVTSMPD 235

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSN 328
           Y  S P      FS++ P        LL +ML +DP KRIS   AL HP+   +  P  +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  229 bits (585), Expect = 4e-74
 Identities = 109/290 (37%), Positives = 155/290 (53%), Gaps = 9/290 (3%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ IG G YG+V  + N    E  A+KKI    E+      T+RE+ +L+ L+H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++ L DV+    R     + LV+E +D      +      L +   + FL QLL G+ Y 
Sbjct: 62  IVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   +LHRDLKP NLL+N   +LKI DFGLAR      +  T  +VT WYRAP++L+   
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            Y T+ID+WSVGCIFAE++   P+FPG    +QL  I  ILG+   ++   +   +  KY
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV--TELPKY 234

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
             +       P+           IDLL KML  DP +RI+  +AL+H Y 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 4e-74
 Identities = 115/296 (38%), Positives = 160/296 (54%), Gaps = 7/296 (2%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY  ++ IG G YG V  + NRET+E VA+K++    ++       LRE+ LL+ L+H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++ L DV+    +       +               +  L  +  + FLFQLL+GL + H
Sbjct: 63  IVRLHDVLHSDKKLTL----VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S N+LHRDLKP NLL+N N +LK+ +FGLAR      +  +  VVT WYR P++L     
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           Y TSID+WS GCIFAEL    +P+FPG +  +QLK I  +LG+  EE    +   K   Y
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--KLPDY 236

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP 325
                Y   T    + P  +    DLLQ +L  +P +RIS  EALQHPY S    P
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 5e-74
 Identities = 69/304 (22%), Positives = 126/304 (41%), Gaps = 24/304 (7%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            +  I  +G G  G+V    ++ +   +A K I+   +  +   + +REL++L       
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-QIIRELQVLHECNSPY 65

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           ++                + +  E MD   L Q++K +  +           +++GL YL
Sbjct: 66  IVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 150 HSAN-ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
              + I+HRD+KP N+LVN+  ++K+CDFG++      +     +V TR Y +PE L   
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGT 178

Query: 209 DNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLE-------- 259
            +Y    D+WS+G    E+  GR PI P      +L     + G   E            
Sbjct: 179 -HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237

Query: 260 ---FIDNPKARKYIKSLPYTPGTPFSRLYPDAH-PLAIDLLQKMLVFDPTKRISVTEALQ 315
               +D+       + L Y    P  +L          D + K L+ +P +R  + + + 
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

Query: 316 HPYM 319
           H ++
Sbjct: 298 HAFI 301

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 3e-71
 Identities = 112/300 (37%), Positives = 162/300 (54%), Gaps = 12/300 (4%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEK-VAIKKINNAFENRVDALRTLRELKLLRHL- 86
           D +Y  +  IG GAYG V  + + +   + VA+K++          L T+RE+ +LRHL 
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 87  --QHENVIALKDVMMPSHRRNFKDVYLVYELM--DTDLHQIIKSSQALTNDHCQYFLFQL 142
             +H NV+ L DV   S       + LV+E +  D   +        +  +  +  +FQL
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           LRGL +LHS  ++HRDLKP N+LV ++  +K+ DFGLAR  + +    +  VVT WYRAP
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTLWYRAP 184

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+LL   +Y T +D+WSVGCIFAE+  RKP+F G+  ++QL  I++++G   EED     
Sbjct: 185 EVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
               + +          P  +   D   L  DLL K L F+P KRIS   AL HPY   L
Sbjct: 244 ALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 8e-70
 Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 39/294 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLRHLQHE 89
            +  ++ +G GAYG V  +VNR T E VA+K ++   +  VD    + +E+ + + L HE
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 63

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTDLH-QIIKSSQALTNDHCQYFLFQLLRGLKY 148
           NV+         +       YL  E          I+    +     Q F  QL+ G+ Y
Sbjct: 64  NVVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLL 206
           LH   I HRD+KP NLL++   +LKI DFGLA     N + + + +   T  Y APELL 
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             + +   +DVWS G +   +L  +  +       Q                        
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--------------- 223

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                         +   +       + LL K+LV +P+ RI++ +  +  + +
Sbjct: 224 -------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 1e-69
 Identities = 68/300 (22%), Positives = 128/300 (42%), Gaps = 36/300 (12%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
           KY   + IG+GA G V ++++  T ++VAI+++N   + +      + E+ ++R  ++ N
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLH 150
           ++   D           ++++V E +       + +   +          + L+ L++LH
Sbjct: 79  IVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133

Query: 151 SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDN 210
           S  ++HRD+K  N+L+  +  +K+ DFG       +    +  V T ++ APE ++    
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKA 192

Query: 211 YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYI 270
           YG  +D+WS+G +  E++  +P +     L  L LI                        
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN--------------------- 231

Query: 271 KSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPP 330
                  GTP  +       +  D L + L  D  KR S  E LQH ++      SS  P
Sbjct: 232 -------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 2e-69
 Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 41/295 (13%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
           +  I  +G GA+G V  + N+ET+   A K I+   E  ++    + E+ +L    H N+
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNI 71

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDTDL--HQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           + L D     +      ++++ E          +++  + LT    Q    Q L  L YL
Sbjct: 72  VKLLDAFYYENN-----LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           H   I+HRDLK GN+L   + D+K+ DFG++  +    Q    ++ T ++ APE+++C  
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186

Query: 210 N----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK 265
           +    Y    DVWS+G    E+   +P       LN +++++ I  S             
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHE---LNPMRVLLKIAKSEP----------- 232

Query: 266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                         P             D L+K L  +   R + ++ LQHP+++
Sbjct: 233 --------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  217 bits (553), Expect = 2e-68
 Identities = 68/329 (20%), Positives = 130/329 (39%), Gaps = 43/329 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y   + +G GA+G+V     R T    A K +    E+  + +R  +E++ +  L+H  
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR--KEIQTMSVLRHPT 84

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMDTD--LHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
           ++ L D     +      + ++YE M       ++      ++ D    ++ Q+ +GL +
Sbjct: 85  LVNLHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139

Query: 149 LHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +H  N +H DLKP N++     + +LK+ DFGL    + K         T  + APE+  
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEVAE 198

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
                G   D+WSVG +   LL     F G      L+ + +                  
Sbjct: 199 G-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS------------------ 239

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS 326
                             +        D ++K+L+ DP  R+++ +AL+HP+++P   P 
Sbjct: 240 ---------CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290

Query: 327 SN---PPAQVPIDLDMDEESGEEMIREMM 352
            +   P ++     D  +   +     + 
Sbjct: 291 RDSQIPSSRYTKIRDSIKTKYDAWPEPLP 319

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  213 bits (543), Expect = 3e-67
 Identities = 89/320 (27%), Positives = 164/320 (51%), Gaps = 22/320 (6%)

Query: 9   NGIRSPGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE 68
           N  R      Y      +     Y  ++ +GRG Y  V  ++N   NEKV +K +    +
Sbjct: 14  NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK 73

Query: 69  NRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS 126
            ++      RE+K+L +L+   N+I L D++     R      LV+E ++ TD  Q+ ++
Sbjct: 74  KKI-----KREIKILENLRGGPNIITLADIVKDPVSRTP---ALVFEHVNNTDFKQLYQT 125

Query: 127 SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-NCDLKICDFGLARTSNG 185
              LT+   +++++++L+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA   + 
Sbjct: 126 ---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH- 181

Query: 186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLK 244
             Q     V +R+++ PELL+    Y  S+D+WS+GC+ A ++  ++P F G +  +QL 
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241

Query: 245 LIINILGSRREED-LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAH-----PLAIDLLQK 298
            I  +LG+    D ++  +     ++   L       + R     +     P A+D L K
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 299 MLVFDPTKRISVTEALQHPY 318
           +L +D   R++  EA++HPY
Sbjct: 302 LLRYDHQSRLTAREAMEHPY 321

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  212 bits (541), Expect = 3e-67
 Identities = 76/344 (22%), Positives = 134/344 (38%), Gaps = 47/344 (13%)

Query: 20  SMWQTLFEID--TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RT 76
            + +  F+ D    +  ++ IG G++G V  + +   +E VAIKK++ + +   +     
Sbjct: 3   DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62

Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHC 135
           ++E++ L+ L+H N I  +   +  H       +LV E    +    +    + L     
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEI 117

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV 195
                  L+GL YLHS N++HRD+K GN+L++    +K+ DFG A            +V 
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVG 173

Query: 196 TRWYRAPELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR 253
           T ++ APE++L  D   Y   +DVWS+G    EL  RKP       ++ L  I       
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----- 228

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
                                       +           + +   L   P  R +    
Sbjct: 229 ------------------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

Query: 314 LQHPYMSPLYDPSSNPPAQVPIDLDMDEESGEEMIREMMLKEML 357
           L+H ++     P+      +    D   E      R+M  K++L
Sbjct: 265 LKHRFVLRERPPTVIMD-LIQRTKDAVRELDNLQYRKM--KKIL 305

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 2e-66
 Identities = 67/297 (22%), Positives = 127/297 (42%), Gaps = 42/297 (14%)

Query: 26  FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTL-RELKLLR 84
           + ++  +   +P+G+G +G V  +  +++   +A+K +  A   +      L RE+++  
Sbjct: 3   WALE-DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLL 143
           HL+H N++ L      + R     VYL+ E      +++ ++            ++ +L 
Sbjct: 62  HLRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 116

Query: 144 RGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPE 203
             L Y HS  ++HRD+KP NLL+ +  +LKI DFG +  +       T    T  Y  PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTTLCGTLDYLPPE 174

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
           ++     +   +D+WS+G +  E L  KP F         K I  +              
Sbjct: 175 MIE-GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------ 221

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                            F     +    A DL+ ++L  +P++R  + E L+HP+++
Sbjct: 222 ----------------TFPDFVTEG---ARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 9e-66
 Identities = 73/298 (24%), Positives = 116/298 (38%), Gaps = 44/298 (14%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y  +  IG G+YG       +   + +  K+++       +    + E+ LLR L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQII----KSSQALTNDHCQYFLFQLLRG 145
           ++   D +     R    +Y+V E  +  DL  +I    K  Q L  +     + QL   
Sbjct: 65  IVRYYDRI---IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 146 LKYLH-----SANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
           LK  H        +LHRDLKP N+ ++   ++K+ DFGLAR  N    F   +V T +Y 
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           +PE +    +Y    D+WS+GC+  EL    P F           I              
Sbjct: 182 SPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------------ 228

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
                               F R+         +++ +ML      R SV E L++P 
Sbjct: 229 ------------------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (529), Expect = 2e-65
 Identities = 80/316 (25%), Positives = 129/316 (40%), Gaps = 39/316 (12%)

Query: 22  WQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK 81
           W+   +I   Y     +G GA+  V  + ++ T + VAIK I        +      E+ 
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG-SMENEIA 59

Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLF 140
           +L  ++H N++AL D+           +YL+ +L+   +L   I      T       +F
Sbjct: 60  VLHKIKHPNIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIF 114

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLV---NANCDLKICDFGLARTSNGKNQFMTEYVVTR 197
           Q+L  +KYLH   I+HRDLKP NLL    + +  + I DFGL++  +     ++    T 
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGTP 173

Query: 198 WYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED 257
            Y APE+L     Y  ++D WS+G I   LL   P F         + I+          
Sbjct: 174 GYVAPEVL-AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK--------- 223

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                                   S  + D    A D ++ ++  DP KR +  +ALQHP
Sbjct: 224 ------------------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP 265

Query: 318 YMSPLYDPSSNPPAQV 333
           +++       N    V
Sbjct: 266 WIAGDTALDKNIHQSV 281

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  205 bits (523), Expect = 7e-65
 Identities = 83/303 (27%), Positives = 136/303 (44%), Gaps = 47/303 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-------RTLRELKLL 83
            Y P + +GRG   +V   +++ T ++ A+K I+        A         TL+E+ +L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 84  RHLQ-HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQ 141
           R +  H N+I LKD    +        +LV++LM   +L   +     L+    +  +  
Sbjct: 64  RKVSGHPNIIQLKDTYETNTF-----FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           LL  +  LH  NI+HRDLKP N+L++ + ++K+ DFG +   +   + + E   T  Y A
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLA 177

Query: 202 PELLLCCDN-----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
           PE++ C  N     YG  +D+WS G I   LL   P F   + +  L++I++        
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG------- 230

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                             Y  G+P    + D      DL+ + LV  P KR +  EAL H
Sbjct: 231 -----------------NYQFGSP---EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270

Query: 317 PYM 319
           P+ 
Sbjct: 271 PFF 273

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  207 bits (529), Expect = 7e-65
 Identities = 70/308 (22%), Positives = 130/308 (42%), Gaps = 43/308 (13%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHEN 90
            Y  ++ +G GA+G+V   V + T      K IN  +   +D      E+ ++  L H  
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPK 87

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKY 148
           +I L D        +  ++ L+ E +   +L   I +    ++      ++ Q   GLK+
Sbjct: 88  LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142

Query: 149 LHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +H  +I+H D+KP N++        +KI DFGLA   N  ++ +     T  + APE++ 
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVD 201

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
             +  G   D+W++G +   LL     F G + L  L+ +                    
Sbjct: 202 -REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----------------- 243

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS 326
                             +    P A D ++ +L  +P KR++V +AL+HP++   +   
Sbjct: 244 ----------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH--- 290

Query: 327 SNPPAQVP 334
           SN  +++P
Sbjct: 291 SNLTSRIP 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 4e-64
 Identities = 65/310 (20%), Positives = 128/310 (41%), Gaps = 41/310 (13%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           E+  KY+  + +GRG +GIV   V   + +    K +        D +   +E+ +L   
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIA 58

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLR 144
           +H N++ L +        + +++ +++E +   D+ + I +S   L       ++ Q+  
Sbjct: 59  RHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113

Query: 145 GLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
            L++LHS NI H D++P N++     +  +KI +FG AR     + F   +    +Y   
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
                 D   T+ D+WS+G +   LL     F        ++ I+N              
Sbjct: 174 VHQ--HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-------------- 217

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL 322
                           T     + +    A+D + ++LV +   R++ +EALQHP++   
Sbjct: 218 -------------AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

Query: 323 YDPSSNPPAQ 332
            +  S    +
Sbjct: 265 IERVSTKVIR 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 5e-63
 Identities = 65/297 (21%), Positives = 125/297 (42%), Gaps = 38/297 (12%)

Query: 28  IDTKYVPI-KPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
            D +++     IGRG++  V   ++ ET  +VA  ++ +    + +  R   E ++L+ L
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRG 145
           QH N++   D    + +   K + LV ELM +  L   +K  + +     + +  Q+L+G
Sbjct: 66  QHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124

Query: 146 LKYLHSAN--ILHRDLKPGNLLVNA-NCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
           L++LH+    I+HRDLK  N+ +      +KI D GLA        F    + T  + AP
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAP 182

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
           E+    + Y  S+DV++ G    E+   +  +   +   Q+   +               
Sbjct: 183 EMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--------------- 225

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM 319
                        T G   +     A P   ++++  +  +  +R S+ + L H + 
Sbjct: 226 -------------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-59
 Identities = 71/302 (23%), Positives = 121/302 (40%), Gaps = 47/302 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHE 89
            +   K +G G++  V  +    T+ + AIK +      + + +    RE  ++  L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
             + L        +     +Y         +L + I+   +      +++  +++  L+Y
Sbjct: 69  FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLL 206
           LH   I+HRDLKP N+L+N +  ++I DFG A+  +   K      +V T  Y +PELL 
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
              +   S D+W++GCI  +L+   P F         + II                   
Sbjct: 184 -EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------------------ 224

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA------LQHPYMS 320
                 L Y     F        P A DL++K+LV D TKR+   E         HP+  
Sbjct: 225 ------LEYDFPEKFF-------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

Query: 321 PL 322
            +
Sbjct: 272 SV 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-59
 Identities = 89/331 (26%), Positives = 140/331 (42%), Gaps = 41/331 (12%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELK-LLRHL 86
           ID   V  + +G G  G V    N+ T EK A+K +        D  +  RE++   R  
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRAS 62

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLL 143
           Q  +++ + DV    +    K + +V E +D  +L   I+    QA T       +  + 
Sbjct: 63  QCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121

Query: 144 RGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
             ++YLHS NI HRD+KP NLL  +   N  LK+ DFG A+ +   N   T    T +Y 
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYV 180

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
           APE +L  + Y  S D+WS+G I   LL   P F     L     +              
Sbjct: 181 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------------- 225

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS 320
                 +  I+   Y    P    + +       L++ +L  +PT+R+++TE + HP++ 
Sbjct: 226 ------KTRIRMGQYEFPNP---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276

Query: 321 PLYDPSSNPPAQVPIDLDMDEESGEEMIREM 351
                    P      L  D+E  E++  EM
Sbjct: 277 QSTKV-PQTPLHTSRVLKEDKERWEDVKEEM 306

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-58
 Identities = 85/324 (26%), Positives = 136/324 (41%), Gaps = 51/324 (15%)

Query: 24  TLF---EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRT 76
           T+F    +D  Y   + +G G + +V     + T  + A K I      +    V     
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60

Query: 77  LRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHC 135
            RE+ +L+ +QH NVI L +V       N  DV L+ EL+    L   +   ++LT +  
Sbjct: 61  EREVSILKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEA 115

Query: 136 QYFLFQLLRGLKYLHSANILHRDLKPGNLLVN----ANCDLKICDFGLARTSNGKNQFMT 191
             FL Q+L G+ YLHS  I H DLKP N+++         +KI DFGLA   +  N+   
Sbjct: 116 TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FK 174

Query: 192 EYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILG 251
               T  + APE++   +  G   D+WS+G I   LL     F G      L  +  +  
Sbjct: 175 NIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-- 231

Query: 252 SRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT 311
                                            + +   LA D ++++LV DP KR+++ 
Sbjct: 232 -------------------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266

Query: 312 EALQHPYMSP-----LYDPSSNPP 330
           ++LQHP++ P         + + P
Sbjct: 267 DSLQHPWIKPKDTQQALSSAWSHP 290

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 8e-57
 Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 53/307 (17%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN----NAFENRVDALRTLRELKLL 83
           ++++Y     +G G +G V S +    N  VAIK +     + +    +  R   E+ LL
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 84  RHLQ--HENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFL 139
           + +      VI L D              L+ E  +   DL   I    AL  +  + F 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFF 116

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFGLARTSNGKNQFMTEYVVTRW 198
           +Q+L  +++ H+  +LHRD+K  N+L++ N  +LK+ DFG       K+   T++  TR 
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRV 174

Query: 199 YRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           Y  PE +     +G S  VWS+G +  +++     F   E + + ++             
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------- 224

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPY 318
                                               L++  L   P+ R +  E   HP+
Sbjct: 225 ---------------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257

Query: 319 MSPLYDP 325
           M  +  P
Sbjct: 258 MQDVLLP 264

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 82/340 (24%), Positives = 140/340 (41%), Gaps = 51/340 (15%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRH-LQHE 89
           ++  K +G+G++G V  +  ++TN+  AIK +  +      D   T+ E ++L    +H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            +  +              ++ V E ++  DL   I+S          ++  +++ GL++
Sbjct: 64  FLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LHS  I++RDLK  N+L++ +  +KI DFG+ + +   +     +  T  Y APE+LL  
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL-G 177

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y  S+D WS G +  E+L  +  F G +       I               DNP   +
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------DNPFYPR 224

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT-EALQHPYMSPL----- 322
           ++                     A DLL K+ V +P KR+ V  +  QHP    +     
Sbjct: 225 WL------------------EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 266

Query: 323 ----YDPSSNPPAQVPIDLDM-DEESGEEMIREMMLKEML 357
                DP   P  + P D    D+E   E  R       L
Sbjct: 267 ERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRAL 306

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 9e-55
 Identities = 55/298 (18%), Positives = 112/298 (37%), Gaps = 41/298 (13%)

Query: 26  FEIDT-KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +EI   +    + IG G++G V      + +  VA+K +N              E+ +LR
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQA-LTNDHCQYFLFQL 142
             +H N++                + +V +  + + L+  +   +             Q 
Sbjct: 60  KTRHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYR 200
            +G+ YLH+ +I+HRDLK  N+ ++ +  +KI DFGLA   +    +    +   +  + 
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 201 APELLLCCDN--YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL 258
           APE++   D   Y    DV++ G +  EL+  +  +      +Q+  ++           
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---------- 223

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                   R Y+           S++  +       L+ + L     +R    + L  
Sbjct: 224 --------RGYLSP-------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 61/301 (20%), Positives = 119/301 (39%), Gaps = 45/301 (14%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAF----ENRVDALRTLRELKLLRHLQ 87
           +   + IGRG +G V      +T +  A+K ++       +    AL     L L+    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGL 146
              ++ +        +     +  + +LM+  DLH  +      +    +++  +++ GL
Sbjct: 66  CPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 147 KYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLL 206
           +++H+  +++RDLKP N+L++ +  ++I D GLA   + K    +    T  Y APE+L 
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG--THGYMAPEVLQ 178

Query: 207 CCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA 266
               Y +S D +S+GC+  +LL     F   +  ++ ++    L    E           
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----------- 227

Query: 267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISV-----TEALQHPYMSP 321
                            L     P    LL+ +L  D  +R+        E  + P+   
Sbjct: 228 -----------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270

Query: 322 L 322
           L
Sbjct: 271 L 271

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  178 bits (451), Expect = 3e-54
 Identities = 60/296 (20%), Positives = 109/296 (36%), Gaps = 34/296 (11%)

Query: 27  EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKIN-NAFENRVDALRTLRELKLLRH 85
            +  +Y   + +G G    V  + +   +  VA+K +  +   +    LR  RE +    
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLR 144
           L H  ++A+ D             Y+V E +D   L  I+ +   +T       +    +
Sbjct: 64  LNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVTRWYRA 201
            L + H   I+HRD+KP N++++A   +K+ DFG+AR    S          + T  Y +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           PE     D+     DV+S+GC+  E+L  +P F G   ++     +              
Sbjct: 183 PEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------------- 228

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP 317
                             P S  +         ++ K L  +P  R      ++  
Sbjct: 229 --------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 2e-52
 Identities = 68/322 (21%), Positives = 134/322 (41%), Gaps = 49/322 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHE 89
            +  +K +G+G +G V     + T    A+K +        D +  T+ E ++L++ +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTD-LHQIIKSSQALTNDHCQYFLFQLLRGLKY 148
            + ALK       R     +  V E  +   L   +   +  T +  +++  +++  L+Y
Sbjct: 66  FLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 149 LHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCC 208
           LHS ++++RD+K  NL+++ +  +KI DFGL +        M  +  T  Y APE +L  
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLED 179

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
           ++YG ++D W +G +  E++  +  F   +     +LI+        E++ F        
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------EEIRFPRT----- 227

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSP-- 321
                                P A  LL  +L  DP +R+        E ++H +     
Sbjct: 228 -------------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268

Query: 322 ---LYDPSSNPPAQVPIDLDMD 340
              +      PP +  +  ++D
Sbjct: 269 WQDVVQKKLLPPFKPQVTSEVD 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  171 bits (434), Expect = 8e-51
 Identities = 76/343 (22%), Positives = 130/343 (37%), Gaps = 43/343 (12%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQH 88
           D +Y+ ++ +G G +  V  + +   N  VA+K +     ++V       E+KLL+ +  
Sbjct: 12  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVND 68

Query: 89  ENVIALKDVMMP----------SHRRNFKDVYLVYELMDTDLHQIIKSSQALTN--DHCQ 136
            +      +                 N   V +V+E++  +L  +IK  +       + +
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 137 YFLFQLLRGLKYLH-SANILHRDLKPGNLLVNAN------CDLKICDFGLARTSNGKNQF 189
               QLL GL Y+H    I+H D+KP N+L+           +KI D G A   +     
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPG------TECLNQL 243
             +    R YR+PE+LL    +G   D+WS  C+  EL+    +F        T+  + +
Sbjct: 189 SIQT---REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244

Query: 244 KLIINILGSRREEDLE-------FIDNPKARKYIKSLPYTPGTPF----SRLYPDAHPLA 292
             II +LG      L        F ++    + I  L + P         +   D     
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304

Query: 293 IDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPI 335
            D L  ML  DP KR      + HP++               +
Sbjct: 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL 347

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (425), Expect = 8e-50
 Identities = 64/296 (21%), Positives = 124/296 (41%), Gaps = 47/296 (15%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHEN 90
           +  ++ +G G++G V    +R      A+K +      R+  +  T  E  +L  + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 91  VIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
           +I +      + +     ++++ + ++  +L  +++ SQ   N   +++  ++   L+YL
Sbjct: 66  IIRMWGTFQDAQQ-----IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           HS +I++RDLKP N+L++ N  +KI DFG A+              T  Y APE ++   
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAPE-VVSTK 176

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            Y  SID WS G +  E+L     F  +  +   + I+N        +L F         
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------AELRF--------- 220

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMS 320
                           P  +    DLL +++  D ++R+        +   HP+  
Sbjct: 221 ---------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  168 bits (425), Expect = 2e-49
 Identities = 62/333 (18%), Positives = 132/333 (39%), Gaps = 50/333 (15%)

Query: 31  KYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDAL-RTLRELKLLRHLQHE 89
           ++  IK +G G++G V    ++E+    A+K ++     ++  +  TL E ++L+ +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 90  NVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYL 149
            ++ L+     +         ++  +   ++   ++     +  H +++  Q++   +YL
Sbjct: 102 FLVKLEFSFKDNSNLY----MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCD 209
           HS ++++RDLKP NLL++    +++ DFG A+   G+         T    APE++L   
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTLCGTPEALAPEIIL-SK 213

Query: 210 NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
            Y  ++D W++G +  E+    P F   + +   + I++                     
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--------------------- 252

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSP--- 321
                       S    D      DLL+ +L  D TKR       V +   H + +    
Sbjct: 253 ------GKVRFPSHFSSDLK----DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302

Query: 322 --LYDPSSNPPAQVPIDLDMDEESGEEMIREMM 352
             +Y      P         D  + ++   E +
Sbjct: 303 IAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEI 335

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 1e-48
 Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 49/295 (16%)

Query: 27  EID-TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
            ++  +   ++ IG+G +G V          KVA+K I N    +      L E  ++  
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQ----AFLAEASVMTQ 56

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQL 142
           L+H N++ L  V++         +Y+V E M    L   ++S     L  D    F   +
Sbjct: 57  LRHSNLVQLLGVIVEEKGG----LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAP 202
              ++YL   N +HRDL   N+LV+ +   K+ DFGL + ++          +   + AP
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAP 169

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFI 261
           E L     + T  DVWS G +  E+    +  +P     + +  +       +   ++  
Sbjct: 170 EALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------EKGYKMDAP 222

Query: 262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
           D                           P   ++++     D   R S  +  + 
Sbjct: 223 DG------------------------CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 6e-48
 Identities = 64/328 (19%), Positives = 130/328 (39%), Gaps = 49/328 (14%)

Query: 31  KYVPIKPIGRGAYGIVC---SSVNRETNEKVAIKKIN--NAFENRVDALRTLRELKLLRH 85
            +  +K +G GAYG V         +T +  A+K +      +       T  E ++L H
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLR 144
           ++    +    V +    +    ++L+ + ++  +L   +   +  T    Q ++ +++ 
Sbjct: 85  IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAP 202
            L++LH   I++RD+K  N+L+++N  + + DFGL++   ++   +         +    
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 203 ELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
            +      +  ++D WS+G +  ELL     F      N    I                
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---------------- 244

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHP 317
              +R+ +KS P  P         +   LA DL+Q++L+ DP KR+        E  +H 
Sbjct: 245 ---SRRILKSEPPYP--------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 293

Query: 318 YMSP-----LYDPSSNPPAQVPIDLDMD 340
           +        L       P +  I  ++D
Sbjct: 294 FFQKINWDDLAAKKVPAPFKPVIRDELD 321

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-47
 Identities = 56/303 (18%), Positives = 112/303 (36%), Gaps = 49/303 (16%)

Query: 28  IDTKYVPI--KPIGRGAYGIV--CSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLL 83
           +D K + +  K +G G +G V       ++  + VA+K + N   +       L E  ++
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 84  RHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQL 142
           + L +  ++ +  +             LV E+ +   L++ ++ ++ + + +    + Q+
Sbjct: 63  QQLDNPYIVRMIGICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF---MTEYVVTRWY 199
             G+KYL  +N +HRDL   N+L+      KI DFGL++       +    T       +
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDL 258
            APE  +    + +  DVWS G +  E     +  + G +      ++            
Sbjct: 177 YAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------- 225

Query: 259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEALQ 315
                       + +    G P             DL+     +D   R     V   L+
Sbjct: 226 -----------GERMGCPAGCP---------REMYDLMNLCWTYDVENRPGFAAVELRLR 265

Query: 316 HPY 318
           + Y
Sbjct: 266 NYY 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-46
 Identities = 63/306 (20%), Positives = 108/306 (35%), Gaps = 34/306 (11%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           I    V  + IG+G +G V     +   E+VA+K  ++  E          E+     L+
Sbjct: 1   IARTIVLQESIGKGRFGEVWR--GKWRGEEVAVKIFSSREERS---WFREAEIYQTVMLR 55

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGL 146
           HEN++             +  ++LV +  +   L   +     +T +           GL
Sbjct: 56  HENILGFIAADN-KDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGL 113

Query: 147 KYLHSA--------NILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFM----TEYV 194
            +LH           I HRDLK  N+LV  N    I D GLA   +     +       V
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 195 VTRWYRAPELLLCCDN-----YGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI 249
            T+ Y APE+L    N          D++++G +F E+  R  I    E        +  
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS 309
                EE  + +   K R         P  P      +A  +   ++++    +   R++
Sbjct: 234 SDPSVEEMRKVVCEQKLR---------PNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284

Query: 310 VTEALQ 315
                +
Sbjct: 285 ALRIKK 290

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-46
 Identities = 55/303 (18%), Positives = 105/303 (34%), Gaps = 48/303 (15%)

Query: 26  FEID-TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +E+       ++ +G G +G V        + KVA+K +    +  +     L E  L++
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK---QGSMSPDAFLAEANLMK 63

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDL---HQIIKSSQALTNDHCQYFLFQ 141
            LQH+ ++ L  V+        + +Y++ E M+           S   LT +       Q
Sbjct: 64  QLQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRA 201
           +  G+ ++   N +HRDL+  N+LV+     KI DFGLAR          E         
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177

Query: 202 PELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEF 260
               +    +    DVWS G +  E++   +  +PG      ++ +       R ++   
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP- 236

Query: 261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEALQHP 317
                                             L++      P  R +   +   L+  
Sbjct: 237 -----------------------------EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

Query: 318 YMS 320
           + +
Sbjct: 268 FTA 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-45
 Identities = 68/314 (21%), Positives = 112/314 (35%), Gaps = 52/314 (16%)

Query: 26  FEIDTK-YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +EI  +       +G+G +G V       T   VAIK +       +     L+E ++++
Sbjct: 12  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK---PGTMSPEAFLQEAQVMK 67

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMD---TDLHQIIKSSQALTNDHCQYFLFQ 141
            L+HE ++ L  V+        + +Y+V E M           ++ + L          Q
Sbjct: 68  KLRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121

Query: 142 LLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-TSNGKNQFMTEYVVTRWYR 200
           +  G+ Y+   N +HRDL+  N+LV  N   K+ DFGLAR   + +            + 
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           APE  L    +    DVWS G +  EL    +  +PG      L  +             
Sbjct: 182 APEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------- 231

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ--HP 317
                        +P  P  P             DL+ +    +P +R +          
Sbjct: 232 ------------RMPCPPECP---------ESLHDLMCQCWRKEPEERPTFEYLQAFLED 270

Query: 318 YMS---PLYDPSSN 328
           Y +   P Y P  N
Sbjct: 271 YFTSTEPQYQPGEN 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  153 bits (388), Expect = 9e-45
 Identities = 58/292 (19%), Positives = 108/292 (36%), Gaps = 37/292 (12%)

Query: 26  FEID-TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLR 84
           +E++ T       +G G YG V   V ++ +  VA+K +    E+ ++    L+E  +++
Sbjct: 12  WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMK 68

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLR 144
            ++H N++ L  V            ++ Y  +   L +   + Q ++     Y   Q+  
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISS 126

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPEL 204
            ++YL   N +HRDL   N LV  N  +K+ DFGL+R   G                   
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 205 LLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN 263
            L  + +    DVW+ G +  E+       +PG +     +L+                 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------- 233

Query: 264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
                    +    G P             +L++    ++P+ R S  E  Q
Sbjct: 234 --------RMERPEGCP---------EKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-44
 Identities = 70/325 (21%), Positives = 115/325 (35%), Gaps = 70/325 (21%)

Query: 26  FEID-TKYVPIKPIGRGAYGIVCSSVNRETNE-----KVAIKKINNAFENRVDALRTLRE 79
           +E         K +G GA+G V ++     ++     +VA+K +    ++  +    + E
Sbjct: 32  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSE 90

Query: 80  LKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ--------- 128
           LK++  L  HEN++ L      S       +YL++E     DL   ++S +         
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145

Query: 129 --------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKI 174
                          LT +    F +Q+ +G+++L   + +HRDL   N+LV     +KI
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 205

Query: 175 CDFGLAR--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-K 231
           CDFGLAR   S+          +   + APE L     Y    DVWS G +  E+     
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGV 264

Query: 232 PIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPL 291
             +PG         +I                     +    P             A   
Sbjct: 265 NPYPGIPVDANFYKLIQ------------------NGFKMDQP-----------FYATEE 295

Query: 292 AIDLLQKMLVFDPTKRISVTEALQH 316
              ++Q    FD  KR S       
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-44
 Identities = 58/294 (19%), Positives = 102/294 (34%), Gaps = 44/294 (14%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDAL-RTLRELKLLRHLQ 87
              ++ +G G++G+V        + K   VA+K +     ++ +A+   +RE+  +  L 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFLFQLLRG 145
           H N+I L  V++         + +V EL    + L ++ K            +  Q+  G
Sbjct: 70  HRNLIRLYGVVL------TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYRAPE 203
           + YL S   +HRDL   NLL+     +KI DFGL R    N  +  M E+    +     
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
             L    +  + D W  G    E+    +  + G      L  I                
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID--------------- 228

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                K  + LP     P             +++ +     P  R +       
Sbjct: 229 -----KEGERLPRPEDCP---------QDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 51/313 (16%), Positives = 99/313 (31%), Gaps = 46/313 (14%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           +  +Y   + IG G++G +    +    E+VAIK      ++     +   E K+ + +Q
Sbjct: 5   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQ 60

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQI-IKSSQALTNDHCQYFLFQLLRGL 146
               I            N     +V EL+   L  +    S+  +         Q++  +
Sbjct: 61  GGVGIPTIRWCGAEGDYN----VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 147 KYLHSANILHRDLKPGNLLVN---ANCDLKICDFGLAR-------TSNGKNQFMTEYVVT 196
           +Y+HS N +HRD+KP N L+        + I DFGLA+         +   +       T
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
             Y +    L  +      D+ S+G +          + G +   +              
Sbjct: 177 ARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR------------- 222

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEA 313
                     +KY +       TP   L           L          +     + + 
Sbjct: 223 ----------QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272

Query: 314 LQHPYMSPLYDPS 326
            ++ +    +   
Sbjct: 273 FRNLFHRQGFSYD 285

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 6e-44
 Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 49/294 (16%)

Query: 38  IGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALK 95
           +G G +G V   V R   ++  VAIK +    E   D    +RE +++  L +  ++ L 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRLI 75

Query: 96  DVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSAN 153
            V           + LV E+     LH+ +    + +   +    L Q+  G+KYL   N
Sbjct: 76  GVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129

Query: 154 ILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVV---TRWYRAPELLLCCDN 210
            +HRDL   N+L+      KI DFGL++     + + T          + APE +     
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-FRK 188

Query: 211 YGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY 269
           + +  DVWS G    E L   +  +   +    +  I                       
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------------------- 227

Query: 270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS---VTEALQHPYMS 320
            K +   P  P         P    L+    ++    R     V + ++  Y S
Sbjct: 228 GKRMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-43
 Identities = 63/299 (21%), Positives = 107/299 (35%), Gaps = 46/299 (15%)

Query: 26  FEIDT-KYVPIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELK 81
           +EI   +    + IG G +G V   +          VAIK   N   + V   + L+E  
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 60

Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM--DTDLHQIIKSSQALTNDHCQYFL 139
            +R   H +++ L  V+  +       V+++ EL         +     +L       + 
Sbjct: 61  TMRQFDHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWY 199
           +QL   L YL S   +HRD+   N+LV++N  +K+ DFGL+R       +          
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

Query: 200 RAPELLLCCDNYGTSIDVWSVGCIFAELL--GRKPIFPGTECLNQLKLIINILGSRREED 257
                 +    + ++ DVW  G    E+L  G KP     + +    +I  I    R   
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVIGRIENGERLP- 229

Query: 258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                                     + P+  P    L+ K   +DP++R   TE    
Sbjct: 230 --------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 9e-42
 Identities = 55/294 (18%), Positives = 97/294 (32%), Gaps = 45/294 (15%)

Query: 28  IDTK-YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHL 86
           ID K    +K +G G +G+V     R     VAIK I    E  +     + E K++ +L
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK---EGSMSEDEFIEEAKVMMNL 56

Query: 87  QHENVIALKDVMMPSHRRNFKDVYLVYELM--DTDLHQIIKSSQALTNDHCQYFLFQLLR 144
            HE ++ L  V           ++++ E M     L+ + +                +  
Sbjct: 57  SHEKLVQLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 111

Query: 145 GLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR-TSNGKNQFMTEYVVTRWYRAPE 203
            ++YL S   LHRDL   N LVN    +K+ DFGL+R   + +            +  PE
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171

Query: 204 LLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFID 262
            +L    + +  D+W+ G +  E+    K  +         +   +I    R        
Sbjct: 172 -VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER---FTNSETAEHIAQGLRLYRPHLAS 227

Query: 263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                                           ++         +R +    L +
Sbjct: 228 ---------------------------EKVYTIMYSCWHEKADERPTFKILLSN 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 68/343 (19%), Positives = 119/343 (34%), Gaps = 59/343 (17%)

Query: 29  DTKYVPIKPIGRGAYGIVCSSVNRETNE----KVAIKKINNAFENRVDALRTLRELKLLR 84
           +T++  IK +G GA+G V   +     E     VAIK++  A   + +    L E  ++ 
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMA 66

Query: 85  HLQHENVIALKDVMMPSHRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFLFQL 142
            + + +V  L  + + S       V L+ +LM     L  + +    + + +   +  Q+
Sbjct: 67  SVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 143 LRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGKNQFMTEYVVTRWYR 200
            +G+ YL    ++HRDL   N+LV     +KI DFGLA+   +  K        V   + 
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 201 APELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLE 259
           A E +L    Y    DVWS G    EL+      + G                   E   
Sbjct: 181 ALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------------ASEISS 224

Query: 260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH--- 316
            ++  +                             ++ K  + D   R    E +     
Sbjct: 225 ILEKGERLPQPPICT---------------IDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

Query: 317 ----PYMSPLYDPSSNPPAQVPIDLD-----MDEESGEEMIRE 350
               P    +           P D +     MDEE  ++++  
Sbjct: 270 MARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDA 312

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 4e-41
 Identities = 57/288 (19%), Positives = 103/288 (35%), Gaps = 42/288 (14%)

Query: 32  YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV 91
              ++ IG G +G+V         +KVAIK I     +  D +    E +++  L H  +
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKL 62

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMDT-DLHQIIKSSQALTN-DHCQYFLFQLLRGLKYL 149
           + L  V +         + LV+E M+   L   +++ + L   +        +  G+ YL
Sbjct: 63  VQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 150 HSANILHRDLKPGNLLVNANCDLKICDFGLAR-TSNGKNQFMTEYVVTRWYRAPELLLCC 208
             A ++HRDL   N LV  N  +K+ DFG+ R   + +    T       + +PE+    
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 209 DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK 268
             Y +  DVWS G +  E+     I    E  +  +++ +I    R              
Sbjct: 178 -RYSSKSDVWSFGVLMWEVFSEGKIPY--ENRSNSEVVEDISTGFRLYKPRLAS------ 228

Query: 269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                                     ++       P  R + +  L+ 
Sbjct: 229 ---------------------THVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (362), Expect = 7e-41
 Identities = 63/301 (20%), Positives = 102/301 (33%), Gaps = 47/301 (15%)

Query: 27  EIDTKYVPI-KPIGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKL 82
           EID   V I + IG G +G VCS   +   ++   VAIK + + +  +      L E  +
Sbjct: 22  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 80

Query: 83  LRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQII--KSSQALTNDHCQYFLF 140
           +    H NVI L+ V+  S       V ++ E M+         ++    T       L 
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135

Query: 141 QLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYVVTRWYR 200
            +  G+KYL   N +HRDL   N+LVN+N   K+ DFGL+R         T         
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195

Query: 201 APELL----LCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRRE 255
                    +    + ++ DVWS G +  E++   +  +      + +  I      R  
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--DYRLP 253

Query: 256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
                                          D       L+      D   R    + + 
Sbjct: 254 PP----------------------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 316 H 316
            
Sbjct: 286 T 286

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 1e-40
 Identities = 61/318 (19%), Positives = 103/318 (32%), Gaps = 70/318 (22%)

Query: 31  KYVPIKPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH 85
               ++ IG GA+G V        +  E    VA+K +       + A    RE  L+  
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-DFQREAALMAE 72

Query: 86  LQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS------------------ 126
             + N++ L  V           + L++E M   DL++ ++S                  
Sbjct: 73  FDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 127 ------SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
                    L+         Q+  G+ YL     +HRDL   N LV  N  +KI DFGL+
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 181 R--TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGT 237
           R   S    +      +   +  PE +     Y T  DVW+ G +  E+       + G 
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGM 246

Query: 238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQ 297
                            EE + ++ +       ++ P                   +L++
Sbjct: 247 A---------------HEEVIYYVRDGNILACPENCP---------------LELYNLMR 276

Query: 298 KMLVFDPTKRISVTEALQ 315
                 P  R S     +
Sbjct: 277 LCWSKLPADRPSFCSIHR 294

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-40
 Identities = 67/319 (21%), Positives = 113/319 (35%), Gaps = 65/319 (20%)

Query: 26  FEID-TKYVPIKPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRTLRE 79
           +E    +    K +G GA+G V        +  +    VA+K +     +  +    + E
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSE 76

Query: 80  LKLLRHL-QHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKSSQ--------- 128
           LK+L +L  H N++ L                ++ E     DL   ++  +         
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 129 ---------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL 179
                    AL  +    F +Q+ +G+ +L S N +HRDL   N+L+      KICDFGL
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191

Query: 180 ARTSNGKNQFM--TEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPG 236
           AR     + ++      +   + APE +  C  Y    DVWS G    EL       +PG
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 237 TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLL 296
               ++   +I        E    +                          A     D++
Sbjct: 251 MPVDSKFYKMIK-------EGFRMLSP----------------------EHAPAEMYDIM 281

Query: 297 QKMLVFDPTKRISVTEALQ 315
           +     DP KR +  + +Q
Sbjct: 282 KTCWDADPLKRPTFKQIVQ 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (358), Expect = 3e-40
 Identities = 45/301 (14%), Positives = 92/301 (30%), Gaps = 45/301 (14%)

Query: 28  IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ 87
           +   Y   + IG G++G++    N   N++VAIK        R DA +   E +  + L 
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLA 58

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGL 146
               I      +    +      LV +L+   L  ++    +  +         Q+L  +
Sbjct: 59  GCTGI----PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 147 KYLHSANILHRDLKPGNLLVNANC-----DLKICDFGLAR-------TSNGKNQFMTEYV 194
           + +H  ++++RD+KP N L+          + + DFG+ +         +   +      
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR 254
            T  Y +    L  +      D+ ++G +F   L     + G +     +    I   ++
Sbjct: 175 GTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233

Query: 255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL 314
                                   TP   L           +                  
Sbjct: 234 S-----------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270

Query: 315 Q 315
            
Sbjct: 271 G 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-39
 Identities = 65/303 (21%), Positives = 107/303 (35%), Gaps = 59/303 (19%)

Query: 35  IKPIGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLRELKLLRHL-QHENV 91
              IG G +G V  +  ++   +   AIK++   + ++ D      EL++L  L  H N+
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 92  IALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIK----------------SSQALTNDH 134
           I L               YL  E     +L   ++                ++  L++  
Sbjct: 74  INLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 135 CQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQFMTEYV 194
             +F   + RG+ YL     +HRDL   N+LV  N   KI DFGL+R         T   
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGR 187

Query: 195 VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSR 253
           +   + A E  L    Y T+ DVWS G +  E++      + G  C    + +    G R
Sbjct: 188 LPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--GYR 244

Query: 254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA 313
            E+                              +      DL+++     P +R S  + 
Sbjct: 245 LEKP----------------------------LNCDDEVYDLMRQCWREKPYERPSFAQI 276

Query: 314 LQH 316
           L  
Sbjct: 277 LVS 279

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-38
 Identities = 62/317 (19%), Positives = 110/317 (34%), Gaps = 60/317 (18%)

Query: 26  FEID-TKYVPIKPIGRGAYGIVC-----SSVNRETNEKVAIKKINNAFENRVDALRTLRE 79
           +E    +    KP+GRGA+G V            T   VA+K +     +          
Sbjct: 8   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 67

Query: 80  LKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIKS------------ 126
             L+    H NV+ L              + ++ E     +L   ++S            
Sbjct: 68  KILIHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123

Query: 127 ----SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR- 181
                  LT +H   + FQ+ +G+++L S   +HRDL   N+L++    +KICDFGLAR 
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 182 -TSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTEC 239
              +       +  +   + APE +     Y    DVWS G +  E+       +PG + 
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 240 LNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKM 299
             +    +     +    +   D                           P     +   
Sbjct: 243 DEEFCRRL-----KEGTRMRAPDY------------------------TTPEMYQTMLDC 273

Query: 300 LVFDPTKRISVTEALQH 316
              +P++R + +E ++H
Sbjct: 274 WHGEPSQRPTFSELVEH 290

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-38
 Identities = 59/299 (19%), Positives = 105/299 (35%), Gaps = 46/299 (15%)

Query: 27  EIDT-KYVPIKPIGRGAYGIVCSSVNRETNEK----VAIKKINNAFENRVDALRTLRELK 81
           EI        K IG G +G V   + + ++ K    VAIK +   +  +   +  L E  
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAG 61

Query: 82  LLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELM--DTDLHQIIKSSQALTNDHCQYFL 139
           ++    H N+I L+ V+       +K + ++ E M        + +     +       L
Sbjct: 62  IMGQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116

Query: 140 FQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR---TSNGKNQFMTEYVVT 196
             +  G+KYL + N +HRDL   N+LVN+N   K+ DFGL+R            +   + 
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 197 RWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREE 256
             + APE +        S DVWS G +  E++                           E
Sbjct: 177 IRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYW--------------ELSNHE 221

Query: 257 DLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ 315
            ++ I++          P                    L+ +    +  +R    + + 
Sbjct: 222 VMKAINDGFRLPTPMDCP---------------SAIYQLMMQCWQQERARRPKFADIVS 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-38
 Identities = 61/289 (21%), Positives = 107/289 (37%), Gaps = 46/289 (15%)

Query: 38  IGRGAYGIVCSSVNRETNEK---VAIKKINNAFENRVDALRTLRELKLLRHLQHENVIAL 94
           IGRG +G V      + + K    A+K +N   +   +  + L E  +++   H NV++L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSL 93

Query: 95  KDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQ--YFLFQLLRGLKYLHSA 152
             + + S         +V   M     +    ++           F  Q+ +G+K+L S 
Sbjct: 94  LGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 153 NILHRDLKPGNLLVNANCDLKICDFGLAR----TSNGKNQFMTEYVVTRWYRAPELLLCC 208
             +HRDL   N +++    +K+ DFGLAR             T   +   + A E L   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-T 208

Query: 209 DNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR 267
             + T  DVWS G +  EL+    P +P    +N   + + +L  RR    E+  +P   
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYLLQGRRLLQPEYCPDP--- 262

Query: 268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH 316
                                     +++ K        R S +E +  
Sbjct: 263 ------------------------LYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-37
 Identities = 58/311 (18%), Positives = 115/311 (36%), Gaps = 57/311 (18%)

Query: 26  FEID-TKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRE 79
           +E+   K    + +G+G++G+V   V +     E   +VAIK +N A   R + +  L E
Sbjct: 15  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 73

Query: 80  LKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIK----------SSQ 128
             +++     +V+ L  V+            ++ ELM   DL   ++             
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128

Query: 129 ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLAR--TSNGK 186
             +         ++  G+ YL++   +HRDL   N +V  +  +KI DFG+ R       
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGTECLNQLKL 245
            +   + ++   + +PE L     + T  DVWS G +  E+    +  + G      L+ 
Sbjct: 189 YRKGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247

Query: 246 IINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPT 305
           ++   G   +                               +   +  +L++    ++P 
Sbjct: 248 VME--GGLLD----------------------------KPDNCPDMLFELMRMCWQYNPK 277

Query: 306 KRISVTEALQH 316
            R S  E +  
Sbjct: 278 MRPSFLEIISS 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 8e-37
 Identities = 58/319 (18%), Positives = 117/319 (36%), Gaps = 64/319 (20%)

Query: 26  FEID-TKYVPIKPIGRGAYGIVCSSVNRETNE-------KVAIKKINNAFENRVDALRTL 77
           +E+   + V  KP+G GA+G V  +     ++       KVA+K + +    + D    +
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLI 66

Query: 78  RELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVYELMD-TDLHQIIK----------- 125
            E+++++ +     I    + +         +Y++ E     +L + ++           
Sbjct: 67  SEMEMMKMIGKHKNI----INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122

Query: 126 -----SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLA 180
                  + L++       +Q+ RG++YL S   +HRDL   N+LV  +  +KI DFGLA
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182

Query: 181 RTSNGKNQFMTEYV--VTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELL-GRKPIFPGT 237
           R  +  + +       +   + APE L     Y    DVWS G +  E+       +PG 
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 238 ECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQ 297
                            EE  + +          +                      +++
Sbjct: 242 P---------------VEELFKLLKEGHRMDKPSNCT---------------NELYMMMR 271

Query: 298 KMLVFDPTKRISVTEALQH 316
                 P++R +  + ++ 
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.4 bits (239), Expect = 3e-24
 Identities = 28/198 (14%), Positives = 61/198 (30%), Gaps = 29/198 (14%)

Query: 36  KPIGRGAYGIVCSSVNRETNEKVAIKKI--------NNAFENRVDALRTLRELKLLRHLQ 87
           K +G G    V +  + E   +  +K              +     L            +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 88  HENVIALKDVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLK 147
              +  L+ + +P     ++   ++ EL+D      ++       ++    L  +L  + 
Sbjct: 65  FRALQKLQGLAVP-KVYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMILEEVA 117

Query: 148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF----MTEYVVTRWYRAPE 203
             +   I+H DL   N+LV+    + I DF  +     +            +  ++    
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR-- 174

Query: 204 LLLCCDNYGTSIDVWSVG 221
                  Y T  D+ S  
Sbjct: 175 ------TYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	373
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.64
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.48
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.37
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.77

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-66  Score=474.94  Aligned_cols=343  Identities=43%  Similarity=0.800  Sum_probs=289.3

Q ss_pred             CCcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeee
Q 017334           14 PGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA   93 (373)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~   93 (373)
                      .|+....+.++.+++.++|++++.||+|+||+||+|+++.+|+.||||++++..........+.+|+.+|+.++|||||+
T Consensus         2 ~~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~   81 (346)
T d1cm8a_           2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG   81 (346)
T ss_dssp             CSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCC
T ss_pred             CCcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeE
Confidence            35555667777788999999999999999999999999999999999999877667677778899999999999999999


Q ss_pred             eceeecCCC-CCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334           94 LKDVMMPSH-RRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus        94 ~~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                      +++++.... .....++|+||||++++|..+++. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        82 l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~  160 (346)
T d1cm8a_          82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL  160 (346)
T ss_dssp             CSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE
T ss_pred             EEEEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccc
Confidence            999996543 234457899999998888887765 689999999999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      ||+|||+|......   .+..+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..+....+.
T Consensus       161 kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~  237 (346)
T d1cm8a_         161 KILDFGLARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT  237 (346)
T ss_dssp             EECCCTTCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccccccceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCC
Confidence            99999999876432   356789999999999988677899999999999999999999999999999999999999999


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQ  332 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~  332 (373)
                      ++...................+......+....+.+++.+.+||++||..||++|||+.|+|+||||+.+..+...+..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~  317 (346)
T d1cm8a_         238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ  317 (346)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC
T ss_pred             CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC
Confidence            99988888887777888888888888888888999999999999999999999999999999999999887665555433


Q ss_pred             CCCCCCccc-ccCHHHHHHHHHHHHHhcCc
Q 017334          333 VPIDLDMDE-ESGEEMIREMMLKEMLHYHP  361 (373)
Q Consensus       333 ~~~~~~~~~-~~~~~~~~~~~~~e~~~~~~  361 (373)
                       ..+...+. +...+.+++++.+|+..+.|
T Consensus       318 -~~~~~~~~~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         318 -KYDDSFDDVDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             -CCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred             -CCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence             23333332 56778999999999988776

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-64  Score=465.31  Aligned_cols=337  Identities=50%  Similarity=0.927  Sum_probs=285.8

Q ss_pred             eeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           24 TLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        24 ~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++++..+|++++.||+|+||+||+|+++.+|+.||||++.+.. .......+++|+.+|++++||||+++++++.....
T Consensus         2 ~~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            46788999999999999999999999999999999999997543 34455678899999999999999999999976654


Q ss_pred             CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          104 RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .....+|+++++++|+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55567888888888999999976 57999999999999999999999999999999999999999999999999999765


Q ss_pred             CCC---CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          184 NGK---NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       184 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      ...   .......+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+....+...++.+.......
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            332   22345668999999999987767789999999999999999999999999999999999999999888887777


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQVPIDLDMD  340 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  340 (373)
                      .............+.....++...++.+++.+++||.+||+.||++|||+.|+|+||||.....+...+....+...+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~~~  319 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDME  319 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC-----
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCChh
Confidence            77777777778888888888888899999999999999999999999999999999999988776666555555554433


Q ss_pred             -cccCHHHHHHHHHHHHHhcCcc
Q 017334          341 -EESGEEMIREMMLKEMLHYHPE  362 (373)
Q Consensus       341 -~~~~~~~~~~~~~~e~~~~~~~  362 (373)
                       ++...+.+++++.+|..++.|.
T Consensus       320 ~~~~~~~~l~~l~~~e~~~~~~~  342 (345)
T d1pmea_         320 LDDLPKEKLKELIFEETARFQPG  342 (345)
T ss_dssp             ---CCHHHHHHHHHHHSGGGSTT
T ss_pred             hhhCCHHHHHHHHHHHHHhcCCC
Confidence             2556778899999999988886

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-64  Score=464.63  Aligned_cols=344  Identities=46%  Similarity=0.841  Sum_probs=295.1

Q ss_pred             CCcceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeee
Q 017334           14 PGKHYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIA   93 (373)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~   93 (373)
                      |++.-.....++|++.++|++++.||+|+||+||+|+++.+|+.||||++.+...+.....++.+|+.+|+.++||||++
T Consensus         2 ~~~~~~~~~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~   81 (348)
T d2gfsa1           2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG   81 (348)
T ss_dssp             CCEEEEECSSSEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcEEEecCCccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeee
Confidence            44445556788899999999999999999999999999999999999999887777777778899999999999999999


Q ss_pred             eceeecCCCC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334           94 LKDVMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus        94 ~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                      +++++..... ++.+..++++++.+|+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~  160 (348)
T d2gfsa1          82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL  160 (348)
T ss_dssp             CSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             EEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccc
Confidence            9999865432 33455666666667899998865 579999999999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCC
Q 017334          173 KICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGS  252 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  252 (373)
                      |++|||++....   ....+..||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+.+..+.
T Consensus       161 kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~  237 (348)
T d2gfsa1         161 KILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  237 (348)
T ss_dssp             EECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccchhcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999999987543   33456689999999999887667899999999999999999999999999999999999999999


Q ss_pred             CChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCCCCCCCC
Q 017334          253 RREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPSSNPPAQ  332 (373)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~  332 (373)
                      +...............+.......+...+...+..+++.+++||++||+.||++|||+.|+|+||||+...++..++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~  317 (348)
T d2gfsa1         238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD  317 (348)
T ss_dssp             CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCC
T ss_pred             CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCC
Confidence            98888887777777788888888888888888889999999999999999999999999999999999887776665443


Q ss_pred             CCCCCCc-ccccCHHHHHHHHHHHHHhcCcc
Q 017334          333 VPIDLDM-DEESGEEMIREMMLKEMLHYHPE  362 (373)
Q Consensus       333 ~~~~~~~-~~~~~~~~~~~~~~~e~~~~~~~  362 (373)
                       +.+... ..+...+.+++.+.+|+.++.|.
T Consensus       318 -~~~~~~~~~~~~~~~~k~~~~~e~~~~~p~  347 (348)
T d2gfsa1         318 -PYDQSFESRDLLIDEWKSLTYDEVISFVPP  347 (348)
T ss_dssp             -CCCCGGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred             -CCCCcccchhcCHHHHHHHHHHHhhccCCC
Confidence             444443 34667899999999999998874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-65  Score=450.29  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=214.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..... .....+.+|+.+++.++||||+++++++     .+.+.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~   78 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   78 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence            6899999999999999999999999999999999754322 2234578999999999999999999999     445789


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC--
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK--  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--  186 (373)
                      |+|||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.....  
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999996 699999988889999999999999999999999999999999999999999999999999999865322  


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .....+.+||+.|+|||++.+...++.++|||||||++|+|++|++||..............  ..              
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~--~~--------------  222 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EK--------------  222 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH--TT--------------
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh--cC--------------
Confidence            23345678999999999998754557889999999999999999999977654332222111  00              


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                  ......++.+|+++.+||++||+.||++|||++|+|+||||+.
T Consensus       223 ------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         223 ------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             ------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             ------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                        0001112457899999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-64  Score=450.92  Aligned_cols=255  Identities=25%  Similarity=0.436  Sum_probs=221.5

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.......  ...+.+|+.+++.++||||+++++++     ...+.
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   91 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSY-----LVGDE   91 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCE
Confidence            468999999999999999999999999999999997654333  34578999999999999999999999     44477


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+|||||+ |+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+......
T Consensus        92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            999999996 699988765 579999999999999999999999999999999999999999999999999998776555


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.....                
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~----------------  233 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT----------------  233 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS----------------
T ss_pred             ccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence            55667789999999999977 6789999999999999999999999988876666555543110                


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                  +....++.+|+.+++||.+||+.||++|||+.|+|+||||+
T Consensus       234 ------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~  274 (293)
T d1yhwa1         234 ------------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (293)
T ss_dssp             ------------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred             ------------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence                        00112245789999999999999999999999999999996

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-64  Score=445.80  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=219.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+.... ......+.+|+.+++.++||||+++++++     .+.+.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence            6899999999999999999999999999999999754322 22244577899999999999999999999     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+|||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... 
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            999999996 699999998889999999999999999999999999999999999999999999999999999765433 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                       .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.+.-                 
T Consensus       160 -~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------------  220 (263)
T d2j4za1         160 -RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------------  220 (263)
T ss_dssp             -CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------------
T ss_pred             -cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence             2355689999999999987 678999999999999999999999999887666655543310                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                    ...+..+|+++++||.+||+.||++|||++|+|+||||+
T Consensus       221 --------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         221 --------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             --------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence                          012245789999999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-64  Score=445.47  Aligned_cols=256  Identities=28%  Similarity=0.450  Sum_probs=210.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++............+.+|+++++.++||||+++++++...   ..+.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence            689999999999999999999999999999999987766666677788999999999999999999998542   23568


Q ss_pred             EEEeecCC-ccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEEcCCCCeEEcccCc
Q 017334          110 YLVYELMD-TDLHQIIKS----SQALTNDHCQYFLFQLLRGLKYLHSAN-----ILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~-----ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                      |+|||||+ |+|.+++..    .+.+++.+++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            99999996 699998853    467999999999999999999999876     99999999999999999999999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      |+..........+.+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.+.          
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~----------  229 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------  229 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----------
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC----------
Confidence            9877655555567899999999999976 67999999999999999999999999988776666555431          


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYM  319 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~  319 (373)
                                          .+...+..+|+++.+||++||+.||++|||+.|+|+|||+
T Consensus       230 --------------------~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         230 --------------------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             --------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --------------------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                1112234678999999999999999999999999999995

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-64  Score=453.11  Aligned_cols=284  Identities=40%  Similarity=0.665  Sum_probs=233.7

Q ss_pred             eeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChH---HHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEE
Q 017334           34 PIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRV---DALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVY  110 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  110 (373)
                      .++.||+|+||+||+|+++.+|+.||||+++.......   ....+.+|+.+++.++||||+++++++     ...+++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence            47889999999999999999999999999975433221   123577999999999999999999999     4457799


Q ss_pred             EEeecCCccH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 017334          111 LVYELMDTDL-HQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQF  189 (373)
Q Consensus       111 lv~e~~~g~L-~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  189 (373)
                      +||||+.|++ ..+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.........
T Consensus        77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            9999998644 444455678999999999999999999999999999999999999999999999999999877665555


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARKY  269 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  269 (373)
                      ..+.+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++..|.+.++.+....+.........  
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~--  234 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY--  234 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh--
Confidence            667789999999999987677899999999999999999999999999999999999999998776654332211100  


Q ss_pred             HHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          270 IKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                       ......+..++...++.+++.+++||++||+.||++|||++|+|+||||+....+
T Consensus       235 -~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         235 -VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             -CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             -hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence             0112223344556667889999999999999999999999999999999865433

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.8e-64  Score=451.40  Aligned_cols=264  Identities=29%  Similarity=0.446  Sum_probs=210.3

Q ss_pred             ceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           23 QTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        23 ~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      +...++.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++    
T Consensus         2 ~~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~----   76 (307)
T d1a06a_           2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIY----   76 (307)
T ss_dssp             EECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEE----
T ss_pred             CCCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence            445678899999999999999999999999999999999997654332 234567899999999999999999999    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---CCCCeEEcccC
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN---ANCDLKICDFG  178 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~---~~~~~kL~Dfg  178 (373)
                       ++.+.+|+|||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+.   .++.+||+|||
T Consensus        77 -~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          77 -ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             -EECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccc
Confidence             45578999999996 79999999889999999999999999999999999999999999999995   47899999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      +|+.... .....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+.+...       
T Consensus       156 ~a~~~~~-~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-------  226 (307)
T d1a06a_         156 LSKMEDP-GSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-------  226 (307)
T ss_dssp             ------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC-------
T ss_pred             eeEEccC-CCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------
Confidence            9986543 333456789999999999977 6799999999999999999999999998876666555543110       


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                          ......++.+|+.+++||.+||+.||++|||+.|+++||||+.
T Consensus       227 --------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         227 --------------------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             --------------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             --------------------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                                0111234568999999999999999999999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-63  Score=448.30  Aligned_cols=289  Identities=39%  Similarity=0.684  Sum_probs=241.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|++++++++||||+++++++     ...+++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence            589999999999999999999999999999999976544444455778999999999999999999999     445789


Q ss_pred             EEEeecCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMDTDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      |+||||+++++.+++..  ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99999999887776643  4579999999999999999999999999999999999999999999999999998876666


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      .......||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+....+.....  ..
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~  234 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MP  234 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--ST
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc--cc
Confidence            6677779999999999988766778999999999999999999999999999999999988888776554432211  11


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      ......+......+....+.+|+.+++||++||+.||++|||++|+|+||||+.+..|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            1112223333344455667889999999999999999999999999999999877544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-63  Score=451.08  Aligned_cols=256  Identities=24%  Similarity=0.449  Sum_probs=226.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+|+.++||||+++++++     ++.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence            689999999999999999999999999999999976532 222345678999999999999999999999     55578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            999999996 7999999998999999999999999999999999999999999999999999999999999998766555


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+...  .               
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~---------------  221 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--E---------------  221 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C---------------
T ss_pred             cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--C---------------
Confidence            66677899999999999987 67899999999999999999999999998876666555431  0               


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                    ...+..+|+++++||++||++||++|++     ++|+++||||..+
T Consensus       222 --------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         222 --------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             --------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence                          1123568999999999999999999994     8999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-62  Score=435.70  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=217.4

Q ss_pred             cCce-eeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKY-VPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y-~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +++| ++.+.||+|+||+||+|+++.+++.||+|++............+.+|+++|++++||||+++++++.... ....
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~   85 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK   85 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCC
Confidence            4555 6777899999999999999999999999999877666666777889999999999999999999985432 3346


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEc-CCCCeEEcccCccccc
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSAN--ILHRDLKPGNLLVN-ANCDLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~Nill~-~~~~~kL~Dfg~a~~~  183 (373)
                      .+|+||||++ |+|.+++.+.+.+++.+++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+..
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            7999999996 699999998889999999999999999999999999  99999999999997 4789999999999865


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ...  ...+.+||+.|+|||++.+  .++.++|||||||++|+|++|++||.+......+....  .....         
T Consensus       166 ~~~--~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i--~~~~~---------  230 (270)
T d1t4ha_         166 RAS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--TSGVK---------  230 (270)
T ss_dssp             CTT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH--TTTCC---------
T ss_pred             cCC--ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH--HcCCC---------
Confidence            332  3456789999999999865  59999999999999999999999998765443332211  11100         


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMS  320 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~  320 (373)
                                       ........++++.+||.+||+.||++|||+.|+|+||||+
T Consensus       231 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 -----------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -----------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -----------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                             0112245788899999999999999999999999999985

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-63  Score=444.11  Aligned_cols=257  Identities=26%  Similarity=0.439  Sum_probs=218.9

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.++++++||||+++++++     ++.+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~   81 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDE   81 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSS
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECC
Confidence            3689999999999999999999999999999999975432 222334678999999999999999999999     4557


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            8999999996 699999998899999999999999999999999999999999999999999999999999999876432


Q ss_pred             --CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 --NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                        .....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.+.-              
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~--------------  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--------------  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC--------------
T ss_pred             CcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC--------------
Confidence              233456789999999999987 679999999999999999999999999887766665554310              


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHH------HhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTE------ALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~e------il~hp~~~~~  322 (373)
                                       ...+..+++.+++||++||+.||++|||++|      +++||||+.+
T Consensus       227 -----------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         227 -----------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             -----------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence                             0122457899999999999999999999987      5889999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-63  Score=446.00  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=219.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .+.|++++.||+|+||+||+|+++.+|+.||||++......  ....+.+|+++|+.++|||||++++++     .+.+.
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   83 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAF-----YYENN   83 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCe
Confidence            46799999999999999999999999999999999754322  334577999999999999999999999     44478


Q ss_pred             EEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          109 VYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      +|+|||||+ |+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|......
T Consensus        84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            999999996 699998764 467999999999999999999999999999999999999999999999999999765433


Q ss_pred             CccccceeeccccCchhhhhc----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          187 NQFMTEYVVTRWYRAPELLLC----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .....+.+||+.|+|||++.+    ...|+.++|||||||++|+|++|++||.+.+..+.+..+.+..  +         
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~---------  232 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--P---------  232 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--C---------
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence            333456789999999999853    3468899999999999999999999999888777666654410  0         


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                       +.....+.+|+++++||++||+.||++|||+.|+|+||||+.
T Consensus       233 -----------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         233 -----------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             -----------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             -----------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                             001112457899999999999999999999999999999963

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-62  Score=439.59  Aligned_cols=262  Identities=31%  Similarity=0.494  Sum_probs=224.7

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC----hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN----RVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++++....    ......+.+|+.+|+.++|||||++++++    
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~----   82 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY----   82 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence            4678999999999999999999999999999999999754321    12345678999999999999999999999    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----CeEEccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC----DLKICDF  177 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~----~~kL~Df  177 (373)
                       ++.+.+|+|||||+ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++    .+||+||
T Consensus        83 -~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          83 -ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             -EECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence             55578999999996 69999999888999999999999999999999999999999999999998877    4999999


Q ss_pred             CcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          178 GLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      |+|...... ....+..||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..+........   
T Consensus       162 G~a~~~~~~-~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~---  236 (293)
T d1jksa_         162 GLAHKIDFG-NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE---  236 (293)
T ss_dssp             TTCEECTTS-CBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC---
T ss_pred             hhhhhcCCC-ccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC---
Confidence            999876433 33455689999999999976 6789999999999999999999999998887776666544211111   


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                              ...++.+|+.+++||++||+.||++|||++|+|+||||++.
T Consensus       237 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         237 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             ------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             ------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                                    12235678999999999999999999999999999999753

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-63  Score=454.19  Aligned_cols=283  Identities=22%  Similarity=0.357  Sum_probs=216.5

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|+++.... ......+.+|+.+|+.++|||||++++++     .+.+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~   77 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDG   77 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSS
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            46899999999999999999999999999999999976533 33445778999999999999999999999     4447


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      ++|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++++||+|||+|.....
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            7999999997 6999999988899999999999999999999997 5999999999999999999999999999986432


Q ss_pred             CCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHHHhCCCChhhhcc----
Q 017334          186 KNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQ-LKLIINILGSRREEDLEF----  260 (373)
Q Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~----  260 (373)
                        ....+.+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+..+. ...+....+.........    
T Consensus       158 --~~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 --SMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             --HTC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             --CccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence              22356799999999999987 6799999999999999999999999987665432 222222222111100000    


Q ss_pred             ----------cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          261 ----------IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       261 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                ...................  ..-....|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCC--CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCc--cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                      0000000011100000000  0001236889999999999999999999999999999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-61  Score=444.52  Aligned_cols=336  Identities=43%  Similarity=0.760  Sum_probs=261.1

Q ss_pred             ceeEecceeeeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeece
Q 017334           17 HYYSMWQTLFEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKD   96 (373)
Q Consensus        17 ~~~~~~~~~~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   96 (373)
                      ..+.+.+..|.+.++|++++.||+|+||+||+|+++.+|+.||||++.+...+.....++.+|+.+++.++||||+++++
T Consensus         4 ~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~   83 (355)
T d2b1pa1           4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN   83 (355)
T ss_dssp             EEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             EEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence            35667777888889999999999999999999999999999999999887777777778899999999999999999999


Q ss_pred             eecCCCC-CCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEc
Q 017334           97 VMMPSHR-RNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus        97 ~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      +|..... +...++|+||||+.|++.+.+.  ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++
T Consensus        84 ~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             EECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEecccccccCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeee
Confidence            9965432 3557899999999988877664  579999999999999999999999999999999999999999999999


Q ss_pred             ccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      |||+++.... .......++|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......+...++.+..
T Consensus       162 df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         162 DFGLARTAGT-SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             CCCC----------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhhhhcccc-ccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            9999876543 334456689999999999987 68999999999999999999999999999999999999998888877


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccC------------CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLY------------PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLY  323 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~  323 (373)
                      +.+.... .....+....+......+....            ...++.+.+||++||..||++||||+|+|+||||+...
T Consensus       240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         240 EFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHTTSC-HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHHhh-hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            6655433 3344444444433333322221            12467799999999999999999999999999998765


Q ss_pred             CCCCCCCC-CCCCCCCcc-cccCHHHHHHHHHHHHH
Q 017334          324 DPSSNPPA-QVPIDLDMD-EESGEEMIREMMLKEML  357 (373)
Q Consensus       324 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~e~~  357 (373)
                      ++...... +...+.+.+ .+...+.+++.+.+|.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (355)
T d2b1pa1         319 DPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM  354 (355)
T ss_dssp             CHHHHTCCCC-------CCCCCCHHHHHHHHHHHHH
T ss_pred             CcccccCCCCCCCCcchhhhhcCHHHHHHHHHHHhc
Confidence            43332222 222333333 36667789999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.9e-62  Score=446.97  Aligned_cols=261  Identities=25%  Similarity=0.431  Sum_probs=224.3

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +-++|++++.||+|+||+||+|+++.+|+.||||++.+..  ......+.+|+.+|+.++||||+++++++     .+.+
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~   96 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDN   96 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETT
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            3478999999999999999999999999999999997543  33455678999999999999999999999     4457


Q ss_pred             eEEEEeecCC-ccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--CCCeEEcccCccccc
Q 017334          108 DVYLVYELMD-TDLHQIIK-SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA--NCDLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~--~~~~kL~Dfg~a~~~  183 (373)
                      .+|+|||||+ |+|.+++. ..+.+++.+++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+|+..
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            8999999996 69999985 4467999999999999999999999999999999999999964  578999999999876


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+......         
T Consensus       177 ~~~-~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------  245 (350)
T d1koaa2         177 DPK-QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------  245 (350)
T ss_dssp             CTT-SCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC---------
T ss_pred             ccc-cccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            433 33456789999999999987 6789999999999999999999999999887777777655221111         


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYD  324 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~  324 (373)
                                        ...++.+|+.+++||.+||+.||++|||+.|+|+||||+....
T Consensus       246 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         246 ------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             ------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             ------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                              1223467899999999999999999999999999999986543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-62  Score=439.59  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=217.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-hHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-RVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ...|++++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+.+|+.++|||||++++++.     +.+
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~   88 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REH   88 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECC
Confidence            35699999999999999999999999999999999765433 344556889999999999999999999994     447


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+|||||. |+|..++..++.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..... 
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            7999999997 56766677778999999999999999999999999999999999999999999999999999986532 


Q ss_pred             CccccceeeccccCchhhhhcC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          187 NQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                         ....+||+.|+|||++.+.  ..|+.++|||||||++|+|++|.+||.+.+..+.+..+...  ..           
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~--~~-----------  231 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ES-----------  231 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC-----------
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CC-----------
Confidence               2456899999999998652  45899999999999999999999999887766655554431  00           


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                               +       ......+|+.+++||.+||+.||++|||++|+|+||||..
T Consensus       232 ---------~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         232 ---------P-------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             ---------C-------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ---------C-------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                     0       0112457899999999999999999999999999999964

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.7e-61  Score=443.67  Aligned_cols=259  Identities=26%  Similarity=0.454  Sum_probs=223.8

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++++..  ......+.+|+.+|+.++||||+++++++     .+.+
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~   99 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKY   99 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSS
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            3478999999999999999999999999999999997543  33445677999999999999999999999     4557


Q ss_pred             eEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--CCCCeEEcccCccccc
Q 017334          108 DVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVN--ANCDLKICDFGLARTS  183 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~--~~~~~kL~Dfg~a~~~  183 (373)
                      .+|+|||||+ |+|.+.+... .++++.+++.++.||+.||+|||++||+||||||+|||++  .++.+||+|||+|...
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence            8999999996 6999887654 4699999999999999999999999999999999999998  5789999999999876


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.....          
T Consensus       180 ~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----------  247 (352)
T d1koba_         180 NPD-EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF----------  247 (352)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC----------
T ss_pred             CCC-CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence            443 33456789999999999977 679999999999999999999999999988777776665421111          


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                       ....++.+|+++.+||++||+.||.+|||+.|+|+||||+..
T Consensus       248 -----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         248 -----------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             -----------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                             122346789999999999999999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.6e-62  Score=439.44  Aligned_cols=253  Identities=25%  Similarity=0.438  Sum_probs=222.1

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+++.++||||+++++++     ...+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            679999999999999999999999999999999975432 222345677999999999999999999999     44578


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +|+|||||. |+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            999999996 699999999899999999999999999999999999999999999999999999999999999876433 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                        ..+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....+.+.-                 
T Consensus       158 --~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------------  217 (316)
T d1fota_         158 --TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------------  217 (316)
T ss_dssp             --BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------------
T ss_pred             --cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------------
Confidence              345789999999999976 678999999999999999999999999988777666655410                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                    ...++.+++.+.++|.+||..||++|+     |++++++||||+++
T Consensus       218 --------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         218 --------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence                          012356789999999999999999996     89999999999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3e-61  Score=428.12  Aligned_cols=261  Identities=30%  Similarity=0.490  Sum_probs=223.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccC-------hHHHHHHHHHHHHHhhCC-CCCeeeeceeecC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFEN-------RVDALRTLRELKLLRHLQ-HENVIALKDVMMP  100 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  100 (373)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+....       ......+.+|+.++++++ ||||+++++++  
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--   79 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence            58999999999999999999999999999999999764322       122335779999999997 99999999999  


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGL  179 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~  179 (373)
                         .+.+++|+||||++ |+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        80 ---~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          80 ---ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             ---ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence               45578999999996 69999999889999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhc-----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCC
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLC-----CDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRR  254 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (373)
                      +...... ......+||+.|+|||++.+     ...++.++||||+||++|+|++|++||.+.+.......+.+.--.  
T Consensus       157 a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~--  233 (277)
T d1phka_         157 SCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--  233 (277)
T ss_dssp             CEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--
T ss_pred             eeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC--
Confidence            9876543 33456789999999999864     235788999999999999999999999988876666655541100  


Q ss_pred             hhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          255 EEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                               ......+.+|+++++||.+||+.||++|||++|+|+||||+.+
T Consensus       234 -------------------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         234 -------------------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             -------------------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             -------------------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                                     0011234688999999999999999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-61  Score=436.15  Aligned_cols=288  Identities=40%  Similarity=0.668  Sum_probs=236.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC-CcEEEEEEccccccChHHHHHHHHHHHHHhhC---CCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET-NEKVAIKKINNAFENRVDALRTLRELKLLRHL---QHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~-g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~  104 (373)
                      .++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+++.+   +||||+++++++......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            57999999999999999999999765 66799999976544333333455677776665   799999999998765445


Q ss_pred             CcceEEEEeecCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMDTDLHQIIK--SSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ....+|++|||+++++..+..  ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            567899999999876554443  345799999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .. ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+....+....
T Consensus       166 ~~-~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         166 YS-FQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CC-GGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hc-ccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            53 2334566789999999999987 679999999999999999999999999999999999999999988776554322


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      ....    .........+.....+.+++.+++||++||+.||++|||+.|+|+||||+.+
T Consensus       244 ~~~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         244 ALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             SSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cchh----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            1110    1122233344556667899999999999999999999999999999999865

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.6e-62  Score=435.12  Aligned_cols=284  Identities=39%  Similarity=0.670  Sum_probs=235.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|+++ +|+.||||+++...........+.+|+.+|++++||||+++++++     .+.+..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence            68999999999999999999986 789999999976654444456788999999999999999999999     444779


Q ss_pred             EEEeecCCccHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMDTDLHQ-IIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~g~L~~-~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      |++||++.+++.. +....+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+........
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9999999865544 445567899999999999999999999999999999999999999999999999999987655555


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      ......+++.|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+++..+.+.++.+....+.....  ...
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~  233 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE--LPK  233 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STT
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh--hhh
Confidence            556668999999999998777789999999999999999999999999999999999999888876554432211  111


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ...........++....+.+++.+.|||++||+.||++|||+.|+|+||||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            12233334445566777889999999999999999999999999999999963

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.7e-61  Score=442.37  Aligned_cols=253  Identities=24%  Similarity=0.436  Sum_probs=221.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++     .....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccccc
Confidence            689999999999999999999999999999999975432 222344678999999999999999999999     44577


Q ss_pred             EEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          109 VYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      +++||||+. |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..... 
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            999999996 799999988889999999999999999999999999999999999999999999999999999876433 


Q ss_pred             ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          188 QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                        ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....                 
T Consensus       195 --~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-----------------  254 (350)
T d1rdqe_         195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-----------------  254 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------
T ss_pred             --cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC-----------------
Confidence              345789999999999987 678999999999999999999999999887766666654410                 


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                    ...+..+++++.+||++||+.||.+|+     |++++++||||+..
T Consensus       255 --------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         255 --------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             --------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence                          012345889999999999999999995     89999999999864

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-61  Score=438.12  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=221.6

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHh-hCCCCCeeeeceeecCCCCCCcc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLR-HLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++... .......+.+|..++. .++||||+++++++     .+.+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            579999999999999999999999999999999975432 1222334566777654 68999999999999     5557


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      .+|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.....
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            8999999996 699999999899999999999999999999999999999999999999999999999999999876655


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhH
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKA  266 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  266 (373)
                      .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+...  .              
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~--------------  219 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N--------------  219 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C--------------
T ss_pred             cccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------
Confidence            566667799999999999987 67999999999999999999999999998877766655431  0              


Q ss_pred             HHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHH-HHhCCCCCCCC
Q 017334          267 RKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT-EALQHPYMSPL  322 (373)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~-eil~hp~~~~~  322 (373)
                                     ...+..+|+.+.+||++||+.||++|||+. ++++||||+.+
T Consensus       220 ---------------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         220 ---------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             ---------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             ---------------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence                           012245789999999999999999999995 89999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-60  Score=440.81  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=215.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc----ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE----NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+...    ......+..+++.+++.++||||+++++++     ..
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HT   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----EC
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----EE
Confidence            689999999999999999999999999999999865422    112222333457778888999999999999     44


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      .+.+|+||||++ |+|.+++.....+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            578999999996 7999999988999999999999999999999999999999999999999999999999999998664


Q ss_pred             CCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          185 GKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                      ..  .....+||+.|+|||++.+...|+.++|||||||++|+|++|++||.+.+..+...........            
T Consensus       159 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------------  224 (364)
T d1omwa3         159 KK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------------  224 (364)
T ss_dssp             SS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------------
T ss_pred             CC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------------
Confidence            33  2345689999999999976567999999999999999999999999876544433222211110            


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCC-----HHHHhCCCCCCCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRIS-----VTEALQHPYMSPL  322 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t-----~~eil~hp~~~~~  322 (373)
                                      ....+..+|+++++||.+||+.||++|||     ++|+++||||+++
T Consensus       225 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         225 ----------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             ----------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             ----------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence                            11223568999999999999999999999     7999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-60  Score=433.58  Aligned_cols=258  Identities=25%  Similarity=0.444  Sum_probs=222.7

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      +|-++|++++.||+|+||+||+|+++.+|+.||||+++...   .+...+.+|+.+|+.++||||+++++++     ++.
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~   73 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESF-----ESM   73 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EET
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence            45689999999999999999999999999999999997643   2334567999999999999999999999     455


Q ss_pred             ceEEEEeecCC-ccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC--CCeEEcccCcccc
Q 017334          107 KDVYLVYELMD-TDLHQIIKSSQ-ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN--CDLKICDFGLART  182 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~--~~~kL~Dfg~a~~  182 (373)
                      +.+|+|||||+ |+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+  ..+||+|||++..
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence            78999999997 69999998665 79999999999999999999999999999999999999855  4799999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                      .... ......++|+.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|.+.....+        
T Consensus       154 ~~~~-~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--------  223 (321)
T d1tkia_         154 LKPG-DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------  223 (321)
T ss_dssp             CCTT-CEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------
T ss_pred             cccC-CcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            6433 33456788999999999876 5789999999999999999999999999888777777765221111        


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                         ...++.+|+++++||++||..||++|||+.|+|+||||+.
T Consensus       224 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         224 -------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             -------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             -------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                               1223568899999999999999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-59  Score=433.43  Aligned_cols=287  Identities=34%  Similarity=0.623  Sum_probs=234.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC-CCCcce
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH-RRNFKD  108 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~  108 (373)
                      -+|+.++.||+|+||+||+|+++.+|+.||||++.+....      ..+|+.+|++++||||+++++++.... ..+..+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            3799999999999999999999999999999999754322      236999999999999999999986542 234567


Q ss_pred             EEEEeecCCccHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCccccc
Q 017334          109 VYLVYELMDTDLHQII----KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLARTS  183 (373)
Q Consensus       109 ~~lv~e~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~~  183 (373)
                      +|+||||+++++.+.+    .....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            8999999997665544    3456799999999999999999999999999999999999999876 8999999999876


Q ss_pred             CCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          184 NGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      ... ....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+++..+.+.+|.+..+.+.....
T Consensus       174 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         174 VRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            433 3345678999999999988767899999999999999999999999999999999999999999887765543221


Q ss_pred             hhHHHHHHhCCCCCCCCcc-ccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFS-RLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDPS  326 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~~  326 (373)
                      ....   ...+.....++. ...+..++++.+||.+||..||++|||+.|+|+||||+.+..+.
T Consensus       253 ~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  313 (350)
T d1q5ka_         253 NYTE---FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN  313 (350)
T ss_dssp             ---C---CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred             chhh---ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence            1100   011111222222 23456899999999999999999999999999999998876544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-60  Score=430.20  Aligned_cols=291  Identities=36%  Similarity=0.577  Sum_probs=230.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC---CCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR---RNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~~  106 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++.....   ...
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            89999999999999999999999999999999997665554455567899999999999999999999855321   234


Q ss_pred             ceEEEEeecCCccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          107 KDVYLVYELMDTDLHQII-KSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +++|+||||+++++.... .....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~  169 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  169 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence            679999999986555544 4556899999999999999999999999999999999999999999999999999975542


Q ss_pred             C----CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          186 K----NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       186 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .    .....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+.+..+.+........
T Consensus       170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (318)
T d3blha1         170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV  249 (318)
T ss_dssp             -----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTC
T ss_pred             ccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcccc
Confidence            2    223345689999999999987678999999999999999999999999999999999999999998887766555


Q ss_pred             CChhHHHHHHhCCCCCCCCccccC--CCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLY--PDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                      ................. .....+  ...++.+.|||.+||+.||++|||++|+|+||||+.
T Consensus       250 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         250 DNYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             CCC-------CCSSCCB-CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             chhhhhhhhcccccccc-cchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            44433332222211111 100000  124778899999999999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-59  Score=420.93  Aligned_cols=289  Identities=41%  Similarity=0.657  Sum_probs=240.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..........++.+|+.+++.++||||+++++++     .+....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            689999999999999999999999999999999977666666677888999999999999999999999     445779


Q ss_pred             EEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc
Q 017334          110 YLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ  188 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  188 (373)
                      ++|++++. ++|..++...+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+........
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            99999997 47777778888999999999999999999999999999999999999999999999999999987765555


Q ss_pred             cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCC-CCCCCchHHHHHHHHHhCCCChhhhcccCChhHH
Q 017334          189 FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPI-FPGTECLNQLKLIINILGSRREEDLEFIDNPKAR  267 (373)
Q Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  267 (373)
                      ......+++.|+|||++.+...++.++|||||||++|+|++|+.| |.+.+..+.+..+....+.+....+.......  
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  234 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP--  234 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST--
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc--
Confidence            555667889999999998766789999999999999999988755 67777788888888888876655433221100  


Q ss_pred             HHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCCCCC
Q 017334          268 KYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPLYDP  325 (373)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~~~~  325 (373)
                      ..................+.+++.+.+||++||+.||++||||+|+|+||||+.+.+|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            0000000111223344556789999999999999999999999999999999876543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-60  Score=424.65  Aligned_cols=251  Identities=27%  Similarity=0.427  Sum_probs=212.0

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccCh----HHHHHHHHHHHHHhhCC--CCCeeeeceeecCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENR----VDALRTLRELKLLRHLQ--HENVIALKDVMMPS  101 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~  101 (373)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++.+.....    ....++.+|+.++++++  ||||+++++++   
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---   78 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---   78 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE---
Confidence            4689999999999999999999999999999999997543211    11223558999999987  89999999999   


Q ss_pred             CCCCcceEEEEeecCC--ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CCeEEcccC
Q 017334          102 HRRNFKDVYLVYELMD--TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN-CDLKICDFG  178 (373)
Q Consensus       102 ~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~-~~~kL~Dfg  178 (373)
                        ...+.+|+||||+.  +++.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus        79 --~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          79 --ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             --ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             --eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence              45578999999995  4888899888899999999999999999999999999999999999999854 789999999


Q ss_pred             cccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          179 LARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      +|.....  ...++.+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+      .+.+          
T Consensus       157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~----------  218 (273)
T d1xwsa_         157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR----------  218 (273)
T ss_dssp             TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH----------
T ss_pred             cceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh----------
Confidence            9976533  334567899999999999875556788999999999999999999997532      1111          


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                                   ..        ....+.+|+++++||++||+.||++|||++|+|+||||++.
T Consensus       219 -------------~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         219 -------------GQ--------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             -------------CC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             -------------cc--------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                         00        01234688999999999999999999999999999999865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-59  Score=427.53  Aligned_cols=261  Identities=29%  Similarity=0.417  Sum_probs=208.2

Q ss_pred             ecCceeeee-eeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhh-CCCCCeeeeceeecCCCCCC
Q 017334           28 IDTKYVPIK-PIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRH-LQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        28 ~~~~Y~~~~-~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~  105 (373)
                      +-++|++++ .||+|+||+||+|+++.+|+.||||++++.       ..+.+|+.++.+ .+||||++++++|.... ..
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cC
Confidence            447899886 599999999999999999999999998642       245689998655 47999999999985421 23


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCCeEEcccCc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGL  179 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~---~~~~kL~Dfg~  179 (373)
                      ..++|+|||||+ |+|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            467999999996 6999999864  36999999999999999999999999999999999999986   45799999999


Q ss_pred             ccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhc
Q 017334          180 ARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLE  259 (373)
Q Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (373)
                      |+..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+......       
T Consensus       161 a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-------  231 (335)
T d2ozaa1         161 AKETTSH-NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-------  231 (335)
T ss_dssp             CEECCCC-CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-------
T ss_pred             eeeccCC-CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-------
Confidence            9876443 33456789999999999876 67999999999999999999999999876654443333221100       


Q ss_pred             ccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCC
Q 017334          260 FIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSP  321 (373)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~  321 (373)
                                      .........++.+|+++++||++||+.||++|||+.|+++||||..
T Consensus       232 ----------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 ----------------GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             ----------------CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             ----------------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence                            0000001112357899999999999999999999999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.6e-58  Score=406.94  Aligned_cols=262  Identities=23%  Similarity=0.314  Sum_probs=212.4

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .|.++|++.+.||+|+||+||+|+++.+|+.||||++++... +......+.+|+.+++.++||||+++++++...+ ..
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CC
Confidence            578999999999999999999999999999999999987644 3445567889999999999999999999986543 23


Q ss_pred             cceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccC
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSN  184 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~  184 (373)
                      ...+|+||||++ ++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+....
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence            356899999997 6999999888899999999999999999999999999999999999999999999999999986543


Q ss_pred             CC---CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          185 GK---NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       185 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      ..   .......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.+..           
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~-----------  230 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED-----------  230 (277)
T ss_dssp             ----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-----------
T ss_pred             cccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC-----------
Confidence            22   233456689999999999976 679999999999999999999999999887666555443310           


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-CHHHHhCCCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-SVTEALQHPY  318 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-t~~eil~hp~  318 (373)
                                      ..+.....+.+|+.+.+||++||+.||++|| |++++ .|+|
T Consensus       231 ----------------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l  271 (277)
T d1o6ya_         231 ----------------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADL  271 (277)
T ss_dssp             ----------------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHH
T ss_pred             ----------------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHH
Confidence                            1112234467899999999999999999999 55554 4544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=403.31  Aligned_cols=254  Identities=20%  Similarity=0.289  Sum_probs=207.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||+||+|+.+   ..||||+++...........+.+|+.++++++||||++++++...      +.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            478999999999999999999764   359999998766666667788899999999999999999998632      35


Q ss_pred             EEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC-
Q 017334          109 VYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG-  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~-  185 (373)
                      +++|||||+ |+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... 
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            899999997 7999999754 5799999999999999999999999999999999999999999999999999976543 


Q ss_pred             -CCccccceeeccccCchhhhhcC--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcccC
Q 017334          186 -KNQFMTEYVVTRWYRAPELLLCC--DNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEFID  262 (373)
Q Consensus       186 -~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  262 (373)
                       ......+..||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+....+..+......          
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----------  227 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL----------  227 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC----------
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----------
Confidence             22334566899999999998642  35899999999999999999999999887766555444331111          


Q ss_pred             ChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          263 NPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                     ..........+++.+.+||.+||+.||++|||+.+++++
T Consensus       228 ---------------~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         228 ---------------SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ---------------CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                           011223446688999999999999999999999999876

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-57  Score=413.87  Aligned_cols=285  Identities=30%  Similarity=0.529  Sum_probs=221.1

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  104 (373)
                      +...++|++++.||+|+||+||+|+++.+|+.||||+++...     ..++.+|+.+|+.++ ||||+++++++...   
T Consensus        31 ~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---  102 (328)
T d3bqca1          31 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDP---  102 (328)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECT---
T ss_pred             CCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEec---
Confidence            345578999999999999999999999999999999986532     235778999999996 99999999998543   


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-CeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANC-DLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~-~~kL~Dfg~a~~  182 (373)
                      ....+++||||++ ++|..+   .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             CCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence            3367999999997 577654   35799999999999999999999999999999999999998766 599999999987


Q ss_pred             cCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCChhhhccc
Q 017334          183 SNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT-ECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .... ......++|+.|+|||++.+...++.++||||+||++|+|++|..||... +..++...+...+|.+........
T Consensus       180 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         180 YHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             ccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            6433 33456789999999999988677899999999999999999999988654 445566667666664322211110


Q ss_pred             C-ChhHHHHHHhCCCCCCCCccc-----cCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCCCCCCC
Q 017334          262 D-NPKARKYIKSLPYTPGTPFSR-----LYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHPYMSPL  322 (373)
Q Consensus       262 ~-~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp~~~~~  322 (373)
                      . ......+...........+..     ....+++++.|||++||+.||++|||++|+|+||||+.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            0 000000111111111111111     123478999999999999999999999999999999865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-56  Score=401.11  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=207.1

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++.....   ..++.+|+.+|++++|||||++++++.     ..+.
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   87 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPP   87 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEe-----eCCe
Confidence            47899999999999999999999999999999999765433   345789999999999999999999994     4467


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +|+|||||+ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            999999996 7999998654  5789999999999999999999999999999999999999999999999999987644


Q ss_pred             CC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCC-CCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK-PIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .. .......|++.|+|||++.+ ..++.++|||||||++|+|++|. +||.+.+.......+...              
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~--------------  232 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------------  232 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT--------------
T ss_pred             CCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC--------------
Confidence            32 33445578999999999987 57999999999999999999865 555555443333322210              


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                      .....+..+++.+.+||.+||+.||++|||+.++++
T Consensus       233 ----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         233 ----------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                            001223567899999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=407.24  Aligned_cols=251  Identities=26%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCc-----EEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNE-----KVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHR  103 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~-----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  103 (373)
                      ++|++.+.||+|+||+||+|+++.+++     .||+|++..... ......+.+|+.++.++ +|||||++++++     
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----  110 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGAC-----  110 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence            689999999999999999999876553     699999865432 23344678999999998 799999999999     


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQ-----------------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDL  159 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl  159 (373)
                      ...+.+|+|||||+ |+|.+++....                       .+++.+++.++.||+.||+|||++||+||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            44467999999996 79999997542                       4889999999999999999999999999999


Q ss_pred             CCCceEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCC
Q 017334          160 KPGNLLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPG  236 (373)
Q Consensus       160 kp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~  236 (373)
                      ||+|||++.++.+||+|||+|+......  ....+..||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999997654322  23446688999999999987 679999999999999999997 8999988


Q ss_pred             CCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          237 TECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .+....+..+...-.                             ....+..+++++.+||.+||+.||++|||++||++|
T Consensus       270 ~~~~~~~~~~~~~~~-----------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVDANFYKLIQNGF-----------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCSHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHhcCC-----------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            776665554433100                             001234578999999999999999999999999976

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=399.29  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=201.8

Q ss_pred             eeeeccCceEEEEEEeC--CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEEEe
Q 017334           36 KPIGRGAYGIVCSSVNR--ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        36 ~~lg~G~~g~V~~a~~~--~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      +.||+|+||+||+|.++  .+++.||||+++....+......+.+|+.+|++++|||||++++++..      +..|+||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            46999999999999864  456789999997665555556678899999999999999999998832      3478999


Q ss_pred             ecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCCc---c
Q 017334          114 ELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKNQ---F  189 (373)
Q Consensus       114 e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~  189 (373)
                      ||++ |+|.+++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......   .
T Consensus        87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9996 79999999989999999999999999999999999999999999999999999999999999986543322   2


Q ss_pred             ccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChhHHH
Q 017334          190 MTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPKARK  268 (373)
Q Consensus       190 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  268 (373)
                      .....||+.|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+.+  +.                
T Consensus       167 ~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~--~~----------------  227 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GE----------------  227 (277)
T ss_dssp             ----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--TC----------------
T ss_pred             ccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--CC----------------
Confidence            234578999999999977 578999999999999999997 8999998776655544432  00                


Q ss_pred             HHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHH---hCCCCC
Q 017334          269 YIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA---LQHPYM  319 (373)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~ei---l~hp~~  319 (373)
                                  ....+..+++++.+||.+||+.||++|||+.++   |+|+|+
T Consensus       228 ------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         228 ------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             ------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence                        011234678999999999999999999999998   456554

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-56  Score=392.07  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|+++ +++.||||+++......   .++.+|+.++++++||||+++++++..     .+.+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~   75 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPI   75 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceecc-----CCce
Confidence            68999999999999999999986 56789999997654333   457899999999999999999999943     3669


Q ss_pred             EEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++||||++ |+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus        76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            99999996 7999988754 568999999999999999999999999999999999999999999999999997654332


Q ss_pred             -ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 -QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                       .......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+.+....             
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-------------  221 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------  221 (263)
T ss_dssp             ---------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-------------
T ss_pred             ceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-------------
Confidence             22344678999999999977 579999999999999999998 57888777665555555431100             


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                       ..+..+++++.+||.+||+.||++|||++++++|
T Consensus       222 -----------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 -----------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             1123467889999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-56  Score=398.45  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=197.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCc---EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNE---KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~---~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .++|++.+.||+|+||+||+|+++.+|+   .||||++.... .......+.+|+.+|++++|||||++++++.     .
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~   98 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----K   98 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----e
Confidence            4789999999999999999999987765   58899886543 3344567889999999999999999999994     3


Q ss_pred             cceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                      .+.+|+|||||+ |+|.+++... +.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++..
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            467999999996 6999988764 57999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCCc-----cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhh
Q 017334          184 NGKNQ-----FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREED  257 (373)
Q Consensus       184 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (373)
                      .....     ......||+.|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+.+...      
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~------  251 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR------  251 (299)
T ss_dssp             -----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            43221     1223467899999999976 679999999999999999997 8999988876665555432100      


Q ss_pred             hcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          258 LEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                              ......+++.+.+||.+||+.||++|||+.|++++
T Consensus       252 ------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 ------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                    01124578899999999999999999999988763

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-56  Score=394.55  Aligned_cols=255  Identities=22%  Similarity=0.344  Sum_probs=210.3

Q ss_pred             ecCceeeeee-eeccCceEEEEEEeCC--CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           28 IDTKYVPIKP-IGRGAYGIVCSSVNRE--TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        28 ~~~~Y~~~~~-lg~G~~g~V~~a~~~~--~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      -.++|.+.+. ||+|+||+||+|.++.  ++..||||+++.. .......++.+|+++|++++|||||++++++..    
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----   80 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----   80 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----
Confidence            3467888884 9999999999998764  4457999999754 344556678899999999999999999998832    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        +.+|+||||++ |+|.+++.. ++.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        81 --~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          81 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             --CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence              34899999997 699998765 46799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ......   ......||+.|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+.+.  .      
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~------  229 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--K------  229 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--C------
T ss_pred             ccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C------
Confidence            644322   2234568999999999976 578999999999999999997 89999987766655544321  0      


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHH---hCCCCCC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEA---LQHPYMS  320 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~ei---l~hp~~~  320 (373)
                                            ....++.+++++.+||.+||+.||++|||+.++   |+|+|+.
T Consensus       230 ----------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         230 ----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                                  012235688999999999999999999999877   5677763

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-56  Score=404.19  Aligned_cols=261  Identities=24%  Similarity=0.378  Sum_probs=216.0

Q ss_pred             CceeeeeeeeccCceEEEEEEe---CCCCcEEEEEEcccccc--ChHHHHHHHHHHHHHhhCCC-CCeeeeceeecCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVN---RETNEKVAIKKINNAFE--NRVDALRTLRELKLLRHLQH-ENVIALKDVMMPSHR  103 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~---~~~g~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~  103 (373)
                      ++|++++.||+|+||+||+|++   +.+|+.||||++++...  .......+.+|+.++++++| |||+++++++     
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-----   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence            7799999999999999999987   45789999999975432  22223356789999999976 8999999999     


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      .....++++|||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            44578999999996 79999999989999999999999999999999999999999999999999999999999999976


Q ss_pred             cCCC-CccccceeeccccCchhhhhcCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          183 SNGK-NQFMTEYVVTRWYRAPELLLCCD-NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       183 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .... .....+..|++.|+|||.+.+.. .++.++|||||||++|+|++|.+||.+.+..+....+.+...         
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~---------  249 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL---------  249 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH---------
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc---------
Confidence            5432 23345668999999999997643 478899999999999999999999988765555444433211         


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCC-----CHHHHhCCCCCCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRI-----SVTEALQHPYMSPL  322 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~-----t~~eil~hp~~~~~  322 (373)
                                ...        ...+..+|+++++||.+||++||.+||     |++|+++||||+++
T Consensus       250 ----------~~~--------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         250 ----------KSE--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             ----------HCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             ----------cCC--------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence                      000        112345889999999999999999999     58999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-56  Score=393.76  Aligned_cols=251  Identities=22%  Similarity=0.345  Sum_probs=207.3

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++++.||+|+||.||+|+++ +++.||||+++.....   ...+.+|+.++++++|||||++++++..      +.
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~   81 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP   81 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence            478999999999999999999986 6788999999765433   2457899999999999999999998732      34


Q ss_pred             EEEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +|+||||++ |+|.+++...  ..+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence            799999996 7998877543  3699999999999999999999999999999999999999999999999999987643


Q ss_pred             CC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 KN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      .. .......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+.+..             
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~-------------  227 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-------------  227 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------
T ss_pred             CccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            32 23345678999999999976 578999999999999999998 567777666555444443210             


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC--CCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ--HPYMS  320 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~--hp~~~  320 (373)
                                       ....+..+++.+.+||.+||+.||++|||++++++  |+||.
T Consensus       228 -----------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         228 -----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                             00112457889999999999999999999999998  77764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-55  Score=386.42  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=209.4

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||+||+|+++ +++.||||++++.....   ..+.+|+.++++++||||+++++++.     ..+.+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~   74 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPI   74 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEe-----eCCce
Confidence            68999999999999999999985 77899999998654443   35789999999999999999999994     44679


Q ss_pred             EEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 017334          110 YLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN  187 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  187 (373)
                      ++||||++ |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            99999996 788888654 4679999999999999999999999999999999999999999999999999997654322


Q ss_pred             -ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          188 -QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       188 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                       .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+....+.+....             
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-------------  220 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-------------  220 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-------------
T ss_pred             ceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence             23344678999999999987 578999999999999999997 89999988876666555431100             


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                       ..+...++.+.+||++||+.||++|||+.++++|
T Consensus       221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                             1123467889999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-55  Score=386.56  Aligned_cols=250  Identities=25%  Similarity=0.364  Sum_probs=199.2

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCC---CcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRET---NEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~---g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .++|++.+.||+|+||.||+|++..+   +..||||+++.. ........+.+|+.++++++||||+++++++..     
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            37999999999999999999998654   356899988654 334445678899999999999999999999832     


Q ss_pred             cceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                       +.+|+||||+. |+|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence             45899999996 788887754 457999999999999999999999999999999999999999999999999999865


Q ss_pred             CCCC-ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhccc
Q 017334          184 NGKN-QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFI  261 (373)
Q Consensus       184 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  261 (373)
                      .... .......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.+.  .         
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~--~---------  226 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--E---------  226 (273)
T ss_dssp             ------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--C---------
T ss_pred             cCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C---------
Confidence            4322 22344578999999999976 679999999999999999987 89999988777766655431  0         


Q ss_pred             CChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          262 DNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                         ....++.+++.+.+||.+||+.||++|||+.|+++|
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         227 -------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                               012346688999999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-54  Score=381.80  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=203.8

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcce
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKD  108 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  108 (373)
                      .++|++.+.||+|+||.||+|+++.+ +.||||+++......   ..+.+|+.++++++|||||++++++..      +.
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~   85 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE------EP   85 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence            37899999999999999999998755 579999997654433   457899999999999999999998732      34


Q ss_pred             EEEEeecCC-ccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCC
Q 017334          109 VYLVYELMD-TDLHQIIKS--SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNG  185 (373)
Q Consensus       109 ~~lv~e~~~-g~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~  185 (373)
                      +++||||+. |+|..++..  .+.+++.++..++.||+.||+|||++||+||||||+||||+.++++||+|||+++....
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            799999996 788888753  35799999999999999999999999999999999999999999999999999976533


Q ss_pred             C-CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCChhhhcccCC
Q 017334          186 K-NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDLEFIDN  263 (373)
Q Consensus       186 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  263 (373)
                      . ........||+.|+|||++.. ..++.++|||||||++|||++| .+|+.+....+.+..+.+..             
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~-------------  231 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------  231 (285)
T ss_dssp             ----------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------
T ss_pred             CCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------------
Confidence            2 223344678999999999976 6789999999999999999985 56666665555554443210             


Q ss_pred             hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC--CCCCCCC
Q 017334          264 PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ--HPYMSPL  322 (373)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~--hp~~~~~  322 (373)
                                       .....+.+++++++||.+||+.||++|||+++|++  ++||...
T Consensus       232 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         232 -----------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                             01123567899999999999999999999999998  8898754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=378.84  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCC----cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETN----EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .++|++.+.||+|+||.||+|.++.++    ..||||+++... .......+.+|+.++++++|||||++++++.     
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----   79 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----   79 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----
Confidence            357999999999999999999987655    469999997543 3344556889999999999999999999994     


Q ss_pred             CcceEEEEeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                      ..+..++||||+. |++.+.+... +.+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            3466999999996 6788777654 6799999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCC---ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKN---QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      .....   .......||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+.+..+....+.....       
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------  231 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-------  231 (283)
T ss_dssp             --------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------
T ss_pred             ccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-------
Confidence            54322   22334568999999999977 6799999999999999999985 566655554444443322100       


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                             ......+++.+.+||.+||+.||++|||+.++++
T Consensus       232 -----------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 -----------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             -----------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                   0112457788999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-54  Score=388.81  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=200.8

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCc----EEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCC
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNE----KVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRN  105 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  105 (373)
                      .+|++++.||+|+||+||+|.+..+|+    +||+|+++.... ......+.+|+.++++++|||||++++++..     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLT-----   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            579999999999999999999988876    588888764322 2234568899999999999999999999853     


Q ss_pred             cceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCccccc
Q 017334          106 FKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTS  183 (373)
Q Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~  183 (373)
                       +..++++|++. |+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..
T Consensus        83 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          83 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             -CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence             23677778774 788887765 467999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCc--cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcc
Q 017334          184 NGKNQ--FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEF  260 (373)
Q Consensus       184 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (373)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+....+.+...         
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~---------  231 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---------  231 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC---------
T ss_pred             ccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            43322  2334568999999999987 579999999999999999997 8999988776665555443100         


Q ss_pred             cCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCCC
Q 017334          261 IDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQHP  317 (373)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~hp  317 (373)
                                           ...++.+++.+.+||.+||+.||++|||+.++++|.
T Consensus       232 ---------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         232 ---------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             ---------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---------------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence                                 012245788999999999999999999999999873

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-54  Score=385.32  Aligned_cols=253  Identities=26%  Similarity=0.384  Sum_probs=197.4

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC-----CCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE-----TNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSH  102 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~-----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|.+..     +++.||||+++.... ......+.+|..++.++ +|+||+.+++++... 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence            3689999999999999999999754     456899999875433 33445667788887777 599999999887433 


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLL  165 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nil  165 (373)
                         ...+++|||||+ |+|.+++...                ..+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus        90 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  166 (299)
T ss_dssp             ---TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ---CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence               256899999996 7999999643                24889999999999999999999999999999999999


Q ss_pred             EcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchHH
Q 017334          166 VNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQ  242 (373)
Q Consensus       166 l~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~  242 (373)
                      |+.++++||+|||+|+......  .......||+.|+|||++.+ ..++.++||||+||++|||++| .+||.+.+..+.
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999997654322  23445689999999999987 6799999999999999999976 578987765554


Q ss_pred             HHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          243 LKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      +..+.....                             .......+++++.+||.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         246 FCRRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCC-----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            443332100                             011234578899999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-53  Score=382.32  Aligned_cols=251  Identities=23%  Similarity=0.304  Sum_probs=207.7

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCC
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSH  102 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  102 (373)
                      -.++|++++.||+|+||+||+|+.+     .+++.||||+++... ......++.+|+.++++++||||+++++++.   
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~---   86 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA---   86 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeec---
Confidence            3578999999999999999999875     356789999997543 3344567889999999999999999999994   


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQ------------------------ALTNDHCQYFLFQLLRGLKYLHSANILHR  157 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  157 (373)
                        ..+..++||||++ |+|.+++....                        .+++.++..++.||+.||+|||++||+||
T Consensus        87 --~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr  164 (301)
T d1lufa_          87 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR  164 (301)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             --cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence              3467999999996 79999986432                        48899999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEcccCcccccCCC--CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCC-CCC
Q 017334          158 DLKPGNLLVNANCDLKICDFGLARTSNGK--NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRK-PIF  234 (373)
Q Consensus       158 Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf  234 (373)
                      ||||+|||++.++.+||+|||+|+.....  .....+..||+.|+|||.+.+ ..++.++|||||||++|||++|. +||
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999755332  222345678899999999987 67999999999999999999884 789


Q ss_pred             CCCCchHHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHh
Q 017334          235 PGTECLNQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEAL  314 (373)
Q Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil  314 (373)
                      .+.+..+....+.+.                              .....+..+++++.+||.+||+.||++|||+.||+
T Consensus       244 ~~~~~~e~~~~v~~~------------------------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~  293 (301)
T d1lufa_         244 YGMAHEEVIYYVRDG------------------------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIH  293 (301)
T ss_dssp             TTSCHHHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHHHHcC------------------------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            888776666554321                              01122356789999999999999999999999996


Q ss_pred             C
Q 017334          315 Q  315 (373)
Q Consensus       315 ~  315 (373)
                      +
T Consensus       294 ~  294 (301)
T d1lufa_         294 R  294 (301)
T ss_dssp             H
T ss_pred             H
Confidence            5

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=374.27  Aligned_cols=243  Identities=25%  Similarity=0.375  Sum_probs=197.3

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceE
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDV  109 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  109 (373)
                      ++|++++.||+|+||.||+|+++  |+.||||++++..    ....+.+|++++++++||||+++++++...    .+.+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~   76 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL   76 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcE
Confidence            67999999999999999999985  7899999997543    234578999999999999999999988542    2458


Q ss_pred             EEEeecCC-ccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCC
Q 017334          110 YLVYELMD-TDLHQIIKSS--QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGK  186 (373)
Q Consensus       110 ~lv~e~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  186 (373)
                      |+||||++ |+|.+++...  ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999996 7999998654  35899999999999999999999999999999999999999999999999999865332


Q ss_pred             CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhhcccCChh
Q 017334          187 NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDLEFIDNPK  265 (373)
Q Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  265 (373)
                         .....+|+.|+|||++.+ ..++.++|||||||++|||++ |++||...+..+....+.+.                
T Consensus       157 ---~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~----------------  216 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------------  216 (262)
T ss_dssp             --------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT----------------
T ss_pred             ---CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC----------------
Confidence               344577899999999987 579999999999999999997 78999887766655544220                


Q ss_pred             HHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          266 ARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                    ......+.+++.+.+||++||+.||++|||+.+++++
T Consensus       217 --------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 --------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                          0012235578999999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=377.93  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=202.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCCCC-------cEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRETN-------EKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMP  100 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~~g-------~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  100 (373)
                      .++|++.+.||+|+||.||+|++..++       ..||||+++... .......+.+|...+.++ +|||||++++++. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccc-
Confidence            379999999999999999999976554       479999997654 334455678899998888 6999999999994 


Q ss_pred             CCCCCcceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334          101 SHRRNFKDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                          ..+.+++||||++ |+|.+++...                ..+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        90 ----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N  165 (299)
T d1fgka_          90 ----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  165 (299)
T ss_dssp             ----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             ----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence                3467999999996 7999999754                358999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCC--CccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGK--NQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      ||++.++.+||+|||++......  ........+|+.|+|||.+.+ ..|+.++|||||||++|+|++ |.+||.+.+..
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            99999999999999999755322  223345678999999999977 689999999999999999997 79999887765


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      .....+.+.  .                            .......+++.+.+||.+||+.||++|||+.|+++
T Consensus       245 ~~~~~i~~~--~----------------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 ELFKLLKEG--H----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHTT--C----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcC--C----------------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            544433220  0                            01123457899999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=376.72  Aligned_cols=251  Identities=21%  Similarity=0.287  Sum_probs=196.7

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC-CC--cEEEEEEcccccc-ChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE-TN--EKVAIKKINNAFE-NRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRR  104 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~-~g--~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  104 (373)
                      .++|++++.||+|+||.||+|+... ++  ..||||++++... .......+.+|+.++++++||||+++++++..    
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----   82 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   82 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----
Confidence            5779999999999999999998643 33  3689999976543 33445578899999999999999999999843    


Q ss_pred             CcceEEEEeecCC-ccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccc
Q 017334          105 NFKDVYLVYELMD-TDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLART  182 (373)
Q Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~  182 (373)
                        ..+++||||++ |++.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        83 --~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          83 --PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             --cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence              34789999996 788877654 45799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCc---cccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHhCCCChhhh
Q 017334          183 SNGKNQ---FMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECLNQLKLIINILGSRREEDL  258 (373)
Q Consensus       183 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (373)
                      ......   ......|+..|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+.+..        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~--------  231 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG--------  231 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC--------
T ss_pred             cccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC--------
Confidence            643322   2234467889999999987 678999999999999999997 899999888777666554310        


Q ss_pred             cccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          259 EFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                           ......+.+++.+.+||.+||+.||++|||+.+|++
T Consensus       232 ---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         232 ---------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ---------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                 001123567899999999999999999999999863

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-52  Score=373.79  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=209.0

Q ss_pred             cCceeeeeeeeccCceEEEEEEeC-----CCCcEEEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNR-----ETNEKVAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSH  102 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~-----~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  102 (373)
                      .++|++.+.||+|+||.||+|.++     .+++.||||+++... .......+.+|+.+++.+ +|||||++++++    
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~----   96 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGAC----   96 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence            489999999999999999999863     467789999997643 344556788999999999 599999999999    


Q ss_pred             CCCcceEEEEeecCC-ccHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017334          103 RRNFKDVYLVYELMD-TDLHQIIKSSQ------------------ALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGN  163 (373)
Q Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  163 (373)
                       .....+|+|||||+ |+|.+++....                  .+++.++..++.||+.||+|||++||+||||||+|
T Consensus        97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             -eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence             44467999999996 79999986543                  58999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCch
Q 017334          164 LLVNANCDLKICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLG-RKPIFPGTECL  240 (373)
Q Consensus       164 ill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  240 (373)
                      ||++.++.+||+|||.++......  ......+||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999998664332  23345688999999999986 678999999999999999997 77888777766


Q ss_pred             HHHHHHHHHhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          241 NQLKLIINILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                      +.+..+...-..                             ......+++.+.+||.+||+.||++|||+.+|++
T Consensus       255 ~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKEGFR-----------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCCC-----------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            655554431100                             0112357889999999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=378.63  Aligned_cols=249  Identities=25%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcE--EEEEEccccccChHHHHHHHHHHHHHhhC-CCCCeeeeceeecCCCCCCc
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEK--VAIKKINNAFENRVDALRTLRELKLLRHL-QHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~--~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~  106 (373)
                      ++|++.+.||+|+||+||+|+++.+|..  ||||++.... .......+.+|+++|.++ +||||+++++++.     ..
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~   83 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HR   83 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ET
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cC
Confidence            6899999999999999999999988875  6777765332 223345688999999999 6999999999994     34


Q ss_pred             ceEEEEeecCC-ccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q 017334          107 KDVYLVYELMD-TDLHQIIKSS----------------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNAN  169 (373)
Q Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~  169 (373)
                      +.+|+||||++ |+|.+++...                ..+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            67999999996 7999998643                579999999999999999999999999999999999999999


Q ss_pred             CCeEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHH
Q 017334          170 CDLKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIIN  248 (373)
Q Consensus       170 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~  248 (373)
                      +.+||+|||+++...... ......||..|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+....+.+
T Consensus       164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~  241 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  241 (309)
T ss_dssp             GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CceEEccccccccccccc-cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence            999999999997653222 2234578999999999977 5789999999999999999986 578887776555544322


Q ss_pred             HhCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          249 ILGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                      .  .                            ....+..+++++.+||.+||+.||++|||+.++++|
T Consensus       242 ~--~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 G--Y----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             T--C----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c--C----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            0  0                            011234578999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=372.67  Aligned_cols=255  Identities=22%  Similarity=0.370  Sum_probs=211.6

Q ss_pred             cCceeeeeeeeccCceEEEEEEeCC-----CCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCC
Q 017334           29 DTKYVPIKPIGRGAYGIVCSSVNRE-----TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHR  103 (373)
Q Consensus        29 ~~~Y~~~~~lg~G~~g~V~~a~~~~-----~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  103 (373)
                      .++|++.+.||+|+||+||+|.++.     +++.||||+++... .......+.+|+.++++++||||+++++++.    
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~----   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS----   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe----
Confidence            4899999999999999999998853     45789999997543 4445557889999999999999999999994    


Q ss_pred             CCcceEEEEeecCC-ccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCe
Q 017334          104 RNFKDVYLVYELMD-TDLHQIIKSS----------QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDL  172 (373)
Q Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~  172 (373)
                       .....++||||+. |+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++
T Consensus        94 -~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          94 -QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             -cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence             3466999999996 7999988532          246889999999999999999999999999999999999999999


Q ss_pred             EEcccCcccccCCCC--ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHH
Q 017334          173 KICDFGLARTSNGKN--QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGR-KPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       173 kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~  249 (373)
                      ||+|||+++......  .......||+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+.+..+.+.
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~  251 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  251 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence            999999997653322  22344578999999999987 6789999999999999999988 5889888776666655431


Q ss_pred             hCCCChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC------CCCCC
Q 017334          250 LGSRREEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ------HPYMS  320 (373)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~------hp~~~  320 (373)
                        .                            .....+.+++.+.+||.+||+.||++|||+.++++      +|+|+
T Consensus       252 --~----------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         252 --G----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             --C----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             --C----------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence              0                            01123457889999999999999999999999998      56654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-51  Score=370.08  Aligned_cols=262  Identities=19%  Similarity=0.204  Sum_probs=203.2

Q ss_pred             eecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCc
Q 017334           27 EIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        27 ~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  106 (373)
                      .+.++|++++.||+|+||+||+|++..+|+.||||++.......    ++.+|+++++.++|+|++..+..+.    ...
T Consensus         4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~i~~~l~~~~~i~~~~~~~----~~~   75 (299)
T d1ckia_           4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCG----AEG   75 (299)
T ss_dssp             EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC----CHHHHHHHHHHSTTSTTCCCEEEEE----EET
T ss_pred             eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH----HHHHHHHHHHHccCCCcccEEEEEE----ecC
Confidence            46789999999999999999999999999999999986543322    3568999999998776655544432    233


Q ss_pred             ceEEEEeecCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCCeEEcccCcccc
Q 017334          107 KDVYLVYELMDTDLHQIIKS-SQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA---NCDLKICDFGLART  182 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~---~~~~kL~Dfg~a~~  182 (373)
                      ...++||||+++++.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.
T Consensus        76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            67899999999988777654 568999999999999999999999999999999999999864   45799999999986


Q ss_pred             cCCCC-------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCCCh
Q 017334          183 SNGKN-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSRRE  255 (373)
Q Consensus       183 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (373)
                      .....       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+.......  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--  232 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--  232 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc--
Confidence            54321       12345689999999999987 679999999999999999999999998766544433332211000  


Q ss_pred             hhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHH---HHhCCCCCC
Q 017334          256 EDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVT---EALQHPYMS  320 (373)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~---eil~hp~~~  320 (373)
                                     .      ..+.....+.+++++.+||.+||+.||++||++.   ++|+|+|.+
T Consensus       233 ---------------~------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         233 ---------------M------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             ---------------H------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---------------C------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                           0      0112233466889999999999999999999986   557777653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.7e-51  Score=365.07  Aligned_cols=255  Identities=16%  Similarity=0.195  Sum_probs=205.3

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCCc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~  106 (373)
                      +.++|++++.||+|+||+||+|++..+|+.||||++.......    .+.+|++.++.++ |+|++.+++++     ...
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~   73 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIPNVYYFG-----QEG   73 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC----CHHHHHHHHHHTTTCTTCCCEEEEE-----EET
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH----HHHHHHHHHHHhcCCCCCCEEEEEe-----ecC
Confidence            5789999999999999999999999999999999986543222    3567889999997 58999999988     444


Q ss_pred             ceEEEEeecCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-----CCCeEEcccCcc
Q 017334          107 KDVYLVYELMDTDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNA-----NCDLKICDFGLA  180 (373)
Q Consensus       107 ~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~-----~~~~kL~Dfg~a  180 (373)
                      ...++||||++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|
T Consensus        74 ~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          74 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccccee
Confidence            779999999999999998765 47999999999999999999999999999999999999975     568999999999


Q ss_pred             cccCCCC-------ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHhCCC
Q 017334          181 RTSNGKN-------QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINILGSR  253 (373)
Q Consensus       181 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  253 (373)
                      +......       ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            7643211       12345689999999999987 679999999999999999999999998765443333222211000


Q ss_pred             ChhhhcccCChhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhC
Q 017334          254 REEDLEFIDNPKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQ  315 (373)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~  315 (373)
                                       .      ..+..++.+.+++++.+++..|+..+|++||+.+.+.+
T Consensus       233 -----------------~------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         233 -----------------Q------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             -----------------H------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             -----------------C------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                             0      01122334567889999999999999999998765543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=362.46  Aligned_cols=246  Identities=24%  Similarity=0.324  Sum_probs=194.9

Q ss_pred             eeeeeccCceEEEEEEeCCCC---cEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcceEEE
Q 017334           35 IKPIGRGAYGIVCSSVNRETN---EKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFKDVYL  111 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l  111 (373)
                      .++||+|+||+||+|++..++   ..||||++++. .......++.+|++++++++||||+++++++...    .+..++
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~l  106 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLV  106 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEE
Confidence            568999999999999986643   36899998753 3455567789999999999999999999987432    357999


Q ss_pred             EeecCC-ccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEcccCcccccCCCC--
Q 017334          112 VYELMD-TDLHQIIKSS-QALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSNGKN--  187 (373)
Q Consensus       112 v~e~~~-g~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--  187 (373)
                      |||||+ |+|.+++... ..+++.++..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++......  
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999997 7999988754 457788899999999999999999999999999999999999999999999998654322  


Q ss_pred             --ccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CchHHHHHHHHHhCCCChhhhcccCCh
Q 017334          188 --QFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGT-ECLNQLKLIINILGSRREEDLEFIDNP  264 (373)
Q Consensus       188 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~  264 (373)
                        .......||+.|+|||.+.+ ..++.++|||||||++|||++|..||... +..+....+.+  |.            
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~------------  251 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GR------------  251 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TC------------
T ss_pred             cceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC------------
Confidence              22334578999999999876 57899999999999999999876665443 22222222211  00            


Q ss_pred             hHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          265 KARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                                 .     ....+.+++.+.+||.+||+.||++||++.||++|
T Consensus       252 -----------~-----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 -----------R-----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -----------C-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------C-----CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                       0     01124578899999999999999999999999988

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-50  Score=371.19  Aligned_cols=284  Identities=26%  Similarity=0.393  Sum_probs=209.7

Q ss_pred             CceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-----------CCCeeeeceee
Q 017334           30 TKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-----------HENVIALKDVM   98 (373)
Q Consensus        30 ~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~   98 (373)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++..   .....+.+|+.+++.+.           |+||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            57999999999999999999999999999999997542   22345667888887764           57899999887


Q ss_pred             cCCCCCCcceEEEEeecC--CccHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCC--
Q 017334           99 MPSHRRNFKDVYLVYELM--DTDLHQII--KSSQALTNDHCQYFLFQLLRGLKYLHS-ANILHRDLKPGNLLVNANCD--  171 (373)
Q Consensus        99 ~~~~~~~~~~~~lv~e~~--~g~L~~~l--~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~Nill~~~~~--  171 (373)
                      ...   .....+++++++  .++.....  .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.  
T Consensus        90 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             eec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            432   224455666655  34433333  344689999999999999999999998 89999999999999987664  


Q ss_pred             ----eEEcccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------chH
Q 017334          172 ----LKICDFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFPGTE------CLN  241 (373)
Q Consensus       172 ----~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~  241 (373)
                          +||+|||.+.....   .....+||+.|+|||++.+ ..++.++||||+||++++|++|++||.+.+      ..+
T Consensus       167 ~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeeccccccccc---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                99999999876533   2345689999999999987 678999999999999999999999997543      234


Q ss_pred             HHHHHHHHhCCCChhhhcccCChhHHHHHHh------CCCCCCCC-------ccccCCCCCHHHHHHHHhhcCcCCCCCC
Q 017334          242 QLKLIINILGSRREEDLEFIDNPKARKYIKS------LPYTPGTP-------FSRLYPDAHPLAIDLLQKMLVFDPTKRI  308 (373)
Q Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~s~~~~~ll~~~L~~dP~~R~  308 (373)
                      .+..+...+|..+...........  .+...      .......+       ........++.+.|||.+||++||.+||
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTR--TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHH--HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHhCCCCHHHhhcccccc--cccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence            566777788876655443222110  00000      00000000       0011223567899999999999999999


Q ss_pred             CHHHHhCCCCCCCCCCC
Q 017334          309 SVTEALQHPYMSPLYDP  325 (373)
Q Consensus       309 t~~eil~hp~~~~~~~~  325 (373)
                      |++|+|+||||+.....
T Consensus       321 ta~e~L~Hp~f~~~~~~  337 (362)
T d1q8ya_         321 DAGGLVNHPWLKDTLGM  337 (362)
T ss_dssp             CHHHHHTCGGGTTCTTC
T ss_pred             CHHHHhcCcccCCCCCc
Confidence            99999999999866433

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=361.04  Aligned_cols=272  Identities=22%  Similarity=0.247  Sum_probs=192.2

Q ss_pred             ecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCeeeeceeecCCCCCCcc
Q 017334           28 IDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENVIALKDVMMPSHRRNFK  107 (373)
Q Consensus        28 ~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  107 (373)
                      |.++|.+.+.||+|+||.||+|+.  +|+.||||+++....   .......|+..+..++||||+++++++.... ....
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~   74 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT   74 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccce
Confidence            357899999999999999999986  589999999864321   1112224555566789999999999986543 3335


Q ss_pred             eEEEEeecCC-ccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCceEEcCCCCeEEcccC
Q 017334          108 DVYLVYELMD-TDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHS--------ANILHRDLKPGNLLVNANCDLKICDFG  178 (373)
Q Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~--------~~ivH~Dlkp~Nill~~~~~~kL~Dfg  178 (373)
                      .+|+|||||. |+|.+++++ ..+++.+...++.|++.||+|||+        +||+||||||+||||+.++.+||+|||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            7999999996 799999986 469999999999999999999996        599999999999999999999999999


Q ss_pred             cccccCCCCc----cccceeeccccCchhhhhcCC-----CCCchhhhHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 017334          179 LARTSNGKNQ----FMTEYVVTRWYRAPELLLCCD-----NYGTSIDVWSVGCIFAELLGRKPIFPGTECLNQLKLIINI  249 (373)
Q Consensus       179 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  249 (373)
                      +++.......    .....+||+.|+|||++.+..     .++.++|||||||++|||++|.+||..........     
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-----  228 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-----  228 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-----
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch-----
Confidence            9976543221    234568999999999986532     25678999999999999999998875432111000     


Q ss_pred             hCCCChhhhcccCC-hhHHHHHHhCCCCCCCCccccCCCCCHHHHHHHHhhcCcCCCCCCCHHHHhCC
Q 017334          250 LGSRREEDLEFIDN-PKARKYIKSLPYTPGTPFSRLYPDAHPLAIDLLQKMLVFDPTKRISVTEALQH  316 (373)
Q Consensus       250 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~L~~dP~~R~t~~eil~h  316 (373)
                           ......... .........-...+..+...........+.+|+.+||+.||++|||+.|++++
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         229 -----YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             -----TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             -----hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 000000000 00111111100001100000011123458899999999999999999999763

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.2e-27  Score=198.10  Aligned_cols=170  Identities=18%  Similarity=0.117  Sum_probs=121.5

Q ss_pred             eeeeeeeeccCceEEEEEEeCCCCcEEEEEEcccccc----------------ChHHHHHHHHHHHHHhhCCCCCeeeec
Q 017334           32 YVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFE----------------NRVDALRTLRELKLLRHLQHENVIALK   95 (373)
Q Consensus        32 Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~----------------~~~~~~~~~~E~~~l~~l~hpniv~~~   95 (373)
                      |.+.++||+|+||+||+|++. +|+.||||+++....                .........+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            467899999999999999985 689999998753211                011122345788999999999998877


Q ss_pred             eeecCCCCCCcceEEEEeecCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEc
Q 017334           96 DVMMPSHRRNFKDVYLVYELMDTDLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKIC  175 (373)
Q Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~Nill~~~~~~kL~  175 (373)
                      ++.     .    .+++|||+++...      ..++...+..++.||+.+|+|||++||+||||||+|||++.+ .++|+
T Consensus        81 ~~~-----~----~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             Eec-----C----CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence            664     1    3799999986422      235667778899999999999999999999999999999965 59999


Q ss_pred             ccCcccccCCCCccccceeeccccCchhhhhcCCCCCchhhhHHHHH
Q 017334          176 DFGLARTSNGKNQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGC  222 (373)
Q Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  222 (373)
                      |||.|........  ..+.......-.+.+.  +.|+.++|+||+.-
T Consensus       145 DFG~a~~~~~~~~--~~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEGW--REILERDVRNIITYFS--RTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTTH--HHHHHHHHHHHHHHHH--HHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCCc--HHHHHHHHHHHHHHHc--CCCCCcccHHHHHH
Confidence            9999876532221  1110000000012222  45788999999754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.64  E-value=7.3e-08  Score=82.23  Aligned_cols=142  Identities=17%  Similarity=0.134  Sum_probs=90.7

Q ss_pred             eeecCceeeeeeeeccCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCC
Q 017334           26 FEIDTKYVPIKPIGRGAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRR  104 (373)
Q Consensus        26 ~~~~~~Y~~~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  104 (373)
                      ..+-+.|++++..+.++.+.||+..  .++..+++|+........  ...+.+|...++.+. +-.+.+++.+.     +
T Consensus        10 ~~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~   80 (263)
T d1j7la_          10 KKLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFE-----R   80 (263)
T ss_dssp             HHHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEE-----E
T ss_pred             HHhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEE-----e
Confidence            3344778888876666678999875  346678899875432221  113457888887775 43355566555     3


Q ss_pred             CcceEEEEeecCCc-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 017334          105 NFKDVYLVYELMDT-DLHQIIKSSQALTNDHCQYFLFQLLRGLKYLHSA-------------------------------  152 (373)
Q Consensus       105 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~-------------------------------  152 (373)
                      ..+..++||++++| ++.+...     +......++.++...++.||+.                               
T Consensus        81 ~~~~~~lv~~~l~G~~~~~~~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          81 HDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHTT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             cCCceEEEEEeccccccccccc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            33678999999987 5543321     1112233344444555555531                               


Q ss_pred             ----------------------------CccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          153 ----------------------------NILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       153 ----------------------------~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                                                  .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                        26899999999999977666799998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.22  E-value=1.4e-06  Score=78.63  Aligned_cols=77  Identities=18%  Similarity=0.074  Sum_probs=45.7

Q ss_pred             eeeeeccCceEEEEEEeCCCCcEEEEEEcccc-----ccChHHHHHHHHHHHHHhhCC-C--CCeeeeceeecCCCCCCc
Q 017334           35 IKPIGRGAYGIVCSSVNRETNEKVAIKKINNA-----FENRVDALRTLRELKLLRHLQ-H--ENVIALKDVMMPSHRRNF  106 (373)
Q Consensus        35 ~~~lg~G~~g~V~~a~~~~~g~~~aiK~~~~~-----~~~~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~~~~~~  106 (373)
                      .+.||.|....||++.+..+|+.+++|.-...     ........+..+|...|+.+. +  ..+++++.+-  .     
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~-----  103 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T-----  103 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T-----
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C-----
Confidence            55689999999999998888889999964321     001112224456888887663 2  2344555432  1     


Q ss_pred             ceEEEEeecCCc
Q 017334          107 KDVYLVYELMDT  118 (373)
Q Consensus       107 ~~~~lv~e~~~g  118 (373)
                      ...++|||++++
T Consensus       104 ~~~~lvmE~L~~  115 (392)
T d2pula1         104 EMAVTVMEDLSH  115 (392)
T ss_dssp             TTTEEEECCCTT
T ss_pred             CCCEEEEeccCC
Confidence            234789999964

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=8.6e-06  Score=68.54  Aligned_cols=71  Identities=15%  Similarity=0.031  Sum_probs=44.5

Q ss_pred             eeeccC-ceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCC--CCCeeeeceeecCCCCCCcceEEEEe
Q 017334           37 PIGRGA-YGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ--HENVIALKDVMMPSHRRNFKDVYLVY  113 (373)
Q Consensus        37 ~lg~G~-~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~~~~~~lv~  113 (373)
                      .+..|. .+.||+... .+|..+++|........     .+.+|...++.+.  .-.+.+++.+.     .+.+..++||
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~   85 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLL   85 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEE
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEE
Confidence            344454 468898865 35667888976544322     2446777777664  23355566655     2335689999


Q ss_pred             ecCCc
Q 017334          114 ELMDT  118 (373)
Q Consensus       114 e~~~g  118 (373)
                      ++++|
T Consensus        86 ~~i~G   90 (255)
T d1nd4a_          86 GEVPG   90 (255)
T ss_dssp             ECCSS
T ss_pred             Eeeec
Confidence            99976

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.48  E-value=0.0003  Score=62.97  Aligned_cols=72  Identities=17%  Similarity=0.122  Sum_probs=48.0

Q ss_pred             eeeeeeccCceEEEEEEeCC-------CCcEEEEEEccccccChHHHHHHHHHHHHHhhCC-CCCeeeeceeecCCCCCC
Q 017334           34 PIKPIGRGAYGIVCSSVNRE-------TNEKVAIKKINNAFENRVDALRTLRELKLLRHLQ-HENVIALKDVMMPSHRRN  105 (373)
Q Consensus        34 ~~~~lg~G~~g~V~~a~~~~-------~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  105 (373)
                      -++.|+.|-.-.+|++....       .++.|.+++.... ...   ....+|..+++.+. +.-..++++++     .+
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~-----~~  116 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE---SHLVAESVIFTLLSERHLGPKLYGIF-----SG  116 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chh---hHHHHHHHHHHHHHhCCCCCeEEEEc-----CC
Confidence            35678888888999987643       3467888887532 222   23457888888886 43344666666     22


Q ss_pred             cceEEEEeecCCc
Q 017334          106 FKDVYLVYELMDT  118 (373)
Q Consensus       106 ~~~~~lv~e~~~g  118 (373)
                          .+|+||++|
T Consensus       117 ----g~I~efi~g  125 (395)
T d1nw1a_         117 ----GRLEEYIPS  125 (395)
T ss_dssp             ----EEEECCCCE
T ss_pred             ----ceEEEEecc
Confidence                588999876

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.37  E-value=0.001  Score=57.62  Aligned_cols=74  Identities=14%  Similarity=0.026  Sum_probs=42.8

Q ss_pred             cCceEEEEEEeCCCCcEEEEEEccccccChHHHHHHHHHHHHHhhCCCCCe--eeeceeecCCCCCCcceEEEEeecCCc
Q 017334           41 GAYGIVCSSVNRETNEKVAIKKINNAFENRVDALRTLRELKLLRHLQHENV--IALKDVMMPSHRRNFKDVYLVYELMDT  118 (373)
Q Consensus        41 G~~g~V~~a~~~~~g~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~~~~~~~~~~~lv~e~~~g  118 (373)
                      +.--.||++.. .+|..|++|+.+.....   ...+..|...+..|....+  +.....--.......+..+.++++++|
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            33468999876 47888999997643222   2345678888877752222  222211111111234568889999875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.77  E-value=0.0083  Score=51.27  Aligned_cols=30  Identities=27%  Similarity=0.315  Sum_probs=26.6

Q ss_pred             CCccccCCCCCceEEcCCCCeEEcccCccc
Q 017334          152 ANILHRDLKPGNLLVNANCDLKICDFGLAR  181 (373)
Q Consensus       152 ~~ivH~Dlkp~Nill~~~~~~kL~Dfg~a~  181 (373)
                      .|++|+|+.++||+++.+...-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            369999999999999988777899999774